<SEC-DOCUMENT>0001193125-18-188631.txt : 20180611
<SEC-HEADER>0001193125-18-188631.hdr.sgml : 20180611
<ACCEPTANCE-DATETIME>20180611061100
ACCESSION NUMBER:		0001193125-18-188631
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		43
FILED AS OF DATE:		20180611
DATE AS OF CHANGE:		20180611

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ElectroCore, LLC
		CENTRAL INDEX KEY:			0001560258
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				203454976
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-225084
		FILM NUMBER:		18890885

	BUSINESS ADDRESS:	
		STREET 1:		51 GIBRALTAR AVENUE, SUITE 3C
		CITY:			MORRIS PLAINS
		STATE:			NJ
		ZIP:			07950
		BUSINESS PHONE:		973-290-0097

	MAIL ADDRESS:	
		STREET 1:		51 GIBRALTAR AVENUE, SUITE 3C
		CITY:			MORRIS PLAINS
		STATE:			NJ
		ZIP:			07950
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>d472601ds1a.htm
<DESCRIPTION>AMENDMENT NO. 2 TO FORM S-1
<TEXT>
<HTML><HEAD>
<TITLE>Amendment No. 2 to Form S-1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>As filed with the Securities and Exchange Commission on June 11, 2018 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right"><B>Registration No.&nbsp;333-225084 </B></P> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:13pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:13pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES
AND EXCHANGE COMMISSION </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>  <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:13pt; font-family:Times New Roman" ALIGN="center"><B>Amendment
No. 2 </B></P>  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:13pt; font-family:Times New Roman" ALIGN="center"><B>to </B></P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:13pt; font-family:Times New Roman" ALIGN="center"><B><FONT
STYLE="white-space:nowrap">FORM&nbsp;S-1</FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:13pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><I>UNDER </I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><I>THE
SECURITIES ACT OF 1933 </I></B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:19pt; font-family:Times New Roman" ALIGN="center"><B>Electrocore, LLC* </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Exact
name of Registrant as specified in its charter) </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>3845</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">20-345-4976</FONT></FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>incorporation or organization)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Primary Standard Industrial</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Classification Code Number)</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>150 Allen Road, Suite 201</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Basking Ridge, New Jersey 07920</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(973) <FONT STYLE="white-space:nowrap">290-0097</FONT></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification Number)</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="5" ALIGN="center"><B>(Address, including zip code, and telephone number, including area code, of Registrant&#146;s principal executive offices)</B></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Francis R. Amato </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Chief
Executive Officer </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Electrocore, LLC </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>150 Allen Road, Suite 201 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Basking Ridge, New Jersey 07920 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(973) <FONT STYLE="white-space:nowrap">290-0097</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name, address, including zip code, and telephone number, including area code, of agent for service) </B></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><I>with copies to: </I></B></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>John L. Cleary, II, Esq.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Ira L. Kotel, Esq.</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Dentons
US LLP</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>1221 Avenue of the Americas</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>New York, New York 10020</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(212) <FONT STYLE="white-space:nowrap">768-6700</FONT></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Peter N. Handrinos, Esq.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Nathan Ajiashvili, Esq.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Latham&nbsp;&amp; Watkins LLP</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>200 Clarendon Street</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Boston, Massachusetts 02116</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(617) <FONT STYLE="white-space:nowrap">948-6000</FONT></B></P></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this Registration Statement. </B></P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule&nbsp;415 under the Securities Act of
1933 check the following box:&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">If this Form is filed to register additional securities for an offering pursuant to Rule&nbsp;462(b) under
the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">If this Form is a post-effective amendment filed pursuant to Rule&nbsp;462(c) under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">If this Form is a post-effective
amendment filed pursuant to Rule&nbsp;462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a <FONT STYLE="white-space:nowrap">non-accelerated</FONT>
filer, a smaller reporting company or an emerging growth company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer,&#148; &#147;smaller reporting company&#148; and &#147;emerging growth company&#148; in <FONT
STYLE="white-space:nowrap">Rule&nbsp;12b-2</FONT> of the Exchange Act.: </P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="14%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="65%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">Large&nbsp;accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">Non-accelerated filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;&nbsp;&nbsp;(do not check if a smaller reporting company)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Smaller&nbsp;reporting&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Emerging&nbsp;growth&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD></TR>
</TABLE> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided to Section 7(a)(2)(B) of the Securities Act.&nbsp;&nbsp;&#9746; </P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>   <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>The Registrant hereby
amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective
in accordance with Section&nbsp;8(a) of the Securities Act of 1933 or until the Registration Statement shall become effective on such date as the Commission, acting pursuant to said Section&nbsp;8(a), may determine. </B></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXPLANATORY NOTE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Electrocore, LLC, the registrant whose name appears on the cover of this registration statement, is a Delaware limited liability company.
Prior to the closing of this offering, Electrocore, LLC intends to convert into a Delaware corporation pursuant to a statutory conversion and change its name to electroCore, Inc. As a result of the corporate conversion, the holders of units of
Electrocore, LLC will become holders of common stock and options to purchase common stock of electroCore, Inc. Holders of warrants to purchase units of Electrocore, LLC will become holders of warrants to purchase common stock of electroCore, Inc.
See &#147;Corporate Conversion.&#148; Except as disclosed in the accompanying prospectus, the consolidated financial statements and selected historical consolidated financial data and other financial information included in this registration
statement are those of Electrocore, LLC and do not give effect to the corporate conversion. </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial Narrow"><FONT COLOR="#c6093b"><B>The information in this preliminary prospectus is not complete and may be changed. We
may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and it is not soliciting offers to buy these
securities in any state where the offer or sale is not permitted. </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#c6093b"><B>Subject to Completion, Dated June 11, 2018 </B></FONT></P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>4,333,333 Shares </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>ELECTROCORE, INC. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:18pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-size:18pt"><B>Common Stock</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g472601g58e92.jpg" ALT="LOGO">
</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">electroCore, Inc. is offering 4,333,333 shares of its common stock. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The initial public offering price of our common stock is expected to be between $14.00 and $16.00 per share. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">This is our initial public offering and no public market currently exists for our common stock. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We have applied for the listing of our common stock on The Nasdaq Global Select Market under the symbol &#147;ECOR.&#148; </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:12pt; font-family:Times New Roman"><B>Investing in
our common stock involves risks. See &#147;<A HREF="#rom472601_4">Risk Factors</A>&#148; beginning on page&nbsp;13 to read about factors you should consider before buying shares of our common stock. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are an &#145;&#145;emerging growth company&#146;&#146; as defined under the U.S. federal securities laws and, as such, intend to comply
with certain reduced public company reporting requirements for this and future filings. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="72%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per&nbsp;Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Initial public offering price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underwriting discounts and commissions(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds, before expenses, to electroCore, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">We have agreed to reimburse the underwriters for certain expenses. We refer you to &#147;Underwriting&#148; for additional disclosure regarding total underwriting compensation. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The underwriters have an option to purchase a maximum of 649,999 additional shares. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain of our direct and indirect unitholders, including entities affiliated with certain of our directors, have indicated an interest in
purchasing an aggregate of $20&nbsp;million in shares of our common stock in this offering at the initial public offering price per share. However, because indications of interest are not binding agreements or commitments to purchase, the
underwriters may determine to sell more, less or no shares in this offering to any of these holders, or any of these holders may determine to purchase more, less or no shares in this offering. The underwriters will receive the same underwriting
discount on any shares purchased by these holders as they will on any other shares sold to the public in this offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Neither the
Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Delivery of the shares of common stock will be made on or
about&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2018. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Joint Bookrunners: </I></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:18pt" ALIGN="center">


<TR>
<TD WIDTH="31%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="31%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="34%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:18pt">
<TD VALIGN="top"><B>Evercore&nbsp;ISI</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>Cantor</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:18pt; font-family:Times New Roman"><B>JMP&nbsp;Securities</B></P></TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Lead Manager: </I></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:18pt" ALIGN="center">


<TR>
<TD WIDTH="40%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="58%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:18pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>BTIG</B></P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of this prospectus
is&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2018 </B></P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="95%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom472601_1">Prospectus Summary</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom472601_4">Risk Factors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom472601_5">Special Note Regarding Forward-Looking Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom472601_6">Use of Proceeds</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom472601_7">Dividend Policy</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom472601_8">Corporate Conversion</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom472601_9">Capitalization</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom472601_10">Dilution</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom472601_11">Selected Consolidated Financial Data</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom472601_12">Management&#146;s Discussion and Analysis of Financial Condition and Results
 of Operations</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom472601_13">Business</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">92</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom472601_14">Management</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">147</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom472601_15">Executive and Director Compensation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">158</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom472601_17">Certain Relationships and Related Party Transactions</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">173</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom472601_18">Principal Stockholders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">180</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom472601_101">Pricing Sensitivity Analysis </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">183</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom472601_19">Description of Capital Stock</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">185</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom472601_20">Shares Eligible for Future Sale</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">191</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom472601_21">Certain Material U.S. Federal Income and Estate Tax Considerations for <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> Holders of Common Stock</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">193</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom472601_22">Underwriting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">197</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom472601_23">Legal Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">204</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom472601_24">Experts</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">204</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom472601_25">Where You Can Find More Information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">204</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom472601_26">Index to Consolidated Financial Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither we nor the underwriters have authorized anyone to provide you with any information other than that contained in this prospectus, any
amendment or supplement to this prospectus or in any free writing prospectus we may authorize to be delivered or made available to you. The underwriters and we take no responsibility for, and can provide no assurance as to the reliability of, any
other information that others may give you. We and the underwriters are offering to sell, and seeking offers to buy, shares of our common stock only in jurisdictions where offers and sales are permitted. The information contained in this prospectus
is current only as of the date on the front of this prospectus, regardless of the time of delivery of this prospectus or any sale of shares of our common stock. Our business, financial condition, results of operations and prospects may have changed
since that date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For investors outside the United States: We have not, and the underwriters have not, done anything that would permit
this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside the United States who come into possession of this prospectus must inform
themselves about, and observe any restrictions relating to, the offering of the shares of common stock and the distribution of this prospectus outside the United States. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MARKET DATA AND FORECASTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated, information in this prospectus concerning economic conditions, our industry, and our markets, including our
general expectations and competitive position, market opportunity and market </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
size, is based on a variety of sources, including information from independent industry analysts and publications, as well as our own estimates and research. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our estimates are derived from industry and general publications, studies and surveys conducted by third-parties, as well as data from our own
internal research. These publications, studies and surveys generally indicate that their information has been obtained from sources believed to be reliable, although they do not guarantee the accuracy or completeness of such information, and we have
not independently verified industry data from such third-party sources. While we believe our internal research is reliable and that our internal estimates are reasonable, such research has not been verified by any independent source and our internal
estimates are based on our good faith beliefs as of the respective dates of such estimates. We are responsible for all of the disclosure in this prospectus. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FINANCIAL STATEMENT PRESENTATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The financial statements for the years ended December&nbsp;31, 2017 and 2016, and as of and for the three months ended March 31, 2018 and
2017, represent the operations of Electrocore, LLC and its subsidiaries and affiliate. Prior to the closing of this offering, we will complete a corporate conversion pursuant to which electroCore, Inc. will succeed to the business of Electrocore,
LLC and its consolidated subsidiaries and affiliate, and the unitholders of Electrocore, LLC will become stockholders and option holders of electroCore, Inc., as described under the heading &#147;Corporate Conversion.&#148; In this prospectus, we
refer to this transaction as the &#147;corporate conversion.&#148; We expect that our conversion from a Delaware limited liability company to a Delaware corporation will not have a material effect on our consolidated financial statements at the time
of the corporate conversion. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TRADEMARKS AND TRADENAMES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus includes our trademarks such as electroCore<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, gammaCore<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP> and gammaCore Sapphire&#153; which are protected under applicable intellectual property laws and are the property, prior to the corporate conversion discussed herein, of Electrocore, LLC, and
after the corporate conversion, of electroCore, Inc. Solely for convenience, trademarks, service marks and tradenames referred to in this prospectus may appear without the <SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, <SUP
STYLE="font-size:85%; vertical-align:top">TM</SUP> or <SUP STYLE="font-size:85%; vertical-align:top">SM</SUP> symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law,
our rights or the right of the applicable licensor to these trademarks, service marks and tradenames. This prospectus may also contain trademarks, service marks, tradenames and copyrights of other companies, which are the property of their
respective owners. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>GLOSSARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A glossary of scientific and technical terms used throughout this prospectus is included beginning on page&nbsp;144. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ABOUT THIS PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except where the context otherwise requires or where otherwise indicated, the terms &#147;electroCore,&#148; &#147;we,&#148; &#147;us,&#148;
&#147;our,&#148; &#147;our company,&#148; and &#147;our business&#148; refer, prior to the corporate conversion discussed herein, to Electrocore, LLC, and after the corporate conversion, to electroCore, Inc. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom472601_1"></A>PROSPECTUS SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>This summary highlights certain information about us and this offering contained elsewhere in this prospectus. Because it is only a
summary, it does not contain all the information that you should consider before investing in shares of our common stock and it is qualified in its entirety by, and should be read in conjunction with, the more detailed information appearing
elsewhere in this prospectus. Before you decide to invest in our common stock, you should read the entire prospectus carefully, including &#147;Risk Factors&#148; beginning on page 13</I><B><I> </I></B><I>and our consolidated financial statements
and the accompanying notes included in this prospectus. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a commercial-stage bioelectronic medicine company with a platform <FONT STYLE="white-space:nowrap">non-invasive</FONT> vagus nerve
stimulation therapy initially focused on neurology and rheumatology. Our therapy, gammaCore, has pharmacologic effects on the peripheral and central nervous systems, which modulate neurotransmitters and immune function. gammaCore is <FONT
STYLE="white-space:nowrap">FDA-cleared</FONT> for the acute treatment of pain associated with migraine and episodic cluster headache in adults. In order to generate advocacy among physicians and patient demand in the form of prescriptions submitted
to payors, we recently initiated a product registry for episodic cluster headache. Having established a base of advocacy among key opinion leaders in the headache field through the product registry, our strategy is to commercially launch in migraine
and episodic cluster headache in the third quarter of 2018. Based on our clinical data, we are pursuing label expansions for the prevention of migraine, migraine in adolescents and post-traumatic headache, and are also engaging in clinical
development for potential new labeling claims in rheumatology, including Sj&ouml;gren&#146;s syndrome and rheumatoid arthritis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">gammaCore
is the first <FONT STYLE="white-space:nowrap">FDA-cleared,</FONT> prescription-only vagus nerve stimulation, or VNS, therapy administered in discrete doses using a proprietary,
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">simple-to-use</FONT></FONT> handheld delivery system. Multiple published studies suggest that VNS works through the modulation of neurotransmitters, and has a measurable pharmacologic
effect similar to several classes of medications, including selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, GABA analogues, acetylcholine esterase inhibitors and triptan medications, all of which are commonly
prescribed. gammaCore activates those fibers in the vagus nerve which are therapeutically relevant for neurotransmitter modulation. This is enabled by our proprietary high-frequency burst waveform that safely and comfortably passes through the skin
and stimulates the targeted nerve fibers. Research also indicates that VNS, including gammaCore, modulates the immune system to produce a measurable effect on inflammatory cytokines, as measured in blood samples, comparable to medications that
inhibit these cytokines. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Background of Vagus Nerve Stimulation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The vagus nerve is the largest and most extensive cranial nerve, connecting the brainstem to nearly every organ in the chest and abdomen,
including the heart, lungs, liver, stomach, spleen, kidneys, and digestive tract. Over the past two decades, the body of scientific evidence in support of VNS in multiple medical conditions has been growing. However, this potential has remained
unfulfilled because the therapy could only be delivered using electrodes affixed to the vagus nerve, connected to a signal generator implanted in the chest wall. To implant these devices, the vagus nerve must be surgically exposed from its
anatomical position entwined with the carotid artery. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Therapy Delivery Platform </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">gammaCore stimulates the vagus nerve through a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">simple-to-use</FONT></FONT>
handheld delivery system dispensing therapy on a <FONT STYLE="white-space:nowrap">31-day</FONT> prescription basis and, like medications delivered by metered-dose inhalers, patients <FONT STYLE="white-space:nowrap">self-administer</FONT> discrete
doses. Our delivery platform enables access to VNS for a much broader patient </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
population than previously possible, making it a potential preferred treatment option. gammaCore&#146;s successor, gammaCore Sapphire, is a rechargeable and reloadable version of our product
intended for multi-year use. It is activated on a monthly basis through the input of a unique, prescription-only authorization code, delivered via a radio-frequency identification, or RFID, card. In the future, this authorization code may be
delivered through the internet, leveraging the Bluetooth capabilities of gammaCore Sapphire. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Competitive Strengths </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe the competitive strengths of our company and our novel and proprietary self-administered bioelectronic therapy include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Innovative bioelectronic medicine approach.</I></B> Our gammaCore therapy uses a proprietary electric signal to safely deliver bioelectronic medicine, which causes targeted pharmacologic-like changes in
neurotransmitter expression and in the immune system without systemic exposure to exogenous chemicals. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Our <FONT STYLE="white-space:nowrap">non-invasive</FONT> therapy unlocks the long-held potential of VNS.</I></B> VNS therapy can, for the first time, be delivered comfortably through the skin using gammaCore. This
eliminates the need for costly, invasive surgery that has been reserved for the most refractory patients, requiring the implantation of a permanent medical device. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Commercializing our therapy through traditional pharmaceutical channels.</I></B> Our <FONT STYLE="white-space:nowrap">non-invasive</FONT> delivery modality permits medical professionals to prescribe VNS through
the same channel they would any other specialty medication. Refills delivered on a monthly basis enable us to seek widespread commercial payor coverage and reimbursement under a traditional pharmaceutical model. We have agreements in place with
commercial payors that we believe, based on our estimates, will provide for reimbursement for gammaCore as a pharmacy benefit for approximately 17&nbsp;million commercial lives with such number expected to increase to as many as 45&nbsp;million
lives under these agreements over the next several calendar quarters. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Highly scalable and low investment manufacturing with digital refills.</I></B> Our low manufacturing and assembly costs allow us to scale to meet demand with minimal additional investment. Refills through RFID or
Bluetooth may offer attractive gross margins. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Potential for rapid label expansion in headache and regulatory approval in additional indications.</I></B> In April 2017, the FDA cleared gammaCore for commercial sale in the United States and established a new
therapeutic category: external vagal nerve stimulator for the treatment of headache. Through an expedited pathway, gammaCore received clearance for the acute treatment of pain associated with migraine in January 2018. We believe a similar regulatory
pathway may be available to us for additional indications in rheumatology. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Broad intellectual property protection.</I></B> Among our key issued patents, we have coverage on using our high-frequency burst signal for treating certain medical conditions until 2031, the <FONT
STYLE="white-space:nowrap">low-pass</FONT> filtering of that signal to ensure safe and comfortable transmission through the skin until 2031, the <FONT STYLE="white-space:nowrap">non-invasive</FONT> treatment of headache conditions until 2029, and
the remote network-enabled communication for the delivery of neuromodulation therapies for a broad range of medical conditions until 2033. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Highly experienced management team.</I></B> Our management team includes executives with significant experience in the pharmaceutical and medical device industries, including positions at Pfizer Inc, Merck &amp;
Co., Novartis International AG, Stryker Corporation and Zimmer Biomet. Members of our team have been involved in the launch and marketing of products including Motrin, Celebrex, and the migraine drugs Axert and Maxalt. Our team&#146;s pharmaceutical
experience in clinical development, sales, marketing and reimbursement, and its medical device experience in research, development and regulatory affairs, allow us to pursue our strategy and growth plans. </TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>gammaCore Headache Pipeline </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes our headache-related areas of focus for gammaCore: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g04w27.jpg" ALT="LOGO">
 </P> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top">The gammaCore product registry for the acute treatment of cluster headache constitutes our initial commercialization efforts for our product. The full product launch is expected in the third quarter of 2018.
</TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Migraine </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Migraine is
a debilitating primary headache condition characterized by severe throbbing pain or a pulsing sensation, usually on one side of the head. Migraine affects approximately 12% of the adult population globally and disproportionately impacts women of
childbearing years. In the United States, there are approximately 36&nbsp;million migraine sufferers. Medications used to treat migraine include triptans, ergotamines, and anti-epileptic medications. Despite the fact that neurologists recognize the
limited efficacy of, and the potential for abuse associated with, opioids, this class of medication continues to be prescribed for migraine at high rates, particularly in emergency departments. According to the U.S. Pharmacist, a leading pharmacy
publication, upwards of 60% of the migraine patient population is dissatisfied with, or has contraindications to, the current standard of care migraine treatments. We estimate the addressable market for the acute treatment of migraine in the United
States in 2018 will be approximately $3.8&nbsp;billion. Five million migraine sufferers are treated annually by approximately 1,100 U.S. headache specialists, primarily neurologists. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our FDA clearance for the acute treatment of migraine is principally supported by our pivotal trial, PRESTO. Statistical significance was
achieved for complete pain relief at 30 minutes (gammaCore, 12.7%; sham, 4.2%; <I>p</I>=0.01), and maintained at 60 minutes (gammaCore, 21.0%; sham, 10.0%; <I>p</I>=0.02). The primary endpoint of PRESTO was pain-freedom at 120 minutes. While this
trial did not reach statistical significance with respect to its primary endpoint, a repeated-measures test examined the inconsistency between the <FONT STYLE="white-space:nowrap">120-minute</FONT> finding and the
<FONT STYLE="white-space:nowrap">30-</FONT> and <FONT STYLE="white-space:nowrap">60-minute</FONT> findings. This test demonstrated the statistical significance of gammaCore&#146;s superiority over sham for the pain-free outcome through 120 minutes
(gammaCore, 30.4%; sham, 19.7%; <I>p</I>=0.01). No serious adverse events were attributable to gammaCore in PRESTO, and the most commonly occurring adverse events were application site reactions, all of which were mild, transient, and tended to be
self-limiting in nature. Based on these findings, the FDA cleared gammaCore for the acute treatment of migraine in adults. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cluster Headache </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cluster headache is a series of relatively short but extremely painful headaches that has been described by patients and physicians as one of
the most painful conditions in medicine. The suicide rate among these patients is 20 times the U.S. national average, leading to the condition being referred to as the &#147;suicide headache.&#148; There are approximately 350,000 cluster headache
sufferers in the United States, approximately 225,000 of whom seek treatment each year primarily from the same headache specialists who treat migraine, and we estimate the total annual addressable U.S. market for the acute treatment of these
patients in 2018 will be approximately $400&nbsp;million. Prior to gammaCore, there was only one <FONT STYLE="white-space:nowrap">FDA-approved,</FONT> commercially available acute cluster headache treatment, injectable sumatriptan, and according to
a 2016 market research survey, 87% of respondents reported dissatisfaction with the then-available treatment options for cluster headache. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our FDA clearance for the acute treatment of episodic cluster headache is supported by two pivotal trials: ACT 1 and ACT 2. The primary
endpoints of these trials were pain reduction and pain freedom within 15&nbsp;minutes of the onset of the attack, respectively. While neither trial reached statistical significance with respect to its primary endpoint in the combined episodic and
chronic cluster headache populations, both trials reached statistical significance (<I>p</I>&lt;0.01 in each trial) on the primary endpoint in their predefined analysis of the episodic cluster headache subpopulation. To further define the benefit of
gammaCore for the acute treatment of episodic cluster headache, the data from ACT 1 and ACT 2 were pooled to assess the overall response to each trial&#146;s primary endpoint. Results of this pooled analysis reached statistical significance for the
proportion of patients achieving mild or pain-free status at 15 minutes for the first attack (<I>p</I>&lt;0.01 for the pooled data) and for the proportion of all treated attacks reaching pain freedom at 15 minutes (<I>p</I>&lt;0.01 for the pooled
data). No serious adverse events were attributable to gammaCore in ACT 1 or ACT 2. The most commonly occurring adverse events were application site reactions, all of which were mild, transient, and tended to be self-limiting in nature. Based on
these findings, the FDA cleared gammaCore for the acute treatment of episodic cluster headache in adults. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Important advantages of
gammaCore over other acute treatments for migraine and episodic cluster headache include its ease of use and suitability to be applied for as many attacks as a patient experiences per day, without the <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">frequency-of-use</FONT></FONT> restrictions and contraindications associated with other treatments. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Strategy </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our goal is to be a leader in bioelectronic medicine by using our proprietary <FONT STYLE="white-space:nowrap">non-invasive</FONT> VNS platform
therapy to deliver better patient outcomes. The key elements of our strategy include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Drive acceptance of our gammaCore products as a leading headache therapy, introducing it in cluster headache and expanding into migraine.</I></B> We plan to establish gammaCore as the first-line treatment for
episodic cluster headache patients, who have few alternative treatment options available to them. We will then leverage this position to expand into the broader headache market for migraine in the third quarter of 2018. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Drive reimbursement of our therapy.</I></B> We are actively engaging with over 50 national and regional commercial insurance payors in the United States with the goal of securing reimbursement coverage as a
pharmacy benefit. We have agreements with commercial payors in place that we believe, based on our estimates, will provide for reimbursement for gammaCore as a pharmacy benefit for approximately 17 million commercial lives, with such number expected
to increase to as many as 45&nbsp;million lives under these agreements over the next several calendar quarters. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Build a leading commercial presence.</I></B> We are establishing a robust commercial capacity, including a specialty distribution channel with a concierge service to quickly onboard patients and manage payor
interactions, and a direct sales force to target high prescribing neurology specialists and headache centers. </TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Rapidly advance our pipeline.</I></B> In 2018, we expect to initiate pivotal trials to support potential label expansion in headache, including additional trials in migraine prevention and migraine in adolescents.
In 2018, we also expect to initiate our first major trial in rheumatology, a pivotal trial in Sj&ouml;gren&#146;s syndrome. Over the next 24 months, we anticipate additional sponsored trials will be conducted in both neurology and rheumatology,
including in rheumatoid arthritis. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Rheumatology Pipeline </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Modulation of the peripheral immune system by VNS provides mechanistic support for the study of gammaCore in the treatment of inflammatory
disorders. The systemic anti-inflammatory effects of VNS are believed to result from the activation of nerve fibers that release norepinephrine, causing specialized immune cells to release acetylcholine. This acetylcholine release activates a
receptor on other immune cells, which blocks the pathways that promote inflammation. Based on initial positive results from our pilot trials, in 2018 we expect to initiate a pivotal trial designed to support regulatory approvals in our first
rheumatologic condition, Sj&ouml;gren&#146;s syndrome, and over the next 24 months, a pivotal trial in rheumatoid arthritis. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Manufacturing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are the <FONT STYLE="white-space:nowrap">FDA-registered</FONT> manufacturer of our gammaCore products, and we currently have sufficient
capacity to meet anticipated demand for our therapy for the foreseeable future. We rely upon third-party suppliers, located both within and outside the United States, for substantially all of the component parts of gammaCore, including injection
molded housings, printed circuit board assemblies, batteries, electrodes and conductive gel. We assemble, program and package our gammaCore products at our Basking Ridge, NJ facility and ship them into our distribution network. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The generation of our proprietary signal does not require custom electronic components. Therefore, we believe long-term supply agreements with
our suppliers are not necessary as all the components used in our products are either high-volume, <FONT STYLE="white-space:nowrap">non-custom</FONT> commodity components, or are readily available from multiple vendors. In cases where single sources
exist, we have purchased such components with sufficient reserves to permit continued production of our product should simple design modifications be required. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Commercialization </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe the
significant unmet need and highly-targeted market of episodic cluster headache represents an ideal entry point for our therapy into the headache market, providing an opportunity to gain relevance with treating clinicians in order to support an
expansion into migraine. Our commercial strategy will initially focus on the following priorities: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Drive advocacy of gammaCore as a leading headache therapy.</I></B> Our strategy is to establish gammaCore as a preferred treatment option, initially in episodic cluster headache and expanding into migraine. We are
developing advocacy for gammaCore among key opinion leaders through our clinical program and initial product registry. We currently have in excess of 300 clinicians trained on gammaCore use and over 600 unique prescribers. Of these, 50 are key
opinion leaders who will lead a series of programs to educate their colleagues on our clinical data and our specialty pharmacy distributor and its national network of specialty pharmacies. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Drive reimbursement of our therapy.</I></B> Through our product registry and initial commercialization
efforts we are generating prescriptions and patient claims to prompt commercial payors to initiate reimbursement policies for gammaCore. We have engaged over 50 national and regional commercial insurance payors in the United States with the goal of
obtaining reimbursement coverage as a pharmacy benefit. gammaCore is currently the subject of agreements with commercial payors that we believe, </P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
based on our estimates, will provide for reimbursement for gammaCore as a pharmacy benefit for approximately 17&nbsp;million commercial lives, with such number expected to increase to as many as
45&nbsp;million lives under those agreements over the next several calendar quarters. In addition, our access negotiations have entered the active clinical review stage with more than a dozen additional insurance plans covering approximately
120&nbsp;million additional commercial lives. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Build a leading commercial presence.</I></B> We have partnered with an established specialty pharmacy distributor to provide physician and patient support to quickly onboard patients and manage payor interactions.
This support includes adjudication of all gammaCore prescriptions, payor claims for reimbursement, and patient support and training. Our sales force targets high-prescribing U.S. neurology practices and headache centers. We currently have a sales
force of 18, with three medical science liaisons. We plan to hire an additional 14&nbsp;territory business managers, who will ultimately cover 6,400 high-prescribers of headache medications. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Associated with our Business </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our
business is subject to a number of risks and uncertainties you should be aware of before making an investment decision. These risks are discussed more fully in the &#147;Risk Factors&#148; section immediately following this prospectus summary. These
risks include the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We have a history of significant losses. If we do not achieve and sustain profitability, our financial condition could suffer. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We will be required to obtain additional funds in the future, and these funds may not be available on acceptable terms or at all. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">If third-party payors do not provide adequate coverage and reimbursement for gammaCore, our business will be negatively impacted. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Third-party payors may not agree to cover gammaCore through pharmacy benefit plans, which will hinder our commercialization strategy and require changes to our existing business that could delay and negatively impact
our ability to generate net sales. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We must demonstrate to physicians the merits of our gammaCore therapy compared to those of our competitors. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We only recently began commercializing gammaCore in the United States and we may never achieve market acceptance. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Our business is subject to extensive governmental regulation that makes it expensive and time consuming for us to bring our gammaCore therapy to market in the United States and to expand the use of our gammaCore therapy
to additional therapeutic indications. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Clinical trials are very expensive, time-consuming and difficult to design and implement and involve uncertain outcomes. Furthermore, results of earlier preclinical studies and clinical trials may not be predictive of
results of future preclinical studies or clinical trials. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">If our competitors are better able to develop and market treatments that are safer, more effective, less costly, easier to use or otherwise more attractive than gammaCore, our business will be adversely impacted.
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We rely upon third-party, and in certain cases single-source suppliers for many of the components and materials used in manufacturing gammaCore, and for critical manufacturing and packaging services, making us
vulnerable to supply shortages and problems and price fluctuations, which could harm our business. </TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We rely on a variety of intellectual property rights, and if we are unable to maintain or protect our intellectual property, our business and results of operations will be harmed. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Our principal stockholders and management own a significant percentage of our stock and will be able to exert significant control over matters subject to stockholder approval. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We have identified a material weakness in our internal control over financial reporting. If we are unable to remediate this material weakness, or if we experience additional material weaknesses in the future, we may not
be able to accurately or timely report our financial condition or results of operations and investors may lose confidence in our financial reports and the market price of our common stock could be adversely affected. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate Conversion </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently
operate as a Delaware limited liability company under the name Electrocore, LLC. Prior to the closing of this offering, Electrocore, LLC will convert into a Delaware corporation pursuant to a statutory conversion and change its name to electroCore,
Inc. As a result of the corporate conversion, the holders of the different classes and series of units of Electrocore, LLC, or Units, and warrants to purchase Units, will become holders of common stock of electroCore, Inc. and warrants to purchase
common stock of electroCore, Inc., and, for certain holders, options to purchase our common stock. The number of shares of our common stock, options to purchase our common stock, and warrants to purchase our common stock that holders of Units and
warrants to purchase Units will be entitled to receive in the corporate conversion will be determined in accordance with the plan of conversion and our Third Amended and Restated Limited Liability Company Agreement, dated November&nbsp;21, 2017, or
the Operating Agreement, and varies depending on which class and series of Units a holder owns, and the terms of the applicable warrants. The number of shares of common stock certain holders of our Units will receive in connection with the corporate
conversion will also vary depending on the initial public offering price set forth on the cover page of this prospectus. See &#147;Corporate Conversion.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information in this prospectus is based on our estimate that, in the corporate conversion, outstanding Units (including Units originally
issued as Profits Interests (as defined herein)) will convert into 23,228,095 shares (or 23,470,034 shares after taking into account shares of common stock issuable in respect of the accrued preferred return on our Series A Preferred Units) of our
common stock, outstanding warrants to purchase Units will convert into warrants to purchase 721,965 shares of common stock, and options to purchase 2,146,039 shares of our common stock will be issued to certain holders of Units that were originally
issued as Profits Interests, in each case, based on an initial public offering price per share of common stock of $15.00, which is the midpoint of the price range set forth on the cover page of this prospectus. To the extent that the actual initial
public offering price per share for this offering is greater or less than $15.00, the actual number of shares of common stock, options and warrants to be issued in connection with the conversion will be adjusted accordingly. See &#147;Pricing
Sensitivity Analysis&#148; for how the number of shares to be issued in the corporate conversion or issuable thereafter upon exercise of options and warrants would be affected by an initial public offering price per share of common stock at the
low-, mid- and high-points of the estimated price range set forth on the cover of this prospectus or if the underwriters&#146; option to purchase additional shares of common stock is exercised in full. Unless the context otherwise requires, and as
further described below in &#147;Corporate Conversion,&#148; references to Units exclude Units originally issued as Profits Interests. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The purpose of the corporate conversion is to reorganize our corporate structure so that the entity that is offering our common stock to the
public in this offering is a corporation rather than a limited liability company and so that our existing investors will own our common stock rather than equity interests in a limited liability company. For further information regarding the
corporate conversion, see &#147;Corporate Conversion.&#148; References in this prospectus to our capitalization and other matters pertaining to our equity and shares prior to the corporate conversion relate to the capitalization and equity and
shares of Electrocore, LLC, and after the corporate conversion, to electroCore, Inc. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Implications of Being an Emerging Growth Company </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are an &#147;emerging growth company&#148; as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, which permits us
to elect not to be subject to certain disclosure and other requirements that otherwise would have been applicable to us had we not been an &#147;emerging growth company.&#148; These provisions include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">only two years of audited financial statements, in addition to any required unaudited interim financial statements, with correspondingly reduced &#147;Management&#146;s Discussion and Analysis of Financial Condition and
Results of Operations&#148; disclosure in this prospectus; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reduced disclosure about our executive compensation arrangements; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">no <FONT STYLE="white-space:nowrap">non-binding</FONT> advisory votes on executive compensation or golden parachute arrangements; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">exemption from the auditor attestation requirement in the assessment of our internal control over financial reporting. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may take advantage of these exemptions for up to five years or such earlier time as we are no longer an &#147;emerging growth
company.&#148; We will qualify as an &#147;emerging growth company&#148; until the earliest of (1)&nbsp;the last day of our fiscal year following the fifth anniversary of the date of completion of this offering, (2)&nbsp;the last day of our fiscal
year in which we have annual gross revenue of $1.07&nbsp;billion or more, (3)&nbsp;the date on which we have, during the previous three-year period, issued more than $1.0&nbsp;billion in <FONT STYLE="white-space:nowrap">non-convertible</FONT> debt
and (4)&nbsp;the last day of the fiscal year in which we become a &#147;large accelerated filer&#148; as defined in Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> under the Securities Exchange Act of 1934, as amended, or the Exchange Act. Under
this definition, we will be an &#147;emerging growth company&#148; upon completion of this offering and could remain an &#147;emerging growth company&#148; until as late as December&nbsp;31, 2023. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the JOBS Act provides that an emerging growth company can take advantage of an extended transition period for complying with new
or revised accounting standards. This allows an emerging growth company to delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have irrevocably elected not to avail ourselves of
this exemption from new or revised accounting standards and, therefore, we will comply with new or revised accounting standards when they are required to be adopted by other public companies that are not emerging growth companies. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Electrocore, LLC
was established in Delaware in September 2005. Prior to the closing of this offering, we will complete a corporate conversion pursuant to which electroCore, Inc. will succeed to the business of Electrocore, LLC and its consolidated subsidiaries and
affiliate, and the equity holders of Electrocore, LLC will become stockholders, option holders and warrant holders of electroCore, Inc. See &#147;Corporate Conversion.&#148; Our principal executive offices are located at 150 Allen Rd., Suite 201,
Basking Ridge, New Jersey 07920, and our telephone number at that address is (973) <FONT STYLE="white-space:nowrap">290-0097.</FONT> Our website is located at <I>www.electrocore.com</I>. Our website, and the information on our website, is neither
part of this prospectus nor incorporated by reference herein. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom472601_2"></A>THE OFFERING </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Common stock offered by us </P></TD>
<TD>4,333,333 shares. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Common stock to be outstanding after this offering </P></TD>
<TD>27,561,428 shares (or 28,211,427 shares if the underwriters&#146; option to purchase additional shares is exercised in full). </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Underwriters&#146; option to purchase additional shares of common stock from us </P></TD>
<TD>We have granted the underwriters a <FONT STYLE="white-space:nowrap">30-day</FONT> option to purchase an additional 649,999 shares. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Use of proceeds </P></TD>
<TD>We estimate, based upon an assumed initial public offering price of $15.00 per share, which is the midpoint of the price range set forth on the cover page of this prospectus, we will receive net proceeds from the offering of approximately
$56.5&nbsp;million (or approximately $65.6&nbsp;million if the underwriters&#146; option to purchase additional shares is exercised in full), after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by
us. We intend to use the proceeds from this offering as follows: (i)&nbsp;to hire additional territory business managers and expand marketing programs to prepare for the full commercial launch of our gammaCore products; (ii)&nbsp;to fund the
research and development of our gammaCore products for other indications in headache and rheumatology; (iii)&nbsp;to fund the build out of a specialty distribution channel for the anticipated launch of gammaCore Sapphire in the third quarter of
2018; and (iv)&nbsp;the remainder to fund working capital and general corporate purposes. See &#147;Use of Proceeds.&#148; </TD></TR></TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Risk factors </P></TD>
<TD>You should carefully read and consider the information set forth under the heading &#147;Risk Factors&#148; beginning on page&nbsp;13 of this prospectus and all other information set forth in this prospectus before investing in our common stock.
</TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Proposed Nasdaq Global Select Market symbol </P></TD>
<TD>&#147;ECOR&#148; </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The common stock to be outstanding after this offering is based on 23,228,095 shares outstanding as if
the corporate conversion had been effected as of June 1, 2018, and excludes the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">2,146,039 shares issuable upon the exercise of options that will be issued in connection with the corporate conversion in respect of Units originally issued as Profits Interests, at an exercise price equal to the
initial public offering price of $15.00 per share, which is the midpoint of the price range set forth on the cover page of this prospectus, following the corporate conversion; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">721,965 shares issuable upon the exercise of warrants outstanding at a <FONT STYLE="white-space:nowrap">weighted-average</FONT> exercise price of $12.50 per share following the corporate conversion; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">2,708,731 shares of common stock reserved for issuance pursuant to future awards under our 2018 Omnibus Equity Incentive Plan, or the 2018 Plan, as well as any increase in the number of shares of common stock reserved
for future issuance under the 2018 Plan, which will become effective immediately prior to the consummation of this offering; and </TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the issuance of 241,939 shares of common stock in satisfaction of approximately $3.6 million of accrued but unpaid preferred return to holders of our Series A Preferred Units (which we expect to pay in shares of common
stock valued at the offering price) based upon an assumed offering price of $15.00 per share, which is the midpoint of the estimated initial offering price range set forth on the cover of this prospectus. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated, this prospectus assumes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the completion of our corporate conversion, as a result of which Units (other than Units originally issued as Profits Interests) will be converted into 21,882,865 shares of common stock of electroCore, Inc. (after
giving effect to an 18:1 conversion ratio of all Units, other than the conversion of the Profits Interests&#151;See &#147;Corporate Conversion&#148;), warrants to purchase Units will be converted into the right to purchase 721,965 shares of common
stock of electroCore, Inc., and Units that were originally issued as Profits Interests will be converted into 1,345,230 shares of our common stock and, with respect to such Units held by persons who are our employees and consultants at the time of
the conversion, options to purchase 2,146,039 shares of common stock of electroCore, Inc., in each case, based on the assumed initial public offering price of $15.00 per share, which is the midpoint of the price range set forth on the cover page of
this prospectus; </TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">an initial public offering price of $15.00 per share, which is the midpoint of the estimated initial public offering price range set forth on the cover page of this prospectus; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">no exercise of the outstanding options and warrants described above; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">no exercise of the underwriters&#146; option to purchase up to an additional 649,999 shares of our common stock. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The number of shares of common stock of electroCore, Inc. that holders of Units will receive in the corporate conversion and the number of
shares of common stock that options and warrants will be exercisable for following the corporate conversion will vary depending on the initial public offering price. See &#147;Pricing Sensitivity Analysis&#148; for additional information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain of our direct and indirect unitholders, including entities affiliated with certain of our directors, have indicated an interest in
purchasing an aggregate of $20 million in shares of our common stock in this offering at the initial public offering price per share. However, because indications of interest are not binding agreements or commitments to purchase, the underwriters
may determine to sell more, less or no shares in this offering to any of these holders, or any of these holders may determine to purchase more, less or no shares in this offering. The underwriters will receive the same underwriting discount on any
shares purchased by these holders as they will on any other shares sold to the public in this offering. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom472601_3"></A>SUMMARY CONSOLIDATED FINANCIAL DATA </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following tables present summary consolidated financial data for our business. You should read this data together with our audited and
unaudited consolidated financial statements and related notes appearing elsewhere in this prospectus and the information under the captions &#147;Selected Consolidated Financial Data,&#148; &#147;Capitalization&#148; and &#147;Management&#146;s
Discussion and Analysis of Financial Condition and Results of Operations.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We derived the following consolidated statements of
operations data for the three months ended March&nbsp;31, 2018 and 2017 and the following balance sheet data as of March&nbsp;31, 2018 from our unaudited consolidated financial statements appearing elsewhere in this prospectus. The unaudited
consolidated financial statements include, in the opinion of management, all adjustments that management considers necessary for the fair presentation of the consolidated financial information set forth in those statements. We derived the following
consolidated statements of operations data for the years ended December&nbsp;31, 2017 and 2016 from our audited consolidated financial statements appearing elsewhere in this prospectus. We have prepared the unaudited consolidated financial
information set forth below on the same basis as our audited consolidated financial statements and have included all adjustments, consisting of only normal recurring adjustments, that we consider necessary for a fair presentation of our financial
position and operating results for such periods. Our historical results are not necessarily indicative of our future results. The results for any interim period are not necessarily indicative of the results that may be expected for a full year. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>
<TD WIDTH="58%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three months ended<BR>March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Years ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2016</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><B>(in&nbsp;thousands,&nbsp;except&nbsp;unit&nbsp;and per&nbsp;unit&nbsp;amounts)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Consolidated statements of operations:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Net sales</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">81.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">116.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">811.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">254.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Cost of goods sold</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">518.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">123.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Gross profit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">292.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">130.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,306.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,726.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,830.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,971.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Selling, general and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,824.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,059.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,106.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,169.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,131.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,785.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,937.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,140.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,098.9</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,741.6</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(25,644.6</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(15,010.2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Other expense (income)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,040.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,295.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">234.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Net loss on settlement of convertible bridge notes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,868.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Amortization of debt issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">269.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">827.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">536.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Change in fair value of warrant liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">245.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">178.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(861.8</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Change in fair value of derivative instrument related to convertible bridge notes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">128.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">348.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Interest and other income, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(109.3</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(99.0</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">208.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,443.5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,356.9</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(36,028.9</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(15,781.5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Less: Net income (loss) attributable to noncontrolling interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(236.4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44.1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Net loss attributable to Electrocore, LLC, subsidiaries and affiliate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(9,498.5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(6,356.9</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(35,792.5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(15,737.4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Pro forma net loss per share data(1):</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Pro forma net loss per share&#151;basic and diluted (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:9pt">(0.36</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:9pt">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:9pt">(0.72</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:9pt">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:9pt">(2.16</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:9pt">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:9pt">(1.80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:9pt">)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Pro forma weighted average number of common shares used to calculate loss per share&#151;basic and
diluted (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:9pt">21,949,259</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:9pt">9,266,116</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:9pt">17,127,652</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:9pt">8,364,789</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD></TR>
</TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">We have presented pro forma basic and diluted net loss per share for the three months ended March&nbsp;31, 2018 and 2017 and the years ended December&nbsp;31, 2017 and 2016, which consists of our historical net loss
attributable to Electrocore LLC, subsidiaries and affiliate, divided by the pro forma basic and diluted weighted average number of shares of common stock outstanding after giving effect to the conversion of all of our outstanding Common Units,
Series&nbsp;A Preferred Units and Series&nbsp;B Preferred Units into 23,228,095 shares of our common stock prior to the closing of this offering. Net loss used in calculating net loss per share does not reflect (i)&nbsp;the estimated expenses of
this offering or (ii)&nbsp;compensation and expenses for our board of directors and other costs related to operating as a public company. For more information on how we calculate basic and diluted pro forma weighted average number of shares
outstanding, see Note&nbsp;9 to our audited consolidated financial statements and Note 11 to our unaudited consolidated financial statements included elsewhere in this prospectus. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>
<TD WIDTH="68%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of March&nbsp;31, 2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Actual</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro&nbsp;forma(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro&nbsp;forma&nbsp;as<BR>adjusted(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(unaudited; in thousands) </B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Consolidated balance sheet data:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,520.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,520.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">59,402.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Debt securities and other investments available for sale</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,186.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,186.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,186.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Working capital(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,397.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,397.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79,897.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,274.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,274.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86,848.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Series A Preferred Units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53,518.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Series B Preferred Units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68,755.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Common Units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,180.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Common Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Additional Paid In Capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,863.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">185,295.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">241,790.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total members&#146;/stockholders&#146; equity (deficit)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(98,833.1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,440.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79,940.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Pro forma to reflect our conversion from a Delaware limited liability company to a Delaware corporation prior to the closing of this offering, in which all outstanding Units of Electrocore, LLC will be converted
into&nbsp;23,228,095 shares (which excludes 241,939 shares of common stock issuable in satisfaction of the accrued preferred return on our Series A Preferred Units) of common stock of electroCore, Inc. at an assumed initial public offering price of
$15.00 per share, which is the midpoint of the price range set forth on the cover page of this prospectus. The number of shares of common stock of electroCore, Inc. that holders of Units will receive in the corporate conversion and the number of
shares of common stock that options and warrants will be exercisable for following the corporate conversion will vary depending on the initial public offering price. See &#147;Pricing Sensitivity Analysis&#148; for more information.
</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Pro forma as adjusted gives further effect to the sale of shares of our common stock in this offering at an assumed initial public offering price of $15.00 per share, which is the midpoint of the price range set forth
on the cover page of this prospectus, after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us. See &#147;Pricing Sensitivity Analysis&#148; for how some of the information provided above
would be affected by the initial public offering price per share of common stock at the low-, mid- and high-points of the estimated price range indicated on the cover of this prospectus or if the underwriters&#146; option to purchase additional
shares of common stock is exercised in full. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">We define working capital as current assets less current liabilities. </TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom472601_4"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Investing in our common stock involves a high degree of risk. You should carefully consider the risks and uncertainties described below,
together with all of the other information in this prospectus, including our consolidated financial statements and related notes, before investing in our common stock. The risks and uncertainties described below are not the only ones we face.
Additional risks and uncertainties that we are unaware of, or that we currently believe are not material, may also become important factors that affect us. If any of the following risks occur, our business, operating results and prospects could be
materially harmed. In that event, the price of our common stock could decline, and you could lose part or all of your investment. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to
our Financial Position, Operating Results and Need for Additional Capital </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We have a history of significant losses. If we do not achieve and
sustain profitability, our financial condition could suffer. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have experienced significant net losses, and we expect to continue
to incur losses for the foreseeable future as we seek to grow our sales and marketing infrastructure, to increase market acceptance of our gammaCore therapy for the acute treatment of episodic cluster headache, or eCH, and the acute treatment of
migraine, fund our research and development activities, to expand our manufacturing capabilities, and to obtain regulatory clearance or approval for other products or indications in the United States and internationally. We incurred net losses of
$35.8&nbsp;million and $9.5&nbsp;million for the year ended December&nbsp;31, 2017 and the three months ended March&nbsp;31, 2018, respectively. As of December&nbsp;31, 2017 and March&nbsp;31, 2018, our accumulated deficit was $152.9&nbsp;million
and $162.4&nbsp;million, respectively. Our prior losses, combined with expected future losses, have had and will continue to have, for the foreseeable future, an adverse effect on our stockholders&#146; deficit and working capital. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To become and remain profitable, we must successfully commercialize our gammaCore therapy and continue to identify promising new areas of
treatment with significant market potential. This will require us to be successful in a range of challenging activities, including completing clinical trials of gammaCore for additional therapeutic indications, developing commercial scale
manufacturing processes, obtaining additional marketing clearance or approval from regulatory authorities, obtaining adequate coverage and reimbursement from payors, manufacturing, marketing and selling any current and future product candidates for
which we may obtain marketing clearance or approval, and satisfying any post-marketing requirements. We may never succeed in any or all of these activities and, even if we do, we may never generate sufficient revenue to achieve profitability. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Even if we do achieve profitability, we may not be able to sustain or increase profitability in subsequent periods. Our failure to become and
remain profitable would decrease the value of our company and could impair our ability to raise capital, maintain our research and development efforts, expand our business or continue our operations. A decline in the value of our company also could
cause you to lose all or part of your investment. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We will be required to obtain additional funds in the future, and these funds may not be
available on acceptable terms or at all. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our operations have consumed substantial amounts of cash since inception, and we
anticipate our expenses will increase as we expand our commercial sales force in the United States, investigate the use of our gammaCore therapy for the treatment of additional new indications, including Sj&ouml;gren&#146;s syndrome and rheumatoid
arthritis, and continue to grow our business and transition to operating as a public company. We believe that our growth will depend, in part, on our ability to fund our efforts to commercialize our gammaCore therapy for the acute treatment of eCH
and the acute treatment of migraine, and to pursue research and development activities for additional indications for our gammaCore therapy. Our existing resources may not allow us to conduct all of the activities that we believe would be beneficial
for our future growth. As a result, we may need to seek additional funds in the future. If we are unable to raise funds on favorable terms, or at all, we </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
may not be able to support our commercialization efforts or increase our research and development activities and the growth of our business may be negatively impacted. As a result, we may be
unable to compete effectively. For the year ended December&nbsp;31, 2017 and the three months ended March 31, 2018, our net cash used in operating activities was $25.3&nbsp;million and $9.7 million, respectively, and as of December&nbsp;31, 2017 and
March&nbsp;31, 2018 we had $13.2 million and $1.5 million in cash and cash equivalents, as well as $24.0 million in marketable securities and $25.2&nbsp;million in debt securities and other investments available for sale, respectively. We expect
that our existing capital resources, together with the net proceeds from this offering, will enable us to fund our operating expenses and capital expenditure requirements through at least the next 12&nbsp;months. This estimate is based on
assumptions that may prove to be wrong, and we could exhaust our available capital resources sooner than we expect. Changes, including those relating to our development activities and regulatory matters, may occur beyond our control that would cause
us to consume our available capital more quickly. Our future capital requirements will depend on many factors, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the outcome, timing of, and costs involved in, seeking and obtaining clearances or approvals from the FDA and other regulatory authorities, including the potential for the FDA and other regulatory authorities to require
that we perform more studies, clinical trials or tests on our gammaCore therapy than we currently expect; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the scope and timing of our investment in our U.S. commercial infrastructure and sales force; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the research and development activities we intend to undertake in order to expand our headache indications and enhancements to our gammaCore therapy that we intend to pursue; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the costs of commercialization activities including sales, marketing, manufacturing and distribution; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the degree and rate of market acceptance of our gammaCore therapy; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our need to implement additional infrastructure and internal systems; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to hire additional personnel to support our operations as a public company; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the emergence of competing therapies or other adverse market developments. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To finance these
activities, we may seek funds through borrowings or through additional rounds of financing, including private or public equity or debt offerings and collaborative arrangements with corporate partners. We may be unable to raise funds on favorable
terms, if at all. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The sale of additional equity or convertible debt securities could result in additional dilution to our stockholders.
If we borrow additional funds or issue debt securities, lenders or security holders could have rights superior to holders of our common stock and such indebtedness could contain covenants that will restrict our operations. We might have to obtain
funds through arrangements with collaborative partners or others that may require us to relinquish rights to our technologies, therapeutic candidates, or products that we otherwise would not relinquish. If we do not obtain additional resources, our
ability to capitalize on business opportunities will be limited, we may be unable to compete effectively and the growth of our business will be harmed. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If third-party payors do not provide adequate coverage and reimbursement for the use of gammaCore, we will be unable to generate significant revenues.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our success in marketing and commercializing gammaCore depends and will depend in large part on whether U.S. and international
government health administrative authorities, private health insurers and other payor organizations provide adequate coverage and reimbursement for the cost of our products. Many third-party payors do not currently cover VNS for any indications
other than epilepsy because they have determined all other VNS modalities to be investigational or experimental. If physicians or insurers do not find our clinical data </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
compelling or wish to wait for additional studies, they may choose not to use or provide coverage and reimbursement for gammaCore. We cannot provide assurance that data we or others may generate
in the future will be consistent with that observed in our existing clinical studies, or that our current or future published clinical evidence will be sufficient to obtain adequate coverage and reimbursement for our products. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the United States, we expect to derive nearly all of our sales from prescriptions of gammaCore from neurologists and primary care
physicians. Access to adequate coverage and reimbursement by third-party payors for treatment of cluster and migraine headaches using our gammaCore therapy is essential to the acceptance of our products by customers and patients, because without
such coverage and reimbursement, customers and patients will have to be willing to bear the entire cost of our therapy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Third-party
payors, whether foreign or domestic, or governmental or commercial, are developing increasingly sophisticated methods of controlling healthcare costs. In addition, in the United States, no uniform policy of coverage and reimbursement for our
gammaCore therapy exists among third-party payors. Therefore, coverage and reimbursement for our gammaCore therapy can differ significantly from payor to payor. In addition, payors continually review new technologies for possible coverage and can,
without notice, deny coverage for these new products and procedures. As a result, the coverage determination process is often a time-consuming and costly process that will require us to provide scientific and clinical support for the use of our
gammaCore therapy to each payor separately, with no assurance that coverage and adequate reimbursement will be obtained, or maintained if obtained. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Reimbursement systems in international markets vary significantly by country and by region within some countries, and reimbursement approvals
must be obtained on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis. In many international markets, a product must be approved for reimbursement before it can be approved for sale in that
country. Further, many international markets have government-managed healthcare systems that control reimbursement for new devices and procedures. In most markets, there are private insurance systems as well as government-managed systems. If
sufficient and timely coverage and reimbursement is not available for our current or future products, in either the United States or internationally, the demand for our products and our revenues will be adversely affected. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Third-party payors may not agree to cover gammaCore through pharmacy benefit plans, which will hinder our commercialization strategy and require changes
to our existing business that could delay and negatively impact our ability to generate revenue. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our commercialization strategy in
the United States advocates for coverage and reimbursement for gammaCore under payors&#146; pharmacy benefit. This pathway may allow patients to obtain our therapy through payment of a co-payment rather than being personally responsible for the
costs of our product until meeting an annual deductible. While some commercial payors may provide coverage under their pharmacy benefit plans, other third-party payors, including government health programs and private insurers, may not be willing or
able to cover gammaCore under pharmacy benefit plans, which are often limited to coverage of prescription drug products. For example, Medicare&#146;s voluntary pharmacy benefit, Medicare Part D, limits coverage under this benefit to prescription
drugs, biologicals, and supplies used in the delivery of insulin, but does not cover medical devices like gammaCore or its supplies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To
obtain coverage and reimbursement from Medicare and any other third-party payor that will not cover gammaCore under a pharmacy benefit, we may be required to seek coverage and reimbursement as a medical device or item of durable medical equipment.
If needed to obtain third-party payor coverage and reimbursement under an alternative benefit, these potential changes may entail numerous risks, including increased operating expenses, requirements to comply with healthcare regulatory laws, the
loss of or delay in obtaining revenue, and uncertainty in our ability to successfully implement the modifications. The failure to obtain recognition by third-party payors under the pharmacy benefit model could require us to modify our
commercialization strategy, our distribution model, our pricing, and our operations, any of which could have a material adverse effect on the sales of gammaCore and the results of our operations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We must demonstrate to physicians the merits of our gammaCore therapy compared to those of our
competitors. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Physicians play a significant role in determining the course of a patient&#146;s treatment and, as a result, the type
of product that will be used to treat a patient. As a result, our success depends, in large part, on effectively marketing our gammaCore therapy to physicians. In order for our gammaCore therapy to gain widespread adoption, we must successfully
demonstrate to physicians the merits of our gammaCore therapy for the acute treatment of eCH and the acute treatment of migraine, compared to our competitors&#146; products, including products recently approved or being developed in Phase 3 by
Allergan plc, Amgen Inc. (with a co-marketing arrangement with Novartis International AG), Biohaven Pharmacuticals, Inc., Eli Lilly and Company, Alder Biopharmacuticals, Inc. and Teva Pharmaceutical Industries Ltd., for use in treating patients with
cluster and migraine headaches, particularly because noninvasive VNS, or nVNS, is relatively new as compared to existing traditional treatments for cluster and migraine headaches. Acceptance of our gammaCore therapy depends on educating physicians
as to the distinctive characteristics, perceived benefits, safety, ease of use and cost-effectiveness of our gammaCore therapy as compared to our competitors&#146; products, and communicating to physicians the proper use of our gammaCore therapy. If
we are not successful in convincing physicians of the merits of our gammaCore therapy or educating them on the benefits of our gammaCore therapy, they may not prescribe our gammaCore therapy and we may be unable to increase our sales, sustain our
growth or achieve profitability. In addition, we believe support of our products by physicians is essential for market acceptance and adoption. If we do not receive support from physicians or long-term data does not show the benefits of using our
gammaCore therapy, physicians may not use it. In such circumstances, our results of operations would be materially adversely affected. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our
operating results may vary significantly from quarter to quarter because of seasonality or otherwise. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our quarterly revenue and
results of operations may fluctuate from quarter to quarter due to, among others, the following reasons: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">physician and payor acceptance of our gammaCore therapy; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the timing, expense and results of research and development activities, clinical trials and regulatory clearance or approvals; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">fluctuations in our expenses associated with expanding our commercial operations and operating as a public company; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the introduction of new products, therapies and technologies by competitors; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the productivity of our sales representatives; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">supplier, manufacturing or quality problems with our products; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the timing of stocking orders from our distributors; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">changes in our pricing policies or in the pricing policies of our competitors or suppliers; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">adverse developments in coverage amounts or government and third-party payors&#146; reimbursement policies. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our results may also fluctuate on a seasonal basis due to the seasonality of cluster and migraine headache attacks, which could affect the
comparability of our results between periods. These seasonal variations are difficult to predict accurately, may vary across different markets, and at times may be entirely unpredictable, which introduces additional risk into our business as we may
rely upon forecasts of customer demand to build inventory in advance of anticipated sales. In addition, we believe our limited history commercializing our gammaCore therapy has, in part, made our seasonal patterns more difficult to discern, making
it more difficult to predict future seasonal patterns. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because of these and other factors, it is likely that in some future period our operating
results will not meet investor expectations or those of public market analysts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any unanticipated change in revenues or operating results
is likely to cause our stock price to fluctuate. New information may cause investors and analysts to revalue our business, which could cause a decline in our stock price. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Failure to protect our information technology infrastructure against cyber-based attacks, network security breaches, service interruptions, or data
corruption could significantly disrupt our operations and adversely affect our business and operating results. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We rely on
information technology and telephone networks and systems, including the internet, to process and transmit sensitive electronic information and to manage or support a variety of business processes and activities, including sales, billing, marketing,
procurement and supply chain, manufacturing, and distribution. We also rely on information technology systems to support our proprietary data warehouse, which, among other things, maintains patient product serial numbers and allows for prescription
refills at specialty pharmacies through RFID cards. In addition, we use enterprise information technology systems to record, process, and summarize financial information and results of operations for internal reporting purposes and to comply with
regulatory, financial reporting, legal, and tax requirements. Our information technology systems, some of which are managed by third-parties, and the information technology systems of third parties may be susceptible to damage, disruptions, or
shutdowns due to computer viruses, attacks by computer hackers, failures during the process of upgrading or replacing software, databases or components thereof, power outages, hardware failures, telecommunication failures, user errors, or
catastrophic events. Despite the precautionary measures we and third parties have taken to prevent breakdowns in information technology and telephone systems, if these systems are breached or suffer severe damage, disruption, or shutdown and we are
unable to effectively resolve the issues in a timely manner, our business and operating results may suffer and we may be subject to related lawsuits. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may engage in future acquisitions that increase our capital requirements, dilute our stockholders, cause us to incur debt or assume contingent
liabilities and subject us to other risks. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may evaluate various strategic transactions, including licensing or acquiring
complementary therapies, products, technologies or businesses. Any potential acquisitions may entail numerous risks, including increased operating expenses and cash requirements, assimilation of operations and products, retention of key employees,
diversion of our management&#146;s attention and uncertainties in our ability to maintain key business relationships of the acquired entities. In addition, if we undertake acquisitions, we may issue dilutive securities, assume or incur debt
obligations, incur large <FONT STYLE="white-space:nowrap">one-time</FONT> expenses and acquire intangible assets that could result in significant future amortization expense. Moreover, we may not be able to locate suitable acquisition opportunities
and this inability could impair our ability to grow or obtain access to technology or products that may be important to the development of our business. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our reported financial results may be adversely affected by new accounting pronouncements or changes in existing accounting standards and practices.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Generally accepted accounting principles in the United States, or GAAP, are subject to interpretation by the Financial Accounting
Standards Board, or FASB, the American Institute of Certified Public Accountants, or the AICPA, the SEC and various bodies formed to promulgate and interpret appropriate accounting principles. For example, in May 2014, the FASB issued ASU 2014-09
Revenue from Contracts with Customers (Topic 606), which outlines a comprehensive revenue recognition model and supersedes most current revenue recognition guidance. We were required to implement this guidance in 2018. The new standard defines a
five-step approach for recognizing revenue, which may require a company to use more judgment and make more estimates than under the previous guidance. Amongst the elements in the new standard are requirements for an entity to recognize the amount of
revenue to which it expects to be entitled for the transfer of promised goods or services to customers and make expanded disclosures. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The new standard requires us to make a variety of estimates and judgments that are subject
to risks and complexities, including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price, and allocating the transaction price to each separate performance
obligation. The new standard may also impact the realization of revenue from units of gammaCore provided in connection with our patient assistance programs (such as our voucher and co-payment assistance programs) and our rebate arrangements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Such changes to our revenue recognition accounting may significantly affect our results of operations to the extent that actual revenues
differ significantly from estimated and previous quarter revenues, or that we are required to accelerate or defer recognition of revenue under certain arrangements, which have caused and may potentially continue to cause the amount of revenue we
recognize to vary materially from quarter to quarter. While the adoption of the new standard will not change the cash flows we receive from our contracts with customers, the changes to our reporting practices and the potential fluctuations in our
reported revenue could cause a decline and/or fluctuations in the price of our common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Business and the Development of Our
gammaCore Therapy </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our business is subject to extensive governmental regulation that makes it expensive and time consuming for us to bring our
gammaCore therapy to market in the United States and to expand the use of our gammaCore therapy to additional therapeutic indications. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our gammaCore therapy must comply with regulatory requirements imposed by the FDA in the United States and similar agencies in foreign
jurisdictions. These requirements involve lengthy and detailed laboratory and clinical testing procedures, sampling activities, extensive agency review processes, and other costly and time-consuming procedures. It often takes several years to
satisfy these requirements, depending on the complexity and novelty of the product. We also are subject to numerous additional licensing and regulatory requirements relating to safe working conditions, manufacturing practices, environmental
protection, fire hazard control, and disposal of hazardous or potentially hazardous substances. Some of the most important requirements we must comply with include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the Federal Food, Drug, and Cosmetic Act and the FDA&#146;s implementing regulations (Title&nbsp;21&nbsp;CFR); </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">CE mark requirements of the European Union, or EU; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Medical Device Quality Management System Requirements (ISO&nbsp;13485:2003); </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Occupational Safety and Health Administration requirements; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">New Jersey Department of Health Services requirements. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Government regulation may impede our
ability to conduct clinical trials and to manufacture and sell our existing therapy and any future products. Government regulation also could delay our marketing of new products for a considerable period of time and impose costly procedures on our
activities. The FDA and other regulatory agencies may not clear or approve our gammaCore therapy in additional therapeutic areas that we may pursue, including Sj&ouml;gren&#146;s syndrome and rheumatoid arthritis, on a timely basis, if at all. Any
delay in obtaining, or failure to obtain, such clearances or approvals could negatively impact our marketing of our gammaCore therapy and impede our ability to bring future products to market. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our gammaCore therapy will remain subject to strict regulatory controls on manufacturing, marketing and use. We may be forced to modify or
recall a product after release in response to regulatory action or unanticipated difficulties encountered in general use. Any such action could have a material effect on the reputation of our gammaCore therapy and on our business and financial
position. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, regulations may change, and any additional regulation could limit or restrict our ability to use any of our
technologies, which could harm our business. We could also be subject to new international, federal, state </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or local regulations that could affect our research and development programs and harm our business in unforeseen ways. If this happens, we may have to incur significant costs to comply with such
laws and regulations, which will harm our results of operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may in the future become involved in lawsuits to protect or enforce our
intellectual property, which could be expensive and time consuming, and ultimately unsuccessful, and could result in the diversion of significant resources, thereby hindering our ability to effectively commercialize our existing or future products.
If we are unable to obtain, maintain, protect, and enforce our intellectual property, our business will be negatively affected. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The markets in which we compete and expect to compete are subject to rapid technological change and frequent litigation regarding patent and
other intellectual property rights. It is possible that our patents or licenses may not withstand challenges made by others or protect our rights adequately. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our success depends in large part on our ability to secure effective patent protection for our products and processes in the United States and
internationally. We have filed and intend to continue to file patent applications for various aspects of our technology and trademark applications to protect our brand and business, and copyright applications to protect our software. We seek to
obtain and maintain patents and other intellectual property rights to restrict the ability of others to market products or services that misappropriate our technology and work product and/or infringe our intellectual property to compete with our
products and services. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">However, we face the risks that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We may fail to secure necessary patents, potentially permitting competitors to market competing products and services and make, use or sell products or offer services that are substantially the same as ours without
incurring the sizeable development costs that we have incurred, which would adversely affect our ability to compete. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Patents may not issue from any of our currently pending or future patent applications. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Our already-granted patents and any future patents may not survive legal challenges to their scope, validity or enforceability, or provide significant protection for us, and they may be challenged in a post grant review
or inter partes review proceeding, <FONT STYLE="white-space:nowrap">re-examined</FONT> or invalidated, and/or may be found to be unenforceable or not cover competing processes, products or services. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Even if our patents are determined by the U.S. Patent and Trademark Office, or USPTO, foreign patent office, or a
court to be valid and enforceable, they may not be drafted or interpreted sufficiently broadly to prevent others from marketing products and services similar to ours or designing around our patents. For example, third parties may be able to develop
therapies, or make systems or devices, that are similar to ours but that are not covered by the claims of our patents. Third parties may assert that we or our licensors were not the first to make the inventions covered by our issued patents or
pending patent applications. The claims of our issued patents or patent applications when issued may not cover our commercial technology or the future products and services that we develop. We may not have freedom to operate unimpeded by the patent
rights of others. Third parties may have dominating, blocking or other patents relevant to our technology of which we are not aware. In addition, because patent applications in the United States and many foreign jurisdictions are typically not
published until 18&nbsp;months after the filing of certain priority documents (or, in some cases, are not published until they issue as patents) and because publications in the scientific literature often lag behind actual discoveries, we cannot be
certain that others have not filed patent applications for our technology or our contemplated technology. Any such patent applications may have priority over our patent applications or issued patents, which could further require us to obtain rights
from third parties to issued patents or pending patent applications covering such technologies to allow us to commercialize our technology. If another party has filed a U.S. patent application on inventions similar to ours, depending on when the
timing of the filing date falls under certain patent laws, we may have to participate in a priority contest </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
(such as an interference proceeding) declared by the USPTO to determine priority of invention in the United States. There may be prior public disclosures of which we are not aware that could
invalidate our patents or a portion of the claims of our patents. Further, we may not develop additional proprietary technologies and, even if we do, they may not be patentable. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Patent law can be highly uncertain and involve complex legal and factual questions for which important principles remain unresolved. In the United States and in many foreign jurisdictions, policies regarding the breadth
of claims allowed in patents can be inconsistent. The U.S. Supreme Court and the U.S. Court of Appeals for the Federal Circuit have made, and will likely continue to make, changes in how the patent laws of the United States are interpreted.
Similarly, foreign courts have made, and will likely continue to make, changes in how the patent laws in their respective jurisdictions are interpreted. We cannot predict future changes in the interpretation of patent laws or changes to patent laws
that might be enacted into law by U.S. and foreign legislative bodies. Those changes may materially affect our patents or patent applications, our ability to obtain patents, or the patents and patent applications of our licensors. Future protection
for our proprietary rights is uncertain because legal means afford only limited protection and may not adequately protect our rights or permit us to gain or keep our competitive advantage, which could adversely affect our financial condition and
results of operations. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Monitoring unauthorized uses of our intellectual property is difficult and costly. From time to time, we seek to analyze our competitors&#146; therapies, products and services, and may in the future seek to enforce our
patents or other proprietary rights against potential infringement. However, the steps we have taken to protect our proprietary rights may not be adequate to prevent misappropriation of our intellectual property. We may not be able to detect
unauthorized use of, or take appropriate steps to enforce, our intellectual property rights. Our competitors may also independently develop similar technology. Any inability to meaningfully protect our intellectual property could result in
competitors offering products that incorporate our product features, which could reduce demand for our gammaCore therapy. In addition, we may need to defend our patents from third-party challenges, including interferences, derivation proceedings, <FONT
STYLE="white-space:nowrap">re-examination</FONT> proceedings, post-grant review, inter partes review, third-party submissions, oppositions, nullity actions, or other patent proceedings. We may need to initiate infringement claims or litigation.
Adverse proceedings such as litigation can be expensive, time consuming and may divert the efforts of our technical and managerial personnel, which could in turn harm our business, whether or not we receive a determination favorable to us. In
addition, in an infringement proceeding, a court may decide that the patent we seek to enforce is invalid or unenforceable, or may refuse to enjoin the other party from using the technology at issue on the grounds that the patent in question does
not cover the technology in question. An adverse result in any litigation could place one or more of our patents at risk of being invalidated or interpreted narrowly. Some of our competitors may be able to devote significantly more resources to
intellectual property litigation, and may have patent portfolios, including significantly broader patent portfolios, to assert against us, if we assert our rights against them. Further, because of the substantial discovery required in connection
with intellectual property litigation, there is a risk that some of our confidential information could be disclosed or otherwise compromised during litigation. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We may not be able to accurately estimate or control our future operating expenses in relation to obtaining, enforcing and/or defending intellectual property, which could lead to cash shortfalls. Our operating expenses
may fluctuate significantly in the future as a result of the costs of preparing, filing, prosecuting, defending and enforcing patent claims and other patent related costs, including litigation costs and the results of such litigation.
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We may also be forced to enter into cross-license agreements with competitors in order to manufacture, use, sell, offer for sale, import and/or export products or services that are covered by our competitors&#146;
intellectual property rights. If we need to use our intellectual property to enter such cross-license agreements, it may compromise the value of our intellectual property due to the fact that our competitors may be able to manufacture, use, sell,
offer for sale, import and/or export our patented technology. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For additional information regarding risks related to our intellectual property, see
&#147;&#151;Risks Related to Intellectual Property.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If serious adverse events or other undesirable side effects are identified during the use
of our gammaCore therapy in investigator-sponsored trials, it may adversely affect our development of such product candidates. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Undesirable side effects caused by our gammaCore therapy or future product candidates could cause us or regulatory authorities to interrupt,
delay or halt nonclinical studies and clinical trials, or could make it more difficult for us to enroll patients in our clinical trials and could, if injuries occur, result in product liability litigation. If serious adverse events or other
undesirable side effects or unexpected characteristics of our gammaCore therapy or future product candidates are observed in investigator-sponsored trials, further clinical development of such product candidate may be delayed or we may not be able
to continue development of such product candidate at all, and the occurrence of these events could have a material adverse effect on our business. Undesirable side effects caused by our gammaCore therapy or future product candidates could also
result in the delay or denial of regulatory clearance or approval by the FDA or other regulatory authorities or in more restrictive labels than we desire. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Clinical trials are very expensive, time-consuming and difficult to design and implement and involve uncertain outcomes. Furthermore, results of earlier
preclinical studies and clinical trials may not be predictive of results of future preclinical studies or clinical trials. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
risk of failure for our gammaCore therapy in additional treatment areas is high. It is difficult if not impossible to predict when or if any of our product candidates will receive regulatory clearance or approval in additional areas of indication
outside of the acute treatment of eCH and the acute treatment of migraine. To obtain the requisite regulatory clearance or approvals to market and sell our gammaCore therapy in additional indications, we must demonstrate through extensive
preclinical studies and clinical trials that it is safe and effective in humans for use in each additional target indication. Clinical testing is expensive and can take many years to complete, and the outcome is inherently uncertain. Failure can
occur at any time during the clinical trial process. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the results of preclinical studies and early clinical trials may not be
predictive of the results of later-stage preclinical studies or clinical trials. The results generated to date in preclinical studies or clinical trials for our gammaCore therapy in cluster and migraine headaches do not ensure that later preclinical
studies or clinical trials will demonstrate similar results in other therapeutic indications, and it should be noted that we did not achieve the primary endpoints in our pivotal trials for cluster and migraine headaches. There can be no assurance
that the FDA and other regulatory authorities will be satisfied by data from our clinical trials even where we believe such data to be compelling. Our gammaCore therapy may fail to show the desired safety and efficacy traits in additional areas of
indication in future clinical trials despite having progressed through preclinical and earlier stage clinical trials. Many companies in the pharmaceutical and medical device industries have suffered significant setbacks in later-stage clinical
trials due to lack of efficacy or adverse safety profiles, notwithstanding promising results in earlier trials, and we cannot be certain that we will not face similar setbacks. Moreover, preclinical and clinical data are often susceptible to varying
interpretations and analyses, and many companies that have believed their product candidates performed satisfactorily in preclinical studies and clinical trials have nonetheless failed to obtain marketing clearance or approval of their products.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In some instances, there can be significant variability in safety or efficacy results between different clinical trials of the same
product candidate due to numerous factors, including changes in clinical trial procedures set forth in protocols, differences in the size and type of the patient populations, adherence to the dosing regimen and other clinical trial protocols, and
the rate of dropout among clinical trial participants. If we fail to produce positive results in our planned preclinical studies or clinical trials of any of our product candidates, the development timeline and regulatory approval and
commercialization prospects for our product candidates, and, correspondingly, our business and financial prospects, would be materially adversely affected. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We depend on enrollment of patients in our clinical trials for our product candidates. If we are
unable to enroll patients in our clinical trials, our research and development efforts could be adversely affected. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Identifying
and qualifying patients to participate in clinical trials for our gammaCore therapy in additional areas of indications is critical to our success. Successful and timely completion of clinical trials will require that we enroll a sufficient number of
patients who remain in the study until its conclusion. If we are unable to enroll a sufficient number of patients in our clinical trials, our timelines for recruiting patients, conducting clinical trials and obtaining regulatory clearance or
approval of our gammaCore therapy in additional areas of indication may be delayed. These delays could result in increased costs, delays in advancing our product development, delays in testing the effectiveness of our technology or termination of
our clinical trials altogether. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We cannot predict how successful we will be at enrolling patients in future clinical trials. Patient
enrollment is affected by other factors including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the eligibility criteria for the trial in question; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the perceived risks and benefits of the product candidate in the trial; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">clinicians&#146; and patients&#146; perceptions as to the potential advantages of the product candidate being studied in relation to other available therapies, including any new drugs that may be approved for the
indications we are investigating or drugs that may be used <FONT STYLE="white-space:nowrap">off-label</FONT> for these indications; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the size of the patient population required for analysis of the trial&#146;s primary endpoints; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">competition for patients for competitive product candidates undergoing clinical trials; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the efforts to facilitate timely enrollment in clinical trials; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the design of the trial; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the patient referral practices of physicians; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to recruit clinical trial investigators with the appropriate competencies and experience; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the ability to monitor patients adequately during and after treatment; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the risk that patients enrolled in clinical trials will drop out of the trials before completion; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the ability to obtain and maintain patient consents; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the number of patients with the indication being studied and the difficult of diagnosing the relevant condition or disease; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the proximity and availability of clinical trial sites for prospective patients. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition,
our clinical trials will compete with other clinical trials that are in the same therapeutic areas as we are targeting, and this competition will reduce the number and types of patients available to us, because some patients who might have opted to
enroll in our trials may instead opt to enroll in a trial being conducted by one of our competitors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Delays in the completion of any
clinical trial of our gammaCore therapy will increase our costs, slow down our expansion into additional treatment indications and approval process, and delay or potentially jeopardize our ability to commence product sales and generate future
revenue. In addition, many of the factors that may lead to a delay in the commencement or completion of clinical trials may also ultimately lead to the denial of regulatory clearance or approval of our gammaCore therapy in additional treatment
indications. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Clinical trials may be delayed, suspended or terminated for many reasons, which will increase our expenses and delay the time it takes
to develop and expand our gammaCore therapy in additional treatment indications. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may experience delays in our ongoing or future
preclinical studies or clinical trials, and we do not know whether future preclinical studies or clinical trials will begin on time, need to be redesigned, enroll an adequate </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
number of patients on time or be completed on schedule, if at all. The commencement and completion of clinical trials for the expansion of our gammaCore therapy in additional areas of indication,
such as Sj&ouml;gren&#146;s syndrome and rheumatoid arthritis, may be delayed, suspended or terminated as a result of many factors, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the FDA or other regulators disagreeing as to the design, protocol or implementation of our clinical trials; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the delay or refusal of regulators or institutional review boards, or IRBs, to authorize us to commence a clinical trial at a prospective trial site; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">changes in regulatory requirements, policies and guidelines; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">delays or failure to reach agreement on acceptable terms with prospective clinical research organizations, or CROs, and clinical trial sites, the terms of which can be subject to extensive negotiation and may vary
significantly among different CROs and trial sites; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">delays in patient enrollment and variability in the number and types of patients available for clinical trials; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the inability to enroll a sufficient number of patients in trials, particularly in orphan indications, to observe statistically significant treatment effects in the trial; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">having clinical sites deviate from the trial protocol or dropping out of a trial; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">negative or inconclusive results from ongoing preclinical studies or clinical trials, which may require us to conduct additional preclinical studies or clinical trials or to abandon projects that we expect to be
promising; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">safety or tolerability concerns that could cause us to suspend or terminate a trial if we find that the participants are being exposed to unacceptable health risks; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reports from preclinical or clinical testing of other similar therapies that raise safety or efficacy concerns; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">regulators or IRBs requiring that we or our investigators suspend or terminate clinical research for various reasons, including noncompliance with regulatory requirements or safety concerns, among others;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">lower than anticipated retention rates of patients and volunteers in clinical trials; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our CROs or clinical trial sites failing to comply with regulatory requirements or meet their contractual obligations to us in a timely manner, or at all, deviating from the protocol or dropping out of a trial;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">delays relating to adding new clinical trial sites; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">difficulty in maintaining contact with patients after treatment, resulting in incomplete data; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">delays in establishing the appropriate dosage levels; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the quality of the product candidate falling below acceptable standards; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the inability to manufacture sufficient quantities of our gammaCore therapy to commence or complete clinical trials; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">exceeding budgeted costs due to difficulty in accurately predicting costs associated with clinical trials. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We could also encounter delays if a clinical trial is suspended or terminated by us, by the IRBs or Ethics Committees of the institutions at
which such trials are being conducted, by the Data Safety Monitoring Board for such trial or by the FDA or other regulatory authorities. Such authorities may suspend or terminate a clinical trial due to a number of factors, including failure to
conduct the clinical trial in accordance with regulatory requirements, including the FDA&#146;s current Good Clinical Practice, or GCP, regulations, or our clinical protocols, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
inspection of the clinical trial operations or trial site by the FDA resulting in the imposition of a clinical hold, unforeseen safety issues or adverse side effects, failure to demonstrate a
benefit from using a drug, changes in governmental regulations or administrative actions or lack of adequate funding to continue the clinical trial. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we may encounter delays if the FDA concludes that our financial relationships with investigators results in a perceived or actual
conflict of interest that may have affected the interpretation of a study, the integrity of the data generated at the applicable clinical trial site or the utility of the clinical trial itself. Principal investigators for our clinical trials may
serve as scientific advisors or consultants to us from time to time and receive cash compensation and/or stock options in connection with such services. If these relationships and any related compensation to or ownership interest by the clinical
investigator carrying out the study result in perceived or actual conflicts of interest, or if the FDA concludes that the financial relationship may have affected interpretation of the study, the integrity of the data generated at the applicable
clinical trial site may be questioned and the utility of the clinical trial itself may be jeopardized, which could result in the delay or rejection by the FDA. Any such delay or rejection could prevent us from commercializing any of our products
currently in development. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we experience delays in the commencement or completion of any clinical trial of our product candidates, or
if any of our clinical trials are terminated, the commercial prospects of our gammaCore therapy may be harmed, and our ability to generate revenue from sales may be delayed or materially diminished. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not know whether any of our future preclinical studies or clinical trials will begin as planned, will need to be restructured or will be
completed on schedule, or at all. Any delays in completing our clinical trials will increase our costs, slow down our product candidate development and approval process and jeopardize our ability to commence sales and generate associated revenue.
Any of these occurrences may significantly harm our business, financial condition and prospects. In addition, many of the factors that cause, or lead to, a delay in the commencement or completion of clinical trials may also ultimately lead to the
denial, suspension or revocation of expanded regulatory clearance or approval of our product candidates. Significant preclinical study or clinical trial delays also could shorten any periods during which we may have the exclusive right to
commercialize our product candidates or allow our competitors to bring products to market before we do and impair our ability to successfully commercialize our product candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Even if our products are approved or cleared in the United States and European Economic Area, or EEA, (which is composed of the 28 Member
States of the EU plus Norway, Iceland and Liechtenstein), comparable regulatory authorities of additional foreign countries must also approve the manufacturing and marketing of our products in those countries. Approval and clearance procedures vary
among jurisdictions and can involve requirements and administrative review periods different from, and greater than, those in the United States or the EEA, including additional preclinical studies or clinical trials. Any of these occurrences may
harm our business, financial condition and prospects significantly. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we fail to properly manage our anticipated growth, our business could
suffer. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have been growing rapidly in recent periods and have a relatively short history of operating as a commercial company.
We intend to continue to grow and may experience periods of rapid growth and expansion, which could place a significant additional strain on our limited personnel, information technology systems and other resources. In particular, expanding our
direct sales force in the United&nbsp;States requires significant management, financial and other supporting resources. Any failure by us to manage our growth effectively could have an adverse effect on our ability to achieve our development and
commercialization goals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To achieve our goals, we must successfully increase manufacturing output to meet potential expected customer
demand. In the future, we may experience difficulties with manufacturing, quality control, component supply, inventory, distribution and shortages of qualified personnel, among other problems. These problems could result in delays in availability of
our gammaCore therapy and increases in expenses. Any such delay or increased expense could adversely affect our ability to generate our revenue. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Future growth will also impose significant added responsibilities on management, including
the need to identify, recruit, train and integrate additional employees. In addition, rapid and significant growth will place a strain on our administrative and operational infrastructure. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to manage our operations and growth we will need to continue to improve our operational and management controls, reporting and
information technology systems and financial internal control procedures. If we are unable to manage our growth effectively, it may be difficult for us to execute our business strategy and our operating results and business could suffer. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we fail to develop and retain an effective direct sales force in the United States, our business could suffer. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to commercialize our gammaCore therapy for the acute treatment of eCH and the acute treatment of migraine, in the United States, we
must continue to build a substantial direct sales force. As we initiate our commercial launch in eCH and migraine and increase our marketing efforts, we will need to retain, grow and develop our direct sales personnel. We intend to make a
significant investment in recruiting and training sales representatives and there is significant competition for such personnel. Once hired, the training process is lengthy because it requires significant education for new sales representatives to
achieve the level of clinical competency with our products expected by physicians. Upon completion of the training, our sales representatives typically require lead time in the field to grow their network of accounts and achieve the productivity
levels we expect them to reach in any individual territory. Furthermore, the use of our products often requires or benefits from direct support from us. If we are unable to attract, motivate, develop and retain a sufficient number of qualified sales
personnel, and if our sales representatives do not achieve the productivity levels we expect them to reach, our revenue will not grow at the rate we expect and our financial performance will suffer. Also, to the extent we hire personnel from our
competitors, we may have to wait until applicable <FONT STYLE="white-space:nowrap">non-competition</FONT> provisions have expired before deploying such personnel in restricted territories or incur costs to relocate personnel outside of such
territories, and we have been in the past, and may be subject to future allegations that these new hires have been improperly solicited, or that they have divulged to us proprietary or other confidential information of their former employers. Any of
these risks may adversely affect our business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We only recently began commercializing our gammaCore therapy for the acute treatment of eCH and
acute treatment of migraine headache in the United States and we may never achieve market acceptance. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have a limited history of
commercializing our product outside the United States, and a very limited history of selling our gammaCore therapy in the United States. Our gammaCore therapy received <I>de novo</I> grant and clearance by the FDA for the acute treatment of pain
associated with eCH in adults in April 2017. Additionally, our gammaCore therapy was cleared by the FDA in January 2018 for the acute treatment of pain associated with migraine in adults. Furthermore, our gammaCore therapy has not yet been cleared
by the FDA for treatment of chronic cluster headache or preventive treatment of CH or migraine. We have limited experience engaging in commercial activities and limited established relationships with physicians, hospitals and payors as well as
third-party suppliers on whom we depend for the manufacture of our product. We may be unable to gain broader market acceptance in the countries in which we have already begun to commercialize our gammaCore therapy, or, if approved by the FDA for
additional indications, unable to successfully commercialize it in the United States for a number of reasons, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">established competitors with strong relationships with customers, including physicians, hospitals and third-party suppliers; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">limitations in our ability to demonstrate differentiation and advantages of our product compared to competing products and the relative safety, efficacy and ease of use of our product; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the limited size of our sales force and the learning curve required to gain experience selling our product; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the inability to obtain sufficient supply of the components for our gammaCore therapy or secure second-source suppliers if our main suppliers are unable to fulfill our orders; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">insufficient financial or other resources to support our commercialization efforts necessary to reach profitability; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the introduction and market acceptance of new, more effective or less expensive competing products and technologies. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If our competitors are better able to develop and market CH and migraine treatments that are safer, more effective, less costly, easier to use or
otherwise more attractive than our gammaCore therapy, our business will be adversely impacted. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The pharmaceutical and medical
device industries are highly competitive and subject to rapid innovation and change. Our success depends, in part, upon our ability to establish a competitive position in the cluster and migraine markets by securing broad market acceptance of our
gammaCore therapy. We believe that the primary competitive factors in the cluster and migraine markets are demonstrated clinical effectiveness, product safety, reliability and durability, ease of use, product support and service, minimal side
effects and salesforce experience and relationships. We face significant competition in the United States and internationally, which we believe will intensify over time. Many of the companies developing or marketing competing products enjoy several
advantages over us, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">more experienced sales forces; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">greater name recognition; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">more established sales and marketing programs and distribution networks; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">earlier regulatory clearance or approval; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">long established relationships with physicians and hospitals; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">significant patent portfolios, including issued U.S. and foreign patents and pending patent applications, as well as the resources to enforce patents against us or any of our third-party suppliers and distributors;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the ability to acquire and integrate our competitors and/or their technology; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">demonstrated ability to develop product enhancements and new product offerings; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">established history of product reliability, safety and durability; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the ability to offer rebates or bundle multiple product offerings to offer greater discounts or incentives; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">greater financial and human resources for product development, sales, and marketing; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">greater experience in and resources for conducting research and development, clinical studies, manufacturing, preparing regulatory submissions, obtaining regulatory clearance or approval for products and marketing
approved products. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our competitors may develop and patent processes or products earlier than us, obtain patents that may
apply to us at any time, obtain regulatory clearance or approvals for competing products or processes more rapidly than us or develop more effective or less expensive products or technologies that render our technology or products obsolete or less
competitive. We also face fierce competition in recruiting and retaining qualified sales, scientific, and management personnel, establishing clinical trial sites and enrolling patients in clinical studies. If our competitors are more successful than
us in these matters, our business may be harmed. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Many of our competitors are large, well-established companies with substantially greater resources
than us and have a long history of competing in the CH and migraine markets. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Many of our current and potential competitors are
publicly traded, or are divisions of publicly-traded, major pharmaceutical and medical device companies that have substantially greater financial, technical, sales and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
marketing resources than we do. We will face steep competition from Allergan plc, Amgen Inc., Novartis International AG and Teva Pharmaceutical Industries Ltd., all of which are better
capitalized and have a history of commercializing products around the world. We estimate the addressable U.S. market for eCH and migraine headache will be approximately $400 million and $3.8&nbsp;billion in 2018, respectively. Given the size of the
existing and potential market in the United States, we expect that as we continue and try to expand our commercial efforts in the United States our current and future competitors will take aggressive action to protect their current market position.
We will face significant competition in establishing our market share in the United States and may encounter unforeseen obstacles and competitive challenges in the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we face a particular challenge overcoming the long-standing practices by some physicians of using the headache products of our
larger, more established competitors. Physicians who use our competitors&#146; products for the treatment of cluster and migraine headache may be reluctant to try new products from a source with which they are less familiar. If these physicians do
not try and subsequently adopt our product, then our financial performance will be adversely affected. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, a number of our
competitors are currently conducting, or we anticipate will be conducting, clinical trials to demonstrate the results of their headache products. The results of these trials may be equivalent to, or potentially better than, the results of our
clinical trials, which could have a material adverse effect on us. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Traditional products used to treat CH and migraine have been available for
decades, while our gammaCore therapy has only been commercially available in Europe for several years, and for less than one year in the United States, and, as a result, we have a limited track record compared to our competitors. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Traditional products used to treat CH and migraine have been commercially available for decades, while we only began commercializing our
gammaCore therapy in Europe to treat CH and migraine several years ago, and within the past year in the United States. Because we have a limited commercial track record compared to our competitors and our gammaCore therapy generally has been
utilized by patients for less time than other headache therapies, physicians may be slower to adopt or recommend our gammaCore therapy. Further, while we believe our international commercial experience and our clinical trials support the safety and
effectiveness of our gammaCore therapy for the acute treatment of eCH and migraine headache, future studies or patient experience over a longer period of time may indicate that treatment with gammaCore is less attractive than treatment with
competitive products or that our gammaCore therapy causes unexpected or serious complications or other unforeseen negative effects. Such results would likely slow the adoption of our gammaCore therapy and significantly reduce our sales, which would
harm our business and adversely affect our results of operations. Furthermore, if patients with traditional or other headache products were to experience unexpected or serious complications or other unforeseen effects, the market for our gammaCore
therapy may be adversely affected, even if such effects are not directly attributable to our gammaCore therapy. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may expend our limited resources
to pursue a particular product candidate or disease and fail to capitalize on product candidates or diseases that may be more profitable or for which there is a greater likelihood of success. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because we have limited financial and managerial resources, we focus our research programs and product candidates on specific conditions. As a
result, we may forego or delay pursuit of opportunities with other product candidates or other diseases or conditions that may later prove to have greater commercial potential. Our resource allocation decisions may cause us to fail to capitalize on
viable commercial products or profitable market opportunities. Our spending on current and future research and development programs and product candidates for specific conditions may not yield any commercially viable products. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our international operations subject us to certain operating risks, which could adversely impact our results of operations and financial condition.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sales of gammaCore outside the United States represented a substantial portion of our net sales in the years ended
December&nbsp;31, 2016 and 2017, respectively. In 2012, we began selling gammaCore in the EU through </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
distributors. As of February 1, 2018, we sell gammaCore directly in 14 countries in the EU and through distributors and agents located in Munich, Germany and Leeds, UK. The sale and shipment of
gammaCore across international borders, as well as the purchase of components from international sources, subjects us to U.S. and foreign governmental trade, import and export, and customs regulations and laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Compliance with these regulations and laws is costly and exposes us to penalties for <FONT STYLE="white-space:nowrap">non-compliance.</FONT>
Other laws and regulations that can significantly impact us include various anti-bribery laws, including the U.S.&nbsp;Foreign Corrupt Practices Act, as well as export controls laws. Any failure to comply with applicable legal and regulatory
obligations could impact us in a variety of ways that include, but are not limited to, significant criminal, civil and administrative penalties, including imprisonment of individuals, fines and penalties, denial of export privileges, seizure of
shipments, restrictions on certain business activities and exclusion or debarment from government contracting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The administration of
President Trump has publicly supported potential trade proposals, including import tariffs and other tariffs, including the U.S. administration&#146;s recent introduction of tariffs on China and China&#146;s retaliatory tariffs on certain products
from the United States, as well as modifications to international trade policy and other changes that may affect U.S. trade relations with other countries. We source a significant amount of the components used in gammaCore from Chinese sources so
any tariffs or other trade restrictions impacting the import of these components from China could have a material adverse impact on us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our international operations expose us and our distributors to risks inherent in operating in foreign jurisdictions. These risks include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">difficulties in enforcing our intellectual property rights and in defending against third-party threats and intellectual property enforcement actions against us, our distributors or any of our third-party suppliers;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reduced or varied protection for intellectual property rights in some countries; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">pricing pressure that we may experience internationally; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a shortage of high-quality salespeople and distributors; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">third-party reimbursement policies that may require some of the patients who receive our products to directly absorb medical costs or that may necessitate the reduction of the selling prices of gammaCore;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">competitive disadvantage to competition with established business and customer relationships; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">foreign currency exchange rate fluctuations; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the imposition of additional U.S. and foreign governmental controls or regulations; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">economic instability; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">changes in duties and tariffs, license obligations and other <FONT STYLE="white-space:nowrap">non-tariff</FONT> barriers to trade; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the imposition of restrictions on the activities of foreign agents, representatives and distributors; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">scrutiny of foreign tax authorities which could result in significant fines, penalties and additional taxes being imposed on us; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">laws and business practices favoring local companies; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">longer payment cycles; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">difficulties in maintaining consistency with our internal guidelines; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">difficulties in enforcing agreements and collecting receivables through certain foreign legal systems; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the imposition of costly and lengthy new export licensing requirements; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the imposition of U.S. or international sanctions against a country, company, person or entity with whom we do business that would restrict or prohibit continued business with the sanctioned country, company, person or
entity; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the imposition of new trade restrictions. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we experience any of these risks, our sales in <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> jurisdictions may be harmed and our results of operations would suffer. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our results may be impacted by
changes in foreign currency exchange rates. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have international operations and, as a result, an increase in the value of the
U.S. dollar relative to foreign currencies could require us to reduce our selling price or risk making our products less competitive in international markets, or our costs could increase. Also, if our international sales increase, we may enter into
a greater number of transactions denominated in <FONT STYLE="white-space:nowrap">non-U.S.</FONT> dollars, which could expose us to increased foreign currency risks, including currency fluctuations and exchange rate risks. We do not currently engage
in any hedging transactions. If we are unable to address these risks and challenges effectively, our international operations may not be successful and our business could be harmed. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may not be able to establish or strengthen our brand. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that establishing and strengthening the electroCore and gammaCore brands is critical to achieving widespread acceptance of our
gammaCore therapy to treat eCH and migraine, particularly because of the highly competitive nature of the market for headache therapies. Promoting and positioning our brand will depend largely on the success of our marketing efforts and our ability
to provide physicians with a reliable product for successful treatment of cluster and migraine headaches. Given the established nature of our competitors, and our lack of commercialization in the United States, it is likely that our future marketing
efforts will require us to incur significant additional expenses. These brand promotion activities may not yield increased sales and, even if they do, any sales increases may not offset the expenses we incur to promote our brand. If we fail to
successfully promote and maintain our brand, or if we incur substantial expenses in an unsuccessful attempt to promote and maintain our brand, our gammaCore therapy may not be accepted by physicians, which would adversely affect our business,
results of operations and financial condition. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may face product liability claims that could result in costly litigation and significant
liabilities. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Manufacturing and marketing of gammaCore, and clinical testing of our gammaCore therapy to initially treat eCH and
migraine, may expose us to individual product liability claims, class action lawsuits or actions, and other individual or mass tort claims. Although we have, and intend to maintain, liability insurance, the insurers may deny our claims, coverage
limits of our insurance policies may not be adequate and one or more successful claims brought against us may have a material adverse effect on our business and results of operations. These risks are heightened in the event any product recalls take
place as a result of any product design defect or defect in product warnings or labeling. Product liability claims could negatively affect our reputation, our continued product sales and our ability to obtain and maintain regulatory clearance or
approval for our products. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we fail to retain our key executives or recruit and hire new employees, our operations and financial results may be
adversely effected while we attract other highly qualified personnel. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our future success depends, in part, on our ability to
continue to retain our executive officers and other key employees and recruit and hire new employees. All of our executive officers and other employees are <FONT STYLE="white-space:nowrap">at-will</FONT> employees, and therefore may terminate
employment with us at any time with no advance notice. The replacement of any of our key personnel likely would involve significant time and costs, may significantly delay or prevent the achievement of our business objectives and may harm our
business. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, many of our employees have become or will soon become vested in a substantial
amount of stock or number of stock options. Our employees may be more likely to leave us if the shares they own or the shares underlying their vested options have significantly appreciated in value relative to the original purchase prices of the
shares or the exercise prices of the options, or if the exercise prices of the options that they hold are significantly below the market price of our common stock. Further, our employees&#146; ability to exercise those options and sell their stock
in a public market after the closing of this offering may result in a higher than normal turnover rate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our future success also depends
on our ability to retain executive officers and other key employees and attract new key employees. Many executive officers and employees in the pharmaceutical and medical device industries are subject to strict
<FONT STYLE="white-space:nowrap">non-compete</FONT> or confidentiality agreements with their employers, which may include our main competitors. In addition, some of our existing and future employees are or may be subject to confidentiality
agreements with previous employers. Our competitors may allege breaches of and seek to enforce such <FONT STYLE="white-space:nowrap">non-compete</FONT> agreements or initiate litigation based on such confidentiality agreements. Such litigation,
whether or not meritorious, may impede our ability to attract or use executive officers and other key employees who have been employed by our competitors and may result in intellectual property claims against us. It is likely that we will experience
similar aggressive lawsuit tactics by our competitors as they seek to protect their market position, particularly as we prepare to expand in new or existing markets. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our employees, independent contractors, consultants, commercial collaborators, principal investigators, CROs and vendors may engage in misconduct or
other improper activities, including non-compliance with regulatory standards and requirements. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are exposed to the risk that
our employees, independent contractors, consultants, commercial collaborators, principal investigators, CROs and vendors may engage in fraudulent conduct or other illegal activity. Misconduct by these parties could include intentional, reckless or
negligent conduct or unauthorized activities that violates (1)&nbsp;the laws and regulations of the FDA and other similar regulatory authorities, including those laws requiring the reporting of true, complete and accurate information to such
authorities, (2)&nbsp;manufacturing standards, (3)&nbsp;federal and state data privacy, security, fraud and abuse and other healthcare laws and regulations in the United States and abroad and (4)&nbsp;laws that require the true, complete and
accurate reporting of financial information or data. In particular, sales, marketing and business arrangements in the healthcare industry are subject to extensive laws and regulations intended to prevent fraud, misconduct, kickbacks, self-dealing
and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements. Misconduct by these
parties could also involve the improper use of individually identifiable information, including information obtained in the course of clinical trials, creating fraudulent data in our preclinical studies or clinical trials or illegal misappropriation
of product candidates, which could result in regulatory sanctions and serious harm to our reputation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although we intend to adopt a code
of business conduct and ethics, it is not always possible to identify and deter misconduct by employees and other third parties, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged
risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws or regulations. Additionally, we are subject to the risk that a person or government could
allege such fraud or other misconduct, even if none occurred. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business,
including the imposition of significant civil, criminal and administrative penalties, including damages, fines, disgorgement, imprisonment, exclusion from participation in government healthcare programs, such as Medicare and Medicaid, contractual
damages, reputational harm and the curtailment or restructuring of our operations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risk Related to our Dependence on Third Parties </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We rely upon third-party, single-source, and in certain cases sole-source, suppliers for many of the components and materials used in gammaCore, and for
critical manufacturing and packaging services, making us vulnerable to supply shortages and problems and price fluctuations, which could harm our business. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A number of the critical components used in gammaCore are supplied to us from single-source, or in certain cases sole-source, suppliers. Our
suppliers may encounter problems during manufacturing for a variety of reasons, including, for example, failure to follow specific protocols and procedures, failure to comply with applicable legal and regulatory requirements, equipment malfunction
and environmental factors, failure to properly conduct their own business affairs, and infringement of third-party intellectual property rights, any of which could delay or impede their ability to meet our requirements. Our ability to supply
gammaCore commercially depends, in part, on our ability to obtain a supply of these components that has been manufactured in accordance with regulatory requirements and in sufficient quantities for commercialization and clinical testing. We have not
entered into manufacturing, supply or quality agreements with all of our single-source and sole-source suppliers, some of which supply components critical to our products. Although we believe that long-term agreements with our suppliers are not
necessary as all the components in our products are either high-volume, non-custom commodity components or are readily available from multiple vendors, there can be no assurance that our single-source or sole-source suppliers will be able to meet
our demand for their products and services, either because of the informal nature of our arrangements with those suppliers, or our limited experience with those suppliers, or due to our relative importance as a customer to those suppliers. It may be
difficult for us to assess their ability to timely meet our demand in the future based on past performance. While our suppliers have generally met our demand for their products on a timely basis in the past, they may subordinate our needs in the
future to their other customers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Establishing additional or replacement suppliers for the components or processes used in gammaCore, if
required, may not be accomplished quickly. If we are able to find a replacement supplier, such replacement supplier would need to be qualified and may require additional regulatory authority approval, which could result in further delay. While we
seek to maintain adequate inventory of the single-source or sole-source components and materials used in our products, any interruption or delay in the supply of components or materials, or our inability to obtain components or materials from
alternate sources at acceptable prices in a timely manner, could impair our ability to meet the demand of our customers and cause them to cancel orders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If our third-party suppliers fail to deliver the required commercial quantities of materials, or the level of services we require, on a timely
basis and at commercially reasonable prices, and we are unable to find one or more replacement suppliers capable of production at a substantially equivalent cost in substantially equivalent volumes and quality and on a timely basis, the continued
commercialization of gammaCore would be impeded, delayed, limited or prevented, which could harm our business, results of operations, financial condition and prospects. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We rely in part on a small group of third-party distributors to effectively distribute our products outside the United States. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We depend in part on a small group of third-party distributors for the marketing and selling of our products in certain territories in Europe.
We depend on these distributors&#146; efforts to market our products, yet we are unable to control their efforts completely. These distributors typically sell a variety of other <FONT STYLE="white-space:nowrap">non-competing</FONT> products that may
limit the resources they dedicate to selling our gammaCore therapy. In addition, we are unable to ensure that our distributors comply with all applicable laws regarding the sale of our products. If our distributors fail to effectively market and
sell gammaCore in full compliance with applicable laws, our operating results and business may suffer. Recruiting and retaining qualified third-party distributors and training them in our technology and product offerings requires significant time
and resources. To develop and expand our distribution, we must continue to scale and improve our processes and procedures that support our distributors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Further, if our relationship with a successful distributor terminates, we may be unable to replace that distributor without disruption to our business. If we fail to maintain positive
relationships with our distributors, fail to develop new relationships with other distributors, including in new markets, fail to manage, train or incentivize existing distributors effectively, or fail to provide distributors with competitive
products on attractive terms, or if these distributors are not successful in their sales efforts, our revenue may decrease and our operating results, reputation and business may be harmed. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We intend to rely upon only one third-party distributor to distribute our products in the United States. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We intend to rely upon one specialty pharmaceutical distributor, who collaborates with a large network of specialty pharmacies, to distribute
our products in the United States. We depend on this distributor to distribute our products, which includes providing adjudication of prescriptions and reimbursement claims, as well as patient support and training services, but are unable to control
its performance. This distributor may distribute a variety of other specialty pharmaceutical products that may limit the resources dedicated to the distribution of our products. In addition, we are unable to ensure that this distributor will comply
with all applicable laws related to the distribution of our products. If this distributor fails to distribute our products in compliance with applicable laws, our operating results and business may suffer. Recruiting, training and retaining
third-party distributors in the distribution of our proprietary product offerings requires significant time and resources. In addition, an affiliate of this distributor provides pharmaceutical patient hub services for patients that are prescribed
our gammaCore therapy, and has been electronically integrated with our proprietary data warehouse system and web portal. If our relationship with this distributor terminates, we may be unable to replace this distributor without disruption to our
business. Any new distributor may not integrate as seamlessly with our data warehouse system and web portal, leading to disruptions in service for patients that are prescribed our therapy, which may cause these patients to seek alternative therapy.
Our distributor also may not pay us on time or at all due to disputes, financial issues or bankruptcy events. Any such payment issues may materially affect our operating results until we are able to resolve the issues, or find a sufficient
replacement for our distributor. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We rely on third parties to conduct and support our clinical trials, and those third parties may not perform
satisfactorily, including failing to meet deadlines for the completion of such trials. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not independently conduct clinical
trials for our product candidates. We rely on third parties, such as CROs, clinical data management organizations, medical institutions and clinical investigators, to perform this function. Our reliance on these third parties for clinical
development activities reduces our control over these activities but does not relieve us of our responsibilities. Furthermore, some of the sites for our clinical trials are outside the United States. The performance of these sites may be adversely
affected by various issues, including less advanced medical infrastructure, lack of familiarity with conducting clinical trials in accordance with U.S.&nbsp;standards, insufficient training of personnel, communication difficulties or change in local
regulations. We remain responsible for ensuring that each of our clinical trials is conducted in accordance with the general investigational plan and protocols for the study. Moreover, the FDA requires us to comply with GCP for conducting, recording
and reporting the results of clinical trials to assure that data and reported results are credible and accurate and that the rights, integrity and confidentiality of patients in clinical trials are protected. Furthermore, these third parties may
also have relationships with other entities, including our competitors. If these third parties do not successfully carry out their contractual duties, meet expected deadlines or conduct our clinical trials in accordance with regulatory requirements
or our stated protocols, we will not be able to obtain, or may be delayed in obtaining, regulatory clearance or approval for our product candidates and will not be able to, or may be delayed in our efforts to, successfully commercialize our
products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We also rely on other third parties to store and distribute supplies for our clinical trials. Any performance failure on the
part of our existing or future distributors could delay clinical development or regulatory clearance or approval of our product candidates or commercialization of our products, producing additional losses and depriving us of potential product
revenues. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we do not successfully enter into future collaborations for the development and commercialization
of our gammaCore therapy in international markets our business may be harmed. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may choose to enter into collaboration agreements
with third parties with respect to development and commercialization of our gammaCore therapy in international markets. We will have limited control over the amount and timing of resources that our collaborators dedicate to the development or
commercialization of our gammaCore therapy. Our ability to generate revenues from these arrangements will depend in part on our collaborators&#146; abilities to successfully perform the functions assigned to them in these arrangements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Collaborations involving our gammaCore therapy, such as our collaboration with Desitin, are subject to numerous risks, which may include the
following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">collaborators have significant discretion in determining the efforts and resources that they will apply to a collaborations; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">collaborators may not pursue development and commercialization of our product candidates or may elect not to continue or renew development or commercialization programs based on clinical trial results, changes in their
strategic focus due to the acquisition of competitive products, availability of funding or other external factors, such as a business combination that diverts resources or creates competing priorities; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">collaborators may delay clinical trials, provide insufficient funding for a clinical trial, stop a clinical trial, abandon a product candidate, repeat or conduct new clinical trials or require a new formulation of a
product candidate for clinical testing; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">collaborators could independently develop, or develop with third parties, products that compete directly or indirectly with our products or product candidates; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a collaborator with marketing and distribution rights to one or more products may not commit sufficient resources to their marketing and distribution; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">collaborators may not properly maintain or defend our intellectual property rights or may use our intellectual property or proprietary information in a way that gives rise to actual or threatened litigation that could
jeopardize or invalidate our intellectual property or proprietary information or expose us to potential liability; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">disputes may arise between us and a collaborator that cause the delay or termination of the research, development or commercialization of our product candidates or that result in costly litigation or arbitration that
diverts management attention and resources; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">collaborations may be terminated and, if terminated, may result in a need for additional capital to pursue further development or commercialization of the applicable product candidates; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">collaborators may own or <FONT STYLE="white-space:nowrap">co-own</FONT> intellectual property covering our products that result from our collaborating with them, and in such cases, we would not have the exclusive right
to commercialize such intellectual property. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any termination or disruption of any future collaboration could result in
delayed development of product candidates, increased cost to develop product candidates or termination of development of a product candidate. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we
are not able to establish or maintain collaborations, we may have to alter some of our future development and commercialization plans. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our product development programs and the potential commercialization of our gammaCore therapy will require substantial additional capital to
fund expenses. For some of our product candidates, we may decide to collaborate with pharmaceutical and medical device companies for the future development and potential commercialization of those product candidates. Furthermore, we may find that
our programs require the use of proprietary rights held by third parties, and the growth of our business may depend in part on our ability to acquire, <FONT STYLE="white-space:nowrap">in-license</FONT> or use these proprietary rights. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We face significant competition in seeking appropriate collaborators, and a number of more
established companies may also be pursuing strategies to license or acquire third-party intellectual property rights that we may consider attractive. These established companies may have a competitive advantage over us due to their size, financial
resources and greater clinical development and commercialization capabilities. In addition, companies that perceive us to be a competitor may be unwilling to assign or license rights to us. Whether we reach a definitive agreement for a collaboration
will depend upon, among other things, our assessment of the collaborator&#146;s resources and expertise, the terms and conditions of the proposed collaboration and the proposed collaborator&#146;s evaluation of a number of factors. Those factors may
include the design or results of clinical trials, the likelihood of clearance or approval by the FDA, compliance with the Essential Requirements of the EU Medical Devices Directive or similar foreign regulations, the potential market for the subject
product candidate, the costs and complexities of manufacturing and delivering such product candidate to patients, competing products, the existence of uncertainty with respect to our ownership of technology, which can exist if there is a challenge
to such ownership without regard to the merits of the challenge, and industry and market conditions generally. The collaborator may also consider alternative product candidates or technologies for similar indications that may be available to
collaborate on and whether such a collaboration could be more attractive than the one with us for our product candidate. We may also be restricted under existing license agreements from entering into agreements on certain terms with potential
collaborators. Collaborations are complex and time-consuming to negotiate and document. In addition, there have been a significant number of recent business combinations among large pharmaceutical companies that have resulted in a reduced number of
potential future collaborators. We may not be able to negotiate collaborations on a timely basis, on acceptable terms, or at all. Even if we are able to obtain a license to intellectual property of interest, we may not be able to secure exclusive
rights, in which case others could use the same rights and compete with us. If we are unable to successfully obtain rights to required third-party intellectual property rights or maintain the existing intellectual property rights we have, we may
have to curtail the development of such product candidate, reduce or delay its development program or one or more of our other development programs, delay its potential commercialization or reduce the scope of any sales or marketing activities, or
increase our expenditures and undertake development or commercialization activities at our own expense. If we elect to increase our expenditures to fund development or commercialization activities on our own, we may need to obtain additional
capital, which may not be available to us on acceptable terms, or at all. If we do not have sufficient funds, we may not be able to further develop our product candidates or bring them to market and generate product revenue. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We, or third-party manufacturers on whom we rely, may be unable to successfully <FONT STYLE="white-space:nowrap">scale-up</FONT> manufacturing of our
gammaCore therapy or its component parts in sufficient quality and quantity, which would delay or prevent us from developing and commercializing any approved products. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to conduct clinical trials of our gammaCore therapy and commercialize any approved products, we, or our manufacturers, will need to
manufacture them in large quantities. We, or our manufacturers, may be unable to successfully increase manufacturing capacity in a timely or cost-effective manner, or at all. In addition, quality issues may arise during <FONT
STYLE="white-space:nowrap">scale-up</FONT> activities. If we, or any of our manufacturers, are unable to successfully scale up manufacturing in sufficient quality and quantity, the development, testing, and clinical trials of our gammaCore therapy
may be delayed or infeasible, and regulatory clearance, approval or commercial launch of any resulting product may be delayed or not obtained, which could significantly harm our business. If we are unable to obtain or maintain third-party
manufacturing for commercial supply of our product candidates, or to do so on commercially reasonable terms, we may not be able to develop and commercialize our gammaCore therapy successfully. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We are required to maintain high levels of inventory due to our single-source supply vendors, which could consume a significant amount of our resources,
reduce our cash flows and lead to inventory impairment charges. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our gammaCore therapy consists of a substantial number of
individual components. In order to market and sell gammaCore effectively, we often must maintain high levels of inventory of the product and its components. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
The manufacturing process requires lengthy lead times during which components of our gammaCore therapy may become obsolete, and we may over- or under-estimate the amount needed of a given
component, in which case we may expend extra resources or be constrained in the amount of end product that we can produce. As compared to direct manufacturers, our dependence on third-party manufacturers exposes us to greater lead times increasing
our risk of inventory obsolesce comparatively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Intellectual Property </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We rely on a variety of intellectual property rights, and if we are unable to maintain or protect our intellectual property, our business and results of
operations will be harmed. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our commercial success will depend, in part, on our ability to obtain and maintain intellectual
property protection for our products, processes, and related technologies in the United States, Europe and elsewhere, successfully defend our intellectual property rights against third-party challenges and successfully enforce our intellectual
property rights to prevent third-party infringement. While we rely primarily upon a combination of patents, copyrights, trademarks and trade secret protection, as well as nondisclosure, confidentiality and other contractual agreements to protect the
intellectual property related to our brands, products and other proprietary technologies, protection derived from patents is relatively limited. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The process of obtaining patent protection is expensive and time-consuming, and we may not be able to prosecute all necessary or desirable
patent applications at a reasonable cost or in a timely manner. We may choose not to seek patent protection for certain innovations or products and may choose not to pursue patent protection in certain jurisdictions, and under the laws of certain
jurisdictions, patents or other intellectual property rights may be unavailable or limited in scope and, in any event, any patent protection we obtain may be limited. As a result, some of our products are not, and in the future may not be, protected
by patents. We generally apply for patents in those countries where we intend to make, have made, use, offer for sale, or sell products and where we assess the risk of infringement to justify the cost of seeking patent protection. However, we do not
seek protection in all countries where we sell products and we may not accurately predict all the countries where patent protection would ultimately be desirable. If we fail to timely file a patent application in any such country or major market, we
may be precluded from doing so at a later date. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own products and, further, may export otherwise infringing products to territories in
which we have patent protection that may not be sufficient to terminate infringing activities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, we cannot guarantee that any
patents will be issued from any pending or future owned or licensed patent applications, or that any current or future patents will provide us with any meaningful protection or competitive advantage. Even if issued, existing or future patents may be
challenged, including with respect to ownership, narrowed, invalidated, held unenforceable or circumvented, any of which could limit our ability to prevent competitors and other third parties from developing and marketing similar products or limit
the length of terms of patent protection we may have for our products and technologies. Other companies may also design around technologies we have patented, licensed or developed. In addition, the issuance of a patent does not give us the right to
practice the patented invention. Third parties may have blocking patents that could prevent us from marketing our products or practicing our own patented technology. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The patent positions of pharmaceutical and medical device companies can be highly uncertain and involve complex legal, scientific and factual
questions for which important legal principles remain unresolved. The standards that the USPTO and its foreign counterparts use to grant patents are not always applied predictably or uniformly. Changes in either the patent laws, implementing
regulations or the interpretation of patent laws may diminish the value of our rights. The legal systems of certain countries do not protect intellectual property rights to the same extent as the laws of the United States, and many companies have
encountered significant problems in protecting and defending such rights in foreign jurisdictions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because patent applications in the
United States, Europe and many other jurisdictions are typically not published until 18 months after filing, or in some cases not at all, and because publications of discoveries in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
scientific literature lag behind actual discoveries, we cannot be certain that we were the first to conceive or reduce to practice the inventions claimed in our issued patents or pending patent
applications, or that we were the first to file for protection of the inventions set forth in our patents or pending patent applications. We can give no assurance that all of the potentially relevant art relating to our patents and patent
applications has been found; overlooked prior art could be used by a third party to challenge the validity, enforceability and scope of our patents or prevent a patent from issuing from a pending patent application. As a result, we may not be able
to obtain or maintain protection for certain inventions. Therefore, the validity, enforceability and scope of our patents in the United States, Europe and in other countries cannot be predicted with certainty and, as a result, any patents that we
own or license may not provide sufficient protection against our competitors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Third parties may challenge any existing patent or future
patent we own or license through adversarial proceedings in the issuing offices or in court proceedings, including as a response to any assertion of our patents against them. In any of these proceedings, a court or agency with jurisdiction may find
our patents invalid and/or unenforceable, or even if valid and enforceable, insufficient to provide protection against competing products and services sufficient to achieve our business objectives. We may be subject to a third-party <FONT
STYLE="white-space:nowrap">pre-issuance</FONT> submission of prior art to the USPTO, or reexamination by the USPTO if a third party asserts a substantial question of patentability against any claim of a U.S. patent we own or license. The adoption of
the Leahy-Smith America Invents Act, or the Leahy-Smith Act, in September 2011 established additional opportunities for third parties to invalidate U.S. patent claims, including inter partes review and post-grant review proceedings. Outside of the
United States, patents we own or license may become subject to patent opposition or similar proceedings, which may result in loss of scope of some claims or the entire patent. In addition, such proceedings are very complex and expensive, and may
divert our management&#146;s attention from our core business. If any of our patents are challenged, invalidated, circumvented by third parties or otherwise limited or expire prior to the commercialization of our products, and if we do not own or
have exclusive rights to other enforceable patents protecting our products or other technologies, competitors and other third parties could market products and use processes that are substantially similar to, or superior to, ours and our business
would suffer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The degree of future protection for our proprietary rights is uncertain because legal means afford only limited protection
and may not adequately protect our rights or permit us to gain or keep a competitive advantage. For example: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">others may be able to develop products that are similar to, or better than, ours in a way that is not covered by the claims of our patents; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we might not have been the first to conceive or reduce to practice the inventions covered by our patents or pending patent applications; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we might not have been the first to file patent applications for our inventions; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any patents that we obtain may not provide us with any competitive advantages or may ultimately be found invalid or unenforceable; or </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we may not develop additional proprietary technologies that are patentable. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may become involved in
lawsuits to protect or enforce our patents, which could be expensive, <FONT STYLE="white-space:nowrap">time-consuming</FONT> and unsuccessful. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Competitors may infringe our patents. To counter infringement or unauthorized use, we may be required to file one or more lawsuit and assert
infringement claims, which can be expensive and time-consuming. In addition, in an infringement proceeding, a court may decide that a patent of ours is invalid or unenforceable, or may refuse to enjoin the other party from using the technology at
issue on the grounds that our patents do not cover the technology in question. The standards that courts use to interpret patents are not always applied predictably or uniformly and can change, particularly as new technologies develop. As a result,
we cannot predict with certainty how much protection, if any, will be given to our patents if we attempt to enforce them and they </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
are challenged in court. Further, even if we prevail against an infringer in U.S. district court, there is always the risk that the infringer will file an appeal and the district court judgment
will be overturned at the appeals court and/or that an adverse decision will be issued by the appeals court relating to the validity or enforceability of our patents. An adverse result in any litigation proceeding could put one or more of our
patents at risk of being invalidated or interpreted in a manner insufficient to achieve our business objectives. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our commercial success depends
significantly on our ability to operate without infringing upon the intellectual property rights of third parties. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
pharmaceutical and medical device industries are subject to rapid technological change and substantial litigation regarding patent and other intellectual property rights. Our competitors in both the United States and abroad, many of which have
substantially greater resources and have made substantial investments in patent portfolios and competing technologies, may have applied for or obtained or may in the future apply for or obtain, patents that will prevent, limit or otherwise interfere
with our ability to make, use and sell our products and services. Numerous third-party patents exist in the fields relating to our products and services, and it is difficult for industry participants, including us, to identify all third-party patent
rights relevant to our products, services and technologies. Moreover, because some patent applications are maintained as confidential for a certain period of time, we cannot be certain that third parties have not filed patent applications that cover
our products, services and technologies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Patents could be issued to third parties that we may ultimately be found to infringe. Third
parties may have or obtain valid and enforceable patents or proprietary rights that could block us from developing products using our technology. Our failure to obtain or maintain a license to any technology that we require may materially harm our
business, financial condition and results of operations. Furthermore, we would be exposed to a threat of litigation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From time to time,
we may be party to, or threatened with, litigation or other proceedings with third parties, including <FONT STYLE="white-space:nowrap">non-practicing</FONT> entities, who allege that our products, components of our products, services, and/or
proprietary technologies infringe, misappropriate or otherwise violate their intellectual property rights. The types of situations in which we may become a party to such litigation or proceedings include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we or our collaborators may initiate litigation or other proceedings against third parties seeking to invalidate the patents held by those third parties or to obtain a judgment that our products or processes do not
infringe those third parties&#146; patents; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we or our collaborators may participate at substantial cost in International Trade Commission proceedings to abate importation of products that would compete unfairly with our products; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">if our competitors file patent applications that claim technology also claimed by us or our licensors, we or our licensors may be required to participate in interference, derivation or opposition proceedings to
determine the priority of invention, which could jeopardize our patent rights and potentially provide a third party with a dominant patent position; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">if third parties initiate litigation claiming that our processes or products infringe their patent or other intellectual property rights, we and our collaborators will need to defend against such proceedings;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">if third parties initiate litigation or other proceedings seeking to invalidate patents owned by or licensed to us or to obtain a declaratory judgment that their products, services, or technologies do not infringe our
patents or patents licensed to us, we will need to defend against such proceedings; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we may be subject to ownership disputes relating to intellectual property, including disputes arising from conflicting obligations of consultants or others who are involved in developing our products; and
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">if a license to necessary technology is terminated, the licensor may initiate litigation claiming that our processes or products infringe or misappropriate its patent or other intellectual property rights and/or that we
breached our obligations under the license agreement, and we and our collaborators would need to defend against such proceedings. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These lawsuits and proceedings, regardless of merit, are time-consuming and expensive to
initiate, maintain, defend or settle, and could divert the time and attention of managerial and technical personnel, which could materially adversely affect our business. Any such claim could also force use to do one or more of the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">incur substantial monetary liability for infringement or other violations of intellectual property rights, which we may have to pay if a court decides that the product, service, or technology at issue infringes or
violates the third party&#146;s rights, and if the court finds that the infringement was willful, we could be ordered to pay treble damages and the third party&#146;s attorneys&#146; fees; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">pay substantial damages to our customers or end users to discontinue use or replace infringing technology with <FONT STYLE="white-space:nowrap">non-infringing</FONT> technology; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">stop manufacturing, offering for sale, selling, using, importing, exporting or licensing the product or technology incorporating the allegedly infringing technology or stop incorporating the allegedly infringing
technology into such product, service, or technology; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">obtain from the owner of the infringed intellectual property right a license, which may require us to pay substantial upfront fees or royalties to sell or use the relevant technology and which may not be available on
commercially reasonable terms, or at all; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">redesign our products, services, and technology so they do not infringe or violate the third party&#146;s intellectual property rights, which may not be possible or may require substantial monetary expenditures and
time; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">enter into cross-licenses with our competitors, which could weaken our overall intellectual property position; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">lose the opportunity to license our technology to others or to collect royalty payments based upon successful protection and assertion of our intellectual property against others; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">find alternative suppliers for <FONT STYLE="white-space:nowrap">non-infringing</FONT> products and technologies, which could be costly and create significant delay; or </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">relinquish rights associated with one or more of our patent claims, if our claims are held invalid or otherwise unenforceable. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Some of our competitors may be able to sustain the costs of complex intellectual property litigation more effectively than we can because they
have substantially greater resources. In addition, intellectual property litigation, regardless of its outcome, may cause negative publicity, adversely impact prospective customers, cause product shipment delays, or prohibit us from manufacturing,
marketing or otherwise commercializing our products, services and technology. Any uncertainties resulting from the initiation and continuation of any litigation could have a material adverse effect on our ability to raise additional funds or
otherwise have a material adverse effect on our business, results of operation, financial condition or cash flows. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we may
indemnify our customers and distributors against claims relating to the infringement of intellectual property rights of third parties related to our products. Third parties may assert infringement claims against our customers or distributors. These
claims may require us to initiate or defend protracted and costly litigation on behalf of our customers or distributors, regardless of the merits of these claims. If any of these claims succeed, we may be forced to pay damages on behalf of our
customers, suppliers or distributors, or may be required to obtain licenses for the products or services they use. If we cannot obtain all necessary licenses on commercially reasonable terms, our customers may be forced to stop using our products or
services. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there
is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. There could also be public announcements of the results of hearings, motions or other interim proceedings or developments, which
could have a material adverse effect on the price of our </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
common stock. If securities analysts or investors perceive these results to be negative, it could have a material adverse effect on the price of our common stock. The occurrence of any of these
events may have a material adverse effect on our business, results of operation, financial condition or cash flows. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we are unable to protect the
confidentiality of our trade secrets, our business and competitive position may be harmed. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to patent, copyright, and
trademark protection, we also rely on trade secrets, including unpatented <FONT STYLE="white-space:nowrap">know-how,</FONT> technology and other proprietary information, to maintain our competitive position. We seek to protect our trade secrets, in
part, by entering into <FONT STYLE="white-space:nowrap">non-disclosure</FONT> and confidentiality agreements with parties who have access to them, such as our consultants and vendors, or our former or current employees. We also enter into
confidentiality and invention and patent assignment agreements with our employees and consultants. Despite these efforts, however, any of these parties may breach the agreements and disclose our trade secrets and other unpatented or unregistered
proprietary information, and once disclosed, we are likely to lose trade secret protection. Monitoring unauthorized uses and disclosures of our intellectual property is difficult, and we do not know whether the steps we have taken to protect our
intellectual property will be effective. In addition, we may not be able to obtain adequate remedies for any such breaches. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive and
time-consuming, and the outcome is unpredictable. In addition, some courts inside and outside the United States are less willing or unwilling to enforce trade secret protection. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, our competitors may independently develop knowledge, methods and <FONT STYLE="white-space:nowrap">know-how</FONT> similar,
equivalent, or superior to our proprietary technology. Competitors could purchase our products and attempt to reverse engineer and replicate some or all of the competitive advantages we derive from our development efforts, willfully infringe our
intellectual property rights, design around our protected technology, or develop their own competitive technologies that fall outside of our intellectual property rights. In addition, our key employees, consultants, suppliers or other individuals
with access to our proprietary technology and <FONT STYLE="white-space:nowrap">know-how</FONT> may incorporate that technology and <FONT STYLE="white-space:nowrap">know-how</FONT> into projects and inventions developed independently or with third
parties. As a result, disputes may arise regarding the ownership of the proprietary rights to such technology or <FONT STYLE="white-space:nowrap">know-how,</FONT> and any such dispute may not be resolved in our favor. If any of our trade secrets
were to be lawfully obtained or independently developed by a competitor, we would have no right to prevent them, or those to whom they communicate it, from using that technology or information to compete with us and our competitive position could be
adversely affected. If our intellectual property is not adequately protected so as to protect our market against competitors&#146; products and processes, our competitive position could be adversely affected, as could our business. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Changes in patent law could diminish the value of patents in general, thereby impairing our ability to protect our existing and future products and
processes. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As is the case with other pharmaceutical and medical device companies, our success is heavily dependent on intellectual
property, particularly patents. Obtaining and enforcing patents in the biopharmaceutical industry involves both technological and legal complexity, and is therefore costly, time-consuming, and inherently uncertain. In addition, the United States has
recently enacted and is currently implementing wide-ranging patent reform legislation. Recent patent reform legislation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense
of our issued patents. On September&nbsp;16, 2011, the Leahy-Smith Act was signed into law. The Leahy-Smith Act includes a number of significant changes to U.S. patent law. These include provisions that affect the way patent applications are
prosecuted, redefine prior art, may affect patent litigation, and switched the United States patent system from a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;first-to-invent&#148;</FONT></FONT> system to a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;first-to-file&#148;</FONT></FONT> system. Under a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;first-to-file&#148;</FONT></FONT> system, assuming the other
requirements for patentability are met, the first inventor to file&nbsp;a patent application generally will be entitled to the patent on an invention regardless of whether another inventor had conceived or reduced to practice the invention earlier.
The USPTO recently developed new regulations and procedures to govern administration of the Leahy-Smith Act, and many of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
substantive changes to patent law associated with the Leahy-Smith Act, in particular, the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-to-file</FONT></FONT> provisions,
only became effective on March&nbsp;16, 2013. Accordingly, it is not clear what, if any, impact the Leahy-Smith Act will have on the operation of our business. The Leahy-Smith Act and its implementation could increase the uncertainties and costs
surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could have a material adverse effect on our business and financial condition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, patent reform legislation may pass in the future that could lead to additional uncertainties and increased costs surrounding the
prosecution, enforcement and defense of our patents and pending patent applications. Recent U.S. Supreme Court rulings have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in
certain situations. Furthermore, the U.S. Supreme Court and the U.S. Court of Appeals for the Federal Circuit have made, and will likely continue to make, changes in how the patent laws of the United States are interpreted. Similarly, foreign courts
have made, and will likely continue to make, changes in how the patent laws in their respective jurisdictions are interpreted. We cannot predict future changes in the interpretation of patent laws or changes to patent laws that might be enacted into
law by United States and foreign legislative bodies. Those changes may materially affect our patents or patent applications and our ability to obtain additional patent protection in the future. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Obtaining and maintaining patent protection depends on compliance with various procedural, document submission, fee payment and other requirements
imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for <FONT STYLE="white-space:nowrap">non-compliance</FONT> with these requirements. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment, and other
similar provisions during the patent application process. In addition, periodic maintenance fees on issued patents often must be paid to the USPTO and foreign patent agencies over the lifetime of the patent. While an unintentional lapse can in many
cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete
loss of patent rights in the relevant jurisdiction. <FONT STYLE="white-space:nowrap">Non-compliance</FONT> events that could result in abandonment or lapse of a patent or patent application include, but are not limited to, failure to respond to
official actions within prescribed time limits, <FONT STYLE="white-space:nowrap">non-payment</FONT> of fees and failure to properly legalize and submit formal documents. If we fail to maintain the patents and patent applications covering our
products or procedures, we may not be able to stop a competitor from marketing products that are the same as or similar to our own, which would have a material adverse effect on our business. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our markets of interest and our
business may be adversely affected. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our registered or unregistered trademarks or trade names may be challenged, infringed,
circumvented, declared generic or determined to be infringing on other marks. We may not be able to protect our rights in these trademarks and trade names, which we need in order to build name recognition with potential partners or customers in our
markets of interest. In addition, third parties have used trademarks similar and identical to our trademarks in foreign jurisdictions, and have filed or may in the future file for registration of such trademarks. If they succeed in registering or
developing common law rights in such trademarks, and if we are not successful in challenging such third-party rights, we may not be able to use these trademarks to market our products in those countries. In any case, if we are unable to establish
name recognition based on our trademarks and trade names, then we may not be able to compete effectively and our business may be adversely affected. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we cannot show access and copying then our copyrights may not provide protection for our software and our business may be adversely affected.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Copyrights protect works of authorship such as software, but proving infringement requires a showing of access to the work and
copying of the work. Because software is not readily available or accessible, it may be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
difficult to determine and prove that a third party had access to our software and/or that they copied our software. Because our software may be accessible by obtaining or accessing our product
offerings and technology, third parties may be able to download or reproduce our software and reverse engineer our software programs. Software programs can be rewritten in ways that significantly modify it from the original program, which may make
it difficult to prove the copying prong of a copyright infringement showing. If we are unable to establish the two prongs of a copyright infringement analysis, then our copyrights may provide limited or no protection for our software. Copyright
infringement suits are expensive and any damages we seek may be inadequate to compensate us for the costs of litigation and for damage to our business resulting from the copyright infringement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may not be able to adequately protect our intellectual property rights throughout the world. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Filing, prosecuting and defending patents on our products in all countries throughout the world would be prohibitively expensive. The
requirements for patentability may differ in certain countries, particularly developing countries, and the breadth of patent claims allowed can be inconsistent. In addition, the laws of some foreign countries may not protect our intellectual
property rights to the same extent as laws in the United States. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States. Competitors may use our technologies in
jurisdictions where we have not obtained patent protection to develop their own products and, further, may export otherwise infringing products to territories in which we have patent protection that may not be sufficient to terminate infringing
activities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not have patent rights in certain foreign countries in which a market may exist. Moreover, in foreign jurisdictions
where we do have patent rights, proceedings to enforce such rights could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly,
and our patent applications at risk of not issuing. Additionally, such proceedings could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate and the damages or other remedies awarded, if any, may
not be commercially meaningful. Thus, we may not be able to stop a competitor from marketing and selling in foreign countries products and services that are the same as or similar to our products and services, and our competitive position in the
international market would be harmed. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may not identify relevant third-party patents or may incorrectly interpret the relevance, scope or
expiration of a third-party patent which might adversely affect our ability to develop and market our products. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We cannot
guarantee that any of our or our licensors&#146; patent searches or analyses, including the identification of relevant patents, the scope of patent claims or the expiration of relevant patents, are complete or thorough, nor can we be certain that we
have identified each and every third-party patent and pending application in the United States and abroad that is relevant to or necessary for the commercialization of our products in any jurisdiction. For example, U.S. patent applications filed
before November&nbsp;29, 2000 and certain U.S. patent applications filed after that date that will not be filed outside the United States remain confidential until patents issue. Patent applications in the United States and elsewhere are published
approximately 18&nbsp;months after the earliest filing for which priority is claimed, with such earliest filing date being commonly referred to as the priority date. Therefore, patent applications covering our products could have been filed by
others without our knowledge. Additionally, pending patent applications that have been published can, subject to certain limitations, be later amended in a manner that could cover our product candidates or the use of our products. The scope of a
patent claim is determined by an interpretation of the law, the written disclosure in a patent and the patent&#146;s prosecution history. Our interpretation of the relevance or the scope of a patent or a pending application may be incorrect, which
may negatively impact our ability to market our products. We may incorrectly determine that our products are not covered by a third-party patent or may incorrectly predict whether a third party&#146;s pending patent application will issue with
claims of relevant scope. Our determination of the expiration date of any patent in the United States or abroad that we consider relevant may be incorrect, which may negatively impact our ability to develop and market our products and services. Our
failure to identify and correctly interpret relevant patents may negatively impact our ability to develop and market our products and services. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we fail to identify and correctly interpret relevant patents, we may be subject to
infringement claims. We cannot guarantee that we will be able to successfully settle or otherwise resolve such infringement claims. If we fail in any such dispute, in addition to being forced to pay damages, we may be temporarily or permanently
prohibited from commercializing any of our products that are held to be infringing. We might, if possible, also be forced to redesign products or services so that we no longer infringe the third-party intellectual property rights. Any of these
events, even if we were ultimately to prevail, could require us to divert substantial financial and management resources that we would otherwise be able to devote to our business. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Patent terms may be inadequate to protect our competitive position on our products for an adequate amount of time. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Patents have a limited lifespan, and the protection patents afford is limited. In the United States, if all maintenance fees are timely paid,
the natural expiration of a patent is generally 20&nbsp;years from its earliest U.S. <FONT STYLE="white-space:nowrap">non-provisional</FONT> filing date. Even if patents covering our products are obtained, once the patent life has expired for
patents covering a product, we may be open to competition from competitive products and services. As a result, our patent portfolio may not provide us with sufficient rights to exclude others from commercializing product candidates similar or
identical to ours. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Intellectual property rights do not necessarily address all potential threats to our business. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Once granted, patents may remain open to invalidity challenges including opposition, interference,
<FONT STYLE="white-space:nowrap">re-examination,</FONT> post-grant review, inter partes review, nullification or derivation action in court or before patent offices or similar proceedings for a given period after allowance or grant, during which
time third parties can raise objections against such grant. In the course of such proceedings, which may continue for a protracted period of time, the patent owner may be compelled to limit the scope of the allowed or granted claims thus attacked,
or may lose the allowed or granted claims altogether. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the degree of future protection afforded by our intellectual property
rights is uncertain because even granted intellectual property rights have limitations, and may not adequately protect our business, provide a barrier to entry against our competitors or potential competitors or permit us to maintain our competitive
advantage. Moreover, if a third party has intellectual property rights that cover the practice of our technology, we may not be able to fully exercise or extract value from our intellectual property rights. The following examples are illustrative:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">others may be able to develop and/or practice technology that is similar to our technology or aspects of our technology, but that are not covered by the claims of the patents that we own or control, assuming such
patents have issued or do issue; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we or our licensors or any future strategic partners might not have been the first to conceive or reduce to practice the inventions covered by the issued patents or pending patent applications that we own or have
exclusively licensed; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we or our licensors or any future strategic partners might not have been the first to file patent applications covering certain of our inventions; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">others may independently develop similar or alternative technologies or duplicate any of our technologies without infringing our intellectual property rights; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">it is possible that our pending patent applications will not lead to issued patents; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">issued patents that we own or have exclusively licensed may not provide us with any competitive advantage, or may be held invalid or unenforceable, as a result of legal challenges by our competitors; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our competitors might conduct research and development activities in countries where we do not have patent rights and then use the information learned from such activities to develop competitive products for sale in our
major commercial markets; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">third parties performing manufacturing or testing for us using our products or technologies could use the intellectual property of others without obtaining a proper license; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">parties may assert an ownership interest in our intellectual property and, if successful, such disputes may preclude us from exercising exclusive rights over that intellectual property; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we may not develop or <FONT STYLE="white-space:nowrap">in-license</FONT> additional proprietary technologies that are patentable; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we may not be able to obtain and maintain necessary licenses on commercially reasonable terms, or at all; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the patents of others may have an adverse effect on our business. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Should any of these events
occur, they could significantly harm our business and results of operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may be subject to claims that our employees, consultants or
independent contractors have wrongfully used or disclosed confidential information of their former employers or other third parties. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do and may employ individuals who were previously employed at universities or other pharmaceutical or medical device companies, including
our licensors, competitors or potential competitors. Although we try to ensure that our employees, consultants and independent contractors do not use the proprietary information or <FONT STYLE="white-space:nowrap">know-how</FONT> of others in their
work for us, and we are not currently subject to any claims that our employees, consultants or independent contractors have wrongfully used or disclosed confidential information of third parties, we may in the future be subject to such claims.
Litigation may be necessary to defend against these claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel. Such intellectual property rights could be
awarded to a third party, and we could be required to obtain a license from such third party to commercialize our technology or products. Such a license may not be available on commercially reasonable terms or at all. Even if we are successful in
defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees, and could result in customers seeking other sources for the technology, or in ceasing from doing business with us.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our intellectual property agreements with third parties may be subject to disagreements over contract interpretation, which could narrow the scope
of our rights to the relevant intellectual property or technology. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain provisions in our intellectual property agreements may
be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could affect the scope of our rights to the relevant intellectual property or technology, or affect financial or other obligations
under the relevant agreement, either of which could have a material adverse effect on our business, financial condition, results of operations and prospects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, while it is our policy to require our employees and contractors who may be involved in the conception or development of
intellectual property to execute agreements assigning such intellectual property to us, we may be unsuccessful in executing such an agreement with each party who in fact conceives or develops intellectual property that we regard as our own. Our
assignment agreements may not be self-executing or may be breached, and we may be forced to bring claims against third parties, or defend claims they may bring against us, to determine the ownership of what we regard as our intellectual property.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may not be successful in obtaining necessary intellectual property rights to future products through acquisitions and <FONT
STYLE="white-space:nowrap">in-licenses.</FONT> </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although we intend to develop products and technology through our own internal
research, we may also seek to acquire or <FONT STYLE="white-space:nowrap">in-license</FONT> technologies to grow our product offerings and technology portfolio. However, we may be unable to acquire or
<FONT STYLE="white-space:nowrap">in-license</FONT> intellectual property rights relating to, or necessary for, any such products </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or technology from third parties on commercially reasonable terms or at all. In that event, we may be unable to develop or commercialize such products or technology. We may also be unable to
identify products or technology that we believe are an appropriate strategic fit for our company and protect intellectual property relating to, or necessary for, such products and technology. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">in-licensing</FONT> and acquisition of third-party intellectual property rights for product candidates is
a competitive area, and a number of more established companies are also pursuing strategies to <FONT STYLE="white-space:nowrap">in-license</FONT> or acquire third-party intellectual property rights for products that we may consider attractive or
necessary. These established companies may have a competitive advantage over us due to their size, cash resources and greater clinical development and commercialization capabilities. Furthermore, companies that perceive us to be a competitor may be
unwilling to assign or license rights to us. If we are unable to successfully obtain rights to additional technologies or products, our business, financial condition, results of operations and prospects for growth could suffer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we expect that competition for the <FONT STYLE="white-space:nowrap">in-licensing</FONT> or acquisition of third-party
intellectual property rights for products and technologies that are attractive to us may increase in the future, which may mean fewer suitable opportunities for us as well as higher acquisition or licensing costs. We may be unable to <FONT
STYLE="white-space:nowrap">in-license</FONT> or acquire the third-party intellectual property rights for products or technology on terms that would allow us to make an appropriate return on our investment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Regulation of our Industry </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our
future success depends on our ability to develop, receive regulatory clearance or approval for, and introduce new products or product enhancements that will be accepted by the market in a timely manner. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is important to our business that we build a pipeline of product offerings for treatment of our target indications. As such, our success
will depend in part on our ability to develop and introduce new products. However, we may not be able to successfully develop and obtain regulatory clearance or approval for product enhancements, or new products, or these products may not be
accepted by physicians or the payors who financially support many of the procedures performed with our products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The success of any new
product offering or enhancement to an existing product will depend on a number of factors, including our ability to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">identify and anticipate physician and patient needs properly; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">develop and introduce new products or product enhancements in a timely manner; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">avoid infringing upon the intellectual property rights of third parties; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">demonstrate, if required, the safety and efficacy of new products with data from preclinical and clinical studies; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">obtain the necessary regulatory clearances or approvals for new products or product enhancements; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">comply fully with FDA and foreign regulations on marketing of new devices or modified products; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">provide adequate training to potential users of our products; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">receive adequate coverage and reimbursement for procedures performed with our products. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we
do not develop new products or product enhancements in time to meet market demand or if there is insufficient demand for these products or enhancements, or if our competitors introduce new products with functionalities that are superior to ours, our
results of operations will suffer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>gammaCore is subject to extensive governmental regulation, and our failure to comply with applicable
requirements could cause our business to suffer. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The medical device industry is regulated extensively by governmental authorities,
principally the FDA and corresponding state and foreign regulatory agencies and authorities, such as the EU legislative bodies and the EEA Member States, Competent Authorities and notified bodies. The FDA and other U.S., EEA and foreign governmental
agencies and authorities regulate and oversee, among other things, with respect to medical devices: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">design, development and manufacturing; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">testing, labeling, content and language of instructions for use and storage; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">clinical trials; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">product safety; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">risk assessment and management; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">marketing, sales and distribution; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">pre-market</FONT> regulatory clearance and approval; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">conformity assessment procedures; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">record-keeping procedures; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">advertising and promotion; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">recalls and other field safety corrective actions; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">post-market surveillance, including reporting of deaths or serious injuries and malfunctions that, if they were to recur, could lead to death or serious injury; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">post-market studies; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">product import and export. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The laws and regulations to which we are subject are complex and
have tended to become more stringent over time. Legislative or regulatory changes could result in restrictions on our ability to carry on or expand our operations, higher than anticipated costs or lower than anticipated sales. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our failure to comply with U.S. federal and state regulations or EEA or other foreign regulations applicable in the countries where we operate
could lead to the issuance of warning letters or untitled letters, the imposition of injunctions, suspensions or loss of regulatory clearance or approvals, product recalls, termination of distribution, product seizures or civil penalties. In the
most extreme cases, criminal sanctions or closure of our manufacturing facilities are possible. If any of these risks materialize, our business would be adversely affected. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>gammaCore is also subject to extensive governmental regulation in foreign jurisdictions, such as Europe, and our failure to comply with applicable
requirements could cause our business to suffer. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the EEA, gammaCore must comply with the Essential Requirements laid down in
Annex&nbsp;I to Directive 93/42/EEC on the approximation of the laws of the Member States relating to medical devices or the EU Medical Devices Directive. Compliance with these requirements is a prerequisite to be able to affix the CE mark to
gammaCore, without which they cannot be marketed or sold in the EEA. To demonstrate compliance with the Essential Requirements and obtain the right to affix the CE Mark medical devices manufacturers must undergo a conformity assessment procedure,
which varies according to the type of medical device and its classification. Except for low risk medical devices (Class&nbsp;I with no measuring function and which are not sterile), where the manufacturer can issue an EC Declaration of Conformity
based on a self-assessment of the conformity of its products with the Essential Requirements, a conformity assessment procedure requires the intervention of a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Notified Body, which is an organization designated by a competent authority of an EEA country to conduct conformity assessments. Depending on the relevant conformity assessment procedure, the
Notified Body would audit and examine the Technical File and the quality system for the manufacture, design and final inspection of the medical devices. The Notified Body issues a CE Certificate of Conformity following successful completion of a
conformity assessment procedure conducted in relation to the medical device and its manufacturer and their conformity with the Essential Requirements. This Certificate entitles the manufacturer to affix the CE mark to its medical devices after
having prepared and signed a related EC Declaration of Conformity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a general rule, demonstration of conformity of medical devices and
their manufacturers with the Essential Requirements must be based, among other things, on the evaluation of clinical data supporting the safety and performance of the products during normal conditions of use. Specifically, a manufacturer must
demonstrate that the device achieves its intended performance during normal conditions of use and that the known and foreseeable risks, and any adverse events, are minimized and acceptable when weighed against the benefits of its intended
performance, and that any claims made about the performance and safety of the device, such as product labeling and instructions for use, are supported by suitable evidence. This assessment must be based on clinical data, which can be obtained from
(1)&nbsp;clinical studies conducted on the devices being assessed, (2)&nbsp;scientific literature from similar devices whose equivalence with the assessed device can be demonstrated or (3)&nbsp;both clinical studies and scientific literature. With
respect to Class&nbsp;III devices, the manufacturer must conduct clinical studies to obtain the required clinical data, unless reliance on existing clinical data from equivalent devices can be justified. The conduct of clinical studies in the EEA is
governed by detailed regulatory obligations. These may include the requirement of prior authorization by the competent authorities of the country in which the study takes place and the requirement to obtain a positive opinion from a competent Ethics
Committee. This process can be expensive and time-consuming. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Moreover, on May 25, 2017 the new Medical Devices Regulation (2017/745 or
MDR) entered into force. Following its entry into application on May 26, 2020, the Regulations will introduce substantial changes to the obligations with which medical device manufacturers must comply in the EU. High risk medical devices will be
subject to additional scrutiny during the conformity assessment procedure. Specifically, the EU Medical Devices Regulation repeals and replaces the EU Medical Devices Directive. Unlike directives, which must be implemented into the national laws of
the EEA Member States, the regulations would be directly applicable, i.e., without the need for adoption of EEA Member State laws implementing them, in all EEA Member States and are intended to eliminate current differences in the regulation of
medical devices among EEA Member States. The EU Medical Devices Regulation, among other things, is intended to establish a uniform, transparent, predictable and sustainable regulatory framework across the EEA for medical devices and ensure a high
level of safety and health while supporting innovation. The EU Medical Devices Regulation will however only become applicable three years after publication (in May 2020). Once applicable, the new regulations will among other things: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">strengthen the rules on placing devices on the market and reinforce surveillance once they are available; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">establish explicit provisions on manufacturers&#146; responsibilities for the <FONT STYLE="white-space:nowrap">follow-up</FONT> of the quality, performance and safety of devices placed on the market; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">improve the traceability of medical devices throughout the supply chain to the <FONT STYLE="white-space:nowrap">end-user</FONT> or patient through a unique identification number; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">set up a central database to provide patients, healthcare professionals and the public with comprehensive information on products available in the EU; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">strengthened rules for the assessment of certain high-risk devices which may have to undergo an additional check by experts before they are placed on the market. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Once applicable, the Medical Devices Regulation may impose increased compliance obligations for us to access the EU market. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to continue to sell gammaCore in Europe, we must maintain our CE Mark and continue
to comply with certain EU Directives and, in the future with the EU Medical Devices Regulation. Our failure to continue to comply with applicable foreign regulatory requirements, including those administered by authorities of the EEA countries,
could result in enforcement actions against us, including refusal, suspension or withdrawal of our CE Certificates of Conformity by our Notified Body (the British Standards Institution, or BSI), which could impair our ability to market products in
the EEA in the future. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we fail to maintain regulatory approvals and clearances, or are unable to obtain, or experience significant delays in
obtaining, FDA clearances or approvals for our future products or product enhancements, our ability to commercially distribute and market these products could suffer. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our products are subject to rigorous regulation by the FDA and numerous other federal, state and foreign governmental authorities. The process
of obtaining regulatory clearances or approvals to market a medical device can be costly and time consuming, and we may not be able to obtain these clearances or approvals on a timely basis, if at all. In particular, the FDA permits commercial
distribution of a new medical device only after the device has received clearance under Section&nbsp;510(k) of the Federal Food, Drug and Cosmetic Act, or is the subject of an approved premarket approval application, or PMA unless the device is
specifically exempt from those requirements. The FDA will clear marketing of a lower risk medical device through the 510(k) process if the manufacturer demonstrates that the new product is substantially equivalent to a legally marketed
&#147;predicate&#148; device. High risk devices deemed to pose the greatest risk, such as life-sustaining, life-supporting, or implantable devices, or devices not deemed substantially equivalent to a legally marketed &#147;predicate&#148; device,
require the approval of a PMA. The PMA process is more costly, lengthy and uncertain than the 510(k) clearance process. A PMA application must be supported by extensive data, including, but not limited to, technical, preclinical, clinical trial,
manufacturing and labeling data, to demonstrate to the FDA&#146;s satisfaction the safety and efficacy of the device for its intended use. Our currently commercialized gammaCore products have been cleared through the 510(k) process. However, we may
need to submit a PMA to expand our labeling claims to include certain indications. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our failure to comply with U.S. federal, state and
foreign governmental regulations could lead to the issuance of warning letters or untitled letters, the imposition of injunctions, suspensions or loss of regulatory clearance or approvals, product recalls, termination of distribution, product
seizures or civil penalties. In the most extreme cases, criminal sanctions or closure of our manufacturing facility are possible. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Foreign
governmental authorities that regulate the manufacture and sale of medical devices have become increasingly stringent and, to the extent we market and sell our products internationally, we may be subject to rigorous international regulation in the
future. In these circumstances, we would rely significantly on our foreign independent distributors to comply with the varying regulations, and any failures on their part could result in restrictions on the sale of our products in foreign countries.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Modifications to our products may require new regulatory clearances or approvals or may require us to recall or cease marketing our products until
clearances or approvals are obtained. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Modifications to or expansion of our indications for use of our gammaCore products may
require new regulatory approvals or clearances, including 510(k) clearances or PMA approvals, or require us to recall or cease marketing the modified devices until these clearances or approvals are obtained. The FDA requires device manufacturers to
initially make and document a determination of whether or not a modification requires a new approval, supplement or clearance. A manufacturer may determine that a modification does not significantly affect safety or efficacy and does not represent a
major change in its intended use, so that no new 510(k) clearance is not necessary. However, the FDA can review a manufacturer&#146;s decision and may disagree. The FDA may also on its own initiative determine that a new clearance or approval is
required. We may make modifications to our products in the future that we believe do not or will not require additional clearances or approvals. If the FDA disagrees and requires new clearances or approvals for the modifications, we may be
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
required to recall and to stop marketing our products as modified, which could require us to redesign our products and harm our operating results. In these circumstances, we may be subject to
significant enforcement actions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a manufacturer determines that a modification to an
<FONT STYLE="white-space:nowrap">FDA-cleared</FONT> device could significantly affect its safety or efficacy, or would constitute a major change in its intended use, then the manufacturer must file for a new 510(k) clearance or possibly a PMA
application. Where we determine that modifications to our products require a new 510(k) clearance or PMA application, we may not be able to obtain those additional clearances or approvals for the modifications or additional indications in a timely
manner, or at all. For those products sold in the EU, we must notify our E.U. Notified Body, if significant changes are made to the products or if there are substantial changes to our quality assurance systems affecting those products. Obtaining
clearances and approvals can be a time consuming process, and delays in obtaining required future clearances or approvals would adversely affect our ability to introduce new or enhanced products in a timely manner, which in turn would harm our
future growth. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>There is no guarantee that the FDA will grant 510(k) clearance or PMA approval of our future products and failure to obtain
necessary clearances or approvals for our future products would adversely affect our ability to grow our business. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Some of our new
products or expanded indications for use will require FDA clearance of a 510(k), or may require FDA approval of a PMA. The FDA may not approve or clear these products for the indications that are necessary or desirable for successful
commercialization. Indeed, the FDA may refuse our requests for 510(k) clearance or premarket approval of new products, new intended uses or modifications to existing products. Failure to receive clearance or approval for our new products would have
an adverse effect on our ability to expand our business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Even if our products are cleared or approved by regulatory authorities, if we or our
suppliers fail to comply with ongoing FDA or other foreign regulatory authority requirements, or if we experience unanticipated problems with our products, these products could be subject to restrictions or withdrawal from the market. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any product for which we obtain clearance or approval, and the manufacturing processes, reporting requirements, post-approval clinical data and
promotional activities for such product, will be subject to continued regulatory review, oversight and periodic inspections by the FDA and other domestic and foreign regulatory bodies. In particular, we and our suppliers are required to comply with
FDA&#146;s Quality System Regulation, or QSR, and International Standards Organization, or ISO, regulations for the manufacture of our products and other regulations which cover the methods and documentation of the design, testing, production,
control, quality assurance, labeling, packaging, storage and shipping of any product for which we obtain clearance or approval. Regulatory bodies, such as the FDA, enforce the QSR and other regulations through periodic inspections. The failure by us
or one of our suppliers to comply with applicable statutes and regulations administered by the FDA and other regulatory bodies, or the failure to timely and adequately respond to any adverse inspectional observations or product safety issues, could
result in, among other things, any of the following enforcement actions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">untitled letters, warning letters, fines, injunctions, consent decrees and civil penalties; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">unanticipated expenditures to address or defend such actions </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">customer notifications for repair, replacement, refunds; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">recall, detention or seizure of our products; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">operating restrictions or partial suspension or total shutdown of production; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">refusing or delaying our requests for 510(k) clearance or PMA approval of new products or modified products; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">operating restrictions; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">withdrawing 510(k) clearances on PMA approvals that have already been granted; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">refusal to grant export approval for our products; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">criminal prosecution. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any of these actions were to occur it would harm our reputation and
cause our product sales and profitability to suffer and may prevent us from generating revenue. Furthermore, our key component suppliers may not currently be or may not continue to be in compliance with all applicable regulatory requirements which
could result in our failure to produce our products on a timely basis and in the required quantities, if at all. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Even if regulatory
clearance or approval of a product is granted, such clearance or approval may be subject to limitations on the intended uses for which the product may be marketed and reduce our potential to successfully commercialize the product and generate
revenue from the product. If the FDA determines that our promotional materials, labeling, training or other marketing or educational activities constitute promotion of an unapproved use, it could request that we cease or modify our training or
promotional materials or subject us to regulatory enforcement actions. It is also possible that other federal, state or foreign enforcement authorities might take action if they consider our training or other promotional materials to constitute
promotion of an unapproved use, which could result in significant fines or penalties under other statutory authorities, such as laws prohibiting false claims for reimbursement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we may be required to conduct costly post-market testing and surveillance to monitor the safety or effectiveness of our products,
and we must comply with medical device reporting, or MDR, requirements, including the reporting of adverse events and malfunctions related to our products. Later discovery of previously unknown problems with our products, including unanticipated
adverse events or adverse events of unanticipated severity or frequency, manufacturing problems, or failure to comply with regulatory requirements such as QSR may result in changes to labeling, restrictions on such products or manufacturing
processes, withdrawal of the products from the market, voluntary or mandatory recalls, a requirement to repair, replace or refund the cost of any medical device we manufacture or distribute, fines, suspension of regulatory clearances or approvals,
product seizures, injunctions or the imposition of civil or criminal penalties which would adversely affect our business, operating results and prospects. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The misuse or <FONT STYLE="white-space:nowrap">off-label</FONT> use of our gammaCore therapy may harm our image in the marketplace, result in injuries
that lead to product liability suits, which could be costly to our business, or result in costly investigations and sanctions from the FDA and other regulatory bodies if we are deemed to have engaged in
<FONT STYLE="white-space:nowrap">off-label</FONT> promotion. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">gammaCore has been CE Marked in the EEA and cleared by the FDA for
the acute treatment of eCH and the acute treatment of migraine headache in the United States. We may only promote or market our gammaCore therapy for its specifically approved indications as described on the approved label. We train our marketing
and sales force against promoting our products for uses outside of the approved indications for use, known as <FONT STYLE="white-space:nowrap">&#147;off-label</FONT> uses.&#148; We cannot, however, prevent a physician from prescribing our product <FONT
STYLE="white-space:nowrap">off-label,</FONT> when in the physician&#146;s independent professional medical judgment he or she deems appropriate. There may be increased risk of injury to patients if patients attempt to use our product <FONT
STYLE="white-space:nowrap">off-label.</FONT> Furthermore, the use of our product for indications other than those cleared or approved by the applicable regulatory body may not effectively treat such conditions, which could harm our reputation in the
marketplace among physicians and patients. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Patients may also misuse our product or use improper techniques if they are not adequately
trained, potentially leading to injury and an increased risk of product liability. If our product is misused or used with improper technique, we may become subject to costly litigation by our customers or their patients. Product liability claims
could divert management&#146;s attention from our core business, be expensive to defend, and result in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
sizable damage awards against us that may not be covered by insurance. In addition, if our products are approved for sale in the United States and the FDA determines that our promotional
materials or training constitute promotion of an <FONT STYLE="white-space:nowrap">off-label</FONT> use, it could request that we modify our training or promotional materials or subject us to regulatory or enforcement actions, including the issuance
of an untitled letter, a warning letter, injunction, seizure, civil fine or criminal penalties. It is also possible that other federal, state or foreign enforcement authorities might take action if they consider our business activities to constitute
promotion of an <FONT STYLE="white-space:nowrap">off-label</FONT> use, which could result in significant penalties, including, but not limited to, criminal, civil and/or administrative penalties, damages, fines, disgorgement, exclusion from
participation in government healthcare programs, and the curtailment of our operations. Further, our competitors could bring civil actions under relevant unfair competition and advertising laws should they believe our business activities and product
promotional activities are improper. Any of these events could significantly harm our business and results of operations and cause our stock price to decline. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, the advertising and promotion of our products is subject to EEA Member States&#146; national laws implementing Directive 93/42/EEC on
the approximation of the laws of the Member States relating to medical devices, Directive 2006/114/EC concerning misleading and comparative advertising, and Directive 2005/29/EC on unfair commercial practices, as well as other EEA Member State
legislation governing the advertising and promotion of medical devices. EEA Member State legislation may also restrict or impose limitations on our ability to advertise our products directly to the general public. In addition, voluntary EU and
national Codes of Conduct provide guidelines on the advertising and promotion of our products to the general public and may impose limitations on our promotional activities with healthcare professionals. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>gammaCore may in the future be subject to notifications, recalls, or voluntary market withdrawals that could harm our reputation, business and financial
results. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The FDA, EEA Competent Authorities and similar foreign governmental authorities have the authority to request or require
the recall of commercialized products in the event of regulatory noncompliance or material deficiencies or defects in design or manufacture that could affect patient safety. In the case of the FDA, the authority to require a recall must be based on
an FDA finding that there is a reasonable probability that the device would cause serious injury or death. In addition, foreign governmental bodies have the authority to require the recall of our products in the event of material deficiencies or
defects in design or manufacture. Manufacturers may, under their own initiative, recall a product if any material deficiency in a device is found. A government-mandated or voluntary recall by us or one of our distributors could occur as a result of
component failures, manufacturing errors, design or labeling defects or other deficiencies and issues. Recalls of any of our products would divert managerial and financial resources and have an adverse effect on our financial condition and results
of operations. We must notify the FDA of all device recalls and corrections, and certain classifications of recalls and corrections require more extensive reporting within 10 working days after the recall is initiated. Companies are required to
maintain certain records of recalls and corrections, even if they are not subject to more extensive reporting requirements. We may initiate voluntary market withdrawals or other market actions involving our gammaCore products in the future that we
determine do not require notification of the FDA. If the FDA disagrees with our determinations, they could require us to report those actions as recalls. A future recall announcement could harm our reputation with customers and negatively affect our
sales. In addition, the FDA could take enforcement action for failing to report the recalls or corrections when they were conducted. Consumer class action claims and/or product liability claims are a greater risk following a product recall or market
withdrawal. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We are required to report certain malfunctions, deaths, and serious injuries associated with our products, which can result in
voluntary corrective actions or agency enforcement actions. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the FDA MDR regulations, medical device manufacturers are
required to submit information to the FDA when they receive a report or become aware that a device has or may have caused or contributed to a death or serious injury or has or may have a malfunction that would likely cause or contribute to death or
serious injury if the malfunction were to recur. All manufacturers placing medical devices on the market in the EEA are legally </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
bound to report incidents involving devices they produce or sell to the regulatory agency, or competent authority, in whose jurisdiction the incident occurred. Under the Directive 93/42/EEC on
the approximation of the laws of the Member States relating to medical devices, an incident is defined as any malfunction or deterioration in the characteristics and/or performance of a device, as well as any inadequacy in the labeling or the
instructions for use which, directly or indirectly, might lead to or might have led to the death of a patient, or user or of other persons or to a serious deterioration in their state of health. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Malfunction of our products could result in future voluntary corrective actions, such as recalls, including corrections, or customer
notifications, or agency action, such as inspection or enforcement actions. If malfunctions do occur, we may be unable to correct the malfunctions adequately or prevent further malfunctions, in which case we may need to cease manufacture and
distribution of the affected products, initiate voluntary recalls, and redesign the products. Regulatory authorities may also take actions against us, such as ordering recalls, imposing fines, or seizing the affected products. Any corrective action,
whether voluntary or involuntary, will require the dedication of our time and capital, distract management from operating our business, and may harm our reputation and financial results. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Legislative or regulatory reforms may make it more difficult and costly for us to obtain regulatory approval of our product candidates and to
manufacture, market and distribute our products after approval is obtained. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From time to time, legislation is drafted and
introduced in Congress that could significantly change the statutory provisions governing the regulatory approval, manufacture and marketing of regulated products or the reimbursement thereof. In addition, FDA regulations and guidance are often
revised or reinterpreted by the FDA in ways that may significantly affect our business and our products. Any new regulations or revisions or reinterpretations of existing regulations may impose additional costs or lengthen review times of future
products. It is impossible to predict whether legislative changes will be enacted or FDA regulations, guidance or interpretations changed, and what the impact of such changes, if any, may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Moreover, the policies of the Trump Administration and their impact on the regulation of our products in the United States remain
uncertain.&nbsp;The outcome of the 2016 election and the forthcoming 2018 <FONT STYLE="white-space:nowrap">mid-term</FONT> elections could result in significant legislative and regulatory reforms impacting the FDA&#146;s regulation of our
products.&nbsp;Any change in the laws or regulations that govern the clearance and approval processes relating to our current and future products could make it more difficult and costly to obtain clearance or approval for new products, or to
produce, market and distribute existing products. Significant delays in receiving clearance or approval, or the failure to receive clearance or approval for our new products would have an adverse effect on our ability to expand our business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the EU, on May&nbsp;25, 2017 the new Medical Devices Regulation (2017/745 or MDR) was adopted. Following its entry into application on
May&nbsp;26, 2020, the Regulations will introduce substantial changes to the obligations with which medical device manufacturers must comply in the EU. High risk medical devices will be subject to additional scrutiny during the conformity assessment
procedure. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We are subject to federal, state and foreign healthcare laws and regulations, and a finding of failure to comply with such laws and
regulations could have a material adverse effect on our business. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are subject to healthcare fraud and abuse regulation and
enforcement by federal, state and foreign governments, which could significantly impact our business. In the United States, the laws that may affect our ability to operate include, but are not limited to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal Anti-Kickback Statute, which prohibits, among other things, persons and entities from knowingly and
willfully soliciting, receiving, offering, or paying remuneration, directly or indirectly, in cash or in kind, in exchange for or to induce either the referral of an individual for, or the purchase, lease, order or recommendation of, any good,
facility, item or service for which payment may be made, </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
in whole or in part, under federal healthcare programs such as Medicare and Medicaid. A person or entity does not need to have actual knowledge of this statute or specific intent to violate it in
order to have committed a violation. Moreover, the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the federal
civil False Claims Act. Violations of the federal Anti-Kickback Statute may result in civil monetary penalties up to $74,792 (and adjusted for inflation) for each violation, plus up to three times the remuneration involved. Civil penalties for such
conduct can further be assessed under the federal False Claims Act. Violations can also result in criminal penalties, including criminal fines of up to $100,000 and imprisonment of up to 10&nbsp;years. Similarly, violations can result in exclusion
from participation in government healthcare programs, including Medicare and Medicaid; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">in the event that third-party payors require us to be a durable medical equipment, or DME, supplier or we sell our products directly to providers who are DME suppliers that submit claims to such payors, we may be
subject to the federal Stark physician self-referral law, which prohibits a physician from making a referral for certain designated health services covered by the Medicare program, including DME, if the physician or an immediate family member has a
financial relationship with the entity providing the designated health services, and prohibits that entity from billing or presenting a claim for the designated health services furnished pursuant to the prohibited referral, unless an exception
applies. Sanctions for violating the Stark Law include denial of payment, civil monetary penalties of up to $24,253 (and adjusted for inflation) per claim submitted and exclusion from the federal health care programs. Failure to refund amounts
received as a result of a prohibited referral on a timely basis may constitute a false or fraudulent claim and may result in civil penalties and additional penalties under the FCA. The statute also provides for a penalty of up to $161,692 (and
adjusted for inflation) for a circumvention scheme. Various states also have corollary laws to the Stark Law, including laws that require physicians to disclose any financial interest they may have with a healthcare provider to their patients when
referring patients to that provider. Both the scope and exceptions for such laws vary from state to state. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">federal civil and criminal false claims laws and civil monetary penalty laws, including civil whistleblower or qui tam actions, that prohibit, among other things, knowingly presenting, or causing to be presented, claims
for payment of federal funds that are false or fraudulent, knowingly making a false statement material to an obligation to pay or transmit money or property to the federal government or knowingly concealing or knowingly and improperly avoiding or
decreasing an obligation to pay or transmit money or property to the federal government. These laws can apply to manufacturers who provide information on coverage, coding, and reimbursement of their products to persons who bill third-party payors.
Private individuals can bring False Claims Act &#147;qui tam&#148; actions, on behalf of the government and such individuals, commonly known as &#147;whistleblowers,&#148; may share in amounts paid by the entity to the government in fines or
settlement. When an entity is determined to have violated the federal civil False Claims Act, the government may impose civil fines and penalties ranging from $11,181 to $22,363 for each false claim, plus treble damages, and exclude the entity from
participation in Medicare, Medicaid and other federal healthcare programs; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, which created federal criminal laws that prohibit executing a scheme to defraud any healthcare benefit program or making false
statements relating to healthcare matters. A person or entity does not need to have actual knowledge of these statutes or specific intent to violate them; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH,
and their respective implementing regulations, which impose requirements on certain covered healthcare providers, health plans and healthcare clearinghouses as well as their business associates that perform services for them that involve
individually identifiable health information, relating to the privacy, security and transmission of individually identifiable health information without appropriate authorization, including mandatory contractual terms as well as
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
directly applicable privacy and security standards and requirements. Failure to comply with the HIPAA privacy and security standards can result in civil monetary penalties up to $55,910&nbsp;per
violation, not to exceed $1.68&nbsp;million per calendar year for <FONT STYLE="white-space:nowrap">non-compliance</FONT> of an identical provision, and, in certain circumstances, criminal penalties with fines up to $250,000 per violation and/or
imprisonment. State attorneys general can also bring a civil action to enjoin a HIPAA violation or to obtain statutory damages on behalf of residents of his or her state; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the federal physician sunshine requirements under the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act, or collectively, the ACA, which require certain
applicable manufacturers of drugs, devices, biologics, and medical supplies for which payment is available under Medicare, Medicaid or the Children&#146;s Health Insurance Program, or CHIP, to report annually to the U.S. Department of Health and
Human Services Centers for Medicare and Medicaid Services, or CMS, information related to payments and other transfers of value to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals,
and ownership and investment interests held by physicians and their immediate family members. Applicable manufacturers are required to submit annual reports to CMS. Failure to submit required information may result in civil monetary penalties of
between $1,105 and $11,052 per failure (up to an aggregate of $165,786 per year), and between $11,052 and $110,524 per &#147;knowing&#148; failure (up to an aggregate of $1.105&nbsp;million per year), for all payments, transfers of value or
ownership or investment interests that are not timely, accurately, and completely reported in an annual submission, and may result in liability under other federal laws or regulations; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">state and foreign law equivalents of each of the above federal laws, such as state anti-kickback and false claims laws that may apply to items or services reimbursed by any third-party payor, including commercial
insurers; state laws that require device companies to comply with the industry&#146;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government, or otherwise restrict payments that may be made to
healthcare providers and other potential referral sources; state laws that require device manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers or marketing expenditures;
and state and foreign laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and often are not preempted by HIPAA. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These laws and regulations, among other things, constrain our business, marketing and other promotional activities by limiting the kinds of
financial arrangements we may have with physicians or other entities or individuals in a position to prescribe or recommend our products. We have entered into consulting agreements and other arrangements with physicians, including some who have
ownership interests in us and/or prescribe our products to patients. Compensation under some of these arrangements includes the provision of Profits Interests in our company. We could be adversely affected if regulatory agencies determine our
financial relationships with such physicians to be in violation of applicable laws. Due to the breadth of these laws, the narrowness of statutory exceptions and regulatory safe harbors available, and the range of interpretations to which they are
subject, it is possible that some of our current or future practices might be challenged under one or more of these laws. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The scope
and enforcement of each of these laws is uncertain and subject to rapid change in the current environment of healthcare reform, especially in light of the lack of applicable precedent and regulations. Federal and state enforcement bodies have
recently increased their scrutiny of interactions between healthcare companies and healthcare providers, which has led to a number of investigations, prosecutions, convictions and settlements in the healthcare industry. Responding to investigations
can be <FONT STYLE="white-space:nowrap">time-and</FONT> resource-consuming and can divert management&#146;s attention from the business. Additionally, as a result of these investigations, healthcare providers and entities may have to agree to
additional onerous compliance and reporting requirements as part of a consent decree or corporate integrity agreement. Any such investigation or settlement could increase our costs or otherwise have an adverse effect on our business. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If our operations are challenged or found to be in violation of any of the laws described
above or any other governmental regulations that apply to us now or in the future, we may be subject to penalties, including civil and criminal penalties, damages, fines, disgorgement, exclusion from governmental health care programs, and the
curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business and our financial results. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Healthcare legislative reform measures may have a material adverse effect on us. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the United States, there have been and continue to be a number of legislative initiatives to contain healthcare costs. ACA, which was passed
in 2010, substantially changed the way health care is financed by both governmental and private insurers and significantly impacts the U.S. healthcare industry. The ACA included, among other things, a deductible 2.3% excise tax on any entity that
manufactures or imports medical devices offered for sale in the United States, with limited exceptions, effective January&nbsp;1, 2013. Through a series of legislative amendments, the tax was suspended for 2016 through 2019. Absent further
legislative action, the device excise tax will be reinstated on medical device sales starting January&nbsp;1, 2020. If reinstated, this excise tax would result in a significant increase in the tax burden on our industry, and if the efforts we would
undertake to offset the excise tax are unsuccessful as we begin to sell the product in the United States, the potential increased tax burden could have an adverse effect on our results of operations and cash flows. Other elements of the ACA,
including comparative effectiveness research and payment system reforms, including shared savings pilots and other provisions, may significantly affect the payment for, and the availability of, healthcare services and result in fundamental changes
to federal healthcare reimbursement programs, any of which may materially affect numerous aspects of our business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not yet know the
full impact that the ACA will have on our business. The taxes imposed by the ACA and the expansion in the government&#146;s role in the U.S. healthcare industry may result in decreased profits to us, lower reimbursement by payors for our products,
and/or reduced medical procedure volumes, all of which may have a material adverse impact on our business, financial condition, results of operations, or cash flows. Certain legislative changes to, and regulatory changes under, the ACA have occurred
in the 115<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Congress and under the Trump Administration. For instance, the Tax Cuts and Jobs Acts was enacted, which, among other things, removes penalties for not complying with the individual
mandate to carry health insurance beginning in 2019. Additional legislative changes to and regulatory changes under the ACA remain possible. Moreover, all or a portion of the ACA and related subsequent legislation may be modified, repealed or
otherwise invalidated through judicial challenge, which could result in lower numbers of insured individuals, reduced coverage for insured individuals and adversely affect our business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, other legislative changes have been proposed and adopted in the United States since the ACA was enacted. On August&nbsp;2, 2011,
the Budget Control Act of 2011 among other things includes aggregate reductions of Medicare payments to providers of 2% per fiscal year, which went into effect on April&nbsp;1, 2013, and will remain in effect through 2027 unless additional
Congressional action is taken. On January&nbsp;2, 2013, the American Taxpayer Relief Act of 2012 was signed into law which, among other things, further reduced Medicare payments to certain providers, including hospitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect that additional state and federal healthcare reform measures will be adopted in the future, any of which could limit the amounts
that federal and state governments will pay for healthcare products and services, which could result in reduced demand for our product candidates or additional pricing pressures. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Common Stock and This Offering </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We will incur significantly increased costs and devote substantial management time as a result of operating as a public company. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a public company, we will incur significant legal, accounting and other expenses that we did not incur as a private company. For example, we
will be subject to the reporting requirements of the Exchange Act, and will </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
be required to comply with the applicable requirements of the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act, and the Dodd-Frank Wall Street Reform and Consumer Protection Act, as well as
rules and regulations subsequently implemented by the Securities and Exchange Commission, or SEC, and Nasdaq, including the establishment and maintenance of effective disclosure and financial controls and changes in corporate governance practices.
We expect that compliance with these requirements will increase our legal and financial compliance costs and will make some activities more time consuming and costly. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we expect that our management and other personnel will need to divert attention from operational and other business matters to
devote substantial time to these public company requirements. In particular, we expect to incur significant expenses and devote substantial management effort toward ensuring compliance with the requirements of Section&nbsp;404 of the Sarbanes-Oxley
Act, which will increase when we are no longer an emerging growth company, as defined by the JOBS Act. We will need to hire additional accounting and financial staff with appropriate public company experience and technical accounting knowledge and
may need to establish an internal audit function. We cannot predict or estimate the amount of additional costs we may incur as a result of becoming a public company or the timing of such costs. Additional compensation costs and any future equity
awards will increase our compensation expense, which would increase our general and administrative expense and could adversely affect our profitability. We also expect that operating as a public company will make it more difficult and expensive for
us to obtain director and officer liability insurance on reasonable terms. As a result, it may be more difficult for us to attract and retain qualified people to serve on our board of directors, our board committees or as executive officers. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our stock price may be volatile and you may not be able to resell shares of our common stock at or above the price you paid. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The trading price of our common stock following this offering could be highly volatile and could be subject to wide fluctuations in response to
various factors, some of which are beyond our control. These factors include those discussed in this &#147;Risk Factors&#148; section of this prospectus and others such as: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">announcements related to regulatory clearance to market gammaCore for the treatment of various conditions in the United States; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">results from, or any delays in, clinical trial programs relating to our product candidates; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">announcements of new products by us or our competitors; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">adverse actions taken by regulatory agencies with respect to our clinical trials, manufacturing supply chain or sales and marketing activities; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our operating results; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">changes or developments in laws or regulations applicable to our products; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any adverse changes in our relationship with any manufacturers or suppliers; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the success of our efforts to acquire or develop additional products; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any intellectual property infringement actions in which we may become involved; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">announcements concerning our competitors or the medical device industry in general; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">achievement of expected product sales and profitability; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">manufacture, supply or distribution shortages; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">actual or anticipated fluctuations in our operating results; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">FDA or other U.S. or foreign regulatory actions affecting us or our industry or other healthcare reform measures in the United States; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">changes in financial estimates or recommendations by securities analysts; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">trading volume of our common stock; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">sales of our common stock by us, our executive officers and directors or our stockholders in the future; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">general economic and market conditions and overall fluctuations in the U.S. equity markets; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the loss of any of our key scientific or management personnel. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the stock markets
in general, and the markets for pharmaceutical and medical device stocks in particular, have experienced volatility. These broad market fluctuations may adversely affect the trading price or liquidity of our common stock. In the past, when the
market price of a stock has been volatile, holders of that stock have sometimes instituted securities class action litigation against the issuer. If any of our stockholders were to bring such a lawsuit against us, we could incur substantial costs
defending the lawsuit and the attention of our management would be diverted from the operation of our business, which could seriously harm our financial position. Any adverse determination in litigation could also subject us to significant
liabilities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We have broad discretion to determine how to use the funds raised in this offering, and may use them in ways that may not enhance our
operating results or the price of our common stock. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our management will have broad discretion over the use of proceeds from this
offering, and we could spend the proceeds from this offering in ways our stockholders may not agree with or that do not yield a favorable return, if at all. We currently expect to use the net proceeds from this offering as follows: (i)&nbsp;to hire
additional territory business managers and expand marketing programs to prepare for the full commercial launch of our gammaCore products; (ii)&nbsp;to fund the research and development of our gammaCore products for other indications in headache and
rheumatology; (iii)&nbsp;to fund the build out of a specialty distribution channel for the anticipated launch of gammaCore Sapphire in the third quarter of 2018; and (iv)&nbsp;the remainder to fund working capital and general corporate purposes. If
we do not invest or apply the proceeds of this offering in ways that improve our operating results, we may fail to achieve expected financial results, which could cause our stock price to decline. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>An active, liquid and orderly market for our common stock may not develop, and you may not be able to resell your common stock at or above the public
offering price. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to this offering, there was no public market for shares of our common stock, and an active public market for
our shares may not develop or be sustained after this offering. We and the representatives of the underwriters have determined the initial public offering price of our common stock through negotiation. This price does not necessarily reflect the
price at which investors in the market will be willing to buy and sell our shares following this offering. In addition, an active trading market may not develop following the consummation of this offering or, if it does develop, may not be
sustained. The lack of an active market may impair your ability to sell your shares at the time you wish to sell them or at a price that you consider reasonable. An inactive market may also impair our ability to raise capital by selling shares and
may impair our ability to acquire other businesses or technologies or <FONT STYLE="white-space:nowrap">in-license</FONT> new product candidates using our shares as consideration. In addition, because certain of our direct and indirect unitholders,
including entities affiliated with certain of our directors, have indicated an interest in purchasing an aggregate of approximately $20 million in shares of our common stock in this offering at the initial public offering price, the overall trading
market for our shares may not be as active as it otherwise would have been had these shares been purchased by other investors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If securities or
industry analysts do not publish research or reports about our business, or if they issue an adverse or misleading opinion regarding our stock, our stock price and trading volume could decline. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The trading market for our common stock will be influenced by the research and reports that industry or securities analysts publish about us or
our business. We do not currently have and may never obtain research coverage by securities and industry analysts. If no or few securities or industry analysts commence coverage of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
us, the trading price for our stock would be negatively impacted. In the event we obtain securities or industry analyst coverage, if any of the analysts who cover us issues an adverse or
misleading opinion regarding us, our business model, our intellectual property or our stock performance, or if our clinical trials and operating results fail to meet the expectations of analysts, our stock price would likely decline. If one or more
of these analysts cease coverage of us or fail to publish reports on us regularly, we could lose visibility in the financial markets, which in turn could cause our stock price or trading volume to decline. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We are an &#147;emerging growth company&#148; and as a result of the reduced disclosure and governance requirements applicable to emerging growth
companies, our common stock may be less attractive to investors. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are an &#147;emerging growth company,&#148; as defined in the
JOBS Act, and we intend to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with
the auditor attestation requirements of Section&nbsp;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements and exemptions from the requirements of holding a
nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. We cannot predict if investors will find our common stock less attractive because we will rely on these exemptions.
If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may be more volatile. We may take advantage of these reporting exemptions until we are no longer
an emerging growth company. We will remain an emerging growth company until the earlier of (1)&nbsp;the last day of the fiscal year (a)&nbsp;following the fifth anniversary of the completion of this offering, (b)&nbsp;in which we have total annual
gross revenue of at least $1.07&nbsp;billion, or (c)&nbsp;in which we are deemed to be a large accelerated filer, which means the market value of our common stock that is held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> exceeds
$700&nbsp;million as of the prior June&nbsp;30, and (2)&nbsp;the date on which we have issued more than $1.0&nbsp;billion in <FONT STYLE="white-space:nowrap">non-convertible</FONT> debt during the prior three-year period. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We have identified a material weakness in our internal control over financial reporting. If we are unable to remediate this material weakness, or if we
experience additional material weaknesses in the future, we may not be able to accurately or timely report our financial condition or results of operations and investors may lose confidence in our financial reports and the market price of our common
stock could be adversely affected. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a public company, we will be required to maintain internal control over financial reporting
and to report any material weaknesses in such internal control. Section 404 of the Sarbanes-Oxley Act requires that we evaluate and determine the effectiveness of our internal control over financial reporting and, beginning with our second annual
report following this offering, which will be for our fiscal year ending December 31, 2019, provide a management report on internal control over financial reporting. The Sarbanes-Oxley Act also requires that our management report on internal control
over financial reporting be attested to by our independent registered public accounting firm, to the extent we are no longer an &#147;emerging growth company,&#148; as defined by the JOBS Act. We do not expect to have our independent registered
public accounting firm attest to our management report on internal control over financial reporting for so long as we are an emerging growth company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are in the process of designing and implementing the internal control over financial reporting required to comply with this obligation,
which process will be time consuming, costly and complicated. Prior to the completion of this offering, we have been a private company with limited accounting personnel and other resources to address our internal control over financial reporting. In
preparation of our consolidated financial statements to meet the requirements for this offering, we determined that a material weakness in our internal control over financial reporting related to the accounting for complex transactions existed
during each of the years ended December 31, 2016 and 2017, and was unremediated as of December 31, 2017. This material weakness contributed to an error to our consolidated financial statements for the year ended December 31, 2016 relating to the
misclassification of our Series&nbsp;A Preferred Units as permanent equity instead of temporary equity. This deficiency did not result in a material misstatement to our 2016 consolidated financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To remediate this material weakness in our internal control over financial reporting and
address the deficiency in our team&#146;s accounting processes, we plan to hire additional accounting personnel, establish and document accounting policies and procedures, and implement management review controls. While we intend to implement a plan
to remediate this material weakness, we cannot predict the success of such plan or the outcome of our assessment of these plans at this time. We can give no assurance that this implementation will remediate this material weakness in our internal
control or that material weaknesses or significant deficiencies in our internal control over financial reporting will not be identified in the future. If we are unable to remediate this material weakness, or if we experience additional material
weaknesses in the future or otherwise fail to maintain an effective system of internal controls, we may not be able to accurately or timely report our financial condition or results of operations and investors may lose confidence in the accuracy and
completeness of our financial reports and the market price of our common stock could be adversely affected, and we could become subject to investigations by the stock exchange on which our securities are listed, the SEC, or other regulatory
authorities, which could require additional financial and management resources. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Purchasers in this offering will experience immediate and
substantial dilution in the book value of their investment. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The initial public offering price of our common stock is substantially
higher than the net tangible book value per share of our common stock immediately after this offering. Accordingly, if you purchase our common stock in this offering, you will incur immediate substantial dilution of approximately $12.13 per share,
based on the initial public offering price of $15.00 per share. In addition, following this offering, purchasers in this offering will have contributed approximately 28.6% of the total gross consideration paid by stockholders to us to purchase
shares of our common stock, but will own only approximately 15.6% of the shares of common stock outstanding immediately after this offering. Furthermore, if the underwriters exercise their option to purchase additional shares, outstanding options or
convertible securities are exercised, or we sell shares of our common stock in future financings, you could experience further dilution. For a further description of the dilution that you will experience immediately after this offering, see the
section titled &#147;Dilution.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Sales of a substantial number of shares of our common stock in the public market could cause our stock price
to fall. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If our existing stockholders sell, or indicate an intention to sell, substantial amounts of our common stock in the
public market after the <FONT STYLE="white-space:nowrap">lock-up</FONT> and other legal restrictions on resale discussed in this prospectus lapse, the trading price of our common stock could decline. Based upon the number of shares outstanding as of
June&nbsp;1, 2018, upon the closing of this offering, we will have outstanding a total of approximately 27.8 million shares of common stock, assuming no exercise of the underwriters&#146; option to purchase additional shares. Of these shares,
approximately 5.0 million shares or less of our common stock, plus any shares sold upon exercise of the underwriters&#146; option to purchase additional shares, will be freely tradable, without restriction, in the public market immediately following
this offering. Evercore Group L.L.C., however, may, in its sole discretion, permit our officers, directors and other stockholders who are subject to <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements to sell shares prior to the expiration of
the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain of our direct and indirect unitholders, including entities
affiliated with certain of our directors, have indicated an interest in purchasing an aggregate of $20&nbsp;million in shares of our common stock in this offering at the initial public offering price per share. Any such shares purchased by these
holders who are considered to be our affiliates could not be resold in the public market immediately following this offering as a result of restrictions under securities laws, but would be able to be sold following the expiration of these
restrictions as described in the &#147;Shares Eligible for Future Sale&#148; section of this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The <FONT
STYLE="white-space:nowrap">lock-up</FONT> agreements pertaining to this offering will expire 180&nbsp;days from the date of this prospectus. After the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements expire, up to an additional
approximately 23 million shares of common stock will be eligible for sale in the public market, approximately 16.9 million of which are held by current directors, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
executive officers and other affiliates and may be subject to Rule&nbsp;144 under the Securities Act of 1933, as amended, or the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, upon expiration of the lock-up agreements noted above, approximately 0.5 million shares of common stock that are subject to
outstanding options will become eligible for sale in the public market to the extent permitted by the provisions of various vesting schedules, the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements and Rule&nbsp;144 and Rule&nbsp;701 under
the Securities Act. If these additional shares of common stock are sold, or if it is perceived that they will be sold, in the public market, the trading price of our common stock could decline. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After this offering, the holders of approximately 16.7 million shares of our outstanding common stock, including shares issuable upon exercise
of outstanding options, will be entitled to rights with respect to the registration of their shares under the Securities Act, subject to vesting schedules and to the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements described above.
Registration of these shares under the Securities Act would result in the shares becoming freely tradable without restriction under the Securities Act, except for shares purchased by affiliates. Any sales of securities by these stockholders could
have a material adverse effect on the trading price of our common stock. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our principal stockholders and management own a significant
percentage of our stock and will be able to exert significant control over matters subject to stockholder approval. </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of June
1, 2018, our executive officers, directors, holders of 5% or more of our capital stock and their respective affiliates, including Core Ventures II, LLC and Core Ventures IV, LLC, entities controlled by two of our directors, Joseph P. Errico and
Thomas J. Errico, M.D., and Merck Global Health Innovation Fund, LLC, beneficially owned approximately 17.4 million shares of our outstanding voting stock and, upon the closing of this offering, that same group will beneficially own approximately
62.5% of our outstanding voting stock (assuming no exercise of the underwriters&#146; option to purchase additional shares and no exercise of outstanding options). Therefore, even after this offering these stockholders will have the ability to
influence us through this ownership position. These stockholders may be able to determine all matters requiring stockholder approval. For example, these stockholders may be able to control elections of directors, amendments of our organizational
documents, or approval of any merger, sale of assets, or other major corporate transaction. This may prevent or discourage unsolicited acquisition proposals or offers for our common stock that you may feel are in your best interest as one of our
stockholders. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Provisions in our charter documents and under Delaware law could discourage a takeover that stockholders may consider favorable
and may lead to entrenchment of management. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our certificate of incorporation and bylaws that will be in effect prior to the
consummation of this offering will contain provisions that could significantly reduce the value of our shares to a potential acquirer or delay or prevent changes in control or changes in our management without the consent of our board of directors.
The provisions in our charter documents will include the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a classified board of directors with three-year staggered terms, which may delay the ability of stockholders to change the membership of a majority of our board of directors; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">no cumulative voting in the election of directors, which limits the ability of minority stockholders to elect director candidates; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the exclusive right of our board of directors to elect a director to fill a vacancy created by the expansion of the board of directors or the resignation, death or removal of a director, which prevents stockholders from
being able to fill vacancies on our board of directors; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the required approval of at least 66 2/3% of the shares entitled to vote to remove a director for cause, and the prohibition on removal of directors without cause; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the ability of our board of directors to authorize the issuance of shares of preferred stock and to determine the price and other terms of those shares, including preferences and voting rights, without stockholder
approval, which could be used to significantly dilute the ownership of a hostile acquiror; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the ability of our board of directors to alter our bylaws without obtaining stockholder approval; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the required approval of at least 66 2/3% of the shares entitled to vote at an election of directors to adopt, amend or repeal our bylaws or repeal the provisions of our amended and restated certificate of incorporation
regarding the election and removal of directors; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a prohibition on stockholder action by written consent, which forces stockholder action to be taken at an annual or special meeting of our stockholders; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the requirement that a special meeting of stockholders may be called only by the chairman of the board of directors, the chief executive officer, the president or the board of directors, which may delay the ability of
our stockholders to force consideration of a proposal or to take action, including the removal of directors; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">advance notice procedures that stockholders must comply with in order to nominate candidates to our board of directors or to propose matters to be acted upon at a stockholders&#146; meeting, which may discourage or
deter a potential acquiror from conducting a solicitation of proxies to elect the acquiror&#146;s own slate of directors or otherwise attempting to obtain control of us. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, these provisions would apply even if we were to receive an offer that some stockholders may consider beneficial. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are also subject to the anti-takeover provisions contained in Section&nbsp;203 of the Delaware General Corporation Law. Under
Section&nbsp;203, a corporation may not, in general, engage in a business combination with any holder of 15% or more of its capital stock unless the holder has held the stock for three years or, among other exceptions, the board of directors has
approved the transaction. For a description of our capital stock, see the section titled &#147;Description of Capital Stock.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Claims for
indemnification by our directors and officers may reduce our available funds to satisfy successful third-party claims against us and may reduce the amount of money available to us. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our certificate of incorporation and bylaws provide that we will indemnify our directors and officers to the fullest extent permitted by
Delaware law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, as permitted by Section&nbsp;145 of the Delaware General Corporation Law, or the DGCL, our amended and
restated bylaws to be effective immediately prior to the completion of this offering and our indemnification agreements that we have entered into with our directors and officers provide that: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we will indemnify our directors and officers for serving us in those capacities or for serving other business enterprises at our request, to the fullest extent permitted by Delaware law. Delaware law provides that a
corporation may indemnify such person if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the registrant and, with respect to any criminal proceeding, had no reasonable
cause to believe such person&#146;s conduct was unlawful; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we may, in our discretion, indemnify employees and agents in those circumstances where indemnification is permitted by applicable law; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we are required to advance expenses, as incurred, to our directors and officers in connection with defending a proceeding, except that such directors or officers shall undertake to repay such advances if it is
ultimately determined that such person is not entitled to indemnification; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we will not be obligated pursuant to our amended and restated bylaws to indemnify a person with respect to proceedings initiated by that person against us or our other indemnitees, except with respect to proceedings
authorized by our board of directors or brought to enforce a right to indemnification; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the rights conferred in our amended and restated bylaws are not exclusive, and we are authorized to enter into indemnification agreements with our directors, officers, employees and agents and to obtain insurance to
indemnify such persons; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we may not retroactively amend our amended and restated bylaw provisions to reduce our indemnification obligations to directors, officers, employees and agents. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We do not currently intend to pay dividends on our common stock, and, consequently, your ability to achieve a return on your investment will depend on
appreciation in the price of our common stock. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not currently intend to pay any cash dividends on our common stock for the
foreseeable future. We currently intend to invest our future earnings, if any, to fund our growth. Therefore, you are not likely to receive any dividends on your common stock for the foreseeable future. Since we do not intend to pay dividends, your
ability to receive a return on your investment will depend on any future appreciation in the market value of our common stock. There is no guarantee that our common stock will appreciate or even maintain the price at which our holders have purchased
it. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Comprehensive U.S. federal income tax reform could adversely affect us. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December&nbsp;22, 2017, President Trump signed into law the &#147;Tax Cuts and Jobs Act&#148;, or TCJA, that significantly reforms the Internal Revenue Code
of 1986, or the Code, as amended. The TCJA, among other things, includes changes to U.S. federal tax rates, imposes significant additional limitations on the deductibility of interest, allows for the expensing of capital expenditures, and puts into
effect the migration from a &#147;worldwide&#148; system of taxation to a modified territorial system. We continue to examine the impact this tax reform legislation may have on our business. The impact of this tax reform on holders of our common
stock is uncertain and could be adverse. This prospectus does not discuss any such tax legislation or the manner in which it might affect purchasers of our common stock. We urge our stockholders, including purchasers of common stock in this
offering, to consult with their legal and tax advisors with respect to such legislation and the potential tax consequences of investing in our common stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our amended and restated certificate of incorporation provides that the Court of Chancery of the State of Delaware and the federal district courts of
the United States will be the exclusive forums for substantially all disputes between us and our stockholders, which could limit our stockholders&#146; ability to obtain a favorable judicial forum for disputes with us or our directors, officers, or
employees. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our certificate of incorporation provides that the Court of Chancery of the State of Delaware is the exclusive forum
for: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any derivative action or proceeding brought on our behalf; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any action asserting a breach of fiduciary duty; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any action asserting a claim against us arising under the Delaware General Corporation Law, our certificate of incorporation, or our bylaws; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any action asserting a claim against us that is governed by the internal-affairs doctrine. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our certificate of incorporation further provides that the federal district courts of the United States will be the exclusive forum for
resolving any complaint asserting a cause of action arising under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These exclusive-forum provisions may limit a
stockholder&#146;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers, or other employees, which may discourage lawsuits against us and our directors, officers, and other employees.
If a court were to find either exclusive-forum provision in our certificate of incorporation to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving the dispute in other jurisdictions, which could
seriously harm our business. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom472601_5"></A>SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus contains statements that express our opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding
future events or future results, in contrast with statements that reflect historical facts. Many of these statements are contained under the headings &#147;Prospectus Summary,&#148; &#147;Management&#146;s Discussion and Analysis of Financial
Condition and Results of Operations&#148; and &#147;Business.&#148; In some cases, we have identified such forward-looking statements with typical conditional words such as &#147;anticipate,&#148; &#147;intend,&#148; &#147;believe,&#148;
&#147;estimate,&#148; &#147;plan,&#148; &#147;seek,&#148; &#147;project,&#148; &#147;expect,&#148; &#147;may,&#148; &#147;will,&#148; &#147;would,&#148; &#147;could,&#148; &#147;should,&#148; the negative of these terms or other comparable
terminology. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Forward-looking statements are not a guarantee of performance, and you should not place undue reliance on such statements.
We have based forward-looking statements largely on our current expectations and projections about future events. Forward-looking statements are subject to many uncertainties and other variable circumstances, including those discussed in this
prospectus under the headings &#147;Risk Factors&#148; and &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations,&#148; many of which are outside of our control, that could cause our actual results and
experience to differ materially from any forward-looking statement. Given these risks and uncertainties, you are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements included in this prospectus
are made only as of the date hereof. We do not undertake, and specifically decline, any obligation to update any such statements or to publicly announce the results of any revisions to any of such statements to reflect future events or developments.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom472601_6"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We estimate, based upon an assumed initial public offering price of $15.00 per share, which is the midpoint of the price range set forth on
the cover page of this prospectus, we will receive net proceeds from this offering of approximately $56.5 million (or $65.6 million if the underwriters exercise their option to purchase additional shares of common stock in full), after deducting
estimated underwriting discounts and commissions and estimated offering expenses payable by us. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The principal purposes of this
offering are to obtain additional capital to support our operations, create a public market for our common stock and to facilitate future access to the public equity markets. We currently estimate that we will use the net proceeds from this offering
as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(i) approximately $35.0 million to fund our activities related to commercialization of our gammaCore products, including the
full market launch of such products in the United States, initially for the acute treatment of migraine and episodic cluster headache. For example, we intend to hire additional territory business managers which will expand our coverage of
high-prescribers of headache medications. We also expect to use a portion of these funds to create and develop patient and professional promotional tactics across multiple channels including social, digital, and print media; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(ii) approximately $10.0 million to fund expansion of our clinical program into additional indications in headache and rheumatology. For
example, in 2018, we expect to initiate trials to support potential label expansion in headache, including pivotal trials in migraine prevention and migraine in adolescents, and pilot trials in post-traumatic headache. In 2018, we also expect to
initiate a pivotal trial in Sj&#246;gren&#146;s syndrome, our first rheumatology indication, and over the next 24 months, we expect to initiate a pivotal trial in rheumatoid arthritis. We also expect to deploy proceeds from this offering to conduct
premarket activities in rheumatology consisting of market analysis, physician and patient segmentation research, and promotional/campaign development; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(iii) approximately $3.0 million to fund the build out of our specialty distribution channel for the anticipated launch of gammaCore Sapphire,
the successor to gammaCore, in the third quarter of 2018. For example, our specialty distribution platform will require specialized scanning hardware at every specialty pharmacy site, a data warehouse with custom software, training of specialty
pharmacists, and support within the network for handling patient volume; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(iv) the remaining balance for working capital, including
inventory, and other corporate purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we may also use a portion of our net proceeds from this offering to acquire and
invest in complementary products, technologies, services or businesses; however, we currently have no plans, agreements or commitments to complete any such transaction nor are we involved in negotiations to do so. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our expected use of net proceeds from this offering represents our current intentions based upon our plans and business condition. As of the
date of this prospectus, we cannot predict with certainty all of the particular uses for the net proceeds to be received upon the completion of this offering or the amounts that we will actually spend on the uses set forth above. The amounts and
timing of our actual use of the net proceeds will vary depending on numerous factors, including the factors described under the heading &#147;Risk Factors&#148; in this prospectus. As a result, management will have broad discretion in its
application of the net proceeds, and investors will be relying on our judgment in such application. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pending use of the net proceeds from
this offering, we may invest in short- and intermediate-term interest-bearing obligations, investment-grade instruments, certificates of deposit or direct or guaranteed obligations of the U.S.&nbsp;government. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although it is difficult to predict future liquidity requirements, we believe that the net proceeds from this offering, together with our
existing cash and cash equivalents, will be sufficient to fund our operations for at least the next 12 months, and that thereafter we may need additional funding to finance our commercialization, clinical development and specialty distribution
activities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom472601_7"></A>DIVIDEND POLICY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have never declared or paid cash dividends on our capital stock. We do not expect to pay dividends on our common stock for the foreseeable
future. Instead, we anticipate that all of our earnings, if any, will be used for the operation and growth of our business. Any future determination to declare cash dividends would be subject to the discretion of our board of directors and would
depend upon various factors, including our results of operations, financial condition and capital requirements, restrictions that may be imposed by applicable law and our contracts and other factors deemed relevant by our board of directors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom472601_8"></A>CORPORATE CONVERSION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently operate as a Delaware limited liability company under the name Electrocore, LLC. Prior to the closing of this offering,
Electrocore, LLC will convert into a Delaware corporation pursuant to a statutory conversion and change its name to electroCore, Inc. In order to consummate the corporate conversion, a certificate of conversion will be filed with the Secretary of
State of the State of Delaware. As part of the corporate conversion (after giving effect to the automatic conversion of our Preferred Units) and satisfaction of the accrued preferred return on our Series A Preferred Units, based on the assumed
initial public offering price of $15.00 per share, which is the midpoint of the price range set forth on the cover page of this prospectus, all Units will be converted into an aggregate of 23,470,034 shares of our common stock and options to
purchase 2,146,039 shares of our common stock as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">holders of our common units, or Common Units, other than Common Units that were originally issued as &#147;profits interests&#148; (as such term is used for purposes of the Code), or Profits Interests, will receive an
aggregate of 12,099,280 shares of our common stock; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">holders of our Series A Preferred Units will receive an aggregate of 4,181,856 shares of our common stock, which includes 241,939 shares of our common stock as payment in full of the approximately $3.6&nbsp;million
accrued and unpaid preferred return payable in respect of the Series A Preferred Units; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">holders of our Series B Preferred Units will receive an aggregate of 5,843,668 shares of our common stock; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">holders of our Profits Interests will receive an aggregate of 1,345,230 shares of our common stock and, with respect to such holders who are our employees or consultants at the time of the corporate conversion, options
to purchase an aggregate of 2,146,039 shares of our common stock, with an exercise price equal to the initial public offering price. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, based on the assumed initial public offering price of $15.00 per share, which is the midpoint of the price range set forth on the
cover page of this prospectus: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">warrants, other than warrants that expire in connection with this offering, to purchase Common Units will be converted into warrants to purchase 151,364 shares of our common stock; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">warrants to purchase Series A Preferred Units will be converted into warrants to purchase 20,561 shares of our common stock; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">warrants to purchase Series B Preferred Units will be converted into warrants to purchase 550,040 shares of our common stock. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The number of shares of common stock and the number of shares of common stock issuable pursuant to options and warrants in connection with the
corporate conversion will be determined pursuant to the applicable provisions of the plan of conversion, which is based upon terms of our Operating Agreement. The Operating Agreement provides that each outstanding series of our Preferred Units will
automatically convert (which we refer to as the Automatic Conversion) into Common Units at the applicable conversion ratio (currently, on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-for-one</FONT></FONT> basis) upon
either the closing of a Qualified Public Offering, as defined in the Operating Agreement, or the written consent executed by members of Electrocore, LLC holding a sufficient number of each class of our Preferred Units and Common Units as required
under our Operating Agreement. We anticipate receiving written consents from the required holders of our Units to effect the Automatic Conversion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following the Automatic Conversion and effective upon the consummation of the corporate conversion, all of the outstanding Units will convert
into a number of shares of common stock and options to purchase common stock of electroCore, Inc. based upon the value of Electrocore, LLC at the time of this offering with a value implied by the initial public offering price of the shares of common
stock sold in this offering. Upon conversion, the shares of common stock of electroCore, Inc. and options to purchase our common stock will be allocated among the various classes and series of Units in accordance with the distribution and other
applicable provisions </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
set forth in the Operating Agreement. Similarly, the number of shares of common stock for which warrants will become exercisable following the corporate conversion will be determined based on the
terms of such warrants. No cash or fractional shares of common stock will be issued in connection with the corporate conversion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Immediately prior to the corporate conversion, all outstanding Preferred Units of Electrocore, LLC will first be converted into our Common
Units on a one-for-one basis and thereafter in connection with the corporate conversion all Common Units, other than Common Units issued as Profits Interests, will be converted into common stock on a one share of common stock for every 18 Unit
basis. In addition, we expect to issue 241,939 shares of our common stock to the holders of our Series A Preferred Units to satisfy approximately $3.6 million of accrued and unpaid preferred return on such units. Additionally, in connection with the
corporate conversion, our Profits Interests will be converted into (i)&nbsp;shares of our common stock, and (ii)&nbsp;with respect to Profits Interests that are held by our current employees and consultants at the time of the conversion, options to
purchase our common stock. The number of shares of common stock and the number of options to be issued to each such holder of Profits Interests will be determined based upon the appreciation in our value after the date of grant of the applicable
Profits Interests through the completion of this offering. The exercise price of these options will be equal to the initial public offering price. Following the corporate conversion, the vesting provisions applicable to the Profits Interests as in
effect prior to the corporate conversion will apply, in substantially the same manner, to the shares of common stock and options issued in respect of such Profits Interests in the corporate conversion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because the exact number of shares of our common stock to be issued to holders of Units in the corporate conversion, the number of shares of
common stock for which warrants will be exercisable following the corporate conversion and the number of shares of common stock and options to purchase common stock that holders of Profits Interests will receive in the corporate conversion is based
on the initial public offering price, to the extent that the actual initial public offering price per share for this offering is greater or less than $15.00, which is the midpoint of the price range set forth on the cover page of this prospectus,
the actual number of shares of common stock to be issued to holders of Units, the number of shares of common stock for which options and warrants will be exercisable and the total number of shares of common stock outstanding following the corporate
conversion will be adjusted accordingly. See &#147;Pricing Sensitivity Analysis&#148; for how the number of shares to be issued in the corporate conversion or issuable thereafter upon exercise of options and warrants would be affected by an initial
public offering price per share of common stock at the low-, mid- and high-points of the estimated price range set forth on the cover of this prospectus or if the underwriters&#146; option to purchase additional shares of common stock is exercised
in full. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the corporate conversion, electroCore, Inc. will hold all property and assets of Electrocore, LLC and all of
the debts and obligations of Electrocore, LLC will become the debts and obligations of electroCore, Inc. by operation of law. electroCore, Inc. will be governed by a certificate of incorporation filed with the Delaware Secretary of State and bylaws,
the material portions of each of which are described under the heading &#147;Description of Capital Stock.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the effective date of
the corporate conversion, the members of the board of managers of Electrocore, LLC will become the members of electroCore, Inc.&#146;s board of directors and the officers of Electrocore, LLC will become the officers of electroCore, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The purpose of the corporate conversion is to reorganize our corporate structure so that the entity that is offering common stock to the
public in this offering is a corporation rather than a limited liability company and so that our existing investors will own our common stock rather than equity interests in a limited liability company. References in this prospectus to our
capitalization and other matters pertaining to our equity and shares prior to the corporate conversion relate to the capitalization and equity and units of Electrocore, LLC, and after the corporate conversion, to electroCore, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The audited consolidated financial statements included elsewhere in this prospectus are those of Electrocore, LLC and its subsidiaries and
affiliate. We expect that our conversion from a Delaware limited liability company to a Delaware corporation will not have a material effect on our consolidated financial statements at the time of the corporate conversion. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom472601_9"></A>CAPITALIZATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth our cash, cash equivalents, debt securities and other investments available for sale and securities and our
capitalization as of March&nbsp;31, 2018: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">on an actual basis; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">on a pro forma basis to give effect to the corporate conversion, based on the assumed initial public offering price of $15.00 per share, which is the midpoint of the price range set forth on the cover page of this
prospectus; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">on a pro forma as adjusted basis to give further effect to&nbsp;the sale of 4,333,333 shares of our common stock in this offering, assuming an initial public offering price of $15.00 per share, which is the midpoint of
the price range set forth on the cover page of this prospectus, after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The pro forma and pro forma as adjusted information below is illustrative only, and our capitalization following the corporate conversion and
the closing of this offering will depend on the actual initial public offering price and other terms of this offering determined at pricing. You should read the following information together with the information contained under the headings
&#147;Selected Consolidated Financial Data&#148; and &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; and our audited and unaudited consolidated financial statements and the accompanying notes
appearing elsewhere in this prospectus. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9.5pt" ALIGN="center">


<TR>
<TD WIDTH="64%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of March&nbsp;31, 2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Actual</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro&nbsp;forma(1)(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro&nbsp;forma&nbsp;as<BR>adjusted(3)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(unaudited; in thousands, except unit and share<BR>data)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Cash, cash equivalents, debt securities and other investments available for sale</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">26,706.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">26,706.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">84,588.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Warrant liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,485.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,485.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,485.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Convertible Preferred Units:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Series A Preferred Units, 71,050,860 units authorized, 70,918,506&nbsp;units issued and
outstanding, actual; none issued and outstanding, pro forma, and pro forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53,518.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Series B Preferred Units, 123,000,000 units authorized, 105,186,020&nbsp;units issued and
outstanding, actual; none issued and outstanding, pro forma, and pro forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68,755.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Total convertible Preferred Units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">122,274.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Members&#146;/ stockholders&#146; equity:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Preferred stock, par value $0.001 per share; no shares authorized, issued and outstanding,
actual; 10,000,000 shares authorized, none issued and outstanding, pro forma, and pro forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Common stock, par value $0.001 per share; no shares authorized, issued and outstanding, actual;
500,000,000 shares authorized, none issued and outstanding, pro forma; 27,561,428 shares issued and outstanding, pro forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Common Units, 600,000,000 units authorized, 218,982,140 units issued and outstanding, actual;
none issued and outstanding, pro forma, and pro forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,180.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Additional <FONT STYLE="white-space:nowrap">paid-in-capital</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,863.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">185,295.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">241,790.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(162,427.5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(162,427.5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(162,427.5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Accumulated other comprehensive income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(59.0</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(59.0</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(59.0</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Noncontrolling interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">609.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">609.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">609.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Total members&#146;/stockholders&#146; equity (deficit)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(98,833.1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,440.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79,940.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Total capitalization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">25,926.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">25,926.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">82,426.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">In connection with the corporate conversion, Common Units, Series A Preferred Units, Series B Preferred Units, additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital and accumulated deficit will be reduced
to zero to reflect the elimination of all outstanding Units and other interests in Electrocore, LLC and corresponding adjustments will be reflected as common stock, additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital, and total
stockholders&#146; equity (deficit). </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">The following table presents the number of shares of common stock issuable in connection with the corporate conversion to holders of Series A Preferred Units, Series B Preferred Units, Common Units and Profits
Interests, based on the assumed initial public offering price per common share of $15.00, which is the midpoint of the price range set forth on the cover page of this prospectus. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9.5pt" ALIGN="center">


<TR>
<TD WIDTH="81%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Common stock issuable for:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Common Units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,099,280</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Series A Preferred Units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,939,917</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Series B Preferred Units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,843,668</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Profits Interests</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,345,230</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,228,095</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The capitalization table presented above excludes, after giving effect to the corporate conversion: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">2,146,039 shares of common stock issuable upon exercise of outstanding options or options to be issued for certain Profits Interests to purchase shares of common stock, at a weighted-average exercise price equal to the
assumed initial public offering price per share of common stock of $15.00, which is the midpoint of the price range set forth on the cover page of this prospectus; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">an additional 2,708,731 shares of common stock reserved for future issuance under the 2018 Plan, as well as any increase in the number of shares of common stock reserved for future issuance under the 2018 Plan; and
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">721,965 shares issuable upon the exercise of warrants at a weighted-average exercise price of $12.50 per share following the corporate conversion. See &#147;Corporate Conversion&#148; and &#147;Pricing Sensitivity
Analysis&#148; for additional information; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">241,939 shares of common stock issuable in satisfaction of the accrued preferred return on the Series A Preferred Units. </TD></TR></TABLE>
<P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">Each $1.00 increase (decrease) in the assumed initial public offering price of $15.00 per share, which is the midpoint of the price range set forth on the cover page of this prospectus, would increase (decrease) the pro
forma as adjusted amount of each of cash, cash equivalents, debt securities and other investments available for sale, additional <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">paid-in-capital,</FONT></FONT> total
stockholders&#146; equity and total capitalization by approximately $4.0 million, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting the estimated underwriting
discounts and commissions and estimated offering expenses payable by us. Similarly, each increase (decrease) of 1.0&nbsp;million shares in the number of shares offered by us at the assumed initial public offering price of $15.00 per share, which is
the midpoint of the price range set forth on the cover page of this prospectus, would increase (decrease) the pro forma as adjusted amount of each of cash, cash equivalents, debt securities and other investments available for sale, additional <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">paid-in-capital,</FONT></FONT> total stockholders&#146; equity and total capitalization by approximately $14.0 million. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom472601_10"></A>DILUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you invest in our common stock, your ownership interest will be diluted immediately to the extent of the difference between the initial
public offering price per share of our common stock and the pro forma as adjusted net tangible book value per share of our common stock immediately after this offering. Net tangible book value per share represents the book value of our total
tangible assets less the book value of our total liabilities divided by the number of shares of common stock then issued and outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After giving effect to the corporate conversion, pro forma net tangible book value as of March 31, 2018 was $23.4 million, or $1.01 per share
based on the 23,228,095 shares of common stock issued and outstanding after the corporate conversion based on an assumed initial public offering price of $15.00 per share (the midpoint of the price range set forth on the cover page of this
prospectus). After giving effect to our sale of common stock in this offering at the initial public offering price of $15.00 per share (the midpoint of the price range set forth on the cover page of this prospectus), and after deducting estimated
underwriting discounts and commissions and estimated offering expenses payable by us, our pro forma as adjusted net tangible book value as of March 31, 2018 would have been $79.0 million, or $2.87 per share (assuming no exercise of the
underwriters&#146; option to purchase additional shares of our common stock). This represents an immediate and substantial dilution of $12.13 per share to new investors purchasing common stock in this offering. The following table illustrates this
dilution per share: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="87%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assumed initial public offering price per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net tangible book value per share as of March&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Increase in net tangible book value per share attributable to this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma as adjusted net tangible book value per share after giving effect to this
offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dilution per share to new investors in this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">12.13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the underwriters exercise their option to purchase additional shares in full, our pro forma as adjusted net
tangible book value per share after this offering would be $3.12 per share, and the dilution in pro forma net tangible book value per share to new investors in this offering would be $11.88 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes, on a pro forma as adjusted basis as of March 31, 2018, the differences between the number of shares of common
stock purchased from us, the total price and the average price per share paid by existing stockholders and by the new investors in this offering, before deducting estimated underwriting discounts and commissions and estimated offering expenses
payable by us, at an assumed initial public offering price of $15.00 per&nbsp;share (the midpoint of the price range set forth on the cover page of this prospectus). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="60%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares purchased</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total&nbsp;consideration</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Average<BR>price&nbsp;per<BR>share</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(in&nbsp;millions)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Existing investors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">162.50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6.99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">New investors in this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">227.50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">See &#147;Pricing Sensitivity Analysis&#148; for how some of the information presented above would be
affected by an initial public offering price per share of common stock at the low-, mid- and high-points of the estimated price range set forth on the cover of this prospectus or if the underwriters&#146; option to purchase additional shares of
common stock is exercised in full. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The discussion and table above assume no exercise of stock options that will be outstanding
after giving effect to the corporate conversion and no issuance of shares of our common stock reserved for issuance under our 2018 Plan, which include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">2,146,039 shares issuable upon the exercise of options to be outstanding after giving effect to the corporate conversion at an exercise price equal to the initial public offering price of $15.00 per share following the
corporate conversion; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">721,965 shares issuable upon the exercise of warrants at a weighted-average exercise price of $12.50 per share following the corporate conversion; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">2,708,731 shares of common stock reserved for issuance pursuant to future awards under the 2018 Plan, which will become effective immediately prior to the consummation of this offering. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The discussion and table also does not give effect to the issuance of 241,939 shares of common stock in satisfaction of approximately $3.6
million of accrued but unpaid preferred return to holders of our Series&nbsp;A Preferred Units based upon an assumed offering price of $15.00 per share, which is the midpoint of the price range set forth on the cover page of this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, after giving effect to the corporate conversion, all of our outstanding options to be outstanding after giving effect to the corporate
conversion and warrants were exercised, our pro forma as adjusted net tangible book value as of March&nbsp;31, 2018 would have been $2.48 per share and our pro forma as adjusted net tangible book value after giving effect to this offering would have
been $3.98 per share, causing dilution to new investors purchasing shares in this offering of $11.02 per share. Shares purchased by new investors would then represent 14.2% of the shares purchased from us for 24.4% of the total consideration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent that options to be outstanding after giving effect to the corporate conversion are exercised, new options are issued under the
2018 Plan, or we issue additional shares of common stock in the future, there will be further dilution to investors participating in this offering. In addition, we may choose to raise additional capital because of market conditions or strategic
considerations, even if we believe that we have sufficient funds for our current or future operating plans. If we raise additional capital through the sale of equity or convertible debt securities, the issuance of these securities could result in
further dilution to our stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The number of shares of common stock of electroCore, Inc. that holders of units will receive in the
corporate conversion and the number of shares of common stock that options and warrants will be exercisable for following the corporate conversion will vary depending on the initial public offering price set forth on the cover page of this
prospectus. See &#147;Corporate Conversion and &#147;Pricing Sensitivity Analysis&#148; for additional information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain of our direct
and indirect unitholders, including entities affiliated with certain of our directors, have indicated an interest in purchasing an aggregate of $20 million in shares of our common stock in this offering at the initial public offering price per
share. Based on an assumed initial public offering price of $15.00 per share, these holders would purchase up to an aggregate of 1,333,333 of the 4,333,333 shares in this offering based on these indications of interest. However, because indications
of interest are not binding agreements or commitments to purchase, these holders may determine to purchase fewer shares than they indicate an interest in purchasing or not to purchase any shares in this offering. It is also possible that these
holders could indicate an interest in purchasing more shares of our common stock. In addition, the underwriters could determine to sell fewer shares to any of these holders than the holders indicate an interest in purchasing or not to sell any
shares to these holders. The foregoing discussion and tables do not reflect any of these potential purchases by these holders or their affiliated entities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">70 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom472601_11"></A>SELECTED CONSOLIDATED FINANCIAL DATA </B></P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selected consolidated statements of operations data for the three months ended March&nbsp;31, 2018 and 2017 and the selected consolidated
balance sheet data as of March&nbsp;31, 2018 are derived from our unaudited consolidated financial statements included elsewhere in this prospectus. The selected consolidated statement of operations data for the years ended December&nbsp;31, 2017
and 2016 and the selected consolidated balance sheet data as of December&nbsp;31, 2017 and 2016 are derived from our audited consolidated financial statements included elsewhere in this prospectus. We have prepared the unaudited consolidated
financial information set forth below on the same basis as our audited consolidated financial statements and have included all adjustments, consisting of only normal recurring adjustments, that we consider necessary for fair presentation of our
financial position and operating results for such periods. Our historical results are not necessarily indicative of the results that may be expected in any future period. The results for any interim period are not necessarily indicative of the
results that may be expected for a full year. The selected consolidated financial data below should be read in conjunction with the section entitled &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of
Operations&#148; and our audited and unaudited consolidated financial statements and related notes included elsewhere in this prospectus. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="54%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Three&nbsp;months&nbsp;ended&nbsp;March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Years ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2018&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2017&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2017&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2016&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><B>(in thousands, except unit and per unit amounts)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Consolidated statements of operations:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net sales</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">81.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">116.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">811.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">254.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of goods sold</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">518.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">123.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross profit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">292.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">130.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,306.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,726.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,830.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,971.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Selling, general and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,824.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,059.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,106.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,169.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,131.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,785.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,937.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,140.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,098.9</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,741.6</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(25,644.6</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(15,010.2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other expense (income)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,040.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,295.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">234.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss on settlement of convertible bridge notes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,868.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization of debt issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">269.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">827.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">536.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of warrant liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">245.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">178.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(861.8</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of derivative instrument related to convertible bridge notes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">128.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">348.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest and other income, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(109.3</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(99.0</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">208.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,443.5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,356.9</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(36,028.9</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(15,781.5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less Net income (loss) attributable to noncontrolling interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(236.4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44.1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss attributable to Electrocore, LLC, subsidiaries and affiliate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(9,498.5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(6,356.9</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(35,792.5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(15,737.4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Pro forma net loss per share data(1):</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net loss per share &#151; basic and diluted (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.36</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.72</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(2.16</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1.80</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma weighted average number of common shares used to calculate loss per share &#151; basic
and diluted (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,949,259</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,266,116</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,127,652</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,364,789</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">71 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="67%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>As&nbsp;of&nbsp;March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>As of December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2016</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(Unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="6" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>in thousands</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Consolidated balance sheet data:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,520.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,224.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">416.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debt securities and other investments available for sale</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,186.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,950.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Working capital(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,397.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,914.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,629.4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,274.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39,232.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">622.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Long-term debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,666.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series A Preferred Units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53,518.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53,518.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53,518.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series B Preferred Units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68,755.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68,755.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,180.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,180.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,912.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total members&#146;/stockholders&#146; equity (deficit)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(98,833.1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(89,467.6</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(61,053.5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">We have presented pro forma basic and diluted net loss per share for the three months ended March 31, 2018 and the years ended December 31, 2017 and 2016, which consists of our historical net loss attributable to
Electrocore LLC, subsidiaries and affiliate, divided by the pro forma basic and diluted weighted average number of shares of common stock outstanding after giving effect to the conversion of all of our outstanding Common Units, Series&nbsp;A
Preferred Units and Series&nbsp;B Preferred Units into 23,228,095 shares of our common stock prior to the closing of this offering. Net loss used in calculating net loss per share does not reflect (i)&nbsp;the estimated expenses of this offering or
(ii)&nbsp;compensation and expenses for our board of directors and other costs related to operating as a public company. For more information on how we calculate basic and diluted pro forma weighted average number of shares outstanding, see
Note&nbsp;9 to our audited consolidated financial statements and Note 11 to our unaudited consolidated financial statements included elsewhere in this prospectus. The calculations described above do not give effect to the potential issuance of
241,939 shares of common stock at the initial public offering price in satisfaction of accrued but unpaid preferred return to our preferred stockholders (which we expect to pay in shares of common stock valued at the offering price).
</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">We define working capital as current assets less current liabilities. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">72 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom472601_12"></A>MANAGEMENT&#146;S DISCUSSION AND ANALYSIS OF FINANCIAL </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDITION AND RESULTS OF OPERATIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The following discussion of our results of operations and financial condition should be read together with the &#147;Selected Consolidated
Financial Data&#148; section, our audited and unaudited historical financial statements and the notes therein included in this prospectus as well as the discussion in the Business section of this prospectus. This discussion contains forward-looking
statements that involve risks and uncertainties. The forward-looking statements are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry, business and future financial results.
Our actual results could differ materially from the results contemplated by these forward-looking statements due to a number of factors, including those discussed in the sections of this prospectus entitled &#147;Risk Factors&#148; and &#147;Special
Note Regarding Forward-Looking Statements.&#148; </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a commercial-stage bioelectronic medicine company with a platform non-invasive vagus nerve stimulation therapy initially focused on
neurology and rheumatology. Our therapy, gammaCore, has pharmacologic effects on the peripheral and central nervous systems, which modulate neurotransmitters and immune function. gammaCore is FDA-cleared for the acute treatment of pain associated
with migraine and episodic cluster headache. Based on our clinical data, we are pursuing label expansions for the prevention of migraine, migraine in adolescents and post-traumatic headache, and are also engaging in clinical development for
potential new labeling claims in rheumatology, including Sj&ouml;gren&#146;s syndrome and rheumatoid arthritis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following our initial FDA
clearance, our commercial strategy has been to establish gammaCore as a first-line treatment option for episodic cluster headache patients, who have few alternative treatment options available to them. This strategy is supported by a product
registry initiated in July 2017 to build advocacy among key opinion leaders in 55 leading headache centers in the United States, and to generate patient demand in the form of prescriptions submitted to payors. We intend to leverage this advocacy as
we expand into the broader headache market for both migraine and cluster headache in the third quarter of 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since our inception in
2005, we have devoted substantially all of our resources to the development of vagus nerve stimulation, or VNS, and the commercialization of our gammaCore therapy. Since our inception, we have received gross cash proceeds of approximately
$160.3&nbsp;million from the sale of our equity securities, including the conversion or exercise of our convertible promissory notes, term loan and warrants. From August 2017 through December 2017, in connection with closings of our Series B
Preferred Unit financing, we received net cash proceeds of approximately $44.5 million net of the conversion of outstanding convertible promissory notes, or Bridge Notes, accrued interest thereon and advisor fees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have never been profitable and have incurred net losses in each year since our inception. We incurred net losses of $9.5 million and $6.4
million for the three months ended March&nbsp;31, 2018 and March&nbsp;31, 2017, respectively, and net losses of $35.8 million and $15.7 million for the years ended December&nbsp;31, 2017 and December&nbsp;31, 2016, respectively. As of March&nbsp;31,
2018, our accumulated deficit was $162.4&nbsp;million. We expect to continue to incur substantial net losses and negative cash flows from operations for at least the next several years as we commercialize gammaCore for the acute treatment of pain
associated with migraine and episodic cluster headache in adults. We intend to make a significant investment in building our U.S. commercial infrastructure and in recruiting and training our sales representatives. We also intend to continue to make
significant investments in research and development to expand our gammaCore therapy for the treatment of other indications, including additional headache conditions and rheumatology. Furthermore, upon the closing of this offering, we expect to incur
additional costs associated with operating as a public company, including significant legal, accounting, investor relations and other expenses that we did not incur as a private company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a result, we will need substantial additional funding to support our continuing operations and pursue our growth strategy. Until such time
as we can generate sufficient revenue to cover our operating expenses and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">73 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
growth strategy, if ever, we expect to finance our operations through the sale of equity, debt financings or other capital sources, including potential collaborations with other companies and
other strategic transactions. We may be unable to raise additional funds or enter into such other agreements or arrangements when needed on favorable terms, or at all. If we fail to raise capital or enter into such agreements as, and when needed, we
may have to significantly delay, scale back or discontinue the development and commercialization of gammaCore, or delay our pursuit of potential additional labeling claims. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We face a variety of challenges and risks, which we will need to address and manage as we pursue our strategy, including our ability to
develop and retain an effective sales force, achieve market acceptance of gammaCore among physicians, patients and third-party payors, and expand the use of gammaCore to additional therapeutic indications. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because of the numerous risks and uncertainties associated with our commercialization efforts, as well as research and clinical development
activities, we are unable to predict the timing or amount of increased expenses, or when, if ever, we will be able to achieve or maintain profitability. Even if we are able to increase sales of gammaCore, we may not become profitable. If we fail to
become profitable or are unable to sustain profitability, then we may be unable to continue our operations at planned levels and be forced to reduce or terminate our operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of March&nbsp;31, 2018, we had cash and cash equivalents, debt securities and other investments available for sale, of $26.7 million. We
believe that the anticipated net proceeds from this offering, together with our existing cash resources, will enable us to fund our operating expenses and capital expenditure requirements through at least June 2019. We have based these estimates on
assumptions that may prove to be wrong, and we could exhaust our available capital resources sooner than we expect. See &#147;&#151; Liquidity and Capital Resources.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Statutory Corporate Conversion </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently operate as a Delaware limited liability company, under the name Electrocore, LLC. Prior to the closing of this offering,
Electrocore, LLC will convert into a Delaware corporation pursuant to a statutory conversion and change its name to electroCore, Inc. As a result of the corporate conversion, the holders of the different classes and series of units of Electrocore,
LLC will become holders of common stock and options to purchase common stock of electroCore, Inc. Immediately prior to the corporate conversion, all outstanding Preferred Units will first convert into our Common Units on a one-for-one basis in
accordance with the automatic conversion provision of our Operating Agreement and thereafter in connection with the corporate conversion our Common Units, other than Common Units issued as Profits Interests, will convert into shares of our common
stock on a one share of common stock for every 18 Unit basis. Our Profits Interests will be converted into (i)&nbsp;shares of our common stock, and (ii)&nbsp;with respect to Profits Interests that are held by our current employees and consultants at
the time of the corporate conversion, options to purchase our common stock. The number of shares of common stock and the number of options to be issued in respect of the Profits Interests will be determined based upon the appreciation in our value
after the date of grant of the applicable Profits Interest through the completion of this offering. The exercise price of these options will be equal to our initial public offering price. Following the corporate conversion, the vesting provisions
applicable to the Profits Interests as in effect prior to the corporate conversion will apply, in substantially the same manner, to the shares of common stock and options issued in respect of such Profits Interests in the corporate conversion. Other
than warrants that expire in connection with the completion of this offering, holders of warrants to purchase units of ElectroCore, LLC will become holders of warrants to purchase common stock of electroCore, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The purpose of the corporate conversion is to reorganize our corporate structure so that the entity that is offering our common stock to the
public in this offering is a corporation rather than a limited liability company and so that our existing investors will own our common stock rather than equity interests in a limited liability company. For further information regarding the
corporate conversion, see &#147;Corporate Conversion.&#148; References in&nbsp;this prospectus to our capitalization and other matters pertaining to our equity prior to the corporate conversion relate to the capitalization and equity of Electrocore,
LLC, and after the corporate conversion, to electroCore, Inc. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">74 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements included elsewhere in this prospectus are those of
Electrocore, LLC and its subsidiaries and affiliate. We expect that our conversion from a Delaware limited liability company to a Delaware corporation will not have a material effect on our consolidated financial statements at the time of the
corporate conversion. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Components of Our Results of Operations </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Net Sales </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect to generate
the majority of our net sales from the United States. In April 2017, we received FDA clearance for gammaCore for the acute treatment of pain associated with episodic cluster headache. In July 2017, we began a product registry for episodic cluster
headache in the United States and as a result generated our first U.S. revenue relative to this FDA clearance. Through this registry, we are seeking to establish a base of advocacy among key opinion leaders in the headache field and to generate
patient demand through prescriptions submitted to the payors. Given our limited resources, we believe that choosing to enter the market with a targeted product registry that prioritized early development of advocacy and reimbursement best positions
us for commercial launch in the United States in the third quarter of 2018. In January 2018, we received FDA clearance for gammaCore for the acute treatment of pain associated with migraine headaches. In July 2017, we implemented a co-payment
assistance program whereby we assumed responsibility for a fixed amount of copayment for the patient. Costs for this program were immaterial for the year ended 2017. For the three months ended March&nbsp;31, 2018 costs for this program are reflected
as a reduction of the transaction price of units sold within our net sales. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In February 2018 we began a formal physician training program
highlighting the clinical evidence and benefits of gammaCore for the acute treatment of pain associated with migraine and episodic cluster headache. Concurrently, to incentivize these physicians to issue prescriptions and increase market
penetration, we began a voucher program providing new patients with a one-time 31-day therapy at no charge to the patient. While the voucher program has increased demand, the transaction price for each unit sold through the voucher program is
reduced by the amount of the one-time free <FONT STYLE="white-space:nowrap">31-day</FONT> therapy which offsets the effects of the increased demand for gammaCore. Our revenue reflects only gammaCore units sold either for new patients, or existing
patients refills, that are not related to our voucher program. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to December&nbsp;31, 2017, we generated the majority of our revenue
from the European CE Mark approval for gammaCore that we obtained in 2011 for five different indications, including primary headache. This allowed us to commercialize gammaCore in the European Economic Area and other countries that recognize the
European CE Mark. Following receipt of our CE marks in 2011 and prior to receipt of our FDA clearance in the United States, we limited our commercialization effort outside the United States to Germany and the United Kingdom. Revenue, however, was
minimal primarily due to limited published pivotal clinical data to support reimbursement in these countries. Now that our pivotal trials (ACT 1, ACT 2 and PRESTO) have been completed, we are awaiting publication of the PRESTO data. These data are
expected to be published prior to the end of 2018, along with the published ACT 1 and ACT 2 data, to the reimbursement authorities in Germany and the United Kingdom for review for reimbursement consideration. We intend to explore select
international markets to commercialize our gammaCore therapy based on reimbursement outcomes and as our resources permit, using direct, dealer and distributor sales models as the targeted market best dictates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect net sales of gammaCore to increase in the future as a result of new FDA clearances for indications for our therapy and as we expand
our sales, marketing and distribution capabilities to support growth in the United States and in select markets internationally. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cost of Goods Sold
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cost of goods sold consists primarily of direct material, direct labor and overhead costs. A significant portion of our cost of
goods sold consists of overhead costs such as quality assurance, warehousing and shipment, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">75 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
facilities, depreciation on equipment and operations supervision and management. Due to our relatively low production volumes compared to our available assembling capacity, a large portion of our
costs for our gammaCore therapy consists of overhead expense. If our production volumes increase as expected in the future, we anticipate that our per unit production costs will decrease. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Gross Profit </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We calculate gross
profit as net sales less cost of goods sold. Our gross profit has been and will continue to be affected by a variety of factors, including production volumes, assembly costs, product reliability and the implementation of cost-reduction strategies
over time. We expect our gross profit to increase over time as our production volume increases and as we spread the fixed portion of our assembly and production overhead costs over a larger number of units produced, thereby significantly reducing
our per unit assembly costs. However, our gross profit as a percentage of net sales, or gross margin, will be impacted by numerous factors including commencement of sales of our next generation product gammaCore Sapphire in the United States, or any
other future products, which may have higher product costs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Research and Development </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our research and development expenses consist primarily of employee compensation, engineering, product development, tooling, proprietary data
warehouse development and enhancements, quality assurance, clinical trial and regulatory expenses incurred in the development and FDA clearance of our gammaCore therapy. Research and development expenses also include consulting services, outside
services and materials. We expense research and development costs as they are incurred. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Selling, General and Administrative </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our selling, general and administrative expenses consist primarily of personnel related costs (including compensation, benefits, and unit based
compensation) for executive, finance, administrative and field based personnel, costs for commercial related infrastructure, and market development. In anticipation of clearance from the FDA and commencement of commercial sales in the United States,
we incurred a significant increase in compensation costs as additional personnel were hired to oversee the execution of the commercial plan in the United States and Europe. Significant expenses include costs associated with marketing and
advertising, salesforce, professional fees for legal services, including legal services associated with our efforts to obtain and maintain broad protection for the intellectual property related to our products, rent, compliance, payor reimbursement
development, accounting services, and consulting fees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect selling, general and administrative expenses to continue to grow as we
seek to execute our commercial and research and development plans. We also expect other non-employee-related costs, including outside services and accounting and legal costs to increase. The timing of these increased expenditures and their magnitude
are primarily dependent on the commercial success and sales growth of gammaCore and gammaCore Sapphire. In addition, we expect to incur increased selling, general and administrative expenses in connection with being a public company, which may
further increase when we are no longer able to rely on certain &#147;emerging growth company&#148; exemptions we are afforded under the JOBS Act. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Amortization of Debt Issuance Costs </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Amortization of debt issuance costs consist primarily of the amortization of costs, including cash, warrants and common units issued to
advisors and bankers, in conjunction with our issuance of Bridge Notes. These items were recorded as a discount on the Bridge Notes and amortized on a straight line basis over the term of the Bridge Notes until their conversion to Series B Preferred
Units in August 2017. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">76 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Net Loss on Settlement of Bridge Notes </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The loss on settlement of debt is attributable to the conversion of the Bridge Notes into Series B Preferred Units in August 2017 (see Note 12
to the audited consolidated financial statements included elsewhere in this prospectus). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Interest Expense </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest expense consists of interest on our term loans and Bridge Notes. Interest includes both the stated fixed rate of interest on the term
loans and Bridge Notes, as well as the amortization of debt discount over the term of the Bridge Notes. The debt discount relates to the warrants, embedded derivative, and Common Units issued in conjunction with our Bridge Notes. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Net Income (Loss) Attributable to Non-Controlling Interest </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From our inception through March&nbsp;31, 2018, we consolidated the financial results of our affiliate, electroCore (Aust) Pty Limited.
Although we did not have a controlling ownership interest in electroCore (Aust) Pty Limited during that period, we determined that electroCore (Aust) Pty Limited was a variable interest entity, of which we were the primary beneficiary. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Results of Operations </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Three months ended
March&nbsp;31, 2018 compared to three months ended March&nbsp;31, 2017 </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth amounts from our
consolidated statements of operations for the three months ended March&nbsp;31, 2018 and 2017. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="76%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Three&nbsp;months&nbsp;ended&nbsp;March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2018&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2017&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Consolidated statements of operations:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net sales</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">81.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">116.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of goods sold</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross profit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,306.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,726.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Selling, general and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,824.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,059.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,131.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,785.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,098.9</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,741.6</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,040.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization of debt issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">269.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of warrant liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">245.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">178.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of derivative instrument related to convertible bridge notes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">128.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest and other income, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(109.3</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">208.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,443.5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,356.9</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Net income attributable to noncontrolling interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss attributable to Electrocore, LLC, subsidiaries and affiliate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(9,498.5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(6,356.9</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">77 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Net Sales </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net sales decreased $35.7 thousand to $81.2 thousand for three months ended March&nbsp;31, 2018, from $116.9 thousand for the three months
ended March&nbsp;31, 2017. The decrease is primarily due to a reduction in the transaction price related to the cost of voucher program and the co-payment assistance program. Net sales are not recognized for gammaCore units redeemed, or estimated to
be redeemed under the Company&#146;s voucher program. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Costs of Goods Sold </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cost of goods sold decreased $23.8 thousand to $48.9 thousand for three months ended March&nbsp;31, 2018, from $72.7 thousand for the three
months ended March&nbsp;31, 2017. The decrease is a result of units dispensed under the voucher program. Units estimated to be dispensed under the voucher program are recognized in selling, general, and administrative expenses, which costs are not
recognized in cost of goods sold. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Gross Profit </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Gross profit decreased $12.0 thousand to $32.2 thousand for three months ended March&nbsp;31, 2018, from $44.2 thousand for the three months
ended March&nbsp;31, 2017. This decrease reflects the impact of additional units sold offset by the costs of the voucher and co-payment program, which were subtracted from costs of goods sold for the period. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Research and Development </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Research
and development expenses increased $0.6 million to $2.3 million for three months ended March&nbsp;31, 2018, from $1.7 million for the three months ended March&nbsp;31, 2017. This increase was primarily the result of an increase in headcount and
increased compensation expenses related to personnel of $563.0 thousand, an increase in research studies of $200.0 thousand, which was offset by a decrease in other related expenses. We plan to increase our research and development expenses in 2018
to support product development, product enhancements and future clinical studies, to further develop and update our existing technologies and to expand our gammaCore therapy for the treatment of other indications, including additional headache
conditions and rheumatology. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Selling, General and Administrative </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Selling, general and administrative expense increased $3.7 million to $6.8 million for three months ended March&nbsp;31, 2018, from $3.1
million for the three months ended March&nbsp;31, 2017. This increase is primarily a result of increased costs of $1.1 million related to newly hired personnel, increased consulting expense of $1.1 million, increased professional fees of $0.5
million, increased training costs of $0.4 million, increased third party valuation costs of $0.1 million and an increase in other related expenses. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Interest Expense </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest expense
for the three months ended March&nbsp;31, 2017 was $1.0 million, which is primarily due to interest incurred on the outstanding Bridge Notes as well as amortization of the debt discount. There was no interest expense for the three months ended
March&nbsp;31, 2018 as a result of the conversion of the Bridge Notes into Series B Preferred Units in August 2017. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Amortization of Debt Issuance
Costs </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Amortization of debt issuance costs, which relate to the Bridge Notes issued during 2017 and 2016, was $269.2 thousand for
three months ended March&nbsp;31, 2017. There was no amortization of debt issuance costs for the three months ended March&nbsp;31, 2018 as a result of the conversion of the Bridge Notes into Series B Preferred Units in August 2017. The debt issuance
costs were amortized on a straight-line basis over the term of the Bridge Notes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">78 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Change in Fair Value of Warrant Liability and Derivative Instrument related to Convertible Bridge
Notes </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The change in fair value of the warrant liability is based on revaluation of the warrants during the three months ended
March&nbsp;31, 2018. The effect of the revaluation of the warrant liability for the three months ended March&nbsp;31, 2018 was a change of $245.9 thousand compared to a change of $178.0 thousand for the three months ended March&nbsp;31, 2017. The
effect of the revaluation of the derivative instrument was $128.1 thousand for the three months ended March&nbsp;31, 2017. There was no liability associated with the derivative instrument as of March&nbsp;31, 2018 as a result of the conversion of
the related Bridge Notes into Series B Preferred Units in August 2017. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Interest and Other Income, Net </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest and other income, net was $109.3 thousand for the three months ended March&nbsp;31, 2018, which resulted from return on our debt
securities and other investments available for sale. We had no debt securities or other investments available for sale as of March&nbsp;31, 2017 and, as a result, there was no interest and other income, net for the three months ended March&nbsp;31,
2017. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other expense
includes, among other expenses, our best estimate of the costs expected to be incurred in connection with a lawsuit brought by a financial advisor seeking additional compensation in connection with our Series B Preferred Unit financing. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Net Income Attributable to Non-Controlling Interest </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net income attributable to non-controlling interest increased to $55.0 thousand for the three months ended March&nbsp;31, 2018, from $0 for the
three months ended March&nbsp;31, 2017. This increase is due to increased income related to our joint venture entity in Australia. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Net Loss
Attributable to Electrocore, LLC, subsidiaries and affiliate </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net loss attributable to Electrocore, LLC, subsidiaries and affiliate
increased by $3.1 million to $9.5&nbsp;million for the three months ended March&nbsp;31, 2018, from $6.4 million for the three months ended March&nbsp;31, 2017. The increase is primarily due to the items described above. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">79 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Year ended December&nbsp;31, 2017 compared to year ended December&nbsp;31, 2016 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth amounts from our consolidated statements of operations for the years ended December&nbsp;31, 2017 and 2016. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="78%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Years ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2016</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Consolidated statements of operations:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net sales</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">811.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">254.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of goods sold</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">518.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">123.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross profit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">292.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">130.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,830.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,971.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Selling, general and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,106.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,169.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,937.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,140.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(25,644.6</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(15,010.2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,295.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">234.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss on settlement of convertible bridge notes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,868.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization of debt issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">827.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">536.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest and other income, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(99.0</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of warrant liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(861.8</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of derivative instrument related to convertible bridge notes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">348.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(36,028.9</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(15,781.5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Net loss attributable to noncontrolling interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(236.4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44.1)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss attributable to Electrocore, LLC, subsidiaries and affiliate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(35,792.5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(15,737.4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Net Sales </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net sales increased $0.5 million to $0.8 million for the year ended December&nbsp;31, 2017, from $0.3&nbsp;million for the year ended
December&nbsp;31, 2016. This increase was primarily due to increased sales resulting from the establishment of our gammaCore product registry in the United States, as well as increased sales in Europe. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Costs of Goods Sold </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cost of goods
sold increased $0.4 million to $0.5 million for the year ended December&nbsp;31, 2017, from $0.1 million for the year ended December&nbsp;31, 2016. This increase was due to an increase in the number of gammaCore units sold, and increased direct
labor and overhead costs per unit as a result of additional staff required to assemble more units. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Gross Profit </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Gross profit increased $0.2 million to $0.3 million for the year ended December&nbsp;31, 2017 from $0.1&nbsp;million for the year ended
December&nbsp;31, 2016. This increase was due to an increase in the number of gammaCore units sold, offset slightly by an increase of assembly cost per unit. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Research and Development </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Research
and development expenses decreased $0.2 million to $7.8 million for the year ended December&nbsp;31, 2017 from $8.0 million for the year ended December&nbsp;31, 2016. The decrease was the result of an increase of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">80 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
expenses related to the proprietary data warehouse development costs and associated software for gammaCore data collection of $1.2&nbsp;million, offset by decreases in costs of manufacturing of
$0.9 million, and other related costs of $0.5 million. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Selling, General and Administrative </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Selling, general and administrative expense increased by $10.9 million to $18.1 million for the year ended December&nbsp;31, 2017 from $7.2
million for the year ended December&nbsp;31, 2016. This increase is primarily a result of increased personnel costs of $1.4 million related to newly hired personnel, increased legal and compliance costs of $0.6 million, increased costs of market
preparation, medical education, materials, samples, studies and travel of $3.6 million, and increased costs of $4.2 million related to consultants and service providers associated with the anticipated commercial launch of gammaCore and gammaCore
Sapphire. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Interest Expense </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Interest expense increased by $6.1 million to $6.3 million for the year ended December&nbsp;31, 2017 from $0.2 million for the year ended
December&nbsp;31, 2016. This increase is primarily due to the issuance of additional Bridge Notes in 2017 of $19.9 million and the related amortization of debt discount as well as interest incurred on the Bridge Notes. The Bridge Notes and any
related accrued interest were converted to Series B Preferred Units in August 2017. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Net Loss on Settlement of Convertible Bridge Notes </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the conversion of the Bridge Notes into Series B Preferred Units, we incurred a loss on the settlement of $3.9 million in the year ended
December&nbsp;31, 2017. This loss was calculated as the difference between the Series B Preferred Units issued (and the related warrants and Common Units issued in conjunction with the Bridge Financing), and the carrying value of the settled Bridge
Notes (which includes the related debt discount and discount for debt issuance costs), accrued interest, and the embedded derivative liability. There was no net loss on settlement for the year ended December&nbsp;31, 2016 since all Bridge Notes were
converted in August 2017. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Amortization of Debt Issuance Costs </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Amortization of debt issuance costs, which relate to the Bridge Notes issued during 2017 and 2016, increased by $0.3 million to $0.8 million
for the year ended December&nbsp;31, 2017 from $0.5 million for the year ended December&nbsp;31, 2016. These debt issuance costs were amortized on a straight-line basis over the term of the Bridge Notes that we issued in fiscal years 2017 and 2016.
This increase was driven by the additional Bridge Notes that were issued in 2017 and the full amortization of the remaining debt issuance costs as a result of the conversion of the debt to Series B Preferred Units in August 2017. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Change in Fair Value of Warrant Liability and Derivative Instrument related to Convertible Bridge Notes </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The change in fair value of the warrant liability and derivative instrument is based on revaluation of those instruments occurring during the
year ended December&nbsp;31, 2017. Revaluation of the warrant liability and the liability associated with the derivative instrument was immaterial during the year ended December&nbsp;31, 2016. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Net Loss Attributable to Non-Controlling Interest </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net loss attributable to non-controlling interest increased by $192.3 thousand to $236.4 thousand for the year ended December&nbsp;31, 2017
from $44.1&nbsp;thousand for the year ended December&nbsp;31, 2016. The increase is due to losses related to our joint venture entity in Australia. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">81 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Net Loss Attributable to Electrocore, LLC, subsidiaries and affiliate </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net loss attributable to Electrocore, LLC, subsidiaries and affiliate increased by $20.1 million to $35.8&nbsp;million for the year ended
December&nbsp;31, 2017 from $15.7 million for the year ended December&nbsp;31, 2016. The increase is primarily due to the items described above. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Liquidity and Capital Resources </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have financed our operations to date primarily through the sale of our equity securities, including the issuance of equity securities upon
the conversion of our convertible promissory notes, term loan and exercise of warrants. Historically, cash outflows have primarily been associated with cash used for operating activities such as the expansion and support of our sales and marketing
infrastructure, increased research and development activities, and other working capital needs. As of March&nbsp;31, 2018, we had cash and cash equivalents of $1.5 million, and debt securities and other investments available for sale of $25.2
million, and as of December&nbsp;31, 2017 we had cash and cash equivalents of $13.2 million, and marketable securities of $24.0 million. Cash in excess of immediate requirements is invested with a view to liquidity and capital preservation.
Currently, our cash and cash equivalents, and debt securities and other investments available for sale, are held in cash, money market bank accounts and treasury notes, all of which have original maturities of less than 90&nbsp;days. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Until we can generate a sufficient amount of cash from operations, we expect to finance future cash needs through public or private equity or
debt offerings. Additional capital may not be available on reasonable terms, if at all. If we are unable to raise additional capital in sufficient amounts or on terms acceptable to us, we may have to significantly scale back our operations or delay,
scale back or discontinue the continuing development of gammaCore. If we raise additional funds through the issuance of additional debt or equity securities, it could result in dilution to our existing unitholders and increased fixed payment
obligations, and these securities may have rights senior to those of our common units. If we incur indebtedness, we could become subject to covenants that would restrict our operations, such as limitations on our ability to incur additional debt,
limitations on our ability to acquire, sell or license intellectual property rights and other operating restrictions that could adversely impact our ability to conduct our business. Any of these events could significantly harm our business,
financial condition and prospects. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cash Flows </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the significant sources and uses of cash for the periods noted below: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="65%"></TD>
<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Three&nbsp;months&nbsp;ended&nbsp;March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2018&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2017&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(unaudited; in millions)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net cash (used in) provided by</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(9.7</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(4.3</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1.4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Operating Activities </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities was $9.7 million for the three months ended March&nbsp;31, 2018, compared to $4.3&nbsp;million for the
three months ended March&nbsp;31, 2017. This increase in net cash used in operating activities of $5.4 million was associated with net changes in working capital and an increase in net loss of $3.1 million, which was the result of our increase in
expenditures for selling, general and administrative items, including those related to our co-payment and voucher program. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">82 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Investing Activities </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities was $1.4 million for the three months ended March&nbsp;31, 2018 compared to $0 for the three months ended
March&nbsp;31, 2017 and reflects the net investment activity of $1.3 million and the purchase of additional property and equipment of $0.1 million. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Financing Activities </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash
used in financing activities was $0.5 million for the three months ended March&nbsp;31, 2018, which was a decrease of $4.7 million from net cash provided by financing activities of $4.2 million for the three months ended March&nbsp;31, 2017. This
decrease was primarily the result of no financing activities during the first quarter of 2018, as well as the deferral of costs incurred for expected future financing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the significant sources and uses of cash for the periods noted below: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="71%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Years&nbsp;ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2017&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2016&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(in millions)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net cash (used in) provided by</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(25.3</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(13.2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(24.1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Operating Activities </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities was $25.3 million for the year ended December&nbsp;31, 2017, compared to $13.2&nbsp;million for the year
ended December&nbsp;31, 2016. This increase in net cash used in operating activities of $12.1 million was associated with net changes in working capital and an increase in net loss of $20.2 million, which was the result of our increase in
expenditures for selling, general and administrative items. The changes in working capital reflect the increased inventory associated with our product registry and the anticipated launch of gammaCore as well as net changes associated with the timing
of payments. Offsetting uses were non-cash items including the amortization of debt discount and issuance costs of $6.1 million related to the Bridge Notes and the loss on the settlement of Bridge Notes of $3.9 million. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Investing Activities </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash
used in investing activities was $24.1 million for the year ended December&nbsp;31, 2017 compared to $0 for the year ended December&nbsp;31, 2016, and reflects the utilization of cash proceeds from issuance of the Bridge Notes and the sale of the
Series B Preferred Units for the purchase of marketable securities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Financing Activities </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities was $62.5 million for the year ended December&nbsp;31, 2017 and $9.3&nbsp;million for the year ended
December&nbsp;31, 2016, an increase of $53.2 million. This increase was primarily the result of the receipt of $19.9 million&nbsp;in net cash proceeds from the issuance of the Bridge Notes as well as $44.5 million in net cash proceeds from the
issuance of the Series B Preferred Units. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Capital Resources </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of March&nbsp;31, 2018, we had cash and cash equivalents of $1.5 million, and debt securities and other investments available for sale of
$25.2 million. We believe that the anticipated net proceeds from this offering, together with our existing cash resources, will enable us to fund our operating expenses and capital expenditure requirements through at least June 2019. We have based
these estimates on assumptions that may prove to be wrong, and we could exhaust our available capital resources sooner than we expect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">83 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Series A Preferred Units </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From March&nbsp;28, 2013 through September 2016, we received net proceeds of $50.7&nbsp;million from the sale of Series A Preferred Units at an
initial closing and several required milestone closings, several optional milestone closings, as well as from the conversion of certain loan amounts and the exercise of certain related warrants, net of related issuance costs. Investors in the Series
A Preferred Unit financings directly or indirectly included the following related parties of ours: Core Ventures II, LLC, or CV II, an entity that holds more than 5% of our outstanding units and in which Joseph P. Errico and Dr.&nbsp;Thomas J.
Errico, two of our directors, have a pecuniary interest and for which they serve as managers with voting control; Peter&nbsp;S. Staats, M.D., our Chief Medical Officer and a former director, and Nicholas Colucci, a director, and Kathryn Theofilos, a
former director of our company and currently an owner of more than 5% of our outstanding units, invested through CV&nbsp;II; Merck Global Health Innovation Fund, LLC, or GHI, an entity for which one of our directors, David M. Rubin, serves as a
Managing Director, and which owns greater than 5% of our outstanding units; and James&nbsp;L.L. Tullis, and the Tullis Opportunity Fund II, or TOP II, an entity in which Mr.&nbsp;Tullis, one of our directors, has a pecuniary interest and for which
he serves as the managing partner of its general partner. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Term Loans </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December&nbsp;22, 2015, Pacific Western Bank loaned us $1.25 million pursuant to a Loan and Security Agreement, which also provided for
three additional term loans aggregating $6.25 million, available at various dates through June 2017. In connection with this loan, we issued 66,177 warrants to Pacific Western Bank to purchase our Series A Preferred Units at an exercise price of
$0.85 per Unit. The warrants expire on December&nbsp;22, 2025. In May 2016, the Company repaid the $1.25 million term loan balance in full and the Loan and Security Agreement was terminated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December&nbsp;22, 2015, CV II also loaned us $1.25 million pursuant to a Loan and Security Agreement. In connection with this loan, we
issued 66,177 warrants to CV II expiring on December&nbsp;22, 2025 to purchase our Series A Preferred Units at an exercise price of $0.85 per unit. Pursuant to the terms of this loan, CV II elected to convert the loan of $1.25 million and related
accrued interest of $49.9 thousand into approximately 1.5&nbsp;million Series A Preferred Units in two installments in March 2016 and September 2016 at a price per unit of $0.85. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Bridge Note Financing </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From
September 2016 through June 2017, we issued an aggregate of $25.6&nbsp;million of Bridge Notes to existing and new investors. The Bridge Notes accrued interest at an annual interest rate of 10% and had a maturity date one year from the date of
issuance. Each Bridge Note was originally convertible into the equity securities issued in a subsequent equity financing that raised not less than $8.0&nbsp;million, or a Qualified Equity Financing, at a 10% discount to the price of the equity
securities issuable in the Qualified Equity Financing. The Bridge Notes were also convertible, at the option of the investors into Series A Preferred Units at $0.85 per Unit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each purchaser of a Bridge Note also received warrant coverage of 20% of the principal amount of its Bridge Note. The Bridge Note warrants are
exercisable from the date of the issuance of the Qualified Equity Financing until June&nbsp;29, 2021 and entitle each holder to purchase an amount of securities issued in the Qualified Equity Financing equal to 20% of principal amount of the Bridge
Notes purchased by each such investor divided by the price of the Qualified Equity Financing. The exercise price is equal to the Qualified Equity Financing price. Upon the closing of our Series B Preferred Unit financing in August 2017, the
outstanding Bridge Note warrants became exercisable for 7.7&nbsp;million Series B Preferred Units with an exercise price of $0.70 per unit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In September 2016 the terms of the Bridge Note Financing were amended to provide that, in addition to a Bridge Note and warrant, future bridge
investors, depending on the purchaser and amount invested, would receive up to two common units for each dollar of principal amount of Bridge Note purchased. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From December 2016 to June 2017, as compensation for placing Bridge Notes with investors in the principal amount of $12.3 million, our
placement agents received cash of $1.2 million, 5.4&nbsp;million common units, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">84 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and 1.6&nbsp;million warrants to purchase Series B Preferred Units at an exercise price of $0.70 per unit. Investors in the Bridge Notes financing included related parties as described in
&#147;Certain Relationships and Related Party Transactions.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Series B Preferred Units </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2017, we issued and sold at a price of $0.70 per unit, in serial closings, $73.6 million of our Series B Preferred Units, inclusive of the
automatic conversion of $25.6 million of our Bridge Notes plus $1.1&nbsp;million of accrued and unpaid interest thereon. In connection with such closings, we issued to investors in such closings warrants for the purchase of 35.5&nbsp;million Common
Units at an exercise price of $1.25 per Common Unit. In connection therewith, we also issued to our financial advisors warrants for the purchase of 2.7&nbsp;million Common Units at an exercise price of $0.70 per Common Unit, and warrants for the
purchase of 0.3&nbsp;million Series B Preferred Units at an exercise price of $0.70 per Series B Preferred Unit. Investors in the Series B Preferred Unit financings included related parties as described in &#147;Certain Relationships and Related
Party Transactions.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contractual Obligations </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the normal course of business, we enter into obligations and commitments that require future contractual payments. The commitments result
primarily from lease for office space and leased equipment. The following table summarizes our contractual obligations and commercial commitments as of December&nbsp;31, 2017: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="42%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Less&nbsp;than&nbsp;1&nbsp;year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>1 to 3 years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>3&nbsp;to&nbsp;5&nbsp;years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>More&nbsp;than&nbsp;5&nbsp;years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease Rental Payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">552,524</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,687,764</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">195,437</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,435,725</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The table above reflects only payment obligations that are fixed and determinable based on our current
agreements. Our operating lease commitment relates to the facility leased for our corporate headquarters in Basking Ridge, New Jersey. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Off-Balance
Sheet Arrangements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We did not have during the periods presented, and we do not have any off-balance sheet arrangements, as defined in
the rules and regulations of the SEC. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Internal Control Over Financial Reporting </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the audit of our consolidated financial statements for the years ended December&nbsp;31, 2017 and 2016, we identified a
material weakness in our internal control over financial reporting related to the accounting for complex transactions. For additional information, see the &#147;Risk Factors &#151; Risks Related to Our Common Stock and This Offering &#151; We have
identified a material weakness in our internal control over financial reporting. If we are unable to remediate this material weakness, or if we experience additional material weaknesses in the future, we may not be able to accurately or timely
report our financial condition or results of operations and investors may lose confidence in our financial reports and the market price of our common stock could be adversely affected.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Quantitative and Qualitative Disclosures About Market Risk </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We develop our products in the United States and sell those products into more than four countries. As a result, our financial results could be
affected by factors such as changes in foreign currency exchange rates or weak economic conditions in foreign markets. Most of our sales in Europe are denominated in the U.S.&nbsp;dollar and Euro. As our sales in currencies other than the U.S.
dollar increase, our exposure to foreign currency fluctuations may increase. In addition, changes in exchange rates also may affect the end-user prices of our products compared to those of our foreign competitors, who may be selling their products
based on local currency pricing. These factors may make our products less competitive in some countries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">85 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the U.S. dollar uniformly increased or decreased in strength by 10% relative to the
currencies in which our sales were denominated, our net income would have correspondingly increased or decreased by an immaterial amount for the three months ended March&nbsp;31, 2018. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our exposure to market interest rate risk is confined to our cash and cash equivalents and debt securities and other investments available for
sale. As of March&nbsp;31, 2018, we had cash and cash equivalents of $1.5 million, and debt securities and other investments available for sale of $25.2 million. The goals of our investment policy are preservation of capital, fulfillment of
liquidity needs and fiduciary control of cash and investments. We also seek to maximize income from our investments without assuming significant risk. To achieve our goals, we may maintain a portfolio of cash equivalents and investments in a variety
of securities of high credit quality. The securities in our investment portfolio, if any, are not leveraged, are classified as either available for sale or held-to-maturity and are, due to their very short-term nature, subject to minimal interest
rate risk. We currently do not hedge interest rate exposure. Because of the short-term maturities of our cash equivalents, we do not believe that an increase in market rates would have any material negative impact on interest income recognized in
our statement of operations. We have no investments denominated in foreign currencies and therefore our investments are not subject to foreign currency exchange risk. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All of the potential changes noted above are based on sensitivity analyses performed on our financial position as of March&nbsp;31, 2018. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Critical Accounting Policies and Estimates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The preparation of our financial statements are in accordance with GAAP . We are required to make estimates and assumptions that affect the
reported amounts of assets and liabilities as of the date of the consolidated financial statements, the reported amounts of net sales and expenses during the reporting periods and the related disclosures in the consolidated financial statements. We
believe that the following accounting policies described in Note&nbsp;2: &#147;Summary of Significant Accounting Policies&#148; in the audited consolidated financial statements included elsewhere in this prospectus, are critical because they involve
a higher degree of judgment and uncertainty. As a result, these accounting policies could materially affect our financial statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On
an ongoing basis, we evaluate these estimates and judgments based on historical experiences and various other factors that are believed to reflect the current circumstances. While we believe our estimates, assumptions and judgments are reasonable,
they are based on information presently available. Actual results may differ significantly from these estimates due to changes in judgments, assumptions and conditions as a result of unforeseen events or otherwise, which could have a material impact
on our financial position and results of operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Revenue Recognition </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We operate in one reportable segment and all of our net sales are derived from sales of our gammaCore product, net of specialty pharmaceutical
distribution discounts. Products are sold to a specialty pharmaceutical distributor on a per unit wholesale acquisition cost basis. We recognize revenue upon transferring product to our customer FOB destination. Transfer of control is deemed to
occur when we have transferred physical possession of the product FOB destination, the customer has accepted the product and has legal title and significant risks and rewards of ownership, and we have present right to payment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the audited consolidated statements of operations for the years ended December&nbsp;31, 2017 and 2016, revenue is presented under ASC Topic
605, <I>Revenue Recognition</I>. Under this basis, revenue is recognized when the following criteria are met: persuasive evidence of an arrangement exists, the customer assumes ownership and risk of loss, the sales price is fixed or determinable,
and collection is reasonably assured. Accordingly, the Company recognized revenue when the delivery of the product was completed. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">86 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Effective January&nbsp;1, 2018, we adopted ASC Topic 606, <I>Revenue from Contracts with
Customers</I>. Under this basis, revenue is recognized when an entity transfers control of promised goods to a customer in an amount that reflects the consideration the entity is entitled to receive in exchange for those goods. Indicators that
control has transferred include (1)&nbsp;the Company has a present right to payment for the product, (2)&nbsp;the Company has transferred the physical possession of the product, (3)&nbsp;the customer has legal title to the product, (4)&nbsp;the
customer has significant risks and rewards of ownership and (5)&nbsp;the customer has accepted the product. The Company determined that, like under ASC 605, revenue is recognized when the delivery of the product is completed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We adopted ASC 606 using the full retrospective method. The adoption did not result in material impacts to our historical financial statements
and no adjustments were made to present the unaudited consolidated financial statements for the three months ended March&nbsp;31, 2017. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under ASC 606 the vouchers issued under our voucher program, which began in February 2018 represent consideration payable to our specialty
pharmaceutical distributor&#146;s customer, the specialty pharmacy. This voucher program, provides new patients with a one time, 31 days of therapy at no charge. As a result, vouchers are accounted for as a reduction in transaction price.
Accordingly, the Company excludes from revenue the number of vouchers redeemed in the period and estimates of the number of vouchers to be redeemed. The corresponding costs associated with the vouchers are recorded as promotional expenses within
selling, general and administrative expenses. Variable consideration estimates were made using the expected value amount method, which is appropriate when there are limited outcomes of variable consideration. In this case, vouchers are either
redeemed, or they are not redeemed. For the three months ended March&nbsp;31, 2018, $169.7 thousand of vouchers were redeemed and $124.7 thousand of vouchers were estimated to be redeemed in a subsequent period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Similarly, our co-payment reimbursement program, which was implemented in July 2017, is also considered variable consideration and each
co-payment reimbursement made was accounted for as a reduction in the transaction price, which impacted our net sales for the three months ended March&nbsp;31, 2018 by $29.0 thousand. The reductions in revenue/costs of these programs are accounted
for a promotional items and are included in our selling, general and administrative expenses. The co-payment reimbursement program costs for the year ended December&nbsp;31, 2017 were immaterial. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the current time, we do not provide an allowance for returns. Therapy delivered from our gammaCore products and subsequent refills are sold
in 31-day increments to our specialty pharmaceutical distributor. Once activated, our products stop delivering therapy after 31 days, at which time the patient discards the product, in the case of gammaCore, and can receive a refill prescription for
a new 31-day gammaCore product. In the case of the gammaCore Sapphire, which will begin commercial sales in mid-2018, patients with a prescription refill can receive the next 31 days of therapy via our refill RFID card. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expense the cost, as incurred, of product damaged as a result of shipping to our specialty pharmaceutical distributors. This expense,
historically, has been immaterial. We expect to receive payment on all of our customer receivables within one year and therefore classify all receivables as current assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Accounts receivable are net of an allowance for doubtful accounts, which are accounts from which payment is not expected to be received
although product was provided and revenue was earned. Receivables are written off when deemed uncollectible. Recoveries of receivables previously written off are recorded when received. To date, we have not provided an allowance for doubtful
accounts, based on historical experience. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Inventories </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We value inventory at the lower of cost or net realizable value. Cost is determined on a first in first out basis. This policy requires us to
make estimates regarding the net realizable value of our inventory, including an assessment of excess or obsolete inventory. We evaluate inventory for excess quantities and obsolescence based </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">87 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
on an estimate of the future demand for our product within a specified timeframe, and record an allowance to reduce the carrying value of inventory as determined necessary. The estimates we use
for demand are also used for near-term capacity planning and inventory purchasing and are consistent with our revenue forecasts. If our actual demand is less than our forecast demand, we may be required to take additional excess inventory charges,
which would decrease gross margin and adversely impact net operating results in the future. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Income Taxes </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Currently, we are a limited liability company and therefore tax attributes are passed through to our members. Prior to the closing of this
offering, we will convert to a Delaware corporation. We will be taxed at the rates applicable within each jurisdiction in which we will operate and/or generate revenue. The composite income tax rate, tax provisions, deferred tax assets and deferred
tax liabilities will vary according to the jurisdiction in which profits arise. Tax laws are complex and subject to different interpretations by management and the respective governmental taxing authorities, and require us to exercise judgment in
determining our income tax provision, our deferred tax assets and liabilities and the valuation allowance recorded against our net deferred tax assets. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Research and Development Expenses </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We incur significant expenditures on research and development costs, including clinical testing for regulatory purposes and these expenses have
been expensed as incurred. Our research and development expenses primarily consist of pilot and pivotal clinical trials relative to current and future therapeutic indications, product engineering, technical updates, quality assurance and regulatory
expenses. Additionally, these expenses are comprised of development and enhancements to our proprietary data warehouse, which maintains patient product serial numbers and interacts in real time, with a device placed at the specialty pharmacy to
program RFID refill cards. Research and development expenses also include employee unit-based compensation, consulting services, outside services, materials, and supplies relating to clinical trials including products revisions, data statistics and
patient recruitment. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Unit-Based Compensation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We record compensation costs related to our unit-based awards, which currently include Common Units issued as Profits Interests, based on the
fair value of such awards. Compensation expense is recognized over the vesting period during which an employee is required to provide services in exchange for the award. All unit-based awards are expensed on a straight-line basis over the vesting
period, which is generally four years. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Measurement of unit-based payment transactions with non-employees is based on the fair value
of whichever is more reliably measurable: (a)&nbsp;the goods or services received; or (b)&nbsp;the equity instruments issued. The fair value of the unit-based payment transaction is determined at the earlier of performance commitment date or
performance completion date. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The estimation of the fair value of each profits unit grant or issuance on the date of grant involves
numerous assumptions by management. Although we calculate the fair value under the Black-Scholes option pricing model, which is a standard option pricing model, this model still requires the use of numerous assumptions, including, among others, the
expected life (turnover), volatility of the underlying equity security, a risk free interest rate and expected dividends. We do not have publicly traded equity and have a limited operating history and a lack of company-specific historical and
implied volatility data, and therefore we have estimated stock price volatility based upon an index of the historical volatilities of a group of publicly-traded industry peer companies. We have estimated the expected term of our Common Units issued
as Profits Interest using the &#147;simplified&#148; method, whereby the expected life equals the average of the vesting term and the original contractual term of the option. The use of different values by management in connection with these
assumptions in the Black-Scholes option pricing model could produce substantially different results. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">88 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Determination of the Fair Value of Common Units </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As there has been no public market for our common units to date, the estimated fair value of our common units has been supported by third-party
valuations with input of a combination of objective and subjective factors that management believe are relevant. Our third-party valuations resulted in valuations of our Common Units of $0.14 per unit as of March&nbsp;31, 2017, $0.21 per unit as of
June&nbsp;30, 2017, $0.35 per unit as of September&nbsp;30, 2017, $0.69 per unit as of December&nbsp;31, 2017 and $0.77 per unit as of March&nbsp;31, 2018. These third-party valuations were performed in accordance with the guidance outlined in the
AICPA&#146;s Accounting and Valuation Guide,<I>&nbsp;Valuation of Privately-Held-Company Equity Securities Issued as Compensation. </I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our third-party valuation of common units was prepared using the discounted cash flow, or DCF, method, a form of the income approach, to
estimate our equity value. In order to estimate equity value, the DCF method uses the estimated present value of future net cash flows for the expected life of the related assets or business, discounted at a rate of return that considers the
relative risk of achieving those cash flows, the time value of money and the current stage of development of the business. The total fair value of equity on a marketable basis was then allocated between each class of equity, including common units,
preferred units, Profits Interests, and warrants, applying a hybrid method of allocation. Under the hybrid method, a probability-weighted expected return method and an option pricing model were utilized. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The assumptions underlying these valuations represent management&#146;s best estimates, which involve inherent uncertainties and the
application of management judgment. As a result, if factors or expected outcomes change and we use significantly different assumptions or estimates, our share-based compensation expense could be materially different. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following the closing of this offering, the fair value of our common shares will be determined based on the quoted market price of our common
shares. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Profits Interests Granted </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes by grant period the number of Profits Interests units granted by us during 2017 and the three months ended
March&nbsp;31, 2018 as well as the estimated fair value of such grants as of the grant date: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="56%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:70.20pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Three months ended</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;units</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair value<BR>per&nbsp;underlying&nbsp;unit<BR>at date of grant</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">March 31, 2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,022,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">0.020&nbsp;-&nbsp;0.082</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June 30, 2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,820,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.020&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">September 30, 2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,170,335</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.014&nbsp;-&nbsp;0.500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December 31, 2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,193,754</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.029&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">March 31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,112,218</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.020&nbsp;-&nbsp;0.140</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Bridge Notes and Warrants </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Bridge Notes, common units and warrants to purchase securities in the Qualified Equity Financing (except that, for issuances prior to
September&nbsp;9, 2016, no Common Units were issued in respect thereof) were issued to investors simultaneously in exchange for cash equal to the principal amount of the Bridge Notes. In addition, the Bridge Notes were issued with an embedded
automatic conversion feature in which outstanding Bridge Notes are converted to Series&nbsp;B Preferred Units upon occurrence of the Qualified Equity Financing. Each of these separate financial instruments and embedded features require separate
accounting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The proceeds of the bridge financing transactions were required to be allocated to each of the Bridge Notes, Common Units,
and warrants. In addition, the embedded option to convert to Series A Preferred Units and the automatic conversion feature to Series B Preferred Units were determined to be embedded derivatives that require bifurcation from the Bridge Notes and
separate accounting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">89 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The warrants were evaluated by management and determined to be liability classified. As
such, the warrants are measured at fair value with changes in fair value recognized in net income. After subtracting the fair value of the warrants at issuance, the remaining proceeds were allocated to the Bridge Notes (inclusive of the embedded
automatic conversion feature) and common units at their relative fair values. The embedded option to convert to Series A Preferred Units and the automatic conversion feature to Series&nbsp;B Preferred Units was then separated from the Bridge Notes
and measured at fair value with changes in fair value recognized in net income. The residual amount of proceeds were then allocated to the Bridge Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a consequence of the allocation of proceeds of the bridge financing to the financial instruments and embedded derivative described above,
the Bridge Notes were issued at a discount. This discount has been amortized over the life of the Bridge Notes. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Valuation of Bridge Notes
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to allocate proceeds of the bridge financing transactions, a determination of the fair value of the common unit, warrant
and conversion features of the Bridge Notes was required. We used an alternative discounted cash flow method to value the Bridge Notes. More specifically, we determined the fair value of the straight convertible debt component by discounting
principal and interest payments back to the present value at a 45% required rate of return over a dollar-weighted average term of 0.84 years as of December&nbsp;31, 2016 and as of June&nbsp;30, 2017 we used a 45% required rate of return over a
dollar-weighted average term of 0.17 years. As of December&nbsp;31, 2016 and June&nbsp;30, 2017, we determined the fair value of the embedded value of the option&#146;s ability to convert at a 10% discount into the next Qualified Equity Financing.
For June&nbsp;30, 2017, this was done by discounting the difference between the aggregate Bridge Note principal plus interest at a 10% discount to the next Qualified Equity Financing and the aggregate Bridge Note principal plus interest at a 45%
required rate of return less a 10% discount for lack of marketability times a 95% probability of a Qualified Equity Financing closing prior to the maturity date of the Bridge Note. For December&nbsp;31, 2016, this was done by discounting the
difference between the aggregate Bridge Note principal plus interest at a 10% discount to the next Qualified Equity Financing and the aggregate Bridge Note principal plus interest at a 50% required rate of return less a 10% discount for lack of
marketability times an 80% probability of a Qualified Equity Financing closing prior to the maturity date of the Bridge Note. Changes to the assumptions used in such valuation could have a significant impact on these fair values. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Valuation of Derivative Liability Associated with Bridge Notes </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The derivative liability relating to the debt component of the Bridge Notes is measured at fair value and is subsequently remeasured at fair
value at each reporting date. Changes in the fair value of the derivative liability are recognized as a component of amortization of debt discount and issuance cost in our consolidated statement of operations. We continued to recognize changes in
the fair value of the derivative liability embedded in the Bridge Notes until the conversion into the Qualified Equity Financing, which occurred in connection with the conversion of the Bridge Notes into Series B Preferred Units in August 2017. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The embedded option to convert to Series A Preferred Units was deemed to be de minimus. The derivative liability related to the automatic
conversion of the Bridge Notes in the Qualified Equity Financing was recorded at fair value using an alternative discounted cash flow method. The derivative liability related to the Bridge Notes was recorded at fair value determined by using an
alternative discounted cash flow method. This method of valuation involves using inputs such as a 50% required rate of return, an 80% probability of a Qualified Equity Financing closing prior to the maturity of the Bridge Notes, and an option&#146;s
ability to convert at a 10% discount into the expected next Qualified Equity Financing. Changes to the assumptions used in such valuation could have a significant impact on the fair value of the derivative liability. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Valuation of Warrant Liability </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As
discussed above, the warrants to purchase securities in the Qualified Equity Financing were determined to be liability classified. We determined that such warrants potentially obligated us to repurchase or redeem the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">90 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
future Qualified Equity Financing, as the terms of the Qualified Equity Financing was unknown at the time the warrants were issued alongside the Bridge Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The warrants are recorded as a liability on our balance sheet at their fair value and are revalued at each reporting date, with fair value
changes recognized as amortization of debt discount and issuance cost in the consolidated statement of operations. We will continue to adjust the liability for changes in fair value until the earlier of the exercise or expiration of the warrants, or
the issuance of securities in a Qualified Equity Financing, at which time the classification of the warrants as liabilities or as equity is reassessed. We estimate the fair value of the liability using option pricing models and assumptions that are
based on the individual characteristics of the warrants or instruments on the valuation date, including assumptions for expected volatility, expected life, yield, and risk-free interest rate. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Valuation of Series B Preferred Units and Warrants </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Beginning in August 2017 through December 2017, we simultaneously issued Series B Preferred Units (which constituted the Qualified Equity
Financing noted above), warrants to purchase Series B Preferred Units at $0.70 per unit, warrants to purchase Common Units for $1.25 per unit, and warrants to purchase Common Units for $0.70 per unit. The Series B Preferred Units and warrants were
evaluated by management and determined to be equity classified. Both of these instruments require separate accounting and the proceeds of the issuance of the Series B Preferred Units were required to be allocated to each instrument on a relative
fair value basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to allocate proceeds of the issuance of Series B Preferred Units and warrants to purchase Common Units, a
valuation of both instruments at fair value was required. We used a hybrid method to value the Series B Preferred Units and warrants to purchase Common Units. Under the hybrid method, a probability-weighted expected return method and an option
pricing model were utilized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recent Accounting Pronouncements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A description of recently issued accounting pronouncements that may potentially impact our financial position and results of operations is
disclosed in Note&nbsp;2 &#147;Summary of Significant Accounting Policies&#148; in each of our audited and unaudited consolidated financial statements appearing elsewhere in this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Emerging Growth Company Status </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In April
2012, the JOBS Act was enacted by the federal government. Section&nbsp;107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period for complying with new or revised accounting standards. Thus, an
emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have irrevocably elected to &#147;opt out&#148; of this provision and, as a result, we will comply
with new or revised accounting standards when they are required to be adopted by public companies that are not emerging growth companies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, as an emerging growth company, we will not be required to provide an auditor&#146;s attestation report on our internal control
over financial reporting in future annual reports on Form 10-K as otherwise required by Section&nbsp;404(b) of the Sarbanes-Oxley Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">91 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom472601_13"></A>BUSINESS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a commercial-stage
bioelectronic medicine company with a platform <FONT STYLE="white-space:nowrap">non-invasive</FONT> vagus nerve stimulation therapy initially focused on neurology and rheumatology. Our therapy, gammaCore, has pharmacologic effects on the peripheral
and central nervous systems, which modulate neurotransmitters and immune function. gammaCore is <FONT STYLE="white-space:nowrap">FDA-cleared</FONT> for the acute treatment of pain associated with migraine and episodic cluster headache in adults.
Based on our clinical data, we are pursuing label expansions for the prevention of migraine, migraine in adolescents and post-traumatic headache, and we are also engaging in clinical development for potential new labeling claims in rheumatology,
including Sj&ouml;gren&#146;s syndrome and rheumatoid arthritis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">gammaCore is the first
<FONT STYLE="white-space:nowrap">FDA-cleared,</FONT> prescription-only vagus nerve stimulation, or VNS, therapy administered in discrete doses using a proprietary,
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">simple-to-use</FONT></FONT> handheld delivery system. Multiple published studies suggest that VNS works through the modulation of neurotransmitters, and has a measurable pharmacologic
effect similar to several classes of medications, including selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, GABA analogues, acetylcholine esterase inhibitors and triptan medications, all of which are commonly
prescribed. gammaCore activates those fibers in the vagus nerve which are therapeutically relevant for neurotransmitter modulation. This is enabled by our proprietary high-frequency burst waveform that safely and comfortably passes through the skin
and stimulates the targeted nerve fibers. Research also indicates that VNS, including gammaCore, modulates the immune system to produce a measurable effect on inflammatory cytokines, as measured in blood samples, comparable to medications that
inhibit these cytokines. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Migraine is a debilitating primary headache condition characterized by severe throbbing pain or a pulsing
sensation, usually on one side of the head. Migraine affects approximately 12% of the adult population globally and disproportionately impacts women of childbearing years. In the United States, there are approximately 36&nbsp;million migraine
sufferers and, according to the U.S. Pharmacist, a leading pharmacy publication, upwards of 60% of the migraine patient population is dissatisfied with, or has contraindications to, the current standard of care treatments for migraine, such as
triptan medications. We estimate the total addressable market for the acute treatment of migraine in the United States in 2018 will be approximately $3.8&nbsp;billion. Five million migraine sufferers are treated by approximately 1,100 U.S. headache
specialists, primarily neurologists. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cluster headache, or CH, is a series of relatively short but extremely painful headaches that has
been described by patients and physicians as one of the most painful conditions in medicine. The suicide rate among these patients is 20 times the U.S. national average, leading to the condition being referred to as the &#147;suicide headache.&#148;
There are approximately 350,000 CH sufferers in the United States, approximately 225,000 of whom seek treatment each year primarily from the same headache specialists who treat migraine, and we estimate the total addressable U.S. market for the
acute treatment of these patients in 2018 is approximately $400 million. We believe the significant unmet need and highly-targeted market of CH represents an ideal entry point for our therapy into the headache market, providing an opportunity to
gain relevance with treating clinicians in order to support an expansion into migraine. Prior to gammaCore, there was only one <FONT STYLE="white-space:nowrap">FDA-approved,</FONT> commercially available acute CH treatment, injectable sumatriptan,
and according to a 2016 market research survey, 87% of respondents reported dissatisfaction with the then-available treatment options for CH. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Historically, vagus nerve stimulation, or VNS, required a highly invasive surgical procedure to implant a costly medical device that cannot be
removed. Due to these limitations, VNS has only been indicated for the most severe patients. gammaCore stimulates the vagus nerve through an <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">easy-to-use</FONT></FONT> handheld
delivery system dispensing therapy on a <FONT STYLE="white-space:nowrap">31-day</FONT> prescription basis, enabling access to VNS therapy to a much broader patient population than previously possible. gammaCore&#146;s successor, gammaCore Sapphire,
is a rechargeable and reloadable version of our product intended for multi-year use. It is activated on a monthly basis through the input </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">92 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of a unique, prescription-only authorization code, delivered via a radio-frequency identification, or RFID, card. In the future, this authorization code may be delivered through the internet,
leveraging the Bluetooth capabilities of the gammaCore Sapphire. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following the FDA&#146;s review and grant of our <I>de novo</I>
application, in April 2017, our gammaCore therapy was <FONT STYLE="white-space:nowrap">FDA-cleared</FONT> for commercial sale in the United States for the acute treatment of pain associated with episodic cluster headache, or eCH, in adults. A <I>de
novo</I> review is a regulatory pathway for products deemed by the FDA to be low to moderate risk, but without an applicable predicate. With the successful completion of our <I>de novo</I> review, a new regulatory category was created, which enabled
us to seek label expansion for our product through the less burdensome 510(k) pathway, utilizing our own product as the predicate. The new regulatory category for external vagal nerve stimulation resulting from our <I>de novo</I> review encompasses
the treatment of all headache conditions. gammaCore Sapphire was cleared by the FDA through the 510(k) pathway in December 2017. In January 2018, the FDA cleared our gammaCore therapy as an acute treatment for pain associated with migraine in
adults. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to our lead indications for the acute treatment of pain associated with both migraine and eCH in adults, we are also
pursuing clinical programs to support label expansion filings for adolescent migraine, headache prevention indications, and the treatment of post-traumatic headache. Table 1 below summarizes our headache-related areas of focus for gammaCore: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Table 1: Our Headache Pipeline </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g04w27.jpg" ALT="LOGO">
 </P> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top">The gammaCore product registry for the acute treatment of cluster headache constitutes our initial commercialization efforts for our product. The full product launch is expected in the third quarter of 2018.
</TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Modulation of the peripheral immune system by VNS provides mechanistic support for the study of gammaCore in the treatment
of inflammatory disorders. Based on initial positive results from our pilot trials, we expect to initiate a series of pivotal trials designed to support regulatory approvals in multiple rheumatologic conditions, including Sj&ouml;gren&#146;s
syndrome and rheumatoid arthritis. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">93 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Background of VNS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The vagus nerve is the largest and most extensive cranial nerve, connecting the brainstem to nearly every organ in the chest and abdomen,
including the heart, lungs, liver, stomach, spleen, kidneys, and digestive tract, as shown in Figure 1 below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Figure 1: The distribution
of the vagus nerve to multiple organs </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g65j14.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Activation of the vagus nerve causes the release of neurotransmitters, both in the central and peripheral
nervous systems, modulating how the brain and peripheral organs function. In the central nervous system, VNS activates areas of the brainstem that release norepinephrine, acetylcholine, serotonin, GABA and other important neurotransmitters. These
effects can be used to treat multiple conditions, including epilepsy, depression and headache. The impact of neurotransmitter modulation in the periphery has been shown to have multiple beneficial effects, including the reduction of systemic
inflammatory cytokines. VNS is being studied for use in a number of inflammatory conditions, including Sj&ouml;gren&#146;s syndrome, rheumatoid arthritis and Crohn&#146;s disease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Over the past two decades, the body of scientific evidence in support of VNS in multiple medical conditions has been growing. However, this
potential has remained unfulfilled because the therapy could only be delivered using electrodes wrapped around the vagus nerve, connected to a signal generator implanted in the chest wall. To implant these devices, the vagus nerve must be surgically
exposed from its anatomical position, entwined with the carotid artery. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to gammaCore, VNS was only accessible to the most
refractory patients, who were willing to endure surgery, and payors were forced to spend tens of thousands of dollars prior to determining the efficacy of the post-surgical therapy for those patients. With the clearance of gammaCore, this safe and
effective therapy can now be noninvasively self-administered, at a fraction of the initial cost, exponentially expanding its accessibility for the potential treatment of multiple medical conditions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preclinical Evidence of gammaCore&#146;s Activation of the Vagus Nerve </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the development of gammaCore, we pioneered a series of inventions that enable the comfortable passage of our proprietary therapeutic
signal to specifically targeted fibers of the vagus nerve. Confirmation that our delivery technology successfully activates the vagus nerve has been published by independent researchers who performed electromagnetic field modeling demonstrating that
our therapy establishes the necessary charge gradients in the targeted nerve fibers, without depositing a net charge to the overall tissue that would cause significant discomfort. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">94 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Confirmation of this electromagnetic field modeling has been conducted in humans, and
published by multiple independent research groups. Specifically, these experiments show that gammaCore produces changes in electroencephalography, or EEG, similar to what has been observed with VNS delivered using surgically implanted devices, and
does so in a dose-dependent manner, consistent with chemical and biologic pharmaceutical products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we have sponsored
research by multiple groups of independent scientists to demonstrate that gammaCore activates the critical areas in the brainstem necessary to provide clinically beneficial effects. These studies included both functional magnetic resonance imaging,
and magnetoencephalography, both of which showed that gammaCore activates critical areas in the brainstem, including the substantia nigra, the nucleus raphe magnus, or NRM, the periaqueductal gray, or PAG, and the thalamus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additional studies showed that when these areas of the brainstem were activated by VNS, including gammaCore, there was a measurable
upregulation in the neurotransmitters that modulate pain, including norepinephrine, GABA, acetylcholine, and serotonin. VNS modulates not only the functional state of the central nervous system, but also the activation state of the immune system.
VNS, including gammaCore, has also been shown to produce a measureable inhibition of the inflammatory cytokines IL-6, IL -1&szlig; and TNF-<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Multiple peer-reviewed publications suggest that by upregulating these neurotransmitters and by inhibiting inflammatory cytokines,VNS, including gammaCore,
has pharmacologic effects similar to that of selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, GABA analogues, acetylcholine esterase inhibitors, triptans and many anti-inflammatory therapies because they are
thought to function through the same or similar mechanisms, and produce similar, measurable changes in neurotransmitter and cytokine levels. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our
Therapy Delivery Platform </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our gammaCore therapy is the first and only treatment that
<FONT STYLE="white-space:nowrap">non-invasively</FONT> activates the therapeutically relevant fibers in the cervical trunk of the vagus nerve. More specifically, our therapy employs proprietary signals that are capable of passing through skin while
minimizing the activation of skin pain receptors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our therapy is prescription-only, and like medications delivered by metered-dose
inhalers, patients self-administer discrete doses using a handheld unit that can be either disposable or reusable. In either case, the therapy is dispensed through a monthly prescription from a specialty pharmacy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">gammaCore Sapphire is the <FONT STYLE="white-space:nowrap">non-disposable,</FONT> rechargeable and reloadable option for patients requiring
therapy on an <FONT STYLE="white-space:nowrap">on-going</FONT> basis. It is refilled monthly through the input of a unique, prescription-only authorization code, delivered through an RFID card dispensed by mail through our specialty pharmacy
distributor. In the future this refill may be dispensed directly through the internet using Bluetooth. We currently expect to commercially launch gammaCore Sapphire in the United States in the third quarter of 2018 and within select foreign markets
in the fourth quarter of 2018. In general, we will no longer market the predicate disposable version of our gammaCore product in markets where the gammaCore Sapphire is launched. In select cases, we may continue to use the predicate gammaCore
product, for example, there may some clinical studies in which we may still use the original gammaCore product. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Competitive Strengths </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe the competitive strengths of our company and our novel and proprietary self-administered bioelectronic therapy include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Innovative bioelectronic medicine approach.</I></B> Our gammaCore therapy uses a proprietary electric signal to safely deliver bioelectronic medicine, which causes targeted pharmacologic-like changes in
neurotransmitter expression and in the immune system, without systemic exposure to exogenous chemicals. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">95 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Our <FONT STYLE="white-space:nowrap">non-invasive</FONT> therapy unlocks the long-held potential of VNS. </I></B>VNS therapy can, for the first time, be delivered safely and comfortably through the skin using
gammaCore. This eliminates the need for costly, invasive surgery that requires the implantation of a permanent medical device. VNS therapy is no longer reserved for the most refractory patients, and is now a first-line treatment option.
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Commercializing our therapy through traditional pharmaceutical channels. </I></B>Our <FONT STYLE="white-space:nowrap">non-invasive</FONT> delivery modality permits medical professionals to prescribe VNS through
the same channel they would any other specialty medication. Refills delivered on a monthly basis enable us to seek widespread commercial payor coverage and reimbursement under a traditional pharmaceutical model. We have agreements in place with
commercial payors that we believe, based on our estimates, will provide for reimbursement for gammaCore as a pharmacy benefit for approximately 17&nbsp;million commercial lives, with such number expected to increase to as many as 45&nbsp;million
lives under those agreements over the next several calendar quarters. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Highly scalable and low investment manufacturing with digital refills</I></B>. Our low manufacturing and assembly costs allow us to scale to meet demand with minimal additional investment. Refills through RFID or
Bluetooth may offer attractive gross margins. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Potential for rapid label expansion in headache and regulatory approval in additional indications.</I></B> The safety profile of gammaCore enabled us to utilize the <I>de novo</I> regulatory pathway through which
the FDA established a new therapeutic category: external vagal nerve stimulator for the treatment of headache. Through the 510(k) pathway, we received clearance for our gammaCore therapy for the acute treatment of pain associated with migraine in
adults in January 2018. We believe a similar regulatory pathway may be available to us for additional indications in rheumatology. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Broad intellectual property protection.</I></B> Among our key issued patents, we have coverage on using our high-frequency burst signal for treating certain medical conditions until 2031, the <FONT
STYLE="white-space:nowrap">low-pass</FONT> filtering of that signal to ensure safe and comfortable transmission through the skin until 2031, the <FONT STYLE="white-space:nowrap">non-invasive</FONT> treatment of headache conditions until 2029, and
the remote network-enabled communication for the delivery of neuromodulation therapy for a broad range of medical conditions until 2033. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Highly experienced management team</I></B>. Our management team includes a diverse group of executives with significant experience in senior positions in the pharmaceutical and medical device industries, including
positions at Pfizer, Merck, Novartis, Stryker and Zimmer Biomet. Members of our team have been involved in the launch and marketing of products including Motrin, Celebrex, and the migraine drugs Axert and Maxalt. Our team&#146;s pharmaceutical
experience in clinical development, sales, marketing and reimbursement, and its medical device experience in research, development and regulatory affairs, allow us to pursue our strategy and growth plans. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Strategy </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our goal is to be a leader
in bioelectronic medicine by using our proprietary <FONT STYLE="white-space:nowrap">non-invasive</FONT> VNS platform therapy to deliver better patient outcomes. The key elements of our strategy include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Drive acceptance of our gammaCore products as a leading headache therapy, introducing it in cluster headache and expanding into migraine.</I></B> We plan to establish gammaCore as the first-line treatment option
for neurologists when treating eCH patients, who have few alternative treatment options available to them. We will then leverage this position to expand into the broader headache market for migraine in the third quarter of 2018. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Drive reimbursement of our therapy</I></B><I>.</I> We are actively engaging with over 50 national and
regional commercial insurance payors in the United States with the goal of securing reimbursement coverage as a pharmacy benefit. To date, we have secured agreements with commercial payors that we believe, based on our estimates, will provide for
reimbursement for gammaCore as a pharmacy benefit for approximately 17&nbsp;million commercial lives, with such number expected to increase to as many as 45&nbsp;million lives under those agreements over the next several calendar quarters, and are
in active </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">96 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
clinical review discussions with more than a dozen additional insurance plans covering approximately 120&nbsp;million additional commercial lives. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Build a leading commercial presence.</I></B> We are establishing a robust commercial capacity, including a specialty distribution channel with a patient-focused concierge service to quickly onboard patients and
manage payor interactions. We are expanding our direct sales force to target high prescribing neurology specialists and headache centers that originate the substantial majority of new prescriptions for severe headache patients in the United States.
In the first year following our commercial launch into migraine, we expect to be able to target 120 national headache centers and approximately 6,400 physicians. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Rapidly advance our pipeline</I></B>. In 2018, we expect to initiate pivotal trials to support potential label expansion in headache, including additional trials in migraine prevention and migraine in adolescents.
In 2018, we also expect to initiate our first major trial in rheumatology, a pivotal trial in Sj&ouml;gren&#146;s syndrome. Over the next 24 months, we anticipate additional sponsored trials will be conducted in both neurology and rheumatology,
including in rheumatoid arthritis. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Lead Indications in Headache </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In January 2018, gammaCore was cleared by the FDA for commercial sale in the United States as an acute treatment for pain associated with
migraine in adults. This followed the April 2017 grant of our <I>de novo</I> application by the FDA that cleared our gammaCore for commercial sale in the United States for the acute treatment of pain associated with episodic cluster headache, or
eCH, in adults. In accordance with our strategy to establish gammaCore as the preferred treatment for neurologists across headache, we initially targeted a high unmet need population in eCH to establish relevance with prescribing clinicians and gain
reimbursement from payors. From this position, we are now expanding into the broader headache market, starting with migraine. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CH
sufferers experience a series of relatively short but extremely painful headaches that have been described by patients and physicians as one of the most painful conditions in medicine. CH predominantly affects males in their prime earning ages of 20
to 50, with bouts of frequent attacks, known as cluster periods, often occurring every other day, and up to eight times a day. Individual attacks can last from 15 minutes to as long as three hours, with these frequent attacks continuing for a
prolonged period. Among CH patients, 85% to 90% experience eCH, with cluster periods, or bouts, lasting from two to 12 weeks, followed by a remission period often cycling into bout twice per year. Chronic CH, or cCH, patients experience no periods
of remission or remission periods of less than 3 months in a <FONT STYLE="white-space:nowrap">12-month</FONT> period. The suicide rate of CH sufferers is 20&nbsp;times the U.S. national average, leading to the condition being referred to as the
&#147;suicide headache.&#148; In the United States, CH affects approximately 350,000 people. There is only one <FONT STYLE="white-space:nowrap">FDA-approved</FONT> commercially available pharmaceutical option for acute CH treatment, and none for its
prevention. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Migraine, the third most common disease in the world, is a debilitating primary headache condition characterized by severe
throbbing pain or a pulsing sensation, usually on one side of the head, often associated with nausea and sensitivity to light and sound. Migraine impacts more than 36&nbsp;million people in the United States, disproportionately affecting women of
childbearing years, with peak onset during the adolescent ages of 12 to 16. While migraine sufferers have a number of approved and available treatments, the side effects and incomplete efficacy of these options continues to drive a high level of
dissatisfaction with current therapies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our first FDA clearance, received following the grant of our <I>de novo</I> application, was for
the acute treatment of eCH in adults, and is supported by two pivotal trials: our ACT 1 trial, or ACT 1, and our ACT 2 trial, or ACT 2. The primary endpoints of these trials were pain reduction and pain-freedom within 15 minutes of the onset of the
attack, respectively. While neither trial reached statistical significance with respect to its primary endpoint in the combined eCH and cCH populations, both trials reached statistical significance (ACT 1; 34.2%; ACT 2; 47.5%; <I>p</I>&lt;0.01 in
each trial) on the primary endpoint in the eCH cohort. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">97 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our FDA clearance for the acute treatment of migraine in adults is principally supported by
our pivotal trial, PRESTO. The primary endpoint of PRESTO was pain-freedom at 120 minutes. While this trial did not reach statistical significance with respect to its primary endpoint, statistical significance was achieved for complete pain relief
at 30 minutes (12.7%; <I>p</I>=0.01), and maintained at 60 minutes (<I></I>21.0%;<I> p</I>=0.02), and under a repeated-measures analysis, through the full <FONT STYLE="white-space:nowrap">120-minute</FONT> period (30.4%; <I>p</I>=0.01). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Limitations of Pharmaceutical Treatment Options in Headache </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There is only one <FONT STYLE="white-space:nowrap">FDA-approved</FONT> commercially available pharmaceutical treatment for the acute treatment
of CH, injectable sumatriptan. Patients have typically been limited to fewer than 10 injections per month, primarily due to cost and toxicity. In addition, the technical difficulty of subcutaneously self-injecting a medication during a CH attack may
also limit use of this therapy.&nbsp;As a result, patients typically have enough medication to treat, on average, only a fraction of their monthly CH attacks. There are no approved treatments for the prevention of CH, driving patients to use <FONT
STYLE="white-space:nowrap">off-label</FONT> medications, such as lithium, valproic acid and high-dose verapamil, which have unproven efficacy and the potential for significant toxicity, including adverse cardiac events.&nbsp;In a 2016 market
research survey of CH patients, 87% of the respondents were dissatisfied with the then-available treatment options. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although there are
more prescription therapies available for migraineurs than CH sufferers, according to the U.S. Pharmacist, a leading pharmacy publication, upwards of 60% of the migraine patient population has reported dissatisfaction with, or has contraindications
to, the current standard of care treatments for migraine. These medications include triptans, ergotamines and anti-epileptic medications. Despite the fact that neurologists recognize the limited efficacy of, and the potential for abuse associated
with, opioids, they continue to be prescribed at high rates, particularly in emergency departments for the treatment of migraine.&nbsp;Many other primary headache conditions, and secondary headaches, such as post-traumatic headache, have proven
refractory to pharmaceutical interventions, presenting a significant unmet need in the market. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cluster Headache </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>The Condition</I></B>. CH sufferers experience a series of relatively short but extremely painful headaches. The clinical criteria for CH
define the attacks as frequent, severe, short-duration head and eye socket pain, accompanied by autonomic symptoms, such as sweating, tearing, swelling of the eyelid, and sinus congestion on only one side of the face. CH patients are typically
agitated, pacing, moaning and sobbing, and often beat or claw at their heads in desperation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CH patients, and the physicians who treat
them, describe the attacks as one of the most painful conditions in medicine. The prevalence of CH is three times higher in males than in females, and peaks in their prime earning ages of 20 to 50. Attacks can last from 15 minutes to as long as
three hours, with these frequent attacks occurring, on average, twice per day. For some, they can occur as many as eight times per day. CH is known as the &#147;suicide headache&#148; because the suicide rate among CH sufferers is a reported 20
times higher than that for the general population in the United States. During attacks, CH patients have been known to harm themselves as a distraction from the excruciating pain. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CH can be either episodic, eCH, or chronic, cCH. eCH sufferers experience alternating periods of attacks and remission lasting weeks or
months. cCH sufferers experience extended periods of attacks, occurring without a remission period, or with remissions lasting less than three months, for at least one year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Prevalence and market size</I></B>. The estimated prevalence of CH in the United States ranges from 0.1% to 0.2% of the total
population, with consensus around 350,000 as the number of affected patients, of which 225,000 patients seek medical treatment annually. eCH patients average approximately four months per year in bout. We estimate the total addressable market for
the acute treatment of eCH in the United States in 2018 will be approximately $400&nbsp;million. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">98 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Economic Burden</I></B>. According to a recent published study in The American Journal
of Managed Care, the overall average medical costs for eCH patients over a three-year period exceeded $22,500, compared with $10,140 among <FONT STYLE="white-space:nowrap">non-headache</FONT> sufferers. Similarly, the overall average pharmacy costs
per eCH patient during this period were $8,200, which was nearly double that of the <FONT STYLE="white-space:nowrap">non-headache</FONT> sufferers. Participants in surveys of sufferers indicate that CH is associated with a large socioeconomic
burden. For example, research found that nearly 20% of patients with CH reported loss of employment and approximately 8% are unemployed or receiving disability services due to the disorder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Other Therapies for Cluster Headache</I></B>. Other than gammaCore, there is only one
<FONT STYLE="white-space:nowrap">FDA-approved</FONT> commercially available therapy for acute treatment for CH, injectable sumatriptan (Imitrex). The side effect profile and cost of Imitrex, however, typically limits patient access to only six to 10
doses per month, which usually enables patients to treat only a small fraction of their attacks each month. Even at this limited access level, the monthly cost of Imitrex for CH patients and their insurance providers averages more than $700. Imitrex
use is also limited by the requirement for patients to subcutaneously self-inject, which may be particularly difficult to do while experiencing a CH attack. In a 2016 market research survey of CH patients, 87% of the respondents were dissatisfied
with the then-available treatment options. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preclinical Evidence of VNS Mechanisms of Action in Acute Cluster Headache </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is generally believed that the neural circuit involved in CH includes activation and inhibition of the trigeminal cervical complex, or TCC,
shown in Figure 2 below. The TCC is a region of the brainstem associated with pain processing. Activation of facial nerves, including those relaying through the sphenopalatine ganglion, or SPG, activate the TCC. This belief is supported by evidence
showing that activation of this pathway can cause <FONT STYLE="white-space:nowrap">CH-like</FONT> attacks. Inhibition of the TCC is provided by inhibitory neurotransmitters, like serotonin, GABA and norepinephrine, which are released by neurons
residing in the PAG, the NRM, and the locus coeruleus, or LC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Figure 2: The neural circuit believed to be associated with CH. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g74m47.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(Figure adapted from S. Akerman and P. Goadsby, with permission) </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">One possible mechanism by which gammaCore acutely treats CH attacks may be through enhancement of inhibitory signals to the TCC. To test this,
we sponsored research in which recording electrodes were inserted </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">99 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
into the TCCs of rats to measure the effects of VNS on normal activity, or ongoing spontaneous neuronal firing, and activity under pain-simulated conditions, or dural-evoked pain fiber firing,
the latter being caused by irritation of the outermost covering of the brain, or dura. As seen in the published graphs in Figures 3 and 4 below, VNS significantly suppressed activity in the TCC in both cases. These data suggest that the
strengthening of the inhibition pathways is a mechanism of action for gammaCore. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Figure 3: VNS applied in two doses, separated by five
minutes, was able to suppress ongoing spontaneous firing of the neurons in the TCC, by more than 50%, with a duration of effect greater than two hours. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g03b57.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Figure 4: A pair of VNS doses, separated by five minutes was able to suppress firing of the pain fibers in
the&nbsp;TCC under pain simulated conditions by approximately 30%, with a stable duration of effect of more than two&nbsp;hours. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g78i68.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">100 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Clinical Data of gammaCore as an Acute Treatment for Cluster Headache </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have completed one pilot trial and two parallel pivotal trials examining the efficacy, safety and tolerability of gammaCore for the acute treatment of CH as
summarized in Table 2 below: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Table 2: Overview of our CH trials for gammaCore </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g68j40.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Our First Open-Label Trial </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We sponsored an open-label trial of gammaCore for the acute treatment and prevention of CH at the Royal Free Hospital, published in 2015. The
trial enrolled 25 patients, 19 of whom provided evaluable data. Of these evaluable patients, 11 had cCH and 8 had eCH. Seven of the cCH patients were considered to be drug-refractory and had failed reasonable attempts with multiple different
preventative agents. Five patients with cCH provided long-term data for a full 52 weeks. In this trial, an evaluation of the efficacy of the therapy was based on patient-reported estimates of their CH attack frequency. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Fifteen of the 19 evaluable patients in this trial reported an overall improvement in their condition from baseline, with four stating that
their condition had remained the same. No patients reported a worsening of their preexisting condition. Results demonstrated a mean improvement of 48% in CH attack frequency. Five of the eleven cCH patients had a
<FONT STYLE="white-space:nowrap">one-year</FONT> extended <FONT STYLE="white-space:nowrap">follow-up,</FONT> which showed a mean estimated improvement in attack frequency at 26 weeks of 62% and maintenance at 52 weeks of 58%. In regard to acute
efficacy, patients in this trial reported that gammaCore aborted attacks within an average time of 11 minutes of initial treatment. The long-term durability of this response was stable in four of the five patients with cCH who reported on their
gammaCore use at both 26 and 52 weeks. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No serious adverse events were reported in this trial during and after treatment. Adverse events
of mild severity reported in this trial included local discomfort during and after device use and mild skin reactions to the conductive gel. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our
Registration Trials for Acute Treatment of CH &#150; ACT 1 and ACT 2 </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our first FDA clearance, received following the grant of our
<I>de novo</I> application, was for the acute treatment of eCH, and is supported by two multi-center, randomized clinical studies, ACT 1 and ACT 2. These trials, in aggregate, enrolled 253 patients, including both eCH and cCH patients. The primary
endpoints of these trials were pain reduction and pain freedom within 15 minutes of the onset of the attack, i.e. mild pain or pain-free in ACT 1 and pain-free in ACT 2. Neither trial reached statistical significance with respect to the primary
endpoint in the total population, but they did reach statistical significance on the primary endpoint and multiple secondary endpoints in their eCH subpopulation. eCH represents <FONT STYLE="white-space:nowrap">80-90%</FONT> of the overall CH
population. In ACT 1, our gammaCore therapy demonstrated an ability to reduce pain to mild or pain-free status in eCH patients within 15 minutes of the onset of the attack more than three times as frequently as the sham treatment (gammaCore, 34.2%;
sham, 10.6%; <I>p</I>&lt;0.01). In ACT 2, which had a more stringent primary endpoint, our </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">101 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
gammaCore therapy demonstrated an even stronger therapeutic effect compared to the sham treatment among eCH patients (gammaCore, 47.5%; sham, 6.2%; <I>p</I>&lt;0.01). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our ACT 1 Trial &#150; gammaCore for the Acute Treatment of Episodic and Chronic Cluster Headache </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ACT 1 was a pivotal, randomized, double-blind, sham-controlled prospective trial of gammaCore for the acute treatment of CH. The trial enrolled
150 patients and was conducted at 20 centers in the United States, including academic medical centers and other tertiary headache clinics. ACT 1 was designed to assess the superiority of our gammaCore therapy in comparison to sham treatment and was
comprised of two phases: (1)&nbsp;a double-blind phase in which patients were randomized to receive gammaCore therapy or sham treatment for one month or until five CH attacks were treated and (2)&nbsp;an open-label phase in which patients who
completed the double-blind phase could subsequently receive three months of our gammaCore therapy. The primary endpoint for the trial was response rate, defined as the proportion of patients who achieved pain relief (pain intensity of 0 or 1 on a 5
point scale) at 15 minutes after treatment initiation for the first CH attack treated. Investigators, patients, and study coordinators were blinded to treatment assignments in the double-blind phase of the trial. The ACT 1 results were published in
2016. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Figure 5: ACT 1 Trial Consort Diagram </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g74b95.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As shown in Figure 5 above, in ACT 1, 150 patients were enrolled and 133 patients met the criteria for the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">intent-to-treat,</FONT></FONT> or ITT, population (gammaCore, n=60; sham, n=73). Of the 133 patients in the ITT population, 128 patients entered the open-label period, 100 of whom completed
the trial. Twenty-eight patients did not complete the open-label period for a variety of reasons, the most common of which was persistence of their CH condition during the treatment period. Demographic and baseline characteristics were similar
between the gammaCore and sham cohorts and were consistent with those of a typical CH population. Of the 133 patients in the ITT cohort, most had eCH (85)&nbsp;and the remaining had cCH (48). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Response rates for the primary endpoint in the total ITT population, which includes both eCH and cCH patients, were numerically superior for
gammaCore than for sham treatment (gammaCore, 26.7%; sham, 15.1%; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">102 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<I>p</I>=0.1). Additionally, as shown in Figure 6 below, in a predefined analysis of the eCH subpopulation, a significantly higher response rate was demonstrated with gammaCore than with sham
(gammaCore, 34.2%; sham, 10.6%; <I>p</I>&lt;0.01). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Superior sustained treatment response rates were statistically significant for
gammaCore compared with sham among the total population (gammaCore, 26.7%; sham, 12.3%; <I>p</I>=0.04), however, this superior response was most pronounced for the eCH subpopulation (gammaCore, 34.2%; sham, 10.6%; <I>p</I>&lt;0.01). This observation
of strongest clinical benefit in the eCH cohort was also demonstrated with respect to the proportion of patients who were responders at 15 minutes for <FONT STYLE="FONT-FAMILY:SYMBOL">&#179;</FONT>50% of their treated attacks (gammaCore, 34.2%;
sham, 14.9%; <I>p</I>=0.04). Results were also significant in the eCH subpopulation for the proportion of those who were pain-free at 15 minutes for <FONT STYLE="FONT-FAMILY:SYMBOL">&#179;</FONT>50% of treated attacks (gammaCore, 15.8%; sham, 2.1%;
<I>p</I>=0.04). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Figure 6: Selected Results for eCH Patients in the ACT 1 Trial </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g93s62.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No serious adverse events, or SAEs, were attributable to gammaCore in ACT 1. Across all patients, 33%
(49/150) had one or more adverse events, or AEs, during the double-blind period (gammaCore, 18; sham, 31). AEs occurred in 35 patients during the double-blind phase, at more than double the rate in the sham cohort than the gammaCore subpopulation.
During the open-label period, 33% (42/128) of all patients had one or more AEs. As shown in Table 3 below, the most commonly occurring adverse events relating to the therapy, or ADEs, were application site reactions, all of which were mild,
transient, and tended to be self-limiting in nature. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Table 3: Most Commonly Reported ADEs from the ACT 1 Trial </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g31r20.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">103 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ACT 1 was the first randomized, double-blind, sham-controlled trial evaluating the effects
of <FONT STYLE="white-space:nowrap">non-invasive</FONT> neuromodulation for the acute treatment of CH. As seen in the pre-defined subpopulation analysis, gammaCore demonstrated significant therapeutic benefit across a broad range of endpoints for
the eCH subpopulation, including first attack response rate, sustained treatment response rate, the percentage of patients who responded to gammaCore for <FONT STYLE="FONT-FAMILY:SYMBOL">&#179;</FONT>50% of their attacks, and of those, the
percentage who were pain-free. These results suggest that response to an initial gammaCore treatment predicts likely response to treatment for subsequent attacks. In addition, among the full study population, the average duration of attack for the
first attack treated was reduced among the gammaCore-treated cohort by an average of 9.5 minutes while the sham-treated group reported an attack duration that increased by 12.8 minutes. This difference was statistically significant (<I>p</I>=0.03).
Among the eCH subpopulation, this difference was more pronounced, with the gammaCore group experiencing an average decrease in attack duration of 14.4 minutes, while the sham-treated group reported their average attack duration rise by 16.3 minutes
(<I>p</I>=0.03). Attack duration has not traditionally been used to quantify clinical meaningfulness of treatments in CH, however, given the extreme nature of the pain associated with these attacks, it is further support for the value of our
gammaCore therapy, especially among eCH patients. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our ACT 2 Trial &#151; gammaCore for the Acute Treatment of Episodic and Chronic Cluster Headache
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ACT 2 was a pivotal, randomized, double-blind, sham-controlled prospective trial of gammaCore for the acute treatment of eCH and
cCH. The trial enrolled 103 patients and was conducted in four European countries at academic medical centers and other tertiary headache clinics. ACT 2 was designed to assess the superiority of our gammaCore therapy in comparison to sham treatment
and was comprised of three phases: (1)&nbsp;a <FONT STYLE="white-space:nowrap">one-week</FONT> <FONT STYLE="white-space:nowrap">run-in</FONT> period, (2)&nbsp;a <FONT STYLE="white-space:nowrap">two-week,</FONT> randomized, double-blind period during
which patients were treated with either our gammaCore or sham therapy, and (3)&nbsp;a <FONT STYLE="white-space:nowrap">two-week,</FONT> open-label period in which patients could subsequently receive gammaCore therapy. The primary endpoint for the
trial was response rate, defined as the proportion of all attacks that achieved pain freedom at 15 minutes after treatment initiation. Investigators, patients, and trial coordinators were blinded to treatment assignments during the double-blind
period. In total, 495 attacks were treated with active gammaCore therapy and 400 with the sham treatment. The ACT 2 trial results were published in 2017. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">104 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Figure 7: ACT 2 Trial Consort Diagram </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g35a87.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As shown in Figure 7 above, in ACT 2, 103 patients were enrolled, 102 patients met the criteria for the
safety population, and 92 patients met the criteria for the ITT population (gammaCore, n=48; sham, n=44). Of the 92 patients in the randomized phase of our ACT 2 trial, 83 entered the open-label period and 79 completed the trial. Demographic and
baseline characteristics were similar between the gammaCore and sham cohorts and were consistent with those of a typical CH population. Of all 102 patients in the safety population, most had cCH (71%) and the remaining 29% had eCH. Although eCH
occurs more frequently than cCH, we enrolled more cCH patients in the ACT 2 trial because a greater proportion of them are in bout at any given time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Figure 8: Selected Results for predefined eCH subpopulation in the ACT 2 Trial </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g14p33.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">105 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As shown in Figure 8 above, consistent with the results from the ACT 1 trial, a predefined
subpopulation analysis in ACT 2 demonstrated a higher response rate to gammaCore in the eCH subpopulation than in the cCH subpopulation. In the eCH subpopulation, a higher proportion of treated attacks achieved pain-free status with gammaCore than
with sham (gammaCore, 47.5%; sham, 6.2%; <I>p</I>&lt;0.01). No treatment difference for this endpoint was seen in the cCH cohort (gammaCore, 4.8%; sham, 12.9%; <I>p</I>=0.13) in this trial. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The mean proportion of treated attacks per subject that achieved responder status within 30 minutes was greater with gammaCore than with sham
for the total ITT population (gammaCore, 42.7%; sham, 27.6%; <I>p</I>=0.05). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As shown in Table 4 below, the proportion of subjects who
achieved responder status with statistical significance for <FONT STYLE="FONT-FAMILY:SYMBOL">&#179;</FONT>50% of treated attacks at 15 minutes was higher with gammaCore than with sham in the total ITT population (gammaCore, 39.6%; sham, 13.6%;
<I>p</I>&lt;0.01) and the eCH subpopulation (gammaCore, 64.3%; sham, 15.4%; <I>p</I>&lt;0.01), but was not higher with statistical significance in the cCH cohort (gammaCore, 29.4%; sham, 12.9%; <I>p</I>=0.11). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Table 4: Selected Results for the ACT 2 Trial </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g42y14.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No SAEs were attributable to gammaCore in ACT 2. Of all patients, 33% (34/102) had one or more AEs during
the double-blind phase of the trial. Of the <FONT STYLE="white-space:nowrap">non-serious</FONT> AEs, 19 patients (gammaCore, 9; sham, 10) experienced one or more treatment-related AEs during the double-blind phase of the trial. As shown in Table 5
below, the most commonly occurring of these AEs were application site reactions, all of which were mild, transient, and tended to be self-limiting in nature. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Table 5: Most Commonly Reported ADEs from the ACT 2 Trial </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g59g06.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The ACT 2 trial results confirm and
extend the findings from ACT 1. ACT 2 demonstrated the significant therapeutic benefit of gammaCore across a broad range of endpoints, including the mean proportion of treated attacks per subject that achieved responder status within 15 minutes
across all patients. The greatest clinical benefit was observed in a predefined analysis of the eCH subpopulation, including the proportion of all treated attacks that achieved pain-free status within 15 minutes and 30 minutes. These results suggest
that initial response to our gammaCore therapy predicts likely response to treatment for subsequent attacks. As with our ACT 1 trial, gammaCore was well tolerated in ACT 2. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">106 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our Pooled Analysis of ACT1 and ACT2 for the Acute Treatment of Episodic Cluster Headache </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To further define the benefit of gammaCore for the acute treatment of eCH, the data from ACT 1 and ACT 2 were pooled to assess the overall
response to each trial&#146;s primary endpoint, as shown in Figure 9 below. Collectively there were 112 eCH patients and 113 cCH in the pooled data set. Among the 112 patients with eCH, more patients who treated with gammaCore achieved mild or
pain-free status at 15 minutes for the first attack treated (the ACT1 primary endpoint) compared with those in the sham cohort (gammaCore, 38.5%; sham, 11.7%; <I>p</I>&lt;0.01). Similarly, the proportion of all treated attacks in these eCH
subpopulation reaching pain freedom at 15 minutes (the ACT 2 primary endpoint) was greater in the gammaCore cohort compared to the sham cohort (gammaCore, 24.1%; sham, 7.3%; <I>p</I>&lt;0.01). Both studies individually met statistical significance
on this endpoint (ACT 1: gammaCore, 15%; sham, 6%; <I>p</I>&lt;0.05; ACT 2: gammaCore, 48%; sham, 6%; <I>p</I>&lt;0.05). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The proportion
of these eCH patients who achieved mild or pain-free status at 15 minutes in <FONT STYLE="FONT-FAMILY:SYMBOL">&#179;</FONT>50% of their treated attacks was higher for gammaCore compared to sham (gammaCore, 42.3%; sham, 15.0%; <I>p</I>=0.01). These
findings are consistent with the findings of each trial individually (ACT 1: gammaCore, 34.2%; sham, 14.9%; <I>p</I>=0.04; ACT 2: gammaCore, 64.3%; sham, 15.4%; <I>p</I>=0.02). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Figure 9: Selected Results of the Pooled Analysis of the ACT 1 and ACT 2 Trials for eCH Patients </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g88r67.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This analysis demonstrated that gammaCore is effective and well tolerated in aborting attacks in eCH, but
did not appear to have similar efficacy in cCH. Important advantages over existing treatment options are that gammaCore is <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">easy-to-use</FONT></FONT> and may be applied for as many
attacks as a patient experiences per day, without the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">frequency-of-use</FONT></FONT> restrictions and contraindications associated with other treatments. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Migraine </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>The Condition</I></B>.
Migraine is a debilitating condition characterized by severe throbbing pain usually on one side of the head, often associated with nausea and sensitivity to light and sound. The pain associated with migraine attacks often has a pulsing quality that
is synchronized with heartbeat and is typically worsened by physical activity. According to the International Classification of Headache Disorders, the pain phase of a migraine can last for four to 72 hours. More than two-thirds of sufferers are
unable to work or function normally during the pain phase of a migraine attack. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Migraine attacks are characterized by the presence or
absence of a preceding aura phase. Aura is a phenomenon associated with neural hyperactivation and synchronized depolarization in the brain, and is </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">107 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
characterized by visual or other functional disturbances. 30% of patients report aura preceding at least a portion of the migraine attacks they experience. Migraines are categorized by the
frequency with which they occur. With chronic migraine, affecting 10% of the total migraine population, patients suffer migraine attacks on 15 or more days of the month, on average. With episodic migraine, patients experience 14 or fewer migraine
attacks per month. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Prevalence and Market Size</I></B>. According to the World Health Organization, migraine ranks as the third most
common disease in the world and the leading cause of disability among neurological disorders. Migraine will affect approximately 12% of the adult population globally, currently affecting approximately 36&nbsp;million people in the United States, the
majority of whom are women of childbearing years. Population-based studies of insured individuals reveal that, annually, 4.5% of the adult population seeks treatment for primary headache, the vast majority of which is for migraine. In the United
States and EU, research has found that the age of first diagnosis of migraine peaks in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">early-to-mid</FONT></FONT> teens and the disease continues to persist throughout adulthood
for many of these sufferers, demonstrating that it is often a disorder of long duration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An estimated five million migraine patients in
the United States require the care of a headache specialist. These specialists, many of whom also treat CH, comprise the approximately 1,100 physicians who practice in over 120 tertiary care centers in the United States. Although the triptan drug
class is the current standard of care for the acute treatment of migraine, according to the U.S. Pharmacist, a leading pharmacy publication, more than 60% of patients have reported dissatisfaction with, or have contraindications to, the current
standard of care, such as triptan medications. This dissatisfaction may partly explain the <FONT STYLE="white-space:nowrap">sub-25%</FONT> penetration rate for available generic triptan medications. Despite <SUP
STYLE="font-size:85%; vertical-align:top"></SUP>these limitations, we estimate that the addressable market for the acute treatment of migraine in the United States in 2018 will be approximately $3.8&nbsp;billion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Economic Burden</I></B>. Over the past several decades, migraine has been associated with persistently greater total annual medical
costs. An independent study conducted in 1999 found that migraine sufferers in California had annual total medical expenses two and a half times higher than <FONT STYLE="white-space:nowrap">non-migraine</FONT> sufferers. A 2011 study conducted by
GNS Healthcare and sponsored by us demonstrated consistent results among the nearly 5% of 21&nbsp;million privately insured patients in the United States who receive diagnosis of migraine annually. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Current Acute Migraine Treatments and Their Limitations</I></B>. Triptan medications, or Triptans, are a family of tryptamine-based
drugs first sold in the 1990s, which account for approximately 80% of the acute treatments prescribed for migraine. Triptans are sold in oral, nasal, and subcutaneous formulations. Through their binding to specific seratonin receptor subgroups,
Triptans cause constriction of blood vessels in the outer covering of the brain, or the meninges. This vasoconstrictive activity also affects blood vessels in other areas of the body, including the heart, which accounts for important risks
associated with their use, and labeling limitations on the frequency of their use. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other less commonly prescribed acute migraine
treatments include ergotamines and analgesics, including <FONT STYLE="white-space:nowrap">non-steroidal</FONT> anti-inflammatory drugs, or NSAIDs, acetaminophen and antiemetics. Dihydroergotamine, or DHE, is a grain fungus derivative that, like
triptans, is a potent vasoconstrictor. DHE has been used for more than 50 years for the treatment of migraine, but modern physicians rarely prescribe it because of significant side effects. More specifically, ergotamines and triptans are both
vasoconstrictors with labels citing the risk of their use in migraine sufferers with risk factors for cardiovascular disease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Opioids are
often dispensed for migraine attacks in emergency departments; however, in the treatment guidelines referenced by the National Institutes of Health, their use is not recommended for the acute treatment of migraine. Opioid use for migraine is
associated with increased disability and health care utilization. The U.S. Centers for Disease Control and Prevention has recognized the growing issue of opioid misuse, abuse and addiction and officially classified prescription opioid abuse as an
epidemic. Data from a 2009 study conducted by the American Migraine Prevalence and Prevention Study suggests that about 16% of migraine patients are current opioid users and 16% of those patients are likely dependent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">108 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preclinical Evidence of nVNS Mechanism of Action in Acute Migraine </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although the cause of migraine is multifactorial, one validated model, shown in Figure 10 below, involves the activation of nerve fibers in the
dura through a mechanism similar to the one previously described for CH. These fibers lie in close proximity to blood vessels passing through the dura, and connect through the trigeminal ganglion to the TCC. Excessive firing of the TCC involves the
increased release of the excitatory neurotransmitter glutamate and is associated with migrainous pain. As in the case of CH, this activation is typically opposed by the release of inhibitory neurotransmitters, including serotonin, norepinephrine,
and GABA. Migraine pain may be experienced when excessive firing from the TCC exceeds the inhibitory mechanisms, or if the inhibitory mechanisms are not present. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Figure 10: The neural circuit believed to be associated with migraine </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g12h51.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>(Figure adapted from S. Akerman and P. Goadsby, with permission)</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To show the effects of nVNS, we sponsored a preclinical study at Thomas Jefferson University, published in 2014. In this study, animals were
sensitized, rendering them allodynic, or sensitive to touch, and susceptible to increased pain when the known migraine trigger, nitroglycerine, or GTN, was administered. Previous research had shown significant increases in glutamate expression in
the TCC, specifically in the trigeminal nucleus caudalis from GTN exposure. The results of our study, provided in Figures 11 and 12 below, showed that administration of nVNS simultaneously with, or 90&nbsp;minutes after GTN was administered, reduced
both the pain behavior and the over-expression of glutamate. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">109 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Figure 11: <FONT STYLE="white-space:nowrap">Co-administered</FONT> nVNS prevents the
significant increase in glutamate expression triggered by GTN in sensitized animals. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g79t06.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Figure 12: Administration of nVNS, 90 minutes after GTN reduces over-expression of glutamate that occurs in
sensitized animals. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g60r02.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The pulsating character of migraine pain supports the inference of a relationship between activated nerve
fibers and blood vessels that are in close proximity with one another. This pulsating feature, typically exacerbated by exercise, led early observers to suspect vasodilation as an underlying cause. As previously mentioned, triptans, which are
vasoconstrictors, are the most widely prescribed medications for the acute treatment of migraine. Further, over the past decade, research in headache has included a focus on calcitonin gene-related peptide, or CGRP, which is a peptide released by
neurons under a variety of stress conditions. CGRP is the most potent, endogenously produced vasodilator. The administration of exogenous CGRP in sensitized animals and human migraineurs has been shown to trigger pain-related behavior and migraines.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Models of CGRP activity in migraine suggest that neurons releasing CGRP in the TCC result in the activation of pain pathway neurons,
leading to acute headache pain. While several stresses can cause the release of CGRP, the inflammatory cytokine tumor necrosis factor alpha, or TNF-<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>, is known to trigger its synthesis and release from
neurons. Heightened expression of TNF-<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT> has been correlated with heightened expression of CGRP as well as its receptors. As previously mentioned, published results of multiple studies show that VNS is
capable of suppressing TNF-<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT> in the central nervous system. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">110 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To further study the effects of our gammaCore therapy in migraine, and specifically as it
relates to CGRP, we sponsored a series of studies in which animals were sensitized by chronic inflammation. These animals experience migraine-like pain upon exposure to a known migraine trigger, umbellulone. The results of this study, as shown in
Figure 13 below, demonstrated that nVNS reduces pain responses of sensitized animals relative to that of na&iuml;ve animals, whether the therapy is delivered before or after the trigger is administered. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Figure 13: Administration of nVNS after umbellulone exposure reduces pain-associated behavior in inflammation-sensitized animals. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g32l30.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the reduction in pain, nVNS reduced the expression of intracellular biomarkers of
inflammation. These biomarkers are associated with an upregulation in TNF-<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>, and correspondingly, in CGRP synthesis and expression. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Clinical Data in support of gammaCore for Acute Migraine Treatment </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have completed one pilot and one pivotal trial examining the efficacy, safety and tolerability of gammaCore for the acute treatment of
migraine headache as summarized in Table 6 below: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Table 6: Overview of Our Acute Migraine Trials for gammaCore </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g91s12.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our First Open Label Trial in Acute Migraine </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We sponsored a multi-center, pilot clinical trial to investigate the use of gammaCore for the acute treatment of migraine headache, published
in 2014. The trial was an open-label, <FONT STYLE="white-space:nowrap">single-arm,</FONT> multiple-attack trial conducted at four headache centers in the United States. Patients were asked to treat up to four acute migraine attacks with gammaCore
over a six week period. The trial enrolled 30 patients, 25 of whom were female and 27 of whom treated at least one attack. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">111 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Nineteen of the 27 patients treated their first attack at a pain level that was moderate or
severe at baseline. Four of these 19 patients (21%) reported being pain free at two hours. Nine of 19 patients (47%) reported pain relief, defined as mild pain or pain free, at the same time point. The eight remaining patients treated their first
attack while at mild pain at baseline, five of whom (63%) were pain free at two hours. Overall, these 27 patients treated 80 migraines, 54 of which were treated with a baseline pain level of moderate or severe. Twelve of 54 attacks (22%) were
reported as pain free at two hours, and 23 of 54 attacks (43%) reached pain relief. The remaining 26 attacks were treated at mild pain, and pain freedom was achieved for 10 of these attacks (38%). The efficacy results from this trial are similar to
other acute treatments for migraine. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This pilot trial demonstrated gammaCore is well tolerated in patients with acute migraine. Adverse
events were of mild severity, transient in duration, and included local discomfort during and after gammaCore use, as well as mild skin reactions to the conductive gel. Based on the results of this trial, the authors noted that gammaCore seemed
better tolerated than triptan medications and did not appear to have the cardiovascular or cerebrovascular risks associated with them. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The PRESTO
Trial&nbsp;&#151; Our Registration Trial for the Acute Treatment of Migraine </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our PRESTO trial, or PRESTO, was a pivotal, randomized,
double-blind, sham-controlled prospective trial of gammaCore for the acute treatment of migraine. The trial enrolled 285 patients and was conducted at 10 centers in Italy, including academic medical centers and other tertiary headache clinics.
PRESTO was designed to assess the superiority of our gammaCore therapy in comparison to sham treatment and included three four-week periods: (1)&nbsp;a <FONT STYLE="white-space:nowrap">run-in</FONT> period; (2)&nbsp;a double-blind period; and
(3)&nbsp;an open-label period. Patients treated up to five migraine attacks with gammaCore or sham in the double-blind period and up to five additional attacks with gammaCore in the <FONT STYLE="white-space:nowrap">open-label</FONT> period. The
primary endpoint for the trial was response rate, defined as the proportion of patients who achieved pain freedom at 120 minutes after treatment initiation for the first migraine treated. Investigators, patients, and study coordinators were blinded
to treatment assignments in the double blind phase of the trial. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Figure 14: PRESTO Trial Consort Diagram </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g50s06.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">112 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As shown in Figure 14 above, 285 patients were enrolled into the <FONT
STYLE="white-space:nowrap">run-in</FONT> period of PRESTO, 248 of whom were eligible for randomization into the double-blind period. 37 patients did not randomize, the majority of whom failed to meet the entry criteria for randomization. 243 of the
248 enrolled patients treated at least one attack and represent the ITT population (gammaCore, n=120; sham, n=123). Of the ITT population, 239 entered the open label period, and 238 finished the open label period. Demographic and baseline
characteristics were generally well balanced between the gammaCore and sham cohorts, however, clinically relevant trends were observed with respect to preventative medication use and pain level at baseline. A higher proportion of patients in the
gammaCore cohort treated their first attack when its intensity was severe. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As shown in Figure 15 below, the proportion of patients in the
gammaCore cohort who became pain-free after treating the first attack was significantly higher than those who treated with sham at 30 minutes (gammaCore, 12.7%; sham, 4.2%; <I>p</I><I></I>=0.01) and 60 minutes (gammaCore, 21.0%; sham, 10.0%;
<I>p</I><I></I>=0.02) but not at 120 minutes (gammaCore, 30.4%; sham, 19.7%; <I>p</I><I></I>=0.07; primary endpoint). A repeated-measures test, recommended by our independent statisticians, examined the inconsistency between the <FONT
STYLE="white-space:nowrap">120-minute</FONT> finding and the <FONT STYLE="white-space:nowrap">30-</FONT> and <FONT STYLE="white-space:nowrap">60-minute</FONT> findings and demonstrated the statistical significance of gammaCore&#146;s superiority
over sham for the pain-free outcome through 120&nbsp;minutes (odds ratio: 2.3; 95% CI: 1.2, 4.4; <I>p</I><I></I>=0.01). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Figure 15: Primary
Endpoint and Repeated Measures Analysis of the PRESTO Trial for Acute Migraine </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g41e45.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As shown in Figure 16 below, the proportion of patients who achieved pain relief, defined as mild or no
pain, at 120 minutes was significantly higher with gammaCore than with sham for the first treated migraine attack (gammaCore, 40.8%; sham, 27.6%; <I>p</I><I></I>=0.03). The proportion of patients who responded at 120 minutes for <FONT
STYLE="FONT-FAMILY:SYMBOL">&#179;</FONT>50% of their attacks was significantly higher with gammaCore than with sham for both pain freedom (gammaCore, 32.4%; sham, 18.2%; <I>p</I><I></I>=0.02) and pain relief (gammaCore, 47.6%; sham, 32.3%;
<I>p</I><I></I>=0.03). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">113 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Figure 16: Selected Secondary and Exploratory Results of the PRESTO Trial for Acute Migraine
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g25h10.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As shown in Figure 17 below, mean percentage pain reduction for the first attack was significantly greater
with gammaCore than with sham at 60 minutes (gammaCore, <FONT STYLE="white-space:nowrap">-25.4%;</FONT> sham, <FONT STYLE="white-space:nowrap">-7.7%;</FONT> <I>p</I>=0.03) and 120 minutes (gammaCore, <FONT STYLE="white-space:nowrap">-34.8%;</FONT>
sham, <FONT STYLE="white-space:nowrap">-5.4%;</FONT> <I>p</I>&lt;0.01). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Figure 17: Percent Pain Relief Results of the PRESTO Trial for
Acute Migraine </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g38l20.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No SAEs were attributable to gammaCore in PRESTO. Of all patients, 18% (45/248) had <FONT
STYLE="FONT-FAMILY:SYMBOL">&#179;</FONT>1 AE during the trial. As shown in Table 7 below, the most commonly occurring device-related AEs of these were application site reactions, all of which were mild, transient, and tended to be self-limiting in
nature. The PRESTO trial demonstrated gammaCore to have a highly favorable tolerability profile. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">114 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Table 7: Most Commonly Reported Device-Related ADEs from the PRESTO Trial </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g05u71.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Headache Prevention </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The grant by FDA of our <I>de novo</I> application resulted in a new Class&nbsp;II regulatory category: external vagal nerve stimulator for
headache. The establishment of this product category permits us to apply for label expansions through the 510(k) regulatory pathway utilizing our own product as the predicate. It is our intention to seek the expansion of our label for the prevention
of both migraine and eCH. As described below, we have run, and continue to conduct, additional clinical studies which may support label expansion for the acute treatment and prevention of other primary and secondary headaches. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cluster Headache Prevention </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As described
previously, CH is believed to be the result of stimuli from facial nerves that activate the TCC, and which are opposed by inhibitory neurotransmitters from key areas of the brainstem. Acute activation of these inhibitory mechanisms has been proposed
as the basis for gammaCore&#146;s clinical efficacy in the treatment of CH attacks. The clustering of these attacks suggests a prolonged susceptibility of CH patients to loss of inhibition, or excessive activation. Prevention, therefore, may be
possible by reducing the susceptibility of the circuit either by sustained elevation of baseline inhibition, or elimination of the stimuli activating the facial nerves. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In one model of CH, prolonged irritation of the facial tissue, which includes the sinus passages around the orbital socket, may cause
activation of the facial nerves. Periodic inflammation of the sinuses may be related to the observed increase in episodic CH activity in the spring and fall, when allergens are more prevalent. Consistent with this mechanism, corticosteroids, like
prednisone, have shown efficacy as a preventative treatment for patients entering a cluster bout. Unfortunately, because of the side effects of prolonged steroid use, steroids are typically only prescribed in short duration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Currently Used Therapies for Cluster Headache Prevention and Their Limitations. </I></B>There are currently no FDA approved medications
for the prevention of CH, driving <FONT STYLE="white-space:nowrap">off-label</FONT> use of medications, such as lithium, valproic acid and high-dose verapamil. These medications have unproven efficacy and the potential for significant health risks,
including adverse cardiac events, organ toxicity and birth defects. As a result, patients are confronted with the difficult choice of continuing to suffer CH attacks unabated or to try treatments with uncertain clinical benefit and the potential for
serious medical consequences. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our PREVA Trial &#151; gammaCore for Prevention and Acute Treatment of Chronic Cluster Headache </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our PREVA trial, or PREVA, was a prospective, multi-center, open-label, randomized, controlled, parallel-group trial of gammaCore for the
prevention of cCH. The trial enrolled 114 patients with 97 patients randomized and was conducted at 10 sites in Europe, including academic medical centers and other tertiary headache clinics. PREVA was designed to assess the superiority of
adjunctive use of our gammaCore therapy with standard of care medications in comparison to standard of care medication alone, and included three periods: (1)&nbsp;a <FONT STYLE="white-space:nowrap">two-week</FONT> baseline phase during which all
patients received only their individualized standard of care, or SoC, (2)&nbsp;a four-week randomized period during which participants were randomly assigned the adjunctive treatment or SoC </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">115 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
arms; and (3)&nbsp;a four-week open label period during which all participants received adjunctive gammaCore therapy. The primary endpoint for the trial was defined as the mean change from
baseline in the number of weekly attacks in the third and fourth week of the randomized period compared with the average weekly attack rate in the baseline period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Figure 18: PREVA Trial Consort Diagram </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g99q63.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As shown in Figure 18 above, in PREVA, 114 patients were enrolled and assessed at baseline, 97 of whom
provided baseline data and were considered reliable trial participants. Of these patients, 93 met the criteria for inclusion in the ITT population having provided evaluable data (gammaCore, n=45; SoC, n=48). Of the ITT population, 92 provided data
in the open-label period (gammaCore, n=44; SoC, n=48). Demographics and baseline characteristics were similar between these groups and were representative of the overall CH population. Use of SoC medications was also comparable between groups. A
modified ITT, or mITT, population, defined to include only patients with measurable data across the respective study periods (gammaCore, 37/45; SoC, 47/48), was also provided in the primary publication of these data in 2016. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As shown in Figure 19 below, during the randomized period, participants receiving adjunctive gammaCore treatment had a significantly greater
reduction from baseline in the number of CH attacks per week compared to those receiving SoC alone (gammaCore, <FONT STYLE="white-space:nowrap">-5.9;</FONT> SoC, <FONT STYLE="white-space:nowrap">-2.1;</FONT> <I>p</I>&lt;0.02). In the mITT
population, the therapeutic benefit was more pronounced in the adjunctive gammaCore cohort (gammaCore, <FONT STYLE="white-space:nowrap">-7.2;</FONT> SoC, <FONT STYLE="white-space:nowrap">-2.1;</FONT> <I>p</I>&lt;0.001). To determine the efficacy of
longer-term prophylactic use of gammaCore, the reduction in the number of CH attacks during the open label period was examined in the 30 patients who continued adjunctive gammaCore use through this period. These patients reported a statistically
significant reduction of two CH attacks per week (<I>p</I>&lt;0.001) compared with the randomized period, suggesting further benefit with continued adjunctive use of our therapy. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">116 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Figure 19: Primary Endpoint Analysis of the ITT and mITT Populations for the PREVA Trial </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g27j76.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As shown in Figure 20 below, in the ITT population, a significantly higher proportion of the patients
receiving adjunctive gammaCore treatment experienced a <FONT STYLE="FONT-FAMILY:SYMBOL">&#179;</FONT>50% reduction in CH attack frequency during the randomized period compared with the SoC cohort (gammaCore, 40.0%; SoC, 8.3%; <I>p</I>&lt;0.001).
Similarly, the response rate in the mITT population was also significantly higher for individuals receiving adjunctive gammaCore therapy (gammaCore, 48.6%; SoC, 8.5%; <I>p</I>&lt;0.001), suggesting that patients who remained in the trial had greater
response. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Figure 20: Responder Rate Analysis for the ITT and mITT Populations in the PREVA Trial </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g63r32.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The use of abortive medications to acutely treat CH attacks was reported during all three periods of the
trial. Changes in the use of acute medication are generally used as a surrogate for efficacy in preventing the occurrence of CH attacks. Reliable data on the use of abortive medications was only available in the mITT population. The number of times
abortive medications were used in this population during the last two weeks of each trial period is shown in Figure 21 below. During the randomized period, the gammaCore cohort reported a statistically significant decrease of 61.1%
(<I>p</I>&lt;0.01) in the frequency of use of subcutaneous sumatriptan injections over the baseline period, whereas the SoC cohort reported an 10.3% increase in the use of this injected medication over
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">117 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
baseline. Changes in the use of high-flow oxygen showed a similar difference in favor of adjunctive gammaCore use in that the reduction in its use among the gammaCore cohort was 62.4%
(<I>p</I>=0.02) compared with only a 14.3% reduction in the SoC cohort. Similar results were seen in the open-label period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Figure 21:
Change in Abortive Medication Use for the mITT Population in the PREVA Trial </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g31e92.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In our PREVA trial, no SAEs were attributable to gammaCore. During the two months of treatment, similar
proportions of participants in the gammaCore cohort and SoC cohort (gammaCore, 52%; SoC, 49%) reported AEs. Most AEs were mild or moderate (93% (108/116)). Overall, as shown in Table 8 below, the most common AEs were CH attacks (gammaCore, 1; SoC,
5), along with nasopharyngitis, dizziness, oropharyngeal pain, and neck pain. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Table 8: Most Commonly Reported AEs from the PREVA Trial
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g11c10.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In summary, this trial met its primary endpoint by demonstrating that daily adjunctive prophylactic use of
our gammaCore therapy significantly reduced the number of CH attacks per week, which led to substantial reductions in abortive medication use. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">118 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Prevention of Migraine </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At sufficient exposure, migraine triggers such as lack of sleep, low oxygen levels and toxins, like alcohol, are capable of causing headaches.
Some individuals experience migraine attacks after modest exposure to these and other triggers. When identifiable, avoidance of such triggers is a staple technique for migraine prevention. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Despite trigger identification and employment of a corresponding avoidance strategy, there remains a high unmet need among migraineurs for
safe and effective preventative therapies. According to the U.S.&nbsp;Agency for Healthcare Research and Quality, only about 12% of adults with high frequency or chronic migraine take preventive medications. According to the American Migraine
Foundation, medication side effects often limit the use of migraine medications. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Currently Used Therapies for Migraine Prevention
and Their Limitations. </I></B>Five products are currently approved by the FDA for the prevention of migraine: anti-epileptic drugs, topiramate (Topamax) and valproic acid (Depakote), beta-blockers, propranolol (Inderal) and timolol (Blocadren), and
BOTOX. BOTOX is the only product that has been approved by the FDA for the prevention of chronic migraine, and its label is limited to that subgroup. In all cases, these medications were first approved for other uses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These current treatments are ineffective or inconvenient for many patients, and their use has been limited by issues with tolerability and
side effects, including cognitive impairment, nausea, fatigue and sleep disturbance. Anti-epileptic drugs are also associated with poor pregnancy outcomes and fetal abnormalities, which is a concern for women of childbearing years. In clinical
trials, these medications require four to six weeks of daily administration before most patients experience measurable clinical benefit. For example, BOTOX requires approximately 31 subcutaneous injections at various sites on the head and neck,
repeated every 12 weeks. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe there is a need for a new therapy that can either prevent migraines or reduce their severity to a
level at which supplemental existing abortive therapies can provide relief as needed, with reduced side effects. Such a therapy could provide benefit for both patients on existing therapies and patients who have abandoned therapy. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Mechanisms of Action Evidence Supporting gammaCore Use in Migraine Prevention </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Approximately 25% of all migraine patients experience sensory symptoms known as &#147;aura&#148; prior to the pain stage of at least a portion
of their migraine attacks. Aura is characterized by visual symptoms, most frequently, or by other symptoms associated with synchronized depolarization in the brain. This synchronized depolarization, referred to as cortical spreading depression, or
CSD, is believed to occur more readily when the brain is in a hyperexcitability state. Based on their ability to reduce brain hyperexcitability, several anti-epileptic drugs are used for the prevention of migraine. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To investigate the effects of VNS, which was first used clinically in epilepsy, on hyperexcitability, we sponsored a series of <FONT
STYLE="white-space:nowrap">pre-clinical</FONT> studies at the Massachusetts General Hospital. The results, published in 2016, showed that our gammaCore therapy rapidly increased the thresholds for triggering CSDs, and reduced brain
hyperexcitability. In contrast to the chemical medications mentioned above, a <FONT STYLE="white-space:nowrap">two-minute</FONT> dose of our therapy was able to multiply by approximately 2.5 times the intensity of the trigger required to initiate
CSDs within 20 minutes of initial treatment. This compares favorably to drug treatments that require weeks to months of daily administration, often with associated side effects, before achieving clinical benefit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Recently published genetic and epigenetic studies suggest a strong association between migraine and genes tied to severe inflammatory
conditions. These findings, coupled with recent breakthroughs in our understanding of how the immune system affects the expression of neurotransmitters, CGRP, and their receptors, may enhance our explanations of how hyperexcitability arises. To
further this understanding, we sponsored studies in which prolonged inflammation was used to sensitize animals to respond to migraine triggers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">119 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In this work, twice-daily gammaCore treatments, administered during the prolonged
inflammation period, inhibited sensitization. Animals treated with gammaCore were indistinguishable from a <FONT STYLE="white-space:nowrap">non-sensitized</FONT> animal group in their lack of response to the migraine trigger, which contrasted with
the sensitized group not treated with gammaCore, which responded with pain behavior. Brainstem tissue from the untreated, sensitized group was analyzed, and showed evidence of CGRP synthesis, as well as a greater number of actual CGRP vesicles. In
contrast, both <FONT STYLE="white-space:nowrap">non-sensitized</FONT> animals and gammaCore-treated animals exhibit normal intracellular biomarkers of CGRP synthesis and normal levels of CGRP vesicles. Further tissue analysis revealed that pain
pathway neurons in sensitized animals exhibited elevated expression levels of CGRP receptors. In contrast, the <FONT STYLE="white-space:nowrap">non-sensitized</FONT> and the gammaCore-treated animals showed no elevation in CGRP receptor populations.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe these preclinical studies provide mechanistic support for the development of gammaCore for the prevention of migraine. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Clinical Data in Support of gammaCore for Migraine Prevention </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our EVENT Trial &#150; Chronic Migraine Headache Prevention with gammaCore </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our EVENT trial was a multi-center, randomized, sham-controlled pilot clinical trial with respect to the use of our gammaCore therapy for the
prevention of chronic migraine and was published in 2016. This prospective double-blind pilot trial was conducted at six tertiary care headache centers in the United States. The trial included three consecutive periods: (1)&nbsp;a <FONT
STYLE="white-space:nowrap">one-month</FONT> baseline period during which patients provided data regarding their frequency of headache attacks to serve as a baseline comparator; (2)&nbsp;a <FONT STYLE="white-space:nowrap">two-month,</FONT>
randomized, sham-controlled period during which patients received prophylactic treatment with gammaCore or a sham; and (3)&nbsp;a <FONT STYLE="white-space:nowrap">six-month</FONT> open-label period during which all patients received gammaCore. The
primary objective of the EVENT trial was to assess the feasibility, safety, and tolerability of our gammaCore therapy, and as such, was not powered to reach statistical significance with respect to any efficacy measures. The trial enrolled 59
patients. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At baseline, the mean number of headache days in the gammaCore cohort (n=30) was 20.8 and 22.0 for the sham cohort (n=29). At
the conclusion of the randomized period, the gammaCore cohort had experienced an average reduction of 1.4 migraine days while the sham cohort experienced a 0.2&nbsp;migraine day decrease. The mean change from baseline was not statistically
significant between groups. A per protocol cohort was identified in whom the mean migraine day reductions for the gammaCore and sham cohorts were 2.0 and 0.1, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the open-label period, the original gammaCore cohort experienced continued reductions in migraine days. In this period, patients in the
sham cohort gained access to gammaCore and began to show improvement. The data from this trial demonstrated that continued use of our gammaCore therapy provides increased benefit. A <I>post hoc</I> completers analysis demonstrated statistically
significant and clinically meaningful reductions from baseline at the conclusion of the trial in both cohorts (initial gammaCore randomization cohort, 8.0 <FONT STYLE="white-space:nowrap">migraine-day</FONT> reduction; initial sham randomization
cohort, 6.0). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The primary purpose of this trial was safety and tolerability. Our gammaCore therapy was well tolerated and mild to
moderate adverse events were generally similar in both groups. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The PREMIUM Trial &#150; Our Registration Trial for the Prevention of Migraine
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our PREMIUM trial, or PREMIUM, is a pivotal, randomized, double-blind, sham-controlled prospective trial of gammaCore for the
prevention of migraine. The trial was conducted at 22 centers in Europe, included academic medical centers and other tertiary headache clinics, and enrolled 477 patients into a <FONT STYLE="white-space:nowrap">28-day</FONT> baseline <FONT
STYLE="white-space:nowrap">run-in</FONT> period, 341 of whom are included in the safety population and 332 of whom are included in the ITT population. PREMIUM was designed to assess the superiority of our gammaCore therapy in comparison to sham
treatment and included three distinct periods: (1)&nbsp;a <FONT STYLE="white-space:nowrap">28-day</FONT> <FONT STYLE="white-space:nowrap">run-in</FONT> period; (2)&nbsp;a three-month double-blind period; and (3)&nbsp;a
<FONT STYLE="white-space:nowrap">six-month</FONT> open-label period. PREMIUM has progressed through both the randomized and open-label study periods. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">120 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Unless otherwise specified, the data presented herein below relate to the randomized period only and are the result of preliminary analytics performed by our independent third-party
statisticians. Patients were instructed to treat themselves with two <FONT STYLE="white-space:nowrap">120-second</FONT> doses of gammaCore therapy or sham treatment, twice per day. Patients randomized to the sham treatment were offered the
opportunity to use gammaCore during the open-label period. The primary endpoint for the trial is a reduction in the average number of migraine days per month during the third month of the randomized period compared to the average number of migraine
days per month in the baseline period between the two cohorts. Investigators, patients, and study coordinators were blinded to treatment assignments in the double blind phase of the trial. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Figure 22: PREMIUM Trial Consort Diagram </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g88e65.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As shown in Figure 22 above, in PREMIUM, all patients randomized (gammaCore, n=165; sham, n=167) represent
the ITT population. Of these patients, 278 (gammaCore, n=138; sham, n=140) complied with the trial requirement to self-administer no fewer than <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the specified treatments per month during the
randomized period. This population represents an mITT. Demographic and baseline characteristics were generally well balanced between the gammaCore and sham cohorts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the ITT and mITT populations, the baseline average number of migraine days per month was similar between the two cohorts (gammaCore, 7.94
and 8.06, respectively; sham, 7.80 and 7.78, respectively). The primary endpoint was not met for the ITT population (gammaCore, <FONT STYLE="white-space:nowrap">-2.26;</FONT> sham, <FONT STYLE="white-space:nowrap">-1.80;</FONT> <I>p</I>=0.15; linear
regression). However, as shown in Figure 23 below, statistical significance was achieved in reduction of migraine days per month, the primary endpoint metric, for the mITT population (gammaCore, <FONT STYLE="white-space:nowrap">-2.27</FONT> migraine
days; sham, <FONT STYLE="white-space:nowrap">-1.53</FONT> migraine days; <I>p</I>=0.04; linear regression). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">121 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Figure 23: Primary Endpoint Analysis of the ITT and mITT Populations for the PREMIUM Trial
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g76j74.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As shown in Figures 24 and 25 below, with respect to key secondary and exploratory endpoints, statistical
significance was achieved across several measurements in the mITT population. As shown in Figure 24 below, the average percentage reduction in migraine days per month among the mITT population was greater for the gammaCore cohort compared with sham
(gammaCore, 26.7%; sham, 16.8%; <I>p</I>&lt;0.05). As shown in Figure 25 below, the reduction in the average number of headache days per month among the mITT population was greater for the gammaCore cohort compared with sham (gammaCore, <FONT
STYLE="white-space:nowrap">-2.85;</FONT> sham, 1.99; <I>p</I>=0.05). The mean reduction in days on which medication was required was statistically significant greater in the gammaCore cohort as compared with sham among the mITT population
(gammaCore, <FONT STYLE="white-space:nowrap">-1.94;</FONT> sham, <FONT STYLE="white-space:nowrap">-1.14;</FONT> <I>p</I>&lt;0.04). While not reaching statistical significance, the proportion of patients experiencing at least a 50% reduction in
migraine days per month demonstrated a trend toward significance consistent with the previously reported endpoints (gammaCore, 31.6%; sham, 22.1%; <I>p</I>&lt;0.08). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Figures 24 and 25: Additional Secondary and Exploratory Endpoint Analysis for the PREMIUM Trial </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="43%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="54%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000;width:183.90pt ; display:inline;" ALIGN="center">


<IMG SRC="g472601g26p26.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"> <P STYLE="margin-top:0pt;margin-bottom:1pt" ALIGN="center">


<IMG SRC="g472601g86x34.jpg" ALT="LOGO">
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">122 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In our PREMIUM trial, no SAEs were attributed to gammaCore. Of all randomized patients,
25.8% (88/341; gammaCore, 31/169; sham, 57/172) had <FONT STYLE="FONT-FAMILY:SYMBOL">&#179;</FONT> to 1 ADE during the trial. As shown in Table 9 below, the most commonly occurring ADEs were application site irritation, all of which were
non-serious, transient, and tended to be self-limiting in nature. The PREMIUM trial demonstrated that our gammaCore therapy for acute migraine treatment has a highly favorable tolerability profile. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Table 9: Most Commonly Reported ADEs from the PREMIUM Trial </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g48k39.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Data from the recently completed open-label period of the PREMIUM trial was generally consistent with the
earlier results from the randomized period with continued reductions in the number of migraine and headache days per month, as well as an increase in the number of subjects who had 50% reduction in the number of their monthly migraine days compared
to when they started the trial. Non-invasive vagus nerve stimulation continued to enjoy a highly favorable safety and tolerability profile. We expect to present full data from the PREMIUM trial at a medical congress before the end of 2018. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Additional Headache Opportunities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Migraine in Adolescents.</I></B> Peak migraine penetrance occurs during adolescence and parents may be hesitant to place children on
medication. Our clinician advisors have indicated their belief that our gammaCore therapy would be particularly well received in this population given its tolerability profile. We are currently partnered with opinion leaders from academic medical
centers and other tertiary headache centers to develop a clinical trial that we expect to initiate in the second half of 2018 to support a label expansion for gammaCore to include patients as young as 12 years of age. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Post-Traumatic Headache.</I></B> Unlike migraine and CH, which are primary headaches, Post-Traumatic Headaches, or PTH, are classified
as secondary headaches because they have a clear causation associated with head trauma. Research has shown that head trauma activates immune cells in the central nervous system. This activation can lead to a disruption in neurotransmitter
expression, hyperexcitation, and to the production of CGRP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">VNS, including gammaCore therapy, has been shown to be effective in reducing
this immune cell activation. Our clinical and scientific advisors have indicated their belief that our gammaCore therapy has the potential to offer therapeutic benefit for this patient population. We are currently developing a clinical trial that we
expect to initiate in the second half of 2018 to support a label expansion for gammaCore to include PTH. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Pipeline </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Rheumatology </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Anti-inflammatory Mechanisms of VNS
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The systemic anti-inflammatory effects of VNS are believed to result from the activation of sympathetic fibers in the splenic nerve,
through a connection at the celiac ganglion. These sympathetic fibers release norepinephrine into the spleen in close proximity to a specialized group of immune cells that release acetylcholine, or ACh. This release of ACh activates a receptor, the
alpha 7 nicotinic ACh receptor, or <FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>7nAChR, on cytokine-releasing immune cells called macrophages. Activation of these receptors is believed to function by blocking transcription factors that promote
inflammatory cytokine expression. Based on the role of ACh in activating this pathway, which is shown in Figure 26 below, it has been termed the cholinergic anti-inflammatory pathway, or CAP. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">123 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Figure 26: The Cholinergic Anti-Inflammatory Pathway </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g62o45.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sj&ouml;gren&#146;s Syndrome </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Paralleling our market penetration strategy in headache, we have chosen to enter rheumatology in Sj&ocirc;gren&#146;s syndrome, a condition
with high unmet need and no currently approved disease modifying treatments. We believe that further expansion into other areas of rheumatology from this base of relevance among clinicians will maximize our ability to penetrate areas like rheumatoid
arthritis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sj&ouml;gren&#146;s syndrome is a chronic inflammatory condition characterized by damage to, and ultimate loss of,
moisture-producing glands. The primary clinical consequence of this damage is dry mouth and dry eyes, which can cause significant tooth loss and ocular injury. Related similar symptoms can include dry skin, a chronic cough, and vaginal dryness.
Primary Sj&ouml;gren&#146;s syndrome, defined as being independent of other rheumatologic conditions, affects approximately 600,000 people in the United States, primarily women. Secondary Sj&ouml;gren&#146;s syndrome arises in conjunction with other
inflammatory conditions, and increases the number of Sj&ouml;gren&#146;s sufferers to approximately four million people in the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is believed that the disease begins with increased inflammatory cytokine levels of <FONT STYLE="white-space:nowrap">interleukin-1</FONT>
beta, or <FONT STYLE="white-space:nowrap">IL-1&szlig;.</FONT> The elevated level of <FONT STYLE="white-space:nowrap">IL-1&szlig;</FONT> is believed to be the underlying cause of the debilitating fatigue and sleepiness, symptoms that are often the
cause of the greatest loss in quality of life among Sj&ouml;gren&#146;s patients. This fatigue is a symptom of what is referred to as cytokine-induced sickness behavior. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sickness behavior is a coordinated set of behavioral changes associated with extended periods of inflammation, including inability to
concentrate, lethargy, malaise, fatigue, sleepiness, hyperalgesia, depression, and anxiety. These symptoms are common across many conditions in rheumatology. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An initial open label pilot trial of gammaCore for the treatment of primary Sj&ouml;gren&#146;s syndrome was funded by the U.K. Arthritis
Foundation, the results of which were recently presented at the 2017 American College of Rheumatology annual meeting. This trial enrolled 15 patients, all of whom provided evaluable data. At the beginning of this trial, enrolled patients provided
baseline self-assessments of multiple key symptoms of their condition and blood samples were taken to establish baseline cytokine and other biomarker expression levels. During this first visit, patients were treated with gammaCore and additional
blood samples were taken 90 minutes after this initial treatment. Patients were instructed to self-administer gammaCore twice daily, each treatment comprising two doses. Patients returned after seven days to provide self-assessments and additional
blood samples. Patients continued this treatment protocol through a total of 26 days. On day 28, after a <FONT STYLE="white-space:nowrap">two-day</FONT> treatment hiatus, patients provided self-assessments of their symptoms and additional blood
samples both before, and 90 minutes following a final gammaCore treatment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">124 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As shown in Figure 27 below, cytokine levels of both
<FONT STYLE="white-space:nowrap">IL-1&szlig;</FONT> and TNF-<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT> were significantly reduced from timepoint 1, or baseline, to timepoint 2, 90 minutes following their first treatment with gammaCore. The
levels of these cytokines remained at these reduced levels, or lower, at timepoint&nbsp;3, which was their day seven visit, and timepoints 4 and 5, both of which occurred at their day 28 visit (both before and after their final gammaCore
treatments). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Figure 27: Reductions in <FONT STYLE="white-space:nowrap">IL-1&szlig;</FONT> and
TNF-<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT> from baseline through Day 28 in Sj&ouml;gren&#146;s syndrome patients using gammaCore therapy. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g90p66.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As shown in Figure 28 below, the clinical results from this open-label pilot trial demonstrated statistical
significance for reductions in physical fatigue and sleepiness, and trends toward significance for mental fatigue and abnormal fatigue. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">125 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Figure 28: Reductions in key fatigue and sleepiness measurements from baseline through Day 26
in Sj&ouml;gren&#146;s syndrome patients using gammaCore therapy. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g06d13.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are currently preparing for a <FONT STYLE="white-space:nowrap">pre-investigational</FONT> device
exemption, or IDE, meeting with the FDA to gain clarity regarding a pivotal trial design that could support an application for a labeling claim for the signs and symptoms of Sj&ouml;gren&#146;s syndrome, and confirm that the FDA&#146;s review of
such an application would proceed through the <I>de novo</I> pathway. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Rheumatoid Arthritis </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Rheumatoid arthritis, or RA, is a chronic autoimmune disorder primarily affecting joints, and in particular the synovial tissue within the
joint capsule. The condition is characterized by observable inflammation in the synovial tissue of affected joints, with associated warmth, swelling, pain, and loss of function around the inflammation. Symptoms typically worsen following rest. The
most commonly affected areas include smaller joints of the body such as the wrists, hands, and feet, and typically affects the same joints on both sides of the body. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Uncontrolled RA is associated with significant morbidity and increased mortality. The current standard of care involves treating patients
early and aggressively to prevent, or significantly retard the progression of joint damage. This is important, as progression of joint damage is directly correlated with debility, disability and loss of function. Approximately 2.4&nbsp;million
patients, predominantly women, suffer from RA in the United States. Current treatments for RA have been shown to possess a disease modifying effect, in addition to being effective at controlling signs and symptoms. Some agents used in the treatment
of RA, most notably the biologics have shown effectiveness in the treatment of psoriatic arthritis and ankylosing spondylitis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Inflammatory cytokines have long been identified in the pathogenesis of RA. Medications that inhibit immune activity, either broadly, like
corticosteroids, or biologic agents, specifically targeting individual </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">126 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
cytokines, have been key treatment options for RA patients. Typically, patients with RA initiate treatment with methotrexate, or MTX, which is sufficient to arrest the disease progression and
provide relief of the disabling symptoms in approximately 25% of the affected population. Despite being generically available, the average cost of chronic MTX treatment in the United States still averages greater than $200 per month. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Incomplete response to MTX requires additional therapy, typically in the form of a biologic treatment, the most common of which are antibodies
or antibody-like proteins that bind to TNF-<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>. By targeting TNF-<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>, these treatments alter the normal functioning of the immune system, and as such carry
significant risks related to opportunistic infections and several forms of cancers. Approximately 40% of patients with RA are successfully treated with this class of medications, but at an average cost of $30,000 per year. Estimates suggest that of
the more than $30&nbsp;billion of annual global sales of these medications, sales for RA and related conditions of ankylosing spondylitis and psoriatic arthritis exceed $15&nbsp;billion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Those patients who are inadequately managed by MTX and/or
<FONT STYLE="white-space:nowrap">anti-TNF-</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT> agents, typically advance to other biologic agents that attempt to either block the circulating levels of other target inflammatory cytokines, or block
the intracellular pathways that promote the production of inflammatory cytokines. The latter includes the Janus kinase inhibitors, such as Xeljanz, which have an annual cost currently ranging from $40,000 to over $60,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Initial clinical evidence for the use of VNS in RA was published in 2016 reporting on an open label pilot trial of implanted VNS among a group
of 17 RA patients who had failed standard of care therapy (7 MTX incomplete responders and 10 who had failed at least two biologic agents). As shown in Figure 29 below, the results of this trial demonstrated clinical improvement in disease activity
score, or DAS28, over a <FONT STYLE="white-space:nowrap">six-week</FONT> period of about 2.5 points in MTX incomplete responders and about 1.5 points in biologic failures greater than 1.5 points. Patients had their VNS therapy deactivated for a <FONT
STYLE="white-space:nowrap">two-week</FONT> period following the initial <FONT STYLE="white-space:nowrap">six-week</FONT> treatment period, during which time DAS28 scores rapidly returned to prior activity levels. This trend reversed and trended
towards improvement when VNS therapy was <FONT STYLE="white-space:nowrap">re-initiated.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Figure 29: Mean change in DAS scores
reported following implantation of and activation of VNS devices. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g06a80.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are currently preparing for a <FONT STYLE="white-space:nowrap">pre-IDE</FONT> meeting with the FDA to
confer with its reviewers regarding a multi-center, randomized, double blind, sham-controlled trial of gammaCore therapy for the treatment of RA and to confirm that the FDA&#146;s review of such an application would proceed through the <I>de
novo</I> pathway for a signs and symptoms labeling claim. As our potential trials progress, we may, at the appropriate time, conduct premarket activities in rheumatology, such as market analysis, physician and patient segmentation research, and
promotional and campaign development. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">127 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Manufacturing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are the <FONT STYLE="white-space:nowrap">FDA-registered</FONT> manufacturer of our gammaCore products. We rely upon third-party suppliers,
located both within and outside the United States, for substantially all of the component parts of gammaCore, including injection molded housings, printed circuit board assemblies, batteries, electrodes and conductive gel. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At our facility in Basking Ridge, NJ, we inspect the component parts following receipt to ensure they meet their design specifications. This
quality inspection involves physical measurements and electrical performance testing. After successful completion of this inspection, our proprietary software is loaded into the microcontroller located on the printed circuit board. The battery and
electrodes are connected to the printed circuit board, which is then placed in a plastic housing. The gammaCore is then configured to deliver the number of days of therapy to be prescribed, and a final test is performed on the unit to ensure it
meets our performance specifications. The unit is then packaged, along with appropriate labeling, instructions for use and conductive gel, and shipped into our distribution network. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently have sufficient capacity to meet anticipated demand for our therapy for the foreseeable future. As demand rises, we may choose to
maximize operating efficiencies by transferring manufacturing to one or more company-approved contract manufacturers. We are currently evaluating potential third-party manufacturers; however, we do not anticipate such a transfer will occur prior to
2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to protect against the risk of supply chain disruption, we are qualifying alternative vendors and suppliers to ensure
timely access to components necessary for the manufacture and assembly of our gammaCore products. We will also retain the expertise and capabilities to fulfill our commercial product needs internally, if necessary. These measures include purchasing
a sufficient advanced supply of key components to reasonably assure that no component shortages will interrupt our ability to manufacture and deliver our products to patients on a timely basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The generation of our proprietary signal does not require custom electronic components. Therefore, we believe long-term manufacturing, supply
and quality agreements with our suppliers are not necessary as all the components used in our products are either high-volume, <FONT STYLE="white-space:nowrap">non-custom</FONT> commodity components, or are readily available from multiple vendors.
The majority of these components have multiple sources, and the few with single-sources have been purchased with sufficient reserves to permit continued production of our product should simple design modifications be required. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Coverage and Reimbursement </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Commercial
payors in the United States typically make coverage and reimbursement decisions with respect to new therapies based on three key factors: the strength of the therapy&#146;s clinical data; initial patient demand; and the absolute and relative cost of
the therapy. Our payor engagement strategy was initiated 18 months prior to market entry, with pipeline presentations across the largest <FONT STYLE="white-space:nowrap">two-dozen</FONT> commercial payors in the United States. We engaged with payors
directly and through experienced consultants specializing in securing coverage and reimbursement. Many of these payors have indicated that we should advocate for reimbursement of our product as a pharmacy benefit. This pathway may allow patients to
obtain our therapy through payment of a <FONT STYLE="white-space:nowrap">co-payment</FONT> rather than being personally responsible for the costs of our product until meeting an annual deductible. The pathway may also permit payors to manage
utilization of gammaCore through different tiers of coverage requiring varying <FONT STYLE="white-space:nowrap">co-pay</FONT> amounts, prior authorizations, and requirements that patients fail less expensive treatments before gaining access to more
expensive therapies. While some commercial payors may provide coverage under their pharmacy benefit plans, other payors, including governmental and private insurers, may not be willing or authorized to provide coverage for our therapy under pharmacy
plans that more commonly cover prescription drug products. These payors may require us to seek coverage for gammaCore as a medical supply or item of durable medical equipment, which could result in the application of different pricing,
reimbursement, and patient cost-sharing policies to our products. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">128 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our strategy has been to gain early access for the narrowly defined market of CH where
patients have only one other <FONT STYLE="white-space:nowrap">FDA-approved</FONT> commercially available acute treatment option. To address the key factors used to make coverage and reimbursement decisions, we provide payors published data from our
multiple clinical trials. Our commercial product registry is designed to generate patient demand in the form of prescriptions submitted to the payors. In concert with this commercial registry, we have established a comprehensive publication program
to highlight evidence of the high cost of CH patients and to support the use of gammaCore as a cost-effective treatment option. To demonstrate this, we hired a pharmacy benefit management company that reviewed data from four of its regional health
plans, totaling 2.5&nbsp;million members. This review revealed that pharmacy costs for CH patients were double that of patients in a matched group of <FONT STYLE="white-space:nowrap">non-CH</FONT> sufferers, and were 2.3 times more likely to be
prescribed an opioid. However, many third-party payors do not currently cover our products because they have determined gammaCore and other <FONT STYLE="white-space:nowrap">non-invasive</FONT> VNS treatments to be experimental or investigational.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the U.S. government, state legislatures and foreign governments have continued implementing cost-containment programs,
including price controls and restrictions on coverage and reimbursement. Adoption of price controls and cost-containment measures, and adoption of more restrictive policies in jurisdictions with existing controls and measures, could limit our net
sales and results. Decreases in third-party reimbursement for our products or decisions by third-party payors to not cover our products could reduce physician utilization of our products and have a material adverse effect on our sales, results of
operations and financial condition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As part of our broad payor engagement strategy we are seeking to secure pharmacy benefit
reimbursement for our therapy by working with both commercial payors and pharmacy benefit managers, also known as PBMs. PBMs are third party groups who manage the pharmacy benefits offered by the commercial payors. In the U.S. market, there are
three major large PBMs. We have entered into an agreement with one of these major PBMs, which manages approximately 60 million U.S. lives. Pursuant to this agreement, gammaCore will be covered, depending on the commercial payor that the PBM serves,
and the specific plan, for commercially covered U.S. patients, as either a preferred brand or non-preferred brand. As a preferred brand, or Tier 2 product, the coverage would require a monthly copayment paid by the patient of approximately $30. As a
non-preferred brand, considered a Tier 3 product, the monthly copayment would likely be between $60 and $75. Under this agreement, we anticipate, based on our estimates, that approximately 15&nbsp;million U.S. commercial lives will shortly have
access to our therapy as either a Tier 2 or Tier 3 product, and we anticipate this number will grow to at least 45 million lives under this agreement over the coming quarters as we, together with this PBM, engage with additional commercial payors to
position our product across the payors&#146; plans. The strategy of engaging with payors and PBMs is continuing as we engage the other major PBMs and payors towards the goal of increasing patient access to our therapy. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Commercialization </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our commercial
strategy will initially focus on the following priorities: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Drive advocacy of gammaCore as a leading headache therapy. </I></B>Our strategy is to establish gammaCore as a preferred treatment option, initially in eCH and expanding into migraine. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We are developing advocacy for gammaCore among key opinion leaders, who are well-known or emerging leaders in the areas of headache and neurology, through our clinical program and initial product registry. We currently
have in excess of 300 clinicians trained on gammaCore use and over 600 unique prescribers. Of these, 50 are key opinion leaders who are compensated by us on a per diem basis pursuant to one-year agreements to lead a series of programs to educate
their colleagues on our clinical data and our specialty pharmacy distributor and its network of specialty pharmacies. Through the second quarter of 2018, we have scheduled 50
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">peer-to-peer</FONT></FONT> educational programs, which will be led by these key opinion leaders. An additional 150 such programs are scheduled for the third and fourth quarters of
2018. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We established our proprietary gammaCore product registry in July 2017 to enroll patients diagnosed with eCH.
Through our registry, which we maintain, non-federal health care program </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">129 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
patients are offered two free months of gammaCore therapy and are asked to report their outcomes across quality of life criteria. At enrollment, patients report baseline information such as
number of years living with eCH, time, duration and intensity of attacks. Patients also provide information regarding their medication usage prior to and during registry participation in conjunction with their use of gammaCore, their number of
attacks treated with gammaCore, their number of stimulations with our therapy and the impact of our therapy on their pain intensity and duration. Because payors and physicians value real world data, we believe the registry data will aid in their
assessment of gammaCore. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Drive reimbursement of our therapy</I></B><I>.</I> Through our product registry and initial commercialization efforts we are generating prescriptions and patient claims to prompt commercial payors to initiate
clinical review and subsequent reimbursement policies for gammaCore. We have engaged over 50 national and regional commercial insurance payors in the United States with the goal of obtaining reimbursement coverage as a pharmacy benefit. Agreements
with commercial payors are in place that we believe, based on our estimates, will provide for reimbursement for gammaCore as a pharmacy benefit for approximately 17&nbsp;million commercial lives, including a contract with a large PBM that we
believe, based on our estimates, will initially cover 15&nbsp;million commercial lives, with such number expected to increase over the next several quarters to as many as 45&nbsp;million lives under such agreement. In addition, our access
negotiations have entered the active clinical review stage with more than a dozen additional insurance plans covering approximately 120&nbsp;million additional commercial lives. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Build a leading commercial presence.</I></B> Our sales force targets high-prescribing neurology practices and headache centers in the United States. Currently, our sales force consists of four regional business
directors and 18 territory business managers. In addition, three medical science liaisons provide medical affairs support. We plan to hire an additional 14 territory business managers, who will ultimately cover 6,400 high-prescribers of headache
medications and an additional two medical science liaisons. Based on the extent and nature of insurance coverage provided by payors for gammaCore, we may hire up to an additional 16 territory business managers for aggregate coverage of 9,600
prescribers. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Leveraging a national specialty pharmacy distribution network</I></B><B>. </B>Through our specialty pharmacy distributor, we have access to an established national specialty pharmacy distribution network that
provides physician and patient support to quickly onboard patients and manage payor interactions. This support includes adjudication of all gammaCore prescriptions, payor claims for reimbursement, and patient support and training. Our specialty
pharmacy distributor is national in scope, supports the national shipping and dispensing of our therapy and has access to a network of hundreds of individual specialty pharmacists throughout the United States. This pharmacy network is scalable in
size allowing for customized solutions to fit our distribution needs for the foreseeable future. It also has the capacity to adjudicate claims for reimbursement for our products from all commercial payors segments. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Our Proprietary gammaCore Ecosystem</I></B>. We continue to focus on fostering advocacy among key opinion leaders and securing
reimbursement policies with payors by leveraging the high unmet need in CH, setting the stage for our expansion into migraine. Consistent with this strategy, we have structured our distribution around a pharma-like model, forming an essential piece
of our proprietary stakeholder-connecting ecosystem. This ecosystem engages patients, physicians, insurance providers, and our specialty pharmacy in a network that offers these stakeholders: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Physician ease of use. </I></B>Physicians can enter prescriptions through a <FONT STYLE="white-space:nowrap">web-based</FONT> interface engaging our trained care specialists to register new patients;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Rapid prescription insurance adjudication.</I></B> These care specialists work with our specialty pharmacy distributor to accelerate the insurance adjudication process, contacting the physician and/or the patient
if additional information is required; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">130 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Concierge patient engagement and personalized training. </I></B>The specialty pharmacy contacts the patient to obtain the <FONT STYLE="white-space:nowrap">co-pay,</FONT> ships gammaCore directly to the
patient&#146;s home, reviews the contents of the shipment with the patient on delivery, trains the patient on gammaCore use, and follows up within 48 hours to answer any additional questions the patient may have; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Ongoing patient support. </I></B>Care specialists follow up with patients every month to answer any questions, remind them of refills, and support compliance with the therapy. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A key feature of the highly connected ecosystem we have constructed is our HIPAA-compliant, cloud-based data warehouse. The web portal feature
of this network enables unprecedented engagement with patients through which we can provide training and educational material, and offer interactive diaries that provide us real-time feedback. This interactive experience will be expanded to engage
with patients through their smart phones, informing them of key information such as the distance they are from their gammaCore and the time to their next dose or refill. In the future, we intend to incorporate additional features that may allow the
smartphone to assist patients with identification and/or prediction of their risk factors and triggers. The portal is designed to promote patient engagement and the ability for the ecosystem to improve treatment outcomes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The logistics of gammaCore distribution are significantly more efficient than that of traditional pharmaceutical therapies. Pharmaceutical
therapies are typically distributed through a multi-tiered supply chain involving wholesalers, warehoused supply centers, and individual pharmacy branches, all of which separate the patient from the manufacturer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By connecting our proprietary data warehouse directly to the specialty pharmacies that distribute our therapy, gammaCore&#146;s distribution
eliminates several tiers of the traditional supply chain. Each gammaCore can be refilled electronically through the delivery of unique digital authorization codes, which are maintained in this cloud-based warehouse. We provide these codes to these
specialty pharmacies by permitting them access to our database, and to the patient through RFID cards programmed by the pharmacists we have trained. More specifically, following adjudication of the prescription and securing payment or payor
authorization, these trained pharmacists are granted access to our cloud-based system and program an RFID card, in real-time, using a tablet computer that we provide. This digital warehouse has the capability to provide refill authorization codes
directly from the warehouse to the patient through Bluetooth technology, further increasing the ease and efficiency of prescription refills by eliminating the need for RFID cards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An important limitation of the traditional pharmaceutical distribution model is that manufacturers can only track prescriptions through the
purchase of data from a third party, which is typically several months old, making real-time responsiveness impossible. Our system captures real-time information regarding the patient, therapy usage, and refill status. All sales and marketing data
are completely current, and available at a maximally granular level, enabling real-time decision-making. The build out of our specialty distribution channel will require specialized scanning hardware for use by our specialty pharmacy distributor and
its network of specialty pharmacies, enhancements to our data warehouse including custom software, the training of specialty pharmacists who will distribute our therapy, and increased patient support for handling expected increases in patient
volume. We also expect to create and develop patient and professional promotional tactics across multiple channels including social, digital, and print media. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In October 2016, we entered into a non-exclusive master services agreement for the provision of specialty pharmacy distribution services in
the United States with Asembia LLC, or Asembia. Asembia provides us with access to its national network of specialty pharmacies and distribution services pursuant to one or more statements of work, or SOWs, arising under the agreement, including
product stocking programs and integrated pharmacy dispensing systems, patient education and support, claims management and reimbursement assistance, professional compliance counseling and a patient hub services program with data capture and
reporting capabilities. The agreement has an initial term of three years and is renewable automatically for successive one-year terms unless either party submits a termination notice at least 90 days prior to the end of the then-current
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">131 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
term. We may terminate the agreement or all or any part of any SOW at any time upon 90 days&#146; written notice to Asembia. The agreement may also be terminated for cause upon written notice to
the other party in the event of a material breach that is uncured for 30 days following written notice of such deficiency. The agreement provides for customary transitional services in those instances where we elect to use another service provider
or our own employees to perform the services. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Competition </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While we believe that our proprietary gammaCore therapy provides us with competitive advantages, we face potential competition from many
different sources, including pharmaceutical, biotechnology and other healthcare companies. In addition, academic institutions, governmental agencies and public and private research institutions are actively conducting research in overlapping fields
of interest. Our gammaCore therapy will compete with existing therapies and therapies that may become available in the future. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe
the key competitive factors affecting the success of our therapy are its safety, efficacy, convenience, price, the availability of generic drugs and the availability of coverage and reimbursement from government and other third-party payors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Many of the companies we are competing with now, or with which we may compete in the future, have significantly greater financial resources
and expertise in research and development, manufacturing, preclinical testing, conducting clinical trials, obtaining regulatory approvals and marketing approved drugs than we do. Smaller or early-stage companies may also prove to be significant
competitors, particularly through collaborative arrangements with large and established companies. These competitors also compete with us in recruiting and retaining qualified scientific and management personnel and establishing clinical trial sites
and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
primary headache, we face competition from companies that develop and/or sell the following types of treatments: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Treatments for Cluster Headache
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The most frequently used acute treatments for CH attacks are subcutaneous sumatriptan and inhaled oxygen. Alternative treatments
include intranasal triptans and intravenous DHE. Only subcutaneous sumatriptan and intravenous DHE are approved in the United States for the acute treatment of CH. There are currently no <FONT STYLE="white-space:nowrap">FDA-approved</FONT>
commercially available medications for the prevention of CH. Medications that are used <FONT STYLE="white-space:nowrap">off-label</FONT> include verapamil, lithium, and valproate. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Treatments for Migraine </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The most
frequently prescribed therapy for the acute treatment of migraine are oral or nasal triptans. Additional prescribed products include prescription strength NSAIDs. Small molecule CGRP receptor agonists are currently in Phase 3 development by Allergan
plc and Biohaven Pharmaceuticals Inc. for the acute treatment of migraines. Certain classes of anti-epileptic medicine and beta-blocker medications have been approved by the FDA for the prevention of migraine. There is currently only one therapy
approved for the prevention of chronic migraine, BOTOX marketed by Allergan plc. There are currently three antibodies to CGRP and its receptor in Phase 3 development for the prevention of migraine by Alder Biopharmaceuticals, Inc. Teva
Pharmaceutical Industries Ltd., and Eli Lilly and Company, with a fourth product developed by Amgen Inc., which is in a co-marketing partnership with Novartis International AG, approved by the FDA in May 2018. There are a number of medical devices
that have been marketed for the treatment of migraine, including Cefaly and the Spring TMS device. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">132 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Intellectual Property </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We actively seek to protect the intellectual property and proprietary technology that we believe is important to our business, which includes
seeking and maintaining patents covering our technology and products, proprietary processes and any other inventions that are commercially or strategically important to the development of our business. We also rely upon trademarks to build and
maintain the integrity of our brand, and we seek to protect the confidentiality of trade secrets that may be important to the development of our business. For more information, please see &#147;Risk Factors&#151;Risks Related to Intellectual
Property.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Patents and Patent Applications </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of February&nbsp;1, 2018, we held more than 140 patents and patent applications, including more than 70 issued U.S. patents, more than 25
U.S. patent applications, and more than 40 international patents and applications. All of our current issued patents are projected to expire between 2026 and 2033. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">More specifically, our current therapy embodies a number of critical proprietary innovations, including a patented high-frequency burst signal
that is capable of passing comfortably through the capacitance of the skin. In addition, our therapy utilizes a patented low pass filtration that substantially eliminates high frequency harmonics that would otherwise activate pain receptors in the
skin. The combined result is a mild sensation that activates the target fibers in the cervical vagus nerve. While physically possible to administer electricity through the skin of the neck that will activate the same vagal fibers without these
innovations, the intensity of pain receptor activation makes it virtually impossible to do so without causing unacceptably high pain levels. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, we have claims covering the methods of treating various headache conditions using our innovative therapy. We also have claims
covering our innovative distribution capabilities, including the remote network-enabled communication for delivery of neuromodulation therapy for a broad range of medical conditions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The term of individual patents depends on the legal term for patents in the countries in which they are granted. In most countries, including
the United States, the patent term is generally 20 years from the earliest claimed filing date of a <FONT STYLE="white-space:nowrap">non-provisional</FONT> patent application in the applicable country. We cannot assure you that patents will be
issued from any of our pending applications or that, if patents are issued, they will be of sufficient scope or strength to provide meaningful protection for our technology. Notwithstanding the scope of the patent protection available to us, a
competitor could develop treatment methods or devices that are not covered by our patents. Furthermore, numerous U.S. and foreign issued patents and patent applications owned by third parties exist in the fields in which we are developing products.
Because patent applications can take many years to issue, there may be applications unknown to us, which applications may later result in issued patents that our existing or future products or proprietary technologies may be alleged to infringe.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There has been substantial litigation regarding patent and other intellectual property rights in the medical device industry. In the
future, we may need to engage in litigation to enforce our issued patents, to protect our trade secrets or <FONT STYLE="white-space:nowrap">know-how,</FONT> to defend against claims of infringement of the rights of others or to determine the scope
and validity of the proprietary rights of others. Litigation could be costly and could divert our attention from other functions and responsibilities. Adverse determinations in litigation could subject us to significant liabilities to third parties,
could require us to seek licenses from third parties and could prevent us from manufacturing, selling or using our gammaCore products, any of which could severely harm our business. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Copyrights, Trademarks and Trade Secrets </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The software programs associated with gammaCore and our proprietary ecosystem are protected by U.S. copyright law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">133 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of February 1, 2018, our trademark portfolio contained six U.S. trademark registrations,
including electroCore<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, gammaCore<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> and gammaCore Sapphire<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, four pending
U.S.&nbsp;trademark applications and one registered European trademark, electroCore<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We also rely upon trade secrets, <FONT STYLE="white-space:nowrap">know-how</FONT> and continuing technological innovation, and may pursue
licensing opportunities in the future, to develop and maintain our competitive position. We seek to protect our proprietary rights through a variety of methods, including confidentiality agreements and proprietary information agreements with
suppliers, employees, consultants and others who may have access to proprietary information, under which they are bound to assign to us inventions made during the term of their employment or term of service. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Government Regulation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>United States </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our products and operations are subject to extensive and rigorous regulation by the U.S. Food and Drug Administration, or FDA, under the
Federal Food, Drug, and Cosmetic Act, or FFDCA, and its implementing regulations, guidance documentation, and standards. Our gammaCore products are regulated by the FDA as medical devices. The FDA regulates the design, development, research,
testing, manufacturing, safety, labeling, storage, recordkeeping, promotion, distribution, sale and advertising of medical devices in the United States to ensure that medical products distributed domestically are safe and effective for their
intended uses. The FDA also regulates the export of medical devices manufactured in the United States to international markets. Any violations of these laws and regulations could result in a material adverse effect on our business, financial
condition and results of operations. In addition, if there is a change in law, regulation or judicial interpretation, we may be required to change our business practices, which could have a material adverse effect on our business, financial
condition and results of operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the FFDCA, medical devices are classified into one of three classes&#151;Class&nbsp;I,
Class&nbsp;II or Class&nbsp;III&#151;depending on the degree of risk associated with each medical device and the extent of control needed to ensure safety and effectiveness. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Class&nbsp;I devices are those for which safety and effectiveness can be assured by adherence to FDA&#146;s &#147;general controls&#148; for
medical devices, which include compliance with the applicable portions of the FDA&#146;s Quality System Regulation, or QSR, facility registration and product listing, reporting of adverse medical events, and appropriate, truthful and <FONT
STYLE="white-space:nowrap">non-misleading</FONT> labeling, advertising, and promotional materials. Some Class&nbsp;I devices also require premarket clearance by the FDA through the 510(k) premarket notification process described below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Class&nbsp;II devices are subject to FDA&#146;s general controls, and any other &#147;special controls&#148; deemed necessary by FDA to ensure
the safety and effectiveness of the device, such as performance standards, product-specific guidance documents, special labeling requirements, patient registries or post-market surveillance. Premarket review and clearance by the FDA for
Class&nbsp;II devices is accomplished through the 510(k) premarket notification procedure, though certain Class&nbsp;II devices are exempt from this premarket review process. When a 510(k) is required, the manufacturer must submit to the FDA a
premarket notification submission demonstrating that the device is &#147;substantially equivalent&#148; to a legally marketed device, which in some cases may require submission of clinical data. Unless a specific exemption applies, 510(k) premarket
notification submissions are subject to user fees. If the FDA determines that the device, or its intended use, is not substantially equivalent to a legally marketed device, the FDA will place the device, or the particular use of the device, into
Class&nbsp;III, and the device sponsor must then fulfill much more rigorous premarketing requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Class&nbsp;III devices, consisting
of devices deemed by the FDA to pose the greatest risk, such as life-sustaining, life-supporting or implantable devices, or devices deemed not substantially equivalent to a predicate device. The safety and effectiveness of Class&nbsp;III devices
cannot be assured solely by general or special controls. Submission </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">134 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and FDA approval of a premarket approval, or PMA, application is required before marketing of a Class&nbsp;III device can proceed. As with 510(k) submissions, unless subject to an exemption, PMA
submissions are subject to user fees. The PMA process is much more demanding than the 510(k) premarket notification process. A PMA application, which is intended to demonstrate that the device is safe and effective, must be supported by extensive
data, typically including data from preclinical studies and human clinical trials. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>510(k) Clearance </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To obtain 510(k) clearance for a medical device, an applicant must submit to the FDA a premarket notification submission demonstrating that the
proposed device is &#147;substantially equivalent&#148; to a legally marketed device, known as a &#147;predicate device.&#148; A legally marketed predicate device may include a device that was legally marketed prior to May&nbsp;28, 1976 for which a
PMA is not required (known as a <FONT STYLE="white-space:nowrap">&#147;pre-amendments</FONT> device&#148; based on the date of enactment of the Medical Device Amendments of 1976), a device that has been reclassified from Class&nbsp;III to
Class&nbsp;II or Class&nbsp;I, or a device that was found substantially equivalent through the 510(k) process. A device is substantially equivalent if, with respect to the predicate device, it has the same intended use and has either (i)&nbsp;the
same technological characteristics, or (ii)&nbsp;different technological characteristics, but the information provided in the 510(k) submission demonstrates that the device does not raise new questions of safety and effectiveness and is at least as
safe and effective as the predicate device. A showing of substantial equivalence sometimes, but not always, requires clinical data. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Before the FDA will accept a 510(k) submission for substantive review, the FDA will first assess whether the submission satisfies a minimum
threshold of acceptability. If the FDA determines that the 510(k) submission is incomplete, the FDA will issue a &#147;Refuse to Accept&#148; letter which generally outlines the information the FDA believes is necessary to permit a substantive
review and to reach a determination regarding substantial equivalence. An applicant must submit the requested information before the FDA will proceed with additional review of the submission. Once the 510(k) submission is accepted for review, by
regulation, the FDA has 90 days to review and issue a determination. As a practical matter, clearance often takes longer. The FDA may require additional information, including clinical data, to make a determination regarding substantial equivalence.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the FDA agrees that the device is substantially equivalent to a predicate device currently on the market, it will grant 510(k)
clearance to commercially market the device. If the FDA determines that the device is &#147;not substantially equivalent&#148; to a previously cleared device, the device is automatically designated as a Class&nbsp;III device. The device sponsor must
then fulfill more rigorous PMA requirements, or can request a risk-based classification determination for the device in accordance with the &#147;de novo&#148; process, which is a route to market for novel medical devices that are low to moderate
risk and are not substantially equivalent to a predicate device. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After a device receives 510(k) marketing clearance, any modification
that could significantly affect its safety or effectiveness, or that would constitute a major change or modification in its intended use, will require a new 510(k) marketing clearance or, depending on the modification, PMA approval. The
determination as to whether or not a modification could significantly affect the device&#146;s safety or effectiveness is initially left to the manufacturer using available FDA guidance. Many minor modifications today are accomplished by a
&#147;letter to file&#148; in which the manufacture documents the rationale for the change and why a new 510(k) is not required. However, the FDA may review such letters to file to evaluate the regulatory status of the modified product at any time
and may require the manufacturer to cease marketing and recall the modified device until 510(k) clearance or PMA approval is obtained. The manufacturer may also be subject to significant regulatory fines or penalties. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>PMA Approval </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A PMA must be
submitted to the FDA for any device that is classified in Class&nbsp;III or otherwise cannot be cleared through the 510(k) process (although the FDA has discretion to continue to allow certain <FONT STYLE="white-space:nowrap">pre-amendment</FONT>
Class&nbsp;III devices to use the 510(k) process). PMA applications must be supported by, among other things, valid scientific evidence demonstrating the safety and effectiveness of the device, which typically requires extensive
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">135 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
data, including technical, preclinical, clinical and manufacturing data. The PMA must also contain a full description of the device and its components, a full description of the methods,
facilities, and controls used for manufacturing, and proposed labeling. Following receipt of a PMA application, once the FDA determines that the application is sufficiently complete to permit a substantive review, the FDA will formally accept the
application for review. The FDA, by statute and by regulation, has <FONT STYLE="white-space:nowrap">180-days</FONT> to review an &#147;accepted&#148; PMA application, although the review of an application more often occurs over a significantly
longer period of time, and can take up to several years. During the review period, the FDA will typically request additional information or clarification of the information already provided. Also, an advisory panel of experts from outside the FDA
may be convened to review and evaluate the application and provide recommendations to the FDA as to the approvability of the device. The FDA may or may not accept the panel&#146;s recommendation. In addition, the FDA will generally conduct a <FONT
STYLE="white-space:nowrap">pre-approval</FONT> inspection of the manufacturing facility or facilities to ensure compliance with the QSR. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the FDA evaluations of both the PMA application and the manufacturing facilities are favorable, the FDA will either issue an approval
letter or an approvable letter, which usually contains a number of conditions that must be met in order to secure final approval of the PMA. If the FDA&#146;s evaluation of the PMA or manufacturing facilities is not favorable, the FDA will deny
approval of the PMA or issue a not approvable letter. A not approvable letter will outline the deficiencies in the application and, where practical, will identify what is necessary to make the PMA approvable. The FDA may also determine that
additional clinical trials are necessary, in which case the PMA approval may be delayed for several months or years while the trials are conducted. Once granted, PMA approval may be withdrawn by the FDA if compliance with post-approval requirements,
conditions of approval or other regulatory standards is not maintained or problems are identified following initial marketing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
approving a PMA the FDA may also require some form of post-market surveillance when necessary to protect the public health or to provide additional safety and effectiveness data for the device. In such cases, the manufacturer might be required to
follow certain patient groups for a number of years and makes periodic reports to the FDA on the clinical status of those patients. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">New
PMAs or PMA supplements are required for modifications that affect the safety or effectiveness of a <FONT STYLE="white-space:nowrap">PMA-approved</FONT> device, including, for example, certain types of modifications to the device&#146;s indication
for use, manufacturing process, labeling and design. PMA supplements often require submission of the same type of information as a PMA, except that the supplement is limited to information needed to support any changes from the device covered by the
original PMA and may not require as extensive clinical data or the convening of an advisory panel. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>De Novo Classification </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Medical device types that the FDA has not previously classified as Class&nbsp;I, II or III are automatically classified into Class&nbsp;III
regardless of the level of risk they pose. The Food and Drug Administration Modernization Act of 1997 established a new route to market for low to moderate risk medical devices that are automatically placed into Class&nbsp;III due to the absence of
a predicate device, called the &#147;Request for Evaluation of Automatic Class&nbsp;III Designation,&#148; or the <I>de novo</I> classification procedure. This procedure allows a manufacturer whose novel device is automatically classified into
Class&nbsp;III to request down-classification of its medical device into Class&nbsp;I or Class&nbsp;II on the basis that the device presents low or moderate risk, rather than requiring the submission and approval of a PMA application. Prior to the
enactment of the Food and Drug Administration Safety and Innovation Act of 2012, or the FDASIA, a medical device could only be eligible for <I>de novo</I> classification if the manufacturer first submitted a 510(k) premarket notification and
received a determination from the FDA that the device was not substantially equivalent. FDASIA streamlined the <I>de novo</I> classification pathway by permitting manufacturers to request <I>de novo</I> classification directly without first
submitting a 510(k) premarket notification to the FDA and receiving a not substantially equivalent determination. Under FDASIA, the FDA is required to classify the device within 120 days following receipt of the <I>de novo</I> application. If the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">136 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
manufacturer seeks reclassification into Class&nbsp;II, the manufacturer must include a draft proposal for special controls that are necessary to provide a reasonable assurance of the safety and
effectiveness of the medical device. In addition, the FDA may reject the reclassification petition if it identifies a legally marketed predicate device that would be appropriate for a 510(k) or determines that the device is not low to moderate risk
or that general controls would be inadequate to control the risks and special controls cannot be developed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In March 2014 we filed a <FONT
STYLE="white-space:nowrap">pre-submission</FONT> package with the FDA requesting a meeting to discuss the viability of using the <I>de novo</I> pathway to gain authorization to commercialize our gammaCore product for an initial indication in CH. In
June 2014, FDA met with us and confirmed that the <I>de novo</I> pathway would be appropriate for our submission. In October 2014 we filed our initial <I>de novo</I> application with FDA. As is customary for many applications for commercial approval
(Class II or Class&nbsp;III), FDA in a letter to us in May 2015 denied our initial application stating that our initial filing did not yet support a <I>de novo</I> clearance based on the information in the initial filing. In June 2015 we
participated in an in person meeting with FDA representatives to discuss the issues raised by the FDA in its May 2015 denial letter. In October 2015, based on our June 2015 meeting with FDA, we resubmitted our <I>de novo</I> application with two
proposed indications: (i)&nbsp;acute treatment of eCH; and (ii)&nbsp;prophylactic treatment of cCH. In February 2016, we received a letter from FDA indicating that our <I>de novo</I> application, with some further requested <FONT
STYLE="white-space:nowrap">re-analysis,</FONT> included sufficient data to support <I>de novo</I> classification and clearance of gammaCore for at least one indication. We performed and submitted to the FDA the requested <FONT
STYLE="white-space:nowrap">re-analysis</FONT> in March 2016 and, following additional correspondence and meetings with FDA, in April 2017, FDA approved our <I>de novo</I> classification request and cleared our gammaCore therapy in the United States
for the acute treatment of pain associated with eCH in adults. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on this approval, of our <I>de novo </I>classification request,
gammaCore has been down classified to Class&nbsp;II under a new Class&nbsp;II device regulatory category for <FONT STYLE="white-space:nowrap">non-invasive</FONT> cervical vagus nerve stimulators for the treatment of headache. The establishment of
this category created a 510(k) regulatory pathway for the potential expansion of the gammaCore label to include acute treatment and/or prevention of pain associated with migraine and cCH, as well as acute treatment and/or prevention of other primary
and secondary headaches. In January 2018, the FDA cleared gammaCore for acute treatment of pain associated with migraine headaches in adult patients, and we have conducted several additional clinical studies with a view to supporting additional
label expansion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, we anticipate utilizing the <I>de novo</I> classification process to obtain marketing authorization for
our product candidates under development outside the headache field. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Clinical Studies </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">When FDA clearance or approval of a Class&nbsp;I, Class&nbsp;II or Class&nbsp;III device requires human clinical trials, and if the device
presents a &#147;significant risk&#148; to human health, the device sponsor is required to file an IDE application with the FDA and obtain IDE approval prior to commencing the human clinical trial. If the device is considered a <FONT
STYLE="white-space:nowrap">&#147;non-significant</FONT> risk,&#148; IDE submission to FDA is not required. Instead, only approval from the Institutional Review Board, or IRB, overseeing the investigation at each clinical trial site is required.
Human clinical studies are generally required in connection with approval of Class&nbsp;III devices and may be required for Class&nbsp;I and II devices. The FDA or the IRB at each institution at which a clinical trial is being performed may suspend
a clinical trial at any time for various reasons, including a belief that the subjects are being exposed to an unacceptable health risk. Even if a trial is completed, the results of clinical testing may not adequately demonstrate the safety and
efficacy of the device or may otherwise not be sufficient to obtain FDA clearance or approval to market the product in the United States. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Continuing Regulation </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After a
device is placed on the market, numerous regulatory requirements apply. These&nbsp;include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Product listing and establishment registration, which helps facilitate FDA inspections and other regulatory action; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">137 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">QSR, which requires manufacturers, including third-party manufacturers, to follow stringent design, testing, control, documentation and other quality assurance procedures during all aspects of the design and
manufacturing process; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">labeling regulations and FDA prohibitions against the promotion of products for uncleared or unapproved <FONT STYLE="white-space:nowrap">&#147;off-label&#148;</FONT> uses; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">clearance of product modifications that could significantly affect safety or efficacy or that would constitute a major change in intended use of one of our cleared devices; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">approval of product modifications that affect the safety or effectiveness of one of our approved devices; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">medical device reporting regulations, which require that manufacturers comply with FDA requirements to report if their device may have caused or contributed to a death or serious injury, or has malfunctioned in a way
that would likely cause or contribute to a death or serious injury if the malfunction of the device or a similar device were to recur; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">post-approval restrictions or conditions, including post-approval study commitments; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">post-market surveillance regulations, which apply when necessary to protect the public health or to provide additional safety and effectiveness data for the device; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the FDA&#146;s recall authority, whereby it can ask, or under certain conditions order, device manufacturers to recall from the market a product that is in violation of governing laws and regulations; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">regulations pertaining to voluntary recalls; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">notices of corrections or removals. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Advertising and promotion of medical devices, in addition
to being regulated by the FDA, are also regulated by the Federal Trade Commission and by state regulatory and enforcement authorities. Recently, promotional activities for <FONT STYLE="white-space:nowrap">FDA-regulated</FONT> products of other
companies have been the subject of enforcement action brought under healthcare reimbursement laws and consumer protection statutes. In addition, under the federal Lanham Act and similar state laws, competitors and others can initiate litigation
relating to advertising claims. If the FDA determines that our promotional materials or training constitutes promotion of an unapproved or uncleared use, it could request that we modify our training or promotional materials or subject us to
regulatory or enforcement actions. It is also possible that other federal, state or foreign enforcement authorities might take action if they consider our promotional or training materials to constitute promotion of an unapproved or uncleared use,
which could result in significant fines or penalties under other statutory authorities, such as laws prohibiting false claims for reimbursement. In that event, our reputation could be damaged and adoption of the products would be impaired. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, our products could be subject to voluntary recall if we or the FDA determine, for any reason, that our products pose a risk of
injury or are otherwise defective. Moreover, the FDA can order a mandatory recall if there is a reasonable probability that our gammaCore therapy would cause serious adverse health consequences or death. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The FDA has broad post-market and regulatory enforcement powers. We are subject to unannounced inspections by the FDA to determine our
compliance with the QSR and other regulations, and these inspections may include the manufacturing facilities of some of our subcontractors. Failure by us or by our suppliers to comply with applicable regulatory requirements can result in
enforcement action by the FDA or other regulatory authorities, which may result in sanctions including, but not limited to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">untitled letters, warning letters, fines, injunctions, consent decrees and civil penalties; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">unanticipated expenditures to address or defend such actions </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">138 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">customer notifications for repair, replacement, refunds; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">recall, detention or seizure of our products; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">operating restrictions or partial suspension or total shutdown of production; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">refusing or delaying our requests for 510(k) clearance or PMA approval of new products or modified products; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">operating restrictions; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">withdrawing 510(k) clearances or PMA approvals that have already been granted; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">refusal to grant export approval for our products; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">criminal prosecution. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To date, our facility has not been inspected by the FDA. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>International </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our international
sales are subject to regulatory requirements in the countries in which our products are sold. The regulatory review process varies from country to country and may in some cases require the submission of clinical data. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have received CE Mark approval in Europe for our gammaCore therapy to treat, among other indications, primary headaches, including
migraines, and asthma. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the EEA, gammaCore must comply with the Essential Requirements laid down in Annex I to Directive 93/42/EEC on
the approximation of the laws of the Member States relating to medical devices or the EU Medical Devices Directive. Compliance with these requirements is a prerequisite to be able to affix the CE mark to gammaCore, without which they cannot be
marketed or sold in the EEA. To demonstrate compliance with the Essential Requirements and obtain the right to affix the CE Mark medical devices manufacturers must undergo a conformity assessment procedure, which varies according to the type of
medical device and its classification. Except for low risk medical devices (Class I with no measuring function and which are not sterile), where the manufacturer can issue an EC Declaration of Conformity based on a self-assessment of the conformity
of its products with the Essential Requirements, a conformity assessment procedure requires the intervention of a Notified Body, which is an organization designated by a competent authority of an EEA country to conduct conformity assessments.
Depending on the relevant conformity assessment procedure, the Notified Body would audit and examine the Technical File and the quality system for the manufacture, design and final inspection of the medical devices. The Notified Body issues a CE
Certificate of Conformity following successful completion of a conformity assessment procedure conducted in relation to the medical device and its manufacturer and their conformity with the Essential Requirements. This Certificate entitles the
manufacturer to affix the CE mark to its medical devices after having prepared and signed a related EC Declaration of Conformity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a
general rule, demonstration of conformity of medical devices and their manufacturers with the Essential Requirements must be based, among other things, on the evaluation of clinical data supporting the safety and performance of the products during
normal conditions of use. Specifically, a manufacturer must demonstrate that the device achieves its intended performance during normal conditions of use and that the known and foreseeable risks, and any adverse events, are minimized and acceptable
when weighed against the benefits of its intended performance, and that any claims made about the performance and safety of the device (e.g., product labeling and instructions for use) are supported by suitable evidence. This assessment must be
based on clinical data, which can be obtained from (1)&nbsp;clinical studies conducted on the devices being assessed, (2)&nbsp;scientific literature from similar devices whose equivalence with the assessed device can be demonstrated or (3)&nbsp;both
clinical studies and scientific literature. With respect to Class&nbsp;III devices, the manufacturer must conduct </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">139 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
clinical studies to obtain the required clinical data, unless reliance on existing clinical data from equivalent devices can be justified. The conduct of clinical studies in the EEA is governed
by detailed regulatory obligations. These may include the requirement of prior authorization by the competent authorities of the country in which the study takes place and the requirement to obtain a positive opinion from a competent Ethics
Committee. This process can be expensive and time-consuming. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Moreover, in May 2017, the EU Medical Devices Regulation (Regulation
2017/745) was adopted. The EU Medical Devices Regulation repeals and replaces the EU Medical Devices Directive. Unlike directives, which must be implemented into the national laws of the EEA Member States, the regulations would be directly
applicable, i.e., without the need for adoption of EEA Member State laws implementing them, in all EEA member States and are intended to eliminate current differences in the regulation of medical devices among EEA member States. The EU Medical
Devices Regulation, among other things, is intended to establish a uniform, transparent, predictable and sustainable regulatory framework across the EEA for medical devices and ensure a high level of safety and health while supporting innovation.
The EU Medical Devices Regulation will however only become applicable three years after publication (in May 2020). Once applicable, the new regulations will among other things: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">strengthen the rules on placing devices on the market and reinforce surveillance once they are available; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">establish explicit provisions on manufacturers&#146; responsibilities for the <FONT STYLE="white-space:nowrap">follow-up</FONT> of the quality, performance and safety of devices placed on the market; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">improve the traceability of medical devices throughout the supply chain to the <FONT STYLE="white-space:nowrap">end-user</FONT> or patient through a unique identification number; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">set up a central database to provide patients, healthcare professionals and the public with comprehensive information on products available in the EU; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">strengthened rules for the assessment of certain high-risk devices which may have to undergo an additional check by experts before they are placed on the market. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other Regulations </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are also
subject to healthcare fraud and abuse regulation in the jurisdictions in which we will conduct our business. These laws include, without limitation, applicable anti-kickback, false claims, physician sunshine and patient privacy and security laws and
regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Anti-Kickback Statute</I></B>:<I> </I>The federal Anti-Kickback Statute prohibits, among other things, persons or
entities from knowingly and willfully soliciting, offering, receiving or paying any remuneration, directly or indirectly, overtly or covertly, in cash or in kind, in exchange for or to induce either the referral of an individual for, or the
purchase, lease, order or recommendation of, any good, facility, item or service for which payment may be made, in whole or in part, under federal healthcare programs such as Medicare and Medicaid. The federal Anti-Kickback Statute is broad and
prohibits many arrangements and practices that are lawful in businesses outside of the healthcare industry. The term &#147;remuneration&#148; includes kickbacks, bribes, or rebates and also has been broadly interpreted to include anything of value,
including for example, gifts, discounts, the furnishing of supplies or equipment, credit arrangements, payments of cash, waivers of payments, ownership interests, relieving a referral source of a financial or administrative burden and providing
anything at less than its fair market value. In addition, longstanding OIG guidance makes clear that the opportunity for a referring physician to earn a profit, including through an investment in an entity for which he or she generates business,
could constitute illegal remuneration under the Anti-Kickback Statute. The Anti-Kickback Statute is violated if even one purpose of the remuneration is to induce such referrals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are a number of narrow statutory exceptions and regulatory safe harbors protecting certain defined business arrangements from
prosecution under the federal Anti-Kickback Statute. These statutory exceptions and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">140 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
safe harbors set forth provisions that, if all their applicable requirements are met, will assure healthcare providers and other parties that they may not be prosecuted under the federal
Anti-Kickback Statute. The failure of a transaction or arrangement to fit precisely within one or more applicable statutory exceptions or safe harbors does not necessarily mean that it is illegal or that prosecution will be pursued. However, conduct
and business arrangements that do not fully satisfy all requirements of an applicable safe harbor may result in increased scrutiny by government enforcement authorities and will be evaluated on a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">case-by-case</FONT></FONT> basis based on a cumulative review of all of its facts and circumstances. Further, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in
order to have committed a violation. In addition, the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the federal
civil False Claims Act which is discussed below. Penalties for violations of the Anti-Kickback Statute include, but are not limited to, civil monetary penalties up to $74,792 (and adjusted for inflation) for each violation, plus up to three times
the remuneration involved, criminal fines of up to $100,000 and imprisonment of up to 10 years, disgorgement, individual imprisonment, possible exclusion from Medicare, Medicaid and other federal healthcare programs, and the curtailment or
restructuring of operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that third-party payors require us to be a DME supplier or we sell our products directly to
providers who are DME suppliers that submit claims to such payors, we may be subject to the federal Stark physician self-referral law, which prohibits a physician from making a referral for certain designated health services covered by the Medicare
program, including DME, if the physician or an immediate family member has a financial relationship with the entity providing the designated health services, and prohibits that entity from billing or presenting a claim for the designated health
services furnished pursuant to the prohibited referral, unless an exception applies. Sanctions for violating the Stark Law include denial of payment, civil monetary penalties of up to $24,253 (and adjusted for inflation) per claim submitted and
exclusion from the federal health care programs. Failure to refund amounts received as a result of a prohibited referral on a timely basis may constitute a false or fraudulent claim and may result in civil penalties and additional penalties under
the FCA. The statute also provides for a penalty of up to $161,692 (and adjusted for inflation) for a circumvention scheme. Various states also have corollary laws to the Stark Law, including laws that require physicians to disclose any financial
interest they may have with a healthcare provider to their patients when referring patients to that provider. Both the scope and exceptions for such laws vary from state to state. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Federal Civil False Claims Act</I></B>: The federal civil False Claims Act prohibits, among other things, persons or entities from
knowingly presenting or causing to be presented a false or fraudulent claim for, or the knowing use of false statements to obtain, payment of federal funds. In addition, private individuals have the ability to bring actions under the civil False
Claims Act in the name of the government alleging false and fraudulent claims presented to or paid by the government (or other violations of the statutes) and to share in any amounts paid by the entity to the government in fines or settlement. Such
suits, known as qui tam actions, have increased significantly in the healthcare industry in recent years. Manufacturers can be held liable under these laws if they are deemed to &#147;cause&#148; the submission of false or fraudulent claims by, for
example, providing inaccurate billing or coding information to customers or promoting a product <FONT STYLE="white-space:nowrap">off-label.</FONT> Penalties for a federal civil False Claims Act violation include three times the actual damages
sustained by the government, plus mandatory civil penalties of between from $11,181 to $22,363 (and adjusted for inflation) for each false claim, plus treble damages, the potential for exclusion from participation in federal healthcare programs. The
majority of states also have statutes or regulations similar to the federal Anti-Kickback and False Claims Act, which apply to items and services reimbursed under Medicaid and other state programs, or, in several states, apply regardless of the
payor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Civil Monetary Penalties</I></B>. The Civil Monetary Penalty Act of 1981 imposes penalties against any person or entity
that, among other things, is determined to have presented or caused to be presented a claim to a federal healthcare program that the person knows or should know is for an item or service that was not provided as claimed or is false or fraudulent, or
offering or transferring remuneration to a federal healthcare beneficiary that a person knows or should know is likely to influence the beneficiary&#146;s decision to order or receive items or services reimbursable by the government from a
particular provider or supplier. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">141 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Federal Healthcare Fraud Laws</I></B>. Other federal healthcare fraud-related laws
also provide criminal liability for violations. The Criminal Healthcare Fraud statute (18 U.S.C. &#167; 1347) prohibits knowingly and willfully executing a scheme to defraud any healthcare benefit program, including private third-party payors.
Federal criminal law at 18 U.S.C. &#167; 1001, among other sections, prohibits knowingly and willfully falsifying, concealing, or covering up a material fact or making any materially false, fictitious, or fraudulent statement in connection with the
delivery of or payment for healthcare benefits, items, or services. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Health Insurance Portability and Accountability Act of
1996:</I></B> The federal Health Insurance Portability and Accountability Act, or HIPAA, created several new federal crimes, including healthcare fraud and false statements relating to healthcare matters. The healthcare fraud statute prohibits
knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program, including private third-party payors. The false statements statute prohibits knowingly and willfully falsifying, concealing or covering
up a material fact or making any materially false, fictitious or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items or services. Similar to the federal Anti-Kickback Statute, a person or entity does not
need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, HIPAA
and its implementing regulations established uniform standards for certain covered entities, which are healthcare providers, health plans and healthcare clearinghouses, as well as their business associates and subcontractors, governing the conduct
of specified electronic healthcare transactions and protecting the security and privacy of protected health information. HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, or HITECH created four new tiers of
civil monetary penalties and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce the federal HIPAA laws and seek attorneys&#146; fees and costs associated with pursuing federal
civil actions. Additionally, certain states have adopted comparable privacy and security laws and regulations, some of which may be more stringent than HIPAA and HITECH. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>The Federal Physician Payments Sunshine Act:</I></B> The federal Physician Payments Sunshine Act requires certain manufacturers of
drugs, devices, biologics and medical supplies for which payment is available under Medicare, Medicaid or the Children&#146;s Health Insurance Program, with certain exceptions, to report annually to the Centers for Medicare&nbsp;&amp; Medicaid
Services, or CMS, information related to &#147;payments or other transfers of value&#148; made to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals, and to report annually to CMS
certain ownership and investment interests held by physicians and their immediate family members. Failure to submit required information may result in civil monetary penalties of $11,052 per failure up to an aggregate of $165,786 per year (or up to
an aggregate of $1.105&nbsp;million per year for &#147;knowing failures&#148;), for all payments, transfers of value or ownership or investment interests that are not timely, accurately, and completely reported in an annual submission, and may
result in liability under other federal laws or regulations. Certain states also require device manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers or marketing
expenditures, require pharmaceutical companies to comply with the industry&#146;s voluntary compliance guidelines and the applicable compliance guidance promulgated by the U.S. federal government, or otherwise restrict payments that may be made to
healthcare providers and other potential referral sources. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>EU Data Protection Legislation:</I></B> We are subject to laws and
regulations in <FONT STYLE="white-space:nowrap">non-U.S.</FONT> countries covering data privacy and the protection of health-related and other personal information. EU member states and other jurisdictions have adopted data protection laws and
regulations, which impose significant compliance obligations. For example, the EU Data Protection Directive, as implemented into national laws by the EU member states, imposes strict obligations and restrictions on the ability to collect, analyze
and transfer personal data, including health data from clinical trials and adverse event reporting. Failing to comply with these laws could lead to government enforcement actions and significant penalties against us, and adversely impact our
operating results. The EU General Data Protection Regulation, or GDPR, will become applicable on May&nbsp;25, 2018 and will replace the EU Data Protection Directive. Unlike the Directive (which needed to be implemented
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">142 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
by national laws), the GDPR is directly applicable in each EU Member State, resulting in a more uniform application of data privacy laws across the EU. The GDPR imposes stricter requirements and
onerous accountability obligations on companies that process personal data, especially if they process sensitive personal data (such as data concerning health). Fines for <FONT STYLE="white-space:nowrap">non-compliance</FONT> with the GDPR will be
significant &#150; up to &#128;&nbsp;20&nbsp;million or 4% of global turnover, whichever is higher. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>The Foreign Corrupt Practices
Act:</I></B> The Foreign Corrupt Practices Act, or FCPA, prohibits any U.S.&nbsp;individual or business from paying, offering, or authorizing payment or offering of anything of value, directly or indirectly, to any foreign official, political party
or candidate for the purpose of influencing any act or decision of the foreign entity in order to assist the individual or business in obtaining or retaining business. The FCPA also obligates companies whose securities are listed in the United
States to comply with accounting provisions requiring the company to maintain books and records that accurately and fairly reflect all transactions of the corporation, including international subsidiaries, and to devise and maintain an adequate
system of internal accounting controls for international operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Healthcare Reform </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The United States and some foreign jurisdictions are considering or have enacted a number of legislative and regulatory proposals to change the
healthcare system in ways that could affect our ability to sell our products profitably. Among policy makers and payors in the United States and elsewhere, there is significant interest in promoting changes in healthcare systems with the stated
goals of containing healthcare costs, improving quality or expanding access. Current and future legislative proposals to further reform healthcare or reduce healthcare costs may limit coverage of or lower reimbursement for our products. The cost
containment measures that payors and providers are instituting and the effect of any healthcare reform initiative implemented in the future could impact our revenue from the sale of our products. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The implementation of the Affordable Care Act in the United States, for example, has changed healthcare financing and delivery by both
governmental and private insurers substantially, and affected medical device manufacturers significantly. The Affordable Care Act imposed, among other things, a new federal excise tax on the sale of certain medical devices, which, through a series
of legislative amendments, was suspended for 2016 through 2019, and which, absent further legislative action, will be reinstated on medical device sales starting January 1, 2020; provided incentives to programs that increase the federal
government&#146;s comparative effectiveness research, and implemented payment system reforms including a national pilot program on payment bundling to encourage hospitals, physicians and other providers to improve the coordination, quality and
efficiency of certain healthcare services through bundled payment models. Additionally, the Affordable Care Act has expanded eligibility criteria for Medicaid programs and created a new Patient-Centered Outcomes Research Institute to oversee,
identify priorities in, and conduct comparative clinical effectiveness research, along with funding for such research. We do not yet know the full impact that the Affordable Care Act will have on our business. There have been judicial and
Congressional challenges to certain aspects of the Affordable Care Act, and we expect additional challenges and amendments in the future. Moreover, the Trump Administration and the U.S. Congress may take further action regarding the Affordable Care
Act, including, but not limited to, repeal or replacement. Most recently, the Tax Cuts and Jobs Acts was enacted, which, among other things, removes penalties for not complying with the individual mandate to carry health insurance beginning in 2019.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, other legislative changes have been proposed and adopted since the Affordable Care Act was enacted. For example, the Budget
Control Act of 2011, among other things, included reductions to Medicare payments to providers of 2% per fiscal year, which went into effect on April&nbsp;1, 2013 and, due to subsequent legislative amendments to the statute, will remain in effect
through 2027 unless additional Congressional action is taken. Additionally, the American Taxpayer Relief Act of 2012, among other things, reduced Medicare payments to several providers, including hospitals, and increased the statute of limitations
period for the government to recover overpayments to providers from three to five years. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">143 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect additional state and federal healthcare reform measures to be adopted in the
future, any of which could limit the amounts that federal and state governments will pay for healthcare products and services, which could result in reduced demand for our products or additional pricing pressure. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Employees </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of May 21, 2018, we
employed 64 full-time employees. Substantially all of our employees are located in Basking Ridge, New Jersey. None of our employees are represented by a labor union or covered by a collective bargaining agreement. We consider our relationship with
our employees to be good. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Facilities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our principal offices occupy approximately 25,000 square feet of leased office space in Basking Ridge, New Jersey, pursuant to a lease
agreement that expires in April&nbsp;30, 2022. We believe that our current facilities are suitable and adequate to meet our current needs. We may in the future add new facilities or expand existing facilities as we add employees, and we believe that
suitable additional or substitute space will be available as needed to accommodate any such expansion of our operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Legal Proceedings </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From time to time we may become involved in various legal proceedings, including those that may arise in the ordinary course of business.
Although the outcomes of these legal proceedings cannot be predicted with certainty, other than as set forth below, we are not subject to any material legal proceedings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On May&nbsp;11, 2018, Madison Global Partners, a division of Trident Partners, Ltd., or Madison Global, filed a complaint against us in the
Supreme Court of the State of New York, County of New York (Index No.&nbsp;652329/2018). We are party to an engagement letter, as amended, with Madison Global pursuant to which it acted as our financial advisor. Madison Global has claimed that under
the terms of the engagement letter, as amended, it is owed $575,000 plus warrants to purchase additional shares of our capital stock beyond those we have agreed to issue to it. The Company believes it has paid all amounts due to Madison Global under
the terms of the engagement letter, as amended. While the Company believes that it has substantial legal and factual defenses to the claims in this lawsuit and intends to vigorously defend the case and may consider bringing counterclaims against
Madison Global, the outcome of the litigation is difficult to predict and quantify at this time. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Glossary </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>7nAChR&#148; refers to a receptor, specifically the alpha 7 nicotinic ACh receptor, that
resides on the surface of many cell types, including macrophages and microglia, the dominant immune cell of the brain. Activation of this receptor by neurotransmitters, including acetylcholine, has been shown to cause a change in the inflammation
state mediated by these cells, which has led to this immune modulatory pathway being referred to as &#147;the cholinergic anti-inflammatory pathway&#148;, or &#147;CAP&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;ACh&#148; means acetylcholine, which is a neurotransmitter released by certain neurons in the brain and by the vagus nerve. ACh is also
released by a class of immune cells in response to certain stimuli. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;CAP&#148; means the cholinergic anti-inflammatory pathway,
which is an autonomic reflex that inhibits the release of <FONT STYLE="white-space:nowrap">pro-inflammatory</FONT> proteins called cytokines involving signaling in the vagus nerve, the release of acetylcholine and the activation of alpha 7 nicotinic
ACh receptors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;CGRP&#148; means calcitonin gene&#150;related peptide, which is a protein produced by, and released by neurons. CGRP
activates other neurons that are involved in pain perception. CGRP is also known to be a powerful vasodilator, causing dilation of blood vessels. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">144 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;CH&#148; means cluster headache, which is a headache disorder in which patients
experience attacks of severe head pain, typically centered around the eye on one side, which occur from once every other day to eight times a day for a period that may last for a week, months or years. The attacks typically last 15 minutes to 180
minutes and the pain is typically associated tearing, eyelid dropping, sweating, congestion and/or runny nose. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;cCH&#148; means
chronic CH, which is a classification of CH defined by CH attacks occurring for more than one year without remission, or with remission periods lasting less than three months. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;CSD&#148; means cortical spreading depression, which is a slow moving, self-propagated wave of depolarization of neurons and glial cells
that spreads across the brain. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;eCH&#148; means episodic CH, which is a classification of CH defined by CH attacks occurring in
periods lasting from seven days to one year, separated by pain-free periods lasting at least three months. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;DAS&#148; means disease
activity score, which is an assessment used to measure rheumatoid arthritis (RA) disease activity, to determine whether the signs and symptoms have reduced or stopped, and if treatment needs to be adjusted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;DHE&#148; means dihydroergotamine, which is a medication indicated for medically refractory migraine headaches. Its therapeutic activity
has been attributed to activity against certain serotonin receptors, and has potent vasoconstricting effects on intracranial blood vessels. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;EEG&#148; means electroencephalography, which involves the measurement and recording of electrical activity in the brain. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;functional magnetic resonance imaging&#148; is an imaging technique that allows for, among other things, the measurement of brain
activity through the detection of changes in blood oxygenation and flow that occur in response to neuronal activity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;GABA&#148;
means gamma-aminobutyric acid, which is one of the primary inhibitory neurotransmitters in the brain. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">&#147;IL-1&szlig;&#147;means</FONT> interleukin-1 beta, which is a
<FONT STYLE="white-space:nowrap">pro-inflammatory</FONT> cytokine involved in immune responses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;LC&#148; means locus coeruleus,
which is a small region of the brainstem that is the sole source of norepinephrine in the brain. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;magnetoencephalography&#148; is an
imaging technique utilizing superconducting coils to measure the tiny magnetic fields generated by nerve activity within the brain from outside the skull. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;MTX&#148; means methotrexate, which is an immunosuppressive medication, originally used in oncology, and now used widely as a first line
treatment for rheumatoid arthritis (RA) and related inflammatory disorders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;nVNS&#148; means noninvasive vagus nerve stimulation,
which is a therapy employing the modulation of signals carried along certain fibers in the cervical vagus nerve which is achieved by the delivery of electric signals passed through the skin without physically penetrating the body. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;NRM&#148; means the nucleus raphe magnus, which is a structure in the brainstem that is a major component in the endogenous pain
inhibitory system and that produces and releases serotonin. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;PAG&#148; means the periaqueductal gray, which is a structure in the
brainstem that is a major component in the endogenous pain inhibitory system and that produces and releases the neurotransmitter GABA. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">145 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;PTH&#148; means post-traumatic headache, which is a headache condition resembling
migraine that results from a traumatic head injury. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;RA&#148; means rheumatoid arthritis, which is a common autoimmune disease
characterized by chronic joint inflammation leading to pain, swelling, and ultimately the degeneration of cartilage and bone within the affected joint. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;SN&#148; means the substantia nigra, which is a large midbrain structure that can be divided into two parts, one of which synthesizes
and releases a neurotransmitter called dopamine, and the other of which synthesizes and releases the neurotransmitter GABA neurons. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;SPG&#148; means sphenopalatine ganglion, which is a nerve bundle behind the bony structure of the nose that connects to the nerves in
and around the eye socket. Activity in the SPG has been associated with CH. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;TCC&#148; means the trigeminal cervical complex, which
is a region of the brainstem that serves as a primary center and relay for pain, having inputs known to be associated with the generation and perception of head pain. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;TNF-<FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>&#148; means tumor necrosis factor alpha, which is a
<FONT STYLE="white-space:nowrap">pro-inflammatory</FONT> protein, or cytokine, involved in inflammatory events, and is associated with both the initiation and conclusion of inflammatory processes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;VNS&#148; means vagus nerve stimulation, which is a therapy involving the triggering of signals within certain fibers of the vagus nerve
known to alter biologic function through the promotion of neurotransmitter release. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">146 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom472601_14"></A>MANAGEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the name, age as of June 1, 2018 and position of the individuals who currently serve as executive officers,
directors and key employees of Electrocore, LLC, and are expected to continue to serve as the executive officers, directors and key employees of electroCore, Inc. following the corporate conversion and the completion of this offering. The following
also includes certain information regarding the individual experience, qualifications, attributes and skills of our executive officers, directors and key employees, as well as brief statements of those aspects of our directors&#146; backgrounds that
led us to conclude that they are qualified to serve as directors. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="30%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="64%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:20.00pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Age</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:35.90pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Position(s)</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B></B><B><I>Executive officers</I></B><B>:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Francis R. Amato</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Executive Officer and Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph P. Errico</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Science and Strategy Officer and Chairman of the Board</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Peter S. Staats, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Medical Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Glenn S. Vraniak</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Financial Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B></B><B><I>Key employees:</I></B><B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Roland D. Duhart</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Commercial Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Eric J. Liebler</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Senior Vice President, Neurology</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven M. Mendez</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Technical Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael Romaniw</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Vice President, Quality Assurance</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bruce J. Simon, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Vice President, Research</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B></B><B><I><FONT STYLE="white-space:nowrap">Non-employee</FONT>
directors</I></B><B>:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael G. Atieh</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director Designee*</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nicholas Colucci</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Carrie S. Cox</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director and Chairman of the Board Designee*</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thomas J. Errico, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trevor J. Moody</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stephen L. Ondra, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director Designee*</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael W. Ross</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director**</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David M. Rubin, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director**</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James L.L. Tullis</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Will assume office as an independent director upon the effectiveness of the registration statement to which this prospectus is a part. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">**</TD>
<TD ALIGN="left" VALIGN="top">Will resign at or prior to the effectiveness of the registration statement to which this prospectus is a part. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Officers </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Francis R.
Amato</I></B><I> </I>has served as our Chief Executive Officer since July 2016, and as a member of our board of directors since June 2017. Mr.&nbsp;Amato previously served as our Chief Operating Officer from July 2012 through July 2016. Prior to
joining our company, he spent 22 years within the pharmaceutical industry, most recently as Vice President of the Specialty Commercial Operations Group, Global Human Health at Merck &amp; Co. Before joining Merck, Mr.&nbsp;Amato gained extensive
commercial experience as Executive Director, Global Business Operations at Schering-Plough, Business Unit Lead, Oncology at Ligand Pharmaceuticals, National Sales Director, Specialty Managed Markets at Pfizer Inc. and National Sales Director,
Hospitals at Pharmacia Corporation. Prior to joining the pharmaceutical industry, Mr.&nbsp;Amato was an Infantry Medic in the 82nd Airborne Division of the United States Army. Mr.&nbsp;Amato received his B.A. in Political Science from St.
John&#146;s University and his Executive MBA from Pepperdine University&#146;s Graziadio School of Management. Our board of directors believes that Mr.&nbsp;Amato&#146;s extensive senior management experience in the pharmaceutical industry qualifies
him for service on our board of directors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">147 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Joseph P. Errico</I></B><I> </I>has served as our Chief Science and Strategy Officer
since July 2016, and previously served as our Chief Executive Officer from January 2010 to July 2016. Mr.&nbsp;Errico has also served as a member of our board of directors since 2005, when he <FONT STYLE="white-space:nowrap">co-founded</FONT> our
company with Thomas J. Errico and Peter S. Staats, and as chairman of our board of directors since March 2013. Prior to founding our company, Mr.&nbsp;Errico served as the General Manager of the Motion Preservation Unit of Stryker Spine, a Division
of Stryker Corporation, from August 2004 through December 2007. Prior to that, Mr.&nbsp;Errico <FONT STYLE="white-space:nowrap">co-founded</FONT> and served as the Chief Executive Officer and director for Spinecore, Inc., from September 2001 through
August 2004, when that company was sold to Stryker Corporation. Mr.&nbsp;Errico received his B.S. in Aeronautical Engineering from the Massachusetts Institute of Technology, his M.S.&nbsp;in Mechanical Engineering and Materials Science from Duke
University School of Engineering and his J.D.&nbsp;from Duke University School of Law. Our board of directors believes that Mr.&nbsp;Errico&#146;s extensive senior management experience in innovative healthcare technology companies, and his
extensive knowledge and contributions to our company&#146;s intellectual property, products, business, and the science of VNS, qualify him to serve on our board of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Peter S. Staats, M.D.</I></B> has served as our Chief Medical Officer since May 2017. Dr. Staats also served as a member of our board of
directors from 2005, when he co-founded our company with Thomas J. Errico and Joseph P. Errico, until January 2018. Dr. Staats has also served as Chief Medical Officer of National Spine and Pain, LLC, the largest pain practice in the United States,
since May 2017. From December 2003 to July 2017, he held the roles of physician and a managing partner of Premier Pain Centers, LLC. Dr. Staats was also the founder of the division of pain medicine in the Department of Anesthesiology and Critical
Care Medicine at Johns Hopkins University, where he served as its director for years. He has served the non-profit Positive Outcomes Worldwide as founder and Chief Executive Officer since 2015. Dr. Staats was President of ASIPP, a national Physician
Advocacy Organization from 2015 to 2016 and President of the NJ Society of International Pain Physicians, a state Physician Advocacy Organization, from 2013 to 2015. He has served as President of the North American Neuromodulation Society from 2002
to 2003. He has served as Director for the World Institute of Pain since 2015 and is currently chairman of the board of examination for the WIP. Peter received his M.D. from the University of Michigan Medical School and completed his residency and
fellowship training at the Johns Hopkins University School of Medicine. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Glenn S. Vraniak </I></B>has served as our Chief Financial
Officer since August 2016. Prior to joining our company, from January&nbsp;2016 to August&nbsp;2016, Mr.&nbsp;Vraniak provided healthcare consulting services to private equity and healthcare companies as a principal of GSV Advisory Services, LLC.
From February 2014 to January 2016, Mr.&nbsp;Vraniak served as Chief Financial Officer at G&amp;W Laboratories, Inc., a specialty pharmaceutical company, where he executed the growth strategy by acquiring two companies and over 35 products. Prior to
that, from October 2011 through July 2013, he was President of Aprecia Pharmaceuticals, Inc., a 3D printing technology enabled pharmaceutical company. From 2003 through 2011, Mr.&nbsp;Vraniak was the CFO and Head of Strategic Planning for Prasco
Laboratories, a generic pharmaceutical company. From January 2000 to January 2002, he served as Executive VP for GE Capital, and subsequently founded Preceptus, a boutique consulting firm focused on helping small and
<FONT STYLE="white-space:nowrap">mid-market</FONT> companies achieve efficient and scalable growth in the healthcare and technology sectors. Mr.&nbsp;Vraniak received an Electronic Engineering Technology degree and a Managerial MBA in Finance from
the Rutgers University Center for Management Development. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other Key Employees </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Roland D. Duhart </I></B>has served as our Chief Commercial Officer since January 2018, and previously served as our Global Vice
President, Sales and Marketing since July 2016. Prior to joining our company, from February 2015 to June 2016, Mr.&nbsp;Duhart held the position of VP, Business Development at Publicis Touchpoint Solutions, a full-service healthcare
commercialization company. Previously, from December 2012 to January 2015, he served as Sr. VP, Business Development&nbsp;&amp; Client Services at VMS BioMarketing, a healthcare company. In addition, Mr.&nbsp;Duhart has led sales and marketing teams
with increasing scope of responsibility at Schering Plough, Pharmacia-Upjohn, Novartis, and Amylin. Mr.&nbsp;Duhart received his B.S. in Business Administration, Finance from California State University, Northridge. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">148 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Eric J. Liebler </I></B>has served as our Senior Vice President, Neurology since
January 2013. Prior to joining our company, Mr.&nbsp;Liebler served from January 2010 to December 2012 as President and member of the board of directors of Nautilus Neurosciences, a neurology-focused pharmaceutical company that he <FONT
STYLE="white-space:nowrap">co-founded</FONT> in 2009. At Nautilus, Mr.&nbsp;Liebler was involved in all facets of the organization and its early success, including initial funding, product commercialization, and sales and marketing. Prior to
founding Nautilus, Mr.&nbsp;Liebler served from September 2007 to December 2008 as Executive Vice President, Corporate Development at Pharmacopeia Inc. Prior to that, he served as Senior Vice President, Strategic Planning and Communication at
Questor Pharmaceuticals from August 2006 to September 2007. Mr.&nbsp;Liebler was Managing Partner of Nisola, LLC, a biopharmaceutical consulting firm, from November 2005 to September 2007. He served as Vice President, Business Development at Enzon
Pharmaceuticals from December 2002 to November 2005. Previously, Mr.&nbsp;Liebler served as President of Amarin Pharmaceuticals and spent more than 10 years with Elan Corporation and its predecessor Athena Neurosciences, where he served in a number
of increasingly senior roles in marketing, investor relations and strategic planning. He also previously served for more than 10 years on the Board of Trustees of the American Academy of Neurology Foundation, now the American Brain Foundation.
Mr.&nbsp;Liebler received his B.A.&nbsp;from Tufts University. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Steven M. Mendez </I></B>has served as our Chief Technical Officer
since July 2016, and previously served as Chief Science Officer from 2005 to 2016. Prior to joining our company, from 1998 to 2005, Mr.&nbsp;Mendez was Vice President at EBI, LLC, a subsidiary of Biomet Inc., where he was responsible for electronic,
bracing, and softgood products, in addition to overseeing the development of external and implantable electrical/thermal therapy medical devices. Prior to that, Mr.&nbsp;Mendez held engineering positions at Adaptive Instruments Corporation from 1995
to 1998, Walchem Corporation from 1990 to 1994, Wang Laboratories from 1986 to 1989, and United Technologies Corporation from 1983 to 1986. Mr.&nbsp;Mendez received his B.A. in Biology and B.S. in Electrical Engineering from Lehigh University and
his M.S. in Electrical Engineering from the Rensselaer Polytechnic Institute. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Michael Romaniw </I></B>has served as our Vice
President, Quality Assurance since January 2011. Prior to joining our company, Mr.&nbsp;Romaniw served as Director of Regulatory Compliance at EBI, LLC, a subsidiary of Biomet Inc. from May 2005 to January 2008, and again from June 2010 to December
2010. Between his periods employment at EBI, Mr.&nbsp;Romaniw held the position of Director of Quality Assurance&nbsp;&amp; Regulatory Compliance at Orthofix Spinal Implants, an affiliate of Blackstone Medical Inc., where he was responsible for
product quality control, quality engineering, supplier management, and product complaint handling, as well as the management of field actions and recalls. Prior to that, Mr.&nbsp;Romaniw held various roles relating to manufacturing, design and
development, and quality management at companies including Synthes, Sulzer Orthopedics, Kirschner Medical, and 3M Orthopedic Products. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Bruce J. Simon, Ph.D.</I></B> has served as our Vice President, Research since January 2008. Prior to joining our company,
Dr.&nbsp;Simon served as Senior Director of Research at EBI, LLC, a division of Biomet, Inc., from September 1991 to December 2007, where he directed research on the effects of electric and electromagnetic fields on bone, cartilage and soft tissue
repair. He has authored or <FONT STYLE="white-space:nowrap">co-authored</FONT> more than 60 peer-reviewed publications and has 40 issued or pending patents. Dr.&nbsp;Simon obtained a B.S. in Physics from the Massachusetts Institute of Technology and
a Ph.D. in Physiology and Biophysics from the University of Iowa. After completing his Ph.D., he spent several years as a Research Assistant Professor at the University of Maryland and then as an Assistant Professor at the University of Texas. His
research focused on various aspects of electrophysiology, including excitation-contraction coupling in muscle and biophysical modeling. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT
STYLE="white-space:nowrap">Non-employee</FONT> Directors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Michael G. Atieh </I></B>will assume service as a director upon
effectiveness of the registration statement to which this prospectus is a part. Since 1992, Mr. Atieh has served on the board of directors of Chubb Limited, a publicly traded global insurance company, where he chairs the audit committee and is a
member of the executive committee. From September 2014 until his retirement in March 2016, Mr. Atieh was Executive Vice President, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">149 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Chief Financial and Business Officer of Ophthotech Inc., a public biotechnology company. From February 2009 until its acquisition in February 2012, Mr. Atieh was Executive Chairman of Eyetech
Inc., a private specialty pharmaceutical company. He was Executive Vice President and Chief Financial Officer of OSI Pharmaceuticals, a public biotechnology company, from 2005 until December 2008. He also served as a member of the board of directors
of Theravance Biopharma, Inc. from June 2014 to April 2015, and as a member of the board of directors and chairman of the audit committee for OSI Pharmaceuticals from June 2003 to May 2005. Previously, Mr. Atieh served at Dendrite International,
Inc. as Group President from January 2002 to February 2004 and as Senior Vice President and Chief Financial Officer from October 2000 to December 2001. He also served as Vice President of U.S. Human Health, a division of Merck &amp; Co., Inc., from
January 1999 to September 2000, as Senior Vice President &#151; Merck-Medco Managed Care, L.L.C., an indirect wholly-owned subsidiary of Merck, from April 1994 to December 1998, as Vice President &#151; Public Affairs of Merck from January 1994 to
April 1994 and as Treasurer of Merck from April 1990 to December 1993. Mr. Atieh received his B.A. in Accounting and Finance from Upsala College in 1975. Mr. Atieh is qualified to serve on our board of directors because of his demonstrated
leadership in the biomedical field, including deep knowledge of sales and operations gained from over a decade of experience in these disciplines, as well as his knowledge of financial and financing matters, his current and prior board experience,
and his ability to serve as a financial expert on our audit committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Carrie S. Cox</I></B> will assume service as a director and
the Chairman of the board of directors upon effectiveness of the registration statement to which this prospectus is a part. Since 2010, Ms. Cox has served as the Chief Executive Officer of Humacyte, Inc., a regenerative medical technology company,
where she also holds the position of Chairman of the Board and is a member of its audit committee. Prior to serving as Chief Executive Officer of Humacyte, Inc., Ms. Cox served as Chairman of Prism Pharmaceuticals, which was sold to Baxter
Corporation in 2011. Ms. Cox was EVP and President, Global Pharmaceuticals, at Schering-Plough Corporation, from 2003 until its merger with Merck &amp; Co., Inc., in November 2009. Prior to joining Schering-Plough, Ms. Cox served as President of
Pharmacia Corporation&#146;s pharmaceutical business until its merger with Pfizer Inc. in 2003. Previously, Ms. Cox served as SVP of Global Business Management at Pharmacia &amp; Upjohn (the predecessor to Pharmacia), and as VP of Women&#146;s
Healthcare at Wyeth-Ayerst. She spent her early career at Sandoz pharmaceuticals (now Novartis) in a variety of commercial roles of increasing responsibility. Ms. Cox currently serves on the Boards of Directors of Texas Instruments, Cardinal Health,
and Celgene, and she has served as Lead Director for Texas Instruments. She received her B.S. from Massachusetts College of Pharmacy. Ms. Cox is qualified to serve on our board of directors by virtue of her distinguished career in global healthcare
and her significant experience and leadership serving in executive positions of some of the largest and most successful multi-national healthcare companies in the world, including with responsibility for those companies&#146; financial performance
and significant capital and research and development investments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Nicholas Colucci </I></B>has served on our board of directors
since August 2017. Since February 2018, Mr.&nbsp;Colucci has been Chairman of Publicis Health, a healthcare communications company. From May 2007 to January 2018, Mr. Colucci served as Chief Executive Officer of Publicis Health, and prior thereto,
held a variety of account, strategy and leadership roles at Publicis Health, beginning in 1997. Prior to that, Mr.&nbsp;Colucci served as Vice President of Marketing&nbsp;&amp; Sales at EyeSys Technologies (from 1995 to 1997) and as Marketing
Director at <FONT STYLE="white-space:nowrap">Hoffman-La</FONT> Roche (from 1982 to 1995). Mr.&nbsp;Colucci has also previously served on the boards of directors of SDI/Verispan, a healthcare market research company, and of National Rehab, a wound
care distribution company. Mr.&nbsp;Colucci received his B.S. in Neuroscience from the University of Rochester and his M.B.A. from Loyola University Maryland. Our board of directors believes that Mr.&nbsp;Colucci&#146;s background, with more than 30
years of experience across important life sciences and communications industries, qualifies him to serve on our board of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Thomas J. Errico, M.D.</I></B> has served on our board of directors since September 2005, when he
<FONT STYLE="white-space:nowrap">co-founded</FONT> the company with Joseph P. Errico and Peter S. Staats. Dr.&nbsp;Errico has been a board-certified orthopedic surgeon since 1986, and currently serves as the Chief of Division of Spine Surgery in
Orthopedics for NYU Langone Health, a position he has held since 1997. He is also currently a Professor of Orthopedic and Neurologic Surgery </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">150 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in the NYU School of Medicine. In addition, Dr.&nbsp;Errico is a member of the International Society for the Advancement of Spine Surgery, and served as its President from 2010 to 2011. He is
also an original member of the North American Spine Society, and served as its President from 2003 to 2004. Dr.&nbsp;Errico has founded multiple companies in the healthcare industry, including Spinecore, Inc. in 2002, where he served as a director
until it was sold to Stryker, Inc. in 2004. Dr.&nbsp;Errico was also a founding member of K2M Group Holdings, Inc. in January 2004. Dr.&nbsp;Errico holds a B.S. in Zoology from Rutgers University and an M.D. from Rutgers Medical School, formerly the
University of Medicine and Dentistry of New Jersey. Our board of directors believes Dr.&nbsp;Errico is qualified to serve on our board of directors due to his long tenure as a practicing spine-surgeon and his leadership role with a world class
academic medical institution, as well as serving as a <FONT STYLE="white-space:nowrap">co-founder,</FONT> director and investor in a number of successful early stage healthcare companies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Trevor J. Moody </I></B>has served on our board of directors since March 2013. Mr.&nbsp;Moody has served since January 2010 as President
of TM Strategic Advisors LLC, a management consultancy serving the boards, investors, and senior management of both emerging and established medical technology companies. He also currently serves as Medical Device Partner at MH Carnegie&nbsp;&amp;
Co. Pty Ltd (since October 2013), where he makes venture capital investments in medical device companies. From July 2015 to December 2015, Mr.&nbsp;Moody served as interim CEO of a MH Carnegie&nbsp;&amp; Co. portfolio company, Cardiac Dimensions Pty
Ltd. From 1999 to 2010, Mr.&nbsp;Moody was at Frazier Healthcare Ventures, a large healthcare-focused venture capital and private equity investment firm. He was a General Partner at Frazier Healthcare Ventures from 2005 to 2010. Prior to that, he
was a Senior Consultant at The Wilkerson Group, a leading healthcare strategic consultancy. Mr.&nbsp;Moody currently also serves on the board of trustees of a <FONT STYLE="white-space:nowrap">non-profit</FONT> called the Center for Infectious
Disease Research, and on the boards of several private corporations, including EBR Systems, Inc., Renew Medical Pty Ltd, Serene Medical Pty Ltd, Brain Protection Company Pty Ltd and Simplify Medical Pty Ltd. Mr.&nbsp;Moody received his B.S. in
Engineering from the University of Southern Queensland, Australia, and his M.S. in Management from the Massachusetts Institute of Technology (Sloan School). Our board of directors believes that Mr.&nbsp;Moody&#146;s experience, with over 25 years in
the development, commercialization and funding of innovative, growth-oriented medical technologies, qualifies him to serve on our board of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Stephen L. Ondra, M.D.</I></B> will assume service as a director upon effectiveness of the registration statement to which this
prospectus is a part. Dr.&nbsp;Ondra is Chief Executive Officer of North Star Healthcare Consulting, a healthcare technology consulting company that he founded in 2017. From 2013 to 2016, Dr.&nbsp;Ondra served as Senior Vice President and Chief
Medical Officer of Health Care Service Corporation, the largest customer-owned health insurance company in the United States, which operates as Blue Cross and Blue Shield in Illinois, Montana, New Mexico, Oklahoma and Texas.&nbsp;Prior to his move
to the payer sector, from 2012 to 2013, Dr.&nbsp;Ondra served as Senior Vice President and Chief Medical Officer of Northwestern Memorial Hospital.&nbsp;Dr.&nbsp;Ondra had left Northwestern in 2009 when he was appointed by President Obama as the
Senior Policy Advisor for Health Affairs of the U.S. Department of Veterans Affairs. He was detailed to the Executive Office of the President of the United States from 2010 to 2012. At the White House, he served in several positions, including <FONT
STYLE="white-space:nowrap">Co-Chair</FONT> of the National Science and Technology Council for Health Information Technology, as a member of the Federal Health Information Technology Policy and Standards Committees, and as a member of the
Implementation Deputy Group for the Affordable Care Act. In 2015, Dr.&nbsp;Ondra was appointed to be a member of the Guiding Committee of the Department of Health and Human Services Health Care Payment &#151; Learning and Action Network. He also has
served as an adjunct senior fellow at the Center for a New American Society from 2015 to 2018. A Board Certified Neurosurgeon, Dr.&nbsp;Ondra was a Professor of Neurosurgery and Residency Program Director at Northwestern University&#146;s Feinberg
School of Medicine from 1996 to 2009. He has also served as the interim chair of Neurological Surgery at Northwestern.&nbsp;Dr.&nbsp;Ondra is a Trustee of Illinois Wesleyan University and has served on the board of TriWest Healthcare Alliance, the
Louis W. Sullivan Institute for Healthcare Transformation, and was Chair of the scientific advisory boards of the Defense Spinal Cord/Column Injury and the Spine Blast Injury of the Department of Defense. Dr.&nbsp;Ondra attended the U.S. Military
Academy and completed <FONT STYLE="white-space:nowrap">pre-medical</FONT> studies at Illinois Wesleyan University, obtaining his B.A. He then received his M.D. from Rush Medical College in Chicago and subsequently completed residency training in
Neurosurgery at the Walter Reed Army Medical Center in Washington D.C. As </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">151 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
an U.S. Army physician, Dr.&nbsp;Ondra served with distinction in Operations Desert Shield and Desert Storm and was awarded Bronze Star and Army Commendation Medals. We believe Dr.&nbsp;Ondra is
qualified to serve on our board due to his expertise and achievements in medicine, medical policy, health information technology and innovation, as well as his keen understanding of healthcare policy and complex healthcare delivery systems, which
has made him a source of counsel for numerous CEOs, health care executives and policymakers in the United States and internationally. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Michael W. Ross </I></B>has served on our board of directors since March 2018. Since October 2016, Mr. Ross has served on the board of
directors of Fresco Foods Inc., a company in the food and beverage industry. Mr. Ross has worked for the Vinik Family Office since September 2017, directing the financial and operating strategies of private equity portfolio companies. Prior to his
role with the Vinik Family Office, from January 2004 to August 2017, Mr. Ross independently provided strategic and financial consulting and executive management to various small to mid-size companies. During his employment with Publix Super Markets,
Inc. from 2000 to 2005, he held the position of manager of business analysis, providing analytical support to corporate strategy initiatives. From March 2013 to May 2016, he served as a strategy consultant and CFO to JJ Virgin &amp; Associates, a
nutrition, health and wellness company. From January 2014 to June 2014, Mr. Ross acted as CEO of Thunderbolt International, Inc., a company engaged in the design, manufacture, and sale of specialized electronics. Mr. Ross obtained a B.S. in
mechanical engineering from Case Western Reserve University and his MBA in finance, MIS, and Marketing Strategy from the University of South Florida. Our board of directors believes that Mr. Ross&#146; background and experience as a CEO and CFO of
various companies qualifies him to serve on our board of directors. Mr. Ross will resign from our board at or prior to the effectiveness of the registration statement to which this prospectus is a part. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>David M. Rubin, Ph.D. </I></B>has served as a member of our board of directors since March 2013. Dr.&nbsp;Rubin is currently a managing
director at GHI, where he is responsible for identifying investment opportunities in emerging health care solutions and services, with a particular emphasis on oncology and infectious disease digital health. Prior to joining GHI, Dr.&nbsp;Rubin was
portfolio director for Merck&nbsp;&amp; Co.&#146;s MRL Oncology franchise. Dr.&nbsp;Rubin joined Merck in 2007 from Cognia Corporation, a venture-backed research and development software and content products company, where he was the president and
chief executive officer. Previously, Dr.&nbsp;Rubin was at The Wilkerson Group/IBM Global Services. Dr.&nbsp;Rubin previously served on the board of VirtualScopics, Inc. (Nasdaq: VSCP) from 2012 through 2014. Dr.&nbsp;Rubin currently serves on the
boards of directors of OpGen, Inc., (Nasdaq: OPGN) and Navigating Cancer, Inc. Dr.&nbsp;Rubin was a National Institute of Health and American Cancer Society post-doctoral fellow at Harvard Medical School. Dr.&nbsp;Rubin also received training in
post graduate business at Harvard University. Dr.&nbsp;Rubin holds a Ph.D.&nbsp;from Temple University in Molecular Biology and a B.A. from SUNY Binghamton in Biology. Dr.&nbsp;Rubin&#146;s extensive background working with precision medicine and
diagnostic companies, his investing experience, his current executive position with Merck GHI and scientific background qualify Dr.&nbsp;Rubin to serve on to our board of directors. Dr. Rubin will resign from our board at or prior to the
effectiveness of the registration statement to which this prospectus is a part. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>James L.L. Tullis </I></B>has served as a member of
our board of directors since July 2014. Mr.&nbsp;Tullis founded Tullis Health Investors, a venture capital firm specializing in investments in the healthcare industry, in 1986, and has served as its Chief Executive Officer since its inception. Prior
to that, Mr.&nbsp;Tullis was a Senior Vice President at E.F.&nbsp;Hutton&nbsp;&amp; Co., a stock brokerage firm, and a principal at Morgan Stanley&nbsp;&amp; Co., where he worked with the healthcare investment research and banking teams.
Mr.&nbsp;Tullis has served as a member of the board of directors since 2006, and as chairman of the board of directors, since 2017, of Lord Abbett Mutual Funds. Since 1998, he has also served as a member of the board of directors of Crane Co., an
industrial products manufacturing company. Since March 2018, Mr. Tullis has been a member of the board of directors of ATEC Spine, a provider of spine surgery solutions. Mr.&nbsp;Tullis also currently serves as a member of the board of directors of
several private companies, including LivHOME, Inc., an <FONT STYLE="white-space:nowrap">at-home</FONT> senior care company, SupplyPro, Inc., an inventory management solutions company, and Exagen Diagnostics, Inc., a diagnostics company focused on
autoimmune rheumatic diseases. Mr.&nbsp;Tullis holds a B.A. from Stanford University and an M.B.A. from Harvard Business School. Mr.&nbsp;Tullis&#146; extensive experience serving as a venture capitalist and board member for
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">152 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
numerous companies in the health care industry contributed to our board of directors&#146; conclusion that Mr.&nbsp;Tullis should serve as a director of our company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Composition </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors
currently consists of eight members. The current members of our board of directors have been designated pursuant to the Operating Agreement. The Operating Agreement provides (subject to certain conditions and qualifications specified therein
relating to securities ownership and otherwise) that our board is composed of: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">one director designated by each of our founding investors, Joseph P. Errico, Dr.&nbsp;Thomas&nbsp;J. Errico, and Kathryn K. Theofilos, two of such seats being filled by Joseph&nbsp;P. Errico and Dr.&nbsp;Thomas&nbsp;J.
Errico and one seat being vacant; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">one director designated by Merck GHI, for which Dr.&nbsp;David&nbsp;M. Rubin has been designated; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">one director designated by Core Ventures II, LLC, for which Nicholas Colucci has been designated; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">one director designated by AIH-Electro, LLC, for which Michael W. Ross has been designated; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">three other directors designated by the holders of a majority of our outstanding membership units, who have designated Francis R. Amato, Trevor J. Moody and James L.L. Tullis. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Operating Agreement will terminate upon the completion of the corporate conversion and, thereafter, our directors will be elected by the
vote of our common stockholders. Under our bylaws to be effective upon the completion of the corporate conversion, the number of directors will be determined from time to time by our board of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of the current members of our board of directors other than Michael W. Ross and David M.&nbsp;Rubin, Ph.D., is expected to serve as a
director following the corporate conversion and completion of this offering. Each of Michael G. Atieh, Carrie S. Cox and Stephen L. Ondra will assume service as a director upon effectiveness of the registration statement to which this prospectus is
a part. At such time, Carrie S. Cox will assume the role of Chairman of our board of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are no family relationships among
any of our directors and executive officers, except that Dr.&nbsp;Thomas J.&nbsp;Errico is the uncle of Joseph P. Errico. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Classified Board of
Directors </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with our certificate of incorporation to be effective upon the completion of the corporate conversion, our
board of directors will be divided into three classes with staggered, three-year terms. At each annual meeting of stockholders, the successors to directors whose terms then expire will be elected to serve from the time of election and qualification
until the third annual meeting following their election. Effective upon the consummation of this offering, we expect that our directors will be divided among the three classes as follows: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the Class&nbsp;I directors will be Michael G. Atieh, Stephen L. Ondra, M.D., and Francis R. Amato, and their terms will expire at our first annual meeting of stockholders following this offering; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the Class&nbsp;II directors will be Trevor J. Moody, James L.L. Tullis, and Joseph P. Errico, and their terms will expire at our second annual meeting of stockholders following this offering; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the Class&nbsp;III directors will be Nicholas Colucci, Carrie S. Cox, and Thomas J. Errico, M.D., and their terms will expire at our third annual meeting of stockholders following this offering. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to our certificate of incorporation to be effective upon the completion of the corporate conversion, only our board of directors will
be able to fill vacancies on our board of directors until the next succeeding </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">153 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
annual meeting of stockholders. Any additional directorships resulting from an increase in the number of directors will be distributed among the three classes so that, as nearly as possible, each
class will consist of <FONT STYLE="white-space:nowrap">one-third</FONT> of the directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The classification of our board of directors
may have the effect of delaying or preventing changes in our control or management. See &#147;Description of Capital Stock &#151; Anti-Takeover Provisions &#151; Our Certificate of Incorporation and Bylaws.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Director Independence </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
connection with this offering, we have applied to list our common stock on The Nasdaq Global Select Market, or Nasdaq. Under Nasdaq rules, independent directors must comprise a majority of our board of directors within a specified period of the
completion of this offering. In addition, Nasdaq rules require that, subject to specified exceptions, each member of a listed company&#146;s audit, compensation and nominating and governance committees be independent. Under Nasdaq rules, a director
will only qualify as an &#147;independent director&#148; if, in the opinion of that company&#146;s board of directors, that person does not have a relationship that would interfere with the exercise of independent judgment in carrying out the
responsibilities of a director. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Audit committee members must also satisfy the independence criteria set forth in <FONT
STYLE="white-space:nowrap">Rule&nbsp;10A-3</FONT> under the Exchange Act. In order to be considered independent for purposes of <FONT STYLE="white-space:nowrap">Rule&nbsp;10A-3,</FONT> a member of an audit committee of a listed company may not,
other than in his or her capacity as a member of the audit committee, the board of directors or any other board committee: (i)&nbsp;accept, directly or indirectly, any consulting, advisory or other compensatory fee from the listed company or any of
its subsidiaries; or (ii)&nbsp;be an affiliated person of the listed company or any of its subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors has
undertaken a review of the independence of each director and considered whether each director has a material relationship with us that could compromise his ability to exercise independent judgment in carrying out his responsibilities. As a result of
this review, our board of directors has determined that each of our directors other than Messrs.&nbsp;Amato and Joseph P. Errico, are &#147;independent directors&#148; as defined under the applicable rules and regulations of the SEC, and the listing
requirements and rules of Nasdaq. In making these determinations, our board of directors has reviewed and discussed information provided by the directors and us with regard to each director&#146;s business and personal activities and relationships
as they may relate to us and our management, including the beneficial ownership of our capital stock by each <FONT STYLE="white-space:nowrap">non-employee</FONT> director and the transactions involving them described in the section entitled
&#147;Certain Relationships and Related-Party Transactions.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Audit Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Effective as of the date the registration statement of which this prospectus is part is declared effective, we will establish an audit
committee to consist of Michael G.&nbsp;Atieh, Carrie S. Cox, and James L.L. Tullis, with Mr. Atieh serving as chairman. Our board of directors has affirmatively determined that each member of the audit committee meets the definition of
&#147;independent director&#148; for purposes of the rules and the independence requirements of <FONT STYLE="white-space:nowrap">Rule&nbsp;10A-3</FONT> of the Exchange Act. Our board of directors will also determine which member qualifies as an
&#147;audit committee financial expert&#148; under SEC rules and regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our audit committee will be responsible for, among other
matters: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">appointing, compensating, retaining, evaluating, terminating and overseeing our independent registered public accounting firm; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">discussing with our independent registered public accounting firm their independence from management; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing with our independent registered public accounting firm the scope and results of their audit; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">154 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">approving all audit and permissible <FONT STYLE="white-space:nowrap">non-audit</FONT> services to be performed by our independent registered public accounting firm; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">overseeing the financial reporting process and discussing with management and our independent registered public accounting firm the interim and annual financial statements that we file with the Securities and Exchange
Commission; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing and monitoring our accounting principles, accounting policies, financial and accounting controls and compliance with legal and regulatory requirements; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">establishing procedures for the confidential anonymous submission of concerns regarding questionable accounting, internal control or auditing matters; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing and approving related person transactions. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors has adopted a
written charter for the audit committee, which will be available on our website. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Compensation Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Effective as of the date the registration statement of which this prospectus is part is declared effective, we will reconstitute our
compensation committee to consist of Nicholas Colucci, Thomas J. Errico, M.D., and Trevor J. Moody, with Mr. Colucci serving as chairman. Our board of directors has affirmatively determined that each member of the reconstituted compensation
committee meets the heightened definition of &#147;independent director&#148; for purposes of the Nasdaq rules applicable to members of the compensation committee, and the definition of <FONT STYLE="white-space:nowrap">&#147;non-employee</FONT>
director&#148; for purposes of Section&nbsp;16 of the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The compensation committee will be responsible for, among other
matters: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">establishing and approving, and making recommendations to the board of directors regarding, performance goals and objectives relevant to the compensation of our chief executive officer, evaluating the performance of our
chief executive officer in light of those goals and objectives and recommending to the full board of directors for approval, the chief executive officer&#146;s compensation, including incentive-based and equity-based compensation, based on that
evaluation; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">setting the compensation of our other executive officers, based in part on recommendations of the chief executive officer; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing and approving, and making recommendations to the board of directors regarding, employment agreements, severance arrangements and change of control agreements for the chief executive officer and other executive
officers, as appropriate; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">exercising administrative authority under our stock plans and employee benefit plans; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">establishing policies and making recommendations to our board of directors regarding director compensation; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing compensation plans, programs and policies; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">handling such other matters that are specifically delegated to the compensation committee by the board of directors from time to time. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors has adopted a written charter for the compensation committee, which will be available on our website. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Nominating and Governance Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Effective as of the date the registration statement of which this prospectus is part is declared effective, we will establish a nominating and
governance committee to consist of Nicholas Colucci, Thomas J. Errico, M.D., and Stephen L. Ondra, M.D., with Dr. Errico serving as chairman. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">155 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The nominating and governance committee will be responsible for, among other matters: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">annually reviewing the list of director selection criteria contained in our corporate governance necessary or appropriate changes thereto; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">identifying, reviewing and evaluating candidates, including candidates submitted by stockholders, for election to our board of directors and recommending to our board of directors (i)&nbsp;nominees to fill vacancies or
new positions on our board of directors and (ii)&nbsp;the slate of nominees to stand for election by our stockholders at each annual meeting of stockholders; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">annually recommending to our board of directors (i)&nbsp;the assignment of directors to serve on each committee; (ii)&nbsp;the chairperson of each committee and (iii)&nbsp;the chairperson of our board of directors or
lead independent director, as appropriate; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">developing, recommending, overseeing the implementation of and monitoring compliance with, our corporate governance guidelines, and periodically reviewing and recommending any necessary or appropriate changes to our
corporate governance guidelines; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing the adequacy of our certificate of incorporation and bylaws and recommending to our board of directors, as conditions dictate, amendments for consideration by the stockholders; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing our code of business conduct and ethics and recommending any changes to our board of directors; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">such other matters as directed by our board of directors. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors has adopted
a written charter for the nominating and governance committee, which will be available on our website. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Role of the Board of Directors in Risk
Oversight </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">One of the key functions of our board of directors is informed oversight of our risk management process. The board of
directors does not have a standing risk management committee, but rather administers this oversight function directly through the board of directors as a whole, as well as through various standing committees of our board of directors that address
risks inherent in their respective areas of oversight. In particular, our board of directors is responsible for monitoring and assessing strategic risk exposure and following this offering our audit committee will have the responsibility to consider
and discuss our major financial risk exposures and the steps our management has taken to monitor and control these exposures, including guidelines and policies to govern the process by which risk assessment and management is undertaken. The
nominating and governance committee will monitor compliance with legal and regulatory requirements and the effectiveness of our corporate governance practices, including whether they are successful in preventing illegal or improper
liability-creating conduct. Our nominating and governance committee will also be responsible for overseeing our risk management efforts generally, including the allocation of risk management functions among our board of directors and its committees.
Our compensation committee will assess and monitor whether any of our compensation policies and programs has the potential to encourage excessive risk-taking. Our audit committee will periodically review the general process for the oversight of risk
management by our board of directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation Committee Interlocks and Insider Participation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of the effectiveness of the registration statement to which this prospectus is a part, none of the members of our compensation committee
will have been at any time during the prior three years one of our officers or employees. As of such effectiveness, none of our executive officers will serve, or have served in the past fiscal year, as a member of the board of directors or
compensation committee of any third party that has one or more executive officers serving on our board of directors or compensation committee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">156 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Code of Business Conduct&nbsp;and Ethics </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the effectiveness of the registration statement to which this prospectus is a part, we will adopt a written code of business conduct
and ethics that applies to our directors, officers and employees, including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. A copy of the code will be
posted on our website, which is located at <I>www.electrocore.com</I>. If we make any substantive amendments to, or grant any waivers from, the code of business conduct and ethics for any officer or director, we will disclose the nature of such
amendment or waiver on our website or in a current report on Form <FONT STYLE="white-space:nowrap">8-K.</FONT> We do not incorporate the information on or accessible through our website into this prospectus, and you should not consider any
information on, or that can be accessed through, our website as part of this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">157 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom472601_15"></A>EXECUTIVE AND DIRECTOR COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Compensation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This section
discusses the material components of the executive compensation program offered to our named executive officers and our Chief Financial Officer, whom we refer to as our &#147;NEOs.&#148; For 2017, our NEOs were: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Francis R. Amato, Chief Executive Officer, Director; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Joseph P. Errico, Chief Science and Strategy Officer, Director; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Peter S. Staats, M.D., Chief Medical Officer; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Glenn S. Vraniak, Chief Financial Officer. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This discussion may contain forward-looking
statements that are based on our current plans, considerations, expectations and determinations regarding future compensation programs. Actual compensation programs that we adopt following the closing of this offering may differ materially from the
currently planned programs summarized in this discussion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are an &#147;emerging growth company,&#148; within the meaning of the JOBS
Act, and have elected to comply with the reduced compensation disclosure requirements available to emerging growth companies under the JOBS Act. See &#147;Prospectus Summary &#151; Implications of Being an Emerging Growth Company.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2017 Summary Compensation Table </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; width:97.90pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name and Principal Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Salary&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Bonus<BR>($)(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Option</B><br><B>Awards<BR>($)(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Non-equity<BR>incentive plan<BR>compensation&nbsp;($)(3)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>All Other<BR>Compensation&nbsp;($)(4)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Total&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Francis R. Amato</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">400,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">156,469</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">125,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,369</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">767,838</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; font-size:10pt; font-family:Times New Roman"><I>Chief Executive Officer, Director</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph P. Errico</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">350,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">104,838</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,369</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">541,207</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; font-size:10pt; font-family:Times New Roman"><I>Chief Science&nbsp;&amp; Strategy Officer, Director</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Peter S. Staats, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">151,667</TD>
<TD NOWRAP VALIGN="bottom">(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,820</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">198,487</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; font-size:10pt; font-family:Times New Roman"><I>Chief Medical Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Glenn S. Vraniak</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">300,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52,419</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,369</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">403,778</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; font-size:10pt; font-family:Times New Roman"><I>Chief Financial Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Represents discretionary cash bonuses approved by the compensation committee of our board of directors for performance during 2017. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Represents the grant date fair value of Common Units issued as Profits Interests in Electrocore, LLC computed in accordance with FASB ASC 718. See Note 13 to the consolidated financial statements for the fiscal year
ended December&nbsp;31, 2017 included with this prospectus for a description of the assumptions used in valuing our Common Units. These Common Units are intended to constitute profits interests for U.S. federal income tax purposes. Despite the fact
that the Common Units that are intended to constitute Profits Interests do not require the payment of an exercise price, for purposes of this table we believe they are most similar economically to stock options and are properly classified as
&#147;options&#148; under the definition provided in Item 402(a)(6)(i) of Regulation S-K as an instrument with an &#147;option-like feature.&#148; </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">Represents a contingent cash bonus paid to Mr. Amato following receipt by us of the FDA grant of our <I>de novo</I> application and the closing of our Series B Preferred Unit financing, as discussed below under
&#147;&#151;&nbsp;Narrative Disclosure to Summary Compensation Table.&#148; </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">These amounts consist of payments of health care premiums and contributions to health savings accounts on behalf of the NEO. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">158 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top">Represents a prorated amount of base salary earned by Dr.&nbsp;Staats beginning upon his commencement of employment on May&nbsp;1, 2017. Pursuant to his employment agreement, Dr.&nbsp;Staats was entitled to an annual
base salary of $140,000 for the three calendar months beginning May&nbsp;1, 2017, and an annual base salary of $280,000 beginning August 1, 2017. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Narrative Disclosure to Summary Compensation Table </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The primary elements of compensation for our NEOs are base salary, annual discretionary bonuses, performance bonuses and equity compensation
awards. The NEOs also participate in employee benefit plans and programs that we offer to our other full-time employees on the same basis. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Base
Salaries </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We pay our NEOs a base salary to compensate them for the satisfactory performance of services rendered to us. The base
salary payable to each NEO is intended to provide a fixed component of compensation reflecting the executive&#146;s skill set, experience, role and responsibilities. Base salaries for our NEOs have generally been set at levels deemed necessary to
attract and retain individuals with superior talent. No changes to the base salaries of our NEOs occurred for 2017. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Performance Bonuses
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We offer our NEOs the opportunity to earn annual discretionary cash bonuses, as determined by our board of directors or the
compensation committee annually at their discretion. Actual bonus amounts for our NEOs are determined by our compensation committee after consideration of Mr.&nbsp;Amato and Mr.&nbsp;Errico&#146;s recommendations (except with respect to their
individual bonuses). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For 2017, annual bonuses were based on such factors as the board and the compensation committee deemed appropriate,
including the FDA grant of our <I>de novo</I> approval, successful completion of our Series B Preferred Unit financing and the individual NEO&#146;s performance as it relates to his area of responsibility. In addition, Mr.&nbsp;Amato received a
contractual bonus award required by his employment offer letter. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Equity Compensation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have granted equity awards to our employees, including our NEOs, as the long-term incentive component of our compensation program.
Historically, these awards have consisted of Common Units in Electrocore, LLC that were granted to employees when they commence employment with us. Our Board and Compensation Committee have also from time to time granted additional awards to key
employees as they determined appropriate to motivate, retain or reward such employees. These Common Unit grants are intended to qualify as Profits Interests for U.S. federal income tax purposes entitling the holder to participate in our future
appreciation from and after the date of grant of the applicable Common Units. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Profits Interests granted to our NEOs are typically subject
to time-based vesting conditions and may be subject to accelerated vesting in certain circumstances, including as described below in the sections titled &#147;Unit Forfeiture Agreements&#148; and &#147;&#151;Potential Payments Upon a Change in
Control.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with his elevation to Chief Executive Officer in July 2016 and as additional incentive to retain his
services, Mr.&nbsp;Amato was granted 3,500,000 Profits Interests to bring his ownership percentage in the company to 3%, together with certain anti-dilution protection to maintain his ownership at 3% through the final closing of our Series B
Preferred Unit financing. Pursuant to such anti-dilution rights, Mr.&nbsp;Amato was granted, in the aggregate, an additional 7,942,573 Profits Interests in 2017 taking into account the final closings of our Series B Preferred Unit financing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">159 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In July 2016, as additional incentive to retain his services, Mr.&nbsp;Errico was granted
1,700,000 Profits Interests, together with certain anti-dilution protection such that 2,400,000 of his Common Units would, as of the final closing of our Series B Preferred Unit financing, represent no less than 2% of our total outstanding
capitalization. Pursuant to such anti-dilution rights, Mr.&nbsp;Errico was granted, in the aggregate, an additional 5,321,715 Profits Interests in 2017 taking into account the final closings of our Series B Preferred Unit financing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with Dr. Staats becoming our Chief Medical Officer on May 1, 2017, Dr. Staats was granted 1,500,000 Profits Interests. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the hiring of Mr.&nbsp;Vraniak in July 2016 as our Chief Financial Officer, he was granted (i) 225,000 Profits Interests in
lieu of his cash salary for the six-month period August&nbsp;15, 2016 through December&nbsp;31, 2016, and (ii) 1,700,000 Profits Interests, together with certain anti-dilution protection such that 1,700,000 of his Common Units would, as of the final
closing of our Series B Preferred Unit financing, represent no less than 1% of our total outstanding capitalization. Pursuant to such anti-dilution rights, Mr.&nbsp;Vraniak was granted in the aggregate an additional 2,660,858 Profits Interests in
2017 taking into account the final closings of our Series B Preferred Unit financing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Refer to the Outstanding Equity Awards as of
December&nbsp;31, 2017 table below for a description of the vesting terms that apply to these awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with this offering,
we intend to adopt the 2018 Plan, to facilitate the grant of equity-based incentives to our directors, employees (including our NEOs) and consultants and to enable us to obtain and retain the services of these individuals, which we believe is
essential to our long-term success. For additional information about the 2018 Plan, refer to the section titled &#147;&#151;2018 Incentive Award Plan&#148; below. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Retirement, Health, Welfare and Additional Benefits </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our NEOs are eligible to participate in our employee benefit plans and programs, including medical and dental benefits and flexible spending
accounts, to the same extent as our other full-time employees, subject to the terms and eligibility requirements of those plans. We also sponsor a 401(k) defined contribution plan in which our NEOs may participate, subject to limits imposed by the
Internal Revenue Code, to the same extent as our other full-time employees. Currently, we do not match any of the contributions made by participants in the&nbsp;401(k). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Outstanding Equity Awards as of December&nbsp;31, 2017 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information with respect to outstanding Profits Interests awards for each of our NEOs as of December&nbsp;31,
2017. For the Profits Interests, the table reflects both vested and unvested units. Profits Interests are subject to time-based vesting and to an additional requirement that a minimum valuation threshold be met before the holder of the Profits
Interests is entitled to a distribution in respect of such award. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">160 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the corporate conversion, outstanding Profits Interests of our NEOs will
be converted into (i)&nbsp;shares of our common stock, and (ii)&nbsp;provided the NEO is an employee at the time of the conversion, options to purchase our common stock. The number of shares of common stock and the number of options to be issued to
each such NEO in respect of his Profits Interests will be determined based upon the appreciation in our value after the date of grant of the applicable Profits Interest through the completion of this offering. The exercise price of these options
will be equal to the offering price. Following the corporate conversion, the vesting provisions applicable to the Profits Interests as in effect prior to the corporate conversion will apply, in substantially the same manner, to the shares of common
stock and options issued in respect of such Profits Interests in the conversion. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="58%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Option Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; width:20.00pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options&nbsp;(#)<BR>Exercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Number of<BR>Securities</B><br><B>Underlying</B><br><B>Unexercised</B><br><B>Options&nbsp;(#)<BR>Unexercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Option<BR>Exercise<BR>Price&nbsp;($)(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Option<BR>Expiration<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Francis R. Amato</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">700,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">300,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">120,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">120,000</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,312,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,187,500</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,846,648</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,077,747</TD>
<TD NOWRAP VALIGN="bottom">(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,131,817</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,886,361</TD>
<TD NOWRAP VALIGN="bottom">(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph P. Errico</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,400,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">637,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,062,500</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,237,299</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,062,164</TD>
<TD NOWRAP VALIGN="bottom">(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">758,345</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,263,908</TD>
<TD NOWRAP VALIGN="bottom">(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Peter S. Staats, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">350,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">450,000</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,500,000</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Glenn S. Vraniak</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">637,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,062,500</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">225,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">618,650</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,031,083</TD>
<TD NOWRAP VALIGN="bottom">(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">379,172</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">631,954</TD>
<TD NOWRAP VALIGN="bottom">(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">These Common Units were issued as &#147;profits interests&#148; for U.S. federal income tax purposes and do not require the payment of an exercise price, but rather entitle the holder to participate in our future
appreciation from and after the date of grant of the applicable Common Units. Despite this, for purposes of this table we believe they are most similar economically to stock options and are properly classified as &#147;options&#148; under the
definition provided in Item 402(a)(6)(i) of Regulation S-K as an instrument with an &#147;option-like feature.&#148; The prices reflected in this column represent the fair market value of our Common Units on the date on which the Profits Interests
were granted. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">The awards vest as to 25% of such grant on the one year anniversary of the vesting commencement date and quarterly thereafter in equal installments until fully vested at the fourth anniversary of such award subject to
accelerated vesting in certain circumstances as described below under &#147;&#151; Unit Forfeiture Agreements&#148;, or Standard Vesting Schedule. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">These awards represent grants in satisfaction of certain anti-dilution protection in favor of certain NEOs. See &#147;&#151; Employment Agreements with Our Named Executive Officers&#148; above. The awards vest in
accordance with our Standard Vesting Schedule, but the vesting commencement date for these awards began on the date on which the NEO received a right to anti-dilution protection as described above. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">161 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Effect of the Corporate Conversion and this Offering </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Refer to &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#151;Statutory Corporate
Conversion&#148; for more information regarding the distribution of our common stock to employees, including our NEOs, in respect of their holdings of our Common Units at the time of the corporate conversion. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Employment Agreements with Our Named Executive Officers </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Francis R. Amato </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&nbsp;3,
2012, we entered into an employment agreement with Mr.&nbsp;Amato, or the Prior Amato Agreement, providing for base salary, annual target cash bonus opportunity, and standard employee benefit plan participation. In July 2016, we entered into an
amended and restated employment agreement, or the Amato Agreement, which superseded and replaced the Prior Amato Agreement in its entirety. Mr.&nbsp;Amato&#146;s base salary currently is $400,000 with an annual target cash bonus opportunity of up to
17.5% of his annual base salary, payable solely at the discretion of our board of directors. Please see the section above entitled &#147;&#151;2017 Summary Compensation Table&#151;Performance Bonuses&#148; for a further description of the annual
bonus awarded to Mr.&nbsp;Amato for 2017. Under the Amato Agreement, Mr.&nbsp;Amato&#146;s employment is terminable <FONT STYLE="white-space:nowrap">at-will</FONT> and is subject to our standard confidential information and invention assignment
provisions and certain <FONT STYLE="white-space:nowrap">non-competition</FONT> covenants during Mr.&nbsp;Amato&#146;s employment with us and, with respect to the non-competition covenant, a period of one year after Mr.&nbsp;Amato&#146;s termination.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Amato Agreement, in the event Mr.&nbsp;Amato&#146;s employment is terminated by us other than for &#147;cause&#148; (as defined
below) or as a result of Mr.&nbsp;Amato&#146;s resigning for &#147;good reason&#148; (as defined below), then Mr.&nbsp;Amato will receive (i)&nbsp;a severance payment equal to six&nbsp;months of Mr.&nbsp;Amato&#146;s base salary, payable in equal
monthly installments as salary continuation, and (ii)&nbsp;payment or reimbursement by us of COBRA premiums for up to six&nbsp;months. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Amato Agreement, Mr.&nbsp;Amato was granted certain Profits Interests, together with certain anti-dilution protection. See
&#147;Equity Compensation&#148; above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the Amato Agreement, &#147;cause&#148; means: (i)&nbsp;Mr. Amato&#146;s gross
negligence or willful misconduct in the performance of Mr. Amato&#146;s duties; (ii)&nbsp;the conviction of, or plea of guilty or nolo contendere to, the commission of a felony by Mr.&nbsp;Amato; (iii)&nbsp;the commission of an act of fraud or
embezzlement by Mr. Amato against us; or (iv)&nbsp;Mr. Amato&#146;s breach of any material provision of the Amato Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes
of the Amato Agreement, &#147;good reason&#148; means: (i)&nbsp;a material adverse change in Mr.&nbsp;Amato&#146;s position, duties, responsibilities, or status with our company; (ii)&nbsp;a material breach by us of any provision of the Amato
Agreement, including without limitation, any reduction in Mr.&nbsp;Amato&#146;s base salary other than in connection with an across the board salary reduction by us for senior management due to material cash flow problems; or (iii)&nbsp;without
Mr.&nbsp;Amato&#146;s consent, relocation of his principal business location by us outside of the northern New Jersey/New York metropolitan area. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Amato Agreement will be terminated effective on the date the registration statement of which this prospectus is part is declared effective
and he will sign a Confidentiality and Assignment Agreement which, will include certain non-competition and non-solicitation covenants. Following the termination of the Amato Agreement, Mr. Amato will continue his employment on an at-will basis
subject to the terms of the Executive Severance Policy that will be adopted by us concurrently with the termination of the Amato Agreement. See &#147;&#151;&nbsp;Executive Severance Policy&#148; below. At that time, Mr. Amato&#146;s base salary will
be increased to $475,000 with an annual target cash bonus opportunity of up to 60% of his annual base salary, payable solely at the discretion of our board of directors. Upon completion of this offering, Mr. Amato will be entitled to a cash bonus of
$150,000. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">162 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Joseph P. Errico </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&nbsp;28, 2013, we entered into an employment agreement with Mr.&nbsp;Errico, or the Prior Errico Agreement, providing for base salary,
performance bonus opportunity, and standard employee benefit plan participation. In July 2016, we entered into an amended and restated employment agreement, or the Errico Agreement, which superseded and replaced the Prior Errico Agreement in its
entirety. Mr.&nbsp;Errico&#146;s base salary currently is $350,000 and he is eligible for a performance bonus payable solely at the discretion of our board of directors. Please see the section above entitled &#147;&#151; 2017 Summary Compensation
Table &#151; Performance Bonuses&#148; for a further description of the annual bonus awarded to Mr.&nbsp;Errico for 2017. Under the Errico Agreement, Mr.&nbsp;Errico&#146;s employment is terminable <FONT STYLE="white-space:nowrap">at-will</FONT> and
is subject to our standard confidential information and invention assignment provisions and certain <FONT STYLE="white-space:nowrap">non-competition</FONT> covenants during Mr.&nbsp;Errico&#146;s employment with us and for the duration that
Mr.&nbsp;Errico is receiving severance payments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Errico Agreement, in the event Mr.&nbsp;Errico&#146;s employment is terminated
by us other than for &#147;cause&#148; (as defined below) or as a result of Mr.&nbsp;Errico resigning for &#147;good reason&#148; (as defined below), then Mr.&nbsp;Errico will receive (i)&nbsp;a severance payment equal to 12 months of
Mr.&nbsp;Errico&#146;s base salary, payable in equal monthly installments as salary continuation, and (ii)&nbsp;payment or reimbursement by us of COBRA premiums for up to 12&nbsp;months. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Errico Agreement, Mr.&nbsp;Errico was granted certain Profits Interests, together with certain anti-dilution protection. See
&#147;&#151; 2017 Summary Compensation Table &#151; Equity Compensation&#148; above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Errico Agreement will be terminated effective on
the date the registration statement of which this prospectus is part is declared effective and he will sign a Confidentiality and Assignment Agreement, which will include certain non-competition and non-solicitation covenants. Following the
termination of the Errico Agreement, Mr. Errico will continue his employment on an at-will basis subject to the terms of the Executive Severance Policy that will be adopted by us concurrently with the termination of the Errico Agreement. See
&#147;&#151;Executive Severance Policy&#148; below. At that time, Mr. Errico&#146;s base salary will be increased to $415,000 with an annual target cash bonus opportunity of up to 40% of his annual base salary, payable solely at the discretion of
our board of directors. Upon completion of this offering, Mr. Errico will be entitled to a cash bonus of $150,000. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Peter S. Staats, M.D.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On May&nbsp;1, 2017, we entered into an employment agreement with Dr.&nbsp;Staats, providing for base salary, annual discretionary
bonus opportunity, and standard employee benefit plan participation, or the Staats Agreement. In 2017, Dr.&nbsp;Staats&#146; base salary was initially $140,000 and increased to $280,000 as of August&nbsp;1, 2017 and he is eligible for an annual
discretionary bonus, as well as reimbursement for expenses associated with continuing medical education credits in connection with maintaining his accreditation as a licensed physician. Please see the section above entitled &#147;&#151; 2017 Summary
Compensation Table &#151; Performance Bonuses&#148; for a further description of the annual bonus awarded to Dr.&nbsp;Staats&#146;s for 2017. Under the Staats Agreement, Dr.&nbsp;Staats&#146; employment is terminable
<FONT STYLE="white-space:nowrap">at-will</FONT> and is subject to our standard confidential information and invention assignment provisions and certain <FONT STYLE="white-space:nowrap">non-competition</FONT> covenants during Dr.&nbsp;Staats&#146;
employment with us and for a period of six months after Dr.&nbsp;Staats&#146; termination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Staats Agreement will be terminated
effective on the date the registration statement of which this prospectus is part is declared effective and he will sign a Confidentiality and Assignment Agreement, which will include certain non-competition and non-solicitation covenants. Following
the termination of the Staats Agreement, Dr. Staats will continue his employment on an at-will basis subject to the terms of the Executive Severance Policy that will be adopted by us concurrently with the termination of the Staats Agreement. See
&#147;&#151;Executive Severance Policy&#148; below. At that time, Dr. Staat&#146;s base salary will be increased to $325,000 with an annual target cash bonus opportunity of up to 40% of his annual base salary, payable solely at the discretion of our
board of directors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">163 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Glenn S. Vraniak </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On July&nbsp;25, 2016, we entered into an employment agreement with Mr.&nbsp;Vraniak, providing for base salary, annual performance bonus
opportunity, and standard employee benefit plan participation, or the Vraniak Agreement. In 2017, Mr.&nbsp;Vraniak&#146;s base salary was $300,000 and he is eligible for an annual performance bonus opportunity, payable solely at the discretion of
our board of directors. Please see the section above entitled &#147;&#151;&nbsp;2017 Summary Compensation Table &#151; Performance Bonuses&#148; for a further description of the annual bonus awarded to Mr.&nbsp;Vraniak for 2017. Under the Vraniak
Agreement, Mr.&nbsp;Vraniak&#146;s employment is terminable <FONT STYLE="white-space:nowrap">at-will</FONT> and is subject to our standard confidential information and invention assignment provisions and certain
<FONT STYLE="white-space:nowrap">non-competition</FONT> covenants during Mr.&nbsp;Vraniak&#146;s employment with us and, with respect to the non-competition covenant, a period of one year after Mr.&nbsp;Vraniak&#146;s termination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the Vraniak Agreement, in the event Mr.&nbsp;Vraniak&#146;s employment is terminated by us other than for &#147;cause&#148; (as defined
below) or as a result of Mr.&nbsp;Vraniak&#146;s resigning for &#147;good reason&#148; (as defined below), then Mr.&nbsp;Vraniak will receive (i)&nbsp;a severance payment equal to six months of Mr.&nbsp;Vraniak&#146;s base salary, payable in equal
monthly installments as salary continuation, and (ii)&nbsp;payment or reimbursement by us of COBRA premiums for up to six months. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For
purposes of the Errico Agreement and the Vraniak Agreement, &#147;cause&#148; means: (i)&nbsp;the officer&#146;s gross negligence or willful misconduct in the performance of his duties to us; (ii)&nbsp;the conviction of, or plea of guilty or nolo
contendere to, the commission of a felony by the officer; (iii)&nbsp;the commission by the officer of an act of fraud or embezzlement against us; or (iv)&nbsp;the officer&#146;s breach of any material provision of the applicable Agreement, subject
to prior written notice to him and a reasonable cure period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the Errico Agreement and the Vraniak Agreement, &#147;good
reason&#148; means: (i)&nbsp;a material adverse change in the officer&#146;s position, duties, responsibilities, or status with us; (ii)&nbsp;a material breach by us of any provision of his employment agreement, including without limitation, any
reduction in his base salary other than in connection with an across the board salary reduction by us for senior management due to material cash flow problems; or (iii)&nbsp;without the officer&#146;s consent, relocation of his principal business
location by us outside of the northern New Jersey/New York metropolitan area. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Vraniak Agreement will be terminated effective on the
date the registration statement of which this prospectus is part is declared effective and he will sign a Confidentiality and Assignment Agreement, which will include certain non-competition and non-solicitation covenants. Following the termination
of the Vraniak Agreement, Mr. Vraniak will continue his employment on an at-will basis subject to the terms of the Executive Severance Policy that will be adopted by us concurrently with the termination of the Vraniak Agreement. See
&#147;&#151;&nbsp;Executive Severance Policy&#148; below. At that time, Mr. Vraniak&#146;s base salary will be increased to $330,000 with an annual target cash bonus opportunity of 40% of his annual base salary, payable solely at the discretion of
our board of directors. Upon completion of this offering, Mr. Vraniak will be entitled to a cash bonus of $100,000. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Severance Policy
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Effective as of the date the registration statement to which the prospectus is part is declared effective, we will implement an
Executive Severance Policy to replace the severance benefits previously provided pursuant to individual employment agreements that will be terminated effective as of such date. Under the Executive Severance Policy, if we terminate an eligible member
of our senior management team (including Mr.&nbsp;Amato, Mr.&nbsp;Errico, Dr.&nbsp;Staats or Mr.&nbsp;Vraniak) without &#147;cause&#148; or if the executive resigns for &#147;good reason&#148; (as those terms are defined below), we will provide the
following severance benefits: (i)&nbsp;severance payment in an amount equal to six months of base salary (or one year of base salary and target bonus in the case of our Chief Executive Officer or Chief Science and Strategy Officer) payable in equal
installments over the six-month or one-year period, as applicable, and (ii)&nbsp;reimbursement of COBRA premiums for group health continuation coverage paid </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">164 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
by the terminated executive for the duration of the &#147;severance period&#148; (as defined below). If the termination without cause or resignation for good reason occurs within two years after
a &#147;change in control&#148; we will provide the following severance benefits in lieu of the benefits provided in the previous sentence: (i)&nbsp;a lump sum severance payment in an amount equal to one year of base salary (or one and <FONT
STYLE="white-space:nowrap">one-half</FONT> (1.5) years of the sum of base salary and target bonus in the case of our Chief Executive Officer or Chief Science and Strategy Officer), and (ii)&nbsp;reimbursement of COBRA premiums for group health
continuation coverage paid by the terminated executive for the duration of the severance period, and (iii)&nbsp;acceleration of vesting for all outstanding equity compensation and an extension of the period of time to exercise outstanding stock
options and stock appreciation rights until the earlier of 150 days following the executive&#146;s termination of employment or the original expiration date for such options or stock appreciation rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the Executive Severance Policy, &#147;cause&#148; means any of the following: (a)&nbsp;the executive&#146;s willful failure to
fulfill, in any material respect, his or her duties and responsibilities to us (other than by reason of death, illness or disability); (b) the executive&#146;s willful misconduct, gross negligence or willful acts of personal dishonesty in the
performance of his or her duties to us that directly, materially and demonstrably impairs or damages our property, goodwill, reputation, business or finances; (c)&nbsp;the conviction of, or plea of nolo contendere by, the executive to, a felony or a
crime involving moral turpitude that materially and demonstrably impairs or damages our property, goodwill, reputation, business or finances; (d)&nbsp;the executive&#146;s commission of fraud or embezzlement against us; (e)&nbsp;the executive&#146;s
willful or intentional violation of any lawful policy that directly, materially and demonstrably impairs or damages our property, goodwill, reputation, business or finances; or (f)&nbsp;the executive&#146;s breach of the terms of any confidentiality
and assignment agreement, which contains restrictive covenants in favor of us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the Executive Severance Policy &#147;good
reason&#148; means any of the following (a)&nbsp;any material reduction in the executives base annual compensation prior to a &#147;change in control&#148;; provided, however, that a reduction in the executives base annual compensation shall not
constitute &#147;good reason&#148; if we reduce the annual base compensation of all participants in the Executive Severance Policy on a substantially equivalent basis; (b)&nbsp;any material reduction in the executive&#146;s base annual compensation
during the period commencing on or after a &#147;change in control&#148; and ending on the second anniversary of a &#147;change in control&#148;; (c) any material diminution in the executive&#146;s authority, duties, offices, title or
responsibilities; or (d)&nbsp;a transfer of executive&#146;s principal place of employment to a location that is more than 30 miles from the executive&#146;s then current principal place of employment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the Executive Severance Policy, &#147;severance period&#148; means the number of months set forth in the table below based on
the executive&#146;s employment position as the time of his involuntary termination of employment that results in the executive&#146;s termination for &#147;good reason&#148;: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; width:73.45pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Employment Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Severance Period</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Prior&nbsp;to&nbsp;a</B><br><B>Change&nbsp;in&nbsp;Control</B><br><B>or on or After
the<BR>Second&nbsp;Anniversary<BR>of&nbsp;a&nbsp;Change&nbsp;in&nbsp;Control</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Two-Year&nbsp;Period</B><br><B>After a</B><br><B>Change&nbsp;in&nbsp;Control</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CEO or CSSO:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12&nbsp;months</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18&nbsp;months</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All Other Participants:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6 months</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12 months</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Unit Forfeiture Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with a grant of our Profits Interests, each of our NEOs enters into a standard form of Unit Forfeiture Agreement, which provides
for, among other things, acceleration upon a change in control event, as well as upon death or disability. In the event there is a change of control, then one hundred percent of the NEO&#146;s then-unvested Profits Interests will immediately vest,
subject to the NEO remaining employed with us until the change in control transaction. Upon an NEO&#146;s death, one hundred percent of the NEO&#146;s then-unvested Profits </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">165 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Interests will immediately vest and fifty percent of the NEO&#146;s then-unvested Profits Interests will immediately vest upon the NEO&#146;s disability, in both instances subject to the NEO
remaining employed with us until such date. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Potential Payments Upon a Change in Control </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The unvested Profits Interests held by our NEOs vest in full upon a change in control of our company, subject to the NEO remaining employed
with us until the change in control transaction. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2017 Operating Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In November 2017, we amended and restated our Operating Agreement. Our Operating Agreement provides for the grant of Common Units that
constitute Profits Interests for income tax purposes to our employees (including officers), <FONT STYLE="white-space:nowrap">non-employee</FONT> consultants and <FONT STYLE="white-space:nowrap">non-employee</FONT> directors and those of our
affiliates. Under our Operating Agreement, our compensation committee has been delegated the authority to administer the Profits Interests in order to provide a means to attract, retain and motivate our directors, employees and consultants upon
whose judgment, initiative and efforts our continued success, growth and development are dependent. In addition to the discretion to grant Profits Interests, the compensation committee sets the vesting terms for awards pursuant to a unit forfeiture
agreement. Each Profits Interest includes a minimum valuation threshold that must be achieved before the interest is entitled to receive any distributions under the Operating Agreement. As of December&nbsp;31, 2017, there were 43.1 million issued
and outstanding Profits Interests, of which 19.2 million were vested. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Profits Interests are generally issued pursuant to a Unit
Forfeiture Agreement as described above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the corporate conversion, holders of Profits Interests will be converted into
(i)&nbsp;shares of our common stock, and (ii)&nbsp;with respect to holders of Profits Interests who are our employees and consultants at the time of the corporate conversion, options to purchase our common stock. The exercise price of these options
will be equal to the offering price. The number of shares of common stock and options to purchase common stock to be issued to each such holder will be determined based upon the appreciation in our value after the date of grant of the applicable
Profits Interest through the completion of this offering. Following the corporate conversion, the vesting provisions applicable to the Profits Interests as in effect prior to the corporate conversion will apply, in substantially the same manner, to
the shares of common stock and options issued in respect of such Profits Interests. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We anticipate that this equity policy under the
current Operating Agreement will be replaced by the 2018 Plan. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2018 Omnibus Incentive Compensation Plan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is currently anticipated that prior to the completion of this offering, our board of directors and our stockholders will adopt the 2018
Plan, which will become effective on the date on which the registration statement of which this prospectus is part is declared effective by the SEC. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>General </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2018 Plan will cover
the grant of awards to our employees (including officers), <FONT STYLE="white-space:nowrap">non-employee</FONT> consultants and <FONT STYLE="white-space:nowrap">non-employee</FONT> directors and those of our affiliates. For purposes of the 2018 Plan
, our affiliates include any corporation, partnership, limited liability company, joint venture or other entity, with respect to which we, directly or indirectly, own either (i)&nbsp;stock of a corporation possessing more than fifty percent (50%) of
the total combined voting power of all classes of stock entitled to vote, or more than fifty percent (50%) of the total value of all shares of all classes of stock of such corporation, or (ii)&nbsp;an aggregate of more than fifty percent (50%) of
the profits interest or capital interest of any <FONT STYLE="white-space:nowrap">non-corporate</FONT> entity. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">166 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect that the compensation committee of the board of directors will administer the 2018
Plan. The committee may delegate any or all of its administrative authority to our Chief Executive Officer or to a management committee except with respect to awards to executive officers who are subject to Section&nbsp;16 of the Exchange Act. In
addition, the full board of directors must serve as the committee with respect to any awards to our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Up to a maximum of 6.2 million shares of our common stock may be delivered in settlement of awards granted under the 2018 Plan initially. The
number of shares authorized for issuance will increase beginning in 2019, and occurring each year thereafter through 2028 by 4% of the number of our shares of common stock issued and outstanding on a fully-diluted basis as of the last day of the
preceding fiscal year (or such lesser number of shares as determined by our board of directors in its sole discretion). In no event, however, shall the aggregate number of shares that may be issued pursuant to this annual increase under the 2018
Plan exceed 45.0&nbsp;million. Up to a maximum of 40.0&nbsp;million shares of our common stock may be issued under the 2018 Plan pursuant to the exercise of incentive stock options. The stock delivered to settle awards made under the 2018 Plan may
be authorized and unissued shares or treasury shares, including shares repurchased by us for purposes of the 2018 Plan. If any shares subject to any award granted under the 2018 plan (other than a substitute award as described below) is forfeited or
otherwise terminated without delivery of such shares (or if such shares are returned to us due to a forfeiture restriction under such award), the shares subject to such awards will again be available for issuance under the 2018 Plan. However, any
shares that are withheld or applied as payment for shares issued upon exercise of an award or for the withholding or payment of taxes due upon exercise of the award will continue to be treated as having been delivered under the 2018 Plan and will
not again be available for grant under the 2018 Plan. Upon settlement of any stock appreciation rights, or SARs, the number of shares underlying the portion of the SARs that is exercised will be treated as having been delivered for purposes of
determining the maximum number of shares available for grant under the 2018 Plan and shall not again be treated as available for issuance under the 2018 Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a dividend or other distribution (whether in cash, shares of common stock or other property), recapitalization, forward or reverse stock
split, subdivision, consolidation or reduction of capital, reorganization, merger, consolidation, scheme of arrangement, <FONT STYLE="white-space:nowrap">split-up,</FONT> <FONT STYLE="white-space:nowrap">spin-off</FONT> or combination involving us
or repurchase or exchange of our shares or other securities, or other rights to purchase shares of our securities or other similar transaction or event affects our common stock such that the committee determines that an adjustment is appropriate in
order to prevent dilution or enlargement of the benefits (or potential benefits) provided to grantees under the 2018 Plan, the committee will make an equitable change or adjustment as it deems appropriate in the number and kind of securities subject
to awards (whether or not then outstanding) and the related exercise price relating to an award in order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under the 2018 Plan. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Types of Awards </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2018 Plan
permits the granting of any or all of the following types of awards to all grantees: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">stock options, including incentive stock options, or ISOs; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">stock appreciation rights, or SARs; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">restricted shares; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">deferred stock and restricted stock units; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">performance units and performance shares; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">dividend equivalents; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">bonus shares; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">other stock-based awards. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">167 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Generally, awards under the 2018 Plan are granted for no consideration other than prior and
future services. Awards granted under the 2018 Plan may, in the discretion of the committee, be granted alone or in addition to, in tandem with or in substitution for, any other award under the 2018 Plan or other plan of ours; provided, however,
that if an SAR is granted in tandem with an ISO, the SAR and ISO must have the same grant date and term and the exercise price of the SAR may not be less than the exercise price of the ISO. The material terms of each award will be set forth in a
written award agreement between the grantee and us. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock Options and SARs </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The committee is authorized to grant SARs and stock options (including ISOs except that an ISO may only be granted to an employee of ours or
one of our subsidiary corporations). A stock option allows a grantee to purchase a specified number of shares of our common stock at a predetermined price per share (the &#147;exercise price&#148;) during a fixed period measured from the date of
grant. An SAR entitles the grantee to receive the excess of the fair market value of a specified number of shares on the date of exercise over a predetermined exercise price per share. The exercise price of an option or an SAR will be determined by
the committee and set forth in the award agreement but the exercise price may not be less than the fair market value of a share of common stock on the grant date. The term of each option or SAR is determined by the committee and set forth in the
award agreement, except that the term may not exceed 10 years. Options may be exercised by payment of the purchase price through one or more of the following means: payment in cash (including personal check or wire transfer), by delivering shares of
our common stock previously owned by the grantee, or with the approval of the committee, by delivery of shares of our common stock acquired upon the exercise of such option or by delivering restricted shares. The committee may also permit a grantee
to pay the exercise price of an option through the sale of shares acquired upon exercise of the option through a broker-dealer to whom the grantee has delivered irrevocable instructions to deliver sales proceeds sufficient to pay the purchase price
to us. The grant of ISOs are contingent upon shareholder approval of the 2018 Plan within 12 months of its adoption by our board of directors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Restricted Shares </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The committee
may award restricted shares consisting of shares of our common stock which remain subject to a risk of forfeiture and may not be disposed of by grantees until certain restrictions established by the committee lapse. The vesting conditions may be
service-based (i.e., requiring continuous service for a specified period) or performance-based (i.e., requiring achievement of certain specified performance objectives) or both. A grantee receiving restricted shares will have all of the rights of a
stockholder, including the right to vote the shares and the right to receive any dividends, except as otherwise provided in the award agreement. Upon termination of the grantee&#146;s affiliation with us during the restriction period (or, if
applicable, upon the failure to satisfy the specified performance objectives during the restriction period), the restricted shares will be forfeited as provided in the award agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Restricted Stock Units and Deferred Stock </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The committee may also grant restricted stock unit awards and/or deferred stock awards. A deferred stock award is the grant of a right to
receive a specified number of shares of our common stock at the end of specified deferral periods or upon the occurrence of a specified event, which satisfies the requirements of Section&nbsp;409A of the Internal Revenue Code. A restricted stock
unit award is the grant of a right to receive a specified number of shares of our common stock upon lapse of a specified forfeiture condition (such as completion of a specified period of service or achievement of certain specified performance
objectives). If the service condition and/or specified performance objectives are not satisfied during the restriction period, the award will lapse without the issuance of the shares underlying such award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Restricted stock units and deferred stock awards carry no voting or other rights associated with stock ownership until the shares underlying
the award are delivered in settlement of the award. The award agreement </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">168 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
will provide whether grantees may receive dividend equivalents with respect to restricted stock units or deferred stock, and if so, whether such dividend equivalents are distributed when credited
or deemed to be reinvested in additional shares of restricted stock units or deferred stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Performance Units </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The committee may grant performance units, which entitle a grantee to cash or shares conditioned upon the fulfillment of certain performance
conditions and other restrictions as specified by the committee and reflected in the award agreement. The initial value of a performance unit will be determined by the committee at the time of grant. The committee will determine the terms and
conditions of such awards, including performance and other restrictions placed on these awards, which will be reflected in the award agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Performance Shares </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The committee
may grant performance shares, which entitle a grantee to a certain number of shares of common stock, conditioned upon the fulfillment of certain performance conditions and other restrictions as specified by the committee and reflected in the award
agreement. The committee will determine the terms and conditions of such awards, including performance and other restrictions placed on these awards, which will be reflected in the award agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Bonus Shares </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The committee may
grant fully vested shares of our common stock as bonus shares on such terms and conditions as specified in the award agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Dividend
Equivalents </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The committee is authorized to grant dividend equivalents which provide a grantee the right to receive payment equal
to the dividends paid on a specified number of shares of our common stock. Dividend equivalents may be paid directly to grantees or may be deferred for later delivery under the 2018 Plan. If deferred such dividend equivalents may be credited with
interest or may be deemed to be invested in shares of our common stock or in other property. No dividend equivalents may be granted in conjunction with any grant of stock options or SARs. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other Stock-Based Awards </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order
to enable us to respond to material developments in the area of taxes and other legislation and regulations and interpretations thereof, and to trends in executive compensation practices, the 2018 Plan authorizes the committee to grant awards that
are valued in whole or in part by reference to or otherwise based on our securities. The committee determines the terms and conditions of such awards, including consideration paid for awards granted as share purchase rights and whether awards are
paid in shares or cash. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Merger, Consolidation or Similar Corporate Transaction </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If there is a merger or consolidation of us with or into another corporation or a sale of substantially all of our stock, or, collectively, a
Corporate Transaction, and the outstanding awards are not assumed by surviving company (or its parent company) or replaced with economically equivalent awards granted by the surviving company (or its parent company), the committee will cancel any
outstanding awards that are not vested and nonforfeitable as of the consummation of such Corporate Transaction (unless the committee accelerates the vesting of any such awards) and with respect to any vested and nonforfeitable awards, the committee
may either (i)&nbsp;allow all grantees to exercise options and SARs within a reasonable period prior to the consummation of the Corporate Transaction and cancel any outstanding options or SARs that remain unexercised upon consummation
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">169 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of the Corporate Transaction, or (ii)&nbsp;cancel any or all of such outstanding awards (including options and SARs) in exchange for a payment (in cash, or in securities or other property) in an
amount equal to the amount that the grantee would have received (net of the exercise price with respect to any options or SARs) if the vested awards were settled or distributed or such vested options and SARs were exercised immediately prior to the
consummation of the Corporate Transaction. If an exercise price of the option or SAR exceeds the fair market value of our common stock and the option or SAR is not assumed or replaced by the surviving company (or its parent company), such options
and SARs will be cancelled without any payment to the grantee. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Amendment to and Termination of the 2018 Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2018 Plan may be amended, altered, suspended, discontinued or terminated by our board of directors without further stockholder approval,
unless such approval of an amendment or alteration is required by law or regulation or under the rules of any stock exchange or automated quotation system on which the common stock is then listed or quoted. Thus, stockholder approval will not
necessarily be required for amendments which might increase the cost of the 2018 Plan or broaden eligibility. Stockholder approval will not be deemed to be required under laws or regulations that condition favorable treatment of grantees on such
approval, although our board of directors may, in its discretion, seek stockholder approval in any circumstance in which it deems such approval advisable. No ISOs may be awarded after any amendment to the 2018 Plan that either broadens eligibility
or increase the number of shares available for delivery in the form of ISOs unless such amendment is approved by our stockholders within 12 months of the date the board of directors approve the adoption of such amendment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, subject to the terms of the 2018 Plan, no amendment or termination of the 2018 Plan may materially and adversely affect the right
of a grantee under any award granted under the 2018 Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless earlier terminated by our board of directors, the 2018 Plan will
terminate when no shares remain reserved and available for issuance or, if earlier, on the tenth anniversary of the effective date of the 2018 Plan. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director Compensation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other than with
respect to Mr. Moody as described below, we have historically generally not provided cash retainers to any of our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors. We have, upon a member joining our Board, granted awards of Profits
Interests to our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors as compensation for their service on our board. We have also, from time to time, granted Profits Interests to certain board members for service on special committees.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2017 Director Compensation Table </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table provides information regarding the compensation earned during 2017 by our non-executive directors: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="60%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; width:20.00pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Fees&nbsp;Earned<BR>or Paid in<BR>Cash ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Option&nbsp;Awards<BR>($)(6)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Total ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trevor J. Moody</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20,000</TD>
<TD NOWRAP VALIGN="bottom">(1)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nicholas Colucci</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thomas J. Errico, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David M. Rubin, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Peter S. Staats, M.D.<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reese Terry<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kathryn Theofilos<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James L.L. Tullis</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jeffrey N. Vinik<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Mr. Moody receives $5,000 per quarter for serving on our board of directors. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">170 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Dr. Staats did not receive any compensation for his service as a director in 2017. Dr. Staats&#146; compensation for his service as our Chief Medical Officer is fully reflected in &#147;&#151;2017 Summary Compensation
table&#148; above. Dr. Staats ceased serving as a member of our board of directors in January 2018. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">Mr. Terry served on our board of directors until August 2017. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">Ms. Theofilos served as a member of our board of directors until February 2018. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top">Mr. Vinik ceased serving as a member of our board of directors in March 2018. He was replaced by Michael W. Ross, who does not receive compensation for his service as a director. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top">Represents the grant date fair value of Common Units issued as Profits Interests in Electrocore, LLC computed in accordance with FASB ASC 718. See Note 13 to the consolidated financial statements for the fiscal year
ended December 31, 2016 included with this prospectus for a description of the assumptions used in valuing our Common Units. These Common Units are intended to constitute profits interests for U.S. federal income tax purposes. Despite the fact that
the Common Units that are intended to constitute profits interests do not require the payment of an exercise price, we believe they are most similar economically to stock options and are properly classified as &#147;options&#148; under the
definition provided in Item 402(a)(6)(i) of Regulation S-K as an instrument with an &#147;option-like feature.&#148; </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
table below shows the number of vested and unvested Profits Interests, by grant date, held as of December&nbsp;31, 2017 by each person who served as a <FONT STYLE="white-space:nowrap">non-employee</FONT> director during the year ended
December&nbsp;31, 2017. The Profits Interests held by Dr. Staats as of December&nbsp;31, 2017 are reflected in the &#147;Outstanding Awards&#148; table above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Grant Date</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Profits&nbsp;Interests</B><br><B>Vested&nbsp;and&nbsp;Unvested</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; width:20.00pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Vested</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Unvested</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nicholas Colucci</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/1/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">(1)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thomas J. Errico, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/1/2009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trevor J. Moody</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4/1/2013</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/27/2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">400,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">125,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">275,000</TD>
<TD NOWRAP VALIGN="bottom">(1)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David M. Rubin, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&#151;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&#151;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&#151;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&#151;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kathryn K. Theofilos</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/1/2009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reese Terry</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7/5/2014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/27/2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">400,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">400,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James L.L. Tullis</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8/1/2014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jeffrey N. Vinik</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&#151;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&#151;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&#151;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&#151;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Each award vests 25% at the first anniversary of the grant date, and thereafter vests quarterly in equal installments until fully vested at the fourth anniversary. Each award is also subject to acceleration upon a
change of control event, as well as upon death or disability as set forth in our standard form of Unit Forfeiture Agreement. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At the
effective time of this offering, we intend to implement a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director Compensation Policy, which will provide compensation parameters for our <FONT STYLE="white-space:nowrap">non-employee</FONT>
directors under which each <FONT STYLE="white-space:nowrap">non-employee</FONT> director will receive the following amounts for their service on our board of directors: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">an inaugural equity award valued at $200,000 shall be made at the effective time of this offering and upon the earlier of any new <FONT STYLE="white-space:nowrap">non-employee</FONT> director&#146;s initial appointment
or election to our board of directors. The inaugural grants will vest in three equal annual installments at the close of business on the day before each of the next three annual meetings of stockholders following the grant of such award;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">at each annual meeting of stockholders, an equity award valued at $100,000 as of the business day immediately preceding the date of grant, which will vest in a single installment on the next annual meeting of
stockholders; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">171 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">an annual cash retainer of $40,000; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">if the director serves on a committee of our board of directors, an additional annual retainer as follows: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">chairman of the audit committee: $16,000; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">audit committee member other than the chairman: $8,000; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">chairman of the compensation committee: $10,000; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">compensation committee member other than the chairman: $5,000; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">chairman of the nominating and corporate governance committee: $7,500; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">nominating and corporate governance committee member other than the chairman: $3,750. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the
event that an independent chairman of the board is elected, his or her annual cash retainer and annual equity awards will be 150% of the annual cash retainer and annual equity awards granted to other
<FONT STYLE="white-space:nowrap">non-employee</FONT> members of our board of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each director will have an opportunity to elect
to receive his or her inaugural and annual equity awards in the form of stock options, deferred stock units that settle upon separation from service with us or restricted stock units that settle upon vesting. Each current director will need make an
initial election before the consummation of this offering and new directors will need to make their elections before becoming a director. Such election will remain in effect for future annual equity awards unless and until the director files a new
election with us which will become effective with respect to annual equity awards granted in calendar years following the calendar year in which such election is filed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Annual cash retainers, annual committee membership retainers and annual committee chair retainers will each be payable in 12 monthly
installments on the first day of each month provided that no payment shall be made to any director who is no longer serving as a <FONT STYLE="white-space:nowrap">non-employee</FONT> member of our board on the relevant payment date. No retainer will
be paid under the program for service prior to the program&#146;s effectiveness. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each member of our board of directors is entitled to be
reimbursed for reasonable travel and other expenses incurred in connection with attending meetings of the board of directors and any committee of the board of directors on which he or she serves. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">172 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom472601_17"></A>CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other than compensation agreements and other arrangements which are described under &#147;Executive and Director Compensation&#148; and the
transactions described below, since January&nbsp;1, 2016, there has not been, and there is not currently proposed, any transaction or series of similar transactions to which we were or will be a party in which the amount involved exceeded or will
exceed $120,000 and in which any of our directors, executive officers or holders of more than 5% of our capital stock, or 5% Security Holders, or an affiliate or family member thereof, had or will have a direct or indirect material interest. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Participation in this Offering </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain of our direct and indirect unitholders, including entities affiliated with certain of our directors, have indicated an interest in
purchasing an aggregate of $20.0 million in shares of our common stock in this offering at the initial public offering price per share. Based on an assumed initial public offering price of $15.00 per share, these holders would purchase up to an
aggregate of 1,333,333 of the 4,333,333 shares in this offering based on these indications of interest. However, because indications of interest are not binding agreements or commitments to purchase, these holders may determine to purchase fewer
shares than they indicate an interest in purchasing or not to purchase any shares in this offering. It is also possible that these holders could indicate an interest in purchasing more shares of our common stock. In addition, the underwriters could
determine to sell fewer shares to any of these holders than the holders indicate an interest in purchasing or not to sell any shares to these holders. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Operating Agreement of Electrocore, LLC </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are party to the Operating Agreement with our current members. The Operating Agreement, which contains provisions relating to membership
interests and the right of our members to appoint the members to our board of directors, will terminate upon the closing of this offering. See &#147;Management&#151;Board Composition.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Series A Equity Issuances </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In March 2016,
we consummated a final closing of our Series A financing pursuant to which we issued approximately 3.0&nbsp;million Series A Preferred Units at an issue price of $0.85 per unit, or approximately $2.6&nbsp;million in the aggregate. In connection with
such closing, GHI, a 5% Security Holder, purchased approximately 1.0&nbsp;million Series A Preferred Units for $0.9 million and CV II, a 5% Security Holder, purchased approximately 2.0&nbsp;million Series A Preferred Units for approximately
$1.7&nbsp;million, including amounts converted pursuant to a term loan conversion as described below. In addition, CV II exercised an outstanding warrant and acquired approximately 2.3&nbsp;million Series A Preferred Units for $1.7 million. Dr.
Rubin, one of our directors, serves as a Managing Director of GHI. Mr. Errico and Dr.&nbsp;Errico, two of our directors, have a pecuniary interest in, serve as managers of, and have voting control over CV&nbsp;II. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Term Loan Conversion </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In December 2015,
CV II loaned us $1.25 million pursuant to a Loan and Security Agreement. In connection with this loan, we issued 66,177 warrants to CV II to purchase Series A Preferred Units at an exercise price of $0.85 per unit. These warrants expire on
December&nbsp;22, 2025. Pursuant to the terms of this loan, CV II elected to convert the term loan of $1.25 million and related accrued interest of $49,935 into approximately 1.5&nbsp;million Series A Preferred Units in two installments in March
2016 and September 2016 at a price of $0.85 per Unit. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Bridge Financing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Beginning in June 2016, we commenced a note and warrant financing, or the Bridge Financing, pursuant to which we issued to investors a
convertible promissory note, or Bridge Note, with annual interest of 10%. Each investor in the Bridge Financing was also issued a warrant, or Bridge Warrant, to purchase a number of shares </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">173 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
issued in our next Qualified Equity Financing, or the Next Round Securities, equal to 20% of the original principal amount of the investor&#146;s Bridge Note divided by the purchase price payable
for such equity securities in the Qualified Equity Financing, or the Next Round Price. The Bridge Notes, together with all accrued interest, were originally automatically convertible upon the closing of the Qualified Equity Financing into the Next
Round Securities at a per share price equal to 90% of the Next Round Price, or optionally convertible at any time at the holder&#146;s option into our Series A Preferred Units at a price of $0.85 per unit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ECNG is a limited liability company in which Mr. Errico and Dr.&nbsp;Errico have a pecuniary interest, which they serve as managers and over
which they have voting control. In June and July 2016, ECNG purchased in the aggregate $1.5 million in Bridge Notes. In September 2016, ECNG converted approximately $1.5&nbsp;million in principal and accrued interest under its Bridge Notes into
approximately 1.8&nbsp;million Series A Preferred Units. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following the Bridge Note conversion noted above, the terms of the Bridge
Financing were amended to provide that future investors in the Bridge Financing were entitled to receive, in addition to their Bridge Note and Bridge Warrant, up to two Common Units for each dollar invested in the Bridge Financing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From September 2016 through June 2017, we raised approximately $25.6 million from the issuance of additional Bridge Notes and issued
approximately 41.9 million Common Units to the bridge investors. In addition, we issued 5.4 million common units to our financial advisor as compensation for its services. Of these amounts, CV&nbsp;II purchased approximately $16.9&nbsp;million in
Bridge Notes and was issued approximately 33.7&nbsp;million Common Units. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Series B Financing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Commitment Letter.</I></B> In July 2017, CV II, GHI, Mr. Tullis, one of our directors, and Tullis Opportunity Fund II, or &#147;TOP
II,&#148; an entity for which Mr.&nbsp;Tullis serves as the managing partner of its general partner, entered into a commitment letter with us pursuant to which such investors agreed, among other things, to invest in the aggregate approximately
$9.0&nbsp;million in the initial closing of our Series B Preferred Unit financing and to consent to certain amendments to our Operating Agreement. In exchange for such commitments, the investors were issued two Common Units for each dollar
committed. The table below summarizes these issuances. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="71%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; width:28.40pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Investor</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Series&nbsp;B<BR>Commitment<BR>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Common<BR>Units&nbsp;Issued</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">GHI</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CV II</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,870,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,740,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James L.L. Tullis(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">300,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">600,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9,170,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,340,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Includes amounts for TOP II. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">174 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I><B><I>Reduction in Preferred Liquidation Preference</I></B><I>.</I> In August 2017,
in connection with the initial closing of our Series B Preferred Unit financing, among other things, (i)&nbsp;the holders of our Series A Preferred Units agreed to eliminate approximately $54.9&nbsp;million in liquidation preference in exchange for
the issuance to such holders of approximately 46.9&nbsp;million Common Units, and (ii)&nbsp;the holders of Common Units that were entitled to approximately $30.9&nbsp;million in liquidation preference agreed to eliminate such preference in exchange
for the issuance to such holders of approximately 26.4&nbsp;million Common Units. The table below summarizes the issuances to certain related parties in connection with this transaction. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="83%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; width:29.30pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Member</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Common<BR>Units Issued<BR>in Exchange<BR>for&nbsp;Reduction<BR>in&nbsp;Liquidation<BR>Preference</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">GHI</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,384,615</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CV II(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,818,632</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ECNG, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,304,356</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James L.L. Tullis(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,442,308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Includes units issued for the benefit of Mr. Errico, Dr. Errico and Mrs. Theofilos, and their affiliates. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Includes units issued to TOP II and Mr.&nbsp;Tullis&#146; spouse and family, and trusts for the benefit of his spouse and family. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Initial Series B Closing</I></B>. In August 2017, we consummated the initial closing of our Series B Preferred Unit financing pursuant
to which we issued approximately 51.3&nbsp;million Series B Preferred Units for approximately $35.8&nbsp;million in the aggregate. Each investor in our Series B financing was issued Series B Preferred Units at a price of $0.70 per unit, together
with a warrant, or Series B Common Warrant, to purchase a number of our Common Units equal to 50% of the original issue price of the Series B Preferred Units purchased by such investor in our Series B Preferred Unit financing, divided by $1.25. The
exercise price for the Common Units purchasable pursuant to the Series B Common Warrants is $1.25 per unit and the Series B Common Warrants have a five-year term; provided that the Series B Common Warrants will expire upon the closing of this
offering, if not previously exercised. The table below summarizes the issuances at our initial Series B closing to certain related parties. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="52%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; width:35.10pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Purchaser</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Series B<BR>Investment<BR>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Series B<BR>Units&nbsp;Purchased</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Common&nbsp;Units<BR>Underlying<BR>Series B</B><br><B>Common<BR>Warrants</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">GHI</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,142,858</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CV II(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">21,530,416</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,757,737</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,612,166</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ECNG, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">990,463</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,414,947</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">396,185</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James L.L. Tullis(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">300,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">428,572</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">120,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Includes the conversion of approximately $17.7&nbsp;million in principal and accrued interest under outstanding Bridge Notes. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Includes amounts for TOP II. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Additional Series B Closings</I></B>. From September
through December 2017, we consummated additional closings under our Series B financing pursuant to which we issued in the aggregate an additional approximately 53.9&nbsp;million Series B Preferred Units at an issue price of $0.70 per unit, or
approximately $37.8&nbsp;million in the aggregate. In connection with such closings, certain related parties purchased Series B Preferred Units. Each investor in our additional Series B closings was issued a Series B Common Warrant in the form of
the initial Series B Preferred Unit closing, except that the terms of the Series B Preferred Units financing were&nbsp;amended to provide that for any investor who, together with its affiliates, purchased not less than&nbsp;$15.0&nbsp;million of
Series B </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">175 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Preferred Units (excluding amounts purchased at the initial Series B closing),&nbsp;the Series B Common Warrant coverage amount for such investor was increased from 50% to 100%. The table below
summarizes the issuances at our additional Series B closings to certain related parties. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="58%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Series B</B><br><B>Investment<BR>Amount</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Series B<BR>Preferred&nbsp;Units<BR>Purchased</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Common&nbsp;Units<BR>Underlying</B><br><B>Series&nbsp;B</B><br><B>Common<BR>Warrants</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; width:35.10pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Purchaser</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">American Investment Holdings(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,714,286</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,800,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vinik Family Foundation(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,714,286</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CV II</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,400,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,360,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">American Investment Holdings and Vinik Family Foundation are affiliates of Jeffrey N. Vinik, who served as one of our directors during 2017 and resigned in March 2018. AIH-Electro, LLC designated Michael W. Ross to
replace Mr. Vinik on our board of directors in March 2018. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor Rights Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the terms of our Amended and Restated Investor Rights Agreement, certain holders of our units, including CV II, GHI, ECNG, TOP II,
Mr. Errico, Dr.&nbsp;Errico, Mrs. Theofilos, and certain of their affiliates, are entitled to certain demand and piggyback registration rights with respect to our securities held by them, certain information and observer rights, and certain
additional rights. Certain provisions of the investor rights agreement will terminate in connection with this offering. See &#147;Description of Capital Stock&#148; for additional information. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Agreement with Publicis Healthcare Solutions, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a party to a master services agreement with Publicis Healthcare Solutions, Inc., or Publicis, a leading provider of pharmaceutical
support services and contract sales personnel. Publicis is an affiliate of Publicis Health, whose chairman and former Chief Executive Officer is Nicholas Colucci. Mr. Colucci has served on our board of directors since August 2017. During 2017, we
paid Publicis approximately $950,000 for its services and provision of two medical science liaisons on terms we consider to be arms&#146; length between the parties. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Conversion to Corporate Form </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to
the closing of this offering, we will convert from a Delaware limited liability company to a Delaware corporation under the name electroCore, Inc. Existing holders, including our 5% Security Holders, executive officers and directors, of our Common
Units, Series A Preferred Units and Series B Preferred Units, and warrants to purchase our Units, will receive the number of shares of common stock, the number of warrants, and the number of options, respectively, described in this prospectus as a
result of the corporate conversion. The existing securities held by our officers, directors, nominees for director and 5% Security Holders, executive officers and directors will be converted on the same basis as all other holders of such securities.
See &#147;Corporate Conversion&#148; and &#147;Principal Stockholders&#148; for additional information. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table details
the number of Profits Interests held by each of our executive officers and the number of shares of common stock and options each executive officer will receive as a result of the conversion of these Profits Interests in the corporation conversion.
</P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="29%"></TD>
<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; width:20.00pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Profits<BR>Interest</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Shares&nbsp;of&nbsp;common&nbsp;stock<BR>upon&nbsp;corporate&nbsp;conversion</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Options granted<BR>upon&nbsp;corporate&nbsp;conversion</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Francis R. Amato</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">16,832,573</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">6,323,966</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">10,508,607</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph P. Errico</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">11,901,715</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">2,346,399</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">9,555,316</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Peter S. Staats, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">4,410,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">2,053,176</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">2,356,824 </TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Glenn S. Vraniak</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">4,585,858</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">2,121,021</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">2,464,837</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">176 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Limitation of Liability and Indemnification </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As permitted by Delaware law, we intend to adopt provisions in our certificate of incorporation, which will be effective as of the closing date
of this offering, that limit or eliminate the personal liability of our directors. Our certificate of incorporation will limit the liability of directors to the maximum extent permitted by Delaware law. Delaware law provides that directors of a
corporation will not be personally liable for monetary damages for breaches of their fiduciary duties as directors, except liability for: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any breach of the director&#146;s duty of loyalty to us or our stockholders; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any unlawful payments related to dividends or unlawful stock repurchases, redemptions or other distributions; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any transaction from which the director derived an improper personal benefit. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These
limitations do not apply to liabilities arising under federal securities laws and do not affect the availability of equitable remedies, including injunctive relief or rescission. If Delaware law is amended to authorize the further elimination or
limiting of a director, then the liability of our directors will be eliminated or limited to the fullest extent permitted by Delaware law as so amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As permitted by Delaware law, our certificate of incorporation that will be effective as of the closing date of this offering will also
provide that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we will indemnify our directors and officers to the fullest extent permitted by law; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we may indemnify our other employees and other agents to the same extent that we indemnify our officers and directors, unless otherwise determined by our board of directors; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we will advance expenses to our directors and officers in connection with legal proceedings in connection with a legal proceeding to the fullest extent permitted by law. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We anticipate entering into indemnification agreements with our directors and officers to provide such officers and directors with additional
contractual assurances regarding the scope of their indemnification. We expect that each of these indemnification agreements will provide that we will indemnify the director or officer to the fullest extent permitted by law for claims arising in his
capacity as a director or officer, provided that he acted in good faith and in a manner that he reasonably believed to be in, or not opposed to, our best interests and, with respect to any criminal proceeding, had no reasonable cause to believe that
his conduct was unlawful. We expect that each of these indemnification agreements will provide that in the event that we do not assume the defense of a claim against a director or officer, we will be required to advance his expenses in connection
with his defense, provided that he undertakes to repay all amounts advanced if it is ultimately determined that he is not entitled to be indemnified by us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We also intend to purchase and maintain insurance on behalf of any person who is or was a director or officer against any loss arising from
any claim asserted against him or her and incurred by him or her in any such capacity, subject to certain exclusions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that
these provisions and agreements are necessary to attract and retain qualified persons as directors and officers. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons
controlling our company pursuant to the foregoing provisions, we understand that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">177 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Policies and Procedures with Respect to Related Party Transactions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with the charter of our audit committee, which will become effective upon the closing of this offering, and our policy on related
party transactions, which our board of directors will adopt in connection with this offering, our audit committee will be responsible for reviewing and approving related party transactions. The related party transaction policy will apply to
transactions, arrangements and relationships where the aggregate amount involved will or may be expected to exceed $120,000 in any calendar year, where we are a participant and in which a related person has or will have a direct or indirect material
interest. A related person is: (1)&nbsp;any of our directors, nominees for director or executive officers; (2)&nbsp;any immediate family member of a director, nominee for director or executive officer; and (3)&nbsp;any person, and his or her
immediate family members, or entity that was a beneficial owner of 5% or more of any of our outstanding equity securities at the time the transaction occurred or existed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the course of its review and approval of related party transactions, our audit committee will consider the relevant facts and circumstances
to decide whether to approve such transactions. Our audit committee will approve only those transactions that it determines are in our best interest. In particular, our policy on related party transactions will require our audit committee to
consider, among other factors it deems appropriate: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">whether the related party transaction is on terms no less favorable than terms generally available to an unaffiliated third party under the same or similar circumstances; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the extent of the related party&#146;s interest in the transaction. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to our policy on
related party transactions, our audit committee will identify the following categories of transactions as deemed to be preapproved by the audit committee, even if the aggregate amount involved exceeds the $120,000 threshold: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our employment of any executive officer or compensation paid by us to any executive officer if our compensation committee approved (or recommended that our board of directors approve) such compensation;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any compensation paid to a director if the compensation is required to be reported in our proxy statement under Item&nbsp;402 of the SEC&#146;s compensation disclosure requirements; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any transaction with another company at which a related person&#146;s only relationship is as an employee (other than an executive officer), director or beneficial owner of less than 10% of that company&#146;s shares,
if the aggregate amount involved does not exceed the greater of $1.0&nbsp;million, or 2% of that company&#146;s total annual net product revenues; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any charitable contribution, grant or endowment made by us to a charitable organization, foundation or university at which a related person&#146;s only relationship is as an employee (other than an executive officer) or
a director, if the aggregate amount involved does not exceed the lesser of $1.0&nbsp;million, or 2% of the charitable organization&#146;s total annual receipts; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any transaction where the related person&#146;s interest arises solely from the ownership of our common stock and all holders of our common stock received the same benefit on a pro rata basis; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any transaction involving a related person where the rates or charges involved are determined by competitive bids; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any transaction with a related person involving the rendering of services as a common or contract carrier, or public utility, at rates or charges fixed in conformity with law or governmental authority; and
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any transaction with a related person involving services as a bank depositary of funds, transfer agent, registrar, trustee under a trust indenture, or similar services. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, our code of business conduct and ethics, which will become effective upon the closing of this offering, requires that each of our
employees and directors inform his or her superior or the chairman of the audit </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">178 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
committee, respectively, of any material transaction or relationship that comes to their attention that could reasonably be expected to create a conflict of interest. Further, at least annually,
each director and executive officer will complete a detailed questionnaire that asks questions about any business relationship that may give rise to a conflict of interest and all transactions in which we are involved and in which the executive
officer, a director or a related person has a direct or indirect material interest. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">179 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom472601_18"></A>PRINCIPAL STOCKHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information as of June 1, 2018 regarding the beneficial ownership of our common stock, giving pro forma effect
to our conversion from a Delaware limited liability company to a Delaware corporation, by: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">each person or group who is known by us to beneficially own more than 5% of our outstanding shares of common stock; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">each of our executive officers; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">each of our directors; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">all of our executive officers and directors as a group. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Beneficial ownership for the purposes
of the following table is determined in accordance with the rules and regulations of the SEC. These rules generally provide that a person is the beneficial owner of securities if such person has or shares the power to vote or direct the voting of
securities, or to dispose or direct the disposition of securities or has the right to acquire such powers within 60 days. For purposes of calculating each person&#146;s percentage ownership, common stock issuable pursuant to options exercisable
within 60 days are included as outstanding and beneficially owned for that person or group, but are not deemed outstanding for the purposes of computing the percentage ownership of any other person. Except as disclosed in the footnotes to this table
and subject to applicable community property laws, we believe that each beneficial owner identified in the table possesses sole voting and investment power over all common stock shown as beneficially owned by the beneficial owner. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The percentage of beneficial ownership is based on 23,470,034 shares of common stock outstanding prior to this offering after giving effect to
our conversion from a Delaware limited liability company to a Delaware corporation and the issuance of shares of common stock in satisfaction of our accrued and unpaid preferred return on our Series A Preferred Units, 27,803,368 shares of common
stock to be outstanding after the completion of this offering, assuming no exercise of the underwriters&#146; option to purchase additional shares of our common stock and 28,453,368 shares of common stock to be outstanding after the completion of
this offering, assuming exercise of the underwriters&#146; option to purchase additional shares of our common stock in full. The percentage of beneficial ownership further assumes that the corporate conversion had occurred on June 1, 2018, based on
the assumed initial public offering price of $15.00 per share (the midpoint of the price range set forth on the cover page of this prospectus). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The number of shares of common stock, and the number of shares of common stock subject to options, of electroCore, Inc. that holders of our
Profits Interests will receive in the corporate conversion will vary depending on the initial public offering price set forth on the cover page of this prospectus. See &#147;Corporate Conversion&#148; and &#147;Pricing Sensitivity Analysis&#148; for
additional information. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated in the table or footnotes below, the address for each beneficial owner is c/o
Electrocore, LLC, 150 Allen Road, Suite 201, Basking Ridge, New Jersey 07920. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain of our direct and indirect unitholders, including
entities affiliated with certain of our directors, have indicated an interest in purchasing an aggregate of $20 million in shares of our common stock in this offering at the initial public offering price per share. Based on an assumed initial public
offering price of $15.00 per share, these holders would purchase up to an aggregate of 1,333,333 of the 4,333,333 shares in this offering based on these indications of interest. However, because indications of interest are not binding agreements or
commitments to purchase, these holders may determine to purchase fewer shares than they indicate an interest in purchasing or not to purchase any shares in this offering. It is also possible that these holders could indicate an interest in
purchasing more shares of our common stock. In addition, the underwriters could determine to sell </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">180 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
fewer shares to any of these holders than the holders indicate an interest in purchasing or not to sell any shares to these holders. The following table does not reflect any of these potential
purchases by these holders or their affiliated entities. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="6" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>After this offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Prior to this offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Assuming&nbsp;underwriters&#146;</B><br><B>option to purchase</B><br><B>additional&nbsp;shares&nbsp;is not</B><br><B>exercised</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Assuming&nbsp;underwriters&#146;</B><br><B>option to purchase</B><br><B>additional shares</B><br><B>is exercised in full</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of Shares<BR>beneficially owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of shares</B><br><B>beneficially owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of shares</B><br><B>beneficially owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:20.00pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B><br><B>of Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage</B><br><B>of Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B><br><B>of shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage<BR>of shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B><br><B>of shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage<BR>of shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>5% or more stockholders</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Core Ventures II, LLC<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,921,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,921,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,921,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">101 JFK Parkway, Short Hills, NJ 07078</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Core Ventures IV, LLC<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,441,646</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,441,646</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,441,646</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">101 JFK Parkway, Short Hills, NJ
07078<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Merck Global Health Innovation Fund,</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,093,696</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,093,696</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,093,696</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">One Merck Drive 2W116, Whitehouse Station, NJ 08889</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kathryn Theofilos<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP><BR>c/o The Theo
Group</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,368,768</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.8</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,368,768</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,368,768</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.8</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">11621 Kew Gardens Ave., Suite 109</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:4.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Palm Beach Gardens, FL 33410</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Executive officers and directors</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Francis R. Amato<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">360,855</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">360,855</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.3</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">360,855</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph P. Errico<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,100,813</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,100,813</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,100,813</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Peter S. Staats, M.D.<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">469,327</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">469,327</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.7</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">469,327</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Glenn S. Vraniak<SUP STYLE="font-size:85%; vertical-align:top"></SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">117,835</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">117,835</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">117,835</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael G. Atieh<SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,524</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,524</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,524</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nicholas Colucci<SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,396</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,396</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,396</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Carrie S. Cox<SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thomas J. Errico, M.D.<SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,806,063</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,806,063</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,806,063</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Trevor Moody<SUP STYLE="font-size:85%; vertical-align:top"></SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,833</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,833</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,833</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stephen L. Ondra, M.D.<SUP STYLE="font-size:85%; vertical-align:top">(10)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael W. Ross<SUP STYLE="font-size:85%; vertical-align:top">(11)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Rubin, Ph.D.<SUP STYLE="font-size:85%; vertical-align:top">(12)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James L.L. Tullis<SUP STYLE="font-size:85%; vertical-align:top">(13)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">261,409</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">261,409</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">261,409</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Executive officers and directors as a group (13 persons)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,157,585</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,157,585</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,157,585</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Indicates beneficial ownership of less than 1.0%. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Joseph P. Errico and Thomas J. Errico, M.D., are the managing members of Core Ventures II, LLC, or CV&nbsp;II, and Core Ventures IV, LLC, or CV IV, and as such have shared voting and dispositive power over the shares
and warrants held by these entities. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Includes (i)&nbsp;110,747 shares held directly by Mrs.&nbsp;Theofilos, (ii)&nbsp;111,660 shares held by CV&nbsp;II, CV&nbsp;IV and certain other entities controlled by Joseph P. Errico and Dr. Thomas J. Errico (the
&#147;Other Entities&#148;) for the benefit of Mrs.&nbsp;Theofilos, and (iii)&nbsp;1,146,361 shares and warrants held by the Other Entities for the benefit of a trust and certain entities in which Mrs.&nbsp;Theofilos is a beneficiary or has a
pecuniary interest. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">Includes (i)&nbsp;351,331 shares held directly by Mr. Amato, and (ii) 9,524 shares held for the benefit of Mr.&nbsp;Amato indirectly by CV II. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">181 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">Includes (i) 632,349 shares held directly by Mr.&nbsp;Errico and 125,173 shares held by Mr.&nbsp;Errico&#146;s spouse, children and trusts for the benefit of Mr.&nbsp;Errico&#146;s spouse and children and (ii) 1,005,260
shares and warrants held for the benefit of Mr.&nbsp;Errico indirectly by the Other Entities. Also includes 11,021,465 shares and warrants held by the Other Entities for the benefit of persons other than Mr.&nbsp;Errico. Mr.&nbsp;Errico serves as a
manager of CV&nbsp;II, CV&nbsp;IV, and the Other Entities and has or shares voting control over such shares and warrants. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top">Includes (i) 151,233 shares held directly by Dr.&nbsp;Staats and his spouse, and (ii) 318,094 shares and warrants held for the benefit of Prand Enterprises, LLC, an entity controlled by Dr. Staats, indirectly by
CV&nbsp;II, CV&nbsp;IV and the Other Entities. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top">Mr. Atieh is a director designee. Consists of shares held by CV II for the benefit of Mr. Atieh. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top">Includes (i)&nbsp;1,255 shares held directly by Mr.&nbsp;Colucci, and (ii)&nbsp;43,141 shares and warrants held for the benefit of Mr.&nbsp;Colucci indirectly by CV II and CV IV. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top">Ms. Cox is a director designee. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top">Includes (i) 443,318 shares held directly by Dr.&nbsp;Errico and 19,454 shares held by trusts for the benefit of Dr.&nbsp;Errico&#146;s family members, and (ii)&nbsp;685,454 shares and warrants held for the benefit of
Dr.&nbsp;Errico indirectly by CV II, CV IV, and the Other Entities. Also includes 11,334,525 shares and warrants held by CV II, CV IV, and the Other Entities for the benefit of persons other than Dr.&nbsp;Errico. Dr.&nbsp;Errico serves as a manager
of CV II, CV IV, and certain of the Other Entities and has or shares voting control over such shares and warrants. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top">Dr. Ondra is a director designee. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top">Mr. Ross was appointed to our board of directors by American Investment Holdings, LLC, but he does not have nor share voting power wither respect to shares of our capital stock owned by American Investment Holdings,
LLC. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top">Dr. Rubin is the managing director of Merck GHI, but he does not have nor share voting power with respect to shares of our capital stock owned by Merck GHI. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(13)</TD>
<TD ALIGN="left" VALIGN="top">Represents (i) 97,894 shares held directly by Mr.&nbsp;Tullis and 64,597 shares held directly by his spouse and family trusts, and (ii) 98,918 shares held directly by Tullis Opportunity Fund II LP. </TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">182 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom472601_101"></A>PRICING SENSITIVITY ANALYSIS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Throughout this prospectus we provide information assuming that the initial public offering price per share of common stock is $15.00, which
is the mid-point of the estimated price range set forth on the cover of this prospectus. However, some of the information that we provide will be affected if the initial public offering price per share of common stock in this offering is different
from the mid-point of the estimated price range set forth on the cover of this prospectus. The following table presents how some of the information set forth in this prospectus would be affected by an initial public offering price per share of
common stock at the low-, mid- and high-points of the estimated price range set forth on the cover of this prospectus, assuming that the underwriters&#146; option to purchase additional common units is not exercised. See &#147;Corporate
Conversion&#148; for additional information. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8.5pt" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Price per share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>$14.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>$15.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>$16.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in thousands, except percentages and<BR>per share data)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman"><B>Shares, warrants and options issued in corporate conversion</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Common stock issuable for:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Common Units</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,099,280</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,099,280</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,099,280</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Series A Preferred Units</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,199,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,181,856</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,166,733</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Series B Preferred Units</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,843,668</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,843,668</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,843,668</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Profits Interests</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,218,252</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,345,230</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,454,931</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,360,335</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,470,034</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,564,612</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Warrants issuable for:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Common Units</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">151,364</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">151,364</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">151,364</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Series A Preferred Units</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,561</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,561</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,561</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Series B Preferred Units</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">550,040</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">550,040</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">550,040</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">721,965</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">721,965</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">721,965</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Options issuable for:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Common Units</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,272,391</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,146,039</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,036,880</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman"><B>Equity ownership percentages following this offering</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Existing owners in this offering</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84.3</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">New investors in this offering</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15.7</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Existing owners in this offering assuming exercise of all outstanding options and
warrants</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">New investors in this offering assuming exercise of all outstanding options and warrants</P></TD>

<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman"><B>Net proceeds</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Net proceeds from this offering (approximate)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">52,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">56,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">60,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman"><B>Pro forma as adjusted capitalization</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">55,373</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">59,403</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">63,433</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Warrant liability</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,485</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,485</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,485</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Stockholders&#146; equity (deficit)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Common stock, $0.001 par value per share</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Preferred stock, $0.001 par value per share</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Additional paid-in capital</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">237,765</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">241,791</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">245,816</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(162,427</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(162,427</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(162,427</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Accumulated other comprehensive income</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(59</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(59</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(59</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Total stockholders&#146; equity (deficit)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,911</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79,941</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">83,971</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Total capitalization</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">78,396</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">82,426</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">86,456</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman"><B>Dilution</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Pro forma as adjusted net tangible book deficit per share after giving effect to this
offering</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Dilution per share to new investors in this offering</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10.73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12.13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13.37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Pro forma as adjusted net tangible book deficit per share after giving effect to this offering
assuming exercise of all outstanding options and warrants</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Dilution per share to new investors in this offering assuming exercise of all outstanding options
and warrants</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11.02</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">183 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, throughout this prospectus we provide information assuming that the
underwriters&#146; option to purchase additional shares of common stock from us is not exercised. However, some of the information that we provide will be affected if the underwriters&#146; option to purchase additional shares of common stock is
exercised. The following table presents how some of the information set forth in this prospectus would be affected if the underwriters exercise in full their option to purchase additional shares of common stock where the initial public offering
price per share of common stock is at the low-, mid- and high-points of the estimated price range set forth on the cover of this prospectus. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8.5pt" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Price per share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$14.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$15.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>$16.00</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in thousands, except percentages and<BR>per share data)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman"><B>Shares, warrants and options issued in conversion</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Common stock issuable for:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Common Units</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,099,280</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,099,280</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,099,280</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Series A Preferred Units</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,199,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,181,856</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,166,733</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Series B Preferred Units</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,843,668</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,843,668</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,843,668</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Profits Interests</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,218,252</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,345,230</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,454,931</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,360,335</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,470,034</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,564,612</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Warrants issuable for:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Common Unit</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">151,364</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">151,364</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">151,364</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Series A Preferred Units</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,561</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,561</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,561</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Series B Preferred Units</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">550,040</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">550,040</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">550,040</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">721,965</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">721,965</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">721,965</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Options issuable for:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Common Units</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,272,391</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,146,039</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,036,880</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman"><B>Equity ownership percentages following this offering</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Existing owners in this offering</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">New investors in this offering</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Existing owners in this offering assuming exercise of all outstanding options and
warrants</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">New investors in this offering assuming exercise of all outstanding options and warrants</P></TD>

<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman"><B>Net proceeds</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Net proceeds from this offering (approximate)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">60,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">65,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">70,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman"><B>Pro forma as adjusted capitalization</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">63,836</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">68,470</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">73,105</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Warrant liability</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,485</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,485</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,485</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Stockholders&#146; equity (deficit)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Common stock, $0.001 par value per share</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Preferred stock, $0.001 par value per share</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Additional paid-in capital</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">246,227</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250,858</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">255,488</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(162,427</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(162,427</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(162,427</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Accumulated other comprehensive income</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(59</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(59</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(59</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Total stockholders&#146; equity (deficit)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84,374</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">89,009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">93,643</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Total capitalization</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">86,859</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">91,494</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">96,128</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman"><B>Dilution</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Pro forma as adjusted net tangible book deficit per share after giving effect to this
offering</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.88</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Dilution per share to new investors in this offering</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11.84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Pro forma as adjusted net tangible book deficit per share after giving effect to this offering
assuming exercise of all outstanding options and warrants</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.81</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:Times New Roman">Dilution per share to new investors in this offering assuming exercise of all outstanding options
and warrants</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10.81</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12.19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">184 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom472601_19"></A>DESCRIPTION OF CAPITAL STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The following description summarizes important terms of our capital stock. For a complete description, you should refer to our certificate
of incorporation and bylaws, forms of which have been filed as exhibits to the registration statement of which this prospectus is a part, as well as the relevant portions of the DGCL. References to our certificate of incorporation and bylaws are to
our certificate of incorporation and our bylaws, respectively, each of which will become effective upon completion of the corporate conversion that will occur prior to the closing of this offering. The description of our common stock and preferred
stock reflects the completion of the corporate conversion that will occur prior to the closing of this offering. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the closing of this offering, our authorized capital stock will consist of: (i) 500,000,000 shares of common stock, par value $0.001 per
share; and (ii) 10,000,000 shares of preferred stock, par value $0.001 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of June 1, 2018, we had no outstanding shares of
common stock, and no holders of common stock of record, After giving effect to the completion of the corporate conversion described above in the section entitled &#147;Corporate Conversion&#148; and based on an assumed initial public offering price
of $15.00 (the midpoint of the range set forth on the cover page of this prospectus), upon completion of the corporate conversion (including the issuance of shares of common stock in respect of our accumulated preferred return on Series A Preferred
Units) and the closing of this offering, there will be 27,803,368 shares of common stock outstanding and no shares of preferred stock outstanding. See &#147;Corporate Conversion&#148; and &#147;Pricing Sensitivity Analysis&#148; for additional
information </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Voting Rights
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each holder of our common stock will be entitled to one vote for each share on all matters submitted to a vote of the
stockholders, including the election of directors. Under our certificate of incorporation and our amended and restated bylaws that will be in effect following the completion of this offering, our stockholders will not have cumulative voting rights.
Because of this, the holders of a majority of the shares of common stock entitled to vote in any election of directors will be able to elect all of the directors standing for election, if they should so choose. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Dividend Rights </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to
preferences that may be applicable to any then-outstanding preferred stock, holders of common stock will not be entitled to receive ratably those dividends, if any, as may be declared from time to time by the board of directors out of legally
available funds. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Liquidation Rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of our liquidation, dissolution or winding up, holders of common stock will be entitled to share ratably in the net assets legally
available for distribution to stockholders after the payment of all of our debts and other liabilities and the satisfaction of any liquidation preference granted to the holders of any then-outstanding shares of preferred stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other Rights and Preferences </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of our common stock will have no preemptive, conversion or subscription rights and there will be no redemption or sinking fund
provisions applicable to the common stock. The rights, preferences and privileges of the holders of common stock will be subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock that we may
designate in the future. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">185 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preferred Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following the corporate conversion and the completion of this offering, our board of directors will have the authority, without further action
by our stockholders, to issue up to 10.0 million shares of preferred stock in one or more series, to establish from time to time the number of shares to be included in each such series, to fix the rights, preferences and privileges of the shares of
each series and any qualifications, limitations or restrictions thereon, and to increase or decrease the number of shares of any such series, but not below the number of shares of such series then outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting
power or other rights of the holders of our common stock. The purpose of authorizing our board of directors to issue preferred stock and determine its rights and preferences is to eliminate delays associated with a stockholder vote on specific
issuances. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing a change of control of our
company and may adversely affect the market price of our common stock and the voting and other rights of the holders of our common stock. It is not possible to state the actual effect of the issuance of any shares of preferred stock on the rights of
holders of common stock until the board of directors determines the specific rights attached to that preferred stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have no present
plans to issue any shares of preferred stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Registration Rights </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under our Amended and Restated Investor Rights Agreement, following the consummation of this offering, the holders of approximately 16.2
million shares of common stock, or their transferees, will have the right to require us to register their shares under the Securities Act so that those shares may be publicly resold, or to include their shares in any registration statement we file,
in each case as described below. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Demand Registration Rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on the number of shares outstanding as of 2018, after the consummation of this offering, the holders of approximately 16.2 million shares
of our common stock (on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis), or their transferees, will be entitled to certain demand registration rights. Beginning one hundred eighty (180)&nbsp;days following the effectiveness of the
registration statement of which this prospectus is a part, the holders of at least 55% of these shares can, on not more than three occasions, request that we register at least 40% of the shares issued to such holders, or a lesser percentage if the
anticipated aggregate offering price, net of underwriting discounts and commissions, would exceed $5,000,000. Additionally, we will not be required to effect a demand registration during the period beginning 60 days prior to our good faith estimate
of the filing of, and ending 180 days following the effectiveness of, a company-initiated registration statement relating to an initial public offering of our securities. These registration rights are further subject to specified conditions and
limitations, including the right of the underwriters, if any, to limit the number of shares included in any such registration under specified circumstances. Upon such a request, we are required to use commercially reasonable efforts to effect the
registration as soon as practicable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Piggyback Registration Rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on the number of shares outstanding as of 2018, after the consummation of this offering, in the event that we determine to register any
of our securities under the Securities Act (subject to certain exceptions), either for our own account or for the account of other security holders, the holders of approximately 16.2 million shares of our common stock (on an <FONT
STYLE="white-space:nowrap">as-converted</FONT> basis), or their transferees, will be entitled to certain &#147;piggyback&#148; registration rights allowing the holders to include their shares in such registration, subject to certain marketing and
other limitations. As a result, whenever we propose to file a registration statement under the Securities Act, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">186 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
other than with respect to a registration related to employee benefit plans, the offer and sale of debt securities, or corporate reorganizations or certain other transactions, the holders of
these shares are entitled to notice of the registration and have the right, subject to limitations that the underwriters may impose on the number of shares included in the registration, to include their shares in the registration. In an underwritten
offering, the managing underwriter, if any, has the right, subject to specified conditions, to limit the number of shares such holders may include. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Registration on Form <FONT STYLE="white-space:nowrap">S-3</FONT> </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on the number of shares outstanding as of 2018, after the consummation of this offering, the holders of approximately 16.2 million shares
of our common stock (on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis), or their transferees, will be entitled to certain Form <FONT STYLE="white-space:nowrap">S-3</FONT> registration rights. The holders of at least 20% of these
shares can make a written request that we register their shares on Form <FONT STYLE="white-space:nowrap">S-3</FONT> if we are eligible to file a registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> and if the aggregate price to
the public of the shares offered is at least $500,000 net of certain expenses related to the sale of the shares. These stockholders may make an unlimited number of requests for registration on Form <FONT STYLE="white-space:nowrap">S-3,</FONT> but in
no event shall we be required to file more than two registrations on Form <FONT STYLE="white-space:nowrap">S-3</FONT> within any <FONT STYLE="white-space:nowrap">12-month</FONT> period. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Expenses of Registration </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will
pay all expenses relating to any demand, piggyback or Form <FONT STYLE="white-space:nowrap">S-3</FONT> registration, other than underwriting discounts and commissions, subject to specified conditions and limitations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Termination of Registration Rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registration rights granted under the Amended and Restated Investor Rights Agreement will terminate, with respect to a particular holder,
at the earlier of: (i) such time as that holder and its affiliates may sell all of their shares of common stock pursuant to Rule 144 under the Securities Act during any <FONT STYLE="white-space:nowrap">90-day</FONT> period; and (ii)&nbsp;the seven
year anniversary of this offering. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Anti-Takeover Provisions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The provisions of Delaware law, and our certificate of incorporation and our bylaws could have the effect of delaying, deferring or
discouraging another person from acquiring control of our company. These provisions, which are summarized below, may have the effect of discouraging takeover bids. They are also designed, in part, to encourage persons seeking to acquire control of
us to negotiate first with our board of directors. We believe that the benefits of increased protection of our potential ability to negotiate with an unfriendly or unsolicited acquirer outweigh the disadvantages of discouraging a proposal to acquire
us because negotiation of these proposals could result in an improvement of their terms. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Section&nbsp;203 of the Delaware General Corporation Law
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are subject to Section&nbsp;203 of the DGCL, which prohibits a Delaware corporation from engaging in any business combination
with any interested stockholder for a period of three years after the date that such stockholder became an interested stockholder, with the following exceptions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">before such date, the board of directors of the corporation approved either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">upon completion of the transaction that resulted in the stockholder becoming an interested stockholder, the
interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction began, excluding for purposes of determining the voting stock outstanding, but not the outstanding voting stock owned by the
interested stockholder, those shares owned (i)&nbsp;by persons </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">187 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
who are directors and also officers and (ii)&nbsp;employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan
will be tendered in a tender or exchange offer; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">on or after such date, the business combination is approved by the board of directors and authorized at an annual or special meeting of the stockholders, and not by written consent, by the affirmative vote of at least
66 2/3% of the outstanding voting stock that is not owned by the interested stockholder. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In general, Section&nbsp;203
defines a &#147;business combination&#148; to include the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any merger or consolidation involving the corporation and the interested stockholder; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any sale, transfer, pledge or other disposition of 10% or more of the assets of the corporation involving the interested stockholder; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">subject to specified exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any transaction involving the corporation that has the effect of increasing the proportionate share of the stock or any class or series of the corporation beneficially owned by the interested stockholder; or
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits by or through the corporation. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In general, Section&nbsp;203 defines an &#147;interested stockholder&#148; as an entity or person who, together with the person&#146;s
affiliates and associates, beneficially owns, or within three years prior to the time of determination of interested stockholder status did own, 15% or more of the outstanding voting stock of the corporation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our Certificate of Incorporation and Bylaws </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our certificate of incorporation and bylaws will include a number of provisions that could deter hostile takeovers or delay or prevent changes
in control of our company, including the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Classified Board.</I></B> Our certificate of incorporation will provide for our board of directors to be divided into three classes with staggered three-year terms. Only one class of directors will be elected at
each annual meeting of our stockholders, with the other classes continuing for the remainder of their respective three-year terms. Because our stockholders do not have cumulative voting rights, stockholders holding a majority of the shares of common
stock outstanding will be able to elect all of our directors. Our certificate of incorporation and our bylaws will also provide that directors may be removed by the stockholders only for cause upon the vote of 66 2/3% or more of our outstanding
common stock. Furthermore, the authorized number of directors may be changed only by resolution of the board of directors, and vacancies and newly created directorships on the board of directors may, except as otherwise required by law or determined
by the board, only be filled by a majority vote of the directors then serving on the board, even though less than a quorum. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Special Meetings of Stockholders and Stockholder Action by Written Consent. </I></B>Our certificate of incorporation and bylaws will provide that all stockholder actions must be effected at a duly called meeting
of stockholders and will eliminate the right of stockholders to act by written consent without a meeting. Our bylaws will also provide that only our chairman of the board, Chief Executive Officer (or if there is no Chief Executive Officer, the
President) or the board of directors pursuant to a resolution adopted by a majority of the total number of authorized directors may call a special meeting of stockholders. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Advance Notice Requirements for Stockholder Proposals</I></B>. Our bylaws will provide that stockholders seeking to present proposals before a meeting of stockholders, including the nomination of director
candidates, must provide timely advance notice in writing, and will specify requirements as to the form and content of a stockholder&#146;s notice. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">188 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Amendment to Certificate of Incorporation and Bylaws.</I></B> Our certificate of incorporation and bylaws will provide that the stockholders cannot amend the provisions described above except by a vote of 66 2/3%
or more of our outstanding common stock. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The combination of these provisions will make it more difficult for our existing
stockholders to replace our board of directors as well as for another party to obtain control of us by replacing our board of directors. Since our board of directors has the power to retain and discharge our officers, these provisions could also
make it more difficult for existing stockholders or another party to effect a change in management. In addition, the authorization of undesignated preferred stock makes it possible for our board of directors to issue preferred stock with voting or
other rights or preferences that could impede any attempt to effect a change of control of our company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These provisions are intended to
enhance the likelihood of continued stability in the composition of our board of directors and its policies and to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed to reduce our vulnerability to
hostile takeovers and to discourage tactics that may be used in proxy fights. However, such provisions could have the effect of discouraging others from making tender offers for our shares and may have the effect of delaying changes in our control
or management. As a consequence, these provisions may also inhibit fluctuations in the market price of our stock that could result from actual or rumored takeover attempts. We believe that the benefits of these provisions, including increased
protection of our potential ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure our company, outweigh the disadvantages of discouraging takeover proposals, because negotiation of takeover
proposals could result in an improvement of their terms. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Choice of Forum </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our certificate of incorporation will provide that the Court of Chancery of the state of Delaware will be the exclusive forum for: (i) any
derivative action or proceeding brought on our behalf; (ii) any action asserting a breach of fiduciary duty; (iii) any action asserting a claim against us arising pursuant to the DGCL, our certificate of incorporation or our bylaws; (iv) or any
action asserting a claim against us that is governed by the internal affairs doctrine. Our certificate of incorporation further provides that the federal district courts of the United States will be the exclusive forum for resolving any complaint
asserting a cause of action arising under the Securities Act. The enforceability of similar choice of forum provisions in some other companies&#146; certificates of incorporation has been challenged in legal proceedings, and it is possible that, in
connection with any action, a court could find the choice of forum provisions contained in our certificate of incorporation to be inapplicable or unenforceable in such action. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Limitation of Liability and Indemnification </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our certificate of incorporation will provide that no director will be personally liable for monetary damages for breach of any fiduciary duty
as a director, except with respect to liability: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">for any breach of the director&#146;s duty of loyalty to us or our stockholders; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">for acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">under Section&nbsp;174 of the DGCL (governing distributions to stockholders); or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">for any transaction from which the director derived any improper personal benefit. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the
DGCL is amended to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of our directors will be eliminated or limited to the fullest extent permitted by the DGCL, as so amended. The
modification or repeal of this provision of our certificate of incorporation will not adversely affect any right or protection of a director existing at the time of such modification or repeal. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">189 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our bylaws will also provide that we will, to the fullest extent permitted by law, indemnify
our directors and officers against all liabilities and expenses in any suit or proceeding or arising out of their status as an officer or director or their activities in these capacities. We will also indemnify any person who, at our request, is or
was serving as a director, officer, employee, agent or trustee of another corporation or of a partnership, limited liability company, joint venture, trust or other enterprise. We may, by action of our board of directors, provide indemnification to
our employees and agents within the same scope and effect as the foregoing indemnification of directors and officers. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transfer Agent and Registrar
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The transfer agent and registrar for our common stock will be Broadridge Corporate Issuer Solutions, Inc. 1717 Arch Street, Suite
1300, Philadelphia, Pennsylvania 19103. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stock Exchange Listing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have applied to list our common stock on the Nasdaq Global Select Market under the symbol &#147;ECOR.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">190 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom472601_20"></A>SHARES ELIGIBLE FOR FUTURE SALE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to this offering, there has not been a public market for shares of our common stock, and we cannot predict the effect, if any, that
market sales of shares of our common stock or the availability of shares of our common stock for sale will have on the market price of our common stock prevailing from time to time. Nevertheless, sales of substantial amounts of our common stock,
including shares issued upon exercise of outstanding options, in the public market following this offering could adversely affect market prices prevailing from time to time and could impair our ability to raise capital through the sale of our equity
securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based upon the number of shares of our common stock outstanding as of June 1, 2018, and after giving effect to the corporate
conversion, based on the assumed initial public offering price of $15.00 (the midpoint of the price range set forth on the cover page of this prospectus) we will have 27,803,368 shares of common stock outstanding upon the closing of this offering.
Of these outstanding shares, all of the shares of common stock sold in this offering will be freely tradable, except that any shares purchased in this offering by our affiliates, as that term is defined in Rule 144 under the Securities Act, would
only be able to be sold in compliance with the Rule 144 limitations described below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The remaining outstanding shares of our common stock
will be deemed &#147;restricted securities&#148; as defined in Rule 144. Restricted securities may be sold in the public market only if they are registered under the Securities Act or if they qualify for an exemption from registration under Rule 144
or Rule 701 promulgated under the Securities Act, which rules are summarized below. In addition, all of our security holders have entered into market standoff agreements with us or <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements with the
underwriters under which they have agreed, subject to specific exceptions, not to sell any of our stock for at least 180 days following the date of this prospectus, as described below. As a result of these agreements and the provisions of our
amended and restated investors&#146; rights agreement described above under &#147;Description of Capital Stock&#151;Registration Rights,&#148; subject to the provisions of Rule 144 or Rule 701, shares will be available for sale in the public market
as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">beginning on the date of this prospectus, all of the shares sold in this offering will be immediately available for sale in the public market (except as described above); and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">beginning 181 days after the date of this prospectus, approximately 23.0 million additional shares will become eligible for sale in the public market, of which approximately 17.3 million shares will be held by
affiliates and subject to the volume and other restrictions of Rule 144, as described below. </TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain of our direct and
indirect unitholders, including entities affiliated with certain of our directors, have indicated an interest in purchasing an aggregate of $20 million in shares of our common stock in this offering at the initial public offering price per share.
Any such shares purchased by these holders who are considered to be our affiliates could not be resold in the public market immediately following this offering as a result of restrictions under securities laws, but would be able to be sold following
the expiration of these restrictions, as described below. However, because indications of interest are not binding agreements or commitments to purchase, the underwriters may determine to sell more, less or no shares in this offering to any of these
holders, or any of these holders may determine to purchase more, less or no shares in this offering. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Lock-Up</FONT>
and Market Standoff Agreements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All of our directors, executive officers and substantially all of our security holders are subject to <FONT
STYLE="white-space:nowrap">lock-up</FONT> agreements or market standoff provisions that, subject to certain exceptions, prohibit them from directly or indirectly offering, pledging, selling, contracting to sell, selling any option or contract to
purchase, purchasing any option or contract to purchase, granting any option, right or warrant to purchase or otherwise transferring or disposing of any shares of our common stock, options to acquire shares of our common stock or any securities
convertible into or exercisable or exchangeable for common stock, whether now owned or hereafter acquired, or entering into any swap or any other agreement or any transaction that transfer, in whole or in part, directly or indirectly, the economic
consequence of ownership, for a period of 180 days following the date of this prospectus, without the prior written consent of Evercore Group L.L.C. See the section entitled &#147;Underwriting.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">191 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Rule 144 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In general, under Rule 144 as currently in effect, once we have been subject to public company reporting requirements for at least 90 days, a
person who is not deemed to have been one of our affiliates for purposes of the Securities Act at any time during the 90 days preceding a sale and who has beneficially owned the shares proposed to be sold for at least six months, including the
holding period of any prior owner other than our affiliates, is entitled to sell those shares without complying with the manner of sale, volume limitation or notice provisions of Rule 144, subject to compliance with the public information
requirements of Rule 144. If such a person has beneficially owned the shares proposed to be sold for at least one year, including the holding period of any prior owner other than our affiliates, then that person would be entitled to sell those
shares without complying with any of the requirements of Rule 144. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In general, under Rule 144, as currently in effect, our affiliates or
persons selling shares on behalf of our affiliates are entitled to sell upon expiration of the <FONT STYLE="white-space:nowrap">lock-up</FONT> and market standoff agreements described above, within any three-month period, a number of shares that
does not exceed the greater of: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">1% of the number of shares of our common stock then outstanding, which will equal approximately 278,000 shares immediately after this offering; or </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the average weekly trading volume of our common stock during the four calendar weeks preceding the filing of a notice on Form 144 with respect to that sale. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sales under Rule 144 by our affiliates or persons selling shares on behalf of our affiliates are also subject to certain manner of sale
provisions and notice requirements and to the availability of current public information about us. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Rule 701 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Rule 701 generally allows a stockholder who purchased shares of our common stock pursuant to a written compensatory plan or contract and who is
not deemed to have been an affiliate of our company during the immediately preceding 90 days to sell these shares in reliance upon Rule 144, but without being required to comply with the public information, holding period, volume limitation or
notice provisions of Rule 144. Rule 701 also permits affiliates of our company to sell their Rule 701 shares under Rule 144 without complying with the holding period requirements of Rule 144. All holders of Rule 701 shares, however, are required by
that rule to wait until 90 days after the date of this prospectus before selling those shares pursuant to Rule 701 and are subject to the <FONT STYLE="white-space:nowrap">lock-up</FONT> and market standoff agreements described above. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stock Options </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with this
offering, we intend to file a registration statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> under the Securities Act covering all of the shares of our common stock subject to outstanding options and the shares of our common stock
reserved for issuance under our stock plans. We expect to file this registration statement as soon as permitted under the Securities Act. However, the shares registered on Form <FONT STYLE="white-space:nowrap">S-8</FONT> may be subject to the volume
limitations and the manner of sale, notice and public information requirements of Rule 144 and will not be eligible for resale until expiration of the <FONT STYLE="white-space:nowrap">lock-up</FONT> and market standoff agreements to which they are
subject. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Registration Rights </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
have granted demand, piggyback and Form <FONT STYLE="white-space:nowrap">S-3</FONT> registration rights to certain of our stockholders to sell our common stock. Registration of the sale of these shares under the Securities Act would result in these
shares becoming freely tradable without restriction under the Securities Act immediately upon the effectiveness of the registration, except for shares purchased by affiliates. For a further description of these rights, see &#147;Description of
Capital Stock&#151;Registration Rights.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">192 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom472601_21"></A>CERTAIN MATERIAL U.S. FEDERAL INCOME AND ESTATE TAX
CONSIDERATIONS </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR <FONT STYLE="white-space:nowrap">NON-U.S.</FONT> HOLDERS OF COMMON STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a general discussion of material U.S. federal income tax considerations and certain U.S.&nbsp;estate tax considerations
relating to the ownership and disposition of our common stock applicable to <FONT STYLE="white-space:nowrap">non-U.S.&nbsp;holders.</FONT> For purposes of this discussion, a <FONT STYLE="white-space:nowrap">&#147;non-U.S.</FONT> holder&#148; means a
beneficial owner of our common stock (other than an entity or arrangement that is treated as a partnership for U.S. federal income tax purposes) that is not, for U.S. federal income tax purposes, any of the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">an individual who is a citizen or resident of the United States; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a corporation (or other entity treated as a corporation for U.S. federal income tax purposes) created or organized in the United States or under the laws of the United States, any state thereof or the District of
Columbia; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">an estate, the income of which is includable in gross income for U.S. federal income tax purposes regardless of its source; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a trust if (i)&nbsp;a court within the United States is able to exercise primary supervision over the administration of the trust and one or more &#147;U.S. persons,&#148; as defined under the U.S. Internal Revenue Code
of 1986, as amended (which we refer to as the Code), have the authority to control all substantial decisions of the trust or (ii)&nbsp;such trust has made a valid election to be treated as a U.S. person for U.S.&nbsp;federal income tax purposes.
</TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This discussion is based on current provisions of the Code, final, temporary and proposed Treasury regulations promulgated
thereunder (which we refer to as the Treasury Regulations), judicial decisions, published rulings and administrative pronouncements of the U.S. Internal Revenue Service, or IRS, all in effect as of the date of this prospectus and all of which are
subject to change or to differing interpretation, possibly with retroactive effect. Any change could alter the tax consequences to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders described herein. There can be no assurance that the IRS,
will not challenge one or more of the tax consequences described herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This discussion is limited to
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders that hold our common stock as a &#147;capital asset&#148; within the meaning of Section&nbsp;1221 of the Code (generally, property held for investment). This discussion does not address all
aspects of U.S. federal income and estate taxation that may be relevant to a particular <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder in light of that <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s individual circumstances
nor does it address any aspects of U.S. state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> taxes, the alternative minimum tax, or the unearned income Medicare contribution tax on net investment income. This discussion also does not
consider any specific facts or circumstances that may apply to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder and does not address the special tax rules applicable to particular <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders,
such as: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">banks, insurance companies and other financial institutions; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">brokers or dealers or traders in securities; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">tax-exempt</FONT> organizations; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">pension plans; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">persons who hold our common stock as part of a straddle, hedge, conversion transaction, synthetic security or other integrated investment or who have elected to mark securities to market; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">&#147;controlled foreign corporations,&#148; &#147;passive foreign investment companies,&#148; and corporations that accumulate earnings to avoid U.S. federal income tax; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">persons who hold or receive our common stock pursuant to the exercise of any employee stock option or otherwise as compensation; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">persons for whom our common stock constitutes &#147;qualified small business stock&#148; within the meaning of Section&nbsp;1202 of the Code; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">193 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">persons subject to special tax accounting rules as a result of any item of gross income with respect to our common stock being taken into account in an applicable financial statement; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">non-U.S.</FONT> governments; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">U.S. expatriates and former citizens or long-term residents of the United States. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a
partnership (or other entity or arrangement treated as a partnership for U.S. federal income tax purposes) holds our common stock, the tax treatment of a partner therein will generally depend on the status of the partner and the activities of the
partnership. Partners of a partnership holding our common stock should consult their tax advisors as to the particular U.S. federal income tax consequences applicable to them. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIS SUMMARY IS NOT INTENDED TO CONSTITUTE A COMPLETE DESCRIPTION OF ALL TAX CONSEQUENCES FOR <FONT STYLE="white-space:nowrap">NON-U.S.</FONT>
HOLDERS RELATING TO THE OWNERSHIP AND DISPOSITION OF OUR COMMON STOCK. PROSPECTIVE HOLDERS OF OUR COMMON STOCK SHOULD CONSULT WITH THEIR TAX ADVISORS REGARDING THE TAX CONSEQUENCES TO THEM (INCLUDING THE APPLICATION AND EFFECT OF ANY STATE, LOCAL, <FONT
STYLE="white-space:nowrap">NON-U.S.</FONT> INCOME AND OTHER TAX LAWS) OF THE OWNERSHIP AND DISPOSITION OF OUR COMMON STOCK. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Distributions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As discussed under &#147;Dividend Policy&#148; above, we do not expect to make distributions on our common stock in the foreseeable future.
However, if we do make distributions of cash or property on our common stock, such distributions will constitute dividends for U.S. federal income tax purposes to the extent paid from our current or accumulated earnings and profits, as determined
under U.S. federal income tax principles. Amounts of distributions not treated as dividends for U.S. federal income tax purposes will first constitute a <FONT STYLE="white-space:nowrap">tax-free</FONT> return of capital of the <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s investment and be applied against and reduce a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s adjusted tax basis in its common stock, but not below zero. Any remaining excess
will be treated as capital gain and will be treated as described below under &#147;Gain on Sale or Other Disposition of Common Stock.&#148; Any such distributions will also be subject to the discussions below under the headings &#147;FATCA&#148; and
&#147;Backup Withholding, Information Reporting and Other Reporting Requirements.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the discussion in the next paragraph
regarding effectively connected income, dividends paid to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder generally will be subject to withholding of U.S. federal income tax at a 30% rate or such lower rate as may be specified by an
applicable income tax treaty between the United States and such holder&#146;s country of residence. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dividends we pay to a <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder that are effectively connected with its conduct of a trade or business within the United States (and, if required by an applicable tax treaty, are attributable to a U.S. permanent establishment or a
fixed base maintained by such <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder) will generally be exempt from the U.S. federal withholding tax, as described above, if the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder complies with
applicable certification and disclosure requirements (generally including provision of a valid IRS Form <FONT STYLE="white-space:nowrap">W-8ECI</FONT> (or applicable successor form) certifying that the dividends are effectively connected with the <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s conduct of a trade or business within the United States). Instead, such dividends generally will be subject to U.S. federal income tax on a net income basis, at regular U.S. federal income tax
rates as would apply if such holder were a U.S. person (as defined in the Code). Any U.S. effectively connected income received by a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder that is classified as a corporation for U.S.&nbsp;federal
income tax purposes, may also be subject to an additional &#147;branch profits tax&#148; at a rate of 30% (or such lower rate as may be specified by an applicable income tax treaty). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder of our common stock who claims the benefit of an applicable income tax treaty
between the United States and such holder&#146;s country of residence generally will be required to provide a properly executed IRS Form <FONT STYLE="white-space:nowrap">W-8BEN</FONT> or <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> (or successor form) and satisfy applicable certification and other requirements. <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders are urged to consult their tax advisors regarding their
entitlement to benefits under a relevant income tax treaty and the specific methods available to them to satisfy these requirements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">194 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Gain on Sale or Other Disposition of Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the discussion below under the headings &#147;FATCA&#148; and &#147;Backup Withholding, Information Reporting and Other Reporting
Requirements,&#148; a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder generally will not be subject to U.S. federal income tax on any gain realized upon the sale or other disposition of the <FONT STYLE="white-space:nowrap">non-U.S.</FONT>
holder&#146;s shares of common stock unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the gain is effectively connected with a trade or business carried on by the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder within the United States (and, if required by an applicable income tax treaty, is
attributable to a U.S. permanent establishment or fixed base maintained by such <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder); </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is an individual and is present in the United States for 183 days or more in the taxable year of disposition and certain other conditions are met; or
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we are or have been a &#147;U.S. real property holding corporation&#148; for U.S. federal income tax purposes at any time within the shorter of the five-year period preceding such disposition or such <FONT
STYLE="white-space:nowrap">non-U.S.&nbsp;holder&#146;s</FONT> holding period of our common stock, and, provided that our common stock is regularly traded in an established securities market within the meaning of applicable Treasury Regulations, the <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder has held, directly or constructively, at any time during said period, more than 5% of our common stock. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Gain that is effectively connected with the conduct of a trade or business in the United States generally will be subject to U.S. federal
income tax on a net income tax basis, at regular U.S. federal income tax rates. If the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> corporation, the branch profits tax described above
also may apply to such effectively connected gain. An individual <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder who is subject to U.S. federal income tax because the <FONT STYLE="white-space:nowrap">non-U.S.&nbsp;holder</FONT> was present
in the United States for 183 days or more during the year of sale or other disposition of our common stock will be subject to a flat 30% tax (or such lower rate as may be specified by an applicable income tax treaty) on the gain derived from such
sale or other disposition, which may be offset by certain U.S. source capital losses, if any. We believe that we are not and we do not anticipate becoming a U.S. real property holding corporation for U.S. federal income tax purposes. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FATCA </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Foreign Account Tax Compliance
Act, or FATCA, imposes a U.S. federal withholding tax of 30% on certain payments to foreign financial institutions, investment funds and certain other <FONT STYLE="white-space:nowrap">non-U.S.</FONT> persons that fail to comply with certain
information reporting and certification requirements pertaining to their direct and indirect U.S.&nbsp;securityholders and/or U.S. accountholders and are not otherwise exempt. Under applicable Treasury Regulations and IRS guidance, this withholding
currently applies to payments of dividends, if any, on our common stock and will apply to payments of gross proceeds from a sale or other disposition of our common stock made on or after January&nbsp;1, 2019. An intergovernmental agreement between
the U.S. and an applicable foreign country may modify the requirements described in this paragraph. Prospective investors are encouraged to consult with their tax advisors regarding the possible implications of this legislation on their investment
in our common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Backup Withholding, Information Reporting and Other Reporting Requirements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We must report annually to the IRS and to each <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder the amount of any distributions paid to,
and the tax withheld with respect to, each <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder. These reporting requirements apply regardless of whether withholding was reduced or eliminated by an applicable income tax treaty. Copies of this
information reporting may also be made available under the provisions of a specific income tax treaty or agreement with the tax authorities in the country in which the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder resides or is
established. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder will generally be subject to backup withholding for dividends on
our common stock paid to such holder unless such holder certifies under penalties of perjury that, among other things, it is a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">195 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
holder (provided that the payor does not have actual knowledge or reason to know that such holder is a U.S. person) or otherwise establishes an exemption. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Information reporting and backup withholding generally will apply to the proceeds of a disposition of our common stock by a <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder effected by or through the U.S. office of any broker, U.S. or <FONT STYLE="white-space:nowrap">non-U.S.,</FONT> unless the holder certifies its status as a
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder and satisfies certain other requirements, or otherwise establishes an exemption. Generally, information reporting and backup withholding will not apply to a payment of disposition proceeds to a
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder where the transaction is effected outside the United States through a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> office of a broker. However, for information reporting purposes,
dispositions effected through a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> office of a broker with substantial U.S. ownership or operations generally will be treated in a manner similar to dispositions effected through a U.S. office of a
broker. <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders should consult their tax advisors regarding the application of the information reporting and backup withholding rules to them. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Backup withholding is not an additional income tax. Any amounts withheld under the backup withholding rules from a payment to a <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder generally can be credited against the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s U.S. federal income tax liability, if any, or refunded, provided that the required information is
furnished to the IRS in a timely manner. <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders should consult their tax advisors regarding the application of the information reporting and backup withholding rules to them. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>U.S. Federal Estate Tax </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares of our
common stock that are owned or treated as owned by an individual who is not a citizen or resident of the United States (as specially defined for U.S. federal estate tax purposes) at the time of death are considered U.S. situs assets and will be
included in the individual&#146;s gross estate for U.S. federal estate tax purposes. Such shares, therefore, may be subject to U.S. federal estate tax, unless an applicable estate tax or other treaty provides otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>The preceding discussion of material U.S. federal income tax considerations and certain U.S. estate tax considerations is for information
only. It is not legal or tax advice. Prospective investors should consult their tax advisors regarding the particular U.S. federal, state, local and <FONT STYLE="white-space:nowrap">non-U.S.</FONT> tax consequences of owning and disposing of our
common stock, including the consequences of any proposed changes in applicable laws. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">196 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom472601_22"></A>UNDERWRITING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Evercore Group L.L.C., Cantor Fitzgerald &amp; Co., and JMP Securities LLC are acting as representatives of each of the underwriters named
below. Subject to the terms and conditions set forth in an underwriting agreement among us and the underwriters, we have agreed to sell to the underwriters, and each of the underwriters has agreed, severally and not jointly, to purchase from us, the
number of shares of our common stock set forth opposite its name below. </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="74%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:46.20pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Underwriters</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Evercore Group L.L.C.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cantor Fitzgerald &amp; Co.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">JMP Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BTIG, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,333,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriting agreement provides that the obligations of the several underwriters to pay for and
accept delivery of the shares of common stock offered by this prospectus are subject to the approval of certain legal matters by their counsel and to certain other conditions, including the receipt by the underwriters of officers&#146; certificates,
legal opinions and &#147;comfort&#148; letters from our outside auditors. The underwriters are obligated to take and pay for all of the shares of common stock offered by this prospectus if any such shares are taken. However, the underwriters are not
required to take or pay for the shares covered by the underwriters&#146; option to purchase additional shares described below. If an underwriter defaults, the underwriting agreement provides that the purchase commitments of the <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> underwriters may be increased or the underwriting agreement may be terminated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have
agreed to indemnify the several underwriters against certain liabilities, including liabilities under the Securities Act relating to losses or claims resulting from material misstatements in or omissions from this prospectus, the registration
statement of which this prospectus is a part, certain free writing prospectuses that may be used in the offering and in any marketing materials used in connection with this offering and to contribute to payments the underwriters may be required to
make in respect of those liabilities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Discounts and Commissions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The representatives have advised us that the underwriters propose initially to offer the shares to the public at the public offering price set
forth on the cover page of this prospectus and to dealers at that price less a concession not in excess of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share. After the initial offering, the public offering price,
concession or any other term of this offering may be changed. The underwriters reserve the right to withdraw, cancel or modify offers to the public and to reject orders in whole or in part. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table shows the public offering price, underwriting discount and proceeds, before expenses, to us. The information assumes
either no exercise or full exercise by the underwriters of their option to purchase additional shares. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="64%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per&nbsp;Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Without<BR>Option</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>With<BR>Option</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Public Offering Price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underwriter Discount</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds, before expenses, to us</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The estimated offering expenses payable by us, exclusive of the underwriting discount and commissions, are
approximately $4.0&nbsp;million. We have also agreed to reimburse the underwriters for certain of their expenses in an amount not to exceed $35,000. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">197 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Option to Purchase Additional Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have granted to the underwriters an option, exercisable for 30 days from the date of this prospectus, to purchase up to 649,999 additional
shares of common stock at the public offering price listed on the cover page of this prospectus, less the underwriting discount and commissions. To the extent the option is exercised, each underwriter will become obligated, subject to certain
conditions, to purchase the same percentage of the additional shares of common stock as the number listed next to the underwriter&#146;s name in the table above bears to the total number of shares of common stock listed next to the names of all
underwriters in the preceding table. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No Sales of Similar Securities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We, our executive officers and directors and substantially all of our other existing security holders have agreed not to sell or transfer any
shares of our common stock or securities convertible into, exchangeable for, exercisable for, or repayable with shares of our common stock, for 180 days after the date of this prospectus without first obtaining the written consent of Evercore Group
L.L.C. Specifically, we and these other persons have agreed, with certain limited exceptions, not to directly or indirectly: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">offer, pledge, announce the intention to sell, sell or contract to sell any shares of our common stock; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">sell any option or contract to purchase any shares of our common stock; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">purchase any option or contract to sell any shares of our common stock; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">grant any option, right or warrant to purchase any shares of our common stock; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">dispose of or otherwise transfer any shares of our common stock; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">demand that we file a registration statement related to our common stock; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">enter into any swap or other agreement that transfers, in whole or in part, the economic consequence of ownership of any shares of our common stock whether any such swap or transaction is to be settled by delivery of
shares or other securities, in cash or otherwise. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This <FONT STYLE="white-space:nowrap">lock-up</FONT> provision applies to
shares of our common stock and to securities convertible into or exchangeable or exercisable for or repayable with shares of our common stock. It also applies to shares of our common stock owned now or acquired later by the person executing the
agreement or for which the person executing the agreement later acquires the power of disposition. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Listing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have applied to list our common stock on The Nasdaq Global Select Market under the symbol &#147;ECOR.&#148; In order to meet the
requirements for listing on that exchange, the underwriters have undertaken to sell a minimum number of shares to a minimum number of beneficial owners as required by that exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Before this offering, there has been no public market for our common stock. The initial public offering price will be determined through
negotiations between us and the representatives. In addition to prevailing market conditions, the factors to be considered in determining the initial public offering price are: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the valuation multiples of publicly traded companies that the representatives believe to be comparable to us; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our financial information; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the history of, and the prospects for, our company and the industry in which we compete; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">an assessment of our management, its past and present operations and the prospects for, and timing of, our future net sales; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the present state of our development; and </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">198 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the above factors in relation to market values and various valuation measures of other companies engaged in activities similar to ours. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An active trading market for the shares may not develop. It is also possible that after this offering the shares will not trade in the public
market at or above the initial public offering price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriters do not expect to sell more than 5% of the shares in the aggregate
to accounts over which they exercise discretionary authority. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Price Stabilization, Short Positions and Penalty Bids </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Until the distribution of the shares is completed, SEC rules may limit underwriters and selling group members from bidding for and purchasing
shares of our common stock. However, the underwriters may engage in transactions that stabilize the price of our common stock, such as bids or purchases to peg, fix or maintain that price. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with this offering, the underwriters may purchase and sell shares of our common stock in the open market. These transactions may
include short sales, purchases on the open market to cover positions created by short sales and stabilizing transactions. Short sales involve the sale by the underwriters of a greater number of shares than they are required to purchase in this
offering. &#147;Covered&#148; short sales are sales made in an amount not greater than the underwriters&#146; option to purchase additional shares described above. The underwriters may close out any covered short position by either exercising their
option or purchasing shares in the open market. In determining the source of shares to close out the covered short position, the underwriters will consider, among other things, the price of shares available for purchase in the open market as
compared to the price at which they may purchase shares through the option granted to them. &#147;Naked&#148; short sales are sales in excess of the overallotment option. The underwriters must close out any naked short position by purchasing shares
in the open market. A naked short position is more likely to be created if the underwriters are concerned that there may be downward pressure on the price of our common stock in the open market after pricing that could adversely affect investors who
purchase in this offering. Stabilizing transactions consist of various bids for or purchases of shares of our common stock made by the underwriters in the open market prior to the completion of this offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriters may also impose a penalty bid. This occurs when a particular underwriter repays to the underwriters a portion of the
underwriting discount received by it because the representatives have repurchased shares sold by or for the account of such underwriter in stabilizing or short covering transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Similar to other purchase transactions, the underwriters&#146; purchases to cover the syndicate short sales may have the effect of raising or
maintaining the market price of our common stock or preventing or retarding a decline in the market price of our common stock. As a result, the price of our common stock may be higher than the price that might otherwise exist in the open market. The
underwriters may conduct these transactions on Nasdaq, in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither we nor any of the underwriters make any representation or prediction as to the direction or magnitude of any effect that the
transactions described above may have on the price of our common stock. In addition, neither we nor any of the underwriters make any representation that the representatives will engage in these transactions or that these transactions, once
commenced, will not be discontinued without notice. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Electronic Offer, Sale and Distribution of Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with this offering, certain of the underwriters or securities dealers may distribute prospectuses by electronic means, such as <FONT
STYLE="white-space:nowrap">e-mail.</FONT> In addition, one or more of the underwriters may facilitate internet distribution for this offering to certain of their internet subscription customers. Any such underwriter may allocate a limited number of
shares for sale to its online brokerage customers. An electronic prospectus is available on the internet websites maintained by any such underwriter. Other than the prospectus in electronic format, the information on the websites of any such
underwriter is not part of this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">199 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other Relationships </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriters and their respective affiliates are full service financial institutions engaged in various activities, which may include
securities trading, commercial and investment banking, financial advisory, investment management, investment research, principal investment, hedging, financing and brokerage activities. Certain of the underwriters and their affiliates have engaged
in, and may in the future engage in, investment banking and other commercial dealings in the ordinary course of business with us or our affiliates. They have received, or may in the future receive, customary fees and commissions for these
transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the ordinary course of their various business activities, the underwriters and their respective affiliates may make or
hold a broad array of investments and actively trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their own account and for the accounts of their customers, and such investment
and securities activities may involve securities and/or instruments of the issuer. The underwriters and their respective affiliates may also make investment recommendations and/or publish or express independent research views in respect of such
securities or instruments and may at any time hold, or recommend to clients that they acquire, long and/or short positions in such securities and instruments. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Selling Restrictions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>European Economic Area
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In relation to each Member State of the European Economic Area which has implemented the Prospectus Directive (each, a
&#147;Relevant Member State&#148;) an offer to the public of any shares of our common stock may not be made in that Relevant Member State, except that an offer to the public in that Relevant Member State of any shares of our common stock may be made
at any time under the following exemptions under the Prospectus Directive, if they have been implemented in that Relevant Member State: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top">to any legal entity which is a &#147;qualified investor&#148; as defined in the Prospectus Directive; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top">to fewer than 100 or, if the Relevant Member State has implemented the relevant provision of the 2010 PD Amending Directive, 150, natural or legal persons (other than qualified investors as defined in the Prospectus
Directive), as permitted under the Prospectus Directive, subject to obtaining the prior consent of the representatives for any such offer; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top">in any other circumstances falling within Article 3(2) of the Prospectus Directive, provided that no such offer of shares of our common stock shall result in a requirement for the publication by us or any underwriter of
a prospectus pursuant to Article 3 of the Prospectus Directive. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the purposes of this provision, the expression an
&#147;offer to the public&#148; in relation to any shares of our common stock in any Relevant Member State means the communication in any form and by any means of sufficient information on the terms of the offer and any shares of our common stock to
be offered so as to enable an investor to decide to purchase any shares of our common stock, as the same may be varied in that Member State by any measure implementing the Prospectus Directive in that Member State, the expression &#147;Prospectus
Directive&#148; means Directive 2003/71/EC (and amendments thereto, including the 2010 PD Amending Directive, to the extent implemented in the Relevant Member State), and includes any relevant implementing measure in the Relevant Member State, and
the expression &#147;2010 PD Amending Directive&#148; means Directive 2010/73/EU. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>United Kingdom </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each underwriter has represented and agreed that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top">it has only communicated or caused to be communicated and will only communicate or cause to be communicated an invitation or inducement to engage in investment activity (within the meaning of Section&nbsp;21 of the
Financial Services and Markets Act 2000 (the &#147;FSMA&#148;)) received by it in connection with the issue or sale of the shares of our common stock in circumstances in which Section<U></U>&nbsp;21(1) of the FSMA does not apply to us; and
</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">200 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top">it has complied and will comply with all applicable provisions of the FSMA with respect to anything done by it in relation to the shares of our common stock in, from or otherwise involving the United Kingdom.
</TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Canada </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares of
common stock may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National Instrument 45-106 Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and
are permitted clients, as defined in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the shares of common stock must be made in accordance with an exemption from, or in a transaction
not subject to, the prospectus requirements of applicable securities laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Securities legislation in certain provinces or territories of
Canada may provide a purchaser with remedies for rescission or damages if this prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the
time limit prescribed by the securities legislation of the purchaser&#146;s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#146;s province or territory for particulars of
these rights or consult with a legal advisor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to section 3A.3 of National Instrument 33-105 Underwriting Conflicts (NI 33-105),
the underwriters are not required to comply with the disclosure requirements of NI 33-105 regarding underwriter conflicts of interest in connection with this offering. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Hong Kong </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The common stock may not be
offered or sold in Hong Kong by means of any document other than (i)&nbsp;in circumstances which do not constitute an offer to the public within the meaning of the Companies Ordinance (Cap. 32, Laws of Hong Kong), or (ii)&nbsp;to &#147;professional
investors&#148; within the meaning of the Securities and Futures Ordinance (Cap. 571, Laws of Hong Kong) and any rules made thereunder, or (iii)&nbsp;in other circumstances which do not result in the document being a &#147;prospectus&#148; within
the meaning of the Companies Ordinance (Cap. 32, Laws of Hong Kong) and no advertisement, invitation or document relating to the shares may be issued or may be in the possession of any person for the purpose of issue (in each case whether in Hong
Kong or elsewhere), which is directed at, or the contents of which are likely to be accessed or read by, the public in Hong Kong (except if permitted to do so under the laws of Hong Kong) other than with respect to common shares which are or are
intended to be disposed of only to persons outside Hong Kong or only to &#147;professional investors&#148; within the meaning of the Securities and Futures Ordinance (Cap. 571, Laws of Hong Kong) and any rules made thereunder. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Singapore </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus has not been
registered as a prospectus with the Monetary Authority of Singapore. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Accordingly, this prospectus and any other document or material in
connection with the offer or sale, or invitation for subscription or purchase, of the common stock may not be circulated or distributed, nor may the common shares be offered or sold, or be made the subject of an invitation for subscription or
purchase, whether directly or indirectly, to persons in Singapore other than (i)&nbsp;to an institutional investor under Section&nbsp;274 of the Securities and Futures Act, Chapter 289 of Singapore (the &#147;SFA&#148;), (ii) to a relevant person
pursuant to Section&nbsp;275(1), or any person pursuant to Section&nbsp;275(1A), and in accordance with the conditions specified in Section&nbsp;275 of the SFA or (iii)&nbsp;otherwise pursuant to, and in accordance with the conditions of, any other
applicable provision of the SFA, in each case subject to compliance with conditions set forth in the SFA. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">201 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Where the common stock are subscribed or purchased under Section&nbsp;275 of the SFA by a
relevant person which is: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top">a corporation (which is not an accredited investor (as defined in Section<U></U>&nbsp;4A of the SFA)) the sole business of which is to hold investments and the entire share capital of which is owned by one or more
individuals, each of whom is an accredited investor; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top">a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each beneficiary of the trust is an individual who is an accredited investor, shares, debentures and units of
shares and debentures of that corporation or the beneficiaries&#146; rights and interest (howsoever described) in that trust shall not be transferred within six months after that corporation or that trust has acquired the common shares pursuant to
an offer made under Section&nbsp;275 of the SFA except: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top">to an institutional investor (for corporations, under Section<U></U>&nbsp;274 of the SFA) or to a relevant person defined in Section&nbsp;275(2) of the SFA, or to any person pursuant to an offer that is made on terms
that such shares, debentures and units of shares and debentures of that corporation or such rights and interest in that trust are acquired at a consideration of not less than S$200,000 (or its equivalent in a foreign currency) for each transaction,
whether such amount is to be paid for in cash or by exchange of securities or other assets, and further for corporations, in accordance with the conditions specified in Section&nbsp;275 of the SFA; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top">where no consideration is or will be given for the transfer; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top">where the transfer is by operation of law. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Switzerland </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The common stock may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange (the &#147;SIX&#148;) or on any
other stock exchange or regulated trading facility in Switzerland. This document has been prepared without regard to the disclosure standards for issuance prospectuses under art. 652a or art. 1156 of the Swiss Code of Obligations or the disclosure
standards for listing prospectuses under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland. Neither this document nor any other offering or marketing material relating
to the common shares or the offering may be publicly distributed or otherwise made publicly available in Switzerland. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither this
document nor any other offering or marketing material relating to the offering, or the common stock have been or will be filed with or approved by any Swiss regulatory authority. In particular, this document will not be filed with, and the offer of
common stock will not be supervised by, the Swiss Financial Market Supervisory Authority FINMA, and the offer of common shares has not been and will not be authorized under the Swiss Federal Act on Collective Investment Schemes (&#147;CISA&#148;).
Accordingly, no public distribution, offering or advertising, as defined in CISA, its implementing ordinances and notices, and no distribution to any <FONT STYLE="white-space:nowrap">non-qualified</FONT> investor, as defined in CISA, its
implementing ordinances and notices, shall be undertaken in or from Switzerland, and the investor protection afforded to acquirers of interests in collective investment schemes under CISA does not extend to acquirers of common stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>United Arab Emirates </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This offering has
not been approved or licensed by the Central Bank of the United Arab Emirates (the &#147;UAE&#148;), Securities and Commodities Authority of the UAE and/or any other relevant licensing authority in the UAE including any licensing authority
incorporated under the laws and regulations of any of the free zones established and operating in the territory of the UAE, in particular the Dubai Financial Services Authority (&#147;DFSA&#148;), a regulatory authority of the Dubai International
Financial Centre (&#147;DIFC&#148;). The offering does not constitute a public offer of securities in the UAE, DIFC and/or any other free zone in accordance with the Commercial Companies Law, Federal Law No 8 of 1984 (as amended), DFSA Offered
Securities Rules and Nasdaq Dubai Listing Rules, accordingly, or otherwise. The common shares may not be offered to the public in the UAE and/or any of the free zones. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">202 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The common shares may be offered and issued only to a limited number of investors in the UAE
or any of its free zones who qualify as sophisticated investors under the relevant laws and regulations of the UAE or the free zone concerned. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>France
</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus (including any amendment, supplement or replacement thereto) is not being distributed in the context of a public
offering in France within the meaning of Article L. <FONT STYLE="white-space:nowrap">411-1</FONT> of the French Monetary and Financial Code (Code mon&eacute;taire et financier). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus has not been and will not be submitted to the French Autorit&eacute; des march&eacute;s financiers (the &#147;AMF&#148;) for
approval in France and accordingly may not and will not be distributed to the public in France. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to Article <FONT
STYLE="white-space:nowrap">211-3</FONT> of the AMF General Regulation, French residents are hereby informed that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top">the transaction does not require a prospectus to be submitted for approval to the AMF; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top">persons or entities referred to in Point 2&deg;, Section II of Article L. <FONT STYLE="white-space:nowrap">411-2</FONT> of the Monetary and Financial Code may take part in the transaction solely for their own account,
as provided in Articles D. <FONT STYLE="white-space:nowrap">411-1,</FONT> D. <FONT STYLE="white-space:nowrap">734-1,</FONT> D. <FONT STYLE="white-space:nowrap">744-1,</FONT> D. <FONT STYLE="white-space:nowrap">754-1</FONT> and D. <FONT
STYLE="white-space:nowrap">764-1</FONT> of the Monetary and Financial Code; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top">the financial instruments thus acquired cannot be distributed directly or indirectly to the public otherwise than in accordance with Articles L. <FONT STYLE="white-space:nowrap">411-1,</FONT> L. <FONT
STYLE="white-space:nowrap">411-2,</FONT> L. <FONT STYLE="white-space:nowrap">412-1</FONT> and L. <FONT STYLE="white-space:nowrap">621-8</FONT> to L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">621-8-3</FONT></FONT> of the
Monetary and Financial Code. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus is not to be further distributed or reproduced (in whole or in part) in France
by the recipients of this prospectus. This prospectus has been distributed on the understanding that such recipients will only participate in the issue or sale of our common stock for their own account and undertake not to transfer, directly or
indirectly, our common stock to the public in France, other than in compliance with all applicable laws and regulations and in particular with Articles L. <FONT STYLE="white-space:nowrap">411-1</FONT> and L.
<FONT STYLE="white-space:nowrap">411-2</FONT> of the French Monetary and Financial Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">203 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom472601_23"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The validity of the shares of common stock offered by this prospectus will be passed upon for us by our counsel, Dentons US LLP. Certain legal
matters will be passed upon for the underwriters by Latham&nbsp;&amp; Watkins LLP. Members of Dentons US LLP own interests that will represent more than $50,000 of our common stock. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom472601_24"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements of Electrocore, LLC, subsidiaries and affiliate as of December&nbsp;31, 2017 and 2016, and for each of
the years in the <FONT STYLE="white-space:nowrap">two-year</FONT> period ended December&nbsp;31, 2017, have been included herein and in the registration statement in reliance upon the report of KPMG LLP, independent registered public accounting
firm, appearing elsewhere herein, and upon the authority of said firm as experts in accounting and auditing. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom472601_25"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have filed with the SEC a registration statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT> under the Securities Act with respect
to the shares of common stock offered hereby. This prospectus, which constitutes a part of the registration statement, does not contain all of the information set forth in the registration statement or the exhibits filed therewith. For further
information about us and the common stock offered hereby, reference is made to the registration statement and the exhibits filed therewith. Statements contained in this prospectus regarding the contents of any contract or any other document that is
filed as an exhibit to the registration statement are not necessarily complete, and in each instance we refer you to the copy of such contract or other document filed as an exhibit to the registration statement. A copy of the registration statement
and the exhibits filed therewith may be inspected without charge at the public reference room maintained by the SEC, located at 100 F Street, NE, Washington, DC 20549, and copies of all or any part of the registration statement may be obtained from
that office. Please call the SEC at <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-SEC-0330</FONT></FONT></FONT> for further information about the public reference room. The SEC also
maintains a website that contains reports, proxy and information statements and other information regarding registrants that file electronically with the SEC. The address of the website is www.sec.gov. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently do not file periodic reports with the SEC. Upon the closing of our initial public offering, we will be required to file periodic
reports, proxy statements and other information with the SEC pursuant to the Exchange Act. These periodic reports, proxy statements and other information will be available for inspection and copying at the SEC&#146;s public reference facilities and
the website of the SEC referred to above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We also maintain a website at www.electrocore.com. Upon completion of this offering, you may
access these materials at our website free of charge as soon as reasonably practicable after they are electronically filed with, or furnished to, the SEC. Information contained on our website is not a part of this prospectus and the inclusion of our
website address in this prospectus is an inactive textual reference only. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">204 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>ELECTROCORE, LLC, SUBSIDIARIES AND AFFILIATE </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom472601_26"></A>Index to Consolidated Financial Statements </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Audited Consolidated Financial Statements: </B></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="94%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#f_rider472601_1a">Report of Independent Registered Public Accounting Firm </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">F-2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#f_rider472601_1">Consolidated Balance Sheets as of December&nbsp;31, 2017 and
2016</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">F-3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#f_rider472601_2">Consolidated Statements of Operations for the years ended December&nbsp;
31, 2017 and 2016</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">F-4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#f_rider472601_3">Consolidated Statements of Comprehensive Loss for the years ended December&nbsp;31,
 2017 and 2016</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">F-5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#f_rider472601_4">Consolidated Statements of Changes in Convertible Preferred Units and Members&#146;
 Equity (Deficit) for the years ended December&nbsp;31, 2017 and 2016</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">F-6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#f_rider472601_5">Consolidated Statements of Cash Flows for the years ended December&nbsp;
31, 2017 and 2016</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">F-7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#f_rider472601_6">Notes to Consolidated Financial Statements for the years ended December&nbsp;31,
 2017 and 2016</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">F-8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Unaudited Consolidated Financial Statements:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#f_rider472601_7">Consolidated Balance Sheets as of March&nbsp;31, 2018 and December&nbsp;
31, 2017</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">F-27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#f_rider472601_8">Consolidated Statements of Operations for the three months ended March 31,
 2018 and March&nbsp;31, 2017</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">F-28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#f_rider472601_9">Consolidated Statements of Comprehensive Loss for the three months ended March
 31, 2018 and March&nbsp;31, 2017</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">F-29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#f_rider472601_10">Consolidated Statements of Cash Flows for the three months ended March 31,
 2018 and March&nbsp;31, 2017</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">F-30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#f_rider472601_11">Notes to Consolidated Interim Financial Statements </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">F-31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-1 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="f_rider472601_1a"></A>Report of Independent Registered Public Accounting Firm
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the Members and Board of Directors </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Electrocore,
LLC, Subsidiaries and Affiliate: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Opinion on the Consolidated Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have audited the accompanying consolidated balance sheets of Electrocore, LLC, Subsidiaries and Affiliate (the Company) as of December&nbsp;31, 2017 and
2016, the related consolidated statements of operations, comprehensive loss, changes in convertible preferred units and members&#146; equity (deficit), and cash flows for each of the years in the two-year period ended December&nbsp;31, 2017, and the
related notes (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December&nbsp;31, 2017 and 2016, and the
results of its operations and its cash flows for each of the years in the two-year period ended December&nbsp;31, 2017, in conformity with U.S.&nbsp;generally accepted accounting principles. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Basis for Opinion </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These consolidated financial
statements are the responsibility of the Company&#146;s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company
Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission
and the PCAOB. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We conducted our audits in accordance with the standards of the PCAOB and in accordance with auditing standards generally accepted in the
United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits
included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test
basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall
presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>/s/ KPMG
LLP&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have served as the Company&#146;s auditor since 2015. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Short
Hills, New Jersey </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">March 30, 2018 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-2 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="f_rider472601_1"></A>ELECTROCORE, LLC, SUBSIDIARIES AND AFFILIATE </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Consolidated Balance Sheets </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(In U.S. dollars, except for unit data) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>
<TD WIDTH="75%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2016</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Current assets:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,224,194</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">416,336</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,950,566</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accounts receivable, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">103,209</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,710</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Inventories</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">327,787</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48,471</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">570,755</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,422</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Deferred financing costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">856,895</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39,033,406</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">505,939</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Property and equipment &#150; net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">168,646</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48,426</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Security deposits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,604</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,651</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">39,232,656</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">622,016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top" ALIGN="center"><B>Liabilities, Convertible Preferred Units and Members&#146; Equity (Deficit)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Current liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accounts payable and accrued expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,879,775</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,296,539</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Warrant liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,239,544</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">480,636</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Derivative instrument related to convertible bridge notes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">358,146</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:9pt">6,119,319</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:9pt">4,135,321</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Noncurrent liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Convertible bridge notes, net of unamortized debt discount and issuance costs of $1,955,137 at
December&nbsp;31, 2016</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,665,993</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Deferred rent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">306,886</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">355,724</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,426,205</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,495,180</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Commitments and contingencies (Note 15)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Convertible Preferred Units:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Series A Preferred Units, 71,050,860 Units authorized at December&nbsp;31, 2017 and 2016,
70,918,506 Units issued and outstanding at December&nbsp;31, 2017 and 2016</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53,518,463</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53,518,463</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Series B Preferred Units, 123,000,000 Units authorized at December&nbsp;31, 2017 and 0&nbsp;units
authorized at December&nbsp;31, 2016; 105,186,020 Units issued and outstanding at December&nbsp;31, 2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68,755,544</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Series B-1 Preferred Units, 23,529,412 Units authorized at December&nbsp;31, 2017 and 0&nbsp;Units
authorized at December 31, 2016; 0 Units issued and outstanding at December&nbsp;31, 2017 and 2016</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total convertible preferred units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">122,274,007</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53,518,463</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Members&#146; equity (deficit):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Common Units, 600,000,000 Units authorized at December&nbsp;31, 2017 and 150,000,000 units
authorized at December&nbsp;31, 2016; 218,982,140 Units issued and outstanding at December&nbsp;31, 2017; 90,711,018 Units issued and outstanding at December&nbsp;31, 2016</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,180,619</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,912,091</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Additional paid-in capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,596,485</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,126,416</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(152,928,928</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(100,706,419</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accumulated other comprehensive income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,213</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">214,006</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total equity (deficit) attributable to Electrocore, LLC, subsidiaries and affiliate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(90,071,611</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(61,453,906</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Noncontrolling interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">604,055</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">400,421</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total members&#146; equity (deficit)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(89,467,556</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(61,053,485</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total liabilities, convertible preferred units and members&#146; equity (deficit)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">39,232,656</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">622,016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">See accompanying notes to consolidated financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-3 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="f_rider472601_2"></A>ELECTROCORE, LLC, SUBSIDIARIES AND AFFILIATE </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Consolidated Statements of Operations </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(In U.S. dollars, except for unit data) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="74%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Years ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2016</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net sales</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">811,457</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">254,138</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of goods sold</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">518,532</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">123,731</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross profit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">292,925</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">130,407</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,830,868</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,971,342</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Selling, general and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,106,647</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,169,305</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,937,515</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,140,647</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(25,644,590</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(15,010,240</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other expense (income)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,295,854</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">234,352</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss on settlement of convertible bridge notes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,868,771</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization of debt issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">827,317</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">536,893</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest and other income, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(99,027</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of warrant liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(861,773</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of derivative instrument related to convertible bridge notes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">348,163</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,885</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(36,028,780</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(15,781,485</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Net loss attributable to noncontrolling interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(236,358</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,146</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss attributable to Electrocore, LLC, subsidiaries and affiliate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(35,792,422</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(15,737,339</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net loss per Unit &#151; Basic and Diluted (unaudited) (Note&nbsp;9)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.12</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.10</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma weighted average number of Common Units used to calculate net loss per Unit &#151; Basic
and Diluted (unaudited) (Note&nbsp;9)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">308,297,737</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,566,206</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">See accompanying notes to consolidated financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-4 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="f_rider472601_3"></A>ELECTROCORE, LLC, SUBSIDIARIES AND AFFILIATE </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Consolidated Statements of Comprehensive Loss </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(In U.S. dollars) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="74%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Years ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2016</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(36,028,780</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(15,781,485</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other comprehensive income:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign currency translation adjustment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(113,492</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,742</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unrealized loss on securities available for sale</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(20,301</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other comprehensive (loss) income:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(133,793</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,742</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(36,162,573</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(15,772,743</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Net comprehensive loss attributable to noncontrolling interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(222,405</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(59,067</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net comprehensive loss attributable to Electrocore, LLC, subsidiaries and affiliates</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(35,940,168</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(15,713,676</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">See accompanying notes to consolidated financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-5 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="f_rider472601_4"></A>ELECTROCORE, LLC, SUBSIDIARIES AND AFFILIATE </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Consolidated Statements of Changes in Convertible Preferred Units and Members&#146; Equity (Deficit) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(In U.S. dollars, except for unit data) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:7pt" ALIGN="center">


<TR>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Convertible Preferred Units</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="26" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Electrocore, LLC Stockholders</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="font-size:24pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Series A</B></P> <P ALIGN="center" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:7pt"><B>Preferred
Units</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="font-size:24pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Series B</B></P> <P ALIGN="center" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:7pt"><B>Preferred
Units</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="font-size:24pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Common</B></P> <P ALIGN="center" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:7pt"><B>Units</B></P></TD>

<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Additional</B><br><B>paid-in</B><br><B>capital</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Treasury</B><br><B>units</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated</B><br><B>deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated</B><br><B>other</B><br><B>comprehensive</B><br><B>income</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Equity</B><br><B>(deficit)</B><br><B>attributable</B><br><B>to</B><br><B>Electrocore,</B><br><B>LLC,</B><br><B>subsidiaries</B><br><B>and</B><br>
<B>affiliates</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Noncontrolling</B><br><B>interest</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>members&#146;</B><br><B>equity&nbsp;(deficit)</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><FONT STYLE="font-size:7pt"><B>Units</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><FONT STYLE="font-size:7pt"><B>Amount</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><FONT STYLE="font-size:7pt"><B>Units</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><FONT STYLE="font-size:7pt"><B>Amount</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><FONT STYLE="font-size:7pt"><B>Units</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><FONT STYLE="font-size:7pt"><B>Amount</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Balances as of January&nbsp;1, 2016</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,327,023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">47,325,765</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,029,864</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30,912,091</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,764,497</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(82,658</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(84,969,080</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">190,343</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(47,184,807</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">399,518</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(49,920,474</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(15,737,339</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(15,737,339</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,146</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(15,781,485</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Other comprehensive income</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,663</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,663</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14,921</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,742</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Issuance of Series A Preferred Units, net</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,266,741</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,366,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Conversion of term loan, including accrued interest to Series A Preferred Units, net</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,529,335</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,299,935</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Conversion of convertible bridge notes, including accrued interest to Series&nbsp;A Preferred
Units</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,795,407</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,526,096</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Noncontrolling interest contributions</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,970</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,970</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Unit-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">142,583</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">142,583</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">142,583</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Cancellation of Treasury Units</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(82,658</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82,658</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Common Units issued in connection with convertible bridge notes, net</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,681,154</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,301,994</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,301,994</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,301,994</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Balances as of December&nbsp;31, 2016</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,918,506</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">53,518,463</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90,711,018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30,912,091</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,126,416</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(100,706,419</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">214,006</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(61,453,906</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">400,421</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(61,053,485</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(35,792,423</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(35,792,423</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(236,358</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(36,028,781</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Other comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(133,793</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(133,793</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(133,793</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Issuance of Series B Preferred Units, net</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:7pt">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:7pt">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:7pt">105,186,020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:7pt">68,755,544</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:7pt">18,340,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:7pt">4,074,447</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:7pt">(2,012,611</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:7pt">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:7pt">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:7pt">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:7pt">2,061,836</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:7pt">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:7pt">2,061,836</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Noncontrolling interest contributions</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">439,992</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">439,992</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Unit-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">462,329</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">462,329</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">462,329</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Common Units issued in connection with convertible bridge notes, net</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,565,948</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,194,081</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(409,735</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,784,346</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,784,346</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:6.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Common Units issued in exchange for elimination of preference</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:7pt">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:7pt">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:7pt">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:7pt">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:7pt">73,365,174</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:7pt">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:7pt">16,430,086</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:7pt">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:7pt">(16,430,086</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:7pt">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:7pt">&#151;&nbsp;&nbsp; </FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:7pt">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:7pt">&#151;&nbsp;&nbsp; </FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:7pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Times New Roman">Balances as of December&nbsp;31, 2017</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,918,506</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">53,518,463</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">105,186,020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">68,755,544</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">218,982,140</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">40,180,619</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">22,596,485</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(152,928,928</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">80,213</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(90,071,611</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">604,055</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(89,467,556</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">See accompanying notes to consolidated financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-6 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="f_rider472601_5"></A>ELECTROCORE, LLC, SUBSIDIARIES AND AFFILIATE </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Consolidated Statements of Cash Flows </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(In U.S. dollars) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="78%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Years ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2016</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Cash flows from operating activities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(36,028,780</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(15,781,485</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Adjustments to reconcile net loss to net cash used in operating activities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Amortization of debt discount and issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,079,690</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">536,893</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Change in fair value on warrants and embedded derivative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(513,610</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Non-cash interest expense on convertible bridge notes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,045,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Unit-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">462,329</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">142,583</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,306</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53,425</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Net loss on settlement of convertible bridge note</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,868,771</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Loss on disposal of property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,474</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">436,641</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Changes in operating assets and liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Accounts receivable, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(78,499</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,113</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Inventories</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(279,316</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,006</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Prepaid expenses and other assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(517,286</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,331</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Accounts payable and accrued expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">212,335</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,673,414</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Deferred rent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(48,839</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,481</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:9.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Net cash used in operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(25,329,258</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(13,225,765</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Cash flows from investing activities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Purchase of marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(32,427,517</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Proceeds from maturities of marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,460,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Purchases of property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(152,526</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:9.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Net cash used in investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(24,120,043</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Cash flows from financing activities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Proceeds from issuance of Series B Preferred Units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46,911,300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Proceeds from issuance of convertible bridge notes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,965,091</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,121,130</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Financing costs related to issuance of convertible bridge notes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,170,949</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Deferred financing costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(397,994</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Financing costs related to issuance of Series B Preferred Units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,819,046</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Proceeds from issuance of Series A Preferred Units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,366,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Repayment of term loan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,250,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Other proceeds, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,515</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:9.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Net cash provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,488,402</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,273,312</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Effect of changes in exchange rates on cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(231,243</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43,301</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:9.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Net increase (decrease) in cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,807,858</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,909,152</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Cash and cash equivalents &#151; beginning of year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">416,336</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,325,488</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Cash and cash equivalents &#151; end of year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,224,194</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">416,336</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Supplemental schedule of noncash financing activity:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Conversion of term loan, including accrued interest, to Series A Preferred Units, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,299,935</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Conversion of convertible bridge notes, including accrued interest, to Series A Preferred
Units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,526,096</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Common Units issued in exchange for elimination of liquidation preference</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,430,086</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Common Units issued in connection with convertible bridge notes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,194,081</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,301,994</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Series B warrants issued in connection with convertible bridge notes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,620,681</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">480,636</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Conversion of convertible bridge notes including accrued interest to Series B Preferred
Units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,718,910</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Common units issued in connection with Series B financing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,074,447</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Common warrants issued in connection with Series B financing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">362,081</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Debt issuance costs included in accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250,215</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Deferred financing costs accrued</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">458,901</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Cash paid during the year for:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">373</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">43,209</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">See accompanying notes to consolidated financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-7 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="f_rider472601_6"></A>ELECTROCORE, LLC, SUBSIDIARIES AND AFFILIATE </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Consolidated Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>December&nbsp;31, 2017 and 2016 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(1)
Business and Organization </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Electrocore, LLC (electroCore) is a bioelectronic medicine company, engaged in developing a range of patient-administered
non-invasive Vagus Nerve Stimulation (nVNS) therapies initially focused on the treatment of multiple conditions in neurology, rheumatology and other fields. electroCore was founded in 2005 and its focus currently is on primary headache (migraine and
cluster headache), with trials continuing in other neurological and inflammatory disorders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">electroCore, headquartered in New Jersey, has wholly owned
subsidiaries as follows: electroCore Bermuda, Ltd., electroCore Germany GmbH, and electroCore UK Ltd. In addition, an affiliate, electroCore (Aust) Pty Limited, is subject to electroCore&#146;s control on bases other than voting interests and is a
variable interest entity (VIE), for which electroCore is the primary beneficiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">electroCore, its wholly owned subsidiaries and electroCore (Aust) Pty
Limited are collectively referred to as the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In Europe, the Company has received CE Marks for its noninvasive neuro-stimulation therapy
(gammaCore<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>) to treat primary headache, bronchoconstriction, epilepsy, gastric motility disorders, and depression and anxiety. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In April 2017, U.S. Food and Drug Administration (FDA) released the use of gammaCore<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, a non-invasive
vagus nerve stimulator therapy, for the acute treatment of pain associated with episodic cluster headache in adult patients. gammaCore<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> transmits a mild electrical stimulation to the vagus
nerve through the skin, resulting in a reduction of pain, besides other benefits. This was the first FDA product release for the Company in the U.S. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
January 2018, the FDA released the use of gammaCore<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> for the treatment of pain associated with migraine headache in adult patients. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(2) Summary of Significant Accounting Policies </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(a)
Principles of Consolidation </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accompanying consolidated financial statements include the accounts of electroCore and its wholly owned
subsidiaries. electroCore (Aust) Pty Limited, a VIE for which electroCore is the primary beneficiary, is also consolidated with the non-controlled equity presented as non-controlling interest. All intercompany balances and transactions have been
eliminated in consolidation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(b) Use of Estimates </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of financial statements in conformity with U.S.&nbsp;generally accepted accounting principles requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting
period. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include the useful lives of fixed assets; allowances for doubtful accounts and sales returns; valuation of inventory, property and
equipment, warrants and derivative instruments, <FONT STYLE="white-space:nowrap">Unit-based</FONT> compensation, and contingencies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(c) Cash and
Cash Equivalents </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents
and all investments with maturities of greater than three months from date of purchase are </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-8 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
classified as marketable securities available-for-sale. The Company maintains its U.S.&nbsp;operating cash balances in financial institutions which are insured by the Federal Deposit Insurance
Corporation (FDIC) up to $250,000 each. At times, such balances may be in excess of the FDIC insurance limit. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(d) Marketable Securities
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Marketable securities, all of which are available-for-sale, consist of corporate debt securities, U.S. bonds, U.S. sponsored agencies and
municipal bonds. Marketable securities are carried at fair value, with unrealized gains and losses reported as accumulated other comprehensive income, except for losses from impairments which are determined to be other-than-temporary. Realized gains
and losses, and declines in value judged to be other-than-temporary on available-for-sale securities are included in the determination of net loss and are included in interest and other income net, at which time the average costs basis of these
securities are adjusted to fair values. Fair values are based on quoted market prices at the reporting date. Interest and dividends on available-for-sale securities are included other income net. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(e) Concentration of Credit Risk </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cash, cash
equivalents and marketable securities are financial instruments that potentially subject the Company to concentration of credit risk. The Company periodically invests its cash in corporate debt securities, U.S. bonds, U.S. sponsored agencies and
municipal bonds with strong credit ratings. The Company has established guidelines relative to diversification and maturities that are designed to help ensure safety and liquidity. These guidelines are periodically reviewed to take advantage of
trends in yields and interest rates. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(f) Accounts Receivable </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company maintains an allowance for doubtful accounts for estimated losses
inherent in its accounts receivable portfolio. Management considers an account receivable to be past due when it is not settled under its stated terms. In establishing the required allowance, management considers historical losses adjusted to take
into account current market conditions and customers&#146; financial condition, the amount of receivables in dispute, and the current receivables aging and current payment patterns. Account balances are charged off against the allowance after all
means of collection have been exhausted and the potential for recovery is considered remote. The Company does not have any off balance sheet credit exposure related to its customers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company controls its exposure to credit risk through credit analysis and approvals, credit limits, and monitoring procedures. Collateral is generally not
required for the Company&#146;s accounts receivables. Management believes the credit risk is limited. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(g) Inventories </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Inventory, which consists of the raw materials, work-in-process and finished product of GammaCore, is stated at the lower of cost and net realizable value.
Inventory is valued on a first in first out basis. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the Company&#146;s product is subject to strict quality control and monitoring which the Company performs throughout the manufacturing process.
If certain units of product no longer meet quality specification or become obsolete, the Company records a charge to cost of sales sold to write down such unmarketable inventory to zero. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(h) Property and Equipment </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Property and equipment
are stated at cost. Depreciation and amortization is computed by the straight line method based on the estimated useful lives of the respective assets, as discussed below. Leasehold improvements are </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-9 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
amortized over the lesser of the lease terms or the estimated useful lives of the assets. Amounts expended for maintenance and repairs are charged to expense as incurred, and expenditures for
major renewals and improvements are capitalized. Upon disposition of property and equipment, the related cost and accumulated depreciation and amortization are removed from the accounts, and any gain or loss is reflected in the accompanying
Consolidated Statements of Operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Depreciation is computed using the following estimated useful lives: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="81%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Machinery and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">3&#150;15&nbsp;years</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Furniture and fixtures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">5&#150;10 years</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Computer equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">5 years</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(i) Impairment of <FONT STYLE="white-space:nowrap">Long-Lived</FONT> Assets </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Long lived assets, such as property, plant, and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying
amount of an asset may not be recoverable. If circumstances require a long lived asset or asset group be tested for possible impairment, the Company first compares undiscounted cash flows expected to be generated by that asset or asset group to its
carrying amount. If the carrying amount of the long lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent that the carrying amount exceeds its fair value. Fair value is determined
through various valuation techniques including discounted cash flow models, quoted market values and third party independent appraisals, as considered necessary. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(j) Convertible Preferred Units </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has
classified convertible preferred units (Series A Preferred Units and Series B Preferred Units) as temporary equity in the accompanying consolidated balance sheets due to certain change in control events that could trigger the payment of the Series A
Preferred and Series B Preferred liquidation preferences being outside of the Company&#146;s control, including sale or transfer of control of the Company, as certain holders of the preferred units could cause the liquidation of the Units in these
situations. The Company does not accrete the carrying values of the preferred units to the redemption values since a change in control event was not considered probable as of December&nbsp;31, 2017 and 2016. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subsequent adjustments of the carrying values to the ultimate redemption values will be made only when it becomes probable that such a change in control event
will occur. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(k) Members&#146; Equity (Deficit) </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s Units have no par value. Each member&#146;s liability is limited to the respective members&#146; equity. Additional <FONT
STYLE="white-space:nowrap">paid-in</FONT> capital represents recognition of <FONT STYLE="white-space:nowrap">Unit-based</FONT> compensation, warrants classified as equity instruments, and the fair value of Common Units issued in connection with
certain convertible promissory notes (the &#147;Bridge Notes&#148;). The Company records cost of repurchasing member Units as Treasury Units. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(l)
Revenue Recognition </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company recognizes revenue when the following criteria are met: persuasive evidence of an arrangement exists, the customer
assumes ownership and risk of loss, the sales price is fixed or determinable, and collection is reasonably assured. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Revenue, net of specialty
pharmaceutical distribution discounts, is generated from sales of our gammaCore products. The gammaCore products are currently sold through a specialty pharmaceutical distributor on a fixed per-unit wholesale acquisition cost basis. The arrangement
is in the form of a written agreement between the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-10 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
parties. Furthermore, the terms of sales to the distributor are FOB destination, under which the title and risk of loss is assumed by the buyer at the time of receipt. Accordingly, the Company
recognizes revenues when the products are received by the distributor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s policy is not to provide for returns for product sales. No
allowance for returns has been provided for sales to our specialty pharmaceutical distributor. Instead, damaged or defective products are replaced at no charge under the Company&#146;s standard warranty. For the years ended December&nbsp;31, 2017
and 2016, the replacement costs were immaterial. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amounts collected on behalf of third parties, such as value added taxes, are not included in the
transaction price, and not included in net revenue, as they are collected from the customer on behalf of the respective taxing authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Shipping and
handling costs are reported as selling, general and administrative expenses. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(m) Research and Development </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Research and development costs are expensed as incurred. Costs incurred for clinical trials for patients and investigators are expensed as services are
performed in accordance with the agreements in place with the institutions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(n) <FONT STYLE="white-space:nowrap">Unit-based</FONT> Compensation
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company measures <FONT STYLE="white-space:nowrap">Unit-based</FONT> compensation at <FONT STYLE="white-space:nowrap">grant-date</FONT> fair
value and recognizes employee compensation expense on a <FONT STYLE="white-space:nowrap">straight-line</FONT> basis over the vesting period of the award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Measurement of Unit-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a)&nbsp;the goods or
services received; or (b)&nbsp;the equity instruments issued. The fair value of the Unit-based payment transaction is determined at the earlier of performance commitment date or performance completion date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Determining the appropriate fair value of <FONT STYLE="white-space:nowrap">Unit-based</FONT> awards requires the input of subjective assumptions, including
the fair value of the Company&#146;s Units, the expected life of the Units, and expected volatility. The Company uses the <FONT STYLE="white-space:nowrap">Black-Scholes</FONT> option pricing model to value its
<FONT STYLE="white-space:nowrap">Unit-based</FONT> awards. The assumptions used in calculating the fair value of <FONT STYLE="white-space:nowrap">Unit-based</FONT> awards represent management&#146;s best estimates and involve inherent uncertainties
and the application of management&#146;s judgment. As a result, if factors change and management uses different assumptions, <FONT STYLE="white-space:nowrap">Unit-based</FONT> compensation expense could be materially different for future awards.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The expected life of the Units was estimated using the &#147;simplified method,&#148; as the Company has no historical information regarding the expected
life of the Units and employment duration for its Unit grants. The simplified method is based on the average of the vesting tranches and the contractual life of each grant. For volatility, the Company uses comparable public companies as a basis for
its expected volatility to calculate the fair value of Unit grants. The <FONT STYLE="white-space:nowrap">risk-free</FONT> interest rate is based on U.S.&nbsp;Treasury notes with a term approximating the expected life of the Unit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company accounts for forfeitures of Unit-based awards as they occur. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(o) Warrants and Other Derivative Instruments </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
connection with the issuance of certain debt and equity instruments, the Company has issued warrants to purchase equity interests. In certain circumstances, these warrants are liability classified, rather than as equity. Additionally, the debt and
equity instruments may contain embedded derivative instruments, such as variable </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-11 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
conversion options, which are required to be evaluated under the provisions of Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 815, <I>Derivatives and
Hedging</I> (ASC Topic 815), bifurcated from the host instrument and accounted for separately as a derivative instrument liability. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2017 and 2016,
related to the issuance of the Bridge Notes, the Company issued warrants to purchase its Series B Preferred Units (see Note 12) and recorded them as liabilities due to the fact that whether the underlying Series B Preferred Units would be redeemable
was not known at the time of their issuance. In addition, the Company also recognized an embedded derivative related to the conversion option of the Bridge Notes. The warrants were valued using the probability weighted expected return method and
option pricing models. The embedded derivative instrument was recorded at fair value using an alternative discounted cash flow method. Key assumptions used in the valuation model were based on the terms and conditions of the warrants and the
embedded derivative. At the time of the conversion of the Bridge Notes into the Series B Preferred Units, the warrants remained classified as a liability. These warrants and derivative instruments are remeasured at each balance sheet date with
changes in fair value recorded in the Consolidated Statements of Operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(p) Foreign Currency Translation and Transactions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Operations in <FONT STYLE="white-space:nowrap">non-U.S.&nbsp;entities</FONT> are recorded in the functional currency of each entity. For financial reporting
purposes, the functional currency of an entity is determined by a review of the source of an entity&#146;s most predominant cash flows. The results of operations for <FONT STYLE="white-space:nowrap">non-U.S.&nbsp;dollar</FONT> functional currency
entities are translated from functional currencies into U.S.&nbsp;dollars using the average currency rate during each month, which approximates the results that would be obtained using actual currency rates on the dates of individual transactions.
Assets and liabilities are translated using currency rates at the end of the period. Adjustments resulting from translating the financial statements of the foreign entities into the U.S.&nbsp;dollar are excluded from the determination of net loss
and are recorded as a component of other comprehensive loss. Foreign currency transaction gains and losses related to assets and liabilities that are denominated in a currency other than the functional currency are reported in the Consolidated
Statements of Operations in the period they occur. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(q) Income Taxes </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is a limited liability company, which is treated as a partnership for Federal and state income tax purposes. Accordingly, the Company is not
subject to income taxes. No provision has been made for Federal and state income taxes since these taxes are the personal responsibility of the Members. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company assesses its risk for unrecognized tax liabilities for known or anticipated tax issues based on its analysis of whether, and the extent to which,
additional taxes will be due. As of December&nbsp;31, 2017 and 2016, the Company determined that it is more likely than not that a liability for tax risks are not required. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(r) Net Comprehensive Loss </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Net comprehensive loss
consists of net loss, foreign exchange translation adjustments and unrealized gains (losses) on securities available for sale and is presented in the Consolidated Statements of Comprehensive Loss. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(s) Fair Value of Financial Instruments </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain
assets and liabilities are reported on a recurring basis at fair value. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for
the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial
assets and liabilities carried at fair value are to be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-12 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Level 1&#151;Quoted prices in active markets for identical assets or liabilities. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Level 2&#151;Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets
or liabilities, or other inputs that are observable or can be corroborated by observable market data. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Level 3&#151;Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow
methodologies and similar techniques. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(t) Segment Information </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company operates in one reportable segment within the United States, Europe and Australia. Management uses one measurement of profitability and does not
segregate its business for internal reporting, making operating decisions, and assessing financial performance. Net sales within the United States and outside the United States were approximately $241,500 and $570,000, respectively, for the year
ended December&nbsp;31, 2017. Sales to a U.S., UK and German customer accounted for 30%, 34% and 33% of total sales, respectively, for the year ended December&nbsp;31, 2017. Net sales within the United States and outside the United States were
approximately $10,000 and $244,000, respectively, for the year ended December&nbsp;31, 2016. Sales to a UK and German customer accounted for 57% and 19% of total sales, respectively, for the year ended December&nbsp;31, 2016. All long-lived assets
are maintained in the United States. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(u) Deferred Financing Costs </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Deferred financing costs, primarily costs of direct incremental legal, accounting and other fees relating to the Company&#146;s contemplated initial public
offering (&#147;IPO&#148;), are capitalized as incurred. The deferred transaction costs will be offset against IPO proceeds upon the consummation of the offering. In the event the IPO is terminated which would include a postponement of 90 days or
greater, any deferred transaction costs will be expensed. The Company has capitalized costs totaling $856,895 that have been incurred in connection with ongoing equity raising initiatives. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(v) Immaterial Correction </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have made a
correcting adjustment to our Consolidated Balance Sheet as of December 31, 2016 due to an immaterial prior period error regarding the classification of Series A Preferred Units in such Consolidated Balance Sheet. This correcting adjustment has
appropriately classified Series A Preferred Units outside of Members&#146; equity (deficit) and presented such amounts within mezzanine/temporary members&#146; equity. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(w) Recent Accounting Pronouncements </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In May 2014,
the FASB issued Accounting Standard Update (ASU) 2014-09, <I>Revenue from Contracts with Customers, </I>Topic 606, which provides a framework for the recognition of revenue, with the objective that recognized revenues properly reflect amounts an
entity is entitled to receive in exchange for goods and services. This guidance will be effective for interim and annual reporting periods beginning after December&nbsp;15, 2017. The Company is in the process of evaluating the new standard and
assessing the impact, if any, ASU 2014-09 will have on the Company&#146;s consolidated financial statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In January 2016, the FASB issued ASU
2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities (Subtopic 825-10). The ASU revises the measurement and presentation of investments in certain financial assets and liabilities and enhances disclosures about those
investments. The update will be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-13 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
effective for fiscal years beginning after December&nbsp;15, 2017. The adoption of ASU 2016-01 is to be applied on a cumulative-effect adjustment to the balance sheet as of the beginning of the
fiscal year of adoption. The Company is assessing ASU No.&nbsp;2016-01&#146;s impact and will adopt it when effective. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I></I>In February 2016, the FASB
issued ASU No.&nbsp;2016-02, <I>Leases</I> (Topic 842), which requires lessees to recognize most leases on the balance sheet. The provisions of this guidance are effective for annual periods beginning after December&nbsp;15, 2018, and interim
periods within those years, with early adoption permitted. The Company is assessing ASU No.&nbsp;2016-02&#146;s impact and will adopt it when effective.<I> </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I></I>In August 2016, the FASB issued ASU No.&nbsp;2016-15, <I>Statement of Cash Flows: Classification of Certain Cash Receipts and Cash Payments,</I> (Topic
230). This ASU will make eight targeted changes to how cash receipts and cash payments are presented and classified in the statement of cash flows. The ASU will be effective for fiscal years beginning after December&nbsp;15, 2017. This standard will
require adoption on a retrospective basis unless it is impracticable to apply, in which case it would be required to apply the amendments prospectively as of the earliest date practicable. The Company is assessing ASU No.&nbsp;2016-15&#146;s impact
and will adopt it when effective.<I> </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(3) Significant Risks and Uncertainties </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s budgeted cash requirements for 2018 and beyond include expenses related to continuing development and clinical evaluation of its products
and therapies, as well as preparing for related commercialization of our products. Based on the Company&#146;s available cash resources and cash flow projections as of the date the consolidated financial statements were available for issuance, it
believes it has sufficient funds to continue its operations and research and development programs at least through April, 2019. Until the Company can generate significant cash from its operations, the Company expects to continue to fund its
operations with its available financial resources. These financial resources may not be adequate to sustain its operations and the Company will be required to finance future cash needs through the sale of additional equity or debt securities.
However, the Company cannot be certain that additional financing will be available when needed or that, if available, financing will be obtained on terms favorable to the Company or its Members. The capital markets have experienced volatility in
recent years, which has resulted in uncertainties with respect to availability of capital and hence the timing to meet an entity&#146;s liquidity needs. Having insufficient funds may require the Company to delay,
<FONT STYLE="white-space:nowrap">scale-back</FONT> or eliminate some or all of its programs or renegotiate less favorable terms than it would otherwise choose. Failure to obtain adequate financing also may adversely affect its ability to operate as
a going concern. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to the FDA release received by the Company for two indications (see Note 1), the Company is seeking approvals and clearances
by the FDA for additional indications. In connection therewith, the Company will incur additional time and costs and will require additional funding to obtain such approvals and clearances. The additional time, costs, and funding is expected to be
substantial. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is highly dependent upon the technical and management skills of several of its officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s potential growth may cause a significant strain on its management, operational, and financial resources. Its ability to manage its growth
effectively will require it to continue to implement and improve its operational and financial systems. The Company&#146;s success also depends in large part on a limited number of current key technical, marketing, and sales employees and on the
Company&#146;s ability to continue to attract and retain additional highly talented personnel. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has foreign currency exchange risks related to
revenue and operating expenses in currencies other than the local currencies in which they operate. The Company is exposed to currency risk from the potential changes in functional currency values of their foreign currency denominated assets,
liabilities, and cash flows. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-14 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(4) Marketable Securities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company considers all of its current investments to be available-for-sale. Marketable securities at December&nbsp;31, 2017 consisted of the following: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="57%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amortized</B><br><B>Cost</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unrealized</B><br><B>Gain</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unrealized<BR>(Loss)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair</B><br><B>Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Treasury Notes (Included in Cash and Cash Equivalents)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">999,726</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(86</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">999,640</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Corporate Debt Securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">19,014,590</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">923</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(17,827</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">18,997,686</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Commercial Paper</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,979,367</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,227</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,978,140</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S. Government Sponsored Agencies</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,496,824</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,029</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,494,795</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificate of Deposits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">480,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(55</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">479,945</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Marketable Securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">23,970,781</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">923</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(21,138</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">23,950,566</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">24,970,507</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">923</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(21,224</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">24,950,206</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Maturities of debt securities classified as available-for-sale were as follows at December&nbsp;31, 2017: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="79%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair&nbsp;Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Due within one year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">23,950,566</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Due after one year through five years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">23,950,566</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company had no marketable securities at December&nbsp;31, 2016. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(5) Fair Value Measurements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A summary of the assets and
liabilities carried at fair value in accordance with the hierarchy defined above is as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="55%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair Value Hierarchy</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Carrying<BR>Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Quoted&nbsp;Prices</B><br><B>in active</B><br><B>markets</B><br><B>for&nbsp;identical</B><br><B>instruments</B><br><B>(Level 1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Significant</B><br><B>other</B><br><B>observable</B><br><B>inputs</B><br><B>(Level 2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Significant</B><br><B>unobservable</B><br><B>inputs</B><br><B>(Level 3)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>December&nbsp;31, 2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,224,194</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,224,194</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Marketable Securities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Corporate Debt Securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,997,686</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,997,686</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Commercial Paper</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,978,140</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,978,140</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S. Government Sponsored Agencies</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,494,795</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,494,795</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificate of Deposits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">479,945</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">479,945</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">37,174,760</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">37,174,760</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrant liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,239,544</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,239,544</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-15 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="60%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair Value Hierarchy</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Carrying<BR>Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Quoted&nbsp;Prices</B><br><B>in active</B><br><B>markets</B><br><B>for&nbsp;identical</B><br><B>instruments</B><br><B>(Level 1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Significant</B><br><B>other</B><br><B>observable</B><br><B>inputs</B><br><B>(Level 2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Significant</B><br><B>unobservable</B><br><B>inputs</B><br><B>(Level 3)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>December&nbsp;31, 2016</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">416,336</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">416,336</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrant liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">480,636</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">480,636</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Derivative instrument related to convertible bridge notes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">358,146</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">358,146</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the years ended December&nbsp;31, 2017 and 2016, the Company has not changed the manner in which it values assets and
liabilities that are measured at fair value using Level 3 inputs. The Company recognizes transfers between levels of the fair value hierarchy as of the end of the reporting period. There were no transfers within the hierarchy during the years ended
December&nbsp;31, 2017 and 2016. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents, consisted of cash in bank checking and savings accounts, money market funds and U.S. treasury
notes and are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices in active markets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Marketable
securities classified as debt securities available for sale consist of investments in of corporate debt securities, commercial paper, U.S. government sponsored agencies and certificate of deposits. The Company&#146;s marketable securities are valued
using quoted prices in active markets and therefore these securities were classified as Level 1. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The warrant liability was recorded at fair value
determined by using the probability weighted expected return method and option pricing models. This method of valuation involves using inputs such as the fair value of the Company&#146;s Common Units, unit price volatility, the contractual term of
the warrant, risk free interest rates and dividend yields. Due to the nature of these inputs, the valuation of the warrant liability was considered a Level 3 measurement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2017 and 2016, the estimated fair values of the warrant liability were computed using the following assumptions: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="83%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2016</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock price volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65.3</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71.7</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk-free interest rates</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.59</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.33</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual dividend yield</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected life (years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The derivative liability as of December&nbsp;31, 2016 related to the convertible bridge notes was recorded at fair value
determined by using an alternative discounted cash flow method. This method of valuation involves using inputs such as (1)&nbsp;a 50% required rate of return, (2)&nbsp;80% probability of a qualified financing round closing prior to the maturity of
the convertible Bridge Notes, and (3)&nbsp;the option&#146;s ability to convert at a 10% discount into the expected next qualified financing round. Due to the nature of these inputs, the valuation of the derivative instrument was considered a Level
3 measurement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-16 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A roll-forward of the recurring fair value measurements of the liabilities categorized with Level 3 inputs
are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="65%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Warrant</B><br><B>liabilities</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Derivative</B><br><B>instrument</B><br><B>related&nbsp;to</B><br><B>convertible</B><br><B>bridge&nbsp;notes</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Opening Balance as of January&nbsp;1, 2016</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">480,636</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">358,146</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Settlements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes in fair value recognized</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing Balance as of December&nbsp;31, 2016</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">480,636</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">358,146</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,620,681</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,789,472</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Settlements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,495,781</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes in fair value recognized</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(861,773</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">348,163</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing Balance as of December&nbsp;31, 2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,239,544</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During 2017, the warrant liability increased due to the issuance of additional Bridge Notes, the issuance of Series&nbsp;B
Preferred Units as well as fees to bankers and advisors all of which included additional warrants deemed to be liability classified. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During 2017, the
embedded derivative increased due to the issuance of additional Bridge Notes which contained the conversion feature deemed to be a derivative. As of December&nbsp;31, 2017, the derivative instrument related to the Convertible Bridge Notes was
eliminated at the time of the conversion of the Bridge Notes to the Series B Preferred Units. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At December 31, 2016, the fair value of the Company&#146;s
convertible bridge notes outstanding was $5,621,130. The convertible bridge notes do not have quoted prices in active markets and are valued using a discounted cash flow methodology. This methodology uses significant unobservable inputs, which are
deemed to be level 3 inputs in the fair value hierarchy. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(6) Inventories </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Inventories as of December&nbsp;31, 2017 and 2016 consisted of the following: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="72%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2016</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Raw materials</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">116,909</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,267</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Work in process</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finished goods</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">193,763</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,204</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">327,787</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">48,471</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-17 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(7) Property and Equipment &#151; Net </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Property and equipment, net as of December&nbsp;31, 2017 and 2016 consisted of the following: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="69%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2016</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Machinery and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">452,614</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">379,614</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Furniture and fixture</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">156,512</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87,664</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Computer equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">138,534</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">127,856</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property, plant and equipment &#151; gross</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">747,660</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">595,134</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less accumulated depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(579,014</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(546,708</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property, plant and equipment &#151; net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">168,646</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">48,426</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Depreciation and amortization expense for the years ended December&nbsp;31, 2017 and 2016 were $32,306 and $53,425,
respectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(8) Accounts Payable and Accrued Expenses </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued expenses as of December&nbsp;31, 2017 and 2016 consisted of the following: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="66%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2016</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,380,059</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">740,832</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">840,383</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,241,117</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Due to employees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">659,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">225,963</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88,627</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,879,775</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,296,539</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(9) Pro Forma Net Loss Per Unit (Unaudited) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unaudited pro forma basic and diluted net loss per unit for the years ended December&nbsp;31, 2017 and 2016, gives effect to the assumed automatic conversion
into Common Units of all of our Series A Preferred Units and Series B Preferred Units immediately prior to the closing of an initial public offering (IPO) by the Company. In connection with such automatic conversion, the Series A Preferred Unit will
convert into 70,918,506 shares of the Company&#146;s common stock on a conversion ratio of 1:1 and the Series B Preferred Unit will also convert into 105,186,020 shares of the Company&#146;s common stock on a conversion ratio of 1:1. For purposes of
pro forma basic and diluted net loss per unit, all Series A Preferred Units and Series B Preferred Units have been treated as though they have been converted to common stock at the later of the issuance date or January&nbsp;1, 2016. Unaudited pro
forma loss per unit does not consider shares issued in an IPO. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, unaudited pro forma net loss per Unit gives effect to income tax adjustments
as if the Company was a taxable entity as of the beginning of the period. Prior to consummation of an IPO, the Company will convert into a C-corporation and will be subject to federal and state income taxes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has reported a net loss for the years ended December&nbsp;31, 2017 and 2016. Further, based on the Company&#146;s history of generating operating
losses and its anticipation of operating losses continuing in the foreseeable future, the Company has determined that it would not have been more likely than not that the tax benefits from these net operating losses would be realized and a full
valuation allowance against all deferred tax assets would be recorded on a pro forma basis. Therefore, for the purposes of the pro forma tax provision, income tax expense is determined to be zero. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has excluded all common equivalent shares outstanding for Profits Interests, warrants and convertible instruments from the calculation of diluted
net loss per share because all such securities are antidilutive. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-18 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes the computation of pro forma basic and diluted net loss per unit attributable
to common stockholders for the years ended December&nbsp;31, 2017 and 2016. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="74%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Years ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2016</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Numerator &#151; Basic and Diluted</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations before income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(35,792,422</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(15,737,339</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma provisions/(benefit) for income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(35,792,422</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(15,737,339</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Denominator &#151; Basic and Diluted</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average pro forma Common Units outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">157,858,731</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82,233,294</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average pro forma Common Units issued upon conversion of Series A Preferred
Units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,918,506</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68,332,912</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average pro forma Common Units issued upon conversion of Series B Preferred
Units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79,520,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma weighted average number of Common Units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">308,297,737</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,566,206</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net loss per Unit, Basic and Diluted</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.12</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.10</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(10) Convertible Preferred Units and Members&#146; Equity </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s operating agreement, as amended and restated in August 2017 and then again in November 2017, permits the issuance of four classes of Units
&#151; Series A Preferred Units, Series B Preferred Units, Series&nbsp;B-1 Preferred Units and Common Units. Each member is entitled to one vote for each Unit held and the Units of all classes and series shall vote together as a single class on all
matters (on an as converted to Common Unit basis). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The amended and restated operating agreement contains specific provisions for payments in respect of
the Series A Preferred Units, the Series B Preferred Units and the Common Units for liquidating and non-liquidating distributions. There are also provisions for payments in respect of the Series A Preferred Units, Series B Preferred Units and Common
Units when certain deemed liquidation events occur, which are a merger or consolidation of the Company or sale of all or substantially all of the assets of the Company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Elimination of Series A Preferred Unit Distribution Preference and Common Unit Distribution Preference </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On August&nbsp;18, 2017, in exchange for the modification of certain liquidation preferences payable to the holders of the Series A Preferred Units, each
holder of the Series A Preferred Units received Common Units based on a fraction where the numerator was the issue price for the Series A Preferred Units held and the denominator was 1.17. This resulted in the issuance of 46,943,104 Common Units at
a total fair value of $16,430,086 on August&nbsp;18, 2017. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Similarly, on August&nbsp;18, 2017, for the elimination of the entire preference amount of
$30,912,091 payable to the Common Investors, as defined in the original operating agreement, each such investor received Common Units based on the fraction, the numerator of which was the Common Preference Amount due each Common Investor and the
denominator of which was 1.17. This resulted in the issuance of 26,422,070 Common Units at a total fair value of $9,247,724 on August&nbsp;18, 2017. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Series A Preferred Units </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Series A Preferred
Units are entitled to a preference on distributions, ahead of the Common Units but behind Series B Preferred Units, in the amount of $54,923,430 plus the Series A Preferred Return (as described below), as of December&nbsp;31, 2017. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-19 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Series A Preferred Units are entitled to a return in an annual non-compounded amount with respect to
each outstanding Series A Preferred Unit equal to the product of the Series A Preferred Return Percentage and the Series A Unreturned Capital Value for each Unit, which shall accrue to the extent not paid. The Series A Preferred Return Percentage is
4% and may be reduced to 2% if certain requirements are met as outlined in the amended and restated operating agreement. Additionally, except upon an IPO or a liquidation event, the payment of the Series A Preferred Return is at the sole discretion
of the Board of Managers. As of December&nbsp;31, 2017 and December&nbsp;31, 2016, the Series A Preferred Return in arrears aggregated to $7,535,079 and $5,338,142, respectively. Following the 2017 amendments to the operating agreement, the Series A
Preferred Return payable upon a public offering of the Company&#146;s common stock was fixed at $3,629,092 and is payable, at the Company&#146;s election, in cash or shares of the Company&#146;s common stock but is expected to be paid in common
stock. This incremental value would be recorded as a distribution to Series&nbsp;A Preferred Unit holders in the event of a public offering of the Company&#146;s common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Series A Preferred Units are convertible into Common Units at the option of the holder, or mandatorily upon the occurrence of an initial public offering
or other specified events into one Common Unit as outlined in amended and restated operating agreement. In addition, in connection with the Company&#146;s Operating Agreement the Company has the ability to reserve a sufficient number of Common Units
to enable the conversion of all Series A Preferred Units. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Series A Preferred Units also have other protective provisions that prohibit the Company
from taking certain actions as outlined in the amended and restated operating agreement without the prior written consent of the holders of not less than 66% of the total outstanding Series A Preferred Units, which consent, subject to certain
exceptions, must include the consent of Core Ventures II, LLC (CV II) and Merck Global Health Innovation Fund, LLC (Merck GHI). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The holders of the Series
A Preferred Units, including CVII and Merck GHI purchased an aggregate amount of $50,692,432 of Series A Preferred Units through December&nbsp;31, 2016, at an initial closing and several required milestone closings, several optional milestone
closings, as well as from the exercise of certain warrants, net of related issuance costs. No Series A Preferred Units were issued after December&nbsp;31, 2016. The Series A Preferred Units were issued as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="27%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="3" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:42.40pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Closing&nbsp;date</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="5" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of Series A</B><br><B>Preferred&nbsp;Units/warrants</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Price<BR>per</B><br><B>unit</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Aggregate</B><br><B>issuance</B><br><B>price</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fiscal year</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2015</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2016</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">March&nbsp;2013</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,400,669</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Preferred&nbsp;Units</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.73527</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Total,&nbsp;initial&nbsp;closing</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">December&nbsp;2013</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,533,482</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Preferred Units</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.73527</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,333,334</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,333,334</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">April&nbsp;2014</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,066,964</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Preferred Units</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.73527</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,666,666</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,666,666</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">June&nbsp;2014</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,800,222</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Preferred Units</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.73527</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Total, required<BR>milestone closing</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">September&nbsp;2014</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,882,353</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Preferred Units</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">January&nbsp;2015</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,882,353</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Preferred Units</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">April 2015</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,882,353</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Preferred Units</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">November,&nbsp;2015</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,552,941</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Preferred Units</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,064,065</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,064,065</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">March, 2016</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Preferred Units</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,700,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,700,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Total, optional<BR>milestone closing</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">18,764,065</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,333,334</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,666,666</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,064,065</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,700,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">November,&nbsp;2015</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,266,741</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Exercise&nbsp;of&nbsp;warrants</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.73527</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,666,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">March, 2016</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,266,741</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Exercise of warrants</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.73527</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,666,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Issuance costs</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(953,466</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(300,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(151,501</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Net proceeds</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">17,379,868</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">16,366,666</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,579,231</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,366,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-20 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2016 and December&nbsp;31, 2017, there were outstanding (i)&nbsp;warrants to
purchase 132,354 Series&nbsp;A Preferred Units issued in connection with the Company&#146;s venture debt financing (see Note&nbsp;11), and (ii)&nbsp;warrants to purchase 89,412 Series&nbsp;A Preferred Units issued to one of the Company&#146;s
financial advisors. All other warrants to purchase Series&nbsp;A Preferred Units have either been exercised or have expired and no new warrants to purchase Series&nbsp;A Preferred Units were issued in 2017. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Series B Preferred Units </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2017, the Company
entered into a Series B Preferred Unit Purchase Agreement with, among others, CV II, Merck GHI and AIH. Under the terms of the Purchase Agreement, as amended, through December&nbsp;31, 2017, the Company received cash proceeds of $46.9 million and
converted $26.7 million of Bridge Notes and related accrued and unpaid interest for an aggregate amount of $73,630,210 (inclusive of amounts mentioned in Note 12 related to conversion of Bridge Notes and related accrued and unpaid interest) through
the sale of Series B Preferred Units at an initial closing and several additional closings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Series B Preferred Units are entitled to a preference on
distributions ahead of the Series A Preferred Units and the Common Units, in the amount of $73,630,210 as of December, 31, 2017. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Series B Preferred
Units are convertible into Common Units at the option of the holder, or mandatorily upon the occurrence of an initial public offering or other specified event, into one common unit as outlined in the amended and restated operating agreement. In
addition, in connection with the Company&#146;s Operating Agreement the Company has the ability to reserve a sufficient number of Common Units to enable the conversion of all Series B Preferred Units. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Series B Preferred Units also have other protective provisions that prohibit the Company from taking certain actions as outlined in the amended and
restated operating agreement without the prior written consent of the holders of not less than 66%&nbsp;of the total outstanding Series B Preferred Units, which consent, subject to certain exceptions, must include the consent of CV II, Merck GHI and
American Investment Holdings LLC (AIH). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with these Series B Preferred Unit closings, the Company also issued 18,340,000 common units to
investors at a relative fair value of $4,074,447. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with all Series B Preferred Unit closings, the Company also issued warrants for the
purchase of 35,452,084 Common Units at an exercise price of $1.25 per Unit, which warrants expire on the earlier of 5 years from issuance and the closing of the Company&#146;s IPO. The Company also issued warrants to advisors for the purchase of
2,724,549 Common Units at an exercise price of $0.70 per Unit and 72,000 common warrants at $1.25 per Unit. The fair value of these warrants to purchase common units are recorded within additional-paid-in-capital. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At December&nbsp;31, 2017, there were warrants to purchase (i) 7,739,092 Series B Preferred Units at $0.70 per unit outstanding that were issued to purchasers
of our Bridge Notes (see Note 12) and (ii) 1,820,134 Series B Preferred Units at $0.70 per unit that were issued to our financial advisors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(11) Term
Loan </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December&nbsp;22, 2015, the Company entered into a Loan and Security Agreement (the Bank Agreement) with Pacific Western Bank (Bank) pursuant
to which the Company received a term loan of $1,250,000. The Bank Agreement also provided for three additional term loans aggregating $6,250,000, available at various dates through June 2017. In connection with the financing, the Bank received
66,177 warrants to purchase Series A Preferred Units at an exercise price of $0.85 per Unit. These warrants expire on December&nbsp;22, 2025. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">One of the
conditions related to the Bank Agreement required the Company to receive proceeds of not less than $8,000,000 on or prior to April&nbsp;30, 2016, from the issuance of Series A Preferred Units. Due to the Company&#146;s
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-21 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
failure to satisfy such requirement, the Bank delivered a Notice of Default and in May 2016, the Company repaid the $1,250,000 term loan balance in full and the Bank Agreement was terminated.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December&nbsp;22, 2015, the Company also entered into a Loan and Security Agreement (CV II Agreement) with CV II pursuant to which the Company
received a term loan from CV II of $1,250,000 (CV II term loan). The CV II term loan was subordinated to the term loan received from the Bank. In connection with the financing, CV II received 66,177 warrants to purchase Series A Preferred Units at
an exercise price of $0.85 per Unit. These warrants expire on December&nbsp;22, 2025. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the terms of the CV II Agreement, CV II opted to
convert the term loan of $1,250,000 and related accrued interest of $49,935 into the Company&#146;s Series A Preferred Units in 2016, at a per Unit price of $0.85 per Unit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of the warrants issued to the Bank and CV II aggregated $59,030. The Company also incurred issuance costs related to the financing of $134,137.
The fair value of the warrants and issuance costs attributable to the loan per the Bank Agreement aggregating $96,584 were recognized under amortization of debt discount and issuance costs for the year ended December&nbsp;31, 2016. The fair value of
the warrants and issuance costs attributable to the proceeds received from the CV II term loan aggregating $96,583 were recognized as a reduction from the amount allocated to Series A Preferred Units. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Interest on both the loans were payable at a variable annual rate of 7.30% plus LIBOR subject to a minimum of 7.5%. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2017 and 2016, respectively, warrants to purchase 132,354, Series A Preferred Units issued in connection with the term loans remained
outstanding. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(12) Convertible Bridge Notes </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Beginning in June 2016, the Company commenced raising new capital under a Bridge Note and Warrant Purchase Agreement (the Bridge Financing). Under the original
terms of the Bridge Financing, investors were issued a convertible promissory note (the Bridge Note) bearing annual interest at 10%, and a warrant to purchase the securities issued in the Company&#146;s next equity financing (the Next Round
Securities) in an amount equal to 20% of the face amount of the Bridge Note (the Bridge Note Warrants). The face value and accrued interest under the Bridge Notes were originally automatically convertible into the Next Round Securities upon the
Company&#146;s next bona fide equity financing round that raised not less than $8 million (exclusive of the Bridge Notes) (Qualified Equity Round) at a 10% discount to the purchase price payable for such Next Round Securities (the Next Round Price).
In addition, the Bridge Notes were also convertible into Series A Preferred Units at $0.85 per Unit, at the option of the holders. In September 2016 the terms of the Bridge Financing were amended (September 2016 amendment) to provide that subsequent
purchasers of Bridge Notes would also receive up to two Common Units for each one dollar of principal amount of Bridge Notes purchased. The Bridge Note Warrants are exercisable for a period of five years and entitle each holder to purchase the Next
Round Securities in an amount equal to 20% of principal amount of the Bridge Notes purchased by each such investor divided by the Next Round Price, with an exercise price equal to the Next Round Price. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2016, the Company issued Bridge Notes aggregating $7,121,130 (including $5,060,025 purchased by CV II and $1,500,000 purchased by ECNG, LLC (ECNG), an
investor affiliated with CV II). In September 2016, ECNG elected to convert $1,500,000 of its holdings in Bridge Notes, and accrued interest of $26,096, into 1,795,407 Series A Preferred Units. The remaining Bridge Notes were outstanding as of
December&nbsp;31, 2016, with a maturity date of one year from the applicable original issuance dates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2017, the Company issued Bridge Notes
aggregating $19,965,091. The terms of these Bridge Notes were the same as those issued in 2016. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-22 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since the Bridge Note Warrants entitle the holders to purchase securities in the Qualified Equity Round at
the purchase price payable for the related equity securities, the exercise price of the warrants was undetermined at the time of their issuance. Also, because the terms of redemption of the Series B Preferred Units were unknown at the time of their
issuance as well as the deemed liquidation terms discussed in Note 10, the warrants are recorded as liabilities. In connection with the Bridge Note closings, at the time of the Qualified Equity Round, the Company issued 7,739,092 Bridge Note
Warrants all of which are outstanding as of December&nbsp;31, 2017. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under ASC Topic 815, certain contractual terms that meet the accounting definition of
a derivative must be accounted for separately from the financial instrument in which they are embedded. The Company has concluded that the right of the Bridge Note investors to convert the face value and accrued interest to Company&#146;s equity
securities constitutes embedded derivatives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the Bridge Financing closing in 2016 the Company determined the amount attributable to the Common Units
issued in 2016 in connection with the Bridge Notes at relative fair value at $1,274,804 and the amounts attributable to Bridge Note Warrants and embedded derivatives related to Qualified Equity Financing at fair values at $480,636 and $358,146
respectively at December&nbsp;31, 2016. The fair value for the embedded derivative related to the option to convert to Series A Preferred Units was deemed immaterial. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the Bridge Financing closing in 2017, the Company determined the amount attributable to the Common Units issued in 2017 in connection with the Bridge
Notes at relative fair value at $4,241,180 and the amounts attributable to Bridge Note Warrants and embedded derivatives related to Qualified Equity Financing at fair values at $2,149,100 and $1,789,472 respectively. The fair value for the embedded
derivative related to the option to convert to Series A Preferred Units was deemed immaterial. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2016, the amount related to Common
Units, Bridge Note Warrants and the embedded derivatives were recorded as a discount on the Bridge Notes and are being amortized over the maturity term of the respective Bridge Notes. At December&nbsp;31, 2016, the unamortized discount on the Bridge
Notes was $1,758,361. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the Bridge Financing, the Company engaged two advisors (the Advisors) to serve as placement agents. The Advisors
are entitled to a combined placement agent fee of 10% of the principal amount of the Bridge Notes sold to investors first introduced to the Company by the Advisors, five-year warrants to purchase securities in the Qualified Equity Round at the
purchase price payable for the related equity securities (Advisor Warrants), and the right to purchase 9% of the number of securities issuable upon the conversion of the Bridge Notes issued to such investors. In addition, one of the Advisors is also
entitled to receive one-half of a Common Unit for each one dollar of principal amount of Bridge Notes purchased by investors first introduced to the Company by such Advisor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31, 2017 and 2016, investors introduced by the Advisors purchased Bridge Notes with an aggregate principal amount of
$11,771,119 and $561,105, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2017, with respect to such Bridge Notes and associated Common Units and Bridge Note Warrants, the Company
incurred total costs of $2,467,455 (inclusive of $952,901 representing fair value of 5,095,218 common units and $495,510 representing fair value of 1,692,431 Advisor Warrants, to be issued by the Company at the time of the Qualified Equity Round);
$1,791,422 of such amount was recognized as a discount on the Bridge Notes and will be amortized over the maturity term of the Bridge Notes. Based on the fair values of the financial instruments issued in connection with the Bridge Notes, the
remaining amount was allocated as follows: $409,735 to Common Units and $266,297 to Bridge Note Warrants. The amount allocated to Common Units was netted against the related proceeds and the amount related to Bridge Note Warrants was expensed during
the year ended December&nbsp;31, 2017. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2016, with respect to such Bridge Notes and associated Common Units and Bridge Note Warrants, the Company
incurred total costs of $133,289 (inclusive of $15,712 representing fair value of 72,142 Advisor </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-23 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Warrants, to be issued by the Company at the time of the Qualified Equity Round); $109,933 of such amount was recognized as a discount on the Bridge Notes and will be amortized over the maturity
term of the Bridge Notes. Based on the fair values of the financial instruments issued in connection with the Bridge Notes, the remaining amount was allocated as follows: $9,282 to Common Units and $14,014 to Bridge Note Warrants. The amount
allocated to Common Units was netted against the related proceeds and the amount related to Bridge Note Warrants was expensed during the year ended December&nbsp;31, 2016. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As permitted by ASC Topic 470-10-45-14, Debt, as of December&nbsp;31, 2016, the Bridge Notes have been classified as long-term liabilities. In connection with
the initial closing under the Series B Preferred Unit Purchase Agreement entered into in August 2017, all outstanding Bridge Notes (aggregating $25,586,220), together with all related accrued and unpaid interest aggregating $1,132,690, were
automatically converted into Series B Preferred Units, at $0.70 per Unit. At this time all unamortized debt discount and discount related to debt issuance costs was derecognized and included in Net loss on settlement of convertible bridge notes.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(13) <FONT STYLE="white-space:nowrap">Unit-Based</FONT> Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with employment and service provider agreements the Company has awarded grantees Units that constitute profits interests for income tax purposes,
subject to certain restrictions defined in each Unit forfeiture agreement. The Company maintains a Unit award account for each of the grantees. Generally, the Units vest 25% on the one year anniversary of the employment start date or agreement date
and the balance ratably per quarter thereafter over an additional three-year period. After the restrictions lapse, the grantees become fully vested in such Units. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following summarizes activity related to the Company&#146;s unvested Unit awards for the year ended December&nbsp;31, 2017 and 2016: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="61%"></TD>
<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Weighted average</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;units</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>grant&nbsp;date&nbsp;fair&nbsp;value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding Balance as of January&nbsp;1, 2016</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,052,914</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.06</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,251,553</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vested</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(845,449</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.05</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Forfeited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,934,170</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.05</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding Balance as of December&nbsp;31, 2016</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,524,848</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,206,589</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.02</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vested</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,095,715</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.03</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding Balance as of December&nbsp;31, 2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,635,722</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.04</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2017 and 2016 there were $933,398 and $878,471, respectively, of total unrecognized compensation cost
related to unvested Unit-based compensation awards respectively, which are expected to be recognized over a weighted average period of four years. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Company utilizes the Black Scholes option pricing model for estimating the fair value of all Units granted. The fair value of each Unit is estimated on the date of the grant. The fair value is then amortized using graded-vesting over the requisite
service period for each separately vesting portion of the award as if the award was, in-substance, multiple awards. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-24 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The weighted average assumptions for the Units granted during the years ended December&nbsp;31, 2017 and
2016 are provided in the following table: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="79%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2016</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Valuation assumptions:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected dividend yield</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70.92</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79.10</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected term (years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk-free interest rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.26</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.64</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The risk-free interest rate is the average U.S. Treasury rate with a term that most closely resembles the expected life of the
award for the year in which the award was granted. The expected life is the period of time that the awards granted are expected to remain outstanding. The expected life is calculated using a simplified method, as permitted by the accounting
standards. Expected volatility is a measure of the amount by which the Unit price has fluctuated or is expected to fluctuate during a period. For volatility, the Company uses comparable public companies as a basis for its expected volatility. The
Company does not pay regular dividends on its Units and does not anticipate paying any dividends in the foreseeable future. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the years ended
December&nbsp;31, 2017 and 2016, Unit-based compensation expense is reported as a component of selling, general and administrative and research and development expense in the Company&#146;s Consolidated Statement of Operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(14) Variable Interest Entity </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As discussed in note 1,
electroCore is the primary beneficiary of electroCore (Aust) Pty Limited. electroCore has contributed certain intellectual property rights, all rights to distribute, market and sell specified products in Australia and New Zealand, and other rights
outlined in the shareholders&#146; deed of electroCore (Aust) Pty Limited in return for 50% of the shares of such entity. In addition, electroCore can also appoint two of the four directors and can exercise significant influence. This along with the
fact that electroCore is electroCore (Aust) Pty Limited&#146;s only supplier causes electroCore, for accounting purposes, to be the primary beneficiary of electroCore (Aust) Pty Limited. The activities related to electroCore (Aust) Pty Limited are
not material to the consolidated financial statements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(15) Commitments and Contingencies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(a) Operating Lease </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company leases office
space under operating leases through April 2022. Future minimum lease payments under non-cancelable operating leases (with initial or remaining lease terms in excess of one year) as of December&nbsp;31, 2017 are as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="80%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Year ending December&nbsp;31:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">552,524</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">564,939</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">577,353</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">545,472</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">195,437</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,435,725</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the years ended December&nbsp;31, 2017 and 2016, rental expense related to the leases were $493,067 and $529,271,
respectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-25 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(b) Legal Proceedings </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company may from time to time be involved in various claims and legal actions arising in the ordinary course of its business. In the opinion of management,
the ultimate disposition of any of these matters will not have a material adverse effect on the Company&#146;s consolidated financial position, results of operations, or liquidity. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(16) Employee Benefit Plan </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has a defined
contribution 401(k) profit sharing plan which covers all employees. Employees are eligible upon date of hire. Employee contributions are voluntary and are based on specific percentages of compensation, which may not exceed maximum amounts
established by Internal Revenue Code. Employer contributions are discretionary. There were no employer contributions for the years ended December&nbsp;31, 2017 and 2016. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(17) Subsequent Events </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has evaluated
subsequent events for the balance sheet date through March&nbsp;30, 2018, the date at which the consolidated financial statements were available to be issued and determined that there are no other items to disclose, except as disclosed in note 1.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-26 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="f_rider472601_7"></A>ELECTROCORE, LLC, SUBSIDIARIES AND AFFILIATE </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Consolidated Balance Sheets </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9.5pt" ALIGN="center">


<TR>
<TD WIDTH="74%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(Unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top" ALIGN="center"><B>Assets</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Current assets:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,520,466</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,224,194</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Debt securities and other investments available for sale</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,186,020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,950,566</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Accounts receivable, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">255,862</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">103,209</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Inventories</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">321,187</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">327,787</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,345,630</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">570,755</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Deferred financing costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,308,475</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">856,895</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Total current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,937,640</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39,033,406</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Property and equipment&#151;net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">306,433</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">168,646</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Security deposits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,604</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,604</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">31,274,677</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">39,232,656</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top" ALIGN="center"><B>Liabilities, Convertible Preferred Units and Members&#146; Deficit</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Current liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Accounts payable and accrued expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,055,275</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,879,775</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Warrant liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,485,398</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,239,544</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Total current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,540,673</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,119,319</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Noncurrent liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Deferred rent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">293,124</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">306,886</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Total liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,833,797</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,426,205</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Commitments and contingencies (Note 16)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Convertible Preferred Units:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Series A Preferred Units, 71,050,860 Units authorized at March&nbsp;31, 2018 and at
December&nbsp;31, 2017; 70,918,506 Units issued and outstanding at March&nbsp;31, 2018 and at December&nbsp;31, 2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53,518,463</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53,518,463</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Series B Preferred Units, 123,000,000 Units authorized at March&nbsp;31, 2018 and at
December&nbsp;31, 2017; 105,186,020 Units issued and outstanding at March&nbsp;31, 2018 and at December&nbsp;31, 2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68,755,544</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68,755,544</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Series B-1 Preferred Units, 23,529,412 Units authorized at March&nbsp;31, 2018 and at
December&nbsp;31, 2017; 0 Units issued and outstanding at March&nbsp;31, 2018 and at December&nbsp;31, 2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Total convertible preferred units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">122,274,007</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">122,274,007</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Members&#146; deficit:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Common Units, 600,000,000 Units authorized at March&nbsp;31, 2018 and at December&nbsp;31, 2017;
218,982,140 Units issued and outstanding at March&nbsp;31, 2018 and at December&nbsp;31, 2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,180,619</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,180,619</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Additional paid-in capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,863,630</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,596,485</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(162,427,468</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(152,928,928</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Accumulated other comprehensive (loss) income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(59,048</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80,213</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Total deficit attributable to Electrocore, LLC, subsidiaries and affiliate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(99,442,267</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(90,071,611</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Noncontrolling interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">609,140</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">604,055</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Total members&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(98,833,127</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(89,467,556</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:9.5pt; font-family:Times New Roman">Total liabilities, convertible preferred units and members&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">31,274,677</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">39,232,656</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">See accompanying notes to consolidated financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-27 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="f_rider472601_8"></A>ELECTROCORE, LLC, SUBSIDIARIES AND AFFILIATE </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Consolidated Statements of Operations </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="74%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Three months ended March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net sales</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">81,187</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">116,933</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of goods sold</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48,948</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72,747</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross profit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,239</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,186</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,306,335</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,726,557</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Selling, general and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,824,814</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,059,261</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,131,149</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,785,818</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,098,910</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,741,632</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other expense (income)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,040,093</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization of debt issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">269,162</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of warrant liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">245,854</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">177,976</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of derivative instrument related to convertible bridge notes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">128,063</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest and other income, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(109,283</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">208,054</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,443,535</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,356,926</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Net income attributable to noncontrolling interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,005</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss attributable to Electrocore, LLC, subsidiaries and affiliate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(9,498,540</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(6,356,926</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma Net loss per Unit&#151;Basic and Diluted (unaudited) (Note&nbsp;11)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.02</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.04</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma Weighted average number of Common Units and potential Common Units
outstanding&#151;Basic and Diluted (unaudited) (Note&nbsp;11)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">395,086,660</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">166,790,093</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">See accompanying notes to consolidated financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-28 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="f_rider472601_9"></A>ELECTROCORE, LLC, SUBSIDIARIES AND AFFILIATE </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Consolidated Statements of Comprehensive Loss </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="74%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Three&nbsp;months&nbsp;ended&nbsp;March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2018&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2017&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(9,443,535</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(6,356,926</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other comprehensive (loss) income:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign currency translation adjustment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(114,329</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,767</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unrealized loss on debt securities and other investments available for sale</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(24,932</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other comprehensive (loss) income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(139,261</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,767</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,582,796</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,343,159</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Net comprehensive income attributable to noncontrolling interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,085</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,934</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net comprehensive loss attributable to Electrocore, LLC, subsidiaries and affiliates</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(9,587,881</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(6,351,093</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">See accompanying notes to consolidated financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-29 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="f_rider472601_10"></A>ELECTROCORE, LLC, SUBSIDIARIES AND AFFILIATE </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Consolidated Statements of Cash Flows </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="76%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Three months ended March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash flows from operating activities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(9,443,535</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(6,356,926</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustments to reconcile net loss to net cash used in operating activities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization of debt discount and debt issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,041,132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of warrants and embedded derivative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">245,854</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">306,039</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unit-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">267,145</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,806</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,212</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,629</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(68,468</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(12,023</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes in operating assets and liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts receivable, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(152,653</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(76,181</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventories</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(99,005</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(774,874</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(36,743</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">249,151</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">917,197</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred rent</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(13,762</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,657</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:9.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,677,330</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,260,732</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash flows from investing activities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase of debt securities and other investments available for sale</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,431,839</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from maturities of debt securities and other investments available for sale</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,190,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchases of property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(144,999</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,677</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:9.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,386,838</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,677</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash flows from financing activities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from issuance of convertible bridge notes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,546,141</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financing costs related to the issuance of Convertible Bridge Notes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(377,297</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred financing costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(525,231</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:9.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash (used in) provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(525,231</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,168,844</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effect of changes in exchange rates on cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(114,329</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,341</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:9.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net decrease in cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(11,703,728</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(57,224</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents&#151;beginning of period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,224,194</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">416,336</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents&#151;end of period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,520,466</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">359,112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Supplemental schedule of noncash financing activity:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series B warrants issued in connection with convertible bridge notes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">665,374</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debt issuance cost included in accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">126,645</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred financing costs in accounts payable and accrued expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">926,349</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common units issued in connection with convertible bridge notes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">862,721</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">See accompanying notes to consolidated financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-30 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="f_rider472601_11"></A>ELECTROCORE, LLC, SUBSIDIARIES AND AFFILIATE </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Consolidated Financial Statements </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(1) Business and
Organization </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Electrocore, LLC (&#147;electroCore&#148; or the &#147;Company&#148;) is a bioelectronic medicine company, engaged in developing a range
of patient-administered non-invasive Vagus Nerve Stimulation (nVNS) therapies initially focused on the treatment of multiple conditions in neurology, rheumatology and other fields. electroCore was founded in 2005 and its focus currently is on
primary headache (migraine and cluster headache), with trials continuing in other neurological and inflammatory disorders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">electroCore, headquartered in
New Jersey, has wholly owned subsidiaries which include: electroCore Bermuda, Ltd., electroCore Germany GmbH, and electroCore UK Ltd. In addition, an affiliate, electroCore (Aust) Pty Limited, is subject to electroCore&#146;s control on bases other
than voting interests and is a variable interest entity (VIE), for which electroCore is the primary beneficiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In Europe, the Company has received CE
Marks for its noninvasive neuro-stimulation therapy (gammaCore<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>) to treat primary headache, bronchoconstriction, epilepsy, gastric motility disorders, and depression and anxiety. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In January 2018, the U.S. Food and Drug Administration (FDA) released the use of gammaCore<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, a
non-invasive vagus nerve stimulator therapy for the treatment of pain associated with migraine headache in adult patients. Previously in April 2017 the FDA released the use of gammaCore<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> for
the acute treatment of pain associated with episodic cluster headache in adult patients. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(2) Basis of Presentation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accompanying unaudited consolidated financial statements were prepared in conformity with U.S. generally accepted accounting principles (U.S. GAAP) and
with Article 10 of Regulation S-X for interim financial reporting. In compliance with those rules, certain information and footnote disclosures normally included in annual consolidated financial statements prepared in accordance with U.S. GAAP have
been condensed or omitted. These consolidated financial statements should be read in conjunction with the Company&#146;s consolidated financial statements and related notes for the fiscal year ended December&nbsp;31, 2017. In the opinion of
management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair statement of the results of interim periods have been included. The results of operations and cash flows reported in these consolidated
financial statements should not be regarded as necessarily indicative of results that may be expected for the entire fiscal year. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(3) Summary of
Significant Accounting Policies </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(a) Principles of Consolidation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accompanying consolidated financial statements include the accounts of electroCore and its wholly owned subsidiaries. electroCore (Aust) Pty Limited, a VIE
for which electroCore is the primary beneficiary, is also consolidated with the non-controlled equity presented as non-controlling interest. All intercompany balances and transactions have been eliminated in consolidation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(b) Use of Estimates </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of financial
statements in conformity with U.S.&nbsp;generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at
the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-31 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Significant items subject to such estimates and assumptions include the useful lives of fixed assets; allowances for doubtful accounts and sales returns; valuation of inventory, warrants, <FONT
STYLE="white-space:nowrap">Unit-based</FONT> compensation, vouchers, and contingencies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(c) Recently Adopted Accounting Pronouncements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In May 2014, the FASB issued Accounting Standard Update (ASU) 2014-09, Revenue from Contracts with Customers (&#147;ASC 606&#148;). ASC 606 provides a
comprehensive framework under which revenue is recognized when an entity transfers promised goods and services to a customer in an amount that reflects the consideration an entity is entitled to receive in exchange for those goods and services.
Furthermore, ASC 606 contains expanded disclosure requirements to enable users of the financial statements to better understand the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company adopted ASC 606 effective January&nbsp;1, 2018, using the full retrospective method. The adoption of ASC 606 did not have a material impact on our
consolidated balance sheet, statements of operations, or cash flows for the three months ended March&nbsp;31, 2017. The primary impact of adoption related to the enhancement of our disclosures as provided in Note 5&#151;Revenue Recognition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In January 2016, the FASB issued ASU 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities (Subtopic 825-10). The ASU revises the
measurement and presentation of investments in certain financial assets and liabilities and enhances disclosures about those investments. We adopted this guidance on January&nbsp;1, 2018, which had no material impact on our consolidated balance
sheet, statement of operations or cash flows. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In August 2016, the FASB issued ASU No.&nbsp;2016-15, Statement of Cash Flows: Classification of Certain
Cash Receipts and Cash Payments, (Topic 230). This ASU makes eight targeted changes to how cash receipts and cash payments are presented and classified in the statement of cash flows. We adopted this guidance on January&nbsp;1, 2018, which had no
material impact on our consolidated statement of cash flows. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(d) Recent Accounting Pronouncements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In February 2016, the FASB issued ASU No.&nbsp;2016-02, Leases (Topic 842), which requires lessees to recognize most leases on the balance sheet. The
provisions of this guidance are effective for annual periods beginning after December&nbsp;15, 2018, and interim periods within those years, with early adoption permitted. The Company is assessing ASU No.&nbsp;2016-02&#146;s impact and will adopt it
when effective. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We reviewed all other recently issued accounting pronouncements and concluded that they were either not applicable or not expected to
have a material impact on the consolidated financial statements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(4) Significant Risks and Uncertainties </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s budgeted cash requirements for 2018 and beyond include expenses related to continuing development and clinical evaluation of its products
and therapies, as well as preparing for related commercialization of our products. Based on the Company&#146;s available cash resources, cash flow projections as of the date the consolidated financial statements were available for issuance and
reductions in third party consulting costs, it believes it has sufficient funds to continue only operations that are primarily related to current product commercialization efforts at least through June, 2019. Until the Company can generate
significant cash from its operations, the Company expects to continue to fund its operations with its available financial resources. These financial resources may not be adequate to sustain its operations and the Company will be required to finance
future cash needs through the sale of additional equity or debt securities. However, the Company cannot be certain that additional financing will be available when needed or that, if available, financing will be obtained on terms favorable to the
Company or its Members. The capital markets have experienced volatility in recent years, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-32 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
which has resulted in uncertainties with respect to availability of capital and hence the timing to meet an entity&#146;s liquidity needs. Having insufficient funds may require the Company to
delay, <FONT STYLE="white-space:nowrap">scale-back</FONT> or eliminate some or all of its programs or renegotiate less favorable terms than it would otherwise choose. Failure to obtain adequate financing also may adversely affect its ability to
operate as a going concern. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to the FDA release received by the Company for two indications (see Note 1), the Company is seeking approvals and
clearances by the FDA for additional indications. In connection therewith, the Company will incur additional time and costs and will require additional funding to obtain such approvals and clearances. The additional time, costs, and funding is
expected to be substantial. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is highly dependent upon the technical and management skills of several of its officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s potential growth may cause a significant strain on its management, operational, and financial resources. Its ability to manage its growth
effectively will require it to continue to implement and improve its operational and financial systems. The Company&#146;s success also depends in large part on a limited number of current key technical, marketing, and sales employees and on the
Company&#146;s ability to continue to attract and retain additional highly talented personnel. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has foreign currency exchange risks related to
revenue and operating expenses in currencies other than the local currencies in which they operate. The Company is exposed to currency risk from the potential changes in functional currency values of their foreign currency denominated assets,
liabilities, and cash flows. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company deals primarily with one specialty pharmaceutical distributor in the United States. At March&nbsp;31, 2018 and
December&nbsp;31, 2017, the accounts receivable related to this distributor was $187,795 and $31,740, respectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(5) Revenue Recognition </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Performance Obligations </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Revenue, net of specialty
pharmaceutical distribution discounts, vouchers and co-payments assistance is solely generated from the sales of the gammaCore product. Sales are made to a specialty pharmaceutical distributor (&#147;customer&#148;) and revenue is recognized when
delivery of the product is completed. The Company deems control to have transferred upon the completion of delivery because that is the point in which (1)&nbsp;it has a present right to payment for the product, (2)&nbsp;it has transferred the
physical possession of the product, (3)&nbsp;the customer has legal title to the product, (4)&nbsp;the customer has significant risks and rewards of ownership and (5)&nbsp;the customer has accepted the product. After the products have been delivered
and control has transferred, the Company has no remaining unsatisfied performance obligations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Revenue is measured based on the consideration that the
Company expects to receive in exchange for gammaCore, which represents the transaction price. The transaction price includes the fixed per-unit price of the product and variable consideration in the form of trade credits, vouchers and co-payment
assistance. The per-unit price is based on the Company established wholesale acquisition cost less a contractually agreed upon distributor discount with the customer. Trade credits are discounts that are contingent upon a timely remittance of
payment and is estimated based on historical experience. Vouchers are redeemable by select new patients for an initial 31-day therapy (i.e. one gammaCore device) free of charge. The Company initially estimated that 90% of the vouchers assigned to
patients will be redeemed. The transaction price of the devices estimated to be redeemed through vouchers are recognized as contra-revenue. All other costs for units related to the voucher program and any other redemption costs due to the specialty
pharmacy were included as promotional expenses in selling, general and administrative expense. For the three months ended March&nbsp;31, 2018 contra-revenue and promotional expenses related to the vouchers redeemed and estimated to be redeemed were
$323,665 and $76,516, respectively. In addition, reimbursement for co-payments made by patients is also considered variable consideration. Net sales reflect a reduction of $29,207 for payments made in conjunction with the program. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-33 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In accordance with Company policy, no allowance for product returns has been provided. Damaged or defective
products are replaced at no charge under the Company&#146;s standard warranty. For the three months ended March&nbsp;31, 2018 and 2017, the replacement costs were immaterial. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment for products is due in accordance with the terms agreed upon with customers, generally within 31 days of shipment to the customer. Accordingly, our
contracts with customers do not include a significant financing component. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Disaggregation of Net Sales </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides additional information pertaining to our net sales disaggregated by geographic market for the three months ended March&nbsp;31,
2018 and 2017: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="64%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>For the three months ended<BR>March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2018&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2017&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Geographic Market</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">United States</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9,606</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,215</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">United Kingdom</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64,982</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64,956</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Germany</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">805</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,423</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,794</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,339</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Net Sales</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">81,187</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">116,933</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Contract Balances </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company generally invoices the customer and recognizes revenue once its performance obligations are satisfied, at which point payment is unconditional.
Accordingly under ASC 606, the contracts do not give rise to contract assets or liabilities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(6) Cash, Cash Equivalents and Debt Securities and other
Investments Available for Sale </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following tables summarizes the Company&#146;s cash, cash equivalents and debt securities and other investments
available for sale as of March&nbsp;31, 2018 and December&nbsp;31, 2017. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="57%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>As of March&nbsp;31, 2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amortized</B><br><B>Cost</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unrealized</B><br><B>Gain</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unrealized<BR>(Loss)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair</B><br><B>Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,520,466</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,520,466</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Corporate Debt Securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,060,602</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(24,604</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,035,998</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Commercial Paper</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,945,402</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14,637</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,930,765</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S. Government Sponsored Agencies</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,990,460</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,301</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,985,159</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S. Treasury Bonds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">994,789</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(689</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">994,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificate of Deposits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">240,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">239,998</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total debt securities and other investments available for sale</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">25,231,253</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(45,233</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">25,186,020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total cash, cash equivalents and debt securities and other investments available for sale</P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">26,751,719</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(45,233</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">26,706,486</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-34 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Maturities of debt securities and certificate of deposits classified as available-for-sale were as follows
at March&nbsp;31, 2018: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="79%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair&nbsp;Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Due within one year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">25,186,020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Due after one year through five years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">25,186,020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="57%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>As of December&nbsp;31, 2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amortized</B><br><B>Cost</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unrealized</B><br><B>Gain</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unrealized<BR>(Loss)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair</B><br><B>Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,224,280</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(86</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,224,194</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Corporate Debt Securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">19,014,590</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">923</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(17,827</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">18,997,686</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Commercial Paper</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,979,367</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,227</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,978,140</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S. Government Sponsored Agencies</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,496,824</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,029</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,494,795</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificate of Deposits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">480,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(55</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">479,945</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total debt securities and other investments available for sale</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">23,970,781</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">923</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(21,138</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">23,950,566</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total cash, cash equivalents and debt securities and other investments available for sale</P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">37,195,061</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">923</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(21,224</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">37,174,760</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Maturities of debt securities and certificate of deposits classified as available-for-sale were as follows at
December&nbsp;31, 2017: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="79%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair&nbsp;Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Due within one year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">23,950,566</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Due after one year through five years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">23,950,566</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(7) Fair Value Measurements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain assets and liabilities are reported on a recurring basis at fair value. Fair value is defined as the exchange price that would be received for an asset
or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value
must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of
which the first two are considered observable and the last is considered unobservable: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Level 1&#151;Quoted prices in active markets for identical assets or liabilities. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Level 2&#151;Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets
or liabilities, or other inputs that are observable or can be corroborated by observable market data. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Level 3&#151;Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow
methodologies and similar techniques. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-35 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A summary of the assets and liabilities carried at fair value in accordance with the hierarchy defined above
is as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="55%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Fair Value Hierarchy</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Quoted&nbsp;Prices</B><br><B>in active</B><br><B>markets</B><br><B>for&nbsp;identical</B><br><B>instruments</B><br><B>(Level 1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Significant</B><br><B>other</B><br><B>observable</B><br><B>inputs</B><br><B>(Level 2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Significant</B><br><B>unobservable</B><br><B>inputs</B><br><B>(Level 3)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>March&nbsp;31, 2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,520,466</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,520,466</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debt Securities and other Investments Available for Sale:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Corporate Debt Securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,035,998</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,035,998</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Commercial Paper</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,930,765</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,930,765</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S. Government Sponsored Agencies</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,985,159</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,985,159</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S. Treasury Bonds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">994,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">994,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificate of Deposits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">239,998</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">239,998</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">26,706,486</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">26,706,486</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrant liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,485,398</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,485,398</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="55%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Fair Value Hierarchy</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Quoted&nbsp;Prices</B><br><B>in active</B><br><B>markets</B><br><B>for&nbsp;identical</B><br><B>instruments</B><br><B>(Level 1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Significant</B><br><B>other</B><br><B>observable</B><br><B>inputs</B><br><B>(Level 2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Significant</B><br><B>unobservable</B><br><B>inputs</B><br><B>(Level 3)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>December&nbsp;31, 2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,224,194</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,224,194</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Debt Securities and other Investments Available for Sale:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Corporate Debt Securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,997,686</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,997,686</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Commercial Paper</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,978,140</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,978,140</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S. Government Sponsored Agencies</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,494,795</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,494,795</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Certificate of Deposits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">479,945</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">479,945</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">37,174,760</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">37,174,760</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Liabilities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrant liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,239,544</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,239,544</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the periods ended March&nbsp;31, 2018 and December&nbsp;31, 2017, the Company has not changed the manner in which it
values assets and liabilities that are measured at fair value using Level 3 inputs. The Company recognizes transfers between levels of the fair value hierarchy as of the end of the reporting period. There were no transfers within the hierarchy
during the three months ended March&nbsp;31, 2018 and 2017. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents consisted of cash in bank checking and savings accounts, money
market funds and U.S. treasury notes and are classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices in active markets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Marketable securities classified as debt securities available for sale consist of investments in corporate debt securities, commercial paper, U.S. government
sponsored agencies and certificate of deposits. The Company&#146;s marketable securities are valued using quoted prices in active markets and therefore these securities were classified as Level 1. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-36 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The warrant liability was recorded at fair value determined by using the probability weighted expected
return method and option pricing models. This method of valuation involves using inputs such as the fair value of the Company&#146;s Common Units, unit price volatility, the contractual term of the warrant, risk free interest rates and dividend
yields. Due to the nature of these inputs, the valuation of the warrant liability was considered a Level 3 measurement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of March&nbsp;31, 2018 and
December&nbsp;31, 2017, the estimated fair values of the warrant liability were computed using the following assumptions: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="69%"></TD>
<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>March&nbsp;31,<BR>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock price volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65.3</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk-free interest rates</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.82</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.59</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual dividend yield</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected life (years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This discounted cash flow method of valuation involves using inputs such as (1)&nbsp;a 50% required rate of return,
(2)&nbsp;80% probability of a qualified financing round closing prior to the maturity of the convertible Bridge Notes, and (3)&nbsp;the option&#146;s ability to convert at a 10% discount into the expected next qualified financing round. Due to the
nature of these inputs, the valuation of the derivative instrument was considered a Level 3 measurement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The significant unobservable inputs used in the
fair value measurement of the Company&#146;s Series B warrants as of March&nbsp;31, 2018 were a 28% weighted average cost of capital and a Series A dividend yield of 4%, and expected holding periods, volatility factors and risk-free interest rates
for each respective exit scenario, including an IPO, strategic exit and second attempt at an IPO if the initial IPO is unsuccessful. A significant increase in the volatility factor, risk-free interest rate, Series B dividend yield or expected
holding periods excluding the IPO in isolation could result in a significantly higher value for the Series B warrants. A significant increase in the discount rate, Series A dividend yield or expected holding period for the IPO in insolation could
result in a significantly lower value for the Series B warrants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A roll-forward of the recurring fair value measurements of the liabilities categorized
with Level 3 inputs are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="80%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Warrant</B><br><B>liabilities</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Opening Balance as of January&nbsp;1, 2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">480,636</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,620,681</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Settlements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes in fair value recognized</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(861,773</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing Balance as of December&nbsp;31, 2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,239,544</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Settlements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes in fair value recognized</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">245,854</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Closing Balance as of March&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,485,398</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the three months ended March&nbsp;31, 2018, the warrant liability increased due to the change in fair value of the
warrants. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-37 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(8) Inventories </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Inventories as of March&nbsp;31, 2018 and December&nbsp;31, 2017 consisted of the following: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="68%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>March&nbsp;31,<BR>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Raw materials</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">93,826</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">116,909</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Work in process</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,241</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finished goods</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">127,120</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">193,763</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">321,187</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">327,787</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(9) Property and Equipment&#151;Net </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Property and equipment, net as of March&nbsp;31, 2018 and December&nbsp;31, 2017 consisted of the following: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="67%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>March&nbsp;31,<BR>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Machinery and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">481,865</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">452,614</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Furniture and fixture</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">156,512</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">156,512</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Computer equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">112,587</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">138,534</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Construction in process</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">115,749</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property, plant and equipment &#150; gross</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">866,713</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">747,660</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less accumulated depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(560,280</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(579,014</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property, plant and equipment &#150; net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">306,433</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">168,646</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Depreciation and amortization expense for the three months ended March&nbsp;31, 2018 and March&nbsp;31, 2017 were $7,212 and
$6,629, respectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(10) Accounts Payable and Accrued Expenses </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued expenses as of March&nbsp;31, 2018 and December&nbsp;31, 2017 consisted of the following: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="66%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>March&nbsp;31,<BR>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>December&nbsp;31,<BR>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,232,133</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">840,383</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued professional fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,952,596</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,288,020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Due to employees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">503,336</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">659,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other accrued expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">367,210</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">92,039</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,055,275</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,879,775</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(11) Pro Forma Net Loss Per Unit </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Basic and diluted net loss per unit for the three months ended March&nbsp;31, 2018 and 2017, gives effect to the assumed automatic conversion of all the
outstanding Series A Preferred Units and Series B Preferred Units into Common Units on a one-for-one basis in connection with the initial public offering (IPO) by the Company. In connection with the automatic conversion, the Series A Preferred Units
will convert into 70,918,506 shares of the Company&#146;s Common Units on a conversion ratio of 1:1 and the Series B Preferred Units will convert into 105,186,020 of the Company&#146;s Common Units on a conversion ratio of 1:1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, Net loss per Unit gives effect to income tax adjustments as if the Company was a taxable entity as of the beginning of the period. Prior to
consummation of an IPO, the Company will convert into a C-corporation and will be subject to Federal and state income taxes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-38 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has reported a net loss for the three months ended March&nbsp;31, 2018 and 2017. Based on the
Company&#146;s history of generating operating losses and its anticipation of operating losses continuing in the foreseeable future, the Company has determined that it would not have been more likely than not that the tax benefits from these net
operating losses would be realized and a full valuation allowance against all deferred tax assets would be recorded on a pro forma basis. Therefore, for the purposes of the pro forma tax provision, income tax expense is determined to be zero. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has excluded all common equivalent shares outstanding for Profits Interests, warrants and convertible instruments from the calculation of diluted
net loss per share because all such securities are antidilutive. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes the computation of pro forma basic and diluted net loss
per unit attributable to common stockholders for the three months ended March&nbsp;31, 2018 and 2017. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="71%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>For the three months ended<BR>March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Numerator&#151;Basic and Diluted</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations before income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(9,498,540</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(6,356,926</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma provisions/(benefit) for income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(9,498,540</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(6,356,926</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Denominator&#151;Basic and Diluted</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average pro forma Common Units outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">218,982,140</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95,871,587</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average pro forma Common Units issued upon conversion of Series A Preferred
Units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,918,506</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,918,506</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average pro forma Common Units issued upon conversion of Series B Preferred
Units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">105,186,014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma weighted average number of Common Units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">395,086,660</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">166,790,093</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net loss per Unit, Basic and Diluted</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.02</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.04</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(12) Convertible Preferred Units and Members&#146; Equity </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s operating agreement, as amended and restated in August 2017 and then again in November 2017, permits the issuance of four classes of
Units&#151;Series A Preferred Units, Series B Preferred Units, Series B-1 Preferred Units and Common Units. Each member is entitled to one vote for each Unit held and the Units of all classes and series shall vote together as a single class on all
matters (on an as converted to Common Unit basis). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The amended and restated operating agreement contains specific provisions for payments in respect of
the Series A Preferred Units, the Series B Preferred Units and the Common Units for liquidating and non-liquidating distributions. There are also provisions for payments in respect of the Series A Preferred Units, Series B Preferred Units and Common
Units when certain deemed liquidation events occur, which are a merger or consolidation of the Company or sale of all or substantially all of the assets of the Company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Series A Preferred Units </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Series A Preferred
Units are entitled to a preference on distributions, ahead of the Common Units but behind Series B Preferred Units, in the amount of $54,923,430 plus the Series A Preferred Return (as described below), as of March&nbsp;31, 2018. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Series A Preferred Units are entitled to a return in an annual non-compounded amount with respect to each outstanding Series A Preferred Unit equal to the
product of the Series A Preferred Return Percentage and the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-39 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Series A Unreturned Capital Value for each Unit, which shall accrue to the extent not paid. The Series A Preferred Return Percentage is 4% and may be reduced to 2% if certain requirements are met
as outlined in the amended and restated operating agreement. Additionally, except upon an IPO or a liquidation event, the payment of the Series A Preferred Return is at the sole discretion of the Board of Managers. As of March&nbsp;31, 2018, the
Series A Preferred Return in arrears aggregated to $8,076,789. Following the 2017 amendments to the operating agreement, the Series A Preferred Return payable upon a public offering of the Company&#146;s common stock was fixed at $3,629,092 and is
payable, at the Company&#146;s election, in cash or shares of the Company&#146;s common stock but is expected to be paid in common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Series A
Preferred Units are convertible into Common Units at the option of the holder, or mandatorily upon the occurrence of an initial public offering or other specified events into one Common Unit as outlined in amended and restated operating agreement.
In addition, in connection with the Company&#146;s Operating Agreement the Company has the ability to reserve a sufficient number of Common Units to enable the conversion of all Series A Preferred Units. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Series A Preferred Units also have other protective provisions that prohibit the Company from taking certain actions as outlined in the amended and
restated operating agreement without the prior written consent of the holders of not less than 66% of the total outstanding Series A Preferred Units, which consent, subject to certain exceptions, must include the consent of Core Ventures II, LLC (CV
II) and Merck Global Health Innovation Fund, LLC (Merck GHI). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Series A Preferred Units also have other protective provisions that prohibit the
Company from taking certain actions as outlined in the amended and restated operating agreement without the prior written consent of the holders of not less than 66% of the total outstanding Series A Preferred Units, which consent, subject to
certain exceptions, must include the consent of Core Ventures II, LLC (CBII) and Merck Global Health Innovation Fund, LLC (Merck GHL). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of
March&nbsp;31, 2018, warrants issued in connection with Series A Preferred Units financing rounds have either been exercised or have expired and no new warrants related to Series A Preferred Units were issued in 2018. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of March&nbsp;31, 2018, warrants to purchase 132,354 Series A Preferred Units issued in connection with the term loans remain outstanding. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Series B Preferred Units </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2017, the Company
entered into a Series B Preferred Unit Purchase Agreement with, among others, CV II, Merck GHI and AIH. Under the terms of the Purchase Agreement, as amended, through December&nbsp;31, 2017, the Company received cash proceeds of $46,911,300 and
converted $26,718,910 of Bridge Notes and related accrued and unpaid interest for an aggregate amount of $73,630,210 (inclusive of amounts mentioned in Note 13 related to conversion of Bridge Notes and related accrued and unpaid interest) through
the sale of Series B Preferred Units at an initial closing and several additional closings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Series B Preferred Units are entitled to a preference on
distributions ahead of the Series A Preferred Units and the Common Units, in the amount of $73,630,210 as of March&nbsp;31, 2018 and December&nbsp;31, 2017. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Series B Preferred Units are convertible into Common Units at the option of the holder, or mandatorily upon the occurrence of an initial public offering
or other specified event, into one common unit as outlined in the amended and restated operating agreement. In addition, in connection with the Company&#146;s Operating Agreement the Company has the ability to reserve a sufficient number of Common
Units to enable the conversion of all Series B Preferred Units. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Series B Preferred Units also have other protective provisions that prohibit the
Company from taking certain actions as outlined in the amended and restated operating agreement without the prior written consent of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-40 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
holders of not less than 66%&nbsp;of the total outstanding Series B Preferred Units, which consent, subject to certain exceptions, must include the consent of CV II, Merck GHI and American
Investment Holdings LLC (AIH). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with these Series B Preferred Unit closings, the Company also issued 18,340,000 common units to investors at
a relative fair value of $4,074,447. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with all Series B Preferred Unit closings, the Company also issued warrants for the purchase of
35,452,084 Common Units at an exercise price of $1.25 per Unit, which warrants expire on the earlier of 5 years from issuance and the closing of the Company&#146;s IPO. The Company also issued warrants to advisors for the purchase of 2,724,549
Common Units at an exercise price of $0.70 per Unit and 72,000 common warrants at $1.25 per Unit. The fair value of these warrants to purchase common units are recorded within additional-paid-in-capital. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of March&nbsp;31, 2018 and December&nbsp;31, 2017, there were warrants to purchase (i)&nbsp;7,739,092 Series B Preferred Units at $0.70 per unit
outstanding that were issued to purchasers of our Bridge Notes (see Note 13) and (ii)&nbsp;1,820,134 Series B Preferred Units at $0.70 per unit that were issued to our financial advisors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(13) Convertible Bridge Notes </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the three months ended
March&nbsp;31, 2017, the Company issued Bridge Notes aggregating $4,545,141 including warrant coverage. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since the Bridge Note Warrants entitle the
holders to purchase securities in the Qualified Equity Round at the purchase price payable for the related equity securities, the exercise price of the warrants was undetermined at the time of their issuance. Also, because the terms of redemption of
the Series B Preferred Units were unknown at the time of their issuance as well as the deemed liquidation terms discussed in Note 12, the warrants are recorded as liabilities. In connection with the Bridge Note closings, at the time of the Qualified
Equity Round, the Company issued 7,739,092 Bridge Note Warrants all of which are outstanding as of March&nbsp;31, 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2017, all
Bridge Notes were converted to Series B Preferred Units. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(14) <FONT STYLE="white-space:nowrap">Unit-Based</FONT> Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with employment and service provider agreements the Company has awarded grantees Units that constitute profits interests for income tax purposes,
subject to certain restrictions defined in each Unit forfeiture agreement. The Company maintains a Unit award account for each of the grantees. Generally, the Units vest 25% on the one year anniversary of the employment start date or agreement date
and the balance ratably per quarter thereafter over an additional three-year period. After the restrictions lapse, the grantees become fully vested in such Units. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following summarizes activity related to the Company&#146;s unvested Unit awards for the period ended March&nbsp;31, 2018: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="61%"></TD>
<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Number&nbsp;of&nbsp;units</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Weighted average<BR>grant&nbsp;date&nbsp;fair&nbsp;value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding Balance as of January 1, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,635,723</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.04</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,112,218</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vested</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,328,229</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Forfeited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(83,479</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding Balance as of March 31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38,336,233</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-41 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of March&nbsp;31, 2018 there were $3,325,777 of total unrecognized compensation cost related to unvested
Unit-based compensation awards respectively, which are expected to be recognized over a weighted average period of four years. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company utilizes the
Black Scholes option pricing model for estimating the fair value of all Units granted. The fair value of each Unit is estimated on the date of the grant. The fair value is then amortized using graded-vesting over the requisite service period for
each separately vesting portion of the award as if the award was, in-substance, multiple awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The weighted average assumptions for the Units granted
during the three months ended March&nbsp;31, 2018 and 2017 are provided in the following table: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="69%"></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>For&nbsp;the&nbsp;three&nbsp;months&nbsp;ended<BR>March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2018&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2017&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Valuation assumptions:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected dividend yield</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65.34</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82.60</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected term (years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk-free interest rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.53</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.77</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The risk-free interest rate is the average U.S. Treasury rate with a term that most closely resembles the expected life of the
award for the year in which the award was granted. The expected life is the period of time that the awards granted are expected to remain outstanding, which takes into account potential future liquidity events. Expected volatility is a measure of
the amount by which the Unit price has fluctuated or is expected to fluctuate during a period. For volatility, the Company uses comparable public companies as a basis for its expected volatility. The Company does not pay regular dividends on its
Units and does not anticipate paying any dividends in the foreseeable future. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the three months ended March&nbsp;31, 2018 and 2017, Unit-based
compensation expense is reported as a component of selling, general and administrative and research and development expense in the Company&#146;s consolidated statement of operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(15) Variable Interest Entity </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As discussed in note 1,
electroCore is the primary beneficiary of electroCore (Aust) Pty Limited. electroCore has contributed certain intellectual property rights, all rights to distribute, market and sell specified products in Australia and New Zealand, and other rights
outlined in the shareholders&#146; deed of electroCore (Aust) Pty Limited in return for 50% of the shares of such entity. In addition, electroCore can also appoint two of the four directors and can exercise significant influence. This along with the
fact that electroCore is electroCore (Aust) Pty Limited&#146;s only supplier causes electroCore, for accounting purposes, to be the primary beneficiary of electroCore (Aust) Pty Limited. The activities related to electroCore (Aust) Pty Limited are
not material to the consolidated financial statements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(16) Commitments and Contingencies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(a) Operating Lease </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company leases office
space under operating leases through April 2022. For the three months ended March&nbsp;31, 2018 and 2017, rental expense related to the leases for each period was $122,818. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>(b) Legal Proceedings </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company may from time
to time be involved in various claims and legal actions arising in the ordinary course of its business. In the opinion of management, the ultimate disposition of any of these matters will not have a material adverse effect on the Company&#146;s
consolidated financial position, results of operations, or liquidity. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-42 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(17) Subsequent Events </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In May 2018, a former financial advisor to the company filed a complaint against the Company seeking additional compensation in connection with the
Company&#146;s 2017 Series B Preferred Unit financing (see note 12). The Company believes that it has substantial legal and factual defenses to the claims in such lawsuit and intends to vigorously defend the case. Based on our best estimate of this
matter, we have established a legal reserve relative to this matter. The Company does not believe resolution of this matter would have a material adverse effect on its financial position or operations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-43 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Through and
including&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2018 (the 25th day after the date of this prospectus), all dealers effecting transactions in these securities, whether or not participating in
this offering, may be required to deliver a prospectus. This delivery requirement is in addition to a dealer&#146;s obligation to deliver a prospectus when acting as an underwriter and with respect to an unsold allotment or subscription. </P>
<P STYLE="margin-top:72pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>4,333,333 Shares </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g472601g23w48.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>PROSPECTUS
</B></P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:100pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Joint Bookrunners: </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Evercore ISI </B></P>  <P STYLE="margin-top:30pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Cantor
</B></P>  <P STYLE="margin-top:30pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>JMP&nbsp;Securities </B></P>
<P STYLE="margin-top:30pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Lead Manager: </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>BTIG </B></P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2018 </B></P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION NOT REQUIRED IN PROSPECTUS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;13.</B></TD>
<TD ALIGN="left" VALIGN="top"><B></B><B><I>Other Expenses of Issuance and Distribution.</I></B><B> </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table
sets forth the costs and expenses, other than the underwriting discounts and commissions, payable by the registrant in connection with the sale of common stock being registered. All amounts are estimates except for the Securities and Exchange
Commission, or SEC, registration fee, the FINRA filing fee and The Nasdaq Global Select Market listing fee. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="76%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; width:15.95pt; display:inline; font-size:8pt; font-family:Times New Roman; "><B>Item</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Amount&nbsp;to&nbsp;be<BR>paid</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SEC registration fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9,926.80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FINRA filing fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11,712.50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Nasdaq Global Select Market Listing fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">125,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Printing and engraving expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">400,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Legal fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounting fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transfer Agent fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Miscellaneous expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">643,360</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,950,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;14.</B></TD>
<TD ALIGN="left" VALIGN="top"><B></B><B><I>Indemnification of Directors and Officers.</I></B><B> </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the closing of
this offering, Electrocore, LLC intends to convert into a Delaware corporation pursuant to a statutory conversion and change its name to electroCore, Inc. As permitted by Section&nbsp;102 of the Delaware General Corporation Law, our certificate of
incorporation and bylaws to be effective upon the corporate conversion will contain provisions that limit or eliminate the personal liability of our directors for a breach of their fiduciary duty of care as a director. The duty of care generally
requires that, when acting on behalf of the corporation, directors exercise an informed business judgment based on all material information reasonably available to them. Consequently, a director will not be personally liable to us or our
stockholders for monetary damages for breach of fiduciary duty as a director, except for liability for: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any breach of the director&#146;s duty of loyalty to us or our stockholders; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any act related to unlawful stock repurchases, redemptions or other distributions or payment of dividends; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any transaction from which the director derived an improper personal benefit. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These
limitations of liability do not affect the availability of equitable remedies such as injunctive relief or rescission. Our certificate of incorporation will also authorize us to indemnify our officers, directors and other agents to the fullest
extent permitted under Delaware law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As permitted by Section&nbsp;145 of the Delaware General Corporation Law, our bylaws will provide
that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we may indemnify our directors, officers, and employees to the fullest extent permitted by the Delaware General Corporation Law, subject to limited exceptions; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we may advance expenses to our directors, officers and employees in connection with a legal proceeding to the fullest extent permitted by the Delaware General Corporation Law, subject to limited exceptions; and
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the rights provided in our bylaws are not exclusive. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-1 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our certificate of incorporation to be in effect upon the corporate conversion, attached as
Exhibit&nbsp;3.1 hereto, and our bylaws to be in effect upon the corporate conversion, attached as Exhibit&nbsp;3.2 hereto, provide for the indemnification provisions described above and elsewhere herein. We intend to enter into separate
indemnification agreements with our directors and officers which may be broader than the specific indemnification provisions contained in the Delaware General Corporation Law. These indemnification agreements will generally require us, among other
things, to indemnify our officers and directors against liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct. These indemnification agreements will also
generally require us to advance any expenses incurred by the directors or officers as a result of any proceeding against them as to which they could be indemnified. In addition, we have purchased a policy of directors&#146; and officers&#146;
liability insurance that insures our directors and officers against the cost of defense, settlement or payment of a judgment in some circumstances. These indemnification provisions and the indemnification agreements may be sufficiently broad to
permit indemnification of our officers and directors for liabilities, including reimbursement of expenses incurred, arising under the Securities Act of 1933, as amended, or the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The form of Underwriting Agreement, attached as Exhibit&nbsp;1.1 hereto, provides for indemnification by the underwriters of us and our
officers who sign this Registration Statement and directors for specified liabilities, including matters arising under the Securities Act. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;15.</B></TD>
<TD ALIGN="left" VALIGN="top"><B></B><B><I>Recent Sales of Unregistered Securities.</I></B><B> </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following sets forth
information regarding all unregistered securities sold by us since January&nbsp;1, 2015 through the date of the prospectus that forms a part of this registration statement. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">From January 2015 through March 2016, we issued Series A Preferred Units for aggregate consideration of $13.8 million. In connection with such transactions, we issued 16.3 million Series A Preferred Units.
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">In November 2015, we issued 2.3 million Series A Preferred Units to existing investors at a purchase price of approximately $0.74 per unit, for aggregate consideration of approximately $1.7&nbsp;million, in connection
with the exercise of warrants to purchase our Series A Preferred Units. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">In December 2015, we issued 66,177 warrants to purchase Series A Preferred Units to Core Ventures II, LLC, in connection a Loan and Security Agreement, pursuant to which we borrowed $1.25&nbsp;million.
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">In December 2015, we issued 66,177 warrants to purchase Series A Preferred Units to Pacific Western Bank, in connection with a Loan and Security Agreement, pursuant to which we borrowed $1.25&nbsp;million.
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">In March 2016, we issued 2.3 million Series A Preferred Units at a purchase price of approximately $0.74 per unit, for aggregate consideration of approximately $1.7&nbsp;million, in connection with the exercise of
warrants to purchase Series A Preferred Units. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">From June 2016 through August 2016, we issued convertible promissory notes of $1.5 million. We issued 1.8 million Series A Preferred Units when such notes converted in September 2016. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">In September 2016, we issued 1.5 million Series A Preferred Units upon conversion of $1.3&nbsp;million of a term loan by Core Ventures II, LLC. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">From September 2016 through June 2017, we issued Series B convertible promissory notes for aggregate consideration of $25.6 million. In connection with such transactions, we issued to such investors an aggregate of 41.9
million Common Units and warrants to purchase 7.31 million Series B Preferred Units, including to existing investors and investors affiliated with our board of directors. In addition, in connection with such transactions we issued 5.4&nbsp;million
Common Units and warrants to purchase 1.6 million Series B Preferred Units to our placement agents. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-2 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">In July 2017, we issued 18.34 million Common Units to existing investors who committed to invest $9.17 million into our Series B financing. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">From August 2017 through December 2017, we issued Series&nbsp;B Preferred Units for aggregate consideration of $73.6 million. In connection with such transactions, we issued 105.2 million Series B Preferred Units, and
warrants to purchase 35.45 million Common Units, including to existing investors, those affiliated with members of our board of directors and our placement agents. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Since January&nbsp;1, 2015, we have granted, net of forfeitures, 52.1 million Profits Interests to employees, consultants and certain members of our board of directors. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We claimed exemption from registration under the Securities Act for the sales and issuances of securities in the transactions described above
under Section&nbsp;4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder, in that such sales and issuances did not involve a public offering, or under Rule 701 promulgated under the Securities Act, in that they were offered and
sold either pursuant to written compensatory plans or pursuant to a written contract relating to compensation, as provided by Rule 701. All of the purchasers of unregistered securities for which we relied on Section&nbsp;4(a)(2) and/or Regulation D
represented that they were accredited investors as defined under the Securities Act. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;16.</B></TD>
<TD ALIGN="left" VALIGN="top"><B></B><B><I>Exhibits and Financial Statement Schedules.</I></B><B> </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Exhibits. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-3 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD WIDTH="87%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:25.30pt; display:inline; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>1.1**</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d472601dex11.htm">Form of Underwriting Agreement </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>3.1***</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Certificate of Incorporation of electroCore, Inc. (to be effective upon completion of the Registrant&#146;s conversion from a limited liability company to a corporation)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>3.2*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518169701/d472601dex32.htm">Form of Bylaws of electroCore, Inc. (to be effective upon completion of the Registrant&#146;s conversion from a limited liability company to a
 corporation) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>3.3*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518169701/d472601dex33.htm">Second Amended and Restated Limited Liability Company Agreement, dated as of August&nbsp;
18, 2017, by and among ElectroCore, LLC and the members party thereto </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>3.4*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518169701/d472601dex34.htm">Third Amended and Restated Limited Liability Company Agreement, dated as of November&nbsp;
21, 2017, by and among ElectroCore, LLC and the members party thereto </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>5.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518184430/d472601dex51.htm">Opinion of Dentons US LLP </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518169701/d472601dex101.htm">Investors&#146; Rights Agreement, dated as of March&nbsp;28, 2013, by and among ElectroCore, LLC and the investors party thereto
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.2*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518169701/d472601dex102.htm">Amended and Restated Investors&#146; Rights Agreement, dated as of August&nbsp;
18, 2017, by and among Electrocore, LLC and the investors party thereto </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.3*&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518169701/d472601dex103.htm">Form of ElectroCore, LLC Unit Forfeiture Agreement </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.4*&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518184430/d472601dex104.htm">electroCore, Inc. 2018 Omnibus Equity Incentive Plan </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.5*&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518169701/d472601dex105.htm">Form of Employee Incentive Stock Option Agreement for electroCore, Inc. 2018 Omnibus Equity Incentive Plan </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.6*&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518169701/d472601dex106.htm">Form of Non-qualified Stock Option Agreement for electroCore, Inc. 2018 Omnibus Equity Incentive Plan </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.7*&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518169701/d472601dex107.htm">Form of Employee Restricted Stock Award Agreement for electroCore, Inc. 2018 Omnibus Equity Incentive Plan </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.8*&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518169701/d472601dex108.htm">Form of Non-Employee Director Inaugural Deferred Stock Unit Award Agreement for electroCore, Inc. 2018 Omnibus Equity Incentive Plan
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.9*&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518169701/d472601dex109.htm">Form of Non-Employee Director Inaugural Non-qualified Stock Option Agreement for electroCore, Inc. 2018 Omnibus Equity Incentive Plan
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.10*&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518169701/d472601dex1010.htm">Form of Non-Employee Director Inaugural Restricted Stock Unit Agreement for electroCore, Inc. 2018 Omnibus Equity Incentive Plan
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.11*&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518169701/d472601dex1011.htm">Form of Non-Employee Director Annual Deferred Stock Unit Award Agreement for electroCore, Inc. 2018 Omnibus Equity Incentive Plan
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.12*&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518169701/d472601dex1012.htm">Form of Non-Employee Director Annual Non-qualified Stock Option Agreement for electroCore, Inc. 2018 Omnibus Equity Incentive Plan
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.13*&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518169701/d472601dex1013.htm">Form of Non-Employee Director Annual Restricted Stock Unit Agreement for electroCore, Inc. 2018 Omnibus Equity Incentive Plan
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.14*&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518169701/d472601dex1014.htm">Form of Indemnification Agreement between the Registrant and each of its executive officers and directors </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.15*&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518169701/d472601dex1015.htm">Form of electroCore, Inc. Management Severance Plan (to be effective upon completion of Registrant&#146;s conversion from a limited liability
 company to a corporation) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.16*&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518169701/d472601dex1016.htm">Form of electroCore, Inc. Non-Employee Director Compensation Policy (to be effective upon completion of Registrant&#146;s conversion from a
limited liability company to a corporation) </A></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-4 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD WIDTH="87%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:25.30pt; display:inline; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.17*&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518169701/d472601dex1017.htm">Employment Offer Letter, dated as of July 18, 2016, by and between ElectroCore, LLC and Francis R. Amato </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">10.18*&#134;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;
</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518169701/d472601dex1018.htm">Employment Offer Letter, dated as of July 18, 2016, by and between
 ElectroCore, LLC and Joseph P. Errico </A></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.19*&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518169701/d472601dex1019.htm">Employment Offer Letter, dated as of May 1, 2017, by and between ElectroCore, LLC and Peter S. Staats </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.20*&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518169701/d472601dex1020.htm">Employment Offer Letter, dated as of July 25, 2016, by and between ElectroCore, LLC and Glenn S. Vraniak </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.21*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518169701/d472601dex1021.htm">Office Lease between 150 Allen Road, LLC and Electrocore, LLC </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.22*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518169701/d472601dex1022.htm">Form of Common Unit Warrant </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.23*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518169701/d472601dex1023.htm">Form of Series A Warrant </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.24*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518169701/d472601dex1024.htm">Form of Bridge Warrant </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.25*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518169701/d472601dex1025.htm">Master Services Agreement dated October 17, 2016 between ElectroCore, LLC and Asembia LLC </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>21.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518169701/d472601dex211.htm">List of subsidiaries of Electrocore, LLC </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518184430/d472601dex51.htm">Consent of Dentons US LLP (included as part of Exhibit 5.1) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.2**</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d472601dex232.htm">Consent of KPMG LLP, independent registered public accounting firm </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>24.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518169701/d472601ds1.htm">Powers of Attorney (included on signature pages) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518169701/d472601dex991.htm">Consent of Michael G. Atieh </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.2*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518169701/d472601dex992.htm">Consent of Stephen L. Ondra, M.D. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.3*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1560258/000119312518184430/d472601dex993.htm">Consent of Carrie S. Cox </A></TD></TR></TABLE>
<P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Previously filed. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">**</TD>
<TD ALIGN="left" VALIGN="top">Filed herewith. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">***</TD>
<TD ALIGN="left" VALIGN="top">To be filed by amendment. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#134;</TD>
<TD ALIGN="left" VALIGN="top">Indicates management agreement. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>(b) Financial Statement Schedules. </I></B>Schedules
not listed above have been omitted because the information required to be set forth therein is not applicable or is shown in the financial statements or notes thereto. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><B>Item&nbsp;17.</B></TD>
<TD ALIGN="left" VALIGN="top"><B></B><B><I>Undertakings.</I></B><B> </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Insofar as indemnification for liabilities arising
under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the SEC such indemnification is
against public policy as expressed in the Securities Act, and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director,
officer, or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless
in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question of whether such indemnification by it is against public policy as expressed in the Securities Act and will
be governed by the final adjudication of such issue. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-5 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned Registrant hereby undertakes that: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top">For purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this Registration Statement in reliance upon Rule 430A and contained in a form of
prospectus filed by the Registrant pursuant to Rule&nbsp;424(b)(1) or (4)&nbsp;or 497(h) under the Securities Act shall be deemed to be part of this Registration Statement as of the time it was declared effective. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top">For the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities
offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned Registrant hereby undertakes to provide to the underwriters at the closing specified in the underwriting agreement
certificates in such denominations and registered in such names as required by the underwriters to permit prompt delivery to each purchaser. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-6 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="ii472601_sig"></A>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant has duly caused this Amendment No. 2 to the
Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Basking Ridge, State of New Jersey, on this 11<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> day of June 2018. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>ELECTROCORE, LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Francis R. Amato</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Francis R. Amato</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B><I>Chief Executive Officer</I></B></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the
following persons in the capacities and on the dates indicated. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="42%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="41%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:33.30pt; display:inline; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Signature</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:15.95pt; display:inline; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Title</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:16.00pt; display:inline; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Date</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Francis R. Amato </P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Francis R. Amato</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Executive Officer and Director <I>(Principal Executive Officer)</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">June 11, 2018</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Glenn S. Vraniak </P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Glenn S. Vraniak</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Financial Officer<BR><I>(Principal Financial and Accounting Officer)</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">June 11, 2018</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Joseph P. Errico</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chairman of the Board</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">June 11, 2018</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Nicholas Colucci</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">June 11, 2018</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Thomas J. Errico, M.D.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">June 11, 2018</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Trevor J. Moody</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">June 11, 2018</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="2">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="2" ALIGN="center">June 11, 2018</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Michael W. Ross</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Dr. David M. Rubin</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">June 11, 2018</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>James L.L. Tullis</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">June 11, 2018</TD></TR>
</TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Pursuant to Power of Attorney </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="42%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="8%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Francis R. Amato </P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Francis R. Amato </B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Attorney-in-Fact</B></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-7 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>d472601dex11.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-1.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 1.1 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>[&nbsp;&nbsp;&nbsp;&nbsp;] Shares </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>electroCore, Inc. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PURCHASE
AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">[&nbsp;&nbsp;&nbsp;&nbsp;],&nbsp;2018 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">EVERCORE GROUP L.L.C. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CANTOR FITZGERALD &amp; CO. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">JMP SECURITIES LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As Representatives of the several </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;Underwriters named in Schedule&nbsp;I hereto </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Evercore Group L.L.C. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">55 East 52nd Street </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10055 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Cantor Fitzgerald &amp; Co. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">499 Park Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, NY 10022 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o JMP Securities LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">600 Montgomery Street, </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Suite 1100 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">San Francisco, CA 94111 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">electroCore, Inc., a
Delaware corporation (the <B>&#147;</B><B><I>Company&#148;</I></B>), proposes to sell to the several Underwriters named in Schedule&nbsp;I hereto (the <B><I>&#147;Underwriters&#148;</I></B>) an aggregate of [&nbsp;&nbsp;&nbsp;&nbsp;] shares (the
<B><I>&#147;Firm Shares&#148;</I></B>) of Common Stock, $0.001 par value per share (the <B><I>&#147;Common Stock&#148;</I></B>), of the Company. The Company has also granted to the several Underwriters an option to purchase up to
[&nbsp;&nbsp;&nbsp;&nbsp;] additional shares of Common Stock, on the terms and for the purposes set forth in Section&nbsp;3 hereof (the <B><I>&#147;Option Shares&#148;</I></B>). The Firm Shares and any Option Shares purchased pursuant to this
purchase agreement (this <B><I>&#147;Agreement&#148;</I></B>) are herein collectively called the <B><I>&#147;Securities.&#148;</I></B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following actions have been effected in accordance with Delaware law: (i)&nbsp;ElectroCore, LLC, a Delaware limited liability company
(&#147;<B><I>ElectroCore LLC</I></B>&#148;), has been converted into a Delaware corporation pursuant to a statutory conversion and (ii)&nbsp;ElectroCore LLC has changed its name to electroCore, Inc. Such actions are collectively referred to herein
as the &#147;<B><I>Corporate Conversion</I></B>.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company hereby confirms its agreement with respect to the sale of the
Securities to the several Underwriters, for whom Evercore Group L.L.C., Cantor Fitzgerald &amp; Co., and JMP Securities LLC are acting as representatives (the <B><I>&#147;Representatives&#148;</I></B>). </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <B><I>Registration Statement and Prospectus</I></B>. A registration statement on <FONT
STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> (File&nbsp;No. <FONT STYLE="white-space:nowrap">333-225084)</FONT> with respect to the Securities, including a preliminary form of prospectus, has been prepared by the Company in conformity with the
requirements of the Securities Act of 1933, as amended (the <B><I>&#147;Act&#148;</I></B>), and the rules and regulations (the <B><I>&#147;Rules and Regulations&#148;</I></B>) of the Securities and Exchange Commission (the
<B><I>&#147;Commission&#148;</I></B>) thereunder and has been filed with the Commission. Such registration statement, including the amendments, exhibits and schedules thereto, as of the time it became effective, including the Rule 430A Information
(as defined below), is referred to herein as the <B><I>&#147;Registration Statement&#148;</I></B>. The Company will prepare and file a prospectus pursuant to Rule&nbsp;424(b) of the Rules and Regulations that discloses the information previously
omitted from the prospectus in the Registration Statement in reliance upon Rule&nbsp;430A of the Rules and Regulations, which information will be deemed retroactively to be a part of the Registration Statement in accordance with Rule 430A of the
Rules and Regulations (<B><I>&#147;Rule 430A Information&#148;</I></B>). If the Company has elected to rely upon Rule&nbsp;462(b) of the Rules and Regulations to increase the size of the offering registered under the Act, the Company will prepare
and file with the Commission a registration statement with respect to such increase pursuant to Rule&nbsp;462(b) of the Rules and Regulations (such registration statement, including the contents of the Registration Statement incorporated by
reference therein is the <B><I>&#147;Rule 462(b) Registration Statement&#148;</I></B>). References herein to the <B><I>&#147;Registration Statement&#148;</I></B> will be deemed to include the Rule 462(b) Registration Statement at and after the time
of filing of the Rule 462(b) Registration Statement. <B><I>&#147;Preliminary Prospectus&#148;</I></B> means any prospectus included in the Registration Statement prior to the effective time of the Registration Statement, any prospectus filed with
the Commission pursuant to Rule 424(a) under the Rules and Regulations and each prospectus that omits Rule 430A Information used after the effective time of the Registration Statement. <B><I>&#147;Prospectus&#148;</I></B> means the prospectus that
discloses the public offering price and other final terms of the Securities and the offering and otherwise satisfies Section&nbsp;10(a) of the Act.<I> </I>All references in this Agreement to the Registration Statement, any Preliminary Prospectus,
the Prospectus or any amendment or supplement to any of the foregoing, is deemed to include the copy filed with the Commission pursuant to its Electronic Data Gathering, Analysis and Retrieval System or any successor system thereto
(<B><I>&#147;EDGAR&#148;</I></B>). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <B><I>Representations and Warranties of the Company</I></B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) The Company represents and warrants to, and agrees with, the several Underwriters as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(i) <I><U>Registration Statement and Prospectuses</U></I>. The Registration Statement and any post-effective amendment thereto
has become effective under the Act. No stop order suspending the effectiveness of the Registration Statement or any <FONT STYLE="white-space:nowrap">post-effective</FONT> amendment thereto has been issued by the Commission, and no proceeding for
that purpose has been initiated or, to the Company&#146;s knowledge, threatened by the Commission. No order preventing or suspending the use of any Preliminary Prospectus or the Prospectus (or any supplement thereto) has been issued by the
Commission and no proceeding for that purpose has been initiated or, to the Company&#146;s knowledge, threatened by the Commission. As of the time each part of the Registration Statement (or any <FONT STYLE="white-space:nowrap">post-effective</FONT>
amendment thereto) became or becomes effective, such part conformed or will conform in all material respects to the requirements of the Act and the Rules and Regulations. Upon the filing or first use within the meaning of the Rules and Regulations,
each Preliminary Prospectus and the Prospectus (or any supplement to either) conformed or will conform in all material respects to the requirements of the Act and the Rules and Regulations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(ii) <I><U>Accurate Disclosure</U></I>. Each Preliminary Prospectus, at the time
of filing thereof or the time of first use within the meaning of the Rules and Regulations, did not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements
therein, in the light of the circumstances under which they were made, not misleading. Neither the Registration Statement nor any amendment thereto, at the effective time of each part thereof, at the First Closing Date (as defined below) or at the
Second Closing Date (as defined below), contained, contains or will contain an untrue statement of a material fact or omitted, omits or will omit to state a material fact required to be stated therein or necessary to make the statements therein not
misleading. As of the Time of Sale (as defined below), neither (A)&nbsp;the Time of Sale Disclosure Package (as defined below) nor (B)&nbsp;any issuer free writing prospectus (as defined below), when considered together with the Time of Sale
Disclosure Package, included an untrue statement of a material fact or omitted to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. Neither the
Prospectus nor any supplement thereto, as of its issue date, at the time of any filing with the Commission pursuant to Rule 424(b) of the Rules and Regulations, at the First Closing Date or at the Second Closing Date, included, includes or will
include an untrue statement of a material fact or omitted, omits or will omit to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. The representations
and warranties in this Section&nbsp;2(a)(ii) shall not apply to statements in or omissions from any Preliminary Prospectus, the Registration Statement (or any amendment thereto), the Time of Sale Disclosure Package or the Prospectus (or any
supplement thereto) made in reliance upon, and in conformity with, written information furnished to the Company by you, or by any Underwriter through you, specifically for use in the preparation of such document, it being understood and agreed that
the only such information furnished by any Underwriter consists of the information described as such in Section&nbsp;6(e). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Each reference
to an <B><I>&#147;issuer free writing prospectus&#148;</I></B> herein means an issuer free writing prospectus as defined in Rule 433 of the Rules and Regulations. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>&#147;Time of Sale Disclosure Package&#148;</I></B> means the Preliminary Prospectus dated [&nbsp;&nbsp;&nbsp;&nbsp;], 2018, any free
writing prospectus set forth on Schedule III and the information on Schedule IV, all considered together. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Each reference to a
<B><I>&#147;free writing prospectus&#148;</I></B> herein means a free writing prospectus as defined in Rule 405 of the Rules and Regulations. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>&#147;Time of Sale&#148;</I></B> means [&nbsp;&nbsp;&nbsp;&nbsp;]:[&nbsp;&nbsp;&nbsp;&nbsp;] [a./p.]m. (Eastern time) on the date of this
Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(iii) <I><U>Issuer Free Writing Prospectuses</U></I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(A) Each issuer free writing prospectus, as of its issue date and at all subsequent times through the completion of the public
offer and sale of the Securities or until any earlier date that the Company notified or notifies the Representatives as described in Section&nbsp;4(c)(ii), did not, does not and will not include any information that conflicted, conflicts or will
conflict with the information contained in the Registration Statement, any Preliminary Prospectus or the Prospectus. The foregoing sentence does not apply to statements in or omissions from any issuer free writing prospectus based upon and in
conformity with written information furnished to the Company by you or by any Underwriter through you specifically for use therein; it being understood and agreed that the only such information furnished by any Underwriter consists of the
information described as such in Section&nbsp;6(e). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(B) At the time of filing the Registration Statement and any
post-effective amendment thereto, and at the date hereof, the Company was not and is not an &#147;ineligible issuer,&#148; as defined in Rule 405 of the Rules and Regulations, without taking account of any determination by the Commission pursuant to
Rule 405 of the Rules and Regulations that it is not necessary that the Company be considered an ineligible issuer. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(C)
Each issuer free writing prospectus satisfied, as of its issue date and at all subsequent times through the completion of the public offer and sale of the Securities, all other conditions to use thereof as set forth in Rules 164 and 433 under the
Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(iv) <I><U>Emerging Growth Company</U></I>. From the time of initial confidential submission of the Registration
Statement to the Commission (or, if earlier, the first date on which the Company engaged directly or through any person authorized to act on its behalf in any
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication (as defined below)) through the date hereof, the Company has been and is an &#147;emerging growth company,&#148; as defined in
Section&nbsp;2(a) of the Act (an <B><I>&#147;Emerging Growth Company&#148;</I></B>). <B><I><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;Testing-the-Waters</FONT></FONT> Communication&#148;</I></B> means any oral or written
communication with potential investors undertaken in reliance on Section&nbsp;5(d) of the Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(v) <I><U><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Materials</U></I>. The Company (i)&nbsp;has not alone engaged in any
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communications, other than <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communications with the
prior consent of the Representatives with entities that are qualified institutional buyers within the meaning of Rule&nbsp;144A under the Act or institutions that are accredited investors within the meaning of Rule&nbsp;501 under the Act and
(ii)&nbsp;has not authorized anyone other than the Representatives to engage in <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communications. The Company has not distributed any Written <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communications (as defined below) other than those listed on Schedule&nbsp;V hereto. <B><I>&#147;Written <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication&#148;</I></B> means any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication that is a written communication within
the meaning of Rule&nbsp;405 under the Act. Any individual Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication does not conflict with the information contained in the Registration
Statement or the Time of Sale Disclosure Package, complied in all material respects with the Act, and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
when taken together with the Time of Sale Disclosure Package as of the Time of Sale, did not contain any untrue statement of a material fact or omit to state a material fact necessary in order to
make the statements therein, in the light of the circumstances under which they were made, not misleading. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(vi) <I><U>No
Other Offering Materials</U></I>. The Company has not distributed and will not distribute any prospectus or other offering material in connection with the offering and sale of the Securities other than any Preliminary Prospectus, the Time of Sale
Disclosure Package or the Prospectus or other materials permitted by the Act to be distributed by the Company (it being understood that <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communications
are not covered by the foregoing); <I>provided, however,</I> that, except as set forth on Schedule III, the Company has not made and will not make any offer relating to the Securities that would constitute a free writing prospectus, except in
accordance with the provisions of Section&nbsp;4(m) of this Agreement and, except as set forth on Schedule&nbsp;V, the Company has not made and will not make any communication relating to the Securities that would constitute a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication, except in accordance with the provisions of Section&nbsp;2(a)(v) of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(vii) <I><U>Financial Statements</U></I>. The financial statements of the Company, together with the related notes, set forth
in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus comply in all material respects with the requirements of the Act and fairly present the financial condition of the Company and its consolidated subsidiaries as of
the dates indicated and the results of operations and changes in cash flows for the periods therein specified in conformity with generally accepted accounting principles in the United States (&#147;<B><I>GAAP</I></B>&#148;) consistently applied
throughout the periods involved; the supporting schedules included in the Registration Statement present fairly the information required to be stated therein; and, except as disclosed in the Time of Sale Disclosure Package and the Prospectus, there
are no material <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet arrangements (as defined in Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Act, Item&nbsp;303(a)(4)(ii)) or any other relationships with unconsolidated
entities or other persons, that may have a material current or, to the Company&#146;s knowledge, material future effect on the Company&#146;s financial condition, results of operations, liquidity, capital expenditures, capital resources or
significant components of revenue or expenses. No other financial statements or schedules are required to be included in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus. KPMG LLP, which has expressed its opinion
with respect to the financial statements and schedules filed as a part of the Registration Statement and included in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, is (x)&nbsp;an independent public accounting
firm within the meaning of the Act and the Rules and Regulations, (y)&nbsp;a registered public accounting firm (as defined in Section&nbsp;2(a)(12) of the Sarbanes-Oxley Act of 2002 (the <B><I>&#147;Sarbanes-Oxley Act&#148;</I></B>)) and
(z)&nbsp;not in violation of the auditor independence requirements of the Sarbanes-Oxley Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(viii) <I><U>Organization
and Good Standing</U></I>.<I> </I>Each of the Company and its subsidiaries has been duly organized and is validly existing in good standing under the laws of its jurisdiction of incorporation or organization. Each of the Company and its subsidiaries
has full power and authority to own its properties and conduct its business as </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
currently being carried on and as described in the Registration Statement, the Time of Sale Disclosure Package and Prospectus, and is duly qualified to do business and in good standing in each
jurisdiction in which it owns or leases real property or in which the conduct of its business makes such qualification necessary and in which the failure to so qualify would reasonably be expected to have a material adverse effect upon the business,
prospects, management, properties, operations, condition (financial or otherwise) or results of operations of the Company and its subsidiaries, taken as a whole (a <B><I>&#147;Material Adverse Effect&#148;</I></B>). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(ix) <I><U>Absence of Certain Events</U></I>. Except as contemplated in the Time of Sale Disclosure Package and in the
Prospectus, subsequent to the respective dates as of which information is given in the Time of Sale Disclosure Package, neither the Company nor any of its subsidiaries has incurred any material liabilities or obligations, direct or contingent, or
entered into any material transactions, or declared or paid any dividends or made any distribution of any kind with respect to its capital stock; and there has not been any change in the capital stock, or any material change in the <FONT
STYLE="white-space:nowrap">short-term</FONT> or <FONT STYLE="white-space:nowrap">long-term</FONT> debt (other than as a result of the conversion of convertible securities), or any issuance of options, warrants, convertible securities or other rights
to purchase the capital stock, of the Company or any of its subsidiaries, or any material adverse change in the general affairs, condition (financial or otherwise), business, prospects, management, properties, operations or results of operations of
the Company and its subsidiaries, taken as a whole (a <B><I>&#147;Material Adverse Change&#148;</I></B>) or any development which could reasonably be expected to result in any Material Adverse Change. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(x) <I><U>Absence of</U></I><U> </U><I><U>Proceedings</U></I>. Except as set forth in the Time of Sale Disclosure Package and
in the Prospectus, there is not pending or, to the knowledge of the Company, threatened or contemplated, any action, suit or proceeding (a)&nbsp;to which the Company or any of its subsidiaries is a party or (b)&nbsp;which has as the subject thereof
any officer or director of the Company or any subsidiary, any employee benefit plan sponsored by the Company or any subsidiary or any property or assets owned or leased by the Company or any subsidiary before or by any court or Governmental
Authority (as defined below), or any arbitrator, which, individually or in the aggregate, might result in any Material Adverse Change, or would materially and adversely affect the ability of the Company to perform its obligations under this
Agreement or which are otherwise material in the context of the sale of the Securities. There are no current or, to the knowledge of the Company, pending, legal, governmental or regulatory actions, suits or proceedings (x)&nbsp;to which the Company
or any of its subsidiaries is subject or (y)&nbsp;which has as the subject thereof any officer or director of the Company or any subsidiary, any employee plan sponsored by the Company or any subsidiary or any property or assets owned or leased by
the Company or any subsidiary, that are required to be described in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus by the Act or by the Rules and Regulations and that have not been so described. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xi) <I><U>Authorization; No Conflicts; Authority</U></I>. This Agreement has been duly authorized, executed and delivered by
the Company, and constitutes a valid, legal and binding obligation of the Company, enforceable in accordance with its terms, except as rights to indemnity hereunder may be limited by federal or state securities laws and
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
except as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting the rights of creditors generally and subject to general principles of equity. The
execution, delivery and performance of this Agreement and the consummation of the transactions herein contemplated will not (A)&nbsp;conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default
under, or result in the creation or imposition of any lien, charge or encumbrance upon any property or assets of the Company or any of its subsidiaries pursuant to any indenture, mortgage, deed of trust, loan agreement or other agreement or
instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any of the property or assets of the Company or any of its subsidiaries is subject, (B)&nbsp;result in any
violation of the provisions of the Company&#146;s charter or <FONT STYLE="white-space:nowrap">by-laws</FONT> or (C)&nbsp;result in the violation of any law or statute or any judgment, order, rule, regulation or decree of any court or arbitrator or
federal, state, local or foreign governmental agency or regulatory authority having jurisdiction over the Company or any of its subsidiaries or any of their properties or assets (each, a <B><I>&#147;Governmental Authority&#148;</I></B>), except in
the case of clause (A)&nbsp;as would not reasonably be expected to result in a Material Adverse Effect. No consent, approval, authorization or order of, or registration or filing with any Governmental Authority is required for the execution,
delivery and performance of this Agreement or for the consummation of the transactions contemplated hereby, including the issuance or sale of the Securities by the Company, except such as may be required under the Act, the rules of the Financial
Industry Regulatory Authority, Inc. (<I>&#147;</I><B><I>FINRA</I></B><I>&#148;</I>) or state securities or blue sky laws; and the Company has full power and authority to enter into this Agreement and to consummate the transactions contemplated
hereby, including the authorization, issuance and sale of the Securities as contemplated by this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xii)
<I><U>Capitalization; the Securities; Registration Rights</U></I>. All of the issued and outstanding shares of capital stock of the Company, including the outstanding shares of Common Stock, are duly authorized and validly issued, fully paid and
nonassessable, have been issued in compliance with all federal and state and foreign securities laws, were not issued in violation of or subject to any preemptive rights or other rights to subscribe for or purchase securities that have not been
waived in writing (a copy of which has been delivered to counsel to the Representatives), and the holders thereof are not subject to personal liability by reason of being such holders; the Securities which may be sold hereunder by the Company have
been duly authorized and, when issued, delivered and paid for in accordance with the terms of this Agreement, will have been validly issued and will be fully paid and nonassessable, and the holders thereof will not be subject to personal liability
by reason of being such holders; and the capital stock of the Company, including the Common Stock, conforms to the description thereof in the Registration Statement, in the Time of Sale Disclosure Package and in the Prospectus. Except as otherwise
stated in the Registration Statement, in the Time of Sale Disclosure Package and in the Prospectus, (A)&nbsp;there are no preemptive rights or other rights to subscribe for or to purchase, or any restriction upon the voting or transfer of, any
shares of Common Stock pursuant to the Company&#146;s charter, <FONT STYLE="white-space:nowrap">by-laws</FONT> or any agreement or other instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its
subsidiaries is bound, (B)&nbsp;neither the filing of the Registration Statement nor the offering or sale of the Securities as contemplated by this Agreement </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
gives rise to any rights for or relating to the registration of any shares of Common Stock or other securities of the Company (collectively, <B><I>&#147;Registration Rights&#148;</I></B>) that
have not been waived and (C)&nbsp;any person to whom the Company has granted Registration Rights has agreed not to exercise or has otherwise waived such rights until after expiration of the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period (as
defined below). All of the issued and outstanding shares of capital stock of each of the Company&#146;s subsidiaries have been duly and validly authorized and issued and are fully paid and nonassessable, and, except as otherwise described in the
Registration Statement, in the Time of Sale Disclosure Package and in the Prospectus, the Company owns of record and beneficially, free and clear of any security interests, claims, liens, proxies, equities or other encumbrances, all of the issued
and outstanding shares of such stock. The Company has an authorized and outstanding capitalization as set forth in the Registration Statement, in the Time of Sale Disclosure Package and in the Prospectus under the caption &#147;Capitalization.&#148;
The Common Stock (including the Securities) conforms in all material respects to the description thereof contained in the Time of Sale Disclosure Package and the Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xiii) <I><U>Stock Options</U></I>. Except as described in the Registration Statement, in the Time of Sale Disclosure Package
and in the Prospectus, there are no options, warrants, agreements, contracts or other rights in existence to purchase or acquire from the Company or any subsidiary of the Company any shares of the capital stock of the Company or any subsidiary of
the Company. The description of the Company&#146;s stock option, stock bonus and other stock plans or arrangements (the <B><I>&#147;Company Stock Plans&#148;</I></B>), and the options (the <B><I>&#147;Options&#148;</I></B>) or other rights granted
thereunder, set forth in the Time of Sale Disclosure Package and the Prospectus accurately and fairly presents in all material respects the information required to be shown with respect to such plans, arrangements, options and rights. Each grant of
an Option (A)&nbsp;was duly authorized no later than the date on which the grant of such Option was by its terms to be effective by all necessary corporate action, including, as applicable, approval by the board of managers or directors of the
Company (or a duly constituted and authorized committee thereof) and any required member or stockholder approval by the necessary number of votes or written consents, and the award agreement governing such grant (if any) was duly executed and
delivered by each party thereto and (B)&nbsp;was made in accordance with the terms of the applicable Company Stock Plan, and all applicable laws and regulatory rules or requirements, including all applicable federal securities laws. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xiv) <I><U>Compliance with Laws</U></I>. Except as would not reasonably be expected to have a Material Adverse Effect:
(A)&nbsp;the Company and each of its subsidiaries holds, and is operating in compliance with, all franchises, grants, authorizations, licenses, permits, easements, consents, certificates and orders of any Governmental Authority or <FONT
STYLE="white-space:nowrap">self-regulatory</FONT> body required for the conduct of its business and all such franchises, grants, authorizations, licenses, permits, easements, consents, certifications and orders are valid and in full force and
effect; (B)&nbsp;neither the Company nor any of its subsidiaries has received notice of any revocation or modification of any such franchise, grant, authorization, license, permit, easement, consent, certification or order or has reason to believe
that any such franchise, grant, authorization, license, permit, easement, consent, certification or order will not be renewed in the ordinary course; and (C)&nbsp;the Company and each of its subsidiaries is in compliance with all applicable federal,
state, local and foreign laws, regulations, orders and decrees. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xv) <I><U>Ownership of Assets</U></I>. The Company and its subsidiaries have
good and marketable title to all property (whether real or personal) described in the Registration Statement, in the Time of Sale Disclosure Package and in the Prospectus as being owned by them, in each case free and clear of all liens, claims,
security interests, other encumbrances or defects except such as would not reasonably be expected to have a Material Adverse Effect or as are described in the Registration Statement, in the Time of Sale Disclosure Package and in the Prospectus. The
property held under lease by the Company and its subsidiaries is held by them under valid, subsisting and enforceable leases with only such exceptions with respect to any particular lease as do not interfere with the conduct of the business of the
Company or its subsidiaries except as would not reasonably be expected to have a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xvi)
<I><U>Intellectual Property</U></I>. The Company and each of its subsidiaries own, possess, license or have other rights to use, or can acquire on reasonable terms, all Intellectual Property, which to the knowledge of the Company have been duly and
properly filed and maintained, reasonably necessary for the conduct of the Company&#146;s and it subsidiaries&#146; respective businesses as now conducted or as described in the Registration Statement, the Time of Sale Disclosure Package and the
Prospectus to be conducted, except as such failure to own, possess, license or have other rights to use, or acquire such rights would not reasonably be expected to result in a Material Adverse Effect. Furthermore, (A)&nbsp;to the knowledge of the
Company, there is no infringement, misappropriation or violation by third parties of any such Intellectual Property, except as such infringement, misappropriation or violation would not reasonably be expected to result in a Material Adverse Effect;
(B)&nbsp;there is no pending or, to the knowledge of the Company, threatened, action, suit, proceeding or claim by others challenging the Company&#146;s or any of its subsidiaries&#146; rights in or to any such Intellectual Property, except as such
action, suit, proceeding or claim would not reasonably be expected to result in a Material Adverse Effect, and the Company is unaware of any facts which would form a reasonable basis for any such claim; (C)&nbsp;the Intellectual Property owned by
the Company and its subsidiaries, and to the knowledge of the Company, the Intellectual Property licensed to the Company and its subsidiaries, has not been adjudged invalid or unenforceable, in whole or in part, and there is no pending or, to the
knowledge of the Company, threatened action, suit, proceeding or claim by others challenging the validity or scope of any such Intellectual Property, except as such action, suit, proceeding or claim would not reasonably be expected to result in a
Material Adverse Effect, and the Company is unaware of any facts which would form a reasonable basis for any such claim; (D)&nbsp;there is no pending or, to the knowledge of the Company, threatened action, suit, proceeding or claim by others that
the Company or any of its subsidiaries infringes, misappropriates or otherwise violates any Intellectual Property or other proprietary rights of others, or would, upon the commercialization of any product described in the Registration Statement, the
Time of Sale Disclosure Package and the Prospectus, except as such action, suit, proceeding or claim would not reasonably be expected to result in a Material Adverse Effect, and neither the Company nor any of its subsidiaries has received any
written notice of such claim and the Company is unaware of any other fact which </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
would form a reasonable basis for any such claim; (E)&nbsp;to the knowledge of the Company, no employee of the Company or any of its subsidiaries is in or has ever been in violation of any term
of any employment contract, patent disclosure agreement, invention assignment agreement, <FONT STYLE="white-space:nowrap">non-competition</FONT> agreement, <FONT STYLE="white-space:nowrap">non-solicitation</FONT> agreement, nondisclosure agreement
or any restrictive covenant to or with a former employer where the basis of such violation relates to such employee&#146;s employment with the Company or any of its subsidiaries or actions undertaken by the employee while employed with the Company
or any of its subsidiaries, except as such violation would not reasonably be expected to result in a Material Adverse Effect; and (F)&nbsp;to the knowledge of the Company, there are no rights of third parties to any Intellectual Property owned by
the Company and its subsidiaries, except as such rights would not reasonably be expected to result in a Material Adverse Effect. Except as would not reasonably be expected to have a Material Adverse Effect, (A)&nbsp;the Company has disclosed to the
U.S. Patent and Trademark Office (&#147;<B>USPTO</B>&#148;) all material information of which it is aware that is relevant to the patentability of its inventions to the extent required by 37 C.F.R. Section&nbsp;1.56, and (B)&nbsp;the Company has not
made any misrepresentation or concealed any information material to patentability of a claimed invention from the USPTO in any of the patents or patent applications owned or licensed to the Company, or in connection with the prosecution thereof, in
violation of 37 C.F.R. Section&nbsp;1.56. <B><I>&#147;Intellectual Property&#148;</I></B> shall mean all patents, patent applications, trademarks and service marks, trademark and service mark registrations, trade names, copyrights, licenses,
inventions, trade secrets, domain names, technology, <FONT STYLE="white-space:nowrap">know-how</FONT> and other intellectual property. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xvii) <I><U>No Violations or Defaults</U></I>. Neither the Company nor any of its subsidiaries is in violation of (A)&nbsp;its
respective charter, <FONT STYLE="white-space:nowrap">by-laws</FONT> or other organizational documents, or (B)&nbsp;in breach of or otherwise in default, and no event has occurred which, with notice or lapse of time or both, would constitute such a
default in the performance of any material obligation, agreement or condition contained in any bond, debenture, note, indenture, loan agreement or any other material contract, lease or other instrument to which it is subject or by which any of them
may be bound, or to which any of the material property or assets of the Company or any of its subsidiaries is subject, except in the case of clause (B), as would not reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xviii) <I><U>Taxes</U></I>. The Company and its subsidiaries have timely filed all federal, state, local and foreign income
and franchise tax returns required to be filed by them or have properly requested extensions thereof (except as any such failure to file would not reasonably be expected to have a Material Adverse Effect) and are not in default in the payment of any
taxes which were payable pursuant to said returns or any assessments with respect thereto, other than any which the Company or any of its subsidiaries is contesting in good faith or as would not reasonably be expected to have a Material Adverse
Effect. There is no pending dispute with any taxing authority relating to any of such returns, and the Company has no knowledge of any proposed liability for any tax to be imposed upon the properties or assets of the Company or any of its
subsidiaries for which there is not an adequate reserve reflected in the Company&#146;s financial statements included in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, except where such dispute or liability would
not reasonably be expected to have a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xix) <I><U>Exchange Listing and Exchange Act Registration</U></I>. The
Securities have been approved for listing on the The Nasdaq Global Select Market Stock Exchange (&#147;<B><I>Nasdaq</I></B>&#148;) upon official notice of issuance and, on the date the Registration Statement became effective, the Company&#146;s
Registration Statement on Form <FONT STYLE="white-space:nowrap">8-A</FONT> or other applicable form under the Securities Exchange Act of 1934, as amended (the <B><I>&#147;Exchange Act&#148;</I></B>), became effective. Except as previously disclosed
to counsel for the Underwriters or as set forth in the Time of Sale Disclosure Package and the Prospectus, there are no affiliations with members of FINRA among the Company&#146;s officers or directors or, to the knowledge of the Company, any five
percent or greater stockholders of the Company or any beneficial owner of the Company&#146;s unregistered equity securities that were acquired during the <FONT STYLE="white-space:nowrap">180-day</FONT> period immediately preceding the initial filing
date of the Registration Statement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xx) <I><U>Disclosure</U></I>. The statements set forth in the Time of Sale Disclosure
Package and the Prospectus under the caption &#147;Description of Capital Stock,&#148; insofar as they purport to constitute a summary of the terms of the Common Stock, and under the captions &#147;Material U.S. Federal Income Tax Consequences to <FONT
STYLE="white-space:nowrap">Non-U.S.&nbsp;Holders</FONT> of Our Common Stock&#148; and &#147;Shares Eligible for Future Sale,&#148; insofar as they purport to describe the provisions of the laws and documents referred to therein, are accurate
summaries in all material respects. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xxi) <I><U>Ownership of Other Entities</U></I>. Other than the subsidiaries of the
Company listed in Schedule VI hereto and its interest in electroCore (Aust) Pty Limited, the Company, directly or indirectly, owns no capital stock or other equity or ownership or proprietary interest in any corporation, partnership, association,
trust or other entity. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xxii) <I><U>Internal Controls</U></I>. The Company and its subsidiaries maintain a system of
internal accounting controls sufficient to provide reasonable assurances that (i)&nbsp;transactions are executed in accordance with management&#146;s general or specific authorization; (ii)&nbsp;transactions are recorded as necessary to permit
preparation of financial statements in conformity with GAAP and to maintain accountability for assets; (iii)&nbsp;access to assets is permitted only in accordance with management&#146;s general or specific authorization; and (iv)&nbsp;the recorded
accountability for assets is compared with existing assets at reasonable intervals and appropriate action is taken with respect to any differences. Except as disclosed in the Registration Statement, in the Time of Sale Disclosure Package and in the
Prospectus, none of the Company, its board of directors and audit committee is aware of any &#147;material weaknesses&#148; (as defined by the Public Company Accounting Oversight Board) in its internal control over financial reporting, or any fraud,
whether or not material, that involves management or other employees of the Company or its subsidiaries who have a significant role in the Company&#146;s internal controls; and since the end of the latest audited fiscal year, there has been no
change in the Company&#146;s internal control over financial reporting (whether or not remediated) that has materially adversely affected, or is reasonably likely to materially adversely affect, the Company&#146;s internal control over financial
reporting. The Company&#146;s board of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
directors has, subject to the exceptions, cure periods and the <FONT STYLE="white-space:nowrap">phase-in</FONT> periods specified in the applicable stock exchange rules (<B><I>&#147;Exchange
Rules&#148;</I></B>), validly appointed an audit committee to oversee internal accounting controls whose composition satisfies the applicable requirements of the Exchange Rules and the Company&#146;s board of directors and/or the audit committee has
adopted a charter that satisfies the requirements of the Exchange Rules. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xxiii) <I><U>No Brokers or Finders</U></I>.
Other than as contemplated by this Agreement, the Company has not incurred and will not incur any liability for any finder&#146;s or broker&#146;s fee or agent&#146;s commission in connection with the execution and delivery of this Agreement or the
consummation of the transactions contemplated hereby. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xxiv) <I><U>Insurance</U></I>. The Company and each of its
subsidiaries carries, or is covered by, insurance from reputable insurers in such amounts and covering such risks as the Company and each subsidiary reasonably considers adequate for the conduct of its business and the value of its properties and
the properties of its subsidiaries and as is customary for companies engaged in similar businesses in similar industries; all policies of insurance and any fidelity or surety bonds insuring the Company or any of its subsidiaries or its business,
assets, employees, officers and directors are in full force and effect; the Company and its subsidiaries are in compliance with the terms of such policies and instruments in all material respects; there are no claims by the Company or any of its
subsidiaries under any such policy or instrument as to which any insurance company is denying liability or defending under a reservation of rights clause; neither the Company nor any of its subsidiaries has been refused any insurance coverage sought
or applied for; and neither the Company nor any of its subsidiaries has reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may
be necessary to continue its business at a cost that would not reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xxv) <I><U>Investment Company Act</U></I>. The Company is not and, after giving effect to the offering and sale of the
Securities and application of the use of proceeds therefrom as described in the Time of Sale Disclosure Package and the Prospectus, will not be required to register as an &#147;investment company,&#148; as such term is defined in the Investment
Company Act of 1940, as amended. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xxvi) <I><U>Sarbanes-Oxley Act</U></I>. The Company is in compliance in all material
respects with all applicable provisions of the Sarbanes-Oxley Act and the rules and regulations of the Commission thereunder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xxvii) <I><U>Disclosure Controls</U></I>. The Company has established and maintains disclosure controls and procedures (as
defined in Rules <FONT STYLE="white-space:nowrap">13a-14</FONT> and <FONT STYLE="white-space:nowrap">15d-14</FONT> under the Exchange Act) and such controls and procedures are effective in ensuring that material information relating to the Company,
including its subsidiaries, is made known to the principal executive officer and the principal financial officer. The Company has utilized such controls and procedures in preparing and evaluating the disclosures in the Registration Statement, in the
Time of Sale Disclosure Package and in the Prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xxviii) <I><U>Anti-Bribery and Anti-Money Laundering Laws</U></I>. Each of the
Company, its subsidiaries, its affiliates and any of their respective officers, directors, supervisors, managers, or employees, and to the Company&#146;s knowledge, its agents, has not violated, its participation in the offering will not violate,
and the Company and each of its subsidiaries has instituted and maintains policies and procedures designed to ensure continued compliance with, each of the following laws to the extent applicable to the Company or any of its subsidiaries:
(A)&nbsp;anti-bribery laws, including but not limited to, any applicable law, rule, or regulation of any locality, including but not limited to any law, rule, or regulation promulgated to implement the OECD Convention on Combating Bribery of Foreign
Public Officials in International Business Transactions, signed December&nbsp;17, 1997, including the U.S. Foreign Corrupt Practices Act of 1977, as amended, the U.K. Bribery Act 2010, or any other law, rule or regulation of similar purposes and
scope or (B)&nbsp;anti-money laundering laws, including but not limited to, applicable federal, state, international, foreign or other laws, regulations or government guidance regarding anti-money laundering, including, without limitation, Title 18
U.S.&nbsp;Code section 1956 and 1957, the Patriot Act, the Bank Secrecy Act, and international anti-money laundering principles or procedures by an intergovernmental group or organization, such as the Financial Action Task Force on Money Laundering,
of which the United States is a member and with which designation the United States representative to the group or organization continues to concur, all as amended, and any Executive order, directive, or regulation pursuant to the authority of any
of the foregoing, or any orders or licenses issued thereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xxix) <I><U>OFAC</U></I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(A) Neither the Company nor any of its subsidiaries, nor any or their directors, officers or employees, nor, to the
Company&#146;s knowledge, any agent, affiliate or representative of the Company or its subsidiaries, is an individual or entity that is, or is owned or controlled by an individual or entity that is: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(1) the subject of any applicable sanctions administered or enforced by the U.S. Department of Treasury&#146;s Office of
Foreign Assets Control, the United Nations Security Council, the European Union, Her Majesty&#146;s Treasury, or other relevant sanctions authority (collectively, <B><I>&#147;Sanctions&#148;</I></B>), nor </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(2) located, organized or resident in a country or territory that is the subject of Sanctions (including, without limitation,
Cuba, Iran, North Korea, Sudan, Syria and Crimea). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(B) Neither the Company nor any of its subsidiaries will, directly or indirectly,
use the proceeds of the offering, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other individual or entity: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(1) to fund or facilitate any activities or business of or with any individual or entity or in any country or territory that,
at the time of such funding or facilitation, is the subject of Sanctions; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(2) in any other manner that will result in
a violation of Sanctions by any individual or entity (including any individual or entity participating in the offering, whether as underwriter, advisor, investor or otherwise). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(C) For the past five years, neither the Company nor any of its subsidiaries has knowingly engaged in, and is not now knowingly
engaged in, any dealings or transactions with any individual or entity, or in any country or territory, that at the time of the dealing or transaction is or was the subject of Sanctions. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xxx) <I><U>Compliance with Environmental Laws</U></I>. Except as disclosed in the Time of Disclosure Package and the
Prospectus, neither the Company nor any of its subsidiaries is in violation of any statute, any rule, regulation, decision or order of any Governmental Authority or any court, domestic or foreign, relating to the use, disposal or release of
hazardous or toxic substances or relating to the protection or restoration of the environment or human exposure to hazardous or toxic substances (collectively, <B><I>&#147;Environmental Laws&#148;</I></B>), owns or operates any real property
contaminated with any substance that is subject to any Environmental Laws, is liable for any <FONT STYLE="white-space:nowrap">off-site</FONT> disposal or contamination pursuant to any Environmental Laws, or is subject to any claim relating to any
Environmental Laws, which violation, contamination, liability or claim would individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; and the Company is not aware of any pending investigation which might lead to
such a claim. Neither the Company nor any of its subsidiaries anticipates incurring any material capital expenditures relating to compliance with Environmental Laws. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xxxi) <I><U>Compliance with Occupational Laws</U></I>. The Company and each of its subsidiaries (A)&nbsp;is in compliance, in
all material respects, with any and all applicable foreign, federal, state and local laws, rules, regulations, treaties, statutes and codes promulgated by any and all Governmental Authorities (including pursuant to the Occupational Health and Safety
Act) relating to the protection of human health and safety in the workplace (<B><I>&#147;Occupational Laws&#148;</I></B>); (B) has received all material permits, licenses or other approvals required of it under applicable Occupational Laws to
conduct its business as currently conducted; and (C)&nbsp;is in compliance, in all material respects, with all terms and conditions of such permit, license or approval. No action, proceeding, revocation proceeding, writ, injunction or claim is
pending or, to the Company&#146;s knowledge, threatened against the Company or any of its subsidiaries relating to Occupational Laws, and the Company does not have knowledge of any facts, circumstances or developments relating to its operations or
cost accounting practices that could reasonably be expected to form the basis for or give rise to such actions, suits, investigations or proceedings except for any of the foregoing that would not reasonably be expected to have a Material Adverse
Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xxxii) <I><U>ERISA and Employee Benefits Matters</U></I>. (A)&nbsp;To the
knowledge of the Company, no &#147;prohibited transaction&#148; as defined under Section&nbsp;406 of ERISA or Section&nbsp;4975 of the Code and not exempt under ERISA Section&nbsp;408 and the regulations and published interpretations thereunder has
occurred with respect to any Employee Benefit Plan. At no time has the Company or any ERISA Affiliate maintained, sponsored, participated in, contributed to or has or had any liability or obligation in respect of any Employee Benefit Plan subject to
Part 3 of Subtitle B of Title I of ERISA, Title IV of ERISA, or Section&nbsp;412 of the Code or any &#147;multiemployer plan&#148; as defined in Section&nbsp;3(37) of ERISA or any multiple employer plan for which the Company or any ERISA Affiliate
has incurred or would reasonably be expected to incur liability under Section&nbsp;4063 or 4064 of ERISA. No Employee Benefit Plan provides or promises, or at any time provided or promised, retiree health, life insurance, or other retiree welfare
benefits except as may be required by the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended, or similar state law. Each Employee Benefit Plan is and has been operated in material compliance with its terms and all applicable laws,
including but not limited to ERISA and the Code and, to the knowledge of the Company, no event has occurred (including a &#147;reportable event&#148; as such term is defined in Section&nbsp;4043 of ERISA) and no condition exists that would
reasonably be expected to subject the Company or any ERISA Affiliate to any material tax, fine, lien, penalty or liability imposed by ERISA, the Code or other applicable law. Each Employee Benefit Plan intended to be qualified under Code
Section&nbsp;401(a) is so qualified and has a favorable determination or opinion letter from the IRS upon which it can rely, and any such determination or opinion letter remains in effect and has not been revoked; to the knowledge of the Company,
nothing has occurred since the date of any such determination or opinion letter that is reasonably likely to adversely affect such qualification; (B)&nbsp;with respect to each Foreign Benefit Plan, such Foreign Benefit Plan (1)&nbsp;if intended to
qualify for special tax treatment, meets, in all material respects, the requirements for such treatment, and (2)&nbsp;if required to be funded, is funded to the extent required by applicable law, and with respect to all other Foreign Benefit Plans,
adequate reserves therefor have been established on the accounting statements of the applicable Company or subsidiary; (C)&nbsp;the Company does not have any obligations under any collective bargaining agreement with any union and to the knowledge
of the Company, no organization efforts are underway with respect to Company employees. As used in this Agreement, <B><I>&#147;Code&#148;</I></B> means the Internal Revenue Code of 1986, as amended; <B><I>&#147;Employee Benefit Plan&#148;</I></B>
means any &#147;employee benefit plan&#148; within the meaning of Section&nbsp;3(3) of ERISA, including, without limitation, all stock purchase, stock option, stock-based severance, employment, <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">change-in-control,</FONT></FONT> medical, disability, fringe benefit, bonus, incentive, deferred compensation, employee loan and all other material employee benefit plans, agreements, programs, policies or other
arrangements, whether or not subject to ERISA, under which (x)&nbsp;any current or former employee, director or independent contractor of the Company or its subsidiaries has any present or future right to benefits and which are contributed to,
sponsored by or maintained by the Company or any of its subsidiaries or (y)&nbsp;the Company or any of its subsidiaries has had or has any present or future obligation or liability; <B><I>&#147;ERISA&#148;</I></B> means the Employee Retirement
Income Security Act of 1974, as amended; <B><I>&#147;ERISA Affiliate&#148;</I></B> means any member of the company&#146;s controlled group as defined in Code Section&nbsp;414(b), (c), (m) or (o); and <B><I>&#147;Foreign Benefit Plan&#148;</I></B>
means any Employee Benefit Plan established, maintained or contributed to outside of the United States of America or which covers any employee working or residing outside of the United States. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xxxiii) <I><U>Related Party Transactions</U></I>. There are no relationships,
direct or indirect, or related-party transactions involving the Company or any other person required to be described in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus which have not been described in such
documents as required. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xxxiv) <I><U>Business Arrangements</U></I>. Except as disclosed in the Registration Statement, the
Time of Sale Disclosure Package and the Prospectus, neither the Company nor any of its subsidiaries has granted rights to develop, manufacture, produce, assemble, distribute, license, market or sell its products to any other person and is not bound
by any agreement that materially and adversely affects the exclusive right of the Company or such subsidiary to develop, manufacture, produce, assemble, distribute, license, market or sell its products. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xxxv) <I><U>Labor Matters</U></I>. No labor dispute with the employees of the Company or any of its subsidiaries exists or is
threatened or imminent, and the Company is not aware of any existing or imminent labor disturbance by the employees of any of its or its subsidiaries&#146; principal suppliers, contractors or customers, that could reasonably be expected to have a
Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xxxvi) <I><U>Restrictions on Subsidiary Payments to the Company</U></I>. No subsidiary of the
Company is currently prohibited, directly or indirectly, from paying any dividends to the Company, from making any other distribution on such subsidiary&#146;s capital stock, from repaying to the Company any loans or advances to such subsidiary from
the Company or from transferring any of such subsidiary&#146;s property or assets to the Company or any other subsidiary of the Company, except as described in or contemplated by the Time of Sale Disclosure Package and the Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xxxvii) <I><U>Disclosure of Legal Matters</U></I>. There are no statutes, regulations, legal or governmental proceedings or
contracts or other documents required to be described in the Time of Sale Disclosure Package or in the Prospectus or included as exhibits to the Registration Statement that are not described or included as required. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xxxviii) <I><U>Statistical Information</U></I>. Any third-party statistical and
<FONT STYLE="white-space:nowrap">market-related</FONT> data included in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus are based on or derived from sources that the Company believes to be reliable and accurate in
all material respects. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xxxix) <I><U>Forward-looking Statements</U></I>. No forward-looking statement (within the meaning
of Section&nbsp;27A of the Act and Section&nbsp;21E of the Exchange Act) contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed
other than in good faith. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xl) <I><U>Regulatory Compliance</U></I><I>.</I> The Company and its directors,
officers, employees and, to the knowledge of the Company, agents, are, and at all times have been, in compliance with all applicable Health Care Laws, except where failure to be so in compliance would not result in a Material Adverse Effect, and
have not engaged in activities which are, as applicable, cause for false claims liability, civil penalties, or mandatory or permissive exclusion from Medicare, Medicaid, or any other state or federal health care program. For purposes of this
Agreement, &#147;<B><I>Health Care Laws</I></B>&#148; shall mean the federal Anti-kickback Statute (42 U.S.C. &#167; <FONT STYLE="white-space:nowrap">1320a-7b(b)),</FONT> the Physician Payment Sunshine Act (42 U.S.C.
<FONT STYLE="white-space:nowrap">&#167;&nbsp;1320a-7h),</FONT> the civil False Claims Act (31 U.S.C. &#167;&#167;&nbsp;3729 et seq.), the criminal False Claims Act (42 U.S.C. &#167; <FONT STYLE="white-space:nowrap">1320a-7b(a)),</FONT> all criminal
laws relating to health care fraud and abuse, including but not limited to 18 U.S.C. Sections 286 and 287, and the health care fraud criminal provisions under the Health Insurance Portability and Accountability Act of 1996 (42 U.S.C. &#167; 1320d et
seq.) (&#147;<B><I>HIPAA</I></B>&#148;), the exclusion laws (42 U.S.C. &#167; <FONT STYLE="white-space:nowrap">1320a-7),</FONT> the civil monetary penalties law (42 U.S.C. &#167; <FONT STYLE="white-space:nowrap">1320a-7a),</FONT> HIPAA, as amended
by the Health Information Technology for Economic and Clinical Health Act (42 U.S.C. &#167;&#167; 17921 et seq.), the Federal Food, Drug, and Cosmetic Act (21 U.S.C. &#167;&#167; 301 et seq.), the Controlled Substances Act (21 U.S.C. &#167;&#167;
801 et seq.), Medicare (Title XVIII of the Social Security Act), Medicaid (Title XIX of the Social Security Act), the regulations promulgated pursuant to such laws, and any other similar local, state, federal or foreign law. The Company has not
received any FDA Form 483, notice of adverse finding, warning letter, untitled letter or other correspondence or notice from the U.S. Food and Drug Administration (&#147;<B><I>FDA</I></B>&#148;) or any other Governmental Authority alleging or
asserting noncompliance with any Health Care Laws applicable to the Company. Additionally, the Company is not a party to or has any ongoing reporting obligations pursuant to any corporate integrity agreements, deferred prosecution agreements,
monitoring agreements, consent decrees, settlement orders, plans of correction or similar agreements with or imposed by any Governmental Authority. Neither the Company nor, to the knowledge of the Company, its employees, officers, directors or
agents has been excluded, suspended or debarred from participation in any U.S. federal health care program or human clinical research or, to the knowledge of the Company, is subject to a governmental inquiry, investigation, proceeding, or other
similar action that could reasonably be expected to result in debarment, suspension, or exclusion. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xli)
<I><U>Licenses</U></I>. The Company possesses, and is operating in compliance with the terms of, all certificates, approvals, clearances, exemptions, registrations, franchises, licenses, permits and other authorizations issued by all applicable
Governmental Authorities required for the conduct of the business as currently conducted (collectively, &#147;<B><I>Licenses</I></B>&#148;), including without limitation, all such Licenses required by the FDA or any component thereof, the United
States Drug Enforcement Administration and/or by any other U.S., state, local or foreign government or drug or medical device regulatory agency or Governmental Authority (as defined above), except where failure to be so in compliance would not
result in a Material Adverse Effect. All such Licenses are in full force and effect. The Company has not received any written notice of proceedings relating to the revocation, termination or modification of any Licenses that, singly or in the
aggregate, if determined adversely to the Company, would result in a Material Adverse Effect. To the Company&#146;s knowledge, no party granting any such Licenses has taken or intends to take any action to limit, suspend or revoke the same in any
material respect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xlii) <I><U>Clinical Trials</U></I>. The preclinical studies and clinical trials
conducted by or on behalf of or sponsored by the Company, described in the Prospectus and Preliminary Prospectus, were and, if still pending, are being conducted in all material respects in accordance with the experimental protocols established for
each such study or trial and all Licenses and Health Care Laws, including, without limitation, the Federal Food, Drug and Cosmetic Act and its applicable implementing regulations at 21 C.F.R. Parts 50, 54, 56, 58, 312 and 812, except where the
failure to be so in compliance has not resulted and would not reasonably be expected to result in a Material Adverse Effect; the descriptions of the results of such studies and trials contained in the Registration Statement, the Time of Sale
Disclosure Package and the Prospectus are accurate and complete in all material respects and fairly present the data derived from such studies and trials; except to the extent disclosed in the Registration Statement, the Time of Sale Disclosure
Package and the Prospectus, to the Company&#146;s knowledge, there are no studies or trials, the results of which are materially inconsistent with or otherwise materially call into question the study and trial results described or referred to in the
Registration Statement, the Time of Sale Disclosure Package and the Prospectus; no investigational new drug application or investigational device exemption filed by or on behalf of the Company with the FDA has been terminated or suspended by the
FDA, and neither the FDA nor any applicable foreign regulatory agency has commenced, or, to the knowledge of the Company, threatened to initiate, any action to place a clinical hold order on, or otherwise terminate, delay or suspend, any proposed or
ongoing clinical investigation conducted or proposed to be conducted by or on behalf of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xliii)
<I><U>Recalls</U></I>. The Company has not conducted any recalls, corrections, market withdrawals or replacements, or issued any field notifications, safety alerts or other notices relating to an alleged lack of safety or regulatory compliance of
any Company product (&#147;<B><I>Safety Notices</I></B>&#148;), except where such actions would not, individually or in the aggregate, result in a Material Adverse Effect. The Company has not received any material complaints with respect to any
Company product that are currently unresolved. To the Company&#146;s knowledge, there are no facts that would be reasonably likely to result in (i)&nbsp;a material Safety Notice with respect to any Company product, (ii)&nbsp;a material change in
labeling of any Company product; or (iii)&nbsp;a termination or suspension of marketing or testing of any Company product. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xliv) <I><U>No Rated Debt or Preferred Securities</U></I>. There are no debt or preferred securities issued, or guaranteed, by
the Company or its subsidiaries that are rated by a &#147;nationally recognized statistical rating organization,&#148; as such term is defined in Section&nbsp;3(a)(62) of the Exchange Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(xlv) <I><U>Corporate Conversion</U></I>. The Corporate Conversion has been consummated (i)&nbsp;in accordance with the
applicable provisions of Delaware law and (ii)&nbsp;as set forth in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus under the heading &#147;Corporate Conversion.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <I><U>Effect of Certificates</U></I>. Any certificate signed by any officer of the Company
and delivered to you or to counsel for the Underwriters pursuant to this Agreement shall be deemed a representation and warranty by the Company to each Underwriter as to the matters covered thereby. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <B><I>Purchase, Sale and Delivery of Securities.</I></B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <I><U>Firm Shares</U></I>. On the basis of the representations, warranties and agreements herein contained, but subject to the terms and
conditions herein set forth, the Company agrees to issue and sell the Firm Shares to the several Underwriters, and each Underwriter agrees, severally and not jointly, to purchase from the Company the number of Firm Shares set forth opposite the name
of such Underwriter in Schedule&nbsp;I hereto. The purchase price for each Firm Share shall be $[&nbsp;&nbsp;&nbsp;&nbsp;] per share. The obligation of each Underwriter to the Company shall be to purchase from the Company that number of Firm Shares
(to be adjusted by the Representatives to avoid fractional shares) which represents the same proportion of the number of Firm Shares to be sold by the Company pursuant to this Agreement as the number of Firm Shares set forth opposite the name of
such Underwriter in Schedule&nbsp;I hereto represents to the total number of Firm Shares to be purchased by all Underwriters pursuant to this Agreement. In making this Agreement, each Underwriter is contracting severally and not jointly; except as
provided in paragraph&nbsp;(d) of this Section&nbsp;3 and in Section&nbsp;8 hereof, the agreement of each Underwriter is to purchase only the respective number of Firm Shares specified in Schedule&nbsp;I. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <I><U>Option Shares</U></I>. On the basis of the representations, warranties and agreements herein contained, but subject to the terms and
conditions herein set forth, the Company hereby grants to the several Underwriters an option to purchase all or any portion of the Option Shares at the same purchase price as the Firm Shares, for use solely in covering any <FONT
STYLE="white-space:nowrap">over-allotments</FONT> made by the Underwriters in the sale and distribution of the Firm Shares. The option granted hereunder may be exercised in whole or in part at any time (but not more than once) within 30 days after
the effective date of this Agreement upon notice (confirmed in writing) by the Representatives to the Company setting forth the aggregate number of Option Shares as to which the several Underwriters are exercising the option and the date and time,
as determined by you, when the Option Shares are to be delivered, but in no event earlier than the First Closing Date (as defined below) nor earlier than the second business day or later than the tenth business day after the date on which the option
shall have been exercised. The number of Option Shares to be purchased by each Underwriter shall be the same percentage of the total number of Option Shares to be purchased by the several Underwriters as the number of Firm Shares to be purchased by
such Underwriter is of the total number of Firm Shares to be purchased by the several Underwriters, as adjusted by the Representatives in such manner as the Representatives deem advisable to avoid fractional shares. No Option Shares shall be sold
and delivered unless the Firm Shares previously have been, or simultaneously are, sold and delivered. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <I><U>Payment and
Delivery</U></I>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(i) The Securities to be purchased by each Underwriter hereunder, in book-entry form in such authorized
denominations and registered in such names as Evercore Group L.L.C. may request upon at least forty-eight hours&#146; prior notice to the Company, shall be delivered by or on behalf of the Company to Evercore Group L.L.C.,
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
through the facilities of the Depository Trust Company (<B><I>&#147;DTC&#148;</I></B>), for the account of such Underwriter, with any transfer taxes payable in connection with the transfer of the
Securities to the Underwriters duly paid, against payment by or on behalf of such Underwriter of the purchase price therefor by wire transfer of Federal <FONT STYLE="white-space:nowrap">(same-day)</FONT> funds to the account specified by the Company
to Evercore Group L.L.C. at least forty-eight hours in advance. The time and date of such delivery and payment shall be, with respect to the Firm Shares, 9:30&nbsp;a.m., New York City time, on [&nbsp;&nbsp;&nbsp;&nbsp;], 2018 or such other time and
date as Evercore Group L.L.C. and the Company may agree upon in writing, and, with respect to the Option Shares, 9:30&nbsp;a.m., New York City time, on the date specified by Evercore Group L.L.C. in each written notice given by Evercore Group L.L.C.
of the Underwriters&#146; election to purchase such Option Shares, or such other time and date as Evercore Group L.L.C. and the Company may agree upon in writing. Such time and date for delivery of the Firm Shares is herein called the
<B><I>&#147;First Closing Date&#148;</I></B>, each such time and date for delivery of the Option Shares, if not the First Closing Date, is herein called a <B><I>&#147;Second Closing Date&#148;</I></B>, and each such time and date for delivery is
herein called a <B><I>&#147;Closing&#148;</I></B>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(ii) The documents to be delivered at each Closing by or on behalf of
the parties hereto pursuant to Section&nbsp;5 hereof, including the cross receipt for the Securities and any additional documents requested by the Underwriters pursuant to Section&nbsp;5(j) hereof, will be delivered at the offices of
Latham&nbsp;&amp; Watkins LLP, John Hancock Tower, 27<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Floor, 200 Clarendon Street, Boston, MA 02116 (the <B><I>&#147;Closing Location&#148;</I></B>), and the Securities will be delivered to
Evercore Group L.L.C., through the facilities of the DTC, for the account of such Underwriter, all at such Closing. A meeting will be held at the Closing Location at [5:00]&nbsp;p.m., New York City time, on the New York Business Day next preceding
such Closing, at which meeting the final drafts of the documents to be delivered pursuant to the preceding sentence will be available for review by the parties hereto. For the purposes of this Section&nbsp;3, <B><I>&#147;New York Business
Day&#148;</I></B> shall mean each Monday, Tuesday, Wednesday, Thursday and Friday which is not a day on which banking institutions in New York City are generally authorized or obligated by law or executive order to close. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) <I><U>Purchase by Representatives on Behalf of Underwriters</U></I>. It is understood that you, individually and not as Representatives of
the several Underwriters, may (but shall not be obligated to) make payment to the Company, on behalf of any Underwriter for the Securities to be purchased by such Underwriter. Any such payment by you shall not relieve any such Underwriter of any of
its obligations hereunder. Nothing herein contained shall constitute any of the Underwriters an unincorporated association or partner with the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <B><I>Covenants</I></B>. The Company covenants and agrees with the several Underwriters as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <I><U>Required Filings</U></I>. The Company will prepare and file a Prospectus with the Commission containing the Rule&nbsp;430A
Information omitted from the Preliminary Prospectus within the time period required by, and otherwise in accordance with the provisions of, Rules&nbsp;424(b) and 430A of the Rules and Regulations. If the Company has elected to rely upon
Rule&nbsp;462(b) of the Rules and Regulations to increase the size of the offering registered under the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Act and the Rule 462(b) Registration Statement has not yet been filed and become effective, the Company will prepare and file the Rule 462 Registration Statement with the Commission within the
time period required by, and otherwise in accordance with the provisions of, Rule&nbsp;462(b) and the Act. The Company will prepare and file with the Commission, promptly upon your request, any amendments or supplements to the Registration Statement
or Prospectus that, in your opinion with the advice of counsel, may be necessary or advisable in connection with the distribution of the Securities by the Underwriters; and the Company will furnish the Representatives and counsel for the
Underwriters a copy of any proposed amendment or supplement to the Registration Statement or Prospectus and will not file any amendment or supplement to the Registration Statement or Prospectus to which you shall reasonably object by notice to the
Company after having been furnished a copy a reasonable time prior to the filing. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <I><U>Notification of Certain Commission
Actions</U></I>. The Company will advise you, promptly after it shall receive notice or obtain knowledge thereof, of the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement, or any post-effective
amendment thereto or preventing or suspending the use of any Preliminary Prospectus, the Time of Sale Disclosure Package, the Prospectus or any issuer free writing prospectus, of the suspension of the qualification of the Securities for offering or
sale in any jurisdiction, or of the initiation or threatening of any proceeding for any such purpose; and the Company will promptly use its best efforts to prevent the issuance of any stop order or to obtain its withdrawal if such a stop order
should be issued. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <I><U>Continued Compliance with Securities Laws</U></I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(i) Within the time during which a prospectus (assuming the absence of Rule 172 of the Rules and Regulations) relating to the
Securities is required to be delivered under the Act by any Underwriter or dealer, the Company will comply with all requirements imposed upon it by the Act, as now and hereafter amended, and by the Rules and Regulations, as from time to time in
force, so far as necessary to permit the continuance of sales of or dealings in the Securities as contemplated by the provisions hereof, the Time of Sale Disclosure Package and the Prospectus. If during such period any event occurs as a result of
which the Prospectus (or if the Prospectus is not yet available to prospective purchasers, the Time of Sale Disclosure Package) would include an untrue statement of a material fact or omit to state a material fact necessary to make the statements
therein, in the light of the circumstances then existing, not misleading, or if during such period it is necessary to amend the Registration Statement or supplement the Prospectus (or if the Prospectus is not yet available to prospective investors,
the Time of Sale Disclosure Package) to comply with the Act, the Company will promptly (x)&nbsp;notify you of such untrue statement or omission, (y)&nbsp;amend the Registration Statement or supplement the Prospectus (or, if the Prospectus is not yet
available to prospective purchasers, the Time of Sale Disclosure Package) (at the expense of the Company) so as to correct such statement or omission or effect such compliance and (z)&nbsp;notify you when any amendment to the Registration Statement
is filed or becomes effective or when any supplement to the Prospectus (or, if the Prospectus is not yet available to prospective purchasers, the Time of Sale Disclosure Package) is filed. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(ii) If at any time when a prospectus relating to the Securities is required to
be delivered under the Act following issuance of an issuer free writing prospectus or Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication there occurred or occurs an event or
development as a result of which such issuer free writing prospectus or Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication conflicted or would conflict with the information
contained in the Registration Statement, any Preliminary Prospectus or the Prospectus relating to the Securities or included or would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order
to make the statements therein, in the light of the circumstances prevailing at that subsequent time, not misleading, the Company (x)&nbsp;has promptly notified or promptly will notify the Representatives of such conflict, untrue statement or
omission, (y)&nbsp;has promptly amended or will promptly amend or supplement, at its own expense, such issuer free writing prospectus or Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT>
Communication to eliminate or correct such conflict, untrue statement or omission and (z)&nbsp;has notified or promptly will notify you when such amendment or supplement was or is filed with the Commission to the extent required to be filed by the
Rules and Regulations. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) <I><U>Blue Sky Qualifications</U></I>. The Company shall take or cause to be taken all necessary action to
qualify the Securities for sale under the securities laws of such domestic United States or foreign jurisdictions as you reasonably designate and to continue such qualifications in effect so long as required for the distribution of the Securities,
except that the Company shall not be required in connection therewith to qualify as a foreign corporation, subject itself to local taxation, or to execute a general consent to service of process in any state. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) <I><U>Provision of Documents</U></I>. The Company will furnish, at its own expense, to the Underwriters and counsel for the Underwriters
copies of the Registration Statement (three of which will be signed and will include all consents and exhibits filed therewith), and to the Underwriters and any dealer each Preliminary Prospectus, the Time of Sale Disclosure Package, the Prospectus,
any issuer free writing prospectus and all amendments and supplements to such documents, in each case as soon as available and in such quantities as you may from time to time reasonably request. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f) <I><U>Rule 158</U></I>. The Company will make generally available to its security holders as soon as practicable, but in no event later
than 15 months after the end of the Company&#146;s current fiscal quarter, an earnings statement (which need not be audited) covering a <FONT STYLE="white-space:nowrap">12-month</FONT> period beginning after the effective date of the Registration
Statement (which, for purposes of this paragraph, will be deemed to be the effective date of the Rule&nbsp;462(b) Registration Statement, if applicable) that shall satisfy the provisions of Section&nbsp;11(a) of the Act and Rule&nbsp;158 of the
Rules and Regulations. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(g) <I><U>Payment and Reimbursement of Expenses</U></I>. The Company, whether or not the transactions contemplated
hereunder are consummated or this Agreement is terminated, will pay or cause to be paid (A)&nbsp;all expenses (including transfer taxes allocated to the respective transferees) incurred in connection with the delivery to the Underwriters of the
Securities, (B)&nbsp;all expenses and fees (including, without limitation, fees and expenses of the Company&#146;s accountants and counsel but, except as otherwise provided below, not including fees of the Underwriters&#146; counsel) in connection
with the preparation, printing, filing, delivery, and shipping </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of the Registration Statement (including the financial statements therein and all amendments, schedules, and exhibits thereto), the Securities, each Preliminary Prospectus, the Time of Sale
Disclosure Package, the Prospectus, any issuer free writing prospectus and any amendment thereof or supplement thereto, and the printing, delivery, and shipping of this Agreement and other underwriting documents, including Blue Sky Memoranda
(covering the states and other applicable jurisdictions), (C) all filing fees and reasonable and documented fees and disbursements of the Underwriters&#146; counsel incurred in connection with the qualification of the Securities for offering and
sale by the Underwriters or by dealers under the securities or blue sky laws of the states and other jurisdictions which you shall designate, (D)&nbsp;the fees and expenses of the Custodian and any transfer agent or registrar, (E)&nbsp;the filing
fees and reasonable and documented fees and disbursements of Underwriters&#146; counsel incident to any required review and approval by FINRA of the terms of the sale of the Securities, (F)&nbsp;listing fees, if any, (G)&nbsp;the cost and expenses
of the Company relating to investor presentations or any &#147;road show&#148; undertaken in connection with marketing of the Securities, including, without limitation, expenses associated with the preparation or dissemination of any electronic road
show, expenses associated with the production of road show slides and graphics, fees and expenses of any consultants engaged in connection with the road show presentations with the prior approval of the Company, travel and lodging expenses of the
representatives and officers of the Company and any such consultants, and 50% of the cost of any aircraft chartered in connection with the road show, and (H)&nbsp;all other costs and expenses of the Company incident to the performance of its
obligations hereunder that are not otherwise specifically provided for herein; provided that in the case of clauses (C)&nbsp;and (E), the Company shall not be obligated to reimburse fees and expenses of counsel for the Underwriters in excess of
$10,000 and $35,000, respectively. If this Agreement is terminated by the Representatives pursuant to Section&nbsp;9 hereof or if the sale of the Securities provided for herein is not consummated by reason of any failure, refusal or inability on the
part of the Company to perform any agreement on its part to be performed, or because any other condition of the Underwriters&#146; obligations hereunder required to be fulfilled by the Company is not fulfilled, the Company will reimburse the several
Underwriters for all reasonable, documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> accountable disbursements (including but not limited to reasonable, documented fees and disbursements of
counsel, printing expenses, travel expenses, postage, facsimile and telephone charges subject to the limitations set forth above) incurred by the Underwriters in connection with their investigation, preparing to market and marketing the Securities
or in contemplation of performing their obligations hereunder. It is understood, however, that except as otherwise explicitly set forth in this Section&nbsp;4(g), the Underwriters shall pay all of their own costs and expenses, including any travel,
lodging and other expenses of the Underwriters or any of their employees or representatives incurred by them in connection with any road show and any travel and lodging expenses incurred in connection with drafting sessions and other meetings. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(h) <I><U>Use of Proceeds</U></I>. The Company will apply the net proceeds from the sale of the Securities to be sold by it hereunder for the
purposes set forth in the Time of Sale Disclosure Package and in the Prospectus and will file such reports with the Commission with respect to the sale of the Securities and the application of the proceeds therefrom as may be required in accordance
with Rule&nbsp;463 of the Rules and Regulations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(i) <I><U>Company Lock Up</U></I>. The Company will not, without the prior written consent of
Evercore Group L.L.C., from the date of execution of this Agreement and continuing to and including the date 180 days after the date of the Prospectus (the <B><I><FONT STYLE="white-space:nowrap">&#147;Lock-Up</FONT> Period&#148;</I></B>), (A) offer,
pledge, announce the intention to sell, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase or otherwise transfer or dispose of, directly or
indirectly, any shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock or (B)&nbsp;enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of
ownership of the Common Stock, whether any such transaction described in clause (A)&nbsp;or (B) above is to be settled by delivery of Common Stock or such other securities, in cash or otherwise, except (i)&nbsp;to the Underwriters pursuant to this
Agreement; (ii)&nbsp;the issuance by the Company of shares of Common Stock to pay the accrued but unpaid preferred return to holders of Series A Preferred Units of ElectroCore LLC as described in the Time of Sale Disclosure Package and in the
Prospectus; (iii)&nbsp;the issuance by the Company of shares of Common Stock upon the exercise of any stock options or warrants, or upon the conversion of any shares of preferred stock of the Company, outstanding as of the date hereof and disclosed
in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus; (iv)&nbsp;the issuance by the Company of shares of Common Stock or securities convertible into shares of Common Stock pursuant to the Company&#146;s equity
incentive plans in effect on the date hereof and described in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus; <I>provided </I>that prior to the issuance of any such shares of Common Stock or securities convertible
into shares of Common Stock where such shares or securities vest within the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period, the Company shall cause each recipient of such grant or issuance to execute and deliver to you a <FONT
STYLE="white-space:nowrap">lock-up</FONT> agreement substantially in the form of Exhibit&nbsp;A hereto (a &#147;<B><I><FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement</I></B>&#148;) and issue stop order restrictions to its transfer agent
and registrar for the Common Stock with respect to any transaction or contemplated transaction that would constitute a breach or default under the applicable <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement; (v)&nbsp;the filing of a
registration statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> with respect to the Company&#146;s equity incentive plans in effect on the date hereof and described in the Registration Statement, the Time of Sale Disclosure Package and
the Prospectus; and (vi)&nbsp;the sale or issuance of or entry into an agreement providing for the issuance of shares of Common Stock, or any security convertible into or exercisable for shares of Common Stock, in connection with the acquisition by
the Company of the securities, business or assets of another person or entity or pursuant to an employee benefit plan assumed by the Company in connection with such acquisition, or in connection with joint ventures, commercial relationships or other
strategic transactions; <I>provided</I>, that the aggregate number of shares of Common Stock that the Company may sell or issue or agree to sell or issue pursuant to this clause (vi)&nbsp;shall not exceed 5% of the total number of shares of Common
Stock issued and outstanding immediately following the completion of the transactions contemplated by this Agreement, and provided further, that the Company shall cause each recipient of such shares or other securities to execute and deliver to you,
on or prior to such issuance, a <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement and issue stop order restrictions to its transfer agent and registrar for the Common Stock with respect to any transaction or contemplated transaction that
would constitute a breach of or default under the applicable <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement. The Company agrees not to accelerate the vesting of any option or warrant or the lapse of any repurchase right prior to the
expiration of the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(j) <I><U>Stockholder
<FONT STYLE="white-space:nowrap">Lock-Ups</FONT></U></I>. The Company has caused to be delivered to you prior to the date of this Agreement a <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement, from each individual or entity listed on
Schedule II. The Company will enforce the terms of each <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement and issue <FONT STYLE="white-space:nowrap">stop-transfer</FONT> instructions to its transfer agent and registrar for the Common Stock
with respect to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any transaction or contemplated transaction that would constitute a breach of or default under the applicable <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement. If Evercore Group L.L.C.,
in its sole discretion, agrees to release or waive the restrictions of any <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement between an officer or director of the Company and the Representatives and provides the Company with notice of the
impending release or waiver at least three business days before the effective date of such release or waiver, the Company agrees to announce the impending release or waiver by means of a press release substantially in the form of Exhibit B hereto,
issued through a major news service, at least two business days before the effective date of the release or waiver. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(k) <I><U>No Market
Stabilization or Manipulation</U></I>. The Company has not taken and will not take, directly or indirectly, any action designed to or which might reasonably be expected to cause or result in, or which has constituted, the stabilization or
manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities, and has not effected any sales of Common Stock which are required to be disclosed in response to Item&nbsp;701 of <FONT
STYLE="white-space:nowrap">Regulation&nbsp;S-K</FONT> under the Act which have not been so disclosed in the Registration Statement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(l)
<I><U>SEC Reports</U></I>. The Company will file on a timely basis with the Commission such periodic and current reports as required by the Rules and Regulations for so long as a prospectus relating to the Securities is required to be delivered
under the Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(m) <I><U>Free Writing Prospectuses</U></I>. The Company represents and agrees that, unless it obtains the prior written
consent of Evercore Group L.L.C., and each Underwriter severally represents and agrees that, unless it obtains the prior written consent of the Company and Evercore Group L.L.C., it has not made and will not make any offer relating to the Securities
that would constitute an issuer free writing prospectus or that would otherwise constitute a free writing prospectus required to be filed with the Commission; provided that the prior written consent of the parties hereto shall be deemed to have been
given in respect of the free writing prospectuses included in Schedule III. Any such free writing prospectus consented to by the Company and Evercore Group L.L.C. is hereinafter referred to as a <B><I>&#147;Permitted Free Writing
Prospectus.&#148;</I></B> The Company represents that it has treated or agrees that it will treat each Permitted Free Writing Prospectus as an issuer free writing prospectus, and has complied and will comply with the requirements of Rules 164 and
433 of the Rules and Regulations applicable to any Permitted Free Writing Prospectus. The Company represents that it has satisfied and agrees that it will satisfy the conditions in Rule 433 to avoid a requirement to file with the Commission any
electronic road show. Each Underwriter severally represents and agrees that, (A)&nbsp;unless it obtains the prior written consent of the Company and Evercore Group L.L.C., it has not distributed, and will not distribute any Written <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication other than those listed on Schedule&nbsp;V, and (B)&nbsp;any
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication undertaken by it was with entities that are qualified institutional buyers with the meaning of Rule&nbsp;144A under the Act or
institutions that are accredited investors within the meaning of Rule&nbsp;501 under the Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(n) <I><U>Emerging Growth Company</U></I>.
The Company will promptly notify the Representatives if the Company ceases to be an Emerging Growth Company at any time prior to the later of (A)&nbsp;completion of the distribution of Securities within the meaning of the Act and (B)&nbsp;completion
of the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <B><I>Conditions of Underwriters&#146; Obligations</I></B>. The obligations of the several
Underwriters hereunder are subject to the accuracy, as of the date hereof and at each of the First Closing Date and the Second Closing Date (as if made at such Closing Date), of and compliance with all representations, warranties and agreements of
the Company contained herein, to the performance by the Company of its obligations hereunder and to the following additional conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <I><U>Required Filings; Absence of Certain Commission Actions</U></I>. All filings required by Rules&nbsp;424, 430A and 433 of the Rules
and Regulations shall have been timely made (without reliance on Rule 424(b)(8) or Rule 164(b)); no stop order suspending the effectiveness of the Registration Statement or any part thereof or any amendment thereof, nor suspending or preventing the
use of the Time of Sale Disclosure Package, the Prospectus or any issuer free writing prospectus shall have been issued; no proceedings for the issuance of such an order shall have been initiated or threatened; and any request of the Commission for
additional information (to be included in the Registration Statement, the Time of Sale Disclosure Package, the Prospectus, any issuer free writing prospectus or otherwise) shall have been complied with to your reasonable satisfaction. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <I><U>Continued Compliance with Securities Laws</U></I>. No Underwriter shall have advised the Company that (i)&nbsp;the Registration
Statement or any amendment thereof or supplement thereto contains an untrue statement of a material fact which, in your opinion, is material or omits to state a material fact which, in your opinion, is required to be stated therein or necessary to
make the statements therein not misleading, or (ii)&nbsp;the Time of Sale Disclosure Package or the Prospectus, or any amendment thereof or supplement thereto, or any issuer free writing prospectus contains an untrue statement of fact which, in your
opinion, is material, or omits to state a fact which, in your opinion, is material and is required to be stated therein, or necessary to make the statements therein, in light of the circumstances under which they are made, not misleading. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <I><U>Absence of Certain Events</U></I>. Except as contemplated in the Time of Sale Disclosure Package and in the Prospectus, subsequent to
the respective dates as of which information is given in the Time of Sale Disclosure Package and the Prospectus, neither the Company nor any of its subsidiaries shall have incurred any material liabilities or obligations, direct or contingent, or
entered into any material transactions, or declared or paid any dividends or made any distribution of any kind with respect to its capital stock; and there shall not have been any change in the capital stock, or any material change in the <FONT
STYLE="white-space:nowrap">short-term</FONT> or <FONT STYLE="white-space:nowrap">long-term</FONT> debt of the Company (other than as a result of the conversion of convertible securities), or any issuance of options, warrants, convertible securities
or other rights to purchase the capital stock of the Company or any of its subsidiaries, or any Material Adverse Change or any development involving a prospective Material Adverse Change (whether or not arising in the ordinary course of business),
that, in your judgment, makes it impractical or inadvisable to offer or deliver the Securities on the terms and in the manner contemplated in the Time of Sale Disclosure Package and in the Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) <I><U>Opinion of Company Counsel</U></I>. On each Closing Date, there shall have been furnished to you, as Representatives of the several
Underwriters, the opinion of Dentons US LLP, corporate and intellectual property counsel for the Company, dated such Closing Date and addressed to you in form and substance satisfactory to the Representatives and previously agreed upon with counsel
to the Representatives. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) <I><U>Opinion of Company Regulatory Counsel</U></I>. On each Closing Date, there shall have
been furnished to you, as Representatives of the several Underwriters, the opinion of Hogan Lovells US LLP, regulatory counsel for the Company, dated such Closing Date and addressed to you in form and substance satisfactory to the Representatives
and previously agreed upon with counsel to the Representatives. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f) <I><U>Opinion of Underwriters&#146; Counsel</U></I>. On each Closing
Date, there shall have been furnished to you, as Representatives of the several Underwriters, such opinion or opinions from Latham&nbsp;&amp; Watkins LLP, counsel for the several Underwriters, dated such Closing Date and addressed to you, with
respect to the formation of the Company, the validity of the Securities, the Registration Statement, the Time of Sale Disclosure Package or the Prospectus and other related matters as you reasonably may request, and such counsel shall have received
such papers and information as they request to enable them to pass upon such matters. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(g) <I><U>Comfort Letter</U></I>. On the date
hereof, on the effective date of any <FONT STYLE="white-space:nowrap">post-effective</FONT> amendment to the Registration Statement filed after the date hereof and on each Closing Date you, as Representatives of the several Underwriters, shall have
received a letter of KPMG LLP, dated such date and addressed to you, in form and substance satisfactory to you. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(h) <I><U>Officers&#146;
Certificate</U></I>. On each Closing Date, there shall have been furnished to you, as Representatives of the Underwriters, a certificate, dated such Closing Date and addressed to you, signed by the chief executive officer and by the chief financial
officer of the Company, to the effect that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(i) The representations and warranties of the Company in this Agreement are
true and correct as if made at and as of such Closing Date, and the Company has complied with all the agreements and satisfied all the conditions on its part to be performed or satisfied at or prior to such Closing Date; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman">(ii) No stop order or other order suspending the effectiveness of the Registration Statement or any part thereof or any
amendment thereof or the qualification of the Securities for offering or sale, nor suspending or preventing the use of the Time of Sale Disclosure Package, the Prospectus or any issuer free writing prospectus, has been issued, and no proceeding for
that purpose has been instituted or, to the best of their knowledge, is contemplated by the Commission or any state or regulatory body. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(i) <I><U><FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement</U></I>. The Underwriters shall have received all of the <FONT
STYLE="white-space:nowrap">Lock-Up</FONT> Agreements referenced in Section&nbsp;4 and the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements shall remain in full force and effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(j) <I><U>Other Documents</U></I>. The Company shall have furnished to you and counsel for the Underwriters such additional documents,
certificates and evidence as you or they may have reasonably requested, including satisfactory evidence that the Corporate Conversion has been consummated. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(k) <I><U>FINRA No Objections</U></I>. FINRA shall have raised no objection to the fairness and
reasonableness of the underwriting terms and arrangements. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(l) <I><U>Exchange Listing</U></I>. The Securities to be delivered on such
Closing Date will have been approved for listing on Nasdaq, subject to official notice of issuance. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(m) <U>[</U><I><U>CFO
Certificate</U></I>. On the date hereof and on each of the First Closing Date and the Second Closing Date, as applicable, the Company shall have furnished to the Representatives a certificate, dated as of such date, signed on behalf of the Company
by its Chief Financial Officer, regarding certain financial information set forth in the Preliminary Prospectus and the Prospectus, respectively, in form and substance satisfactory to the
Underwriters.]<SUP STYLE="font-size:85%; vertical-align:top">1</SUP> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All such opinions, certificates, letters and other documents will be
in compliance with the provisions hereof only if they are reasonably satisfactory in form and substance to you and counsel for the Underwriters. The Company will furnish you with such conformed copies of such opinions, certificates, letters and
other documents as you shall reasonably request. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <B><I>Indemnification and Contribution</I></B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <I><U>Indemnification by the Company</U></I>. The Company agrees to indemnify and hold harmless each Underwriter, its affiliates, directors
and officers and each person, if any, who controls such Underwriter within the meaning of Section&nbsp;15 of the Act or Section&nbsp;20 of the Exchange Act, from and against any losses, claims, damages or liabilities, joint or several, to which such
Underwriter may become subject, under the Act or otherwise (including in settlement of any litigation if such settlement is effected with the written consent of the Company), insofar as such losses, claims, damages or liabilities (or actions in
respect thereof) (i)&nbsp;arise out of or are based upon an untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, including the 430A Information and any other information deemed to be a part of the
Registration Statement at the time of effectiveness and at any subsequent time pursuant to the Rules and Regulations, if applicable, any Preliminary Prospectus, the Time of Sale Disclosure Package, the Prospectus, or any amendment or supplement
thereto, any issuer free writing prospectus, any issuer information that the Company has filed or is required to file pursuant to Rule 433(d) of the Rules and Regulations, or any Written <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication, or any road show as defined in Rule&nbsp;433(h) under the Act (a <B><I>&#147;road show&#148;</I></B>), or (ii)&nbsp;arise out of or are based upon the omission or alleged
omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, and will reimburse each Underwriter for any legal or other expenses reasonably incurred by it in connection with
investigating or defending against such loss, claim, damage, liability or action as such expenses are incurred; <I>provided, however,</I> that the Company will not be liable in any such case to the extent that any such loss, claim, damage, liability
or action arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made in reliance upon and in conformity with written information furnished to the Company by you, or by any Underwriter through
you, specifically for use in the preparation thereof; it being understood and agreed that the only information furnished by an Underwriter consists of the information described as such in<BR> Section&nbsp;6(e). </P>
<P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">NTD: if applicable. TBD. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <I><U>Indemnification by the Underwriters</U></I>. Each Underwriter will, severally and not
jointly, indemnify and hold harmless the Company, its affiliates, directors and officers and each person, if any, who controls the Company within the meaning of Section&nbsp;15 of the Act and Section&nbsp;20 of the Exchange Act, from and against any
losses, claims, damages or liabilities to which the Company may become subject, under the Act or otherwise (including in settlement of any litigation, if such settlement is effected with the written consent of such Underwriter), insofar as such
losses, claims, damages or liabilities (or actions in respect thereof) (i)&nbsp;arise out of or are based upon an untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, any Preliminary Prospectus,
the Time of Sale Disclosure Package, the Prospectus, or any amendment or supplement thereto, any issuer free writing prospectus, any issuer information that the Company has filed or is required to file pursuant to Rule 433(d) of the Rules and
Regulations, or any Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication, or any road show, or (ii)&nbsp;arise out of or are based upon the omission or alleged omission to state
therein a material fact required to be stated therein or necessary to make the statements therein not misleading, in each case to the extent, but only to the extent, that such untrue statement or alleged untrue statement or omission or alleged
omission was made in conformity with written information furnished to the Company by you, or by such Underwriter through you, specifically for use in the preparation thereof (it being understood and agreed that the only information furnished by an
Underwriter consists of the information described as such in Section&nbsp;6(e)), and will reimburse the Company for any legal or other expenses reasonably incurred by the Company in connection with investigating or defending against any such loss,
claim, damage, liability or action as such expenses are incurred. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <I><U>Notice and Procedures</U></I>. Promptly after receipt by an
indemnified party under subsection (a)&nbsp;or (b) above of notice of the commencement of any action, such indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party under such subsection, notify the
indemnifying party in writing of the commencement thereof; but the omission so to notify the indemnifying party shall not relieve the indemnifying party from any liability that it may have to any indemnified party except to the extent such
indemnifying party has been materially prejudiced by such failure (through the forfeiture of substantive rights or defenses). In case any such action shall be brought against any indemnified party, and it shall notify the indemnifying party of the
commencement thereof, the indemnifying party shall be entitled to participate in, and, to the extent that it shall wish, jointly with any other indemnifying party similarly notified, to assume the defense thereof, with counsel reasonably
satisfactory to such indemnified party, and after notice from the indemnifying party to such indemnified party of the indemnifying party&#146;s election so to assume the defense thereof, the indemnifying party shall not be liable to such indemnified
party under such subsection for any legal or other expenses subsequently incurred by such indemnified party in connection with the defense thereof other than reasonable costs of investigation; provided, however, that if, in the sole judgment of the
Representatives, it is advisable for the Underwriters to be represented as a group by separate counsel, the Representatives shall have the right to employ a single counsel (in addition to local counsel) to represent the Representatives and all
Underwriters who may be subject to liability arising from any claim in respect of which indemnity may be sought by the Underwriters under subsection&nbsp;(a) of this Section&nbsp;6, in which event the reasonable fees and
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
expenses of such separate counsel shall be borne by the indemnifying party or parties and reimbursed to the Underwriters as incurred. An indemnifying party shall not be obligated under any
settlement agreement relating to any action under this Section&nbsp;6 to which it has not agreed in writing. In addition, no indemnifying party shall, without the prior written consent of the indemnified party (which consent shall not be
unreasonably withheld or delayed) effect any settlement of any pending or threatened proceeding unless such settlement includes an unconditional release of such indemnified party for all liability on claims that are the subject matter of such
proceeding and does not include a statement as to, or an admission of, fault, culpability or a failure to act by or on behalf of an indemnified party. Notwithstanding the foregoing, if at any time an indemnified party shall have requested an
indemnifying party to reimburse the indemnified party for fees and expenses of counsel pursuant to this Section&nbsp;6(c), such indemnifying party agrees that it shall be liable for any settlement effected without its written consent if
(i)&nbsp;such settlement is entered into more than 45&nbsp;days after receipt by such indemnifying party of the aforesaid request and (ii)&nbsp;such indemnifying party shall not have reimbursed such indemnified party in accordance with such request
prior to the date of such settlement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) <I><U>Contribution; Limitations on Liability;
<FONT STYLE="white-space:nowrap">Non-Exclusive</FONT> Remedy</U></I>. If the indemnification provided for in this Section&nbsp;6 is unavailable or insufficient to hold harmless an indemnified party under subsection&nbsp;(a) or (b)&nbsp;above, then
each indemnifying party shall contribute to the amount paid or payable by such indemnified party as a result of the losses, claims, damages or liabilities referred to in subsection&nbsp;(a) or (b)&nbsp;above, (i)&nbsp;in such proportion as is
appropriate to reflect the relative benefits received by the Company on the one hand and the Underwriters on the other from the offering of the Securities or (ii)&nbsp;if the allocation provided by clause&nbsp;(i) above is not permitted by
applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause&nbsp;(i) above but also the relative fault of the Company on the one hand and the Underwriters on the other in connection with the
statements or omissions that resulted in such losses, claims, damages or liabilities, as well as any other relevant equitable considerations. The relative benefits received by the Company on the one hand and the Underwriters on the other shall be
deemed to be in the same proportion as the total net proceeds from the offering (before deducting expenses) received by the Company bear to the total underwriting discounts and commissions received by the Underwriters, in each case as set forth in
the table on the cover page of the Prospectus. The relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact
relates to information supplied by the Company or the Underwriters and the parties&#146; relative intent, knowledge, access to information and opportunity to correct or prevent such untrue statement or omission. The Company and the Underwriters
agree that it would not be just and equitable if contributions pursuant to this subsection&nbsp;(d) were to be determined by pro rata allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of
allocation which does not take account of the equitable considerations referred to in the first sentence of this subsection&nbsp;(d). The amount paid by an indemnified party as a result of the losses, claims, damages or liabilities referred to in
the first sentence of this subsection&nbsp;(d) shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending against any action or claim which is the subject of
this subsection&nbsp;(d). Notwithstanding the provisions of this subsection&nbsp;(d), no Underwriter shall be required to contribute any amount in excess of the amount by which the total underwriting
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
discounts and commissions received by such Underwriter with respect to the Securities exceeds the amount of any damages that such Underwriter has otherwise been required to pay by reason of such
untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f) of the Act) shall be entitled to contribution from any person who was not guilty of such
fraudulent misrepresentation. The Underwriters&#146; obligations in this subsection&nbsp;(d) to contribute are several in proportion to their respective underwriting obligations and not joint. The remedies provided for in this Section&nbsp;6 are not
exclusive and shall not limit any rights or remedies that might otherwise be available to any indemnified party at law or in equity. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e)
<I><U>Information Provided by the Underwriters</U></I>. The Underwriters severally confirm and the Company acknowledges that the concession figure and the information concerning sales to discretionary accounts appearing under the <FONT
STYLE="white-space:nowrap">sub-caption</FONT> &#147;Discounts and Commissions&#148; under the caption &#147;Underwriting,&#148; the information regarding stabilizing transactions and passive market making contained under the <FONT
STYLE="white-space:nowrap">sub-caption</FONT> &#147;Price Stabilization, Short Positions and Penalty Bids&#148; under the caption &#147;Underwriting&#148; and the information regarding internet distribution contained under the <FONT
STYLE="white-space:nowrap">sub-caption</FONT> &#147;Electronic Offer, Sale and Distribution of Shares&#148; under the caption &#147;Underwriting,&#148; in the Time of Sale Disclosure Package and in the Prospectus are correct and constitute the only
information concerning such Underwriters furnished in writing to the Company by or on behalf of the Underwriters specifically for inclusion in the Registration Statement, any Preliminary Prospectus, the Time of Sale Disclosure Package, the
Prospectus or any issuer free writing prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <B><I>Representations and Agreements to Survive Delivery</I></B>. All
representations, warranties, and agreements of the Company herein or in certificates delivered pursuant hereto, and the agreements of the several Underwriters and the Company contained in Section&nbsp;6 hereof, shall remain operative and in full
force and effect regardless of any investigation made by or on behalf of any Underwriter or any controlling person thereof, or the Company or any of its officers, directors, or controlling persons, and shall survive delivery of, and payment for, the
Securities to and by the Underwriters hereunder and any termination of this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <B><I>Substitution of Underwriters</I></B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <I><U>Obligation to Purchase Under Certain Circumstances</U></I>. If any Underwriter or Underwriters shall fail to take up and pay for the
amount of Firm Shares agreed by such Underwriter or Underwriters to be purchased hereunder, upon tender of such Firm Shares in accordance with the terms hereof, and the amount of Firm Shares not purchased does not aggregate more than 10% of the
total amount of Firm Shares set forth in Schedule&nbsp;I hereto, the remaining Underwriters shall be obligated to take up and pay for (in proportion to their respective underwriting obligations hereunder as set forth in Schedule&nbsp;I hereto except
as may otherwise be determined by you) the Firm Shares that the withdrawing or defaulting Underwriters agreed but failed to purchase. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)
<I><U>Termination Under Certain Circumstances</U></I>. If any Underwriter or Underwriters shall fail to take up and pay for the amount of Firm Shares agreed by such Underwriter or Underwriters to be purchased hereunder, upon tender of such Firm
Shares in accordance with the terms hereof, and the amount of Firm Shares not purchased aggregates more </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
than 10% of the total amount of Firm Shares set forth in Schedule&nbsp;I hereto, and arrangements satisfactory to you for the purchase of such Firm Shares by other persons are not made within
36&nbsp;hours thereafter, this Agreement shall terminate. In the event of any such termination the Company shall not have any liability to any Underwriter (except to the extent provided in Section&nbsp;4(g) and Section&nbsp;6 hereof) nor shall any
Underwriter (other than an Underwriter who shall have failed, otherwise than for some reason permitted under this Agreement, to purchase the amount of Firm Shares agreed by such Underwriter to be purchased hereunder) be under any liability to the
Company (except to the extent provided in Section&nbsp;6 hereof). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <I><U>Postponement of Closing</U></I>. If Firm Shares to which a
default relates are to be purchased by the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters or by any other party or parties, the Representatives or the Company shall have the right to postpone the First Closing Date for not more
than seven business days in order that the necessary changes in the Registration Statement, in the Time of Sale Disclosure Package, in the Prospectus or in any other documents, as well as any other arrangements, may be effected. As used herein, the
term &#147;Underwriter&#148; includes any person substituted for an Underwriter under this Section&nbsp;8. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) <I><U>No Relief from
Liability</U></I>. No action taken pursuant to this Section shall relieve any defaulting Underwriter from liability, if any, in respect of such default. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <B><I>Termination</I></B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <I><U>Right to Terminate</U></I>. You, as Representatives of the several Underwriters, shall have the right to terminate this Agreement by
giving notice as hereinafter specified at any time at or prior to the First Closing Date, and the option referred to in Section&nbsp;3(b), if exercised, may be cancelled at any time prior to the Second Closing Date, if (i)&nbsp;the Company shall
have failed, refused or been unable, at or prior to such Closing Date, to perform any agreement on its part to be performed hereunder, (ii)&nbsp;any other condition of the Underwriters&#146; obligations hereunder is not fulfilled, (iii)&nbsp;trading
on the Nasdaq Stock Market or New York Stock Exchange shall have been wholly suspended, (iv)&nbsp;minimum or maximum prices for trading shall have been fixed, or maximum ranges for prices for securities shall have been required, on the Nasdaq Stock
Market or New York Stock Exchange, by such Exchange or by order of the Commission or any other Governmental Authority, (v)&nbsp;a banking moratorium shall have been declared by federal or state authorities, or (vi)&nbsp;there shall have occurred any
outbreak or escalation of hostilities or any change in financial markets or any calamity or crisis that, in your judgment, is material and adverse and makes it impractical or inadvisable to proceed with the completion of the sale of and payment for
the Securities. Any such termination shall be without liability of any party to any other party except that the provisions of Section&nbsp;4(g) and Section&nbsp;6 hereof shall at all times be effective. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <I><U>Notice of Termination</U></I>. If you elect to terminate this Agreement as provided in this Section, the Company shall be notified
promptly by you by telephone, confirmed by letter. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <B><I>Notices</I></B>. Except as otherwise provided herein, all communications hereunder
shall be in writing and, if to the Underwriters, shall be mailed via overnight delivery service or hand delivered via courier, to the Representatives c/o Evercore Group L.L.C., 55 East 52nd Street New York, New York 10055, Attention: Equity Capital
Markets; (ii)&nbsp;if to the Company, shall be mailed or delivered to it at electroCore, Inc., 150 Allen Road, Suite 201, Basking Ridge, New Jersey 07920, Attention: Chief Executive Officer; or in each case to such other address as the person to be
notified may have requested in writing. Any party to this Agreement may change such address for notices by sending to the parties to this Agreement written notice of a new address for such purpose. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <B><I>Persons Entitled to Benefit of Agreement</I></B>. This Agreement shall inure to the benefit of and be binding upon the parties hereto
and their respective successors and assigns and the controlling persons, officers and directors referred to in Section&nbsp;6. Nothing in this Agreement is intended or shall be construed to give to any other person, firm or corporation any legal or
equitable remedy or claim under or in respect of this Agreement or any provision herein contained. The term &#147;successors and assigns&#148; as herein used shall not include any purchaser, as such purchaser, of any of the Securities from any of
the several Underwriters. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <B><I>Absence of Fiduciary Relationship</I></B>. The Company acknowledges and agrees that: (a)&nbsp;the
Representatives have been retained solely to act as underwriters in connection with the sale of the Securities and that no fiduciary, advisory or agency relationship between the Company and the Representatives has been created in respect of any of
the transactions contemplated by this Agreement, irrespective of whether the Representatives have advised or are advising the Company on other matters; (b)&nbsp;the price and other terms of the Securities set forth in this Agreement were established
by the Company following discussions and arms-length negotiations with the Representatives and the Company is capable of evaluating and understanding and understands and accepts the terms, risks and conditions of the transactions contemplated by
this Agreement; (c)&nbsp;it has been advised that the Representatives and their affiliates are engaged in a broad range of transactions which may involve interests that differ from those of the Company and that the Representatives have no obligation
to disclose such interest and transactions to the Company by virtue of any fiduciary, advisory or agency relationship; (d)&nbsp;it has been advised that the Representatives are acting, in respect of the transactions contemplated by this Agreement,
solely for the benefit of the Representatives and the other Underwriters, and not on behalf of the Company; (e)&nbsp;it, he or she waives to the fullest extent permitted by law, any claims it may have against the Representatives for breach of
fiduciary duty or alleged breach of fiduciary duty in respect of any of the transactions contemplated by this Agreement and agrees that the Representatives shall have no liability (whether direct or indirect) to the Company in respect of such a
fiduciary duty claim on behalf of or in right of the Company, including stockholders, employees or creditors of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.
<B><I>Governing Law; Waiver of Jury Trial</I></B>. This Agreement shall be governed by and construed in accordance with the laws of the State of New York. The Company (on its behalf and, to the extent permitted by applicable law, on behalf of its
stockholders and affiliates), and each of the Underwriters hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement or the
transactions contemplated hereby. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <B><I>Counterparts</I></B>. This Agreement may be executed in one or more counterparts and, if
executed in more than one counterpart, the executed counterparts shall each be deemed to be an original and all such counterparts shall together constitute one and the same instrument. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <B><I>General Provisions</I></B><I>.</I> This Agreement constitutes the entire agreement of
the parties to this Agreement and supersedes all prior written or oral and all contemporaneous oral agreements, understandings and negotiations with respect to the subject matter hereof. This Agreement may not be amended or modified unless in
writing by all of the parties hereto, and no condition herein (express or implied) may be waived unless waived in writing by each party whom the condition is meant to benefit. The Section headings herein are for the convenience of the parties only
and shall not affect the construction or interpretation of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>[Signature Pages Follow] </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Please sign and return to the Company the enclosed duplicates of this Agreement whereupon this
Agreement will become a binding agreement between the Company and the several Underwriters in accordance with its terms. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>electroCore, Inc.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Confirmed as of the date first above mentioned, on behalf of themselves and the other several</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Underwriters named in Schedule I hereto.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">E<SMALL>VERCORE</SMALL> G<SMALL>ROUP</SMALL> L.L.C.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">C<SMALL>ANTOR</SMALL> F<SMALL>ITZGERALD</SMALL> &amp; C<SMALL>O</SMALL>.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">JMP S<SMALL>ECURITIES</SMALL> <SMALL>LLC</SMALL></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Managing Director</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE I </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="83%"></TD>
<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:39.05pt; display:inline; font-size:8pt; font-family:Times New Roman; ">Underwriter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Number&nbsp;of&nbsp;Firm&nbsp;Shares&nbsp;(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Evercore Group L.L.C.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">[&nbsp;&nbsp;&nbsp;&nbsp;]</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cantor Fitzgerald &amp; Co.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">[&nbsp;&nbsp;&nbsp;&nbsp;]</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">JMP Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">[&nbsp;&nbsp;&nbsp;&nbsp;]</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BTIG, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">[&nbsp;&nbsp;&nbsp;&nbsp;]</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">The Underwriters may purchase up to an additional [&nbsp;&nbsp;&nbsp;&nbsp;] Option Shares, to the extent the option described in Section&nbsp;3(b) of the Agreement is exercised, in the proportions and in the manner
described in the Agreement. </TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>List of Individuals and Entities Executing <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Officers </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Bruce J. Simon, Ph.D. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Eric J. Liebler </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Francis R. Amato </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Glenn S. Vraniak </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Joseph P. Errico </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Michael Romaniw </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Peter S. Staats, M.D. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Roland D. Duhart </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Steven M. Mendez </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other Current Employees </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[Names omitted] </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Carrie S. Cox </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David M. Rubin, Ph.D. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">James L.L. Tullis </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Michael W. Ross </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Michael G. Atieh </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Nicholas Colucci </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Thomas J. Errico, M.D. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Trevor J. Moody </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stockholders<SUP STYLE="font-size:85%; vertical-align:top">2</SUP> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2010 Core Investment Partners </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">American Investment Holdings LLC
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Bill Cerullo </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Brent Saunders </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Conure ElectroCore </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Core Ventures 2010 LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Core Ventures II LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Nancy Staats/Prand Enterprises LP
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ECNG LLC </P> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">2</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The names of holders of less than 1% of a class of security have been omitted. </TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">IC-1</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">IC-2</FONT> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">IC-4</FONT> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">James Tullis Irr. Trust FBO Elizabeth Tullis </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">James Tullis Irr. Trust FBO John L Tullis </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">James Tullis Irr.
Trust FBO Sara Tullis Wester </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">John F. Welch, Jr. 2004 Rev Trust </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kathryn K. Theofilos. Esq/ Charles Theofilos </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kenneth Langone
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Linda Tullis </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Linda Tullis Family Trust </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Merck Global Health Innovation, LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Michael Stansky </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NeuroCore Investment Partners </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Paulson Electrocore Investments,
LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Paulson Investment Company LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Reese Terry </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Skyview Investments LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Errico 2010 Dynasty Trust </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Thomas J Errico 2010 Family Trust </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tullis Opportunity Fund II
LP </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vinik Family Foundation </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE III </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Certain Permitted Free Writing Prospectuses </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. [&nbsp;&nbsp;&nbsp;&nbsp;] </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE IV </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Pricing Information </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Number of Firm
Shares: [&nbsp;&nbsp;&nbsp;&nbsp;] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Price per Share to the public: $[&nbsp;&nbsp;&nbsp;&nbsp;] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Number of Option Shares: [&nbsp;&nbsp;&nbsp;&nbsp;] </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE V </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communications </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. Testing the Waters Communication dated March&nbsp;19, 2018. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE VI </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Subsidiaries </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">electroCore Bermuda, Ltd.
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">electroCore Germany GmbH </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">electroCore UK Ltd. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Form of <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[&nbsp;&nbsp;&nbsp;&nbsp;], 2018 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Evercore Group L.L.C. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cantor Fitzgerald &amp; Co. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">JMP Securities LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As representatives of the underwriters named </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">in Schedule I to
the Purchase Agreement </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">referred to below </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c/o</TD>
<TD ALIGN="left" VALIGN="top">Evercore Group L.L.C. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">55 East 52nd Street </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">New York, New York 10055 </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c/o</TD>
<TD ALIGN="left" VALIGN="top">Cantor Fitzgerald &amp; Co. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">499 Park Avenue </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">New York, NY 10022 </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c/o</TD>
<TD ALIGN="left" VALIGN="top">JMP Securities LLC </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">600 Montgomery Street, </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Suite 1100 </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">San Francisco, CA 94111 </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Sirs: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As an inducement to the underwriters (the <B><I>&#147;Underwriters&#148;</I></B>) to execute a purchase agreement (the <B><I>&#147;Purchase
Agreement&#148;</I></B>) providing for a public offering (the <B><I>&#147;Offering&#148;</I></B>) of common stock (the <B><I>&#147;Common Stock&#148;</I></B>), of ElectroCore, LLC and any successor (by merger or otherwise) thereto (the
<B><I>&#147;Company&#148;</I></B>), the undersigned hereby agrees that without, in each case, the prior written consent of Evercore Group L.L.C. (the <B>&#147;</B><B><I>Representative</I></B><B>&#148;</B>) during the period specified in the second
succeeding paragraph (the <B><I><FONT STYLE="white-space:nowrap">&#147;Lock-Up</FONT> Period&#148;</I></B>), the undersigned will not: (1)&nbsp;offer, pledge, announce the intention to sell, sell, contract to sell, sell any option or contract to
purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, make any short sale or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any securities convertible into,
exercisable or exchangeable for or that represent the right to receive Common Stock (including without limitation, Common Stock which may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the
Securities and Exchange Commission and securities which may be issued upon exercise of a stock option or warrant) whether now owned or hereafter acquired (the <B><I>&#147;Undersigned&#146;s Securities&#148;</I></B>); (2) enter into any swap or other
agreement that transfers, in whole or in part, any of the economic consequences of ownership of the Undersigned&#146;s Securities, whether any such transaction described in clause (1)&nbsp;or (2) above is to be settled by delivery of Common Stock or
such other securities, in cash or otherwise; (3)&nbsp;make any demand for or exercise any right with respect to, the registration of any Common Stock or any security convertible into or exercisable or exchangeable for Common Stock; or
(4)&nbsp;publicly disclose the intention to do any of the foregoing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned agrees that the foregoing restrictions preclude the undersigned from engaging in
any hedging or other transaction which is designed to or which reasonably could be expected to lead to or result in a sale or disposition of the Undersigned&#146;s Securities even if such securities would be disposed of by someone other than the
undersigned. Such prohibited hedging or other transactions would include without limitation any short sale or any purchase, sale or grant of any right (including without limitation any put or call option) with respect to any of the
Undersigned&#146;s Securities or with respect to any security that includes, relates to, or derives any significant part of its value from such securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period will commence on the date of this letter agreement and continue to and include the
date<B> </B>180 days after the date of the final prospectus (the <B><I>&#147;Prospectus</I></B><B>&#148;</B>) used to sell Common Stock in the Offering pursuant to the Purchase Agreement, and the undersigned&#146;s obligations hereunder shall
terminate on the first day after such date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the undersigned is an officer or director of the Company, (i)&nbsp;the Representative
agrees that, at least three business days before the effective date of any release or waiver of the foregoing restrictions in connection with a transfer of shares of Common Stock, the Representative will notify the Company of the impending release
or waiver, and (ii)&nbsp;the Company has agreed in the Purchase Agreement to announce the impending release or waiver by issuing a press release through a major news service at least two business days before the effective date of the release or
waiver. Any release or waiver granted by the Representative hereunder to any such officer or director shall only be effective two business days after the publication date of such press release. The provisions of this paragraph will not apply if both
(a)&nbsp;the release or waiver is effected solely to permit a transfer not for consideration, and (b)&nbsp;the transferee has agreed in writing to be bound by the same terms described in this letter agreement that are applicable to the transferor,
to the extent and for the duration that such terms remain in effect at the time of the transfer. The undersigned further agrees that the foregoing provisions shall be equally applicable to any issuer-directed Common Stock that the undersigned may
purchase in the Offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, the undersigned may transfer the Undersigned&#146;s Securities (i)&nbsp;as a
<I>bona fide</I> gift or gifts, (ii)&nbsp;to any immediate family member, any trust, partnership, limited liability company or other entity for the direct or indirect benefit of the undersigned or the immediate family of the undersigned,
(iii)&nbsp;if the undersigned is a corporation, partnership, limited liability company, trust or other business entity (1)&nbsp;to another corporation, partnership, limited liability company, trust or other business entity that is a direct or
indirect affiliate (as defined in Rule 405 promulgated under the Securities Act of 1933, as amended) of the undersigned or (2)&nbsp;in distributions of shares of Common Stock or any security convertible into or exercisable for Common Stock to
limited partners, limited liability company members or stockholders of the undersigned, (iv)&nbsp;if the undersigned is a trust, to the beneficiary of such trust, (v)&nbsp;by testate succession or intestate succession or (vi)&nbsp;pursuant to the
Purchase Agreement; <I>provided,</I> in the case of clauses (i)-(v), that (x)&nbsp;such transfer shall not involve a disposition for value, (y)&nbsp;the transferee agrees in writing with the Representative to be bound by the terms of this letter
agreement, and (z)&nbsp;no filing by any party under Section&nbsp;16(a) of the Securities Exchange Act of 1934, as amended (the <B><I>&#147;Exchange Act&#148;</I></B>), shall be required or shall be made voluntarily in connection with such transfer
(other than a filing on a Form 5 filed within 45 days of December&nbsp;31, 2018, in which case such Form 5 shall include a footnote describing the transaction being reported). For purposes of this letter agreement, &#147;immediate family&#148; shall
mean any relationship by blood, marriage, domestic partnership or adoption, not more remote than first cousin. Additionally, any Common Stock acquired by the undersigned in the Offering </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(other than any issuer-directed Common Stock purchased in the Offering by an officer or director of the Company) or in the open market on or after the date of the Offering will not be subject to
this letter agreement; <I>provided</I> no filing under Section&nbsp;16(a) of the Exchange Act by any party shall be voluntarily made in connection with any subsequent sale, transfer, gift or disposition of such Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the foregoing restrictions shall not apply to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;the exercise of stock options granted pursuant to the Company&#146;s equity incentive plans (including by &#147;net&#148; or
&#147;cashless exercise&#148;); <I>provided</I> that they shall apply to any of the Undersigned&#146;s Securities issued upon such exercise; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;the establishment of any contract, instruction or plan (a <B><I>&#147;Plan&#148;</I></B>) that satisfies all of the requirements of
Rule <FONT STYLE="white-space:nowrap">10b5-1(c)(1)(i)(B)</FONT> under the Exchange Act; <I>provided</I> that no sales of the Undersigned&#146;s Securities shall be made pursuant to such a Plan prior to the expiration of the <FONT
STYLE="white-space:nowrap">Lock-Up</FONT> Period, and such a Plan may only be established if no public announcement of the establishment or existence thereof and no filing with the Securities and Exchange Commission or other regulatory authority in
respect thereof or transactions thereunder or contemplated thereby, by the undersigned, the Company or any other person, shall be required, and no such announcement or filing is made voluntarily, by the undersigned, the Company or any other person,
prior to the expiration of the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) transfers of the Undersigned&#146;s
Securities to the Company to satisfy tax withholding obligations pursuant to the Company&#146;s equity incentive plans that are described in the Prospectus; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) transfers of the Undersigned&#146;s Securities to the Company by an executive officer upon death, disability or termination of employment,
in each case, of such executive officer; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) conversion of the outstanding shares of preferred stock of the Company into shares of Common
Stock, <I>provided</I> that they shall apply to any of the Undersigned&#146;s Securities received upon such conversion; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) transfers of
Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock by operation of law to a spouse, former spouse, domestic partner, former domestic partner, child or other dependent pursuant to a qualified domestic
order or in connection with a divorce settlement; <I>provided</I> if the undersigned is required to file a report under Section&nbsp;16(a) of the Exchange Act reporting a reduction in beneficial ownership of shares of Common Stock during the <FONT
STYLE="white-space:nowrap">Lock-Up</FONT> Period, that the undersigned shall include a statement in such report to the effect that the transfer occurred by operation of law, such as pursuant to a qualified domestic order or in connection with a
divorce settlement, as applicable; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii) transfers of Common Stock or any securities convertible into or exercisable or exchangeable
for Common Stock pursuant to a bona fide third-party tender offer, merger, consolidation or other similar transaction made to all holders of the Company&#146;s capital stock involving a change of control of the Company; <I>provided</I> that in the
event that such tender offer, merger, consolidation or other such transaction is not completed, the Undersigned&#146;s Securities shall remain subject to the restrictions contained in this letter agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In furtherance of the foregoing, the Company and its transfer agent and registrar are hereby
authorized to decline to make any transfer of shares of Common Stock if such transfer would constitute a violation or breach of this letter agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned hereby represents and warrants that the undersigned has full power and authority to enter into this letter agreement and that
upon request, the undersigned will execute any additional documents necessary to ensure the validity or enforcement of this letter agreement. All authority herein conferred or agreed to be conferred and any obligations of the undersigned shall be
binding upon the successors, assigns, heirs or personal representatives of the undersigned. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned understands that the
undersigned shall be released from all obligations under this letter agreement, and this letter agreement shall be void and of no further force or effect, if (i)&nbsp;the Company notifies the Underwriters that it does not intend to proceed with the
Offering, (ii)&nbsp;the Purchase Agreement does not become effective, or if the Purchase Agreement (other than the provisions thereof which survive termination) shall terminate or be terminated prior to payment for and delivery of the Common Stock
to be sold thereunder or (iii)&nbsp;the Offering is not completed by September&nbsp;30, 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For avoidance of doubt, this letter
agreement does not prohibit any of the transactions contemplated by the Corporate Conversion (as defined in the Purchase Agreement). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
undersigned understands that the Underwriters are entering into the Purchase Agreement and proceeding with the Offering in reliance upon this letter agreement. This letter agreement may only be modified, supplemented, or terminated (other than in
accordance with its terms), in a writing executed and delivered by the undersigned and the Representative. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature on following
page] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This letter agreement shall be governed by, and construed in accordance with, the laws of the
State of New York. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Very truly yours,</P> <P STYLE="margin-top:0pt;margin-bottom:1pt;border-bottom:1px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" ALIGN="center">Printed Name of Holder</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Signature</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Printed
Name of Person Signing</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">(and indicate capacity of person signing if signing as custodian, trustee, or on behalf of an entity)</P></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Form of Company Press Release for Waivers or Releases </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>of Officer/Director <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>electroCore, Inc. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>[Date] </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">electroCore, Inc. (the <B>&#147;Company&#148;</B>) announced today that Evercore Group L.L.C., as the representative of the underwriters, is [waiving]
[releasing] [a] <FONT STYLE="white-space:nowrap">lock-up</FONT> restriction[s] with respect to an aggregate of [# of common shares] held by certain [officers] [directors] of the Company. These [officers] [directors] entered into <FONT
STYLE="white-space:nowrap">lock-up</FONT> agreements with the representatives in connection with the Company&#146;s initial public offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This
[waiver] [release] will take effect on [date that is at least 2 business days following date of this press release]. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>This press release is not an
offer for sale of the securities in the United States or in any other jurisdiction where such offer is prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from registration under the
United States Securities Act of 1933, as amended. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-1 </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>3
<FILENAME>d472601dex232.htm
<DESCRIPTION>EX-23.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 23.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Consent of Independent Registered Public Accounting Firm </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board of Directors </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Electrocore, LLC, Subsidiaries and
Affiliate: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We consent to the use of our report included herein and to the reference to our firm under the heading &#147;Experts&#148; in the prospectus.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ KPMG LLP </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Short Hills, New Jersey </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 11, 2018 </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g472601g03b57.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g03b57.jpg
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M(" @(" @(" @(" @(" @(" @(" @( H\/WAP86-K970@96YD/2)W(C\^_]L
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M2]NYO2PTT(KVJY!44& L.OSV:F*O+@!Y^V[BL)O8@(]8,A(H6'O:>Q80U91
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M M?5$"4WT'EI$Q(KY0230:**/&6CBV?CS3_>1'[6O1:+8<?;]O,E' ' ' '
M' ' ' ' *Z)G_E8>O?[@W:O_ *>^IG +%^ . . . . . . . . . . . . .
M . . . 5VTQ_E->]W[MO0[_/W;SE=RT]V97\GS\K!8ER&AP!P!P!P!P!P!G/
ME]N> <9SC'W_ &?J_KS^S'[<_P!&/OX!SP#^<[ZXSY9VUQGR\_+.<8SY?MX
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MO>)BG4KL38W96"C[(EO76541%)5%(9-*\<RF?5Y,W,RC\R$[&F[O1I!BQ1<
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M+.*0^#/OWX.!1I9_B_M*VM>PX?K477%Z1ALH/0=4V8[T5-$9$09Q@V18H8,
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M%=LZD=5O*7S^+GA)P)/*MLR/I,_G.HK6B#KXC"[)A;MXBNFT. 7WK263SKA
MP$>EX^0]H,+/$E&V-\'KOC>C5/2KLU*K10FM"7\V'QKMWUX78Q^Y(^S;N1P>
M<A76SIM#K[KA!ZV:[$*UM5H/5)M-F6JR<8D6AF'O]DW0I+=S6M\=^ZK VO?I
M=QH[FB>'(!P!P!P!P!P!P!P!P!P!P!P!P!P!P!Y8^[R^S]G ' ' ' ' ' '
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MV>Q"5-9EM'V[Q0WB)>J2Y'X"Z;O=;#W$Y77B=_DC-XEV?];]76?U?WZ7A_\
M\ZM$\MF_IZD1^UKT6BP;F2C@%?'=OK;8,N=PWM-UA78!.X'7@<<7@B;]91C&
MKOKTENU(33KA9RK11JL^B4YR,;.HH_>.<I02PVH27-<:I)%47@J[._Y6ZJF3
M6^>JG9J!]M*9CMNP7#P9NZ5=Q^<0@UKHWEM7V0 RDUFE9S<=KMG<5+(@5WV8
MDF:NNOM4MFA%M[1@_9KK";_6>J)&YSC'EYY\O/[,?TYX ]6,Y\O/'G^S^O[?
M^3@'/ ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '
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ML(CDLB S=&19;?%-,,8Q.I@";:8<^A,;(BC;77T.=N"RXB7&6!M/@@X X X
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MB6X_UO\ 76?U_P!^ET _G5HGFK-_3U(C]K7HM%@W,E' ' ' ' ' ' ' ' '
M' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' *S>NE5=^(SW'OB;7A;S>3]8I2F
M\Q5471VC:Q=OF-NT1 #22AVK%(?%=2@TN0+AU*\2&+DVH!'Z5%2DD<,E<#3B
M%%^.7SNE"S+@R. . . . . . <9QC/V9QYXX \L?U^7EY>?ZO+[O^_[^ <\
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M,:X]KL[-N0#@#@'&/+R^S_3_ $^[@'/ ' ' ' ' ' ' ' ' ' ' ' ' ' '
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M#@#@#@%?/B6_H_UU^^ET _G5HKFK-_3U(C]K7HM%@W,E' ' ' ' ' ' ' '
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MN"'KM(R1K27.)+B.21!>1QW!48X8:26,W.N%-U(W"N<RKHNTXX5]T6$<R4<
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M^TQ8$N(<364)[& C\DS)ZLR#=BSF7']$=I6<ZU75KABGA=&I,3@T. . . .
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M9?=9K'5-O@#1;&^J:K4:BHBBV1VT;I99;Z[[DM. . . . . . . . . . .
M. . . . . . . . . . . . . . . . . . . . . . . . . . . >2^_V<
M)_W5O_S-YP#UN . >47_ -C:?[I9_P#/6O!FU_M_^D>DG_Y./Z]O_P!L\&C^
9^ . . . . . . . . . . . . . . ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g472601g04w27.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g04w27.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $& ET# 1$  A$! Q$!_\0
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MXC7F;5 ;6[+Q7M[)D)KA1S0<'#-0X5"_N=KY:OV*T]Z1+^]X=(#_ *CO+/\
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MC[T*Z'L=#+G7FML.S6P9@PYDB("ZT84,-#P'F3EWNVPN:]A9V=TL;1X):X.
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MAJB8L6%-;88TW-N?%E62CWUE@YS&3/50?02UT/,3L>Q:(89V+6-H",H-H1(
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M9>$]D03,R2R9E)JE)1C#$DX#I>&+D.58UK'0W&^U@:2>R!!J3D^TXSVN9M4
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M#%>][R]S(9<*M"R%H3(>(E_\)MYF(CP8C71GDLHV*&1&L,-ETAC6-9<#G!M
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MBG'**-U,4]X(X/$>,.TFFV8"55 LMV-(F--'I(TNIL@K'@ 8A/7+\F<..E9
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M'6,&&'0,%QK@7-,,X&F:\*K->Q>C$UT2E>LVC21[3.[4Y/RP9/H#"].P%62
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M%AQ9&)%_!UAX/;$P8;SPX,<:,>TA:9$-5<9.,?(C@_L-\X)"=(<@.(K'D#+
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M="VASC$DZF#2FTDWJF%3#:SV%,*43:;2H!M4]01-M N3%!%K7; *4$2N-_\
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MP9^'!G)6+$=U+=APYB#$>ZDY+N-UC7EQHT%QH, "3@%VMBRTS#M.6?$EX[&
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M*RD8FJF6; 5$\S;7!1,Z\MCDT"YX9.K98EG6.>&38=E:SQ>V6-TD<K96[)%
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M6AO$*4X\!BL41OCOH,R+ ZGB7(6>F!$1GDME^O8*&V="S;:#M=;&W47GNO!
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MCGM$#45&24-J@4YG*.NM+;?UY'=IE,8V1(A-U.])CD93"GN,6.VD .(J;DR
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M]B+&2PLE95K MM\?HP+V;$) FRP.D<+Q?9YVZ4,.I1-T_<M\TGS 7FT&EBI
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MDKZN3OFJ-TY/$-T9^%FWQ@:?0]-RUL8_E,I?.TO[/3=-[)7U<G?-4;IRY:W
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M\?X@/;B(U!5Q 5H[UH1: FLSGO>%J4T^I"E=>EVH-24*"6YD)EKB!XN3"+/
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M)X@DZ:.VJR;AJZ;+X8JH.&[A'+-)=!9/+%1)5+/)-3#+'/#*^-[7HBRAJ/\
M= !_O)S_ '>+44.8]X^A;,47 N(5_N>E?\4I+_,[NBR9^,./T%:547,E$2B+
M%[K3\*>SAUL!QA(LS;]6/NG["TREN$5>D8IFDI'"KB'8F;1G(B)R01S0<8B\
M+*K(-G3O!R\:-'"!/C1_G\=^N4*(E$2B)1$HB41*(E$6G7.C]V81_HP@/\W+
M5_/CY67^D.Q/\&2'[<RA7O/Y+7] K9_Q?/?L:P5II7EY>E4HB41*(E$2B)1$
MHB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB419RU'
MI@GL)S@4)=W&1)NMV%GML>T<%<T\NPHS%VSM>U[6O:Z;A]?')%OEVR>%EG&&
M:2?WG8=V$K3V19J':UJ"/9F1\O%I&G0VY,VM$ANI$DK*O@BZ"##F9]S7P9<W
MH<-L:8:^'#^'[+>S+9NQ_+1++LPP+2RLF(58,F77Y:RV1&]A-VG<<"'$$/EY
M$.;&CBZ^(8,!S8D3L,$"!@$:T$!V2 \<Q2LBV:M\>U33PM>][WO>_9R444SO
MDHLLIEFJLKEFJKGFIGEE?^CMCV/9E@6;*6/8TE LZS9&$(,K*2S+L.&P8DDD
ME\2(]Q,2-&BN?&C17/BQ7OB/<X_SXM:UK2MVT9JUK7G(]H6C.Q3&F9J8=>B1
M'F@ % &LAL:&PX4&&UD*#":R%"8R&QK1)5V2ZY*(E$2B*[P7]M2/^)$N_F9Q
M10YQW_N*UC:ZRES??A7;RNXIL[@Y#5S&!-M$+-P]M?BY(TDF1M;9;1RFUP,W
MDSH??O!FDJXR;W8*N+K9N,<!B PKHI336NG,,/C6J1M_5,QGNY=-R4$8+QB/
M16$;OCLCDX!>+7,CG,_;Z^P!IM&$G$G47+=;*+D>MKMAW66B]A]\%L$E7&:1
M-'@^/C4L'-M1<BG4L8Y2;#OO#HGL@ 7B['*7,'N* 0'..5*]B0T>[S:X#[*Z
MTV+HZ,X-55DWN:L1?M'"/<!+0B5*X4P&)&O3V.;C!U9UD:*ZZW5%8/Q8@[2W
M< \%U#'(=LA,',<0CH-L"+,M66 G5.T9KHS*%HM(Q/X^:!)K(J$TI&-M8>KB
MXS,Q>_Y^[[LW&H<;V?'-FX?=K[U<^(#FJ.9KN.IX-)X:0.8ZA>CU46$_[EA;
M?['6RX_V<MR6>;.Z^OY!L=&/&1$6>,L& YF+.JE(DP8R9[&LWOT<'Q3T:$TY
MM/)7-IQI]U#A56-#5?)E228V?26:>Q1E-6UF#=MM)\BY5@"^_=N%RK5\Y3/I
MDWQ"^A9+!8TT>/7BY=H4"H*LB#8P%'G;,-7-IX]03O?&#1AHSAQS:5"1;5G+
MY[&A#78<RFEY6BEH82??QG:(09&#$>9F=&N]Q.$!H\"/D@F;)BXSN@/B;%R=
MFT,-IJU(ML7)-^)PUDPH=>CX^.9IPS8_?09]=">]X;.4@O*6\;$K,,R2LZ"E
M]A(&%LMJ(YQR5MK:FW:"A\ACJ1$.Z<POOW-Y/JI]DP4;/%(_G'GO;,>XC'!6
M;*BE/0<#G^^GN337@U8@U%=.JHSY^2WZ7U[N,/,MI2S9C2[MQ)=?MHB <7-C
MB;U9E'-W\F97$Q#C.Y%RMAWOUML[7@A)R0?/%,GXXJ@_*NU&MBA(#3P@^"O?
M0X@#@(\(;4Z-(/NS+#,*U?R\B C7$>:V491^!Q#3 (@'%[#8Y-C"4"=\6$9*
M/$IJ]21']\XM&.0X7%JHFT:$7IUDH2,KH/P[P"YA]WQ\50<..?[Z:>]\8'V!
M:TYMA6 !ZXE#LW(& R&#Y.P?[+54!200&U9I!G/!0URJDKF&DLSG<3VJF"F^
M(1 L#=2UL=S=,&KQ^@BPY_ ,V&?/BIKU5-,>$TKCB *85X%DZ$ZFW!'MVLYV
MFI(&$:-24#>7M2^P$I%D^@[/2TQ$8C#3;'-! W(Q&R5(#B@:48."J T01Q:2
M)^Q=$UCL5'#PT\(X=7P%#DM;\HG064/DI/+O9LGL' RQ:6VB+:0*0Q0 6V Z
M<!H^P%QH8?A[39T&.QN#JV*E2F>OI:P%3H.R6>PEP6V5</CT<:<W*=->#O8Z
M=2Q^+C')J;K$Y%&97L9E&$]J<A8CL2,+;!:!99(8LVW7/QFJ"&IWYQ"0#($Z
MU_%^]#YVX43"M=B1KO0WP<E&J8X@NS?'^=*$8X\"5&C@-1H-!4<-:X:CX%?"
MNLN41/("NJ=(XRF([/D!)&1WV<HK%)1%GT6VT)UN4?PL6"BS#):!NYC <=A!
M[B0XJ9+0U\<:1LZ^5&I8OC@]'>^"F@\(XP<*XU[],=(%5 JZAY(G48LPDF4D
M+@KSCC[/4Q<KVL%.NX%(-;[XA4^VFF3>A(]&DYA&9)&8]BKK1D]PDY  3&N[
M.;1E"1-149HI2FO3JQTZ\._FX4TX#->XZM(&DT(.?-@=-,;KR4T!.]U&B+F(
M9MXSWKB9:-N$3_L8M%MGC34ET[-BH-P^#C"$\"HRW#5Z&LIF\*J+"<8=W7%K
M%I#=TW58312OP:?'$-:#/FTZ\10. IHTUUZ*@9[3IH,3G&S.1.PY-"Y7 8Y/
MQ.O=:+ZMG 14<^</M<X;#&26?OG@U4C"SMY^*E@&-L2,,D\K9N(7 (@J1,,R
M*RD< CGU\)_S(]*84 [^:M,:89@13/HQ)U54?L_2$IDTOW(]CHI$6&F.L>+,
M5CQ0*59 3HHGIG<>UIK("D5R2SQ0&2Z+1Z9@2NKESK=:)KS00R92AIG%V[UN
M_5](^_-FS535_P U>&H;0'3C2AX%G32$3D,&U7#XE*U6;H\#9.V;Y\TPPP5*
M6N5?K,S!C!%19GC*3#%5L4F'>Q98/[*G9FX9505U//*)R+9[4?[H /\ >3G^
M[Q:BAS'O'T+9BBX%Q"O]STK_ (I27^9W=%DS\8<?H*TJHN9*(E$2B)1$HB41
M*(E$2B)1$HBQ[R1T>ALO8;0ZI)%0^36%0H3U; 7@^Q4L@ :/++]UR?M+XWRN
M^NG=/N>5K63MEV]^V[7'X%LJ[!,OLGY02-O1LI8UC.D[&@62)6'93)X/; GK
M0G-O,5T_*EI<9XP]KVL@"&'7S>HW[IL8;-L?8VL*=L.%D[!M=LW:\:U3,Q+3
M?)%AC24A*;0(39&9#@T20?MFV DQ"VX+M78#\4QEY<.O0"7TM7S/<A2._N;^
MS\'VNOHVZOG=Y$KY^B^RD\4UEY<.O0"7TM3<A2._N;^S\'VNFZOG=Y$KY^B^
MRD\4UEY<.O0"7TM3<A2._N;^S\'VNFZOG=Y$KY^B^RD\4UEY<.O0"7TM3<A2
M._N;^S\'VNFZOG=Y$KY^B^RD\4UEY<.O0"7TM3<A2._N;^S\'VNFZOG=Y$KY
M^B^REY\4UCY;N_0*/TK66Y"L[?S.^88'M18[JZT-Y4GY\C>S$\4UCY;N_0*/
MTK3<A6=OYG?,,#VHFZNM#>5)^?(WLQ/%-8^6[OT"C]*TW(5G;^9WS# ]J)NK
MK0WE2?GR-[,3Q36/EN[] H_2M-R%9V_F=\PP/:B;JZT-Y4GY\C>S%.R#AH/"
M.F3?&?/7-G84*6OG>.H)7PR+#6Q#)"UK%\^S9"Z]TL5+WM?.V/;WPQ[/:V'Y
M(5G D?/F=P)_U# ]J*#Y5\^?]BI,9O\ 7D8Z >Y@UJ#\4T?Y;//0:/TG5W(=
MF[^)[S%+^TU=U=:&\J3\^1O9B>*:/\MGGH-'Z3IN0[-W\3WF*7]IINKK0WE2
M?GR-[,3Q31_EL\]!H_2=-R'9N_B>\Q2_M--U=:&\J3\^1O9B>*:/\MGGH-'Z
M3IN0[-W\3WF*7]IINKK0WE2?GR-[,3Q31_EL\]!H?2=-R'9N_B>\QR_M--U=
M:&C(J3K_ 'W'/_XT>E>WBG#?+5]Z%;_2-7<AV7OXG_,DO[16.ZNM+>9(^>9C
MV>GBG#?+5]Z%;_2--R'9>_B?\R2_M%-U=:6\R1\\S'L]/%.&^6K[T*W^D:;D
M.R]_$_YDE_:*;JZTMYDCYYF/9Z>*<-\M7WH5O](TW(=E[^)_S)+^T4W5UI;S
M)'SS,>ST\4X;Y:OO0K?Z0IN0[+TY;S]/[DEQ_P#D3Z$W5UI[S)'SS,>SU//^
M&PEF# %[3LBID:S+XYH7!-L<6_>QRBAC?%2Q*]U.[65[:_9QQ[2^/8MVW9[-
MLMR)9._:T?,TMT]8CY5UJ5(^9DAA3_7$QI_\ H+Q3A?EH_\ 0S?Y_3<B63OV
MM'S-+=/5W5MJ;S)#SQ,= 3Q3A?EH_P#0S?Y_3<B63OVM'S-+=/3=6VIO,D//
M$QT!/%.%^6C_ -#-_G]-R)9._:T?,TMT]-U;:F\R0\\3'0$\4X7Y:/\ T,W^
M?TW(ED;]K1\S2W3E#\JVU-&1MG@\-KS!_P"A'I7GQ3A7EF0]#MOGU7<B6/OU
MM+S/*]-4W5MK;SK.\[3/0T\4X5Y9D/0[;Y]3<B6/OUM+S/*]-3=6VMO.L[SM
M,]#3Q3A7EF0]#MOGU-R)8^_6TO,\KTU-U;:V\ZSO.TST-/%.%>69#T.V^?4W
M(EC[];2\SRO34W5MK;SK.\[3/0U/2'AL'"/F[3"=$W&*X@*3OGD%:IWQR*BF
MA')*UK/\[7Q1R<W2QR[-KYVPME>V-[]BUW(EC@D'+6TC3_Y/*C_K2INK;7(!
M&1UG"M,]JS)T?V0*"\4X3Y9$?1#;YY3<B6-OUM/S1*],3=6VQO/LWSK-=%3Q
M3A/ED1]$-OGE-R)8V_6T_-$KTQ-U;;&\^S?.LUT52 KBO&F9%HZ)2(D69(*V
M47'=3198O,<?NV14<I.%54T<LNU[KW*V*N:?;8)JHY964Q[&R?DG9+R5I2DU
M:>4=IVO(R\9L6/9IDX$BR<:S%L"+,PIB)&AP7NN[=M(9%?#O,AQ8+W"*WK[5
M^5)E+.6?-RMG9/V;94['A.A0+1$W&G'R;GX&-"EXL"'"B1F-O&%MI="9$NOB
M0HK6F&[9]JU;,6R#-DW1:-&J2:#9LW3P10012QM@FDBDG;'!-/#&UL<<,;6Q
MQM;L6M7JB4E)60EH$E)2\&4E)6$R!+2LM"9!@0(,)H9#A084,-9#AL: UK&M
M#0!0!>9)J:F9Z9CSDY,1IJ;FHKX\S,S$1\:/'C17%\2+%BO+GQ(CW$N<YQ))
M-25R*V%P)1$HB41*(KO!?VU(_P")$N_F9Q10YQW_ +BJ115*(E$2B)1$HB41
M*(E$2B)1$HB41*(E$2B)1$HB41*(LD:C_= !_O)S_=XM10YCWCZ%LQ1<"Y[!
M-)6[U)=))PBH,(IK(+X64162S:J8J)+)Y?>J)*87O@IAE]S/#*^-_N7HJW/Q
M'T%8=]G.EK;2PTGGA"$=J*P=QLIM"G .S<L^@C,TSCCZ4#>[M$VA(6/.D1XH
MDJP<N<QSQ^R1>IH7=M^Z%E5]+VBM*T&?/3P*&A6V=!['($AL#O$Y8L'G<SUD
M5=!(>3?!QT[UYC?V:1MZ>2$7!MGP!6V3-YFJ1Q:YD<,QC9PN1PS:V(2\9SH!
MT9CF66^\49\DXQZ%:>I12^[7R#F4.3O!A#Z/#GT7!X.I26< PV+>)N'R*I%L
M!-25;!\[8L7+0,VL(CY11,@:7'CEGB;42BZ4+DQ;%X2\[''-WN]]ZF.\49\D
MXQZ%:>I1+[M?(.9.\49\DXQZ%:>I1+[M?(.9.\49\DXQZ%:>I1+[M?(.9.\4
M9\DXQZ%:>I1+[M?(.9.\49\DXQZ%:>I1+[M?(.9.\49\DXQZ%:>I1+[M?(.9
M.\49\DXQZ%:>I1+[M?(.9.\49\DXQZ%:>I1+[M?(.92A@/'UGO;N(W'W*G51
M^'=7 IJJIW--@V323[?+'L]S12QP11Q_432PP3Q^]QM:B%Q&8Z!Z!K47WBC/
MDG&/0K3U*)?=KY!S)WBC/DG&/0K3U*)?=KY!S)WBC/DG&/0K3U*)?=KY!S)W
MBC/DG&/0K3U*)?=KY!S)WBC/DG&/0K3U*)?=KY!S)WBC/DG&/0K3U*)?=KY!
MS)WBC/DG&/0K3U*)?=KY!S)WBC/DG&/0K3U*)?=KY!S)WBC/DG&/0K3U*)?=
MKY!S*4+!X^JNVR7C<?<98CAJ>&;@4V5RP129HX(H87RQ[.**">.*2*=OO4T\
M<<,>Q:UJ*EQ&;# >@:U%]XHSY)QCT*T]2BE]VOD',G>*,^2<8]"M/4HE]VOD
M',O'>2+^2D7]#,_5K&^SZS?SASJU?P^#W)WDB_DI%_0S/U:7V?6;^<.=*OX?
M![EXN%BV/ZZ+1;'_ "AV=O\ ;C2^WZS?".=7\(<P<?\ E]R]>]$4\F(IZ)9>
MK2^SZS?SASI^$U._-]R=Z(IY,13T2R]6E]GUF_G#G3\)J=^;[E[V!QB]K7M%
M(O>U_NVO8,SO:]K_ *E[7[6LEC>=KY!S+SWBC/DG&/0K3U*)?=KY!S)WBC/D
MG&/0K3U*)?=KY!S*4=!X_D,%)9QN/J(I9/[H(9BFV2+>ZBR=U;H)WQ[5+NV5
ML<E>U_7Y8VOE^I:BMXTKIJ:F@QI2GI47WBC/DG&/0K3U**7W:^0<R=XHSY)Q
MCT*T]2B7W:^0<R=XHSY)QCT*T]2B7W:^0<R=XHSY)QCT*T]2B7W:^0<R=XHS
MY)QCT*T]2B7W:^0<R=XHSY)QCT*T]2B7W:^0<R=XHSY)QCT*T]2B7W:^0<R=
MXHSY)QCT*T]2B7W:^0<RE"P>/JN4<EXW'W&=F Y/'-P*;*YXI)LD$T4<<LL>
MS9)!+'!)'#]1-+#'#'[F-J*EQ%*:AH&I1?>*,^2<8]"M/4HI?=KY!S)WBC/D
MG&/0K3U*)?=KY!S)WBC/DG&/0K3U*)?=KY!S)WBC/DG&/0K3U*)?=KY!S)WB
MC/DG&/0K3U*)?=KY!S)WBC/DG&/0K3U*)?=KY!S)WBC/DG&/0K3U*)?=KY!S
M)WBC/DG&/0K3U*)?=KY!S)WBC/DG&/0K3U*)?=KY!S*4%AX^EF]NA&X^WOF+
M()*70%-DKJH*-\L5FZE\<?OT%L+WP63O]ZIA>^.7W+T5#B<YT$\="HOO%&?)
M.,>A6GJ44ONU\@YD[Q1GR3C'H5IZE$ONU\@YD[Q1GR3C'H5IZE$ONU\@YD[Q
M1GR3C'H5IZE$ONU\@YD[Q1GR3C'H5IZE$ONU\@YD[Q1GR3C'H5IZE$ONU\@Y
MD[Q1GR3C'H5IZE$ONU\@YD[Q1GR3C'H5IZE$ONU\@YD[Q1GR3C'H5IZE$ONU
M\@YD[Q1GR3C'H5IZE$ONU\@YD[Q1GR3C'H5IZE$ONU\@YD[Q1GR3C'H5IZE$
MONU\@YD[Q1GR3C'H5IZE$ONU\@YD[Q1GR3C'H5IZE$ONU\@YD[Q1GR3C'H5I
MZE$ONU\@YD[Q1GR3C'H5IZE$ONU\@YD[Q1GR3C'H5IZE$ONU\@YD[Q1GR3C'
MH5IZE$ONU\@YD[Q1GR3C'H5IZE$ONU\@YD[Q1GR3C'H5IZE$ONU\@YE*A1()
ML1279QX$Q<X(/NYNF8QNW<I=LQ<X9]S63QMGAV^&62>?8O\ ?)YY8W^YE>B!
MQ-03H.K45\Z+%2(W]D=?P<__ $92BHS\1]!77#R3X[[=V1O".[=T^LP@VQM9
MMM/HP#99Q48]!N8^0D&X(AR"A9<(@\<&G;576.U&$XC+)X([S%MDZ_A]W;MC
M82@[S+)I !!Q!KAIT$&O?%#P%:V,M![BX_Q&<%QK&::[UG"=I\U=GN',.V"S
MN1;ZHE&A20/5YC 4-*'U#,N#R >.("N^4;D96.D6616S9;)==%X5J"16A/8C
M'77%<C0&N9SM5_JV3ME]B'(:/VC(IELE)AO41AIU?+'C\ AL68Z^0U)R"VL)
M<QIQM2,I[&.!%";PP*F,LE$A?!$F)D>D^9O3\:O@HX@5T&@ P-<YK4EHQH:5
MX%+ZVT?S#9/-;.).%F4?&B=C )A+(^+W<F3:)A'/ S;&BID!2?JSQP:E*V7(
ME]!=@-"\K+F) :MDUVH8/6V1>0,V90D:#H(_%I_7O#@S:AHIF54CG%WEZ#CD
M8BYN^P3T'?1G2PS;$<#;R#)38S,4^-KK7VQ9_$Y9-7LF;MR(#:34*=<6S>1U
M\Z<70V1#W:DTB05J_+(N;G% 03=PPI>J :<'?U'.NY2/,G@X #'D7"SL@P#C
M&3]TX?YE7#EXU9((.G"Y11B,4)+++X9J*OU!H_-YGEDXS8M,E+H)EQ*8HB41
M*(E$2B)1%U'](LNNEN^-8IK*IXWU7&LKXX*9X6[-SDIM>_8QO:W9O:UK=G]7
ML6M_BK^??RKXL6'LA6*&1(C <CI D,>YH)Z]6_C0$8KWO\EN'#?D#;!?#8X_
M.V=%7-:XTZRV#A4@X8E:#];=>Z7'Y93UJ\P]43'Y>-XU_P"\O2FT0/R,+Q;.
M9>MW+C+]<X6R['ZG954OV/\ SRJ&/&.>-%/?B//WJ[3!&:%#'_\ &WF7CNZ_
MX97\IG_^:FW1?RL3\]W.FTPOR4/\QO,G=U_PROY3/_\ --NB_E8GY[N=-IA?
MDH?YC>9>.[*_A5/_ (\O_P U-LB?E'_G.YU=KA_DV?FMYD[LK^%4_P#CR_\
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MMZJ[607G,<D;"(1O8RX=YKK*:;-<NB<6F3%P!?-BY<2!5Q1+$D4-*"KG8 T
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M=.3^IZ;*\MX-_P#7_HFFY)RRWS9,_I7H*;JO)#>YE)^C.G+S_4]-D^6\'_\
MKWT55W).6&^;)K\VU.A*;JS)'>WE'X;,Z8G]3TV3Y;P?_P"O?15-R3EAOFR:
M_-M3H2;JS)'>WE'X;,Z8O-NCSV/_ /NG$(M_DQ/9?[1>/_WJ[DG+#3E/DW^;
M:A_Z,*;JS)+1DUE%^=9@_P"L*Y+CH[-CM\L,<IW",KYHHK6[5,]V+8K)XJ8V
MOV1MONVME:U_\'9_4O>FY)ROWSY-_F6GT--U7DGO:RBT?U[-TX]MKX?U//8O
MEU"OR9WZ.IN2<K]\^3?YEI]#3=69)[VLHOS[-Z6O;^IY;#_PSN&=G]Y.7_\
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M3+#^DIN9]E?N998_\ZD?N>5-T;L7]TK3\SSO[B6XX;2O_P#TP;;_ *[F6/\
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MNB;9P<ON3P10GW;*?.A/T71-LX.7W)X(H3[ME/G0GZ+HFV<'+[E.O]8Q-P#
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MD9'\!8QOW @)6=DQ@MZU9[^5D<%<OE6A!.R6*<2653D ]1TY*W1R:].V7?\
MTXCPJNS'G3R#BFM-B%K]Z2,^'01KLG7PUAJTVJ(.FW_#]QO%+5;MVW,$56:*
M>S1[D ':HM#4[EHY12'-'0@FQ+; "D#14<)H<<PO 5\&.H<BG9%R-W%'I'*9
M('&(;LE,8VES/<P")D(7@[DK..PW0#V=Z6C4"<QI(&XP%SV[8$,P56:F3,T:
M'AV3$OB^)66(D#1KH.QKCAB:&O>Y%V3:*FEM@1%_*V.PVNSHP4.YK0Z2H08E
M!W& ',(#47%$DWV:3>0D!TBS/)YFA8B/H,&V;6'%1:TIBLA,EBP/>IKQ^*<N
MO,0LT442B)1%UV\V-_;9U7M8''8'*K A#S7P RY:]XHX3R4(N"1UDJXZP8$$
M'&%LFP]HGW'!7%''N5\\4[***99>.OE";*N7F0V6-F63DO;@LR0F<FI2T(T
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M2B)1$HB41*(NHKI&?W<(U_HJC/\ /DJK^>_RL?\ 2'8O^#9#]M6^O?7R6?Z
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'1*(E$7__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g472601g05u71.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g05u71.jpg
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M 0$! 0$! 0'_P  1" "* 6X# 1$  A$! Q$!_\0 '@ !  $% 0$! 0
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MY?%"2I[+/'KG/-P[=*;9+N5\\U5L\U,M\M\=E86+)/NLK0XO+I1FVA. )F
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M>6!^\6Z(K\<\?^#-/UEA^J=>_AK?W*=$-]8:5ZZON5D<8Z&R[82_6*0SI/\
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M>4=$MR5G#%R+FO2Q=&7+QCPNC('8Z4=(UG(&+H\V&I!6YMRT+1YVW7+MPZ"
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MI@%FX:L\G3EF(?*&F7HBZ$MM#=6T;W,4R1RH(]B.8I$WJX69H@3@KE"RM@G
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MZZN[6UO<6L27121;=RW$2V:0 MQC(%>58CO*B%5W'8&.-S67%M#;SSVY,SM
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M'AC,F-N98_F8Y;L*VUF4&L6-PT(G"*4,+W &]-YACDX4C[,[L1O\[EG'67<
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M;B($)U(K44DS1Q"!$Q;1N(0HK%TV9;AU86\M-L@K00PCYHP/Y(LX"Y6P0D&
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M]_2F!W#P%.OOO37?>5O?TI@=P\!446/?L#J1W'6E@2DT#QDQ,8)9DD8[-3@
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MS3VS40C,P"SQ.5N47&VVV74\9\%(H;)OM\,662]=(L7[E)Z[ MGRH\WY_/\
M\^?S06[XZ6R9X5/^++M*'CC,KK&THE(I$C,#6X=B0-%GKV.A-DFL22)F(S,F
M!5Z%F;]+(00CXS=WL.'2%5TGBDJ1R(_/Y^SVU_4*0LUK+JN;[%#/9;'EV1Y
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M )>E*=E"_LUAW-O^7I2G90O[-8=S;_EZ4IV4+^S6'<V_Y>E*=E"_LUAW-O\
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g472601g06a80.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g06a80.jpg
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M$4OFQHNCOC5=@38.-5QID2]31(AB[-\*)-VS]FY03')IIM/%$G>##//K(N[
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M(-MN8)&)8 CGJ@Z9)"1:-8MAK-Q1%;YU8-J8BQV#5>V:*:7!HLW;PZ%2B2Q
M8@DIJCM%Y"; /-'0HJ^:+A+U]>K\;GXI"\KU&G+,J*F.#NT>>]+/JJ+TJ4EE
M><^4@1*#ZTAS N!CD5:!9G8LCBKL4#BTDE,;!L2P1^S#L) \V9-]%DV^R02Y
MG&\WUSYG<8O,JIC/,L9Y W]=?:4DH*,U:!IW$&E%15N58GH0!#,PB;.2ZZVP
MV2+.RB#/5V;=[HI;$B2[IZMKA5??P)<[4WF9WG7:\2YGJ?\ &8KKU5=2Q/\
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M'3E'"$9NZ NL-7CAB<B*NQ+5FS=/'P5J.22(NACIBZ<K58=^CW,TM\$CP!X
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M;$IYSL3=*Z,&NSAP3)UJX:F,,0X(4,;;BZKK:7^RT>O?XR;>>"!X! O1O+]
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MMF]*L>3&Q(I$=H''90PLNVH0]$Q)0L^.. [5&OYW%F.J3LH0<.GSG=KN]?\
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M[#7$YR*4[$9D)BI81[)>QF^TSK<1;P,%(;,I:*S']G!L8W+LY65A,EH85+0
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M1@G)1>16 1K_ )+YOGO/\'.NX0(-U 1'S;HB16O#I$3@*J+Y)I^6BA$_#)(
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MG-Z=IVC['8X][:;3G4UI3 'G1C&X:_0[Z:WJ#D\ID@^9!I%Q<%B3[9K"/U3
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M'*JGBJJC7YW[GYP.!D_,O.\UGE?VA+J2J^2V+5388SKB;&X4 )26&- ;S<D
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MYW$U*'&<*=S=X[O&2[7@D> / '@#P!X \ > / '@#P!X \ > / '@#P!X \
M> / '@#P!X \ > / '@%)]?7!PII??\ .?UY;J/6]OU7^O<3_$<TPZQ/<J?<
M9GN OUOTSB<Y>?\ J69C@+B2?EO_ %?\G^3_ -;\&[541+C")M!R,E]?/%\P
M1O9O).>( 5;],2B,3>\45FQ)-*>S6&.W)",S!VFW(HZAY4*(/'9!.11S <PN
M_=.'CMXX<K**[!M-8-J,+GPV]=_$6:CD]#Z\T5>A4DQG@ZTY#"FH95FP=V8)
M%A0H^PFSMJZ1*B9J@+CPIIF4"'[ TMHBONN]55($5'8;3U>$:6TX7*Z]+>J>
MJ+>YL<\=TD[@G+O-=B6@%L+HB"0NH6,D)V@V#&8(;RRB!U[+@K*JY,06KP"S
M>35&/R]SADEC+40W?)_>J#54T]IRVL)>??,YVM<U*%C!P08.#"&34:)$,6@P
M6.9(Z-V8\<P;IM63)HW2QJF@U:MDDD$$4]==$DD]--,8UUQCP20K$N8>?8&9
MO&0PVI(9&S?2I#<I?)00,PT>6F149%A^[N6+)J8V?+;M#QO3;;3Z.-E"Q%SG
M&7+QPLH-EVOAANSL0O+_ %L<)3QO7;27<P5>;:55!(]5T*:.!;Q)HTK2)N$W
M<:KPVV:OT$)C" ;I/[D9%)FF?!-7"KE9)CJH[=;+!M.[EWOWZDC3_C3ERTAM
MW![ I*$R@;TAI7FEWM2#)SKK8>:E;,&E9+&-VSINJ@Z@R L;B-/!:C!T+58M
M7#=;1P@FKJ$NUW:8W3CS.PV;S!0-S4LSYVM2KHW.Z38,(H,:UW(='KT$FR@V
MS#>)H[?%YJ]5_![BV"C159VHME1JFHLHKO\ -ML$M.<[]<2,8'Z]N(JPJ>RZ
M-@'+U.Q:J;D9X86M#Q<08:,[!:)IJILT98^5PJ7,X%?775![/""FX%TLJ\"[
M,'2FZV1NU4VG+E8;B%[4]:%6_P W:]Z(Y&3KOD]]TM%F5=W1/?V5K7&[F5?:
M1Z4Q1^Q)!I%/8W@C,?P,O+M@LY.ES3T8JIHH0''4DFR#<%5=3+C!3][;O NK
M0E+POG*DZHH6NFJK2#T_7\5KN,:.?I;/EQ45#M!"! FJ@DBFY,%,MMB1A[A+
K39\4=NWF^OU%]O!C;;;>+N2UX,'@#P!X \ > / '@#P!X \ > / '@'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g472601g06d13.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g06d13.jpg
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M)JBA%68UFKHSIRF8TM7A+D*(J*J5PI6M->'IBIJF!B
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M/LZK8]*0%$HJUQ3&E-6_BUX4XS2H#$
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MG3!W3/KRV-\-"E&X*E53&CFZ--VE:UV]Y$-Y@,
M                              (=17"W+>0$FH#5F6Z.T9IV#7"?(=E!
M&6Y4W3B:V'"TK,4DQKWSHM0J:\6+E"C?;)!I#BF++UP84;G(:J[_ !4Z28@
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MRK_D: X*)V/C;TC\(\Z,?ED_J\\J_P"1H#@HG8^-O2/PCSHQ^63^KSRK_D:
MX*)V/C;TC\(\Z,?ED_J\\J_Y&@."B=CXV](_"/.C'Y9/ZO/*O^1H#@HG8^-O
M2/PCSHQ^63^KSRK_ )&@."B=CXV](_"/.C'Y9/ZO/*O^1H#@HG8^-O2/PCSH
MQ^63^KSRK_D: X*)V/C;TC\(\Z,?ED_J\\J_Y&@."B=CXV](_"/.C'Y9/ZO/
M*O\ D: X*)V/C;TFP%5V?!KLK.O[BK%\^Z:N;2AL<L""2+V,>&;V=B,M:4C[
M'G;V(D#>TOK9[(-2Y*J[P>&QO<TG=>X+D293H83H/YJE%5%TI@O>._
M       ,ZK.Y.WS#[JF$0A48KRSV&)%314^UY#6&9O,\@L38J!>K)BD_LNUB
M9$17$2?IY:*%AKF+4$OBJ>=/\5EK99S-*EK,W/R)L%PIK3SXZDW:]J4UG[ZU
MY93IEJ"\I7?<<='*U**;6J2S.JH'2SQ!Y&T1Z013$@CIR=!K=5^-DJ:GG9$^
MFZ2UKEC=JTIFMS0R:*,#PPN:;(4T<>@NC6TT36374!L1$B/;$<^A45FB1M5&
M%G*6]-*6) ^$(E!Q6,%&GI"EVA!QA6,%[F%[;:8QKG& (=U    !G;R\ZKW
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M-^]'=J0+R>SVIZ4K?LZ@?S5**J+I3!>\24
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M6M\B'C]Z^.3(%U)O7F0N\!    @_D/[VZ;SI4)Z]ZW BZ.^G.A. %
M   (CHQY=7^M&ET>EZES<3GR=$&K%9F33]R4$]DS>B+VWS[N=$R%*F2DX_\
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M_F0G 0H        0<P>,I;/F.X]?3WDZ+J3>O,@)Q$
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M7UDRX")H[Z\ZDW@4        (08/&1M?S(<?/IYR:%U)O7F0FM=R<ZDWB%
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MJ@2+DYY!8_F=C $,\C?%ZOCS,VA]"'P"II3>G.<;Q9\6+CEYAZA]7T> A/
M   (0IG\:7CY[W_Z'P4")I7?YD)O H        0?6?OG\C?.!"O4S7(JZ$W>
M=2)I7?YD)P$*        $','C*6SYCN/7T]Y.BZDWKS("<1
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MD]TY#RJ$<2R^ZQ,M?BEE']#SA[*1VE/'0     ^H_P#L#O[HS_)D ?ST&/\
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MZ$W>=2)I7?YD)P$*        $','C*6SYCN/7T]Y.BZDWKS("<1
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MC$5'L>Y;W"18M5JU*45-RFP UN<P
M   ,ZN1/)GISPZTG>&<CD\"=+2BZ!F0N>)3QXF5CN#>VN3:1)&9$3)T-7R=N
M/1[(7PM>6D0O!Y*,]<H*.+(6]]%:BHU5T(2'Q2N3A3:3G,DO$]!"D3HSH&<^
M9YBE+2"J33$"M0O+9\+53U X;H\EZJ"%^22"#EVR/;)AFY9&#]=C 5%3272
MA#MCWQ6=4S"I(#,7PU-,+OEQ\-KUA0-ZUU7.2]$V*'1Q<UY:$D[#+&6PLM(A
M<)(Z[)6A.]/<=8\JLNT@:4:L*:>+3S$!L/YR*UOD0\?O7QR9 NI-Z\R%W@(
M!G9U0?%@QYT:V_?6XXSEEULVOVNSY^$;<S#^ZYD3W2F/HR>,"AUM/5PZ]+OR
M4D_Z//7[M4CZ=B]6;)[IR'E4(XEE]UB9:_%+*/Z'G#V4CM*>.@    !]1_\
M8'?W1G^3( _GH,?XE9_\+;_V0D=2+8ZK6IW1G?*8IXV99]>&5GQEMWZ4FCE!
M\XXT>N;H_P#B*UY^F5N>LZ4#M'D=UL6+VDSY3SUDS(^Y/D-W%9Y1,&G0Y*;4
M     /+?U%O'+N3_ )>>JN$#LYF8ZUI[N]->068:6SC=6Y7N5 \KGBDXVX<
M-4>D7XP-D>9P_P"FT8&@,]_WS)OX%J?*D#:V;3VEL?"DN::/0N-#&T@    #
M-WJ!M7&IZD7$B.\F:]A\FB5@71+:Z(G=@63(*QB=7ISZ8L*T'!Q,=F=U:$3L
M_P L65*QQ./L+TN0)E)[BI6)W(M0@PVNPR;7&FS96N*)3QF9G&ICJIGO2A>3
M]9\2*5C'$NVN3,@H#C9/D5I7HOY"/1Z-DL-#&.19+ _R%=6CO5-B/4!D>(]&
M=D9,B3UT[L=E>R;@DR:U8&2Z%2]541%7135A7:E>/%*'I5 _F !#/(WQ>KX\
MS-H?0A\ J:4WISG&\6?%BXY>8>H?5]'@(3P   \?/(><2%IY#\@V]%5LXD*5
M-?5T8*>&E3#"V]9@RS92=OE/HZ2MN7XP3N9LG,[X1$9R<29DO&Y62S=]&97V
M7)S&45HQHMNV9*/>LM>EYAEHK&ATDI9J(]8$C&A+>1$>ER([V+DK1U6IZ+9C
MLK;9LW-9DK)2N;W*ZVY> RUTAVG9L;)5DE-<);]JQ7+ ;:.4DC.(D)[W0'\-
M*056+">K$?#5D1\0>V3*_@4LG_ZNO?MP.-_86S_SFL;^KM?]V&V/M[RA_P"%
M.7G]HR(_^WF_?1X=5CU0URN"]@=8TI-Y&/&F[0];MAB\C!5,TD7H89LT.#HA
MSH?KK@TKN:S?;&FV,&:E[]G3&[,BX$.6R?E84*;@3K&Q9I4F)9([83E=,1%5
M&I,0H$6K56ZZL-$JBT54Q//KU0%HS5JYS;7G)RQK1L&/$DK':ZS;5=9[YV$D
M.S9=C7Q'69/6C)W8S42)#N33W(QR<(UCJM36H<K-+     'FSYP=2'EC2O+&
MZ*HKJ8QIHA4(=(<B84*R#1YW5E%/%90>4K]E+BX)SE2G<QV?G S3.^V,%$[%
M$::XU*QV=6Y7Y<VGD_:_V/E)60C0O6L&/?F&3#HEZ(L1')6%,0FW4N)3V-=-
M54ZE9Y<_V56;G+-^3=CV3D_.2;;+D)WAK2@VE$F5BS7#7VWI6TI6%P;>#;<3
M@KV*U<N%*:-'5'YG,;Q*WU!/XQHX3-T;W=\W,KN)FE&K6Q@:8TDV3E;(>U3E
MZM;*ATW+T]S<[4P[/](S8<7^ZK;O\0LG#^2G/VTU1_I=9??F_D?_ &6VOWV;
M6]*SEI=G*9JNPVYGUG?5$(<("7'SVJ.-D>V()D2:7;.)2C1K+**58SNR(]R=
MS-.Z%9R=CMMM=\8UV9D9E!-Y1V7'GIR%+P8L*?BRC6RS8C8:PV2\K&1RI%BQ
M77U='<BJCD2B-]BBU5>T^8_.-;&<[)2T;>MJ3LV1FI/*&:LB'"LN'-0Y=TO
MLVRIQL1[9N:FXBQEB3\5KE;$:RXR&B,1R.<[6H<N-R@    'F0ZG/CCRSS=5
MK^SOP[(YE.HEK]U6^20#3N<CJE9_:*^41"@PW.:Y-:^CY[[]Y>;:#_2B2#KQ
MGM_#K [4G?GH!MS-K^"VIVQ+_-Q#?T:.-F
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M_/0#;F;7\%M3MB7^;B&_HT<;,
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MJQ8<O+W41*HJ*CJK145-?H?&H38
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MRJ=+%FRUA60YTW9Y 8B<RT=BJG2'GLFZ0T9JNFKD=LP73Q8)36N&[74]#P&
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M2#KQGM_#K [4G?GH!MS-K^"VIVQ+_-Q#?T:.-F
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MUS='_P 16O/TRMSUG2@=H\CNMBQ>TF?*>>LF9'W)\ANXK/*)@TZ')3:@
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M?S(<?/IYR:%U)O7F0FM=R<ZDWB%       BZ\%^S72MON>L/76'LW5=8"_6
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M%]9,N B:.^O.I-X%        "$&#QD;7\R''SZ><FA=2;UYD)K7<G.I-XA0
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MNF_;#]$#\?\ H^<]V 'YP    "D+#^<BM;Y$/'[U\<F0+J3>O,A=X"
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M I<E*Q6AB<6+<CV>$1-*>5'(1&24$7BC8T1]N0MQ Q).
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M(@           \.?^V2?C7IX?X?RK_:>.@'Z('X_]'SGN, _.
M
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MG_YXSV,X_P#VSCLX_P!X$          /#G_MDGXUZ>'^'\J_VGCH!^B!^/\
MT?.>XP#\X
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M ?G
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MLH<'82=[%84Y+RI([<?VA4;>O*U*TI[)JZ*[%/<*!^<
M
M                                                      #@"Y7&
M3I2L@Y4@9S)DW,#;*U\6T<4NT@1QEY<75H:9 I:<&Y7$,[DZL3TW(7$PG5*J
M6M+BF)-W.1GZ: <^
M#_&3"\&:E9WTP;OIN9H7G;7!FY96Q>IF^NG9[;;0O8XK7?;&,ZZ;&EXVSC.^
MO9 ^CO\ 0]PRJ[\2]ZX-R1E3WP3W#!^%'>F2<G=OW/!N%7_FV2^V[?OC_P C
MV.Z?T0!Q+S*XQ'7&*M+](&=F=)T_*(M"VYS<4J);*Y*EC,BF:E@CR90:6:[O
M">(Q&4R8YN0Z'JBV*.O3IL5A$VJSB@.P
M                                             ,U[MY@VI ^3BVL8
MW%6Y'4-<%\7M[8GCU!SY*5@[DK:TBKQL3EO26WH2\1-&C+8TR-F>(U5=YZGR
M=T5;SIOKN(L.TA>1DB)2N^G>2OIBG?.T060;/?4MO=+LPR)FPP<.:!:-53XW
ME(DC[C2[^2*CV6CQI:I1E>S[]W[WT5FZ)=\J2%!>2,8+QOL)J3>OF-  (
M'!2.2,T3;-7=_690M^[JP,FI^$ZI5G+G*'YMC#&F[DC)4'8[]>W=O1Y.R7@A
M-@_OE6:0E*./+ YT           <'&Y(S2UH(?8^KRN:U"AR2$J<IU27.Y[0
MYK&=PT[@L)3J->X.*!41VVQ6-#<%=U)V,)W+,W YP         '!IY(S*I*[
M1 A7G>0L;''9(Z(.]U6N$S-*U\H:V%7A7N3JB.RM70V1DY3IU!JI+['X,5DD
M%*T6ZD#G             &;W*;C/:EA6W/)W39[NPR2<=/?F10;=/UE@.Q+3
M#[@L-UH RDO8>.JY IVB><F1>9OSA(H/&4A&%#)JJDRXQX.C^JJ:^*B^;_$R
M1<,=J+HU8U]%*FZ\6I/BRD]B:\&E9/%@I[;R%/"/M>.QR@V<)Z">(&==N(5F
MR_:75%:*5C=4V-CY?I(SB$?W>^QN68HAWWHKAIQVX[473I71LU\1,+K6=FUN
MKZ)<9LZ?O3U,*_LQHK>PV'![&]Q][LB/=,SF8ADDX-E*UAS.'=XRX-KDWE*S
M)(2S.J-8<Z.#$:\&%+B!4QOTP2GBOMPTZC7(#
M    #@U$D9DLE:8@>KSI(7QCD4D:T'>ZK;"EFBB^+M;\KRKT)V1$Y1+IE'"<
M)U"@I4J]D,F)"3RDBW=,!S@
M     "+I32-/3B:1RQIC6,&D\\B.6S,;ESY&6ER?VCV"=37Y@[U<E24Q3_ZN
MOYY[_',&;F8C[\>>],W>+F<8JV KDP_G(K6^1#Q^]?')D"ZDWKS(7> @   0
M?R'][=-YTJ$]>];BII[R\RD71WTYT)P$*          0AQT]Z5E_2&Q?63+@
M(FCOKSJ3>!0        A!@\9&U_,AQ\^GG)H74F]>9":UW)SJ3>(4
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M#Q^]?')D"ZDWKS(7> @   0?R'][=-YTJ$]>];BII[R\RD71WTYT)P$*
M      0AQT]Z5E_2&Q?63+@(FCOKSJ3>!0        A!@\9&U_,AQ\^GG)H7
M4F]>9":UW)SJ3>(4        ,;.JURLM3C&;7SLSWBHXTU>7"Y?,%=AZ5_$Y
M8V61:,;G%7((]1DCET[BTNBU;L[["'V=R;.<(6>7S?+(<DATK9C(R\IW,9-2
MM<+RX)2NVN."HJXTXDUZ<+I<.;W=>13%=EC)'8R4U 9?<B9N.<ZVCQL=2SNG
MF^!UN:<_L^IS<UF/T=1VPKM*+1J6=[&%2=@CC<\)ESHE5$N2L14I3=CRKYJ8
M:M9<$"  4?Y8^_KTTOEL3;_3TYW@9-T/^"GRVEX ,0   ^-L9SCL8VSK[NN>
MSKVO9SC&V,YU_I:[8[&^,9UV]SML:YSVNVNW8VP!\@         A"U_R\XR^
M>]__ .F[D&*FA=WG0BZ4W^92;Q"@       !"#_XR-4>9#D']/.,HNI=Z<RD
MUIN7G0F\0H                                      >;A_ZGEJPFR^
M3$+DO(R#;7T?";J;*&X7;U]&6Z:Q.]H5?9T"H:KVIEW3GVM:2R[H!ABD[G,#
ME1\0<F"0JI_"4L?B3=A80,[N"+1:85=J5,:\24I0](X&  %(6'\Y%:WR(>/W
MKXY,@74F]>9"[P$   "#^0_O;IO.E0GKWK<5-/>7F4BZ.^G.A. A0
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M_P"'W5;%_)]J>#*?M1\]/5>9$I_W9RIU_BV3K6OY1-N.'O(_/*ZAXU=>\,Q
M#']WEK29&-9'F5Z(MXM)W2.9.T?,L,:RKU7>QN%F--F9+E-W?O?.3^Y=W,V#
M9=H0K5L^5M&"R)#A3<)(S&1;O"-:JJB(^XYS:X:G*G&=DLDLI)7*_)NR,I9*
M!,2LI;$JDW EYK@_7$)BO>Q&Q>!?$AWJL5?8/<E%3$L\/WG(@    #RW]1;Q
MR[D_Y>>JN$#LYF8ZUI[N]->068:6SC=6Y7N5 \KGBDXVX< -4>D7XP-D>9P_
MZ;1@: SW_?,F_@6I\J0-K9M/:6Q\*2YIH]"XT,;2       \]_*LZNV[G+'*
M4DM1=3:<5BTU5R(M9X2<?)_RW:VB5VQ9UG4'+<2B,26K+LA;F^P6%-\EE<0T
MC9;@7"*W=7@J+1V-MY6",D#-*TK['4F*-T)7:FOE4TFZ?Z$]OJJ?$I:?ONF8
M5FXY'O6;+R8LZVK,N*30K6*0<G,QDNUU6/:,VA)"^6%2IG9H6;)BF_1H8D<K
M3LS6HE:PG88KJT5IC1$1*U711$313$NP],K/)&=VCLB:6U^C[\VKV5\8WI E
M=&=Z9W1*:A<VEV;%Q1Z)Q;7%$>>C7H%A!R56E.-3J"C"C-],B&)3YP+CN*?A
MCTZ\9ET1DEB7L^7A9]8\>JPXA/B>#X1UK:%>T?7C]7MP,KU3$J8Z\ALT3,[V
MXLS:_;G6^YO=EIC&Q ].<@8!E7'374BK7:E5P\^KCH3;-H]:[7*NC09:!T:B
M<G:KETCUB53!&!A10)CLU/TVN:>7\^)K&_92<W,+"J3.4=8X^V+U,>):\D;I
M35.$Z91L":'TT7?_ 'M-6@,0 ,]>J8C5N/">RV]"OPV*5TJI9)HNV1)G'0C!
M]VU[IODQO68RD6E;:9VT,3*==B3==LZ[XSCW!\FW9A)6Q[2F5:]Z092+$N0X
MT66>ZZW0V/!5(L)VQ\-4<FHYQFULQ;9R]R4LM(L""L];$K+\+,R$I:DNR^J^
MRBV=/,?*3;$IC!F&.ANUI@>8?>H),9C&ID^9]]<;:;XUWJB";8QN5OJ:5OC&
MR7.,;%F::&:;?UZ;ZZ[ZYQMKC.-)?;<S^)6C_>:VOUQZ$?<5?^6LE_\ THR#
M_820:BKF2L=ST<ZFSA L*1WK29AJ5-7D29SU!>]J1$K<K1S;B-%J3M]3,XV,
M3[8WSIG;3/9UWVQG[63N4K)RVK.EDE)YBQH]R_$M^U9IC?8/6KI>/%="BIA[
M5Z*FO2B' <Z.:E]BYO\ *FU5M7)^,DC9KH_!2N;C(ZRIA](T%MV%:,A*0YR4
M=[+[[+O;$1*HBT53V@C=)Y^@    &)773))4<<*7+/**.+SR';,Y+-+T,TSG
M%46OV,]KOC;7LX_W9['N#@^<2+%@Y,S#X,2)">DS)HCX;W,<B+&2J7FJBT77
MCB:!]4M-34GFKM&/)S,Q*1TM:QFI&EHT2!%1KIM$<B1(3FO1')@Y$6BI@IYA
M?8IK_P#AJ#_Z-/\ ]V.O?V1M#^/3G]IC?7/-[[8\H?R[;/Z4GOUY>CIF(4*?
MGMQJ,(1I23,22=XP84G)+WQC--V3V<=MIIKMV,_[\=GW1SS-Q-S<;*1C(TU,
M16>LII;D2-$>VJ)#HMUSE2J:EI@=A/4R6Q:T[G0@0)RU+1FX*V':[E@S,[,Q
MX2N:R!=<L.+%>R\W4M*IJ/:..P!Z-@    &$/64_+?BW^BO(+][T(-T9E.K5
ML=RV>5PC7.<CJ;9_;R^3Q#'4=D#3IHOTIO'"/^3]9_T[I@:1SV=3;#[>FO)V
M&R\VOX9:G:T#YUYZ41UU-N@                                  $47
M@UM#G54P,?E]K-S/'D2.=+]Z/63=-:JXBNG5!/?8*'IJWT-G,@6R3>-ZQY7"
MXTF6N,\:G-?"]6]Q*?S4*@$_PQXSS:UI;S99U53*SDK7UM+5Y /MP<C3H9!8
MFX]1.J:1>%:#D79C+6L#.F"1E35!5D?8HLAC<6ENKB:D;*^5-3TTR1"D<V9S
M;BA_1:IA["E&XHC%U)5=%5/5"!_,SZY%<3[=M?D/1]WQ2T8,4T53/X([HX7.
M( \NQ\0CC43*<V$N@K^SSAJ2[2.P]W..HW?1XCFQG><88=4S\D1-JYJ?A:ZO
M3BKMIJ/M@L<*8NI;>ZLMWD3GM(N'- O)J=\>E;LD:=][OY(IO8Z/)U.VQ;,S
MZX3X.T;$F-4^JDU0?C';G;@-2;UYD-  ( !FSU6FS#SQ-5MFRYS;,*[.K0O*
MYF6F-SFG[5^[IVZ1:5C)B<S/:=IMMKC.<E[;Z?U;9'P,J8_K;)^TXZ0H$?@X
M#5X*9AI&@/K&AI2)#6B/3&M%UHBZC9F9NSTM3.9DE9[IRT)!)F?CL6<LN:?(
MS\"DA./O2TU#17P7K=NJYJ+5CG-7!RGG"]J,CX1+;^?KC_W0T-]L#OR/D_\
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M;8?;TUY.PV7FU_#+4[6@?.O/2B.NIMT
M      BRXTUV*X0K)X_/56,%D97-VR%QN.,2V70C1LU/[+L4K9H5+H2_&+C4
MO9U;CR7XI.0?_34IU)?]# J4KC6G%I\:*8O27J,7! [&<JPFO4 Z2R"9QR58
MA\GBR&I.23@\-DD(>DS X1@TUMY$.:%-)$CTI*8%+8<9NJ;G\W1I7I2U^-T@
M&=&TK=B<2X4^2;Z ?S  I"P_G(K6^1#Q^]?')D"ZDWKS(7> @ &=G5!\6#'G
M1K;]];CC.676S:_:[/GX1MS,/[KF1/=*8^C)XP*'6T]7#KTN_)23_H\]?NU2
M/IV+U9LGNG(>50CB67W6)EK\4LH_H></92.TIXZ     'U'_ -@=_=&?Y,@#
M^>@Q_B5G_P +;_V0D=2+8ZK6IW1G?*8IXV99]>&5GQEMWZ4FCE!\XXT>N;H_
M^(K7GZ96YZSI0.T>1W6Q8O:3/E//63,C[D^0W<5GE$P:=#DIM0     \M_46
M\<NY/^7GJKA [.9F.M:>[O37D%F&ELXW5N5[E0/*YXI.-N' #5'I%^,#9'F<
M/^FT8&@,]_WS)OX%J?*D#:V;3VEL?"DN::/0N-#&T@      ,H^H#O115A-+
M',#>0LAM2W^+-_TP@KWC93$BNB<DUQ()35#NMN$]*QL#PCAOM6SAKC),?<9*
MI2QZ3.TLW:%K3(34*;1K&3473A1%3%<$JE:)_@F),G3Q97M-5=E3&8.ET/=A
M6G=LAGUA.]VT(9QG>'"28A%>0M(=$Z?W5.&L>AI<4AL:3Z+BW1TVD4K(EC^L
M6[N+BL*)$=WL$U+7TQ+\ 0 "C_+'W]>FE\MB;?Z>G.\#)NA_P4^6TO !B
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M9U-L/MZ:\G8;+S:_AEJ=K0/G7GI1'74VZ
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M=>EWY*2?]'GK]VJ1].Q>K-D]TY#RJ$<2R^ZQ,M?BEE']#SA[*1VE/'0
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M]GC$>Z5Q:7$WV.5?=$X[[R/+SV3>X&BX?ZRFBF&Z^W4:\@8
M  $(6O\ EYQE\][_ /\ 3=R#%30N[SH1=*;_ #*3>(4      #"'K*?EOQ;_
M $5Y!?O>A!NC,IU:MCN6SRN$:YSD=3;/[>7R>(8ZCL@:=-%^E-XX1_R?K/\
MIW3 TCGLZFV'V]->3L-EYM?PRU.UH'SKSTHCKJ;=
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M U1Z1?C V1YG#_IM&!H#/?\ ?,F_@6I\J0-K9M/:6Q\*2YIH]"XT,;2
M  R@ZA=K6'QKM6B.0,4Y(\8Z;CF(C:%2R2O^5$[LEKBEGJ90XP64L[A H17K
M>X+W.?0H^'F&&RA.G7'-<3?'UF6-9B5Z(=6<9-1%JE%5<%14U;ZZL>6F.VX/
M$.UYE=]*M%G3":<=+"TD[HYJ(O+N+LHD<OJUUC";O=$5C1YE!)#CF2(7M.^-
MS\@QI@ML/2%(3]"7$A<G)$5*+0L\!  */\L??UZ:7RV)M_IZ<[P,FZ'_  4^
M6TO !B   '^=L;9Q_1SC7/;:Y[.=>VQVN-L9VQV.SK[NVO9UQMV?Z.<XV[&W
M8[7('^@         0A:_Y><9?/>__P#3=R#%30N[SH1=*;_,I-XA0      ,
M(>LI^6_%O]%>07[WH0;HS*=6K8[EL\KA&N<Y'4VS^WE\GB&.H[(&G31?I3>.
M$?\ )^L_Z=TP-(Y[.IMA]O37D[#9>;7\,M3M:!\Z\]*(ZZFW0
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MTO !B               0A:_Y><9?/>__P#3=R#%30N[SH1=*;_,I-XA0
M   ,(>LI^6_%O]%>07[WH0;HS*=6K8[EL\KA&N<Y'4VS^WE\GB&.H[(&G31?
MI3>.$?\ )^L_Z=TP-(Y[.IMA]O37D[#9>;7\,M3M:!\Z\]*(ZZFW0
M                           "$^1J&_'*D;$1<77NOX[?QS)IFLG>U$;D
MNK],_%."(XTN2D-"5<XX1K&LMP0D*4Z!=WDN4I5IJ)80G,3&BI2J5K3733WJ
MF#22=<FX9:,8D7-?D35'$2Y,N+9'F>TKFZ:U=.];2%0I,T1)6:"\RX;R.D=?
MMFKL4;JB9&6P)'6<Z4ZJ,EX@96Y1Z?09T;J15W.2N^EROII/2B!_, "D+#^<
MBM;Y$/'[U\<F0+J3>O,A=X"  41ZB\,E\ZXX',\)B\@E[RGL& NN[-&&A<^.
M^S>@>.W6JB6QM)4KE):73?4P_O<@W8LKMC=M<%Z;[8^'E+)3-H6':,E*0^%F
M9B"UD*&KX<.\Y(L-RI?BN9#;[%JK5SD3"E:T-B9IK>LK)C.)DM;UN32R5E6=
M/1HT[-) F9G@8;Y&:@M=P$I!CS,2L2(QM(4%[DK54HBJF$SO4%RL*/5P>:6N
M5M1;+FIMU5*ZHGY1.5[XZ(V1H28WS'NQW=Q=G!$WI=/ZS52HDO'N[X&D_M"R
MK_)C?[?9O[6>@G^D?F9_/!W]W<JOW&?X?^//(-S8GIM1T)=9BMP:7%"E+,JJ
M=)]-U*M&<01IN>H8BDY&FQIFN-CCS2R2\9SN:9IIKMMC]UEY$932]IV=,1K.
M:R# GI2-%?Z^L]UR'"F(;WNNLFG.==:U5HUJN6E$15HAQW*_U0&:2U,D\J+,
MD<JW1YVT<G;:D).#]@,IH7#34W9LS+R\+A(UC0X4/A(T1C+\6(R&RMY[VM15
M3UE#?1YL@       !"''3WI67](;%]9,N B:.^O.I-X%        "$&#QD;7
M\R''SZ><FA=2;UYD)K7<G.I-XA0        Q[ZCDFQ0MY<=>3Z"ZN'=3/K5
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M:41$I1*8TKK75O-,P,0 */\ +'W]>FE\MB;?Z>G.\#)NA_P4^6TO !B
M          0A:_Y><9?/>_\ _3=R#%30N[SH1=*;_,I-XA0        A!_\
M&1JCS(<@_IYQE%U+O3F4FM-R\Z$WB%
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MD[3=MX_\QLXO\CMX         (0?_&1JCS(<@_IYQE%U+O3F4FM-R\Z$WB%
M                                         C:1W)4D/FL8K>66= 8U
M8,UP3M$80_2YA:97)<*5)Z))EC8%RXAS<L+5J54B0]Z)C>_5J52D2=V4$&EZ
M!0K4P_G(K6^1#Q^]?')D"ZDWKS(7> @                $(<=/>E9?TAL7
MUDRX")H[Z\ZDW@4        (08/&1M?S(<?/IYR:%U)O7F0FM=R<ZDWB%
M            */\ +'W]>FE\MB;?Z>G.\#)NA_P4^6TO !B   'QG77;'8VQ
MC;'9UV[&<8SCMM=L;:Y[&?\ ?KMC&VN?Z\;8QG'NXP /D         'QG77.
M=<YQC.=<]MKG.,9SKMVN=>SKG/\ 5GM=MM>SCW>UVSC^K.0!\@         A
M!_\ &1JCS(<@_IYQE%U+O3F4FM-R\Z$WB%
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M"@_SL8?X\ /;.K;X0H/\[&'^/ #VSJV^$*#_ #L8?X\ /;.K;X0H/\[&'^/
M'#'RVG5,A:Y6?-8*9(&5F?H\V..9BT8W2L\G71QR?46I&KKA*9JO6Q*.G[FG
M$&*"<MNFB8TDL]5H>!S/MG5M\(4'^=C#_'@![9U;?"%!_G8P_P > 'MG5M\(
M4'^=C#_'@#]C?/8,[+"&YJF<3<W!3MMJF0M\B9UBQ1MKIL9MJ0F3+##C=M2]
M-S-L%Z;9QIIMMG^CKG. .V
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MWZ:?Q?O##T9J;^QP$OO[)WA+TCP6_33^+]X8>C-3?V. 7W]D[PEZ3NE=]/\
MX*U%,V*QJJX;<7:VL"+GJ%4;F\$HBL8I+&!2K1*6U4H9I"QQE"ZMARAN6K$)
MYJ-43N:D5*$^^VQ)QFFP*YRX*YRIL554MV!B
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MR9-4(-7,[(B?6J%QYQD+C (<J6%,C6VR9ZKR/QXV9>Q"54]J'/L%[@0F,
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MX<#&B>XBRV4,I#H<@:WY,27VF!.+T]/$6
M                      5,Y73.:LT)DD.;*_O,V(3ZOYA''2]./6K?*+#H
MU_=VU0V,TO15FVNB2T)/LS[JM7IN45;'Y]("G5$E3*(B8W&JEZ<5.]JTZ%QV
MZ.6B4KCMHQ1O%"(<NH97%Y3;&&:(3>MU$<FE;F0-K;95 9G&S'FJK9JFHYK/
M(:JG<%XOV"HS/CDD3C14$ET:PH*>:LE\1C%D3"+FBK@JXZZISUP6E=&WE0V7
M++T*TT**TU+++TU+++TUQKIIIIC&NFFFNN,:ZZZZXQKKKC&,8QC&,8[ &)_L
M      =%LF22V(PYTD,'KITM>1-VR$Q- V.01>,/;ZDW7IBG31F=IHYLD5T=
MDK9NK6MJ-]?&)M<UJ<AN5/;.4JV<4P)OIQ_Y&/##7GWWUD\@*T=2[*CZR*SJ
M'6G]S/)&GWA0RR"HKF6JC)13$]CUA,;E#)K+J-LF!SN5<=;/BZN:Q"!1R3P2
M'QMPF]5'VE!Y0,M%.3!=::T5-J4KMQT+136VFZ?BE(0LJ%1,QQ6DF.;D_O;Z
M]>Q6'N2R-Y.P<YOCJ4P-3!'D1IV"TZ-"SQI@8(O'69$V1V+L+)'FIL:D@Q5:
MDJ        ,?+VL693V]Z$B-AP+DQQ]5RQXF=,*%#(BVE42CTFDZ'$AJ3DG4
M5OU\7-JZ;Y)&I%$558O\/L<J(O\ +ZRN>9M]CUK(*M99&D4#+4NA:47S4VZ]
M6C46WXK\.XAQS))?]B(L9/-H\KC&2J_AD7KBL(JV.2QD628BMX+&65N4L:.>
M.44BTBDV9F_V)+2E;,R1LN<KXM%8XC2"*M?3'E]$XBY@$
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M9?("
M
F                                               !_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g472601g11c10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g11c10.jpg
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MTM7D"A<B-#A!='5XM]8C)#(W87>X-D)DM41Q=O_$ !L! 0 " P$!
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M8S$Q#Y0EDVD'M22:==);37$\L;6]G';26L<1,DCP(R1O%,5:%5D\5GX@RI#
M!L@C?D<[1#B^.X9Q^$JWE*6<)#]F_,.)TC[.'2KY8K$IMRP.+R##'E2K+$V^
M:?3]DE10/;+B=O"J5Q 2@+$?!BUD5T\IU'TF^;46DZ-&9&UB.^35^-'OCL$V
M$V.S/2#A%, B"]'96W,PP<V%U"V%FJ<9Q&-.>T;3N$VQ[IMV+K?C@C+D3%RW
M&5E*J.=9;:W:[UK($>3X4)?5CD(<U@'94%.)T:;"9RP91*X.,L@HLK?LE@[)
MXP8M(!,F;:-3UJI,EMP;J9M6H\<S,%&*81%+"WT&9#9,UK"LAEUQ;]RT1+V]
MZMTMJDI!)EC)>(\,;Q&2254EZSFU6-NE*+B0ILTLVB@. DUL8#.T8( C<;9/
M'\4O@ ,1MJGYL=JO6Y2(\K0M)\H)M<F>17:.,;C/C&06V(-O,N$)ZC'45/<?
MCQF<@ KMI%!KA,%69B&)[Z"W[$,S<B&3Z,LVSC+3=#F62P>YLHK;HFD&W5BT
M$O#U);D.EVBQ,P,C#=.LA\92Q#$.347NJ1E+L0W+S&XU$3$ 3)OLF@*-;LSJ
MI" [8F3F"%! *BMOV%VI?$9];$)FA_D_,^0L$+]I5Q#Y14K CU-SF+H=G-QZ
MIZ6.BUCP(&B1'K#G#Y_%7@""(06C<2*'&!\'\[%R&9&3T8KZ(=%OE@EB2RCM
M)5T74+&YE2XB<ZO=W$86&5\$' D#2\6ZV2*9>'C8N1NDU.U,J.UT]Q&=2M+J
M%&AD0:=;PONDC7((.4*QB.#<A$6_DS;:_E_O23AIM=MQ3...=WD>EUIV%)P3
MQ1NNT4=AC\M+E1;G=JZ32<MMUV+M!79NY2271VVRFLGHIKMKCVELC1V]O&XP
M\<,2,,@X98U5AD<C@@\QRKS4[!YYG7FKRR,IZLAG)'+LY&M6=;JU5W1_D_']
MLNR_],DR_P!U*8Z\W\*/Y?#]<C_)N*[>@_QDGU9_S8:YC<R/[7G*G_4A>/\
MN=*.NQIW\OL?J=M^2E5+O^*N?K$WYC5&_JY5>G2E.E*=*4Z4ITI3I2G2E.E*
M=*4Z4ITI3I2G2E.E*DC=?_DUP_\ _:"PO_DC=/5.W_B+_P"L1?[.VJ;CYMM_
MX#_N+BHS=7*K55MG[YFFZ29O7;1)\AEL]3;.5D$WC;.>_+=UHEOKJX0SG'?E
M)7&Z><^WG7OZC ."0"0<CT'O'<:9_'K]-4G4TJ>M%\(SEV\?@UEA'KMS8UR\
MQ:KX6<;H2D\%"@\KLB5@MY/.B\O-%],(BPD89'JQ",/8'#;V8K8&"3]V@. .
M&[_EW.HK;W;0L (;?3Y]2O)"&9DAC;9&L:K\YG*S,<CYL6U0688O0V9FMUD4
MYDFO(K*W3( >1UW.7)ZE7=$HYCG)DG"FLID_9:<F(2;K45,I'QKBHRSSUI0P
M9.C?**CF=:1BQ*8;LG5BUG8-A>>>\4A-@ DB@O76-&R;=T1<D$6 [9T_2>-F
MN$>MV<JS&-+QV@2"0Q+8W1F>&X)$,T,/"XDD3%6\=5PH!+8!!.3:9<H8A(UL
M@E:5 [74 C22$ R122;]B2+N VDY).!D@XRZHNRSL*;\GJYHN47+QZ4@Q83B
M?VY<U+7A6M]0RGJK&R,='#!>2E:UD!X<RF)@P4$16O84^<-RLQFDFBP9DEA,
MKXREKN-;ABLIKI+>[XBMPH+>XMIK62XG*EU5!.B$QJH:2:4 K'$CL3E<'.'3
M))+F. S6Y0CB330SQSQPQ!@K%FB+ .20L:'!>1D4?.S4WZ3[%:J+6/\ -@,Z
MN&W$&7&KF#R.XQ,Y%&8="3 .K(?1\2F<M!WWR*W*R0"25ADVVBKJ,H"*W&."
MS8N'..,;;>S!QCKFW/PCG@336%O 3>:?:7I1Y)%:>2Y>)&M+/:C@21[]Y:8[
M2K(.QC5Z'1HI6O5XTH%M>7%J&5$*Q) KLMQ<DLIV/M*@1C(93UY KD+R#XZB
MZKJ7B5=\/-%#D#Y/5$<DF,&]&B9*,VG6$^D%86]#LY9HMTG(EJ;"BI9&'6Z6
MKK$6F@5@^4>/V#HB\[]I=M//?VTBJLME<*GBYP\$\2S6\G/J8JS1N.KB1L1@
M$ <B>W$45K.A)2YB9O&QE98I&BE3EV9 =>W9(H.2"3$[J]56G2E.E*DHC_8^
M(?ZE _\ M><ZIG^8+]3;\Y*L_P#1GZR/RC4:^KE5J=*5+'C?QV%6[ .5=NS,
MT5C]=\8**5L$DX"Z--R,@L6;S.,U/2\*2W>(NDFS,W8,S8&)&YPU45UAT9DC
M=DLR)N6#UO1N[LP2V,$:JTM[<\(!LX6&*-Y[B3EUE8HRJ#('$="<J"#:M[<2
MQW4SDK';0<0E<9:1W6*%.?8TC@MRSL5@,$@C?-B]D]RYJH&1D$X1I00RC<PI
M*)6 A]$#4;DE4Z/(K1CM4$SMP8WE2CZM8%+LO],H2B7(BVK1H@N8?)MP7L!1
M>K#KEA.RI$;AB\=R\)Z)< 7!M,](CMR8\32QXYQQ[B20HR^5&^32[N)2S\%0
MK0+)_P 1#F(7&."\PWYBC?(\=\ #QCXO.K'(.S-O@7*:KA$7L3BG<4PN"PQE
M;Q6,4-RJI.Z3S(F0'%"[B12P37<L//HG 0(H,0)2B<FT&D<CK)#+DJ^;)9QM
MG--8MFCGE>&^@CMX6FD>ZL;JV4J"%"(TT:"25V8*D2DNY.%!-8MITP:)$EM)
MGFD$:I;W4$[ D$[G$;L4C4 EG;"J.LBNB1/L<^/\3N.W@Q"^+DMJFJBH_A)8
M")GCY6H28V9:1SF8X%BPTJ@\6,$A+9G4T5<.EC[UT0\>D"@HE& N<ZE2^7J7
M(7X074EO;L+6WM[FXN=2BVW<S1PP)IV2R2NJL3<.!M &U-P=OFK@]$Z1;I-,
M#/--##!92!K>-7DE:\P%=%8J!$I.XYRV"HZSD0BY@=G.KQ;@U]DT)N[F$LXN
M\TR_%6VD<,&[,._C,O@[B>4!:0!HGE9\&TF(^(V*-EH$D_+IA"K*-HL"SK!!
MSJGTK#5Q>RVHX8CCO=-6^@R<L'CE$5U QY!^$9(2C*JEE+DJ M4KO3^BI.=Y
M=[:]-K+R 4J\?$@E4<RN\)('4E@I"@-SKEYUVJYE.E*[H_R?C^V79?\ IDF7
M^ZE,=>;^%'\OA^N1_DW%=O0?XR3ZL_YL-<QN9']KSE3_ *D+Q_W.E'78T[^7
MV/U.V_)2JEW_ !5S]8F_,:HW]7*KTZ4ITI3I2G2E.E*=*4Z4ITI3I2G2E.E*
M=*4Z4ITI4D;K_P#)KA__ .T%A?\ R1NGJG;_ ,1?_6(O]G;5-Q\VV_\  ?\
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MMZ+B8*K!8XX481J">7C-,^ I8JL0W'+5RRZ[=<RG2E=T?Y/Q_;+LO_3),O\
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M:1FRU8F.V@0E-.F925B1258<F4D9!'(C!JU<:3*]Q.XNM/ >:5@&NT# ,[$
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MELP&6HWD<J*,P&?QF;R/ASS3'W)&6#(_3(6,L(2Q>+4ZP1-EX,6T"2^RY'!
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MI(>DMO5.E*>$*^TD/26WJG2E/"%?:2'I+;U3I2K._ P\H4!&R 7=V7C*[YR
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1QOW]W@=W=W?W]_?[7MJ5_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g472601g12h51.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g12h51.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[1K*4&AO=&]S:&]P(#,N,  X0DE-! 0
M     !<< 5H  QLE1QP!6@ #&R5'' (   (    X0DE-!"4      !#'71?E
M=+5N]=N^.93 Z7E<.$))300Z      #W    $     $       MP<FEN=$]U
M='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4
M0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%
M6%0    * $@ 4  M $8 4 !' "T -  P       /<')I;G10<F]O9E-E='5P
M3V)J8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U
M<     $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU9
M2P X0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N
M<P   !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
M    0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T
M=F)O;VP      $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,
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M;W @56YT1B-2;'0               !38VP@56YT1B-0<F- 60
M !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M          QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT
M;&]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #
MP     $  @/      0 ".$))300F       .             #^    X0DE-
M! T       0   !X.$))3009       $    'CA"24T#\P      "0
M     0 X0DE-! H       $  #A"24TG$       "@ !          $X0DE-
M _4      $@ +V9F  $ ;&9F  8       $ +V9F  $ H9F:  8       $
M,@    $ 6@    8       $ -0    $ +0    8       $X0DE- _@
M '   /____________________________\#Z     #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z   .$))300(       0     0   D
M  )      #A"24T$'@      !      X0DE-!!H      S4    &
M      /4   %;P         !                          $
M    !6\   /4                      $
M$     $       !N=6QL     @    9B;W5N9'-/8FIC     0       %)C
M=#$    $     %1O<"!L;VYG          !,969T;&]N9P          0G1O
M;6QO;F<   /4     %)G:'1L;VYG   %;P    9S;&EC97-6;$QS     4]B
M:F,    !       %<VQI8V4    2    !W-L:6-E241L;VYG          =G
M<F]U<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X
M   -875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E
M $EM9R     &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @
M;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   #U     !2
M9VAT;&]N9P  !6\    #=7)L5$585     $       !N=6QL5$585     $
M      !-<V=E5$585     $       9A;'1486=415A4     0      #F-E
M;&Q497AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0      "6AO
M<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )
M=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=
M  MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N
M90    ET;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N9P
M   ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L;VYG
M   X0DE-!"@       P    "/_         X0DE-!!$       $! #A"24T$
M%       !    "8X0DE-! P     $'P    !    H    '$   '@  #3X
M$&  &  !_]C_[0 ,061O8F5?0TT  O_N  Y!9&]B90!D@     '_VP"$  P(
M" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,$0P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4% X.#@X4$0P,# P,
M$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,#/_  !$( '$
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MHO\ H%$[%B&Z-)!R\O&PL:S+RK!512-UEAD@#C\V7(.%U?IG4+;*<+(9?;2
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MC[D%-+ZM^L,_K;2R*/MKG5V2-7%K1=7L^E[-K7^I^?ZO_!K=<YK1N<0 .2=
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M(G;](+Y:22"B_P#_V3A"24T$(0      50    $!    #P!! &0 ;P!B &4
M( !0 &@ ;P!T &\ <P!H &\ <    !, 00!D &\ 8@!E "  4 !H &\ = !O
M ', : !O '  ( !# %, -@    $ .$))300B      $N34T *@    @ !P$2
M  ,    !  $   $:  4    !    8@$;  4    !    :@$H  ,    !  (
M  $Q  (    >    <@$R  (    4    D(=I  0    !    I    -  +<;
M   G$  MQL   "<0061O8F4@4&AO=&]S:&]P($-3-B H5VEN9&]W<RD ,C Q
M.#HP-CHP,R Q,#HR-3HP-    Z !  ,    !__\  * "  0    !   %;Z #
M  0    !   #U          & 0,  P    $ !@   1H !0    $   $> 1L
M!0    $   $F 2@  P    $  @   @$ !     $   $N @( !     $
M         $@    !    2     $X0DE- _T       @          /_A 3!-
M30 J    "  ' 1(  P    $      1H !0    $   !B 1L !0    $   !J
M 2@  P    $  @   3$  @   !X   !R 3(  @   !0   "0AVD !     $
M  "D    T    \     !   #P     %!9&]B92!0:&]T;W-H;W @0U,V("A7
M:6YD;W=S*0 R,#$X.C V.C S(#$P.C(U.C T   #H $  P    '__P  H (
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M</,8.TU-HBH:"F$HEL4[>P,36<Z?KET1'.WCF42Z8(=/(A/#]).E^'T.US*
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M%/?,K=Q4&ZHV'BJGB4+"T<;D/W,CBH1\AX$O/YT(*$\:BG=]"]&8G!Z1I-K
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M'C.Y.X\[8Y[<_P .]BCGG>A*0H=F_<3R[<,3GLYA(?1QUWR-^@Y,3G\T[],
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M(;1':2=RVHW%MYA7<WE40YBI<\N34,PJN7042X6%NG[F0OWCF3*>N^$>;$1
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MO!P+YZA/" _1!0_$"#P MRQZ(MZX.&*#*<']F6DEU_K%P$"Q L9MQ7T7@?\
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M>>!0.8\#RY]??^#%'.:,<\ \ML\\YZ>IBG;O]/-.R>U/+'9R\?=R#$WYQO\
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MMW:1KN&6JT.F>X'Y'BGT_P!H_P#V3@?$?^Y-_*S7624BT^G_ "#UN/4GC_\
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M7/1%'536,;:JP(@*8I^:SZ*\S7E21[T.)7!/HQXI,(B A7C])#KA*!$N220
M]1GB&?H[0717'8REAVXZJ6U&NCWR"2,I@6$[;#>L#26G?:'H_ U,8_1> #:;
MFZVM$!I(F^O?/N\UU?9RLYE<6U5O*^F\/ P<QK.CY!4L7!RY#]$%"OIM!.HA
MZXAA$OXF(\T[>+6E'G7RUA(&5*.YXW3>#I:.TGB,%0.M3ID%CB23JDV$[8 S
MV]B[_0&.Q6D=&87%XQK&5ZU,/>VE&HW6 (@@F=H,?ILC)5RY#;F1\/=GV-JU
MNTS.X.>+'JY<N;%/.?.SP2)QG?L/S[&)%P-_QR.7-\EL.7_J4+^Y1\&Z_"?=
MZ7X&_P!(7.8C[>M_,?ZE774'BVQRS\[=_P BKC%IY$JRN!-6VH:(I1U$VVI"
M(X9_'PH$^F;M:B)/ Q(4E,*A3M22F/C'>=N)"W#E8)PI2&\?]I?3*IH^E_9.
M"+A5J_;/IN+7!MY;K-(,"+C:5ZE[/NB5'2CSI/&%KJ-%T4Z3QK-<\"SBTRW,
MVMLG8HP ./CSZ04KC.<JRLY/%E84H*P<+4,*4?24K.[> &M4JO-2JV7/)>2<
MY.9D[^S.1<2O<J= 4J HM,4Z8U&M$@:HCW0T0(S@;$P.DI\X4NW: \67BPE"
M1YQX4!!>/0!AX\*$)1QO.)8X1A70U57NJP'N=4:WZH>20WL#K#B;*BC%)NHV
M&M,EP;8$DS<6!O<]O!/"3V!(&R?ZP Y=V.> >66H))B3D(O)M)/Q51@#5[R(
M]TDBY].W="=PJWPDD =%8QN>_?//W=&D-:0)C=D-W$3M\<E9<XB .[.W=E?Y
MJGZ6<9)\#\_AU:O49_"/#LV\^JH#C:3:4HXOZW3;.^^,_/NZM#F@"S0#P %N
M[N^-UF0-22,H!V<)G;D><D6%>;.3D]<=1\]!MU:WS^BMDMO V#U5L"<C!WSM
MOU9 .<'9?=ZPJ56 7P\2N6^5%70>'L#4.HDW!<-P$^)S\?DJ7$0;WC?OY\.U
M=KZ&:=^LKFSZ>O$\;FFZ:(1D'A^F3B*2X<J0?T<B%AXOF3GB2=\$I];]D6CZ
MITWI#&/'[##X,%K3]5M1Q !#38.@SK""8L=_F?M/QXI:.PF":8.*<'/ )NQL
MDSWM&>_(*6IOHA>&H8B&(F_UOG'HAIW<[<MG)SW%$5;89\M7J2'_ -1^SW_.
M#%GW<O$<NVAOVSC_ /39':(V2,^'?97W?=Z?XW?%2[M<=]8\[%80U*(8B&(A
MB(8B&(AB(8B0\CX'X-4/JN[O5%@$ZVFR<\BY'9R!WVY]>GPY\CI/_$>YG<8M
M;?Q&4KH-&_=GG:#;OB/(;U9D)"E8.,<L;=/ ?BUN9)WS?P^7=N60)S/?R#\4
MH5@#.2<9]K$323@85R'V]?AU]^Y%4W'I >E@[C8XQOCV>QJG-ANN "Z!>(,'
M9V96VPH(&T#O4%_E/O)QU=>BIOSB+"0#F.N"[E[J#KBC';WS,15+B6H0B!G<
MD"N!"YS#PCL045#%X@QCI#M;L%\D\?I71#I1A\ QN&Q4%GO"'$>Z=1T%H.5S
M#@+7.];? X_J&.I5*CF@TJC&.),,UZ;V-@S[A!=((#1$#8 O.W<9Q=>B(:6R
MJLJ*JNE8NG:ND,:J&F\EF<&B%C$S/Z(EVMY$.R$O'Z8@.DE#Q"GG%PI2=@K:
M=-,;HNO2T)CAB&A[<=ACK:T'JQ5:32)!O3-Y826D$M(@KVKV98K!OQ_2#"/+
M2W':%I8;5=JEKG!M1M4%ID'7D:XCW[ZPR7=.EWR>5_-4U9RN95Y34^MK:)S'
M.G]35+44#$RV:S*".'C^5TS!1GG'L7%Q2$_14/U_T>&=/EOU/"M*7:MIIGI;
M0H8.I3P[X#,+3ZO4) :XLN&@&&ZV4-SGBO*,?BJ="K4HLAQ?3Q&M3$>\[K7-
M!<. ,AQ'NMMG 7KII:EY'1U-4_2--2]U+*>IF42^126 = !W"2R5PSN$A7(
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M1RX>_I][0DG>?%+PCEPC'@/OZ_Q9;<.>R%"T?J6=)5I]O65)'"+6UOG8;?W
MC@!MO@['T?CRW?1IH.G,&=49N%HW3M,]JY;IG/\ JQIB_P#\/K <1 U@=A&6
MRTPJ&EY&--=B,?\ >HHO)Z;2>&ST[ASWWZ9WCI(/]M8@[FLOM(@@>N2IZ%Q_
MJYHH_O.PK"3M)O,[RMYI..WU=O;AM+OYE=6D5D'!.?;]K%.?#D6&9\3X([?#
MM\&*6QK \<NW+G\EL.7_ *C"_N4?!NOPGW>E^!O](7-XC[>M_,?ZE77"GLY>
M+528C8597!.IG2?,J[%15S:^*ECFX47"%\)/4#Z(<4_/9BXX$N'D9%0J7\1!
M//,NT(>/'4.^\YYM.78));S#I5[/F:4J5=)8?$NJ8D%]1].H!!:YQ?JM(,0T
M$-%I/:N]Z,=,7:(HC 5FZF'?4^T9<CBX&9](,9W,15/(NO*9O4E+W5I612&;
M4]&.H9U'4Y,7T;*IDKA(BG0AX^'@IM OX1[A*DQ<*AV_0L/G"RG8^':5P(PE
M<42UM,M$5*=[.!@CWKY1,G;V!>YZ+TDW'8?K*3S4I'5=3J$#WV$6=8 "(O\
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M,S-P+@7*V6?*_P!G75"67N"^M)=Z*E=Z*9UY53*)3(8&13^I9=!Z!7TY=5_
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MYTO6INHNI.;5>(I-AI @#.\WWR9)M9?1O0/"4FZ*%1E5U9SZ;7/%1TAKH_=
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M.Z\@%L_HYB($1+G+T< B ]&%B)4]*7RED''&E>7:CG'Z7%DDMYCB?V6(K @
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MKL)C6 W;)C*5P-&Z$:T=OE_5U54\_<#B\V8MU'.%K&<Y6'+IZ$J)SDI)!V.
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M%EDR?'NNFY '('/,;[8\<L41*=P\SR.<C'P+$\TSFK!(Z\ML>YB;.82XWR"
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M5#.0=^8P<<\_<U0!DSMOEY3E;SNI<00(-]G/SCOR3^2<<B>F#D]V?G[&J5I
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MN.Y719A(XF_Z?#RNHR_*0)1(XO1?<CB$/^0>L>VOTF(0GB4Y@JEAYK3L0#@
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MQZ*)\M3BFXJ*F5\=.\1$+6EV\M]4D>]_*BCH4E2W+QY251K?/0Z0OB3!QA]
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MSEXZ>!3P)6I*Q^D04XP,7'/8?JEV\@F=F49W\=G;@-J/>2=5D9"&W@\/XAR
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M+*2KEG.<$K!"D'/"-U)41G!![]\;-ANDS$@S\S<@[9"M$DY2+]GB9VR(3'G
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MAW"N7KP5BK6?J-/4ZH_^BWWMPN[SX%5UFFH!JZHD7+6W8"1>YD;H.<VE<7Z
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M8F9QKF+C_J]:HE;MTIT5\+PMPN#TNSI7C788$4J+-9SFF X.%RTQ D7![YF
MOH[37LP'L+T$[3AJT](Z>TAAQ2P]0PZF65&R:E-I;!FV>8@#5)*E9L?6%0Z9
MZZI#31<6-,[M/5JU2?3E<Z-<N(2*D\5"0ZWSJRE</W:74*_FL/ PKUY1\Z2
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MT-:&ZCH:UI)(@Q>29VW6 :LO)=TIJSKS4K6]3W*CJ:C+WZ?+(VHH.,DM.?\
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MVW,ABR!U[OG9N@Z)7Z0X,S( ?).R01>YX>*Y?IA)Z-:7$DS0U?\ Q0ZW$P1
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M#.D+B(N(X5%"4)0$E3Q(/5]$]!U.DFE*="B']4RHP57-#BS5+AK21:S=A(O
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M84[1,D(3E" 6Y;%,@V$@Y[IR, ;38F9N3:RSB^K3<6:C1D1;]Q\D=D7 $0
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MSDGAVY[DC&Q)&[>-N/15S3#M4$".%NWT';P^EQ4Z;Z[0VF6N  +9@6 R$29
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M$,5)S/:4=!XGX!B'9V?$I3_ZRA\&(/@?0JJ>1\#\&*%1',>(^+%5L_\ #_\
MDE_9_P#Q?8Q!L_"3_4A7[/\ HABI0GK_ *)8I/P'H#ZW2]G@?^(&(<SVE/3^
MU_I%BA,_K^(^+%.P=I^":.1\/M#2,CV?$*%L.7_J4+^Y1\&Z["?=Z7X&_P!(
,7.XC[>M_,?ZE?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g472601g14p33.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g14p33.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L
M0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@ \0$_ P$1  (1 0,1 ?_$ !\
M 0 !!0 # 0$            *!08'" D#! L! O_$ %00   & @$ !08'"P@&
M"@,   (#! 4&!P !" D1$A-6"A05%A>6(3$U.+?4UB(Y='9W>)6TMM77&2-1
M87&FN-,8&D%7@;$D)C(S-E58=9>U)9&4_\0 '0$!  ,  P$! 0
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MI&O98ID<*@#71=_0]5(6-EN2)SZ"2)=ZS3:+-&V=R@LM-VE=E+@0TA]'C<4
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M=YM^N^]R0/@X# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M, 8 P!@# & >,PXDG6MG&EE:%OJULP80:WO^C6Q;UU[_ +, _G2@C>M;T>3O
M6]=>MZ,!O6];^+>M]KX=;P#R!& ?7V!A'U?'V1:%U=?Q=?5O?5@']8 P!@#
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MR-?<7_D$FK_-[YEW+S\U^_OHHEF 5?B#\TSB]^;M2?T:QG -B< 8 P!@# &
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MULJN , 8 P!@# & , 8 P!@%FSOY$0_CE77T@QC)6_S/L9#W>==J+RR"1@#
M& , 8 P!@&EW21 [SH[N>Q?7U=OA=RD!U]77U=JCIUKKZNO77U=?7U=>NO\
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M7_)I>VI)OV9H7(U?YO?,NY>?FOW]]%$LP"K\0?FF<7OS=J3^C6,X!L3@# &
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MB, $7W00CV(.A?#K77E_V!;=9B%V_@TKZUE6VI25/2V5ORT?T""!FH%)& ,
MFD^1^QR/2!RZ033\Q,SWI(AXN;2Z=VM"Y:3;//Y"]]M/I80=W/?=T5WO=]GO
M.Z+[?7V ]6=<H+M+PFWZ==]&C+=LHKQ5]_T:7MJ25A(.3'"^*#D^I,@:V,F+
MN[ZP&+%U*R32.1/<7LDVH9(V0E01##PS10Q6.%/%704<]()TJ]>A&,[S4T:@
MK-;O5\67+FK1:]'E/9C]LUQ(;398 70+.T-+K+@5BK=WMOB),E9[0]AX>0RM
MC61)K;G=N.BS/7A[:W/DQ23([:&PG9##R&%:4%<]HEWJ^+'-AMN7!>E_%IF8
MR>>4-:M45M69(>,*>5M,.A(+"KY%%4\$/?;&B:F<3BO&=Z<4K\BCK1"4,J>H
M.J?(:';[)W&2PQS;EB)M#,MGP,I=ZOBQS5HEY5EV<3?CV<5[X#AGNNQ_4<7>
MKXLBRT7!#V<5YX#AGNNQ_4<7>KXL66BX(>SBO/ <,]UV/ZCB[U?%BRT7!%>:
M6)D8234[$S-3*G.,[XXAI;TC<2:=V0@[TTI&22 PSL!"#O!!V+LA"'KZM:UD
M7OO)M;<57 & , 8 P!@# (UO2Y74R41S2JJ0HG2\H-,9=Q^2QLUPJCD0\4H[
M7FDCBCD78$%IVN(LUTK8Z.T+ 03>.#BZHI[D38../G("HVID8CR)W)7UI'.%
M7A>BZMV;S6_AEXK$E'6^O6M]6]=>NOJW\>OZM]77KKU_5O>#@?N , LV=_(B
M'\<JZ^D&,9*W^9]C(>[SKM1>602, XJ>42_><.97X%1O^)>F<LFR/\H</_Q?
MV&I.GQ_XIJ_[C[3)/EE9MAFXP!@$@?R8W[[94_Y,+N^CYSRJ[9_$-1\]3?70
MG>;._&DKYN=]6SZ;.8R:(>@Z_);E^ +/U<S .>W1#_>O>!/YK-/_ +(MV#E'
M[N+Y47:SHQ@XC & , 8 P"'WY8!\W+AY^6R>?L*FR_[ ?#,0_9I7UI5=JO@]
M)\]'] @1YJ)21@# )L7D<WRETA?X#Q7_ %CD1F=<H/O>$_+KOHT9;ME/=U_R
M:7MJ27Q3G&6LZ:;74ML2.4GD$H1NR>:268/3W)#9"=)9-(9M+]I&1]='1@B;
M5+)E+)%)7Z.Q%N9F1T='+:IR1K5"=.>7FA<VV^XHC]3O&ZBVZ;7J=&!U^TP&
M(K9@_KHB\SEI9(M%:^9(BZ/!T7@<2=R6-D)41NI8@UR9KAT<1FSJ.QI+$Y(D
MD#,K5M*P0>Q6%,<=GVOFZ30",&+H/:J6K+):U#B]SA4)4Q1EY2VG5#8V)Y,\
MG.<4@\8>EXGR/U<VELT)8QN[XWAB:9*]OB%:!LS@# & , 8 P!@# & , 8!%
MTZ5=A24QR6=RF7E).(,[<A*K2.\':)'TGW*>D45#6P=.IDB=KH6T;%723-\O
MI=Q;ED79V.!08F&(P+H+-H^@3EGR-._1<?TAS6Y9//VL.:TYS63\N? DZO#\
MQQQ&!PD+TTL2$:I(A N>'%&UHQKEQP4R)&!0N.))VJ6*!@(2)]&;.4'#"44$
M8Q:UL?S/"?)XTE<%[2ID+&G=6MHW('-L/=D!+@W,&AF%[>UZ(Q0%2C:-&$G%
M[<E!9:+ME&![[M %K0'D;)"P/93>>S/C.[D.S62^-9S8YHEY3DR*>[\W>&\Q
M*>:!8UG]\5W+@GV8D-[TOL'"[8>L"BSOY$0_CE77T@QC)6_S/L9#W>==J+RR
M"1@'%3RB7[SAS*_ J-_Q+TSEDV1_E#A_^+^PU)T^/_%-7_<?:9)\LK-L,W&
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M!(P#BIY1+]YPYE?@5&_XEZ9RR;(_RAP__%_8:DZ?'_BFK_N/M,D^65FV&;C
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M #/L9#W>==J+RR"1@'%3RB7[SAS*_ J-_P 2],Y9-D?Y0X?_ (O[#4G3X_\
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M^V+?:^Z[/Q:UD>3TZD3GT]EOO95< 8 P!@# & , 8 P!@# & , 8 P!@# &
J, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g472601g23w48.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g23w48.jpg
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M! 8' 0((  D3$1(4"A4A%B(7(R0Q08*W)2@X.4)286)R=GB!_\0 ' $!  ,
M P$!              0%!@$" P<(_\0 0A$  @(" @$# P$$!@4+!0   0(#
M! 41 !(A!A,Q%")!40<C,F$5)#-"4H$V<7)SM!8T-4-B9(*1DJ'!16-T=;'_
MV@ , P$  A$#$0 _ -_CQQQXXY7O[86CYUZV.V%A;IVP)AN>;"E(Y^P<+-'P
M]]#Q"DJ:/V3MONFX:NV+@,FZ;N4%$UFZR.BR6^F^FNV+KTX5&=Q(8 J]Z"-E
M8 AA*XC*D'P0W;1!\$'SRG]0 G"93J2&6G-(""008U]P,"/((Z[&OTYC7C[I
M>S:[F,0XS[(/ZFK0.Q-.3<O]&.&^@V/]=UBR&-B"S=[OC/X0CHROA;AMI9\*
MPM\TB8ZI6'&]'H=^_P!V<C)T*\\4N4Q:=*Z2&/(40>SXRP6*['Y:C.P)KS:T
MA/L/IU&_#'7IX98L9DG[V'C[T;I'5,C JAB#^%NPJ?W\6_O ]Y-J3JU+S.\O
M^<:8,"8\(*'SY0>$! QSTP:-%WC<<*$"1C95Z1)DR#Q1%HQ'L&:*SIX\=*I-
MVK9)1=931/3;;'959V5$5G=V"HJ@LS,QTJJ!Y+$D  >23H<ZLRHK.[!412S,
MQ 554;9F)\   DD^ /)YKK6[>MY=;]'^OZ_(V3+UYPT[[SA%<47#W;)X,DG4
M:[.K;MG!7I*4LW/XSL-5S!W7K071D:?MLO)*/?E[*--F&KJ(MT=M6IU,;0S5
M*1%FRXP\L]R4$,F/!LU(5H1D;#6")RUR13J-E6!6.I2<;8MV\C>Q%M"T.).6
MBAJ1D%7OE:]J5KT@.BE<&$+4C([2 M.X7<0&QWYA^;3CQQQXXX\<<>../'''
MCCCQQQXXX\<<>../'''CCCQQQXXX\<<>../'''CCCQQQXXX\<<>../'''CCC
MQQQXXX\<<>../''(D]^!?ZDX3[3C^-/DV-\F]%"M-/I]<Y5?U!,&R7T_V_W8
M44USKG'\XVQC./YQCRRPS^WE\4_^#)46_P#39B/_ ,<KLNO?$Y-/RV/NJ/\
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M57-?'X#'V*B$I]1DA-/=LJ/!E,BR1BNTG\01%(3?@#XY5IA\I906+V<O06W
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MR28YHB&4^=.)$V>FS@DR:L[ACK_HN31;FCH:_N=>LA\$NI-OSK$HQ+GM9='
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KX\<<>../'''CCCQQQXXX\<<>../'''CCCQQQXXX\<<>../'''CCCQQS_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g472601g25h10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g25h10.jpg
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MD(@GT2[3)Z^/%9\6@V0AN37W2ZJUJJT7.J4KFVZM)??I=1UG0<1WP"+E4O&
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MX&":1S<[>8EU6]>E2D>%*9_7/S>(SJX(' ' ' ' ' ' ' ' ' ' ' ' ' '
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MG%Z5(3.O'Z$*OY!(X X X X X X X X X X X X X X X X X X X X X X
MX X!^<[Z:YQC;;77.?\ =C.V,9S_ /+RYX!_<;:Y_P!VV,_^?]&<9_\ \X!_
M> . . . . . . . . . . . . . . . . . . . 4@-?EFP?I>R_@((Y*YDX
MO2I"9UX_0A5_()' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '
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M92LH3 T<O3@O+&L?&V@%EI8$DL_#0,W)C,3)[SS-@MHP<IJ>S;EOQ[<ZEZ?
M@P>I>G9/2E>N5T_I65E9:KFZ2VE-:UT'G679<*S%C=+BQ(G3NEURT:F3TOIF
M33)IG6(M:ZDX2D4NM?:2]:\*IBH:\2K85>G5]3E$H/K(*HR7K>44FJZ3!Y,?
MWL.*U9"X2HD%3.P;/5W7>Q(R6<9& (U%:@F42^4\$]9*)Z>:J>C8JX)D^6]
M;7EW)V4QRZ.#PAC^^1%&3BMGF">^EI6!VYBK1Z9%.VF'NS-J]J>G5"> @7J3
M7_\ +?29DQJ#1V8R[_98*ILIAX/=;?O$[T!M=X]+BM@NC@YF4NUI/'S:EGF&
M%=;-*>XK>U>L93OKE[LT1D:WI1U/"H^_U;9V H^5D0J$TTA9-ZDL%4U:M6A%
M]-%X=)12_23MM/V8:G#QF&0Z2LVK8BPVM8C]4%M2PJL[MT/V5I^.F5UXPP/]
MX>:KNNR\%P<GLH1/JZ>E#B%#:P&@*%C8,@>O+Z\0JB>%-6;W*HOC^^ID]:%9
M=B;FE8(V-J KGWCQ!\W<SO7YG92#,YM <:U<:CD01V:>QZ+<%(-@^PB6,E N
MN'*SN)@8:/<6%[YGQ\T&0^$$8:%Y--=&.K3X.$QL5Z!=E<5Z@\+C%R?68WLJ
M@E#Y1C8:DXXMBE:^Z;5U5Q>!ME+8B9(.>X6[.1#RWW:!Y LL62F'1TD52#&:
MFD,,!-4KJVX+553-P8<%3*BN>LW9P?KT$@9'L)9$;(0@:,1#Z.4M8?*5(]Y&
MPC%DY9*$SWKTV>$>[59'=#:==MF[F7V3S(+H)*N-T]1B;'> . ?G;SO-V\S&
M,[>;GS<;;9UUSMY/Z,9VQKOG7&<^3R[8TVSC']/F[?[L@:6JMZV]B*S>4Y+M
M*BL*5JRA9:M'J%!&=OU%9!O.&K6A.T=-6>9UR>/Y01%Y$'=*VI3N\&SL"3K>
M2DXX>L8H;U6!$;UL/&(R54QQ3&N-%IG14\7#S?62Z.VC6X+UXW"(QU.V-6U3
MTTE;#EJ2CDG!$1M7T1U=KXACZ[A#)Z.-'A Z@J$#;-'Y0[E(P*U.>O=21CUL
MUC+ MCVJ"K6NK1M5?2J9].FAM8K%<\=5K7KFTV<5'6>X!Q->QH^"VTWA&!XM
M L%"]G#[Z.Y#3:+;$&T@C'[:/WVF6FB.=7CK7R+[C%>#,4Z.#DQM,'V,'I9I
MG0L9Z[;:LP7.5<Y!0O?S]_/"]]<;8UVU2QA+">GF)Z9SIE7*BBF2KFP3-PZU
MX3%$SXKGX-2<!5GO:F?S@E_ZD!?@CD534G+SDT76O)S#WM3/YP2_]2 OP1Q5
M-2<O.*+K7DYA[VIG\X)?^I 7X(XJFI.7G%%UKR<QAA?W;X/Z_P!HP%,.D.VM
MOV9.@+BT%13K_1,7;+\?!$B'(JU(23,$"Z(QC.4($GL9'ZZJ.%MEV#CUI)KH
MJQV>*IJ3EYR4:J_C4XU;S5+4X\0AKY,YVZX>*IIC&/+_ $]&9??.?_AC5(!4
MVSG_ /CQ5-2<O.3D+_+3:G,/]H5'8USMOUX\533R9\GD_D'%*FV?_CC"-:*Y
M\G_S\G%4U)R\XR%_EIM3_">2.\1:N??,!CAH%^(-4+6Q;!"JN'S*XNG1#7P
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M+_U("_!'%4U)R\XHNM>3F'O:F?S@E_ZD!?@CBJ:DY><476O)S#WM3/YP2_\
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M!NC=\0UDV#YF<8/</DGJR30@9(QZLG);/P7)T>G'#/CPU-AW!B. . . . .
M. . . . 4@-?EFP?I>R_@((Y*YDXO2I"9UX_0A5_()' ' ' ' ' -;'BB?U.
M]=?_ %%?#B_ZS*<X,FYU[5_S'&R?@Q' ' ' ' ' ' ' ' ' ' ' ' ' ' '
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M&D3!9L5^>.8_9RN(KZ\><N'3]-0U/-#+#$D*3&<L(PU.C0L,<C&DX0$:8D*
MZ#UTW#!@.&D=TQH*'F2RK$?:NI)RU7EI=Q(R[]Z_< 7?X X X X X X X X
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M.I)S29L@UL>)7^0^DW_J3],?M#<<&3?QNU4V3\&(X X X X X X X X X X
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MQF.8[9:-,I(9\S@%4< < UL=X?C->%%^FR??]#G;;@R;F?VJ?/:;)^#$< <
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M/?;/H8YSY^;7**. 9I^'G\;RJ?\ "/?LW+^?./1:_!_OYVUU?/.[Q].]!O\
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MH)LZ1B2XG'PVN[7*8*I9<1A>VTT$7?-D0+8(I%Q*V(5I:]L141["(9F0-.G
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MZW$WXC_%T;RB4*Y>?>^'W7#^BCG.?YMLH0X!EST0^-G3O_-2'^#"3F@>BC[
MNZ'W#9'G'8Q]&="5\(?<V[NMOS6MPD_\XFG=P< N;2G]<M2?YF@?\517+%=#
MKLNOWQ6)]92Q5+^=8]\^]2\7U1.$UOG7XX1#@#@#@$57W7/\GY0?Z8PC]BEZ
M<O%PM]9KXOB>4RQ6KT>\8'=;/H8YSR>;8*(. 9I^'G\;RJ?\(]^S<OY\X]%K
M\'^_G;75\\[O'T[T&_PC=S[M+V^9%Y"3+SBZ=RQP"]76SXQ5!?YU59_',%RW
M[GW7[<COONU]<R11-U+L9;HO>)>[S?M F?<ZXG#(< < < < < < < < < <
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M5]C)-(L:.V!#ZG?'3"],*^LBE^W1HE^K<2>=<SVO2]WX\[(2\K.1H=L,M*!
MF+ORK+3E; LQ_4<Y;4:ST=;%H=)@RKIF+U5#EDK@"6KMR24CE@SJ&%*,=S*U
M=B<6 O(V;(&@0\L G]MP$W,(,6A Z;P,CJ-8:34\^FATA@G GL!>R<QQ;M,>
MQ8K[ B6A<Y8$&ZDI:7^EJ[T6RY:PXTO.3T.QXMNVCU9)3<U#@PYZ(R2CI9R0
MYN>C3<A/R3[,6Q.IE@6FLW7[Q,O-#LN_O5$>^L]9*[AMZ8%L3=XX$U(6;&M^
M!=NR%D+1D)*),1K-A1;1E5M58TC9TO(VG9MHPK92\75B3-C)(R?>=&CDZ. .
M . . . . . . . . . . . . . . 4@-?EFP?I>R_@((Y*YDXO2I"9UX_0A5
M_()(VONJ?Y+A+])*H_W2><N%Q]^_D<Q\Z$5^\N]ORB%XGG-IYN U^. 9/]+O
MC2TK]+]/W=(<TGT1W8/W2.]]WEDH;XZ&+L^;F'?$GD$Z2F><.SO@. 5S6']9
M5>?3D2_?\?SVKM]<5@?'5E^70"OWLZU;S=[]L_5TR3;^=AC@N. . . 1?_=:
M/R:M8?ID5E]D5]\NMQ-^(_Q=&\HE"N7GWOA]UP_HHYSG^;;*$. 9<]$/C9T[
M_P U(?X,).:!Z*/L"[H?<-D><=C'T9T)7PA]S;NZV_-:W"3_ ,XFG=P< N;2
MG]<M2?YF@?\ %45RQ70Z[+K]\5B?64L52_G6/?/O4O%]43A-;YU^.$0X X X
M!%5]US_)^4'^F,(_8I>G+Q<+?6:^+XGE,L5J]'O&!W6SZ&.<\GFV"B#@&:?A
MY_&\JG_"/?LW+^?./1:_!_OYVUU?/.[Q].]!O\(W<^[2]OF1>0DR\XNG<L<
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MRLOMIHGE97.N,945SHFGIE3?R[YTTTUSGR:ZXP!Y> . . . . . . . . .
M>)%!!OKMJ@BDAKNJJOOJBGHGKNNX4V676VQIC7&RJRV^ZJJF?+NHIOMOOG;;
3;.<@>7@#@#@#@#@#@#@#@'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>g472601g26p26.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g26p26.jpg
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M(2(C-U58>)>SUCE!E+?3)$)4DM<8)3%#461QD4939?_$ !T! 0 " @,! 0
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M98I/,.%)/&K32U88IO77S9<U3=A@J, 8 P!@# & , 8 P!@# & , 8 P!@#
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MIDEAJ;VUQUYF=1#UT@;-;J*X6"R.4$C=UO3'<F^-[33<I)<=T47Q&-@]N/4
M=7.+;C";88>GF#)%2(U:SD]#0-2):C:V5V3)MI ;A>]]N'H(^K1X+R4Z[>-5
M)[<JX=="7=#19_.6?6^]@Y(3BWWMN%QY\:7Q"[?8[G"="N48[+3IRDD753WC
MO45?5L$F-;F#:Y5#54SL2(^(DD-DS8ZGZ I<G&1'39GAYUO==FNAA+R-B$:D
MS?TR?'=1Q8MVRN6_(;F"I>>(SRQ<7[,?-)CEE?T@T1*R&/D6&!ZKZNH[#)>P
MOC\Z/BRR&+Q6B:7188 2=9OPH7KY#JJ*%<;ZRK@VVN+6KJG35M+_ $JMOF>X
M](A!8(VRSF+'HZBY61;CQ<3>M5V6X5XYTR^<=E+>YVY"X]'..T=HVO*Y>[(-
M1N=>6&]7).[I7RT+FYK@,3*V;2-PJDE"Z\6O%JM5:\;5M=::U2E.MD#A%T](
MQ;=(\RT3E=-S0*9]'Y5S%PE>YM#H=*;)-N+D@Q\BQNUEWX.+UTF<YV[>$\8(
M_5R!SD\<:G280)/<<ZL%B9W!T9D)N"6H%Q73"+ZU*ZE35C_BKKUT6JK-N71!
M65<]C<=I]JZ$%N'.43O"7QN*3BT9A,YTT6'% LD6<R7VHY):E-TA<;A5J%X<
M'AC9S+4C4CDX'AN?" 3Q^:R$+<Q"D2552F*3PV>E_P J&US!48 P!@# & ,
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M*CG63R)0%4^2-^>'=8XOD@?W4T!.EKR]N3@XG$ITJ82GP9(F**!NI>3 & ,
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M?+D2];6/)6OJ?8RL?DOJ[43+(+# & 4+G[6N'Q%7]',R5K7.NT'BFYE^=.,
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M4-B!6LUI6H2)#%(B23E&M'# '0AZ[6]X)B5&UDVMS,F\$# & , 8 P!@# &
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M#'-;GWCP>P?UQ#?1Q[_JK&&3WKN&.:W/O*%S3V#XM<.MWAO5X"KZ^J./>O\
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MM%SFG4*<D3@1M1)79NK+<CF#\NU*54=<%[C+X1-;$1$,L)C)J&87K;Z]:O>
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M19+<A['5?>8D-]&&3ZCBKS>]BBR6Y#V.J^\Q(;Z,,GU'%7F][%%DMR/Z!7D
M+$$8(-#P# +0P#!&64(@"#O6PB"+2+6PB#O6MZWK>MZWK6];Z\5>;WL462W(
MF&02, 8 P!@# --'28RM>U77QX8;)H^T>17%Q?65_+Y;6-#<>J\Y.V?J[3-0
M&-55,WJMY8RR.4-D)A[%(IZY-$RA[,:U-MC;BZ.?';9UC<E4B\.W4G54;=%3
M&JK5:\/30S4Z/\-Z X;4 3R2:G!CN%-"? Y$TO++&8W(D3*C>75+ "I;'(8
MJ*1Z:;KLF*#FC%'R4[4SRH;PW(TR8I,%.6*NE735U^_'?B9AX(& , AL]]S@
MOER)>MK'DK7U/L96/R7U=J)ED%A@# *%S]K7#XBK^CF9*UKG7:#Q3<R_.G&
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M'I!(OM7 HLEN0\@8O_PCAZ02+[5P*+);D4+G 8OIM<-^".'XD*O_ /()%_\
MH,__ *N3#Y2YUVBBR6Y'B_YE^=0, 8 P!@&];HL?T,V!\YRCU5C6:F?G .4S
M0WH++]OWT;2?D)\G6EW36/V%=!LZS TS?& , 8!DUPR2$+N5-#HU(1C3J+%8
MBC0EG'$#V 1H^O03DYA1Q>__ $$48 >O[A:ST;@BY3=".D%A]=GDG#SR-\(_
M1:\?41UR>0,7_P"$</2"1?:N;4C2319+<B2M[>E:TA2%$ PM,1WG=A-4*%1F
MN\,&:/M'JS3U!G6,8MZ[PT79UO0 ]0 A#H25N , 8 P!@# & , 8 P!@# &
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M,4Z&;*<J&TQUACEQ2X84IK_92DZ?6^PW@E3CPN)4;B2>IIUIGYC[D3Z/_BI
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M;!9I\R5I+.E00J*9!,F3DK*[]UOQ$JNQ.0<+;FMNDH:7!6E"RU]9E;XFW-9
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M,>4#M+Z^UKMF%# 'KWY=;ZM=>]=>^K?5K)5$TZK7Y^X5\S]'>><%^#(=*_\
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>g472601g27j76.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g27j76.jpg
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MR9C/.D<?\I^54<;DK&O7,$O:4KV8C;-NS6TR-H=DC>]'-K6-S;B$[B<W-XU
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MJJLXO3=<PVKH86N!&8.Q(F%K,=5HW)X7!3 V)2[/;F:$!CF^/*TQ2[/3D8
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M;2"DS:%H3$6:FXZ2\"'+0$BQXSGQ'\%+P84&'I.71APV,2C6HA=[/H'RA@#
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M&Y26J3"&'8/_ *9Q0# [UZX1!#O7W,_1*=37J?R$U+3TE<R[<K.2<>#-2DS
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M3L3>P(J^<8]"VQATULT>V% P) F,RX@EFVF0GHRR [$C*+,*V,47NU/6& ,
M8 P!@&-+X5G[6 R>^BJ?YJ6=DQN/V:=XE'Z<$CUYNQS?&870B&MYS;Y !@#
M-H=X-O[3OQ=_IJ_?UAK2S2M\/N@G>]E?FD V/=_L3+=V/\XBGH+DK">6KFT,
MM4.,!?.1,2LIKGS!>-UT)&:"J.S66G7@N-I-<?88UW5R-C)C299(P/JF9VPV
M2!S4QQB1I6^+1))-7)HGL%C)]M*;D7Z:)S8%Z^3U,++]X^OL*;:.0I9=!)5
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M^,N,-629BM6S5BT^,NR]J<W%H$4^Q9V1:3JE[&U*1C"E"HT-$7H!P ","/\
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M?9(O>EM_%PJ'W^'1]?K@T_@N;K7O7]!Q*%@M& , 8 P!@# & , 8 P!@# &
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MFH9I%&Y)&G](B<VMT:W%*:7UC),0.:(:-Y9%KFQN3:YJQ347+P!@# & , 8
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M,LK>!$A*%O<]/3T4NM@# & , 8 P!@# & , 8!0\4^^"S/ST;OHZ@6 5Q@#
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MV?S4[_*%1@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M8 P!@# +2.5 T0\N*]W=Z4J1U=G5:J<G1T<JWARYQ<G%<>8J6KUZU4S&J5BU
M8I--4*E2@TP]0>88::8,P8A;%:KFNTXNN.?'L.NK5$4UK6ON:U6$(UK7]6F/
M JN:[5/J'CS0(=:"&CJ?"'7W-!K.%ZUKK]?UM:9.K[OKX*';-%,4]'UZ-U8:
MHK5D=&XX*EO<FB"Q=M7H5 >OLJ$:Q$UDJ$QP>O?9-(, 9KKWU"]? KQ<1<K
2& , 8 P!@# & , 8 P!@'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>g472601g31e92.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g31e92.jpg
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M(3555W:7U-54>)2VMQD:,38X.5-8=;2UT]<8(B,W07$D)5%TI;,R-'=A_\0
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M4NTK4U$*P%FBCIU5@DZQ5IE2&E>\W%8*C & , 8 P!@# & , 8 P!@# & ,
M8 P!@# & , 8 P!@# & , 8 P!@# & 8\KRIZYJ<J9DUS$6F(E6'8<LMB:@:
M0' #([&G2LM?+Y<X=L<=Y3L_+"2E"X9?9DB,!K99)>NO6!M,AX P!@# & ,
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M4?V)X0BWLH[L#R#NS,T$?9'%&>3Y!@-[ \V , 8 P!@# & , 8 P!@# & ,
M8 P!@& >5MR.'';C'R$OMI94<D=*7IBRK1;H\XJCT2!\6P6(.\E2M*U8F 8H
M2I5YS:!*>H(+&<24:(98!##K6\JPV=6RVV2R11.!6FTR)#C2JX%.FPRW$DZ)
MM**J3>)$3HF\DWHC1MT0O3F67TE7)N64+,:%@M8-<=I646H3((U+']\7J5S!
M,Z]BY328C=$"9.!*H(FBE68H"9LX!J$@L(-@-,V']1TAZ+R;EL4NUR[7,GN.
MTP2'!'*A@24<J=,ZU88FZIRDJ4WL^4N8XVTTEA7O7,FW7G2CPZ06?R#C;L?!
MY5'HVN2@X\QBJGUH=[6G FN]D_%601R:('67E,#.\RBZ7NMG^MWQR.A4<75K
M<,76NA@"XT_219^-,CJ[/9;*^'KV<47K77/A]7V0XPJUJ^<X6M.M5VK!HAZ%
MC95SVUG*;GK^HHJ\2.9(K7>V!43M5-0.;FF86!2%>S&)G=(L;5R<Z+J@ZO%/
M"OCR+Q(Z0Z!JY>N8$M4VL=&H].(3 9M8FQ5V1&8@\V5RDM?B#!#5;>HGI4M>
M$;U;53.AJLZ/QUSVR1)[97QT"0?M>VHA%.?<GX,QK8W2*RIG@M;6-&>/5AQ^
M V="YU9+%/)P77;PF45RT\;+;OB)RAJB,>N%J<W%Z/)KI$LD-?O;Y$'=&QN2
M9N.=FAZ>$Y[6)2K7'%;NU+*F\OZ;=))3E>H%@)#&9T9)F5^D$3D4=*)B#8HC
M[^CL^LJQ@W>)8\3).RQMMN %M1*R:]6NCUV1U7A?W]W,;W"/K6@0CJOP[Z^%
M&90:^8\3D5.UY:<7@,\?G>T[-<Z=A-:D#AZ.2.T^8W29(GLDM_7RE/ Q19"T
M5_+9LFER>5*&M]A;:0XQ[3JZNK4R+ IC3G_[,--O2;U.MD=8QM=7L]CZ^QI
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M:_B7)FE)',WI]9918\E9I),8U6K'/%)\BT%*H]#J7-JB+"A7.ZU,\"T+2?\
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MK^"%QP_@!S :);%G5=23V4A;)&R."PT+]##1%I43FE4J#-%ER01AFP$E#%H
M B&/>O)"'8MZUF?=?D&\J]GO.[K1.Z+*"3(MUDG38_O[T:BZDJ5:)<<R+JP7
MQ%'%U886Z00Q1.E(86Z(UM\_[1OD<M=T7K9;/TNCF3[3=MNL\F#\'NE$/7FS
MK+-ERX.M'<L,$/6CBA76CBAA5:Q-*K/J)[Y!]6)E[ -_SL]%Z/AJN9Y>U7'1
M\AWR#ZL3+V ;_G8H^&JYBJXZ/D.^0?5B9>P#?\[%'PU7,57'1\AWR#ZL3+V
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M(=_(_P#T4F]QYMX>Q1\-5S%5QT?(=_(__12;W'FWA[%'PU7,57'1\AW\C_\
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M4829Y!@=##VA)P"SBA]6]>44:6 PL76 P 1:WK4$GDP!@# & , 8 P!@# &
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M>:S_ .6]??4B*?X"@SURN#WBN7]$W=^YR3Q1Z2?TBO\ _35Z?OT\O?-L:48
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MR"1@$-^D5_F^N=?YF_)W]B<WS8W/[[77^D;%^\RBL?H1?)B\&<E_.?S!& ,
MDAPW_E><5OSD*._:=%\PKR][K?\ ,K5]!,+0>G#\J'Q1UV,Z^&<, 8 P!@#
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MTBO\WUSK_,WY._L3F^;&Y_?:Z_TC8OWF45C]"+Y,7@SDOYS^8(P!@$D.&_\
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MS+]!K[P)BJR7?S%'F^[D.[#W](LR_0:^\"8JLEW\Q1YONY#NP]_2+,OT&OO
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M++  9YVB@FGB '01'&Z(*((T89O6QCT2225H0MZ+*+!U U!)Y, 8 P!@# &
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K# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>g472601g31r20.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g31r20.jpg
M_]C_X  02D9)1@ ! 0(!>@%Z  #_X5E@:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z
M;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N,RUC,#$Q(#8V+C$T
M-38V,2P@,C Q,B\P,B\P-BTQ-#HU-CHR-R @(" @(" @(CX*(" @/')D9CI2
M1$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D
M9BUS>6YT87@M;G,C(CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O
M=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N
M8V]M+WAA<"\Q+C O(@H@(" @(" @(" @("!X;6QN<SIX;7!'26UG/2)H='1P
M.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O9R]I;6<O(CX*(" @(" @(" @/'AM
M<#I#<F5A=&5$871E/C(P,3@M,#(M,#A4,38Z-3 Z-#<M,#<Z,# \+WAM<#I#
M<F5A=&5$871E/@H@(" @(" @(" \>&UP.D-R96%T;W)4;V]L/D%D;V)E($EL
M;'5S=')A=&]R($-3-B H5VEN9&]W<RD\+WAM<#I#<F5A=&]R5&]O;#X*(" @
M(" @(" @/'AM<#I-;V1I9GE$871E/C(P,3@M,#(M,#A4,38Z-3 Z-#@M,#<Z
M,# \+WAM<#I-;V1I9GE$871E/@H@(" @(" @(" \>&UP.DUE=&%D871A1&%T
M93XR,#$X+3 R+3 X5#$V.C4P.C0X+3 W.C P/"]X;7 Z365T861A=&%$871E
M/@H@(" @(" @(" \>&UP.E1H=6UB;F%I;',^"B @(" @(" @(" @(#QR9&8Z
M06QT/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'AM<$=);6<Z=VED=&@^,C4V
M/"]X;7!'26UG.G=I9'1H/@H@(" @(" @(" @(" @(" @(" \>&UP1TEM9SIH
M96EG:'0^,3$R/"]X;7!'26UG.FAE:6=H=#X*(" @(" @(" @(" @(" @(" @
M/'AM<$=);6<Z9F]R;6%T/DI014<\+WAM<$=);6<Z9F]R;6%T/@H@(" @(" @
M(" @(" @(" @(" \>&UP1TEM9SII;6%G93XO.6HO-$%!45-K6DI29T%"06=%
M05E!0F=!040O-U%!<U5':'9D1SEZ84<Y=TE$375-04$T46ML3D$K,$%!04%!
M04)!05E!04%!045!)B-X03M!44)G04%!04%104(O*S1!1&M&:V(R2FQ!1U1!
M04%!04%F+V)!25%!0F=114)!545"9U5&0F=K1T)164I#=V='0F=G3$1!;TM#
M=V]+)B-X03M$0D%-1$%W341!=U%$031014$X3T1"351&0E%417AW8D=X<V-(
M>#AF2'@X9DAX.&9(=T5(0G=C3D1!,%E%0D%91VA54D92;V9(>#AF)B-X03M(
M>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX
M.&9(>#AF2'@X9DAX.&8O.$%!15%G06-!14%!=T52)B-X03M!04E205%-4D%F
M+T5!84E!04%!2$%114)!445!04%!04%!04%!05%&07=)1T%104A#06M+0W=%
M04%G241!445"05%%04%!04%!04%!)B-X03M!44%#07=11D)G8TE#46],14%!
M0T%1341!9U%#0F=C1$)!24=!;DU"06=-4D)!049)4DEX459%1T4R16EC6455
M37!':$)X5WA1:5!")B-X03M5=$AH37A::3A#4GEG=D5L47I25&MQ2WE9,U!#
M3E51;FLV3WI.:&156DA41#!U24E*;TU*0VAG6FA*4D92<5,P5G1.5DM"<GDT
M+U!%)B-X03LQ3U0P6EA71FQA5S%X9%AL.5=:,FAP86UT<V)7-799,U(Q9&YD
M-&58<#=F2#$K9C-/16A984AI26U+:31Y3FIO*T-K-5-6;'!E66U:)B-X03MQ
M8FY*,F5N-4MJ<$M7;7 V:7!Q<75S<F$V=F]204%)0T%1241"455%0E%914-!
M341B445!06A%1$)#15--545&55).:$EG6GAG6D5Y)B-X03MO8DAW1DU(4C13
M3D-&5DII8W9%>DI$4D1G:&%357E7:5DW3$-",U!33F5*16=X9%5K=V=*0VAG
M6DIJ6D9':61K9$95,SAQ3WIW>6=P)B-X03LP*U!Z:$I3:W1-5%4U4%)L9%E7
M5G!B6$8Q95@Q4FQ:;61O85=P<F)',75B,E(Q9&YD-&58<#=F2#$K9C-/16A9
M84AI26U+:31Y3FIO)B-X03LK1&Q*5U=L-6E:;7!U8VY:-F9K<4]K<&%A;G%+
M;7%Q-GET<G$K=B]A04%W1$%104-%44U2040X031";3-D8S=&6%EQ-T9867$W
M1EA9)B-X03MQ-T9867$W1EA9<6HO3#,O04(S.4TO-6DT4#A!:S1U0UA*;$1M
M14)H67-K+TQZ>35:95EV3D57;#-Q,T17-S(Q-4]284UQ4VQR83!L)B-X03MU
M155&:VQ(>%!%1BMZ,WE'4U9#,F-),F%:<F9F:V)::61$638K:VM6>'I%3G5)
M>$Y-<VDR;'IC+U972W5G861*3% P;E5+2V,P8G9X)B-X03MY<UIV2G1/2'I4
M=5 O;DA44S)U;W)0.$%436=U0W0O8G1*2T5H:64U=#-V,6AL56M31EEL1FI'
M6FLS240Q1#=J22M/93509T)I*V=F)B-X03ML2F)Y96-,>E-.5W5M:W-,3T,T
M95@V=DQ$1F9*4$1:+U=U16QN4S=U1E97+V1U>7A-<&):5UDP<D]76&%W=T=,
M96EY3RLO24A1>&)Y)B-X03MF5G14=DEP269685-2;S1R9T9)1S%1='AJ4F]H
M5C$P>4U,*SA)0EDW;6]P05IZ*U!G>D]%364X*V9L1&$K54ET3&EL=G!D474W
M<E9:)B-X03MT4'5*659%8T12>'!!-BMH54\S34=::V-K:T)G5G X2DIN1$QX
M9DIJ3$962C=D+VMD-5<Q1"]%<UAL=E4W,7)R>3EQ3G!P-TIC>')+)B-X03M'
M964V:W1P27AX4T)M6E(V8FAG2U8U3%%I:C5!6FE+=G%N=V=E4T1U+W=$;DAM
M-6AK9%DY9FAK4T--4UAD64-K:V9/2DIK06I-;DM3)B-X03MK8VY/47@X9VEQ
M,U9G1DHX9GE8=U!.-4)M430W<U92.$@O2$%V4#A!;4QT9BM49'AG-G-H>65K
M469K,V]T-V1Y,FQR<3 X4F=E65%Z)B-X03MI2F)N-B]$0EEM-V$T<S1G8F8T
M0WEC2T9Z.71D*W55*TM1,V5#159B+W=$3U!%<C9P*VHU4$U-5',P85!$4&$R
M-75)6E!6=31B5D=2)B-X03LO5E%'4&QC9D4S549(2$A91F@T+VMV9V5A45=F
M-50S.3-O96U.0DA*4')&-7)-=6TS16QN3D)F5VMD=6M%16]K1%<S3E=A<S=!
M+W9F)B-X03LR94Y/5U1/6&8T34)I<TUJ6"]N2'A:3&4U=#1T5F8X05-D<&-/
M=%=I55)815IT3$<V:6AI4FY1<F-T.65C2VAC:'EL2W)1;DEE3WHX)B-X03M&
M3%EV>70X='=E6G)(5$PR.'5:<D-443<O5F)Y.&=)44=3>&UU,$129W=33W-4
M3&%+94I2;C,K:D0T:'$O3DAH:38X:W=T4'E+,&Y8)B-X03M$-69L,$16<FQ,
M6%=P4%1-;#%B<35#=3)O4$A-;U(T-F9U9$\K3TTY0S%1>#9!94U29&IL*WA0
M9V<X:7@W>DHK54TR:"M5>#5I9E99)B-X03LU,#E'1C-T,6E+;$HU2%9'9V8T
M:7EN-&U-8DUG1&A(<%0T96,T-6).57AL:6]7=W)1=CA!:G0V9B]W07A-4#A!
M>6-'5U,U3F-E65%7)B-X03M&:3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867%M
M2&QZ:B]I2%,K44I8-C-"54$P3E!56'9V:UIC;55/66$Y9E%0*U=/-R]W0VMQ
M4#A!)B-X03LW2CA/-C)(979O2"]!0W@S9B]35D@O,E0T-W)99#8K9V8X<V0S
M+S!L4B\X05I0:G5T:$9.63)A5U,S-V%0<4LR3#=,9&U:4D5456IA)B-X03M4
M-G1X-F=J<F=V>E11-VEH9E@P1"]L:G4O=T1P2VHO-THX3S9,0TET1CAV>BMT
M5S!U>#955%-#;#%(=59P="]V4&=.<$%"42]R-D(O)B-X03MY>#-F+U-62"]W
M0FLK2&1&:$4R;&Y9,VEZ4%HV4G%&>6QU<&MN84=:6$5A049I>FQB63A107!.
M5#190V9.24%047),=4Q3-T\V;'1,)B-X03MZ5$PV,G5O2$UC.79.8TI(26IQ
M84UR;S%S1U5G.5%C4F%M=352.6914"M73S<O-E-O+SA!<VYW-V]S3SEF45 K
M5T\W+T%/:W%0+W-N)B-X03MX,U=W:C1:=$,O458U+V]D,7@K=%=T4CEA:G)8
M,#=I;2]W0EAY3SES='%7-E9R.6IP33 P,6A"9%%Y6$9V3F%413-%1#AO8FU-
M>%-P)B-X03M2-U9H.%--4EAR-%EM3F]%9T5&-BMG9CAS9#,O04Y*568O6E!K
M=#!72&5V;T@O3$AD+SA!4U9(+T%.:RM/-C)(979O2"],2&0O=T13)B-X03M6
M2"\R5#0W<EE2='AP:T9T6G!E,T=I86Y$6GE&0DAC>5-H66U-:6QK;S5T9W U
M2VI&9#EW1&=V>E-13S1O3#$Y02\U63=V.$$V4V\O)B-X03LK>69$=6EW-S$Y
M02\U63=V+W!+:B]W0WEF2&1B0T\P4V)19C Q<#E,3S9"*W-W,$IU;WHO04QS
M2"],=FM:6%1+3E=%:7EB5S=&6%EQ)B-X03LW1EA9<3=&6%EQ-T9867$W1EA9
M<6HO3#,O2&8P>B]M3&<O-4],9VQY6E$U:&UV;$QZ;F]':BM325EB;5):=%9S
M9%E7+VDP<S)X4')W)B-X03M,2EIU470U>31W3V91:TA0,#-93%92>$1M=%5O
M17DK1%I'64574E1F.#5!>3-T=F4R:UAL-E@P8FM8<VI14C-H2TMT>BMK2&M9
M;TQE)B-X03ML1D=O,5DY+U1",C=2.$1Z+T=Z3'AV2D50+WIK4BMK9DUE;EAW
M.'-3,TTP1C9T>D1::3DY4G!*1U<X:E=.85<Q86XV.&DW1&-22W9Y)B-X03M(
M9U5/82M.9E))2B]-2&U44W1B<W19=B]!0VAF5U9Z63)B85,X8DQ,8E)C1G1(
M0TUI=$(K-VYJ:&-3.'%N<'HT-S=3-%%25F\T:F0P)B-X03MS,5@X-E<Q2%1R
M=7EF4EDT:%!:>3)T<W-C,S=M,V4T;G5P6E=J:$U:6# R4SA#96XT>%)U1W%O
M=VI$6%9">E@P64)P;B](,R]!37<P)B-X03MN.$US3$-05D):2F=Y4'DS-6QF
M4TY#,74P97=A.'1D5E),9#-:=4U-56YP5$MJ:V5M>#E69E5,4FQ853=-1'E6
M;4=1;$=Y1V-:54,Y)B-X03M&=2]Z9C%$>FID87IB85HU475B-U5.5W1R95 P
M-V5D-W572F)3+VQV9E4T4C(S2G8W.4EX,#1H4C0P>7)W=4=R3&(T=#E%<R]/
M8GIV)B-X03LU:#@R,FQN939L-59V9$-T6F)L-WEZ=7)O>79%-E17='9$=VED
M-$E!5E Q8C%+<60K6# T8U5"2&MB635*16IK.'%Y.7!2.$@O2$%V)B-X03M0
M*UEU,2\U3C-'1'%Y2$I!65=,,6IY6BM:4&QZ>3$U93AV6%1H3E$Q6%):-5I7
M,&,R,W!-+W%.8TM#=6]F1T5&3&A86E)#4R]&5DQ5)B-X03M#:&%*-'E35RM/
M44%"1V%2*V9R-E@U93!05'HU8V0W6%,R65)3+U<K155Z2G%&=F8P0R]6>4%9
M+U%#9%113E@R=TA"6D\V9D<X;7@K)B-X03ME:RMO5U9Z1S-L;6$O2S9D8U=5
M:S=86FTY35AD<F%74FQF.$$P8S=C<EAK450X5% Q<4XS=V$V<C1T.45V=&9/
M5W8V6C5X,4AZ1% U)B-X03M1=2\P:$\P14]P5V-O:U-'3V18:&1&4TUW8V]F
M531#4&=X4#=T,E%F87)H34%25F]%>41D2DQR6#5Q6$]P-D)F84LY9T9I=7),
M4W)')B-X03M.,VPY57=$4S!#<UEG,&9W0V1L1$U&;U%2=5=Y56-61S)-<VQI
M;4-:83%),U%V.$%J=#9F+W=!>$U0.$%Y8T=#6$IL2&U%-"\U5GHU)B-X03MU
M+S5:668X07!-<R\K<752.%%-=D-K-R]!2E9Z-74O-5I99BMK>7HO04]Q=5!I
M0F9#:S<O04I6>C5U+S5:668K:WEZ+T%/<750:4)F)B-X03M#:S<O04I6>C5U
M+S5:668K:WEZ+T%/<750:4)F0VLW+T%*5GHU=2\U6EEF*VMY>B]!3W%U4&E"
M9D-K-R]!2E9Z-74O-5I99BMK>7HO)B-X03M!3W%U4&E"9D-K-R]!2E9Z-74O
M-5I99BMK>7HO04]Q=5!I0F9#:S<O04I6>C5U+S5:668K:WEZ+T%/<750:4)F
M0VLW+T%*5GHU=2\U)B-X03M:668K:WEZ+T%/<750:4)F0VLW+T%*5GHU=2\U
M6EEF*VMY>B]!3W%U4&E"9D-K-R]!2E9Z-74O-5I99BMK>7HO04]Q=5!I0F9#
M:VID)B-X03M$+TPW>E9&<E=N>7E7,$MX>#--3$\S,74P3D%S9TI/,'5#57A3
M630U5V=V*U9C*V)V*U=72"]P37,O.$%Q<F@X44DX2U1+9GDX,&YZ)B-X03M0
M-54Q:5156F1,:'54>'0R:4,S,6UJ0C=7.70W,$M'.5)U26Q&<5EM3DYG,60K
M:&AK26M'8TE%9$4Q,2]5+T]7<5!C3W9L8E-06'5B)B-X03MA1S-B56)Y-'1,
M<2]2-&)73S$Y84LU.5=)<3,W<C%&*T4X5S=N27A!2%9L3&E04E4P83DX,#)D
M-C=81VI2>E=4,SEP94QB>E@Y:$U))B-X03LT=$U+9E9)54HT4'I%4U!!-VPK
M0E-2=C-D8T)!-S!J:3=N;G O3')Z8U-4.59G1F5W=DQ3;B]*-TQV1414-%5K
M6' O-64K83 K<SAR)B-X03MA06-O2%9F.4UT3W!P+WAB9TUW>6IJ:VA0*U9C
M*V)V*U=72"]!2U1,4"]Q<F@X44UF0VMZ8GE9=FUN>3%95S9X-E9(3&0R>C9L
M4C1T)B-X03M2<S1#>39N85)7=V(Q03=K3F)T0GE88F9L,C<Q5&]N;3)W0D$U
M26Y7=%4X,S9J<E0V;&)E5DY(,'!H9%,S='9,65A&<$1D*W%68W=E)B-X03MT
M8T-8.39S8W)P27<T3'I+:C=06D%!1E=64$9F2DIO=$<X,&IY.61A6DIP,%10
M3%E,65)&<C8P8V5O,2ML-TID1W-U>CA)5FA!2#=0)B-X03MF<E=6:3=2=WEQ
M;4TO=T1+=69.,R],3$0O=T)*;&XO,59Y9FE"<CA+4TYI+TPW>E5.1G5O:F)W
M96\Y>F)-<2]83%1C3$A/0V8W,R]+)B-X03M'1&I&<#A/5DE,+VQ84&TW+VQL
M:"]W0VMY>B\V<31F14-00VLW+VQ84&TW+T%*6EEF*VMY>B\V<30K248X2U0P
M:GE8<6YM8GEV0EEC)B-X03M.0VIU<$E,3DQ'-6E857)/0EI&:3%1-FIZ2C53
M.'964B]18T5F6DAC8EI434-85G5J64A*06TU.'IY=S9H1$HU5#!M>%<K<VYS
M2S92)B-X03MC,F1G=T5L>F(S2$]1;5-F,4-V,55+;E-N26Y$=#-O<5AC:G11
M,51Z2F5A6&4V3$1O67-T3G9P8EER2DIQ,7)C>3(X3G0Y5E9%4VAG)B-X03M$
M8T5S5E92.%!,8FYZ6E9904%C-RMX3R]+;41E65!*;FUV5F1E,4Q623E/=')6
M3"LV;G5K=&MV3%!H14IP1V-2<E-58DQY;TUT:DU!)B-X03M5,5-X>4HU240O
M;%A0;3<O04I:668K:WEZ+S9Q-&9%0U!#:VI.1B],>GI9;7-73'1B43A6=4EI
M9CE,=$1S2$(V0UA!8V=P36-C<E5V)B-X03M*9FQV>2]Q*VXV>3)Q-G!B869E
M<F)/=6E2>GI,1#9L,T=06%!)=#A+;U5J35%,;%%78U5*27AN26EQ4D-)24YV
M44(U6B]*;S9V8GAZ)B-X03M3,D5-3%=6=SAQ4C,W4W=H;#!Y,FQJ;#4O5U(K
M*RMV=DY'27962$E$<"LQ;%A&3VTS:&AB12\X040O:TM05F1$:W9B=4=&8C9F
M551Q)B-X03LK;C(Y,FQX8E=X:4IA>&A384YP2$5,;&QJ859P4S)Z2&]!>E=C
M57%,1&AJ65)54&QF.'1,=7<P*U,X,5).3C%35U-X:#%/,'1B;4]3)B-X03LS
M=#%U3'E:2G)H6&Q->&Q%9')(1WI):V@T<SE4<T--2$9*94=+33!Z>4HK5E9X
M<%%V-W)82'0U83-02W=B56)!4V=W+W!";S!R-F)6)B-X03LU0S)T4GI!2W-:
M1'@V9T%'8S<U9FI:26A(=E9T23AM+VLO9&\X1GAQ5%<U34=N,U Q:5A63%%3
M8S4Y3G5R;64S:DII4TYE1C!K54QL)B-X03LQ66=K1#139'=:>E51:6\S;C5A
M*U1T33%$>3EF4&581C$U9'8Y8RMO,T8O34].:$Q:<'%&>&)V24PV34I#;C=I
M,E8Y<$-Z8VU.14-G)B-X03MS4FM*=G9P0F="4U8K82]+2&M$5%0U9F93.5E7
M-U1523-/<G%,,C)L*W)U3%=#54U04FID:U53>E-*=UI76G94;T15-U-J3U)U
M=W-O)B-X03M2<V)O0V939DI.='!/;#--3C!U;VLV,TYB,V@Y55=S.#)N2DAB
M<VIM171+,$%:,FU53U8W9E)H=58O0D92*S%L2V534'EO=51F,U@V)B-X03MB
M:&A&=$5*;TQ28G5#0W8K:EAB*VTV>5-84FMF,3=E1E0V37IF0S0K>51282M/
M9F-Z-$ED-F%89C5A9FQ*8W=A-V4R;7-,8F%F8C9H)B-X03M#=')/=#!J26MC
M:EAH83%H;6M*:6MB-G1&2$]O8SAI4C9824U3,D%:2C=B2CA/3$5T8SAR+VPO
M639B8W)986=,,C=H,4-X:6EU5&97)B-X03MZ0V%Y;49Y6DQH26]W0V=+<D1Z
M:F5R>$UF:5!J35-K5T)J1D9F;4HU2R],>7ET;7502W5R=WHS8S)P1T-/,"MV
M,G,P2S(X='IE>&]6)B-X03LV3W%2>#(P0DQY3U)34W!/3T]C:GI#>FA(;U4P
M:B],>CAO;5<X=D@X>')C5U56;F)3,E5.<&97,$YX3%!&0F-F6$EZ1&-X=$QZ
M:VYT)B-X03M5.5 T4B]E<E1L,'E0:50W;5A"2'934%1T0SAH868X06UX2#5F
M=7!)3E4X<VTT1G9C86IE,T0R.&%X;5%31U534G1A8T=7265M=V%O)B-X03LU
M8VE0,F%337!'3CE74$1%4W)O:F1-.&QF;&QQ9&Q:>E0V>6UM6#@Y<D)09#)Y
M,S%S25DU6C=M949O-'A-0WDK:TE9;5E02U<T>3@O)B-X03MS;U%W335$;VM1
M:65Q8F%F*UA0-4Y04%!A6&9M2E-K9#%#<V0T;7 R551E:DUM;FLO8E(P8U)T
M9%A02FQ(*S9T-EE$:VXS9FID26A$)B-X03MV4S94>4(K5D5B,C=F-&IA6#%U
M5%-7<3-T:T1'<392.6(T=&-&4W9*<C<Y=U S9G-F:7!5.&,K-SA7:F=J,V]4
M5R]+=C5:860U;C!A)B-X03MX=&164S<P<#,Q15@Q-$QQ2U5-,$9X371J2$E9
M=4EJ5U9%:#530V=)67-+57=I56E#9WAJ65=79FQ(>4).0DLR<F%N83)L.7IT
M;S19)B-X03MD378P93,O93)C.3 S23-+>79Y.5=+3S-D9R]#3C-Q4U%+66UC
M=6EE1TMD5U U669L9F5I0F)(6%ID4FYA-3%#3U-#2SET27!'9W,T)B-X03MT
M4VU345)V13=X<38R9'-427=++W9$-U5I8VMH,"]'>6I(13E73'@K6'9**VDK
M87139S%74DY5.'-V0DTK;5AK3GEG;DU$6&XQ5T\U)B-X03MI0T]Q=DY'1F%1
M4DU0:4$K>E$Q12M):V)C,E!#060K4R]W03,K579*14YJ3&0K6'1B=#=I-RMT
M,U%&;C9Y2D8Y5FAL=7%'35-S,&=0)B-X03MP5SA,2GED:DE:84QU=4U*4S9H
M6E)J5WA2=6XV3BM78V--3VYA:T-L,CA';C-597-08TUK16XQ<4\S95-*;%9I
M47-C<VLP57!336Q6)B-X03M8;'-Y1EA"375J25)J,5DS-78X04QU;&%4<"MN
M4S)T-4)D6%9X3&-*34Q6;65)>$ES36M5<7-Z4"LQ3DI#,T5L9552;U<V;6-*
M17-*)B-X03MX05EX:S)T,DMU>%8R2W5X5C)+;S-1=BM/,W O+TU41"]W06Y"
M9VQY6E(U:#EH9C1!+TPO05 V;&I3+RMK6DTQ=FEY-S---$(S3R]W)B-X03M"
M*U@O05 Q3$=L+SE)>5DK3$QV6&=(8S<O04@U9B\X055S85@O=T))>5DK3$QV
M6&=(8S<O04%"*U@O.$$Q3$=L+W=$4TUM4&EY-S$T)B-X03M",T\O=T(K6"]W
M1#%,1VPO.4EY62M,3'989TAC-R]!2#5F.$$O57-A6"\P:DIJ-'-U.65!9'EV
M2C51.&YY5V-D;$IO5F<Y;D-A>%=Z)B-X03M19WA)87-A<6@K16)U,U%D>FHT
M:W4Y4$-&1"]!2#5F+T%057-A6"\P:DIJ-'-U.4A!3S4S*T%0>2]W1"MP63!V
M+W!'5$AX6F0V.$$W)B-X03MN9C1!+TPO+T%+;&I3+SA!<$=42'A:9#8X03=L
M8RM4+T%#8V)!865D0G-$64Q+8FAB5#!2-DEM6E%H:T5F,F5:5E%/5DLP>#A3
M6&5N)B-X03MH2&-O9C1!+TPO.$$V;&I3+W=$<$=42'A:9#9/061Z=CA!9FPO
M=T0Y4WAP9B]336U0:7DW,31",TML<C5*.&M7;'I&9%=V;#=4<F4U)B-X03MT
M,U=70V5+0E5K4U)$>58P6F%&5U5I;TEX.%-896YH2&-S:SAH*U$U2D=K:SAT
M86$X:FMS-W1B25-35%5K:SE38V9&;#-R=VIU82]W)B-X03M"*U@O05 Q3$=L
M+SE)>5DK3$QV4G=$=60O9T0X=B\X07%73DPO=T-K6DUF1FPS<G=$=60O9T0X
M=B]W1'%73DPO04]K6DUF1FPS<G=$)B-X03MU9"]G1#AV+T%0<5=.3"\V4FMX
M.%=8979!3S4S*T%0>2]W1"MP63!V+W!'5$AX6F0V.$$W;&%Z.&YE5&)'8C$W
M3%%,0S%N-'9(-G--)B-X03M#>'9W:U5O-CAL;V%-<D972&-B66Y*23E5:4E(
M4E(O=T(U02\V;&Y3+W=$<$=42'A:9#9/061Z=CA!9FPO=T0Y4WAP9B]336U0
M:7DW)B-X03LQ-$(S3U!K2'E#44%F3$]M14199C9-;7<V-"M,3'94=T1U8V9)
M4&M%,'(U6C!W,#)(*VI*,'@X5UAE=D-/-3,K05!Y+R]W0W!9,'8O)B-X03M!
M2U)K>#A76&5J9TAC-R]!2#5F+T%057-A6"\P:DIJ-'-U.65!9'IV.$%F;"]W
M1#E3>'!F+U--;5!I>3<Q-$(S3R]W0BM8+R]!1DQ')B-X03ML+SA!4TUM4&EY
M-S$T0C-/+W=!069L+R]!3E-X<&8X03!J2FHT<W4Y94%D>G8X069L+SA!.5-X
M<&8O4TUM4&EY-S$T0C-+;'(U0SAH)B-X03M*9%%U;FQR5$9D6%5Q=W1K0D)"
M0D)'4&EY-S X23=M5'HR1G)"13 P.3!);U5&6&MD47%Q4$5K=%%:0DLO=T12
M368X078T+SA!4#A!)B-X03MM<D960WEG,#(K9U<T<W(K3S9G64M6;&@T>4E1
M>6@Q25I823-69W<Y:FEQ<4Y0=&I+,%%U87EO1EHT=V\U0E=Q1DI(2V]"-&UN
M>7A6)B-X03LP=6XR,$U4>7I84'!X4F=S.&IQ1E961S5*2F%G07A69"MI62\Y
M+T@O04E!9C@Q67$W.45X+W=#+VHO=T$O=T-A<U97<' Y<S=/:5A0)B-X03M*
M-&E&:U5+0U999TU!=T1B2&EW3TMU;# V,VEJ85-7-3E/3D)6,UI11D%(8VMT
M:7%L-D=N8W!5*W9*>FAK4T=:9FAQ:W-G56]J1&YS)B-X03MZ0U)3061Z565/
M2W$O=T-I62\X069X+S1!9CA!3E=+=')P16)-0C9X,TY0<V8X,UEQ,2MI62\X
M069X+S1!9CA!3E=+<4XW8C9F63)S)B-X03ML,V4S>5=T<$-/53%X3GAJ:E%D
M2W,W3T9!*V5+<4YY*VE7<'1H9&%P0D%B,3%J<WA+,&%E<SAM>4Q&>6-C,F%U
M=UAR:7)6=$QO5C%F)B-X03M81FAA-G1"4&97<'!D5VM4>'9,169#4TY83$PY
M27A61R]O;5 O9G@O-$%F.#%9<3).26I.9C-X,D9F<V8X,UEQ,2MI62]W1&9X
M+S1!)B-X03MF.#%9<6AU3VLW+S=K679H;49Q,C9B5&UL26HX9C(Y+W,Y8U95
M3&DX.'57,7I,8EA'<S(P3GI"2#8P.$5K:U-/:UA)2C9J<5I!5EAK)B-X03MW
M5W R<6-65G8Y=R\Q,6)(.4IW+UA855-*83%4,5-H-DU%-3AQ93E-5E)8-DIJ
M+S,X9CA!9T(O>E9I<F8V26HT:RMS9&E".6IX<B]L)B-X03M9<3$K:5DO.2](
M+V="+WI6:7)V,%1(+W8T+SA!040O;7)&5D\U<W)/,FAE935U,6=G5&0U6D%Q
M26\V8G-Z041&5FMK1VUX5'@R.'0K)B-X03MK8SAR0T]+2G5)9&Y:5V-+<6PV
M:VQ),V%N9W!0631Q;U=6>#5F=C=Y-7-R2%8W939V3$YI=#5B45!(2DQ#>7-6
M26M26$Q)47=)*TED)B-X03MC56\W.45X+S<K4"]!04$O-7%X43<Y17@O=T,O
M:B]W02]W0V%S5EAX85=G;%$K<V1M0BMX-R\V,DMP5C4V.'1J>DHU9FLP5U<W
M:W,W)B-X03M/.&MJ4SAE0TPQ6E=J-59#2C%#5FLT1FU+:V-14G18:T9,0GHU
M53@K=C5H:6EU9&-V;UEP3#E!.#9Y>7AX4$)&<#50<7AX+UA'6#DU)B-X03MC
M;SE)5D(T+V%K4FLT-'%I-%!Y-#AY:E-:3DIS9D]K.$AP=TQ"1%!"0F-+:T%6
M631M.4QJ9$)/5EE*3U-K:V]71D]/+TY615AF-6,K)B-X03M9,7-R<4I03U9X
M6DIC3S=).&$S0VE/4V4T;6QQ<$XS>35(,3%J0355*TAP>4ML5D-)=69*4&U#
M5%-B47AE87)Y,U<P5R]L.51H9&U2)B-X03LQ=D%79T5Q=&,K<S5T95AW<35*
M3DM51TMQ4&PS>5IQ36UG6&M.=C5Q=DQQ>C%"9$].:&-C8G5%=S(Y=4DU6#E*
M:F-#5"]355!X4$=Y)B-X03LP2DDO6C1H4VA,2#AV9DYZ>C%4>C=D6%%T5F4P
M=F)E5TLU6&Q)6D),>6(P-WE*,&(P,EAI54DR3E%E0D,T<6EO+W=!<V9-,%=M
M+U5))B-X03MV3TXU1W%O-E%Y<4QG3W9+,VEH53$K=&1M:$PP1D)6,C1H5%)G
M<6ER5'E.-6AS8F$O33)U>C9W,#DS65A.<F)41U5,0D1:6&%Z=$5H)B-X03MM
M;FTU33!A:&52649I0GE/*TM%<'10>6LX,C)T='%C569N939-*W!C1#EB84\U
M.5=.,#1G=4=7.%AK5VI8:%9T=T%V1VQ$5E-Z-WDW)B-X03MP;#=P96IW5TXW
M9DYQ3GA#6DLS8FAW>DLP:DUI;C%*2FY00D=#5EIY5%-P>%%M:U@Y-&YZ2#8X
M5E<T<6PK=E=&-W%':C-6;%DS361N)B-X03MD5'!W:G5:66I/<59)<3-P:#1A
M;6QE4'A#:&]D-E5X5FIT,S5/,5-85DQ9>%0R<U9L1D)P:5-Q,7,P:V)(5$HU
M6G94:E0Q-#-H0F0T)B-X03LS43AN*WA2<6HW4W%/:SAU6&@Q-G@Q2G!6;&Q7
M-5-A-6M20D5I=WA753A!:593,&I(;%!D=DHW06YE;T):5FMM2W)K+V$K4GA6
M8FER)B-X03M%<FIY4&1Y-G=U<'!Q<E%U;7%F<$U2>'A%1&=926)D;VHK.&]Z
M1T]";#5K56\W9D17:D)63'!0>2LQ93AL;F%A*W0T1FIN=5I,3W1Q)B-X03M:
M6$1486MU;V5O6D9N:D1Q-&EI4C!A369:*T4P,TMR8VXU8S-51W!7,3="92MS
M66MS8E99>DAW-%%75C-"4'ID,FMF:S-P5W9';U-R)B-X03M-9'IX0VA&5V4T
M<75(.3(S>D@V:FEQ,T9867%K=FTS>3E0<C)L<%IW6'HV9DY&4$AC4EA+2U=O
M.%)Q:$MH;S8X5V\V,4Y/44914E5&)B-X03M62G)R>5!F6&9M8S9X*VM:8EIR
M4R].+UI2.%EP8F54,4Q#3WI);%%H6D]A=$5E:D0T1%%B<U-Q<5DO-&1U13AZ
M4C9K:C%2<#5B;6%3)B-X03MG5VE',E,S4S)'-4I5=E=9;F(T<U9:1FER<U98
M4B\S:2]-9G)X5FIN;2]1=$8X,#9(3&\Y.61Y=U<X>DMZ4S(T55-$9V$P0FQJ
M;%56)B-X03LV2#1E;4MS568X;5!)6E=D66)U-71L=4))2E!Q.&1R1CA-<3-#
M36\T,F\R.4\X6D(T2W%J=&EL5W10>6PX;E<P66I856(R4F%X335F)B-X03LP
M0WIT0UIM1'5W='=X671D3V5686<P-#AA1$9#3# W.'4O3#EJ;U8U-69853=I
M6%)B<C9Q.&1Q.%9U1$1.86Q36D5+=TMJ97%9;WDV)B-X03MU:$A)368R:FEL
M:C%Z*U17:C)V-D]I,&I52D=H:'5O8FTY:W5J14A:<EHU<$EP0W-D<%-D9V)P
M=U9C<E5C84UT3C%6*W%F:WHU9D5-)B-X03MK*VPV:F-386<P5G9B0DQL;UDT
M,F=H45%U:&M3>FMC8V\V=E1I5DUL0WEK8EEQ>E!Y8G!-3V<V83ET3F-2<SAH
M9RM#25!W45<Y<$)A)B-X03M+1BM&3V]T*U@R4C%P,GA1;B\Q-C O,S90=6(K
M;4MU*W97;BLO4CEZ9C!X5C,Q-C O=T(K:C=M+W!I<G9R,7 O=C!F8S,Y3598
M2F8R)B-X03M99%-:4E%%13=.+U1&5G8Q-C O,S90=6(K;4MU*W97;BLO4CEZ
M9C!X5C,Q-C O,S90=6(K;4MU*W97;BLO4CEZ9C!X5C,Q-C O=T(K)B-X03MJ
M-VTO<&ER83,Y;4LO=E)U2V1'+W!I<E@Q-C O,S90=6(K;4MU*W97;BLO4CEZ
M9C!X5C,Q-C O,S90=6(K;4MU*W97;BLO4CEZ9C!X)B-X03M6,S$V,"\S-E!U
M8BMM2W)H9C)F06HQ4E5K2&\S879T:7$S-CEA9C<Y2#-.+U1&6&98<E0O04@V
M4'5B*VU+=2MV5VXK+U(Y>F8P>%8S)B-X03LQ-C O,S90=6(K;4MU*W97;BLO
M4CEZ9C!X5C,Q-C O,S90=6(K;4MU*W97;BLO4CEZ9C!X5F1&93)H:U%#559*
M2%IV2#59<6LO<%,O)B-X03MY3CEX>%8S<%,O>4XY>'A6,W!3+WE..7AX5C-P
M4R]Y3CEX>%8S<%,O>4XY>'A6,W!3+WE..7AX5C-P4R]Y3CEX>%8S<%,O>4XY
M>'A6)B-X03LS<%,O>4XY>'A6,W!3+WE..7AX5C-P4R]Y3CEX>%9V,'!F-4<K
M-#1Q,395=CAJ9F-C5F0V578X04DS,TA&6&5L3"]),S-(1EAE;$PO)B-X03M!
M0TXY>'A6,W!3+WE..7AX5G8P<&8U1RLT-'$Q-E5V.&IF8V-69#95=CAJ9F-C
M5F0V578X:F9C8U9D-E5V.&IF8V-69#95=CAJ9F-C)B-X03M68CE+6"M2=G5/
M2W1E;$PO04-..7AX5C-P4R]Y3CEX>%8S<%,O=T%J9F-C5F0V578X:F9C8U9D
M-E5V.$%),S-(1EAE;$PO23,S2$98)B-X03ME;$PO04-..7AX5E5G:6LY95 T
M1#EO9&HT-'%O965T43$V>#!(-C%O87I486A&8U%/='1$1C9X;FI744=716II
M+T534FAL-2]$>$\O)B-X03M)67%W>3$O37)Z-UE736=V9DMU;V%N<45L>$UY
M>'!&8U),2$4P.#1J:D1*84UH155C2V9%5TIB;415-'!44T1Z,35T3W9X<2]L
M*RM.)B-X03MJ9'E79&U)9E-M161U6&UU4F-85'I',U=V1DDT=U9Q52MY43%'
M-4966G$O;C=Z-6%Z,S%R8F558FTW4TTS4S(Y-T),26YW=TY+55!&)B-X03LW
M855C;FAJ1$IX-6AM6E8V-T)60C9H*UDS;C%79RMR*U=B=FYB,TXP,7I%<U8S
M4S1T-%5U4D5O9C9N2T8Y47AX;FM#1TPX9F@T3GEX)B-X03M6<68X,U!-;&M,
M<%HO2VPY4T]A5DQ3831.>D5*4D=E5$=V,4I11D-%;$])63A56FUO05=X5C9E
M2$I&461V;FEH=FLS:6-69'EB>$]+)B-X03MU-4XT;D988VTX5&EQ-DYM.5)D
M>C%(-CA65SAM.%1I<D<O3S)O95I,3TQ32DY%5U=4;'%52S9J2$1&-GI.86-8
M36DY1S1625@T='8Y)B-X03M:83%X5DET9#AX*V)G8C945'ID1#!O=%931S-T
M-U@V>'=N=$AT,71!>%=/53AP;$QU<6LO17)E,GEQ23%J>D0U<W1D9#%+5T9:
M:'!.)B-X03MP8DY*8GAT0GAJ;&MJ:V=655=2,$1'4UHR;FI#.'%C47)$<E5Q
M<S4U3C1N1E9Y33-X8FYO8U97.&TX5&ER=51E2GA6:FYM2R\X>5%A)B-X03LO
M;VM/;7)).6I/,&=V=45F3U!A4T5F=E@T=#9914Q43W!Q3U1!1#)+<DDK5&5*
M>%8S2G9%-'%U1$XV8F)N<5 Q2$96=DIV131Q-VLS)B-X03MI8U99-S4X=2]-
M,70U96QL.'5+.&UP:&=);S0Q5C-9;%=#06,Q94U$,4](37110D]7-$Y$:7%"
M=F12.'<S1W5S8F4X=7)A>C O56AB)B-X03M85G1B47A44G9A<EE2,VI.3'EI
M;&QQ>G0V4RMM>6XT:'181E9(43EE.#)N>DTY;G%34T=Y;74W=4=&6DEH1U93
M3G!84C0R-&]8:5=+)B-X03M/16,Y-G1)9D1:5FTS2G9%-'$W:S-I8U984G,S
M<4QU96]X5DHO=T)*6%AI=B]!:D989G!+-CA6+S1%67$W.4I86&EV+T%!27A6
M,S93)B-X03MU=D9F*T)'2W4O4U8Q-'(O04U#3591,2MT='%-8V-E;U=L=F52
M>$]*66MU25DU47-G0D%D431.1T%*,WA612]P2S8X5B]W0T)'2W4O)B-X03M3
M5C$T<B]W27A6,S93=79&9BM"1TMU+U-6,31R+W=!0TU69"MK<G)X6"]G4FER
M63%/-T)"0E=O,RMY359A+U-6,31R+T%-0TU69"MK)B-X03MR<GA8+V=2:7$Q
M8C962&0Q5D9E46=Y34551FE!04-45&9957A6,&PY3$E!2D92=W)";$1)<&]Y
M;7%K5DA52'!I<3<Y2EA8:78O06I&)B-X03M7>'%D,D\V-R]W0U--5F$O4U8Q
M-'(O=TEX5C,V4W5V1F8K0D=+=2]35C$T<B]W04--5F0K:W)R>%@O9U)I<G8P
M;&1E2R]W1$%J1E<O)B-X03LP;F0P<%9A2&8W27A6<CE*6%AI=B]!:D989G!+
M-CA6+S1%67$W.4I86&EV+T%!27A684PV5EI':T-O2DA!1'5%6&M1=&%!;6TY
M2VUM)B-X03M+=4XY2UI22U94,5%P55-C1C5"4U%32S!R46M$1E8S-E-U=D9F
M*T)'2W4O4U8Q-'(O=T%#3598=S9J8VUA345R47-".6ME3TMR8G$R)B-X03LP
M*S!73G)Q*U,S5V%225EJ3'A14$Q)94M2<GEC5EIM,E5$8S1Q-C)T<D,V16I7
M=#9K-&EK94=5>&-80U-X;FDV3GAC,%I4<U%D>&EQ)B-X03ML>C!8-C-*6F9P
M4T0V-4-65U<R-5(K<6AF:'A$2GHU070V<55R+TU015EQ:2]W0D5X+S<K4"]!
M1"]M<D989F]M4"]F>"]W0T%(+TY7)B-X03M+=2]2368X078T+SA!4#A!;7)&
M6&9O;5 O9G@O-$%F.#%9<3<Y17@O-RM0+T%!02\U<7A6,S9*:B]W0B](+V="
M+W=!,5EQ-SE%>"\W)B-X03LK4#A!=T$O-7%X5C,V2FHO04XO2"]G0B]Z5FER
M8391:DU"-C4S3E!S9C@S67$Q*VE9+SA!9G@O-$%F.$%.5TMU+U)-9BLO:B]!
M34%0)B-X03LK87-656)Y,S V>&=.>&4S>5=S04E5>E1C63!"63!58VUC1&-M
M9WA65R]2368K+VHO=T%!4"MA<U9D*VE9+SA!9G@O-$%F.$%.5TMT)B-X03MJ
M4T5.9C,U,D9F<V8X,UEQ,2MI62]W1&9X+S1!9C@Q67%H8C V3EE3,C!6.7%C
M3G),95-#1S!J;EI),FUL66=#3TU--$QS4V5G,WA3)B-X03LR5C!K6&E74C%'
M25AK<%E2,GA+97%X4E%Z.%4U.&IX56=N8EE9;UA7:T=M,VEL-U,O:G5&1S5A
M3&DT-FQE<75F,FQ)*V<T<7(O;VU0)B-X03LO9G@O-$%F.#%9<3,K:44T:RMU
M9&E".6IX+S)72W1F;VU0.$$S.&8K04@O3E=+=2]2368K+VHO=T$O-7%X5D0V
M:$AP96TR:C-M;S9H)B-X03M(6E=K9%!5=4QG<$9'=DDP2$HS8TM+:S!X5G0T
M3DY3-E,P92]J5S=L,VIT>GA%:E5"63A53#AJ<W!/2W1X,BMN>5A-;')(9DDY
M>D8O)B-X03ME=TQX3')S1#A3:#9J6F@Y-'A65R]2368K+VHO04U!4"MA<U9D
M*VE9+W=$9G@O-$%F.#%9<79I,'1"2V@Y63=-1#EJ,R]W0F)&54PU)B-X03MW
M.&]8=FU,435.3%-B-FU:2DDU4')01#%'47A/2D9:0GI3:G$V9W%454%J;V-6
M66QB9FLQ-6MT;W91:3AZ6$,R>55E0T%2>7%O;2]3)B-X03M*=C)M:T,S2VE2
M,D(Y36YB>"]Y8U5Q3G K5$AN1S-75U$K8EI7,4-13W8V4D9V271X4GIA:C1N
M*W1%=BLW<RM(>&5.93)+<'9F9FQR)B-X03LU<VYU3E!U8EAZ1DQ:>C)W=&AD
M.$9U2%-D8F%E4V-P4C=S<T9K.5AG,TYN4$9A5C8T<6AD0R]+:GIF<&5O,F0Q
M2C5T=F)Y3T<T3GAE)B-X03MW>6E5+U=A<7%Q:D9R;'=!;U-G*T4Y5"]!2E!&
M5C9$.5-U=CDY;C=X:6@S,4LV+S,R9G9'2W4K<%A8*RMZ.31X5C,Q2S8O,S)F
M=D=+)B-X03MU*W!86"LK>CDT>%8S,4LV+W=".6XW>&EQ-4Q/-41Q4VAO0T-E
M;4M6=C%+-B]W0CEN-WAI:#,Q2S8O,S)F=D=+<$@U=SAM6$AM4%-$)B-X03MP
M+W%M,6)K>%=8:4I"4U-*-%A"5&ML9F=L86TK>E508D95.$9J8V=!8T1T-&UV
M.$%(1EAF57)R+T%(,F9V1TMR;',W:U9Q:#-(=&=6)B-X03MB.5-U=CDY;C=X
M:%9!-G U96XQ03)G9C19<F$T:G5*16]#6E!3*T].83%(1VMY;R]F-TY08TMS
M9'-V>3@Q36%T6C9N3$TP32MN6'0W)B-X03MC0TU!3VQW;'I08U!(>F\V,#11
M,W-I,#1J-#DO:55!1E9&*U@O2C)R-EAQ66MK8U-W<$9D8W!655)I5U,X=EAU
M=T](3U%J,$%X545T)B-X03MV>4]+<VPK<%A8*RMZ.31X5F-,3S4T16-$56M(
M=#<T<%<O57)R+V9:*SA9;V0Y4W5V.3EN-WAI<59E85!,5W V>F]L>G!T=3A6
M=3$P)B-X03MP:6MK=4EF<DM'2G=6;%1G<W-"*T].;5-O8T5!-UEP4W-E5$YE
M8E<U3#<Q56DY2R]/;U%-62]55GDK;')90DM#5D=4:$E#-4<Y5F]/)B-X03M6
M86M+1DQ39DE7=&%B<FE8074U3&TP83AV8CEI-%9E2#%S=6912'A-4T,P;TY2
M>%@Y,G4Q83%66F0Y4W5V.3EN-WAI<G9Q5C$O=G,O)B-X03ME35982EHS2613
M54Y!4C-'2U@O+S)1/3T\+WAM<$=);6<Z:6UA9V4^"B @(" @(" @(" @(" @
M(#PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI!;'0^"B @(" @(" @(#PO
M>&UP.E1H=6UB;F%I;',^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @
M(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X
M;6QN<SIP9&8](FAT=' Z+R]N<RYA9&]B92YC;VTO<&1F+S$N,R\B/@H@(" @
M(" @(" \<&1F.E!R;V1U8V5R/D%D;V)E(%!$1B!L:6)R87)Y(#$P+C Q/"]P
M9&8Z4')O9'5C97(^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \
M<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN
M<SID8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B/@H@(" @
M(" @(" \9&,Z9F]R;6%T/F%P<&QI8V%T:6]N+W!O<W1S8W)I<'0\+V1C.F9O
M<FUA=#X*(" @(" @(" @/&1C.F-R96%T;W(^"B @(" @(" @(" @(#QR9&8Z
M4V5Q/@H@(" @(" @(" @(" @(" \<F1F.FQI/D5R:6,@3&EE8FQE<CPO<F1F
M.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @(#PO9&,Z8W)E
M871O<CX*(" @(" @(" @/&1C.G1I=&QE/@H@(" @(" @(" @(" \<F1F.D%L
M=#X*(" @(" @(" @(" @(" @/')D9CIL:2!X;6PZ;&%N9STB>"UD969A=6QT
M(CYG,S%R,C \+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z06QT/@H@(" @
M(" @(" \+V1C.G1I=&QE/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @
M(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @
M>&UL;G,Z>&UP5%!G/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O="]P
M9R\B"B @(" @(" @(" @('AM;&YS.G-T1&EM/2)H='1P.B\O;G,N861O8F4N
M8V]M+WAA<"\Q+C O<U1Y<&4O1&EM96YS:6]N<R,B"B @(" @(" @(" @('AM
M;&YS.G-T1FYT/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O
M1F]N=",B"B @(" @(" @(" @('AM;&YS.GAM<$<](FAT=' Z+R]N<RYA9&]B
M92YC;VTO>&%P+S$N,"]G+R(^"B @(" @(" @(#QX;7!44&<Z3E!A9V5S/C$\
M+WAM<%109SI.4&%G97,^"B @(" @(" @(#QX;7!44&<Z2&%S5FES:6)L951R
M86YS<&%R96YC>3Y&86QS93PO>&UP5%!G.DAA<U9I<VEB;&54<F%N<W!A<F5N
M8WD^"B @(" @(" @(#QX;7!44&<Z2&%S5FES:6)L94]V97)P<FEN=#Y4<G5E
M/"]X;7!44&<Z2&%S5FES:6)L94]V97)P<FEN=#X*(" @(" @(" @/'AM<%10
M9SI-87A086=E4VEZ92!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @
M(" @(" @(#QS=$1I;3IW/CDV,"XP,# P,# \+W-T1&EM.G<^"B @(" @(" @
M(" @(#QS=$1I;3IH/C4T,"XP,# P,# \+W-T1&EM.F@^"B @(" @(" @(" @
M(#QS=$1I;3IU;FET/E!O:6YT<SPO<W1$:6TZ=6YI=#X*(" @(" @(" @/"]X
M;7!44&<Z36%X4&%G95-I>F4^"B @(" @(" @(#QX;7!44&<Z1F]N=',^"B @
M(" @(" @(" @(#QR9&8Z0F%G/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D
M9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T
M1FYT.F9O;G1.86UE/E1I;65S3F5W4F]M86Y04RU";VQD/"]S=$9N=#IF;VYT
M3F%M93X*(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1&86UI;'D^5&EM
M97,@3F5W(%)O;6%N(%!3/"]S=$9N=#IF;VYT1F%M:6QY/@H@(" @(" @(" @
M(" @(" @(" \<W1&;G0Z9F]N=$9A8V4^0F]L9#PO<W1&;G0Z9F]N=$9A8V4^
M"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT5'EP93Y4>7!E(#$\+W-T
M1FYT.F9O;G14>7!E/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z=F5R<VEO
M;E-T<FEN9SXP,#$N,# Q/"]S=$9N=#IV97)S:6]N4W1R:6YG/@H@(" @(" @
M(" @(" @(" @(" \<W1&;G0Z8V]M<&]S:71E/D9A;'-E/"]S=$9N=#IC;VUP
M;W-I=&4^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT1FEL94YA;64^
M=&EM97-N97=R;VUA;G!S+6)O;&0N<&9B.R!424U%4TY%5U)/34%.4%,M0D],
M1"Y01DT\+W-T1FYT.F9O;G1&:6QE3F%M93X*(" @(" @(" @(" @(" @/"]R
M9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB
M4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N=$YA;64^
M5&EM97-.97=2;VUA;E!3/"]S=$9N=#IF;VYT3F%M93X*(" @(" @(" @(" @
M(" @(" @/'-T1FYT.F9O;G1&86UI;'D^5&EM97,@3F5W(%)O;6%N(%!3/"]S
M=$9N=#IF;VYT1F%M:6QY/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N
M=$9A8V4^4F]M86X\+W-T1FYT.F9O;G1&86-E/@H@(" @(" @(" @(" @(" @
M(" \<W1&;G0Z9F]N=%1Y<&4^5'EP92 Q/"]S=$9N=#IF;VYT5'EP93X*(" @
M(" @(" @(" @(" @(" @/'-T1FYT.G9E<G-I;VY3=')I;F<^,# Q+C P,3PO
M<W1&;G0Z=F5R<VEO;E-T<FEN9SX*(" @(" @(" @(" @(" @(" @/'-T1FYT
M.F-O;7!O<VET93Y&86QS93PO<W1&;G0Z8V]M<&]S:71E/@H@(" @(" @(" @
M(" @(" @(" \<W1&;G0Z9F]N=$9I;&5.86UE/G1I;65S;F5W<F]M86YP<RYP
M9F([(%1)34533D574D]-04Y04RY01DT\+W-T1FYT.F9O;G1&:6QE3F%M93X*
M(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.D)A
M9SX*(" @(" @(" @/"]X;7!44&<Z1F]N=',^"B @(" @(" @(#QX;7!44&<Z
M4&QA=&5.86UE<SX*(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @
M(" @(#QR9&8Z;&D^0WEA;CPO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F
M.FQI/DUA9V5N=&$\+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:3Y9
M96QL;W<\+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:3Y";&%C:SPO
M<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @(#PO>&UP
M5%!G.E!L871E3F%M97,^"B @(" @(" @(#QX;7!44&<Z4W=A=&-H1W)O=7!S
M/@H@(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @/')D9CIL
M:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @
M(#QX;7!'.F=R;W5P3F%M93Y$969A=6QT(%-W871C:"!'<F]U<#PO>&UP1SIG
M<F]U<$YA;64^"B @(" @(" @(" @(" @(" @(#QX;7!'.F=R;W5P5'EP93XP
M/"]X;7!'.F=R;W5P5'EP93X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @
M(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @/"]X;7!44&<Z4W=A=&-H
M1W)O=7!S/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$
M97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP
M34T](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]M;2\B"B @(" @(" @
M(" @('AM;&YS.G-T4F5F/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O
M<U1Y<&4O4F5S;W5R8V52968C(@H@(" @(" @(" @("!X;6QN<SIS=$5V=#TB
M:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E179E
M;G0C(CX*(" @(" @(" @/'AM<$U-.D1O8W5M96YT240^>&UP+F1I9#HQ,3E$
M03A#.#(Y,$1%.#$Q.#4U,#A$-3DY,#8P0T8T13PO>&UP34TZ1&]C=6UE;G1)
M1#X*(" @(" @(" @/'AM<$U-.DEN<W1A;F-E240^>&UP+FEI9#HQ,3E$03A#
M.#(Y,$1%.#$Q.#4U,#A$-3DY,#8P0T8T13PO>&UP34TZ26YS=&%N8V5)1#X*
M(" @(" @(" @/'AM<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#YX;7 N9&ED.C!!
M0D$V,S!%-CDP0T4X,3$Y,30Q.$$T-35%,41#,SDW/"]X;7!-33I/<FEG:6YA
M;$1O8W5M96YT240^"B @(" @(" @(#QX;7!-33I296YD:71I;VY#;&%S<SYD
M969A=6QT/"]X;7!-33I296YD:71I;VY#;&%S<SX*(" @(" @(" @/'AM<$U-
M.D1E<FEV961&<F]M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @
M(" @(" @/'-T4F5F.FEN<W1A;F-E240^>&UP+FEI9#HQ,#E$03A#.#(Y,$1%
M.#$Q.#4U,#A$-3DY,#8P0T8T13PO<W12968Z:6YS=&%N8V5)1#X*(" @(" @
M(" @(" @/'-T4F5F.F1O8W5M96YT240^>&UP+F1I9#HQ,#E$03A#.#(Y,$1%
M.#$Q.#4U,#A$-3DY,#8P0T8T13PO<W12968Z9&]C=6UE;G1)1#X*(" @(" @
M(" @(" @/'-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#YX;7 N9&ED.C!!0D$V
M,S!%-CDP0T4X,3$Y,30Q.$$T-35%,41#,SDW/"]S=%)E9CIO<FEG:6YA;$1O
M8W5M96YT240^"B @(" @(" @(" @(#QS=%)E9CIR96YD:71I;VY#;&%S<SYD
M969A=6QT/"]S=%)E9CIR96YD:71I;VY#;&%S<SX*(" @(" @(" @/"]X;7!-
M33I$97)I=F5D1G)O;3X*(" @(" @(" @/'AM<$U-.DAI<W1O<GD^"B @(" @
M(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP
M87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T
M.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.C!!0D$V,S!%-CDP0T4X,3$Y
M,30Q.$$T-35%,41#,SDW/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @
M(" @(" @(" \<W1%=G0Z=VAE;CXR,#$X+3 R+3 X5# V.C,W.C,Y*S U.C,P
M/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A
M<F5!9V5N=#Y!9&]B92!);&QU<W1R871O<B!#4S8@*%=I;F1O=W,I/"]S=$5V
M=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA
M;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL
M:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O
M=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\
M+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.FEN<W1A
M;F-E240^>&UP+FEI9#HQ,3E$03A#.#(Y,$1%.#$Q.#4U,#A$-3DY,#8P0T8T
M13PO<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @(" @(" @/'-T179T
M.G=H96X^,C Q."TP,BTP.%0Q-CHU,#HT."TP-SHP,#PO<W1%=G0Z=VAE;CX*
M(" @(" @(" @(" @(" @(" @/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@
M26QL=7-T<F%T;W(@0U,V("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N
M=#X*(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z
M8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @
M(#PO<F1F.E-E<3X*(" @(" @(" @/"]X;7!-33I(:7-T;W)Y/@H@(" @(" \
M+W)D9CI$97-C<FEP=&EO;CX*(" @/"]R9&8Z4D1&/@H\+W@Z>&UP;65T83X*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @( H\/WAP86-K970@96YD/2)W(C\^_]L
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M86,@D?AE5,GTA*%:,@[MN&# @YQSYXJ<'/#SI06TYC5;Y1*\',OEU@3&I03
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M=\)U"_G87"-(QCFM0D;N-C!MTP\48+*-K,!UBL+WD!P!>\%&=4R(A2)2?->
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M/68_W2G6KAU]!')?\656_L7:;-0])L_49OXC3=:^9N/68_W2G6KAU]!')?\
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MV"F'+-#!T\JA\(Y)(9)FLD7;I-WJB*+EFW="N#;S0L>CC9O8;HW ?Q2-R@Y
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M==).4'/SDL#;C3EH\A+?"Q>=1BP6>3'*32'JY8D7BH^(QB5M"01FH[#29A&
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MU.#HOIE[ZNGQ4\B'0$_7CYV?AIB'O/3I/A3]6:9ZX_NIP=%],O?5T^*GD0Z
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MEE AVQ0:BP2%F7C;RR.<2JBM@ LI8#G*Z5.QVB2#>9KJW1,RY>2T4O( >%L
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M"$87:@>99FSLN(9#D\0;EE5O'(.Y,K5;%^CCZ7&K.74RY.\2.CFF%,(&PLC
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M([3$2@4P1L5C*)(5^=5P2#*:=K*!-MHRM'')'&XX0=4EW\0;@XW%A(X#/N9
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M7+,2U6'=T)TT ?CC !<!X.VD%Y;#^1W,.\YC:;R.T-G&PJ_+B(BX=*BE4/\
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M)DZ02:+D'3<0'&(O"A#Q>-:NBA19JT50%"FKHF25:L&R[A-3:.P=U;%Y*FK
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M]NQW[Q _;]*9':.\4\8">W8[]X@?M^E,CM'>*>,!/;L=^\0/V_2F1VCO%/&
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MK*,QP:[.R0B AJ0[<\^&AF6V;Q_DB^-Q\*U:-,%GI W( XUDW77=_P !2H\
M<E((4KVT[-D+.;5O&:7<&D;%QL:,OH^7!HQ^%@Y^2>X"$%"+P@TPC,A&NF^0
M_!RN\=9JCFJ"KY'-OI4XY@=>>S\N*W\:O2$R0OC'/"B0*2X3,A7#^/GDD&Q(
M58(^#L+/VAC_ '9/7['8Z0K(FRL$4DT>NVI"*JY/V[K)1!PW25&/?_M^OE4O
M]\4_*9_G9?ITI3OBGY3/\[+].E*=\4_*9_G9?ITI3OBGY3/\[+].E*=\4_*9
M_G9?ITI4GPK++<4X[N66_P#S@K_'OOO_ /QFNE*C5W_A3G_2%O\ B9:4JC\B
MXKF9#?2UYX2 :$76DK["1Q9@JZ796E7+")UBY@\5F!)46DH$>Q>W:F"2YF^8
M,9 DWBDHL&'XIN6\L)+KJG/+'\]9]_V>SG T&X*6C"HO0\71EE<O4ZVICH[:
MOEI-9&0XN7S[@1:LHFV):-H8CL=N\V>%F1%OW"3E!:'O!+<=MC)&AI<J'5.[
M[/*Q^\ /96RAW"2THEO%&RLFK"90YBTG4,+U;90TQ.XT)@L\BE!"$GHF3N18
MF4S<]7):D%FL":V7XZ.85],7$&)65NE'PY3!3/Y?)@]7/)\GDZ_)6\6X8SUS
M.D#I,S7DFAY.S+?E)^(2)S/MD [*<W<#NV&RZ*91U^ 07FT6+!6[ H%.)*!2
MKP=%)$S.C5HSN+,*C/\ MS_-CVU*MV\67MKSBT96T+QP2K.Z(A4"CAEV)6=2
M. VG4MA2^S:LL07GCMX.]2!S&2AI#FBJLW7:OH.+132?I%5%1*@.._J\A_GJ
M_)[8^8<)3(2)$XVWEX&2*8\C:4N>(N3@=0?U1!0N^(=R7M4..S;I%U4BED6W
MY4W+'$?XM"@(M*(?&4VJK&%8;$E3GG^8C_X[1_M^?G6/5G#V?UI*(PHN\IN9
MP=BQ$#GH.11@NH\BKZO+SLBY('/*]VVQ58L9G)4Y^T"S/)SBU3 D85"#X<C(
ML8[D))JC/?SZOM\GY/\ \\N:XFO^!4NA"=8I)NJNQPA$9X3""^PU$FTV-2'B
MS*+H,2^9XXXQG#;<U8XBT!81-=UOF^:MP2R1,F_;+-T4523GO)'Y^H5&)OB3
M8M 12*%8F'CY%\W'\9(H]RK>-S PD,.458W("QE9O)HU$X!*3IP#)!UEBX3C
MFTKV?$8^9R9%' 5 :CM,(@IG/9UD\SVX&/)U5Z1\8(5A6_'VI:^1AK6 M83#
M1D5'Q=H2>%DV@L%LH-%OU7I&.1 GD\D YLUD)!L5BX(J/?E7(\H-;/VKC#94
M'K/\_P"Y_74\:5%-*4TI32E-*4TI32E-*4TI6P=?X&,_\ES_ $Q;2E:_2E-*
M53^N.-!.#\C9S?.9YGB0GC>;,)FX$KOFV=E#21V,/JG1E\5R:X1T48HV+B"4
M  2H*Z<&Y>!?[.I&HBOODT35.>6/Y'7GOZZY9IQZF^]/2BGT70U,FQYDY\C!
M,A,KO<!1^*$>:C?F2D-2<,61%= BU16?56HBY1P68/A.!_)LJ$<B-B:F>>?L
MQ_\ '%3,,KF>QVT[RL@&XB#C*R!M1CHTQ*NC.VS/:!HG&1U0YLT';;I^',SR
M^8G%@N[^"Y:H[/-\$EL^]*$\@.S/M-5I6XAR*'!CJH9^PDZL1I[F!5-. 4\7
M*"AC/E_:T<L]UO/%UT=VHIK!W,,B,13(M%RJ903M(I8038.W30 V5.?]L\L]
M0Q[>>15Z*[BF4#K^#0;(DN9RAD.C,4R,.MM\717*.A60C<DYQWS4WQ7?;L_"
MEMMU%-]E%<MM\\O^ENKFNQTI32E; E_UK?\ U>._H2&E*U^E*:4II2HFOBJF
MEY4K:E.O2BH)"S(%*(9L<1;8OE0C@\)=,&9G!CFNV3?^*GBR#_<>JX02?;-]
MVBJJ::V66R@Y$'LK3T]5I6#2"ZIU)'HY>57C8XB?FAH55VY!QM..U36]2B 8
MI^^:CWA1-0;7",B>OW0P>ML4D#X<FBHR',W"RG9]G_[4XZ4II2FE*:4K8%OY
M4(_Z<Z_X^>E*U^E*:4II2FE*JQR,XO17D1F,;&D]PV+H0O"II)A,@E0H^>J@
MI( ,@EU6K" 9$6 .@YSN ;B7[R7>.TXT.>FEXX&3+E<B394@X_6/R_S_ +9Z
MJZE] #3/DX#MM'95]'"]*F*L)HX;[YYQTV/FHV8 GZ;?;NY;L)(R=2!D8>X[
M8;,WL?C*"N*V!'OK)3R8\N:X>;<>)'.:"E]&OCP%GM; :V'%B2[%L2>/1,VL
M9\5DXTE%A^>37 P"C$I+8,FXT\]9.%X@%%"L5T<_A=Y5'57#/.-TM=SQE)G;
MQJF;GO+J*<G[#<!UG:P&'!JQH..4S'8C'23YJ->&WDDW@40V*Y.!PY3)M)IL
MMWO%B*&-2"I[/L'^^?\ >KWZ5%-*4TI32E-*5*$)_DIQ_K!7^C--*53LE.Y:
MF1?X8&G&.&#UUACCLFV[FV.*ZFV.VW]X_FVVVVU)ZS^4U1D]I[S6%U]E_;CG
MS;7U&HID]I[S3K[+^W'/FVOJ-*9/:>\TZ^R_MQSYMKZC2F3VGO-.OLO[<<^;
M:^HTID]I[S3K[+^W'/FVOJ-*9/:>\TZ^R_MQSYMKZC2F3VGO-.OLO[<<^;:^
MHTID]I[S3K[+^W'/FVOJ-*9/:>\TZ^R_MQSYMKZC2F3VGO-.OLO[<<^;:^HT
MID]I[S3K[+^W'/FVOJ-*9/:>\TZ^R_MQSYMKZC2F3VGO-.OLO[<<^;:^HTID
M]I[S3K[+^W'/FVOJ-*9/:>\TZ^R_MQSYMKZC2F3VGO-.OLO[<<^;:^HTID]I
M[S3K[+^W'/FVOJ-*9/:>\TZ^R_MQSYMKZC2F3VGO-.OLO[<<^;:^HTID]I[S
M7];S^8[[8X[G76^V&V^V.VZ;;?;';???+?;;^\?%MOOOOOOW/Y]]]_Y]*9/:
M>\U_/7V7]N.?-M?4:4R>T]YIU]E_;CGS;7U&E,GM/>:=?9?VXY\VU]1I3)[3
MWFG7V7]N.?-M?4:4R>T]YIU]E_;CGS;7U&E,GM/>:=?9?VXY\VU]1I3)[3WF
MG7V7]N.?-M?4:4R>T]YIU]E_;CGS;7U&E,GM/>:=?9?VXY\VU]1I3)[3WFOZ
MRL"8Y[[;Y'766^V...V^Z;;??;'';;'''XT/XL<=ML<=OYMMMMMOBVTID]I[
MS7\]?9?VXY\VU]1I3)[3WFG7V7]N.?-M?4:4R>T]YIU]E_;CGS;7U&E,GM/>
M:=?9?VXY\VU]1I3)[3WFG7V7]N.?-M?4:4R>T]YIU]E_;CGS;7U&E,GM/>:=
M?9?VXY\VU]1I3)[3WFG7V7]N.?-M?4:4R>T]YIU]E_;CGS;7U&E,GM/>:^<I
M_,<\LL\SKK++++?++++!MOEEEEOW=\M]]T.[OOOOOOOOOO\ 'OOI3)[3WFOC
MK[+^W'/FVOJ-*9/:>\TZ^R_MQSYMKZC2F3VGO-.OLO[<<^;:^HTID]I[S3K[
M+^W'/FVOJ-*9/:>\TZ^R_MQSYMKZC2F3VGO-.OLO[<<^;:^HTID]I[S3K[+^
MW'/FVOJ-*9/:>\TZ^R_MQSYMKZC2F3VGO-.OLO[<<^;:^HTID]I[S3K[+^W'
M/FVOJ-*9/:>\TZ^R_MQSYMKZC2F3VGO-.OLO[<<^;:^HTID]I[S3K[+^W'/F
MVOJ-*9/:>\U8NHI$:)QM\N^?JN%L#CE''//%+'?9/%@-SVQ[F">.W<VR4SW_
M (N[_"_C[G<TJ=S=O^_ZZJH5_E0E_I[S^D*:D]9_*?UUS6!J*4TI32E-*4TI
M32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-
M*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI
M32E-*4TI5H*4_P 52'_J!U_[<*TI7U/8G$<GCO+.,LLL\G*^666Y"1;;Y9;J
MY[Y9;[8FL<=M]]^[OW,<=MMOYMMMOBTJ[8O9[3[ZQNJ4/^;#'TC(_?FE-B]G
MM/OIU2A_S88^D9'[\TIL7L]I]]-XE#MOCWC#';;;X]]]R,C^+_\ W-*;%[/:
M??7T;1N#9;X8X@!66ZGP.][;%C^^ZG?4\U4O@;;'N[EWQ)-13#X/=^&FGGGC
MW<<,M]E-B]GM/OK[^J4/^;#'TC(_?FE-B]GM/OIU2A_S88^D9'[\TIL7L]I]
M].J4/^;#'TC(_?FE-B]GM/OIU2A_S88^D9'[\TIL7L]I]].J4/\ FPQ](R/W
MYI38O9[3[Z=4H?\ -ACZ1D?OS2FQ>SVGWTZI0_YL,?2,C]^:4V+V>T^^G5*'
M_-ACZ1D?OS2FQ>SVGWTZI0_YL,?2,C]^:4V+V>T^^G5*'_-ACZ1D?OS2FQ>S
MVGWTZI0_YL,?2,C]^:4V+V>T^^G5*'_-ACZ1D?OS2FQ>SVGWTZI0_P";#'TC
M(_?FE-B]GM/OIU2A_P V&/I&1^_-*;%[/:??3JE#_FPQ](R/WYI38O9[3[ZR
MUX9#$V[)7&,,OA+IK9*=TE(]]N[@X43Q^#MX[^+^#CMW?X_C[N^E-B]GM/OK
M$ZI0_P";#'TC(_?FE-B]GM/OIU2A_P V&/I&1^_-*;%[/:??3JE#_FPQ](R/
MWYI38O9[3[Z=4H?\V&/I&1^_-*;%[/:??3JE#_FPQ](R/WYI38O9[3[Z=4H?
M\V&/I&1^_-*;%[/:??3JE#_FPQ](R/WYI38O9[3[Z=4H?\V&/I&1^_-*;%[/
M:??3JE#_ )L,?2,C]^:4V+V>T^^LMY#(8@HECA&&7<S:,UM^Z2D>_P##7;)*
MY]S_ )[_ (OA9[]S;^;;XM*;%[/::Q.J4/\ FPQ](R/WYI38O9[3[Z=4H?\
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+\W=[O=^/_N4K_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>g472601g32l30.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g32l30.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[28$4&AO=&]S:&]P(#,N,  X0DE-! 0
M     #$< 5H  QLE1QP"   "   < E  #$5R:6,@3&EE8FQE<AP"!0 ,04-4
M,2!#;VYS;W)T #A"24T$)0      $ @6UK!(?MTQAO()DMWTC_ X0DE-!#H
M     0T    0     0      "W!R:6YT3W5T<'5T    !0    !0<W138F]O
M; $     26YT965N=6T     26YT90    !#;')M    #W!R:6YT4VEX=&5E
M;D)I=&)O;VP     "W!R:6YT97).86UE5$585    !4 80!Z #  ,0 U #$
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M;       0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;
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M;G5M     %!G4',     4&=00P    !,969T56YT1B-2;'0
M  !4;W @56YT1B-2;'0               !38VP@56YT1B-0<F- 60
M     !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL
M;VYG          QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I
M9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T
M ! #P     $  0/      0 !.$))300F       .             #^    X
M0DE-! T       0   !X.$))3009       $    'CA"24T#\P      "0
M         0 X0DE-)Q        H  0         !.$))30/U      !( "]F
M9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &
M       ! #4    ! "T    &       !.$))30/X      !P  #_________
M____________________ ^@     _____________________________P/H
M     /____________________________\#Z     #_________________
M____________ ^@  #A"24T$"       $     $   )    "0      X0DE-
M!!X       0     .$))300:      ,U    !@             #+P  !XD
M         0                         !              >)   #+P
M                   !                         !     !
M;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4
M;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   #+P
M  !29VAT;&]N9P  !XD    &<VQI8V5S5FQ,<P    %/8FIC     0
M!7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M        !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE
M<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O
M=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
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M='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H
M   ,     C_P        .$))3001       ! 0 X0DE-!!0       0    %
M.$))300,     !MX     0   *    !$   !X   ?X   !M< !@  ?_8_^(,
M6$E#0U]04D]&24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )
M  8 ,0  86-S<$U31E0     245#('-21T(               $  /;6  $
M    TRU(4" @
M               18W!R=    5     S9&5S8P   80   !L=W1P=    ?
M   48FMP=    @0    4<EA96@   A@    49UA96@   BP    48EA96@
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M14,V,3DV-BTR+C$
M                     %A96B        #S40 !     1;,6%E:(
M              !865H@        ;Z(  #CU   #D%A96B        !BF0
MMX4  !C:6%E:(        "2@   /A   ML]D97-C         !9)14,@:'1T
M<#HO+W=W=RYI96,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N
M8V@
M    9&5S8P         N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO
M=7(@<W!A8V4@+2!S4D="               N245#(#8Q.38V+3(N,2!$969A
M=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="
M     &1E<V,         +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I
M;B!)14,V,3DV-BTR+C$              "Q2969E<F5N8V4@5FEE=VEN9R!#
M;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ
M      !V:65W       3I/X %%\N !#/%  #[<P !!,+  -<G@    %865H@
M      !,"58 4    %<?YVUE87,          0
M  */     G-I9R      0U)4(&-U<G8        $      4 "@ / !0 &0 >
M ", *  M #( -P [ $  10!* $\ 5 !9 %X 8P!H &T <@!W 'P @0"& (L
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M_P!+I?:K_P#N'=]]/_I=)3']G,_T^1_VZY+]G,_T^1_VZY2^U7_]P[OOI_\
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M"'?FN;_)7.UO+WV/=&Y_N,"!),Z-'T5TO7<+.RL#;?8P,K>U_P"AJ<]Y,^G
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MOI_\&OF]))+]19^S[(_?ZD:?S/TYD;=G]I8E_P!C]4?\JSN&R/6C=[8_G?\
MT9_PB^>$DD/TCTOT/M%?I_M#^;=M^T^IZ4>S;NW_ */U/]'_ -<6ROE5))3]
M5)+Y5224_522^54DE/U4DOE5))3_ /_9.$))300A      !5     0$    /
M $$ 9 !O &( 90 @ %  : !O '0 ;P!S &@ ;P!P    $P!! &0 ;P!B &4
M( !0 &@ ;P!T &\ <P!H &\ <  @ $, 4P V     0 X0DE-!"(      4I-
M30 J    "  ( 1(  P    $  0   1H !0    $   !N 1L !0    $   !V
M 2@  P    $  @   3$  @   !X   !^ 3(  @   !0   "< 3L  @    T
M  "PAVD !     $   #     [  \X?   "<0 #SA\   )Q!!9&]B92!0:&]T
M;W-H;W @0U,V("A7:6YD;W=S*0 R,#$X.C R.C X(# Y.C4S.C(Q $5R:6,@
M3&EE8FQE<@       Z !  ,    !__\  * "  0    !   'B: #  0    !
M   #+P         & 0,  P    $ !@   1H !0    $   $Z 1L !0    $
M  %" 2@  P    $  @   @$ !     $   %* @( !     $
M $@    !    2     $X0DE- _T       @      0   /_A 4Q-30 J
M"  ( 1(  P    $      1H !0    $   !N 1L !0    $   !V 2@  P
M  $  @   3$  @   !X   !^ 3(  @   !0   "< 3L  @    T   "PAVD
M!     $   #     [    \     !   #P     %!9&]B92!0:&]T;W-H;W @
M0U,V("A7:6YD;W=S*0 R,#$X.C R.C X(# Y.C4S.C(Q $5R:6,@3&EE8FQE
M<@       Z !  ,    !__\  * "  0    !   'B: #  0    !   #+P
M       & 0,  P    $ !@   1H !0    $   $Z 1L !0    $   %" 2@
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M 0$! 0$! 0$! 0$! ?_  !$( ,0!T ,!$0 "$0$#$0'_Q  >  $  @(" P$
M            !P@&"0$% P0* O_$ &H0   & 0, ! <'# D0!P0+  $" P0%
M!@< "!$2$R$Q"106&$%16!47(E>7U-@R5F%Q@925EIBQU=8C-3A"D:&VT_ D
M)28G*#,T-E)S=79XL[7!&3=R@K*TT71WX?%%1U-B8V5GA(?"QO_$ !X! 0 "
M @,! 0$            !"0<( @4&"@0#_\0 71$  0($ @8&!@4%"P<("P
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M,"J?2(NPT1>!5TV04;(KN4$57BQF[1)59--1TN1!9R=%L0Y@,NL5LW<.#)I
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MFD;&-&L?'1[9%DP8,6Z31DR9MDRHMFC1J@4B+9LV1(1%NW1(1%%(I4TB%(4
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MACJZKD8/VZBRS A[N?CNV<?!7FVH-63':]MT9QL#/5>/:X.Q6W95NTK>,V6
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MBT^@=?ALYWU*F>7\+ '=LRV7N=I5JB;2J<F8ABY3W,CT#D. 'W)YA.41(8#
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M7]6C_IZEV]ZS/T>_OAP;_;U;] U5?,6/;SQV\D$ X[>?@>C5; R<;Y>N3_\
M45:>PV$,G*T2&;G8 (C3<WW 9WV67TR1 CYGN$.EV"">V[O[./[.<?\ '\>K
M4M'9O@+">_\ T!3AW2S /@J?M).6D#&8.1&)JP#V^G1A;O5UENL%)4$3ID6%
M,X)&4**A"J=$0(8Z93IF.0I^!,0JB9C  E!0@B!@]JO%*'L*V*_VB"L4C?)&
MI/G+"^7VJ1I:I7I>!1(TI-RGZB9P^++6:R'<.9 \,5\ (*-DVQ5A1Z*HAR4H
MO?V9?!3-HI31$T1?DP )1Y[N.?X.W_EH>?;W9HOFX\*00I-Q-CZ( '.-JZ(C
MW_",UE!-VCSZ0*/'HX#CC@-:"Z?W:NEV5(.8DL/OS]8!S7O#39UQ:VT6U79Z
MP.:L5Z-WW-3PXSF)B=QN^!##C?;F'.'*^5K"U*L3!RU9!ZJHRXY]8A&#WCZQ
M[..X0[.X>-<-! MI@FP!8"7KHL!L#9B';N7].D-9NA.GD!H<9F@.)U6W+GPX
M^L2;7)-M^S:++*(L">6MPX O1&-J(<@ ?4@%AZ/ ^CX)AX$/0/V=;^D6<X#^
MD>>:KD_FB^S5"L[DN2CHVK5$TB_8L.MMN,N@+UT@UZT4;E7%UNCUZB?3%%(#
MJJ<<]6D G-T2!SJC2<DYR:TJ:4A+RLS,&%4-+'6"! BQ3#ZR5Q% AZXAM<6]
M9&<V$R]M:(0P7<;+>:'%A0L,X;,2)#AMMA)P+W-:-6&^7B13<D9,AM+WF_JM
M:7&P!*VN['3%.WOIRF*8AEZ_T3E$#%-_4\H/P3!R!NP0'L$>P>=;;= =I;+Z
M26.!:X3&'06N!#A9M3O<',;#M&X\%B+3X0Z+AIS2"UT*I$.!N"'19<@@C(@C
M,$9$9A7\U8JM>$T1-$31$T1-$6DW/_A-<K8FO6YO&T%2\>R-II.2,>Q& 5)=
MO:"1EGH,3!M+1N3EKP=I))J+2F-Z[!V]Q#+P"C!B,M8,>Q<RW*5ZX=O2XDD;
MK^<]ULN%\^U64E_"7X<BJ]!V$:9E!TUGJ.TR$54K*EQ\=!UUSEJ7PXN]M<_,
M7*-KM4BXRP0CV6E;#8)=A6V$$=LNO-%?N$H[13?SEW\+>=JQ_)'A&X:HR&.[
M8UI\M%8!<9=S31<@YBLK2%=0\Q X*P9N4O\ D%SC6.KUW>6E.0K5ZP/[AK2%
MJJ:$3.Q"K_R;)(G=,Y5J4:WGL!)L-N6_N60AO^AKGC6A9,QK77;2.D-SE4P1
M>XJWHQ$J\8L)2 4M$H]K4M2;=+U.7>*PCN%7BY1A8YB+:.W+V+EVB$I'OV3(
MIO>W/S\E4W<1X72SP^%HF[[>,)V).W2L'(Y!.GF>.JRT+&XO3VG9(W95*TN(
MNI9<C'KM"_U;'KN$;)M)TT[5%D)E_+5=^]:PT#/E!.=K<?.Z_9<%6QF_"48L
MK]ONV.1I=YM60*3*8<@B5VER6+ILUOE,T7DN-*^2"7#)":->-'7@31,Y&Y%6
MILS'H=7(%CG#$3K@0.!RV>>5[>U8*^\+)BEK#UI^GA/< M)W6-JUHI];)#XT
M3FIVBVO'.X'([:ZIBZR:VB8V'8,MLF6(21CIF3C[.G,QL4+>#=14RSDS%-_@
M#W[NU9,_\*+A:%@64Y9J7D:H>,W'&U=5B;,YQ?&3J5;RY"UR=H.1V4.?)!WE
MCK$LQM46+R&JA)R_0"Y724_4(_J!ZPFL/-N7//;NNL7Q_P"$N-8G$*E;\+7N
MK3MH>Y7K=)QLQ\A)^RY L]'W+N-O5=3KEK0R2WJ\7[MO(^2>2,=:VT(UCC1L
MQ)*61&'81ZDZ2^5^5[;_ #RW[EG^.O"5XER5D1''T5CO+T4#>]57%5IMTW%T
MM.M4G*]PDKY7XO'DZ6.NTA8'<NC;,:VRKR$I78*<JS21;L7)YXT1)LY$Y+]N
MW]7Z\^.7!6 IF[G!M^SU?-N=8O,!)9&Q] P<S+1S:9BG)G+B3EKO#RL(S;(.
MSOQEJDZH[P;,V7:(%9DDXWJE%3&<E0)<7M?SGL\E6;T4IHB:(FB+6UO*B,=3
M69<#PUXR1)0Q;A%66C/\8M\9V?(D5D&LSM\Q3(F83+N!=)1]0@;)=8.EXWN"
MU@;O8Z\TJ\3V.3 Q/91D&Q1?=O\ /GFI0#%Z&2/!\CB+&MO3R"G=MH*N/<>7
MNT>.1Z5O5L&'SU^GV^=\82>OHWW77=QTR^.HW=O6'7'-U:SA$"F)M''+OR69
M[D<=S&3Z!$U1OC:$R0SA)^FW 8:5R/:,;G>RE5G8]TW;1E@J)FTM&R;9+KY>
M/?N5G$0=>.!A(QCDCI-1(A\YV6<[=ZC=J+A>A5C(LAX_<V4:[=S:!9V1M2%=
M/-2\C.,J,QM<N1*6MD9CV-D6=$BK7)MF#^S1M=:SKR,C'$@I'MBE8+MJ ?=W
M=$(F$W.YZV\ (%^" 4#&0< )2E$>1 3")A,;D1[>.  H&T]OR"M'HI31$T1-
M$31$T1-$31$T1-$31$T1-$31$T1-$31$T14S\($'.TO*P>M&J>H0'^SBM=@\
M@/8/K#@P?O3 .L/Z>ONHQ5V4<]U>I969^CW]\.#?[>J_H&J>?FOF-'O'C_)Y
M#GMX'H]@^CD0'MY[.WM#C5:XR/&SC?=>Q-^_V\[JTT-O##;[;-O_ +UKVW]F
M_8KMS&[;/E9QI6Z?%W-H6 A/>W8Q+)S4J<^\1293-=-&J$5>P+A55RP520<(
M+N3+'Z]%,YN1#5K6 (8A8&P@P?\ NY2'D[+F+)08NS=JAX;EMU=:PO84^Z1G
M%^/\;.)/VKK_  W529'#=;DMINQ?.F4LS2.14LB68)U"OL:Z>,1+#046""T@
MYEB.EC'AXV/45,<C% H%5.=,G B0I1$=>N7C,^/LR5L<&%$M2LP"8Q_[<F>A
MY,"8"']NF^=@=6FGR <=@GZ:@_OE#=G!0W?_ %BIET7)-$31%P/</VA_-J"+
M@A%\W?A2QYW$6(..WWMJZ;GGT&:2G <?8X[_ $\]P<:T$Z0 MI=EC?;(4'+A
M:)$^*L6Z-YOH:G?[YB7V7@PE2'%:9E&K "J&3 M78G.4"E,"I02C@!,_2 >"
M],2*<E$#=),O @'/+00;:8IO^[U\;M\Q#X@KETB!?0E3_P"WP]_PYCS^O-9;
M%% MUN!?_P NJ7_^@#U?8].M_'#-]CM)L>&X=RKFVM _[-O/>KOIQD>_C(I.
M19,Y$$F#,R0/&R*Y2'%LW*<Y2'()"F-U?(=6!  1 3 <2\C0/I GIR6TAZ08
MDM-3$L^+C?%@BNEXT2"Y_P#IRH. <YC@2V[\PXNRN&EH-AO_ (=A0XE"HS(K
M(<5K:-27 1(;'Y^ABQ >"&\"0+VN!8$K8WL=*!6U](4 *0BU? I0#@"@#>3
M  /1P  '9V<!P  '9K>/H#$N@:27N)<YTQATDG:2657,]I<2=]\S<K!>G[*-
MAL#9U50(L +>O+9  #(7R5_-6*K75-$31$T11AEG)C3%-5-:7L4ZET2R#)@#
M1FLDBN8[TYB%4 RQ1+T2=$>>.>1$H<ASR&*=,6E.3T0X2;BN=I,Q683JI)TL
M2DM,PY5^O-PYB+UKHL6'$:&PV2SO4#"7$BY:+E>HPAAB/BZLLH\O-P).(^7C
MS'73 <66@!I+0UN9)UO8!L)L%"]!W9P=]MT-4FU0F8Y>86523>.7;-1%$4D3
MK"8Z:8=8<! G ]#D2@/2$. '6"M'73#HFD'&=!P=!P94J;&KLV9.%.OJDM-P
MX$3J(T9KHD&%*PW%A,+5)UVAM]8G*R]UB70_4<-46<K4>M4^9A2;6.=!@PX[
M8C]9P: TO :#FH3L]QV0RDV\=W;&<*W7EL[;AMO$Y<;5!0C*-B+6IBJ5RCGB
M<F+*_FTS0E%LU&Q&4)N?(LW,NM#QB;U@Q9D7=M]R^W:L.97OO.5_9?X+$+R;
MP6M=JN7,E%1P/=>A3K!<\APF-KI6;):+'1ZU<W#ZSH)UZ(N#9)]3VE\F)-6P
M0(^*U$U@F9I*8:"YEY%-V46&?>?/=?WY*88^O>#T>2$+>X=]MSDS9(N=G/4%
MX^[521KEXR"O7+92+JWI\"2?6JLM:9* O-RKUM90,:I(2B=@DDYY-RX<F,4I
MRY;?><E@V <Q;%<J8X+!5N.B:?1: E6,W1T+EV68Q'N:A,8EIF8?+6*-.VZ8
M<!&T6C9/KA;3("\+#U!>0\2.H1@9DZ<E'J[-V1Y9[/V+VZQ&>#RR2V1I3FJX
MA@W*MBONVNHTJ[R%:@INY)88K5SVU3L!1H-6P*2%BKC7'\U;:;%#'I*.E*A.
MK@NT:^-%*4IR\_+OW=B[V#@?!O-#V[+U>EML96Q+E4IVZ7Z.O]-5AHRZI65M
MDNG.I:62L1XB&EW=OZB\1385&)I6==NK"5N[=R+YTZ)8#/M]^U2N\V_[2DW>
M.!>8]Q@1R\C6F.\6&4\5Z3^,B*-F)=I5ZG_50>Z*;&@Y&S>Z(S9>,'+7K';W
M@CXOURB),O@/ 6]J["P;-=KULD8J7L6$J+*R<*RA(V,>.HTYG#2.K49%0\%&
M JFND9>+BV$# I-XUSUS'KX&$?&0,_B(]T@2P/LV;<E[;O:)MN?A8 >8AIZX
MV=><=RQC,G!3B[LEQ89$F7<<<CHJD$\=WZ,8W0'<$>-=-;2W+.LEF\D=1R<E
MALW<///V<EVU>VO[?ZF#8M9Q-2H,K27I-@;EC(=)KT)[' R1J1,B*9@%24KR
MLS+N&CY7K'2CJ3?NW2J[ETJJ8I4ILJ?7H^SS=S:QC9*SV.)KT%-S!""#N1B*
MHXL#JNL'!A,)!1BG%JL*S82D*H!Y5T)SF Q (19/HB:(FB)HB^?G>E>:C=MR
M$)"VO.6)H.VU#=5'8(A<?9%SFK@*"Q_BQUM8B=S#S,DC:L0O*=N D;0QR;6H
M(U7A9K)#'$UDF(^M0!(^IVE>.R'"%'QY[O(6\#$$'6JSBC&E<IDO$V"H0-"J
M,-5IZ!+$$A)NNQL"P9PTM#EKX!!!%R,<BW>,/<</<SQ99+Q'^INJ'12L[>NV
M,8S=R,@Z:1[!BV7>/GSU9%HS9M&R1UW3MVY7,FBW;-T2'6776.1))(IU%#%(
M41 B\R"Z#I!%RV62<-G"2:Z#A!0BJ*Z*I0.DJBJF)B*)J$,4Y#D,)3E$#%$0
M$!T15AVU" SNZ+@>[<_;@'[ ^0.,QX'[@@/W=% VGM^05H]%*:(FB)HB:(O1
M6DXULNDU</V;=ROP"#=9RBDNL(G%,O5)*'*HITCE,0O0*;I' 2AR(<:(O= 0
M$.0'D![>SU:(N=$31$T1-$31$T1-$31$T1-$7 B =_VOX=$5-?" CQM+RMS_
M /95/^7-9#\XAK#^GO[J,5?U:/\ IZEK,_1Z^^'!O]O5OT#5%\QGI_[HA_ 7
M@=5K[S_6=[R2K3V[&_UF_P"(*2[S_BU'>C^K<?=_8/[<U_O >T.\!#GO 0$.
MP=6O8%^Q6$?PS0OT9+*GK2']OL:_BO$'Z5FEM*\'UDBEX[?Y/7N,VG#)2K6L
M(L#':2#OQA1HXFS."@#!HZ$G5E<(B(J@0#=,.B)N#<=1CS2I@+1DRF/QQ7X=
M";63-"FE\C4YWTDR0@&9L*;)3AA]4)F!_#=7K=9ZFMJNU>NH.%J]B<S(H<@Z
M?,H(;IC5CRT'JQ%!,/\ C$:#K:P%_5UK97S5X<$[@<1*PDQ$IV](TC)9DS0#
M)O[DSH"M[LYFNBT9PH,6"1/&DG;<Q144("?6<*BF8AP+X^'TD="L6I4^D,QO
M =4*K]&>@2_T/B$&8^F(4O&IP$0TD0F&8A34!PZU[.K#[1=0AP':NT<8SA2L
MU.Q*+$;*RCIKTB+Z73R(?H<1\*9!:)K7=U42$]IU6NUBWU-8$$W(UG%>*31$
MT11+;<D2E8O%,IB%#L$VA=W3QHTLK"5JJ$3&*1S%U)R0/V<I.,9HP,XYHHZY
M8QSH%^F1!OUBW) @]MLC^U/9YS\^T+0GX45JJ]W(R[1%QXJHZQ]54/&3(@X*
MF!TI IA! 54BJ#T3' .3DX,8.PQ2AK03I!S4.3TKLFHL!LTV5I=%CB7<]T(1
M3#,9VJZ(QI<&DAMP#F+V()SL;Z-$I%G=#T63A3 E'3=7K\L9D06QGP&Q&0&!
MS(<3U3MMOXY[52?&+)Q'B+%9SXXHTA?%U'*;8&HG02=QZ2?1;D7423$I.@0.
M% +SSR( /;_/0'-,G]*WI4&7$L(]+JD8P6Q'Q@QSW2[GNZV*!$-W&[K[1LY\
MND;*1I#0\)29FA->BU>CP&1/1X<L7-:V8#0(<+U  &Y"^6Y9/$L;"C:[#)OV
M4,E$2;2-09+M9I^ZDQ]RC/NI.ZCE:\Q:H&<@_.<P)2SH$A2(03J@8PAO_G=U
M\S?CR&5_#XJN+<VPL#PWC/\ 9QM[KW,NQA&E'O\ <UF/K[ 1( ]O=W_9^SKY
M_M(_V_Q[^.<5W[?IN=(]V]6!8:_D2D'_ +EI'YH%L.V0<=3?^T/\(KX<<AS_
M (/)B'9W]H#V>OT:WLZ O\5TD<YC#G^&I^!R6!]/_P##X:/_ ,&H?XY;P/<K
M]"(!WZL66NJY >0 0[A[0^[HB:(FB*MVZ6N35IQ<O&0$8XEI )V'<%:M0#K1
M2144%50.0'DJ?2(8P ': <>C6KG2ZPU7L4Z*/H_#M,FJM/0<1TF;?*24$QY@
MRT.#/PHSV0PYI]1T>%>QO8W (!MDW1+5)"CXOA3M2F8<I+-I\]"ZZ('%H?$:
MP-;ZH+AKV+;C9?/E3S!&+<B0F6J?*S54DV$<R=.CN';E $TT2F9K)@(CT $>
M3&*7@!]/;V<B&D71\T5:0:-I@P15*K@^O4ZG2-5=,3<Y-RCH4"#";)S30Y[W
M1#D8CV-LUKG9WR )&;-(N,\.53!M9DI*JRL:9C0X(AP8<1SW1+102+:H&6W/
M*XXV68Y3\'K7\E264&LCE:9AL<Y"F,QW]A2$*S".'57S%G+!UHV_VVYDM;MY
MXY+5Y*JW*?F8FD'8QZB%LDW+I6R.H;Q*!9W +47M]_9YXK"LE>"\Q=D*OV:M
M%R&ZJX3MZMUW>.86J5=-XR;VW:_#[:74$1-R91H>*:QD-&7,I7S1RU<2J#1B
MZ8*-&Z:ABC5V\_/;[]Y6/3/@K*?<,JOLQ6?,D[8;_;K-%3N8H5@WM=,Q;<8Z
M#-CPE88Q&+<>93J4;6W4:RQ;4Q4DK-)9"CYV4;NIJ8@G[LD,$*35YY[K[MG9
MPVBQS72K>"'@FU"EJA5]P%JKLK-XAE,%R=D5HU<FC&QS9=M^+=NUM;M85[(D
M:M[#*-,05.WQ,TJX=MX21]T8M2)E&3L3D*;>&60[N?G8I+CO!F5B+MEEG&>5
M[#[D9#OD=<\DPSBK0;AY,,ZMN#MNX^CP=/GUW9WV/W$9=KM+QEEFHY"17M%:
M1CD&[>NS;!O.@2V9-]MN&Y8%)^"(HRM:QI%P>9+I7)K%.-L84*!E85&>JS*8
M4QV&=&KJ:MK?&U\Q]:)@;3%9ZLS=]&L+K"@V>1T:].\?MG$C&.R6W_#V^*M%
M;-B>*[6OM:6-.Y)K+3:NK#(5F$HF7,TT:NRL)!8IR#C.*B1@ZQDZ,9,'#?R\
M]T%;*N$M;9*&B2TN8G9.LR+YF<EN_(D\;>?)S5X"_!*4INP0*'(<B;N .?A&
M[1X_RC#R/>/:.BE<@8H]H#V=OK]'?_3TAR(=PZ(G3+QSSV=@\CV=_=^;1%P!
MR#W& ?M=OH ?S" _:Y]0\$7(F  Y$>/M]GJ] ]OI#1%ST@]?\';^;T]H=G?V
MAZ]$3I 'I^QHBXZ11XX$!Y[N.W1%2?<INBH& ,A8HI=KJ]==&RH\!!>U6RSP
M--A81H:VT>A-CE?2T8_--R03=[A7KZ+ T:1A4H^P397RZL6A$OR*RN(+[&94
MQ1C3)T+%/H.'R'0ZE=XJ%DTT$I&(C[3!,9MG&ODFQCMDW3%N]3;+D;G,@51,
MP)&%/HCHBQ7<K0FV4=OV9\>.:ZWMWE?C*ZPK6LNT$W+:<DW-??C$QJS9P8K1
MRFZDR-$SMGPBQ<E$6[XBC159,Q%GF.(YY$8]HD5(MSM)",IM8CWS542BHV>,
MH5DV<H*"03$$Z*R9TSB4QB](H]$Q@X,)%1S$E"S+8;]NID:1GU?'L".Y:QH)
M5LF,*=:2(N$<=XQ\8=%EIE0KX_C9C H*!@!)$0Z*0 71<0,SG;/EP%]MU.?O
M3[D_3NS=#]@,'8X+V^CM%0W'V?@C]K138\3[O!1(UA]W2^7Y/&JNX-BC"QM5
MBK<>UEQ[0%7RT?,O9F)9(%K(UA-(CL)6">I."#8S)ILCMGB:BRJBC-(HSO:_
MPYV_F\N*]C,=;W<X^I2]IJVY:.L3QI+0;)S'3F**/ M_$YN6:0A%T'D?#V!4
M[A!](,SG049I)G:>,J N55)-)8IL>)]WAYV\E(\=BK="HP9*2>ZX&\D=J@:0
M0985QZ[9(O12+XVDS=+$9K.&J:_6$;K+-&RJB0$.H@D<1(!+'B?=X+]/,9;B
MV+=9TZW<.$D$$5EU538.QP4B:2"9E5E#\G,(E32(<YN.! I1$.>[7Y9R<EY"
M7C3<U$;!EY>%&CQHC[AK(4O!B3$5Y(#C9D&%$<0&DV&6RQYLAOB.:U@+W.<U
MH: +ESB&M M;,N( R.=E2N_-_=O+F()R8W:U&=F6 7 K&S/\ 8V<OH$&<2F]
M;@FHM'G,N4[L159 94/<YT07C84EU#&'#L'I&Z$XTO-3+<?TDPI02XC?Y&IA
MT)\S']'AZQ-/ <UT2^;;:K;.<;.!7JWX QFUT('#M1U8HB.:>J@D!K6ZPO>,
M'"^S)EW<&YE6YJM2SE<HP9:L;QS2\:#A5KXXVP;CSJC+H@054_V0R9ND03!T
MO@AR!BCR("&LB82QIAC'=,B5K"=6EJU2F3<:1],E>LZOTB7##%A_Y6'"==O6
M-/U?JN!V$$]#4Z34J-->A526C24V(<.*Z#&:T/#(@)8;"^1 62^]-N3]K1S\
MAN./Y[7J%U]CQ/N\$]Z;<G[6CGY#<<?SVB6/$^[P7'O3;D_:T=!__!N./^:H
MZ);F?=X)[TNY3VM77R&8W_G=$L>)]W@GO2[E/:U=?(9C?^=T2QXGW>">]+N4
M]K5U\AF-_P"=T2QXGW>">]+N4]K5U\AF-_YW1+'B?=X)[TVY3VM77R&XW_G=
M$L>)]W@N?>FW)^UHY^0W''\]HECQ/N\$]Z;<G[6CGY#<<?SVB6/$^[P762^&
M=S#V/=H(;Q9B*650.!'\;@S%(O6Q@X,55M[HM9-GUA>B(%\89.D@Z0B*)C<:
M)LN;[.SAY.Y4>S)5-P+K8N.0<A;F9K);"TT3&ENF:W+8JQI71<+6M_4)3Q!*
M;JL;$N&K2(>OR*,3ILP<JD:$2>+K@HH)\/Z>R!HIQ5<-(+:0+$G(_3U+L<CG
M;;OW;EFCH\W_ 'X<&9G.8JAW?]0U6XV 9Y;=EN:TL&^J'U_:#T]_9V@'/J#N
M]&JU_/[-GLR[5:>R]F7-S=G^(*3[1#S,S"1D?&O(UNN0U:?++R+599-0D:>-
MDTDDR-'+4Q#"9JD@<Q@.'5>I3X>K7L#?8K"/X9H>W\F2RIYTA_;W&OXJQ!L_
M*LTK&8B!?JY05S)BJ)6(+@B7A RW[,90Z0&Z2@%$W84!4,/'>(CVZT6Z?]O1
M-%V6?68HXBUH-![!G>YN-HR66>C_ /7Q+_94[C_0B><\U(F%$GSIVBSC)#W)
MD7.7+F@PE0:(OC1KQ;)<XDW?@S<F*U=F9KF2<E:KB*2PD JI#IB8HZ:TQH.D
MS1SMS_>OWV_Z-P]R)SV'+9D"TFZS'.AO[D\2$@D=9BBX!.8%4GKC8;7 (O\
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MD[%Z4]>[CD60-9;U9):USRJ2;126FG:KU\=LVY!NB9=8QCBFD!S F3L @&$
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M%G6UCW&/D)=*5?!*1)XP'EN"1:"J]9.@41<J,TTP/XDX5%-1(S8W6$.'5_"
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MWN[N_C6^'0%#?0M(^W7,UA[?EJB%4SL[1V^S-8&T_P#\9PX-WH\\?:8D$'W
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MK7YI(*0X?]LX[_2+'_?!K:W&WV,Q7^':Y^AZ@M):1_*](_*U,_/I=6\#^_\
MW1_\(Z^>P[#V'X*PT_4]@^2VH;._^IXO^L\S_N8[5N_0A^YN:_&E<_,J0M/]
M-OVW?^2J?_\ N5J=;A+$2:(J[Y>W$X@QL[7IEORQ!XXM[^'3E(T\HW,[<MV3
MI9PV;22+19JLR=%.LU<I$25,;X:9NDGT@#7>TO"^(JU ,U2Z/.3TLV(^$Z+
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M^TUHR_M<4_\ @G$BR?\ ?#_WOS#J@A?0@W8SM9\0IY'^\L?]&1?_  ]MJU[
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%$31%_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>g472601g35a87.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g35a87.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\
M$0@!:0&0 P$1  (1 0,1 ?_$ !\  0 " @(# 0$            '" 8)!0H!
M @0#"__$ &P0  $$ @(  @,'"PL/!PD$"P4#! 8' 0( " D1$A,4%1<9(3%6
MU0H6&")16%F1E9C8-C=!57B3E)>UUN(C,CE487%S=H&6M+:WT=<:)$)T=;C3
M)3,U.&)R>;&S*'>2H28G.DA39H*(LL7&_\0 '0$!   ' 0$
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M (G1G^1&/*X[!\@^K+8]I^4_7F8\CD,<8QQC'&,<8QQC'&,<8R7Z)_7. _X
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M>.OK"<H 03SL4?CVCS>>9KPC;0<$'D^N\?;W'HV8:#5E7E]Y\_?_ ._/S;Y
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M<?J'D/NI4]@G:QF#S0$Y<9(;A&TOCA-@R,81]B?::)*I*8]=KIQN>\^LY H
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M\Q_PCK/Y2K_@/?W>/^4N=$/OA'G\0]K?S'X^!]Y_(D_2HO\ ?X^$=9_*5?\
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MY-E/'&,<8QQC/YMWBD?V0WM[_P#?7*O_ *B/.X:?_P RUO\ LK?_ 'SF%O\
MYRF_Z]7_ &RA',QF.QQC'&,L-UM[371U.F)V9TR?#C7,OB!6O9U');#HC8L"
ML"!''#%V6ATZ@,\"R&)2@"]=C1[O+0H)7W;/&39VR6;.DM%<6DR%'G-I;D)4
M0VX'6EMN.,NM.I!"7&G6E(<0L!1&X5L02""#MEQ'DO15J6RI(*T*;6E:$.(<
M;5L5(6VXE2%)) .Q!Y@$;$9*]H^(EVPN%*U&,UGH/8!;U2U_0\DB,=KFNX?#
M0E.59.6%D0&NZ^BL6BX@'74<CLR'(FD6\,9!EWKA<ADHX?>Z9#VF@Q4P8_4%
MII7%'?>DH<6\\XXJ0^TIEYUU:UJ4\MQM7"2X5;;)X=N$94=GRGNM"UIX76FV
M5(2VVA 9:<#K;:$I2 VE+B0H!'#OSW)W.\X07Q:O$):2QV;BLRBTJFCFQX=<
MH=X0Z]TW/3,1L6 59$*5'S*!(&:[-;0XJ\JB"12&2-]'F[%0J+$IN'>^"3EX
M^<6SM%4E 2XVMML,N1U 2Y#27&77W));=*7D]8D/NK<0%D\*E$#EL!7;M; *
M)0M*EEQ+R28[+BD.(:2R%MA3:N!1:0E"BD#=(W//<Y#6>WO<YR*D(!-\4]RX
MSU9D_4>3L6U61_36,=<9I8CRUCL4,Y2B_K0>KR:OG)1O+7V[:1M&^VHUD:1&
M)Z-=;GP"OW0K9.ZYR)Z"7U^7,;:2PE:=U^5LVD)ZL;H)\HI*N>4/"I>RAN=D
MQ51%#JD^3'4X72@^1Y.[BBKC.RAOL%<.PRN=W7G9G8F=8LFVCJ$CF&L2@,'P
M3;APX)/ZVJRA0&O8:Q]@!,1S#TQD4C0<<J\]F]L(*-MGQ!=R^<.'"EU&C,Q&
MNI83P-]8Z[L5*5Y;SBG7#NHD^4M:CMOL-]@ !ME!Y]R0OK'5<2^%"-]DI\EM
M"6T#9( Y(2!OMN=MR2=SD1\N,I8XQCC&;=_ I_LGG7W_ +*N7_8G87-<U9_F
M"=\L7^V,9F=/_P"=HWR/_P!G=S^KCSB6=/QQC.LGXO\ ^K;JI^[^:_[ >S/.
M5=.WWI-9_P!'1O\ J,+.G]"7WTM*?[;)_L4K(3YY69Z8XXQCC&.,90OLW'[;
MEEN@0D1D=RQF#(]=KM./W=8D) $8N['$OHBI ![TP';[ZIG%%57[D2-1<MR9
M=NU>C\:NQ*Y5DY['H"9INNTU,EV4#2\^V5K?2<-EN_8A2W6Z.2U9)N7FHTI8
M*HB4I91)?4A;$9;C3Q+<E$=U'*];1-03]018M?,U'"JTZ/U-*=<I'9<9IRYC
MNUQJ6G),=! E%2G5QV4K0](2AQG9R.N0TN$_>;[GV4&JN=MY>:!.#514X]E@
MDQV-N"I"[>9XKZ-YF^A>N(Y51L,#*;R3!3)!I@CJLL[RML^;,7&ZK9+:OA/T
M64,K45.NMB2T1-2ZH9KI$;0^FM21G*OQU/\ %)C7LW4,63+CB#X.&'2P4H;"
M0TMYL)6K6/@YTD74:BM$6$F,N5I_3KM@Q)UCJ'3\A%EXHA>,Q(IH=!*CQ7S,
M#Y>;#P4IPJ+B&EE2$QY)*VL)2Y+D$4W'[FWE-F/NT^;(S:%5Q81# +:1U@:%
M5C*JOM]G',+K:&)/];@2.LF5AE2#F/Y(Z26-1M1D\4USD&]I4Z7TO*U/-TL*
MZ@9Z/!1>(-0V$FTF.0=019-]7:@TR[/X$&- \.ES77:2.RB8&509TY+K0.(F
M4UPK4>HXVG(FI#.NW==^.3>44"/6Q$3*.2Q1SJ/4+<,+4)$[P*-#:;N)#JXG
M7";"A%IU0F_H=%C3293F4-Z\EE:Q!.BNL=:NQ<LA9:"."]EUU&)*SFRS0288
M#7))..Y(L0;F1HMU1Q9QG.!I @BUW5TU+IAL(KE545Z[NMOK-6K]?7S<BMM(
MUPB-0W<^"Y5)=DQGGT,*F]0[+1!6M#\='-]AE2P%;1T5P935C9S4T]A2UZ=+
M:(I7&+"MD52Y-U3P9K=FIJ/(:96\F'US45<Q*%,R%\F'GD(*ALTYP/.U8XQC
MC&.,9(OAA?J*[5?NU;>_U1K#GK#T+_>LT1_04;ZUYY@],/WR]8?TP_\ 4G-F
M?.GYS7'&,<8RE-H^'OU=N6QYK:%A16:E3]E-HNRL84,N*WHK")\PA@I,+&Q\
MS@43FX2(24>.&I^S88%P[MHYT6=ZNT5]7KO5>!2#\_;S.3AQ0  (Y;[>2DD;
M]NQ(W'S'.5GW0[K!9,^UL23P(A@BY2@:,GC0";3B+5O82-6*(K5FE9=8QR0B
MX%/TH%NW;:1I*41\BDT:-6@U;1R+9M62+A'[/-R[.7HR 6H#8'OV.P)&_;L=
MMQOZ.>?GKT-ZU:VMO<FL7E6LNS;2U[-F&MGV5I!A]NOP3J-FYZ/KG658@S60
M2,4ZR@?>Z ,J$<H-]M_1]#;&\.$'_P!_7Z\CQJVX=^6W#V#?;?<#?;?D>S,+
MB'AF=/H2!,18/ I4ZC12H)A13(#(K:M:5"8A6EB(ZI6"#KUC(YD3;P!Q-]TT
M74F+Q+026(O$]G67B:KE[LY<([O-MD2ZL\]^?$%;@)&Y'83L.>WFWWS,1G4#
MJ^UN5I/ +<P.L&-;00^5B &WIX/C9,Q (RA#J]FLZJT;+D8S(I%'XPDT#BI%
M) #MPY;(,MW:KUPU9K(MD[^D;<M^[LY>C(<:N';S<QOL.6YW(!VW&YY[ _6=
M^5O_ *[]<+Z)Q^96D5)"I#3K*81<',X7<4PJ<Y ]+12C#:5,%ST$ED9<,G4F
M8@P8Q5N66WV<BW3D<FCLS,NT70@'M\W+M[-\)4I/(>?8D%(4#MOMR(/9S_<9
MC;GHIT_+#R<#0K]@W8-JFJ"G2$7"3.3L=QM9U'/W%HU<*69L9!H\9J-)MH[-
MJ'U_1-2C?5TB:)E6^7">7".[S;?-OO\ 7CC7V[^=1[!VJ&RO-YQR]'FVR0<=
M1*#PYT=_6<YV63[)N^V^N=Y+)M],WP^!NXXYENR6Q;*>[-00^<MOK7VUS%\9
M4]=J(PMKJIB.P]N_SY#B5W_P>'L'Q>[]O;F!TOT>ZKT_/ ]B52#-I2*N4IW#
MXFT7MBPY?&:S$3ET/+2V!Q.&G)<7B\,"Y?)(DD8X,$,-!:[Y55NBBFNEKK )
M&^X\W+M[/WWR)6LC8GMV)Y ;[=A) W/RY82"T[7];RFU)G#PRPR171+&$WL5
MZH4*O]#<D&1H1$6;Y%H_>.6@G1(""&-,LQ*+)FINALY40V<K+*[Q  W/?VY*
M5$@ GDD;#T#??(59]'>NS"=S2?LX[+6SZ>JV,_.QA&S[(3KE,_;HI0+9LL#5
MMI*<0D'*YL.663-GA8-J^4<+N2#91L1=.7:L.$=W?\G/M]>1XU; ;CEMYAOR
M[.>VYV^7ZLR!?I]UY>"ZJ!DH B6"4Q2LJZ\0,.6,GR0QI4$VB\6ADHB)AD[)
MJH25$M&X: &+D)!J1*:)M5E47J:[UXJO'A&P&W(#8?)V8XE<^?:0H]G:-R#[
M3V9&(GPX^IHN&3R#.(1*9,,L(#$(H5+S>U;1FTQ"1.NBVIZN(O!YM*)<4E4#
M U^=31-1,?$BPE,<40;OM\N'""6^D. ?N?J^KY!MDW6+W!W[-^6PV._QMQMS
MW\^^3;1O6RJ>N^LYVK0?)4G]F2)C+I\<E\[FMA2*5REB!&QS!\N?G1Z0%G!)
MV.%-,OE<.]-'3KUKK=/UJNV>1  [//WG?)2HJVW\PV'(#8=OF R>>1R7'&,<
M8QQC/YMWBD?V0WM[_P#?7*O_ *B/.X:?_P RUO\ LK?_ 'SF%O\ YRF_Z]7_
M &RA',QF.QQC'&,E2B@D?DUW4Y&Y8W0=Q606I7H23-73E5DU<Q\M+A# RW<O
M$%VJ[1!8<X<IK.47+=5!/;95-=+?3"FM"4I:(TA;9(<0P\I! !(6EM120"""
M>(#D00>S8Y582E3[*5\T*=;2K<[#A*P%;GEMRWY[C;.Q):U=^&3##TVFANC*
M&J: ]=_%,[+]1U%TWO9"Z -DT,&IBQBL"E-AP>/]@A$ZDY9.S P54!)ZXEL&
M!#$B YH08%@@MXS*:HP]<N)::3)E/NS*.'/[(<9;,I4A@.H9=5$4TA/4K5QH
M>;=6K8D%*E IV!UJM0I:U,L,MQ[21$)WDOI<82RZ4+<;3("U'K4IX5-+; X@
M""E.QR+KO<M!1GM!*Y1X950T]:\X6Z@6C#W$-J:8=@>C4RT+2*RJN5>2*O3-
MZ7!=<SG5BBH@---682LI=79=G&2<A.(.'CH+Y<DEQI*X3:+F1(8:$]ESK)#<
M6S;*4,O[(>3%CQFVF5.%)*WFWD\:4).P5ODS#S")2E5K3+RS#=04,JDP5[J<
M:W4V7WGEK<2@'8-+;/"5'F4Y=:DHKV1KSL)W:N*C^PLR[%]=*GO98M$NO[N\
MZF)3WMIVCF/72%QJ90:_[LEIV*N[-ZX]=W1M2#2<A*#LI#R5S$]FD!C*LJ*2
M<TAC)+D-V)6QY,1N'+?B@+EB+(2W A-RW%MN18S:7 S,EA/6H2A+:D!S=UP-
MAM)O&$26Y$UZ/(<DQVI!*6"^TIR7*7&0E:'WE*3UD>.5!"BHJ2KA^YI*RI0Z
M2:VN^JRNJFNNBFJF^N^FGH^CKOC;.-M=?0SG3T==O/&/1SG7RQCT<^7ESI&:
M9GY\8QQC'&,V[^!3_9/.OO\ V5<O^Q.PN:YJS_,$[Y8O]L8S,Z?_ ,[1OD?_
M +.[G]7'G$LZ?CC&=9/Q?_U;=5/W?S7_ & ]F><JZ=OO2:S_ *.C?]1A9T_H
M2^^EI3_;9/\ 8I64[F]MA(3-Z\@;IJN\+3QO-C:RR:NJ36-0VO@.I622LI_4
MUEE6J!$A&P#5HW2]<Z?R!!37?1!FZVQYGU.FI=M4W=PVXEJ-3KJHB$J25.3[
M2ZF&/ KH_E(2EQ;#,Z8XXM7 VS"6""MUL'T3L[^+6V=15+0IR1:HLI*E!02B
M%75,7KYD]_DI1;2\["B(;2GB6[+2K<(;<(KXAWEKYY3MU76SBDNQ&*>L0?72
M;$PW0BYN8OS&D#U"%&#"3["=@(XPXGPO++,CR/6T':>Z3Y-FFKZI+=E]$5TU
MJ;2FE7;&M-AJ>D?NU.Q5KL(E6S%-N9<=YZ )(F/Q44\@.B"'DE\^#LEU2>)6
MHIZ4*ES3NI=2MP+#P'3MPU3AJ0A$&58NR!5",^TU.,<Q69"[9@M>&%I89'7.
M);"N$3Y5=L:6%6NMF'P*-=B/1+/%,E)M 96+2!"<;[+R':6P222.(Y%>@BZW
M66U-9RRU:.,OM6_H9YINHM-JI+XT$*8J[D[QFD^#U5Q72%2Y.P1"%;;P85D)
M&ZFPE)BCK2XCJBO?-KHK\6]*+N7$341]I#AZ^SJ9S"8L??CEFPJYDROZC9#A
M4H2?N0;7UH1MD>2OMU3XV -)S #C2Y5CDZ U;$HS6Y4,2*R.QI/KNL$C'M#Q
M^S&A=EQZ2YQR1-.F;-M'VRY;39PC[/HXS5=T::GD7+M1<Q'-+(AT\S4-E/O8
M\IB/!HZ\A,NPX&V77Y00\I$1MB*VZZY,<1'(0KC*,//Z0=.LU+=I4RF]2*E6
ML2BKX5,_&>?F7,X%46#QN.M,QBIE*Y2WI+C;:(:%R 5IX0O&W';-]&!0I:T:
M2G]7&WMVUO2[IA(7@-U'O6V8ICW*F4>G0URO&I5&Q:.=O=_ YRF_#O$EF!!L
MV7U3RI?HZ-V9\B0G3^K*74$1K2=[JIMZ$U+;F\-"DF15S:A]")]=.D*V\#Z]
M"F9+:DO,K6@GALUZ_=@L1U7FF;:CE.ZFIM-K:F.15P^*[5]PLH=HPXN%/A,)
MW\+ZE:7H[J5,O-H4 52Y7EW1ZR+*N6N 37=12FW,!;$) B_8OQ)_:>Q;,H;;
M"]F>ZFR>!:>NS![A;;.=G6FWJ_+77..:S=Z3FT5#I:]EN )U0BY6S"6RZS)A
MBGL!7N"0'0D*\(40\UP ;-D;\SFP5&IX=S=:CIHJ"5:<74H>EI=:=CRS:P3.
M1U!;*B.H2"T[Q'FL';EF)]BNQOV/0QN?>UC-9K&F@HC(9=(P+B-BPT4!#'HQ
MCOIL]DY@0B=E9)4GC<!# VS@T808D54=4M6^GKLEHC0WPU?7#:OZJJGN2&85
M;!F-SI$JQEOM2'@H-0(TE4.N82QPS+24$18JWF4J*N,\-AK#6/P181+<H[.S
MA-L/3+&;$7"8C5\5EUAH@N3I,=,J<^I\&)6QBN3(2T\I(3P#BQYSVP&K=A/L
M?8Y BLA+,M(>M(3V\RKJ-8!MY<(Q(=%DHA*I0'G$BR& [I%#*$8 %G+%%9%-
M=%-59'56^;Z-WTZ*.M)US'A1W%6:(4,5=W/,M=9),(I-G7P)-3"\*F)7'BKG
MS(R'5(4I"E)2HILUZ]95JX:2AU3\R0V*]4N7XQIX8BHL(_A84*^=.CV<SP:(
M4OR4P8DA;25)"DA2DA4T6!==152\!C[*LF%P5])%-] ;242 <'7(ZI*HH+.$
M4WBZ6V&2"[EN@X?JX39-UG""2SA/=5/7;5:72FI=1M2WJ&BM+=F D&6Y7PGY
M*&"I*UI0M32%#K5H;<6AE.[JTH6I*"$DC9+;4NGJ%R*S=75;5NS21%;G2V8Z
MW@E24J6D.*2>K0I:$K=5LTA2T)4L%208*E/;$BQE\Z"5Y1%G7!%JFD J+6A,
M8*K'5]PTB(LQA)T$BD1=DTI//R<?&F!SN0-0++79C[3A)+9RIKGFX5_1NR[6
M5$N[U?0:8L=1PY%CI^KMTSD"5!8<D,-R[&R;85 IF)K\5YN$Y,=(=X.)0;!&
M:O.UZ\U86L:HTK>:B@4$N/!O+&J5#68\QYMA]R-7URWTSK9Z(S)9<EHBM M<
M?".,C/68]SH)# '9,V1#/<K]<"K$61"J%A3(M,MW\:CTET6 -'FZ2Z&J:,@2
M:*)NT?6:N&J_GKC'EC"LZ++>TFZ$B,2VN#7,=Z0Q*3&D/1JL,SIL$HF.M!2%
ME2X2G II7"4.(V)Q8](]56Q-9RGHSO%HY]IAZ,7V&I%B784.:%1&W%)6D!$Q
M+:DN)X@MM?+)P@%KC)W*K*A>!KH/(:T)1E$DS=+).-20&9QAE)HO)F"J.NF,
M,26BI80H@KKA=J8CIAOGUB*:#A?4KK3DBGKZ*T\(;E0KYB>IAUM"D%B956#U
M?80'DJ)/7,%,>2%))0Y%G15CA4I:$;-4WS-I.NJWJ5QIE*]"2\VM25AZ+906
MIT&:TI('W)X*D1BE0"D28<E'E)"%JLWX87ZBNU7[M6WO]4:PYZ?="_WK-$?T
M%&^M>>;_ $P_?+UA_3#_ -2<V9\Z?G-<<8QQC'&,<8QQC'&,T!462ZRS[Q2E
MEJICB%1$*CFG8;#P^^B]CDK.[;7)8<=)9LMZ9GI421%,Z+KED*,OX2,D$P]E
M)RE@.W@X(4!9#$75,$%7+EMO\Y\_S=WL[<KJX@UL3OOP\MQL@#< ;=O$=^>P
MY#M)W.1[W<ZUSRYN]EB=1A DRTJ#N_&JK["3R;LTG:("-&^O%675 E@KMPWT
MPCH1DDR%T&67]+.WIX'(**)J[N5LX*'E$;_&V/J!^O\ <9%"@E"5_P )!4D#
MS[*(._S J'GYD=^016UT=LAU/:]HR24NI8IV3[$5W3M\S]71D .PBO\ K3UF
M80D"IM)I)5=S#H*%GU[-9YLM*B%;'VR*[YJ+]K$K295ZWAN0-^\@$_(/G]._
M;V9$I1N4;A7"@J&WG4I6_9N.Q.WD[C;GV]N27-^XGB#M,T2F1L9I$#1?K_7D
MP@)9M!9:)AO86T#-O2..%6\DB#SJI+;)E#E]7S&';EZXA 6FS />6.K  *.H
M[L)69"I7+S<O6?5Z?D\X\V0"&SO_ #B#S!*$@ [CR@.W?F>+S ^?)(HZPNQE
M<=O^S(%ZY/USU\G?:SN,YA$A 0I>98F79%K5=8EHJ LD?I'R,EQ7Z<4$%#-=
M,H"H/+6)/!1&+.G;S&10=[$$[GS#<[><<7U^\^;!"2A'G4$IW&^WD<2M]N>V
M^YY[]@Y[;<Q8WPL>Q=Y6W(K3AER32:6LO'X374GQ8>5HL6K'$D,.9 QD(H,N
MPHVAYG7<H([M&Q%_3,\ R$O#&#)-3)9EN[5;O(H))(.Y\^_F\_J^3)'$@<)
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M;G7N&Q.Q0$@DU=U;)Y^8&WA.@L;L0_6+UY&83K$%QCW5Q(XM(%AVJLF;[/1
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M1)4..S9JN;I^2[&EL3YK*F8(AF&RXRE+DLQF>&09E6,@NJ.BF%\W_0LMTU[
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MJCX65LC3Q=K9#\Q58U6N0)LAR(IZ/'*8[3C,Z&I4J.5R$MM_= H9'4E8Y.U
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MU/,D<.8V\Z/].W;6O79-AI.1;:HDL/4UK,1!?F4Z6J^##*?"2"^V5.Q77O\
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M4IGPA:$)*Y+H^XJ#/6+2VVWLD$E2BKF2CESLW0_B7#[_ )CX=\]O*7FBU@=
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MNVRD6VCJR6/X:JZSE5Y])2F3'LP=OP2L;]G$.W-3L/L5:1P*\5ZJLHA_@B=
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M^+.,XX\>7'XSF_2'/TL>*Z[^11O^$CW9;*'PJ&UY'1T0@$3C4'B8=+*(F,1
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M(>;'@T6%'>A^+D/=:MAO=6["7'9AE'@6'4+*@$AT)V2$!L[[98MCUKZ,[W<
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M@JN^DDO/K^EMA8W)"I,EOIY)>TX1T33U[@RRS':;8CM-L,M(2VTRTA+;3;:
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MH;;;2>?DH:2$( .^_( >?MS]+$O>\+>DX6;6Q<MJV?,HTT8,([+;#L.7323
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M@'_AO-GU$87]D3TGJ! L:UOTHJ8)(^3C86/6#G)MO!'NTCG&LQ\0NZ7K?/\
MYQ"$1&B(%MG'[.$W?O%R-\GC/R>>7.^^,?UN^-O+/,Q%^Q_Z(HFQ3I!IY0_A
M2K6[D@_*AZR6T?DX-O1F)D]._2K)W"M3EI)WY1ZRHCD?(MJO2YZUD^D9E+'P
M'ZL<9QBPK=OZW4/BRH/G/9BWQ0=QMC_I. =89KH,KC.?CV3V8>IVQYZ;)Y3S
MG3FX5O1QT?5!2JOT7IJ.XG;A>\3P79 V[-I+S#C_ "_UF:G8=(>OK0*3.U??
MO-JY*9%K,:8._>PTXAG_ ).SEV9/=9^$-UNIYVF3KNA^O($ZFIA764K0]([,
M?6X\L^LWF4B!EI2IOG;&-\[*%]L[;_;[>>_VW-T;2TRA+;3+;;:  A"$I2A(
M'8$I  2!Y@  ,T]QR0\I2W7EN+6=U*6M2E*/>HG<D^D\\M3CK3,,8QC!J,XQ
MCXL8PL4QC&,?)C&/<OE3K/1[?V92X#Z/;[L\_8U3#]NXU^_%/HOCK/1[?V8X
M#Z/;[L?8U3#]NXU^_%/HOCK/1[?V8X#Z/;[L?8U3#]NXU^_%/HOCK/1[?V8X
M#Z/;[L?8U3#]NXU^_%/HOCK/1[?V8X#Z/;[L?8U3#]NXU^_%/HOCK/1[?V8X
M#Z/;[L?8U3#]NXU^_%/HOCK/1[?V8X#Z/;[L?8U3#]NXU^_%/HOCK/1[?V8X
M#Z/;[L?8U3#]NXU^_%/HOCK/1[?V8X#Z/;[L?8U3#]NXU^_%/HOCK/1[?V8X
M#Z/;[LP*?]%0%KB_<2T8G3UDAO+?7 F>Q9G+QN,*8\E,:L9!&R#;7T_+'I>2
M6//RQY_)CCC![4[_ +_)D0E0[#M\A(S7K8OU.5T(LG==R^H2O(H16SMMH^KF
M665 =&VVWGG.4 D:?L8Q^S]KHL"63TQ\2>FN.5F9DF-_Z:1)C^?=B0ZU_P#(
MH9(XPA[_ "[,=_\ US+;O_SH4?4<IW*_J2;J::W47C=N71#%=O/U39I.(V;%
MI>?R8R@;J5T44QK\F/,UC/E_79SM\?,FWJ6\:VX+*0=OXTMO>OKFU[_/V_-E
MBNFK'/C0(W_Z.M:__B6C;YLA I]1^0U7?;(3N'*1Z>?ZS4K"!!C?7'['I*-,
M@L;Y_NX3TQG[G+M.L;]/;+;7_.BQAO\ U&D^S;*!T[4GLB%/\V3(_P#O6O,=
MQ]1Y)>GYY[O+93^+[7%/I8V^7/G]OF89Q\GEC'VGQ9QG.<9QGRQ/\-+W^.8^
M7P9OW;9+\&ZG^(<^3PESW;YE(GZC]@J.^N3O;Z7D4_\ IZ"(>$"[[8_9]!1X
MW/XTS]S.4]_+[G*:M8:@5V3$(_FQ8I_^=E63#3M0/_RG%_.DR?\ [5IR=8C]
M27=0@.Z2TBLRY)PIKG&5FQ:P @@:IG&<>>NB,9JH.22TV\O+./==3?'Q^BIK
MRT=U'=O;\=E*&_\ %+2Q_P#PH;V^;;+A%/6M_$@1?-\=*WNS_7*<W].^^7+K
M?ZG?Z&5@H@X#]=ZHD;Y'.NV[NR#4_LW1RIIY?;KB9T[.Q_[;RQZ2* A!MM\?
MFC\>?/&/2Y$@[R'GWSV[O/N.G?O\M2LOFV@R-F4,LC;;9EM#0V[ON:$YL%A?
M2EG7 C2/UX#JR! 4O1]6$A8%*+B$_0QZ.GH#0<?8L]/1U^UU]%''HX^+'ECE
M+CV[$^W]F3%"CVG?Y2?=F7?8U3#]NXU^_%/HOCK/1[?V9#@/H]ONQ]C5,/V[
MC7[\4^B^.L]'M_9C@/H]ONQ]C5,/V[C7[\4^B^.L]'M_9C@/H]ONRE-B^$!#
M;+[E4IW1.OXQFP*9A<GC#0;A%\HPD1)ZJG]9,C*J;#L8R^@#<K-O<OTFZZZ[
MXZ%>ZNVF8JQ27EXAOOMS^7V]G[_7..,(* 1L2#VGYQV>?EO\GIRZWV-4P_;N
M-?OQ3Z+Y-UGH]O[,DX#Z/;[L?8U3#]NXU^_%/HOCK/1[?V8X#Z/;[L?8U3#]
MNXU^_%/HOCK/1[?V8X#Z/;[L?8U3#]NXU^_%/HOCK/1[?V8X#Z/;[L?8U3#]
MDW&O+_#%,_\ ^LQ_\^.L]'M_9C@/H]ONR7:YH\=#GR1PN]U-&6_GEEJFCE$>
M/4VQG7*Z>JFVRKISKKG.$EU<):(^EG;1OZ[5-;2!62-NS)DHVYGF<GCDF3XX
MQE5;6NXT%/.XW$\MVN1F^J+\JLW2=K*//1UV5;M47&%&R:3?.WJ5=U455%%]
M=\:>KTTQLK42C<;G*:EG?8>;(E]_2S_G$G^1@?T;R;@3W>T^_)>-7?[![L>_
MI9_SB3_(P/Z-XX$]WM/OQQJ[_8/=CW]+/^<2?Y&!_1O' GN]I]^.-7?[![L>
M_I9_SB3_ ",#^C>.!/=[3[\<:N_V#W8]_2S_ )Q)_D8']&\<">[VGWXXU=_L
M'NQ[^EG_ #B3_(P/Z-XX$]WM/OQQJ[_8/=CW]+/^<2?Y&!_1O' GN]I]^.-7
M?[![L>_I9_SB3_(P/Z-XX$]WM/OQQJ[_ &#W8]_2S_G$G^1@?T;QP)[O:??C
MC5W^P>['OZ6?\XD_R,#^C>.!/=[3[\<:N_V#W8]_2S_G$G^1@?T;QP)[O:??
MCC5W^P>['OZ6?\XD_P C _HWC@3W>T^_'&KO]@]V/?TL_P"<2?Y&!_1O' GN
M]I]^.-7?[![L>_I9_P XD_R,#^C>.!/=[3[\<:N_V#W8]_2S_G$G^1@?T;QP
M)[O:??CC5W^P>['OZ6?\XD_R,#^C>.!/=[3[\<:N_P!@]V/?TL_YQ)_D8']&
M\<">[VGWXXU=_L'NQ[^EG_.)/\C _HWC@3W>T^_'&KO]@]V/?TL_YQ)_D8']
M&\<">[VGWXXU=_L'NQ[^EG_.)/\ (P/Z-XX$]WM/OQQJ[_8/=CW]+/\ G$G^
M1@?T;QP)[O:??CC5W^P>['OZ6?\ .)/\C _HWC@3W>T^_'&KO]@]V/?TL_YQ
M)_D8']&\<">[VGWXXU=_L'NQ[^EG_.)/\C _HWC@3W>T^_'&KO\ 8/=CW]+/
M^<2?Y&!_1O' GN]I]^.-7?[![L>_I9_SB3_(P/Z-XX$]WM/OQQJ[_8/=CW]+
M/^<2?Y&!_1O' GN]I]^.-7?[![L>_I9_SB3_ ",#^C>.!/=[3[\<:N_V#W8]
M_2S_ )Q)_D8']&\<">[VGWXXU=_L'NQ[^EG_ #B3_(P/Z-XX$]WM/OQQJ[_8
M/=CW]+/^<2?Y&!_1O' GN]I]^.-7?[![L>_I9_SB3_(P/Z-XX$]WM/OQQJ[_
M &#W8]_2S_G$G^1@?T;QP)[O:??CC5W^P>['OZ6?\XD_R,#^C>.!/=[3[\<:
MN_V#W8]_2S_G$G^1@?T;QP)[O:??CC5W^P>['OZ6?\XD_P C _HWC@3W>T^_
M'&KO]@]V/?TL_P"<2?Y&!_1O' GN]I]^.-7?[![L>_I9_P XD_R,#^C>.!/=
M[3[\<:N_V#W8]_2S_G$G^1@?T;QP)[O:??CC5W^P>['OZ6?\XD_R,#^C>.!/
M=[3[\<:N_P!@]V/?TL_YQ)_D8']&\<">[VGWXXU=_L'NQ[^EG_.)/\C _HWC
M@3W>T^_'&KO]@]V/?TL_YQ)_D8']&\<">[VGWXXU=_L'NQ[^EG_.)/\ (P/Z
M-XX$]WM/OQQJ[_8/=CW]+/\ G$G^1@?T;QP)[O:??CC5W^P>['OZ6?\ .)/\
MC _HWC@3W>T^_'&KO]@]V9G">P$F2,M&LM6;$Q+QPFW7=:LVS)VPPKMC35RG
MEFF@@JBEG;&ZZ2B&RFR>,Y24UVQC7>!0/-VY$+._/L_?NRZ/*65<<8S6C9.^
MJ<[FF^^VNFFDB,[[[[YQKKIKJ\6SMMMMG.,:ZZXQG.<YSC&,8SG.?+E=/8/D
M&4#VGY3]>:U9!XGG1^/FB0'2YW4N>!WBX\B\JZK+DN"/-GS53*3EI]=E5U[,
M8LLY;JZ[)+HMS*JB*FN=%-==L9QC$SM04-8Z&+*ZJ:]XI"@U-L(D5TI/8H(?
M=;44GS$#8^8YEH6G[VQ:+U?36DYD'A+L2!*D-\0[1QLM+3N/.-]QY\X?X5/I
M/\^K4_-7[7?\$^67PRTC^5.G?SU6_K.7GP/U9^3-_P#FB?\ J^/A4^D_SZM3
M\U?M=_P3X^&6D?RIT[^>JW]9Q\#]6?DS?_FB?^KX^%3Z3_/JU/S5^UW_  3X
M^&6D?RIT[^>JW]9Q\#]6?DS?_FB?^KX^%3Z3_/JU/S5^UW_!/CX9:1_*G3OY
MZK?UG'P/U9^3-_\ FB?^KX^%3Z3_ #ZM3\U?M=_P3X^&6D?RIT[^>JW]9Q\#
M]6?DS?\ YHG_ *OCX5/I/\^K4_-7[7?\$^/AEI'\J=._GJM_6<? _5GY,W_Y
MHG_J^/A4^D_SZM3\U?M=_P $^/AEI'\J=._GJM_6<? _5GY,W_YHG_J^/A4^
MD_SZM3\U?M=_P3X^&6D?RIT[^>JW]9Q\#]6?DS?_ )HG_J^/A4^D_P ^K4_-
M7[7?\$^/AEI'\J=._GJM_6<? _5GY,W_ .:)_P"KX^%3Z3_/JU/S5^UW_!/C
MX9:1_*G3OYZK?UG'P/U9^3-_^:)_ZOG/Q?Q-.D<JD J,I70K%"IUZB-#[VE6
M=O4X'(D7.WJVH]K)+7@,,C:C]VKG"+1E@M[4Z6SJBW144VUUS?0;^CM'%-5M
MS56#J4E2FX5A$E.)2.U2D,.N*"1N.9 '/+*;07E:V'K&GLX#1/"')D&3&05=
MP4\V@$^@=Q[CE\<9\_CQ\>,_'C./V>9;,3CC&.,8XQCC&.,8XQCC&.,8XQCC
M&.,8XQCC&.,8XQCC&.,8XQCC&.,8XQD"WEV?H+K8P#OKMLZ/P921++MXV%<:
MD34MDRK7779WK&85&F)F7R+#/7=/+W<*$?)L_7(8=;)972QO0D28\1E<B4^S
M&8;'$X^^XAIEM.X'$MQPI0@;D#=2@-SE>/&D2WD1XK#TE]P\+;+#:G75J[>%
M"$!2E*Y'D 3R.5I^%3Z3_/NU,_W<=5^UWEG^[C_]2?,%\,M(_E3IW\]5WZSF
M<^!^K/R9O_S1/_N,?"I])_GU:GYJ_:[_ ()\?#+2/Y4Z=_/5;^LX^!^K/R9O
M_P T3_U?'PJ?2?Y]6I^:OVN_X)\?#+2/Y4Z=_/5;^LX^!^K/R9O_ ,T3_P!7
MQ\*GTG^?5J?FK]KO^"?'PRTC^5.G?SU6_K./@?JS\F;_ /-$_P#5\?"I])_G
MU:GYJ_:[_@GQ\,M(_E3IW\]5OZSCX'ZL_)F__-$_]7Q\*GTG^?5J?FK]KO\
M@GQ\,M(_E3IW\]5OZSCX'ZL_)F__ #1/_5\?"I])_GU:GYJ_:[_@GQ\,M(_E
M3IW\]5OZSCX'ZL_)F_\ S1/_ %?'PJ?2?Y]6I^:OVN_X)\?#+2/Y4Z=_/5;^
MLX^!^K/R9O\ \T3_ -7Q\*GTG^?5J?FK]KO^"?'PRTC^5.G?SU6_K./@?JS\
MF;_\T3_U?'PJ?2?Y]6I^:OVN_P""?'PRTC^5.G?SU6_K./@?JS\F;_\ -$_]
M7Q\*GTF_Z4]M'37_ *6ZG5GM8FGIC]G;??:E,:Z::X^/;?;.-==<9SG.,8X&
ML=(D@#5&G23R %U7$DGL 'A.0.D-6 $G3-\ .9)J)X  [23U&6OI;L#2_8F,
MN)?2=CQJPP;%[L,+* W>^I( 5TQG?83)@#Y)F?C!?">/6^Y<@&#2&4,Z+X;9
M1WTWVV!IUI]M#K+B'6G$A;;C:DK0M"ANE2%))2I*AS"@2".8.V8%UIUAQ;3S
M:VG6U%"VW$E"T*2=E)4E0!"DGD01N#R.;P>4\J8XQG6J\8D^9S%XQ40XF0#A
MNR/:R/TK/W@EXN.)N*V6 6-9<U -2#7=-TS3F(BME(845;*)K;A)"30UWQA;
M;FE])NH9FE- :GOZ\I3.KZIQ4-:DA:6I4A2(L=\H4"E?4//H>X% I7U?"H%)
M(S<NC>AB:GUUIVDG@JA3+)'A: HI+L=@+DO,A22%)ZYMI37&DA2./B20H Y6
M<&""QD.-CT<$C0($,S0'B0PADW'"QK%MIA-NS8L6B:39JV1TQC5-%%/337&/
MBUYY)RYDNPE/S9TE^9,E.K>DRI+JWY#[RSNMQYUQ2EN+4>94I1)[\]1XL6-"
MCLQ(<=F+%C-I9CQH[:&6&6D#A0VTTV$H0A(&P2D #NS[W#A%HW7=.%-4F[9%
M5PNKMY^BFBCILHJIMY8SGT=--=ML^6,Y\L?%CE%"%.+0VA)4MQ24(2.U2E$)
M2D>DD@956M+:%+6>%"$J6I1[ E()43\@!.45BO>D5)MXP[WINP0T>G]<6A:]
M<G21B I)S"&5HB-665U;J2E+6/%36A-JL@RD[H2R'M';!T_*Z)KN\,.OV'1#
M)@BP:3JBEE3:6\H-.7D1F+<J-9:7RGTI25IKU&;'B&.XE;L!N2Z\XV\VS')2
MWUW+8/2C'F^ N*TY;QHEM3WE]327I%2D6-=2I84I7 9Z1#?DA]"D-SG([;2'
M&ENOI2ISJ>' >('&9$*SL*K&0FI3FXH/3#>.16:5S*AQ$]8L/-S"+DA<X$R3
M>(/1640;D<:6U)Z8$/,*9VW<IMU,\N9O0O/@R0)%_"BU_P &+;5*YUC57E<^
MQ#H[.)66#$BIDP19M2.*6V_%3X.3):X=DH4M(RWB=+<&8P?!Z29)G_"*KTVB
M' LJ>>R]*N:Z38P7F+1B::YUC@C+9E*#X\'<XN:P@YY">("!?C=#!JG+!BXM
MW!KZDXAX0*PM]H8/=;VRKBSHJU2$'GSE#5HHBJS#'WZ#1D7=HKX2;)-T\.=X
M2^AF6P^8T75%+82&[;1T"2TS&M651H>NG$HH+%Q4F&RVLN)4EV5#96Z[&;4C
MB<4XHMB,;I9BNLB1)T[;P6'*S54V.Z\_6NB1+T:A2KN A,>6ZM ;*5-QI;J6
MVY#B5<*$H'&?GW\0)FRU*.S-"6:($1\=3\KDA5<W7;E,+7]WE68."R59HRE2
M[UT2>%7>R;J+LD%WS!HT=.WKIMOIJVWJ#H8<=\';BZRH9,F:_J:M@QT0[M!E
M7.DXSLRW@(<=KD--L-1FP6Y[JT-/.N-MLMN EP2'I:;;#[DG2EW'CQ&=/3YC
MZI5.L1JG4[[<6KFJ;;GK<6^X^LAR"VE3C3;;CCKB" @Y++^]$3AMKR&J24))
M;OQ0^S5QCYE,Z_+/2+^L*_+V*12+1('(2LJB8LZ'!%&\;)'QK=T0>(:Z*B6N
MBGIZ6%9T0V5IIR%J-BV8#,EZ@2^R[5W,9IEG4%U%HV%1K*7"CUUC(AR9C"YS
M$-];;+:B4R'%)VR]L.E&!77\RA>K'RZPS=K8=:LJB0Z\[1U$BY>2_7QIC\ZO
M9E1HKZ(3TME"WG$ *80%;C\*5F/8EW&ZROFT+=JPC5UBUJ[LR7U\C#%HX0@8
M@E$4IH!3KP\Q?ER4O5",EDVLI3DN/ZJT2=/AJGKMD$=9]55>B&Y^H-'Z?TUJ
M%C4%'?-4-9=*M$SF+>2Q9*JIBKN&\S&8K$RW4%RO5!^*XIMI])0%KR335CK!
MR%2:JN]0T3U'<4J[NPJ$UJH;U5&?KDV<45$IIV2]8JBMJ#<\3?C-AQU@\7"D
M<0Z\06-!(@1FDOJ&Q8@*?U&M>=::E7T/=KV37#<J '+O&>H8\2^MP\DWE $Q
MM'SOJ5_<HAHMJXRNDNW3N6^A:=+LV*JLU-26<AG4J-(WQCLV;:**\<CS7T-.
MF5$8\.AJ77S(PF0^-'A#)24<*DK5;KZ6X4:N>LK'3MQ7QW=/+U32]>[7.*NJ
M=#\1E;C8CRWO Y243HD@Q)7"KP=X*X^-*D#Q,_$)AU:20=$[)KL[") V&1XY
M.PAF<5=H<AHB8RA_'XOLQ#Z2_+VP2B@YDG+I((@29QQ%8Z];9?J+%/6#=(U?
M0I:7T!ZRH;R';0W'YL2HE1:C4"HEG*K*]J;8!Z4:WJJ:.E]TUL&5<&(BPFM+
M#*4,;/E9=+E=2S6:^ZIY59+0Q#E6D63:40E5T>QG/1(/51A8];;/]2T+"='J
MA*5 AN(+JE/[LYL)YQ3.N9P<EC,>F0$M%I8%&2*.'62XXP$,,T'XPDQ<:YT6
M;.VCC11%9/?&?/&-M?/3;&N^F==]==L7<"?-JYD>PK9<B#.B.I?C2XKJV7V'
M4'=*VW&RE25 ]QV(W!W!(RUFPHEC$D09\9F9#E-*9DQ9+:76'VEC92'&U@I4
MD^D<CL1L0#D_>&+)Y 0Z^RNN#Y@E(4^OEY6?146-FGBQ T\@$3="S<!9EG[C
M?=9\[C<1E B)ZO%<^M=-0#9=?TE]U=]O73H^OI.I]$Z7OY@2)EI309,O@2$H
M5+4RE,E:$#8(0M]+BT(')"5!(WVW/E?KVCCZ;UEJ2DB%1B5UM,8B\9*EIC!U
M2HZ%J/-:T,J0A:SS6I)5RWV&Q;FXYJ..,8XQCC&.,8XQCC&.,8XQCC&.,8XQ
MCC&.,8XQCC&.,8XQCC&.,8XQG7ZJ3;%I6;?_ &4EVFIB>S"[K?K:.DW^,.7$
M,J.F;(DM7PJ QW.^,Z!Q&=8H[E)U$=HVP=E!XD6)^TN,M]D?.C[)_5MM8Z]?
MTLJ2\W2T$6O4U!0M26'YLZ$S/=G/H!V<>2U*;C-%>X9;:5U00IYXN>@/V..E
MZRNT-'U&F.TNVO9$XNS%H2I]F)$ENPFX;*SN6V2Y%<D.!&Q=<='6%:660W8W
MGS-GT/E;KA[%(U=,04!#5Y*[+E9*$RZSBXN,O8V,^MZO(2N,9&3SAS)RXAN_
M>N"1=D/#A&*BCI^XROZU5GHFELOO6F-#JU#63+F5=U]#7,6U901I$]F=(\-N
M[9#[L6&A$"-)6RTAB,Z])ENI#;*.#A2X5$)TW46L$T=C%JHU1/NI[]987;[$
M%V$QX)45BF6I,I:YTF.AUU3TAIF/&:*G'5<>ZFPD%4(&?$!A0-K399[!#"0*
MW(S54G1<*S.N6Y\2VMHFV$B$V4'7DVDQDZ8%V[;;2DD*#:#!S==)1LZ?*941
M2VZ-T+VLIS4\9JXBJEZ;GZA@*0FJO'(<ES3D=R5)+MLB :RO5,;:6*]B1*,A
M]:%!;;(X5*UB1TM5D9&G'W:N2F+J"%134K594R)<=%^^B/'#=6N<+*<F*XX@
MSWH\8,,H6DH<=5Q)3^^W>91W+48C'J"L:1.C%@7-5D0?-9#7K!E)YM2+@BK*
MT-,%9,S<B07N$+>F$C1-!+?95LL*;#GCOU6RTGVH@U7+LINLJ.$B+3:6U#9L
MN0KIYV!5:L0RFN6?!X#J),SPN0S&5$CJ4 '$R%O--<7#.>E N6":^)I2YF+D
MVVHZ*O=;EU#3<VRTRMXSTCKYS:X\7P5AV0F2^E))0IA#+CG#Q<$9\1>',8RP
MF0FI;$D49UI6 WS)B#)Y$&2T6A,VEIF&J-W#(D>:KECXDL&5]$<(]I1)-]E%
MDGK;1#S5NXO0=:.SW:N3J2DA6"M57.CZ]AUJS=386M36QK0+0ZQ#<1'AR8TE
M.[\GJU,+V2II95RM)/3#7-0FK*/07$R#\&JG54UYIRN;5 K+.?)KBA;3TMM;
M\N/(C*^XQ^L2\@E27$!.YS<AW39B(_/W1RJSD8EM<V2 KF0Q273^JHPR8K2F
M(-IR -/)J5EZ,5T:O +MNEN-'/BQK4TLD-;,'B/K7Z.)9Z*79,VF;B:BASZV
M\HIEY"L:VFU%/=>17V3E3,BM54>L58EQJ8TM27WVHT0Q4E];S2N%E63>Z2FX
M\2V<E44J%84]S$IYD"PMJ&"VTJ=7(M(DERR?L4P VY%<0DLLNOR1)4&4-.)X
MG4Q\&[*V'VAF59PRA)0WI01)Z%(7N?E$HA@F>2;.=;"?UF.A@P.N:0CJ;9H;
M#&B!PSA=^LZ98#I#O<[9XJMG-2="4?1_57]IK&O<U7*@:P8T?#KZ^TDT\  T
MK-\_:/R41535+<B2HK,2*4LI;=\)4]UP:"1B(^M+?7%G25NE)R--1IVE'=52
MY\ZMCVL[_.[M(S6LQU24PTH;E1Y+TF3QNJ<;$=+/4]8I62$6[/S&LQT:A4I@
MN+KMX34Y2W;3<TJ2"CH6)@0$T]!+2H2XG9<(N3(F5Q[KW/B(W#EZJ_8EVZ:Z
M31LU7<X6-T?U=^_/M:ZX^"FFI.I(^FM/(U4Q*?M9-Q+B,S$UTE%1&EH88BH?
M;ZZR?ZMI++T9:D%Q;B&\Q(UO8TK4*LG5?PEU!'H']0WJ]-/1F:Z/519+L4SX
MZK61%6^]*6RYU->SQNJ=:D("PA#:E\25[\P=C]?Q\?7\T-UC6M<0*S939+1W
M&6@]$+:D(1F%;CF $J88GB!N4KN&\?PV1:X9AGJR;PX_'L-L+<N(_0U;N^)X
M;]U51+^]O+B@KJ)UN>X\N5IVV767K[TR/&=B,Q*]#:YO6*<+DII);B,O/ IR
MW?Z5ZMKQM+9J;.524M-57<^Z;7";93&O:Q-C3,M17Y+4MZ5.4M$3@2WU<9U0
M<E.LL^7DR==.RL4[%,9ED&Q2%&X :'!I*.92N(3L/YF1#<X(?A)E S)V,'&3
MIHNJU<^ROM78TP.*#'S5)5IJHOJ^N-!V.B'JL2WE2(ES$?E0'W:ZSIY6T62N
M))9EU=Q%ASXCK;J$N-]8R6WXS\>0RXI+A"=CT?K2!K!JR\%:2Q)J9+,:8TU/
MKK6-_C,=$J.]&LJJ3*@RFEMJ4VOJW0XQ)9?8=0E38*K(<T7-RR%$=M:A[?=7
M+>ANFH@O;-FZ==+;9L<>RM;"A$OA,S-1E>1I)>29 Q 9C%PQ2-DUT]G[-@[-
MB='6!Y!5MM]@?8GZMMA?V^CGI+S].Y4/W$2.ZM2T09L:9"CN^#!1/4M2VIJE
M/MH\E3K#2PD*+BE?*GV3^EZM5!6:K:C-,VS5JQ5R9#: A<R')BRWD"04C[JY
M&<B)2PM7E);>=25%*6TCNA\^Z,^*L<8SK)^+_P#JVZJ?N_FO^P'LSSE73M]Z
M36?]'1O^HPLZ?T)??2TI_MLG^Q2LA/GE9GICGKOIJIIMIOKKMIOKMIMKMKC;
M7;7;&<;:[:Y\\;:YQG.,ZYQG&<?%GXN1!*2% D$$$$$@@@[@@CF#W$<Q@@$$
M$;@\B#S!![01FJZNO#O>:239O;A&)OJU&UW:5;BHG!I-;*K5R'LHP)>:I"0\
MWD9II5PB/M!BZS(!$BI;5P8)*N'13=@R'L&_T/>=-K1@\>FF+%F^D7>GKV19
M6\#3B7&Y5#&DM<4F54P8KFH9,UQ]"79EE'C%$9A*&XX==?>7PFGZ('!,*-0/
M0':5BGO::/ K)M^IM<>ZD,.;1XUG,DMT3$1ME2FHD!^2%R'BM;Y::9:3:\%U
M!J0&6;G]EYR>/HS^!6<L;D\T+'23^95M&C,0BQ%ZX>;;>FW:QXXX&JC$-6XW
M9!L/U1:H8::XVYS,Z3-2S(RX814PX:J:YH$18%5&B,,U=[/BV5BRTAH#9QR;
M$0^F0LK?"G'BIQ9<)&^Q>CW3\60F656DN6FVJKM<J=92)3[UC2PI-? >=6Z3
MNAN)*6R6$\#!2VR$MIZOG^B_3^E' 82!4%'/<X*/O<8QTQ('V%-&G8[9WM9^
MJBOGZ2F[_+U?W*WV^,/YZ^R_UN.2IZ3=5)E2)@?A]?*>T>^Z? FN$N:&ZL4'
M"GL2&>J1X2/_ ,SL>L[<BOH]TTN.Q%+$KJ8S6J66@);NX1K$N&\!5VDN]:OJ
M"?\ T^XX.S/K+=3:<-#90*?C#6[281*H82;U3//4]U0-'F/=R HH;Z_&W<,R
M'VY%RG_5":?]2<?:\IQNDC5$5ZO?9?B!RLLM2VT4JAM*"9FK(W@ERM8/):'&
M>3#9\EA7E(YY4D:!TY)9G,.L22W85^GZR2$RG051-,2/"JE*3_ 6V[S>6.;R
M?)7GP"^HM,AK%1L-MI*E#*4YGUE#H\_F!9]#V4GLT,3 V,]:1)VLH+50E+,X
M[R22=(.L-5%M$QFXYHHHU6KR.DO5,JC72K-<(JZBFH7YK-7':LW8%#*CS*1I
MRR;2F0E=>[$;ZA3:F^L2DJD!YP)<328Z/M-QKA-N@3S(3:6UTS$=L9#M<W.N
MXS\6Y=;KW%*84B>W*<Z]*T.!LJ"6"RVI2%?-!NFE%P61C#XQC+#;:,C9&'@L
M2E\[D\O@U<"9>U5'R4?!(H<)/!8!L8&KKBW&NB2^Z8M54>UW0:;[I9J6_2EJ
M^W@OPI#U=#7/?@RK>RK:>!66UY)K'$O0'K>QB,-2)BXKZ42$$J2%2$I><"W
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MV;8@N?>()9AL/:X^V[-EV]74;>TD$AVPYT$,QV/0>!A&J[:-JRB83S1*.HZ
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ML;GO/;OVGM[_ )?3VYBQ;K1UT/&Z_DANAJ=+2"IQHD-6!DC6L.>$Z]#@,:X
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M/C[Z2K2B6$4P'N<P@K03ATXD[=\[D@U@T)MDTAJROM#W1WD,E@IOLTKHTU5
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M8UO7<=#:R5A1M$11I-K#9Q51=5FA+)4H5-1>%0&-NWR6[(83G<PCF#;A-RF
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*QEBOXQ^;ZAG_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>g472601g38l20.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g38l20.jpg
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M='B4M;?4UR,D-SEA<7>SMAHR>;08)3,U4H&5L5AD@I'3<G.AHKC_Q  > 0$
M @(# 0$!             08"!P4("00#"O_$ & 1  $!!04#!0<+#PH$!04
M   ! @,$!1$&(5&1T1(Q80=!<:&Q$S0U<G2S\ @4&"(S5'6!LK3!%18R-C="
M4E9S=H24E=/A%R,D0U-5D[74U9:VQ/%78H*BUCAC=Y+2_]H # ,!  (1 Q$
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MELNLR=4JUQG:JH6Y_89.[B592]:\ZTY]R(J7[O;5HEZ?'N/#*IZ1GF93?'F
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M9(9!HS'X9#XTWIVF.Q6*,S='HXPM24/82MK,R-"9(V-:!.#Z4A&B3$)R@^X
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M6V6-G9[HYI]E6M5W4ISG%S69++'3M[W%'_='G<]G;5W3VJM5KLO*[J4HG20
M!]E^NP-FB#P:1A$>: \\0;V3:V<<6 HL!QN]4SK9AH $D@ 8/K&$!10=;UHL
M.M6K^3Y/[V7]13_6'!_76OO%/UE?W!^-^R^7(6S-BX+(!;-**(-WN\TF]F$$
M#,,)),WNF/IRB3#31E%BZP%C,,$#6A#%O;^3Y/[V7]13_6#ZZU]XI^LK^X/8
MN.GLJ9XO"^J2HI'PW0P[=UW+7=8;DA=QIW0M@5V=.&>+'24UE*JAH\<&-Y[V
M)U4(=N;<8YF$C)&XI1G[4@^>+L*D+"Q,3]5%>>MH=\_V/6:,[?<7;3S8VO73
M6SM;--K9:I6M%W'ZN+3J^?N7/K)&>ZO7;K:]<;6SW1M&=K9[BE:5K2J5W53>
M9@WBR:>=C1Z)C]8LU_=@N::%KOQ3)=2W7CKQKEG'\J[2D]I-<F]N;D5:O( X
M0Z\&T^(5%GK6Y8;&0:\M7/QD6S[;]%A=NM!X=WO:\6(^QV1+L%S_ ($K5:;M
MR)NKNNQ3*_I+BO%DT\[&CT3'ZQ8NP7--"+\4R74>+)IYV-'HF/UBQ=@N::"_
M%,EU'BR:>=C1Z)C]8L78+FF@OQ3)=3GMJ*1D*>\='YO<4O=B#X.F81-QG>;Z
MNP9X1MW6Z[(>H767W'TW7KZ</5[J[FKG_!!?CDG\5(R*"Z1M_L^+W_+Y-3[B
MI24FPLCV3'ZN*<I9+)(%V=W%K-*3-2G2?^20!1@<%Z@H0M(VPMP7#+, D[L>
MA^1[E=F'*9'VD@XV3P<K9D3$$TZ;A8A^_6(]=/HQTTCQ'K+*,;"0S*ILUJK2
MUW(=F.7KD)E7)!+;)1TNGTPG+=HWLP=OF(V%AH=F&]9N(%\RKI7#32M[:Q;2
M-;>Y&&:7JI4\/Z0XJ56&D+35BY.5-.\6XPE^6T8E%8R8Z%6#R$Y/W_Q;2H9.
MX,5FNB"1,2B=5K"RT:2'MJJ1PY(OE1UA)&E^2:A[1O:M].CKKH=:MG.^Y:X(
MN'I=0_D7Z3.#SMY!$X+3EC3*8NKS &^*,L=E5,NK9(6ZR8!R.L5A> S=#9:F
M#$E-K+Q<LLN3D(I"ZZ;U8X\0TJ'\YR4$H9&SQ3KYJ<U*\Y<?QFY2,')II<79
MG@<W@&B(K5U@-*"<#B1JYZ@%R1+RQ@$C+\CY/*4;>>O;R5Z9S8UZPES:%R 9
M9Y9A)Z<\P0J4+HL$# & 0#=)E7[E8_,*F5;Y4+A*X96];Q*2P*Q89P5KWEH_
MM]F*K*F8);')1,)Y*6,$'9F-G98$^QEE:&QZ[QT=9*^/(FT])'P.(R3=<M%K
M?[:ER<.GIYKMY/S@Q& , 8!34S^P^6?%I]_5:K)3>G2G:0NY>A>P[M#]9(_R
M5/\ Y0,@DY6 , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# ,27V7I
M[SOB[^<LK_9=,<OE@?"$;Y&GGG95[4]ZPWE"^;:-?SFU"CC +PNCR]_[P;_/
M"XS_ +:83G'S;P5,_@^-^;/#ZH'OV#\JA_.L&X>SK^;6& , 8 P!@'ECC1]/
M.D>D<4/K.$IF&6DI"9$A:8ZVL(G/Q<M YM:DU8R$-Z\IQ9G4HEW9'1,J)<F5
MW3IW5J5(W!.2I+XV DLGE33YN5RF6RUN(V4?MP$!"P;3]&%:5A'S4.Z=J\V5
M;:5G;5K95II4HJK7F)G:&?SIAP[G,\G$V=PJMK#.YG,HV/8AU>(RRVKAB+?/
M676VRPPRWW-&=IEAE&JHRE.@8^--%1UO.;&FMF$I,K5P9Q<!JA.#FO=W6MK3
MD5WPMY?75T6K'1]?&>WI=)[&&]O"Q<[.DM?G1X>%C@J6'#%R1P]5].BG8=-
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M^_JM5DIO3I3M(7<O0O8=VA^LD?Y*G_R@9!)RL 8 P!@# & , 8 P!@# & ,
M8!X'R Y0T'Q:8(_)K]LIEKEHEC_N+Q@3BF=W1QD#\!K<'L]O9V./-KP^.(T;
M0UKW)><E;C4S>C3"/6G)P"+V,2B*NY*T_P"Q:S]%VZ.K7NBY)M -?;$9 ;:+
M#K^\8X"$.NO?N:Z]^[OJUKW=X%%PSN[1KI=^CFW]7DY&P?\ [D/LXKK_ +N\
MA .U_;U=?5]OZN!1>GHHO8>ST7STX@<EIFIKND+VB$[G25A6R@<33%/C,^GQ
MYM5H$#D[H&Z2-#,H<T3:K=6PAP.;@*M(1+TFU6B@J"A""B[Z+3TT+N\$# &
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M2H*7>G1V_3N+TL$$;MV?UIG #\U?I$/]6<&L&2?8->,SV-DD6#$8 P!@# &
M8DOLO3WG?%W\Y97^RZ8Y?+ ^$(WR-//.RKVI[UAO*%\VT:_G-J%'& 7A='E[
M_P!X-_GA<9_VTPG./FW@J9_!\;\V>'U0/?L'Y5#^=8-P]G7\VL1M]'+]><__
M /B2<D/U%6&"5W)T?2I))@@8 P!@# & , 8 P!@# ,=?I2;#159S ;9Y'IW8
ME?/D4XQUM(;AU%[HXP5@XS^I$-S6NEBD;I: WGQ9OB2<@;D9Y XSDY7!8]-:
MS1-Z.0PQD0.8)+9",:@9L[KT1;UI<U@E:T:1$1$2NY>>ZAD48,"EIRX#:83,
M'0N4L<&,;8M(' N;2=*2NC4/&C:5:@,ID*)0[,)"QCCXB].SLE/?&4E0@2*"
MC'9N ,2PD"&!\Y#<CG&L2I57W)02NO#IU/[!C$\G\GXST_>U@T-6-$M[K("4
M30\\:K"KI@*D-A+7&<Q-DD=01N>)X*V,QTUE$.:7Q9MI&5V'Q)54K?SUPZ3T
M]^Y,7S5TXV_V%*'YVJ:>!KRT8RP,D=@IMB1&L"UDF=@1I<S+(S$T,/DUBI#8
M=%Y"BGLM?S'8B!<AGNLG6(NS#%6=<(NIQ^._T3@G-Q)-Y9(VU96;O(D'AS@U
MO4/6+FXU"VN"D\Y&ZLARE&I$B+3;6$%#(-+,-VH(*VGT+J4:+%K>M2SO3I0Q
M:W+T*<E%-$&D:37B>7^XF(U[D.DF]>X4#ZF]-O5O7]NOJXHO#--15..2Z')\
MM4'X'F'H;)?FW%%X9IJ*IQR70>6J#\#S#T-DOS;BB\,TU%4XY+H/+5!^!YAZ
M&R7YMQ1>&::BJ<<ET'EJ@_ \P]#9+\VXHO#--15..2Z#RU0?@>8>ALE^;<47
MAFFHJG')=!Y:H/P/,/0V2_-N*+PS3453CDN@\M4'X'F'H;)?FW%%X9IJ*IQR
M70>6J#\#S#T-DOS;BB\,TU%4XY+H/+5!^!YAZ&R7YMQ1>&::BJ<<ET'EJ@_
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M[]@_*H?SK!N'LZ_FUB-SHW?K3G-_Q(^6?Z[C>"5W_$G8A)'@@8 P!@# & ,
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MZ-CW8_S/%KZ@NDAYI]7_ -%G"*%__8 NK^SJW@R:^]\5"2'!B, 8 P!@# &
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MW/:RV0-B26)HU,RA%;[T^+=Z>G02'2M"]'5F[I7)Z&F?"8>L\;NC$D0DD+'
MEC.TX[2I'A&[%ID"Q5HT99(@"5$$"  "H(P[,W+.].E#%K<O0IRD4:>=HTF_
M; EVOYJ1[FD4"ZM?R0/<UUPC>_<_MWO?W=XJF"=>HIQ7JT.3Y-//P@R_]"@7
MJ1BJ8)UZBBXKU:&#%[+U;EC?;/"0*M^=GW9M=W-L W4EC)$GT&2P/0@DZ9&5
MG ()F]ZV/P@!XM; 'NQ UVM"V;8#O>974_GH?'\![BJE,M5[K!WU_FWWRF,#
M#KS814Q@$QOL?],<KZ7OALG3KU;6<8_VKH"Y"!"8J3]FA+5'O90'-$XH1;&$
M.RA=^C.UHL8M@T W0# 5ZU7@"8^(X^=.#EI'X5A/&>^8>FSOF=*,%B#AYDV>
MWR2#@$U9K&AHG)N@IFX[.8\G<$K+)F[L0L'=N;:G=7$I,8/M@"%6=UEBWO6]
M:1JF"=>ILF_\)>K0K7R:>?A!E_Z% O4C%4P3KU%%Q7JT'DT\_"#+_P!"@7J1
MBJ8)UZBBXKU:#R:>?A!E_P"A0+U(Q5,$Z]11<5ZM!Y-//P@R_P#0H%ZD8JF"
M=>HHN*]6@\FGGX09?^A0+U(Q5,$Z]11<5ZM!Y-//P@R_]"@7J1BJ8)UZBBXK
MU:#R:>?A!E_Z% O4C%4P3KU%%Q7JT-+M-];U-)?K8MBWJ4/^MB%U=8MZ=E?T
MV^SH(>O?U=]D(==?U-:U[F=C'?N;OQ&?DH:A7>O2O:4OF9 P#8_^Q<69Q7=%
MXG/2RR0,Q7_2&MP'@;:FBQJ;0@I(?UF]IWC3JL[PSKUV];5[*UV==@L'N]>H
M+;^&]R+_ $-QC^$]P4O]FO!N]4_I#W#!C%"<--:B!5[;@2Y#= 3J46MZ&:%'
MQ& )P=\XH /)?BE<?%BVM;M-'%#=*G,@U>E5M<8>F)[<$R9$]MABFGU3!.O4
ML%%Q7JT*=JWD+ ;@DH8?$+&M<,G\31N1J&)\A<38W9NC\HB94N0.[PW+H*6M
M94Z9,J;FET)=B$:YN?'J/HU"31#^S*URJ8)UZBBXKU:%R/DT\_"#+_T*!>I&
M*I@G7J*+BO5H/)IY^$&7_H4"]2,53!.O447%>K0>33S\(,O_ $*!>I&*I@G7
MJ*+BO5H/)IY^$&7_ *% O4C%4P3KU%%Q7JT'DT\_"#+_ -"@7J1BJ8)UZBBX
MKU:&)Q[+@:5[?Q XPF*Y,^/@!\DE8 D.B>-DE$B]K"8"[XO;+'V<_9G5K8.H
MXXTKLBWONNWV1AO=@O"$;=3^AIC_ &SO%5*Q:GO6&OK_ $A</[-O!$,!7-J%
M'& 7>]'R6,[GOPA*+/-2F&\O>-98%1&B!'IACN:%A">2%42I3"-)%O1A>E"<
M\C8PZT:2:7V@"X^;>"IG\'QGS9X?5 ]^P?E4/YU@V^GDT\_"#+_T*!>I&: J
MF"=>IM6BXKU:$<O1N,#J=%N8.RYO*$FB^D:YMDC"G20L6CS"KB<@C5&^%1!2
M+1Z@6N\."3LE*$>]Z3IB"^H&E>"=>IDTGV-Z_8IAH2->33S\(,O_ $*!>I&*
MI@G7J8T7%>K0>33S\(,O_0H%ZD8JF"=>HHN*]6@\FGGX09?^A0+U(Q5,$Z]1
M1<5ZM#GMK,XH5/?JI9('DKNQ \#<DT6*3=H75U&]IGC34L[P'5O0=>%=UOM;
M[98]]GLOB1,_I44XKU:%09!(P!@# & , 8!"=TD?*SF=0W(*J(K0 HV&#R2"
M[4I$:\NDCFMZL-Q1V\@W[<;M9MH0B5U_6C')VJC--\C@[8;XR89#<RU0ZK'Z
M$1B)/XR1$5%W_%7JNW[]Z\Z?%-.A7(G-$D<FU8E<&YP3$+4"]"H*5HEJ-44$
M],K2*B!F$*4R@D8#B#R3!E'%#"86,0!:WL8G*P!@# *:F?V'RSXM/OZK59*;
MTZ4[2%W+T+V'=H?K)'^2I_\ *!D$G*P#!)]F%?TM\'O\.;I_U- <V=R?][S+
M\M#_ "'I2[5>ZP?Y-]\I@PU<V$5,8!,Q['Q_KA>&'Q@MC]@%KY7K5_:_,?$<
M?.G!RTC\*PGC//,/3:D9I V4, 8 P!@# & , TI$Y^S:8?&F0?K97G8UW[F[
M\1GY*&H%WKTKVE+9F0, V$?L:;E%0%1=&JGB5DV?'HC)/;ZM5S\4N87':GP!
M:FB@4JKK2H5!7=G"(.T#^4[766+K#KW.OK/RK<I-AK+VK656@M) 2N8,RV#B
M%A8CN_=$<OFGW<GG\VY;9V6]EJGMJW7HAV&Y,^23E'MG9E)U9>R4RG,K:F$7
M"I&PJPJ.EB'".>[.OYV(=M[3O;9K[6EZ452:IUY#\"'F+3V&K;P9!1^SSIT=
M/DA;K)2S91[8;:8ROY3DLTV;6;))9!$,K* D\KQ*TH6Y @V4G0I@%ZU_EKY*
M_P =93E%_P"F-@^QXY:O_#V=_P#[0/\ K#KI[>G1_63,X?/93=S$JD,$?XC(
MXT:2O>RDS<OABY[<VP*=,)E,"E+7+WO9S\:BVE7/A#6SMC@L-:$6V\Y_+7R5
M_CK*<HO_ $P]CQRU?^'L[S@/]877UGR9H>Y']3%JQLM@F,@1M*A\5-;6%PTH
M):4JM"A4+A>%HDQ?<E*W)"0+J,V/MJ2^H.]=K8>>L[RB6*M9'/);9RT,#-HY
MU"O(UY#0R/\ NC$*Z>N7+Q\O=7+MG89>Q#EA:-5J\9NI54K-J^2KE#L/+G4W
MM9968R26OXQW+W47%K#*Z;C'SF(B'4.G<8AZUMMN86(>)5E&:.FJJBT1?=<N
MAKX8 P!@&)+[+T]YWQ=_.65_LNF.7RP/A"-\C3SSLJ]J>]8;RA?-M&OYS:A1
MQ@%X71Y>_P#>#?YX7&?]M,)SCYMX*F?P?&_-GA]4#W[!^50_G6#</9U_-K%/
M1V(Q2'E.Y$2C$>BY+_(7J7/Q,=96UD*>Y7)%@G"12=W+;$R8#E(7]>,:YZ>E
MFCG)T6#$I7*3SA;'L"H< 8 P!@# & , 8 P!@# ,>?I0Z,1WKRW:(C'ZMLJX
M'MWX[54V6XWQ/B=QTO-77E5%W5:;G%))4]KWUR&H\RE[*E3^DG#;)'*,QNX2
M]M$8A3RYQ=K<&F/F/(S96B;Z7JJ7K>MURHB+5,NDF=XP44BXTT17M(-[Z"2)
MH*A=4^GA.P((FW'GO<B>),K3L43:CE+;%(RVJWH]LB\70*5*2.QU&V,R=2H*
M1!.&,56JU/>\$# /YUZ^[KZNM?\ GOJZM?W[Z]=7]^L IN9_8?+/BT^_JM5D
MIO3I3M(7<O0O8=VA^LD?Y*G_ ,H&02<K ,$GV85_2WP>_P .;I_U- <V=R?]
M[S+\M#_(>E+M5[K!_DWWRF##5S814Q@$S'L?'^N%X8?&"V/V 6OE>M7]K\Q\
M1Q\Z<'+2/PK">,\\P]-E#R,G=IPN1TT"OT3LY,;M+BR)HTQQH=E<@>THI%"V
MI(THW35367$VQ#IM>Y$]/)$D>:Q5+4#(-2US]A;VN1.C?I V6G/Z?2GT]!X;
M+;?Y!/MAV1JGG9\.BL&#%WDYBGE-R2'@E.W% R*6V'5$[N<*4*'TQ4>Z)D<[
M=92XDZ='EUU&XFLJXJ,2:6)@NY^/'/Z*8UOI0NSH*P'NRJPC\CDK#)H_) EB
M;)"DE,?!&%A[ZW@*+=E:)G H5;1->UXCTR9(>>:N;C4RAJ<3CW! J/-$'LV
M, 8 P!@&E(G/V;3#XTR#];*\[&N_<W?B,_)0U N]>E>TI;,R!@&1;T8_O8D_
MQ]EO_LV9Y">K4^[6^_-:0?\ 6GM!ZA;[A3K\[K1=D 2%YU*.Y P"5CH???.R
M_P#P1E'^MJYSLSZE/[HTU_,Z9?YQ(#J!ZM?[E$E_/V4_Y#:<R4,]!SRV& ,
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MGCQ(TI1ZKNYO!]-3@L< C#N2P/O-G"5MC;LH6M]GL: $W0M;%L0@;UK0MFV
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MU5P7JU.&.:KRW!*UC@,PTN6(US@F(\*@N^\2-I[<G6F][J;;)!W)SL@!W8S
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MDY4?>\C_ &PQ^Y/7;V8/(S[[M%^P7O[\?0R>:/P4(OE#K;ULQ[&3E1][R/\
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881;).-+WOL&##L#Z8 P!@# & , 8!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>g472601g41e45.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g41e45.jpg
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M(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
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M4(B47O;ZX)Z]$W=[''F7<5/#^E(Y<[$&Q(!KUMQ>G):7[0A\/:[XB^N-R/\
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MK%O(8D*PAZ&+I)0*.R=-GJY=57!PD(JN[O=1EW0@4 H!0"@% * 4 H!0"@%
M* TP[!G'+.0;,Y;C)RAN/CY!'D7XT):[E"N Z5:V@<'&\I9K%9B;&.>/VTU=
MI6DFW-58>)I[*6[B"E=71]2S:32&$@(+'9O)ARP2G.N->_3#?A@NO-CNZ@H5
MY#B8'"]JC)=L]L&)ZRV5#R>NF<HW.\(N]<:GGLYO)=\L#VR91))#'&^XH1C"
MC&O9?)6LGW+K1_L>#I8R&31&-FV>0;\.E,:<Z\R[O35-M^LYVZV5K&)[!;1]
M4&\E4;:FVX J]4LD@X<H99(I8EL!W;.0SQ2V+@6;Q#I*D SAF4]:$,W'<4QQ
M7TK@?H1(IT8:KNDHI$T<4"AH5EBI.3%\LE0A=\'65MU=>WMV:RK'-9*U_LK)
MYXVRM;*U[5-$S7FYL\<R,<DU7@=IWV?^;,/].#7T>4PS71.(QR35> [[/_-F
M'^G!KZ/*89KHG$8Y)JO =]G_ )LP_P!.#7T>4PS71.(QR35> [[/_-F'^G!K
MZ/*89KHG$8Y)JO =]G_FS#_3@U]'E,,UT3B,<DU7@.^S_P V8?Z<&OH\IAFN
MB<1CDFJ\!WV?^;,/].#7T>4PS71.(QR35>!0&UML%=,ZQV'MV<@(XVA>KX3)
M]@2QR.E4A*$$(Y$ KT\:68C6NN\G)!VF.8.,V[)OC=9RK;!%*U\\\;4PS71.
M)*;2JB43'#>OU2UD6Y<!S;^=B)3'F6G"^MHQ%YQ,&.[CA[6: R%3,M(@$<EF
M)T[ \(N["OSL3D 955J<5<C"#%)$LV8V)B,W[#-=/UCUV2+XU^K7G+I)[F%+
M'(S&4I+H]62348D:AL>3W6VS.2T.LS4(HEHR)QAUWYX8J/15?I/Q3=VU49I*
M.L5;H899V89KHG$CUV28;\5X'6+\@8BVC\DECF><?&\6AQO*,RZ2K[Z&)1^*
MR3!9-OG'Y(94B>(X&;P7620R$DW+5_BLJFG=O;//'&[#-=$XCUV2:KP*<QY6
M:V]<Y^)7V'H9@XU:E!5I\Y+;G]9Q,:2V:(3/0%5\;*0=F'R1E@=9N_"KMGRZ
M+U)RWQ24R65Q3IAFNB<2:.R3GYUYM_,=K*.10"'SG7NLS!75OU0-H%VXF'PU
MCLYT_DS[!W'I1)FYQ8&V@V91I%UAL/-X)R19I8/D_2;L,7=W+I%/)AFNB<2/
M79)ATKP+<G^;,!C!3E0&-W LB/#:,1J7[Q;7+S)7,6&E\$RV)';QC%'6>>4S
M($@%DT$1,<L_)7-NF 3NOK@18(N7K<UT_631RTP3'=C^KRETXKOP+,DPV 4W
MJ+(L;U^&VFWB[S;.;&8-( >'-2@^4E8LYA.!L6&R:/&]UB#UDDS04RNDHO;.
MU[4PS71.)&.2:KP/DUY$PE^'C\A8[#X[/ $MD.42BIQKO\2X#R:5X9V3SC$?
M)HQ7-D9D."F6.&04<NY)8YY6QNVME>UJ89KHG$>NR35>!49;;" $>L6.F=,A
M1;? TJX)%MQX#AZ"<:D#&)R-19X\A:+=+ !*B8V,FL\U,<14@(,0SZZ!%VW;
M*,,UT3B/79)JO ZM'>D=<*GT$)EH5=>*1ME,Y2BCO-BHK&H>19(DQ\K/IX1'
M+,-&WXUP@09'2-FPMTR71=H.LT%,%,F&:Z)Q'KLDRWKP/L7W.V#:M.[K6>:P
M?ZKCD..S\E. 6RB!^/7B$;&/#!@VP)!H"];$V;4>/=K6S'J..UNCDFEUU/)C
M3#-=$XCUV2:_J*4CW)V('X'KK8RTAU-$X[M1FV7AB<_VBY@ALB_5<M!KN-*
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M3FI]!S-<<2]M!C/#S8),'"A4PUIN;DG,3J"XZS]WJ#56\!7)J1 -;L,6.R7
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M2)-PZJ19=BR06=(C5$WRB6+7/%6X47)=#]1?E/QBFYL/&H7R-T/+Y'(23L,
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M /";KSRF'OP/\B4 \)NO/*8>_ _R)0#PFZ\\IA[\#_(E /";KSRF'OP/\B4
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MG-Z=!F=0@4 H!0"@% * 4 H!0%'PC[4$?TPGWPWD%2N_Q)Y$!6%0!0"@% *
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M&PW+K7B/ 41_ J'N[SXQ2JYKJHV&Y=:\1X"B/X%0]W>?&*57-=5&PW+K7B/
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MI60;-\>HBEC?+*V&/EOEY+7SRRRO[-[W]G*]_9J#ENP0Y- * 4 H!0"@% *
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MA3 4':6SRRR[(<&$B@@U#LQX<6.&-FK) 0<F$(HW$$/*DE?_ -<)[;_N\/\
ME-I!:W_+_E;V+5*[_$GD0%8=@A]Q2]SP_E4 =@A]Q2]SP_E0#L$/N*7N>'\J
M =@A]Q2]SP_E0#L$/N*7N>'\J =@A]Q2]SP_E0#L$/N*7N>'\J =@A]Q2]SP
M_E0#L$/N*7N>'\J =@A]Q2]SP_E0#L$/N*7N>'\J =@A]Q2]SP_E0#L$/N*7
MN>'\J X),0/+C2 IZWQR9DV+L>[QPM9//)L]04;+XX*8VZV&5TE<[8YX^SC?
MR96]FU 4)IS4,(T1J766D]>,'#*!ZC@<3UO#&9)VJ5(-8O"P;&.@F[XFZZSD
M@[1&#VR;AZXO=9RKCFLK>^>=Z!5JJJN]<5\9<GL$/N*7N>'\J =@A]Q2]SP_
ME0&MU!%'^U[)V[)/R?V;H*_DZF/D\OUSLBMY?)Y/)Y?)_P Z$\R=]?(ALB[!
M#[BE[GA_*A [!#[BE[GA_*@'8(?<4O<\/Y4 [!#[BE[GA_*@'8(?<4O<\/Y4
M!$G]5Y)IX</.+M\$\,+WY+.[7OCCCC?R?4NF/L>6UK5?+@^V$[X&GGH95[T^
MQ9;PA?-N//\ *RH4<4!O6]3:8XY=,+QEQRM;+&X#??EME:U[7\F@-EW]FU_8
M_P!_LU6;X?Q?G?PI7Y7 /LW?]MI;O1_D\4]07L$/N*7N>'\JPJ9'*-V*"<G]
M?3L$)9HN2AJ&R<2-;WNW0LN0(A'S-FC==?))!&RKA9/#M5E$TD^MUU,\,+7R
ML!8W@[K"6:;X6<0]1;&"( MA:LXPZ%UU.@F+T47Q#S&$ZLBL:DPO$J&=$!!/
M$>:&/6EB I^]'/+)=X9.W+91);.$P1$Z"5WKWU,I.P0^XI>YX?RJ2!V"'W%+
MW/#^5 ?2UK8VM;&UL;6_W6M:UK6_^%K>Q0']H!0"@% * 4 H!0&@;I7-Y\BM
M/\A-07U?RA@VG883BL=C]PAO; B#IPB;3IOR $L]I[-@:^J-@%=HP-<@#A$H
M$-$B8H6#CV@MW-B3<<UDSB>0D<D1*8IZ8;L4W9=*8*;^:'$4 H!0"@*/A'VH
M(_IA/OAO(*E=_B3R("L*@"@% * 4 H!0"@% * 4 H!0&"132NWY'L79Q_!S(
MH2)=;2T0>B"8C<<M<#)3&->[7!3";$9*U]<E'8YW(H]B9 I048R&0^\9'AXF
M2L9'$">*(>GI@=9L_0&Y=FSG:+]S(I;&HQ) )?, YAFV7H$Q9H+%ZKO#-;L1
M[@.7CL=N[GL"F,T,3BP9Z^'A-B/(XTR>9%#> X37TW^7R=%3)+0@C;4?B9T'
MM]://S V=RO&.G@&9'M)3$GCQ,FSE!]J0+FL!4@.&'QQZY"BEV8,,RS'C XD
M2Q:HL$ 6G-Z>G67NH0:W$/\ %\*?^&X"_P#,[(Z$\R=]?(ALCH0* 4 H!0$2
M7U7I[3OB[_J6=_PNF-7RX/MA.^!IYZ&5>]/L66\(7S;CS^:RH4<4!O7]39_X
MPW&3_(-^?^7_ &959OA_%^=_"E?E< ^S=_VVEN]'^3Q3TQI7MG6<&)W!RV<Q
MH$>\.KRU, ]*-['W$<0D(*)>NS,&EDH6?-W,KE$<BX^S-FNJ4D9L8#&INB;Q
M!KGA4R.=)(=^:;BC"(%Y#L*/# L]'>N\/.K.%LP)X9ZUYF[/F9Q!!439OF'2
M6*)J+O$;*,$%W>'6005SP K2)3>*3I@L3B1MF<9-E6K=VJT[6V3%V\%#S:(]
M^@NFBX8$\198:\=#'B2#]E@\0P>MFZN?9V JJ@% * 4 H!0"@% * 4 H".WT
MHL-C\LYI0A"21,&(&K\<(V&7G\@TAS_WD+GK6333=\*D6NEQO$4X#@,0<Q?7
M\OG(*YS8>;TV8AO(G8,?9V9 '!+)X.;5HE:\^;47.N-5YDW9=XD24. H#7?.
M^6FW(9LN6:Y2@NMCSJT@AD4#O0DGD1)EJXUL_?.O-1:F;;G(X!T&"YW8T%FY
M7>3.$QQ48<CH.&+Q$HY<)RV)3I\.2)Z=Y%7Z*5IP*(<\[=I"^J_D&J  *,8M
MMBZ^<3%Z]/8PA/=6K]O;/U%,B?C!P@S'VUM'%]6F9Z:CV37ZI#;5V):<8-%&
M$:?H.0HG3U;J(M=_3X^A39.$E4>DL9'S*.%6LAC)84D;%%P7:&&Y08LAWE%R
M-P'8.5WUUDO^Z0:I*N5%/]A@CDO_ +.AQ*"A<U#IBB&.3.6WO>6SK/[" 3M2
MWD4FAY3&U\DXWGC;.V.5K*)WO91+.V22N."F&>&/)4[VY.=,DZ2*ITZ+P*M\
M<!?O*8?L\G_S9J*+T:IQ%4Z=%X#QP%^\IA^SR?\ S9I1>C5.(JG3HO >. OW
ME,/V>3_YLTHO1JG$53IT7@/' 7[RF'[/)_\ -FE%Z-4XBJ=.B\!XX"_>4P_9
MY/\ YLTHO1JG$53IT7@/' 7[RF'[/)_\V:47HU3B*ITZ+P'C@+]Y3#]GD_\
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M+-(<#CP.8/BY9\ICAGDFT8,W#C/'#*^*=[8WO8%:Y,5:Y$S5%0ROH<10"@%
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MO%/VSW';]=^K/AN$J[<FO=$N)\<+M_/$F8YY8.Y/RF_$&]WS#/DS.ML1HU%
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MU+I8"%WJ7<H!0"@(?'JP#VNW#G]=.P/@,RJ_W ]F6AX-"\Z52]7\!*?"Q/\
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M]2SO^%TQJ^7!]L)WP-//0RKWI]BRWA"^;<>?S65"CB@,X.CJ]MEK_P#RN<?
MLY7FGLNNX->WPR[/Y2V4>J>PM^Z)N7X%>O\ )2V"2A6FTWCB@+^\4_;/<=OU
MWZL^&X2KMR:]T2XGQPNW\\29CGE@[D_*;\0;W?,,^3,ZVQ&C44 H!0"@% *
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MZ*Z%#B/B*QCWHVC7.141=Z&U+OL_\V8?Z<&OH\KTSAFNB<3QUCDFJ\!WV?\
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ML^&X2KMR:]T2XGQPNW\\29CGE@[D_*;\0;W?,,^3,ZVQ&C44 H!0"@% * 4
MH!0"@% * 4!C-R_@BNRM!2B%V838FQ*R35KD^QUX&ATDE;J* MKPF0RU!K&)
M\DZBDI%KQH441DT8)C#ZDABZAD0-B\K*O&,:*B4W\37&4XO[7:P.%ST+ B3*
M=IZQV5 B^M@\0A<.C*V@H)/9S((+&S\=U\V8(CICO2)'(&.VAI2%$@<5>%3N
MRC439QJ418/U S\N_'"N.77JM=M^LSDVE6L(F>F0-O#IV9C;9X7#JL7F+866
M70RZBJP5T^Q)CTE_]B_5CCXID5#V7R"/R2C]FN[R$'40ME.KBB'9R6*X8^+9
MU:]LX654O?.TT/65RME:=)VMCFI;+/##JWNGAEBGEFK?&ZF7):9+N3GZ$Z",
M<TT7B5;W&>^<\3]""WS]J,,EU3@,<TT7B1)?5<K>1H\6N*5S18,11OOZ0V13
M& 'H=1-3ZG96]\U%74C-XK87Q\N-D\44<K9>3+M;VMU;WVX-/5T]2OL1O/\
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MY$!6%0"(CZKZ]JKQ-_U!2+^'):K[<'V=/>"-\\TJUZO8TK\.[S:D VLIE(%
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MS65"CB@,X.CJ]MEK_P#RN<? LY7FGLNNX->WPR[/Y2V4>J>PM^Z)N7X%>O\
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M4T_)T4QLLC+4&>%,W ]GABFX5=,2YIDZ2NUUW3-A\DLE.1$C6M:L636-:DK
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MQLFFMAAJG% * 4!&>]4I0C5NR8)T>\!W=+<X%J&7<V X+8TS2D(")J1F(O\
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*% * 4 H!0'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>g472601g42y14.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g42y14.jpg
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M(" @(" @(" @(" @(" @(" @(" @( H\/WAP86-K970@96YD/2)W(C\^_]L
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MN&-MCEN:5252NOY!74A<6"HC)$H@)!NW+EP:(0^V(Z;&-LD'&0'2W,5L8)@
M3&_.S*VMWV2L797%^4(["^4(Q+:\X6TV;'MVBDH8PE/!$Z4EY+%M,X#HU8T9
MWFWV&KFUSVW*S0=:]JY<8[O96*/DYDDG='U&*2SVQ_<U155LIW3H,0R<JCR8
MGY*7]]BBHO;(%UK96^;)_*OFM=6Y)4XX9D7XYBRX;;.8?K0-<=@3C_)MGO95
M843N2442NK96Y.^Y.ZJ:B:J=;K+JVUK8JE=>DK96M/P5$[[T[Z<%UEUUM:5K
MW+G7IHB:(KS_ "?OY99-^K(S^U4,UYN%/H[/MF_DD791?.N^S/YF*L.9?ROY
M6_63.?VH*:[*?Z/!]C%^1JYI/G)/YW?F*C;6RHFB)HB:(FB)HB:(FB)HB:(M
MAB/^M<8_XA"_YDVU23YN3^1WY2I&D>,>U2INB_I,[BOUZY<_;^0:PH?H5'_2
MT_\ :8M:CZ1/]M+^=ROS\BOF+'N%=[@&<9@R-'<=XY"X>W)#+S,P/H"0;61Y
M"PG*(2%;M$72U.V$3YMU'QBU[)NHI1!!NY(7I#QU[AOY?PBIY:G!KXZ>%\LS
MJBC.+&S&<60U+)7$V_98T/<+G22!G=8]V")HX:QKY7M9&(J@8SC9H<^%S!IU
MN<6C-XSF!(E/Y.62[!Q>+ 3#=:GC(C*@^[BRN=ZY)8AI*0=;)&VW'*;2H7##
MXDD0=V2)/-#JU6]OB5VVGSF0$<<F1BBHP4J0&8X79A1TSS0F8,=0?\7(DL P
MD:R XU18M&(:;7.#$&"9ILYUG6H'4(C;RD,+A5 S8XO>C%/+<1:\?*ZHOC"X
MQD9A<6%9Y9V@Y3#[+4S\^VF,X;A+Y+681<Q'\FX_C=LL&[C8OFZ;&5HJ-3:1
M.@]+)9X%(QAP$6R,!R)CTMW7G4P#8\G<]?J\9Y#!7PNPCB15YDJ<.,>U\,K\
MFZCDIHFA[KR7,+7,+7B%T4K<6*-TT4;<VPDII6TF,^FQ8<&/8YLD3<;E#)I"
M6 8MLH\.#F.D;+&;R2-CDD.?2?E'<A[1&^UW=;AK;!.<1*Q<G\KI9G+$^/L:
MFAEXRS!Q+:X^CULFBH=G?:BRBK&9&>3Z(IFFC0*OV0Y <T9#E+&M\#Q5YK:&
MIK8J@/;@'DL\LS78W*6UP?B/<<Y>8VX^,?E:;DN%XKY*44]3#3/BQ3A0S1,C
M(MD33D8S0-# XXH&8-^2  %CIMO_ *;>OD]ODYXEM\D.'9!G,#MRWR8'R\_7
M(.Y3.\)QO<9F]U)DVHD$PE;6*-S4TQ^XI=0N?C$OK':7JL[* 9#3L+;QX*Y7
MA;"\E4RH;3.J\&55.  R*I?24P9=SC&7EL4H^2Q\>/I..RRAU;D*"@9 Z(S"
M"NAEO=SX6U$Y=F >&@OC.ES7VO88KE;W$@_Y,+*NY[:]CS&$$PA,@TXWL;)
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MVC^7R;U,TY_8/W*LXP]8G-FJWFF]=U:LAM?_ '-9G3#D_+R<INXVOGV[Z'D
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M<!B<ME1$W&@T@J48 [4 #,D]+"V[@EOPTJ/1&[NPC*3;%M%&YV!6Q*LA@64
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M&V3-O;=?:G;<NZ<LDD$;;E+[$[:J7VTK??;;2O974I4EAL' +2XGD7%$Y,&
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=NO29]C=5.MM:\8=W?-6ZVO!P7+UI^.E/[=$7_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>g472601g48k39.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g48k39.jpg
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M 0$! 0$! 0$! 0'_P  1" "' :0# 1$  A$! Q$!_\0 '@ !  (" P$! 0
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ME-.5?#'<ARD^T]H3;/F-S/'<+<^CLNT-TUM (XYH[F*#  3,B.CZG64N-?-
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M!'(CF"0:T6I:TI2E6KG?_@7I)_V2DO\ \IIZJC:_K.TOQ4/]!:59G_P;/_\
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M/9?TK^2F_P#1[L5_\]//3EO\'1YE'$#Z[&=WSIPOI;]Y[+^E?R4W_H]V*_\
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M+^E?R4W_ */=BO\ YZ>>G+?X.CS*.('UV,[OG3A?2W[SV7]*_DIO_1[L5_\
M/3STY;_!T>91Q ^NQG=\Z<+Z6_>>R_I7\E-_Z/=BO_GIYZW6-MKO!\XHD1AR
MBS]+=^2[LCAXMI]-@<],3*/$@7 TUDFO(XILD*]+!FRP:@0+YCEA+VP'"MD%
ME>V.5ZCFL?2J>*6&3:6S"DT;Q.!;.#HD4HV#HY'!.#[JWCNM@12)(ME?:HW5
MUS,A&I&##(U\QD=%:5RW^#H\RCB!]=C.[YU)POI;]Y[+^E?R5IO_ $>[%?\
MST\].6_P='F4<0/KL9W?.G"^EOWGLOZ5_)3?^CW8K_YZ>>G+?X.CS*.('UV,
M[OG3A?2W[SV7]*_DIO\ T>[%?_/3STY;_!T>91Q ^NQG=\Z<+Z6_>>R_I7\E
M-_Z/=BO_ )Z>>G+?X.CS*.('UV,[OG3A?2W[SV7]*_DIO_1[L5_\]//3EO\
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M]N5:5RW^#H\RCB!]=C.[YU)POI;]Y[+^E?R5IO\ T>[%?_/3STY;_!T>91Q
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MY88G:585D8]+K;R[Z '!'^'*=:^\'X<JYT=S<1*JQRNBH9&0 \E,T>ZE(_\
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ME D<8(P0Q!R*SOI=,:"1PL+M)$ 2-V[:=3J1@ACH4Y!R-(Q5CU7B)\0I<D%
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MM&9MJ7)M8;6-WB2-)DD*ODS;^9YF)Y#1]LH=)]I1[1QRJJ4GS[-<I/>))"5
MU!'=$(1G"\71TI(Y)8N91$6"6^E(;)/XFE492-"J@ R7@JY99#>8DS N)!*)
M$$<F03BU^&TMX8[B)0&2ZFN9YE8C#-=.S2@@!1I(;3T9(&6)8DFI)<RR/%(6
MPT$<,497/LK H6,\R>8QGJST # '\.;(;3GT*=6P<DJ2QV[LT]TZ2IY1<A3E
MDV37\D.T=]ISN<17 MB%DNE7<9%7<#Y+$F-D<_#_ !,LP0  @PL[(-:N((@]
MG&T-JV!F&)HQ$8T.?LF,!<'(Q_O0W5P5G0S.5N7$DZY]F5PVL,PZ"VOVL]=2
MR[N(-Q!GXJQ6MO'8N;'$KPHZD]]QJHJ9\R,:07VE)X22FOHV+YCCDYGL22@<
M4PL[G7Z<<02=D,1Q4K%3!@(6"/9.RXEG6.SMT6YC,4P50 T3$LT0Y^Q$6.3'
M'I0G!TY Q,^T;YS$SW4K&%@\9+9*NHP'S_J<#D';+8Y9Q4=:[SP]H(>LFN(\
MS5-^-^:H=EZ$I6;!H<ZABNAJRVWS)0P=!6@TA5]&K;7>0#8D5!-9)9XOZQM)
M+#-E!B0A@+*6[M4NHX4$@B:WN+>Y@< -HDMW! *ZERKQEX6&H'1(V"#BH[>Y
M:!Y6QK6:&:"52<:DE4C.<'#(^B53@^V@SRS6OQ_/NQL5E8X(Q\Z7&UB,3/AW
M2.QB2>W$NY1/>;]0$)J/%85RQE#, NZSA:K;26NHIKPP7DD1M!G$' A@DJRL
M3/;RVEK.9C+&KF>..&4EFR8XF=XU4A@8]#NS@QZ6UD-G4JD:QW,\0C$<A41.
M\B !<!Y%5')Y>WJ10I#ZAIRN,$@RI(6W4S2=!TAQ4[T=:5W;-.P#=G::92-6
ML"H/JT<1^<84.L(HV$AO)*0UVK')=SR ?*)Z<.,D&<5UMIB4AMPBR2>*G!%L
M^"&YAFC(6.VM'M;:#I$6^E$MQ+K9F9WFW<*DGVAH=F9S*<227DLL,D;\VFN%
MGFE)YONXS'"@4 *JQZY" ,@ZD"J@C]JFOH-:^#JG1YO_ ":Z&1UC^(JI3T&M
M?!U3H\W_ )-,CK'\12GH-:^#JG1YO_)ID=8_B*4]!K7P=4Z/-_Y-,CK'\12G
MH-:^#JG1YO\ R:9'6/XBE/0:U\'5.CS?^33(ZQ_$4IZ#6O@ZIT>;_P FF1UC
M^(I3T&M?!U3H\W_DTR.L?Q%*]M?@VI$Z6T:E4,R3-%\[[7OG.V Y<4+.^%X@
M@K&V5L1,,;WQO?'*ULK6\5[XWMX_':]?-?3(YVG!CL$7]1=5[?T:_49?Q<G\
MF"O3VXYMDA/<*Z0*K@(94DLJA0L'=(2,[X%RQT<$'"^>9++/.^(>&./E9Y99
M9>+QY7O>][U\[S\!W^->L+,"1GW]0\*PW+S)_P ? Z&1NP4R.H=_C6-;=?</
M"G+S)_Q\#H9&[!3(ZAW^--;=?</"G+S)_P ? Z&1NP4R.H=_C36W7W#PIR\R
M?\? Z&1NP4R.H=_C36W7W#PIR\R?\? Z&1NP4R.H=_C36W7W#PIR\R?\? Z&
M1NP4R.H=_C36W7W#PIR\R?\ 'P.AD;L%,CJ'?XTUMU]P\*<O,G_'P.AD;L%,
MCJ'?XTUMU]P\*<O,G_'P.AD;L%,CJ'?XTUMU]P\*<O,G_'P.AD;L%,CJ'?XT
MUMU]P\*<O,G_ !\#H9&[!3(ZAW^--;=?</"G+S)_Q\#H9&[!3(ZAW^--;=?<
M/"G+S)_Q\#H9&[!3(ZAW^--;=?</"G+S)_Q\#H9&[!3(ZAW^--;=?</"G+S)
M_P ? Z&1NP4R.H=_C36W7W#PIR\R?\? Z&1NP4R.H=_C36W7W#PIR\R?\? Z
M&1NP4R.H=_C36W7W#PIR\R?\? Z&1NP4R.H=_C36W7W#PIR\R?\ 'P.AD;L%
M,CJ'?XTUMU]P\*<O,G_'P.AD;L%,CJ'?XTUMU]P\*<O,G_'P.AD;L%,CJ'?X
MTUMU]P\*<O,G_'P.AD;L%,CJ'?XTUMU]P\*<O,G_ !\#H9&[!3(ZAW^--;=?
M</"G+S)_Q\#H9&[!3(ZAW^--;=?</"G+S)_Q\#H9&[!3(ZAW^--;=?</"G+S
M)_Q\#H9&[!3(ZAW^--;=?</"G+S)_P ? Z&1NP4R.H=_C36W7W#PIR\R?\?
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MUCLUN.=3.-YK-MECF@VZZ& 7".$2*2,Z29T!Q$D\_AFJJ.*L'X='+^)'_FJ
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>H&?CPN7*XVOXPQ<\?_=AE;Q7OX_R\?B\5[>-2O_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>g472601g50s06.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g50s06.jpg
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M1Z:1B%0I;-HZ_-4&B['"1R!U9VS<B>I D(<D+9ND5GJZ*KA"4@;2=HD G)(
MR,@=Z<GIW[^G=@8WV)\EW<WPGW+KU:<,_P VK(;:N/F'HJ.$?BT]J_IT\EW<
MWPGW+KU:<,_S:L;:N/F'HIA'XM/:OZ=/)=W-\)]RZ]6G#/\ -JQMJX^8>BF$
M?BT]J_IT\EW<WPGW+KU:<,_S:L;:N/F'HIA'XM/:OZ=/)=W-\)]RZ]6G#/\
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M?BT]J_IT\EW<WPGW+KU:<,_S:L;:N/F'HIA'XM/:OZ=/)=W-\)]RZ]6G#/\
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M)C(FVO#-%UC$-MID W4SL6C4$FQ")GKVU7"--QIC9'5ZDM?'=(EHAGXH-LY
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M,ZQ!^M\^NM4M-NC9I(>OVXH-(4QAQ2E;M6GTD3FIS=D*"SU'=.XE&$'A$2<
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M0Q"WY]BWO>\KCH'B'S5;GI/C/SU+.1J%,4IBE,4IBE,4IBE,4J6J-^RA&O\
M=>OY@=,D7T>7]1J9'NAY?F-;!LI56IBE,4IBE,4IBE,4IBE,4IBE,4IBE4CY
M)_KY:O\ E-#_ #P^Y51T>7]0JDOI\GZS5>\GJ2F*4Q2F*4Q2F*4Q2F*4Q2L@
MZ&?_ %;O'O\ XA>7]HFVLMZN3T^0?,*V@8J%,4IBE?&X$C4(%Q!6NT8<C4DE
MZWO6M;&82, -;WOJUKK$+6NO>]:U[N\4KK \0NBGY7\7$?1J6$Z)))=SI3T5
MFL0N3CC;?(N02&L.--ER9JE2&&\D>/S.7,BX E/C*=S-C$XCS0BD3GJ,2-4[
M5NU)I>4>N*544H';Z!DY! Z=^<'KW[CGHR.OI%7F#HD^=#I7?(]H.XZ1"J72
M\.*=05S)(E#9AQ_AL0?;N@',RMK9D;PS"K9SU)G=F-K<B6KHC9EV3><W*XB2
M.33)9 R'J(VQ&J;0Z<Y()(R.(W9\6[<-V*N;;_1;VO')[=I%0\::WFG$4OI
M^,G)1CX8M<EKV#UU=U51;B>AK2UVU/$GE2CKQM<FV\3B+ /AEB$L<:GJJ+Z<
MEIQYP682A0*&!QV2-K&<$JSX_<Y'EQT9J%(KT6_):'1JO%%E<)*SY(5*P69T
M@SD'@ZKNV!HXE7[GR.L9CDE&6ZPR&5B10R4"A,,;GF!&*W#V,G\%;W@N3PYC
M,D(U2).H5 D[\$A._&_<,*&[CT[MV['77SSKH9N4LNI^Q6FRXY$+SOAEX2]'
MM4-/VZYS-H]G6JXJ2NZ42BY5D-E4B7-TFB[A&ZY=$$;:+&5:87V4LO?Z!&J
M:\O#8:IMC.1D=\LX\"@-W#JZ*L.NZ-*\*XM-V45%QZKY10D1Z2N2<GJ^I5GE
M<#AD'7TXY\ WFGG-H;X^,[;3%2YK<:T<>=F@3-WP AT4R=:UGM6CCQJAM;ND
MYV,9\(7GI\7HJF<$Z)SEH#CC;S+OA3 J3N.S>3-(7S=,>KZQ..@:CN:FZTF+
MP8BXG574Q87:M8[#H2SN39+P)KK&Y,=N2YG6G60\*O9-&F;%3%0R-Y( PDG.
M02,;1/3X=V>WIG$KHO>2C7".-)4LXP,G(:OXI%N;D<2\5K0NJGPM?&:<\AYH
MR2&H+7CJABA\3JEM:H(W-;VV@C-4MTA>Z02R<I/4B^8":4YQ+]O14-KIWX)V
M>^ ZATCB<[COZ2-_&M[O1Y4].^/O!CB=2%H-B9FL6JJ'KF"S5J1N2!Y2-\DC
ML=1-[JD3NK6>I;G DA428 "M$H.3'!UH91@@;UO%2*.5*(Z"2>TU<C%0IBE,
M4JH_/_\ T#^;'\$?DC_4W,\5$=(\8^>M?''O[ ='_O05I_0QERN.@>(?-5N>
MD^,_/4OY&H4Q2F*4Q2F*4Q2F*4Q2I:HW[*$:_P!UZ_F!TR1?1Y?U&ID>Z'E^
M8UL&RE5:F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*52/DG^OEJ_P"4T/\ /#[E5'1Y
M?U"J2^GR?K-5[R>I*8I3%*8I3%*8I3%*8I3%*R#H9_\ 5N\>_P#B%Y?VB;:R
MWJY/3Y!\PK:!BH4Q2F*4Q2F*4Q2M:B;I5>-2JWE%/%1R]=+D_("S.*_AV.IG
M;57J>0M7,+[*'2JD$STLVF<),_,$=<7.+@0I5")83HDMR6-"DWN 53;)QG@,
MXZ\9QFN&C?2-R"\VJP8IQLXD\E/'<U5Z^R>O6GDA70Z.JN12! J;&]$SO5A*
MGIX W?JKL%T,1E(^^W!M;'%.B/(5[)'I3&.L'Q'?5=8UTK%EQSC[RHE%CPBJ
M[7N>G+^=>,U #XYK92&I^5-N$UPT39<SPO<T6KGUI:JB6J)0DO.1B?'5@C##
M7LRD*5RW[&C;P*CLC*>H$ GB 3CJZ<[L=9ST5 %J=-/>L 8N#KP17U"E+.1O
M#WBQR7DD>D"JPB5UA3&_K&BE?2:JJL=FEP7L%,I823(B9,BL.]W!=%7X#BDC
MR)0>O99 N(4V/==)PHI[.L^@>?HKLFXJ2F*4Q2F*4Q2F*54?G_\ Z!_-C^"/
MR1_J;F>*B.D>,?/6OCCW]@.C_P!Z"M/Z&,N5QT#Q#YJMSTGQGYZE_(U"F*4Q
M2F*4Q2F*4Q2F*5+5&_90C7^Z]?S Z9(OH\OZC4R/=#R_,:V#92JM3%*8I3%*
M8I3%*8I3%*8I3%*8I3%*I'R3_7RT_P#*:'^>'W*J.CR_J%4E]/D_6:KWD]24
MQ2F*4Q2F*4Q2F*4Q2F*5S_0S;UOHWN/VM;UO9;K>Y!FM;\X#D_(ZW2#RAZ_[
M)A)Q9A1H-]0BS " +6A!WK5O5R>GR)^85M!Q4*8I3%*8I3%*8I6M\71ETT>>
MA&OET[<DB3I!)YTAZAL7^#![>YV/84*FD&>Z\<"!1_J.K8+3.',9*7K#(1GD
M)@J7T\C9Y)RIMHC/A3L^3=T=E>V2]%?PW2U]:,4X]U'!>'\XM.OWBL'"\N-4
M @<!MY@ALF5MIDI:HW)@1U5IOU($#=[%JCMIS#DQ1VEJ :5S2(5B=3:5D9)5
M@YPHDC/;450GH<>.26@(SQTNZ3S/DI"*P1N[;0Y\_::[@B^B6]^C8(X\IX&7
M1D-JQN5F.VBBW9V7R]%)7%U=^^%;BK5;7+]*5"K)S@#?DXSO.<[\DU&ZKH+>
M.R6O834L*N&\Z\K0CCY7?&2\HE'5D 7D<C*NKBP'BTV\N8.DH@[^]P>2ODZD
M\K<9"_56XP[:AMDC@RMJ-K1E(-I%1VSDD@$Y*AG.XG<>OHQU'@*W<:UK6M:U
MYM:\VM?N:Q4E,4IBE,4IBE,4JHG2!F%D\"^;AIHPEE%<1.29AA@Q:  LL%-3
M00QC$+>@A"$.MB$+>]:UK6][WU:Q41TCQCYZU^\?@#+H6DBQA$ 8*BK8 P"U
ML(@###670@B#OJV$0=ZWK>MZZ];UU;RN.@>(?-5N>D^,_/4NY&H4Q2F*4Q2F
M*4Q2F*4Q2I:HW[*$:_W7K^8'3)%]'E]-3(]T/+\QK8-E*JU,4IBE,4IBE,4I
MBE,4IBE,4IBE,4JMO(&!.+\E;Y2SIC%BIH3F(W)(0#9B@;=LP2@E204'6QF:
M1G&*.[@!H0^Y*.ZZ#H!)F\G0<9!JFL=?;5,<JU3IBE,4IBE,4IBE,4IBE,4J
MJ].V%R$Z/J06%&X%2#URDXD6'8$LME@A=<2J%QJ\N/<TL)X4R:R8]&X]8[[#
MX/8]5RJ9N+K-&%O13*,RB&O,@D#;W@_,PT!Z*DI!R2-XZ?%X*KI6E0 4=DC
MR0<$#H.X$YZCD;^G-62\K6+X./I'OP&XL?G<9+@\#V&IN]_&(_G?1IY6L7P<
M?2/?@-Q7_.XQ@\#V&G>_C$?SOHT\K6+X./I'OP&XK_G<8P>![#3O?QB/YWT:
M>5K%\''TCWX#<5_SN,8/ ]AIWOXQ'\[Z-/*UB^#CZ1[\!N*_YW&,'@>PT[W\
M8C^=]&GE:Q?!Q](]^ W%?\[C&#P/8:=[^,1_.^C3RM8O@X^D>_ ;BO\ G<8P
M>![#3O?QB/YWT:>5K%\''TCWX#<5_P [C&#P/8:=[^,1_.^C3RM8O@X^D>_
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M6)9$;4OC>N8(Q.$;\LE T*IWC,@9FB8.T%:H*\.3,X%MTG4$)AJ-*F*2!DD
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MDE0.;H),F I5#;Z>G&RE(_X=D_J./'T54Z*]#%S">85:C)83%QW9S+3J?@?
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MJ20;%V.EW@(M;]S9DYM46^K7N;[(Z0,T'?[/5O?W=XIM-?BS^D?33R7WU2D
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M6]:\WN=>M?;ZNO>\4VF?>*[?^JO.N#7U546+?9Z2KC>+[77MZV,._N:,X?\
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M Z:E4K& -YX?MUUH@<NFKM"8+%#AQVX^VW<\ ">:4W68I/J&HX5*B@#$$+E
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M@V<0@J%!NSA;,T;WU7*E;E6QRU*E79RWIY(;-I-BVJYU,$:KMURMLIR5S*)
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M@AIM]?GWH*%CL!C;R@;^V42E*)^UHO6O-FFRO5)<K<@GFK]#A _O8MDM*@/
M#,B2U<.E1Z!6V1?4^\ED< .6*3,(QWTF[W1)/C[DE14]B0*XL?#CC\;OK51F
M7N M^Z8ZW'=#L:+?7U]8S7.PE9@Q;W[HA"WO?V]YAG.7KE<<.5:SF#_=V^RM
M#L:MJ!Z*RR.1+DM;&RG2,0C_ &YMV</E+D]1)\).:\!X;<>B]]:>)R=$+_\
M(WVU<+<;K>_MA-0SU.8'?F\VPBUO6_/KSY!'+SRMH.4ZSFG\^#9W!V.6Y0\U
M3*Y%.2Y8*3I&$ ?>R[HCSHG)/GW5R2?C'$FC>AP^SN3\!-U_FFP_ECR,;]:_
M<[W666XH]A_9+$FV6+W! WKS9EHOJC^5V.1MZCCRP,=[)LEE ..*HT",L_I9
M\M8N3R <E;X(1IYV*3^^CW>[DCQ"1-D('Z.*R9##.1,5WHZO^<W)YH.!_F)9
MVJJRY&@0=:ZNP>18]:/#T;K>O,(89"4=O76()H#>HS6WV[U6'*!&*1<+3IJY
M-C&TH1I\.0H=?WQNX.,)SQ[E.*U6?ZF'0D@*,&XZAM[ASLCNF%*82>K[VY!0
M\<<.Z1GQ[ZSYJOOI#X+L(?"_C-?[:5U&#3S2!S6D):H"'_.3ADT'D5@Q;1A@
M-?6G;KM.7L[>NL!)77K72K+ZKNRO%"-0:2N4#H"W[5.C7-/Y_,2F[4I">LI#
MKR@,X*S@5SN[^I5NK84JQ:I@2SO*6KG"D6\_F\]&7<@I74%%ML$XR$C)J66+
MI,O!O8">2'%^ZZ>3ZZA*YO 2$/(NLD1 ==1RQ:Y5H5JR&U(4+K$(YTJA$4 G
M6S3C"M=6A=LTWRW<F6J"VU!U1"ARW" (5XV[1(VU;@VA4Y+,>0X>I$5]\GH&
M3NKCNH>1CE&TVE;LO3LJ7%0"3+M)1=&=A/2XM,-3K["!UJDLLX&\@#!J]=/7
M_2?(%@')J4M*$68SD; !>;$G] Z+&=0/8M!12!I+-T[1UQUL NVVOB%O7E]G
M?;3!SJR5I6D*0H*2H!25)((((R"".D$;P>@C>*Y>M"VU%#B5(4DD%*@4D$;B
M"#O!!W$=1W&I>R:I:8I3%*8I3%*8I3>^KS[\VM>?>]_:Q2M</([I9N!W&$Y>
MT3B\F253)O$84= :I+%8\I+5D]?=6]P%'QFQV.N .KJ$DE4@83=;$'S?7:RM
M'C2):^;BL/25[N]8;4X1GK5L@A(XE1  WDU*ZXVPCG'W6V$=2WEI;!_-VR"H
M^!()/4*TL7)]4UZ[HJ0\>^,(ADZV9WC*+FF&B3!:Z^HOOJ"0@D[1>]ZZAC[E
M88_=[GKW.Z;V2+HV]2,%U,>&D[_O[NVO'@0P'1M=>RM:,=!P:PK^HK6SD(<>
MDJ&[[PT4HSX5O%O=X4I5GI\>M>QNGPZ2*=C4:9+'@=4I%&Q:$BKFL(P8$LL6
M]_J1"^PB9\\$=6O-HXEQ+4AZM;T=K?7UYUC030P9-R=7Q2PPAK'@"W%/9\90
M/%6+=U8=X8@-C@7WUN>4I;2SCQ;9\=4XEG2/<^9J(T3[S"Y"@"?VNZIX_9TE
MAR(>A?YP-H(@M8T7<]^YW+N'<]:\V@ZUF3:T596\;7=CW^]DD9\?,H:\V*LE
MZHN:O<IB-?F1PK_WE.^?R5!KKR)Y!/PQ&/E[W.]&#WUC,=K2G#B,>]^[L0E;
MZ;L6_P!W>][R[3I/3Z?_ ,>">*I,M7SOD>:K8ZBO!_\ N\?FQXJ<?HL"L;\:
MUI=KM^,NP>W_ /?X:27M_P#F]D^U_%UY4]BU@_)K7\9(_O:E]?[OT]VJX?YI
MC^ZK)FKD7R%81A,8KYNAE,!O6P#:;3G+<,&]>YL(DCZ3L.]?:WK>MY35I/3Z
MO_QX!XIDRT_,^!YJF&HKP/\ [L*\"H\56?'EDGSU,#7TA'.)L;E#,9RLO"1,
MBLK2=6PSR=O%CL"Q/H01Z3*V*?G25I5)>T$.]ICT8R!=G767OJRV5HRS[04R
MJ=&6#E*V)1"DG_9+J'2/'TU<)U-<<$.(AOI/2ER. ".!#:FZE^NNE(OZ#&$;
M?JNXA6TF)V'_ !.Q^)U,$Z-+#OK[!Z^NHU7[L<(6O,(\Y>8H%O>Q"-$++9_2
M<LY,;4%P1P3(4XYGP%;;S./&$'Q56:O\3([HLT,\5,;*"/"$NM/9\16/'6RN
MFNF]XHB,2H>0O1G46G)ZP=_2BF896ZT>M;WK1G>L%FT70]?9UUC#W2PM[W_\
M/>M?_$W@I6GM51\EJ6Y,2-_^3SWDKP.*'U-9/^RA2R>@9-91BZZ>>P%,(BJ.
M!]_AM*1G_>,AS \*DI ZZW4\<.5G0W\H3D#17[!QCC\R7B+))@%GTU7]<RTU
M8;U=S;FTF1QU,RR5>+M=?>\2>Y!OS"^N^L'V=:?DW>*OFI3]RC.>\?=DM*(X
MC;4,I/4H9!W8.^LRW&M[R.<89A/H]^RVPXGQ'9!*3X% 'P5L4]JEQ<][907J
M=KOZ.Y2]<;A_KTSXR]].INXX?^J1OXAKZ-/:I<7/>V4%ZG:[^CN/7&X?Z],^
M,O?3IW'#_P!4C?Q#7T:Z[?*BFJA9NGTX25\U536S9 '^EFQ<]0=O@T81P]Y6
M&"Y&@&L=8RF:RV5P5"VV-_6H6(CC1>QZ'K'OO4CN=,W&X;0 GS.K/^5/_3X8
MJY1!A=SN'N.+D*Z>YVL]".O8KL2>U2XN>]LH+U.UW]'<J>N-P_UZ9\9>^G5M
MW'#_ -4C?Q#7T:>U2XN>]LH+U.UW]'<>N-P_UZ9\9>^G3N.'_JD;^(:^C3VJ
M7%SWME!>IVN_H[CUQN'^O3/C+WTZ=QP_]4C?Q#7T:>U2XN>]LH+U.UW]'<>N
M-P_UZ9\9>^G3N.'_ *I&_B&OHU^@\5.+P!!&#C=0@!AWH01!IZO B"+6^O0@
MBU'=;UO6_/K>M]>M^?6/7"X?Z],^,O?3IW'$_P!5C?Q#7T:F]N;F]H0I&MI0
M(VML0$%I4+<W)2$2%$F)#H!2=(D3 *3IR"@ZT$LDDL!8 ZUH(=:\V6BE*42I
M1*E*.2I1)))Z22=Y)XFK@ ) "0  ,  8  Z  -P%;;,MJN:8I6O>\?LHRC_P
M7^CK3E9'N1Y?G-45^Z/D^85$^35+3%*8I3%*8I5(.DL#V^C]YC:Z^KJX\6@+
M_P D77CZOX^SU9*KW)_;KJHU_G$?G"JP=!.:$'1>\?AG# 640YW1L1@Q!  L
MH-V6&:,0QBZ@A"'K$(0A;Z@AZ][WK6L(]R/+\YJ:1_GE_P##_P J:^ZU.>-A
M7$\/$ X1)H^&+M*]6R2OEM-FTQ\KY(X(SAHW-LHR' /1^-]\;5(3B39@X+V^
ML&Y:C,*(43+M;2@XMRG\N&E^3@+@$^O6I"V%-V6&ZA/<^VG:;<NDK#B(+:DD
M*0WS;TMU*D+1'#*P\.O<F_(OJ3E *)RO_H^G@LI<NTII2C(V24K;ML7:;7,6
ME0*5N;;45LA:%R.>3S*J\L/'2% E)-D68XR6^[>!UC\:5U.>IK(&XP8PFC*A
MS0H()B-=-I9NM]Z-<"CT>2IRMZ*%W;JV,7PGK;EKY0-<K>:GWARVVMW(%FLR
MG($'FS_W<A2%F5.!Z5"9(>;VM[;;8PD?:VCN2'0^BT-+@VEN?<F]E1NUU2W-
MF\X ._8"T"/#(.=DQ66G-D[*W'#E1G[.35TZF*4Q2F*50AXYTA10F'6*R4%9
M\IATTFRRM6YW;7ZL4.B)Z79\AJQNC:E"^35L<M&O#RPEKDKF6C&RIF]U1[<7
M)&>2M*3=DC<D!=NUSL<K66G[?=+7:6[Z_%?B7]TKLZK!"U"]/;=B6J0P4QHL
MM33C!<$I;T9T,,.H4TI?*9/*CS5LMUXBZ3O<^W7*YN69F0S*LC01=4WR98F8
M:VY5R9>VI,F*'4/!LQD-2&^>>;4ET(YN4\MY]$9E 8$Z\3+>U)K.]E2H2@*F
MU%&!>5\=BVI;*&_OH-G[1H#H^V@5Z4'.:A$D7'(S -)Z_NJ?NUI;^36S7*UW
MF\1N4C3!@6#N=5V>5:]7),5F;</6V ]S9L'./)F2%-\VEA#KC2'4F2AG97LW
M$_E NUON5IM3^@-0=VWOGTVQI-STN>Z78< 7"<SMB]%MI41D.!:GUMMNJ;4(
MZG=I&U=5*::>F3'G)C$9QQ!)IJ0X9)AR4TPL(S$QIB<PT@9A ][*&,@TTD0@
M[V68,&PBWREQ*4..(0XEU"%J2EU(4E+B4J(2XD+"5A*P H!20H X4 <BNF(4
MI2$*4@MJ4E*E-J*5*;40"4**%*02D]Z2A2DDC*5$8->_)*FIBE,4J#YSQYK.
M;2 B=$H'2 6F@UO;1<-5O*ZN[2:C-]CJV"7QLQ&L=DNNQH(VB2 >V)0#8RU3
M6>6,8-]$T=RJZZT*XWZQ7R2(*% JM$Y1G6EP9RI/<;RB(Y7^^=AJC/\ !T5H
MFK.371FM&W/7NRQES%@@72(E,2Z(5C"5=UM)"G]C)V6Y:9# ))+1S4GP+FE>
M/&8Y,U<L![NJC0#+3AY,0V-%MMAUTD[6@A67M6L=3B;GV-IBQ?X_95:H48FT
ME,-9(8*22<<[%?<?)=ZH;3NNG8]FO3;>G-2N[+;+#KVU;+F\< )M\MPI4W(<
M5[B#* =45(;COS'"H#XRY2N02_:,;?N]E<<O^GF@IQYU#>S<;<V-Y5-C(V@Z
MPA/NIL<EM(2MR0S%1LYW!L+\R2ED:)+&GALD$=?VU$\,;ZRKDSFT/#2XIRU;
M>YMCBB-.2+D"U*:4H2*TQQI"@@P!I0Q %K>_HFOG^N6Q2F*4Q2J'\Z^D.H+@
M+!")%:3D<^SF0IE0J_J6-G)AS*9'D;V4)7L)PMDQ^+I5'46Z2EU#I&F[)B9M
M3O#QWNT*:\:-(F/HC16EO/N'"6T#JZU*4>]0A/2I:R$I&\FJ;KK3#2WWW$M,
MH]VXKH&>A( WK6K&$H2"I1W 5THN9W2V\O\ F:L=6=]FJFJZB6C.)2T]6*]<
MQL*AN'O80IYF^$F$O\\/,*T5M:6]*@QT:LK:MKC3/V]DZZ-:M$QF0EZZK[J=
MW'N9I2D1D'IPM0V7'B#@_P#=HZ4E"T[SI\_4[JRINWHYA&\=T.!*I"AQ2D[3
M;/DVU]!"TG<-8>M:U[FM:^YK-V989C-I:CM-L-)]RVTA+:!XDI &3UG&3UUJ
M[KSKZRX\XXZL]*W%J6H_\2B37G*M4Z8I3%*V0TST7E^78/CZG:)]QXA3CREA
M_AA13/9UN(86[V"#=FO]2EQIB0+&H\UPF!\OCBXHE@1=\J#$!R%9HSK5!)#A
MY%ZBQNZRIJ6Z(3G-R5,,%Q+7WA$C;40H8;#:QE9P-H$=59%FV/O]S@.1VS*1
MML!UX(+GWU3.RD8.5E:3A(R<$=9Q4@P_H@KEGT[FE:Q#DQP/?IG7[+)9#*F1
MNY0QY2K;&2$MKF\3AR.*)91FA20EM9W%7*SC"RRV0E,,:L0 A$+5)R_QVFFW
MG(5T2VZI"$*,)8!4XI*6A[KI=4H!L?OB=U5$6EYQQ;2),%2VTJ4H"2DX2@$K
M.Y/0@ E?O>NM;5GP(RKY[)8";+H%/3(RN A'+ZPE"6:0)]V-*G5=]QJ4(BR4
MKRA#I1I.-224 (51*@CJ[16][S##O/M(=YMUK;&>;?06W4[R,+0<E)W9QP(-
M8YUOFG%-[;;FR<;;2MMM6[.4J&XCP\:P+*M4Z8I3%*\;UK>NK>NO*+\=B2V6
MI#+3[2NEMU"7$'P[*@1D=1Z1U&JK+ST=8=8=<9<3T+;6I"AY4D''$=!ZZVE\
M+^E[Y?\ #98TLB&8J;@I]$,DE54=GN2YW;D;:7O01)X3*#MJI#!3B2>Z:0IV
MXY7&"E!FU+A%W,0=!S2;KHF.X%/6I?<SN\]RNJ4N.OKPVL[3C*B<])<;Z!LM
MC)K9X&IW$D-W%'/(W#NAI*4OI\*T#9;= W= 0O&25+.ZNZYP<Z0&@N>M?&RV
MI7<YLEC"2D!8%62,Q,1-8.N4ZV$L:I.28(EXCJTX!NF:4M6S6UP" 2=0%M>"
M%[0AYS(COQ'EQI32V'VSA;:Q@C@01E*T*&]*T%2% @I)!%;BTXV^TAYEQ+K+
M@RAQ!RD\0<X*5#H4A0"DG<0*U$<P>T7]4/\  @6NKZ^C&7J_W1+>3A0NO]W_
M #NK^+?[F6A]WY1^JKUO_LSGYQ^9%=EG*M6M,4IBE,4IBE,4K;!EO5Q3%*U[
MWC]E&4?^"_T=:<K(]R/+\YJBOW1\GS"HGR:I:8I3%*8I3%*I-TDH>WP YD:Z
M^KJXY6N+_P D0<Q]7\?9ZOW.OKR56])_;HWU4:W.(_.3YSBNOUPMGS_871[\
M/N%<8=W!B8+"07]:G(IX:59[<[FT@R7Y,HXT5LV."4PE6A\<$Q4+&E_6(STZ
ML,)B\L;B1[]EA[+X[RV<H;O)UHEZ? */7NZ/BU6;; 6EB0\VZX].4A0(6F%'
M:<<0E25-JE*BMN@MN*!Z[R0:":U[K5$2<%&SVMD7.ZA)4DOLM*9;:AI6G!2J
M6^XVVLI4E:8PD.-J2XA!K:HSL[3'FEM86%M0LS(SH4K8TM+8E)0MS:W(B0)T
MB%"C3 +(2I4Q!8"2""2P%E%@"  =:UK6>74J5)FR7YDQ]Z5+E/./R9,AQ;K[
M[[JBMUUUU94MQQQ9*EK42I1))->D,>/'B1V8L5EJ-&C-(8CQV$):999:2$-M
M--H 0AM" $I2D )   Q7)90JM3%*8I3%*8I5 F[B1,T?'ZLZA,DL8$]0CDH@
MNM>Y@]E?8M6PI;U>[5&TH^TWZ5^RXFAT*;@]V3E(_9(LSK4Z2]D\79W^4JU.
MZTONIDP+@(MUT(]I1F.>YNZ&YCFD8NGA)<P\6^YA)84^=E:G>84,(+F4UR=G
M0%R;TE9=/*FP3)MFLVM2NOCG^8<BMZJDWXQV\M!SN@QWTLC:0&^>2>_V,*J?
M[)J-YFMV<;[.0.;8D::7=K2<'UO5]]>R+J7.ZZ7PUO T]Q3F)NVC7*P*EO?A
MZ8/>@1=PV:=U%[TNQ:EBVK2FNK \Q(<DZJC:>8AO-<WS$95GOC%T?,G:6ES#
MK+1;:YI#AYPC;V4Y56V7G3\FY:FT9?&GV&X^FI%]>E,N<YSSXNMG=MS(C[*%
M(RVZX''.<4@<V#L[2MU3]FF5ME,4IBE,4IBE?D8 & &68 )A9@1 & 8=" ,
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M5KWO'[*,H_\ !?Z.M.5D>Y'E^<U17[H^3YA43Y-4M,4IBE,4IBE4KZ1\.A<
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MT<S54_W8<K2P%KD<EE+LW2F6QN!0JM(8H3#95;D^NZ!M;C$0T2AY6(R =Y'
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MD=2$[1DP'".@N.3(H5[H-IR4I^D-.>J?TI/#;6HK7<+$^<!;\;9ND 'H*U%
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MV$MY"A8;H.E+FYJ Z$M>7E;L 1N#V[J5SLXFZ[LN6J#=['ONZ4I0D)2D)2D
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M-PM@@U/\AR#:[:M;V%)%H_;-3UW;3K$V=-KJ)0L#9,I9)U[2@(  E$6\&I2
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MOQWRCT#YR<?/Z9]@*V21D!MO.\]9/4 2?'N ZSO%8(Z\X;=C$KMWDNQW56$
MLZ7<&>CONA'2<AC0) FOJ=2=AE[@^5E7:%9)TSRT%JE\L5-JA-%2'>8;4.<:
M4Z6DHF-U"X,[R<X.$[N.0,U-S8(""DD!QU.T#@I V=YW'/1XNGC5G6'GIR7G
MW**SJE>"8BRQ(BU.1=,KZ;<5-5M$PCL KJL7M[C5I,IGC/,NIZD3LJ1M<E<S
M%M8%5LX0V0&AC#N!Q;"EBB)4<GRC&[=@=/']NR3FTA*3OR4I5G!(R58(.X#
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M?RVL&2;?TCA54&/=I<WNZ1N;CH\RP\ELAQCG-BW^8)794M,:DX$X8;1P-^,
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M)*FW$E]*U$E:72H*))())J+T"#(2PF1"B/IBJ2N*EZ,RZF,M  0I@+0H,J0
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MG5H8GP($N;;YS23WC\65'9<;4EQ&RLM+*)#.UL/M-N I'ISISE(T9J>VQ[C
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M9HSV8V0DLBX!+DV+2]>H_)II-W0^AM.Z8?=0])ML-?=;C1):,V;*D7&:EHD
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M1U5MM]I]Q)]ZYQT]25:?1G)\#@.P51VU^^5^D?33VGW$GWKG'3U)5I]&<8'
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M*>',]/H6*6\G7)M>Z*,DB]\:UUMS>6H.3#SN/"6I)*W10T)R)G;DA8#(_#;
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M?X,+1_XV[?T]VI:S@E=MJBO+2:SZ,6!2K<BD]I0FK79MLU7)Y%4$.,FDF46
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M%1DN!#BD*2%D92$BI8>*@7O=M4E/ESTD,8*<B,[0HX]WJ=L];-)>W1R/I).
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8$1+J4.K991(D*==6A*'7"T6=I#8<7__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>g472601g58e92.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g58e92.jpg
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MKC9!@0DL<D(Q89HME-4JWBA7+;YM0SKX-W_AMD1.)N.)RHR%R$R"/79XO-)
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MA#%L?*QT) %:XY>@,>QZ-65:I-^%J4[S[:"6X,+3Q\W'^3I8?ZO066^+D/\
M<RE<+,^;CZEE64GHG+2#A*=;C^5>K+6(O90ZY[J]2JDJ3B==4+;T*I[E0_TH
M#K#H^=3*&5J9M ];.M89L'<9$JLM9";RBJH^Q9M(PRD(-$?%%[,>R)@Z1.;#
M%=-9M;8N+L67E4MF8U<G<4P7R,&4JY"8Z8WS'@[4R,<QGDN2:%'[5$!-@4[
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M9@.57Z5J^,]1P"6+#G5F6_#W,FO)^G$Y*LQ\AYWVBRL7?P^0.WQ%Z7R[)*R
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M,;8SKG.FZ6-OQMC.O^/\XSC_ !YTDH>LU/V:B*?^A8#_ #USJW25'_IF[?\
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7C33QIIXTT\::>--/&FGC33QIIXTU_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>g472601g59g06.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g59g06.jpg
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M  (1 0,1 ?_$ !X  0 " P$  P$            '" 0%!@D" PH!_\0 91
M 00! P #"@@&"0T-" , !0,$!@<"  $("1$2$Q05%A<85975UADA5EEEEZ3D
M,5%8EM'4"B(U.%)XDJ&W(S,T-D%%2&%T=8BTM20E,C=$1G>!A+.XQ,<H5%=Q
M=H6QQ61GD?_$ !L! 0 " P$!               #! $"!08'_\0 4!$  @$#
M @(%! P*" 4$ P   0(#  01!1(3(105,9/2(D%15 8C,E)3559AE*'1TS,T
M<72!D9*QL_ D-4)$8H2TP4/#Q.'Q)7)SHA9D@O_:  P# 0 "$0,1 #\ \-^8
MG,3ER%Y<\I@X?E-R.$B!/(Z[Q@H4,N^S6 T8-86;)VK$>/8M9.DU9L6;5))L
MT:-DDT&Z"::**>">&..WWFPL+!K"R9K*T)-I;$DVT)))A0DDE,DD\R3VU\HN
M[N[%W= 75P +B8 ":0  2,   V  .P57+SU^9?Y6W)OZ^K4]Z]6^KM/]1L_H
MT/@JOTR\];N>_E\5//7YE_E;<F_KZM3WKTZNT_U&S^C0^"G3+SUNY[^7Q4\]
M?F7^5MR;^OJU/>O3J[3_ %&S^C0^"G3+SUNY[^7Q4\]?F7^5MR;^OJU/>O3J
M[3_4;/Z-#X*=,O/6[GOY?%3SU^9?Y6W)OZ^K4]Z].KM/]1L_HT/@ITR\];N>
M_E\5//7YE_E;<F_KZM3WKTZNT_U&S^C0^"G3+SUNY[^7Q4\]?F7^5MR;^OJU
M/>O3J[3_ %&S^C0^"G3+SUNY[^7Q4\]?F7^5MR;^OJU/>O3J[3_4;/Z-#X*=
M,O/6[GOY?%3SU^9?Y6W)OZ^K4]Z].KM/]1L_HT/@ITR\];N>_E\5//7YE_E;
M<F_KZM3WKTZNT_U&S^C0^"G3+SUNY[^7Q4\]?F7^5MR;^OJU/>O3J[3_ %&S
M^C0^"G3+SUNY[^7Q4\]?F7^5MR;^OJU/>O3J[3_4;/Z-#X*=,O/6[GOY?%3S
MU^9?Y6W)OZ^K4]Z].KM/]1L_HT/@ITR\];N>_E\5//7YE_E;<F_KZM3WKTZN
MT_U&S^C0^"G3+SUNY[^7Q4\]?F7^5MR;^OJU/>O3J[3_ %&S^C0^"G3+SUNY
M[^7Q4\]?F7^5MR;^OJU/>O3J[3_4;/Z-#X*=,O/6[GOY?%3SU^9?Y6W)OZ^K
M4]Z].KM/]1L_HT/@ITR\];N>_E\5//7YE_E;<F_KZM3WKTZNT_U&S^C0^"G3
M+SUNY[^7Q4\]?F7^5MR;^OJU/>O3J[3_ %&S^C0^"G3+SUNY[^7Q58WC-S$Y
M<E)79")/E-R.(I->.?)$FV2?W?9KQ-N2&4M,WPT@A@XDZF*3X>]01>,7:>V*
M[1TBDX;J)JIX9[4[VPL D&+*T&;RS'*VA'(W$8(Y)V$$@CS@X-6+:[NRTF;J
MX/\ 1[@\YI#S$+D'W7:#S!\QYU7+SU^9?Y6W)OZ^K4]Z]7.KM/\ 4;/Z-#X*
MK],O/6[GOY?%3SU^9?Y6W)OZ^K4]Z].KM/\ 4;/Z-#X*=,O/6[GOY?%3SU^9
M?Y6W)OZ^K4]Z].KM/]1L_HT/@ITR\];N>_E\53?2-D])AR->3EA3/(7DU,W=
M:P,W:,[1QY.R@!O&:ZC.R64EFI'.460$3VC<<P7;JGRJ.:K4*BY;+$E&J3A#
M-2M<Q:/:"(W%K9QB:58(OZ&C;YGSLC&R%O+?!VKVM@XSBIX9-2N#((;BY?A1
MM+)_267;&ONG.Z1?)7(W'L&1G&:YNS+TZ1FG7<=:65R#Y91;"91MA,X63=7O
M9CR.S>'E,E4Q\KA,H%S)]')C&G:R#EJB=C14H+R>-7;+OK9TU<(I;PVVDW 8
MPVMB_#<QR*+:$/%(O;'*C1AXW':4=5;!!Q@@UI)/J$17B7%TN]0Z$SRE70]C
MHP<JZGLW*2,@C.0:C3SU^9?Y6W)OZ^K4]Z]3=7:?ZC9_1H?!4?3+SUNY[^7Q
M5*<HNSI&H7657W+)N1/*496%SNYRPK&7Y<AY\['2M_6SX4-G+)JDQG3I\R>1
MI\=#HD&Q5HP7V\(M54,%DE-E-0QVVDR3SVZ6EDTUNL9FCZ+$#&)E=HB<Q $.
M$8@J3[DYP14K3:@D<4S7%T(YMXB?I$F',1 D PY(VE@#D#MK^6M=O2-4@1B(
MJT^1/*:)/9]7</MJ&8.>0T_((22M[ 89%(9,!;P/.B+-P'D8[#=Z-6V<;**M
M^RIDEACGAOD@M])N1(8;2R<1326\F+2(%)HCMDC8-$"&0\FY=O*DLVH0E!+<
M72&2-)4S<2'='(,HX(<@JPYBLVBK=Z27DQ98.G*-Y#<H[ LZ3HDUHY#1_(V;
MC2Y[P,.<F": C$]/Q+<B]:"63TFH/:+JOLF#%Z[3;YMV;E1+6Z@TBSA:XN;6
MRBA3:'D-I&57<0JEML3$ L0N2,9(&<D4@EU&YD6&"XNI)6SM07#@M@$G&Z0
MD $X'/ )\U2>Q:=+L4(QD:*M/EN5WF]<S^VH.4%<CY63C,XKZJMGN]ER"$R]
MC9#B*R_&!^#G^TL&1PR3,@LF;G B.0R14VQA)T)5=FAL5X4T5O*K6B*\4L^.
M"DD;0B2/B[EX;.JJ^05)S4HZV8H%ENVXD<DL9%PY5XXL\1D<2;7V8.X*21@Y
M%0Y95Z](K3^4"QLKD7RHBF5GUI$[B@>SWD%8;CQCK6=)NUHG*VG@^;O.X,C2
M;!WDW;O>]2"6R&6SIFAOOCME8AMM)N.+P;2R?@326\N+6(;)HL<2,YC&2N1D
MC(.>1-123ZA#P^)<72<6-)H\W$AW1R9V.,.>38/(X/I%9%+79TC7(>RHU3],
M\B^4<YLN8KNFL6B+'D5/!Q(\[9LG!%=D-S.3P8S<O=F31RX39X.>^E\$%.X)
M*Y8[XZQ<6^DVD+W%Q:644,8!>0VD1"@D#+;8F(&2!G&!YZ0S:C<2+##<73R/
MD*@N) 6(!) RX&< G&:WU)6/TF7(PG-@U-<A.3<R)US!SEES=KCR<E(#..5_
M%^Y;R:8/\Y19 1+Q?CN"Z"IXD@HLV#H+H.".;9%9-3+6YBT>S$;7%K9QB:58
M8ST-&WROG9&-D+>6^#M7M8@@9-9ADU*X+B&XN7,<;2R?TEEVQK[ISND7R5_M
M'L'GQ7:3#X7& P^;V#+[2Y?A(/7</JRQ)1*U^0DV7!85[=QC*/5+/P)%G83E
MO,8//CF"HF.R^'9GHZ\?MW3;PE@JU<8I1QG0I9(HHX;!I9I)XDC%K'NXMLNZ
MXB<&(&.6)<,\<FQPI!VX(K=CJJ))(TMV$C2*1GZ0Y7ASG;#(K"0ATD8$*Z;E
MSRS56O/7YE_E;<F_KZM3WKU=ZNT_U&S^C0^"JW3+SUNY[^7Q4\]?F7^5MR;^
MOJU/>O3J[3_4;/Z-#X*=,O/6[GOY?%3SU^9?Y6W)OZ^K4]Z].KM/]1L_HT/@
MITR\];N>_E\5//7YE_E;<F_KZM3WKTZNT_U&S^C0^"G3+SUNY[^7Q4\]?F7^
M5MR;^OJU/>O3J[3_ %&S^C0^"G3+SUNY[^7Q58GB%S%Y<F>5_&808Y3\CBHD
MI?U/CB8LE=]FOAQ$>]L"/MGC%^R=2=5L\9NVZBB#EJX240714S25PSPRRQWJ
M7]A8K8WK+96BLMI<E6%M"""(7(((3((/,$<P:GM;R[-U; W5P09X009Y2"#(
MN01NY@U7;SU^9?Y6W)OZ^K4]Z]6^KM/]1L_HT/@J#IEYZW<]_+XJE2O+KZ1N
MU \VDD(Y%\HB,3K4>+*6%-"7(N=1>#0EJ>)8!H]M*9O*YX$B@-Y)"^?@N-C2
M)AN1D)#!5F%:/G""R>$$UOI,#1I):68>8L(HUM(WEE*+N?AQ1Q-(X1?*<JI"
M#!8@$5+'-J$H=DN+DI$ 9'-PZH@8[5W.TBJI9N2@G+'DH.#6OM"_>D2I>3XP
MZT>0_+*&R%<*$DP]H4O:S\VIN+28>B6C,KC99G,'0>31.2"G"!./2B/OR0 X
MP53>"R+MOELIOM#:Z5<)Q(;6QD0,R$K;0Y5T)5XW4QADD1@5=' =2,, :Q)<
M:A"VR2XND;:K &>7FK ,K*0Y#*RD%64E6!R"14=^>OS+_*VY-_7U:GO7J7J[
M3_4;/Z-#X*CZ9>>MW/?R^*GGK\R_RMN3?U]6I[UZ=7:?ZC9_1H?!3IEYZW<]
M_+XJG&!V-TF5FU1;%XPCD+R8-U51?B[Y7)AOR?DPQG MI@\R&1#<ZR,62/+)
M8RPLFJ&B^2 ]?&0FD' 8/N]*-UVB=:6+1X9X+:2ULUGNM_1X^AHQEX8W2;2L
M)7VM?*?)&Q<,V%(-3I)J4D4LR7%R8H-O%?I+ 1[SA-P,@/EMY*\O*;D,GE4'
M>>OS+_*VY-_7U:GO7JSU=I_J-G]&A\%0=,O/6[GOY?%4IS^[.D;JZ,5;,YWR
M)Y3 (M=<3<3FK3BG(>?/F,QBK,N[ /BHY07.GV2.S XP?"'[,ABS(,23-TS=
MM$5T%<,8(K?29WGCBM;)WMI!%.O1(@8W*A@IW1#.5(8$9!!!!P:EDFU")8G>
MXNE692\3=(D(=0Q4D8<]C @YP001CE7QJ2[>D:O:0F(I4O(GE--)&!ALLL$H
M'8<AI^T>(P^#"5CTM,HIE9TPV>I@@K=R5>M&.3DAL/:.W:311%JXS3S/;Z3;
M(LD]I91HTD<08VD1'$E8)&IVQ'&YB%!.!D@9R12*;4)V*17%T[!'D(%Q(#L0
M;G/-QG:H)('/ /*NHJ*>])M>T9LJ9U;R(Y(2&*TZ)'R"T3SSE4<BPV# "KO=
M@P.R%Q+[/ XL@KA_MLQV+9=8]-[FDT5<8.%DD\X[B/1[5X8Y[6T1[ABD""R5
MVE=1DJ@CA?+ <]O;CGC%;12:E.LCQ7%PR0@-*QNF4(I. S%Y5P">6>S/+MKH
M;6>]+71L5DTUMVS^9-?1F'6* JB2D9)>UB,LQ4\E<.<6#%0RH_><YDUF\GA#
M5Q*(X=:LUXZ="I[O119VEOCOEK!U%<ND=O#I\KR0M.@2VA.Z))!"[9X> 4E(
M1T)#JW)E%;2G5859Y9;R-4D6%BT\@Q(R<15QOSY2#<K ;6',$U67SU^9?Y6W
M)OZ^K4]Z]7.KM/\ 4;/Z-#X*K=,O/6[GOY?%3SU^9?Y6W)OZ^K4]Z].KM/\
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ML\3N9SQ9(2=JLQ,:QH"" 3E0:>ES6,.H6<P,D/#:8SO+*A@ ,4BIPAL23&6
MPY9B#D@8-7&I#EAQ=&!^$ *777 8'8-+\1.DSJF8UG%Y=@[X\URA=(&=,:?<
M!944('6)"WKJD$C9$IXH&GLV043P&O9#G#$P^8Q#GW-C>LVILEO++#<ZAHT\
M<TD9%W,;9HC<!HU52MO;(A6+=%$1Y03B;@U7(+NV"V2O,D;PV>I1/$K9@CXR
MN(2&)8&:=FR^UWSR+;,;1'KBS>#82H#)**8<*5;61Z,?H^@0'$M7?'TTOAS
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M=L(QO)64Q=*.%UPCO#6FH+J5S-;)<1&?6;&8.&D6"33TM%CN^,NX1L#L*!)
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M<D>_PQ9MU(D@Y)#N)$6]VP2R<L'3=55!NKEFBGU[:XCNH(;F$DQS1K(FX%6
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M#11Z+7>#T4B#1-TVS<M,UD<'".6>RF-F:)9HI86+!9HY(F*D!@LBE"5)! 8
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MP(R222S,Q,F2SL2S,>;,23S-:2:;%*[2/K.FEF[?;'      V8"JH"J!R"@
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MEPHY4(H=\&M=F#X\LR:9/'K:E#[(;9[6UN)H;B-KNWNKN*)$$IX%J<RL65L
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MB/M9=%]H(<!B A-X4P4&D$'>&"%I=#B6WM(1=W6ZPECDLI_Z/Q(%B5HUB($
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MS=E2/Y/H3\>W@%/KV^/?_?,S\6WQ[=>_^^/^+?\ _P W_%I2HNF!JHX7,8S
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M4TI6R$_V;M_DI#_9[K2E:W2E-*4TI32E-*4TI32E-*4TI6Q$?NJ,_P O:?\
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0"G7U]T_Q=75_=Z_B4K__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>g472601g60r02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g60r02.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[1Z*4&AO=&]S:&]P(#,N,  X0DE-! 0
M     #D< 5H  QLE1QP!6@ #&R5'' (   (  !P"4  ,17)I8R!,:65B;&5R
M' (%  Q!0U0Q($-O;G-O<G0 .$))300E       0V4=OF<QR%N99*4(-SZXG
M\#A"24T$.@     !>0   !     !       +<')I;G1/=71P=70    '
M $-L<E-E;G5M     $-L<E,     4D="0P    !.;2 @5$585    !$ 00!D
M &\ 8@!E "  4@!' $( (  H #$ .0 Y #@ *0       $EN=&5E;G5M
M $EN=&4     0VQR;0    !-<$)L8F]O; $    /<')I;G13:7AT965N0FET
M8F]O;      +<')I;G1E<DYA;65415A4    ) !% &P :0!N "  -0 U #
M,  @ $0 3@ @ $< ; !O &( 80!L "  4 !R &D ;@!T "  1 !R &D =@!E
M '( ( !0 %,       ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O
M &8 ( !3 &4 = !U '        IP<F]O9E-E='5P     0    !";'1N96YU
M;0    QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P     "+0
M !     !       2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O
M;       0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;
M0VYT0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O
M;VP      $EN=')B;V]L      !"8VMG3V)J8P    $       !21T)#
M P    !29" @9&]U8D!OX            $=R;B!D;W5B0&_@
M0FP@(&1O=6) ;^            !"<F1456YT1B-2;'0               !"
M;&0@56YT1B-2;'0               !2<VQT56YT1B-0>&Q =!&J
M  IV96-T;W)$871A8F]O; $     4&=0<V5N=6T     4&=0<P    !09U!#
M     $QE9G15;G1&(U)L=                %1O<"!5;G1&(U)L=
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M   X0DE-! T       0   !X.$))3009       $    'CA"24T#\P
M"0           0 X0DE-! H       $  #A"24TG$       "@ !
M  $X0DE- _0      !( -0    $ +0    8       $X0DE- _<      !P
M /____________________________\#Z   .$))300(       0     0
M D    )      #A"24T$'@      !      X0DE-!!H      S4    &
M          +E   $L@         !                          $
M        !+(   +E                      $
M    $     $       !N=6QL     @    9B;W5N9'-/8FIC     0
M %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M0G1O;6QO;F<   +E     %)G:'1L;VYG   $L@    9S;&EC97-6;$QS
M 4]B:F,    !       %<VQI8V4    2    !W-L:6-E241L;VYG
M  =G<F]U<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG
M:6X    -875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E
M     $EM9R     &8F]U;F1S3V)J8P    $       !28W0Q    !     !4
M;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   "Y0
M  !29VAT;&]N9P  !+(    #=7)L5$585     $       !N=6QL5$585
M  $       !-<V=E5$585     $       9A;'1486=415A4     0
M#F-E;&Q497AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0
M"6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0
M   )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L
M=     MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4
M3F]N90    ET;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N9P
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M &@ ;P!P    $P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <  @ $,
M4P V     0 X0DE-!"(      4I-30 J    "  ( 1(  P    $  0   1H
M!0    $   !N 1L !0    $   !V 2@  P    $  @   3$  @   !X   !^
M 3(  @   !0   "< 3L  @    T   "PAVD !     $   #     [  P_R
M "<0 ##_(   )Q!!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD;W=S*0 R,#$X
M.C R.C X(#$W.C(P.C,V $5R:6,@3&EE8FQE<@       Z !  ,    !__\
M * "  0    !   $LJ #  0    !   "Y0         & 0,  P    $ !@
M 1H !0    $   $Z 1L !0    $   %" 2@  P    $  @   @$ !     $
M  %* @( !     $              $@    !    2     $X0DE- _T
M  @          /_A 4Q-30 J    "  ( 1(  P    $      1H !0    $
M  !N 1L !0    $   !V 2@  P    $  @   3$  @   !X   !^ 3(  @
M !0   "< 3L  @    T   "PAVD !     $   #     [    \     !   #
MP     %!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD;W=S*0 R,#$X.C R.C X
M(#$W.C(P.C,V $5R:6,@3&EE8FQE<@       Z !  ,    !__\  * "  0
M   !   $LJ #  0    !   "Y0         & 0,  P    $ !@   1H !0
M  $   $Z 1L !0    $   %" 2@  P    $  @   @$ !     $   %* @(
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MM2,D)3)18721MAHF)S,W.%AR>8&AP?!"E]'6X2@I-45(9VB%A__$ !0! 0
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M[UN>P-2E]*6[Q8MP>'@[I43JV0,L4G73/:#<6AJ-LZ9LU=G??C7JHS:I6O;
M8%;Q7#]<'D)9&1FP&<+%@G6Y_237E$[6>"979!,,4WAWHIVN]$NC7Y+#P;HC
MWGS=NT&YY8-*,^^H"ZJIFN^XNK([Z'FHD"4'JXYN5%Q+A-*#S35F/]-?%\[P
M=PJW-DC.M&L[3T1ZM]K:1!6MBMU/1>X>N=&&ZPWBV/2[[K%8Z[[4%@XAA<:&
MIV!JW9^QB2G6HPA:'0U;UCZK[(V%T.\.'M3%ZQ:@\0C4VH.N?8J@W_I?N697
MVYCCUNWR9LS>[M%,;$#6/51;<@@55I-.^$W.-699.LDWQ]=NPJ;)=C20E ]/
M=IZ=W9U6Z];3Z^09PG2-RU#0R>K0A. ^+)UZE(KT&&"K1(?(E3G(A&N0XK8.
M<Q\0(MHE#W?8$9[&6YCX*0X!P#@' . < X!P#@' . <#0!7&/X4U%^S'_(!M
M;^;_ /<33/ W_P  X!P/CGD1XJ*N:4G1!T-K*$N2YTAF+&;4XO#;>%OOK0TC
M*UJ2A&%*QZRU83CSSG&.!^8TJ+,1_>Q!&"4B>NIKWH?*8F1_:(\O7;]M'6XW
MZZ/63ZR/6]9/GCSQCSX'H<!BWQCMO=A*=:NHM1ZO[7$#MBKOQ/9-AT(SOX#U
MQL&WZ?KFR:X-DW2>Q[.'E5A5&@5MNY58]0['8JFU<Y-W'EQ:K3(HLNN207_X
M=%LL-[Z.]9;A;=FPMQV:Q:L!$SNQQ\ZPEH=C)R,OYE>P-VT2!L]@2(=QD%FQ
MGPHHM85#%&IT"-(GK:2&"]]>D1+N9$HL%BXBJ[!J%=VP&3#G1CT-]L]L@* "
MAKA\<J94.:/!*G&%EX]ETG8)#^K=S#K#@9L2'(BU\3C +B15DR:F,JYLJ5G+
MB#!4*<8#$"%+(D)0UB.V[.:>J,T0^)3-?84^[!&28\-#;JH>&U1<>SR'X:_B
M-0*B*A,*DJ8AK)1F53)DLA+4VP6G-(5*GSWY,Z;(RE.,O2YLF1*D.94](>==
M6M:@S+@' . < X!P#@' . < X!P#@' .!QG'GC.,_=G'E_KX"4(O2/K9#J5=
MH\>A/HK-5[.E.XH,?FUV]:H784SM*P[G(7C$M1S,Q]E[8MJ.'4UF2^]5FD2T
MC&@R!<>/#:#*S/5;0I_LK3>WQ?7P^;V&U_K4YJ2I[#7.+IEBJ'823I8@)2);
M(( RI*)4PNV.,3!<@R*@V&R#1L^+ L!:/+!%/1(/ISNWUSW;V0V#I6M"SG>(
M[M;5'9&JH.6:P5>_U70%XV?U4K,.3 -$7(PMHEK:GH;*M HHG#\LG*>=6]):
M9EX#,WO"8Z8,ZRU7IVL -UZWUWJ"@R=4UNNZF[4]G-4QS6L9QLQ8Y]#V"]K[
M;5=D['KTPS8#<MQBZO&Y3*2L^)#EQH4IZ.L%[Z\U[2-342GZQUK5PU*U_K^M
M!:?2ZC7H;8\'6JQ71\<4$"BH36,-QH(X?%8BQVL>><-MXRI2EY4K(9CP#@'
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MJX!P#@' . < X!P#@' . < X!P#@' . <!I7P/OER:T_;5W/_.EV!X#M7 .
M< X!P#@' . < X!P#@' 1#XF7RX^_?[E_:#_ ,=)W?'_ )_^7 HY>!<7>C7_
M "1>AOZE[/\ Q\VOP'RN <"+/XW_ *1='\*?L.,ZF.=2GMX+V)UY$[/Q>4[K
M1KQ(E-VLVR*+\&S7LZMNF9N1N:2HEF?\:B>]8(XB8B,>Z^\O@GSP@?2A8O?+
MM?UF\/\ ;Z7O:Q7=*G9JXC::M]HMZ8'U1:3MEZ5,S3OJ?K2I.#J:$H;ACZ2Q
M\CLD\2_:3O=,QY 3&^!&]]( !0C=BZ*+M B9]7@ZW;\>M=Q1T6G>(8+J\YZA
M5R+681GK^08F4'W>Q3'9;4.Y'(,FVU^>-CIJ.8XN;<W% \#T!C 8?33KQ%K$
MEJ6 9UV-0*DL=?X?5=IZ)[Q+RA:.NX^-$A:C3G.5?[T(T9EN%_QV$8]XSYAC
MW>NIVZ_Z_I6MM<KV@)O^V=@@]8#[[K>T[&J6-3T\\[@UM79YHS13@6"-FUC6
ME:LZ=?S[.X[$7LR=3@D#&))Q;;P+&(,F8@9$>M)'/$H[45B+]()9%45;37LV
MW%2I;")<]U[+*59P\O#KCKWDI]><J4O@>1K[,S-1%9(8C)GY42S-3#4ZN)B5
MDM.]XQ%6\AMY4?#OKX94ZA#F6_5RM.%>>.!F? . < X!P#@' . < X!P#@'
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MC-''P40A1=PA86F3I2842PY/(%S"/B1>?(DDIBW7Y2W5AJ?Q"MF[,U%HFR[
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MV\:5SA$ECVGLWD^?DEQ*L?S<".F]X&/;))RX%H>^M"H;/;(V5L('B6"V#(G
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EK'QX[DIMM];B$@K?@' . < X!P#@' . < X!P#@' . < X'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>g472601g62o45.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g62o45.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[1M<4&AO=&]S:&]P(#,N,  X0DE-! 0
M      \< 5H  QLE1QP"   "    .$))300E       0S<_Z?:C'O@D%<':N
MKP7#3CA"24T$.@      Y0   !     !       +<')I;G1/=71P=70    %
M     %!S=%-B;V]L 0    !);G1E96YU;0    !);G1E     $-L<FT    /
M<')I;G13:7AT965N0FET8F]O;      +<')I;G1E<DYA;65415A4     0
M    #W!R:6YT4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %, 90!T
M '4 <       "G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U:6QT
M:6Y0<F]O9@    EP<F]O9D--64L .$))300[      (M    $     $
M !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P=&YB;V]L      !#;&)R
M8F]O;       4F=S36)O;VP      $-R;D-B;V]L      !#;G1#8F]O;
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M(%5N=$8C4')C0%D            08W)O<%=H96Y0<FEN=&EN9V)O;VP
M#F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O<%)E8W1,969T;&]N9P
M       -8W)O<%)E8W12:6=H=&QO;F<         "V-R;W!296-T5&]P;&]N
M9P      .$))30/M       0 \     !  $#P     $  3A"24T$)@
M#@             _@   .$))300-       $    >#A"24T$&0      !
M !XX0DE- _,       D           $ .$))32<0       *  $
M CA"24T#]0      2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H !@
M     0 R     0!:    !@       0 U     0 M    !@       3A"24T#
M^       <   _____________________________P/H     /__________
M__________________\#Z     #_____________________________ ^@
M    _____________________________P/H   X0DE-! @      !     !
M   "0    D      .$))300>       $     #A"24T$&@     #-0    8
M             P0   6-          $                          0
M           %C0   P0                      0
M       0     0       &YU;&P    "    !F)O=6YD<T]B:F,    !
M    4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M  !"=&]M;&]N9P   P0     4F=H=&QO;F<   6-    !G-L:6-E<U9L3',
M   !3V)J8P    $       5S;&EC90   !(    '<VQI8V5)1&QO;F<
M    !V=R;W5P241L;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R
M:6=I;@    UA=71O1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y
M<&4     26UG(     9B;W5N9'-/8FIC     0       %)C=#$    $
M %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO;F<   ,$
M     %)G:'1L;VYG   %C0    -U<FQ415A4     0       &YU;&Q415A4
M     0       $US9V5415A4     0      !F%L=%1A9U1%6%0    !
M   .8V5L;%1E>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !
M   ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L
M=     EV97)T06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A
M=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90
M  !.;VYE    "71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG
M          QB;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO
M;F<      #A"24T$*       #     (_\        #A"24T$$0       0$
M.$))3004       $    /#A"24T$#      0Y0    $   "@    5P   >
M *,@   0R0 8  '_V/_M  Q!9&]B95]#30 "_^X #D%D;V)E &2      ?_;
M (0 # @(" D(# D)#!$+"@L1%0\,# \5&!,3%1,3&!$,# P,# P1# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# $-"PL-#@T0#@X0% X.#A04#@X.#A01
M# P,# P1$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P,_\
M$0@ 5P"@ P$B  (1 0,1 ?_=  0 "O_$ 3\   $% 0$! 0$!          ,
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M>WJV;A6V-;;TQN7Z..QVK+G"K)]?)L9]&RECV>EA_P#7<K])^J6)*>C26?\
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MQY(@<,QIT*^$ZTW>6R^J"X<^:I=,Z;9UGJM>/0"6!P-CM1]'W;&O'YW^$?\
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M;]-_T%>Q^K='S\MYZ9E4WYXK+0T$D%C7!WNV_P#0<K>1C86YWK5ZYL56<D&
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MC)* K0;;/6XO_+F?_P 3C?ER5HK.Q?\ ES/_ .)QORY*T5&Q*6=U;^D=,_\
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MUN^S8VL?IZ'Y+V5^I^BXK]5>%))YXJ%[)/N<(N^&G__9 #A"24T$(0
M50    $!    #P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <    !,
M00!D &\ 8@!E "  4 !H &\ = !O ', : !O '  ( !# %, -@    $ .$))
M300B      %^34T *@    @ # $   ,    !!8T   $!  ,    ! P0   $"
M  ,    #    G@$&  ,    !  (   $2  ,    !  $   $5  ,    !  ,
M  $:  4    !    I $;  4    !    K $H  ,    !  (   $Q  (    >
M    M $R  (    4    TH=I  0    !    Z    2  "  (  @ +<;    G
M$  MQL   "<0061O8F4@4&AO=&]S:&]P($-3-B H5VEN9&]W<RD ,C Q.#HP
M-3HR,B Q-SHP-SHT.0     $D   !P    0P,C(QH $  P    '__P  H (
M!     $   6-H , !     $   ,$          8! P #     0 &   !&@ %
M     0   6X!&P %     0   78!*  #     0 "   " 0 $     0   7X"
M @ $     0              2     $   !(     3A"24T#_0      "
M        _^$!@$U- "H    (  P!   #     06-   ! 0 #     0,$   !
M @ #     P   )X!!@ #     0 "   !$@ #     0     !%0 #     0 #
M   !&@ %     0   *0!&P %     0   *P!*  #     0 "   !,0 "
M'@   +0!,@ "    %    -*':0 $     0   .@   $@  @ "  (   #P
M  $   /      4%D;V)E(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I #(P,3@Z
M,#4Z,C(@,3<Z,#<Z-#D     !)    <    $,#(R,: !  ,    !__\  * "
M  0    !   %C: #  0    !   #!          & 0,  P    $ !@   1H
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MDM?Q"B8H-#=BU#9#14A4969G:&EVA8:'E**G_\0 ' $!  $% 0$
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M'FV[=AYA%NRD -,MA+Q4GND(4VM(4V4DF<T73NE0"S*E ZQ$@)"DA*<0 )Q
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M(Y+Q^!2<]1ANE;Z0* <B81^4N  ._J(>@\\<:8&ZD@<B2 ">43$^R:@)42
M2H_9 )/I YU4,NXK$.H,DT'I'T-]V5<X$>W;D)(>/4!^/ @(<\ZK#2B) 5'4
M))$=01,_"J@VX5:0VLJ&X"22,3D1/P^%<2Y@Q.<1 N3<>FX[=KI6QY[\#_\
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M(>\*U!U*1IEE*['!/C3XLR03 ,+9<.YI(ZRG5=J*5LR]"5K'<7ARLY,W7;5
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M!QNQ?:>\[-<5M;5VX<%FL%+S)T]VO4M.%:DD@C3@A0(/D:P>*<.-RQJ(E?>
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M?9>*7 NU<N5M$+"1JN;55JLK"DJ4K2DZD:2GQ;R*P';=#KUN\2M*[53ZFM)
M$W#*FE:I!)TI5J201"@#MBL[0]=B6+.^05#K^)TZQDVD0=+N-;MM>L#ML9W5
MK.\ML!:8Y>L6FN.$IF/EG+19)1Z9\WYAH\.@Z(*)'UKI<6IA;ANBNUN''F'&
M74 P\T&G&5!QIT%"D!7U=)A2@#.:QW[,NJMU]X\E=LXM;:VG$)5#B VM"M:%
M@I4D$'203J,179I.<O6-O4%UW,;5'5*VBL=I:C>[(M[26:BY=A()W>XQ9:E9
MVX1[D%!A6-:"5<*.%F<<*LQ&(JBDD-KN[1M3XRX'N,GBTL%37=K;6DLLK+K1
MD#]Z7-($*5"%&,XS7#&9?2M67>)GB([HZ2G006FUZT9W5K &ZO"JKN>YSRK"
M7>4N=II^-\H&E*!G"KQ<#$L'L% M;+ES*E R8^6N32?NZC^1J35S6)!BV&MO
M"3K='V4_L[M93SD;0X;;+81;M/W%L1<6+RG%K2XZ6K.TN+4!DM,!*73WJ2>]
M&A7BR (-E7 4]VAFW>>1^_M7%N*4DK#=K;O, -:6@ [#@4=8T'.0,5K-?MPN
M92Q-HKTC+T9T>TDRP1]/LZU--I5NOF#)]*RW8GC!,]H58HJPUEHL8QKQ5FJZ
M2<.LY+()O7ADET=JQPJS"FG$AZ&OHA2@O-E!%G:OVC05^Z"BE;=PM3L$'4!I
M*4@BLQ'!+8.-J3WL-_1H25)TD6MN[;M@^ *A:'5%>0=4$0#%6)>=_&3Y*WN;
M%8Z-B.:K4GC^[8\L^-S0-A0HUJ0R-;6V0[M8Y1(EI&;0LDY>6;&PBK&S#-DR
M%H6/9M$FZRPGR;?LS;AH-LW%TAU-Q;W#5QWC??LFW:[AAM'[K06V[=2F_&@D
MSJ)D");[/L-M!M+]PE:'V7F[@+1WK?<-EEIM/@TE"&2I&4$F=1,Q6#Y#Q#)3
M'<=LR-4H,M@D]J%3R5#O(^\IF"O6&0R7*3B$FV13BI!!Z:'1IKR)A&R_M3)\
M1PS44 A$DTO,V;79,7:N.A]T,IXL[;K;4PH%Q(M@@IDJ21J+R5N$!*@ 0,DF
M*5\*0M7%>\7I3Q%RW4"UAQM+ 24DE:"D++J5K,!0@Q,UJ'GW?G:,P;?:M@F<
MQ[4HYM2UB-J[;(J5M1)QC4&3^P2,+3#L%9M2NO(R&4LKQ%I(+0WR\HS91#=W
M,.2LU"K;_AG9%-EQ%[B3=ZXI2FTNN,J;94E5PH(2MT*T=X%*[H%0"N[U*40V
M-6)^ALVSR[EM]PN7)\;2BV4ZY:UO A 7J<[L2@+" 2HA,*Q<_AG8LB++)/,F
MPC1Q+Y-D+P?%2JAW1!:X[ITA&LGRSP(,3)^U2ETZG+9C*.5B),F\4^102.NX
M,H.A_:IQ2\X?PRV%NUX;E88=(!/>)6TZ2#B-)* 3$&8R(@^/]J[N[XAVTX7P
MHDBW96F],Q![H!M4D0J-#I$S '*8CWRXGA74+CNIQDD4P/6\2W%<IC?.*=3E
M<"G^!TP.4I@#]\ ^_G7SM;R6)* U)4K0)YF=SS)Y<L5LKI*$7#Z&QI0'%0D$
MD \]R2<]2:R5JNL>FE*:4II2FE*:4II2FE*:4J-3*/[K)M _ NWF_P 9^U#4
M#^./Y!_\55>3_ 7_ ##_ +?G?^DE>IJS35Q*@  3^/6E8&S-MAP'N&D:I*9K
MQC7\C.J5#Y'KE?3L(R*K!.M9>JHTG)M9E8EL^;15DK5UK'E1L]7K(SEH9V+2
M/?>PED8V/=MJM:>OP/Z4JP,8;$MJ&'/DI3'^)&<8^A661HUC,RUKOEPL0L<M
M15+@L@-7]EN=IL%@ETIZ#QU1H4I9:2>_(\16(F,@AC&+?R#-:>OP/Z4K\,=X
M?FSB)CJ=$QV!ZJUCJ CB=O3FI'UE%."1P;BNT81Q.FU$\X<Z@4K%5TM%,C?:
M3+BM&S#E:1%[($0>(M:>OP/Z4KC!>'ULTK4-#5V%P%3FD' .<1NXF*.O/O&+
M9?!&)7."<2"9![,N2.DZ7B-VYHS%!X"[=Y$K*'EDI!\/M>FM/7X']*5:M"\,
M;8EC1M%LZCMYKC=O#OV$DP+-6*^6\Q7,5B>]X)BP<JV^USJT@TC<-9*N>,6$
M=(*.H]G2Y1M MFJ;"$@4HMJ3U^!_2E9NV\[5L";58.RU_!%")2V5RG&5CMCM
MW9;A=+#8Y:+KT14H968ME^L%HM+]K U: AJY7HQQ,GBZ_"1K6+A6;%DF".FM
M/7X']*5L)JT3))I7!00 H\CQP'/XO?SP(=O4="0$DQD<YS.^WLH*\^&2MQ2V
M9=QMAESOU35.ERDC5*.Q,)"MFS)DJJR?R:B('4(+R87,LN=V/2L=D=LU'A%/
MYVJMK@W%[!DMI404[@?5/+ ($3N?68K?V]L&4"3)<"5'&G.01N01,P<>F];O
M5.PM!@#]1"^4"!3D#YHBF;C@XFX .?>/IZ"'<-=-<W2;=(0E6E!B8.W0\OM8
M]V#-4N)GG@; CYY^D#-?:1G6Y$DE$1\Q(Q>?+*;OR8. Y ?< E[\F[>_XZR+
M8MO)22J) DQ.2-HGVC;-1W8Q@#&1$B>N]?:P69J6N S042]M.F!"_/[%ZTS%
M-W >_ FX]>.P<_$-)QVYMRGN%+!.25QR])Q!K*8;.K45=#L<9Y9^?.HPLGQ3
M%I/-%0 Q5 5,FOT'^:(G,"B@FX'N =0\<@//Q[=_!^UJ6.[46R%*'V\ R <0
M)C'F<FNFM5:D@ZM.2%),&8B53B.NWGMFK"+)Q2C>99%4(HT2;@_(83"4$S-C
M"L50#E[%#E/@P@/;T^OQRZ2VY=, J"5J>0E*SO,S SRC,1S-;)4AE>K8@E*C
M\-_9&<CK6YGA\;BW4;9YJA2,DJM1))TA*01'#KEK!NI-V5M(MFQ5P4*DS6DE
MTY,I$#MT45%WQP)UJ+'6^D>S7&%,_P"'VRDE+;;:&5'7X7-?A2=H3!5J.\[2
M)BO/N(LE3CA""HY)4!T2?+R&9CEYU.F0_6 & .P@ @(& P#R'(<&*(@/;OR
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M^Y,J V<$SN/JG?K6.HR2# B3SV_KZ? 5J]-2QV\>XZU5"G*41* &$HB!>>"
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M9P7LO9N=Y=!RZ(5H3N0<G>=A/)6\3&:\VXSVV^FO?0NSW[ZX5X%WI@6P2)3
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MYWJ_O? ?I5?O08Y#TK2'_P#-D_\ VW30GI\3^M.]<^]\$_I5!Q!COCM66PB
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M9HT]O*B5Z+9(7@-S',@5SY9?.*B)^3>6"HF @G^<)0#J[Z[TX@$02D$@1 .
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ME*:4II2FE*:4II2FE*:4J-/)_P"ZQ[/_ ,"W>;_&?M0^&H'\<?R_DOK5Y/\
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MT]C(]VNW,4[=9TU1<+(F(/)#)'5(<4S$,(F*9,0,4>X#U"(C0II"].M D<R
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M6WQ<=&UI]9:P@7Y3D')DGSH'HK)HD(9(/FG(HF(@P23@@$&!T]^:K1IR59V
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MITQUG96R4VO7!JFRLD6WEFJ2ACD07%4$R]8E\SYA3D'I.!"IG].HHF)R!#G
M< 3"QJ*0H0J"0#SB! V'+D16W#BTI4E*B N"J#!,; J&8SM.]:?9IS,^V[V2
MMU.J5R%BJ8UC&\P\5E$WZBUE<*O",UJ]7GQCBV;2K1@F+TZ[Y591;H*;I\E!
MX<-[PK@]H[9.NJ=0E24NJ"5.)2J4H4J3K4"9*=LX@1&:X_M!VAXQ;\8X996]
MMW[#G<(=>6E4)0MU+10DI3H3I0HKDE)4H&5 P%;C4VV1EVK\=9(A456$BW*L
MGU)J$$AA*4QDA\PB8F,GU@4QBEZ1$.W @8-<^"E0U)((.T$'E^'3XUUIP2.E
M75I2FE*:4II2FE*:4II2FE*C3R>''BQ[/P_^Q=O-_C/VH:@&7P?^'_[U?3_
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M2$02HJR-(&Y5B-,35O+2%3O\1)QD9.0TZQ=)*,WAH>48RB9  YDC%5,R<K=
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M,<G&O;49FP;,5;(JR+^NL22SU%TZ2CU.DK3SC D0$UM?)O'N)IXMQCB/$6P
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M("J[2[ID([YZ\D9ZX,,WS6YJJXAJ$O!JXZND)"(>6[=-\&E>M)1DT.H1<S9
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M^J/K CQ8@@_6WF4,N5!440 RI2*&2*8>"F.!1\LIA$/FE$W "(>[D?<.MVD
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MA118QR*KY\Y7$>@J#=H@4ZRJACB! *F0P@;D!X$.1VUO9]V@N/Z6FT*)+BH
M$03C'Q.TQ.:U=WQ:UM$K<N%I:$?:(]V^YC'NCE4Q?A2[ [S?<L.)3)L0U:J2
M:L<X=/H=D#Q_0ZLP2D22D0ZLAD&_R/8II^_:L9:-KK\'R35@9N]D""J\9-O(
M_P!H?;"U>MW>$<-N@I]:DI=4A:5)#$.!PE &KZVA.XR1RKR_BMRKBMSK0YKL
MT.)<2L9"EID:9&TA2O0CH8KV^5Z"85R#BH&*13;QD0Q;,&2"9"D(FW:I%22
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MC>2!'6=Z7'6+=("EML-%0"$K4$C408 *E9) /F8Y;5F HE,4#%$!*/<!*("
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M3$4-RU[P>[L5Z5#O (\2)/OV,QO7!<4[+\3X8L@H^DM"8=82H[=402#$8!4
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MK1Q'QB4DX1G7#D'R,7*D55BF;91NF0J;CS@.+?5]I.%W=O9!YRW4-/B&(@$
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M7"-<*S E<[;QCRVK4-P=1==1VZ.H[=*F455=NU%'+I8ZAA.JHHY7,==14YA
M5#G4$3\?.$>.^Q9L$-J!2E+8&X2D #G$1\^E;EFR3;G4PD,I '\(!/O 'MG)
MG?&*R9AK)2N*;U'VT62LHQ(T>Q,S%MERMG$C#R0(^TD15Z3) [;J(MUV8*\
M8Y%$SG(1;J#7]HN$N<3M2TE2B-,:))$[3'L @]<"MG9/J;=.HJ/J=]]IZC$
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MN%J2A*0A9&E),*(,&?,X,'.1SKS[C%PM2@W8LH;:8<+>F!J7"BE3A$;KP(V
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MZW'<1A/';U)C=,CUBMG.Y*S5<23T&\8R=*&$J:$A+"48U@H<X='0[=I&*<0
MX &KR;2X<25):40!.HX! Z20#$[)!)WB)-7FN%<0>:+S=LX6P)DZ42.H"RDG
MV;\IK,+1^S?MT';)RB[:N4DUVSENH1=!PBJ4#I*HK)"=-1-0@@8AR&$IBCR4
M1#6*1!(Q(WK!4E2%%*@4J28((@@]"*_0?T#Z_P P_GU<'U/8?Q-4U&'X:/\
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M\M,D?5F"! D3C[V/9C!KU;]F]@RXI^Y=3J450GIH;$?!14?*!4*I0*0A2I@
M%)U" <  " B)OF 7@I2<B(E*4 +U&.IT^8HH8_=H4%;DDG8F#/(SX1F>7QD"
MO3.]"P/"#$C,SOT&F(@<O+RH _ ./AZ]_?Q]8^[X<_$>]W2,8&/+]9_&H/\
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MF!OC4,*B-C]G(KB.+*XS8/J7<'N4ZB@%I?>)U&?#J@' 23,"/*<[Q4C9=O\
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MS-QSV^&JA.9]G]LQ\X%6TS&>M<=355-*4TI3D0]!XTI7( Z^PCZ@/T\<^_\
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MH8_3K0<3XF;U3:"G(2'5*21!(!3IQ$DS)(P,]*X#M#QYOB;"6@D:BI"R1&"
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M6=61XMM\QF2.@ %7;D)HW8>*QLW8LT$T&C391O+1;H(D!-)!(F3=IJ1")ID
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M9O"QD@@L9=K6LK6*H;K:44"D$C9BJWSM69^^HQ2!1$OL<1D:'5.4"\NNLH*
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M^*4'(&0V/B'[WC+F9@'_ "A^\J/(^[YH%#Z/4=$]J^) _6&W(^?I4_[1;T"
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EB)FY"I@N6$I(,D0 )D&3F8.<SD@^48Q4$IT0"2<1Y1^/NK__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>g472601g63r32.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g63r32.jpg
M_]C_X  02D9)1@ ! 0(!>@%Z  #_X7 0:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z
M;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N,RUC,#$Q(#8V+C$T
M-38V,2P@,C Q,B\P,B\P-BTQ-#HU-CHR-R @(" @(" @(CX*(" @/')D9CI2
M1$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D
M9BUS>6YT87@M;G,C(CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O
M=70](B(*(" @(" @(" @(" @>&UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D
M8R]E;&5M96YT<R\Q+C$O(CX*(" @(" @(" @/&1C.F9O<FUA=#YA<'!L:6-A
M=&EO;B]P;W-T<V-R:7!T/"]D8SIF;W)M870^"B @(" @(" @(#QD8SIT:71L
M93X*(" @(" @(" @(" @/')D9CI!;'0^"B @(" @(" @(" @(" @(#QR9&8Z
M;&D@>&UL.FQA;F<](G@M9&5F875L="(^9S8S<C,R/"]R9&8Z;&D^"B @(" @
M(" @(" @(#PO<F1F.D%L=#X*(" @(" @(" @/"]D8SIT:71L93X*(" @(" @
M/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F
M.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D
M;V)E+F-O;2]X87 O,2XP+R(*(" @(" @(" @(" @>&UL;G,Z>&UP1TEM9STB
M:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+V<O:6UG+R(^"B @(" @(" @
M(#QX;7 Z365T861A=&%$871E/C(P,3@M,#(M,#A4,3@Z-3$Z,S M,#<Z,# \
M+WAM<#I-971A9&%T841A=&4^"B @(" @(" @(#QX;7 Z36]D:69Y1&%T93XR
M,#$X+3 R+3 X5#$X.C4Q.C,P+3 W.C P/"]X;7 Z36]D:69Y1&%T93X*(" @
M(" @(" @/'AM<#I#<F5A=&5$871E/C(P,3@M,#(M,#A4,3@Z-3$Z,S M,#<Z
M,# \+WAM<#I#<F5A=&5$871E/@H@(" @(" @(" \>&UP.D-R96%T;W)4;V]L
M/D%D;V)E($EL;'5S=')A=&]R($-3-B H5VEN9&]W<RD\+WAM<#I#<F5A=&]R
M5&]O;#X*(" @(" @(" @/'AM<#I4:'5M8FYA:6QS/@H@(" @(" @(" @(" \
M<F1F.D%L=#X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E
M/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QX;7!'26UG.G=I9'1H
M/C(U-CPO>&UP1TEM9SIW:61T:#X*(" @(" @(" @(" @(" @(" @/'AM<$=)
M;6<Z:&5I9VAT/C$W-CPO>&UP1TEM9SIH96EG:'0^"B @(" @(" @(" @(" @
M(" @(#QX;7!'26UG.F9O<FUA=#Y*4$5'/"]X;7!'26UG.F9O<FUA=#X*(" @
M(" @(" @(" @(" @(" @/'AM<$=);6<Z:6UA9V4^+SEJ+S1!05%3:UI*4F=!
M0D%G14%904)G04%$+S=107-51VAV9$<Y>F%'.7=)1$UU34%!-%%K;$Y!*S!!
M04%!04%"04%904%!04%%028C>$$[05%"9T%!04%!44%"+RLT041K1FMB,DIL
M04=404%!04%!9B]B04E104)G445"055%0F=51D)G:T="45E*0W=G1T)G9TQ$
M06]+0W=O2R8C>$$[1$)!341!=TU$07=11$$T4$5!.$]$0DU41D)15$5X=V)'
M>'-C2'@X9DAX.&9(>#AF2'=%2$)W8TY$03!914)!64=H55)&4F]F2'@X9B8C
M>$$[2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX
M.&9(>#AF2'@X9DAX.&9(>#AF+SA!04519T%S045!07=%4B8C>$$[04%)4D%1
M35)!9B]%06%)04%!04A!445"05%%04%!04%!04%!04%11D%W24=!44%(0T%K
M2T-W14%!9TE$05%%0D%114%!04%!04%!028C>$$[05%!0T%W449"9V-)0U%O
M3$5!04-!44U$06=10T)G8T1"04E'06Y-0D%G35)"04%&25))>%%614=%,D5I
M8UE%54UP1VA">%=X46E00B8C>$$[571(:$UX6FDX0U)Y9W9%;%%Z4E1K<4MY
M63-00TY546YK-D]Z3FAD55I(5$0P=4E)2F]-2D-H9UIH2E)&4G%3,%9T3E9+
M0G)Y-"]0128C>$$[,4]4,%I85T9L85<Q>&18;#E76C)H<&%M='-B5S5V63-2
M,61N9#1E6' W9D@Q*V8S3T5H66%(:4EM2VDT>4YJ;RM#:S535FQP95EM6B8C
M>$$[<6)N2C)E;C5+:G!+5VUP-FEP<7%U<W)A-G9O4D%!24-!44E$0E%514)1
M645#04U$8E%%04%H141"0T53355%1E523FA)9UIX9UI%>28C>$$[;V)(=T9-
M2%(T4TY#1E9*:6-V17I*1%)$9VAA4U5Y5VE9-TQ#0C-04TYE2D5G>&15:W=G
M2D-H9UI*:EI&1VED:V1&53,X<4]Z=WEG<"8C>$$[,"M0>FA*4VMT3515-5!2
M;&195U9P8EA&,658,5)L6FUD;V%7<')B1S%U8C)2,61N9#1E6' W9D@Q*V8S
M3T5H66%(:4EM2VDT>4YJ;R8C>$$[*T1L2E=7;#5I6FUP=6-N6C9F:W%/:W!A
M86YQ2VUQ<39Y=')Q*W8O84%!=T1!44%#15%-4D%$.$$Y531Q-T9867$W1EA9
M<3=&6%EQ-R8C>$$[1E=04V9M3"M8,&-H:FLX>C93:V=!66\Q.6)"=4I8:T11
M=C T-R],1E5X,&9Z1C5F,75/4U12=%1T3E1J:$E76C=/94\T5D=)<4%X:B8C
M>$$[6G%%*RM+<&AI<G-69&ER<U9D:7)S5F1I<G-656)Y.7-R1S%K=3<R-&IT
M8E=)5FQN;619-#%"3DMS>D5!8FY&56@O-5=8*UA(170O:28C>$$[=E(K24E"
M4#91=&%64%0O9&YT:7%E869Q5VYA;%IX,S)N6%5.-UI406U'-G0U1FQI8T%L
M5'AD0WEM:$)'>'A615EQ-T9867$W1EA9<28C>$$[-T9867$W1EA9<3=&6%EQ
M-T9867$W1EA9<3=&6%EQ-T9867$X+W=$2FXU9F%Z;V0U-6%N=35R6C P8E-R
M,U0W;U)--4Q3,U9Z1$UJ4B8C>$$[.&M7<6A9:E=T1%AT:7))+TI':%AE:&57
M-$Y-=3-J:VYI;75P1V%)<U5P4&13>DQ1<T9/>7E#=3-81E4Y>%8R2W5X5C)+
M=7A6,DMU>"8C>$$[5D)A,UI3,RMI,SEJ0U975S9T<&]),F5O54Y*1U9"86=*
M<%4K1TMV1G!V.$%N2"]7,'1*;W)".4YT<$I&15E:5VQ18T19,CA,<65-4"8C
M>$$[4G)Q1C54-#$U2#1Q-%9:>G%N:TA73')19E R;GAZ5S1M.#%44U-A97I-
M-%9!.6Q$8FHQ:45*53@T:69H1&)91EHQ06AJ:&I1.5552R8C>$$[861+9U5X
M5F9I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<D50>DTX<38Q-6HP
M:3)T3DQU9E)A2V-Y5%(K<5E!.5E:16I*8R8C>$$[4GIF,U5R<DIX;T1T<W=9
M1$970U@O=T-4+VYI-71K;&DQ3F)855E(-% V5GI*-DXR<&IF-GAC4W$X8FQ:
M3&\X15E63D9Q5UHV05E6928C>$$[=#)0-EAI,&UY1V]3479Q66EH4R]K:E9V
M4V%C:%9L84U656AE5E-+-$929D<U+S,T;B]!2"]M<D988V)N+V9I9CA!9BMA
M<U9D>'5F.28C>$$[*THO=T(O-7%X5C-'-2\S-&XO04@O;7)&6&-B;B]F:68X
M068K87-69'AU9CDK2B]W0B\U<7A6,T<U+S,T;B]!2"]M<D988V)N+V9I9B8C
M>$$[.$%F*V%S5F1X=68Y*THO=T(O-7%X5C-'-2\S-&XO04@O;7)&6&-B;B]F
M:68X068K87-69'AU9CDK2B]W0B\U<7A6,T<U+S,T;B]!2"8C>$$[+VUR1EAC
M8FXO9FEF.$%F*V%S5F1X=68Y*THO=T(O-7%X5C-'-2\S-&XO04@O;7)&6&-B
M;B]F:68X068K87-69'AU9CDK2B]W0B\U<28C>$$[>%8S1S4O,S1N+T%(+VUR
M1E9Y0U%6-7-'.$])22]75&EQ-T9867$W1EA9<3=&6%EQ-T95:74O4&YK=7HQ
M239:9&$S6E$S-G0V8G=03R8C>$$[:7-R+T%-:C%.1F)F;V0X5E0S1EA9<3=&
M5D\T+W5X+W)P+WA-67%Q67$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T98
M67%X*S4X-R8C>$$[859$9C-D:DAB6#DS3%I30T<U93!S<FEE3EI$1VMV1#%)
M,%I346MI,6]D<U979C0U<V8X07$Q-G8O=T)W,C<O-G T<3<O2$YJ+W="5R8C
M>$$[=E8O*S1B9"\Y53A65&Y3=%1S.58P,C(Q1WEC=F%88V%Y=W5Y<VA+<TMI
M<7-!4CE/2W%L-V975FIA=F0S='A(83)S5D1*4$TV>'AR528C>$$[9T1K>D5!
M8FUM14,Q471V-6@P0S5T1G9,9E4W4V$P859B9&)I3V5.-'I--4-P14A$1F5B
M1F=!=E4Q1TI"2$Y54S$O67)E3%I.8U)#."8C>$$[9&954S),<4I3;2]X0DLX
M<69#9#9D<T-Q*TMQ3G1E,F0P2$YR4$A/27IX:TU4<2]&<4$P4$5M:&]A-'%R
M67$W1EA9<6<O=T)--E X028C>$$[<% X05)0,38S+U-N1#%F<4AQ<#E9.5 K
M9C!Q."M0=E1&55II<GEA4%0O3D=T*UI*<6EE,SAU85)Q36IZ4FMI>5<T4C5Y
M6D-X:E@V=B8C>$$[9$MN<&)G:C=,1W)L>G-54%8T:$5):T5155)"44EW;$]0
M1VTQ2V)5<&=3=7A6,DMQ9'@O9&HO6%0O:5EX5E5X5C)+=7A6,DMU>%8R2R8C
M>$$[=7A6,DMU>%8R2W5X5C)+;THY8S!23'1,3CE1=&QU-4I7=#0W8WI2:5)P
M:U):1VI60V528TDV<U8V,$E/2W!2<$XU;T=L-FYQ.79,<B8C>$$[3FTQ-69A
M:4I486UA3EI9-4IB94Y5:%I#,TQM>7=&9TMB:D9747=4=WIW>'IW4TQ,1$MO
M94M60T=6;%E65FQ98D5%9$1I<2]&5T]F;"8C>$$[>B]Y9W5H+SAW:V8V<U96
M9E!F;%)03FYL4%503'HS2G,Q=C%25&-H4%5+8TI6:RMZ5F$Q-%4V-4]%=44R
M<D)T22])5T=W.'%W95=P3B8C>$$[96YE>6AU-VI54%=H:5='43--<TM1=W0X
M5%-R>&E!9'9(:U9)2VQC3U1*>$<Q86PO2V9Z45!-:V5P4C9R05I'94\V;'9F
M4VM6;6UT<B8C>$$[>C8T:7I*-GA-<757.4PT4W1),2MJ24MQ,FXU3#,Y=' Q
M=&)F<#!Z4WAP0VPP,&MC=D,T84M%=W$X9U=:6'%N37E*4G1N0VUV6$<Q5R8C
M>$$[,B\U2EAK3G!C,G-0;4(W3T,T37198E=%<$<S=VM7>&14250K-F1M:U!%
M:FM4:F%Q=79F;'@U<&)1=DPR:V%F95(S:'-F6&IV8FTU6B8C>$$[,%=-5#-%
M57EZ4E)Q9G11;VIX>"]&<W!P>#,K1E9#,E@U2%@X9&\X3C-R=G)V46E&:$,V
M:$]58V]01E),=%=75EI.=31X=%9F5E!Y5B8C>$$[=3=K,TUL<G)8;UA&>DM:
M2EAA2C-$;S P<VIX=5!6,T1H-#%0*V]005DR<4UH+TLW5V]D0V@P5#E-=U0R
M<UIT-VEA-&YT5VMU6C=I0R8C>$$[2T]*,6QL33%F4FU%6D0X85!W67!Y<&EQ
M1V<O2FDY:#%I>#%4+T5%<&UT<G%'855"1TA+1T-',E)9:TIK67%!,71*5&,O
M1$MY*U!*="8C>$$[5BMV,U U8E$K9E4P:3DX=DQC86QE4$9*4&,X62]1965E
M84=*9E5H3&HQ5R]F2WI-55!Z3D125C9A049!049!3F=",'!G5FEF-6MA;B8C
M>$$[-6PP-U-,5V)13U%N3GI3-45C5'I34$5)6D=%8UE31S5#=DI+155--F-E
M,5)7=4MS0C%$>FXK8U-7-C-T:&%.3$-R*VYF,G-T;394428C>$$[>E-)-U-P
M1GAJ9%I%=%9J<7(W:&U.3U5L44U+=E=B5RMU3#=2-T<K3G$Y<DID4G=4>5=L
M=V5-<TQ38T=-8F="=FE7=$<Y.$-O,VQC+R8C>$$[-S=4+T%)32\X,#1Q-VQC
M+S<W5"]!24TO.# T<3=L8R\W-U0O04E-+S@P-'$W;&,O-S=4+T%)32\X,#1Q
M-VQC+S<W5"]!24TO.# T<28C>$$[-VQC+S<W5"]!24TO.# T<3=L8R\W-U0O
M04E-+S@P-'$W;&,O-S=4+T%)32\X,#1Q-VQC+S<W5"]!24TO.# T<3=L8R\W
M-U0O04E-+R8C>$$[.# T<3=L8R\W-U0O04E-+S@P-'$W;&,O-S=4+T%)32\X
M,#1Q.'5S+WEA,5-X,6-A:D1R475*4G%$86M:3&Q'36I3371Q5T5N<$=+3R8C
M>$$[5&TY;CA83D113E9!<FIL:%9D<68U2FI5;C%4-GIE<49V-W!R<4-21VY%
M:TQ3,U0S57!(2U)O-F=Y8U5O;U551$978T)G<7IN>7!P5R8C>$$[<V%0;T9P
M<'0O9')Q5C%B:#%A-TI+8VQ,<WE+1F\R,&%%24MK;6<S=TMM,TLU+S,R;B]"
M;B]M;D973V9L,#%X+V=B439):$@Q4T]H3"8C>$$[:V1V.5A&530Q6%9K,')4
M-711=D4O=T)'9T%,*VME5#=S1D9!479C*T]66CAW>'=-:GE$9' X17-S>$-0
M37-D=G9Z4SAV5VUI=S9U,"8C>$$[3G<Y=%!C;3!19G5):4A#.'I6-359;VAT
M.6QE9DIJ<W%K-41486U/85!&2&MZ,5=L;&=N=WDU,65Y3&8X=W1":VXK<6%7
M:RMR-FQ59R8C>$$[-F9A;W%40E5*16HQ=5=T-"M+37!6=FHK,$-O<3(R6D1J
M36IT-6QN9VIM5EA26E56=VMI;$A!659O>711<69%2$96*TMU>%8R2W5X5B8C
M>$$[,DMU>%8T=C5K<W10<W9Z9S K6G1+=7)Q4V4X=&EU;WHS.7AX4U-2;R]H
M9V=%5$M55W!B:C9O1D5F8FET34MV84U#=7A6,DMQ9'@O9"8C>$$[:B]85"]I
M67A657A6,DMU>%9J4&Y44VXQ4S@X=%=J=WEZ-F4R<4\R;W!'6D%O:%A48G=O
M6E=J26]N<BMN,4Y/6$AV5$96+SA!>7)V>28C>$$[9"\Q8B]W1&MT4#A!.#$T
M8E8S+TMV4$M13E5T6EEJ,TU.,61212]0:$MT8T9Q9SE),'4Q,&IZ,4I:5TQZ
M<F%Y-E=*;FAL=5HU,4UG=28C>$$[3TE90UHU2TAJ='1H5FPK0EA9<3=&6%EQ
M.'0O-7E7+SAL4F9F.'A.<B]W06Y2;"MM*W18>'IM>%EU>%8W="]Z:58O>6QE
M="\X=T,O."8C>$$[;FQZ1C%824I$-FEZ0E-X>CAU9BM51C!0+VU%:B]6:7%E
M6#EH86%H85-79#5'2F)A54%34FMK06=%16)G9SE2:TUM3TTT;4UH64Q::28C
M>$$[>7EX>45O;6E%;75F25AL:65X4WA&<SA&=6I/>2]6-35O6'!-;U=60S9/
M1TM32V]$3%=M=S=G6DA$:&AI1E%&0FQN>GIY>31P;7EO1"8C>$$[.'0O2VEZ
M3F-143-&=&-L:5DW:4,W=5EP26Q:;60T-%A344=/3C)L9&U29&E46'-T3%=L
M:V1R8E%7='1&83(V0T]#0D9I:&I(4E518R8C>$$[5D%R-$%9<7%9<3=&6%EQ
M-T9867$W1EAL3VIF;&9Q=6TK96XQ<3=M,'DX:FYU<&)P635J4#8U-5AK:WE4
M.$LX2&YI:FY71D=A=D5+2R8C>$$[57=Q.5=W2S=&6%EQ<#-(.3)0.$%85"]I
M67A657A6,DMS4S$O.'I.03!F5TI.1TU.>F9A;$5I=3EV87!'9G12>51L3U5S
M:U,X,&=H828C>$$[5FQR6&I4=5%#<6]E6E!Z63AU95AY1W5R93=N=#)317)D
M44I%62]5=45A5TM(.35*1W=:;V\R:TQ%8T952&MW>%90.$%Y,S5L,')Z1B8C
M>$$[<'@Q1%1(3#(S<5!%0S-%3E=-,$I+9VMQ1#%(2VA);V5H1TMP<FER2% O
M2VDO=T1B;B\W1W-+<VIW2S=&6%EQ-T98;'8O3U,S+VMQ3"8C>$$[-R]M2G1F
M.$%K-DUV,#,Q<2M/8S),1C)+=F1V*V-3=BM5<C%V+VU!6"]K.'59=7$U0DEF
M55=92U=/9FQZ+W=!;TQO9B]!1$-2+W%X5B8C>$$[:V5+=7A6,DMU>%8R2W5X
M5C)+=7A6,DMU>%8T>C5X=&58-3!A5E!(83-59S4R:V0S244R-&5T1DI'635U
M3%526D55<VYD4DMA:F]3<B8C>$$[,F)!<D=0>D4X-'8U5#AU=G%C5F\Y-4]8
M16-587!),&$W1FUE5F\Q8FEQ;W V.5119#A6641Q9C4R95IR3TYB;4A33&$W
M<U=C4GIZ4B8C>$$[4TAL8E-3<3=*0DUR3U S:T%J6C5Q9G,Y46Y5;6QE<3)U
M<3)M;S92639L8F-Z8E@X8T9Z8CAK64XV8W9&,35,4W%M:F1$9U9'9E=)+R8C
M>$$[0B\X06=(+W!I<6AF87):5T9L8U@Q,GIX5W1R13@Y>$E9-41X:FI5<S=5
M0VMM9TAB0T)A=DAD53@K+SA!3TYE<&%H3G%-.2M)=%)U2R8C>$$[*W1E5SEV
M<4U%<D9G5EDX-&]L3EA2:6I(=7!P;'9G5#=K2S<O04IM9C@T.79E0SA/=%-I
M6EEM:%-K5W!H5D1*2D5'5E)(44]K57IX;R8C>$$[+U963D)J-$4K-54T+TQZ
M>GHK4W-E<'1O9FLR.'!E87!,2DUT;6QV97%P6D5A5G=N<7AH155!33%!44]U
M0U='449K2F5L9E=)+T(O*R8C>$$[068X07!L4W-C.610*U9I5F\Y4#!25#=$
M,2\S<#A+659:2#E9:CA(+T%/068K;4)89E=)+T(O.$%G2"]P:7)V<D5F9R\O
M05 O045X5B8C>$$[,S%I4'=F.$$T0B\V67$X="]W0V-K-6MB.'%R-$%.6#9X
M8F16640K.4AC:DPY3CEA=FHS3FEX9&ER,U@O04IX3F-*-7$Q<VM%+W=#9R8C
M>$$[<C!"8B]D>2M!3UEU<35"2694+S%I4'=F+V=(+T%+6F=P4VYY;EEY-E U
M83 S4S=K.#=I>F=32U9O,&M+1FQ'+T5S<6UN,%EQ;3,Q:28C>$$[4'=F+T%)
M0B\V67$W-GA(-% O=T0O=T)-5EA*27(Q;T-+9GI+5B]70FEQ-T9867$W1EA9
M<3=&6%EQ-T98;'5V3U(K83!-:WA-.7%K="8C>$$[:$=*;6)51FET2DI$*S=I
M4&]U='1Y;65N14]P1E-/6%A#<C%,07)I07=)27%$<U%E;$U65V5H0E)H-F$P
M66QM1D)1;&A1:R]-67%T;B8C>$$[045A9V)!4$@O=T%41TMQ=4MP1C4X+S51
M8GI&+S)Z3'HO<4AF2E$K;TLK0DTR>D8R2W92=BMC968O2G<V0B\P9"]W1%5&
M4&Q/;RMG<"8C>$$[1#=3>E=P634O=T-61B\W8R]W1#).659:2&=6,DMU>%8R
M2W9,9BMC;'8O2E58,R]-5&$O.&Y2;"MM*W18>'IM>%EU>%8W="]Z:58O>28C
M>$$[;&5T+SAW0R\X;FQZ1C%824I$,3(Q.&QE97(Y=%%U3#-83&Y2;75R9U12
M5SA.,4YD<3!9;FQK16-I,6DK<G V5'!(>'1:5EDX95AQ5B8C>$$[3S)#;$,R
M;C5D*V%R97<Q5T8T.4YN;#%0-G5,=%1C6$-R94,R=6I--UA4;4(S3%AC57IX
M>69A.4Y64D)Z0E!&5D-19FLW<6AI=3=E-"8C>$$[87EJ:F4P*W%2,TYR3&-2
M4WE*27-#;49G<7(V3G9B*VLU:6E6;59I,5-&;V%M,65T04)104)11%E!9$M9
M1F1I<G-69&ER<U9D:7)S5B8C>$$[9&ER<U9E4&5D.5-3>"].0WIU-6)%>GEX
M4S)C5FYB>'<X:&1!:&YK8VXQ-"MC.$LX:D-05&)P,38P2W98-#,U>'$O17)Y
M05!&:%%I;R8C>$$[-D5E3T)6,DMU>%94=5 W<V8V-F8X5$=+<6U+<$8U."\U
M46)Z1B\R>DQZ+W%(9DI1*V]+*T)-,GI&,DMV4G8X06Y(;B]!36Y$;T@O4B8C
M>$$[,R\Q0E0U5'%0;TM1*W1F32]M*WDX=DYB3&-7='ID1S5$=7=T4D<S<%)2
M=$=J>75*2DEV:%9P:T9%-4U384%(3F%L:2\O2S!T2'5T428C>$$[:'4Y3#!L
M<%IU671,=64X9$Q3-%-&<FU/0E5306E39C%(;6U"4TM6639G8W$P2S%+<G1C
M+TYE-3 O56)I,G0Y2FEU24EX9'9&9%-8:"8C>$$[:%AH<'I-=# P-#E#5#!H
M>6EK5T=H67E&5'-O,W=+>7)Y-35G=619:S%*6F1/:S Y3$,T1G-N<D]J=DI7
M1DIU9D=-<W%J:DMT0GE*."8C>$$[84=O0W%C-'$W1EAL=B]/4S,O:W%,-R]M
M2G1F*U1O>2]49E=R-#5Z67-867$Y,B\U>$LO-5-V5R\K64)F*U1Y-6DV<FM%
M:#E26F=P428C>$$[;6LV<&$V<G!T='%.;U=.=&12:5=)<T],8U<V5D=+;W9&
M6%EQ-T9867$W1EA9<3=&6%EQ-T9867$X9S@R4S9-=C5W-F1&4'!C<VPS2R8C
M>$$[8E)O-VHV=S9H-49U3&5J3$-%2T99=T9D:GIQ9E1P="LP5F5V-$938GI8
M-7(P>GEX<&8V5#%.6E1A0C%J9#15-3AE5F%&='=.-E5!-B8C>$$[<WA#<4-X
M07A6:F0Y*V1V:V5X;6EH=DAU24=U07I7<&5)0EI5<"LV9$<U57!-9&MR=B]-
M1D<K3DMZ5V4T='I"2$E*54UC:E)T1R])528C>$$[649L3E%E-'A652MS,C,K
M+U4O-$E9<6M8;G4T='HU2#AX05-O4V1-=D%!1T@O3$\K4V@Y458X15IT;4QS
M5F5I+S@T.7-Q+VTO;T1-428C>$$[<6HV,U5N668W>%0U5'%0;TM1*W9R-U-0
M3%=O86AA-FAF5SET9#-L:E@V;$Q/1FLY1FE1>&5)3E9597%J-&=/6'9M=%,W
M571..'$V<"8C>$$[8U)F<$\Q<V(V-&A345$O5UDT6FY33UIF5&Q#.'=X0W5V
M=W14<4YJ:7%N2C5C.&UY>E!03'!E;E!.2D]L,TI+,$5"6G)I2452>D9I="8C
M>$$[5$EL9FAB<4U65$=)-F9#6D1#65EZ2S5K;$MC5C5/44%786Y5;6Y81E94
M-GIB9C<Y5"]G:&ER=G).="]V,5 X06=H:7)Y,R]N2D]E1B8C>$$[+W=!<7(U
M56M6:CE9='1G450O96I,.4XY879J,TYI>&1I<C-8+VY%,E-.4$Y7=&PR0V<R
M2S!*24@K-VPX8WAD5GE#42MN+W).="]V,28C>$$[4"M#1UE+5T]F;#%C5S0X
M:F%'1$MG271)-F=S4$1&5U(O5V)B+V9Q9CA%359D.5IT=CDK<"]W045-5EA*
M2D<Y941H<61E2D(O5FEQ-R8C>$$[1EA9<3=&6%EQ-T9867$W1EAK*VDO;'!Q
M3VYE94HY8W4W:E,W>49R,7!:1FUA8C%L:VYU-4HT6E=7=G!T8TI(3W-54F5T
M06\T-%9E<R8C>$$[6493-UA.03 W5S=15VPK2E1!1TI+=WI3449G>6Q'4FUI
M6D-66DA+<W!X5DI'+TLS>54Q9SEG,6MX=%=K5U))+U=L<$@V84]K4U)F1B8C
M>$$[.$5C6'%%>&]V=W%D>'9I<68R=6XR96TV6&%A9%I2:4=Z<VMG=#=A245K
M2D9%5E)&<6%N6E%":7%.>%9)=E!N+T%#9S-M3"]T;5AN+R8C>$$[049$=FMO
M9E5&9D%M8EII-T98;S,O3U!0+VLT9$$O-D\O=T1Q0VYY;E5F455H.7!:<E5S
M8R]W1$MI+SA!8FXO-T=S2W-J=TLW1EA9<28C>$$[-T98;'8O3U,S+VMQ3#<O
M;4IT9BM4;WDO5&97<C0U>EES6%EQ.3(O-7A++S53=E<O*UE"9BM4>35I-G)K
M16@Y4EIG<%DU*UA0+TM#-B8C>$$[2"]Z0U(O<7A6:V5+=7A6,DMU>%8R2W5X
M5C)+=7A6,DMU>%8T,W$Y=C5F=&9Z;&EH3G1A,FPS2DYA6&%%5U-Z>51V2S16
M-6UM8314,"8C>$$[:C9H0VAL:4\K*S=6=W$Y:W=+-T9867%P,T@Y,E Y9% K
M2FI&5E1&56DX*V8X;TXU:2\W6FPU+S%$=FMO9E5&9D%M8EII-T98;S,O3R8C
M>$$[4% X035/2%%0*VIV+W%#;GEN569156@Y<%IR57-C+SAQ3"\R-2\X07-A
M=W%Y4$%R<U9D:7)S5F57+SA!3U,S+T%*2VDK+S5I8E@O:R8C>$$[-DUV,#,Q
M<2M/8S),1C)+=F1V.$%N17(O04I3=E<O.$%M05@O04I03&U,<7514T@Q1FU#
M;&IN-6,O=T1+0S9(+T%-=VMF-G-66DAI<B8C>$$[<U9D:7)S5F1I<G-69&ER
M<U9D:7)S5F5295EB5S-U+WIK=%=%36\K<79A0V-*1&5Z4E-S>DI+<GE00D4X
M551)65EY3V-I:C115'1H5B8C>$$[-C=G5DPY83$O4TY%=&QU9%5U5G1O2&)G
M<FM-,5-&3&Y:47AO<7%763E!0E4W67%L5"]M5C5&4U0P;C%I0EI$>C1Q9617
M15EQ5U0T9B8C>$$[:59V,D=86GIS=%1I<DEB:BLW2"MU;B]%>&EQ<&EQ4F5F
M4#A!;$)V35@O8DUV4#A!<4AF2E$K;TLK0DTR>D8R2W92=BMC968O04-C3R8C
M>$$[9V8X05(S+S%"5#54<5!O2U$K,',Q<5=/9BM61B]W0S-0+S).659:2&=6
M,DMU>%8R2W9,9BMC;'8O2E58,R]-5&$O.$%*,%IF<'9R5B8C>$$[.&,U<U=,
M<U9E-V8X-&QF.'!8<F8O34%V+THU8WAD5GE#42MO<W=5<V,O3&XO;$)D1"\U
M:$DO,5EQ>5!&6%EQ-T9867$W1EA9<3=&6"8C>$$[67$W1EA9<3A3.'=A:F17
M,S5Y45<Y,6)7.'!N=F)0,#E1:FAD6&II1'A+:U1&<G1!>F9V;$)0;W0Y<6](
M54%Q.71W2VLS;7)Y.4IR*R8C>$$[;414,3%#87=I85%.8V5G<V)#84U!,6AK
M5U)80FIB.6]D>'-D:5)I<D9B-SAK9DLY+UIR8C-T>&-4=D,V1WIU2%=$,4E)
M;U9C47=O,R8C>$$[<"]:4C,U:VYD:4%'2D<R1S%:;&$V5F(R1VHR3VY";G5)
M-T=/0S-J;75$-FMR3$9W44TW2#=43GAQ>#=N07%.*W)7,RLK:R\T15EQ:R8C
M>$$[6&YU,W1X-4@X>$5224-.379#0T9(+TQ/*U-H.5%6.$5:=&U,<U9E:2]W
M1$]087$S-78V07)!37 K=#%",T@K.%4K539J-D-K4',O-B8C>$$[=&)F-S94
M+V=2;713>'HV=F(O.$%+>$ME:VQ0,%)7;D55<CE:=W%Y4#9T8F8W-E0O04E%
M649D.5=T=CA!9E-F.$--5F0Y5W1V.3E*+R8C>$$[=TEX5C,Q83(O=T(Y2B]W
M27A6-6(O=T$U2G=1<"M65CAY4G%P*W-7,C1!0B]V4FPK;2MT6'@W;7A9=7A6
M-W(O>FEB2$<O;7)7=S9H9R8C>$$[3$9A06=(+V1Y*T]9=7$U0DEF5"]!3E=T
M=CDY2B]W04--=U5S8R],<3-T>C5',$UM2D-485(Q2E5E1TMS:BMR5S,K*VLO
M=T-"1TMU*R8C>$$[<E<S*RMK+S1%67%U4T].2SA%0S$V.%%"*W)&5C)+=7A6
M,DMU>%8R2W5X5C)+=DMF375O86Y.*V)L:%I*9E=+,G1S8EAJ8C-,,FMC:28C
M>$$[33!I4%=.2FPK<U-34$@V<V%'26M$;%1B-'%L6'$R0EA9<3=&5D\T+W5X
M+W)P+WA-67%Q67%K6&YZ+VQ"=DU8+T%'>DQZ+W%(9DI1*R8C>$$[;TLK0DTR
M>D8R2W92=BMC968O2G<V0B\P9"\X055&4&Q/;RMG<$0W4WI7<%DU1CA8-6I8
M5F8Y,3908CA08C%,<6)L.2]P<FER23A69"8C>$$[:7)S5F1I<GDS+VY*8B]Y
M5D8Y+WI%,G8O04-D1U@V8C8Q9DA/8D9I-T98=3,O3TI8+TM6-C,O>D%,+WEE
M6$U85F-G:U!Q3$U&3$A0>28C>$$[-2\U45A1+RM94U Y5TMS:GA6,DMU>%8R
M2W5X5C)+=7A6,DMU>%8R2W-".'8O;'1Q1VXV9V(K.#$V8W-D4G4W,D]X:FES
M,VA-8SDS2B8C>$$[8TI(-FMT<S%Z.6@O:7!*<V$X5%-M2W,K>%9:3$Y$0VYQ
M5%-,1VQ1=DIY1D97259252M,14%9<6A0,#=O;%A(-E%T<7AT26IJ,6\O:"8C
M>$$[845C<%9/*WAJ6&1V1'9I<4MU4#=S9C8V9CA41TMQ;4MP1C4X+W=#54<X
M>&8Y<WDX+W=#;V0X;$0V9W(T17IB35A9<3E'+S5X-2\X028C>$$[2G<V0B]W
M0DAF+U5&4&Q/;RMG<$0V>&<X.&%28V593E@P2T=+95,O,&%%5#-+;W%.>4)2
M6#1O:75:3U)$:FIY4E$S-TIA:'!R57!$<"8C>$$[,S4P951,,U5B4WHT5#(Y
M,65G3$4X=C%C;U-*,F=:9E=J;6MJ4$%Q>CAL67%Y:'5"66=G2W,O>%8R2W5X
M5C)+=DQF.$%N2F(O04UL4B8C>$$[9F8X04U482\X;E)L*VTK=%AX>FUX675X
M5C=T+WII5B]Y;&5T+W=$34%V.$%Y95A-6%9C9VM08C O3F9Y-TPU9'9T8V=T
M-W%E1WAU,28C>$$[<T=T;WA#6G!*;4M50V9V4D=.;C5-2&175V@U04AB349+
M+WEZ*UHO;&)89%=/:E=!:VAU-'I+;VIK.45+4D1X<55+4T]'1&-V9W Y;R8C
M>$$[07509V]X5EIH:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-694YX5V-7<R]M
M3S%V<75R5U%U=$@Q07IA6&\Y>F5X,TUZ23!V<4]946MV,28C>$$[:4YG23!9
M3$E+1#=)44Q5:W$Y:W=+;$AM;GDU8F$O<'-D;DYW5F]B;3-U-$I85#%/1#(X
M>7EC;$92.%)51E%E,6-6965A;BM1,&5O428C>$$[;UID5%=/*W17:E-Y=6]O
M<$50,65"6$M,2T9L2$XS:UIF56(K55552U181&%V4V)7>G4W8E(W1S%U<G@W
M<39T-#1)<FDX2W%R5'E*=R8C>$$[5G!75VA!3'-/5D)G5D<K;$HO=C4O=50O
M04IP>%9)=E!C5&IY4#5I4')/9CEX;#5S46XO3$\O.$%K-4M(,4)8=U)M,EEU
M>%9N,S5%6"8C>$$[;'):9FUP;VPS9%1#,W0T=G)2:VU04F56<$UO-TAQ>D%:
M:39Z3$='37EK84@W5S-&:6QK;'=X1FPY3DXO>7)*=%)U=%)/<4U,;3A74B8C
M>$$[2FES.'%R>&TT97-%5F%"4%8Y2D,O1VQ3;T]A5"M58T@X-$]8+TIM;R]M
M1D)8*VIF;$1Q1FML;F8S-74T:SE5.' U-6YK3%1S<E1-,"8C>$$[:F9%5VLT
M:%=.9G,O1# R>"]L3$(O3T,O>5IQ4#5H6GIP970V5G%R4TQP,F\O5U=I04UG
M44QS1S9D54AH;#)(530X;C!'-F%C,FQY628C>$$[<31X5G!H-E5N*R]N*S50
M*V%C=F-D,W!39C<K9C=K+S5P>%8S<%-F-RMF-VLO=T-A8U9E5R]W1$]38V)R
M*U96.%1)>D0V>&)B2&I4*R8C>$$[.4AG0FPK;2MT6'@W;7A9=7A6-TXO=T$T
M>39Z<'5K95E.6G5T4G5487=.84I%<V=1=E8R:S5"84MR;F]P-UIR93!T5FIX
M06-:<2]E-28C>$$[5VTP;51.9D%,<C-F<&5X,FMV-5579&TQ<%HV<F57,$QC
M95!O>5AQ36=J-&E*55I61$MS4WAH54%0=W)51%EN3E0O2W5N+VYF668Q3R8C
M>$$[5B])*W O;2]B2#EB;WHK5&M7<#)'<'A81$IE85EI43)-:7@S045C555A
M4GAX0F94<#9A0TY31D\S3&9Q5&HO2W5N+VYF668Q3"])*R8C>$$[<"]M+V)(
M.6)09$DQ5W<Q:3%.,W Q-#@Y=4A-6F9H=RM)045I:F]P-S5L66,X37-E2T)S
M3TAN,#@X375'66]O-S!P4#DO4#A!8VXO3B8C>$$[3UA.2S5%6F$Q8W8O04LQ
M4#1!67%U>%8R2W5X5C)+=7A6,DMU>%8X.5=Y-C%$*UI(,4\K36QR8E=E=E$S
M3#9-,T9R95@Y23,Y,%E,;R8C>$$[5$)Y.%I#>'!)<45N:S5P44%G659F475"
M6%EQ-T963S0O=7@O<G O>$U9<7%9<6M8;GHO;$)V35@O8DUV4"MO9#AL1#9G
M<C1%>F)-6"8C>$$[67%Y4#AV.$$O;$M,8B]6;"]W0U1:>E0Y=F8T<DPT9F5(
M83EI+W=#37@K4#-05V,X*V4S9&ER,&XX;"\Y-CE5+S1X>&8X4V)..3)&.28C
M>$$[579C2&YF84@V664X=E4X-DXU9#)+=7A6-6(O>FMT+S5+:2LO-6EB6"]K
M-DUV,#,Q<2M/8S),1C)+<RLO2W9R<68O4$0O;5IN2RLP+R8C>$$[,'<Y-2]1
M.4HW3R]64#-$.4Q0<S5"-F@R2W9:=GEI+S525U0O04II<% K24IN5F1I+W="
M>68V>"]1.&8R.2]F:BMQ4#!S,GIB=6QD:28C>$$[<G-69&ER<U9D:7)S5F1I
M<G-666YD+VQN-69U=&)45W!:8G(Y24QE0RME45-,4U)K948T-#-"43%J:BMR
M245(54-U*RM+<W-X5C)+=28C>$$[>%94=5 W<V8V-F8X5$=+<6U+<$8U."\U
M46)Z1B]W0G-Y."\V:#-Y55!Q0W9I>GET-60X=&%L<&0W9&%R<38V9F-14%-#
M171(.&%R0B8C>$$[2DUZ8U=033%-45%C460R2'E/>6Q)9S="1$IO9DMV-51X
M4C-4<#5I:C%,:DI:96UH864S9%DR=30P=6%E<D1B<35-5&UM+W<P2E!I228C
M>$$[8U4K-55U<V)04S=0.'EJ8C99.$PR87!60F)S>GAO>E<T85--3S!K+U P
M,TI5<TI'0DEQ1%1.6#(R4V1(2R],+T%(461R,DXO:DUF:B8C>$$[.7HR6%1T
M0SAS4V%D8C-6.7%V,65344%Z4F=H:7!:<&Q!0V]R=G-)5DIQ4#)H;DE9.5!I
M35%:5'(X2#,Y,S)V4S5D5&U%>D=-3$@O4R8C>$$[4'5(6#=%=S W4F9*2FIG
M.5,Y:75#>'505F0U6&@R5F]V5"M&:$A4:6I-9F9E9V%N2$QS5T14,$QK1'HV
M,3-6*VXY=DIX.'5O,4YM;R8C>$$[:V94,'8K9&9F,7(Y;DY-+WE9+S-S,5=N
M5&A&+WA*<WEE=W9Q;#=G-#-T1#E-4&58<65D1SAU-T9867$X="\U>5<O.$%*
M55@S+TU4828C>$$[+W=$2C!:9G!V<E8X,S9$-54X:UA7:C)..7$O;49B0V%:
M=CA!4S1F:&-X<5=U5E@T27A,3E=S15HO=7IS-#9$9DUY57!8<T5*;&$V1B8C
M>$$[-4-H3FQ),'1J9E=Q6$XU-C!K;#%,1SEZ6E%2>5-+-6I6-%AI;%!P8TDQ
M6D4U1FPR97 T9WEK<4@O3$)K86)6;6I4,#!9=VQ)-FLX428C>$$[5$I15D\U
M<&Y.*S O,#0O968P4%(K>G8Q5"M(-EAS.'9L-WEH13!I=G)953A4-DHK,D,V
M=38W*VES=3%&53EU=6%%-F)!3V,O>'8S5R8C>$$[-U-/<3%"<7-F-#(W>490
M5G)0>7IA,CDT8DUW,U-I1S)7,6Q%<BMR-C!O2F1U3E%+04E3=TLW16=B6DA.
M1$9%2&AO-U)R9F5Y>7=:328C>$$[,&I(:75/.'(R1E50>#-S+R]+3"]!2E)7
M5"]M2VLO-&=M8G9S6"LU4#E9+V]D1#(Y+V9J*W%0,',R>F)U;&1I<G-69&ER
M<U9D:7)S5B8C>$$[9&ER<U9D:7)S5F1I<GAF53E(+T]P-&AD861E6&M5<U5N
M<#-6;DQ*17=M6FMC,TTP1$-58TEY1E995C=-9&=M-7=Q.6%S1S%/-C!M>28C
M>$$[;'9O:W,Y46MI:&MV8EE(,59J;6]R4$=R07)52S%26'9G5D9C8FXO9FEF
M.$%!2"]M<D951')M;%0V<F]U;V%7,#9X3&8R,#%Q,&]J3"8C>$$[1E).1U4U
M06-X5VY,1$4P8E8T6"]!3D-H,FXO53!39CE)42\V<C5L9FTO2D9/+S9&1'10
M*W!O:R\V46@O,5AX+TXK4S!M1V=F.#1T5R8C>$$[,FMA<$9F1'I'.#-P:&@V
M6G1!=&53;&5V<DAX>D4Q,RM%66IJ-5<U5VHQ4&=:0D]R<&QN+T%#<&%$+W$W
M3B]Y24@O3F5A1"M1:"]0*R8C>$$[>CER=78Y14HO;69B*W@S+T%#<&%$+W$W
M3B]Y24@O3F50.&A$*V8X05HK,68Y14HO;69B*WAK2&Q$>4XO:'57-6MH=F9R
M0G565E-(:28C>$$[-# T16YS+W9M9&]E>GAG2DXS8G(K,$\P:G%105DX3DUM
M-#-0*R]%+S1!+S@Q6G-85T\T,U K+T4O=T-!4"].5TMU-#-0*R]%+W=#028C
M>$$[4"].5TMS62]-6'E-+VY8>790;T4Q.$Q*2G!)-5!R0U$K;U(V5$)Q8U1)
M=E@U-5!(4&A.<3AK+S9&1'10*W!O:R]W0VM)9CA!5F9-:B8C>$$[.#,U27 S
M+U%O9' O,4Y%;B]315 K<2M0-79Y5VLY.')F.#0R5RMG;35P<C<S075E1F$R
M;U-N1&PO=T%7="].;7,W5# O=T-A15%4=R8C>$$[.$QS97HY961-4U%/2S O
M+T%/5DQ19CA!5C)B+T%*140O;79.4B])42]N+UHK,3)F*VE%+WI0="]9-R]L
M4S!(+T%&9&TO=T-202\U<B8C>$$[>"]K269Z+W,O878K:44O>E!T+UEY,WER
M-5IF>3EP:E=%5C!*,6%6<&5B4CA45F="4V=F+T%#8S)M:C!V9U$T8G9D,4=U
M,6@Q12M/<28C>$$[,G!/94YZ+W9X4#A!9T0O>E9M5S1A-4))2S@R1&5(145F
M<DIX5F1I<G-69&ER<U9D:7)S5F1I<B]!4"]:/"]X;7!'26UG.FEM86=E/@H@
M(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z06QT
M/@H@(" @(" @(" \+WAM<#I4:'5M8FYA:6QS/@H@(" @(" \+W)D9CI$97-C
M<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*
M(" @(" @(" @(" @>&UL;G,Z>&UP34T](FAT=' Z+R]N<RYA9&]B92YC;VTO
M>&%P+S$N,"]M;2\B"B @(" @(" @(" @('AM;&YS.G-T4F5F/2)H='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V52968C(@H@(" @
M(" @(" @("!X;6QN<SIS=$5V=#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O
M,2XP+W-4>7!E+U)E<V]U<F-E179E;G0C(CX*(" @(" @(" @/'AM<$U-.DEN
M<W1A;F-E240^>&UP+FEI9#HU.3E"-38Y,S,X,$1%.#$Q.#4U,#A$-3DY,#8P
M0T8T13PO>&UP34TZ26YS=&%N8V5)1#X*(" @(" @(" @/'AM<$U-.D1O8W5M
M96YT240^>&UP+F1I9#HU.3E"-38Y,S,X,$1%.#$Q.#4U,#A$-3DY,#8P0T8T
M13PO>&UP34TZ1&]C=6UE;G1)1#X*(" @(" @(" @/'AM<$U-.D]R:6=I;F%L
M1&]C=6UE;G1)1#YU=6ED.C5$,C X.3(T.3-"1D1",3$Y,31!.#4Y,$0S,34P
M.$,X/"]X;7!-33I/<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @(#QX;7!-
M33I296YD:71I;VY#;&%S<SYD969A=6QT/"]X;7!-33I296YD:71I;VY#;&%S
M<SX*(" @(" @(" @/'AM<$U-.D1E<FEV961&<F]M(')D9CIP87)S951Y<&4]
M(E)E<V]U<F-E(CX*(" @(" @(" @(" @/'-T4F5F.FEN<W1A;F-E240^>&UP
M+FEI9#HU.#E"-38Y,S,X,$1%.#$Q.#4U,#A$-3DY,#8P0T8T13PO<W12968Z
M:6YS=&%N8V5)1#X*(" @(" @(" @(" @/'-T4F5F.F1O8W5M96YT240^>&UP
M+F1I9#HU.#E"-38Y,S,X,$1%.#$Q.#4U,#A$-3DY,#8P0T8T13PO<W12968Z
M9&]C=6UE;G1)1#X*(" @(" @(" @(" @/'-T4F5F.F]R:6=I;F%L1&]C=6UE
M;G1)1#YU=6ED.C5$,C X.3(T.3-"1D1",3$Y,31!.#4Y,$0S,34P.$,X/"]S
M=%)E9CIO<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @(" @(#QS=%)E9CIR
M96YD:71I;VY#;&%S<SYD969A=6QT/"]S=%)E9CIR96YD:71I;VY#;&%S<SX*
M(" @(" @(" @/"]X;7!-33I$97)I=F5D1G)O;3X*(" @(" @(" @/'AM<$U-
M.DAI<W1O<GD^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @
M(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @
M(" @(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@
M(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.C@W
M0S,Y,C9%1C(P0T4X,3%!-S8V.$$Y,C1$,T1"1$$S/"]S=$5V=#II;G-T86YC
M94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#$X+3 R+3 X
M5#$P.C(Q.C4V+3 W.C P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!);&QU<W1R871O<B!#4S8@
M*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @
M(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z
M<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @
M(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#HU.3E"-38Y,S,X,$1%.#$Q
M.#4U,#A$-3DY,#8P0T8T13PO<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @
M(" @(" @(" @/'-T179T.G=H96X^,C Q."TP,BTP.%0Q.#HU,3HS,"TP-SHP
M,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G-O9G1W
M87)E06=E;G0^061O8F4@26QL=7-T<F%T;W(@0U,V("A7:6YD;W=S*3PO<W1%
M=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T179T.F-H
M86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z
M;&D^"B @(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @/"]X;7!-33I(
M:7-T;W)Y/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$
M97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z:6QL
M=7-T<F%T;W(](FAT=' Z+R]N<RYA9&]B92YC;VTO:6QL=7-T<F%T;W(O,2XP
M+R(^"B @(" @(" @(#QI;&QU<W1R871O<CI3=&%R='5P4')O9FEL93Y0<FEN
M=#PO:6QL=7-T<F%T;W(Z4W1A<G1U<%!R;V9I;&4^"B @(" @(#PO<F1F.D1E
M<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB
M(@H@(" @(" @(" @("!X;6QN<SIX;7!44&<](FAT=' Z+R]N<RYA9&]B92YC
M;VTO>&%P+S$N,"]T+W!G+R(*(" @(" @(" @(" @>&UL;G,Z<W1$:6T](FAT
M=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]$:6UE;G-I;VYS(R(*
M(" @(" @(" @(" @>&UL;G,Z<W1&;G0](FAT=' Z+R]N<RYA9&]B92YC;VTO
M>&%P+S$N,"]S5'EP92]&;VYT(R(*(" @(" @(" @(" @>&UL;G,Z>&UP1STB
M:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+V<O(CX*(" @(" @(" @/'AM
M<%109SI(87-6:7-I8FQE3W9E<G!R:6YT/E1R=64\+WAM<%109SI(87-6:7-I
M8FQE3W9E<G!R:6YT/@H@(" @(" @(" \>&UP5%!G.DAA<U9I<VEB;&54<F%N
M<W!A<F5N8WD^1F%L<V4\+WAM<%109SI(87-6:7-I8FQE5')A;G-P87)E;F-Y
M/@H@(" @(" @(" \>&UP5%!G.DY086=E<SXQ/"]X;7!44&<Z3E!A9V5S/@H@
M(" @(" @(" \>&UP5%!G.DUA>%!A9V53:7IE(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @/'-T1&EM.G<^-C$R+C P,# P,#PO<W1$
M:6TZ=SX*(" @(" @(" @(" @/'-T1&EM.F@^-SDR+C P,# P,#PO<W1$:6TZ
M:#X*(" @(" @(" @(" @/'-T1&EM.G5N:70^4&]I;G1S/"]S=$1I;3IU;FET
M/@H@(" @(" @(" \+WAM<%109SI-87A086=E4VEZ93X*(" @(" @(" @/'AM
M<%109SI&;VYT<SX*(" @(" @(" @(" @/')D9CI"86<^"B @(" @(" @(" @
M(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @
M(" @(" @(" @(" \<W1&;G0Z9F]N=$YA;64^07)I86Q-5#PO<W1&;G0Z9F]N
M=$YA;64^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT1F%M:6QY/D%R
M:6%L/"]S=$9N=#IF;VYT1F%M:6QY/@H@(" @(" @(" @(" @(" @(" \<W1&
M;G0Z9F]N=$9A8V4^4F5G=6QA<CPO<W1&;G0Z9F]N=$9A8V4^"B @(" @(" @
M(" @(" @(" @(#QS=$9N=#IF;VYT5'EP93Y/<&5N(%1Y<&4\+W-T1FYT.F9O
M;G14>7!E/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z=F5R<VEO;E-T<FEN
M9SY697)S:6]N(#4N,C \+W-T1FYT.G9E<G-I;VY3=')I;F<^"B @(" @(" @
M(" @(" @(" @(#QS=$9N=#IC;VUP;W-I=&4^1F%L<V4\+W-T1FYT.F-O;7!O
M<VET93X*(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1&:6QE3F%M93YA
M<FEA;"YT=&8\+W-T1FYT.F9O;G1&:6QE3F%M93X*(" @(" @(" @(" @(" @
M/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP
M93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N=$YA
M;64^07)I86PM271A;&EC350\+W-T1FYT.F9O;G1.86UE/@H@(" @(" @(" @
M(" @(" @(" \<W1&;G0Z9F]N=$9A;6EL>3Y!<FEA;#PO<W1&;G0Z9F]N=$9A
M;6EL>3X*(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1&86-E/DET86QI
M8SPO<W1&;G0Z9F]N=$9A8V4^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF
M;VYT5'EP93Y/<&5N(%1Y<&4\+W-T1FYT.F9O;G14>7!E/@H@(" @(" @(" @
M(" @(" @(" \<W1&;G0Z=F5R<VEO;E-T<FEN9SY697)S:6]N(#4N,C \+W-T
M1FYT.G9E<G-I;VY3=')I;F<^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IC
M;VUP;W-I=&4^1F%L<V4\+W-T1FYT.F-O;7!O<VET93X*(" @(" @(" @(" @
M(" @(" @/'-T1FYT.F9O;G1&:6QE3F%M93YA<FEA;&DN='1F/"]S=$9N=#IF
M;VYT1FEL94YA;64^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @
M(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1.86UE/D%R:6%L+4)O;&1-5#PO
M<W1&;G0Z9F]N=$YA;64^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT
M1F%M:6QY/D%R:6%L/"]S=$9N=#IF;VYT1F%M:6QY/@H@(" @(" @(" @(" @
M(" @(" \<W1&;G0Z9F]N=$9A8V4^0F]L9#PO<W1&;G0Z9F]N=$9A8V4^"B @
M(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT5'EP93Y/<&5N(%1Y<&4\+W-T
M1FYT.F9O;G14>7!E/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z=F5R<VEO
M;E-T<FEN9SY697)S:6]N(#4N,C \+W-T1FYT.G9E<G-I;VY3=')I;F<^"B @
M(" @(" @(" @(" @(" @(#QS=$9N=#IC;VUP;W-I=&4^1F%L<V4\+W-T1FYT
M.F-O;7!O<VET93X*(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1&:6QE
M3F%M93YA<FEA;&)D+G1T9CPO<W1&;G0Z9F]N=$9I;&5.86UE/@H@(" @(" @
M(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z
M<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$9N
M=#IF;VYT3F%M93Y#86QI8G)I/"]S=$9N=#IF;VYT3F%M93X*(" @(" @(" @
M(" @(" @(" @/'-T1FYT.F9O;G1&86UI;'D^0V%L:6)R:3PO<W1&;G0Z9F]N
M=$9A;6EL>3X*(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1&86-E/E)E
M9W5L87(\+W-T1FYT.F9O;G1&86-E/@H@(" @(" @(" @(" @(" @(" \<W1&
M;G0Z9F]N=%1Y<&4^3W!E;B!4>7!E/"]S=$9N=#IF;VYT5'EP93X*(" @(" @
M(" @(" @(" @(" @/'-T1FYT.G9E<G-I;VY3=')I;F<^5F5R<VEO;B U+C<S
M/"]S=$9N=#IV97)S:6]N4W1R:6YG/@H@(" @(" @(" @(" @(" @(" \<W1&
M;G0Z8V]M<&]S:71E/D9A;'-E/"]S=$9N=#IC;VUP;W-I=&4^"B @(" @(" @
M(" @(" @(" @(#QS=$9N=#IF;VYT1FEL94YA;64^8V%L:6)R:2YT=&8\+W-T
M1FYT.F9O;G1&:6QE3F%M93X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @
M(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B
M/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N=$YA;64^0V%L:6)R:2U)
M=&%L:6,\+W-T1FYT.F9O;G1.86UE/@H@(" @(" @(" @(" @(" @(" \<W1&
M;G0Z9F]N=$9A;6EL>3Y#86QI8G)I/"]S=$9N=#IF;VYT1F%M:6QY/@H@(" @
M(" @(" @(" @(" @(" \<W1&;G0Z9F]N=$9A8V4^271A;&EC/"]S=$9N=#IF
M;VYT1F%C93X*(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G14>7!E/D]P
M96X@5'EP93PO<W1&;G0Z9F]N=%1Y<&4^"B @(" @(" @(" @(" @(" @(#QS
M=$9N=#IV97)S:6]N4W1R:6YG/E9E<G-I;VX@-2XW,SPO<W1&;G0Z=F5R<VEO
M;E-T<FEN9SX*(" @(" @(" @(" @(" @(" @/'-T1FYT.F-O;7!O<VET93Y&
M86QS93PO<W1&;G0Z8V]M<&]S:71E/@H@(" @(" @(" @(" @(" @(" \<W1&
M;G0Z9F]N=$9I;&5.86UE/F-A;&EB<FEI+G1T9CPO<W1&;G0Z9F]N=$9I;&5.
M86UE/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @
M/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @
M(" @(" @(#QS=$9N=#IF;VYT3F%M93Y#86QI8G)I+4)O;&0\+W-T1FYT.F9O
M;G1.86UE/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N=$9A;6EL>3Y#
M86QI8G)I/"]S=$9N=#IF;VYT1F%M:6QY/@H@(" @(" @(" @(" @(" @(" \
M<W1&;G0Z9F]N=$9A8V4^0F]L9#PO<W1&;G0Z9F]N=$9A8V4^"B @(" @(" @
M(" @(" @(" @(#QS=$9N=#IF;VYT5'EP93Y/<&5N(%1Y<&4\+W-T1FYT.F9O
M;G14>7!E/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z=F5R<VEO;E-T<FEN
M9SY697)S:6]N(#4N-S,\+W-T1FYT.G9E<G-I;VY3=')I;F<^"B @(" @(" @
M(" @(" @(" @(#QS=$9N=#IC;VUP;W-I=&4^1F%L<V4\+W-T1FYT.F-O;7!O
M<VET93X*(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1&:6QE3F%M93YC
M86QI8G)I8BYT=&8\+W-T1FYT.F9O;G1&:6QE3F%M93X*(" @(" @(" @(" @
M(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.D)A9SX*(" @(" @(" @
M/"]X;7!44&<Z1F]N=',^"B @(" @(" @(#QX;7!44&<Z4&QA=&5.86UE<SX*
M(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z;&D^
M0WEA;CPO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI/DUA9V5N=&$\
M+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:3Y996QL;W<\+W)D9CIL
M:3X*(" @(" @(" @(" @(" @/')D9CIL:3Y";&%C:SPO<F1F.FQI/@H@(" @
M(" @(" @(" \+W)D9CI397$^"B @(" @(" @(#PO>&UP5%!G.E!L871E3F%M
M97,^"B @(" @(" @(#QX;7!44&<Z4W=A=&-H1W)O=7!S/@H@(" @(" @(" @
M(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54
M>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QX;7!'.F=R;W5P
M3F%M93Y$969A=6QT(%-W871C:"!'<F]U<#PO>&UP1SIG<F]U<$YA;64^"B @
M(" @(" @(" @(" @(" @(#QX;7!'.F=R;W5P5'EP93XP/"]X;7!'.F=R;W5P
M5'EP93X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO
M<F1F.E-E<3X*(" @(" @(" @/"]X;7!44&<Z4W=A=&-H1W)O=7!S/@H@(" @
M(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R
M9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z<&1F/2)H='1P.B\O;G,N
M861O8F4N8V]M+W!D9B\Q+C,O(CX*(" @(" @(" @/'!D9CI0<F]D=6-E<CY!
M9&]B92!01$8@;&EB<F%R>2 Q,"XP,3PO<&1F.E!R;V1U8V5R/@H@(" @(" \
M+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z
M86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z17AT96YS:7-&;VYT4V5N<V4]
M(FAT=' Z+R]W=W<N97AT96YS:7,N8V]M+VUE=&$O1F]N=%-E;G-E+R(^"B @
M(" @(" @(#Q%>'1E;G-I<T9O;G1396YS93IS;'5G/@H@(" @(" @(" @(" \
M<F1F.D)A9SX*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E
M/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#Q%>'1E;G-I<T9O;G13
M96YS93I&;VYT2VEN9#Y/<&5N5'EP92 M(%14/"]%>'1E;G-I<T9O;G1396YS
M93I&;VYT2VEN9#X*(" @(" @(" @(" @(" @(" @/$5X=&5N<VES1F]N=%-E
M;G-E.D9A;6EL>3Y!<FEA;#PO17AT96YS:7-&;VYT4V5N<V4Z1F%M:6QY/@H@
M(" @(" @(" @(" @(" @(" \17AT96YS:7-&;VYT4V5N<V4Z3W5T;&EN949I
M;&53:7IE/C \+T5X=&5N<VES1F]N=%-E;G-E.D]U=&QI;F5&:6QE4VEZ93X*
M(" @(" @(" @(" @(" @(" @/$5X=&5N<VES1F]N=%-E;G-E.D9O=6YD<GD^
M36]N;W1Y<&4@5'EP;V=R87!H>3PO17AT96YS:7-&;VYT4V5N<V4Z1F]U;F1R
M>3X*(" @(" @(" @(" @(" @(" @/$5X=&5N<VES1F]N=%-E;G-E.E9E<G-I
M;VX^-2XR,#PO17AT96YS:7-&;VYT4V5N<V4Z5F5R<VEO;CX*(" @(" @(" @
M(" @(" @(" @/$5X=&5N<VES1F]N=%-E;G-E.DME<FYI;F=#:&5C:W-U;3XP
M/"]%>'1E;G-I<T9O;G1396YS93I+97)N:6YG0VAE8VMS=6T^"B @(" @(" @
M(" @(" @(" @(#Q%>'1E;G-I<T9O;G1396YS93I&;VYT4V5N<V5?,2XR7T-H
M96-K<W5M/C(S-38S-#,T.38\+T5X=&5N<VES1F]N=%-E;G-E.D9O;G1396YS
M95\Q+C)?0VAE8VMS=6T^"B @(" @(" @(" @(" @(" @(#Q%>'1E;G-I<T9O
M;G1396YS93I#:&5C:W-U;3XR,S4V,S0S-#DV/"]%>'1E;G-I<T9O;G1396YS
M93I#:&5C:W-U;3X*(" @(" @(" @(" @(" @(" @/$5X=&5N<VES1F]N=%-E
M;G-E.E!O<W138W)I<'1.86UE/D%R:6%L350\+T5X=&5N<VES1F]N=%-E;G-E
M.E!O<W138W)I<'1.86UE/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @
M(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^
M"B @(" @(" @(" @(" @(" @(#Q%>'1E;G-I<T9O;G1396YS93I&;VYT2VEN
M9#Y/<&5N5'EP92 M(%14/"]%>'1E;G-I<T9O;G1396YS93I&;VYT2VEN9#X*
M(" @(" @(" @(" @(" @(" @/$5X=&5N<VES1F]N=%-E;G-E.D9A;6EL>3Y#
M86QI8G)I/"]%>'1E;G-I<T9O;G1396YS93I&86UI;'D^"B @(" @(" @(" @
M(" @(" @(#Q%>'1E;G-I<T9O;G1396YS93I/=71L:6YE1FEL95-I>F4^,#PO
M17AT96YS:7-&;VYT4V5N<V4Z3W5T;&EN949I;&53:7IE/@H@(" @(" @(" @
M(" @(" @(" \17AT96YS:7-&;VYT4V5N<V4Z1F]U;F1R>3Y-:6-R;W-O9G0\
M+T5X=&5N<VES1F]N=%-E;G-E.D9O=6YD<GD^"B @(" @(" @(" @(" @(" @
M(#Q%>'1E;G-I<T9O;G1396YS93I697)S:6]N/C4N-S,\+T5X=&5N<VES1F]N
M=%-E;G-E.E9E<G-I;VX^"B @(" @(" @(" @(" @(" @(#Q%>'1E;G-I<T9O
M;G1396YS93I+97)N:6YG0VAE8VMS=6T^,#PO17AT96YS:7-&;VYT4V5N<V4Z
M2V5R;FEN9T-H96-K<W5M/@H@(" @(" @(" @(" @(" @(" \17AT96YS:7-&
M;VYT4V5N<V4Z1F]N=%-E;G-E7S$N,E]#:&5C:W-U;3XS-S@P,30S,#PO17AT
M96YS:7-&;VYT4V5N<V4Z1F]N=%-E;G-E7S$N,E]#:&5C:W-U;3X*(" @(" @
M(" @(" @(" @(" @/$5X=&5N<VES1F]N=%-E;G-E.D-H96-K<W5M/C,W.# Q
M-#,P/"]%>'1E;G-I<T9O;G1396YS93I#:&5C:W-U;3X*(" @(" @(" @(" @
M(" @(" @/$5X=&5N<VES1F]N=%-E;G-E.E!O<W138W)I<'1.86UE/D-A;&EB
M<FD\+T5X=&5N<VES1F]N=%-E;G-E.E!O<W138W)I<'1.86UE/@H@(" @(" @
M(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z
M<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#Q%>'1E
M;G-I<T9O;G1396YS93I&;VYT2VEN9#Y/<&5N5'EP92 M(%14/"]%>'1E;G-I
M<T9O;G1396YS93I&;VYT2VEN9#X*(" @(" @(" @(" @(" @(" @/$5X=&5N
M<VES1F]N=%-E;G-E.D9A;6EL>3Y#86QI8G)I/"]%>'1E;G-I<T9O;G1396YS
M93I&86UI;'D^"B @(" @(" @(" @(" @(" @(#Q%>'1E;G-I<T9O;G1396YS
M93I/=71L:6YE1FEL95-I>F4^,#PO17AT96YS:7-&;VYT4V5N<V4Z3W5T;&EN
M949I;&53:7IE/@H@(" @(" @(" @(" @(" @(" \17AT96YS:7-&;VYT4V5N
M<V4Z1F]U;F1R>3Y-:6-R;W-O9G0\+T5X=&5N<VES1F]N=%-E;G-E.D9O=6YD
M<GD^"B @(" @(" @(" @(" @(" @(#Q%>'1E;G-I<T9O;G1396YS93I697)S
M:6]N/C4N-S,\+T5X=&5N<VES1F]N=%-E;G-E.E9E<G-I;VX^"B @(" @(" @
M(" @(" @(" @(#Q%>'1E;G-I<T9O;G1396YS93I+97)N:6YG0VAE8VMS=6T^
M,#PO17AT96YS:7-&;VYT4V5N<V4Z2V5R;FEN9T-H96-K<W5M/@H@(" @(" @
M(" @(" @(" @(" \17AT96YS:7-&;VYT4V5N<V4Z1F]N=%-E;G-E7S$N,E]#
M:&5C:W-U;3XQ,3@S-S<S.3@U/"]%>'1E;G-I<T9O;G1396YS93I&;VYT4V5N
M<V5?,2XR7T-H96-K<W5M/@H@(" @(" @(" @(" @(" @(" \17AT96YS:7-&
M;VYT4V5N<V4Z0VAE8VMS=6T^,3$X,S<W,SDX-3PO17AT96YS:7-&;VYT4V5N
M<V4Z0VAE8VMS=6T^"B @(" @(" @(" @(" @(" @(#Q%>'1E;G-I<T9O;G13
M96YS93I0;W-T4V-R:7!T3F%M93Y#86QI8G)I+4)O;&0\+T5X=&5N<VES1F]N
M=%-E;G-E.E!O<W138W)I<'1.86UE/@H@(" @(" @(" @(" @(" \+W)D9CIL
M:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O
M=7)C92(^"B @(" @(" @(" @(" @(" @(#Q%>'1E;G-I<T9O;G1396YS93I&
M;VYT2VEN9#Y/<&5N5'EP92 M(%14/"]%>'1E;G-I<T9O;G1396YS93I&;VYT
M2VEN9#X*(" @(" @(" @(" @(" @(" @/$5X=&5N<VES1F]N=%-E;G-E.D9A
M;6EL>3Y!<FEA;#PO17AT96YS:7-&;VYT4V5N<V4Z1F%M:6QY/@H@(" @(" @
M(" @(" @(" @(" \17AT96YS:7-&;VYT4V5N<V4Z3W5T;&EN949I;&53:7IE
M/C \+T5X=&5N<VES1F]N=%-E;G-E.D]U=&QI;F5&:6QE4VEZ93X*(" @(" @
M(" @(" @(" @(" @/$5X=&5N<VES1F]N=%-E;G-E.D9O=6YD<GD^36]N;W1Y
M<&4@5'EP;V=R87!H>3PO17AT96YS:7-&;VYT4V5N<V4Z1F]U;F1R>3X*(" @
M(" @(" @(" @(" @(" @/$5X=&5N<VES1F]N=%-E;G-E.E9E<G-I;VX^-2XR
M,#PO17AT96YS:7-&;VYT4V5N<V4Z5F5R<VEO;CX*(" @(" @(" @(" @(" @
M(" @/$5X=&5N<VES1F]N=%-E;G-E.DME<FYI;F=#:&5C:W-U;3XP/"]%>'1E
M;G-I<T9O;G1396YS93I+97)N:6YG0VAE8VMS=6T^"B @(" @(" @(" @(" @
M(" @(#Q%>'1E;G-I<T9O;G1396YS93I&;VYT4V5N<V5?,2XR7T-H96-K<W5M
M/C,V,S8Q-SDW-S0\+T5X=&5N<VES1F]N=%-E;G-E.D9O;G1396YS95\Q+C)?
M0VAE8VMS=6T^"B @(" @(" @(" @(" @(" @(#Q%>'1E;G-I<T9O;G1396YS
M93I#:&5C:W-U;3XS-C,V,3<Y-S<T/"]%>'1E;G-I<T9O;G1396YS93I#:&5C
M:W-U;3X*(" @(" @(" @(" @(" @(" @/$5X=&5N<VES1F]N=%-E;G-E.E!O
M<W138W)I<'1.86UE/D%R:6%L+4)O;&1-5#PO17AT96YS:7-&;VYT4V5N<V4Z
M4&]S=%-C<FEP=$YA;64^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @
M(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*
M(" @(" @(" @(" @(" @(" @/$5X=&5N<VES1F]N=%-E;G-E.D9O;G1+:6YD
M/D]P96Y4>7!E("T@5%0\+T5X=&5N<VES1F]N=%-E;G-E.D9O;G1+:6YD/@H@
M(" @(" @(" @(" @(" @(" \17AT96YS:7-&;VYT4V5N<V4Z1F%M:6QY/D-A
M;&EB<FD\+T5X=&5N<VES1F]N=%-E;G-E.D9A;6EL>3X*(" @(" @(" @(" @
M(" @(" @/$5X=&5N<VES1F]N=%-E;G-E.D]U=&QI;F5&:6QE4VEZ93XP/"]%
M>'1E;G-I<T9O;G1396YS93I/=71L:6YE1FEL95-I>F4^"B @(" @(" @(" @
M(" @(" @(#Q%>'1E;G-I<T9O;G1396YS93I&;W5N9')Y/DUI8W)O<V]F=#PO
M17AT96YS:7-&;VYT4V5N<V4Z1F]U;F1R>3X*(" @(" @(" @(" @(" @(" @
M/$5X=&5N<VES1F]N=%-E;G-E.E9E<G-I;VX^-2XW,SPO17AT96YS:7-&;VYT
M4V5N<V4Z5F5R<VEO;CX*(" @(" @(" @(" @(" @(" @/$5X=&5N<VES1F]N
M=%-E;G-E.DME<FYI;F=#:&5C:W-U;3XP/"]%>'1E;G-I<T9O;G1396YS93I+
M97)N:6YG0VAE8VMS=6T^"B @(" @(" @(" @(" @(" @(#Q%>'1E;G-I<T9O
M;G1396YS93I&;VYT4V5N<V5?,2XR7T-H96-K<W5M/C,P,3DT,3,S,C4\+T5X
M=&5N<VES1F]N=%-E;G-E.D9O;G1396YS95\Q+C)?0VAE8VMS=6T^"B @(" @
M(" @(" @(" @(" @(#Q%>'1E;G-I<T9O;G1396YS93I#:&5C:W-U;3XS,#$Y
M-#$S,S(U/"]%>'1E;G-I<T9O;G1396YS93I#:&5C:W-U;3X*(" @(" @(" @
M(" @(" @(" @/$5X=&5N<VES1F]N=%-E;G-E.E!O<W138W)I<'1.86UE/D-A
M;&EB<FDM271A;&EC/"]%>'1E;G-I<T9O;G1396YS93I0;W-T4V-R:7!T3F%M
M93X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F
M.D)A9SX*(" @(" @(" @/"]%>'1E;G-I<T9O;G1396YS93IS;'5G/@H@(" @
M(" \+W)D9CI$97-C<FEP=&EO;CX*(" @/"]R9&8Z4D1&/@H\+W@Z>&UP;65T
M83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @( H\/WAP86-K970@96YD/2)W(C\^
M_]L 0P ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$!_\  $0@ _@%P P$1  (1 0,1 ?_$ !\  0 !! ,! 0$            )
M!@<("P0%"@,! O_$ %T0   & @$  PD)"@@+! L   (#! 4&!P !" D1%!(3
M%18W55:6UA<A=G>7M;;4U1@V.$%4>)6FM],9&B(Q47&!N",H.5=887F1F-'7
M)31TLPHD)C5"0W63H;*T_\0 '@$! 0 " @,! 0            $"! ,(!08)
M!PK_Q !5$0 "  0"!@4&" @*"@(#     0(#!!$%(08Q46&1T1)!<:&Q$S1T
M@;/P!Q0R,U)SLL$5(C5"4W*4U!87(U5VEJ*UT^$E-E978H*2D]+Q"#<D1+3_
MV@ , P$  A$#$0 _ /?Q@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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MRP@"\"OP<6K&@3KUP$Z!2*E=V,)(?TOM+26T&.J'Z@.5]9O:[DFQ\290\V!
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M7VD^%KE;"QQMK,3I'^:.:)J"G9TQA+0G0$+#5RTM0O5 WTG=[NY6^XR,P08
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MX.J\MO9!;5L.F1YCXDSKU'. W-)_ZE@E\FMMNXR,P08 P!@# & , 8 P!@#
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M 8 P"C;%\GT[^!LG^9%V5:UVKQ(]3['X%99"C & , 8 P!@# & , 8 P!@#
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MU;ZMZ_FW[^6[VOBR^3OJ4'_5!S/Z_A-NC&[GN]N,A"'JT+K%PCY2@ZM;]_\
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M,D>@2K4W2*&+:N4H3D/<6 H<XL*FK-=?9?L6M6SU^Z* X2UG/*E5L8UU0S.
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M=MI*%)X+0(-#3"5Z4*3Q6K*'>K][7W&6F"# & , 8 P!@# & , 8 P!@# &
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M>/N^0_2M[UKJZN>$?!_]OA7Q)!O?]NP]>OZ\&46J#]5_;B)+L&(P!@# & ,
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M7]/6#AIQ(WO^SJ'KJ_MP91:H/U7]N(DQP8C & , 8 P!@# & , 8 P!@# &
M>>WIN+LK:K9QQACUM5SQZU )ZUS*,3:Y.0338!H UO*K:X]PNT*6JJ2P)^BP
M8?8+Y"I&XW(.225\V4P-%,F/L59E\F;2%[,,X%>]KWRLEMLVGUZK6_YM:ZY%
M.BS<F9WZ/_C*OCU91JHV(V$N1;1#H8"9@AZAN2S"2)$DZBN['4KK!-CEK$D
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M#OK%M5::*R]2_P :/#/5K0-)-LNV'Q>WL6S-.'AG7<]A$+?*V^YDU@@P!@#
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MDCE9R'&, 8 P!@&GBO[R[W7\;=C_ $Q><[#T?F=)Z-(]E":#UOM?B6DS9(,
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- , 8 P!@# & , __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>g472601g65j14.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g65j14.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[2L*4&AO=&]S:&]P(#,N,  X0DE-! 0
M     !\< 5H  QLE1QP!6@ #&R5'' %:  ,;)4<< @   @   #A"24T$)0
M    $-/)GTL]C>HHA4@U:H05G"LX0DE-!#H      .4    0     0
M"W!R:6YT3W5T<'5T    !0    !0<W138F]O; $     26YT965N=6T
M26YT90    !#;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT
M97).86UE5$585     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0
M '( ;P!O &8 ( !3 &4 = !U '        IP<F]O9E-E='5P     0    !"
M;'1N96YU;0    QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P
M   "+0   !     !       2<')I;G1/=71P=71/<'1I;VYS    %P    !#
M<'1N8F]O;       0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O
M;       0VYT0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O;
M16UL1&)O;VP      $EN=')B;V]L      !"8VMG3V)J8P    $       !2
M1T)#     P    !29" @9&]U8D!OX            $=R;B!D;W5B0&_@
M        0FP@(&1O=6) ;^            !"<F1456YT1B-2;'0
M      !";&0@56YT1B-2;'0               !2<VQT56YT1B-0>&Q <L
M          IV96-T;W)$871A8F]O; $     4&=0<V5N=6T     4&=0<P
M  !09U!#     $QE9G15;G1&(U)L=                %1O<"!5;G1&(U)L
M=                %-C;"!5;G1&(U!R8T!9            $&-R;W!7:&5N
M4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O;6QO;F<         #&-R
M;W!296-T3&5F=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG
M  MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0      $ /      0 ! \
M   !  $X0DE-!"8       X             /X   #A"24T#\@      "@
M________   X0DE-! T       0   !X.$))3009       $    'CA"24T#
M\P      "0           0 X0DE-! H       $  #A"24TG$       "@ !
M          (X0DE- _4      $@ +V9F  $ ;&9F  8       $ +V9F  $
MH9F:  8       $ ,@    $ 6@    8       $ -0    $ +0    8
M  $X0DE- _@      '   /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H     /____________________________\#Z   .$))300(
M   0     0   D    )      #A"24T$'@      !      X0DE-!!H
M S4    &              ,A   #7P         !
M      $              U\   ,A                      $
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M     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N
M!V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX
M   '9&5F875L=     MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO
M<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG          IL969T3W5T
M<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/
M=71S971L;VYG       X0DE-!"@       P    "/_         X0DE-!!$
M      $! #A"24T$%       !    !HX0DE-! P     (%\    !    H
M )4   '@  $78   ($, &  !_]C_[0 ,061O8F5?0TT  O_N  Y!9&]B90!D
M@     '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,
M$0P,# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4
M% X.#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,
M# P,#/_  !$( )4 H ,!(@ "$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0
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M;_\ MK'_ /2"E^W,/_19?_L'D_\ O.F_;F'_ *++_P#8/)_]YTE:K?L[J?\
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MJT[FN#FAKF^Y%Q[<_%H9CXW2F4TUC:RMEU;6M'@UK6H_[2O_ /*[*_\  ?\
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M?7O?6JG&(4;X=]QQ#ZMO*"82%77"]@WJ_2B/;F8Y'E:SC_.3_M;I?_<RB/\
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MU1='J"IP:USOW]I:[:YW\A7NF]'P.F5EF)7M+OIV'W/=_7>5=23(XL<3Q1B
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M &\ <    !, 00!D &\ 8@!E "  4 !H &\ = !O ', : !O '  ( !# %,
M-@    $ .$))300B      %^34T *@    @ # $   ,    ! U\   $!  ,
M   ! R$   $"  ,    #    G@$&  ,    !  (   $2  ,    !  $   $5
M  ,    !  ,   $:  4    !    I $;  4    !    K $H  ,    !  (
M  $Q  (    >    M $R  (    4    TH=I  0    !    Z    2  "  (
M  @ +<;    G$  MQL   "<0061O8F4@4&AO=&]S:&]P($-3-B H5VEN9&]W
M<RD ,C Q.#HP-3HR,R P-CHS,CHP,      $D   !P    0P,C(QH $  P
M  '__P  H ( !     $   -?H , !     $   ,A          8! P #
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M   !,0 "    '@   +0!,@ "    %    -*':0 $     0   .@   $@  @
M"  (   #P     $   /      4%D;V)E(%!H;W1O<VAO<"!#4S8@*%=I;F1O
M=W,I #(P,3@Z,#4Z,C,@,#8Z,S(Z,#      !)    <    $,#(R,: !  ,
M   !__\  * "  0    !   #7Z #  0    !   #(0         & 0,  P
M  $ !@   1H !0    $   %N 1L !0    $   %V 2@  P    $  @   @$
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M0U62U=;7X1DH-&)RA8:5EJ+3&B8V15-69W6#AY/%Q__$ !T! 0  !P$!
M           ! @0%!@<( PG_Q !,$0 ! P($ P4%!04%!P$( P ! @,1  0%
M$B$Q!A-!!R)18? 4<8&1H3)2L<'1""-"4^$58I+2\18D,T-RHJ,7&"4F-&."
M@Y1$<[+_V@ , P$  A$#$0 _ .O/=-[0:B;3[?D&H7J@6^5=U3;2ON'ICF%=
M1G;RH[9Y.AL3+XHJJ+M5)1.]%MURQVW2*YZF2R%YBU ,445B"]>O?2/6OKI_
M2LL7VEFRQJ3)*4WFR)A)7$# CW(L8YKE\6%DJ2^-<4/6U,>)5/W7+!F.57:.
M-5%,5FN!5;HHE )E&363;&4B/CY_ET]=*L1OM.=BLU6)VXL,]QJU=K%(R7D:
M??J4O)K0\73,.W.NX]R3,.F#NEMY(!JERMM?@GD<5F>6<N9$%HUB]:-GCANJ
M,'YZ^OE2QT'=SMTRAF2[8"HF1F]ARMCI:P-;57T*[<&D<T?U%Y#1]NBXRW2$
M SI5DEZD_L,*RM,16K#+R===2*"$RT9*B<I%0I-5_:-[)F=PR31I'/E<B;!B
M-EE)]D(9N%N<) P083D6L7E=@2VRU;9U.:G**\?1WV]78":E)Y!K)Q<@G'+,
M))BY<)J,'P]>MO&L$T]J#L7??@RBVSFD>6M\E=(:#JYL=9:2NYYG';:K/[G#
M2=%5H9+C7Y>"B;K5IU>+GX.,?N:[,-K$P;NH0B[])4(/RWK)3?M*]D4!"H3[
MS.T8]CGC+',A'!7:=D:V2,NUROCUYEFCC"PM7I\Q,S2[_&3!U>Y=I%,'CNI5
M<J4O;T()HY:J+*1Z/O\ /ST^E*/=]UF/(-GMI7HQTLK+;M+C%5O"ZE3EV/V-
M8(-U0;#E68ORDX?O()U&#QY5Y2<4>-T'2SUXXA8A!$BTL1=!4"D'?IZ]?TID
MU/\ :XTRTU7,=X=[?,P52K;8OP5AMTLC9C0[!3"^09;+1\<6['YFXJ&3NDIC
M:KHJ9@M<G7G P_XO7<(NP=.I6;:L"JC'CX>>WE[ZDFO&=<(XRE&L)DG,>*\?
M3+U@2491%XR%4JG)O(Q199LG(M6$]+L'3AB=PW70*[12.@99%5(%!.F<H0D#
M<BE:2?=]M,(*8&W0;=RBJ?MI@.:\:@*A^!'H( V8.HW "/27D> $>. TS#Q!
M\@1/J*C!.P/RJY_"WVK#Q_WRNW_S_P#C-CCT_P#:34,P\1\QZ];"D'P/R-7
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M^E1'+TG-)WB.FA.OG&AZ=:T\\)[1D0_)90V5IF\?%^(S."WP_,.G\?J?'/U
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MJ LLFU45,*2CQPT2;K)KI-DSF5,4ZO(&#J !$.!U3VN<7.<,8&T+9^V1?N+
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MPSMH?^5'MY_IHQO_ -)=#<,#=U'S\*>SO_RG/\)_2J&WG[02@ FW2[=B@(@
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M%A$U&Y@*8,<TX>%#=9.2F^Q@X.!1YXY] #CU'5 [;(<5<6KB4^SW=JII8Y:
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MM-K456KM+V"75@0BW;.(B',G6'$8U>U:8%T8B\-9ZXT %!@BJ,^#*$2/R8#
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M+=SA+>$7B7D@I#=NP7,I 5WDY)2 ().P,:R1,RL7XAM90<4Q5H)^[?724Z$
M;.@'?33;RK9XS%F.H03&A*97(<YP #'C8EDT$P!Z<@DB!1X'R'(?(-7H</X*
M#F&&VH.VB('T(KP>QW&KA.1[%;]P;CF7"W(,1(SE4&.HK=FK-LR2*DV131(4
MH%#H(4O(!Z<](!\_0/0/0 #5R9MV+=(0PTAI(T 0F( T G?0:"3MI5M6ZZZ<
MSKBW%=5+,DF-XV$]8 KZ!Y !X\CP/ ?4=>U25%+;+>P6R)DAE<UUFME;6A=-
MHC)@JW6;5M%T4\*9@JB4#&:NQZ?=N@1(HMW4C])R&,-TLE )5D!"AX@'-.@.
MLQU\]/*MJ<.LMJ80$@%*4)4F),@I^UU!G0&?,]:;1=LM3]R<N*OAJN'LSN(?
M+QTK)O#HQM9CUUP$XK*S!^XB+E#\Q=)$55P, E*/7SJXMK D3.H!,$Z#<"?T
M]TS(R9+#(7F6$[DR!L8G;J?([=)WK#U'$J:,DVG[^Z/;+F0W4)U5R.Z]75R%
MY+]DPZY!%4_("4LFHCW@#DQ3D*  'LI"5J"Q_".I),G68T WB.GOKUN;E@<L
M-P $=XZ[YCOK&T"8&D4KSA)N1LL8I3H**IG*J)%BK=!C]1CB10P=9"]8]?:Y
M$A1\ '&O0)$9?'ZS[JIQ<I5W1,JT$#63HG?WTR.W1P2]J(R, '*J[,H<Q0*8
M@HM>M18JIC<E(!BD$RAS )0* FZ>? U"6N6A1B%"2.L>8^'Q^-7AEOEL%2_X
M3L9ZB=P/+SBIG=DU8&'J<Z^5(5,QG;6*!,!$1%1NU;O3G'P %ZB2"8@ "/ &
M #?'R 8MB+ZG;HA6Z6VQ]5^_H1.OX5J7C:]#UTTTD]U+2#H.H+DDS_U"/,'6
MGTE'D/ZM4-857K2E&E*H(@'D?32DBJZ4HTJ4J WFC2HST]?T^,4:5&C2E>3<
M"' \^>/3GG[O3S\OZO.E0,'3\_EM\_A\OC?R#"(9KOI%RBR9-4E%W+IPH5)!
M!%%,RJJRRR@@1))-,ACG4.8I2@'D=>%S<LVK2GGUA"$ZDG0?H*G;;6XI+;:5
M*4H@  $DDG\S41.?/;G>SYP/+OJT>_V?*ULC7#EF\@L2U)U8@:N6RAT5"+S\
MLX@*R9,%B&3%1G,/!X^,I#EX$</N>/\  6%.)2;I_E*6VI;;2$M<Q!(R<QQU
M&:2-%(2M,09K86!=F/$V.J;#*;2U#F4CVMUP+Y9,%S(RR] 3J<KA;5I$34:-
MW_NG:"2E5&^,MG]FEXHA3 60O62F59?K&ZA!,WV7"U.RI($$O!A \FJ;SQP4
M  PXU=]J$+ L\-94T?XW[Q1<)U_Y33&41_\ W*F-A.FU;']F_$G4$76.LFXC
M,6;.U"T(28@EQVX2LR=(Y*== 2=*1E[_ '3-F$3G!AM JR11$1+[UF!\Y$ '
MT 0+0&AN/UCJTCM'O3KF;2=R.^H#J0(2/=5V/[.#^R[@DB!F#823N-8=.NW0
M>^:UXW]TG;EUE0!MM=QL7D>2@O<K H( //CN>Y)  ]/@!  \CY*(#TC2_P#J
M-B"9)?:C?_F$_@/$;:#?RJI_]G1D:*?<D;R4 #2)*1/XD>!@5LD?_=)NX%#_
M '2V?4M\8..H4,J2+#X1_.!'OT]^4O5X'@PK#P >?.O9CM0>:S<QQIS-E^UG
MA,3,2E6_X[G>J1_]G=/=Y=XM!@Z#)K\UB8UVC>MJ_P#E,-]*S.+C9(0'70(
M"6;0,VZQY HF'\58*"41X$>@H\>0#[J@]J3ZE94-6F4C11N5)4-/M "T.QU
M+@V\#I3#]G51(!Q1S,2 <MLA6A.HS>V)Z?W3]-6G9A_NC'>K86:K#&N(L2X;
M:JI&32D9)W-W^Q,E3D.4KMHY<C PI%D>>I/WNO.T0,'QHJ ;C5&..[^XE+-^
M\%1H6D@@'Q/-SA4].Z)G0"-<FX?_ &?,&;O%-8E-XTB23<*<2#&D(3:O-*1)
MU!YAF14@/L+?:+[U]X&5,LT;<%-M\D4BIU1*PLKV%=A(!]%61S)PT<UJYC0,
M?%1KA!PP4>2R7=8F71,DN"RIDG")$\LX6Q7$+ZZ2Y<WUU<G,4N-.E"6PF$E*
MD):0A ).<%)!(UE4$ :J[5> \$X4N2WA26D,EI*@I"GB>=S'@I!#[[RR$MH3
M,*!,C0%))ZDD  2%X'D $1$1\\\_ZA^GZ-;-([T],O4>?YC8_P"E:)!F=(@Q
M7T\!QQ\O3C[M1J--6W/O\GC7:]7L568M0GK!8D(H\_[JU=#')*,7[XRG;> 9
M 3&(R.1$@@(JJ'[0%,(].L4XB>2X/948D[AUP@!UE33Q94ZM25Y49DK0H@P!
M$D9M/=E/"S%@Y<J=OVVWD-]XMNHYB"D;G*HF3U,C328F:BK)DC/>",HD4SQG
MVQ6.IPK921FFD@FW=0[IB F%5$&S:.:N'1SMQ,FDDGU+BY[94@.?@#:AQ''\
M0:3=)XI>?;M+6VN@VP75J:O3R5I:4ZVKEI?*'$I<25!2@I,I,@1ND<.X/C>"
M75SAEE8V[C:6PDM6S+*@HN)!(4A,I@?P[?>G8OGV57-C8'N5:<S82;2%CK&K
M8:\SFF1F#MI 6[O22#(&JY.^B@D)^X5-3@!!8@@7J!01P+]G'B!S&K[BO![R
MU9<L3</JLUNI;6\EI2W 4R$ Y2@(&4*RDG, ")K3G$5BO#EI3FU!"2$DY,PW
M(!/RT!!D1I6?W48$BIG&MCFZNP3BK3!-QEFTA M4FTG+^YK%6>LGY4@2)(E6
M:F5*=-<%!6*7I$!XX'S[=NP[!K[A:^QW"L-PYB]PEEZXN7F+)IF[OID.KNWV
M$I=>>RK!#[A6Z"E)"\R0:I<%O2;@,J)U4.OV?XA U[L@2(\HW%195G+5RJ]=
M?S=4EWD-*Q"R#-K#1<K+I/72KE^#=,8B!5K[*.<J.2"1RJ4Z4H5,J8'3< '(
M!P;PE><8\-V[%]PIQ'BED^NX;L%.(N%K2EA]IRX6.5;WKK9Y=U;,H!*T.[DM
M)5W#FMU;6^(LE*PT2RLNC, 1F;[F7,H#="\VLITW)VD6HV0=X\;"1TFYJCBX
M,'#8JYT)-!F6=$%2IG* O$7C%D!REYY*9B42F,8#&_BAUEP!QE^T[;6;5[?6
MMSCM@XG,TY>6=P^5MD2%<SV9Q7V==5D@DR3I&'/V^%EXMGE-:@9DJ2D#Q.4*
M3]?K2BP.].(C)!6%RQ3[)0WR!RE6=.8UT\C0 _@1!XV;D(H8IN2"FV0<#R'P
MJ*% 3ZV9@O[3QPR^;PWM*X?=X7==<6VS<+4<KR4$R^D/-68Y:D@K 2A8"1HX
MK>J*XPE* 5-O#+)B8((U*=1,DB.L"1-.ZJ5]J-YCR2=6G8^7:'Z?C;.$C*$,
M8O4":R/5W4%@ ?C07(FLG_'3+R'/3'#G&/#G%EFB^P'%;2_MW DI4R\TL]X$
M@$(6L!7=/=F1&HJT.,N-&%I(W@]#%:+E+ .,LO+,WUN@$UIA@GV&TRS55820
MM.YW19.'34Z2KAIW/C(DJ8_9.)CHB03&ZLI0XMN2@@$@"2D*VG]35798G>6!
M(MWW$()!4A+BT@Z@F,J@-8@Z$$?.F9S^T3)M'8)PV(Y.KS-39O7<A&4V?45@
MEBG>.!.9M(6E)"6=R:0 (B!W4<*_CI*LF( ;58F^C4-B=!(,:=8$$#4D[>\[
M"LRMN,&00;AM1F,P*,P.FL"50-?,Z1KI&OQ&VK<Y*NET9=GC>JL")E42,:P2
M=F%=4>!]V(6.8UYPW00'@"&5<+=P"B)D#!X'T3B;B#W6TP8)).Q!&D1J8F#/
MQJO<XPPEQ(46,JQIE;8"9&IDD)2#&@&ND^^M(R+MJW9QZ#L\%6L7WY)(HJD6
M1L<A4I!7K\"@@V79/6Y^D/!A<*H=?G\J7U"9.*$$%20$R"HDDP!XR1'G!.GR
MJ>UXMPI3K04UD[TG.V- )F293[H5KX3 #,W%0R]5K2G^-3!%\K:7O)4V#IFD
MTG&DHGU$%7[--6YB36%%=1,&I5I((\3"L4PE O!1KW<;LBT<SF24C<A.A,;R
M)/QGZ5F#N.83=6#CS%XW^[[I;2XG-($D9<VO=(U&^NM3O[?X9: QE7$9%DO'
MRTFDO-RK)V("];/I=TN].V=E!5<I5FZ:J3?I*L8I2)$( AT\!C2WVGG5+;5F
M2K02<RO^F=X$Z#8#:(K1^,WS=[>K6W!0D)0DY4B<O723]J?=O%+B14HB!0#U
M\<^//@?/Z>0].> #]6H:SX#X:^7KPJUZ1,BOHU-2C2E18;E/:<Q.WO=C6MK1
M<3-K+)24!C.QR$O/YAH.*K!8F&3;A+U%LUP=3[]]G-,TS%04B%)6ZP["VUI]
M'LET&T4E-29O<M*1I](CPW^E?7D/VN6TBM4_(<Y0K!/9*L^/NTJ>F_@=?J 6
MTLH_.]2V]WA[2[=>J;$52W)X\OEO8,K46KR,T9@H"2"_9!VDN52MX=^U3V(,
MY"X1:V;NY(4]ZM&E:ML=Y2>J7J0;9"9XF=LL.BUI2Q,V.6>2W[*E/$\3&N(M
MIURD@OT)&[VE(]WT]_Y_4^=7(SVINQ>8FZ+7XS,KIU(9#"E?8JA,89:)&1*V
M0LCV3#U29WN:4HI(C&TE)Y4J,_CT\9D![6I!A:V(Q,@V:KK( HI'K\?ZT\"S
MYAQ/2)-2'NF3\=U&5301=#&6:ZUJ D2MEP'M.#LI:4:.@15$![2O9!,X?F&-
MP/$I6A/VE)$;R0.D]:F"%JV0HCQ"2?'P];U@@W%[?A\AG/#HAX$!#)U($! 0
M\" _;G&I4N(4HI2I)(\%)/X$GJ-ZFY3O\MSQ^PK3Z5@+%NKVW5.$L%DF\[XA
M0BJ[$O9F2,AD:I/'*;*.0.X<'39M)==TN?MEX(DBBHJJH8B:9#',4HT]W?6U
MDP[</N)2EI,Y<Z I:OX4("E"5+5W4@D"=R #'K;6-U=/(988<6M9Z(5W1.JE
M*, ) DJ)@#S)KB.]I-[57+&^ZY2&/<?3LMCG;(U=^[Q=91?-(N4O!&JJG38+
MLJ8S-XV:O  IF]<,]6:-4P047(L[,8Y>=^*>*<0Q*Y=YLAAI1]GM&P"VB,L*
M*T9^<Z")DJ"!J() -=9]F' W#^'-(O,3*2\XE(><<=2AQ2<V8I"2<K;8^R<I
MS+C50!BHWZ_CJ#%N4WOT&0 Z!*4LM%$[GCR8C?[3#DX^>DQTS*@/2)O(:UI=
MXI>EQ0#+RCWLQ6E95IXJ+>VFR"$[@:5T#_;V X:TVW96EHE"$A"5)GOI'V5%
M27,ID"<P W(ZBMP94&"*0W:?QJ7Q"!S&EXE,#^O/49:0 H@' <@4 \>@\:MZ
M[W$%&>0KRD+T@= $R.L=)TJ3_:G#DIYH4PRI1@EO.21$@'.M0C2=(.GA K('
MJ4&U2Y"5BSF\\IIR\&(<#R/4 DD^!Y\>@!Z>OU\#=8@I1FV4$]%95D]-(R'0
M>(/73RE_VPL 8Y\^94-?G,>Z9K%%AX8BQ$P>QASB(](!-1)P$>D1\@5\(>
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M4X^!,<HH!\_7X0X$.?7QJVIQ/%5)2J5+4I.KA$YSU)4$DJTWF29WK''++#W
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M^1$O33-<_=9^:_TH?99^T]'FEN?_ /0J\$IO7'R:F[6#GXX#C(N6B]1@  Y
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MD5/<VCFI23)N<.%&R[B,=MWR@_/^_5&::Q@'R'2 #QZ:Z"["+M2F<08*>Z-
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MHJ-W**P'(8 ,4Y!(<>2B @("'C@0^NMKV>*X7B"$KL;^SNT* *2Q<-.2#J-
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M%YSJCJZOQU6H"?P_*L#;J)6+C69NO2<,Q6:RT6^CE"BV2 Y0=-5$?@-T@)3
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M!P$0+YJ4X4NVOKYH.%Q3BBAH 0H *220 ?N@^9  /6LQML39&'O D(S,H_>
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MB D\6YOD%G]EBJS*LIM>J9&.91W.F581CM5S%QLYUHR# AD2,TW:SIL/2F=
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M171,=-0I@'U*8?IX'G6Q[.]M,0MV[NQN6;NV=3F;?8<2ZVL>2DDB1L0=0="
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M'PPS=\A)S*S9>HV"?$:^!\#O[C%CFNQ*S\VPA&!TUUE'1 431*0P%*=3P4I
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M#G)"5H3.L;&L5XF4V7K7EE)!8)5E4E4*#BA"BE2A(3&DZ CQJ1STUV/6,50
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M38R(.<MMG,5!*N^H92K+&2I<L#;+]LNV-D\;X>Q;!5=60Z/M&67.^G["_!,
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M&,*U!(7*CAVN( DL1OP8>VFH/)C  E* #Z\:8;;_ -HW+3=JVK,G*E:LL"0
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M24DBN8..^"+CAZ[6XPV1;%1!$R4$$ZJG^%70YE1,'302DMC*&1(*A0*?DX"
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MH9V.A\9Z+-K&TRO;?X5Q;;P,*6P=H%4U1$H,J\Q32 >T1RY G2L( )UC@!1
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MA)T+]Y;\LKW0-W%?C/R;SI2OI!JB7IX0:E G9 I2()E H-__  ?CD/A['HB
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MGF)7S5Y=@A:2D(2 =2I)DKTR[&:>HS@\-;8J:N_1;1=6B6C?A9V)$RO'QDB
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M8^8D_#]*<JV_G*_PC]?7OH')&^@?S=MN(N1\ !LV/RAS_P",;\#..! ?D4O
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M.^_R!VGZ[UXAFW5__("?&0!\MMOC^5?"K>=[;@JPN=LV(1*('+U#FZ3$R@"
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MZ^@ #IZ^>G@... UN6L.JT>/CU3(J*,6:AV_=%N<[5$QT.^(&7[)C$$R7>,
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M(Z^C2O/5XY$3!^S_ $?+CSJ4+\1Z]QI7P.'212*F,?I*3P8W!?/@1X+R \B
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MD>+J!)G82H9M =A'0FFL;@M_N07D:[B[%BW<!M^K$J5XTKLF3%;YW;+<_1;
MNV:(+22PMX"/Z3J%D)#[.<]"@IF;R16XJZT]VIX[Q1Q5;?V;8W=OP[@8,7SO
MM,O8\T% AVWAVV4&W$$(AHOJ)0 5D*Y8R#!\' *5K*%J&;-REH<R23/V,X,
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M.AQ#BPU_Q5Y'2X):;R(5ER*!(B2*].'[UY;;R'T%M5NE! "EJ1"RX@J0)@*
M3"B@ G23 %:1"VFZXZJEDH8U'/%!B$8UM]EF:8*?C$/#OT%V4U*R+^79]Y-Q
M[JN8B+L@J  $*N0P@)1U+POP)QE@C[J\+Q0V=JM16E5X\E.<&%$27V!WDA02
M G;NZB*S*WQ15YD96"<H0F<J@<H5]F3.8F-=??J#3Y_8Y1?V<ME9(JIW/V?%
MUQ)PN\<@K(F6GEWLXT473 I3$%1L<QU04+R581*3A,.-=+<#Y>4" 0-@#T[N
MNNDQ'S\:P+M'"@^ 1'>)(B-(@:>9.GB*GD2Y[9.KUXX']6MD5JU)D>O?^/KI
M5S2IJLJ) H7I,!3E'P8IO00]0X#^KCT_1YU*M.8$1,^OS-*M@V OYGP!Y$0#
MT'J,)Q_1\0B/TY']LK: @0! U) B-2=O#T/"']!\!Z]:5<! H"40$0X^7///
M///(^/KJ<@DC7;;R_+S_ -9I&_G^D5<Z0_7Y\^HASZ\<\^NH=X=,WTJ$#\/I
MM50  #@/34WTJ--3F]C&SBR9(M.8+!MHPS,Y,N\;8HJW7.1HD&[F; SMU;<4
M^U#**K-3I.7ECJCIU7)R2,E]I2D(Z<1CUVLT752.I/O^IV_UK.RNSW:O.,Y!
MA,[?,2RC&566<231]2(-TW?KN,5&P:LLZ25:&(LHKATQL:&.<!,--'[!Y]QX
M2T_/UZ\*3\>GU'ZS_I6K0FPG997H-]7(7;!A=A!2S:?:RL:G1(4[>31M<?5H
MFT?:8+-E#OUK''4BH-)UP[.LYEDJW#^_JN#,43%5"??I(Z^?KX^=*W>,!82R
M99&-QR%BNB7.U1<5%04?8+'7(V5EF4-!WBNY+AXQN]=H*+HLHW(-2K%R9-R'
M!-"Q0,7*)E!TS14*IF Z[Z]:T"R[+=I5S4=K6K;KB&P*/VV26CXTI281W[ZW
MS#/'M.4$G8*-3%<A>+.<UCL!E@.9Y/<2XF+(%*X!0*\)T(\O<?6OE6KQOL^M
MD,.\Q\_B]K6%F+[%3DCJ@NT*-$D<5]VE:%+PBZ36[ G?N&]S75MC9Q+&?*MK
M(HI-H'3D3&<BJ.8ZCO>?AK\=:VN"V8[3JN^;2=>V\8EB)!I*QLTS=L*5#(KL
MI6'R&YRS$O69RMN6BL7DQVZO4?[OVR,K.X5EFY$W1Q4TI.G7Q_#U'E&M?&\V
M0;0)"U4>[O-MN'5[;C:8D+!19\]&@_M&MS4I=)3([V28+%:E_OH^0)N8NR*B
MY5O=+7)OI]F"$HY5<F4)(\==]]@.OY"G0@F4PB<0, \^@F-QSX\\<\?+Z?,?
M'.H$ ^<:>O.H GI(! ,Z:CPZ_K7OI /0./O]?[>=0)"8^6GKU/G0B>I^&G]?
MK5> ^@?LTSI]WPJ-' ?0/V:9D^/T/Z4HX /0 _LU$&1(^M*YW<ZS&*KKN+S&
MCG,RB4;5IDT9'@N!TDG+5N]7013$Z:1RG(*!RBGT#UF2,0>H!-KF[B>\5<<4
MW-A)_=+48$R0A:S(B?N@ 3L)C6NI.",-NU<,6ZV$_P#+2H#0F,H6DP1!F-1(
MU)U\&Z87MVW,NXJA5;$E:7F'YYY!9O+F3=)%CR-GX *:0O"D[Q>R=3@2'#DI
M0'SQYMF$7HO.(UV1E03F6 #.@/O\Y\-2-S69XM:7*>%A>72.47&Y/@DD*$)C
M68$P3$2*V3?=$,9RU3K6;OAH-@XBT_>:Z7[04(YG#1#9 BP(H("U<)G I4@4
M!X*X+$53,@5,I#'HN/+NZPUU%PDYK9IE*'-HYA6I1@:=%I$SL#H1$VS@KV:T
ML[D(3S57%VMS-O!Y#;90">O<S0=B8'04HVS:V8>RAAG&5#M-=R*M(8+:EJMM
MAX=&Q6>O6A!B1LRB),XH/&K*,8R7"K]Y$!&D63576(9T8B8J#3V_:-8.8?:.
MN9VDV24.7#C;7,4$M@J44IS$!0$B.L:23IJ/CW"+ZVQ9UYM"4,WBB$@ )4"9
M*@K4YX(T4-0" 02,RI&T=XV Z_2Y1*E52>6@ZPL,;(1S&IK1<7&G74%,& N
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M(P05.[*='I3.F0.0-YXW9Q1@UCQ+@"[QIA\I4A"VGDK4 XVH I<[KA,*04N
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M@MM+82US%Y5(94IW, 3"%I;5.9L$S6MFA3O+?A>1!<$H![R5)(*9*B% *[Q
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-2E&E*-*4:4HTI7__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>g472601g68j40.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g68j40.jpg
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ME*&BL>'P%"(R-55TP2,S<G.RLR0T0D.T\76U4E."@Y+"_]H # ,!  (1 Q$
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MD>,-#!YFP6*O @MR/'N$2!=J+;KDG(UIFL]08(+/%4<6Z6:F.*>2[G*;E&>
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M." 1CPP7(+6PR4NBR&CT'#QTK9/#/.Z:"*F=L,,LNIUN-[VWYY#D%.+G4RW
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M -DG(BN+N@^ZZGYK+/\ V>#.AE?^<A_)Q?\ PZYUJUVCGB@% * 4 H!0"@%
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M^TPCQI\(4%=+9LU7\M^7X6:VK7K.3_HRBHZ[,R1$C()JS;[3<\DF6M<,0 M
MKN]M%%A5U!)I_FWQ$@SQK&TNP!$2&#5A/'-R64@:Q7LT<H+^ZU_GS>+41F'<
M5D%M<YL%'DCU44DN\"&]244:D(],V(1 @>-&&FJ"C0DU-Q<C$&%S;L]E&1V3
MZ+1S8+MP7BKAVQ8,E'87\ME:^SQ/R>XFVD.+@G2!.&D!LYDLGPA.G6^E1J!Y
MA'T+KQME*W4J8/W2H4:,M<JU5<V&]>FC@V68HX9JM\GF6;K(&[\2VWX^\N7O
M$_UUIY#74HW9*V<B=EGN[-BMMG$FY$:QQ:QV1--<PK5R"(7S+=%QF,[F(!';
MK(OG"[Q0C<LXQ?)-GZ;-H#=[=Y6];?ZE.1SB!A"Q^GVT(W3LF($=5ZXOITB7
M#LX4LOL/6>#]H3'B9(T,QDJP&2$(\:9*@Y=%FX0H/[:',.QK)D<,6@7VZEK=
M^/5XM?DUWU=_669K+1;C5TKEQ(1M"=$H%(I;-)X)U443B^4;BDLV,?(2J:NQ
MYQH :S(D*(28R?.#(\:D#\0%?2 CD@W72:1U,"%[_/)\V\GCOAB_&YB7(\F"
M"DS,(WY.105$)*@F-%WPBP\1#G\%;N8SGGA?/-\J!)NU7&9JY1MD7Q;/$6J+
M))48X"^SO;/>1%KPVB"*!,2O+) \C$O!:4#[)CJS079I-'&A,AB4-,XN,4/-
M %^<$ P<=GJ;&ZS Z$$,DPC2+$O-!-P%_5>W>OZ_%KU%6[*XBEQ)P9.M9Y/#
M,[DFZM%2:<%!@R%1IJZ!ZTGQ.5NIS.!"A.."YY-6XTIE''LC2Q1EIJ+C1 K'
M+MHBY.N!*EJL]EG;RVU>K5R-WY2UGO#B%DG:SI[*)%UQB%<FXA+KM$!3961J
M\KS<7D&R#EE<FB_:QX)>0V/LH4W0P7;"0K55B6Q/N54R" B_Z/\ _56_[,8A
MPW2QG$&G;[<T_,$X#(]?2D.D4"P!?'%]!=<2#62@A!TG%47@J(GPTB(%7L9#
M+,&K>3O"DA17R)DU5T@OWER<?+?EXO\ LV$TSK!GIK7$?UN.,/SS".YF,FQ0
MH@T;OW&)DZ2/+8N<&*:+2]T')1=!')%%+JMTT;*8YJV454$&RNJ?RU:?L29?
MZ,D% 5U0"@% * 4!U;ZKE/)N3;5)J0DW,)+%XER]W[!MCI34C%N]NST=&8T=
M2B0,8\50<SM&<CYXI$&@(@$;/L\Q:I]Q,KD6";"^0M9>J+7&[ZK][9=^8\8;
MRFN$MI_:3Y].%]?33@_IJ="8+(Y1C("*TZVILN 0F&9R"1JLVJ;Z0/24V$A)
M',7#/'#L*KPOFQQ2PR;7"VU;6GMY=O%Y-6HNE7E--7F\X-I-GK^/B3:6[#FM
M-HJ/Y<1?L4@B?']]O",'X"2;Q!O<RF6$+M<7R1MC'7@P\!)1K)HL-*-)@V"V
MJ]^*_KMK\OCU=_4;PT*B@% * YVOXRW_ $Z7[S&@)OM3U29S[Z#/\:K0$!H!
M0"@% * U3Y&A=DKOH25U?M:6QJ<9R^!#HG !3:.+PV0CDIF-=;1)3YB1!ORA
M2/HZZ5*^;W:1<1>/^86%XPIA,# ](F)5N/9KU^341[$YMP%RW8L=C7DK+5\\
M2+A=)K0N;!2^OGA(!"LCQ4!M:%D-< I;'IR^;#)K*HV:#SB5Q-\.$I"'O:HH
M.9)F U6[ZV^[5^MTO&^+<VA H!0"@% >TQ_'6?ZTW_>X4!,-G^J-.O?8>^DG
M- 06@% 0V:1@I)V@C ++S4+)!3K4ZV)!FXI[9[=LS?L\PID>99/F;\ 23?YI
ME&J>#0C=/#!805#E$691H!K['N)D=B\BCDP"R=XPDHG;VR=YF%&8$,S!R'86
MSM=N]9%W%P+5-)$2'8QYUBNT8L77;!^;;)FI"8-$GIIP5$W]R7D6OY]11,[X
M:%X7J8!&M9%9E.'D8U)QFT"U9-,=9,I4WU_QTV'C-(], =YTW8PLEL;&V:S=
MY@4*1,4I?S.8CSZ,G1;-5T)TKMWMK<G?7_J7EU>3QLF,5XF.IU$Q0_<9(LB+
M9A=^PZT7[20F.2,Y#.10(4QV&KL-Y "Q^.YSLA(4Y&>PDD4-N,R%S29.0NBD
MB<DEL O9ZN5/EV;-O%X_5L+K"<;(L1C@,+OI^UY2$HN19D(O(MW0+61I[&UA
MB&+8>]##Q<.%AV$ARPQNY+RE!A@>+OU+YJO$1[46,'"+M;-7+9O7ZRNBG"R)
ME'T[,7EA 8?V">U8>D9D%'P 5:0OM0[79;<B9:8L6""0J6RW$H,&1)_-"#%(
M^[@3! ,HXN6R6D"H7>KO7Y>/;Q^7QMGO..(B;&1)S&#;GV5 94SV-M><BBHD
M?KTLDP$;Q*#)!M&!KC)'#2K O'CDF#AI(-<EDG9<"5 1^[)[FR9D&9<+^9VU
M>+4G\\K+^A,<FP [-<Y!-7LHBCYS',8&)*M0^16+LAD=9##B+@T,$"GAA(X7
M;9F\<CZYTPW?.B2ES=AKP<! B"QZ 4![HW^T6'ZZU_?IT!*ME^J+._??(_I9
MW0$(H!0"@% 4[O 3<E!WRSC9DZU<*&8J/7I?6MA&$S)O%$_,0,*(5+ Y)=PY
M>%W;;$> %"%"\G/6"A$5EF3I^%- =>DPWGR/@T'VX^V >\S;.XL<-N,^W38H
M$W8-A.PMRS@IM!39B!9DQ3S'DP1C'5&$#$,!N*8X>[D$G+@\6I=*-/00M9:N
M1R:OKV:K>:]_T-TXW*9FIRLW]"+GW1B- ^/W&R;1&+%+CF0@')YC-N4P"19M
MB T+<KBU/-]=Q.[]8E<ZY:9LL\V.%D+X,;..WB]=^HCB7+=Z_(K?KYR)\4C6
MTK$=I0G>JTMPW#&G<5-R%F]EX&;ZS<@9<D?N!DFFS(F ZY*LX>8* I2,6CDO
MCR<GCKZ.7'NG))C@/,E =N+9Z_+K?JU>XW&H0* 4 H"#;/\ 4UV'[QI;] $*
M ^6Q0Z!]'?HR?S?O$;^Y"&?P5#2J?;EXS>FA04 H#K'Y)S+D;AOK:T"T%)9T
MI+V/%O7<_P!51 2TA+R&Y;8,;1V-&;NYPM,A^:#*%%!$9$,I/CB68Y-1+4J_
MC5VLN<LUW(LK:K[&W=Z[VU;._P"0ED@V]*7,S%C1I>41QW'^>D1T_.F5Y"W,
M #PA_P < ,^<, *:HEH\"0YU8T%(=H,UEG2<B1-/EW[A$A@W1$<G?7Z_ Q\_
MYX.QFIF\_ANOV:V>RN/4FY"Z%(G)(XN(DD2C9:!#R6,U:L(\H]B<C:"-HPJ4
ML(XAF99F47!0&XDH-^-66N)4;NS>QV?KV>9^HOCE6M.0W'K:FR(].#^OI5K;
M1NVIFU9Q!R(?C%YB&@KHV%7>/C\95<%1L?)B5_,B':X2F63>YJDV6-L$VB01
M5Y13V-I>=V(;%]F;!A$FT]K5H/DFY36ZM9$]O7.RZ8QJ/I0P5!B&BHG/62%F
M,326?M;]]EG+0['+!R[<DD2P>SQDQ<L51HCB;V6XM>N]^K_MD3C?,%F!UOI4
M\O#9&4#SZ^L&3M]()X+-S)BIM;=XW2@U?S&Q#W?'D(V>/#2<F.F6D-CJ IX,
M% RYZ3.L >(6=WLX^]LUNWZ)%W<89+))-&MIJ2<\1D+H'R-W]%!CPIFAFX:Q
MV,[+."0 I/S.@V1Q:BAC9NR:XXHXWLBECU]\\[Y9Y _T7N1LI0@4 H"Q=4_E
MJT_8DR_T9(* KJ@% * 4 H"O(5JN#Z\:RYG#QI 2A.Y0=FLHOG)I037(2F37
MQR.&4'9<T_="73_/#!3.P=8>BBKA@JV214PQRL!72'%#0+>/CHKC ;+QT1JA
MGH\8'?2>9D6+'5XU\U)"HRW2?R)SV/(.08,'@4[:_=(&<#QZHPPTR8M;HB;O
MUW\OSY"38:#U3B] %;QQXJ;C4XML@;(G,KF+J3+3/N0R@&9<Y)7,@5/2A-:$
M=CB;D5)B)<,ZC[9B*<CU6;!DDW$7^?+?WEQ4 H!0"@.=K^,M_P!.E^\QH";[
M4]4F<^^@S_&JT! : 4 H!0"@*3G?'K5^R98VFTL:S98^V$-P..0/;>VX>'<!
M6SU8AB,(Q>'3@#&"K-P[74S(($P[O HGUC<E9VV222P?.TF[^4G[R5@=7PZ.
M2,K+&"!YT;+$"Y/-:036:RMB)='E4US%HH%E,A,!84T(*(IW<#H>/!C\L;73
MLULGEEAD(^=A8- * 4 H!0'M,?QUG^M-_P![A0$PV?ZHTZ]]A[Z2<T!!: 4!
MK%RYVG+-2ZC9EX2HD.DDQVKI/43*4.F;<@R@R6X]M0_6CZ<NF;U-8>YSB[&3
M."0QN30<"G!Q(6@4;.AZCELJ)2N_(WYDW^A0W('?DIX@[ CUTE9+MJ!2'0'(
M;9YZ)'S+.\B#FN/S.!2):1!90L-4<-1LK#RPH%,AB."P%F?2B%XRWCR3HRW)
MB4K^=+S_ #[R<*\PR+&9RC4AC4109N0,>2:@8>D??R())XN0@A"=AY0A)(A#
M9"199+(BWT:+B,8F_P @TF0SMVP?QOJ26XCR^/O=?DXO+;QPYBE<)&.%%-*2
M".#;'N-<=E2DCE QE*HH3Y..40<7'.8HS'$D'A2)R]TW!S1I:0M6K5IYH+!B
M!G)"PU4+=_E\MM?N/9G.^P4PG/%=SI_8US,?+<EY)KG8;&/*X8CS3%'BWR(G
MB4?+V(-$,\LF<AA\8--;HN6R6#AFE==7-.][8A;;=<5UYUK*BE_+.73QC%D(
M/'R45E8#<O%O)\%&3(.2!S.+[KR*JI18A+T V8K)%NZ$%0\G?Q-631SKV2;Z
M-R.5H*9-+";6\TO.E\[?-L988/FRZD2)4.%TE,"VS(,\+-=H:U#O71HB L#V
M;(-:/58D?$QIY'Y8F]7B4CD8)8\\@3)^$:,D7[T.9?9BV8BW?U<3\VWSZ]OE
M+=XXR622%?D A(SQ(_:,<D-A1<"H3S0S4&1U@(B3L>&:V;H-TDV+!4@ZLV3L
MGU]L5<KJ9J*7RSR!\7B_5HV4H0* ]T;_ &BP_76O[].@)5LOU19W[[Y']+.Z
M A% * 4 H"L=FZ@@^WF@)E-TI4HE&BV9T*I%=B;$UT\9ELV+H9YMN1UU*HJ0
M<J8,'SUJEB\<N$D$G;JR."=UU;YOG;;W#YV7]YA5./6H5T0"#N**O\8Z,"AV
MRA*2RTDY,#([),)@#9S1X_.N7>PDQDJQ5D+6\\7DF:9A\6?]?=P8*J/!-W\_
M.HD3G4\%=2J;390:3PE&Q(2'UU+2S652UDH0A\?6DSD$*9MV9Q!F"5#NIG*G
M8TL ;BS+-X?)NVY#!PZS5N(,M#8'&X$P5'QY$MEYHNVN])R*32::R0E=FV39
ML[EY9,S!^3E[M&J6"#:Y,N[\SI]=BEUG9%.N F% * 4 H"#;/]378?O&EOT
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MQE;Z] .V)#V<\^,K?7H!VQ(>SGGQE;Z] .V)#V<\^,K?7H!VQ(>SGGQE;Z]
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MP_P7^ O0T9_;E_%+WL[#J%10"@% * 4 H!0"@% * 4 H"01?^V4?U,O]$/Z
MC] * 4 H!0"@% * 4 H!0"@/-/\ K$_^/'_-:@,W*/RC-_M)W^]RH# T H!0
M"@% * 4 H!0"@% * Y4/Z]']*G_GM0&7DWY1&_VH]_B,Z P= * ZHYQK+= O
ME=.=WZ$C9YH6V=/+<<-PD2(8A'V:.K"6C=9O==\@PBLA'-!<WRX][0CT[%C6
M8QPZ:&F>QI8-Q==?Y@4Q%KJUGQ:UYW=:MET_4O&5=HZ*[$TJ*A0<! ]]1;6*
M/,CG@#-1F,0[;""Z^N-AN=JEM%'GP(</3,91I^]3BJP+8SENFPBI)\.<%I(
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MCQN*.7=G'9H_(\@N1H=D@Z7;6P?7CIF0!NO6Q1LZ2LS+O+6;KI67NBYLLW1
MS=L\,LL\,<\;YI];U^%LK7RPZ^U[X=?C:_5QZZUKWQZMK==:U[VZM 5/ =G1
M';A3:8,<&)8.M*;6PUM(<9"R#J-EY2S@\!V<-.QM5@3+IN!2L=V+&G8X@Y[6
ME6[_ ,V(+CF:K3'-4+;._K+:H!0',W_&$/TR7^?&@,K)?RA-_M5__$J4!A*
M4 H!0%8[4F<WA8!)YKW51O;TE766[%&1,AC41129-&RKIT[?2.6/60ILHKE@
M@-%,$O-3XB5?M>O19A&QPZ&#U&KJ'/\ U62A@S8P<!*%80ST#I?DSLL@63:A
MBFL-3[Y*%QD'?F!.2CS H;9H1>:R.5!V!''$3%(<4)CGQMZ1C(D\+:+O;CNT
MO&K:N7CY/UML*/W>#<;CV]J$H((1O/3VK=4;:,S(V^"(1DI%]JF-RAFKABH@
M2<.V"4<<Z4DES:YY 5UN*[=9NBHRQL\6%;>O5[NL]K2FX@^]8@CL.*,<FT(,
MW17B3T@_;=T!D0X1LZ9&B\:;XJKQ% T.7'FP8<X]3E=@Q-FI)X]%2MU@Z0%P
MT H!0"@*^VUZE6S/[OIG_IPE0'R"*'0/J5=$O^;5X4_X?X+_  %Z&C/[<OXI
M>]G8=0J* 4 H"C=D:S+[*GVO>W622>L(8UDTC<8AYK+8K,G.R7S#&,1MRGC&
M68[LT9%1 U.VQ!LO+$L2!20"W68?+*/MEUA/O\2?OZC237?"K<>K6O'TG&C>
MNGQKA_.]\QK1,=-RF8.0<EXH[G7LW%:GFDHO"UC$2F.M @F!"XM*A4?G3!<=
MKYD+)#G/= _)L!-UY[-^/O>,VGY$ZNVGOSBKR)TTIW!1R;;IT]LG5@)/$[("
M,3B^4]A)2(8E2LEO$VADYYC7*KF5,&L-$6S03;!4TK*)K'70A:FGXC8R.MB+
M./!&A5)DB4:"![9^B/=KO1^#UNT22<8,WKEB.<.6ME<,NPKK#F:JB?6YYM4L
MKWPL(*3XQ:NENG];'(C,U8ZN6);LY'[-05C!,F4'8"-W<@-E;J$CUG!4%'W.
M)$&SV F (VP9*-G#D5F_;+V2>8MFPEZ]G(O4K&PU"!0"@% 2"+_VRC^IE_HA
M_0$?H!0"@% :;[-XR8;7Y30;:LYB^LYOJ&/\>-LZ;.Q"9)*G"),OLB>:EEZ)
M'N8(Q9_&GX1HQUH\"$6I S@H_2D6=\FUV[15J_$IV37?3\UU^I"M@<3)I,7_
M "K(B2\-C)79!;14_P"/IU!8JZ6@6T>/P .M!3$J%)!!Z;<$E,XV([:C0)0C
MF8A;DT <=A2?JH*@GL\OKLF1;:O">;3!'=L6"2^.D(ER/XK1+CI/#,F7+#I7
M 99&)-M\^[W;!60X09'GY))26\9-,B(4D5BMVLZBL:)I2)PB1=W$B5*UN\[^
M[5ZK<?7&I]PZWP8$[*B,;)Z>=QB>[>Y$37 F=+R@/-&8#>VLB<::+-SXZ!'2
M@$A%9.2RP/QN,%QB>RHPCBV+3D(+=F(<6$+Y\?SRI[=AL-QIT5L;5,SFTHG+
MB%J(RG4/&R!-V\5.'2ZS8WIJ)R<'(EU\C$4CN.8P@\D.%PSO#+S6Y;-,G#X:
M,5<6:( W[V_/;J-Q:$"@% >:?]8G_P >/^:U 9N4?E&;_:3O][E0&!H!0"@%
M * U.@NMMR:R?<K)3'QVLI#(MQ[Z$[7@(0S-)4$"=H$=4Z2U05#S ZRUV;?1
M\OFPU:6-CW 6/R]E@[,#F#G#-%FY=+N7O]27Z$\G>7ZME5".(,B@$SA^X]7)
MZ_!; !D^2SQQKY1\9':L#-.3">O#,B91=^.C2Y)-09/-10F6$G&46&(RPJ;V
M&4LQC"Y]FT8!?B?>\>J]E?R]_BY#:3CSIT7Q[T/IS104FY-C-0ZSA6NFIMXC
MBV=G+1&/L BIMTV3452:N2ZS-0BNU25S1;*N<D$<KIIXWH0W=M\NLN*@% *
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M_P!.$J ^010Z!]2KHE_S:O"G_#_!?X"]#1G]N7\4O>SL.H5% * 4 H!0"@%
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MM;CU;?G6;E4(% >Z-_M%A^NM?WZ= 2K9?JBSOWWR/Z6=T!"* 4 H!0"@% *
M4 H!0"@% 0;9_J:[#]XTM^@"% ?+8H= ^COT9/YOWB-_<A#/X*AI5/MR\9O3
M0H* 4 H#$GSX2*A"TEDI<< CP$>[+&C9=X@/%BAC!'-R]?D'SK-)NT:-4$\U
M5UUE,$TT\;Y996M:@/5DLKC4-&V,2HZ+CXW-VT'(NRKQ%HFZ)$%L6XX6RQ5R
MLH^*$G.6#4:,9X+OR#K/!LS;K+YXIW K4MR.T, 8$"1[;<#!LP^1K VH9D+
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M+,DS(84')66LQ*EC(@4/<.2!1@V<!8][N_@W;B6Q_NPC7;R!!14CFXGMT/\
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CMC>]K7ZM!O'A>S\3^<[N;_\ WO\ _6__ -Z&3?.]Z_@?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>g472601g74b95.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g74b95.jpg
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MI;6VM[C1V!HD,C@Y0E1Q<G9W@24S=861*$-(*3I28J&Q_\0 '0$!   ' 0$
M              $" P0%!@<("?_$ %X1  $# P(!!P,-"@H&"@,  P$" P0
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MH527U_-^LU7SD]24XI3BE.*4XI3BE.*4XI3BE9!T9L__ *;VO?\  XWF'/\
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MGL6CSZX0R9PN=5:Z31U?95'FY;XI22)K9(YM/A3\TIT B*10<\,8S\E5@M)
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M "H@_E=\Y51U?/\ J%4E]?S?K-5\Y/4E.*4XI3BE.*4XI3BE.*4XI60=&?\
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MM/<?"A4#_P!:CSYX=63MR<=F36+P95H?7K#:4:8NC[U,UK7<-0NVOTO%+I-
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MP%/)[ _4R+_$39]&XR>\^)I@=P\!3R>P/U,B_P 1-GT;C)[SXFF!W#P%/)[
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M.;Y:H5+MLP=9FU*Z:[A32]Q20IT)FSPJ8_%F?RN#'$FN#?*6]">!4HC!S@G
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MM).>!)X5C[GR%\J-KB.S7M.JD,L(*W4P)MNG/A"1DE,6+*<E.X&3AEEP@#)
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M:8;:BIF4\^P92RZVF+)7%<#26HCREI*VUJ#[R8[ 2G:IP*.!1;LB5R76#)6
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M<+VXW)AM2FVII/26T*4E#@!(JDG3M@2T&$V2TI83;';*&4V^*&Q9WU!;]K"
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M"'&,8QC&,8QCLQC&/1C&,8]&,8QZ,8Q[G-?)))).2>))XDD]9)K-@8X#@!P
M'97GBE91TZ?NN;__ /72H/ZK=.<^H7J=/P.Z1_\ 7_\ FF^5\W?5 ?A8U/\
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MN561;6M#*GS.P5?A[M;%N#ADKD\.3":C:W79BR:0NT3=V5U A62DE"G3EE+
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M0L,(C"UP>1K&]TDSJG!,4D]0(Z^WR?+PS4$K2DJRH+)"..TCB"<XX#.W@05
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ME!"5*(0DK60D$X2A(*E*.,)2D$J. !DUC4C<I*<@;B!E1"4C)QE2CP2!VD\
M.)K;H'HXV!)Y!6A=,[-:Z7A6TOEM]P:=73!3K/+KRJ7[6"$-UCW4X.!SU7C>
M]V#"6F'.:1QATWJUIE[-/5)J=O9A%GKVW*W G4#3:7ND0ID9YMN*ZU&=#///
MIFNEF,D!+I2RZIQ)#C3Y;6UQ*NHXRWK0XM37,R8[S:UR$+>1SO-M*BMAUXDE
ML*<0$'*%M!:7#P3UC.O[8K7I11-T'4ZP3^,78>H11-<POU=M4R0GN9LQ;43@
MW1IU@\TCD:G\1GS>>N+9W^"22.(9 TO(,HQ)SPFICC\K$EB5'Z0II<8 N!27
M5-D#FU$%:76UK:<:4!N0ZA90I/'(XU82(Y8>YE+B7R0@I4V%@G> 0DH6E+B'
M!G"D*2% \.-6!KSI@[<2"X$M46[6LDU83):JG5]3*P=C8E,X!$(32-8HBED^
ML5P"*.K7YY1Q\Q4W,@V>-M#J]&R=Y9F(Y&D/79-)M';U;T1R^P\B:2^U%;:A
MN-NN.R7SAIE/NPA)6 I6Y:DIV)4H$XP;ANV2U.\TZTJ* TX^MR0A;:$,-#+C
MA]R5$)R$[4I*MRDIP,UG:;IH))O)'%+0&V] ;"0TK5G83:)NDD%#-&V5E-NN
M+2I<9=7<VJ"4L#19E<S20FI\%04R4,1,?ER(\#JR.RQ,G< (J?KP6T),J!*B
M.&=$A%#O-EO,Q02V\W(0I3+S:,Y=V+*VR-JT@D9G%MWJ5S$N/(0(LB4%-[PO
M$<96VME:4NMK5U(W)VK'%*B,XQV)],VV);5M!3])*X\BDFRE7;?V/5M8N+3(
M$<K=5FFXR7&;0I0)2C)2$R*8Q)-(I#!0DY4$.2EE(8E(DJQX2&ES+O,=#\ID
MH640WK>R^\"@M@7'(:<&#G8VX4H=SC:%%0R$D5!-L=4S'<"TA4EJ8XTT0H+)
MAX+B#PQN6C<MOKSMVG!4#4I="G_2>:^_^E7+_0G87+35G^P)WRQ?ZXQ5?3_^
MUHWR/_U=VOZN/.)5T^G%*TB]5"CY/L)75S5[ U"!-8R5765@UJ8Z&X3MA]@U
M2ZP>R8DUN2K.>Y1MS^\19-'W!<+ L($3J>L[D62,8Y:76VL7FSW*T22H1KK;
MYMND%&-X8FQW8SNW/#=S;BMN>&<9J[M5R>L]WMUVCA)?MD^)/9"N*2[$>;?;
MW#M3O;&1VCM%=;>Q]@:R=;1UQFLKD+33]D4U8$B8;:I:Y7MHK:?0YILN#NT-
M>'#""8+&8J0(8S(Q1MSP_1L;HS/$6RXNS6M-*P$L7SP')=KC24+E%T?.T]=I
MS%ZM4-^S7JSVV;=($Z7I^\1[G%9*H#,E<55Q@B<RVQ+#3C<WH[2T[5!RO?'M
MD:-U3+T'JJ#?K7#>M-RE-7:T76XP[;.AQ+[:W[=)="9KT=,D6^88;KCL8NMK
MB"0X@[DE%0S*:\U_L\N2([<WWU]DZ4%8SNL*[71MRJ*#O3(BF\L:)EXP37+-
M.\L,N=V)R8&5,A1LC#"F500F6+C4)3JYG*R<I;[WK/3ZH#NFN1S6D!PW^SW^
M]LSH^I;M%E.VFVR;7T*U"5:!,ML:6Q-E+>=ES+K*0I;32751V$MJL)UITC?$
MS6M0\JVD9S8L=TL=G=A/Z?M<F*W<[A'N73+D8UUZ+<)$5Z)&0TW&BVR,M*'7
M5-!]]3B9QK)]UNCT9O%-9FXNO\YF6P[DX*[#DD<GU?0EM)0GP=MKYN:XXR'3
MJ2FH -K"VX-"K5.BTX]Q5J#A! 2$D@&HZ@B:ZFW#2+E@Y,-:6BUZ)88;LD&=
M9KU=9"W479^]/R)TM%H@H>+\Q\IYMN.TA##:$94HJ6=HLDO1D2%JA%ZY1=)7
M2Y:O>=<N\V'=K1;&4M*MC-H98AQE72:IH,1&0H../NJ6\XM6 D)0*[1*EM5$
M$!E<+ENZVO#BO50F 0>"3&*R^(,DABI=92--+HM)'0R3VY.2GAU\8&QF4KF5
MGQ%HD%.C7)VYF0B>51I.[W+5?*([>+==+9R4ZV89;NMYNUXM=QM=RE0;@J_P
M7+9<($=,#35I5&C]"?DMM2Y7KA<BMUI3\IT16TJTZ!IO0;5JGVVX<IFD7G7+
M9:+7:KC N-NC3(";'-1<($U]4[4%T3(D=+8CN.QHW0+>$MNH8BM=)6I,@3(N
MO;;@5DQ2X^HS0,H6SHJKV]K2L3Q7L=KV+MM<V$S3U6L!!C+6=3':43(UI$VN
M[X?($H$B0Y,F3H#T+<G1CPMK-ZTU>;%<=+\A^L[>U:#J!Z0[+BWJ;>[A(OMD
MEV9IHW9.G8Z8UOM:9(?BQ$0W%..(<<6\EY];HR]R%GU!:KS U'RQ:3G.W1-C
M981%DVB':(+%FN\:[.."UJO\@R)UQ4P69$I<Q ;;4A"&E-,H;.4/L@H"$V)8
M=PT1L[JU%I),(#65>-<13RFITC"V9CEBJ7N1R1P/*G;4D5A<XT]N" \!39[)
M-@$('% "0K@)&,['PX6LKM8[)IC6&@>4*X0;7>;_ 'N1<EV[4;DM\3K(B)!@
ML)59Y+K9CSXK+R"I_F'RZ6'C":4Y+1?2IFDK;>+OJ+2VN-"P9MQM-DL[%O3.
ML"(K'0[RN3,FO*3=8[;@>A27FEA+//,!H/-"8Z&XJN8VKD],[$LD/BT=WCUO
M@,49W_+_ #2+O<B@\Y9+)RA&C/CS))$R.V84:9&6Y82J7N; >>M;Y"I&W>R)
M7@[9WA5;<G5OU1HB7=+A.Y)-=WBY2H8AVJX0X%VM,NQ!X.IFRX+CNG;HE,]]
MI3;+$Q"&GX38?+"M[^]NXUY.TWK"+;H,/E0T;:8$>7TNY09,RUW2->>:+2H<
M:8AN_P!L483+B7'7XBENLS%EGGD[&-CF(V2IK*U"XDQ2OJ ZT&PI#BL%\H96
M[-4MCJBDE:R)))#'FH9 GLK*VM03!0W-J)Y2N09N<VHD6"F9<G)4')^9.Q(O
MVG57*7;N1C7J;J[[(&;?*?&HGX[T"_0G8(BZFAKL7-7U5L0^^[$<8]:D/.NE
M4IIQ2$+K'WI=COR;?%G\K6BE6QKUD>G1F38&)#4VRS&YIDZ>EHO7.65-Q6RP
MU);?%S4PTUB,ZE*UHK/;IF=*S>?PZUJLW:UQK:?1B&S:NE"R12>O+!9%T3G)
M[(M5G)V;-BQGP.1,;FPHG)G6FJUK:I'@Q"\-2Y"/)>,-I2UZKM%FN>G=1<E&
MN;[9I]TM5\0W!M][LTMFY6A$III*Y7K)/#L*5'F.L264MM/H&'8TAIT;JRVI
M;GIJYW:W7ZQ<INC;+=H-MN=G6[,G6>[QG8%T5&=<4B/Z\0>;F17XC3\=U3CC
M*R"U(8=:414?2(RMDLGFLHJ;J-4= G.WXC"HY<+L[/53R)\>7V%1H$12V-"%
M3//H>W068.#" *944F:7%B3K )G)O;4AR%,4'-0A?7;?:K?J3D.U=>6-,W*Z
MSM,1HT34<*)&B76>;DY8[LB59[F_=[8S,)6TI<EF6MLN,//N)=<4<1,5943K
ME.L'+%I>TOZAM]LA:BD/R;!,E295LA"WHO-L7'NUN9M5Q>B#8XE$=Z*AT(>9
M8;4TA(_<@B>GTE,V75/FV>N\B<[[JR)UPQ2"62^KI%)*]61>LWFO?&_+PIF9
M1S^\.BER3259X""+&>'( E85"&86K30AW'E-@C03<3DWUO!CZ-U#<KY,A6VV
M:@A0;TU<+_%O?K8(K=K4B'&CML.0&N>-P3S3Q5S8 4VN,N!R=S%:V<DZ_P!'
MS']66.!9HLN?<;',FVAR#9)%H]<.D+N252Y#ZWD37.:$$\ZT$\X20XCZJ[N&
MA*_N1UE2NZZ_EJ&#:^TWKC7K9 9&QSF:VH\L1[S*9(YQ: 0AUD\G6Y4K'6-1
M]J0ITJL0G9.])^_Y)3X5'SW'1NN]3Z?@6*VZ+U"S<=0:YU+K.Y(GVR? A69N
M>F+;;="DW*X1840.!$>;+>5N2HL.1%!O>YS29(.K-%Z<ODV]3]76%V!8]&Z>
MTG 7"N4&;+NSD)4FX3Y<>WP)4N4&]S\**TDA20^B4DN!+?.*WA]/2H)_ Z_L
M^TK8CRJ&V)LE::FUEL%<1$B>8##4$1BE>UM$9'X,,Q."4)H=#F]YDR8HP>&Q
M[?5K*,63&P><^[N3O2?L'T78-+EY,AVUPU)DOH"@V[,E2'ITU;04 H,F9*?Y
MG> OFMF\!60/$G*!JGV9ZPO>I TIAJXR4]'9605MQ(K#4.&EW:2GG1%CLAW8
M2CG-VTE.#6P+FZ5IM.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4
MXI3BE.*4XI71QZSVO=G:R]0O.VHXDND-16).*[LV-R$*8XYA+ED121P$@K^0
MN)9)A#8[*7&-'N;:0J" +C'W0@: 2T]M=P(^L:6FQYUG%NYP(DL-O,.-Y 66
MG%+*'D))RI(2O:K'O5I.[:%(SH-]C.Q;D9FPJ9=6VZA6/<[T!.YI1Z@<HR,C
MBD\,D*QG(.H!KCK;O=LQ<@9YM+-(])]VVC?>G!:S7TUM%36HT3?+A;#=3&P%
M?K7$Q@0*20S9#"Y^_DIWV=Q4*2;UN[Q8!P5)9,_K5,EVR%'YJ"VI%M5:Y'38
MI5(84V!',B*ZD%1'WLN,H)2TO+3R5X(J7I\9B=)>YR4M*IHGM=&? 9=#GWX,
MOMD@ C>&W%#*TX6T4@YK5SG;F.K=4]M*,6PE0U2O9#:&H=@6E3'0($L'B#7
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MAQ2VHK24E\K2@Y3'/N1S:MQ[.&,YJQ%B=.K9JJ9)7<:GG4 U)CSU:4=B\SB
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M<M?ZNN5SN5T%]NEN<NLZ3<9,6TW&X0(*9,M9<?4Q%:E;6PM9R>*E'^,HFL?
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M[C&%*\PHLGNL9#V:3K"U6^Y\G7)JUHR%>ID5$OE&F+3<68BKF&("K))GOO\
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M?.=+CKBN"4)P$MLM('N6F&6PEIEI/N6VT)2.K)MIS.5A*<4IQ2NHSU>>BI+
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M#@A2-3CLR8?GN\G8[.Z$+FC2'9:G1TIR0I]D):'2%NEUH-^];'.'>V$?Q4<
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M0X4.;F>' EKR\K<@"-P>G=2N=G W'?ERU0;G(\]A2E*$A*$A*4@ )2   !@
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MPK]%/SX2SJ8\2\NQ3 L5%KEC&4XK"V=6M)P'!*Q2V .PB/5%8 #!:@T@1I>
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MD2@0YK2_HSU]&N$B)X=%<9Q\V*REOZ"NDQ @'2*)K;+58$$9RBWYS<EM%JC
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M?<#*A0I4^.[$?=82MKI2DHBOOQXK,F7(CPVG5IBM->YVS<C@$$;BL$-\)B*
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M+G>%3!I:RLGN3I%I W-Q.#2R,G+EK2K3)"L''&%$DY,4&E@P:::667V]V88
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M %J'4NG "3?[* .))NL$  =9)Y^L;I\U-MSLY2154'!E5-ZVV&JN&U+<9_\
M&H,IFS)$)-&J_JN(28KOC5*Y(:\RSQJEH6,Y:BC3(PITS@N3NCRC2<]C^IEY
M+M16"XW'6>H[?(M"9%L7:K5 G-+CSG42),:3)FO17 EV,VD1&F8Z7T(<>#KS
M@;2VEI;ODSU1G*38+U;H&D+#.CW5;-P1<[G-AN)?ALJ88D1X\1J0V5-2'%&2
MXZ^65*0R6V4;U.*=0UW2.>PJ\F4XI6O>\?NHRC_V7^;K3RLCWH^?ZS5%?OC\
MWU"JJSBC:4LY<2YV33]6V$Y)B0IT[A.*_B<L7$$ [>Y))5OS0O/*)#W0NY+
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M*X211J.2]H5Q^61]DE#"X P6O9)$U('MH6@"+ @@5MKD0I1*0!%C L!.)'C
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M3R4V+'%!!Z<H\I2@<H_)4P2E&!%CPXH'9((G&$@3CI4$ ')QQJI(2KG2<<%
M$8\@ ^L5O-\29GZHR?X@=?HG)\CO'B*H8/<? T\29GZHR?X@=?HG&1WCQ%,'
MN/@:>),S]49/\0.OT3C([QXBF#W'P-/$F9^J,G^('7Z)QD=X\13![CX&GB3,
M_5&3_$#K]$XR.\>(I@]Q\#3Q)F?JC)_B!U^B<9'>/$4P>X^!IXDS/U1D_P 0
M.OT3C([QXBF#W'P-/$F9^J,G^('7Z)QD=X\13![CX&GB3,_5&3_$#K]$XR.\
M>(I@]Q\#3Q)F?JC)_B!U^B<9'>/$4P>X^!IXDS/U1D_Q Z_1.,CO'B*8/<?
MT\29GZHR?X@=?HG&1WCQ%,'N/@:>),S]49/\0.OT3C([QXBF#W'P-/$F9^J,
MG^('7Z)QD=X\13![CX&GB3,_5&3_ ! Z_1.,CO'B*8/<? T\29GZHR?X@=?H
MG&1WCQ%,'N/@:>),S]49/\0.OT3C([QXBF#W'P-/$F9^J,G^('7Z)QD=X\13
M![CX&GB3,_5&3_$#K]$XR.\>(I@]Q\#3Q)F?JC)_B!U^B<9'>/$4P>X^!IXD
MS/U1D_Q Z_1.,CO'B*8/<? T\29GZHR?X@=?HG&1WCQ%,'N/@:>),S]49/\
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M43\=I_\ 2+_[E3SQ>YOP>E.?ES.W]T?C[J3DQ^#J3]$L_O\ 3[FGE$_':?\
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MX901!H@:A(E4]>X[4<*F[O&X/'CG)$2Y2M_1MK*!0=E,0L/4E'$EJ!)/5YR
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MTFK.-1.%K9;,5%W!F*D40@$T+41^RG!K:W!A/!(X[#'$;&2Y%/!K,X*F\UD
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M%2%+(9;CO#6$Z0@DD:>&]#+IC'FB<L"=L0KG-&]*7>.L:@*1M&>/N\G!X9
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M%G 0X#V8YYB6H*6M24!"5*4I*$DD(!)(0"<DA(X DDX''C7HA(*4I25%92D
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ME.E_LX]I_E0^(VHOH#E/;3Y.OCE8?IS=/;W:<^^.JKY3I?[./:?Y4/B-J+Z
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EXSKES;C34B6TR]'CL14NI0ZMEE$B0IUU:$H=<4T6=R&N<7__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>g472601g74m47.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g74m47.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[1QL4&AO=&]S:&]P(#,N,  X0DE-! 0
M     !<< 5H  QLE1QP!6@ #&R5'' (   (    X0DE-!"4      !#'71?E
M=+5N]=N^.93 Z7E<.$))300Z      #W    $     $       MP<FEN=$]U
M='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4
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M<P   !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
M    0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T
M=F)O;VP      $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,
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M;W @56YT1B-2;'0               !38VP@56YT1B-0<F- 60
M !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M          QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT
M;&]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #
MP     $  @/      0 ".$))300F       .             #^    X0DE-
M _(       H  /_______P  .$))300-       $    >#A"24T$&0
M!    !XX0DE- _,       D           $ .$))300*       !   X0DE-
M)Q        H  0         ".$))30/U      !( "]F9@ ! &QF9@ &
M   ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4    !
M "T    &       !.$))30/X      !P  #_________________________
M____ ^@     _____________________________P/H     /__________
M__________________\#Z     #_____________________________ ^@
M #A"24T$"       $     $   )    "0      X0DE-!!X       0
M.$))300:      ,U    !@             #V0  !7           0
M                   !              5P   #V0
M   !                         !     !        ;G5L;     (    &
M8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M    3&5F=&QO;F<          $)T;VUL;VYG   #V0    !29VAT;&]N9P
M!7     &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E    $@
M  =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R:6=I
M;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP
M965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,    !
M        4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M      !"=&]M;&]N9P   ]D     4F=H=&QO;F<   5P     W5R;%1%6%0
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M;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P
M   *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M    "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M    .$))3001       ! 0 X0DE-!!0       0    P.$))300,     !((
M     0   *    !Q   !X   T^   !'L !@  ?_8_^T #$%D;V)E7T--  +_
M[@ .061O8F4 9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5
M$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.
M#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,
M# P,# P,# P,# P,# S_P  1" !Q * # 2(  A$! Q$!_]T !  *_\0!/P
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M3__0]55;+S\?$CU22YWT6-$DCQ5E<GU;-K;UBS%O>&Y#F[J6'0.K:'%K6O\
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M<G^=]2RRR_>W^:L?Z?IY"Z3=U7]RW[\?_P DENZK^Y;]^-_>F_4?\Y=KV/\
MS4F#;U&[IALZG0W&S'"W?2QP<&ME_H>]KK&N=Z/I[_?]-.S_ ),Q_P"KC_\
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M^5?*R2?'9:=WZJ27RJDG+7ZJ27RJDDI__]DX0DE-!"$      %4    ! 0
M  \ 00!D &\ 8@!E "  4 !H &\ = !O ', : !O '     3 $$ 9 !O &(
M90 @ %  : !O '0 ;P!S &@ ;P!P "  0P!3 #8    ! #A"24T$(@     !
M+DU- "H    (  <!$@ #     0 !   !&@ %     0   &(!&P %     0
M &H!*  #     0 "   !,0 "    '@   '(!,@ "    %    )"':0 $
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M          #_X0$P34T *@    @ !P$2  ,    !      $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    >    <@$R  (    4
M    D(=I  0    !    I    -    /      0   \     !061O8F4@4&AO
M=&]S:&]P($-3-B H5VEN9&]W<RD ,C Q.#HP-CHP,R Q,#HR.3HT-0   Z !
M  ,    !__\  * "  0    !   %<* #  0    !   #V0         & 0,
M P    $ !@   1H !0    $   $> 1L !0    $   $F 2@  P    $  @
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MMAI.IL=.5[_/MTPB:T^_SQIOA#Y>5OAA$\=->&G;IJ_*%*C:WPMR^?+QMA$
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M)5A;)S<I7D]TB+M#6CE*\'AWT=V9,VR$,>*W_9?G2\%RUS\0))4H^IF<1U%
MW"H.67WE\CGR>;0W-9+->IL$N2F?*Q2)MK'1.AF0?I"G,U>F9#4)-?<[5'BS
MRV6^S+!3#G%HH-7B(,'H1&'NJ5-.!!;M@'=Y9>F6I'"W#N75DMJE!;*61C3K
M?LZ+/)FFS3DSU?T&!B[N:MWC*/JZY]I;5<TVP&_;K19[.@ SK9)6%HH*>J5#
M>=]-(OG_ -#TPJ+/E3LT\TL'IHB6G>6:=P)NZ(4U+N^QA^>XC$7%\:,E$H#6
M'.,/?W5F+!3)#VM-D\:K]@^3N5.DW>M,_-@*N#B<=U0K=41\._Y85X7?>&UU
MCGV%4M72)"GEX?43* +E+:J&\/NCZFDFX&A&GD<= (8T+^?/FD?',.Q$(,(0
M80@PA!A"#"$&$(,(08D9CF(1P(EHXO%N2-/O^^^+%K -DG Y,_<Q]T7K/]=*
M_7 WYTCP)-E7Y'PU%S;W>VV-5C8@*>[B3]Y[LH%*VM\#TYZ\QSPAX0VWMY?'
MI[=M#A$OXTY5>FD.LJVU[;;6UUO<$'X81';"'2X^_?0Z6\L(>?/OA;W!).NO
M.U^8N.X[80UAF$23PW_#1LF[X<0G36QL.\7^>E_#"(]D)KKW;_=A%1]H-2^;
M]NYG[^"CES!Y"^HZ[_-L(I\_O@V/O'[?CA#SY^Z"Q^U;GR\S?PO\<(9T\UI\
M(7BMMS[NX7MKUY6PA#>OS]Y^Z^$3V]GGSKR<FUC?8>Z_3"'+73V#C#,(FOCF
M],M3EEQ?-\X<"1KUZWMW?L[L(@^(T\^-7X "'7T"C8WY;'>XMX?).F$1#38W
M.U]M?;?GW[80A #?3NUU\0?9W;<L(G/SRR\Y>.0BQN!OIIR))UV^=L(B&* %
MK&_76^$3Q;CEY'FD!V&@\>9^Z_?O:VIPB(#IMT-SU%]/#2Q\_:B=:[\A[M("
M2>=^[SZ<_GIA#+=[?/G=0!-].M_GNM?PQ2KU3YY^$#0D ^?!ZQRG,GZ8[IMI
MZ=GI:_=[@=SIIL,42*6N27^VG?R.>57]\>2TGJ$'/ >RBC[3W1L).P\_O^?;
MC>/L'@?>#&!AV*(080@PA!A"#"$&$(,(080@PA!A"#"$&$(8TMP&^VGWC"$?
M/%_H@.>VPIUE^HN6*EP2=9^C,^3 S4.-U?W:G,-=D0N'MV2TEB\<,<F6'Q1#
M)I>[2'(5PD)QK>U5H,JRRT!AT@4ZZTT=PPH[Y?"/HO\ R:-F[+M!MZA=K0)D
MF[9<JW*00@N+/.3-(PS$J!!$M@ SG76*U,NF6&A[?+$WS&5I8-9WF2>)AFV7
MJ:2.8J\.,MR[+<HQ1I+L0F",L7%LYO,2F*,QJ'1)K#F;=^2S<83]%X&*GA37
M@YU?ELL5V6*4M)1-GS4UQ*W[\*DERHG/()Q5<".\6G:';#;SY3;7L]8ITZQ;
M-7',,A4JSXY&(()J"#@ZJ Y*4!V*0-U:D^L)>A-0!!I98D2K'$OR%09JV6\N
MT+;NK,+2UA)>%-E%P>$K#JT<GE:R&UGE9:LRKCP-USO294E24B4J4D,E#@+8
M?:*RH\>J4Y&@T^@1=<S9:=L[=UN4N]KOVA5/$D3)A7,EB60$,5EAIBQ!3BF;
M$?3?_H?&1$P#+W7*8B6"&D7K@VE]T9L>)98P*6)-EQZA;JW:J]=JT8/,R1$>
MD*UJ4S".,^D*T([%LJK%83,PA)*V( I1P"'+O1SES:/SB^7>S6N[MO[RNJTV
MB9:!8E/*5,4%K$N?](A"BD! PI*1U4CU6KK] PV%^F-E.?FO&.,0N$(,(080
M@PA!A"#"$&$(,(08D9CF/;".#$OY$\=[,CS(L,6;5^*S>2O8(O6?Z^5_:)/<
M7,:_(&PN?Q[O'X>W5(V.O>^7;W0X)!Y%/G^/E[<(.=^?GOX_?"$6!(Y73Y&_
M?WZ;>&$1"!5M@/._XX1+/EY^/D;H#KKW7]]L($-Y;CEGJ:^,-[_GE^.$2X]C
MBNFE>0;FU6A0!S-O;A$>.?+7+V\X>1:_.P&_>2#M:WE;"(AF^YM<W._SX??A
M$Y'L.7G+?P<0ZY%K::;>9UW\.?NPB//GS6$WU.E];=;]YV]_PPA"A5KC<=QU
M'N'CA#/S3SX06!!(N3WZGY[_ !TPAN\\/="I&G7B\-.7,Z^SRPA#2!L#?N'X
MZC")?+3C^[[S[(+=Q'CKT[@?OP@_'(\>_P UK#R2$BW0?.A&$1"$ IOMXC4Z
M^9U\<(1C_9\_#"'GV1D4>$@#ISY\O@,(>?C 5]PZCG;]OS;"'GS[>4,_JO\
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MT)NH[<!-K] =!IW7'?BQ:RUDG'@?8(O6?ZZ7^L(\$BQ2E7]( BXUV^&W+&J
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MC_$'O_JQJ:0%C%E4YU]XIY>-A&78/.OM^)<H7Y[7',Z^6W?B[%3Z<O.1AV@
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MG\(-L"1_)"8!QG4(;-\67OK6D7!=.S__ #EE[W]'5RWD\-T!JS6OEEOF+_\
M-<J__P#>/GQQ)VAVO'_P@KLG _\ J\]XB#=&SQ?^4TKA] NAA4U:K3LK+A,
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MG9M1:I2BBN]V8C>^^)@Y^R4SID05J5?7"D]-DFV@DN=0+DVO8J]_B<?3M]'
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M9PQ?2FD4X2Y.)-?T<@_ :,W&F^F4%) L5 "]D@W]NI/D,7B5?G5GSQB"%/3
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MM*)=I H$3)82E+@@D@AF.K_&/"SK3"1ZA,T?G7 '1]?V'KP^.,.*'3##&QN
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M+$,:AH^24?(O9I-Z6J_Y][WC/DVG%,0B?/7*F("W7,!0IE'Z0J*0WJJ#:/\
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M,,*!Q$6"?6OH#8A12#>Y).@ N.F*5+)24DT2Y SSH>-0!R?MBI54XW.(AB*
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M=/1,7XMV3%26SBTXW9D4DAJP2@D7%STW9Z[+XNN1=MFONT^DS!:&ET2DX9>
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MA!A"#"$&)&8YCVPC@1(W<W@=4$>VW_K8L6HM99IX&G,"+UG^OE?K@]U8\'P
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M ?(^"OA%/2(=G#COJYKKY$(M%A<VN0-C??GIT%OOM@017LY$>=YB4J=\V?\
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M%)=)B>#]V3&0-Z=ELF%"$0EM924/\'G:>7")):<1*&Z7MG,"KMV:K^B:+9K
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ML]TTV/OL;[QL';UB[/[^[=)A*B0>](/*P)2GX<OAMT:8YGVDZ";]W:<_-8P
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M7+X9LG"7GS)%5&NL+SD9NHU.,37$X5 8) &+_2^1:_T1F=RC3TZ/;6FJ9OS
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M,8V!R,C[XW"'8IA!A"#"$&$(,(080@PA!A"#"$&$(#L>7?TP&8UX;X1U[_\
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M^;O#MP\:82E(02%I4=2VNOB584666A:!-2I,P2V<]&%D. !0$@@O6E8^O/\
M)R^3^7>E@VCO?:*=9K+=UY7<N[9$V8I8F&7.0A:E]4$L"M026<$%@<Q9?DLS
MCR-G(IFB<I=6(1.4$#I#JAR@V^D,VT!BY=DW?(8MJA+6(RY%&Y;*A3R T6S2
MD,'M#!JDXV.Y[RD7G)1:4K<%$H+EH20D$I.;@5)!P@EZ:%GX/\J/R>3-C;XF
MV6R346VQ%2IUFM\A7]%B'T<S$QQI0$ $)PJ *@<TIV96FG5!9C@BXG6-SE&"
MNCC=[A\V1:+N<H1Z%/#,I:%_@<RLGJ'QIS?&*TH7Z-V>DAH@J4I)2"%9.T&R
M)0N;/5+EH">K5BI;U#;RESO\8U.ZKMVAO2U2Y%TR+5:$ST)DE,B6M80<3*FJ
MHS#)W%><59.$^QFM$S2L]UEFR?*J=F]22JZX7#*F1YS=%/D\S>XH<Q HM5-I
M#V/TV;*&23'RUA3*;T.B?2OQ<'B/,&KBQ;1!GJWHB;RF$S.M84.7885+2P0D
ML"HIS.M!0/EUB:NQ?)I=,R3(7T6VU]V=<B8A*2I=W6&6H(GKEOA1+G6E6!3/
MF@%3I17Z'W3Z&T=G%;G]%+L'9W4YK< A3DMT6P279;HIDM;$.C1W6A;NMBT6
MR4R4D,UM$%*U5SD2T]'+E^K)HA(]5((8!+<.-7W&.1+3.FI3,F+,Q9F*F*6I
M14LK42%$DU*R20MZ@DO6.>.1M8\];W/4W)OOI^S%D)=0=/,]H<:4WY:#*D4B
M6K$%*J4BN>GP/WQG3J/:+\[>./3N&FCY#2+D56=MS-LUR+V56=>;9)F68).F
MR!4G8O<$F:58S$9>F&#O2IOEAC]*A49A#RYQ&'O!8MFK,MG1Y8M"R:M&?%P+
M4#Z;%+3Z5)0H!:2NH4 0>J^1#$18M!*;/.*200*%-,/6&1!<%W[R(AQVC>="
M@%:*?9399ISG!E1OE9F#-W2>0<]M2\OE;8>R>9(I7-,C5'B,FRO4BI5.)C3'
M:42+5"I$L0:69@FA,7EQHU<F+W#_ ,N.CNW?&;>[9Y,Q"IA5)5THDK5(3,EG
MK+2I )2E09:D(*E!+*#@%LHIG3$*" )@*#,2)JDKR2H*8$I+I"E  J<9GG$L
M.SYJQDMD6&SA2G+]FYG.L-/YKS*SY3NB4)JQ/\9GZ#N$XRI3Z#3C/-&LM=39
MQ#U,%6J>23!79[F0/#O-<]ND!>&TP.+K,+1BXO#N[6YZ)Q(5,DA"A*2I>! 3
MU2HI"YJ4T0I1I4)>A9S%<I4JJ432H%9"<2BIF#E,LJJI*16A4SFNZJKM%:U9
MG*%YW.T1KG3N>:B1JAM&LD-#9'K'1V"1N,MG:7Y7S&2QF&E^'9@9 @[!]2R@
ML\4=JA*-.H]'XK!V#M$6]-'^?7I3=3Q#7)2/39T2IDF1+4E(F+GS%(60*F7T
M1Z-1:HF)*@ 2V()WQ:FJ6B9-6E2BA$I 4FM,?2CI  :*00DTKA<Z4K;JW,^8
M^8Z39AZRP--9I[><OO9<=EQ4QVJY!L]U>J'S!E[FB>LM;:,3-56 4>E%X5)F
M8F9)@B4'5,\QPN?H]+S1L]RZ0F(OKU,KXMEZ4B4%RT'HT]):K2G ;/+F"8!-
M ""M76EI H"D%G=J"+"C,*5J!4<,B2HJZ:8DI)225! ZJR_6ZQ2Y#9F-Y5DK
M[F)EC/5GED27*Z5AF:#9PGC+WD.IT].,Q3!#X9(U4JL4)R437#JIR7 '>(+A
M--(N^4TF?,G.T5?I>9NC=UB+@ZO#!:GIW]*TM(ERC9Y"BA ,D3+0MP"5(1-G
MC"HYK&-,I+*I5M8K6M8G31C4>D*)*:E@I2)1"@-#A*RX8C.II'TB]CS,\RSI
MV7V1V:YQF&.39-$>R_27$8Y,DRQ9_CL>C,0;L&Q;O\6C$4>'J(1%\;$ M7I[
M>&S9H0"I9QX+6 FTSPD  35@ !@*Z 4$>NSNJ3**BHDRTEZDFG?GJ_M>+*T*
M 3ZU^$+3MN-1MYVZ8\JB"4(WJ)'=]T2I+J?4H_\ 4_W]H>(8Y=@49A,[?_TJ
MT\(Y7'Z+X2.'Q'._(XWS:,8;BV=_*38K/W%4T]W=WTCFVR#_ (3;6@E_X<CB
M'"5A^_=2F^L3.TLN^W$GWC<>\\[VUV&.<H^LMHWS$\B2/<[U'PCHR?7G#@H^
M!\UR[XC+.]OK144TL/S%J5U_I0?SQSV^OYZ;,?K+]\;-=7\T+[8_\HV!CJ:G
MLW&K1)9'ZW^(G_,1UY=>HTQT::6G6AC_ $@/,4S;X1KZB0E)#T5\//.,@^T+
M;<.GW^WX8OG<,L-!QU[*[X'(\?.6<<ISM]+=]1;TR3[K"W6Y ']6*)#BVR=3
MB#G=73<-].#BD>.TEDF@'5(%:^=_+.-@)V%][8W<#J$ZO\(P<+BB$&$(,(08
M0@PA!A"#"$&$(,(080@PA&)M;T2[[<)^[ EDK/Z"O9Y^[,(J?[/PCZW':N=?
MK4R8?/\ 0S)X]UM.6_EL-Z'^!7-QLN[],-Y?LCUSOQ:R\IG^+SY,5_2C3.K<
MV=N?.D\P7+@S?J6TZKNQB,7JW*T5G#]'<!4_9-(Y IIFR?(Q!Z[M90?JXM8W
M'Z62U J:S/2%F\2U+,U3!-,(E-@]3A%ZLO>&CR1:!F);M'GM <@L+9)):L(+
MF-CJVNA'H7*48*X+9V.EUF(I5<:V1;&!MZ<=Y72H_8F3B_ H;+L-=(TR^%)_
M##965]M5GO:8,_L2)9T(% 5T+N#O (LE L /GOQEC&YPN$(,(080@PA!A"#"
M$&$(,(080@PA!B1F.8A'71(V<VG2X!Z6XP-?+V^6/-;2UCG=G#,I#>??%^S_
M %J>#D<VCPJ[%9U'MY7OIIO\^&K#X^WWQL*7PC<6?VB,=K===M-_?\3RTQ,2
M_E\_!FX>V'"PU4.EOO\ +E_5A$1KFK]3)=HY3&=ZHS06@@DDR^_1MY8,+%ZB
M#=@$,H;"'-)T6^QJ)MG*$N:+W4\OC.Q&I%R6D++5=-6Y,=>+=[Q"E%.3N2/&
MI56E Z@]':(HY>*<3%+,O1JI%4/0OM>:TO+G.E68EZ1HT_(K5N[I_-VFT$#<
M-&CC*E/H4V9P2'PQW;M6)?6;[%&Y+T^-58SMAEG!C4>NIW))T+)9-4B@:@ :
MN<>"T3749<OJ@,Q/6<84DU((/6<DG,DO4N=NS?.$M4_EN-SK.<680:6H$[J>
M'^)/0'H&9"D<#JQ9H(:O#Z]*6EFZ.K'B4M9 0CB5KF;DN*UWG> L]G0NU+7A
M)E J 2E1/7Q)(5D"P*L-'8%R<%?E\6/9:Z;3>5Z*E]#/2)<A2B"ZY)Q3$IEN
MSD$=8 '](Z4@U1S50JHD\1J8:99?*6L7I[;,4M9]G^387-4]1P.C%+FY/C4/
M;)HY0UDEBR9+<W,H>"[,+,R024I[3=GR+7(E)M5\&1/F3"%&1,<F0@I!Z-*E
M$K *L1]85),<!OG_ "M=O+&)MU[&7A:+HNM$L24R1/G%-H*2H=+A"B@I((0Z
MG4,+ A( &.7,W&9J06Z'ISAU/5.@0S2]P]G(T(A#J^,G<\;.[2"L7)Y*^'B1
M=2SPA2C8VOC-GY+MF%239K)9I%A!20DRESOI"6PDE4PM@J0 1ZW*.?S/\HGY
M4K=-2N^K?-O22E)9$V;,4$ 9CKNV/,@$%3#$[) B5F4I(SSH16,3]29_F*!5
MP0P;Q>8Z!3#-$3BLLSJS<W5;5ZB5&XA$FI9.4:0AFML\2>_ZO;-FII#5M#Q.
MZ/G3Y3_D=ORZK+.O"[+?,G6;I6$E++$I(!455!)<##4J ?,4,?I%_DC?Y8VR
M%I^;MB]KMG;JNRUV@S)*;TP($Z>I0 $I:RV%@GI$K2$K!))) $7EY"I(1!\C
M= ))F:!LTI>:9M(?,LOQQR+!#7\IO\781"&QF%O#)=DI"BP?W5NQ6MY4@-#Q
M(*0K 7%(5*N>RR6PD( GH+$F;O<]8,'8 I !%(H^5V]$7C\HM^6JQVI$^R*M
M"19YJ42B%2$#Z/HU!#@ *Z^$@*+%>)0C:F5:)OE*9XG/*5&W][?H3)\%8U-H
M)$8DU;/3\\46C,5;0=\DMN^-O6>GZEDS!$(#51](UEV+RZKA'";>6VR>C*A+
M#%W;]%ZU-0SZ;FIE&DXTI4""XF#Z1S0K <%B]'?0#+2)V@$Z@$@?U^.VM]K<
M]\>$)GOD,Z^_/PKPBO&DERPY&N[6AW?<T.U'JZ 'IKOISUQ7AF%P4YBE1XE]
M.5=(AT;][9>)?OC@12$0Z..#U"HS#'",0I^9^A?(=$G-VB$/>V7$E88O+F],
MVKL\,PI*%<#5FI/&D&W$G20%YD$$/6N0X\OA#$&PDU<TKE[&(#ZU'&/)L*6T
MU<X3&H$ZTZD9V@<R.[-TF*#.\I2^QA,>=6/I?1.T:AS*'I<XH[LO3MO1L7YB
MW9H],UX4CTB[U.HLIU'4%SX'NB63DPU>E*Z%F?=EK2D=,VHI2QJ_4O?F4D06
M'"B\5B\=I?#8([K@,!D^+QR6XQ*,0B$-EV"K<($MLJ7)ACL,=OI</>&3BSBS
MZW<F;N]M \)G$OK.3UV"B:DL0IG-<P#G5H%.5*)/5 R?#A.7 MP=P 13W3>7
MX"\M8JV>H)"'AM'7!G"HXU;PUS:M8S#&3-Y9,H=%5M&*E1%P9,GQ[9LW-\+9
MW0S>GE"682W:A5$2PX9"K/Q8O^[E6.$F3I10ZO[BB59;0Y16&.,%BCFF!PQ+
MK$H/"W9;G#(2_NX=0R?(9#G-HT=7%P>$-'5T=FBV#NR9LE*29<TJ:5%<CO$/
M909$CM!IED.3#.&HDJ3F3=D],Y2EEF\L'QSB+%X1 86ANQB$.AP@\/?F35+J
M&C-\<82!"W-Z0H-W6' .3!:'8>BP<[SW\7]M>=8,W$@YZ9,2[#)QK2L=S#8;
M#H.XNL+A$/<H5#'%BEW<H=#75@XN+F[H^PP=71U9LG=W8H_59,F:$)Y)&(@-
M"*!\F=AG2G-F%-8Y_K6T&Y'?>ZDBWO\ /;EBVH'%B%%)2X/:QIKG%!4$J<_D
MER>);0OQ]ASB&V7KA.8;.Y>X2*I4^/$-;*%,8-P^W4^!\,="VEPFZKBE-E8P
MXRI+2A2&R;"5JID7JY81SC8Y*CM)M8MG3\X <NJMZC,%^.ZHB9(6"E=BDD$7
MTZ6U\#O[^F.;R1B](4?M*<EO6;+@*-5@^4=$2A6.9U6!=+C4FI'<>W6(T3OK
MFCHJ-O[!:E  '8%4'MXZ;6M[L<]OL?RTV9+9+-'X]:O?76-FNM)&R%^$BHO&
M[VX]8[M[1)=(^T.02#[$H^.]L=&F)>=::930W8WW1KS X!O4W+6GG4P\ D7Y
MFP'<.[R\_/%WC[\M_G5HB.2Y)L]NU]O3"U^=M1]Q]N*)#BV2M74.SK>&9<UW
M1X[75 (T37CF?8>Z-@)V'A^S&[CU#S^$8.'8HA!A"#"$&$(,(080@PA!A"#"
M$&$(,(1B;?Q2QU2?N^?=@0Z5OEA/L^#^)TA%3O9^CAS;=JX4@J_A42987&JO
MT-REIW:GA!)MK<WMC8KS;T&Y]WHG)^M3O^[*D>R=^+67E,_Q??%4>5:>FM5>
MTSRW5@>8)1AIF8G:/3TZYQZ,R;1*L4KUJH3,D.IMF=A$4F^IDW36]O4EP23:
M<2_ LM=!99C2GI_:5MB\P1N:Y91 H>U@[C%,+'CBYZO">'M'LB-A]NG.9_BN
MK:T#D\@ 6&Y5KTMX8P]J ^<;"/S:5J3356))<N' !IQC0;[IMYL2IR,=DVC0
MH:$2[)(*2.-2^\-DT62XR$;]!A"#"$&$(,(080@PA!A"#"$&$(,(08D9CF/;
M".MBG\A:V_I)_P _;X8\UN_%)@T+5%6JG=[.+1Z;( 9Z0<F5[#'A+W(T&USW
M'F?<-.?B;XU>,_IRRA5VMH;Z^/+7X:80\^>RL(+J-CW$G;N\-KVV&#@>=T26
MT\6Y<==8A+G76F*PZ@-/7@*7#)_S&R$ZQAWXU(9O4,E!TC4]E@])*5LVSH7N
M7G5H\,&C-;-KZ%"3;[6)LR\,X,S*4[E]"_G+GG%( 6%DN,"3EQ(?0N^'4C-N
M$;M4 MJHE:R%D66LW(*R3=6J[ZJN5%1N=\;4DCHU@=4I*0EN(?B^9U C#374
M:9A27+Z%6$D.]0-<G,4L=H?4:(SE5B5Z,N;P\,Y9DV%.<RQ5RN4L8I-$>^D(
M=2],0>%NQA$'=PU=6JF98+>'[CM=B+?0WR5W)(L]@G7Q.4>FQ3,&%20LA E@
M G"ITN5,'&M2\?'?^4'M!;)FT]W[.(M,ST6SH0L2$E0053D*.*95BH@8<02,
MAN8]E1"AK&(N3KZ!T](IHEF6H/[JLJ42!PGB&@&AW ";G0VQE=HMH)MGE+6
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M(N$^M:Y-O5N18<CRV./5T+^J S USJ'#D=K!ZY9QDL"72DD)*JAVJ^[/0U[
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MJ#L[::0GUILU9_N"*B>=4Z>'S_COGKB1>%X'_D8\^F4 >7T)A\]W\,MF5_\
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MEA\(JQ(ISB[)OR_PL*_!B=0@L+P2%4(;_5VTH.TO01Y<9F<TBD@_40J( ;$
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MSY>G2>>!6_D[-W0T9S<_>J4]EM/>AM_.#I8-.M_1$]^GCIMB?F^[7?YYE?\
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M"V[C"H@]/2F+)K"Y$V64A:0DJ44CK(("@V)*BE1"%)Q#$%$$.YI$IFRUOA-
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M+8@[/D3E%0F)P@FF)2D)?4NH#O8[@[#//67^FOY"4-H$E\K>]0EQF:E+[6J
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M\\OK*:)*@2HS3F*O5+IO<7.;)5$=AS\UA;V\N+1X<7)\>F$^BSL)40E("%3
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MD*<842T +E3 E*&&*5CPO5R_2*Q8B2:!P !$]"FO6624+0"I3EIF$*9PP]4
M , 7S)KJV0>QFRD4]E&>9-A43JN^0ZHDEY@)&F5JWC4B051A69:F-":2U+>(
M1"9+IS*LL0%\5*F7>GJI>8P> .<(@L3,=>F<*;,8FS=7.M5KFK*5'"Z%2U"B
MC64J8M+XE$FLU3N22 *YO0)"$A0&)E!8.0HM* 6 #"B$LP;/?'4U [$[)]4:
M;FLYQF,UE=(H\SY.E1GMW<IIDY\<%S).\YT_GZ(MX<SF.GT>>974YS+3266S
MM$).>Y=CL0A*8A+,S1>8)9?5PA$HMDY"0D8&"0D.#DD*35E#%11]9P#4 &L2
MJS2U$DD^L5.% AU%))]4M5(J,*FH2H4B3DZ]GY0*?LHL=R5QY<]II'')CC4W
MB*PR:&<,J%!)FC-98A7;\MR[-CK"T?DB(0N?8DW;0AY8PY31UA26<.:EX!;-
MFUI,]:9HG##C  8ATD!'1L0]73GQJ&BM4I"I:D$=4DO7K X@IP=.L[4H*$F-
M"3;V.64F:ZSQ6MR(A5J5IBB$ 7+4.@LG35+D#@DJ0E67)_RM,W"4XDF2WB>X
M1!W*EC\E,+E7\]'B3H/,SNTF&$RZY/4:F=$=K%KFA E]4AW)()*CTG2DJZS$
ME3.6"B  ] U!L\LJQ]9R& 30!T='U>J<DZ/A"JI&;]-2_L8<L5%A+CU2FI&9
M"FT?A4;GE_F.9Z;U#E:F,5G^6ZBS!3.9YIIQ'G*FU/91EJ5*?OD;I+)[\RA5
M(8!3*)L'C\X6Z(T7B:YD;1.56R:MPM,M0(2 %)*@@I"P%)*U*)4RU?6%8RI0
M1";/+2!A*DD8G(4$E6(I)!8!DG#]AB#0,YQ>H@W9$98X/,D6F#\[:ZQ-V>IC
M<8_+DKQ:H$*>I7I\ZP_-A+6=)E+$D.;.4F#^XRZUKI+3.+/*8O$XW&FT"BL3
M@*HT'9G!VD(&US" &EA@Q(275]"9#FK/T9T #@%LWJ$A&(MC/6<!PP^EZ0L"
M';%O-!F1IY2D78L93Z(OKG%9#FRN3G&H;.E&9YAD:>9ID544=8M0J8*IQR3$
M/CRYTU<?SD+^[5EGV7IQC4W(F";9NA$38O<9F-XF=T93%@NV39CX@BH6DT4S
M3 @*9U4^K24A+!)# 8>K%*;.A!IB?J&I'V,1&20_KJ"L6)1WO6/0T=['[+#1
M:99 FB!SC7N9WRE3[0PTX<YYJ%"(]#I.EO+B]U?>:22'"&;"3X:\_F=+:*W3
MJZJ<WQ[>XH_L#"VCW&&CZ[O;V_%VN:L*!$L8^DQ%*2"HS<&-1J>L>C37G$ID
M(0005TZ-L1H @**0" [#&6%:-&U\IW9K9:<F%2:A5-HI#Y@<8I/KG&80QA$6
M$FKA4ER],,Y/,^1B79:?H%)D FZ*PY[F)L[-&;S42:)\C3A#H5"(-#(LY0EP
M9.9HFVF;.2E*R.JU0_6(3A!+D@$"G5"07)()B429<LDI=R[5# $DL&2^9KB)
M+  %FB?^/&6J1HYT:I(.=#I74,&B^-^H!/M&O8'KH&H\?,-VSE+X0TS30RK+
M26YT>ICB63F-TIA#O4C(?,6>C*G6-W7/LQQXT6=A2AO^F'+_ %LB#\_L'UK4
M*'+@D,B4M/D%9PR*+B4'?4,LI8E'HB@E+=.E9*9XL\]!PMCZ_P!'-EAJ)+L<
MV!$>*U)^DQ$*<RRD!4DSI:JO@ZAQ)5^E0$,!4$1IYXS"Y^Z=2I&J.&E&:>C$
M\35".QQBU"Z6TVI[66HE.Z04U<?S!ES-_)CE4U$+G)SEF%0,N<2ER?(;46=6
M\WMF3RR_*+Y&6R(G%DU]'9U$3,<E:1Z:)BUJEI4M76Z!6%TXL3NG G#P# ",
M<U(8)F()%E*4I2I24CJB:,;%F 4%8E/VN8\C1VET8IAVAM.X332ADXU+C3WV
MB56ZD3S(N8?)+/DBURR]0"HD5GMYGS,5)O:&4NF!SI35VDCU#XDP:RI)M18E
M-;69I:B\(EMXA#S'8<X?DF5J"[,K%,"1Z,A*3*GI4B:4!&&6JS+!6B90XE)"
M<*@^1<PA)$].%!5],M12N4H*0%8L2Q.3U%(+L <1(8$.&'V$@D?UG&'"V#')
MW;SEY%(R&%V.7#M[.?A0-"WV))O?NVY_-K8K"@0[MS/LX120QKNX\GIQWZ:$
MTAP(UTTZ$C4^8^[06Q+C>.\13EY\\X:!WI\S]UC?QN,'3O'>(E_CNKV0\@$#
M4"W?IWXE3) /5(-.J>!/GG$0PI _6'SX7/NQ2%#5A1\_#+SI$U+T.>ZCTJ&I
M5X-AH3Y'2WN-[]V)<;QWB'/SY\B!.XVZ?':_A:V)!!(#CO$#V\]YU\YQV#D4
M_3'87M^ZHW-M;\OPW\\>BSL)R*ANE0U=,6]X\MJ!-GF4>ART'=NS^%(]]C:(
MP$&$(,(080@PA!A"#"$&$(,(080@PA!A"#"$&$(,(080@PA!A"#"$&$(,(08
M0@PA!A"#"$&$(,(080CAQ'5Q>_\ XNU]R21[\6;1^+S_ .QF_P"!47[-^,2/
M[5'^(1KO&JQL0UY'3@_M$&$#F1Q/GP@PBH 8O[RO >>>L&$0FI\ZJ#P80R2E
MM7]N? \16#")85[?_6?<.Z#" J[UJGQ-?;!A$?9?5V[,^RNZ#"(TY$-P=_A!
MA$G[7-L]*T\!!A$D )!&9;V/!A%)S[!X@&#"!]8\S!A$IJH/Y81VKTP8I:*X
M4 :IT!(&J03H#8:],>N9*E]),&%@*L"0,AH"W9E'EE39G1IZV_0:$\(XRF3,
M V3^K?=72_7%GHT;LN*OC%P3%N!BU&Z,/ GI[S^.*5(2 2!6E7.A'&+KG/EX
M0<">GO/XXMX1NS_?#$<W\!'LW%P<ENCNM;LQ4I3)!4I2 221N3S.-CLUELZI
M,@JDH)5+022')) =S& GSIHG30)B@ M0 !(  + 1RQ#W$;.K$>" ,7S9+-3Z
M"7E^2-YBUT\[\XO]HPU3@YW3^]F.NGV =+C$IL=E+O(EYI^SO-8=/._.+_:,
M/^@.?][,M?\ !Q3Z)9OS$O\ 9$.GG?G%_M&$_)[E_>K'_(&'HEF_,2_V1#IY
MWYQ?[1@_)[E_>S'_ "!AZ)9OS$O]D0Z>=^<7^T87Z Y?WLR_R1AZ)9OS,O\
M9$.FF_G%_M&$$/<AL[,O\G$BR6:OT,N@IU>(AT\[\XOO,.2Y.B5!27=D% @@
LA.H(V/ERQ5Z/(201*0",)!PAP6!?OK$&=-((,Q9!S&(QRL78MP80@PA'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>g472601g76j74.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g76j74.jpg
M_]C_X  02D9)1@ ! 0(!>@%Z  #_X5QI:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z
M;65T82\B('@Z>&UP=&L](EA-4"!#;W)E(#4N,2XR(CX*(#QR9&8Z4D1&('AM
M;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN
M=&%X+6YS(R(^"B @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @
M('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O9&,O96QE;65N=',O,2XQ+R(*
M(" @('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+R(*
M(" @('AM;&YS.GAM<$=);6<](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N
M,"]G+VEM9R\B"B @("!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D;V)E+F-O
M;2]X87 O,2XP+VUM+R(*(" @('AM;&YS.G-T4F5F/2)H='1P.B\O;G,N861O
M8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V52968C(@H@(" @>&UL;G,Z
M<W1%=G0](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O
M=7)C945V96YT(R(*(" @('AM;&YS.FEL;'5S=')A=&]R/2)H='1P.B\O;G,N
M861O8F4N8V]M+VEL;'5S=')A=&]R+S$N,"\B"B @("!X;6QN<SIX;7!44&<]
M(FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]T+W!G+R(*(" @('AM;&YS
M.G-T1&EM/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O1&EM
M96YS:6]N<R,B"B @("!X;6QN<SIS=$9N=#TB:'1T<#HO+VYS+F%D;V)E+F-O
M;2]X87 O,2XP+W-4>7!E+T9O;G0C(@H@(" @>&UL;G,Z>&UP1STB:'1T<#HO
M+VYS+F%D;V)E+F-O;2]X87 O,2XP+V<O(@H@(" @>&UL;G,Z<&1F/2)H='1P
M.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O(@H@(" @>&UL;G,Z17AT96YS:7-&
M;VYT4V5N<V4](FAT=' Z+R]W=W<N97AT96YS:7,N8V]M+VUE=&$O1F]N=%-E
M;G-E+R(*(" @9&,Z9F]R;6%T/2)A<'!L:6-A=&EO;B]P;W-T<V-R:7!T(@H@
M("!X;7 Z365T861A=&%$871E/2(R,#$X+3 R+3 X5#$Y.C$Y.C$Y+3 W.C P
M(@H@("!X;7 Z36]D:69Y1&%T93TB,C Q."TP,BTP.%0Q.3HQ.3HQ.2TP-SHP
M,"(*(" @>&UP.D-R96%T941A=&4](C(P,3@M,#(M,#A4,3DZ,3DZ,3@M,#<Z
M,# B"B @('AM<#I#<F5A=&]R5&]O;#TB061O8F4@26QL=7-T<F%T;W(@0U,V
M("A7:6YD;W=S*2(*(" @>&UP34TZ26YS=&%N8V5)1#TB>&UP+FEI9#HP-#DY
M.$1!,C-&,$1%.#$Q044R-49$,C0T-3!#,48Y-2(*(" @>&UP34TZ1&]C=6UE
M;G1)1#TB>&UP+F1I9#HP-#DY.$1!,C-&,$1%.#$Q044R-49$,C0T-3!#,48Y
M-2(*(" @>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/2)U=6ED.C5$,C X.3(T
M.3-"1D1",3$Y,31!.#4Y,$0S,34P.$,X(@H@("!X;7!-33I296YD:71I;VY#
M;&%S<STB9&5F875L="(*(" @:6QL=7-T<F%T;W(Z4W1A<G1U<%!R;V9I;&4]
M(E!R:6YT(@H@("!X;7!44&<Z2&%S5FES:6)L94]V97)P<FEN=#TB5')U92(*
M(" @>&UP5%!G.DAA<U9I<VEB;&54<F%N<W!A<F5N8WD](D9A;'-E(@H@("!X
M;7!44&<Z3E!A9V5S/2(Q(@H@("!P9&8Z4')O9'5C97(](D%D;V)E(%!$1B!L
M:6)R87)Y(#$P+C Q(CX*(" @/&1C.G1I=&QE/@H@(" @/')D9CI!;'0^"B @
M(" @/')D9CIL:2!X;6PZ;&%N9STB>"UD969A=6QT(CY0<FEN=#PO<F1F.FQI
M/@H@(" @/"]R9&8Z06QT/@H@(" \+V1C.G1I=&QE/@H@(" \>&UP.E1H=6UB
M;F%I;',^"B @(" \<F1F.D%L=#X*(" @(" \<F1F.FQI"B @(" @('AM<$=)
M;6<Z=VED=&@](C(U-B(*(" @(" @>&UP1TEM9SIH96EG:'0](C$X."(*(" @
M(" @>&UP1TEM9SIF;W)M870](DI014<B"B @(" @('AM<$=);6<Z:6UA9V4]
M(B\Y:B\T04%14VM:2E)G04)!9T5!4T%"24%!1"\W44%S54=H=F1'.7IA1SEW
M241-=4U!0311:VQ.02LP04%!04%!0D%!4T%!04%!14$F(WA!.T%10DE!04%!
M05%!0B\K-$%$:T9K8C)*;$%'5$%!04%!068O8D%)44%"9U%%0D%514)G549"
M9VM'0E%92D-W9T="9V=,1$%O2T-W;TLF(WA!.T1"04U$07=-1$%W441!-%!%
M03A/1$)-5$9"451%>'=B1WAS8TAX.&9(>#AF2'@X9DAW14A"=V-.1$$P645"
M05E':%521E)O9DAX.&8F(WA!.TAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX
M.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9B\X04%%46=!=D%%
M04%W15(F(WA!.T%!25)!44U2068O14%A24%!04%(05%%0D%114%!04%!04%!
M04%!449!=TE'05%!2$-!:TM#=T5!06=)1$%114)!445!04%!04%!04$F(WA!
M.T%104-!=U%&0F=C24-1;TQ%04%#05%-1$%G44-"9V-$0D%)1T%N34)!9TU2
M0D%!1DE227A15D5'13)%:6-9155-<$=H0GA7>%%I4$(F(WA!.U5T2&A->%II
M.$-2>6=V16Q1>E)4:W%+>5DS4$-.55%N:S9/>DYH9%5:2%1$,'5)24IO34I#
M:&=::$I21E)Q4S!6=$Y62T)R>30O4$4F(WA!.S%/5#!:6%=&;&%7,7AD6&PY
M5UHR:'!A;71S8E<U=EDS4C%D;F0T95AP-V9(,2MF,T]%:%EA2&E);4MI-'E.
M:F\K0VLU4U9L<&59;5HF(WA!.W%B;DHR96XU2VIP2U=M<#9I<'%Q=7-R839V
M;U)!04E#05%)1$)1545"45E%0T%-1&)114%!:$5$0D-%4TU514954DYH26=:
M>&=:17DF(WA!.V]B2'=&34A2-%-.0T962FEC=D5Z2D121&=H85-5>5=I63=,
M0T(S4%-.94I%9WAD56MW9TI#:&=:2FI:1D=I9&MD1E4S.'%/>G=Y9W F(WA!
M.S K4'IH2E-K=$U453504FQD65=6<&)81C%E6#%2;%IM9&]A5W!R8D<Q=6(R
M4C%D;F0T95AP-V9(,2MF,T]%:%EA2&E);4MI-'E.:F\F(WA!.RM$;$I75VPU
M:5IM<'5C;EHV9FMQ3VMP86%N<4MM<7$V>71R<2MV+V%!07=$05%!0T5135)!
M1#A!.54T<3=&6%EQ-T9867$W1EA9<3<F(WA!.T951'(P8VMU:#9J2$=P95(W
M5UI54E%3>DU9>4%!0C%*>%8U4#51+TQF4TID83AO='$O;&$S:VA(;$-.3E1A
M-W-%2R]P0D=S,59:+U4F(WA!.VIP.5E6031(3#1Q5CDX5EI2*U1V;&$P,%11
M<C4O=T)%4C9:97HV;&9H;2MR<F)Y=F)R95,O5G=4>%9M:D5:2' Y=5!48D97
M9EEQ-T8F(WA!.UA9<3=&6%EQ-T9867$W1EAH,G)A,RMD:U(Q3S1T2G1226HO
M4SAT;F%R<'-$3"]O9#1I5U53+S9/6%E4=W5X*S%Y64-Q;G%C2W0V1BLF(WA!
M.UAL<F-V-4AF5G9,2U1U3E8Q,SE,=&1726,O5C)A*V4R*W-M4D0K-TQU:E(X
M.7%K161S0W-T+TQJ>5IP96HK869..3-$;U5';E8Q0EDF(WA!.SE-=45T56<O
M,%9R4T%U<T1H1B]D1U5.54HX4$MV9D98;V5+=7A6,DMU>%8R2W5X5C)+=7A6
M,DMU>%8R2W5X5C)+<%A0-6TP841864XF(WA!.T1K;&M';S-!0FE1451.1E5O
M-VA7;D-'1EA+475W4FY$141P:7%A67$W1EA9<3=&6%EQ-T9867$W1EA9<3=&
M6%EQ-T9867$W1EA9<3<F(WA!.T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&
M6%EQ-T9867$W1EA9<6ML>C55=%HO36M'=71D,TMT0GAB-F=P:2MR4$Q(2$Q%
M:W)6:DTF(WA!.W9*575'1D9K0SE+:F)&57I30T)P6FDP86LX*W!!4#=#-'%Q
M9E9R8B]!2#!N+T%J1EAL2"]!1&MG.35A*U-T3D]M4U!A,U4R<E%1:#0F(WA!
M.T=-5$U'9VXK17-P6%EK1$PX2$YH4&LX2S%,4F9Z3#!Y4U=054Y43G)*1D=:
M4VMU<U=Q;&Q6,VIB,'=B;CDT>79%-FQ5<5%W;U)836<F(WA!.T=*+W-A.3!B
M2#55+TUI5WIV-W5,5VUL=#E/=%DW>6532SAM:U%R2VMK9U)85&MN3&I#*S59
M251247A:;$)E2U!C;6EM1VTR4&Y(>3DF(WA!.S5W:S!F5DY5;FYU:&%E;U5%
M;#)&5FUL5F%!,T-1.'5N,C U26$W360X,#-B:R\X04)W63=E;V9P9'@R2$%(
M3U),8V-*+U%Z;38P,WHF(WA!.V9A3S!D,60K9WEQ5W!*9G=R5VI-:D)A>2]%
M5EI#0T)U3RMC=E!(<4EM:DMV.#AF<F5N:&LP,'AC63,O;4@O:69.15%A1C5R
M;C5'4%4F(WA!.U-Y<F%I.$Q,4$LV:%=,04IY44U/6#=T="]S+S575&IH>FYL
M3"M'*UHO2%0S96)83%!P-#@T9GAC4#!J>2]8-R]!0U10>6I"<49T-7HF(WA!
M.S!I0S4Q15@X1C-&3$U%5C5M6&=96D-N3DIL:D\Y3U$R.$1M4F]U3T]O9T10
M:4)"4$TY>#<V8V)8*TA,5%1):'=M2D$U4C=X,U<Y8BLF(WA!.W)7,RLK:R\T
M15HP-WEB=G$Q="]V<% X06=2:7)V<3%T+W9P4"M"1TMU*W)7,RLK:R]W0T)'
M2W9M9C@Q.4\X-V%R*V%U<S)(;'EE65(F(WA!.S)S5FUZ44ID<F%O=G%X4DEO
M55-34DM795)W07$W:VY->D=126DR<58S<W=I=S W>C-E4W=2<G)Y26)I3G!9
M=V18:6MC0E8U.%=I:&TF(WA!.VQM5CDO<VQ+*U!1,'-*:C-F67A&<'1O,VMZ
M.'AD64=M1WDX=W$O-E5H:VYH<&4S1&-04TU16D@Y3E@K2697135C3U%4-'5:
M6&<O1THF(WA!.VQ%9$5G2'94-SAU:C5Q,5A3:$1B6&LP.7A%6DAL6C=R:4])
M;$5D96-J<41U=T$S>FLK,30U6F%K>'AN*T5(;E0Q;EI*=W@P=VQK02LF(WA!
M.V]J;&8V0WE7,3 O>E!C6&QV869P1EDU8FU14DM'=F]Y5F,Y;E)*2&M8=RMZ
M,7I6=VAM;$E2-'5F.5 X06)B<S5Z,#A9;5A"64%V-E F(WA!.S!K5CEQ=EHV
M2C5R=6)E,W5$<41143-0<6-';&UL1D9J2T1K=U5-44=-:6AF=C9B-4M'3%!)
M03A603,Q4&PK=&AK>F%E2DDT05-+-5(F(WA!.TA7+S%B<S0O2W1:-61-,4),
M-6I03D1D1TUM52MO4GA15D%,5C<U=4]X-5--2F-2<VE4<$\R-'=%-&U)04)I
M>F8V=&)F-S94+T%)15HF(WA!.W5(4TYP1$-H<6MA<69%041&5BM+=7A6,DMU
M>%8R2W5X5C)+=7A6,DMU>%94:2]V2G8Y8V8X45A&5E1&6&M(+T]4,'-K4&M4
M5$IO>G@F(WA!.VMJ,6E",&)9,%IB931)3RM8-F8V=F=W>6-N>G9C*V9F3U9W
M<F\R<UA556-Q4U)Z4C(W;3-34DI:6EHS5U)99E16=UI,:5$O140Y<6XF(WA!
M.U1B37)G2&,Q8U)5-U1Z;C5L=$QE4S)T-S!P1$Q!='%Y*VY%85)+:GA$:5-P
M2TXV8S!I8S%O,T9I2S!*=VU)6&E,269,2&UB5SEC.'DF(WA!.VTW,5,U.64T
M:'185TYH2$A'0GEN17)(:D=Q2U=A4C)D;4EQ>D5K,4]A3'0X8T]N,B]N1#E,
M=D]W3CE18B]M;CE$,$MB>E(U:&Q,:S,F(WA!.S@P9G%&>DE)5SE)3C9J=$DS
M25(X43-X4TUD+TA/4D]R>6XK23<Y,C-N,#DW,7-D2&A(.$DR-SDK5S-8,TQ,
M9GI$<D9U1D5-+T5*14PF(WA!.V1!56IA:V%S>DQ4:W K249Z4G9T1'AW4C%-
M-#AJ,'(X9G(U<&YP8V-U638S,2](=S5*-2M8.3-C6&9N>E1P<F@K8VY'4DLP
M02M'3S$F(WA!.V1&1D%!3FQ51$UZ<S):;'%9:R]J,&QW=3%-66AP6D%C='9T
M:TAT*V1C.%4W1EA9<3=&6'EN*V10;5!79$0O3GI72G1,=5!Q.&I$5#4F(WA!
M.T=B9VHO1F)X=WIX1VIQ,S):154K+V9B33-&14=/-U1-,%AN;BM,=DTU*W%#
M5%9,;5I,06-B1T=A5G!O;U%5.4]K8V-H6D9(1#1D:# F(WA!.WDS:$1(:4M9
M5VXU:RMD3%)B6EE.44%7,&I%35%E0S-K0E)F5#1E<'IJ8C%'5#9V2'=:-FQE
M2SA32UE$:D,X4EIH*UAU<F%H86%*-C@F(WA!.T5X5U<T36EZ3U%R1F@V=VLS
M-4$O=&]$;D=D=5I:43%*-&5S4BMT-U1S6$9(2G!H>$,V:V8Q9G!:269-5W5T
M3D)-.3E.23%T2THW9$@F(WA!.V-V1VMI;7%S<V)6454K5V%F.'IK<TAI3WAS
M9C)/,B]+67%)-%)U2U!U.2].5W0O3G9M3T-+2T9,-E)O64-41D9+1FQ687%&
M<'AK1$,F(WA!.V=#:FE/:3EQ6DM/<WEG06-7=RM0,R]G35IA2$1):SA/-3=T
M=G4O0C9V4B]Y960U3D@Q0C-*6C-U:7I-97!*4E-4;3DW14YW;"]7960F(WA!
M.S=F1EI):BMJ*VQN,F)T,$QS5F1I<G-69&ER<U9D:7)S5F5"835Q5#-V-6XS
M;C$K-71R=35T8GDQ=&)7>2MR-C!':E)::48Y3#!:230F(WA!.U,Q1T1/5TA%
M;F1A9S1692LT1F1I<G-6531V-WEB+UA(+T5&>%95>%8T-R]Z;$HO-4PO5"]!
M4'1R42\X055.8UIF<"]Q83AN2CAU6FTF(WA!.TY,<U9:4#A!;#<O>#)P=BM9
M6G8K5&E:;W9A2"]!0F8O041H*VPS=G,Y+VI(*V%F,%!1<S1H-V0R2W-N+T%#
M,"\U5&)49BME,R]*:50F(WA!.TYH,E8O:D5F:CEX9&(R>"]I,'9H+W5G.3%Z
M<UAH,UEQ-T9867$K468K8VA0+TIR870O>&IT9CA!<4=J>D]W9E,P6D]B>FI,
M5T1S5F4F(WA!.VPK4U K565G+W="950O:5IZ:'9A1"]'9C@P4&1D9V8T<U!E
M52MZ4T\V9&ER,7HX;2]W1&II6#,O041%+SAY,7IP=7<O-W58=F55.6\F(WA!
M.U W,E Y6#E,,$1.,C9",DMU>%8R2W5X5C)+=7A6,DMV1790;W5&+TY0-GDX
M079.3FA/;DID6&-N,3,P=%!A4U1J1W)E:&-13"LY6C8F(WA!.R]W0C(T2#=8
M531693(T1E%E<F$Q;RMJ,G8Q=E8W*S,P-C U0E!R1C-+:T5F2G$P6&Y)5E=P
M<#!X5C!M=&%.2'%51VQY6#EU;7 S4T<F(WA!.U<R<U=L451Y4G)5;#!I2C5S
M;S1N8T1T:7%):2]V2G8Y8V8X045&>%95>%8T-R]Z;$HO-4PO5"\K,G1$+T%.
M43%X;"MN*W!R>6-N>34F(WA!.VU9,'5X5FLO-64O.&1Q8B]!2FAM+W=#5&E:
M;W9A2"]&+W=$3T@V6&4K>C,K368U<"]1.4-Z:4AT,UEQ>68X=% K53(P,R]N
M="]W06TF(WA!.TI-,DA:6"M-4BM0,T8Q=F)(*TQ3*T@K-D0S6$]X94AD:7)S
M5F1I<C5"+S5Y12\X04IR870O=T%9-U@O<4=J>D]W9E,P6D]B>FI,5T0F(WA!
M.W-696PK4U K565G+S$U4"M*;D]'.6]0.%HO>E$Y,3)"+VEW.354-TY)-W R
M2W984'EB+S0T;#DO>D4O.'DQ>G!U=R\W=5AV954Y;U F(WA!.S<R4#E8.4PP
M1$XR-D(R2W5X5C)+=7A6,DMU>%8R2W9%9%4Q85<K+TUU26%H;U=L,V0U8EAG
M:'0W,C!E83EK5TM+62MK,7I$8E-->7DF(WA!.TEV>$%Y=S!1.3A+=F)S0W-9
M.#(K5$IT85I,;7<Q0G)(545,3'IU4%AU-U@P-4QE83)90WI&>$)%<CAB9VM3
M3%)Q:F5O,GA66F$K5$PF(WA!.RM$>DI:87@K:VQ63%=$-G!.0D5L,&AN9VE-
M=C%:2D%B=#=9*VUS,5,S,69K6'%Y;$%E259:1DA'-6QN26Q99D=.9T8O:UAX
M6$965# F(WA!.W!0.$%F>B]C;B].3TMV2'8K8V]56F9)1VYK>4TO=T1U5F@R
M4$@O;&UU4$%$3#E0.518:S50;"]->'!D:7)*+WDY+S0W53,O34TS+THF(WA!
M.WA-,%AT1"]I+W=$;D0Y3'9F6C<O04)J+T%$5"MH-D9N15!B=7A6:S,U8D%N
M>G)P=T1&5"LK,T9++W=">$HT,7I99&QF-'A(-"]C6%<F(WA!.SES9C1T3#1F
M-V]08W93:R\S."\S2B]Z5&Y9=D1U.4M4+V9Z+T%(2B]Z5&ER=E-K+S,X+S-*
M+WI4:7)V4VLO,S@O=T)Y9C@P-'$K42\F(WA!.RMC9V=2*V%U<6=S5U!P,G4U
M<%@O04AM:CA!37IS2#!T1U1M.#9Y,6<W1EAP9FMJ+T%*4C9$+UAK+W=#2FY/
M1SEO4#A!1V8X04Y$,U@F(WA!.UE(*TQ$,VQ0<S!J=6Y9<3EA+THU1V)23#)K
M:DHO<%!18V8X069A*TE/9$XR2"]D>3DW>6YT0B]E>"]Q+W!:.395;BLO;BLU
M4"MA8S,F(WA!.V)O1S!J6E15>4UW.$1X+V=":7$O1EA9<3=&6%EQ-T9867$X
M<3%B5"]!0WAP=FXQ-V%B>4PY8BMS>7<S5G)Q=&]9051.3DI785-22EHF(WA!
M.V]M*T=69V%O<#8K3T98<75"6%EQ-T963TPK.&TO=T)C9CA16$965$98:G8O
M041L2B]W0U,O=T)0+W=#,G1$+S%$6$=8-F8V;79*>68F(WA!.TQM6FI3-T97
M5"]L-R]W061Q8B]M1V(O:S1M84PR:"]X9B]/2#9892MZ,RM-9C5P+U$Y0WII
M2'0S67%Y9CAT4"M5,C S+VYT+WE9:WHF(WA!.UED;&8T>$@T+V-85SES9C1T
M3#1F-V]09&,W1C1D,DMU>%8R2W9K2"]!2GE%+W=$2G)A="]X:G1F*V]A4$TW
M0CE,4FLU=D]-=%E/>%8F(WA!.S98-4DO=T-596<O,350.$%I6GIH=F%$+T%"
M;B]!1%$Y,3)"+VEW.354-TY)-W R2W984'EB+S0T;#DO>D4O.$%-=&,V8G-0
M*S=L-S,F(WA!.VQ0840K.6HO049F,'9133-B;TA9<3=&6%EQ-T9867$W1EA9
M<2ME=GI9;3!E1#@R-&)M.'4T8E=Z:"]2=C9713%X8E)83'(Y658T:F$F(WA!
M.T-695AP>&U-3DPX5S-5538T5F4O,F0U85AT<$1E5V-Y6$9P8TES<T4X5$(P
M9$A&5EI71WA"1T)68D9867%P>&8S:S,K=5 X06E#-'$F(WA!.W%9<3AD+S5Y
M:R\X04IF-F8O=T)T84@O<4=U378P+S%.951K*UA->D=L,DMS;B],,R]J=%1F
M.'=Z9CAN17I293!0*TPO04]C4#!U.3DF(WA!.VYV.$%'4#A!3E V2&]78U$Y
M=3=&5U0O;' O>6TR;2\X.78X06MX2FUW-TLO>&E0>"LT=70W62]X85AW+S-1
M938U,DQW-W-69&ER<U8F(WA!.V9)4"]!1&M*+W=#5%<Q8B]!27@R=B]53DAM
M9&<K;&]Y8S-N1U=S2%EQ.4PX:V8X04M0468V.&XO04)--7<S=$(O:E K84AU
M=7=0.$$F(WA!.T9H-WEN,F%2,U1S5F5U9FLS+WAX3#<O;4HO-6QR;E1D:"\S
M8W9E.' W468S<V8V=C98;T=B=#!$<U9D:7)S5F1I<G-69&ER<U9E8BLF(WA!
M.V(O3VHR4&Y'3%)K.'),<617=%10975J16U#95)94U50;W5H6EI*5F]P9CA!
M6F%T3G-+=E(T-#0T-#%J:E5*1V=#;VEI9T%'=T%!-UDF(WA!.T9B>%8R2W%C
M6#DU3B]R:B]!26=U2W%M2W9(9BMC<% O04-8*VXO.$%B5V@O-FAR:DPY4#E4
M6&LU4&QZ37AP9&ER2B]Y.2\T-U4S+TTF(WA!.TTS+TIX33!8=$0O:2]W1&Y$
M.4QV9EHW+T%":B]!1%0K:#9&;D508G5X5FLO-6%F.'!T<'8O4&(O04I-4UIS
M3WEV.%EJ.&9U3')E,E F(WA!.SA7;#A0.3!(=75D:3A/-T9867$W1EAY1"]W
M035#9CA!:S%T5R]W0TUD<B\Q1%(U;EE0<&%-;DXU>&QR0C)+=E,O2D@O04-J
M,$@K=DHF(WA!.R]W051/8TXW468T>B]M:#=R<T0O04)993AP.6UK9# W1EAR
M;C5.+SAC4RLO-6EF*UIA-3 S668Y,TPS=DME,$@Y-T@K<BML-D)M-V0F(WA!
M.T$W1EA9<3=&6%EQ-T9867$W1EAI=C5H6&1I4'I-:F=I,6DU,$\O6DQD1&,V
M5&$S8W1X2S!P5DDT-VU5=#E4-#AM54%.134S2%1#<C$F(WA!.R]323E3:3!Q
M>FHQ4V%/-#%*25DQ=EHT;#12>51"44AD5C=";3-P9U9&-'%X-E!Y>&12*UE.
M3S%74R]M=FUT27)U2U-7-EI&8TQC36HF(WA!.TEK8V-%8U5.1C1%1G5026EL
M4S%-5E1M3EHO5FXT=6](355"56XY:&8X;UEQ<6-B;B]F:68X068K87-695!F
M.$%/54EM2&M$5"MB2U(F(WA!.RML661G<$@O04(W6$AI5&PK;BMP<GEC;GDO
M;5DP=7A6:R\U92]W1$AA;2\U:&TO-4]*;6DY;V8X6"]Z:"ML,W9S.2]J2"MA
M9C!047,F(WA!.S1H-V0R2W-M+TQB;"]J6%1U2D%B.3E1:U9(.7A*,G%-,DA:
M6"M-4BM0,T8Q=F)(*TQ3*T@K-D0S3&IC+S<X5"]!24$O.#%:,DQW-W4F(WA!
M.TYZ+W9X4#A!9T0O>E9I<G5.>B]V>% X06=$+WI6:7)U3GHO=GA0.$%G1"]Z
M5FER-40O-7E#-68X<E8Q6&M15SE/,7%12T0O96%0=%4F(WA!.S5N65!P84UN
M3C4Q;')",DMV4R]*2"]+4%%F-CAN+T5Z;D1E,$@K32\U;V4V-T$O>%EE.' Y
M;6MD,#=&6')8-5!#539*93A'5E(Y6C,F(WA!.W%P4"LV,3A#339B<U K-VPW
M,VQ0840K.6HO5B]3>C=J8R\W.%0O9T0O=T$Q6G4S44YO2F=F:EI34$%+4B]W
M06)(1E8K2W5X5C)+=7@F(WA!.U8R2W5X5C@K-C5Q365P*V%:3E,Q05A-=7,R
M=712=U$V061):TYQ.79A6'!H:653.5=%37@Y1FI,57E&83!(2%E95F915T)8
M67$W1E8F(WA!.T],*SAM+S%X+W=!45A&5E1&6&IV+T]5;B]K=CE0+S=A,% X
M03%$6$=8-F8V;79*>69,;5IJ4S=&5U0O;#<O>#)P=CA!;4=B+T%*3THF(WA!
M.VUI.6]F.%@O04TT9G!D-S=09C1X+VUN.40P3$])93-D:7)*+WDP+S548E1F
M*V4S+T%#66MZ661L9C1X2#0O8UA7.7-F-'1,-&8W;U F(WA!.V1C-T8T9#)+
M=7A6,DMV:T@O;DE4+W=!;71Q,R]!0FIT9BMO85!--T(Y3%)K-79/37193WA6
M-E@U22\U4C9$+UAK+S1M8S1B,F<O>&XF(WA!.R].1#-864@K3$0S;%!S,&IU
M;EEQ.6,O2G8O:FE8,R]-5"]Z3%A/;3=$+W4U93DU5#)G+W99+S%F,'9133-B
M;TA9<7@S>C$U-S!8>58F(WA!.W!%3W$V=6LW,C Q=W1Q9W1L5C,U=6IY0V]:
M:T9+4FYV:S1136I145141'9-;C4S;E)R;E8T1C!Y,6YF5$AA3EDU3E)%1&MP
M2S!D3&<F(WA!.TY!571J245,>&-N261E3S1,05I"2WDW+T%$=78W9E1R=E9"
M-69J9E1R94=E94XO<GA%<G)!2D%+<#E725AL2D5".6\P0G)V4VA.2W4F(WA!
M.S$S.#9D4S!05#=U-'8Y0G1K;G1P5$9(1BMK=4UC:&EE-&IM+V935S9+<$)T
M1#994#(V9V).4E-&5GHK83EX1S$Q9%!C85DX85-.1W4F(WA!.VI/,'1V8S)Q
M9E=%:&EU-S(U<D]K9'4V4#9P8W=Q07!&0RM&54XO>74S54=M=%)&-65H83-U
M8GE'>%=E6%4T3%EC;G1B939L6D1C4G<F(WA!.WAV.$%$9' V2W$O2U5":E)A
M8FA5=S@R*UEV>D]S+T\Y=%EA3G!J6$=I>D,R5T]68F8Q26E7;50V=S@Q>#9I
M*VQW:35G06=E4'AD34LF(WA!.W92<T-U>%8R2W%C6#DU3B]R:B]I0S1Q<5EQ
M.&0O=T-C<% X07E8*VXO=T1B5V@O-FAR:DPY4#A!53$U3U0U8WI-85A9<7EF
M.'9F.$$F(WA!.VIT5&8X=WIF.&Y%>E)E,% K3"\U=R]3-S,R92]X:B].4#9(
M;U=C43EU-T975"]L<"]W07!T<'8O040R+S5-4UIS3WEV.%EJ.&9U3'(F(WA!
M.V4R4#A7;#A0.3!(=75D:3A/-T9867$W1EAY1"]!335#9BM45S%B+VI(82\Y
M43!E6C)$-E=J2GIE8UIA=V1I<C!V>5(O>6HP2"MV2B\F(WA!.WA--7<S=$(O
M:E X06UH-W)S1"]&:#=Y;C)A4C-4<U9E=69K,R]W06-3*R\U:68X06U7=61.
M,D@O04AC=F4X<#=19C-S9C9V-EAO1V(F(WA!.W0P1'-645=R4C9,2F)+3EA7
M,F4R-6=O3'-2;5 Q2T=L4%4R-55R:UI:0D1C;6UC36-P;6]G;C--4VXX.2]L
M<F]7<C,X<U5(;S-S;'DF(WA!.S%V<DXY839F3%@Q65EP2E=A95=/3&Q+<4Q#
M+THQ-6A0,G5)<6-K=U)L>"MB4&M',W4W,C!M,4HQ=61.;2MR,S!)=&)T;6EF
M9SAH3$$F(WA!.U)(-$%K3'-:4'-!2U-4:7))=$DQ97<Q9E0T-RMW9'!,85)N
M44=33U-&=SA4=$9)<GAY<6MI36IO>6Q7545%67%J359D:7)W=GIJ4'$F(WA!
M.W,O-6UP9%-A4F-3,FI3,C!.=6)V-G=G:5=#5FME4T51,VM#8TI$.%DU23-I
M931W;V4V645U>%8R2W%C6#DU3B]R:B]I0S1Q<5EQ.&0F(WA!.R]W0V-P4#A!
M>5@K;B]W1&)7:"\V:')J3#E0.$%5,35/5#5C>DUA6%EQ>68X=F8X06IT5&8X
M=WIF.&Y%>E)E,% K3"\U=R]3-S,R92\F(WA!.WAJ+TY0-DAO5V-1.74W1E=4
M+VQP+W=!<'1P=B]!1#(O-4U36G-/>78X66HX9G5,<F4R4#A7;#A0.3!(=75D
M:3A/-T9867$W1EAY1"\F(WA!.T%--4-F*U17,6(O:DAA+SE1,&5:,D0V5VI*
M>F5C6F%W9&ER,'9Y4B]Y:C!(*W9*+WA--7<S=$(O:E X06UH-W)S1"]&:#=Y
M;C)A4C,F(WA!.U1S5F5U9FLS+W=!8U,K+S5I9CA!;5=U9$XR2"]!2&-V93AP
M-U%F,W-F-G8V6&]'8G0P1'-64S-8+TPR;F$W6G!A6#1C=WAY0U9E1&,F(WA!
M.U1Y0W-O,RM42$UF539A1V%01$QL9'54<&164$),:6AZ<6MU=69Y.#AO,T]O
M6#)O6$9K.#$U<4MU;#-+.7AC3GE74T8W9&Q51U1I:2LF(WA!.VQ+>3!106(Q
M-C5K3TUO<"M74&ML8FTW=4)93S!T.'-Q6$A+-G5M6&A-<WEY2D=J4VQ9,4EU
M<&1K04%,5D<K2W-I<W)#,7-95VAT53DF(WA!.T]*-5IP,E=P87-L>$LP,')6
M66XW56MJ1VYB='1I<79I<G-6944O;4QP96MY+VUQ;#-F5V,S3DI.3VM454EJ
M65-"56EB;$EH5S9K:&LF(WA!.VDS5E1Y2$QA=3(U=W$Y,59L6E%Y:TUR0V])
M,T)"=TMX+W=!,#9F-6]U-U<V1VTS=VEJ-'A',G0W9%!3=51)<V=,.#=L-5-V
M<'-V-TLF(WA!.WAQ,RM6,GA63#5B6'I23BM93FQQ2W=886%+<T5L=DY$2DE%
M=#1Z1S T12]'1R]+>4Y.>5%Q2DQ2<4QX*TI'0D=+<W!J868Q6BM+2U(F(WA!
M.WI&0U=)+UE8+TI/2W%N2S4O=T(Y<"]W6B]W0V%C5F509C@U46U9*U%.4#5Q
M;T@V5F@S1$4O=T1(=&-E24=8-F8V;79*>69,*UIJ4S<F(WA!.T975"]!2F4O
M.&1Q8B]M1V(O:S1M84PR:"]W05@O=T$T9G!D-S=09C1X+VUN.40P3$])93-D
M:7)*=GDR-68T,3 W:4%7+V950DY"+V,F(WA!.U-D-DA.:#)6+VI%9FHY>&1B
M,G@O:3!V:"]U9SEY-5A0*RLP+S1-+S@P-3),=S=U5GHO=G10*T10+TY/2W4U
M6% K*S O-$TO.# T<3<F(WA!.VQC+S<W5"]G>B]Z5&ER-40O=T-C9W58+T%#
M=%A695%!8C W5V]"<5 Y-6\K.4)M9&<K;&]Y8S-N5U=S2%EQ.6,O3%AY-W)E
M<656-#4F(WA!.SE0<S5,;4M/5U-.,VI&44A"-6-F=5E:>#-B;6MY>C%&>&E3
M2T0R4%EU<WA9.$A$2U%"<W-P+W=0-70O-G15+R]!05 Y=6%F.&AN+VTF(WA!
M.T8R,SAP868K94AF-$@X,B\Y5W%F+V=F-V-F>4=F*UE6+VQ,5"]W03A04V9Y
M=S!N5TY,,&TW:79,57=/."].5FQ*56MC1D9244YN460F(WA!.VM96C0T15-&
M8G9..71:-%I-:U1!,DM:;GEU9CDY<"]W6B\U<'IB3VUB47I%+T=Q9V5)66XO
M:E59<79X5C)+=7A6,DMU>%8R2W9"9E F(WA!.U,K5V9-2&Y784]23'5.-VUA
M0S!U=S%J<#%Z4U-Z=4-Q1T=E5V-3=V\U56,Q0VYK=F@P=W$Y<CAV-DY";VUH
M869O.74W>7=A9&)25W,F(WA!.U5K:'$W3$-G449Q9'I407%0>%8R2W%C6#DU
M3B]R:B]I0S1Q<5EQ.&0O=T-C<% X07E8*VXO=T1B5V@O-FAR:DPY4#A!53$U
M3U0U8WHF(WA!.TUA6%EQ>68X=F8X06IT5&8X=WIF.&Y%>E)E,% K3"\U=R]3
M-S,R92]X:B].4#9(;U=C43EU-T975"]L<"]W07!T<'8O040R+S5-4UHF(WA!
M.W-/>78X66HX9G5,<F4R4#A7;#A0.3!(=75D:3A/-T9867$W1EAY1"]!335#
M9BM45S%B+VI(82\Y43!E6C)$-E=J2GIE8UIA=V1I<C8F(WA!.VHO-7AS5S9B
M.'-B-6)34T]'-DXO8T-#5U9$3$=R*VI&>%HT,65)<T%E;T1R6'A'665O*W!V
M>#AM8R]59DY-1V]A=$I,8UA&-'0W<#DF(WA!.VY$8GE196MK34XT=C%O6$5K
M1G9*36A29FEI8C1P1UDQ035N:G11>EDU;T=J*V0T1SAT:31T=%)783%U6F8P
M:&-46')T1S%S45(O<$TF(WA!.U5M<5AW-6MM<6=#9G11>%8K1E8V6FER<U9D
M:7)S5F1I<G-69&ER<U9D:7)X:"]Y-3@S2'IZ2G$X5VDR3FY9+U@R;C4R3C!5
M85I$35@F(WA!.SE784\U4S5I3'-0:6)H1W W03DX2W9:.$-U>%8R2W%C6#DU
M3B]R:B]!26=U2W%M2W9(9BMC<% O04-8*VXO.$%B5V@O-FAR:DPY4#DF(WA!
M.U18:S50;'I->'!D:7)*+WDY+S0W53,O34TS+TIX33!8=$0O:2]W1&Y$.4QV
M9EHW+T%":B]!1%0K:#9&;D508G5X5FLO-6%F.'!T<'8F(WA!.R]08B]!2DU3
M6G-/>78X66HX9G5,<F4R4#A7;#A0.3!(=75D:3A/-T9867$W1EAY1"]W035#
M9CA!:S%T5R]W0TUD<B\Q1%(U;EE0<&$F(WA!.TUN3C5X;')",DMV<6XO;D=(
M+WE85G@O,C!P+RM454]996\K<'9X.&YP9FU1:V589%5)3D-,4V-G:B]J13)5
M33-E5WE4-60P<VLQ2G0F(WA!.TE#4V8K35,T<6U/2W5X5C)+=7A6,DMU>%8R
M2W5X5C)+=D-F>E)V9%)T=GI(3C=&96%G=6XR4S)#,WHR,$XQ2W1S<E1P26E2
M*VLT:'(F(WA!.T]Y0F9J-&YE;GA$0W(R>E-D57-T5S!U,#%3>&LY5WEV;U5U
M3&%3:%AL2$MO6E11,$DR3T)55FER<U95-'8W>6(O6$@O04)"8U96358F(WA!
M.V5/+S@U4V8K4R\P+R]T<E$O=T153F-:9G O<6$X;DHX=5IM3DQS5F5L+SA!
M3U!%554S-6TR:V-Q3$I',79C8VMC0FQ.27ED=V-O,4TF(WA!.U)+1D57,C1:
M1TIS1VXP.7%S2S(U.4MX,$M/-&1O<$A7-V-7-E=S8F]+:%IF:3EF-'4S0TIH
M-&M:<G9!:"].2'EC<G@X;C@T+TYH=7$F(WA!.RMD3%<Q9SAP=$1A-EDP*W-#
M,T]Q46U/37-J5$QB<UDT,6%A2FQ9<&-&,4%%<VQ!2U)S3U1+9D%H+TY(>5AX
M.&XX-"]-=E)O=$\P*T<F(WA!.U%34E<P56-I+UID15932VEM>$%X:FEG1%E!
M4DQ,36EI5#@P4FQJ5S=&6%EQ-T98>40O>FM*+S5.8E9V*TUD<B]!3E$P95HR
M1#97:DHF(WA!.WIE8UIA=V1I<C9P+S5X:"\X;#%C9CET2V8O:S%$;4AQ4'%B
M.&9*-E@U;"\U4GI69BM93S0O=T-45%I1>F0U82\U4GI3=BM93S,O-4XF(WA!
M.TQI<5DT<3=&6%EQ-T9867$W1EA9<3=&6%EQ.%0O3516+TLW+T%*;G=A6'%D
M:G!36%9,2DDU<CET444Q,%I82E@P,'1),FA:;VEA2C8F(WA!.W4T4&=-2W9:
M-T]Z=&)+,&AS-U-*64Q7,U)9;TE52$954D)X5E9!-D%!64968U996618.'AN
M>G)P=&QC0S=T15I:5W4W83-T-4QV4VXF(WA!.VE#4V5L+W!X<V]8:G5'8FEX
M5G!19T$T-W-W>%9L8V-J:5=C0TIJ.%DS0E@K4F9&<U964%9K+S-Y+W="-F8X
M,5EQ.&4O-7EH9&TX9V$F(WA!.V5$1WEF-VQ99'IX+S5:<FIW2GDO5"]5,35/
M5#5F>DUA6%EQ.4TO-7@Q66HX>C=-:%-X*W(S3W=P6"LW4&E2;%=F-E=Z2'IF
M5W9Q>68F(WA!.S<U9C<P+S5Q>D)B:V\O5$XW+VDS.49E:B]O=C%$-C%4-&5F
M<65T-F98;%-L35949C%:4#DX=CA!96XO3E=+=3E75"]F3"]E;B].5TLF(WA!
M.W4Y5U0O9DPO04AP+WI6:7)V5FLO,WDO,W O>E9I<G96:R\S>2]W0C9F.#%9
M<2M1+RMC9VE4*V%U<6MQ5E!P,G5X<%@O04AM:CA#8WHF(WA!.W-(,'1'5&TX
M-GDQ9S=&6#%.+WIJ23=,*UAL=T)'>FHY2E0W:FHO=G%(>$EZ1#%(,4XK4&LY
M2CAY4W8X031D,50Y>30O,$]F97%F-S8F(WA!.V(O2WEH;3=Y,TLO*TAD3"]!
M2$QN+U$T3C9P+W9P9CA!2WA63796:R\S>2\S<"]Z5FER=E9K+S-Y+W="-F8X
M,5EQ,FMJ36%'3FQ(:64F(WA!.U X0V-66#1Q-T9867$W1EA9<3=&6&IV;G9Y
M>C58,4PX>5EB<C!T4W5.670U3E!K=7!,5%1H95)1;VIL:U0Q;4@W<C%/0VMN
M-&=">3(F(WA!.RM)-%9E>%E&9&ER<U95-'8W>6(O049X+WA"8U96359E3R\X
M04]5;B]!2DPO044O+T%,83!0+U5.8UIF<"]Q83AN2CAU6FU.3'-696TF(WA!
M.R]W1$]/9CA!-4Y'>B]W0UEE-2\U3FY+<R]W0DQ::C5V<FI-1G53>CE$="]I
M6#E-*W%/4#%,-FXV3DXV*W(V;DQL6#9+67%M94MU>%8F(WA!.S)+=7A6,DMV
M:T@O;DE4+WEA,G)F.%DW6"]Q1VIZ3W=F4S!:3V)Z:DQ71'-69E-V-4(V+T1O
M;C575%A5;'1.95!*<3AK34YR8F5K2D@F(WA!.V1O66IS6FYH:D%#<5=*6G=+
M1$U05695,W<U37=K+T]0>59Q4FPP:E-:0G%/=7E2470K:#=M3V$R5&IC;4Y1
M2C5N:65*5E54<5AP>4XF(WA!.TLP0D\R54TQ4V8X04TR,'-.2S!7-T9H1D99
M,U9V8EA&,RLO0TIB5SEX2VM%6F=!:E!R9F%,.45(<'%72D@R8TMP>C5%.#=7
M2&Y,4V(F(WA!.VI6=%!J-%=36%5L=&)T-FEU,&E2:%-*1T,W25<U9EEQ4T)3
M=2MW0W-J>%8R2W5X5C)+=7A6,DMU>%8R2W9"-W)49DQ:.'<S2F)425 F(WA!
M.SAB;GI&-FME;"]6-V=V3%E'-4-H+U=,0D],4G-B;C%U9U!W,#=95F4X649D
M:7)S5E4T=C=Y8B]82"]%1GA657A6-58O>FMH;W5S878F(WA!.S5(<V)B4W)'
M-#%#-%15-'!(:'19;FUC24QE9%-X5TU-94Y707(W-61G24(S65I"<RMB+RM6
M9"]M0B\Q3$]R9CE)3GHO04TP6FPX8V4F(WA!.SEQ-%,W+VQ89C5G9CE3>G$S
M+U-$8R\X04Y'4$A(=EAH3#!$.&IV2UAN4%-04#!..65A0F8R.&-6<F1C2'5B
M85=#3G!$165#1U-255$F(WA!.V-M,C-/5EIP07@U<V]!,CEB,')Y4BMA561J
M849F3C=A4D]S;VMV<EHP+U11;DAP>$MF,SDU-E11.&YJ:UEP14]#.#9$<%4T
M8F-R*U@F(WA!.U!)=71A9F]/<V%:8VEY:G4Y5W1J-FI7='I/;DLV4TI9>%!+
M-&EJ:UIR:51K.'HY4G-L2$<K1E5:;VYK5%<Y3S@V5S)R5&%R1F,V2EDF(WA!
M.V%:*VID3C S,&Y2-$%F4D919E5-8D@Y>%5V=T1(;'@V055#<S-X5C)+=7A6
M,DMV:U@O;DE',W5(+TY45E=32C)5>#)T0T9*2"LX,&4F(WA!.UHR2#97;5DS
M96,O5DQV.$$S>DHO=THO<&QT<TMD.55U+W=$9DUN+T%N*VU.<E0V5R]W0V-F
M4$QM:S9T*U<W5RMT5T5D-41"<3 X.&0F(WA!.W9C<'IJ-2]6,&HU3D<S=W8X
M3'14:T0T.5)M2'%0<6)O8VYQ9FUU4%,Q.'-A:RMO-F9"<59J85<P;'<K;C-#
M23A-9W0P36EQ5F186'$F(WA!.VTS=VUM54TQ.6YO;FPK5C=45D8P<3!J=E55
M>7=806AJ.5=->DM/9D-4:4=(24%"<61C5E1'0S-G9U%P0D=K4T8S:TMO;U5&
M-4=,=3$F(WA!.T(S6C),364U3F-66#1Q-T9867$W1EA9<3=&6%EQ-T9867$W
M1EA9<3=&5D],*SAM+S%X+WA"8U96359D:7)$4$UN;F$T,#-89$TP,S$F(WA!
M.W)85$IB>3A3,FET3E,Y3&YF46PP16MT<DQ&9$0P=4-S84-727,W555,=FEQ
M4BM:4'I797IV.5%44G17,&Y5-V5#,F=N16-F<"MR8D,F(WA!.S1L9U9*6DAK
M=EE)8FE*;S578W-':5909S50.$%&:7(P3%$Y42]33VDR1V]6<CEB=#1P>65"
M:7(V:4)Q*VU7;#0Y96Y.=FUE=4MO,T8F(WA!.U=/9BM61B\W8R\X03).659:
M2&=6,DMU>%8R2W5X5E)V8FE7,W1*6C1B85,X;&I5<VQR0UEX2DE2*WEP;65+
M3W8K<S1'2W-*,#<X>&(F(WA!.U=E+SAW4EA/=#961&(V86@T.'=Q5%=D=T))
M,&M&>D=,<5@Q>D-S9%AA36]P;W=8;U-&5G9L8GID-6HQ,C<P:#=B571+=F10
M=6QU<&(F(WA!.WAR5S)K2F%#,VM-87EP24QY5EE7:TUK43E&,6-J-&E7<4])
M5EHY:7%3*V1V*U5-,2]W1#=:,3,O04UM2'A6361-+S0U=' O>&AJ+S0F(WA!
M.VE-5E)/2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMS93AZ*V$U3DIH;5=Z
M=%)D6'-#<DE98FXV>F%W>4LQ44DT3&QB931I;&Y99T(F(WA!.UE6*TDK,DMT
M4RMA<G50>F):84A*<'I25W0Q8G)-,F]3+U=!=G)-2E<K<GAS;'9*8DTV:4=R
M0G P3D0X26)&53=35E9K;4)6.3,R4$(F(WA!.WE$.$MJ66=9<78X07)%9F<O
M=T1W1"\P>%8S,6E0=V8O04E"+S99<3<V>$@T4"]W1"]W0DU643EN<D9H965V
M.$%6;F54-G1+,790.$$F(WA!.W4U0GAL:G!Y6&12,'(R>%9%9E=)+T(O*T%F
M.$%P:7)V<D5F9R]W1'=$+S!X5FIN<G O>7-3=$AP*VE+9EEE=BLY4&A40W))
M+W)%9F<F(WA!.R]W1'=$+S!W2S<V>$@T4"]!34$O.4U69#E9:CA(+S1"+W=#
M;4MU*W-2*T0O05!!4"]41EAF5TDO0B\X06=(+W!I<G9R169G+R]!4"\F(WA!
M.T%%>%9$,T]R,D9T3F%W>G4P8W0Y2UE,4D1(2E=35EEN;4MJ-&5V<'=U,S!9
M<6E0<D5F9R\O05 O045X5C,Q:5!W9CA!-$(O-EEQ:W8F(WA!.VY79$0U3C$T
M569F5')V.$%98V8W;V8R>%9-9$UU22\P8F%B4"]C>"]S4#A!>6HR>%9%+U=)
M+T(O*T%F*VU+=2MS4BM$+W=$05 O5$8F(WA!.U<P;%9Z44)Q*S9S4#%G67%V
M>%8R2W5X5C)+=7A6,DMU>%8R2W!(-78O=T%$+V\V3"]'4#9-+U)V<D0P4#!V
M.$%6+U$Y9FDQ3T@Q:C0F(WA!.T]F1&Q3;3E+-'%H=$\O-59T*VUB6#E'+V]B
M.4YC6B]Q6#%B-G(Y831E<DHY6CE,:"LX<#9V<65P>"]A-58S<FER2F-69&ER
M<U9D:7(F(WA!.WIF4F8K5FLO6'1F+T%%2BMH=G%(-E=U=5 Q,S8Q-C%A<C$Y
M3#1E;$U+<' O>4=B+T%,.7HO<"MW2S<O:TTS+V9U9CA!5#EI<6HU9"\F(WA!
M.WA:+VHV8B]%9C%$,2]W0D9$,% P9#8S1&@Y6C,U*W1V5W9H:%9N5T)867$W
M1EA9<3=&6%EQ>$QZ<BMK=C U-5<O4G9O9EAF<FQZ-E@F(WA!.S%N;#9F*SA-
M+TMV1#1V<S%P:7%++W=#46DO.$%A;B\V97-+=2]W0U%I+SA!86XO-F5S5E-J
M>F8O04DO+T%-2C8Q.5DO4EAO9E5,<C$F(WA!.V94*W,X*TAO='DT,3)R5'!8
M1E=9-EHO>'IB5"]!27=X+W=$15)G5D4T<3=&6%EQ-T9867$W1EA9<3=&6%EQ
M+R\R43T](B\^"B @(" \+W)D9CI!;'0^"B @(#PO>&UP.E1H=6UB;F%I;',^
M"B @(#QX;7!-33I$97)I=F5D1G)O;0H@(" @<W12968Z:6YS=&%N8V5)1#TB
M>&UP+FEI9#HU13,X03 T-S,Y,$1%.#$Q044R-49$,C0T-3!#,48Y-2(*(" @
M('-T4F5F.F1O8W5M96YT240](GAM<"YD:60Z-44S.$$P-#<S.3!$13@Q,4%%
M,C5&1#(T-#4P0S%&.34B"B @("!S=%)E9CIO<FEG:6YA;$1O8W5M96YT240]
M(G5U:60Z-40R,#@Y,C0Y,T)&1$(Q,3DQ-$$X-3DP1#,Q-3 X0S@B"B @("!S
M=%)E9CIR96YD:71I;VY#;&%S<STB9&5F875L="(O/@H@(" \>&UP34TZ2&ES
M=&]R>3X*(" @(#QR9&8Z4V5Q/@H@(" @(#QR9&8Z;&D*(" @(" @<W1%=G0Z
M86-T:6]N/2)S879E9"(*(" @(" @<W1%=G0Z:6YS=&%N8V5)1#TB>&UP+FEI
M9#HU1#,X03 T-S,Y,$1%.#$Q044R-49$,C0T-3!#,48Y-2(*(" @(" @<W1%
M=G0Z=VAE;CTB,C Q."TP,BTP.%0Q.3HQ.#HS.2TP-SHP,"(*(" @(" @<W1%
M=G0Z<V]F='=A<F5!9V5N=#TB061O8F4@26QL=7-T<F%T;W(@0U,V("A7:6YD
M;W=S*2(*(" @(" @<W1%=G0Z8VAA;F=E9#TB+R(O/@H@(" @(#QR9&8Z;&D*
M(" @(" @<W1%=G0Z86-T:6]N/2)S879E9"(*(" @(" @<W1%=G0Z:6YS=&%N
M8V5)1#TB>&UP+FEI9#HP-#DY.$1!,C-&,$1%.#$Q044R-49$,C0T-3!#,48Y
M-2(*(" @(" @<W1%=G0Z=VAE;CTB,C Q."TP,BTP.%0Q.3HQ.3HQ.2TP-SHP
M,"(*(" @(" @<W1%=G0Z<V]F='=A<F5!9V5N=#TB061O8F4@26QL=7-T<F%T
M;W(@0U,V("A7:6YD;W=S*2(*(" @(" @<W1%=G0Z8VAA;F=E9#TB+R(O/@H@
M(" @/"]R9&8Z4V5Q/@H@(" \+WAM<$U-.DAI<W1O<GD^"B @(#QX;7!44&<Z
M36%X4&%G95-I>F4*(" @('-T1&EM.G<](C8Q,BXP,# P,# B"B @("!S=$1I
M;3IH/2(W.3(N,# P,# P(@H@(" @<W1$:6TZ=6YI=#TB4&]I;G1S(B\^"B @
M(#QX;7!44&<Z1F]N=',^"B @(" \<F1F.D)A9SX*(" @(" \<F1F.FQI"B @
M(" @('-T1FYT.F9O;G1.86UE/2)!<FEA;"U";VQD350B"B @(" @('-T1FYT
M.F9O;G1&86UI;'D](D%R:6%L(@H@(" @("!S=$9N=#IF;VYT1F%C93TB0F]L
M9"(*(" @(" @<W1&;G0Z9F]N=%1Y<&4](D]P96X@5'EP92(*(" @(" @<W1&
M;G0Z=F5R<VEO;E-T<FEN9STB5F5R<VEO;B U+C(P(@H@(" @("!S=$9N=#IC
M;VUP;W-I=&4](D9A;'-E(@H@(" @("!S=$9N=#IF;VYT1FEL94YA;64](F%R
M:6%L8F0N='1F(B\^"B @(" @/')D9CIL:0H@(" @("!S=$9N=#IF;VYT3F%M
M93TB07)I86Q-5"(*(" @(" @<W1&;G0Z9F]N=$9A;6EL>3TB07)I86PB"B @
M(" @('-T1FYT.F9O;G1&86-E/2)296=U;&%R(@H@(" @("!S=$9N=#IF;VYT
M5'EP93TB3W!E;B!4>7!E(@H@(" @("!S=$9N=#IV97)S:6]N4W1R:6YG/2)6
M97)S:6]N(#4N,C B"B @(" @('-T1FYT.F-O;7!O<VET93TB1F%L<V4B"B @
M(" @('-T1FYT.F9O;G1&:6QE3F%M93TB87)I86PN='1F(B\^"B @(" @/')D
M9CIL:0H@(" @("!S=$9N=#IF;VYT3F%M93TB07)I86PM271A;&EC350B"B @
M(" @('-T1FYT.F9O;G1&86UI;'D](D%R:6%L(@H@(" @("!S=$9N=#IF;VYT
M1F%C93TB271A;&EC(@H@(" @("!S=$9N=#IF;VYT5'EP93TB3W!E;B!4>7!E
M(@H@(" @("!S=$9N=#IV97)S:6]N4W1R:6YG/2)697)S:6]N(#4N,C B"B @
M(" @('-T1FYT.F-O;7!O<VET93TB1F%L<V4B"B @(" @('-T1FYT.F9O;G1&
M:6QE3F%M93TB87)I86QI+G1T9B(O/@H@(" @/"]R9&8Z0F%G/@H@(" \+WAM
M<%109SI&;VYT<SX*(" @/'AM<%109SI0;&%T94YA;65S/@H@(" @/')D9CI3
M97$^"B @(" @/')D9CIL:3Y#>6%N/"]R9&8Z;&D^"B @(" @/')D9CIL:3Y-
M86=E;G1A/"]R9&8Z;&D^"B @(" @/')D9CIL:3Y996QL;W<\+W)D9CIL:3X*
M(" @(" \<F1F.FQI/D)L86-K/"]R9&8Z;&D^"B @(" \+W)D9CI397$^"B @
M(#PO>&UP5%!G.E!L871E3F%M97,^"B @(#QX;7!44&<Z4W=A=&-H1W)O=7!S
M/@H@(" @/')D9CI397$^"B @(" @/')D9CIL:0H@(" @("!X;7!'.F=R;W5P
M3F%M93TB1&5F875L="!3=V%T8V@@1W)O=7 B"B @(" @('AM<$<Z9W)O=7!4
M>7!E/2(P(B\^"B @(" \+W)D9CI397$^"B @(#PO>&UP5%!G.E-W871C:$=R
M;W5P<SX*(" @/$5X=&5N<VES1F]N=%-E;G-E.G-L=6<^"B @(" \<F1F.D)A
M9SX*(" @(" \<F1F.FQI"B @(" @($5X=&5N<VES1F]N=%-E;G-E.D9O;G1+
M:6YD/2)/<&5N5'EP92 M(%14(@H@(" @("!%>'1E;G-I<T9O;G1396YS93I&
M86UI;'D](D%R:6%L(@H@(" @("!%>'1E;G-I<T9O;G1396YS93I/=71L:6YE
M1FEL95-I>F4](C B"B @(" @($5X=&5N<VES1F]N=%-E;G-E.D9O=6YD<GD]
M(DUO;F]T>7!E(%1Y<&]G<F%P:'DB"B @(" @($5X=&5N<VES1F]N=%-E;G-E
M.E9E<G-I;VX](C4N,C B"B @(" @($5X=&5N<VES1F]N=%-E;G-E.DME<FYI
M;F=#:&5C:W-U;3TB,"(*(" @(" @17AT96YS:7-&;VYT4V5N<V4Z1F]N=%-E
M;G-E7S$N,E]#:&5C:W-U;3TB,S8S-C$W.3<W-"(*(" @(" @17AT96YS:7-&
M;VYT4V5N<V4Z0VAE8VMS=6T](C,V,S8Q-SDW-S0B"B @(" @($5X=&5N<VES
M1F]N=%-E;G-E.E!O<W138W)I<'1.86UE/2)!<FEA;"U";VQD350B+SX*(" @
M(" \<F1F.FQI"B @(" @($5X=&5N<VES1F]N=%-E;G-E.D9O;G1+:6YD/2)/
M<&5N5'EP92 M(%14(@H@(" @("!%>'1E;G-I<T9O;G1396YS93I&86UI;'D]
M(D%R:6%L(@H@(" @("!%>'1E;G-I<T9O;G1396YS93I/=71L:6YE1FEL95-I
M>F4](C B"B @(" @($5X=&5N<VES1F]N=%-E;G-E.D9O=6YD<GD](DUO;F]T
M>7!E(%1Y<&]G<F%P:'DB"B @(" @($5X=&5N<VES1F]N=%-E;G-E.E9E<G-I
M;VX](C4N,C B"B @(" @($5X=&5N<VES1F]N=%-E;G-E.DME<FYI;F=#:&5C
M:W-U;3TB,"(*(" @(" @17AT96YS:7-&;VYT4V5N<V4Z1F]N=%-E;G-E7S$N
M,E]#:&5C:W-U;3TB,C<V,3$U,#<S,B(*(" @(" @17AT96YS:7-&;VYT4V5N
M<V4Z0VAE8VMS=6T](C(W-C$Q-3 W,S(B"B @(" @($5X=&5N<VES1F]N=%-E
M;G-E.E!O<W138W)I<'1.86UE/2)!<FEA;"U)=&%L:6--5"(O/@H@(" @(#QR
M9&8Z;&D*(" @(" @17AT96YS:7-&;VYT4V5N<V4Z1F]N=$MI;F0](D]P96Y4
M>7!E("T@5%0B"B @(" @($5X=&5N<VES1F]N=%-E;G-E.D9A;6EL>3TB07)I
M86PB"B @(" @($5X=&5N<VES1F]N=%-E;G-E.D]U=&QI;F5&:6QE4VEZ93TB
M,"(*(" @(" @17AT96YS:7-&;VYT4V5N<V4Z1F]U;F1R>3TB36]N;W1Y<&4@
M5'EP;V=R87!H>2(*(" @(" @17AT96YS:7-&;VYT4V5N<V4Z5F5R<VEO;CTB
M-2XR,"(*(" @(" @17AT96YS:7-&;VYT4V5N<V4Z2V5R;FEN9T-H96-K<W5M
M/2(P(@H@(" @("!%>'1E;G-I<T9O;G1396YS93I&;VYT4V5N<V5?,2XR7T-H
M96-K<W5M/2(R,S4V,S0S-#DV(@H@(" @("!%>'1E;G-I<T9O;G1396YS93I#
M:&5C:W-U;3TB,C,U-C,T,S0Y-B(*(" @(" @17AT96YS:7-&;VYT4V5N<V4Z
M4&]S=%-C<FEP=$YA;64](D%R:6%L350B+SX*(" @(#PO<F1F.D)A9SX*(" @
M/"]%>'1E;G-I<T9O;G1396YS93IS;'5G/@H@(#PO<F1F.D1E<V-R:7!T:6]N
M/@H@/"]R9&8Z4D1&/@H\+W@Z>&UP;65T83X*(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H\/WAP86-K970@
M96YD/2)W(C\^_]L 0P ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L 0P$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$!_\  $0@ ^ %2 P$1  (1 0,1 ?_$ !\  0 " P$! 0$!
M 0         ("08'"@L%! ,! O_$ % 0   & @$! 0H("@@$!04   (#! 4&
M!P !" D1$A,4%18X.7:6MA=6=7>TM]36&2$U-U576)>UU1HB,4%E>)37,E%A
ME0HC)%*!&"4H0G'_Q  = 0$  @(# 0$              0<&"0($!0,(_\0
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MD8E<R3-LS<W%^/4!8M)5C&T.:XU<G;AS1FA%OK:YVK5FJM^'3J]9IA+S1O\
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M[L<6N5D(21-;.X.W<JE2E,C2$GZ0$'[3B5*E9))&S= "8+8^P7<ECV&42_\
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M\7.G:+IQ\R]@\M4?Z"F7LB^_8\67BYT[1=./F7L,%L[D#75-5_+;3LPR4Q.
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MM;#_ /-C[<:ZBG$B82%BBD;LAQ=I#)7=N86)K(@-@ .<7=V5E(6Y$4,^,DD
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MARIU*)1'RC9J%/QZ3*2TM"FDCN6=F(DM5)R*Z7@I+K#W&7AQ)J+,QY:&V&V
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MB+!S]SW1(+G0T?FW1J[=)R;-1FLS&N:G_FC&[I;/1^;GVSD;GHCK7MP:M!F
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M@&XN/GY\*J]>&#Z<5E6Y;MZ+*-Z(UGJD0M+(COO9-_3"B==A'0-FE$W;# &
M;_XH^<_QW^>VK_?1FS-<FV^%@;TMP][5E3 LJF]EE"]"L3^Q9T[,<VIFG08
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M:Y-M\+ WI;A[VK*F!95-[+*%Z%8G]BSIV8YM3-.@P!@# & , 8 P!@# & ,
MYR9%Q[Y/P?DES<EKWT?*)YX-/(.^U<RBEUVOR&X\1U^%4*6L*Z@44K$,9LF
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M -Q<?/SX55Z\,'TXK*MRW;T64;T1K/5(A:61'?>R;^F%$Z[".@;-*)NV& ,
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M$MN"'G>T-Z[%_P +<LLS(WOGX-\[)U:8*GRZ;TF.O,KNM2QU]9L\-1XP!@#
M& 5X]6?T;'-'YAYC]'*SU:'X7I_VEGO.I/\ ><S]4X\O7+C,*& , W%Q\_/A
M57KPP?3BLJW+=O191O1&L]4B%I9$=][)OZ843KL(Z!LTHF[88 P#?_%'SG^.
M_P ]M7^^C-F:Y-M\+ WI;A[VK*F!95-[+*%Z%8G]BSIV8YM3-.@P!@# ,=DS
MA$TL>DA\Q71U/$T+$[JI>=)E+:3'DD93H#S']1)#'086U.Q$-FE(W<USV!O*
M0:/$M$%/HS><4>Q7*U'M5R:VHY%<GC1%NFM->TY*QZ-1RL<C7:$<K51JWU66
MUEO9=1$*)\GN"=/J:]K"O)YQ\KF$V*V6!)(.XP5^JN(5"Y/<-ED#BDJC:!<R
M.S6RFSY4^6$Q;\1H$2AP4EIG0U>8G.1E%*.1%E73I75X])NQPY/<;&ESF+*Z
M\@J3:W>NPZ'/FQQM.#H5T*!Y0M<1V*5I53X4='] E;XR1@S;J!+WJ1/+2R&=
MRY.2),>%EV*?4KKD'0UON:QEJ>ZJHLUX;FI.^N+3 +"B<O<T#,K/\%3NBU P
M.S@J2(#56])M*5!196E P$"$$TP 1"++L-OX P!@# *,>JM&+9F-S<=%48A'
M*FYZ18X3=378M=\5^7<.XGK6NSU;O5*J!2B6OKE:U:O4T&W1TB:-*>+]_,0L
MX'T#UI8E/-&WO YMMINK471\YN=HTWMH5/Z\99APQ;AM'&*I&X<.M"OQI61R
M *'71:J2[[/8]BDCT9X/+K40RJ;)9BN.[OPM,O)E+P%*VJ$39L\H2$24@<5U
MKI1>-$LG-9+<Q)[! P!@&&SC\F-/KE!?>]ER4U\B]"D+JY4Z4,RR"1@%3'7/
M]%/RX^0*U^NVM,]O#GAJ1\N+U>*=&I=XS'DM^\8>:=ENF&C & 2'XH><)6GR
MFZ>[KQE']TCO(X^\WT_VY2R\>YLW[\ ><:A[#JA?#FF\W+C & 2VX(>=[0WK
ML7_"W++,R-[Y^#?.R=6F"I\NF])CKS*[K4L=?6;/#4>, 8 P!@%>/5G]&QS1
M^8>8_1RL]6A^%Z?]I9[SJ3_><S]4X\O7+C,*& , W%Q\_/A57KPP?3BLJW+=
MO191O1&L]4B%I9$=][)OZ843KL(Z!LTHF[88 P#?_%'SG^._SVU?[Z,V9KDV
MWPL#>EN'O:LJ8%E4WLLH7H5B?V+.G9CFU,TZ# & , KO'P#0F6IR=LQ18Z1P
M*Y)5?9E:+(J\5RVO3-'D]CZ9]'JW).YR)2WS-N1@:=IUT>7M3:D?$BLY,>I2
M [=CJC#F2]F'\HF),?I6W3;L0R\]+K2EIZ0&RGPV<I\XKTG4G8JQ]S^ [FC?
M@L+.W7.SFYF:^Y<4978F)<F&%<FSJ R39AB;I\TE82INCNG?@$C4I)&+(_ (
M*2^ZI45B9R3D;,6"C<UV?G,PM!TX70V&6A&I7?;E(W"R*&Y.42D<%$:FCXC@
MK/R.:Z8;MGQI5:=S6I9*]GARBGPO1$>E]HR4Y>Y2M>WLK[#X@Q1>*M-KE.7X
MN%%YK[$1.'8?.6]-B0OUP$VC+.1+A(T;9-WZ4LT;6Q&:+ $-;]S.X^<OA,!Z
M5^NY_KUF$WF<?6>MR5M85E62%V0OJR82QCDDC1%:4!G<'OXE3W^[42=J;BFC
MJNPHW/D\S&[#CQO. W;7Y.%-H5P^:'*F,<G56QK /*O90J\41OR-)%M,=N4E
M+AOYGB 9/B<X1?W>I+$N,$# & , YF.L[5L)BD]KK<2XD\/'QGDC=;O(RX[D
MY&<>;'NAM3N2:;\9ZYL]U;4]<R6*%M<B8Z>5*;@FBJ0.!RR50JD@,L<+(7H3
M31#Z,70ORG<"(C79OY2[%T7]:\9:[TIWM#(^G]QQ>6N.P"*M:QAE^FQIJB!N
M]:5<)N365-$B%YKB&O[@Z/K=!9*E(*DD36O"O3G(&)V02-<C;5+L8W)1Q=\Y
M=*KXUNO+QEA6#B:;N"](32(8!Y8)Y4K-LJRX!5D<*C$7=I 6G?[%FL<@;,Y2
M5Q2$Z9XG&$C[*F8IR?I$XMJ41BM*U- 7:1N30R.((E^GF,*N3E-":9M&H*><
MV!_E$XN@+Z?&F]CDE01LI @C[W#6!8K<#;8M*M3'=2J7S=OVT1N#$S"8O"9L
M?SVV.*0M)NAB;:%78;GG'Y,:?7*"^][+DIKY%Z%.*ZN5.E#,L@D8!4QUS_13
M\N/D"M?KMK3/;PYX:D?+B]7BG1J7>,QY+?O&'FG9;IAHP!@$A^*'G"5I\ING
MNZ\91_=([R./O-]/]N4LO'N;-^_ 'G&H>PZH7PYIO-RXP!@$MN"'G>T-Z[%_
MPMRRS,C>^?@WSLG5I@J?+IO28Z\RNZU+'7UFSPU'C & , 8!7CU9_1L<T?F'
MF/T<K/5H?A>G_:6>\ZD_WG,_5./+URXS"A@# -Q<?/SX55Z\,'TXK*MRW;T6
M4;T1K/5(A:61'?>R;^F%$Z[".@;-*)NV& , W_Q1\Y_CO\]M7^^C-F:Y-M\+
M WI;A[VK*F!95-[+*%Z%8G]BSIV8YM3-.@P!@# & , 8 P!@# & , H=ZL%F
M6737)'BM/*4NNXJRLU34W(2/!B58\(; YNMT^@_CVGG:3KW^'Q2R(>@B@H4X
M(XXH(D06=4\@)?3TNWUO:%*QN<QS8B*CKHEM&G.1MM?"J+K_ *X+3"Z:O-N'
M\OJ>+0ZL*46!;U?,,5>;(>);QYEG&51)(_9"N4K*WL&,5K)W"0)]0:4MD;>6
MIC>H_+)*V.2Z*/)VUB<P04^A#FYJ\%N)4=R*J6T\A9!@XD>9/QNA;U%#HFTN
M<I94RZ\JFOER5.<KEDZ/42:JK>@-N$MB#RWD+WN/L+XN@*)F,9F ;<RLZ1<J
M5-342H[0FA_KZ]!A%V\8'^\1*6]_M-*CBLB0.D4FC,76$66.ZR J9LT3)J:X
M9,3594@A,L;0LY+*=+!GR)M4$C+D#=$&69-C-(VT2BVZ?Z_KA-ZV6RH'AL8]
MK?#O_3R^' +\#=75L_JJI8QEG=\TV+4FCA=R />A'=\$G%W0T^RAB$+<I[EX
M.)3@J:EV*EN=#ZOD#'/\?]L9A_/<77BYD[#D/(&.?X_[8S#^>XNO%S)V JDZ
MX$/9&WI9\LER7QQX00PUOLOPF325>1VCNFMBQ=\2+G=2D.UW(Q=FCB1Z"+L&
M'6AA"+7MX<5?CJ1U?/B\"?F\7B.C4N\9CR6_>,/-URW##1@# )#\4/.$K3Y3
M=/=UXRC^Z1WD<?>;Z?[<I9>/<V[]^ /.,_[$JA?#FF\W+C & 2LX.HR'#EG1
MB-3W[O"B9EEF^#J5*,[N?%CCO_RU2,XA42+MUK^N2<6/L[==UV;WK=F9&]\_
M!OG9.K3!4^73>DQUYE=UJ6.M'R!CG^/^V,P_GN;/;KQ<R=AJ/'D#'/\ '_;&
M8?SW%UXN9.P#R!CG^/\ MC,/Y[BZ\7,G8!Y QS_'_;&8?SW%UXN9.P#R!CG^
M/^V,P_GN+KQ<R=@*^NJW#&)#TX>92Q/XZ[^GHN8&E=_E,H5D]V$@KL[XF5O!
MZ8\/_,LXDPL7]X=YZM#7_B]/U=\P^!./B.I/]YS/U3CS'\N(PH8 P"5W!:OB
M[7YD<9JT-=1L94[NB!Q8QX+1A<#&P#R^I$0EH$(E*,*L2?1O?-$"5)]&;#W.
MS0=O=:P_*#0FXFP/BK#[YETFVL4.H2#IIL)([I=)B7>S=4@K$A)$5E[YBQ&7
MU9R&6X#Q ["F,\,8E9*MGG4.M2-3;)NC++MF5E(S8R05CI#C+"2)FYJO2%$5
MM[YJZCNF_ LLO[0SI^[))]^<U^?BH2?TWF?V!"_FY^[?QS)W_M]*_P#LL7^2
M'R6SH[PAZ4/21GY0!=E4;=O$,B3-D#:%ZA@?/%C:]>)7HE+/S3&IV\3/3.[>
M+EP2%GBQV;5_>?!5Z4TU^*A)_3>9_8$+^;C\<R=_[?2O_LL7^2&F4O 3B&MC
M;S,D?48I=7$(Z\(8]()4E=*Q/C;%('0"DQL8WE\*ML;8V/#B6C5F(6Q:J(6J
MP)5(DY!@2#=A?BH2?TXF?V!"_FX_'+GO^WTK_P"R1OY(2NJ_I(1Z"SZ 6*3?
M+C($T2E4:EY3>G@Y386]$,KFC=RTI#TAFYYZ$"\"?11;DD ::G";I00$8@AU
MOV<.=S/*X?Q!1*\W&$>:=1JM3ZHV6=1(<)LPLA-PII(*Q4JD18:15A9FZ)#?
MF7SLQULU?!Q1W6$WB;#5?PZ_ \M)MKM&J5(=-MQ!%CNEDJ,G&E%F$@K2(215
M@I%W1(:Q8:/5N:KVWNEK_D#'/\?]L9A_/<_4=UXN9.P_(8\@8Y_C_MC,/Y[B
MZ\7,G8#^Z:$L*120J(\=]^3'%GE=^E4J4E=\*'H8.^)U+T:G/+[H.N[)/*,)
M,#V@, ,&]AVOXN9.P&69 & , 8 P!@# & , Y[^HZZ7+.[9B\NJ"K^0]=W!4
M#I;E.MMJ<>N;/!JJ7V1TO)DU12=3N6PZ_I"[I38_-I2W&#CK2M8FV<PU_K12
M]N&DK<_L.G <D6WY*WTJBHNM+VU:>/7;3IN39Z9G$FO:$K$FTH]&[7ATSM>N
M:RA$AA5KW1!KW7P>.TVNGX&5H:IW6PE<*<SI?+IY8=N3)>Q.SHD<)S8[]LG3
M0C2(X^T@Y;[-NC0FFW!Q61-")H0LWP<1@# ,-G'Y,:?7*"^][+DIKY%Z%(75
MRITH9ED$C *F.N?Z*?EQ\@5K]=M:9[>'/#4CY<7J\4Z-2[QF/);]XP\T[+=,
M-& , D/Q0\X2M/E-T]W7C*/[I'>1Q]YOI_MREEX]S9OWX \XU#V'5"^'--YN
M7& , EMP0\[VAO78O^%N669D;WS\&^=DZM,%3Y=-Z3'7F5W6I8Z^LV>&H\8
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M_&07;_9_QTU#1]G_ ,=UV?\ Q@Y/^>[RG=*D[<'$8 P!@# & , 8 P!@# &
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M4FCK00H3*"1Z,)/(/*1@-).*,"$99I8@C ,.A!%H6M;Q==J\XLFQ.8RO()&
,, 8 P!@# & , __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>g472601g78i68.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g78i68.jpg
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M 1$  A$! Q$!_\0 'P !  $$ P$! 0            D%!@<( 00* @,+_\0
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M@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.!&GY.OT)Z>_O+.@O\
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M <!P' <!P' <!P' TA[YAK4D-5PH'64WLZN&9FV8N#L2;4V4C8>Q(U$#XB2
MQ)T8_E&NS!&/A;*(P M8&[?'RBG7K*4+MM5-$ETMQO>##_BF<WB[HF;N+W4N
MU>2[68T28.;_ )D$F4[WRWJ>KT)PV9NHX6)!VL'%VUI8@FOU6J(Q20Q!B(EC
MIJY<'MRI 3C-,/'WWZ1)]P' C3\G7Z$]/?WEG07^(.+\"2S@. X#@. X#@.
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MVQZZZYWS[6VN,ZZ8]G7/IG?.N,Y]-<9SMG&.!^O <!P' <!P' <!P' <!P'
M<!P' <!P' <!P' <",_OMV0VK,>\K0E5$?D9:0 ATYI.8R',3G\:86? "R<F
M8DI35N236Q@N((4$AY*$L45'C\!CY3# I.I5!!8]V^Y8QC?O\>Z>485ZTC";
M9S;UJN7QLQ+YITG*\@XG"8O5\IL\Q-JB<Q810H<Y+8E*(W%"1R76#IUD?$*1
M(2@G8RDW1'%84OKH^A#.([F4M3NI'?>+>9F9FLVCM^LLM4A? <"-/R=?H3T]
M_>6=!?X@XOP)+.!;\L#$)%&)"!$R8S"RAD*3%CI?'40C@]%WSYDLU:R *WDH
M@_'5R@A=71^P1.@C A1TW2U(C'S3*K90;W2D^:+SL1X]^R5N4)=%6"O);VJ?
MD[&JV=PD>PF$3ZE,HD_>2:-$@[9A)WD$ZO1J:M(\]6>:-3+F*'P\A0'*N51#
M]L^U14PWNWE18FE+1:8G_+*>OGK=Y"_&]_<^ODXA'>:L9;9@<YU9AE-S#26$
M+YB$SJZ2F]ODEN[W8MZT&[N9DQ./)"K[H8XQ*HD[C[440>8D8EYIA4*ZN]?+
MY\W?C_K<'%PSPQ$S,XQ,3$1A..NE)Q>XFO\ K!=4.F4?D\B[]]I+0"!WWQ1&
M 36*]2V,6E"'N%DODXR[@O6>'2Y!KA171SC<%)@[SWR"6N7.4<JI*1YYZ1_V
MY?\ E3E>)Q8V\@T9G.(+.;0B>7[!I772_O(Q<2025^3#("4RB 09]"EQ2C5=
M(PF_W=1 HY:D!2>ZHYRP15V4165:^\L9^%M;]NYG%8PFO\]VALYZJ]K9,$<D
MX5%>P\5AK*;!S4(ITSV%UL]UB7Z0345-K%EKS7LM4$D(P::R!Y[<79A^Q 4W
M#'H8G._R:;%; ?"XPM76.WZ]J\BOE[7C*<<[5F++HFG7CO ^!MCQ" JRF6$=
MK?%3(>$M(P\^ C4ZO"HIBU'1!32[J4E,I#-P<7+;C8L4NJMT%PC)9 ^:=+^S
M$).RRQK2\>U+X9TY79IUBF>M(FV>NC%+;IAW/;U\D[>QBS-[J?UF+KPM,Q=X
M)/B#:JX+W$M:<.JN3=O;G![O9)+>M$OAL2@YE0GCW3@.;"2:Q88X6R<*K4YU
MPOAOQ:SY8S:+\5(OARPPP\,_UKU([-1Y@8,DW%PR%2/]?;S;4M%)M?9Z,/XK
M94ZE#A2,Q@QF!VC)$&[\5'"!IO$#CR>3]2",":+$!8@)9J/P#6K&46K[ZF]V
M5;J=UO[/Q2>5J6LV.'Q\0B?9R0VD%&R"3X>;PZ"R+IW/:J(-600K>W88L$PX
MMHI[_P";K:V9SC+,^A(]B.BSLXR$+4YTYZY^'@E].LVQY<O#Y8^N/J5VQE=@
M]M1T:#3LY#KJ"3]DB7G%FYW1:(ESS I$6M4DQ5[( $&[-%@.9L8U-NM$8(U^
MP;$4P]N'E\[ZRI:G/>X\:Y+6;;CTZ1>9PPO-/OLSU2[<K124551X*P"T)VFU
MYO*M.J7W.G$E@^TGKFEMJR**&2?8RM#+,.E9N+?*.9G(W%RG:]2268Q:GR3>
M8-BX&$4KVPIE-\8TI'/E2^40736Y)Q/1LOM\E<ONI5?9%Q8C$9V+GT8%[40I
MU*#L&@+4!7]CB@[!HX[*!F#XLP!-DRSQZDY=N%G$5=K^_N_&OP5FU/&T3G7.
M+6K';PDFZX@IW%Z"I>-VBN1=V. JZ"AITZ+E\'RKF5BXT.9'5B1W#E[\LOU2
M2#G=V5R\=[$%]MW>[E;9;*FR:5FF&21AO>\9Q9IY%. X#@. X#@. X#@. X#
M@. X#@. X#@. X#@.!IS9?2JN;/N9"Z"DCEPHJL3IDQ(X\,9UXZ$2A_0,Q7G
ME8;N#DC@!^PHRW#21=1R_8P";Q!D=0V6;%6[G1\2R]5WW^4])QCPB/;FV<B\
M&AD)VD&\.BD=BVTL/N97)_F\'8!]3\G?-6;)](2^@]!OH_-/FP]DB\).=5'C
MK5LCEPLIMIC/"L!]H+=N6GHH^E]85I 9D!B43E\ZL _9=J+U@!#AHF/1>I@@
MZXJ$SXH3E4BTW=[C-GPD3&&*0QQDH?0=.6#-R,^7**SZQ[]&$*H[J3VR)S7;
MQ]3@V)TA;5OSZ@82<+38A^6-E:%:PN>R>3IS:L<0O2.1Z.HEJDLR+HN&=CES
M6KP0$?N Z30VLD,+3TKN_.,OWAGRAW;3C*0=+:(>VI732[2_D&Z$S434#J:1
MM"SBD.2[$!VZLJ'014EK*'D<37%$T%#: O<;HL/>I;.<*-5]4Q$3,3.48SE7
M2N&<;I$R]\(M^5FW<;C$@D#".')@_"!2A5E$XS\D_.*3.A[)9VW @LGB@,'@
MN752U8#LF#0D9\6NC\<29-O>N4QO=*SY(Y;0\CTGIFNYG:]H=!.YD(KROH\3
ME<QEAIWU*3& 0 AMNZ?D'7N>TR[A;W2.F<(M6B#AZ]<;),V3=P[7114M-Q,3
MZ2169I%+TC_/&9I'^&J&.B?*HYJ.[H?V%E/8F =IX_Y&)7L+(],Z:NSKO);<
MZC3]T]1%=8(T&C;BT C'=G):M1%0N[WA4V(8!K8:-7[QU\42]T];Q_AJ>":5
M^F8GABDS,<5.*,YPK%Z3PV_TS2;Q5Z":_P"U5GS291^+F^BG;2LQ1I[\(]G<
MY6ZU[1*,I>Y55P_.:0_L3+)-LSSNGJW_ .1XX6=>^62_XM[KWBJ:G3O'M+%>
MG_?WX(CS='M??4IH@T/E(E'0S'8OUH[<W(<ABRS<>WEA:F %9R"-,7!K8:2?
M"-,ZE33'9RS15T3T*;N'+)_LU;(ZHBL3.E/.?Y7/AC6:>4M4YUY&+V@Q C$L
M];X9()7&R@$Q+"T&LJQ[4@HJM9A"MI=&S#9O5%#36VR<G;[8T93-J.JAU$H8
M-<Q^3$):L,FD9T>(BO[UT3*WAA3+_P HBFE[J&^\B$F1-#9=$]A$CC,G;7>!
M@T4)E),8&S:1!;IJ:+PTQ'_R:TQ+K:-Z8B$@D3\/#XG7$H/*CE%G1A+#,<1D
M =:F[VM;UO;G8PO[X8S.-.BT!/D_NXD!<7,VJ2&/J\(5_7\9$5ZVE<W<RK2^
MI#VTN7JVLLU^ IIQ(7\#*R&OT2JFRXM.6#H\T8:-H,K)BA <W4BGC%^L>U/T
MLVG'*M*1A2)QK_JOAAS9FA?D,N&1.C;61=?HC7FU<53<EFVJK/;0E443:)5L
M=4C\:0A[(M4")]0;.%GP$@Z=3H#"SL58J&$M(S)'C84D84O3TOZ?R3:*]+=?
M''35VJ5[N67=]G5-$BD71K1Z,[0RRH+'#,&D]38RZ/9Z;3N^8RXP.N:IZCLN
M-*(&,1UTLV(PL*Y6R*160>/A!3='92D36-/#'UIC=-+XU\;^V#/O;CL(_P"J
M,DKNZ9=('V:#7B]K0B=0]B#2*/G%DIQE&QZC.A7#,>N<U)$T:_G=7-@*#A5I
M)))8D-0398(LVVZK?AOO5<XC.>W3KIRB6B1KLUVUZ^MK](7A8K>21RNNMM6C
M9J::1:,MLTUV)L"K)=*!MAM70@2W0>5H1L9%O7IE,TB381O?>OY"IEC'=)Z5
MTA2T4SK$WFOGY1'G-ETN.QM]M2"]CRFS9BSJH7*Z@CR%A5>IUXE=80A0HWK$
M+)HIV J:8)Q"[]Y5))M(I,R>O:UD)71K'BD5,PIFS=)JLG-RWKO3O0S_ %O2
MM9YQFFD2][_?>\SKG'M8]W[/KZ^S[.OK[?U8Q[7M^W^;UQ[/L_7Z^O(/UX#@
M. X''IZ^G^+_ '^O]O\ Y\#G@. X#@. X#@. X#@. X'&?7]7[<?U>OU_P"K
MU].!SP' <!P' <!P-5>Q_5Q7L67K0KM?5TU$E6)AW(QX*M6E)&(O))+E4<N!
MD$QC=TTS;P8V4A;D?E_#%<,VJ0$J\6-(([F6PM^.'A'C7VF%&A_36*1&S@]B
M9M&VY&)CLZE5N1ZJSSJO-:W"W1/8T=C$\MEBD"KH'-=9)+D)?/"I$ K-5:Y'
MGIY*"L>@X5=TRPP%?WKZT\F O)X$"J1_IP>4$"]SJ'DBZ#,436[!IL6299["
M1O;+1(CE'+Q-KG957;+?1;".=E5,^QZ[[>H2@<!P.J^8L2;1P/),VI!@[3V1
M=,GS=%VT<H[?X23ALOHHBLGM_P#5HIIMKG]>.!::%:5PU71<MH!"6[ENJFNW
M<(14$DN@NEOA1)9%5-AJHDJDIKKNFIIMKOIOKC;7.,XQG@7MP,4W!34)NV$3
M*#S!GNDE,ZXL.K5Y(+2')RL#%[/!X 2W2-%"+ DD-<OFB+)?;WK-VS6=C!RC
MYD\3:Z(Y'KDL??J#U;6BFD'<]>Z9=Q'23N9MB/.:TARHC:8O6R+-[*=Q^P?X
M38Z]9-T&+PEE'XERP128+;[LDDT-54IO>'@KLCZS=>I>%<QV4TG5L@!/-WJK
MD.7@L;?#5%2)L3)7ROP2X[=#51U(0 ,XOOIIKMN5$#W^<_$M$5-%?E:1[>#H
MK=5.M;@8D%5H:H=@Z "1Q9 3^3N*ZC$8U+S.\CE %$?H,U:I!STA55.E!VB6
MK5V955)JI[/5-U]@N0+0M+QT)K&@55U\(CVL1*0# 0?$ +85F#FWFY S$E&"
M;'#9:.EGZBKTD(53W8OG:JKARBJJIOML-[H_"$=>Z.K7Y*Q7U25S"M09+<R'
MQ%X: !Y&F%0YB.J%F>PYBWR@34 2 T$4()YP[W$E'P[=;9FY51V5^2B]IC!8
M;80ML#G47 3 ,S- )(U%240P-#F\@BQ=G((V:19D$%T$R@(X/8EQ+[73#@>1
M9MW;51)9+3? W[.H8K6OI A-FQV%Q<PVLD.E'K!;$P0M^WFP% <[$)!I6@Y:
MJI'Q:8M^^':L2>KEMJR=N6V$\(K;Z9&[,?.>KO7%[/QEK.Z+J5S90;Y#R*G:
M]>Q126,=XPWPUC2S<[N*R0T<QYMHDW!.L+_$"$$&Z3!5OHW1PF&>. X'&<9]
M<?7G'I^KZO3/]/U>O^O@<\!_E_R?[_7P./3Z\?7GZOU?JS_3^OZO\G YX#@.
M X#@. X#@. X#@. S_3Z?T?^' <!P' <!P' <!P' C3\G7Z$]/?WEG07^(.+
M\"2S@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@1Y66U
M\@>W>>I7=;D:_P!>E;>.*C++P1A[1U)T2$I5:&WZR'MWF">'R$;VJ+$8&R[2
M&C-8.EV+2RR@-U)C)"9K,U'T_3-<<MTG76,,<*Y([=7+(:P_(;&HN<E4;<VG
M:A./RJ0P2K3%R32,UW&ZKL6:G#T>@@2.2YT[?.92"@L*;%5HO(1X,A-1Y(D&
M(L45VRA(C'EZUB-X88H\S4[[SR@%EK9R-U.C1*L*^(2R.T[6-IU.+K53<'"G
MM_ V*P2N9)M:T]<1C-EL(9)8+V47V:3%_&Q-;5+\Z@S.9N2VK;SSTOEVC.LL
MY9(3''7LE&FS#L%BO-NT \\Q:9C-\_E,^B/I?@-F;8:%%A7Y2<"=M]C*R,1V
M?8F:O7[UR,#;0O#77 SRPY8TTY>O6C#]1CKY87G2\G,*7A)DMB@F'Q"M+"@'
M9L<R"]>5K7[%$(I9TCMC6S658H63'J=/U[FPXYV!KPC9KY_$XW#2Z>DOE<7,
M)"WO6V-JQ3KAE2M*IO\ ADX#@. X#@1I^3K]">GO[RSH+_$'%^!)9P' <!P'
M <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' IRX<2Y)CS;D6.<
M&1+8@S%%UV394F,9E]F6Y5H/?J);.F;8GL-';$$&RJ:3W8>RRYU5RU0]V%1X
M#@. X#@. X#@8?9=@*4)6DZI)A:$(=6VQT=[.Z]1D0W>5(;#Q0TZ_0W$87^*
MR]8A#(HP]8:Z9>M!1%D2<-TV3E);9O>_6#OVFG?!IGY.OT)Z>_O+.@O\0<7X
M$EG <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <
M!P' <!P' 9^KZ^!%K"*7O!E=4$B!:J"0^#U?W4[&=J_R];RRO'40FD.N6'7L
MVC<%$QMG*U+88S<,7OIG'C*!^"L(@B'K5<H.EI+!4*)1+;+.(B8Z4OA>M/-E
M[METG+]K3\&(O.TEZ5'&Z\EU;63&X+6P2B74?;VG5$L7F4.L)9_8=/3B5."K
M,M\FX<!5I#O$'C<,R3<QU7*Q'9[;9U[_ *E+WI2\3%ZVK::4F/.M&$W'5SO;
MI>XL"W\A79U2A%:H,EB<UV@71G$C:6VWEP-H&C";'/6K1WN%?Q!R<**N](ZL
MW1?#T$53*"BJ3%RMN?UGD1A-<;4F],)RKE-)RKSNR_\ 1&['_::=M_NWZ0?A
M.XMI/>/AFDZ_=^1]$;L?]IIVW^[?I!^$[BVD]X^"DZ_=^1]$;L?]IIVW^[?I
M!^$[BVD]X^"DZ_=^1]$;L?\ ::=M_NWZ0?A.XMI/>/@I.OW?D?1&['_::=M_
MNWZ0?A.XMI/>/@I.OW?DP^TZN]\-[[.@7?D)[-I4$WJ:,%@4WT@G1?:1O[<=
MRZ5LY1%W _'6K=XD&%1!E$BK5XI&VS9=Z7=HI&GBK99BR6Y]_>G1:6YWO7BY
M4_RYSSMICF#Z(W8_[33MO]V_2#\)W%M)[Q\)2=?N_(^B-V/^TT[;_=OT@_"=
MQ;2>\?!2=?N_(^B-V/\ M-.V_P!V_2#\)W%M)[Q\%)U^[\CZ(W8_[33MO]V_
M2#\)W%M)[Q\%)U^[\CZ(W8_[33MO]V_2#\)W%M)[Q\%)U^[\F#HAUB\@3N^;
MH 3#R ]E15!!(?3;RDYNQ@_1E:2R^8F=K(Q= F0CM.MSYRQ8Q+ VM,@'#F/
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M5CUQJ(W:Q$2S+M11N#Q_.A:1-8A'!J\\G$=@C0_+Y6Z8E=8U#(Z[D:)R7'4
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9^CD:?? <!P' <!P' <!P' <!P' <!P/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>g472601g79t06.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g79t06.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[1VV4&AO=&]S:&]P(#,N,  X0DE-! 0
M     #D< 5H  QLE1QP!6@ #&R5'' (   (  !P"4  ,17)I8R!,:65B;&5R
M' (%  Q!0U0Q($-O;G-O<G0 .$))300E       0V4=OF<QR%N99*4(-SZXG
M\#A"24T$.@     !>0   !     !       +<')I;G1/=71P=70    '
M $-L<E-E;G5M     $-L<E,     4D="0P    !.;2 @5$585    !$ 00!D
M &\ 8@!E "  4@!' $( (  H #$ .0 Y #@ *0       $EN=&5E;G5M
M $EN=&4     0VQR;0    !-<$)L8F]O; $    /<')I;G13:7AT965N0FET
M8F]O;      +<')I;G1E<DYA;65415A4    ) !% &P :0!N "  -0 U #
M,  @ $0 3@ @ $< ; !O &( 80!L "  4 !R &D ;@!T "  1 !R &D =@!E
M '( ( !0 %,       ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O
M &8 ( !3 &4 = !U '        IP<F]O9E-E='5P     0    !";'1N96YU
M;0    QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P     "+0
M !     !       2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O
M;       0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;
M0VYT0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O
M;VP      $EN=')B;V]L      !"8VMG3V)J8P    $       !21T)#
M P    !29" @9&]U8D!OX            $=R;B!D;W5B0&_@
M0FP@(&1O=6) ;^            !"<F1456YT1B-2;'0               !"
M;&0@56YT1B-2;'0               !2<VQT56YT1B-0>&Q ="=LD
M  IV96-T;W)$871A8F]O; $     4&=0<V5N=6T     4&=0<P    !09U!#
M     $QE9G15;G1&(U)L=                %1O<"!5;G1&(U)L=
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M   X0DE-! T       0   !X.$))3009       $    'CA"24T#\P
M"0           0 X0DE-! H       $  #A"24TG$       "@ !
M  $X0DE- _0      !( -0    $ +0    8       $X0DE- _<      !P
M /____________________________\#Z   .$))300(       0     0
M D    )      #A"24T$'@      !      X0DE-!!H      S4    &
M          ,/   $MP         !                          $
M        !+<   ,/                      $
M    $     $       !N=6QL     @    9B;W5N9'-/8FIC     0
M %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M0G1O;6QO;F<   ,/     %)G:'1L;VYG   $MP    9S;&EC97-6;$QS
M 4]B:F,    !       %<VQI8V4    2    !W-L:6-E241L;VYG
M  =G<F]U<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG
M:6X    -875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E
M     $EM9R     &8F]U;F1S3V)J8P    $       !28W0Q    !     !4
M;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   ##P
M  !29VAT;&]N9P  !+<    #=7)L5$585     $       !N=6QL5$585
M  $       !-<V=E5$585     $       9A;'1486=415A4     0
M#F-E;&Q497AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0
M"6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0
M   )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L
M=     MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4
M3F]N90    ET;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N9P
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M#+JWLL:X?2K<'-G\[:]L_G(JY'_%3_XA\'^O?_Y^M77)*<KI/UDZ-U?*R<;
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M26NN==K ]UMIOL^@&^WU+'*P)@3SWA5<3!MHI=59DON<ZTV![M2!(<*_=O\
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MW'VM_E+Y8224_P#_V3A"24T$(0      50    $!    #P!! &0 ;P!B &4
M( !0 &@ ;P!T &\ <P!H &\ <    !, 00!D &\ 8@!E "  4 !H &\ = !O
M ', : !O '  ( !# %, -@    $ .$))300B      %*34T *@    @ " $2
M  ,    !  $   $:  4    !    ;@$;  4    !    =@$H  ,    !  (
M  $Q  (    >    ?@$R  (    4    G $[  (    -    L(=I  0    !
M    P    .P ,31    G$  Q-$   "<0061O8F4@4&AO=&]S:&]P($-3-B H
M5VEN9&]W<RD ,C Q.#HP,CHP." Q-SHR,3HP-@!%<FEC($QI96)L97(
M  .@ 0 #     ?__  "@ @ $     0  !+>@ P $     0   P\
M!@$#  ,    !  8   $:  4    !   !.@$;  4    !   !0@$H  ,    !
M  (   (!  0    !   !2@("  0    !              !(     0   $@
M   !.$))30/]       (          #_X0%,34T *@    @ " $2  ,    !
M      $:  4    !    ;@$;  4    !    =@$H  ,    !  (   $Q  (
M   >    ?@$R  (    4    G $[  (    -    L(=I  0    !    P
M .P   /      0   \     !061O8F4@4&AO=&]S:&]P($-3-B H5VEN9&]W
M<RD ,C Q.#HP,CHP." Q-SHR,3HP-@!%<FEC($QI96)L97(       .@ 0 #
M     ?__  "@ @ $     0  !+>@ P $     0   P\         !@$#  ,
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\
M$0@ Z0%G P$1  (1 0,1 ?_$ !\  0 !!0 # 0$            *!@<("0L!
M @4#!/_$ %T0   & @$! P8)!P8("P4)  (#! 4&!P !"!$)$A,*%!4A>+<6
M,3@Y479WD;87(C4W07&U(S9UL;31)#(S-'2!LK,8&B4F)RA&4G*2\$-686C!
M&4)$8V9GEJ'7_\0 % $!                     /_$ !01 0
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MC^MU?_CV-8%88# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MZUKKOU:U@-;T+UZWUU@><!@,!@>.NOIU]^!2$Y_0B/ZW5_\ CV-8%88# 8#
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MC +77IU"(.]AWKKK>O5OX\#WZ]/CP/'77TZP/. P& P& P& P& P& P& P&
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M:6D7.ARAS6)0*0&A3JW%0>N4%: <K.-4#,&(*AP*/G/Z$1_6ZO\ \>QK K#
M8# 8&-O,OY('*SV;;S]V$HP+:]F?\W)P%]B_B_[DX3@9N8# 8# 8# 8# 8#
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M6O;2UL;$:-XD#:J:$*1S],AKY"H;'V71E.08>3*%[*^-IT1*/;G544X)3QD
M" 9Y6;=0>17(3@;=8(T?#06%PKV] B:UX1/CI'0 OBW$&F=]7-Q)",J2(/,_
M-I*TD!-"P/Y;BQ"5K1MHUAX9^>0Z?K,[13ZB\;_X_<6!T-L!@:RNTX[0!Y[/
M^L8?-F&HWRY'6:/JQC21V(;T]R]#MN]%K%#H@KQ,H:WB7LX42E4E>5[6_-OP
M45*65P7D."!4>46$.#RP2X-7]QV[(VYM,J..!L9GY/R8+ @DB*7$,P5Q''_H
MVF2%O2($;@M1Z!HAQ\W2% 2+P*4.^^-,(P089>1E_.NV%[&5M>\VCL#J0X#
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MFWK)>D[:D=YY8U,0"82YS3,R AK:2%\@?6):YJBFUM2IF]"6>I&%*C3DIB=
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M_ V3_MUZO^1%W[,""3Y<?TVR]FSO7Q>D>5?^KJFX][]>\#61Y&7ZNU=L/?\
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M!O1B'O9@7<YT3:[P2=^$F+Z%[#L)IH:SK2[&+BM<%BS6TIC*[J%*I])'252
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M*Z1#;8ZC1'J$RZ2IQ-@;;\!@,!@,!@,#QO6MZWK?Q;^/ LA7_&ZD:LG4RLJ
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M"7RID(8RVJ1O*1:&7#6UMS(VH&=G0I&QI:D:5N;&U G*2(6]O0D%I4:%$D(
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M5-_C.DF6GNT;%)XG&9,5$GPQSBR:1L#2_)6<EV0)EA89<X# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8&O[M0>+6N8/"6\:9::P@]I6$[Q18IJEJG#;%%1#//
MBP;2M[XQ.DO+VVQE^);5CJA3/Y2IO5)TJ]8ETM+(5G@,#53;/ OM"45A7^U\
M9WV9\?*:.F')Z=4A'^/]JU_3["I<T?&?@3#N)[(X19F4)$1$3;+-JF]&_P"#
M;NU)&M$SI539)BP0B7E-[Z%0I.+?:TQF[Z(9TES74]<;J[Y.V^MTY'6M&YS9
M2BI%/("N9;6KM<KK(;QJU18D!<:<2V#!3FJ0(;LE<3;W-22EJ Z0&Q:2Q8*X
MY(49R*LCM".1<<KE\M."ZM& ]G$XI[,K2;KJR?D_&^N;(Y3M7(J%QFPR3T8V
MUY;GR8QY^=V1D7%R-4EF#$YM1 E:<I2F#%U#PO[8]%3138Y6/:TZM,%0PV;M
M3_.^0$#?Y%!^4;SV=_/FG;+W I&8]I@P]I1<@YMQ9]#Z85"=@3.:APFK8K.3
M$3=ZP,G*HI;E#5O*GBI![MD=J6B2T<U[3MNK9]8DO(M.2,W'Y1V7CA#KB1/\
MR0!.,CL;5\Q;$.;HQ$'C;2G)[S3J+-@(PW,("0D"8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# _/_VG_K_NX'Z8'H+X
>P_O_ /KK ]\!@,!@,!@,!@,!@,!@,!@,!@,!@?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>g472601g86x34.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g86x34.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\
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MI74EC"$@3BL\,ULS0;MX1(9V%DAZ-:-6GP22:[-6_*8BJXXYYG90_P /SIU
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M][2;EEKZP,=&I3E=WLXV=+"'4JE*8M:N&I51*_.2*8*1@# & , 8 P!@# &
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M1H]T4>\\.RL88L$O0,&3E?GTSI/G?A+T:7GJ[Z)[>9OA)3%PKO3UZKV,2R;
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M*UX5'W>6S]$07VROFO7[(-W)\'7QBMCS; ,].(=W57_^+]E><8I-MFK$V:#
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M]+A\E5L2:L24HC-APR.RIOS*63U3<DFHJLD#DIBCM),M=<$W[MBJ3%8*1@#
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MA*N+PTJ27%34=ADQC!MM"I P*QESL4A)Q.+&O1$YK7XTV-,*O@TJ^&8UJ$+
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M/J@_^?<U_P >.>S69P&MT>J#_P"?<U_QXY[-8 ]4'_S[FO\ CQSV:P!ZH/\
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M7@P?=Y>7T1B/VR5S+CBF>W5\?@NR_*YDP1X]'<[P?_#5M>0R9L#9G :W1@#
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M[IZ9#+ IV(Q:L9-6)MU4M?BIA*G%=D#YR,'M+#4@D5L".1DI-C#BP#4#9L!
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M7[P0, 8!&GXCO_SKPZ__ ,EE ?Y NK!4W\+WJDEF"D8 P!@# & , 8 P!@#
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MQT1@# -O;W(;\HKN!^96"?YY<Y:KA4_@-D]]Q_\ 1:=N4S?R)XU-\K+*'=&
M1H^#A^"[Z0_F)C7_ .]]@KB=N[E)+L% P!@# & , 8 P"-?L;0';U7M[!.U?
M50IUO<.Q'6^8=?)1%^P;NSF#?EO([.B-CMSX!Q7 @DJJLDK%4ARR)%5NGHFN
MIOHFOMOKL@)1<%1=:HN5<J[TVGQ]\>,7_5/AH_K#VC]F,##:O,G2/?'C%_U3
MX:/ZP]H_9C PVKS)TCWQXQ?]4^&C^L/:/V8P,-J\R=);F74'XD5_6/UC<W\^
MZ0QNM*)[)0;L$8WIXG?!"=&5H. F(5L!&MYI'FP#A-_ZVJ*+K.G3?9'WMINF
MIMY-D51**B5S6J*F2)Z5)=,%(P!@# & , 8 P!@# & , 8!ASV8$]DDAI0[5
M,7K6Y5$2\.4K6!&8&";R.K).B\02,W-M+YQ<$;B\W?1,5L<=Q>$,QM>$7Q@B
M+8+3IB.2)D%!.')GCXM726?.T884Z^4S5C.C+N(@JMDT)GY06/O2M(%<9H\Z
M4M':3/VL@B4F80Q[,!<O?@9V<%#9O5T/4:S#ES Y*V(0S2"N@KBM>37R<N7*
MOA,R*!"V;':5K$%<IE&06B*AP9E-BR*[5Y[Z-HMM=5N')!@.#L2Q!LGZ)H3,
ML0XAD9(H.BK04.;O$V2 A<SX,XP;YL"2:<6),==M8?"M^5N&-?>DWUW-3[C5
M+;C:"\I<)I<Z;;)\Z):*\[+*>E45UX1U2G4G*OH(UKR)Z2L/54[^4J:_H%=>
MP.02/54[^4J:_H%=>P. :F/NM8.0&]8^J2CR5'I!HI>\FTT0+MXNBDWVXKY]
MMRJER!C81;93;C^9SPNLLEYO/EU3XW\FV72X+/;*U.\8?E#3JS7:M]]Z#1"R
M]QT1@# -M_W)(->DNPW;K1E("\?V2IB#;[K"$0*RCC7F<...$EN#P0VCKIIS
M_.UY;I(*<[?\2FVO\W+5<*G\ LGON/\ Z+3MRF;^1/&IO6>JIW\I4U_0*Z]@
M<LH=T>JIW\I4U_0*Z]@< PU\//KA:O7CI-UJI*RY@=CT]K2L T7E02/K5X<"
MC2S)1ULNU&EMX80W?MM.%=.='&SUSSOSSS_O.?)\0J<M7*J9*IF5ZJG?RE37
M] KKV!P4CU5._E*FOZ!77L#@#U5._E*FOZ!77L#@#U5._E*FOZ!77L#@#U5.
M_E*FOZ!77L#@#U5._E*FOZ!77L#@#U5._E*FOZ!77L#@#U5._E*FOZ!77L#@
M#U5._E*FOZ!77L#@#U5._E*FOZ!77L#@#U5._E*FOZ!77L#@#U5._E*FOZ!7
M7L#@#U5._E*FOZ!77L#@#U5._E*FOZ!77L#@#U5._E*FOZ!77L#@#U5._E*F
MOZ!77L#@#U5._E*FOZ!77L#@')9QPPV=(.%I]+""2*NJBC%XS@NC5UIKSY>4
M5]V$+8O=4M^/BVY;.VRW''_ KIS\> 59@# & , 8 P!@# & , 8!1;+[XDF^
MA<'^W+#R=2<J^)"-:\B>-2M,@D8!J->Z[?DO=3?S]R?]GC_+I<%GME:G>,/R
MAIU9KM&^^]"FA)E[CHC & ;>WN0WY17<#\RL$_SRYRU7"I_ ;)[[C_Z+3MRF
M;^1/&IN_*W33B#N4,%[9K-%]"$M%YHR5GD63=Q!!0PM'4UI0VW*\+ $E) W<
M ]%"VC338P@L,UYY>I;H:V4.]1=BXY%L+%[?437(-A(5)9Z]#'@2=2Y=:JV^
MMC\"8'5C40]M&?%]XPL]0:16O6TAC_K$XX65([/CX,*&&%SQ@:+=!1<J>JE0
M73V1K.AV8YU-%I _W?QJ8SS=A#X\0E1$96U<-!+^QK**-!FF^S6%P=H> [&B
M.O*KMP\.@PH(>9.F!HMT(I7Q<XA/8N#6):DYJF(#)@8>UVZV&R>9(@>.*];E
MTQH@DJ':279[Q[_?(\%]1ZOO5BHUX+C3@OAUR[#/TT1-/7=M+]X(& , 8 P!
M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8!1;+[XDF^A<'^W+#R=2
M<J^)"-:\B>-2M,@D8!J->Z[?DO=3?S]R?]GC_+I<%GME:G>,/RAIU9KM&^^]
M"FA)E[CHC & ;>WN0[XNQ7<#G^GR4K!/BX_I^[ES_1EJN%3^ V3WW'_T6G;E
M,W\B>-39TZZ](9V3BL9DW8HJ'C,E+5U<:I2(5J)TCLL"S7MI=D#[-W=Z^31(
M_*Q,ED,:G4&C<&#O(PBW!OF R2'E%GJ<D"C(G90[ZKJY/#HI1.3 KB;=!=WV
MA6,P.QUQD"L>HY30]M)SAB_ELUUK2;29D:F:=;2!B4 ,XZ?E8#@S$';TJ,*(
MC%'4:EC1)RZA_P !2 17=R9_MUXE87;U3L&Z"I)=]8$+!B[&IR8]<[;;,8<<
M5>I4W*YQL;(MJP=*2W76-S&0P11S!I&:*Z%&.AC<).A UKK%D(B7"OKZIM]=
M9SJ>ZED(!?Q"[CKRI$G3$+=\<#*U?48ZMI/.6MWVA#[&?R"YC(PBLTE,EBS2
M!QV-CE6 ]HW-$G$IG)7E,@?8!(V"KZ-=<DZ:KNRY<X,$# & , 8 P!@# & ,
M 8 P!@# & , 8 P!@# & , 8 P!@# & , HME]\23?0N#_;EAY.I.5?$A&M>
M1/&I6F02, BL\5;PN(MXI5;5=7$JMV05"VK"<$ILU*1^+#I4N67(@5P6S!PV
M(EQ";5))-?EQJNFJKOMOKPGRGQKSYV>FNS>2)=J8F9B%*LFUF8+8*M?%="1J
M->C])%:Q]56E*40XHL/JJ(BK2BURJ0>?R06GO[;-E?4]%_;7/9?NJS7Y'E_[
M7$__ !.'K1/QUYDZ1_)!:>_MLV5]3T7]M<?NJS7Y'E_[7$__ !'6B?CKS)TC
M^2"T]_;9LKZGHO[:X_=5FOR/+_VN)_\ B.M$_'7F3I)6O"F\%.$^%E/[8GL5
MOJ56^XM6'A(@['2"$B8JB'1"FE#.CUNX''B^[M1?=3E#=%1-'737CS^-]N?Y
MN>8O->^->6!*P8LC#E$E8KXJ.AQG1=/38C%14=#92E*U15.6%!2$JJCJUIJI
MD3>9XXYC@%2HL"+)'#A)@&"AF#PJ8,%7C<<+%"QS=1X0)$B#Q1%HQ8,6B*SI
MX\=+)-VS=)1==31+3;;@#DMW#=VW0=-5T7+5RBDX;.6ZNBS=PW6TU417063V
MV35153VU4253VVT4TVUVUVYUYXYP#[8 P!@# & , 8 P!@# & , 8 P!@# &
M , 8 P!@# & , 8 P!@&--K7,Y]',(92$VK-_;E?+#'\_C!<1(++D\5C;L$^
MD*/(ZI(1((I))A*Y W;CVL>CZLPAS;9B2>2/8L]X"IQ\V'+D5EUVL]Y=5#4Y
M;9,<P#&;%K6&2Z0@1CI=XRCLF- 6+R2QI)PZ31=[;1P\H1!KZ/$4GB+A@J@[
M23<IJZ:@I]VLO')S4\3W%3;A@[B\38-W'\'%A<ZJNQQ::.'B/&O$8Y4XY01)
ML=^=]M.$]N'&O">^^VBG&DZO"OH(U^!/251Z_ OQ":_5K8OLKD$CU^!?B$U^
MK6Q?97 'K\"_$)K]6MB^RN 8%]B.Z_+&,&"77.P(<X/1$S,8(_B\GHVZ[!FL
M]O=FPTWKBAH%#Q#BMTEC,L(,I*I*3JLF<*1D."X>ZB=0JQ^70YZYA*:ZXT_;
MZ_\ 2TGW/[OVW1C."ZUK"U')WFEK@N6QPQ.FK3G6@3FK]:ST:#2SUB0KWF(5
M<[=3"2MYE;Z369E8OP%"KAZUDW!$@BQ$ICMU)AOKMY/VIKJZH.W5H2#L?*8-
M:\:D,,K62$[9:=?4D>O4HWYL,/6,@#"53S>T0]PS$B\>.1*KR4*1X]0%=(KB
M2C;@3(B#B-EDW[US%-FJE<]?@1/G4SR]?@7XA-?JUL7V5P0/7X%^(37ZM;%]
ME< PI\2F;AG?AS]_&J3*7:*N>E/:ANGLYK^>LFVJBU%SM/39P\>1M!HT0XVV
MXY5<NET6R"?&RJZJ:6FV_ J9VS??)XT,AZ1G81.EZB3V8S+G;2KX#IMSI7-A
M*Z<\ZQ03KSSHJE%]TU->>>/YNZ>^VF_'DVTVVUYXYY%)<_U^!?B$U^K6Q?97
M 'K\"_$)K]6MB^RN /7X%^(37ZM;%]E< >OP+\0FOU:V+[*X ]?@7XA-?JUL
M7V5P!Z_ OQ":_5K8OLK@#U^!?B$U^K6Q?97 'K\"_$)K]6MB^RN /7X%^(37
MZM;%]E< >OP+\0FOU:V+[*X ]?@7XA-?JUL7V5P!Z_ OQ":_5K8OLK@#U^!?
MB$U^K6Q?97 'K\"_$)K]6MB^RN /7X%^(37ZM;%]E< >OP+\0FOU:V+[*X ]
M?@7XA-?JUL7V5P#DLYH'?.D&B+.6:*N5=4D]WD!G0]KKOOSY..5WS^.-F35+
MCG_B6<N$4=./CW4UX^/ *LP!@# & , 8 P!@# +?V-5T'M@,Q!3H0X)-1)EK
M(P;X8;/Q61QN0LFSU@W.Q>71(H#E47,ZC2942H3CYD:]7#%BP=PNJ,*$&CD#
MOHC$HS HO'X3# 8V,Q.*!V ".1\.VT9C X86V3:,![)LGQQJDW;-TM$]./CV
MV\G.V^VV^VVW(%18 P!@# +(6WUSJ"\BT-/65&B1<Y7R<C2AID--9W"2H%*7
M)"4)(FT(0631MVIH70!BT76KE5?CT37A-/A/19QJJ)K3_I%\9U$TZJ4)8>B6
MDT@FQ_A/4XV7W=RJ:IJE0DI'1@5+8=(%VLC06DE>S!E"XII,*XD"A*!RQ<".
M>R*.$GJ'#CD17U]?&5!$NO=.06?&+-BD(9B)F;VDZB[],B<<CABTY,,9'/7,
M6C3TFYC$,>6!(Q@^16 \B 8&ZG4@9-3<L6,%$$W>H%YL 8!A%XF?X-[Q!/\
M[(NUW[!Y[@J9V[??-\:&1=&_>4I_\UM?_P"4Q&"DNE@# & , 8 P!@# & ,
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M]#-"C?O*4_\ FMK_ /RF(P4%TL 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M8 P!@# & , 8 P!@# & , 8 P!@&MM[JI_!7./\ [BZ?_P#\DRP<D+V1OA^B
MIYJ&#N# & ?WC^GC_P#GC_\ O /:ZJK[U];_ $"A_P#EX=@^>5[@# & , 8
<P!@# & , 8 P!@# & , 8 P!@# & , 8 P#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>g472601g88e65.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g88e65.jpg
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MUR0S-F)V=[.XTB8G*#1#5Y&Q)41(9G."E*>RPO#_Q  = 0$  04! 0$
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MZFF%4VA0U2GO\CIV-P>2TPAE:6.V_6,$\=5H6=U@1,RCZ-LFS"R:/9Q/K<G
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M1,(F$3")A%#'(]8J;N/-\N"$\Q,M0TQ:*Q(I)%L!J=4F@[X>G/*'KS@,*-
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M=:\@:TBEPT_*4TUK:;I%:Z+2A(A=6U.[I$+FN9E9Q2)\0-CJGT2Y-JU+L*Q
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MB- 2<,LM:(8"CAD' *,%K0#!$FA!O>RQZTSNX]@[DR-X=I[UJ_8AK;\$V_\
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MI/?)=*92YDM,5BC8F)\8-4.JTTY.'8@$["887XPG"#PA)>C3%!G@-5!NER;
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M6#0@E8H/&8:<:U1!G9&71I@Q&&E-I9IHA&#&+?[#;(XG/C6RNS6,567PK%<
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M:W;WUY96%F9G&2.[<C6JG)4!"=X5"HUJVYQ!(O:W5>ZOLC#F--KDN<#XP;8
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MW<U\Q$MH/;FMK7LC#!K;EL4CC&[IF58X-8WMF9&I$VO"I$X+DZMQ3*5)2Q4
MS1YDM)(UXJ)&AK@!NRM/M )X*ZF5*A,(F$3"+\U#M)?W?O,7^43:G]+''/<\
M#_J?#/\ 8J?_ *;5Y;B?]8UW^U3_ /4<J39M5@IA$PBRL]DTU4H&T;WFU^U4
M9-X' N/,C<TEE.M'!Y,5QQPEKI+X8TLETVQ0GEUA,L2#MJ)0\QM0FT8[$LSI
M(VU[4,:HM%X^V:/'34F"EBI9^;EEJV-,+:GP*:LC$<CG4T%5E=S,KB&O!\4N
M:QS0X7RNVF%"'G9WU$6>-E.XB4P>$QTSR]@;-+!F;SC "YMM0'.!RFUQE+N;
MBOQ:C['SRM&Y*SJ)NJQZX+<#^1E4V)P]@2MD&[M-C\GXS7:ZSJGK&YTL>/X[
M22WS6-TBTN@PPG-,/8G)R=4*:2)E86IPTE/75SGX7!335#IVXEBE)/#B$H=E
M=#1/E$,\],7^%LIP\/CEOFD>T-)81=NSFI:4-KI9HXA$ZBH*B*2DC+;B6I;&
M9(HILO@[ILI:]@\5C22 Z]CP"LNPSIB3\FK5H"66Y<[1'S;[8J,HBW3$]$12
M,N3I*:$C%[MZ1XC<KL0%BVO/(\TSB-HIC":FA:5K96;I*UTW;RWA(R(;LVTM
M0RB@JV4].YW@KZFJI[U4CVMCJGTI+7LAYF")[HI#')/(7.<,@B.4N=1'@D+J
MF6G=-,&\^V&":T#6$OIVU #FNDYR61K7MSLB8 &^.7BX:($@W9E<0E-*,<VL
M6YN1+?/M]G 1VD,F:H;"ZX=(D3!62_#:3?ZV8UCR_M;N?+)2N$2./O"X@AGB
M!9![NZE2[2@M@3Y4N,UXJ7QPT]&8OC@X.QTDDPD,KJ7PELS@UCFB.,>4T$ND
M)#6\W8O6/'AM(86ODFJ!)\7?&+@QD99D%1S#HVDN!SN/DDZ,\HY_)6-_G[QI
MB_$;E3/:.@\I?IG"VB.5'-HF_P J;V]KDYT=N&G(#<#2W2%(TG*&ORRPI)T6
MPN"IN&!$X*6T;@G3(RE049&XPNL?7T,-3*QD<CG3QR-C)<S/3U$M.XL+@'97
M&(N:#J ZQ)(NM?7T[*6JD@C<Y[&MA>QSP [+-#', X#2[1)E)&A(O87LJ:YL
M%AIA$PBR[]A3_=/./O\ @JY?]2=A9SFUG]05WII?[Y MSL__ %M3>B?^[RK]
M7'/$EZ>F$759[23]U;PK_P"DW*C^@#-G@_PFO[)\5_WE@O\ B,"]N^#G_:=A
MO^[\6_N$ZX;GYGK]$EI'!&6XH%K>::K(*7I%*,T] L4MZXDM42,@9J)>C-)6
M(5981[&F6)3BE*8[0#B#2S0!%J[#*Z":*=K8WNAECE:R:*.>%SHWAX;+#*UT
M4T;B+/BD:Z.1I+'M+20K<L8FBEA<Z1C98WQN=%(^&5H>TM+HI8W-DBD -V21
MN:]C@'-<' %5;JOAW6%8.[\]*725V:K?X?N '%V=J&O"$B'G/.Y O:#&]AAT
M91/IKP\!3K7I[E9,@D+J8C2^..QNBQZ,]"VBY3\?V@IJ.DCI\.P".CQ,8RQV
M '%*:9^)LI? H:EL]9BE?+1LI:8OBI*3#G45'3-EDYJG:7"W#8%R=X'@E15U
M+YZ_&Y*O#OBE[<;^+:B)N'.J35RTYAI,-H8ZHU%1EEJ:FO;65D[HV<Y4. -Y
M_::\@# :A/8H-#V4YL/VJ;3FF,LK<:WJ=M.F':A"8C1$C2'[8PA9MG$;+,VT
MATW=[Q/6B<XNIQO&:QLS*O%\3JFU#.;G;4U]5.V>/P@U>282RN$C/"R:K*\.
M;X03-;G#F764^$832.B=2X7AU,Z!V>%U/14T+H7FG%(7Q&.)IC=X*!39F6/@
MX$-^;\5/8\@'B9;=ZQH?Y/)9%,:)0>MEE\3*CBQ42N5L!:7Q+P!;(J6IR%BE
MJ"#2$]402H-($:6 87QWC/.NG^-\3YYU6RO=-X?5<ZZNBC=#'6.DYW.:N.)[
MXF5!//,C<YC7AKB"^*,)YL0_%>'<RVF?1-B\"IN;;1R2-EDI SFLHII)6,D?
M !S3I&M>YA<T$:&5HZSC#/(II,FZ&M#*VZ02J3R)[;&DE,2.(D &T/CHM4)^
MIBJ/$IBM,ZPX0U3=X(DIN$6()0,O8=+C^(55#A>%SXI4U<YFP[#Z*DJ*ETCQ
MB3R*FDIXF/\ %CK7R.-3$T".?,]TX<"XJW7QX+14]9B6)0X=3TT/-5]=654-
M.UC3A[0:>JGE>SQI*1K&BGD<2^'*UL):0T*$WFV>(]7MD,MQS75O$B;70FSF
M(RY+#0IG^3-CVRHG1RF!GDR/BDB="-C=4"B22!W(2$-R5<G+?U:3PX2Q=72[
M-\I6T%1BNS4$6.XD_9R9N$8GALF*&2CH*BDJI:>##&^$5HH))A5T\S*&BI7R
MOGDB>ZBCDRDKF:G'^3_ X<-V@GEP;#VX_$[%,/Q!F'!E76PU--'/-B+N8I#6
M,B-+/$^LJZAL;(8Y6-JY(\P!W>-6=Q:CMJ+*RASK6;':,K,*/<6Z,L2%M42-
MP4-'KF(1KY&U-1+,[2 ]B4>7R692\'OAK4HTZ 1"2&Z/%C5^ <H5;L]%CV*4
M^/5>S^'!S8)Z^LEG90PLJ? '2PT-14/JJ:B96,\#=5,IF4C:AG@YE$C<@R*+
M&]A:/'I<$PZHP2EQRO+7S0T5+%"^LE=3^&MCEK*>!M-45;J5XJVTSZA]4ZG?
MSXC,;LYEUNK.N&=N<6AIK^$M;2[N*9X=FQNBC$B;G1W1*B5R-T<429 4F6N*
M1:G(6)ERDHU20J()4%&@-+ ,/-3X_CM5/!4U.-8M45--!)34U1/B-9+/3TTL
M;HI:>"629TD4$D3WQ211N;&^-SF.:6N(/00X+@U/#-3T^$X9!3U$S*BH@AH*
M6*&>HCD;+'/-$R)K)9HY6,D9*]KGMD:U[7!S01KW&$PQW?VJ5NT1C#I*6$&R
MV.2N+"U+7]F+$(8Q%M3PI2&N+<#8S#!;"C4DAV(P8MZZB%O=F#%L5IJ*HPVF
MQ/$*?#JPYJN@@K*F*BJG   U%+'(V"<V:T7EC<;- Z KLV&8;45<%?48?0SU
MU*,M+6S4D$M73-))(@J7QNFA%R3:-[1<D])7)\UZSDPBEOLM_P!S=,OY5?+[
M_O%V'GZ^\G/]G^P__"&S7^"4*_*GE$_\>[:?\5;0?XM6+([G9KC4PB815SE'
M%2E9M*[KETNC)DC6<@JNCM.V>V.J\]0Q/,&B_KE\DHDS;KNA;5Q(I6[&[=$9
MI:X)^T:D@TA0B3F@C*+D\=%4'N : ;93F'43;N5>E?9B\;EHDOC+M<YI((Y3
M$<=TF[:DFDDL!QY=@.E-.LQ(UO09&[0711*%N,<?"(%:=.G6.K>O>TY+L",H
MZ^CIX;N[_/55<X[J_"(T&F86=;A?J]RE])PJH9(J9%6F1Y4[8>0UH\G4:9:^
M*5:,ZTKA02UMG)Z]*: 12R/+T<V?R4T?.#M&D">3W.]H@.MLH[2?:HSNUUWM
M#=W0VUO=O43QGLPN*<< >A5-5B3&.>Q3/*+:HA/+1F4KB\7IVPES4X.E?1-M
M<7(0X\SM2IG2F1Q:W*29 U= ;T\GB0-(FYD'OWGC]M%/./XV-PXD 7+AN/VT
M6_QSL[^/;&-,XN*FT9Y*D]@4K89<]L>SI+-IMXUQ[?1R.I(P!^>3SAD0F+NI
MZM5N/I22 /)RY6J?%+BM,"I #0./1V*#(X\ +.%@ !XPL[3B0N7H^$-"(7UI
MD:=KD6G-FN._;V0F"DJT1(;!Y*,,DC=HJS"=A[IC:M:Y6[EM#9O^T,YPR#D^
MQ"(#U91VD^U1G=KKO:UNX;FVM[@HHCO9C<>X;,X//85+>0<*D->UU!:ECQT1
MO.:QY-['%?>)F,L.<$S6J3A71]:L1!<Y T&[TWOCJ>K<%Z8Q4I,,VRCB?:JC
M*X@@Y3<EWDC>>E<TCW9[\=8\@G\9 GL9WK:P(M8<,.IU\M"9KZFBD<M9X-D$
M]0P>$A="&^/&/+R<:X)%X!*7&,G&& B:MB(,,*$RCLM;H4&1QL;BX(.:P!T%
MA<]-@N;T)P_JWCO*Y1.XD]6=*9I,X?"X+))/9]BR"P'=?'*].>QQ%$$]\.,
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M'MS=54Q=Y_7[W%E;0H1KXW*XS+W@]Z02!L5E*_#ITA1VC4Q9A!TD [^%OXJ
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M%.RQY":8$11;C)'Q2VL+<,[7@ +G).([82M#%IJ;  N)( :!<DDV  &I))L
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M>XS)(@BT@";U#M.HC,B>DBG0@"3J#=#!L7S/M)R&<I^S+I#4[,5>)4S+GPS
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M:8SNCT>DB:E&JL!U <1WC4:A#%!MA_\ :]&.2<LX!N^4KMN:2,.9AU-+4OU
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#O__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>g472601g88r67.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g88r67.jpg
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MZP6NT[E:E 2$FE$/1AKG&)RJGL^,.#[E)Z3TU%N!S1*)IUW)2NE$35MYRA;
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M?I:K[\A^:_M^),YS"5# DX\BY1V40"E7H1SZX/1.L1KYBB?#X<8QL]CQK5^
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M?^%#9]ELR4UFNF-MF8Y_W!E+JH](,;D6B8\_&(F%1#Z3P+[Y" FB7I=A6O\
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M=MI=V8;=@@5DU'"[#,55U!!QJ73P='S9@6PM3>Q#:"ET 65>MQKA>ZSE;]>
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M4-%QN52J9NXZ]B >6>HB473=IY+M.A%^*FJ\WO\ !R. . . . . . . . .
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MN@! 18PK5(W*8T*D;Z):IQF5GX'>$ Z]3IC&'FA15^YTB]D6A!VKMZ2&BV)
M87=/ +DNO'90S""*<>BO5?\ .4;-/$8J& S2:AY*!D@^#0<(Y2(6.[>Q@6+?
MV2CV(*=:VU9,6!TX)RU>$)T+5<MY><?B(4R!JY,R$V!$,B!%L%-^GFI55YD*
MGK+Q!>O%P3RN:[K\F:/F[* %CPQ9II&UF0O *4V7!C;-XFVDZY4\B'F=13N,
MF)7 !<TKT.2'"MRLQ9,)5$WAL*+2OMH1?C,W^"!P!P!P!P!P!P!P!P!P!P!P
M!P!P!P!P!P!P"S:#BINP@]-TQ<YEPRK;@6U1?-<'Q+$?:E0GEF+])F]RF-0D
M246DJ#T.248*E8[N:'E KE9=\*(-&HF]-W0OS%- :<I"@7\QN19^^CR Z.R;
M<I*+$LJ4&HO7$&?G%IY,!\;S.)$0!5U#G9Q+0Z;:AM10W#</'QRN4X_$8N,"
MA>MWQ>U2V41ZH]/1,>!VK&(V/:1A."5"7$S%:9RI,.G"*@3)RVNY"HY*'=6C
M9)J/,Z.I ==:(O90$"Q1E,714=#8VW$A5='+T^W-5::5*<G?7GHU7E$H_5!0
M$1JBU%@K9$R7L*8L@^RMB4D"Z? =T9&C(=":.353O@<-'/T'Z663Q9*9).6<
MA24D"056NWDVUZS]/NJ/37>3)1,X6*$;"*2*3MEM#5\V*[L(W,K.B\)G1#UA
M^M./?"I*% _5F%VC#L-56Y&%.:?:3:#: -0KAWP*K[)=[7])=!?IO23YU"WA
ME*QI(K")4!G++23W%:<A:&YC%)]O:,3DDJ'EY<[82 G%)YO[<C>SUME .V3;
MQED@E$&K:/HA7VHGM[;3(>,RJ.S(<Y+Q<LT-#6<@EL5<O&6VVZ*,B@DJ,PB7
MB=\[ZZ9P[ 2R/&P3_7&,ZZ/AKG33;?377?805!P!P"@;*M& 4]%]YI94F8Q.
M,Z% H/VH^3=KZ*F9&3;!00MLV8-G;UV_+%7C5@Q:M6RRSARNFGIIG.W TG90
M><Q>QXR/F$,)[&(Z4V>:,2&S D,ROLP>N!SO&61=FP()>B>-5T?*LU3PIYGI
M$L[I;Z*; 8_R'I-UKD\#CU<E*^VQ'XR,GPA@Z&R65!Y0[:6E$Y5#[!R=F0HR
MSE4C<RMC,C1@J[.ER#E68X$S?1326  9@>)JM:^UU_Q%*R#P_NLTB6-NS(2>
M*9D/O[]\.R-QVL.U*L[(-!I9-QSW=C,&N^ YV9@F\T?"DMT1RDA?'G.[?+20
MFV3\*^U$U7'1G>OG2(+!<VW,W@5_31!169A7TTMB32*E6@JU$98U5;0T";E3
M^"-HG8VUN'D6L=!,-A$CS(0(<6R7'B(@,%A?SI\1V%?U[U(AO8M@$C<M.G[]
MKZ);Q@;')3:=G6&]AHLG"(7[44U:2R0'A0J022%1^'%3;MTKH8,:N%9.OYY>
M8R$J>"^E=2\G+[?,?6??]+$:"[)UQ(9K#VM'@9_:T/[((.9N79HQ*Q+[F"]D
M6#'Y ?3*(G8T:DLJNI$J+:#B#/89M*Q+".89-D6#5N%]4QNIS?['8Q'I[UF6
M=[RX2&DDD+(V ^D;R22&P[%/%',]A]A4$3(.73D[(5E-]!<ZZ>TSHD+233CS
M9K!5! A@C&SQAB3"J^W/Q4OE&8?5-09&A0S<#&7TZGEC/PFI,@GN<DLWLJ23
MV]IX,"/"[E8J1<$"CN?3;,>'K*-Q09@34'L&80+Z-F(T^W,74X X!UC R,*.
MC;%@ZU<.HX32#&D==%=,L2:X81(4FN^RB>FBNVX8Z)?8W0V52QH\T3RIA=-9
M),#\9/@M3FL8V-"<27<7DYI'LDF>#FX75UZCL8U$Y6]?V%X>XRSR0PWRTPZQ
MZOE;TO\ D< L@[[0=='#>PVKBUHJHWKLHM$9[Z-R\VT#R%65*5[M%L+(MLX(
M25>;8WAC8"&W?&G,ISJ":LU"NVC;(FBW7:=!B$VI?PST1SD4Q>P_(XY2L;G3
ME\RL:9N&9.FX1UKLCK1'3^3Z!]5HJT']>I?9 5'5)]@T_9X*S=5NZ,@?;X\3
M[Y$V)T7HO6B>RF4IOJ!0$F$:"B,1*:M=?JK.&*[*7S0,5%/KJM"*75.BXLDQ
M.,R@DVM9T(BLM!$FRZ#^)$ S=".J"F>R[54<U]N@M(,ZH]/WDP-U>*VF#RPH
MJ']]\EU1MBW7LI%.9Q<JEYAIF<EBDG662FWU6AA"9Q=Z[+8D0YH]+L63?2%F
M'(UR)OT[*:-5*=7M4^Z*5-T\DI6&3L).WLR4J*U7=?"%3=\V!*PVE]Q.4S%-
MPS.B9'-'XT_;(N43.5XW4?-7)IWL\')K:/!D;B*80+]'/HU<IFH /@Y6""RB
M,&!DAC4D$C3\>D 1\V*!C@,PS1(B3 @FR569D1A-@X;O6#YHLJV=M5TG""JB
M2FFV1!\[B41YI)P\+<EV2,K/@9'* H%17&")*/1 A%1,F+M4/)Y5&00E-XDS
M?J^7&$5Y -TSC/I\>0#ON . . . . . . . . . . . . . . . :<P'AW6'
M#).S7BHVC&0M6Q1\P 2A@3D4;DU ZL.ZMQ]AI*9J4 *KI8::D5PT[/H14=@(
M;2&O&V4*^'1V0$K'@"8\.S'5>K?<B479I^;29E4AU9#UET[A77(W'X"2D;.J
M8N)L%ZW8;%8Q+[D&Q4*@=L5ZX,"4B9I^^G A"3-I&7%)G\+M!Q#U=J^9MT6X
MA5JO5R8&&<M\/>X)#(:RV1(U,L'"=5P/7J=D9$44D2;M%I1-DU:='1V+DZ8<
M2MJ)(G9@P?:N@]VPN&&0ZQ-Y-J6DTH#!2+L2BHF]%W*FVFBNHOS9'3&4WA5O
M66DIG(0U5595M9'F%EQNHU8U(=RTZ6JAO2T=B,<0LJGB40+5.SA<XM]T^>%8
M9'I VD36M2@$*.<L7+H2%:*JZZ^VOX]%3&9]X??8I[)XO9!A#K+-;DC[BLR9
M"VI._E[612V3P'JKV/ZQIS _N&K%N?T*:$+%JZXDFP>7C'&YP3(HJ(-Q7>/1
M>:DQ.==30FNFU47BB)QNZF$>'7?<4:G$S8'KS8<5(&I05"T;+9V2"UK'9'**
MDJ^"L;70>5'U@JH8G/H*>K^0N &P"MXY)78JS#QS:SQL[$-CA815+M/+KU[=
M:+CS&9W4OJW9G7RR+MD\PF("? ;>F=L3@4HL_++2"LMYAV+N"S@\#AZ#@$T8
MXKPU$[%#R*1LG;[>1!;;:3%5:06)'I%'74*!51439TW)MV;MIGMP<C@&-/:F
MCRO8" 1"#BRZH-,5=M(V$;(,I1)H693C5<V5'IA(4HW)HAC20"I(N*$N40:[
M%X+SDANCHL6'([;NDQ*+1>9>E%0Q0[!=#I;8I.P2D(EJF7.U2=6Z_K0G.K!D
MDGF*;>L>PUKVGV#BQZ3V#%+8:-@UXUU*HA6Q0X:C]C:R$6Q=QZ<1$I#13<0:
M$UT53'I1$V?%REF8_P"'OV+&32D3SRS%EP<"5A*S05K:40V>T][WNT5G7/)6
MT$?Z=0F_M,-,*NF4/J-Y&*TTZWALQ.O!E7&/;M9JC-0 9R46[3A6^ZE]5QOU
MWJN@OEV,ZDW7<7:&&6B'7K5*OXR2IU/+HF<V;RK>%@CTHWN*(/A1.I)P17:S
M&.R14>V&P>S*MC,Q8+N@UH"Y @P&.% 141/]^;6FA;]95S;J(=(>'?7?5,W&
MZG:677]'PV AEV^ZYB @; BD31B*\SC9IS"AIH:J6;[F762S6),32"4A)L%-
M5]7+M9T(5;U5,5Z3O1W7:RQG;E]<@%,%#(89L0E.[!/@[HN,L0N("OUY$4\$
M@<KH4^W<U-&28*4@(;*])_%C23G JKXVQ9@T7TYFRC4*\]U.2^MWMK,2;@\.
M&Y)\6['H@Y96K2&]B7]M2V5QXJ3DVFA.9B1DQ;]95WZ#2*KM4D1IZTCDML8O
MKL^)"R=04TTC[>2M/:&P02C5*;.-5^)-Y<\=T9M'6R)!9Q<_"W\J:VY6,OK4
M^K)):Y+PJ%C/$-[-]C+:#"5'$?UT /9[UIN6)5639B-LLY0_#OH/(7R4*" C
MCM\W6*IU]2)UI7I+,(]!^ULA94MO+S-.#I)1M:==*HB,K96#-)D99%JCH+NQ
M2\C[ AMCU4!\ Y]F3=D:SM*-1E)PY7(NJS]0+S\22;!B:0G.T[55=EZHM-.B
MZBE-NO#@[):5+M&0YB'(R5O*TSX*-'K;CA:N0L@;56A#_?XJ-!]+H@,5?&95
MKL1.OH]$XI=J2+-M8$8OV.3XM(QI 16]=OMBNKFV:S>TWPOJW0U=;I*.M44L
M.5$$]TD%%\::X6W12457422V4\[9--1=;?33.-=U5-L9WR.35C?O1FT;CG78
MV4>WX6X9S>"]D?J%(&Y++45:\M^P: Z/5Q2]@;M6<?=-8Z4KV?=>[=DK>2 5
M"AR(IRP$>BR+L\=/M@@Z1;DYJ[4JM4Z2]7;/K?/K]F=6.6(Z#GX! WB4A<A#
MDX?5E)T9>V*H.F9H#/HI3,ZL\!ZFS;(ZZ9KNRJJ=O]LNQDA<G0KY1HD(1:5X
M?/3>BF/3?IE?8.=MYI#VT"C8>$68ZM%K66_8"\IC![QFA.["\[=3<RPL.-2E
M*ACX^'R:8N&H^&(S=@<GLMU&&';>*P6)&-Q-4HNU*:KJ(F^].9-JJ=J=Z&S%
M:M8OM'O>4&OEN-M::'ICI)).1AK&PC$LG]L5=" L<*B%(T3CT5M6QD45K+.5
MXI(2%90=W #$3(1*PC,49B*[KOBOI773VTE\;!I6\K'I2F 4[U@EJ2F%6BXF
MEHUM.S^P2"W)!/8]G 8S IR=C5>OPI(G$-I97L]?JXK'WH2^P*P0TP$ "S"!
M 0%=.J[5JZ>;3KYBA>NG5"X^O,-OL\(=506ORQ*JK\+#90_>R%\/S.(!6A".
M1P3/I<^BF\Q.PF+G50X4<>>-#4D,Q,/J6(AV1ITH+U$JJ+O7II\ZT+*"/#5F
ME<KQ.(@I7%;[J07.NKUHEA%\H1P1(4K&HUJK64MEC+2%5,X!FRTWIA2.>N&I
M&BO)R,HKMD/,'W#:8/SX$,[7KOT5UZ-=;EU?'IM/"/#C[71QI0 D1(J:JAU2
MM7P>KF,ZK&6D53 X0 ZY2ZH9$0&M2U$MY:X(&K.D.UMZ@8Y9E95Z_P!5D,RJ
M(R.?CW,W+!5+]=>;76^_EOTET,]#+Q<2VEYQ&PE)TTPI]K+U35-0NS;%DM?7
M60.2#IZ1=L;&+%*V"/6 >5:T3.Y 07BX,<MM/1]73&Q1EM)GK.BS@*I?IOX*
MG4J=--1DYTWZWVO0DYO<G-7414B=A$ I./:"Y'F5RQ\>;RJRBYPY(S+:KZLP
MY:O1$HC#<>XF>EGVLHZ:$A,NMV7!(_$%M1"KHW>UZ[=FPSZX(' ' ' ' ' '
M ' ' ' (_E=FK%&$8\$L*Q+MFM,F+$KJ5=G+C%E>Y]:'(?F05[VQ<+4\;$2V
MW)F7KEQ%KK'4;O*5*%^I6*:AI)&HG8$-80]0(X*CKF38E476FR^[&M2N/4.S
M4(A5-VA,;#M23%[#Z^PAU;5='GTXAY&%1 ,/Z\L9<6GDAP5)!H225/ E6DP-
M#J[9V?&!%\=C)VP>$-:L9 =PYDTZK\=":]/)<E3<+6<U(6=54&L%,(YA9.=0
M@!*=(^>17?+QQX?#MB6H\@CY ;I]HP5<^CVSMH&<O$=,;J(#5E=D4!R< !Q8
MAIBN\WD,+;Y1-R43A/6#G%,;:@)&5!:+^=FP]<XV<Z#M7.VGDSA+97*>-M\:
M8WVZ6B:EU:TUI7 Y2JZTUZEU+3$[OU&P?E/#?F(;_:+R+L%WIP)OQ3<O$>HV
M#\IX;\Q#?[1>+L%WIP%^*;EXCU&P?E/#?F(;_:+Q=@N]. OQ3<O$>HV#\IX;
M\Q#?[1>+L%WIP%^*;EXCU&P?E/#?F(;_ &B\78+O3@+\4W+Q'J-@_*>&_,0W
M^T7B[!=Z<!?BFY>(]1L'Y3PWYB&_VB\78+O3@+\4W+Q'J-@_*>&_,0W^T7B[
M!=Z<!?BFY>(]1L'Y3PWYB&_VB\78+O3@+\4W+Q'J-@_*>&_,0W^T7B[!=Z<!
M?BFY>(]1L'Y3PWYB&_VB\78+O3@+\4W+Q'J-@_*>&_,0W^T7B[!=Z<!?BFY>
M(]1L'Y3PWYB&_P!HO%V"[TX"_%-R\1ZC8/RGAOS$-_M%XNP7>G 7XIN7B/4;
M!^4\-^8AO]HO%V"[TX"_%-R\1ZC8/RGAOS$-_M%XNP7>G 7XIN7B/4;!^4\-
M^8AO]HO%V"[TX"_%-R\1ZC8/RGAOS$-_M%XNP7>G 7XIN7B/4;!^4\-^8AO]
MHO%V"[TX"_%-R\1ZC8/RGAOS$-_M%XNP7>G 7XIN7B/4;!^4\-^8AO\ :+Q=
M@N]. OQ3<O$>HV#\IX;\Q#?[1>+L%WIP%^*;EXCU&P?E/#?F(;_:+Q=@N].
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MZ]GW;[,0NUJ @?9/I"E3,5[#VQFDXK/8QV8@UN[#)\YKJPK*$-R\5&PR*O\
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M"V@AT[2(;#6CE]JWRU055T$T7!3D<]H>L[( 6E;SL31;2+ 9'B'G9*YMN (
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MW ' ' ' *-@GQ(^_#*Q?T@R?DKIYDZD(31SKUJ5ER"2%W[L1_>-T*_"SL/\
MF>G>:+D_^J37R(/THDJ-J^\@?*B.IR08^:64T< DJ>Y4?MH1+\6.V?[1UQRG
M6X\"L^>N/0?%ALSX1:\V>^F[/2,YD!?S6OX@G^E+PN/^)%&/[H?</@Z9T-^2
MGILFRC@Y' ' ' ' ' ' -:*/BC5,:=2': ]=^\EL1F/S*;P76P:KZEV;-8!(
M#U=3$Y )AK&9(-:>@+M \OC1P$X<II)8U?#726VFNR6V,#K-VHFA;UQ2I]&?
M$PBFN,9WZ<>)-KG;R_Y..C-TJ9QY/X?0B5=<>7]W'EV^'_;C/D!&:_PF>=I$
M'^$RAF-L:[=/_$FU_<\NWUAU];ZX\O\ #E..;^7_ +_-\O!.8OUS'_FG$R%Z
MU=N*Q[29L=C" 5KPJ55)( D<L. 755,UI^?1IW)HZSE<:=/8O-A8U_D;( 3U
M,@+=I84PNAILKMHFBJU4<#E4H90\$#@#@#@#@$'KW8Q\=^'O]ZNT7Y7U^YI6
M3[O)KY4%U113K5Z8'DB>MP0I.:,5 < E">Y*_ME%J_B9V9^F+K_REV[\#.?A
M!SZB*+'9CP@\\T>>M<'HJ.]<[-7.NN,[;;-UM===<9SG;.4]L8QC&/ASG.?@
MQC'PYSS(R^F!OA80V7U[X<72F#S^*R2#S6*]<ZR!RB'S &3C,IC9IA'6B#X.
M?CYIJR+!RC);79%V/(M&[MLKKLFLCIOC..#MM:MM*EZ5,^N#@< < < < < <
M < < C:^*9W1EE?]K1,-ISO=1U4_4SK45[^ZY*]D8G79ZM9I*A=SH8EDSJ)Q
M7TWDG8L@Z6(4C+(_3,+5*3T<$@9D7M!FFM]PJ:LA_1EFZN:J\RKAKT)3%=]R
MH22N#^8X!J"8=C;[>W;&>OF+F&DA5Q&Z4+P^^HY$:J>(*0R?U'W"M(_+:9:!
M"<_A.U5GC77:$0"L];;5E%C:['9Z6*.I,R<00SP=4NKR]::=MYTP?MGVBUC-
M.V?,W@,=![]J2O'4;WB  "90'F)&+HU<M.8K&<X+SY4NY*E;E%!D)/N8K%<S
M/^I<73=*D3]@/^!1+]F_7S8;E-L<-G02Q8%&[%A"BA@!,(T.E,:V=(.@SA\P
M+L$GX]-XU(MDGHEULFMHD[:OVB3L>XPJ@Z;Z+(J)X'/M[:BD806E^H9[A.'M
ME-???8.<[9DS;3R;[3V2[*:>3([/EPFIG9/&_E\BF-//QC7&WDQ*Z>9.I#E%
MV+I7#%=I5_MB9?(QK\Z6OZMY!-5P7HXD-/W7V]-.X/T1P6")"-=)7V$RALF5
M2)>GSL(J#TF,X3;-_0^CQC3.,YSOY_GYQCR>;GRZ+D_^J37R(/THDJ5JN\@;
MJ>^B,,'."J0?>:64T< DA^Y9'!%KXG)%06-T*.<]:+7URV4?)C]<)9D5=9V5
M].HBOKG.N<:ZX3\SR[>?Y?+C&N?+3K<>!4\]<>@^+!9KPBMU?WL]])V>C7[8
MF7R,:_.EK^K>9 7^JX+T<3%/LO3%I7A,.H,C!B(Z&;=<NU(F_9&W*R;?=<^
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M?E?7[FE9/N\FOE075%%.M7I@>2)ZW!"DYHQ4!P"4)[DK^V46K^)G9GZ8NO\
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M#@#@#@#@$'KW8Q\=^'O]ZNT7Y7U^YI63[O)KY4%U113K5Z8'DB>MP0I.:,5
M< E">Y*_ME%J_B9V9^F+K_REV[\#.?A!SZB*+'9CP@\\T>>M<'HIO/\ \&[_
M /VR_P#_ );<R,OIKJ\(#[5UT*_%?J?^S+/@[>=^URFQ[@X' ' ' ' ' ' '
M ' -#7B2EYJ,[DTH/(O+/'0:7U?%HM5FE-O_  O <SE%LJ6H?*3J*/%N][U2
MS9:.W$CJ@*BXW30YNV&%F6Y)7<U(2#'6/#MFE%T5OTY^BG_;=CI-\O!P. .
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M?DW7?FD9/OY7^\/EI3[5_P 0^^ODQ!_YI!3QP#;)X-EG3^INU<EE%;RLM#I
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M@!XYK0_<UG7YS6/) O/)T]A!P#-GPY_LSZ1^^,O_ $>2[FPY O&Y8[^OFWY
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M3UY9UBTRLR1N:.9@YAIBQ$+ (Z[7]$7#J/;ADAWD6RKYIMIJ4+ST=/)H< <
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MZ2CC9OERMHBMNDAA3TBFJ2FVNN<:;9Q\L]E_"15J,D[B66:AWUH)BEK)/$K
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M]QC.-=,82P\?KX1U\F<Z(X3TVVWVUSOL^;HN'S]-YV/ ' ' ' ' ' ' ' '
M' .N%"VP=KNS:95REN^*D<Y6VQOOZP8*/"[O&,ZZZ8]'AT^6PCKY/+HCC33;
M;?;7.^SYNBX'8\ < < < < < < < < < ZX4+;!V6C!IE7*&B[UQC*VV-U/2
M/GKA^OY=M==,>;A=RIC3'F^75/S=<YVSC.V0.QX X X X X X X X X X!UP
MD6V"C6@MGE7+9DEZ%'*VV-U<Z^=MM_E[ZZZ8VSY=L_#C77_9P$NN.QX X X
%X X!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>g472601g90p66.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g90p66.jpg
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MM\C6UR0R-CE"=)&ALR4I,U*X)B@U69*7L416<J*G_\0 & $! 0$! 0
M          $" P3_Q  T$0$  @ #!0<"!@,  P$      1$A,4$"46%QD1*!
MH;'!T?!"<@,B,H*RX5)B\9*BPM+_V@ , P$  A$#$0 _ /OXP& P& P& P&
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MVJ+<^!58D%&0QXJZ%LA,5X3UBU"X# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M6N-W[+D=[JT]!%Y[9M[,-+Y>-^S?> P& P& P& P& P& P& P& P& P& P&
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M.K!L/EU[!!)'3KBL)QOQ$CW*4HE"(N$? 5@?W.;<#"883-343%=:SYQO=[K
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M/UP& P&!"'1'[&[>_3O[)_C8#AK:^G[87?ADP& P& P& P& P& P& P& P&
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MK@,U19:"_GCYOU?4-1Q.7'[ )4U51&=RJ+.H/*)F^KV).Y5(X6^'MA#Z(G9
MX$*%2\9>B6;,6\!/W;@8Z&LVC!=JHU;())B]-,Z>]KNKJSJ(!M%*HKV$5G%]
MR#DLI'8!%0</!J%'FB"3LFH*C[$>R4(.DFK9)P]W0V<K)-FZ:BNVB*>NH9W@
M,!@,!@,"$(1MS]4W[-Z_<XZ)=&=N./W=K_\ $.XY_P"6NO\ PPU],?=M>6RN
M_#)@,!@,#YI^OO9&+02<W!6B7?/PP*.<"N[7:,>YZ]W;4*T[OH 0,=F9^^=!
MEK3:=MJ<:2LU,'1!20 B7%9&7<54DC.&%7LA*15XWU-S5?IVIPC&ZC+=V9RY
MXYX6^DPB.'EQ[X268LR@HHS=#B8PBU0>CR(]ZANV>,7S-SHJV=LW;951NZ:N
M$U$%T%-TE=-T]]M>3"8(!T>ZDU>+FP.%T+ 1X:Q88M6TP$D1[B3#2=:.-'*:
MM9H,I0Z,M@]:[:NW''Q?!$QT.UY4XVT"Z[:)\Z%N=_S?SXYMB4MUYI?KN'-
MZ9@ B#LI*52-R1=FL2)F9"4;#F@=B[/2(\^*R SL+#,&(8.D2)N4 P=FU%"T
MFC!NDWT(GNY/M_NCO\3W=;^S5A=)YQY2H*[ZYG-CQQBQ@?82V.NY$2]7*.I%
M4H&BCY8\UU8.$=099M?%-70!1&:KJ)ON%@@4.9Y<MDD^2W++9PT6$36D3SOT
MF$Q^&MS=$QZI4)?MV=EK4OJ4]A>N]#6L4"3N)=>XK&(!(YK7HR825O F]*4C
M5!G820(2/V7AM.3<W<LV <5HQ>-G6Y9V4+M5<Q$1%3,87C4\9ET%PR8# 8#
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MY4916+OG]>/)?R6<8QB(F(C&YFYF<L=J8RQ?1/A@P& P(0Z(_8W;WZ=_9/\
M&P'#6U]/VPHVU(76-F:P\7.S#5+>O;*@]JA&R,A:"G#>7P GH<C:K]/93UBS
M'1YZ"KEBIKIJ[1YXUVWXUY\^3,37EU;=161<HI.&ZJ2Z"VFJJ*Z*FBJ*J>_'
M&VBB2FG.VBFF^O/&VN^NW.NW'/'/'//&!^N P& P& P& P& P& P& P& P&!
M"<&YUY\33M#QY?I].BO1#GTO+C_-4O[Q&>/+CGZ_UTO/GCR\O\WZ_P _D:^F
M/NVO+979ADP& P,7FD/#3Z,%XA(%3Z @TBD@[7BTME<#D3?U#E!X@X#S"#&H
M[+H\^0<MD542($V-?I<Z>CHYXTWWUV#AG,.[UNT2RL:6U+'^[%N4G4UI2JJ9
M">NZDJ4M6M5WD$GKRN) XKN\8E?=1VLWB+*4#GH\O9]L#+F2C:K,JE,$@SL0
M6:AC<;,:SLW,7$1.U>__ !F.%<N_LW2=S1&^H RL*'-I(+9J&)/&#4;F8%W%
MYG#YA"9$2B<PB$LCSWTEQ9V.R(.0'.M$U78YZFDB5"D"@5^.).S$Q7S?BVS@
M,"%+D^W^Z._Q/=UO[-6%TGG'E*X'_P!@O?\ ='/_ $=\(BKPRO\ 5O\ 0#Z%
M?5S^I&$8:V_U[7W;7G*X,,F P& P& P& P& P& P& P& P(0[8[<_*1\,#7[
MG/<6U-N>/W=?#M[R<<?\MMO^.&MG+;^V/Y[*[\,H.\17]8ZK?IT^&S^4"ZUX
M:V<Y^W;_ (;2\<,F P&!@UBV)':LBKR92IK,789BNS;+HP2N;#M61\J/W&C5
M#9M#:NB\QF#U#5537EVZ9 G#4>AZ;I^LV:IJ+:CYG7FU13';&ENP0N('JH>6
M2>CD^9JDX;*2U"WU"(G(0V@ =)VQ\=*9Y6D9CZL=,!"S!W&Y%L2T"2G=;9E'
M'Y1\@X;)%F*_["D,(8# QQ[*A+"5 (:X3.;&I*'DAP8JUB\F?Q]-A%'$=:EM
M3,O8B',2C9%164BO<8:1&Q1B4I:&7$88%V\:D:HH/]D4NB\1T#*2@^)C^DBD
M0B(@=BSYNQU,2@^OLV" !W+C?3VLL5<:[(L&*/I.'*FO.J6FW/'.!D6 P& P
M&!\/OZ,G^R/#H_@>V_\ 3ZSX>C\#Z_V^KZ0O$5(R-&2]: ID=W#.=>3Q^RT+
MK"])PMX[V<N6:QL,M6+Z7R[KXFRLN.U6R>;RI"1"XQ)@AB2R,A#_ ":F@ >2
M-VYQV>%7IVJK_P!L+W7Q83X?]]&T;!M:BB, \0!&M'5DJ+]<)/VTHKL6L4"P
M(?5D;*RMG+KWM&,JN-XX[L%A+TZX1M29E+!5]K1!NWG#=W%PS,NU&4_EXU.S
MG>Z)G3=$0V]XD%G=DJ@KFJ)I1TL@<2BBO9;JE!K;<F@)0S8!**6GVFI:L786
MOW/+SB+!M2XR7%1TH(2 08=Z@7+I*.ZBS2K0R/)LQ$W?^.U,8ZQLS.['+@F[
MN=<W8:#]B+6D!"7]]Z>ZC4Q2]22([8O5ZG^HTLKL2_7*VQ(+HL:PB?8ZO9S9
MLO#Q2(I5TV(!>OH.7/XB-!2,O((^BL0:N=RQ51ALS,SE,[5\,IB.N_IB5J]F
M.P;N.]Q.YL$OHX&KCJ'V4A]6PCKX'C=:$ZNM6J8N/I)Y;12>'"D+(V4]FEC\
M67+5*_,1&>1@7$&X2 KH"3.CN4IR D5A$QG$XXWCEPSC=.>>5=II_/(U6$./
M3V8N"C6,QIGJ^+N T;DLO*)-MW"+779G&X>(/24LIZYPEQRW$"'SG73G=;9+
MA%)530RA7PV9K'K&A'9Z<Q-<BYC<G[O=C2H=<N D$5)*LERX/A/=['96+"R,
M0OSZ//I,C E@]3^;UC?3SX\S6U]/VPU'W8ZB=3YOVOZ 2>:=8>O,NDEK]L+%
M$6E(9/2U;GSEDB0W03MV;$"Y\6*QIV_F(\49A\2+C64A<$6S$G%HZ_;)I.@@
MU5L(F:G&<M_&'5>*Q6+P6- 89"8V!AT/BPE@!C$4BP<?'XW' 8MNFS&!00,2
MW:"Q D<T22:L1P]JW9M&Z::#=%-/377@R]_@,!@,!@,!@,!@,!@,!@,!@,!@
M0E!-?^\U[3;?L=%.A&OE_P#RO_Q(N?\ EZ/_ #PU/Z-G[MKRV%VX9,!@,!@?
M-_*@I%3:V[4;0?L]]3)%=A+<7M*M&':"IAD:-EHS?\E"7M-6%#NJ*<W'\2SZ
MZ!DWDQZL&?;:-+2@![YT&T_N/-MX2_-X56':F(QJ=8BHN9JZU[.'^6KO53=/
M16CX>XAT4=2$HD2ELUGA\_+3"A^3R686%*2DPE)TV542;Z+.'A<NXT:-6C5F
M-$BT& 84R9#![1JD8F;^;L&UL!@0I<GV_P!T=_B>[K?V:L+I/./*5P/_ +!>
M_P"Z.?\ H[X1%7AE?ZM_H!]"OJY_4C",-;?Z]K[MKSE<&&3 8# 8# 8# 8#
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M8.2Q%S49RP28=H(G%;;>4Z@!*&3@9I0[Z2'>3\$C43!:]A[-D=:0,5L6F$K
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M[H[_ !/=UO[-6%TGG'E*X'_V"]_W1S_T=\(BKPRO]6_T ^A7U<_J1A&&MO\
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MKPJHFCRILBGNIQQZ>^B6RRVR>NW/.NG*JG.O''.^WF'Z8# 8# ]))59&A')
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MWT]MS34QC,RA%*=U^B\IC<^D?:GL1V@IR64\7&0&;FP=D@CL6ZLBQMS,[&;
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MLG^-@.&MKZ?MA=^&3 8# 8$(=4?MEO$[^ES4OY/GI7A9RCEZRN_"& P& P&
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M5ZBVE ;9Y-H<4&:&6$GC##9YJ]- W0E30BF28-UVOLG/*^RFNFNW/!&7LI
M(\BM1YL0_P"3PA20 ^&1)DZY,@4O=W"IL5P@MOR1$)\F!'"A)GZYGI[T'>DM
MQ[<V]:$I'>\5+PN4V+&;*&VC5:%<UC<=S+2JQ:RE$<BDPK'K\Z$-;CEL$?[M
M7#X\RA7,@ /-VRPP>2D@8T-D4-92./N=2G!:G#6ZCKEU_P"MD4IV(B%X/YP!
M%1R?P>85RM&/A=";*C'P:DHT=-P^YZ''-$VSXL*>"I$-0>[-=V95=ZQ=CB(P
MVR%$V:K/@3%;IY,-N3N53]&S(A#)@A.GZT5B\-G5HR&*0XC((G34#L*4'8=#
M)G9YMOLGH%!G#L5E?''(Q V2%!XP>DYT<+C Y8Q@K^N/S_C^0W<VG3EP,:?9
MHSI-P:L6;4W&;%=PPFVJ>5W+6\?/2>>55'IKOSZEY+XP'B4SV>\+,FP%T3A4
MOCPHX1D4=*"FXK"_#6M_SR5AA# 8'P^_HR?[(\.C^![;_P!/K/AZ/P/K_;ZO
MH9\4F%B[9;4_3,6A]_2._P"RX]?@*!%.OLTIVOS >HW\, 1KL".FI^^42=;O
MH-*1<I@XEU&G$=-R=[(.(\?BB@ C%]I&+..SA<X5%9WGI58WGW7;>/A_U3/J
MT@-A/[=A=N ;9G4\:&YM,+MLFF;(G%B^YX3%8G'RB*E""X_6D-BT> @F<6CT
M* 1L"FQU%/3+ML^*G2)HF29NLJC*KK.]<?D+XPCEUWR[%W=5UN4=6M22*=PH
M#**RO*Q[#E\ ZA6%V_--EH%(:5!PP!\$8&NSWCC(JQF]@G7IP@[XY7WB3((,
M:/BQ=@T7-153OPJ)FHUN<X^2U4MV=[&WV^E0?J9V&JD@ H'I72G8PE;)*G^#
M(;LW9ESHVVZB8%2-KRT>YJVM=Q-*D7LK9AWN\Z&%IXT%-2PU2&$&ID3%9W$]
MJ8K=57GG=X<M70NN^S=;R7JG5W;>?2&-U)6=@4K6=T%SDZD8P!'(4%LF*1^2
MLT3TE,JCAC-)FI(6@WEX\4:IK.=D]>-==U=4\)4W6<W6&./!.GALSJ%6;".S
MT_KF6QR=P:5]WNQI>,3"(&A\BC,A%."X/A D%."7#H:38K<Z[>J=,W*R"GH\
M^COSY<X7:BJB<)[,.C6&3 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'S%G
MZY5FEUSJ$U;8?8J:]22\Y[#5%*VD+\/JPIBZU9VAV@3M/L77T&[/[6&!A3Z/
M#KJ 2N)-K*VJ&3OH@#VD(I@=DA@6)EXR>_SYZNFFD3A]48Q$881PG'&.,9OI
MTRN9@,"%+D^W^Z._Q/=UO[-6%TGG'E*Z\(8# 8# A7NS_I'T9^G567]5=V8:
MV?J^V5U89839-<0BWX#,*OLF.CY; Y['R47E<<)Z;[,RH4LVW:NV^VZ6Z;AL
MMQIOZYF^9K-WXYXF@^8.6SUN@NF,L82+U?L>;US-RW2R_P"1$)+9<#CZ\IHN
MV#V^G+WLGU['O&8EI)"3S71)%W<U3.7X>$7JQ2TT5)O7D1M1LV:"K+2%A34U
MG'?&Z?:<XZ:+PPR8# 8'YJJI()*KKJIHH(I[JK+*[ZII)))Z\[J*JJ;\\:)I
MIZ<<[;[[<\:ZZ\<[;<\<<<\X'(KM+?'9+N35-D4UX51U@(EBW'NI[WED[_W!
MU_AK\*7;N#D2J>1\1&=$[IF1U >]B!"35Q$R]?U]P2)/W5AH3@&TC"IJ(C9F
M.W&&?9UK2]W*<>%3;4WAD4YWP;^'CTM,1GNK6Z2!/K;4Q8!$;&ZGC)[&HS$R
M,0&/87%$2,&MVD):3YCT27"A")<J<=D2A%D\);N.>'.J>I=N8[6UA.<ZZW-Z
M3GX;US^M\3.._P#Z#HK</"?U_1*W]UOV=<<?^7C8/VIU8\[_ '.-MB'"?//'
M'.RG''GR9PXQTGV/C^[K1_\ TP\/]>2^A_XO-"=IZ@G'K/+_ #O8N+Q']8N5
MO/Y_5\._=_I?-Z?JN>>>.!4;^L>U^1\N7</^N'TY[U5WZ'_C^5!(7/PAY?YW
ME\E^9WOR[XU\N?G'\._3^;U?&_GQ@KC$]]>=<OZJ4-=M_$EZ;3.S>DU'M+0D
M$6MZ2]S^OLA$UW:E,7I2TIW!M9"6#[E7HRWJU@Z@EBL8?-A+%P5Y9)DB?*K
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MVL"]LVJY9S5N'D,413FRC52NW#<#'TQY>UOB\;C&HONQTC6)PS=*Z_@D8K"
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MV[5JV230;H)Z)))Z)Z:Z\&42>%[_ *MSH3]#[KI_5/%,-;?Z]K[MKSE=>&3
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MK2:?A<23X&4" +VK3$[,TAUL9]2'6UB=>IZ9@DUIZ,:@VT%(/X3'.SL0(LK
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MPND\X\I77A# 8# 8# 8# 8# A6F_M_.\7\4/2O\ H=D<-3^G9[_-=6&3 8#
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MQ,7O^?,&AKD^W^Z._P 3W=;^S5@TGG'E*Z\(8# 8# 8# 8# 8# 8# 8# 8#
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M#K'N?+^A?WMO?#\"J_?[H8*GAUCW/E_0O[VWOA^!5?O]T,%3PZQ[L:)^)A4
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MPHO#!+$C%YGO%V@[4KN=7Y=(<@TA:J/.Z6F^A9B8PGYR="<(8# 8# 8# 8#
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M)T?O_)97CVIPKY*;_P"=R)FYF=\VVIA# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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&& P&!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>g472601g91s12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g91s12.jpg
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M(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
M !$( )L", ,!$0 "$0$#$0'_Q  ?  $  00# 0$!            !P0%!@@!
M PD""@O_Q !.$  ! P0!  $-#@,' @4%   % P0&  $"!P@)$1(3%!46%QE5
M6)*7TQ@A-#565W1UEK2UU-77-G>S,3<X=GBVMR-!(CE1>;@D)C)"@?_$ !P!
M 0 # 0$! 0$            ! @,$!08'"/_$ $X1  $# @($!PP'!08& P$
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M&%H=(X.+6ES6W#&E[M;B!J:TG6==K"YL%"]=*Q2B)1$HB41>E71=?WN<E/\
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M1.R.#'(V>P?-FQHT9?3)@[>O;3 TWM-2XA%)BCXHZX238Y0U$;XI*@M?1?\
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M5-)EC&:%S]&"WN[EQ=?Z/]IJ/<J-].<?MJ;\1VPMJT"SD'@2T],M];&2<'P
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MAH"*/9H,8[6SQV [,2Y8-E()<?DS ,3E,O('),Y#L%2V:=_J,.@--21Q'C
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M)D;&T,)?F#K;"KB@FE-1)%&Y]703-;&7U##2,8!(62,C+3I&:W@!A?=PRY2
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MSI3%CM95NK-+ 0</FIC'2L =*);07$9BT?T>5QC#@\EV9K*7B<D;)FLSX;#
M*?)*"*IDP?*XD1EGT@&;29NZ):'EN46_-W7V:^?4Q\=O\0.B_P"<>L?][!*Y
MJSZG5_9I_P )RU@_;P_Q8_YPNKD%_?WN_P#F]LK_ 'F:I1_4Z3[-!^$U)_V\
MW\63^<J(:Z5DE$2B)1$HB41*(E$2B)1$HB41*(O2KHNO[W.2G_MR](Q_\/\
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M7RRCD_A/5COZCXJ>) Z!/S>7'KHY=_N73ECPC\(#U2B^63D_A/5COZCXJ>)
MZ!/S>7'KHY=_N73ECPC\(#U2B^63D_A/5COZCXJ>) Z!/S>7'KHY=_N73ECP
MC\(#U2B^63D_A/5COZCXJ>) Z!/S>7'KHY=_N73ECPC\(#U2B^63D_A/5COZ
MCXJ>) Z!/S>7'KHY=_N73ECPC\(#U2B^63D_A/5COZCXJ>) Z!/S>7'KHY=_
MN73ECPC\(#U2B^63D_A/5COZCXJ>) Z!/S>7'KHY=_N73ECPC\(#U2B^63D_
MA/5COZCXJ>) Z!/S>7'KHY=_N73ECPC\(#U2B^63D_A/5COZCXJ>) Z!/S>7
M'KHY=_N73ECPC\(#U2B^63D_A/5COZCXJ>) Z!/S>7'KHY=_N73ECPC\(#U2
MB^63D_A/5COZCXJ>) Z!/S>7'KHY=_N73ECPC\(#U2B^63D_A/5COZCXJ>)
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MG%!4K8C2[))PL_%9.AI1!\,3)IH+O1:S=\C95!;!7(JJ3*(E$68Z[_O @O\
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M VDB)%P(QDPQD4;RR>XVDT?S(DMKUZMFOFUJS:RY>:SD>I]03B?R$7$I#/\
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MW*Y+*8'QOADGFKO1YA.0R@CQKY%E]]@9G(5<]X.$GA^88'B44DK=GB."#$L
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MQ=/-M7K^#N&S&?R1ILQ"4NTY,WB8JQ5G!H[:*D1BX(I*<$2#?"9/L9$A'W2
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M[5JF[+G2;1KVR1>,!@]#M@B5?L1K-V[0*%KR%YPZ>D9"!A@@/;!$]L++:=A
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MI)O;4-0L-O3?I\9]/D4>;>T!/-M<J)(X<H2*.Z3G/#PSHV9300O"5E"#B2[
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6GAE;);JXY8WMEC>W55ZGO7M:]$7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>g472601g93s62.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g93s62.jpg
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MN-'2&",W87>9MB0H,D)'2&=QAB4F,S95<H&1V*+_Q  = 0$  @,! 0$!
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MA#L<>A$VF$&IPN';3EEHZL=8/P8D"O61@LPI%TG7%BMS9JGN&8JX2JB,YO\
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M22Q(@7IGAV1N[LXC+3JW%><UM),I7)VF0R$^.,BAOC_C1S1M<ADYS7N3N:5
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MDMZP2Q8@/6J"QR[5D/A$PB818*6YS:>*OE#@SM7$+E#8L59I&"*.MF-8>/\
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MEHG>WNCACCH,?5IAQ'4H]K@,6@U JH?'ZY+Z8?\ C/,7T!\??LQS8'L/N_\
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MU+LTFMD+"GI*?V.?GY^)3RH_,7.\@ZCU'XE(UCK'QK(2C?\ 0I3_ /LMK_\
MX3:,E0KI81,(F$3")A$PB81,(H\'2S0=WD/)^M9$DH-//GF.4U&MU$>'C;R
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M1F.(3WPX!Z<0_P!9F7Z[BAR/ I49CB$]\. >G$/]9F7Z[BAR/ I49CB$]\.
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MSK&&9X#FF.0XGDGGU@^C$-]>WO[.L89G@.:8Y#B>2>?6#Z,0WU[>_LZQAF>
MYICD.)Y)Y]8/HQ#?7M[^SK&&9X#FF.0XGDHK?E:JB4'<%N/87QG86Y-KEDQB
M*.:I(XO)XS_>>MW02S$ZN*L199.R]F"V<%4:/0P@+TG$$P1A=YN%3USFZ5\
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MHWM UK1Y10#] V,O1FBS!A%>;A'_ 'G-ZO '; /^HE\E6;T#YR@:_"F[2?\
ME1<US_,VLJ,OM+;7$Y"I="4"TUL1')TRQQ+2GF(4BA9HW:1.I5A+VG(.5:(/
MVG*-, 8?HDW901=V/JBHJ!45-2!M-*5H-9I45RJ,TV5V#6=@U[?@/ K-3@(V
M.3/S'JYO=V]<UKR"9P(Y"XI#T*PD)]8RM03LU,I+*.+T<0:6<5L8-:,*, 8#
MK ,(M_.'=:.#NY^OT6D.!?=:A!!&%\KO@XC# X=:^GNXX!'=&]'P((.A>W B
MA]Q%Y-A4E?.+Z[E+]"BC3S2R""S#CCC %$DE $8:::8+0"RRRP:V,9@Q[T$
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M;IFQ%I7QX<4Q1W:+#K2@HD!X0;&6$S19A@17FX1_WG-ZO '; /\ J)?)5J]
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MF/.SCYJT)C2B.I'FX@9HPPQC?[IZZ,"Y_0CTCR8LZR[,G[3NMT@6Y:\O8\O
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M@WHA&/.3MDS<M*P1$C6)#@P^^QXK&:<6)#A,TM*(]K07"3'XS+]&IEZNJO\
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63")A$PB81,(F$3")A$PB81,(F$7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>g472601g99q63.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g472601g99q63.jpg
M_]C_X  02D9)1@ ! 0(!>@%Z  #_X8C2:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z
M;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N-BUC,#8W(#<Y+C$U
M-S<T-RP@,C Q-2\P,R\S,"TR,SHT,#HT,B @(" @(" @(CX*(" @/')D9CI2
M1$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D
M9BUS>6YT87@M;G,C(CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O
M=70](B(*(" @(" @(" @(" @>&UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D
M8R]E;&5M96YT<R\Q+C$O(@H@(" @(" @(" @("!X;6QN<SIX;7 ](FAT=' Z
M+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\B"B @(" @(" @(" @('AM;&YS.GAM
M<$=);6<](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]G+VEM9R\B"B @
M(" @(" @(" @('AM;&YS.GAM<$U-/2)H='1P.B\O;G,N861O8F4N8V]M+WAA
M<"\Q+C O;6TO(@H@(" @(" @(" @("!X;6QN<SIS=%)E9CTB:'1T<#HO+VYS
M+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(*(" @(" @
M(" @(" @>&UL;G,Z<W1%=G0](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N
M,"]S5'EP92]297-O=7)C945V96YT(R(*(" @(" @(" @(" @>&UL;G,Z:6QL
M=7-T<F%T;W(](FAT=' Z+R]N<RYA9&]B92YC;VTO:6QL=7-T<F%T;W(O,2XP
M+R(*(" @(" @(" @(" @>&UL;G,Z>&UP5%!G/2)H='1P.B\O;G,N861O8F4N
M8V]M+WAA<"\Q+C O="]P9R\B"B @(" @(" @(" @('AM;&YS.G-T1&EM/2)H
M='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O1&EM96YS:6]N<R,B
M"B @(" @(" @(" @('AM;&YS.G-T1FYT/2)H='1P.B\O;G,N861O8F4N8V]M
M+WAA<"\Q+C O<U1Y<&4O1F]N=",B"B @(" @(" @(" @('AM;&YS.GAM<$<]
M(FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]G+R(*(" @(" @(" @(" @
M>&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O(@H@(" @
M(" @(" @("!X;6QN<SI%>'1E;G-I<T9O;G1396YS93TB:'1T<#HO+W=W=RYE
M>'1E;G-I<RYC;VTO;65T82]&;VYT4V5N<V4O(CX*(" @(" @(" @/&1C.F9O
M<FUA=#YA<'!L:6-A=&EO;B]P;W-T<V-R:7!T/"]D8SIF;W)M870^"B @(" @
M(" @(#QD8SIT:71L93X*(" @(" @(" @(" @/')D9CI!;'0^"B @(" @(" @
M(" @(" @(#QR9&8Z;&D@>&UL.FQA;F<](G@M9&5F875L="(^9SDY<38S/"]R
M9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.D%L=#X*(" @(" @(" @/"]D8SIT
M:71L93X*(" @(" @(" @/'AM<#I-971A9&%T841A=&4^,C Q."TP-BTP,U0Q
M,#HR.3HQ-"LP-3HS,#PO>&UP.DUE=&%D871A1&%T93X*(" @(" @(" @/'AM
M<#I-;V1I9GE$871E/C(P,3@M,#8M,#-4,3 Z,CDZ,30K,#4Z,S \+WAM<#I-
M;V1I9GE$871E/@H@(" @(" @(" \>&UP.D-R96%T941A=&4^,C Q."TP-BTP
M,U0Q,#HR.3HQ-"LP-3HS,#PO>&UP.D-R96%T941A=&4^"B @(" @(" @(#QX
M;7 Z0W)E871O<E1O;VP^061O8F4@26QL=7-T<F%T;W(@0T,@,C Q-2 H5VEN
M9&]W<RD\+WAM<#I#<F5A=&]R5&]O;#X*(" @(" @(" @/'AM<#I4:'5M8FYA
M:6QS/@H@(" @(" @(" @(" \<F1F.D%L=#X*(" @(" @(" @(" @(" @/')D
M9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @
M(" @(#QX;7!'26UG.G=I9'1H/C(U-CPO>&UP1TEM9SIW:61T:#X*(" @(" @
M(" @(" @(" @(" @/'AM<$=);6<Z:&5I9VAT/C(S,CPO>&UP1TEM9SIH96EG
M:'0^"B @(" @(" @(" @(" @(" @(#QX;7!'26UG.F9O<FUA=#Y*4$5'/"]X
M;7!'26UG.F9O<FUA=#X*(" @(" @(" @(" @(" @(" @/'AM<$=);6<Z:6UA
M9V4^+SEJ+S1!05%3:UI*4F=!0D%G14%304))04%$+S=107-51VAV9$<Y>F%'
M.7=)1$UU34%!-%%K;$Y!*S!!04%!04%"04%304%!04%%028C>$$[05%"24%!
M04%!44%"+RLT041K1FMB,DIL04=404%!04%!9B]B04E104)G445"055%0F=5
M1D)G:T="45E*0W=G1T)G9TQ$06]+0W=O2R8C>$$[1$)!341!=TU$07=11$$T
M4$5!.$]$0DU41D)15$5X=V)'>'-C2'@X9DAX.&9(>#AF2'=%2$)W8TY$03!9
M14)!64=H55)&4F]F2'@X9B8C>$$[2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF
M2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF+SA!04519T$V
M045!07=%4B8C>$$[04%)4D%135)!9B]%06%)04%!04A!445"05%%04%!04%!
M04%!04%11D%W24=!44%(0T%K2T-W14%!9TE$05%%0D%114%!04%!04%!028C
M>$$[05%!0T%W449"9V-)0U%O3$5!04-!44U$06=10T)G8T1"04E'06Y-0D%G
M35)"04%&25))>%%614=%,D5I8UE%54UP1VA">%=X46E00B8C>$$[571(:$UX
M6FDX0U)Y9W9%;%%Z4E1K<4MY63-00TY546YK-D]Z3FAD55I(5$0P=4E)2F]-
M2D-H9UIH2E)&4G%3,%9T3E9+0G)Y-"]0128C>$$[,4]4,%I85T9L85<Q>&18
M;#E76C)H<&%M='-B5S5V63-2,61N9#1E6' W9D@Q*V8S3T5H66%(:4EM2VDT
M>4YJ;RM#:S535FQP95EM6B8C>$$[<6)N2C)E;C5+:G!+5VUP-FEP<7%U<W)A
M-G9O4D%!24-!44E$0E%514)1645#04U$8E%%04%H141"0T53355%1E523FA)
M9UIX9UI%>28C>$$[;V)(=T9-2%(T4TY#1E9*:6-V17I*1%)$9VAA4U5Y5VE9
M-TQ#0C-04TYE2D5G>&15:W=G2D-H9UI*:EI&1VED:V1&53,X<4]Z=WEG<"8C
M>$$[,"M0>FA*4VMT3515-5!2;&195U9P8EA&,658,5)L6FUD;V%7<')B1S%U
M8C)2,61N9#1E6' W9D@Q*V8S3T5H66%(:4EM2VDT>4YJ;R8C>$$[*T1L2E=7
M;#5I6FUP=6-N6C9F:W%/:W!A86YQ2VUQ<39Y=')Q*W8O84%!=T1!44%#15%-
M4D%$.$$Y531Q-T9867$W1E5U,3(W;'1R3"8C>$$[.3!E3'E.=S5$<4)1:S!X
M5FEP2DI*2G%4,4IW;V%X5C)+=7A6,DMO4%=B<64Q,'4V=4E/4')P1V933&EQ
M:'IS<%E$<4%4,'A6:U9V*R8C>$$[6#)H<D-I,TTQ.61804@W,C1A*W5O:3=D
M,CE/0U-+2F9K<6=917%N*T%03%AH92\Y>$A54"MQ*TMU+W="-6$X3#,O=4DV
M:"\Q6'A60R8C>$$[870U53AM851P;#-Q;6]097<R3FI%.7AD5&98.5-F:$A'
M<%HR-'!->D=G2%%#=4MP8F%W+VQH3S%T1SDY9#).>&50-F1N86%J9F%P<"8C
M>$$[.7I/,G<O9%<Y-4Q"3$E#5T%"5E-#9'-69$=N-5-Y;TAG,3%,:FY(2DY'
M<T=T6%5Z=DA#0UI7:E-/-5IN-$)46&E$:7)6:D@K5DXV,"8C>$$[85$V<S9Y
M>DTV45%Z87)F=U-Y1TI1.&Y#3V%D2%E+<'%30E1#<4LP1%(O>38X=W<S32MH
M,W1X<4YV851M,6YU3&95.5%E3#%L4DI#<28C>$$[>4-F:2]W04UQ-W%33S-5
M2$%Q868T03AT948W+T%.>$A54#A!<79I<G8X0657=D,Y+W=#-&IQ2"]!1EAX
M5G@X9V57-F1,,&4O-E)V+R8C>$$[05!Q=FER2$EO2G),53E3,'@U,W59-T]6
M4'$X,'1053E+5TI:07)L46]9;WI&46%B:6QA;7!W;U)/2W5X5C)+=7A6,DMP
M.35B=DIM:R8C>$$[93)D:3!96&UL93%#0E%F9FE5<#EG5C)+=7A6,DMU>%8R
M2W5X5DHO32]W1'9*1B]X:R]G8TE6:F5+2%EQ-T9867$W1E5U.'<O.&-7-B8C
M>$$[+W="568X4T=&6'!U4E,W1EA9<6PO;4123%A89$,Q1%)B=#5)-UA5<F53
M,6YE26=30DIL2TU53$)G1%$W5D)X5FE.;BM42&QQ,DYU9B8C>$$[<E9Y>'17
M:F%!2D995W%+27)U0SA!.4\P=&)D3C5B5F52-#AI0V0K;$961B]Y;CAK,D,V
M6%I3-FQC5S!99V@P*S-T<$IR9%!R56QT1B8C>$$[37-,;FQ%2&%:175*1%--
M<40Q6E141E5V2#52+VQ:95A/;C,W86UB;UA*;71R26TT=%A7-&9G-G-K5&E0
M;5=J;S=5:5E';U!+;T9!5B8C>$$[6G(U3CAM,F9L5WEU-U<R=DQM*TXW8R]7
M-34W=W=M478V355!03E#3T)/25-"9C)A*RM"52]W059D:7)S5EE$9F8X<%AR
M6"MT8B\X028C>$$[54]U1D,W1EA9<3=&6%EQ-T95,SAS+S<S>68X04=)+SA3
M6$5P6DQG5C)+=7A6,DMU>%8R2W5X5DHO32\K.&M8+T%":R]G8TE6:F5+2"8C
M>$$[67$W1EA9<3=&54)R.&-S;6I8:7=X=$Q)27EY>$E+<S58-'5+:BM9,&]-
M5EIP82MB+TMT,4-S,$=R,F))=S=Z>'%W4&=Y<U%Y<T\V<R8C>$$[2VIV9U-R
M9C1L.'5F.5A7>B]W0VMI3"]M<D989C1L.'5F.5A7>B\V4TEV.$%M<D989C1L
M.'5F.$%6,7,O*VMI3"]M<D971&5A4$M8;"8C>$$[1'I"-7AT+TUS,G8R36-T
M=F(R,71(1U)B>75Q=U,S1'EC6&MC<BLY5S4T:T9#4&@S-59P:%9B8F52+WDY
M=$ED3FEG,6)4;D9H<4)V,B8C>$$[95-$4S1J26IW3D)*8C!S;W)+34Q*5E-X
M6E=*-#!.4E-I<49T=DE8;&$S,41Y,692*V(T,&9Y-6-Z>G<R<4YA0S)E3S1L
M=4I84E59<R8C>$$[.&)..5E61UE/45919D-';WEQ=E)F.%,K6% X07$V,F8O
M4U)&+W=!,5E&9"]I6'DU+W="6%=Z+S93278K87-69"]I6'DU+S%D8E X028C
M>$$[-E-)=BMA<U9A8GI0-6)64WIA=%IH44MK;31I04%(*WEX5FAC9#EB-FQR
M3W)A;%IU2F)#-&QI4S%U1C-35EEO559P15!D3V160C<P<28C>$$[3G-+159I
M<G-69&ER<U9D:7%B*U=F.3<U4"M-4B]W0TI,:55S;'=+-T9867$W1EA9<3=&
M6%EQ:R]M9CA!,VMI+S1Y9G=/14LX4G0O>B8C>$$[33$V0S@Q0UA5-U-!859B
M4&-R0DIX*W(X;'0Y4E=Y-4Q+6G)J,4]#37IY,6EJ-#!(5E181E58;V8U<D15
M.5)I:4]M8TQ#6&U"9%%Y=B8C>$$[8WEL:VAK;4A#0T](:S1:278R5%=V8D9$
M5FXK6G0W2G)%9&DR;DI*8GDS:E<O=T)93'E7.&MC8C-H=%EA=U-2<WAF649W
M>DHX=3)+="8C>$$[86@U-S@R5T8U<C$S*VI)<G91=$AL941K=D=":31717!Y
M;F%D>C%M2F-M,U96558U2'!I;$1N.#%T5V5Y:78P,%)9<EI7:3EE3#%J4"8C
M>$$[3S5L=$IB<C T55)%53$Y26-8-4=T9G,W-TM&='@K8G1Y67)"8F%Z=$9L
M=DQL25!83C!:;TI&3C%$0R\Q4FQJ:2MS349M3F9S.&%(-R8C>$$[5DM&4SE'
M:W1B5U)U56M+3W@V<WEG;CA2:6AB.5)S=BM794PO04E"9C99<3<V:EIF.',X
M6"]!3"]!17A6,S%'>2]W0U=E3"]G1B]P:28C>$$[<G9Q3FPO>7IX9CA!04PO
M5$971&9L5F%7<B\T=S5W;S-(>DYQ2W)646%!96Y11&)&2EIZ.5)S=BM794PO
M04E"9C99;V0Y4G-V*U=E3"8C>$$[+V=&+W!I<G9Q3FPO>7IX9CA!=CE-5F0Y
M4G-V*U=E3"]!24)F-EEQ,DQ+>4)Q3&5-161$=U@K;4MQ,DMU>%8R2W5X5C)+
M=7A63B],4"8C>$$[*SDX;B]'22\X4UA%<%I,9U8R2W5X5C)+=7A6,DMU>%9*
M+TTO*SAK6"]'5"M"=VA73C1O67)B*V%B,F)Z.61E6&MU3$)R83-T=E9A1B8C
M>$$[5V(V,FIL54MC=U=53GDU3E966#160VMT.%A(1E=',C,U=CA!;6HT,W5.
M2F=D26MD,U=0,45,9E5O0W0O4FU:;%%,9'1'<4UA,%1K5"8C>$$[6$9+=F8O
M;E1Q2U=33F(V0UEB:6)46G(Y6DI:,&QJ4C1L;5IA3$AX86%&=E$O=D991#1L
M-VM9<E-D-D8K6C8V;C5G<TY(:W-"871E=R8C>$$[=$QZ858R9%I%8597:459
M:&]3;F\P:TIC0E<K1W R<7%Z;&U65DQ-47%Q2W-X,D%!-VY&0T5T<BLT=DEL
M;G-.3G9B=3)C5FIU16@T4B8C>$$[=7 V36AL369.5#):9&HQ1S)+<79,5U K
M<DIF+T%005)F.59-5F1Y,6HO<7E8+SA!=T58+T%&57A6,TQ74"MR2F8O.$%!
M4F8Y5DU69"8C>$$[>3%F+T%+<VPO=T0X1$8O,55X5FDS:U!Y6G)0;%ID6$17
M1W S:#%/+VQV1DUH5BM+4#EN;'EL3EI$*S(O5G1Q.4U5<W U87@O,5I,+R8C
M>$$[05 T0TPO<7!I:#-,5U X07%Y6"]!4'=%6"]65$988W19+S9S;"\X03A"
M1B\Q57A6,TQ74"MR2F8O=T1!4F8X05941E=N;#%61DQV;R8C>$$[=6]"4C%)
M:5)Z+W=+3WI(-D)I<38P=3=E-V=%,$1C:TI+;6]+<W)+84UR2W=$2WEK54MS
M2V<Y8U96<U9D:7)S5F1I<G-65&9Y>B]V9B8C>$$[2B]X:5 O16QX2U=3-$9D
M:7)S5F1I<G-69&ER<U939GI0+W9*1B]X:R]G8TE6:F5+2%EQ-T9867$W1E5T
M.'AQ1S!/.5)H5DAJ2T]01B8C>$$[5U!&9V9M1&ER,#1!04%!54$R04="3'-6
M5WE/230R8SE%0EDP-C!!<FER>C-34'HR.&E8*VHS5W-81%A/;F%D84,R37,X
M>5(S22\P<R8C>$$[3UDQ4#%#4S@T3U!34$Y*3TQ,='E!<FEQ6E X06TO-4%5
M,V%P<45S<VQN23!-:V-6;F5/>GE)-U)S<T9)=C,Q2&I917@Q07!5;6TK2R8C
M>$$[=%=V-78K4DHY4&EV6'9:645K=%EB=WAV8E1U>7)02$9+27552U-X=DUQ
M,TUF3T].;5E6.$U69$(K8G9K<35M:&ES-7)Q-DUP8TXV9"8C>$$[;F1":T5C
M36MX2FEE3DIN<4E(6#DR:DAK0T13:'A65&@O3W(X<S5P4D1(<DY:>F)#.%=%
M,C$P<VI1<U%Q;%5-45ES,5)X441K=TE)1B8C>$$[359:1C58.'DR2&U84EET
M63 Y2F\W4V%394I&=44Y2U=T=$\Y=35:0V%R5F]I44<S<#%!3S)+<')I<G-6
M64)D26MF;6Y81E%C5F570R8C>$$[5F=/-W1B4G%4.4E1655,.%9D:7)S5F1I
M<G-65&9Y>B]!3#-Y9CA9:B]W05-817!:3&=6,DMU>%8R2W5X5C)+=7A62B]-
M+SA!=DI&+R8C>$$[>&LO9V-)5FIE2TA9<3=&6%EQ-T95=3AW+W=$2$9U=CE5
M9CA!16AH5C9B:U5U>%9P,58P6D=&5EE%165X>%9I9#,K5DAK0S=S2710;B8C
M>$$[,'%T<$1(1$-K87HS2V9"8E)00D5'6DI&6FE)6E=J2EEK<W9W=%59<6PK
M="M2+WEK,&5Z5G1:*W(V5F)Z4W59<FDT,4-A,$IM;&MA9"8C>$$[+U1M865.
M9WI->D@T5S962#)D<U93,C=S+W=!:4Y)16M:=4Q6-4Q*66)6.5!T3'4U=DIO
M>D-);VMP6C(X:S!G:W!B4G$W:5!K479X:R8C>$$[:75+;VEY.'5F;$9R5W%Z
M-E!B5V,X;#0Y;V)L.713:&EK=$IX2D@V:V1W>%-+4EA&,TE"=V,Q<6%F6C)6
M5&MF;%(U16\O3W=L;&%3128C>$$[5S=03F58<W(X059+:U!*37I#4F5#<7-G
M4$Y6055%2T%-5E0O045(461,,$A3-'1,,'5*;V)+1G!(4DAK:VUB;$Y),#!J
M3DI-,&MJ1B8C>$$[<$I'8C1M>%9(-'$W1E=!,S,O2U8V,2]R5R\X03%$<FA1
M=7A6,DMU>%8R2W5X5DXO3% X079F2B]X:5 O04)*8U-L:W5"6%EQ-T98628C
M>$$[<3=&6%EQ-T95;CAZ02]5-&HR16TO=T1W2G=H5TXT;V1I<G-69&ER<U93
M-WI'94]H6')K17)(15AA9TI01E!I86='-3)(8D98<&-C:R8C>$$[8W-A>5)S
M2&IC0FMD4T-P56EO24DV9S1%<G-69&ER<U931'ID-4LP;GI61&)1-FI*3D=L
M<CE9369O36DQ*W17<W1O+TQM:CE)-3))+R8C>$$[>7%D='-64WI7+WEP.'1A
M>'!-,FTS3GAQ4'!496YY3%AS.7=I;4IL9%-L=&1.8U=I-W(P14Y+9$%-5E1N
M45!+;6PV1DYC4U=*:U Q:28C>$$[2S%T=VMJ0FA(1%I1:4='3D-!1S1G5F(T
M:69I62],1E4U>%8R2W5X5C)+=E!P-31R:GI.<G-S3&,T,&YI9TQJ<#9K5G9(
M>D%09FE7-"8C>$$[;C-Q3S)&0W)I<G-69&ER<U9D:7%B*U=19G(P:#=E:V8K
M2DQI57-L=TLW1EA9<6MH.#@K4U%S>DAZ0G!O5S-L5T,T2G9)2U)Z3U=#4B8C
M>$$[=CAF=W5X:F%I;F,X5#19<3!F4&9K9U13=TAZ1'!N<G='451X9EA,9FUH
M9U5V2TA8;E9F5%9'3%8V04=U2W12*V9V27-L=$YD4BM9.28C>$$[3&4R=#%6
M<#4Q=F)C>'AQ-V-&3'-(;V]:+VA&92LR2W)5."LK55<Q5G1-1V]P.5E26%EY
M;$I"8D@P-&A/-G)D1F9Q-T]K3&5O>6E4:R8C>$$[1C-)<&ER5C$U>#AI5%=Q
M979R*VTO5C=M2G T6$XU04$X55I)85)'-3=Q<%4Q66)$1E5M,7)5=DM':U$R
M='AD-G-40F5X=E!A=&)1>28C>$$[,VY+0TU";FXO=T)'5U=K4T)H>6M)0VEO
M,W=Q=F4O.$%*0U-M1B]-*VYP37-K8TQ23F-W0GA*34,P4T942E5--%5L4C%0
M8D96,3-D928C>$$[5$Q.2&MU+TUT:&)P1U-R=DQC44E&6EI':4E*85%526MJ
M9% Y6E-/;T]+<')&-6-T<&]K;6AU>$I&26]E3U)!1U9L659$2U%A1459,B8C
M>$$[<2\X07=V2"]!371"+W=#0B]T>'189C18:B\U840O=U Y=4YQ9TEF>3ES
M249-9')E,VQP1%5S24Q7-G5R94E%;7 T>%%Z26DO44U66"8C>$$[+W=#0DEV
M.$%Q-V%N+W=">$,K+S=+34-U+W=!0U)F.$%6,C%0+W5)6#,O6E)I<G8X0U)F
M.5AB52\K-&AF9CEL1TMU+W=*1B\Q9'14+R8C>$$[04\T:&9F.$%:4FER1V9)
M5G(O:6UX,4\V:W9.4W14<"MP,V5M:%8Q2R]F;4Q69V]K<5IL<'ER,'=Q>6(O
M04%*1B]W0EAB52\K-&AF9B8C>$$[.6Q'0EAF-$5I+S9U,G O.7A#*R\W2TU6
M9"]G4TPO<3=A;B\S14PW+T%,2TU69"]G4TPO<3=A;B]!3GA#*R\W2TU68V9)
M8TI"1&%R<28C>$$[5$$W1E1F,WA"2'5$4&EQ=F$K5&)/,6=3,W1P0D1"1TM*
M1VE"5D946&]$-#1B5E8O=W9(+T%-=$(O=T-"+W1X=%5*<3)M-EIP3VYZ828C
M>$$[:G%&.%E,4T%!>5-E;5A0>$U&54MQ8VU:;5IG1E914U1S3593-GIV+T%#
M9&1P8D9.9&=I;'9';&IT<F$U<&)81%-12&I+;C%E8WAZ0B8C>$$[;WHY<%-T
M4FEQ0V9Z5"M8674W4S)4>E!9>D,W1G=Y,T56>&)V06=T55=36#%*0DIX56A8
M0G Y4%1&55DR<"M394IA4'I&83-.2'156B8C>$$[3%HP=4A"=FY33S),2D,P
M:D):5VQ8:7A&2T=T85EQ;49R-7$X;6%:<7-M:DYF.$PU5UI*-7!)-59G16MC
M4FYA23-245<T:U=)1GI(>B8C>$$[-4)D-EE&4CA0;F9Y6DY8,&1F,#)3:TIU
M:G=U-$<O8T)U2FPR9C=!8F)L,')I<7)&-70X<51A:6UM438Q65-A;$E85T]X
M4S5H861M:B8C>$$[6FMC0TE.>DI6;S)$8F)%2'=X5DYC5F535R\X07IJ>G P
M,6YQ3FIR3W98;#5A6&)X3&)2,CAC3G8V5G9B:31%551H>&-*354K='-2228C
M>$$[>6=H9T-+2$95,G5V>4PX;S-.=$QB=F18>7).2$Q&239V04=);6MV6D=.
M9E(V,3%/440R5E!!,596-S<X;'9+.3-"9%%M-W9O:W5Y>"8C>$$[;5=.-$M%
M4$XV-TE6849K6E,R,T9G4E0S,W<R<7!"*U5':%$V9DQP839N<68V26YT>D).
M<&]N:E=",TYQ;&]:,C122S=0=VI$8U,S<"8C>$$[:"]I0U9W2W-U4'E:.'-8
M5G!E=UAL>F58575O2T)D6%5P=&DW4TQD9EA05DM#05$Q.55#<2MN=TE&0W5+
M<%(K64AL+SAR=DQ8;&Y2-R8C>$$[5'I"<6LK:F%D85<P;6M7,&MC83-$,T9V
M2T5E5T=73G)E-E9U5%%P2GE61DMS2W%6>%9H.3<U<R\U>'=U<D9R265A8GE#
M1U-36C5V4R8C>$$[=')N;$I&8W=25S@P1$8W3B]G94\S459&2$9.;D=.<E-"
M=F9-4#5">5AZ6&QN-3=V-U-6-W(V,50V;$Y)26Q-,#EY.&-!87DR-5185"8C
M>$$[='EL.51W<&IA,'IZ4F9Z-2]),U(Y2'-D2G-V34Q#>C K0TLQ='<Y<&9-
M,W!W;T58:V91,TY&>%1332\V1U X07E9+S9M2"]P>G9V*R8C>$$[<4=+,#<O
M;UDO=T1*:B]Q668K;D\K+S9O67)3=D(O>FM&*U0P-D8P.'AX04$P;SA&,4=F
M=65*5&EH52\U6#,K55 O57E19CA!275F+R8C>$$[04MP-'$W+VQF9C51+W=$
M57E19CAI-2\K<65+=2]W0U8Y+VQ$+W="5$I"+WE,;B\V<#1Q,#,U.69L159)
M2&UA0E-244U)-7%J,S-J3R8C>$$[2W-%+TM(.'@O269L6%-D6'0Y8S@U5SDU
M4&9A<F18:U!'1C%(<'E045-N,#1H.%4Q3UI8;W5W04<K2W,X+W=#5CDO;$0O
M=T)42D(O>28C>$$[3&XO-G T<3<O;&9F-5$O.51*0B]Y3&XO04]Q94MU+S58
M,RM54"]5>5%F.$%)=68O04MP-'$W+VQF9C51+W=$57E19CAI-2\K<65+=28C
M>$$[+W=#5CDO;$0O=T)42D(O>4QN+S9P-'$W+VQF9C51+SE42D(O>4QN+T%/
M<65+<3!F-31F;$Y)9V1F33%M065G675P*S5L0GA606599B8C>$$[>E$O2GI8
M9$EM,'DW.# R,&--<&ID6EE:3TUK8VM-:7I24TE74FPU2DI'<D-O23(S1TMS
M8G9.5R]*1RMU3&$U=B]0:S$U4$5Y=&-Y5"8C>$$[6$5B1S5-5G=B<4@Q4#-!
M16%X5$=Q3$(V83 R24DR=W%G1F<O-7@X5S-J9UAZ:W=J4S-7,&-E<D-F56A7
M,6AT94PQ='HQ5S)2:5)4-"8C>$$[=CAN-&-65% V,RM2;6\K641D<C5U.5,V
M=3=T2C=7,5=A35)X>DYE45AR<D@K-355;6YT62M8<4TQ3VDX831Q>DQ79GEK
M.'0V=G$P=28C>$$[;S-6>&1!4U-4>G)A;UE05&IN=6)C5S P<V)T0S V;#!!
M-4E*3T)906QA:D%Q:G%(-4YE5TPR4S5-;#%E>'A834AO=&)X=D-Q3$HY5B8C
M>$$[4WDK<TE415A%;F]22W1/6' Y*T9C5E$K:&9K>'!M:RM9:G)",6DY=3!%
M<V0P3&%55S1-;#!K,3%/,'-Z>'AP>2M/.6)I<V%O0C,U9"8C>$$[;%AO;4MU
M>%8R2W5X5C)+=7A6-5@K8C)P2F$K9"]W075),F=M:THQ6C)5>%)L=V%X*VYX
M<4]H<31/+V%P-TA&6'%M2W5X5C)+=7A6,B8C>$$[2W%-=&Q:>E!Z;6=J:V5L
M3U1O<D=N>DEX5EHK:DY.+S5:268K4F$O,'A6,S9-,#,O04I:268K4F$O=T)-
M5F0K:DY.+S5:268K4F$O,"8C>$$[>%8S-DTP,R]!2EI)9BM282]W0DU69"MJ
M3DXO-5I)9BM282\P>%8S-DTP,R]!2EI)9BM282]W0DU69"MJ3DXO-5I)9BM2
M82\P>%8S-B8C>$$[33 S+T%*6DEF*U)A+W="359D*VI.3B\U6DEF*U)A+S!X
M5C,V33 S+T%*6DEF*U)A+W="359D*VI.3B\U6DEF*U)A+S!X5E%K.'9A0B8C
M>$$[235E5%1,4C-05FUG:DI0,&QC5F$O=T%.95A0*W)66B\Y23A8+TY/2W4O
M=S$U8R\V=%9N+T%.23A8+TY/2W4O=S$U8R\V=%9N+W="228C>$$[.%@O3D]+
M=DTO=T$O-U!33DHX;E=.>F)A4V]:9%=S5V%7,'0P-4MQ4VAI1'AO,W@P;U!%
M-UE6971X3UI):VM+3D=854U9,W!Y5V]R4B8C>$$[<45I;RME0E8R2W5X5C)+
M=7A6:$@U:V5A=%(P:4-',C W:4QU-VM70T)N<G=$<VIY33<X4T=+<$A%>#1G
M:FMD<6ET4FHV=E5$1&I->B8C>$$[=E1K85A4;DYK14%W66$W-7EP=G)K;&4Y
M26]W4&]R6$]D+VPS3#-29"]W1'E,:3=Y-SE/*V-F.$%Q*U,O.&EO=C99+WDW
M;#=O<B])=28C>$$[3'9,=C W-7@O=T-R-4PO>4MI+W!J+TQU6'5I=CAI-'4X
M<4TK;V5:8FE7,VQN,5IP6F)2>DQB3SA%4DUC:%)O>7E%:EDX2%IA*T)X+R8C
M>$$[;#-,,U)8*U)C6&568CE/*V-F.$%Q*U,O.&EO=C99+WDW;#=O<B])=4QV
M3'8P-S5X+W=#<C5,+WE+:2]P:B],=5AU:78X:31U.'4O5"8C>$$[=FY(+T%+
M=FMV+TEQ3"MM4#AU-64V2R]Y3&DW>6ET2C@R95I)9%=T8E!58G<S;')F35EO
M<&=P:FQI;$-.24]813A74F=H2%%%1VY52"8C>$$[8EDY;F1Q2$Y09VM.,U@Y
M;V1M:D1(:6ED;5EF6$QV.$$S+THO=U(O<FTV9$\W-C5D+W=#+S50.$%G:B]8
M1EAF6$QV.$$S+THO=U(O<B8C>$$[:7)V<FPS+W8K5"]G:B]81EAF6$QV+V8X
M;B]"2"MU2W4K=5AF*R\U4"M#4#EC5F0Y8W4O.2]W06XO0D@K=4MU*W589BLO
M=T-4+V=J+R8C>$$[049X5C,Q>3<O=T(O>68X04)(*W5+=2MU6&8X078K5"]!
M24DO,7A6,S%Y-R]!3B]Y9CA%9C8T<3<V-60O-R]K+S1)+S%X5C,Q>3<O,R8C
M>$$[+THO=U(O<FEQ5"MB=DXW95<O3&0O<F1W.'-S9&Q(>4518V=U-TU%:E=P
M-F-N64-U4VA(:4Y);$MH8C4Y=5 X06Y*:CAY2DIM94DR<R8C>$$[35I0=WAH
M2D=O4&TP;%1M64Y.1GAV2$MN+W="1$MF;6(O=C8R+W=#4F(O.$%65$0K5VEV
M:GED+S!-<"M:=BLO<F(O:U<O=T0Q57@O3"8C>$$[4EAX-4M6>"]Z:U@K671Z
M2#96=V)/84U-:FA*25=:96-B0C!A:&9Q<G%'2&=2:BM7:79J>59F.$%O6E0X
M>F8X068Q="]Y3&8O04MQ628C>$$[+VQO<C0X;F8Y1$MF;6(O=C8R+S5&=CA!
M.59-9GDP5CAE5'8K:&Q0>DXO,SEB9CA!270O*W%M4#5A2RM02FU0-5<O.$%/
M4C-M92LX,28C>$$[5V5K-B](1DQ"9GE#1TMA14]R3$DS,E%Y<WIQ451T=%%I
M=59:9$]!3$102&U*3D8Y4C5I3U$X=B]!1%HO-#9/:F8X>'<O=T-O2S5Z5B8C
M>$$[.7,O-'5F94A:9&LO,S0Y>%EZ;DA06%!.<FHX=W9.16UO83%9861A4E0S
M96YY4$A(8G)A,TUR4C!U0D9',#-"-G5S:UAX,6I8879E:"8C>$$[>F%$4C1W
M26U23E,X>#-D4&1Y,V1A9%90:6M!3UAK93E%2C5S+TU2<%EP4#!1:3(X;G!S
M,$IT3'(Q1E5V8F\V;"]507(O<$1T.6Y94B8C>$$[;F)Q4D@X=F=O*W)F,VIZ
M+T%&9F%Y1V9.+TXK=RM8-B]S5S(O;7HX>%)B4$ID85-H9C9T-FE#2WEU=FAL
M84<S;$%:5$MZ345--V]Y<B8C>$$[.%953DXO:'=Y,"M#-D5U=C@T9#5(9#58
M.%9'9DY7.&5N8V9,.&9"16%D<G9N3S5M='!R,C-U<F$T84]-<G P3FU487DO
M0R]R1U=A528C>$$[0C132%5C87E!,' X3#%Y=65,14Q!;VIV=F9Y,C8O3#1H
M34UU53=K16568F9S+TA.5%AZ5BM956M!94A355EP1F-Y<UAT3&U,,4=I:28C
M>$$[9UI)5E(U3U-.-FMS:3AJ6&YW<6]Y6#5F0C%L,V12-3<O9#=R,UAX.#%F
M5#,Y1#5F:GI:5#57=G19=G1$=#=R5TQ:8EA52#4K<D5I>28C>$$[271&8W%J
M0DI12D4U2T$S1G1X,SA->$Y20T5::U%.>&-R1$M5;S-)555Y6"]!23=':F8X
M04U94"M4375:+UDS*TU$,T9W3S$O-V<K."8C>$$[32MZ<UAK;EEQ=UA89E!E
M;V%:-6QU8D9'=&)I2S)-1DY+4DA.+TUK<U134U-X15,P<$AX-F5L+W-H:7%#
M5#@T;U)$8G9,65)$-GDW4B8C>$$[47E26&9Q45-Y3$IA<GAG;$U3*V]E3C1X
M8C1247AS4&-+54)"*V-U;VTS5U(Y3F=N84%33F,O5C53>7931V52535-0C9$
M<3!!36=B;B8C>$$[4D-$,WA63613+TYA941Y-V\R<G@R0S(P,2]0=W5O3#%P
M171L:3E+-%E'3R]61$%X6F]&2VMC=FA0,E)7;U951B].6%=4<5)G5%1)6B8C
M>$$[56UK5TLR=#5(93-K5G!486A05FMP35!H*W1.>7!(,D@P<45D-5DO339B
M>D(U9W-.4&ES-&)7,W5R63-%<5!-6'5H5S-G;E5I34MG5R8C>$$[4#DO>$0Q
M4$EQ9&A41DM62BMA9FTW5#E":#%N5F1$4S9T<CDT:W-0<3=*8F-Q<DDP;C)P
M<G9L<VEI34AG>G-E4$AP5E9(6$@U;S9N1"8C>$$[2D)02G!K14YJ3V(U22]5
M=4=&1&%8,$9K2G U9E0T=U)H<%A:+VAE9T$S>%96,#,X>G)N579-*VDV4D9:
M43(P5V]$;F-E<DU7=4-P<R8C>$$[-6)G3D1'1E%'3&Q'1CE5;F9P>$A81EAO
M1TM(67%W5#@X=CA!>59U="]W1%)R+S%&=S5D9RMS3F58-E,K5&,R1&AU>%9'
M84Y&6GIA=B8C>$$[67A8>DML;$IC4DID3S=&1E=*;D%C<WEQ-TM!=&1W<"M7
M03AK>#5V57)J>3DK5S8K63E5:7-99$IN:5-45"]4<S=N5FEL<D1A>7A-8B8C
M>$$[-E=#-5-D4DQ.1S13:65T2G@U2#1823)P-'!6,2M48UEX=&I0;5A3+TM-
M2&QS5&%/=&Y-=%5-3V]'.6(Y279)6DA%<U5T:GED4D=Q0B8C>$$[4W)E;6XK
M=3%E3U1I5&4W1UEJ5WI".'-A;EEQ>50X="\K52\X=F8X06)1="\K5&=Y1U@V
M4WIX+U5(-D,U<3-/95@O;7HO=T%D2%)V*R8C>$$[631F.5%6>FUR-UHO>&,K
M.$]Y-THO=G@W:7AN3T]E=61I<54K6DQZ5V)7>&EB4TEK;'4U8FE'16U32C5K
M4T]2*TQY36MB4G124G8X028C>$$[84=864EW2CE82VUN3DM12' U,FM-3W0O
M;4).6D,U6%-#6&QT27!%="]2:&E+>GE2<'E":VUV9R\W=#)9.%=G6'!3=F,U
M37-704=U3"8C>$$[<C-N;#A)+W!,4TUM56DV-F9J*TPY0T0X;V%X-3=U=&-S
M23E9:'5O<DXW0D=U5FUT;&I8,2M#:W585TU"4U=R.%!Q5C=E;5!T6E!5-"8C
M>$$[<TEG94-R-'4O<#@O,&9&:&=Y6E1)8U8Q6&0K4'@P96=:<EA09&EQ;78O
M2%DP8B]M34@O2FU83G(R3B]J03EX9%@R=B]!2$(Y-%HY;B8C>$$[679*3WA6
M,DMU>%9,4$UV;4-X.'8V2F,V=&5N.7IB<4M,54M89&E&4D%Z555C;4E&5'-/
M<#)X5FDK<B]M:CE1,$129%=H,'<S:#%U,"8C>$$[13ET8GA4:6]U4UEA,C-,
M9U%31FQK671T+V1N8G=5<5,O;E U8U)G3&TQ=3!34T]E-&AN:6HY5TIO66I-
M65-8*T-J>G@R-T]I,$EP,R8C>$$[>%9Q,R]/:E%:6C5X2EDS8T5%3FTQ-E1)
M<7!-4%-E84]A3U-.,E966DAG-&=">E5N<T9*>%9M5VAA,6)A,7!C3V\R>71(
M2$YY2'!/,"8C>$$[8D]J27A6;&8P;FQ134-U-$1B9#DX54DO1EA9<3=&6%EQ
M=U0X.'8X07E6=70O=T12<B\Q1G<U9&<K<TYE6#93*U1C,D1H=7A63B]+928C
M>$$[:%)A-S5G=&1,;75485)82'%'4S574#%M4EDT,FM*15IA4&MA2C U1$EY
M;%%T;$-.;6U6,U@U66%013@P23AW>'AZ:5<S4S)A-T]N5R8C>$$[<UII=6MH
M:U-76EID42MT4FA6;BM0:&)U;W Y;VEP14)K4&0K4&MZ3TUD+S0K869E8F9Y
M93AQ85 U93AW86QA87).3$IP4717=$AE5R8C>$$[0C!K*W-7.6Y+1EI91FM7
M<W!U<%-L6E8R46-22T]4<D-/56MH;$Q%04,X9GI)84A9<7E4.'0O.$%L4#A!
M>3DO,C!,9B]!2D]$25IF<"8C>$$[3%!(.5%F;TQM<F,U-7HK84=L,SDY2D),
M64E*8G%W;5,U4S-9:&966#!P25A136%!3G=L2E=U,5%!4T)V;4IR=$UC,DEW
M2$YY=$AQ0B8C>$$[:7EI4C5-245T.51F4S<U5#-(;TUA9E-+:C=S-68K4TY2
M+TXK,398*U9C2&4S-G0W+W="5WDK+S92,W@O:VY59GI6+VQ80C-U.5<Y+R8C
M>$$[-G1L.2]W0DDW-"]Y5'%0-7$O>7)G-S!,9#9W;'!08E%85G!D=WI8:BML
M87AV031-:F=C=4LK2G!J+TI/;R]M+V%V.$%+=41V4EAQ,R8C>$$[=B]6<W9V
M.$%P2&9(*U-D4B].6"M68TAE-S%B,R]Q,E@S+U-/*U X04I/;R]M<B]+=41V
M84TQ-$%39$YV44)U4V)D-E5X+VMN569Z5B8C>$$[+VQ80C-O5%0Y6C!Y8EAB
M3C=U-W0Y4'1D4&MA959R=65'2U-2+U1A3EDP:4PX.6I*>5II0C!O2S$R,E!:
M;6=L:7EC95%G5C5U=C=3,28C>$$[,&-S3T-&;&U*.#8K5F@Y;E5O<$0O3$AY
M:U S24=/8C V;D=0-&\O3C!O,"M1+W=N-4YR-3 X<&UL9%AT54(W=DMQ1#<R
M24=%6CA:+R8C>$$[:4AZ46-->#!0>5(Q:G)7:E@U<%DS.79D;B]I:59*4&8Y
M:VY,0DE(:S%K14EZ0VAP;%9L2W-!5DEO461W46-647 P;E-J1F%X1WEG328C
M>$$[5FI4-FQ'66LT=SA6-$0P:%-I550T9F@W8EEQ<$1Y-S5F57AK85IA07A1
M;3%I<$)(.$U$8D=&9F@R:E X=E1&5G$K5V9,:7%I<G!6;28C>$$[1FI14F]"
M8GA!2V=6,$-J-&1G1FQC53A'8GA/2V]Y>7-B2WAT:W1B2S-J=&)73&%/0T9&
M:FI513$K1E9!03-X5E=X5F),3$9&1S!K<B8C>$$[<DA'=3=/>$-Q0C=K-'%L
M13-N5'EF1'DY6%A,0E-V,FPK<WA&:#E!875';%%K;C5K95$T,U)7,7DP2FM.
M1C1Y0F@Y2E=O6#9C4$-64R8C>$$[2#AW=&$X<65A4$I7<F%.638Y<#1U-VE.
M1V=%;'I&1T=E2U):5EAK>D%F15DV6DQ'94=12EEZ:EEP.#)195503E9Y>G)A
M85)D,VY!,"8C>$$[6C=71C=H4&]E24]P*V<U;BM*2'9C37=L,TLS*T%F4%@O
M575A<"\P:%A(+TY'4&E2-W=V064U,RM!9E!8+U5U87 O,&A82"].1U!I4B8C
M>$$[-W=V064U1#,S;$AZ6G Y<3DS9C9,9C)L<$94,4QI93%M:FI8:U%O-4\V
M:%)6:4)J-&ME.$QW4S=K4B]G2'HQ+S%,;7%F.4E6>"]Z4B8C>$$[:C1K93A,
M=TAU9"]G2'HQ+S%,;7%F.4E6>"]Z4FHT:V4X3'=(=60O9TAZ,2\Q3&UQ9CE)
M5G@O>E)J-&ME.$QW2'5::BM66#5:96-*9B8C>$$[3V5M,SDY<&QZ<#%J<#!Y
M,U4P,3-%,$YF4U!*55):07)-5UE5,C9$2SAU5U!$5%II>&TW9F)783EY,DQE
M668X06IP3B]Q<BMR0T93>B8C>$$[1D1S5F1I<D(O=T%W4"M5;CAK9CET4B\K
M5$19<%I&<F9M6%0Y2DM1=4AU8BM:4S!&:D%!,')!8F-J56A54W8W8FM$=#$R
M>6I0<5E9;R8C>$$[,TTP,UE.4%!+86E,63-C87@U;W8V*W!C<'!C0C915UE%
M<W8K>6YM56HO9UDQ22]M>FXY4C(W23=9>%AV9#=G-T9I3C5M+V-G6DY',"8C
M>$$[*UDX<G1'=FTV:')X,W5I1#$K2#%I+T@V33%75%<U<#@U1C)E4%)9;V-O
M:$9X47A1;T5I4EDP2%)5055F8TUX:5-E8FMG06-K=G50328C>$$[,VQU,G5F
M<71X<3%N1&1%.%)"2F-22DI7=D=N17-$,49-<VIG>45726UV8S%N3D%':5(X
M,694=%HP:E4Q9'1.=G)E*U=)9U-.8E-P2R8C>$$[1DHV0G5"86QC:E!&2T@Q
M06HS<V]:27DU149F9&%B<#DS+W9887<S2"]'5TY8+S1K1&I(2DM026M,2T5:
M8W=#=&AS6DQ4+VIM,W0Q<"8C>$$[-4@R5FAL3%)#=FA"3C9S2"]#6FTT93%-
M.% T<CDW:#5E>F--*VQE-4TW6'I:<F1I86%N8G)Q1G%+5G5B3E-K-FIX84%L
M:$I4<5-J028C>$$[*T-(3GIP=3(T4S)Y1&@X*VIQ3E0R3DM/.$1X9F5Y<E0Y
M4G-D4G1)-WEX;5<T='!F<U-)9'1T:4-/;TE/>$(S0C8U=DEY0D9H,'!"0B8C
M>$$[;V]J0V@R2W-+."MF;7@U83AO8W)E6FIE87)X<71H0U%#=%)597$K+T-V
M>4HW,'!K-%EZ3&MX;$E$;3A2.'@O;C,U-#%6,U-Y;%13<B8C>$$[5G%G4C(T
M+V55-T5Y=%8K6"MQ4CAS>6\V6617:5=F=5E(<4=T-GAQ37AN=C<R939M4%=3
M5U)N62]-:S%Y-%DT:F\Q;DI).55%4U-A:R8C>$$[,5!J:S)$5TMU>%95:G5,
M:4UG>'E-<$<T;U-/;5)-465J25-)-G-S,$PX,F90,FI/4'$K<E144D-G.4,U
M4')P>$@W245N3&HO04Q';28C>$$[5E,P.%-Z1UEH-C,U3"\U>4DP<E5*23=0
M>DAB:E0W:#EV<FM02F]#>"]M43AN461U<F9137@U-$1&=FAL0EI**V1K,$TO
M=T-5*W-4428C>$$[=7-S36DR:GAY25%Y<W)88TI"56I99S515S!-*WA1-T98
M67$W1E=E645S5SAW+SA!2%-B+T%&5B]6:$-P6FEH,DMU>%8U-RMA;#AM;B8C
M>$$[-G U5'8S575L<&5Z>G-G-FM25W)U45!U=T4P3%-"83)X='!9,65E-EE4
M86ID15-8='@S95-N465#2CEL1C=$3T0Q5W!L;6U:1C=J4R8C>$$[-F5/2T%I
M159M335$<U9D:7%25R]L;C!D4VEV9G)03# W=35V4%0T57(Y6FHY4&A8;"MZ
M,7)49DQZ;75.5C!!*U1J>'=62S<V:R].1R8C>$$[84IP4#9-=#=I2#%F5SEE
M-W5B=FQX-# K<WI.3G<V=%AJ>G!8=FMC=51J25!C05!K2V)-8T]%2#-K+TY-
M8W%B2%EQ-T96=6IY3G S;28C>$$[4S)E03A93E=D;TPR2#EK>4Q%>GA49V9Z
M:C!V5$Y/;TER.6M:=BMX3E9,:CA-.&DV3'1N5%(T9D5(3FYM9$\X,G@S.'<O
M349Z-68X028C>$$[2FUQ-G9A:71Z8E)!46LP*T8U2%=-3E$Q0C0X*U9$:V]I
M>E-#849V:FTV=7)I-G5*3&TT:V%7959I.&MJ16QM6FI5:VLK2GI:>&E!2R8C
M>$$[1&=Y:U-B2VQH43=&6%EQ.4HQ+S@T3E=U:%!(<$]Q87):,C=A=DIF=W=R
M3SA3<F)-15I9*TUC<$%);%9N-&IA<')7=55J14]V8S-(3"8C>$$[.3=&4%!8
M;5(O379N1%=.8CE795=#.74U-6)-6%1C<%DW6G!'34U2*TIW=G!X:TM&53!(
M46):6D-.04)R;$MZ85$U2FDW1EA9<7HO428C>$$[9DYM;UA(-5EE869,9'DU
M;'1R94LR=3=1<V$K;B]P.$-32U!::31.4$=V:6-W9%)!03)/<FPT2C(K<G-X
M,C$R2W5X5C)+<SAW2EET-28C>$$[:"\T-E1F-G$O<7=H57-X43=&6%EQ=U0X
M>#1)<FIZ1#5-9VU54$1,<4UI4TEE:DLQ=31)4'I'2U%H6&EU3D5N:C!V56U9
M<B]D,D=O3B8C>$$[+V0S0R]S<7ID1FU!,EI4.7(W4SEW3U W4C=/;&EK6E)&
M=RLU-G9S+W1#3U=):DQA9C-O=DY3-U8R2W!D-6AS<BLK,%,X=$Y0;DYR928C
M>$$[>E)L24QG3S!:4FEE=DY!5U@V371W>D5:9WE&:'%Y>$UO:T$P5U!7,VLO
M>DQ'0S,V8DUC:4<T5S-D,W9R;&Q2-4I$05<U6&-536I):B8C>$$[<%AN0S-4
M<61J;59,531Z+T%!.3,X,&0Q+W=!2E!Y3%%-12\U,V8S;C-D82MX3'9,,S5F
M95ED3#%44V)I-'4W4S5G,#A80W160WIG5"8C>$$[6$4P>%I$2VMR.#-%<3%9
M4TQX<%$X*W576CE:0V-:04%J:7(W04(P;V1/-"]"<GAA5V-:4DI),B]79G@K
M=#9(;7-D9S=&5D\T=4E,928C>$$[1C4W:5)965EX>6ML8VA6565*2C)'15)*
M3D)":T%,2TTX<C9B9&%H<4U/<UA%5%%71G%'3VUP24-S:W-K:49$3U5)1$EG
M4C)6061Z528C>$$[;6Q/3F5Q-THW4$],,7HK;W9-9'%A.%IF4D@V47I,3C(V
M6DQF375G,FUV-D1E-E!D-U%8:UI1<TYY<D%H:V5M,65,04=M14=L9DE8;B8C
M>$$[1'E8<FYL6%9(<V149TMI<$U&=TXT-55"*S!J9'AU4&PS;V,R1U!+2F4Y
M=S4T>D@S2D1L<E<W1E=195,U+TLP1W!8179M3S-3-W1%="8C>$$[;BMR5SAP
M=492-VIK9U-P=%=J:RMZ>5 R9TUJ3S8R6G=Q.3)75S)Q9FMT8C9V86E7>6UL
M<W)7*VQD<%DW3V1J3$%P:RMR*W$P*W!-<R8C>$$[<V1F5$UI:3%I6FQ"1E%E
M=%I%-B](-FU134PO2#8Q=FYZ5B]Y,G5F2G-&<#5E5S,O045S;6]Z4W1*2%IT
M8GIM,V%E-TLX,C1!0E!3928C>$$[,V]V<78P;T5J-&MU=T5R,U=::E=Z>EA,
M;7 R2W%T=&)81GI-:T9V1S!S,&I"56I11FU,36%!041U5&=L24%757AI5'EE
M=GIF;')C*R8C>$$[5G9Y8SAW-FQQ:3A.6#%"8E)F4C=W=VDX:&)I9CAP:E%K
M9'%$=EA.9FUY8U)C,T9$:&923U9-;EEQ-T9867%Z>D%L:G9M3WIM*W-I-28C
M>$$[5E,P5$M!4T]X2&IH0W!,:6@R2W5X5F@O;FIY>G)M<C8Q-5EV3DUU4D1&
M<&PX6G)W37%%<D=53EA8:TYZ449+8C=S1#)X4WEU-G1B828C>$$[-W0U3&$V
M:%-E,VQ"5U='5E$V37 W37)60D=*0W-B=5!)>7A68E(W*U-Y6#EM,6Y"=7)C
M9DE->7I,-T):94DO;'I786IS;D1K,W)H4"8C>$$[:S=(0C)P;7@W6'A$>E%%
M=6ME87)A=D]W:79%2%)R4V11-2\U-3-!:%9F.$%K66,Q5U1S1UDK;5%,<SAF
M8F-$.55314TX,3=&=&,V6"8C>$$[9E%K9%%,9#4O=T%B8C%H;4A0<VY51"M'
M+VDU8V4Q8T(V,'!T<4-,=3ER97AG-T)P3$LW458K8E)!6E5E>F114#1#,D1T
M2$%F-&=U1B8C>$$[.%0P<W(O.$$V44QZ+W%L:W8U33%(.'=O+VQ,0B]/0V]G
M,6UB+V5F4G)Y4E0K,#1I9T$K66YK:68O:&-U:#).;E!11#1T32LQ.$$V:R8C
M>$$[;W%(>34U<75F-WAR5%154#=66'4U2V8V;T9U:6XO6DU->CA865 X05!L
M.&Y#>3EU9GI)+TY..4XX;6%6851P9%A,4V%L95)K3DA09"8C>$$[:TU%661'
M:FE53$5H2#AW6&PW-75.4&]S5TPV4G8S.5A5-3E::WDO554K>DMC5C)+=7A6
M0C9R;RML-G9:=%IA;F%X,V1S*S5I;%5-028C>$$[96Y*939S3WA'*T98;&9M
M4"]N1R]Y.61U.#)I6'-U;D]34TQE565T1C=+<"M&,4AU95)Y-D]E46$U66]L
M-2]Q;B]/4&8U9S)J5719-R8C>$$[9E5&-CAO6FQ5068X.7933F9O>31A:V11
M,4A!96A9,V1F;&0K64YT255F46)X>4]P:6EA4F9$<6=)>5EZ>%EN1$I#>651
M9D\X8G%J-B8C>$$[1&9Q>F9:53(X9THK5S)(>&]D-E!#;#-+<2]L=C4K6F=0
M.%!A9TLY>F)39V8X4G@X94AE=FA35'%W+TDW.'E,>F<S-DTY0TIU<GI3>"8C
M>$$[;U8K849G+S1:039M3$E90WI4478K8UHW:W5R-C=Q<4EG24Q1,FES-5IE
M-#5U131N+UET;%5T4V5J64U!-G96=DMN-61E579+>6AT3"8C>$$[<VQ&,$)2
M<C)B.35/9'%':D555V\V.$%!8V]L26YM,F=!8VMU+T]B5'17,4@X=DY3<W1-
M9RMS>GET05AI1F5::E-:2$I194E+:C9+-28C>$$[1FM'63)H=5=T651D2W%8
M2E)43W%%;$)*46-G<%!A=E1&0W)I<G-65C=3,&UU<&QJ:55M<#-B<T(T;D97
M831%<%1Q,G106GI#1T9!>B8C>$$[,#5->E9O2SE"455X5D%F-&UV.$$O9F-8
M,TXO>E9H<%AF-&UV+W=$9F-8,TXO=T$Q63!R=CA46"]!4'9U3#=M+S5Q>'!8
M9C1M=B\X028C>$$[9F-8,TXO>E9J4W4O>$YF+T%/*S1V=6(O04IQ>'!89C1M
M=CA!+V9C6#-.+WI6:E-U+W=!5%@O.$%V=4PW;2\U<7AP6&8T;78O05!F8R8C
M>$$[6#-.+WI6:E-U+WA.9B\W-VDK-78K87-A5C,K2G(O.$$S,T8Y>F8X04Y7
M3DLW+T4Q+W=$-S=I*S5V*V%S858S*TIR+R]!2#-&.7IF."8C>$$[,5DP<G8X
M5%@O=T1V=4PW;2]W0V%S858S*TIR+T%0,S-&.7IF.#%9,')V.$%%,2\O04PW
M:2LU=BMA<V%6,RM*<B]W1#,S1CEZ9C@Q628C>$$[,')V.%18+RLK-'9U8B]M
M<D=L9"]I82\O04XY>&9C,R]!1%9J4W4O>$YF.$$K*S1V=6(O;7)';&0O:6$O
M+W=".7AF8S,O3E=.2S<O128C>$$[,2\X03<W:2LU=CA!;7)';&0O:6$O=T0Y
M.7AF8S,O3E=.2S<O04).9B]W0RLT=G5B+VUR1VQD+VEA+SA!.3EX9F,S+TY7
M3DLW+T4Q+R8C>$$[+W9U3#=M+S5Q>'!89C1M=B]W1&9C6#-.+W=!,5DP<G8X
M5%@O05!V=4PW;2\U<7AP6&8T;78O.$%F8U@S3B]Z5FI3=2]X3F8O04\K-"8C
M>$$[=G5B+T%*<7AP5CA0;6$T.5%E=$=H:G(X6$-O24@P:S0P<DES0W-!+TU8
M5VXP;5)89VE%.35D3VQV85)-94M'46]Z:W5W0DE656I::B8C>$$[5')3;55A
M;E5$1&I->C!B=%!G3U=99T]R1$)R,VY#9W)D8698=E-Z;B]W0WEV3D0O04,O
M3"M94&TW>BM1-"]Z:CAM+S Y-78O04]7;B8C>$$[5"\X07!$;2\W2W-F-69L
M+TU(>E@K430O>FHX;F9P-WIF+WDP-F8X03E)8S,O6E9J+TPX=C5G*V$O=T%H
M>"]N2#5/+U0S;2\O04IA9"8C>$$[4"\V435V.$%S<7@O;"M8.'=F3F8U1&HO
M041J.&YF<#=Z9CA!.'1/;B]W1%-(3B\R5EDO>2],*UE0;78X:'@O;D@U3R]4
M,VTO+VQP,"8C>$$[+W=$-E$U=BMY<D@K6#5F>D(X,2]K3U X-"]*,S9E.#,O
M=T1,5' O+T%%:'IF.6Q74#AV>2]M1#5R+TEC9C5X*U-*,&YZ4')!,6$S<R8C
M>$$[=%=&=DQ$9D9O-V$U=&\S:$M3<6I38TI%95-A;UI586I":'9T5&5U6BMG
M-U9'95A#4E)C2%AD;4A$2&E"<TUS>F)U<61I<G-69&ER<R8C>$$[5F1I<G-6
M9&ER<U9D:7)S5F1I<G-64R]8.5A84V1+;'9F5#EA4E-K8T5&95!/5U9X2$=V
M3&5G3'5+;6UW,WEV3FQ'3T)K95%B35=->B8C>$$[:TEJ;5=.1%@O3T)&5&-A
M97!/+T57:S=5.758,6QA,#AA1#5$3V508CAU:T(X,V9J<TUF>G9S9"MN=DXO
M+TQ4<"]W1#!H>F8Y;%=$*R8C>$$[6#5F>D(X,2]K3U X-"]*,S9E.#,O=T1,
M5' O+T%%:'IF.6Q74#AV>2]M1#5R+TEC9C5X*U1V,#DU=CA!*U=N5"]W1'!$
M;2\W2W-F-28C>$$[9FPO34AZ6"M1-"]Z:CAN9G W>F8O=T%T3VXO.4EC,R]!
M1U99+W=!=GDO;40U<B])8V8U>"M4=C Y-78O04]7;E0O.$%P1&TO-TMS9B8C
M>$$[-69L+TU(>E@K430O>FHX;F9P-WIF+WDP-F8X03E)8S,O6E9J+TPX=C5G
M*V$O=T%H>"]N2#5+;' U<3%Y,G9B6F151G1C5V1Z3$AB1R8C>$$[4S%I:VAE
M2U-:>$A'>%8U6G<V;#)#;6Q+5G)V;5AO=3)01FYW4VI6=4QR3WEF0VAX9S-4
M,C-.,#9D-68K8E X07@P9$<O=T-9-&8X028C>$$[549C-7$K,F8X6%!V1'-U
M>68W.&4T<UIZ:FYR;FTQ>"M96&UI5%5.87-.3W1)<#=V5#5(:FIT,71B;59O
M-EA!:6IA8F<Y6%=33#0V>"8C>$$[<G18=E$U=$)O.%E%5$EM<&59-W5N=35B
M=71/<6YX4T%(3'E096E%.#)F;4DP<U5N-DE28F54,#)A13)L,39I<5AT,&13
M+W%!5B\P:"8C>$$[,BMZ<TEZ=#%):BM8=U5F5G8W>#4O<2LQ:TTK8BMB.6@X
M=C$O671T+TYN-6EI,F53-C!L0R]W0E<Y4D)&6EA8=WET1&)Y9TUP;%IM0R8C
M>$$[1V0P6E8K2W%';2]W-%IA9D)D0UA8*V-/.&IU.'(K2VI0;7)E4%1U4&PK
M4&=I3D\Q,WIN8WI7,#$W8C-6=&-.2$=6,#9'>DIT6F9H9B8C>$$[,6I,3DM!
M.$I$<4].6D%A52M&-C584$9I1F=54C,S=C5B9&9L.%%M1UA+9'E#4$MT=C)F
M:FUP<C5Q+TU+4T%01'!+355I=5I73#)L>B8C>$$[1C9J4E)136M+;SAN2D<Y
M4U=295)R>C1655I,.'9G-GDW=6\X.2]U.3$W<C0K879P-RMH.'9X-7-P.')8
M,G-8,F@R.3%R1G-T<G%$."8C>$$[+U9I4EI%5VEU5E)G:V]%:6-L06)I,C0W
M*T=9;6]H0TUY24<T=59H;$M58FM+2UI,+W=!9&I2=BM9=V8X;5IC>BMX=CA9
M2'5,9V1R+R8C>$$[04YW9F5'9EHR3'E4<U93;GI88V%T8C9$8WIA4W)T97%9
M9T1&1TI:1FI-<4-:-#1Z54\V4D9M5F%'<$A1.4U665(O:E!Z=&%A;&$V9"8C
M>$$[1$)*9E(S16LX;'1*95=->3-K.71&3&)29WE*14Q:8F9E950Y-#A82#16
M<4XX57)B4'IP*V$X-E%T4&]-3G974V-Z3#E6=3-0<'@O5B8C>$$[*TU9<3A:
M5B\S,&<U,$MT=TI514-U2V\S>E(U<C@O5T8Q<45M:S9.8U-O:U9Q=&YB5#(S
M,6A$25=U=E=F;&%/>F9'<U512'A(:GE8:R8C>$$[<3%*>%9+<%!/,S5Q47=A
M9V)F4GIC>4IC>F5G8FUW=3$Y2TPV=S1I6#DP06)G1TE+1DUA,5AQ-5!81E4W
M=F(S.'=B;E-):&%R3&%A;B8C>$$[3G%X:%E"1599-U0P5V(K.&4S=59%66-!
M96]9;7(Y3TM%23-M6#@Q8F$W=3E/8E,W931.<D9A4E)A:4QE-5I:2G!*8F5+
M85EH1$=J;R8C>$$[5FQL9FI'454T2&Q157%P6%<S;6XX>%E,:#=E6%1'=7ES
M;#,V6F$P;50Q:U-E-D5:17EL66]64DEO94MU0S!G96]09D95.2],+U90328C
M>$$[97!71V]81W5O-E-I.4LR:79A4S)).40V=D,S=U)45FLT:59N2$IM3E18
M96UW5EI2:6@R2W-E.#@O=T1(2&@O-6I,6"]!2E!,;40R;B8C>$$[+VDX+V,U
M=EHS.2](,W!.;D1V85!0=%4X*S8O1#5K,512-TLR:FQM<S!D-&)95S X<S-!
M4G=T2$U3:G%(4FUL8T956&M/4&-K1$YL1"8C>$$[4U%/3TUY969M4%!B.&0W
M<C4V<5EM66=C=DDK4WAF3F8U:W1B<% X06]M3D-)>#9K0G,W;W5:1FDU=GA0
M<4Q137<T3#A/,W8P3#1'0R8C>$$[-G8W4BMP2&HU<2MN-T-R3C5Q+TU#3S5L
M6G1*5U<Q5G!J2$A(85A(<6Q&939336-M;#1L=CE':F9O2VE19$MG-"]L.$9F
M5G8W>"]2."8C>$$[=DTO2FMC*U5(-F9S4&XK<C=64%1V35!N:3AE,&LQ0S-U
M8D%M:7!&85=,=D902CE:2W8V>3-!-7=X*VAX649P139N8VMC8V-M2$1'*R8C
M>$$[16<K*UA,8G!84&9Y4#954GDU5%9G:C-$;G8U.'1V34LY=C5M."\S1G=S
M2S97:UE->$1Y4U=T=VEO<7A4>4Y&5G!&1$=S56%#8V9!4R8C>$$[*W<R=TA"
M:$%V:39D-#AT*UAM9E1Z,EI$3FQ*-6999E X6'DS5'IY5G%V;4A5.4=.>G(Q
M;6QL965Q>7!(1VLP46%-045.-F,T16EM<"8C>$$[2S<Y859'>'I(,5=/14HQ
M03)0:"MH=C X-7EJ8VA25%<K-C)8+V)1,"]W1#9J66-T-TTO>&E(=F%/,&8W
M:5AU9E%'9'4X83AV+TYN+R8C>$$[04DV3VIF.$%-8U K;TLU>E8Y<R\T=69E
M2%ID:R]W0BM08U=--7AZ,7IS5E-N>DIR52MK5TU5.79B3&1Z>C-%3G1(13AH
M:%AL32]!1B8C>$$[;D-3:T%F-G5864U1;6%*;U9F93 U<VAG3$%V96MH:#@O
M86I06D,X:#!A5U-'5S!I=5E&:5,K;6-V3D=J2VYW5V9O<T9:+VE+5$4P0B8C
M>$$[3DLW6FMY,&-184UT-W(K16-V.$%/=C=':V%M4D9I4%1Z+S1M=G159DLO
M-6=A;')'<3906GI74FAI=CA!5#)U6G)G=U1O:C-#:4YI228C>$$[1V8T4%-5
M4U5,5D\Y0EAP>6QQ3DA'15I%2#9:5GI(3&9N-7-C3W%L3U514GI(;CEJ3W,Q
M>FY/>%946"]J<V%.+WI'1"]!2DUY-71E>"8C>$$[=CA92'5,<2LQ+S=G*SA-
M*WIS6&MN67$W1EA9<6=T83%'5%1D2W5R-D\Q;79:245,2F$R-DY*3$DS44MQ
M<4=B<C%O35994F0O;40U:"8C>$$[5'EH;T]R,C%N1$IF-GI)8DPP;6EN4TYB
M>51K<TAW<WE30TEU:$)*-FIV:6Q!5VXU>F%J5S,K<V%$2D]L,6)Z,V-B470V
M56=3,U=7<28C>$$[0T8K8GE(;F)0>5IA0E%6.%)65E=S+WIF=G U<D]35%)V
M4W1R<3%N;4M,3#9T2DE(;49)-30Q6DI"3#9(1T]I04UX*S$P<7%Z1'E8-28C
M>$$[;U1Z3F]-5W%P2$A&-FIU:E)X4TY-:6Q$4V=K84](;#<P5VYA=4M%.7A6
M,DMU>%8R2W-E.#@O.$%(2&@O-6I,6"]K.'594&%F*TQZ.28C>$$[>FTY;F8S
M.&9E:S)C3SEO-T95=#AW-G,K:V%08V%G:TEU2&@T0EE3+W!H:3=Q9W$O1C9F
M82]L3U=9<V9(241K,5IC;D)%;$E,9GHQ<28C>$$[37-C53,V1V0T:6MZ4W)!
M3'ED*V-$4TEY4G-L;C9$:W1&.%!+5E1V,$=:4C!K9C4S*S5(4"]/=C=#,%(Q
M2DEV:"LO.$$T;79T4VY19B8C>$$[>DHQ=E5D63!A>&YT64E29D=D8G105&U2
M,4UC,7=G.5 Q0W)(:7-#8VIW27%4>3E064<W3F]94FI)9VYA<35D=R]8*W$R
M<DAQ-5-L128C>$$[16,O,B]Q+W-E:C5Q,UEU>%9#,S-7>2\W84=N+T%056)$
M;60R6B]J15!E-%!A4#A!8U,Y>C9!>G0S:EAN2#5O-F)F6&ML=DY9>"MV8R8C
M>$$[5T5Y6$ET<6A42W9P4U%U<7,Q1C5C6FEY,4E"27!59&-X3F1P>FUX1TDU
M=59O=%%-5U534$IG-'9(<'99,S9N=78Q1S=.4'!%4D@S6B8C>$$[>78X04IE
M;R]M+V,Y4"]+940K9#DW9C%X=BM72R]W1"MK0S@O-G!94#5,,4@X,S=L+VQ,
M0B]/*SDS,7AV*U=++R]W0VM#."\V<%DO>28C>$$[6'%0-78S3"]!0VQG+VYF
M96AR=EAB2WIE,U,V:74T2'5P0D1B3$I:6&%M4U5G:TEL670R3D]G=R]Y5G%0
M-78R:CEA+WEN<"\U,S,O<28C>$$[4E Q>'8K5TLO=T0K:T,X+S9P65 U3#%(
M.#,W;"]L3$(O3RLY,S%X=BM72R\O=T-K0S@O-G!9+WE8<5 U=C-,+T%#;&<O
M;F9E-S8T,R8C>$$[+TQ&9B]W1%-"968Y57-F-4PQ2#@S-VPO;$Q"+T\K.44V
M4EIA:'%/=%=->3)K.799,DUH=4IR:35J94%U,W!S:5)X>'E"6$\W.&UB:B8C
M>$$[4V=P,4\R,3=+-T]Y63AN2$U65')/,#EF:GE1-$E',F,U,%1O2%EQ-T98
M67$W1EA9<3=&6%EQ-T9867$W1EA9<3=&56\X,39B9&%H;R8C>$$[<VM6;4$Q
M,T9*1F-127@T:#)G:U=4:%4Y3UE5<EAT5W5587)$-'5/54\X3BMM>2M(:T5U
M-'-41C--3G!.4'8T-4)S>695<FPV2'<U4B8C>$$[;S9(-7%X1V-G97ET440Y
M4#-05D1T4$%2.5@S="]81R\U67(O05 V44QZ+W%L9R]K=E5F>F9U5"]!0VQG
M+VYF93<V-#,O3$9F+W=$4R8C>$$[0F5F.55S9C5,,4@X,S=L+VQ,0B]/*SE1
M=F1:=&)',&QU-WE#.'0W5T9E8S P;&QD<6EQ3S5*:3)W+WE8<5 U=C-F<E@K
M53E0+T\K.28C>$$[5FHQ0EI9,6MJ=$PU-#-!6D=&:F5%14560D@W<D@K4SE2
M+TXK-SEA+WEN<"\U,S-R=G)J9CAS5B\O=T))1C4O,5-W9GE8<5 U=C-,+R8C
M>$$[04-L9R]N9F4W-C0S+TQ&9B]W1%-"968Y57-F-4PQ2#@S-VPO;$Q"+T\K
M.61B,FUO87!F5V-%1FYC43(X3GI"8S-.,6-W>5<V<71T2R8C>$$[<W=25FU6
M2&1N6D%V=VEG1E-4,D]W-TXW37EX>6EC>'=I3&<Y;V1O-'!9:D=*<VPW-6Y4
M4$]-6CAX>%-,9F5O5BM",4A&=3%2,G=H528C>$$[<'A1-T9867$X+SA!>E)V
M-TLS,6YY5DA03VM4;E=O<$%R<T%E0W%Y<S(O64TV:79V:6PV0FEH,DMU>%8R
M2W5X5C)+=7A6,DMU>%8R2R8C>$$[=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R
M2W5X5F@O-7989'1B9FQZ<EIN:U=0,6]04FDU2#=5:FM"5DAI5&EK2B]W0U<W
M;4,U.'9A6B8C>$$[8U<X9VQH:W195U-25%5%96U-54IJ:7)S5EAX4E-3>4Q(
M1W!:,DY!0FER3V-#5U K9"].2"M(9$A3-&IT>&18;#--='):5S=.>%)P5R8C
M>$$[5FY*9'%':7!(1WIM9W%A54=586Y51$1!>E!2=C K035::4DV<T1(-6=E
M96%B=G!.9BM91S0O-TQ-,% X=GDO;6HU=3<O:T]0.#<W2"8C>$$[9CAR03@X
M+WHV5"\P9S-(+T%'5UDO=T%V>2]M:C5R+TEC9C5X*U1V*U9G965F-3E*+W=#
M:T<T+S=,368U9FPO3DAZ6"M1-"]Z:CAM3"8C>$$[*V)R83@X,C9H<&PO<F-'
M;'HS3VQ/6'1M4S%U;W=15U9U16=7.4A.87%.:B]!0D]0.'9Y+VU$-7 O:T]0
M.#0O2FQ(+TMW4%!0."MK+R8C>$$[.4E.>"]W0FQM4#A!3#AV-6\K85 U1&HO
M041J.&YF.$%+=U!04#@K:R]W1%-$8V8Y;&U0.'9Y+VUJ-7(O04-(2"MC9FLW
M+VQ92&YN*R8C>$$[9E-F*VM'-"\W3$UF-69L+TY(>E@K430O>FHX:S(X<2]M
M0G$Y>'(Q<G!7=5%7:G@V:5AJ=$QY,&IE14I-:V)3*VY*2$I*4%5/:V)58R8C
M>$$[34XV3%1E=5HK9S=51V580U)28TA89&UN1$AI0G-04E!4:B]L2#-$3G,V
M=#-P>"]Y:C=H:7)V5&HO;$@S1$9896Y(+TM0=4=+=3E/4"8C>$$[*U5F8TU6
M9#9C9CA!2U!U1TMU.4]0*U5F8TU69#9C9CAO*S19<3<P-"]W0U5F8TU69#9C
M9CAO*S19<3<P-"\U4CEW>%8S<'@O>6HW:"8C>$$[:7)V5&HO;$@S1$95<CAZ
M-C-A84)O9'IQ<S!";D500DEO16]':VQM9%EO;W=4<T]5:G%+;G Q>79,:T5)
M;5(U0FYJ>&UC:$5C>3@W+R8C>$$[04]6:"MD;BM,:'!53F0O4RMR5'IC9F(Q
M4')%4$PU.$(X<S!"-V9.-U$K,3-W-T1&8GDK>#,O2W=03S,X,FQF.4E5+R]!
M1U8T4#5F4"8C>$$[.'HW9C)*+VM-9GHO04Q0,G4O-5="-3(O;3!R+T%+47 O
M=T1S<G@O;#@O>E!T+UEV.&AJ*V8Y;C=5;S@P-G1R2&UN4C5.2#%Y,S!Q-B8C
M>$$[<UI3<FU0-G)D27=D3C%:6%,X5FQ).6HK1U X04PU+VUF8BMX9C5$2#@O
M-U R;S-3+TYV;6)3=$]T=$XP*U!38F5X=$DQ:'0T1G-R9R8C>$$[:%5554%Q
M8G=K+TTT+W=!=FXK6CEV-T8O:TUF>B]S+V%I=CA!;%E(;F(K8E-V*VM+9B]S
M<G@O;#@O=T%Z-V8R3"])62]N+UHK,3,O2R8C>$$[=U!/,S@R;&8Y254O+UI8
M:B],-2]M9F(K>&8U1$@X+S=0,F\O469Z2C%H9%=T3%17<F4Q:W1,-E=/,E,X
M<S!E0F]P6E=#4D(T-4I*=28C>$$[874W2W16645%:EEI<$=8;W4Q>&UN=T5C
M2E!*>$Y:,E5C54])1W=(<&5B;#%$02]Z92\T-2MG+SET6"]S474X,69B4"M,
M;C-H,F9:4"8C>$$[.2M08U=#-7AZ,7)Z830O34QZ4DIQ1W171VY7:U4Y,W X
M:GAX,C8R='I+,&1,9U)2=$YW97)R2D8X9%DQ,G(S;V,R9S!E34-*:U15=B8C
M>$$[360S5#-C=#-7;E94-'!!1&PU2'920V5B4'I%85=+5#E%271V2C9B3D-B
M4S8Y4E9,,C9/<&8Q04LO=T-K3S,R9&A'9'5P169Y*T-J-B8C>$$[="]E4% Y
M6#)S:&YZ9GIF<U!L*W8W1G1V-7,O3557>GE85VMO6"MR96]G:7-R<C1:5VAT
M-5%'57ES>D)$3S9-<2]&5D149C1C37109R8C>$$[=6A,<B]/2&52,V56+T92
M;GI6=DAP,TAY+TAW4D=N83<U>G5:<F%A.70W<3)U1VIJ2S9D1%IK,G-V=W8V
M>&QM;$%E16@Q2$=S9TY+9B8C>$$[0SEC<FYI>$-W2TDW-S,X='5V>2M)5$1,
M;$\U0DAL5S,W4'AZ53$X,69M1DI!2&@P;$=+4EA-<D8W4S5I.5)O;V]'4T95
M951K:F5P3"8C>$$[279),34X2W%-;"M8=V1:9#-5964O=T(S=79D9DAZ5CE0
M9C!0;"M03FQ0;&$K,6DK,$\S=719=&QT9%%F;C9S4TQ):3!6>7%-16Q!:R8C
M>$$[5&MO1&-7,TAF=WI%,45)4FU203-&>7--<%-J8VA25#=24#A!;$LO3"]W
M1'I(9CA!36E832]S8B]!0F=E-'5",G8O8T@S:#=D;EE02B8C>$$[=7A6,DMQ
M1CEF,D]N,FMT-68S359P6G=$;$YC>G5S8V%,,'%Z=5%O2'IX5E0P=E8Y2C%A
M,%<Y,'$Y9S%#>EEL5G5B5U9*;VE63D-!."8C>$$[6EIA:G9V:7%R1&57:S@P
M.$5-.&-S,7%W:G5O:V1784HR45-+<VEG,55L2%9G1#))3TMQ4C%F4U)D>C)2
M=EE"95=S46YU8F(Q53E72R8C>$$[23E*2D5R>59$5#=2,GA64G-0365G86I,
M8GAA9G%%1C8Q,41*8S(W5SAI>DDX351R13=Q-D9L;TAC3#$V+TDT<6DU<GDP
M9VUG9VUN:B8C>$$[:6UU;4UD<D4W<7)3=7%'4FQJ56UR14EJ35%/=TIX5E=X
M5C)+=7A6,DMS3B].;B]L1D4O-6IR4"]!2E!R;40R;"]I."]C-79:,SDO2"8C
M>$$[,W9/.#1H-TYG*W)F;5I(66%T<4YG3$]*+W="2&AW4SEZ=VM,2DA%-$QX
M:4HO5&IF,39,25<O6F%T04TR1U!1.%59>78V=DPS*V908B8C>$$[:S1/5%=C
M36E+-65A1%@X,3=T-V1,;&1'5#!05$1Y5G4O:59H1C9S:6=#1F=E2V<P3F1Z
M-%I,.&=,<FDK>CER1#@X879H*S,Y:7,S-28C>$$[;WIX6$UQ>F%5<5<P8E15
M;5<T6C)+4E!D4FAV5$5.86PW1C9G13!"2%AP:BM11F)3,SDS.54Y+SE*:V1A
M461X=#<O9C5E4VYP,S5L6"8C>$$[;7!084]K9'!P,&-T05EB:'!,9S-,;35-
M1%)7<W-.2VQ5065O:F)::'-".%=/5%%I1C@U9EI7,3<S.'594DA71U9C:"MN
M9G O67(R+R8C>$$[-6U81GIC3&(R*VMR3$LP>&IO3&MN:7%X5'I/<C!I4$<T
M4F)9.&]E,TIF:3-W2%%!0WI,<#-E-&0O3&9N.6I)87=K,$DO8C<O04,U-R8C
M>$$[8VLX.&QE84I0375J2%58<VI9:U-T14DO5E=D5T-G2&MS:4%!:C1Q2&)9
M9VI-9E990FEN=S-F=W!V,"MB>$DS5DHV=B]!0C!.2B\W828C>$$[=6UF.5(X
M3U<Y;68T>$0S=$AA4#EX3#-094TW9#0Q9V8U=F8X8R]19BLR<B]!3FE&,VUR
M-UHO>&,K.$]Z-THO=G@W:7=83T]E=&1I<28C>$$[52M:3F%N,&EX:6YT-UIB
M=65E-&AT;S1N:TU+.'!N-$%S-%-59T0O5GDW0FE%>E).0W(W,FY.:TU"648W
M,'@Q+WI!,4=84WIF4E=-9"8C>$$[<&)Y5VM6,49D6$,S>GAO6FM2=FI+,G%1
M14QZ-UA(8F-R=GAY=GEC4DMI8DXQ431F*TMV+T%'3%%D565'=TLR."]W0E9F
M83$U6#@Y-B8C>$$[;G$R=#).:D]T<4DW<7DK<U-P17-O;%-12W)C<7-3<&IB
M:U%P54UU,SDT5'1J;C!K65%*1C=3<CAE9C(K4TU/<&Q+44)R8V9J.&9A>B8C
M>$$[;DYE-7IS5E)':68X<%@U9B]W0UDW+VU23&TQ-T<O>&=E-'5R-U@O=40W
M=SEU>G-(:S-9<3=&56TX-"M8;3AX95=R-U)5=69Q:EAI2R8C>$$[<3-01FXT
M1EA6=V5+4$4S-U!:=V9F1E=&,VXU37IA:&171C=Q1W-I4RLP.4DT-$QP26)M
M4U91;'DQ=WA383AV3'ED5V17364X:&]08B8C>$$[-&-68C!F.$%*:CE(959D
M4S!,.4I7>B]8-W4P=E S9&@V9&]F<6%1<#96>&$K=3-R2DXY6#541#%&-49J
M,'A6379,,S56,F5J5T=S5R8C>$$[-C-A>3-'<V%F1' P=#4Y6&I%:6E'1C1E
M6'A'44]T2$A&1S)!54QV:7%1=V9K43!.;&)O;7(R+S$R1TM73#8P9%!Q05AV
M;W(V36]0<B8C>$$[2$U"6&E+='EK67-'8F1C3G%G6"]!3V-F<#!D3&\V;F$V
M:F-245A+96Y.871B3SAL>F)4,B]&3'1:8F@T259A-#E8:4DS4$U6<G9S1B8C
M>$$[96TK54Y":S!,>3EA86103CE:=E9$4S9H9#!P-C$S3WAL=4IF2#0U6%EJ
M,GA63V-69&ER<U998BMB4#A!>6EI9CAX,6XO=T%N,7I"-R8C>$$[4R]X969U
M8S-S-RLO:C<S;F5C43EM:&PP>E16=FTQ0F)31F(Y,3E.-W-2<4IM454K17E5
M-45B9$LU3&IL6$1E,V-X-$)D,75H=DU/<B8C>$$[4'!':C-';TI#3&@T94%7
M178V65EU-F]+=GAE;C)V-51K<U=0:FM">5E:8VY"16QJ<2ME.55K=%!85%1%
M:E@P6C)E5G9R.#!C8VM":R8C>$$[46=V0EI34G-V2TPO04@T1W K>E=G3U@K
M56ID8UA59GIE=&0X<BMZ-'1!,4UI3'(W+W="159N;'IZ6C5G,64V,&Q697EA
M3S57-FMV,28C>$$[:FAL3DER855X:5=+6#%M5#DT6%-I,%EF85!).4UC,FYH
M05,K<F%Q,TA8;U)85&9U-F))>%HU>DDU9&(K2'A:=FU!-7)S5E=R+W=!9"8C
M>$$[1%-F*S)R<&XO569$;60R6B]J15!E-%!A4#EX3#-094TW9#0Q:4@U;F%,
M<65P84IA5&%D0V)M9E1,>&)X<E)+97!,2#9-<T1R2%5G8R8C>$$[;%=F;4(S
M-#!'-7I#-U$P-7DT:D5C,TTP3V-9<V]K951Z23-$9VM.6C-Q34YI<E=6,')!
M*S1-44EZ:WHR9FXO;48V9V$O0B]/1%@Q:R8C>$$[+W=$3$QE9CE);'HO04Y5
M.&8U4'HO=T%Y4R]N.$@X.$\K<VXO04I:8GHO<$5U9CA!<6YJ+T%#9FXO;5-8
M."]G+VYH,S%K+SA!3$QE9B8C>$$[.4EL>B]W0E4X9C50>B]Z2DPK9G=F>G<W
M-GEF*U=7."\V4DQN+W%N:B]**V8K6DIF>BM$*V5(9E=4+WEY,VXO4TIC+SE5
M.&8U4'HO>B8C>$$[2DPK9G=F>G<W-GEF*U=7."]W0VM3-2\V<#0O>69N+VU3
M6#@O9R]N:$\O2G5K87!Q9FUF5$QQ3WIU24Y/,#96-VTU=3=I1U-"5TEI928C
M>$$[3DDT=E961V1I.&Q35D)504=P0G!M,3=*,$=31U1J;4]%0C%N86UU>'IX
M.$549'99<S92-34R2W5X5C)+=7A6,DMU>%8R2W5X5C)+=28C>$$[>%8R2W5X
M5FI8-6DV4&8V<C56=4ED4&I-,3="3$)D47=!9T=4-G9-<VIX:74S2FM69W13
M4&EP;5!Q.%)Y67!22$UH=C!U55DX:UI(;R8C>$$[6&M:,4\Q4FEK=VQG;%4P
M94=A1U=+4E0T36IQ<D$O35IX:W1$;4)R:$PQ.&1B:$EV:41V,')99C<X4#A!
M=TQF,'=F:S@S.# O2E U=B8C>$$[1B]/1'8P<EEF-SA0+T%T+U1(.&YM+VUN
M-4PK8GAF>F<W.4LR2"LO1"]W04,S.4UF>65B*V%F:W8U=D8O3T1V,')99C<X
M4#A!=TQF,"8C>$$[>"]*-78U<"M3+VTX6#@T3R]3=&@O=G<O.$,S.4UF>65B
M*V%F:W8U=D8O3T1V,')99C<X4"]!="]42#AN;2]M;C5,*V)X9GIG:G1#="8C
M>$$[8GI7.6,P>3,P-C-L;&EG=F)A-W4W<WAU<T559')/;'<S2U)G1DQV-F9&
M54(U5DYA8U%4;7@W33!/6'A226EH2'9D9C)L<F-F:$=)3B8C>$$[:W8X02\Y
M:ST\+WAM<$=);6<Z:6UA9V4^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@
M(" @(" @(" @(" \+W)D9CI!;'0^"B @(" @(" @(#PO>&UP.E1H=6UB;F%I
M;',^"B @(" @(" @(#QX;7!-33I);G-T86YC94E$/GAM<"YI:60Z8S9D-&0Q
M93@M8C0Q-"TU9C0S+6$P860M,#1B93(R,&)D8S!C/"]X;7!-33I);G-T86YC
M94E$/@H@(" @(" @(" \>&UP34TZ1&]C=6UE;G1)1#YX;7 N9&ED.F,V9#1D
M,64X+6(T,30M-68T,RUA,&%D+3 T8F4R,C!B9&,P8SPO>&UP34TZ1&]C=6UE
M;G1)1#X*(" @(" @(" @/'AM<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#YU=6ED
M.C5$,C X.3(T.3-"1D1",3$Y,31!.#4Y,$0S,34P.$,X/"]X;7!-33I/<FEG
M:6YA;$1O8W5M96YT240^"B @(" @(" @(#QX;7!-33I296YD:71I;VY#;&%S
M<SYD969A=6QT/"]X;7!-33I296YD:71I;VY#;&%S<SX*(" @(" @(" @/'AM
M<$U-.D1E<FEV961&<F]M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @/'-T4F5F.FEN<W1A;F-E240^>&UP+FEI9#IE9F$P-69C9"UE
M,V0X+6$X-#@M83!F-"UE9C0W,C)E,S1C-S<\+W-T4F5F.FEN<W1A;F-E240^
M"B @(" @(" @(" @(#QS=%)E9CID;V-U;65N=$E$/GAM<"YD:60Z969A,#5F
M8V0M93-D."UA.#0X+6$P9C0M968T-S(R93,T8S<W/"]S=%)E9CID;V-U;65N
M=$E$/@H@(" @(" @(" @(" \<W12968Z;W)I9VEN86Q$;V-U;65N=$E$/G5U
M:60Z-40R,#@Y,C0Y,T)&1$(Q,3DQ-$$X-3DP1#,Q-3 X0S@\+W-T4F5F.F]R
M:6=I;F%L1&]C=6UE;G1)1#X*(" @(" @(" @(" @/'-T4F5F.G)E;F1I=&EO
M;D-L87-S/F1E9F%U;'0\+W-T4F5F.G)E;F1I=&EO;D-L87-S/@H@(" @(" @
M(" \+WAM<$U-.D1E<FEV961&<F]M/@H@(" @(" @(" \>&UP34TZ2&ES=&]R
M>3X*(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z
M;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @
M(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z.#5#,SDR-D5&
M,C!#13@Q,4$W-C8X03DR-$0S1$)$03,\+W-T179T.FEN<W1A;F-E240^"B @
M(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,3@M,#(M,#A4,3 Z,30Z
M-#4M,#<Z,# \+W-T179T.G=H96X^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IS;V9T=V%R94%G96YT/D%D;V)E($EL;'5S=')A=&]R($-3-B H5VEN9&]W
M<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @(" @(#QS
M=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @(" @(" @
M(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y
M<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO
M;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%
M=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.F,V9#1D,64X+6(T,30M-68T,RUA,&%D
M+3 T8F4R,C!B9&,P8SPO<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @
M(" @(" @/'-T179T.G=H96X^,C Q."TP-BTP,U0Q,#HR.3HQ-"LP-3HS,#PO
M<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G-O9G1W87)E
M06=E;G0^061O8F4@26QL=7-T<F%T;W(@0T,@,C Q-2 H5VEN9&]W<RD\+W-T
M179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC
M:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @(" @(" @(#PO<F1F
M.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @(#PO>&UP34TZ
M2&ES=&]R>3X*(" @(" @(" @/&EL;'5S=')A=&]R.E-T87)T=7!0<F]F:6QE
M/E!R:6YT/"]I;&QU<W1R871O<CI3=&%R='5P4')O9FEL93X*(" @(" @(" @
M/'AM<%109SI(87-6:7-I8FQE3W9E<G!R:6YT/E1R=64\+WAM<%109SI(87-6
M:7-I8FQE3W9E<G!R:6YT/@H@(" @(" @(" \>&UP5%!G.DAA<U9I<VEB;&54
M<F%N<W!A<F5N8WD^1F%L<V4\+WAM<%109SI(87-6:7-I8FQE5')A;G-P87)E
M;F-Y/@H@(" @(" @(" \>&UP5%!G.DY086=E<SXQ/"]X;7!44&<Z3E!A9V5S
M/@H@(" @(" @(" \>&UP5%!G.DUA>%!A9V53:7IE(')D9CIP87)S951Y<&4]
M(E)E<V]U<F-E(CX*(" @(" @(" @(" @/'-T1&EM.G<^-C$R+C P,# P,#PO
M<W1$:6TZ=SX*(" @(" @(" @(" @/'-T1&EM.F@^-SDR+C P,# P,#PO<W1$
M:6TZ:#X*(" @(" @(" @(" @/'-T1&EM.G5N:70^4&]I;G1S/"]S=$1I;3IU
M;FET/@H@(" @(" @(" \+WAM<%109SI-87A086=E4VEZ93X*(" @(" @(" @
M/'AM<%109SI&;VYT<SX*(" @(" @(" @(" @/')D9CI"86<^"B @(" @(" @
M(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @
M(" @(" @(" @(" @(" \<W1&;G0Z9F]N=$YA;64^07)I86PM0F]L9$U4/"]S
M=$9N=#IF;VYT3F%M93X*(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1&
M86UI;'D^07)I86P\+W-T1FYT.F9O;G1&86UI;'D^"B @(" @(" @(" @(" @
M(" @(#QS=$9N=#IF;VYT1F%C93Y";VQD/"]S=$9N=#IF;VYT1F%C93X*(" @
M(" @(" @(" @(" @(" @/'-T1FYT.F9O;G14>7!E/D]P96X@5'EP93PO<W1&
M;G0Z9F]N=%1Y<&4^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IV97)S:6]N
M4W1R:6YG/E9E<G-I;VX@-2XR,CPO<W1&;G0Z=F5R<VEO;E-T<FEN9SX*(" @
M(" @(" @(" @(" @(" @/'-T1FYT.F-O;7!O<VET93Y&86QS93PO<W1&;G0Z
M8V]M<&]S:71E/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N=$9I;&5.
M86UE/F%R:6%L8F0N='1F/"]S=$9N=#IF;VYT1FEL94YA;64^"B @(" @(" @
M(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI"86<^"B @(" @
M(" @(#PO>&UP5%!G.D9O;G1S/@H@(" @(" @(" \>&UP5%!G.E!L871E3F%M
M97,^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" \<F1F
M.FQI/D-Y86X\+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:3Y-86=E
M;G1A/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D^665L;&]W/"]R
M9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D^0FQA8VL\+W)D9CIL:3X*
M(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @(" \+WAM<%109SI0;&%T
M94YA;65S/@H@(" @(" @(" \>&UP5%!G.E-W871C:$=R;W5P<SX*(" @(" @
M(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A
M<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \>&UP1SIG
M<F]U<$YA;64^1&5F875L="!3=V%T8V@@1W)O=7 \+WAM<$<Z9W)O=7!.86UE
M/@H@(" @(" @(" @(" @(" @(" \>&UP1SIG<F]U<%1Y<&4^,#PO>&UP1SIG
M<F]U<%1Y<&4^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @
M(" \+W)D9CI397$^"B @(" @(" @(#PO>&UP5%!G.E-W871C:$=R;W5P<SX*
M(" @(" @(" @/'!D9CI0<F]D=6-E<CY!9&]B92!01$8@;&EB<F%R>2 Q,"XP
M,3PO<&1F.E!R;V1U8V5R/@H@(" @(" @(" \17AT96YS:7-&;VYT4V5N<V4Z
M<VQU9SX*(" @(" @(" @(" @/')D9CI"86<^"B @(" @(" @(" @(" @(#QR
M9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @
M(" @(" \17AT96YS:7-&;VYT4V5N<V4Z1F]N=$MI;F0^3W!E;E1Y<&4@+2!4
M5#PO17AT96YS:7-&;VYT4V5N<V4Z1F]N=$MI;F0^"B @(" @(" @(" @(" @
M(" @(#Q%>'1E;G-I<T9O;G1396YS93I&86UI;'D^07)I86P\+T5X=&5N<VES
M1F]N=%-E;G-E.D9A;6EL>3X*(" @(" @(" @(" @(" @(" @/$5X=&5N<VES
M1F]N=%-E;G-E.D]U=&QI;F5&:6QE4VEZ93XP/"]%>'1E;G-I<T9O;G1396YS
M93I/=71L:6YE1FEL95-I>F4^"B @(" @(" @(" @(" @(" @(#Q%>'1E;G-I
M<T9O;G1396YS93I&;W5N9')Y/DUO;F]T>7!E(%1Y<&]G<F%P:'D\+T5X=&5N
M<VES1F]N=%-E;G-E.D9O=6YD<GD^"B @(" @(" @(" @(" @(" @(#Q%>'1E
M;G-I<T9O;G1396YS93I697)S:6]N/C4N,C \+T5X=&5N<VES1F]N=%-E;G-E
M.E9E<G-I;VX^"B @(" @(" @(" @(" @(" @(#Q%>'1E;G-I<T9O;G1396YS
M93I+97)N:6YG0VAE8VMS=6T^,#PO17AT96YS:7-&;VYT4V5N<V4Z2V5R;FEN
M9T-H96-K<W5M/@H@(" @(" @(" @(" @(" @(" \17AT96YS:7-&;VYT4V5N
M<V4Z1F]N=%-E;G-E7S$N,E]#:&5C:W-U;3XS-C,V,3<Y-S<T/"]%>'1E;G-I
M<T9O;G1396YS93I&;VYT4V5N<V5?,2XR7T-H96-K<W5M/@H@(" @(" @(" @
M(" @(" @(" \17AT96YS:7-&;VYT4V5N<V4Z0VAE8VMS=6T^,S8S-C$W.3<W
M-#PO17AT96YS:7-&;VYT4V5N<V4Z0VAE8VMS=6T^"B @(" @(" @(" @(" @
M(" @(#Q%>'1E;G-I<T9O;G1396YS93I0;W-T4V-R:7!T3F%M93Y!<FEA;"U"
M;VQD350\+T5X=&5N<VES1F]N=%-E;G-E.E!O<W138W)I<'1.86UE/@H@(" @
M(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z0F%G/@H@
M(" @(" @(" \+T5X=&5N<VES1F]N=%-E;G-E.G-L=6<^"B @(" @(#PO<F1F
M.D1E<V-R:7!T:6]N/@H@(" \+W)D9CI21$8^"CPO>#IX;7!M971A/@H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"CP_>'!A8VME="!E;F0](G<B/S[_VP!#  $!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0'_VP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1
M" %J 9 # 1$  A$! Q$!_\0 'P !  (" @,! 0            <(!@D%"@$"
M! ,+_\0 ;Q    8" 0 #!PP*"PH)!PT! @,$!08'  $("1$2$Q05&!DAE0H6
M%R(Q4UB7F-35UC(W.$%45E=9D]A187%T>):VN-+3UQHC)#5"=8&TM;<E)CE2
M8G9WD;,H,W*'E+&R)RHT0T5'56-E<Z+"T>'_Q  = 0$   <! 0
M     0(#! 4&!PD(_\0 8Q$   4" P,&!@H,"@<&!@,!  $" P0%$082(3%1
MT0<3%$%AH156<8&1L0@6%R(R4E.2TM0C-U1R=I.4E9:UT_ D,T)5<W6TP>'B
M-39B8W2"HB5#LK.V\31$9(.$I"9%1L+_V@ , P$  A$#$0 _ ._Q@ P 8 ,
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MK+9M:WU=:1WUO]O7@M5OJW_IUK?[NM9*OX)^;UD)D?"+S^HQ?W*(K!@ P 8
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M !@ P 8 , )BH;[9C+^]7C_92O)5_!/S>LA,CX1>?U&+_91%8, & # !@ P
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MIB$:1.#8M@(3)2@$$$AV+8A;"44   [$+8NH.NO>]^?(B4?3@ P 8 , & #
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M&=(W\/WC;\@V4_KC8SJW]Q< RM_%5\__ "AXAG2-_#]XV_(-E/ZXV,ZM_<7
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MM:Z][ZNL0M[$+>Q;WO= 5S.YF9[3._I%L," 8 , ,,L:P8?4E>SRU;#>2XY
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MC^03_D#V'Y#]0F1\-/WR?60V7<'ON*^(/\%V@/\ =/$LH"L+18 , & # !@
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MJ&^V8R_O5X_V4KR5?P3\WK(3(^$7G]1B_P!E$5@P 8 , & # !@ P 8 , &
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M;8[ITJ[38N7,ZE6R. B IGIF.0/3<,]N<$B@T*9E8S(]I:"Y&! , & # !@
MP 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 , &
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MC0P#"$8!@0*Q & 6M""((@N>]""+6];"+6]ZWK>MZWU9N60NWNX#4,ZM_<7
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M,^9UI];]2DYS,R:<4R@NI*&SRV+RJ(U'O-1C63F>&+# !@ P 8 , & # !@
MP 8 ;W/4]%Y3NN>?,>K!C>%I<.N6)S)))6+O@SP:)Y@47>)_&)(!+VNY!>FH
MZ/KFI*MT'1I;<_.B?KV$_P!KJ6,HC3U(7)4DN=B.-*;78LQ)>=0RXB^W(K.E
M1EL-2$GU#8,./N-U!+)&?-R$.$M-]+MH4XA5OC%E-)'N49=8_J&9QP=(# #J
ML]))]U;PK_ZS<J/Y ,V<']DU]J>J_P!947]8L#MWL<_MG4W^KZM_8'QAN>9X
M]$AB-@291"X'-IBD:CGU7$XC)),F9$VQ!4/"AB9EKH2U)Q  :()S@8E"D*V$
MLP6C#@[T >_:[R=%@(JM8I-+<D(B-U*IP(#DMRV2*B9*:CJD+N:2R,I<-Q5S
M(K).YEM&/JTU=-I53J+;"I3D"GS)J(R+DN2N+&<?2P@R)1DIY39-ILDSNHM#
MV#5BP\[K+3('17)I_P >WQ,?Q6C][I7:'Q29*4T*F\XL*'PIAK^4MC?/I&N=
M_!:B3Z1=0#8NXNBX]$)T!%T:=4O4?0\SD@H+CT=J!1<:0W$<HDS![D>IU&F-
MN56DTFB5.K3*U3WWJ/"9C=(;@<]<TU!B.TATHQU!U;;*.%1.5.M(:?<G5;",
MI"\"1,5-R*? J*VZ;4ZI5Z?3(E(G,,U:8[(YAR;S6BH+S[JVN?*"VAQU?,P#
MESR,G[Y%*Q0CJ]GFKUR%M6F%LM?8,N/0D,\(I)#:R!Z.AL5N20H4K^!2H5M:
MQN36*ZH1:)3%*!(%I:]."UK/)I@:C0ZEB!U.()-*BX+P[BEJFQ*LTAY<FJXK
M>PZ]$15*CAB$\Y#4VAJ0T^Y0X[I&I:F^>94RXJZI/*!C&JRH%$:.AQZG)Q=7
ML-NSY=+=6TF/3,,M5YJ2JFP,1RVFY9.+<8<9;K+[9DA"5\RZ3J2P]GYX<A 5
M<IL-^;JE4J)'P^EW(J)-;3&)6C(CTBA$^C<&/:'Q0KG"TR1M3^6^&/>PHP1Y
M2SF!*:0*'("<QT6Y23R/X)5B!%%A/8D0B!RFTS!%2?DU"GNKG0:M1YU63)B(
M:I328,B$<5,0C=.:B4DU25(8-:8[6-C<JF+RH:ZO+9P^M<SD[J&,*>S'@SVT
MQ)E,JL*F*CREN51TYD>64E4JS11'(YY8Y+>)"I#LBK>4?)>*V')8])5=,N[%
M +SXV5U(0,T&F#4YR%CY'(8\L[FU+%EC.J9B6P';T820XJ43T"6; 2>>W1\*
M<U,NP3/)]@*I46!,@-8IBS*SA''5;A*E5>F28\*7@9Z:WFD--T2.Y+:K/14J
M6PV[%.G74A#TPUI<:S+F.<:P*Q.B35X;D1:3BC!E'EE&I=1CORXN,FX;EF''
M*S(1%>I)R5)2\MN4F?[U:F(F12'<'DW-R[W-\LAC@(XA*6E]J_E0\U:X1V&+
M&EX9Y!2/:;V8UN.=9^^ODU/V?M4%TT^5; VQP?$19$1-D" MP"1EX')/A)B)
M0I=834J=)AXAY/(N(&9U5:DQI4+%=GI2'T1Z/$ATM&3FSC]$K]7D,Q'354DP
MWE-&K%SN4W$[TJLQ:2=/GQY5#QW)H3T.F.QY$>7A@S9C*94_5I<JI+-6<I!2
M:%2F'93:44Y4QDG<N35U,J*J"-MEH5G=EE6Q:)W%Z<6O)*T#9\ILUIM)7&(V
MTO[C)YRF==RU)7LA3/8QM;8) ?#1FG+G-F2-CF- J:]V%;I>+\33I&'Z]A.@
MX<P\GE I&'(%>.@4^@2</MU"=)AL0*2Y'\'.5N&Y$)+\@GDU0DI:CRG'V">;
M?*]H]2PKAZ$Q7*+B:M5^NJP/5*_,HI5R=6H]=<@PH\MZ=5&W_"#='F(DF;#'
M,KIIFMU^,VQ(-IQ@<,[<W+VC<7DA9#E0UERA16=!VC&I'"FB2IX7%3[>N2+U
MJX5Y-$@9R^K5RXAO?CW>-/:=W8UJI.WJU:^.B 6$D=U%Y)\'SJA"4N/C"@T]
MNO8QP_.@U63!75*BC#.&)]=9K=+<.DPVV6EO1$1IT1<:6TVMYIMF;=1J*WD<
MIN*8<*8E#V%:U.71<*5R%,ID>:FFP%8AQ%!HSM(J+9524XZZEF4N1"DHD1G'
M$-...PS)))/+93RUY!0>\5-3."&MG\NO7:CHY,5 &1-#@6,IMLXDUT>HFZRN
MXD8X?X$1+"D$882V"Q3I5(VAY;3'!N-4(4Q&,IW)M@NKX2;Q&P[782JW&Q;.
MI:#EN50Z&C#:5ICQ*C'I^&72J?2W6C>GRU3*(FGP9,5]++R4.K5?SL?XMIF*
M%T!YJC2DTB1AB'45E%13BK"\0*2I^3 ?GXC;.G=%;<)F%$*)653YD>0PIYE2
MVD)VF9\\CN@8 2WT6_W-TR_A5\OOYQ=AYZ^\G/VO\#_@AAK]201Y4\HG^ON-
M/PJQ!^MI@V.YN8TT, & &DNXN3G,IBEG2'V17=H5:CKC@N\Q=>BIJ85*)T%8
MT7!3$/M*6MRFS6R9LKU&W526Y/:=D4DL#R *SO @XON A[!(9G=5CV6TMV>D
M5B2@R;(R.[FER/8><TEI;785]=XL0HZ3.O27H]6145K+Z@B\LIZNK5O9)ZR@
MPBL+&NYKASC$XRZLJV5(YV^)6DV?P]LF3_'XNM01YQ?$I&P+=:,$".<MMCMU
MGN_?K_Q$O-G;:FYDI1)UN9)O<]ENH[7/4B'(NW2%P]QBS"=&8A+$#]8-C\LZ
M9B*IS QGHFB9\6XC9DA>7YZ(*<QB.C[X97"P+.4ET>M%M:C"X)D@=GB*AGTV
M:G<OW])!S9D9W,M"0H]NQ1I*W>*;NO2E6DEX5+90]5Q(:VY'J>#D;Y1U[,I6
MVP=TKJU"TAT&C\ZD+ Q1J5O2QB2E2&6HW-GC$I2M+DJB[NWNNTR08#T),,QV
MW'8C(]^N[]]^@GYHL]KW3SAH.U[IVVOINZRTN5A;I/TH-#BY+[XW*$3B0J)M
M(5%*)T=*:U*3 MTB*BE2EG%7 IIJW00TO0!QC=FB@VH7J;:];VW'0/\ A'(D
MLKD6^Q>>W40DYM67-V9K:_!WWV7Z[7O;48+8G2*=KD'7;3QH3M/+6HG6A;SF
MTK;*.D]:O"]-+ZND57F#4&3-]ES,R(B6:+2M<%3'DZQ6[NKL^QE.0W]A5WTG
M&K734K7T_O/R")-^],U70>9)>^(RT,E=5K[2+LM<1L^=(X_2606%*(#)3&JG
M3X5T=$TK-1NNV>02M.5RLM9_BLK;)"VN4J8$NC%;<D;&=4>%X4CB*@+BZ-:9
M_/()1*V8]3+867OV^<1YNUB/X5W2/6Q>\21E;0^WRZ;!8)KZ2Z"*+(]:3]3]
MI16 ^SK?G'/5T.JB"*(:*S>/K?,7V3I0,39+5L\VPN<>A#PX-C\.+@2Z6"(:
MC0=W+7FHF>VTMY7[2_?]]HAS1VN1D9DE*LNM[*M;JM<K[+]HQNA>==@<A.4E
M+Q)!54OJRD;9XIV'?T4W/RH,M>YZV)IQ6+77LP:ED0EDD4QY.LCDG=%3I$WT
MI"XI@N3*K'H\)H1%Q(S-6RQ9;ELUUV_X I!)09W(U$LDG:^FBKEJ17L9;2TV
MBHL@Y[<K-<C[AA%>S5LG#U7W,]HHV+\8&_C#.9".65">; A2.:.?(B.KR8M
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MCZCY'K:NC<+=28]M^C#(AJ^M)&H;'MUBKP_,,A4>N"1O2I"^MSHI3N#.I;C
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M;(B:,BR6*QD.NAFVC7PP 8 , -N_04_\IYQ]_P U7+_N3L+-<Q9_H"=Y8O\
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M])+9DQ'FY##J#*Y*;=:4I"B,CZE&.<RS%T& # !@ P 8 , & # !@!'5G6O
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M-(+8E"225]YVVF?69W,^LQNGRP%Z& &K:0?X^>_\[N7^N'9<"W'$8 , & #
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M71767P2G;M,8DV/$SXN21W,,A<^(*.<%$'VX*-[2P6QS"@"$VNJ$9@4+-(5
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MPC\^G4-@O1^3!5/.$?%B2JXJ_0W:BC:Y;DS/) H@.AZ!@C+>P('_ $6@5+2
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MDGO)1$9=9# OQ)44[2([S/\ 2-K01^11D25$?49&9'U#SET+<, & # !@ P
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M#QBK ]ZC_HU1\_QD+M[N 9S[._B'C%6![U'_ $:H^?XR%V]W ,Y]G?Q#QBK
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M"VF',H[RD38\6J(DT"%&K-+Q$Q0'*>_B)!0WE2J6W5F9$>:W2G)TMTXSA)5
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M^%7R^_G%V'GK[R<_:_P/^"&&OU)!'E3RB?Z^XT_"K$'ZVF#8[FYC30P 8 ,
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M039%EDHXC<>)>T1%B=:X2I&J#QD^$QU+&7^5PON4+5B),70]T/A[ZQJ9%%W
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M@RE16434R:_)02BZE$EPB/M%_<SXP 8 , & # !@ P 8 , & # !@ P 8 ,
M& # !@ P 8 , .OGQY+W!%ER<?)'O3?8=-WC<@GAG4_WA8XPZQ[1EUFUS.F]
M*9V33XW+(E+FXU X%A$1X02N;<8(M8A4)RO-7V2^&ZG2N4NI5J1'<\&8C8IT
MFGR\A\PMR%3(=.E1C<(LI2&G(G.J:,\Y,/L.6-*R,>B/L>,04ZI\G5-I,=]!
MU"@.SHT^*:BYY"9=0ESXT@F[YC8=;E<TEVV4WV'T$9&@R*RF?/([N& # !@
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MI]:#R7E'_E?YB_*QN'ZP8]RWDV\0L'_HW1_J8>Z9RA^.^*OS]5/K0>2\H_\
M*_S%^5C</U@Q[EO)MXA8/_1NC_4P]TSE#\=\5?GZJ?6@\EY1_P"5_F+\K&X?
MK!CW+>3;Q"P?^C='^IA[IG*'X[XJ_/U4^M#79TJG$J/\3^$UFWC3EW\L&N?Q
M=YKM$TK'GDS:S\WED2.?QV/.@3FQ:_[3GB,;7)4 H0]=9)H@&@]L#605R7<F
MY$9^T+!_Z-T?ZF*C7*5R@K<2E6-L56.]_P#M^J=23/[J[!:SCAT>56V5QXH6
MQI5<O+U1)Y_3%7361J$G*BW424]^E4'8GUX.3(R7_121.:X+U R4Q6M%D%B"
M4#VH=8+DNY-C(C]H6#]GBW1_J8E5RE\H1*418VQ58E&1?]OU3J/_ (H3/Y+R
MC_RO\Q?E8W#]8,C[EO)MXA8/_1NC_4Q+[IG*'X[XJ_/U4^M!Y+RC_P K_,7Y
M6-P_6#'N6\FWB%@_]&Z/]3#W3.4/QWQ5^?JI]:#R7E'_ )7^8ORL;A^L&/<M
MY-O$+!_Z-T?ZF'NF<H?COBK\_53ZT'DO*/\ RO\ ,7Y6-P_6#'N6\FWB%@_]
M&Z/]3#W3.4/QWQ5^?JI]:'/Q;HRN++)(6>2RM':MTJXZX)G:/M=\759ELQ)H
M=D9@3DKH5")5(U<.7+TQH ')5#PQN0TAX *$O<3RRS Y>D8-PEA]Y4FAX9H%
M'D*2:%2*92*?!?4@]J#>BQVG#0?6DU&D^LABJKC#%=<9*-6<25RJ1TJ)9,5"
MJ3IC)++8LFI#[B"474HDD?:-@F;*-<# !@ P 8 , & # !@ P 8 , & # !@
M P 8 , & # !@ P K'?G#V@>2:YD?[+B*XN<1A*:@C%F0:52FMK-8&\\W9YK
M8@G4%=V&0&LPSQF*-L+BL7L??)IJOP=WT/9V8^I4JEUF*N%5Z=!JD-PR-<2H
M1&)L99I^"I3$EMQI1IN>4U(,RZA?TZJU.CR4S*34)M-EH(R1)@27HDA)*MF)
M+S"VW$DJQ7LHKV*^P5X\EY1_Y7^8ORL;B^L&:G[EO)MXA8/_ $;H_P!3&T^Z
M9RA^.^*OS_5/K0>2\H_\K_,7Y6-P_6#'N6\FWB%@_P#1NC_4P]TSE#\=\5?G
MZJ?6@\EY1_Y7^8ORL;A^L&/<MY-O$+!_Z-T?ZF'NF<H?COBK\_53ZT'DO*/_
M "O\Q?E8W#]8,>Y;R;>(6#_T;H_U,/=,Y0_'?%7Y^JGUH/)>4?\ E?YB_*QN
M'ZP8]RWDV\0L'_HW1_J8>Z9RA^.^*OS]5/K0U"<QJ!#3'2'<"^.<&O7E0DK"
M_E2\JQT"_DA:;BZ+@$/>T)?@UX4/_?;5O2?75O:7>NL7MM^?)3Y+^3<E$7M"
MP?K;_P#S='W_ /!BLCE)Y03:<4>-L573:W_;]4Z__P H;>_)>4?^5_F+\K&X
M?K!DWN6\FWB%@_\ 1NC_ %,4?=,Y0_'?%7Y^JGUH/)>4?^5_F+\K&X?K!CW+
M>3;Q"P?^C='^IA[IG*'X[XJ_/U4^M!Y+RC_RO\Q?E8W#]8,>Y;R;>(6#_P!&
MZ/\ 4P]TSE#\=\5?GZJ?6@\EY1_Y7^8ORL;A^L&/<MY-O$+!_P"C='^IA[IG
M*'X[XJ_/U4^M!Y+NC=^8=N\Q!AWYA WRRN0.A!^^'8BY$ >M"UYM[ ,(M:W[
M46M]6\B7)=R;D9&6 L'W([E__&Z/M+_\,#Y2^4(R,CQOBK73_3]4+O*5<6GH
M7C%1_&=G>&FG801'3Y,L)<I?)G)U>Y9.9HY)RQ%)U\PG<M<GN6R0Y,$P[2$M
MU>%"1L H/*;$R(@T96]RAPH=/C-0X$6/"B,)R,18C+<>.RBYGD:992AMM-S,
M\J$D5S,[:F-0F39E0D.2Y\J1,E/*SO293SC[[JM"S..NJ4M:K$174HSL1:Z#
M>YD1 , -:MAQUQC4N>T3@086$YP6+$)X@[T4L0JE!AR=02/J[(]; /0#=!V+
MN1X3"1]0RQ:RN1W(N_RB@96.PPG(B 8 , & # #3%T^KTSMG1J6NW.+JW(%\
MBF52MC B6+4R96]N26QH\^*4#2F., <XK$[*TNCL>F2 ..*;6Y<N, %,D/-!
M*OX)^;UBM'+[*GLS&?9[TRU\YD7G%]^#;RT/_##B>Y,3HW/+<+CI32+2YK6I
MUZ/:QIKY@:75'WRE,-)[Z;'1$M;'!/V^[(G!(J1*0%*4YI8(IV%Y!37HM9'\
M97K,6FR(E# !@ P 8 , & # !@ P 8 , & # !@ P 8 , & # !@ P 8 , &
M # !@ P 8 , & # !@!UG>DVMJLXYTPG1K>'9Q&VH-<*D9\_-6N:<DF&$RN4
M;W'S)*>(7<68+D3L"LK:X9/<F\TAQ4=Q0*"%!E-7PR[+7]-Q<M),V7;$9WM;
MMMML.S%E06P8 , & # #GXQ'7&5/:!D;"##CUAY83!@#O8$J;MATH5J!:UO1
M9"<O>S!C%[O5H =",& (H&=BN!%<[#:#E 7 8 818LCKN%0R13BU7>)QR!0U
MI72*3R>;J6M!&HXS-Q E"]V=7)X$! WHTQ -C.4'F%AUK6M=>Q;#K8+7ZK^:
MXTZ+NF9X,'*C1P+C_P G+:C&Q[TV3Z!<4G B'2(C6^H+A'54\/A#NZ-9W5O:
M5S*90H5A>M')#SB!EF#T6H<IO)[2I;L&H8SP[&F,*-#\=54BJ=8<2=E-O);<
M7S3B3T4VO*M)Z*20W:!R:X\J<5J;!PC7'XKZ26R^5.?2V\VHKI<:4XA).-J+
M5+B,R%%L48^3RRG$GX&_,OY+D9^O&67NO\F'CSAS\XM"\]R7E'\3*Y^0KX!Y
M93B3\#?F7\ER,_7C'NO\F'CSAS\XM![DO*/XF5S\A7P#RRG$GX&_,OY+D9^O
M&/=?Y,/'G#GYQ:#W)>4?Q,KGY"O@'EE.)/P-^9?R7(S]>,>Z_P F'CSAS\XM
M![DO*/XF5S\A7P&GKIC;*XQ]*%3M:P^&U/S:HV?5-,G.41YX-XF-;Q%) @D+
M60U/K)(VQHL]G7DJ A1-R]E>R#5PFX:9>@$V'E/)BM"]U_DP\><.?G%H5&^2
MCE';._M+KNI6TA++K+L%I^CIYE<0^ O$.J^+^N/G.6V'""ER-P?Y\]\5(\@,
M?I%+Y,[2MZ,;&@ZR78;*QHUKN8@9VT3BM. A2E*%BI0O4JSC'NO\F'CSAS\X
MM"5?)/RCK4:CP97-?_HEGU6W"[WEE.)/P-^9?R7(S]>,>Z_R8>/.'/SBT)?<
MEY1_$RN?D*^ >64XD_ WYE_)<C/UXQ[K_)AX\X<_.+0>Y+RC^)E<_(5\ \LI
MQ)^!OS+^2Y&?KQCW7^3#QYPY^<6@]R7E'\3*Y^0KX!Y93B3\#?F7\ER,_7C'
MNO\ )AX\X<_.+0>Y+RC^)E<_(5\!E\%Z7W@#(I.S1JQ*_M;C>3(G)&RLDRY$
M<?%$$K90].!X$Z!L<[&;-R:'1(Y8</1:95-7B-MAIG]Z"NV<(!8\U1,>X+Q)
M)Z%0L4T.J3,IK*'$J,9R4I"2,U+1&YPGG$H(C-:D(4E!:J,AAZS@3%^'X_3*
MUAFKTZ)=*3E28#Z(R5*/*E*W\AM(4HS(DI6M*E?R2.QVV[ AL+, $PN*Q<8!
MA", P,;2( P"UH01!$%+O0@BUO6PBUO>MZWK>M]6;:-4L6XO00]O65#?Q2C/
MH%J^:X"Q;B]!!ZRH;^*49] M7S7 6+<7H(/65#?Q2C/H%J^:X"Q;B]!!ZRH;
M^*49] M7S7 6+<7H(/65#?Q2C/H%J^:X"Q;B]!!ZRH;^*49] M7S7 6+<7H(
M/65#?Q2C/H%J^:X"Q;B]!!ZRH;^*49] M7S7 6+<7H(/65#?Q2C/H%J^:X"Q
M;B]!!ZRH;^*49] M7S7 6+<7H(/65#?Q2C/H%J^:X"Q;B]!!ZRH;^*49] M7
MS7 6+<7H(/65#?Q2C/H%J^:X"Q;B]!!ZRH;^*49] M7S7 6+<7H(/65#?Q2C
M/H%J^:X"Q;B]!!ZRH;^*49] M7S7 6+<7H(/65#?Q2C/H%J^:X"Q;B]!!ZRH
M;^*49] M7S7 6+<7H(/65#?Q2C/H%J^:X"Q;B]!!ZRH;^*49] M7S7 6+<7H
M(/65#?Q2C/H%J^:X"Q;B]!"HO*#ESPCX<^MY)?TIAL8D\P*4'PZO(_ G:Q;0
MEB9*/9*A='ZTKN,RF;+VE.HUWJI?=,8&)&JV%.L<B#1:#EI-GP:;'7,J,R)
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MK<6?8&_-#:6Z(V"<QEBE+>^Q]$^)UC:QV,R,$N:U38<H4MCDE<4(RC]$HG=
MI,0NR<!7/L>85I&&UT9^BU7PA$K$.4^J.[,I$^73GX<UV(MI^90Y<RFR&Y"4
M(D,.,.DI!J=C/-I=CK-6\8+Q)5*^BK,U>F=!E4J5'9)]N)5(46>S*B-RD.,1
M:S&B5!A;"EK8>;>:,EY6Y#2S:D()-G<Y^-W&)I?NI.CV_AQ5E_(2T\^EO8J_
M;*F_@G5/UC1A\\^R9^UW%_":F_V*J#N"9Z)#X%# #0!TS_V_>CC_ ,^\J_\
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B<<==6XZM;CBU&I;CBC6M:E:J4I2C-2E*,S,S,S,S.YC_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
